PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Alessandrini, F; Menotti, L; Avitabile, E; Appolloni, I; Ceresa, D; Marubbi, D; Campadelli-Fiume, G; Malatesta, P				Alessandrini, Francesco; Menotti, Laura; Avitabile, Elisa; Appolloni, Irene; Ceresa, Davide; Marubbi, Daniela; Campadelli-Fiume, Gabriella; Malatesta, Paolo			Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model	ONCOGENE			English	Article							HERPES-SIMPLEX-VIRUS; PHASE-I; EXPRESSING IL-12; VIRAL THERAPY; STEM-CELLS; GLIOMA; GROWTH; MUTANT; EFFICACY; TUMOR	Oncolytic herpes simplex viruses are proving to be effective in clinical trials against a number of cancers. Here, R-115, an oncolytic herpes simplex virus retargeted to human erbB-2, fully virulent in its target cells, and armed with murine interleukin-12 was evaluated in a murine model of glioblastoma. We show that a single R-115 injection in established tumors resulted, in about 30% of animals, in the complete eradication of the tumor, otherwise invariably lethal. The treatment also induced a significant improvement in the overall median survival time of mice and a resistance to recurrence from the same neoplasia. Such a high degree of protection was unprecedented; it was not observed before following treatments with the commonly used, mutated/attenuated oncolytic viruses. This is the first study providing the evidence of benefits offered by a fully virulent, retargeted, and armed herpes simplex virus in the treatment of glioblastoma and paves the way for clinical translation.	[Alessandrini, Francesco; Appolloni, Irene; Ceresa, Davide; Marubbi, Daniela; Malatesta, Paolo] Univ Genoa, Dept Expt Med, Genoa, Italy; [Menotti, Laura; Avitabile, Elisa] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Marubbi, Daniela; Malatesta, Paolo] Osped Policlin San Martino, IRCCS Oncol, Genoa, Italy; [Campadelli-Fiume, Gabriella] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy	University of Genoa; University of Bologna; University of Bologna	Malatesta, P (corresponding author), Univ Genoa, Dept Expt Med, Genoa, Italy.; Malatesta, P (corresponding author), Osped Policlin San Martino, IRCCS Oncol, Genoa, Italy.	paolo.malatesta@unige.it	Ceresa, Davide/AAB-8518-2019; Appolloni, Irene/AAC-1629-2019; Malatesta, Paolo/J-3570-2012	Malatesta, Paolo/0000-0003-3045-3361; Alessandrini, Francesco/0000-0002-8450-848X; MENOTTI, LAURA/0000-0003-3277-5399; AVITABILE, ELISA/0000-0003-0328-2544	European Research Council (ERC) [340060]; Compagnia di San Paolo, Turin, Italy [2015.9834]; RFO (University of Bologna)	European Research Council (ERC)(European Research Council (ERC)); Compagnia di San Paolo, Turin, Italy(Compagnia di San Paolo); RFO (University of Bologna)	This work was supported by European Research Council (ERC) advanced grant number 340060 to GCF and PM; by Compagnia di San Paolo, Turin, Italy (grant no 2015.9834) "Terapie innovative per il glioblastoma" to PM; by RFO (University of Bologna) to LM and EA. We would like to thank Dr. Antonio Daga for providing human glioma-initiating cells.	Ahmed N, 2010, CLIN CANCER RES, V16, P474, DOI 10.1158/1078-0432.CCR-09-1322; Alessandrini F, 2016, J CANCER, V7, P1791, DOI 10.7150/jca.15564; Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Appolloni I, 2019, CANCER LETT, V442, P213, DOI 10.1016/j.canlet.2018.10.006; Banelli B, 2015, CELL CYCLE, V14, P3418, DOI 10.1080/15384101.2015.1090063; BYSTRYN JC, 1978, J IMMUNOL, V120, P96; Campadelli-Fiume G, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030063; Campadelli-Fiume G, 2011, REV MED VIROL, V21, P213, DOI 10.1002/rmv.691; Cheema TA, 2013, P NATL ACAD SCI USA, V110, P12006, DOI 10.1073/pnas.1307935110; Cody JJ, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/628697; Coffin RS, 2015, CURR OPIN VIROL, V13, P93, DOI 10.1016/j.coviro.2015.06.005; Delman KA, 2000, HUM GENE THER, V11, P2465, DOI 10.1089/10430340050207957; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Duhem-Tonnelle V, 2010, J NEUROPATH EXP NEUR, V69, P606, DOI 10.1097/NEN.0b013e3181e00579; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Favaro R, 2014, CANCER RES, V74, P1833, DOI 10.1158/0008-5472.CAN-13-1942; Gambini E, 2012, MOL THER, V20, P994, DOI 10.1038/mt.2012.22; Gulati S, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-18; Guo HY, 2015, MED MICROBIOL IMMUN, V204, P439, DOI 10.1007/s00430-015-0410-5; Hausler SFM, 2011, CANCER IMMUNOL IMMUN, V60, P1405, DOI 10.1007/s00262-011-1040-4; Hellums EK, 2005, NEURO-ONCOLOGY, V7, P213, DOI 10.1215/S1152851705000074; HIESIGER EM, 1993, J NEURO-ONCOL, V16, P93, DOI 10.1007/BF01324695; Hunter WD, 1999, J VIROL, V73, P6319, DOI 10.1128/JVI.73.8.6319-6326.1999; Kambara H, 2005, CANCER RES, V65, P2832, DOI 10.1158/0008-5472.CAN-04-3227; Kemeny N, 2006, HUM GENE THER, V17, P1214, DOI 10.1089/hum.2006.17.1214; Kimata H, 2006, ANN SURG ONCOL, V13, P1078, DOI 10.1245/ASO.2006.08.035; Korn T, 2017, NAT REV IMMUNOL, V17, P179, DOI 10.1038/nri.2016.144; Lambright ES, 2000, MOL THER, V2, P387, DOI 10.1006/mthe.2000.0133; Leoni V, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007209; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu BL, 2003, GENE THER, V10, P292, DOI 10.1038/sj.gt.3301885; Louis DN., 2016, WHO CLASSIFICATION T; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Markert JM, 2000, GENE THER, V7, P867, DOI 10.1038/sj.gt.3301205; MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332; Menotti L, 2008, J VIROL, V82, P10153, DOI 10.1128/JVI.01133-08; Menotti L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070352; Mineo JF, 2007, J NEURO-ONCOL, V85, P281, DOI 10.1007/s11060-007-9424-1; MINETA T, 1995, NAT MED, V1, P938, DOI 10.1038/nm0995-938; MOSMANN TR, 1989, ADV IMMUNOL, V46, P111, DOI 10.1016/S0065-2776(08)60652-5; Nabika Shinya, 2010, Hiroshima Journal of Medical Sciences, V59, P65; Nakao A, 2011, CANCER GENE THER, V18, P167, DOI 10.1038/cgt.2010.65; Parker JN, 2000, P NATL ACAD SCI USA, V97, P2208, DOI 10.1073/pnas.040557897; Patel DM, 2016, HUM GENE THER CL DEV, V27, P69, DOI 10.1089/humc.2016.031; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Reisoli E, 2012, CANCER GENE THER, V19, P788, DOI 10.1038/cgt.2012.62; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saha D, 2017, CANCER CELL, V32, P253, DOI 10.1016/j.ccell.2017.07.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Thomas ED, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0282-3; Toda M, 1998, J IMMUNOL, V160, P4457; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Uchida H, 2013, MOL THER, V21, P561, DOI 10.1038/mt.2012.211; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van der Woude LL, 2017, TRENDS CANCER, V3, P797, DOI 10.1016/j.trecan.2017.09.006; Veinalde R, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1285992	58	36	36	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2019	38	23					4467	4479		10.1038/s41388-019-0737-2	http://dx.doi.org/10.1038/s41388-019-0737-2			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB4KM	30755732	Green Submitted			2022-12-26	WOS:000470240300003
J	Rua, WM; Venkatachalam, G; Sobota, RM; Chen, LY; Wang, LC; Jacobson, A; Paramasivam, K; Surana, U				Rua, Weimei; Venkatachalam, Gireedhar; Sobota, Radoslaw Mikolaj; Chen, Liyan; Wang, Loo Chien; Jacobson, Alena; Paramasivam, Kathirvel; Surana, Uttam			Resistance to anti-microtubule drug-induced cell death is determined by regulation of BimEL expression	ONCOGENE			English	Article							APOPTOSIS RESISTANCE; DEGRADATION; PHOSPHORYLATION; TRANSCRIPTION; MECHANISMS; TAXOL; B1	Anti-microtubule agents are frequently used as anticancer therapeutics. Cell death induced by these agents is considered to be due to sustained mitotic arrest caused by the activation of spindle assembly checkpoint (SAC). However, some cell types are resistant to mitotic cell death. Cells' ability to escape mitotic arrest (mitotic slippage) is thought to be a major mechanism contributing to this resistance. Here, we show that resistance to cell death induced by anti-mitotic agents is not linked to cells' capacity to undergo mitotic slippage as generally believed but is dependent on the state of BimEL regulation during mitosis. While transcriptional repression of BimEL in the mitotic death-resistant cells involves polycomb repressive complex 2 (PRC2)-mediated histone trimethylation, the BimEL protein is destabilized by cullin 1/4A-beta TrCP-dependent degradation involving activation of cullin 1/4A by neddylation. These results imply that pharmacological augmentation of BimEL activity in anti-microtubule drug-resistant tumors may have important therapeutic implications.	[Rua, Weimei; Venkatachalam, Gireedhar; Sobota, Radoslaw Mikolaj; Chen, Liyan; Wang, Loo Chien; Jacobson, Alena; Paramasivam, Kathirvel; Surana, Uttam] ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore; [Surana, Uttam] ASTAR, Bioproc Technol Inst, Singapore, Singapore; [Surana, Uttam] Natl Univ Singapore, Dept Pharmacol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore	Surana, U (corresponding author), ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.; Surana, U (corresponding author), ASTAR, Bioproc Technol Inst, Singapore, Singapore.; Surana, U (corresponding author), Natl Univ Singapore, Dept Pharmacol, Singapore, Singapore.	mcbucs@imcb.a-star.edu.sg		Surana, Uttam/0000-0002-4785-6514; Ruan, Weimei/0000-0002-3459-5837; Sobota, Radoslaw/0000-0002-2455-2526; Chen, Liyan/0000-0002-5255-0296	Biomedical Research Council of A* STAR (Agency for Science, Technology and Research), Singapore	Biomedical Research Council of A* STAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR))	We thank the members of the US laboratory for helpful discussions and the mouse model unit (IMCB, Singapore) for kindly providing the PLKO. 1 vector and lentiviral packaging vectors. The U.S. lab is supported by the Biomedical Research Council of A* STAR (Agency for Science, Technology and Research), Singapore.	Bah N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.251; Balachandran RS, 2016, J CELL BIOL, V215, P151, DOI 10.1083/jcb.201601083; Brito DA, 2009, CELL MOTIL CYTOSKEL, V66, P437, DOI 10.1002/cm.20316; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Cheung CHA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012564; Chumduri C, 2015, J MOL MED, V93, P559, DOI 10.1007/s00109-014-1242-2; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Haschka MD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7891; He YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157558; Huang S, 2016, ONCOTARGET, V7, P38718, DOI 10.18632/oncotarget.9586; Jiang LY, 2011, J BIOL CHEM, V286, P6971, DOI 10.1074/jbc.M110.186494; KNEHR M, 1995, EXP CELL RES, V217, P546, DOI 10.1006/excr.1995.1121; Kutuk O, 2010, CELL DEATH DIFFER, V17, P1624, DOI 10.1038/cdd.2010.41; Li R, 2005, CELL DEATH DIFFER, V12, P292, DOI 10.1038/sj.cdd.4401554; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Pathan N, 2001, NEOPLASIA, V3, P550, DOI 10.1038/sj.neo.7900213; Ridinger-Saison M, 2013, CELL DEATH DIFFER, V20, P1268, DOI 10.1038/cdd.2013.88; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Sinnott R, 2014, CANCER RES, V74, P3857, DOI 10.1158/0008-5472.CAN-13-3398; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Thomas Y, 2010, CELL CYCLE, V9, P4338, DOI 10.4161/cc.9.21.13593; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wan LX, 2014, DEV CELL, V29, P377, DOI 10.1016/j.devcel.2014.04.022; Wu N, 2017, ONCOL LETT, V13, P1826, DOI 10.3892/ol.2017.5660; Xu ZJ, 2017, ONCOL LETT, V14, P345, DOI 10.3892/ol.2017.6149; Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200; Zhang WZ, 2008, J BIOL CHEM, V283, P16416, DOI 10.1074/jbc.M802360200	31	1	1	2	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4352	4365		10.1038/s41388-019-0727-4	http://dx.doi.org/10.1038/s41388-019-0727-4			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30770899				2022-12-26	WOS:000469339100011
J	Li, AQ; Sun, ZP; Liu, X; Yang, JS; Jin, F; Zhu, L; Jia, WH; De Vos, S; Van Stappen, G; Bossier, P; Yang, WJ				Li, An-Qi; Sun, Zhan-Peng; Liu, Xu; Yang, Jin-Shu; Jin, Feng; Zhu, Lin; Jia, Wen-Huan; De Vos, Stephanie; Van Stappen, Gilbert; Bossier, Peter; Yang, Wei-Jun			The chloride channel cystic fibrosis transmembrane conductance regulator (CFTR) controls cellular quiescence by hyperpolarizing the cell membrane during diapause in the crustacean Artemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis transmembrane conductance regulator (CFTR); cell proliferation; cell cycle; chloride channel; channel activation; Artemia; cellular quiescence; diapause embryo; dormancy maintenance; hyperpolarization	RIBOSOMAL S6 KINASE; CYCLE ARREST; ION CHANNELS; PROLIFERATION; PROTEIN; INHIBITION; CURRENTS; INVOLVEMENT; PROGRESSION; EMBRYOS	Cellular quiescence, a reversible state in which growth, proliferation, and other cellular activities are arrested, is important for self-renewal, differentiation, development, regeneration, and stress resistance. However, the physiological mechanisms underlying cellular quiescence remain largely unknown. In the present study, we used embryos of the crustacean Artemia in the diapause stage, in which these embryos remain quiescent for prolonged periods, as a model to explore the relationship between cell-membrane potential (V-mem) and quiescence. We found that V-mem is hyperpolarized and that the intracellular chloride concentration is high in diapause embryos, whereas V-mem is depolarized and intracellular chloride concentration is reduced in postdiapause embryos and during further embryonic development. We identified and characterized the chloride ion channel protein cystic fibrosis transmembrane conductance regulator (CFTR) of Artemia (Ar-CFTR) and found that its expression is silenced in quiescent cells of Artemia diapause embryos but remains constant in all other embryonic stages. Ar-CFTR knockdown and GlyH-101-mediated chemical inhibition of Ar-CFTR produced diapause embryos having a high V-mem and intracellular chloride concentration, whereas control Artemia embryos released free-swimming nauplius larvae. Transcriptome analysis of embryos at different developmental stages revealed that proliferation, differentiation, and metabolism are suppressed in diapause embryos and restored in postdiapause embryos. Combined with RNA sequencing (RNA-Seq) of GlyH-101-treated MCF-7 breast cancer cells, these analyses revealed that CFTR inhibition down-regulates the Wnt and Aurora Kinase A (AURKA) signaling pathways and up-regulates the p53 signaling pathway. Our findings provide insight into CFTR-mediated regulation of cellular quiescence and V-mem in the Artemia model.	[Li, An-Qi; Sun, Zhan-Peng; Liu, Xu; Yang, Jin-Shu; Jin, Feng; Zhu, Lin; Jia, Wen-Huan; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [De Vos, Stephanie; Van Stappen, Gilbert; Bossier, Peter] Univ Ghent, Dept Anim Prod, Lab Aquaculture, B-9000 Ghent, Belgium; [De Vos, Stephanie; Van Stappen, Gilbert; Bossier, Peter] Univ Ghent, Dept Anim Prod, Artemia Reference Ctr, B-9000 Ghent, Belgium; [Yang, Wei-Jun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266000, Shandong, Peoples R China	Zhejiang University; Ghent University; Ghent University; Qingdao National Laboratory for Marine Science & Technology	Yang, WJ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	w_jyang@zju.edu.cn	; Bossier, Peter/A-8118-2008	Yang, Wei-Jun/0000-0002-4591-8830; Bossier, Peter/0000-0002-6165-9111; Yang, Jin-Shu/0000-0001-6680-7737	National Major Research and Development Projects of China [2016YFA0101201]; National Natural Science Foundation of China [31730084, 41711530710]	National Major Research and Development Projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Major Research and Development Projects of China Grant 2016YFA0101201 and National Natural Science Foundation of China Grants 31730084 and 41711530710. The authors declare that they have no conflicts of interest with the contents of this article.	Abatzopoulos T. J., 2002, ARTEMIA BASIC APPL B, P129; Barman PP, 2011, BIOCHEM BIOPH RES CO, V408, P12, DOI 10.1016/j.bbrc.2011.03.089; Baylie RL, 2010, J PHYSIOL PHARMACOL, V61, P543; BINGGELI R, 1986, J THEOR BIOL, V123, P377, DOI 10.1016/S0022-5193(86)80209-0; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Bordey A, 1997, J NEUROPHYSIOL, V78, P461, DOI 10.1152/jn.1997.78.1.461; BRODWICK MS, 1983, SCIENCE, V222, P1115, DOI 10.1126/science.222.4628.1115; Brown JA, 2017, CELL STEM CELL, V21, P650, DOI 10.1016/j.stem.2017.10.001; Browne R. A., 1991, ARTEMIA BIOL, P37; Chen DF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0239-4; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Chittajallu R, 2002, P NATL ACAD SCI USA, V99, P2350, DOI 10.1073/pnas.042698399; CLEGG JS, 1995, EXP CELL RES, V219, P1, DOI 10.1006/excr.1995.1197; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dai L, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00453-16; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Goddard ET, 2018, NAT CELL BIOL, V20, P1240, DOI 10.1038/s41556-018-0214-0; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; INAGAKI C, 1992, FOLIA PHARMACOL JPN, V99, P307, DOI 10.1254/fpj.99.307; Kito H, 2014, J PHARMACOL SCI, V125, P227, DOI 10.1254/jphs.14002SC; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Konig J, 2001, EMBO REP, V2, P1047, DOI 10.1093/embo-reports/kve232; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Li R, 2012, J BIOL CHEM, V287, P15923, DOI 10.1074/jbc.M111.312413; Liang P, 1999, DEV BIOL, V207, P445, DOI 10.1006/dbio.1998.9138; Liang WB, 2009, HYPERTENSION, V54, P286, DOI 10.1161/HYPERTENSIONAHA.109.130138; Lirakis M, 2018, J INSECT PHYSIOL, V107, P175, DOI 10.1016/j.jinsphys.2018.04.006; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lubzens E, 2010, TOP CURR GENET, V21, P1, DOI 10.1007/978-3-642-12422-8_1; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Nakamura-Ishizu A, 2014, DEVELOPMENT, V141, P4656, DOI 10.1242/dev.106575; NOVAK I, 1992, PFLUG ARCH EUR J PHY, V422, P151, DOI 10.1007/BF00370414; Petrik D, 2018, CELL STEM CELL, V22, P865, DOI 10.1016/j.stem.2018.04.016; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; RANSOM CB, 1995, J NEUROPHYSIOL, V73, P333, DOI 10.1152/jn.1995.73.1.333; Reddy MM, 2005, J MEMBRANE BIOL, V207, P23, DOI 10.1007/s00232-005-0798-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; Scriver C.R., 1995, METABOLIC MOL BASES; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Stuart JA, 2006, COMP BIOCHEM PHYS A, V143, P12, DOI 10.1016/j.cbpa.2005.11.002; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; Tang YB, 2008, CELL PROLIFERAT, V41, P775, DOI 10.1111/j.1365-2184.2008.00551.x; Valcourt JR, 2012, CELL CYCLE, V11, P1680, DOI 10.4161/cc.19879; Wang W, 2014, SCI WORLD J, DOI 10.1155/2014/785140; Wei L, 1999, PFLUG ARCH EUR J PHY, V438, P635, DOI 10.1007/s004240051087; WOODFORK KA, 1995, J CELL PHYSIOL, V162, P163, DOI 10.1002/jcp.1041620202; Wright SH, 2004, ADV PHYSIOL EDUC, V28, P139, DOI 10.1152/advan.00029.2004; Yang F, 2012, CELL STRESS CHAPERON, V17, P577, DOI 10.1007/s12192-012-0333-7; Yang M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00185; Yao G, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0074; Yasuda T, 2008, MOL CELL NEUROSCI, V37, P284, DOI 10.1016/j.mcn.2007.10.003; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; Zheng YJ, 2003, J CELL PHYSIOL, V194, P376, DOI 10.1002/jcp.10218; Zhou R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068374; Zhu L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24460-6	62	2	2	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6598	6611		10.1074/jbc.RA118.005900	http://dx.doi.org/10.1074/jbc.RA118.005900			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30765604	Green Published, hybrid			2022-12-26	WOS:000468402000033
J	Cooke, AC; Nello, AV; Ernst, RK; Schertzer, JW				Cooke, Adam C.; Nello, Alexander V.; Ernst, Robert K.; Schertzer, Jeffrey W.			Analysis of Pseudomonas aeruginosa biofilm membrane vesicles supports multiple mechanisms of biogenesis	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; OUTER-MEMBRANE; PROTEOMIC ANALYSIS; DNA; RELEASE; PA14; COLONIZATION; ACTIVATION; STRAINS; SIGNALS	Outer Membrane Vesicles (OMVs) are ubiquitous in bacterial environments and enable interactions within and between species. OMVs are observed in lab-grown and environmental biofilms, but our understanding of their function comes primarily from planktonic studies. Planktonic OMVs assist in toxin delivery, cell-cell communication, horizontal gene transfer, small RNA trafficking, and immune system evasion. Previous studies reported differences in size and proteomic cargo between planktonic and agar plate biofilm OMVs, suggesting possible differences in function between OMV types. In Pseudomonas aeruginosa interstitial biofilms, extracellular vesicles were reported to arise through cell lysis, in contrast to planktonic OMV biogenesis that involves the Pseudomonas Quinolone Signal (PQS) without appreciable autolysis. Differences in biogenesis mechanism could provide a rationale for observed differences in OMV characteristics between systems. Using nanoparticle tracking, we found that P. aeruginosa PAO1 planktonic and biofilm OMVs had similar characteristics. However, P. aeruginosa PA14 OMVs were smaller, with planktonic OMVs also being smaller than their biofilm counterparts. Large differences in Staphylococcus killing ability were measured between OMVs from different strains, and a smaller within-strain difference was recorded between PA14 planktonic and biofilm OMVs. Across all conditions, the predatory ability of OMVs negatively correlated with their size. To address biogenesis mechanism, we analyzed vesicles from wild type and pqsA mutant biofilms. This showed that PQS is required for physiological-scale production of biofilm OMVs, and time-course analysis confirmed that PQS production precedes OMV production as it does in planktonic cultures. However, a small sub-population of vesicles was detected in pqsA mutant biofilms whose size distribution more resembled sonicated cell debris than wild type OMVs. These results support the idea that, while a small and unique population of vesicles in P. aeruginosa biofilms may result from cell lysis, the PQS-induced mechanism is required to generate the majority of OMVs produced by wild type communities.	[Cooke, Adam C.; Nello, Alexander V.; Schertzer, Jeffrey W.] SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA; [Cooke, Adam C.; Nello, Alexander V.; Schertzer, Jeffrey W.] SUNY Binghamton, Binghamton Biofilm Res Ctr, Binghamton, NY 13902 USA; [Ernst, Robert K.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University System of Maryland; University of Maryland Baltimore	Schertzer, JW (corresponding author), SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA.; Schertzer, JW (corresponding author), SUNY Binghamton, Binghamton Biofilm Res Ctr, Binghamton, NY 13902 USA.	jschertz@binghamton.edu		Ernst, Robert/0000-0001-5016-8694; Cooke, Adam/0000-0002-1458-7178	National Science Foundation [DBI 1429448]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the National Science Foundation (www.nsf.gov), DBI 1429448 to J.W.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altindis E, 2014, P NATL ACAD SCI USA, V111, pE1548, DOI 10.1073/pnas.1403683111; Baumgarten T, 2012, APPL ENVIRON MICROB, V78, P6217, DOI 10.1128/AEM.01525-12; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Choi DS, 2011, PROTEOMICS, V11, P3424, DOI 10.1002/pmic.201000212; Choi JW, 2017, J DENT RES, V96, P458, DOI 10.1177/0022034516685071; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Ciofu O, 2000, J ANTIMICROB CHEMOTH, V45, P9, DOI 10.1093/jac/45.1.9; Conrad A, 2003, LIPIDS, V38, P1093, DOI 10.1007/s11745-006-1165-y; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Couto N, 2015, J PROTEOME RES, V14, P4207, DOI 10.1021/acs.jproteome.5b00312; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Erdbrugger U, 2016, CYTOM PART A, V89A, P123, DOI 10.1002/cyto.a.22795; Evans AGL, 2012, MICROBIOL-SGM, V158, P2742, DOI 10.1099/mic.0.060343-0; FISCHER W, 1983, EUR J BIOCHEM, V133, P523, DOI 10.1111/j.1432-1033.1983.tb07495.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Florez C, 2017, MBIO, V8, DOI 10.1128/mBio.01034-17; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frolund B, 1996, WATER RES, V30, P1749, DOI 10.1016/0043-1354(95)00323-1; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; GANKEMA H, 1980, INFECT IMMUN, V29, P704; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; HALHOUL N, 1975, ARCH ORAL BIOL, V20, P115, DOI 10.1016/0003-9969(75)90164-8; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; HOEKSTRA D, 1976, BIOCHIM BIOPHYS ACTA, V455, P889, DOI 10.1016/0005-2736(76)90058-4; Horspool AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28042-4; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Ionescu M, 2014, P NATL ACAD SCI USA, V111, pE3910, DOI 10.1073/pnas.1414944111; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kadurugamuwa JL, 1996, J BACTERIOL, V178, P2767, DOI 10.1128/jb.178.10.2767-2774.1996; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; KASAHARA M, 1974, J BIOCHEM-TOKYO, V76, P959; KATSUI N, 1982, J BACTERIOL, V151, P1523, DOI 10.1128/JB.151.3.1523-1531.1982; Koeppen K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005672; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kukavica-Ibrulj I, 2008, J BACTERIOL, V190, P2804, DOI 10.1128/JB.01572-07; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Li ZS, 1998, J BACTERIOL, V180, P5478, DOI 10.1128/JB.180.20.5478-5483.1998; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; Manning AJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-258; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mashburn-Warren L, 2008, MOL MICROBIOL, V69, P491, DOI 10.1111/j.1365-2958.2008.06302.x; Mashburn-Warren L, 2009, J BACTERIOL, V191, P3411, DOI 10.1128/JB.00052-09; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; McMahon KJ, 2012, J BACTERIOL, V194, P3241, DOI 10.1128/JB.00016-12; Murphy K, 2014, J BACTERIOL, V196, P1306, DOI 10.1128/JB.01463-13; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Palmer GC, 2011, METHODS MOL BIOL, V692, P207, DOI 10.1007/978-1-60761-971-0_15; Park AJ, 2015, J PROTEOME RES, V14, P4524, DOI 10.1021/acs.jproteome.5b00262; Park AJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00464; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; PETTIT RK, 1992, MOL MICROBIOL, V6, P723, DOI 10.1111/j.1365-2958.1992.tb01521.x; Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; Roier S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10515; Rumbo C, 2011, ANTIMICROB AGENTS CH, V55, P3084, DOI 10.1128/AAC.00929-10; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schaar V, 2011, ANTIMICROB AGENTS CH, V55, P3845, DOI 10.1128/AAC.01772-10; Schertzer JW, 2012, MBIO, V3, DOI 10.1128/mBio.00297-11; Schertzer JW, 2010, MOL MICROBIOL, V77, P1527, DOI 10.1111/j.1365-2958.2010.07303.x; Schooling SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06; Schooling SR, 2009, J BACTERIOL, V191, P4097, DOI 10.1128/JB.00717-08; Schwechheimer C, 2015, NAT REV MICROBIOL, V13, P605, DOI 10.1038/nrmicro3525; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Tashiro Y, 2010, APPL ENVIRON MICROB, V76, P3732, DOI 10.1128/AEM.02794-09; Toyofuku M, 2019, NAT REV MICROBIOL, V17, P13, DOI 10.1038/s41579-018-0112-2; Toyofuku M, 2012, J PROTEOME RES, V11, P4906, DOI 10.1021/pr300395j; Turnbull L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11220; Vasilyeva NV, 2008, FEBS J, V275, P3827, DOI 10.1111/j.1742-4658.2008.06530.x; Vella BD, 2015, PSEUDOMONAS, VVII, P217, DOI DOI 10.1007/978-94-017-9555-5_9; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yonezawa H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-197	79	39	41	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212275	10.1371/journal.pone.0212275	http://dx.doi.org/10.1371/journal.pone.0212275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763382	gold, Green Submitted, Green Published			2022-12-26	WOS:000458763900058
J	Papanikolaou, NE; Kavallieratos, NG; Kondakis, M; Boukouvala, MC; Nika, EP; Demiris, N				Papanikolaou, Nikos E.; Kavallieratos, Nickolas G.; Kondakis, Marios; Boukouvala, Maria C.; Nika, Erifili P.; Demiris, Nikos			Elucidating fitness components of the invasive dermestid beetle Trogoderma granarium combining deterministic and stochastic demography	PLOS ONE			English	Article							EVERTS COLEOPTERA-DERMESTIDAE; PROPYLEA-QUATUORDECIMPUNCTATA COLEOPTERA; TEMPERATURE-DEPENDENT DEVELOPMENT; TRIBOLIUM-CONFUSUM; EFFICACY; INSECTICIDES; PARAMETERS; REGRESSION; SURVIVAL; ADULTS	The invasive dermestid khapra beetle, Trogoderma granarium, is an important pest of stored products that is subject to strict phytosanitary measures. In this study, we conducted a demographic analysis of this species at 30, 35 and 40 degrees C, combining deterministic and stochastic approaches. The net reproductive rate, the intrinsic rate of increase, the finite rate of increase and the doubling time did not differ significantly between 30 and 35 degrees C, while at 40 degrees C we detected negative values of the intrinsic rate of increase and the doubling time. The Briere model fit the data well with respect to the intrinsic rate of increase. Females of roughly 63, 42 and 21 days old reached their maximum reproductive potential at 30, 35 and 40 degrees C, respectively. The stochastic models of this study allowed for checking model fit and the characterization of the most suitable distribution for each component of the process. We expect these results to have bearing on the management of T. granarium since they could be combined with models related to international trade and climatic change, alerting specialists towards early detection strategies against this species.	[Papanikolaou, Nikos E.; Kavallieratos, Nickolas G.; Boukouvala, Maria C.] Agr Univ Athens, Dept Crop Sci, Lab Agr Zool & Entomol, Athens, Greece; [Papanikolaou, Nikos E.] Greek Minist Rural Dev & Food, Directorate Plant Produce Protect, Athens, Greece; [Papanikolaou, Nikos E.; Nika, Erifili P.] Benaki Phytopathol Inst, Athens, Greece; [Kondakis, Marios; Demiris, Nikos] Athens Univ Econ & Business, Dept Stat, Athens, Greece; [Boukouvala, Maria C.] Univ Ioannina, Dept Chem, Lab Organ Chem, Ioannina, Greece; [Demiris, Nikos] Univ Cambridge, Sch Clin Med, Cambridge Clin Trials Unit, Coton House,Cambridge Biomed Res Campus, Cambridge, England	Agricultural University of Athens; Athens University of Economics & Business; University of Ioannina; University of Cambridge	Papanikolaou, NE (corresponding author), Agr Univ Athens, Dept Crop Sci, Lab Agr Zool & Entomol, Athens, Greece.; Papanikolaou, NE (corresponding author), Greek Minist Rural Dev & Food, Directorate Plant Produce Protect, Athens, Greece.; Papanikolaou, NE (corresponding author), Benaki Phytopathol Inst, Athens, Greece.	nepapanikolaou@yahoo.gr	Boukouvala, Maria/AAD-2553-2022; Nika, Erifili P./AAC-1228-2022; Kavallieratos, Nickolas G./AAB-7500-2022	Kavallieratos, Nickolas G./0000-0001-5851-5013; Kavallieratos, Nickolas/0000-0003-4342-1289; Nika, Erifili P./0000-0003-2718-7816	Special Account for Research Funds (Agricultural University of Athens); Foundation for Education and European Culture; Athens University of Economics and Business' Research Centre "Action for Extroversion and Excellence"	Special Account for Research Funds (Agricultural University of Athens); Foundation for Education and European Culture; Athens University of Economics and Business' Research Centre "Action for Extroversion and Excellence"	The financial and/or structural support provided by the Special Account for Research Funds (Agricultural University of Athens) is greatly appreciated. N.E.P. gratefully acknowledges financial support from the Foundation for Education and European Culture under a postdoctoral research grant. In addition, N.D. gratefully acknowledges financial support from the Athens University of Economics and Business' Research Centre "Action for Extroversion and Excellence". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken AD, 1975, USDA TECHNICAL B, V31; [Anonymous], 2010, R LANG ENV STAT COMP; Arthur FH, 2018, J ECON ENTOMOL, V111, P612, DOI 10.1093/jee/toy040; Athanassiou CG, 2015, J STORED PROD RES, V62, P101, DOI 10.1016/j.jspr.2015.04.003; Athanassiou CG, 2014, J PEST SCI, V87, P469, DOI 10.1007/s10340-014-0563-9; BANKS HJ, 1977, J STORED PROD RES, V13, P183, DOI 10.1016/0022-474X(77)90028-5; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; Boukouvala MC, 2017, J PEST SCI, V90, P569, DOI 10.1007/s10340-016-0808-x; Bradshaw CJA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12986; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Burg S.P., 2014, HYPOBARIC STORAGE FO; Burges HD, 2008, J STORED PROD RES, V44, P32, DOI 10.1016/j.jspr.2005.12.003; CAREY JR, 1985, J ECON ENTOMOL, V78, P523, DOI 10.1093/jee/78.3.523; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; Carey JR., 1993, APPL DEMOGRAPHY BIOL; Colunga-Garcia M., 2013, NeoBiota, P103; Compagnoni A, 2016, ECOL MONOGR, V86, P480, DOI 10.1002/ecm.1228; Cox D. R., 1984, ANAL SURVIVAL DATA; Cuperus G., 2012, STORED PRODUCT PROTE, P297; Dixon AFG, 2009, FUNCT ECOL, V23, P257, DOI 10.1111/j.1365-2435.2008.01489.x; Douma JC, 2016, ECOL MODEL, V339, P58, DOI 10.1016/j.ecolmodel.2016.08.009; Engen S, 2009, AM NAT, V174, P795, DOI 10.1086/647930; EPPO, 1981, Bulletin OEPP, V11, P1; EPPO (European and Mediterranean Plant Protection Organization), 2013, EPPO B, V43, P431, DOI DOI 10.1111/EPP.12080; European and Mediterranean Plant Protection Organization (EPPO), 2018, 2EPPO GLOB DAT BAS; Gelman A., 2021, BAYESIAN DATA ANAL; Ghimire MN, 2017, J STORED PROD RES, V72, P75, DOI 10.1016/j.jspr.2017.02.006; Ghosh SK, 2006, J STAT PLAN INFER, V136, P1360, DOI 10.1016/j.jspi.2004.10.008; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Hill DS, 2002, 2002 PESTS STORAGE F; HOWE R. W., 1965, Journal of Stored Products Research, V1, P177, DOI 10.1016/0022-474X(65)90018-4; Huey RB, 2001, AM NAT, V158, P204, DOI 10.1086/321314; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; Jonzen N, 2010, J ANIM ECOL, V79, P109, DOI 10.1111/j.1365-2656.2009.01601.x; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kavallieratos NG, 2018, J STORED PROD RES, V78, P50, DOI 10.1016/j.jspr.2018.05.011; Kavallieratos NG, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01837; Kavallieratos NG, 2017, J STORED PROD RES, V71, P81, DOI 10.1016/j.jspr.2016.12.003; Kavallieratos NG, 2011, J FOOD PROTECT, V74, P1288, DOI 10.4315/0362-028X.JFP-10-575; Kontodimas DC, 2008, EUR J ENTOMOL, V105, P427, DOI 10.14411/eje.2008.054; Kriticos Darren J., 2013, NeoBiota, V18, P1; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; LINDGREN DAVID L., 1955, HILGARDIA, V24, P1; LINDGREN DL, 1959, J ECON ENTOMOL, V52, P312, DOI 10.1093/jee/52.2.312; Lowe S., 2000, ENCY BIOL INVASIONS; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Nedved O., 2009, ENCY INSECTS, P990, DOI [10.1016/B978-0-12-374144-8.00261-7, DOI 10.1016/B978-0-12-374144-8.00261-7]; Neven LG, 2000, POSTHARVEST BIOL TEC, V21, P103, DOI 10.1016/S0925-5214(00)00169-1; Norris A.L., 2012, SOLAR RAD, P195; Orr HA, 2009, NAT REV GENET, V10, P531, DOI 10.1038/nrg2603; Papanikolaou NE, 2014, ANN ENTOMOL SOC AM, V107, P158, DOI 10.1603/AN13130; Papanikolaou NE, 2013, ANN ENTOMOL SOC AM, V106, P228, DOI 10.1603/AN12104; Peacock E.R., 1993, ADULTS LARVAE HIDE L; Polanco Andrea M., 2011, Insects, V2, P173, DOI 10.3390/insects2020173; Rahman Khan A., 1945, INDIAN JOUR AGRIC SCI, V15, P85; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Stark JD, 2016, PEERJ, V4, DOI 10.7717/peerj.2067; Van der Have T. M., 2008, THESIS; Yemshanov D, 2014, ECOL ECON, V104, P61, DOI 10.1016/j.ecolecon.2014.04.024; Zeki E, 2015, EUR J ENTOMOL, V112, P193, DOI 10.14411/eje.2015.004	61	23	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212182	10.1371/journal.pone.0212182	http://dx.doi.org/10.1371/journal.pone.0212182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763344	Green Published, gold, Green Submitted			2022-12-26	WOS:000458763900049
J	Steinmark, IE; James, AL; Chung, PH; Morton, PE; Parsons, M; Dreiss, CA; Lorenz, CD; Yahioglu, G; Suhling, K				Steinmark, Ida Emilie; James, Arjuna L.; Chung, Pei-Hua; Morton, Penny E.; Parsons, Maddy; Dreiss, Cecile A.; Lorenz, Christian D.; Yahioglu, Gokhan; Suhling, Klaus			Targeted fluorescence lifetime probes reveal responsive organelle viscosity and membrane fluidity	PLOS ONE			English	Article							MOLECULAR ROTOR; CELL; DYNAMICS; DIFFUSION; RECOVERY; MITOCHONDRIA; GUI	The only way to visually observe cellular viscosity, which can greatly influence biological reactions and has been linked to several human diseases, is through viscosity imaging. Imaging cellular viscosity has allowed the mapping of viscosity in cells, and the next frontier is targeted viscosity imaging of organelles and their microenvironments. Here we present a fluorescent molecular rotor/FLIM framework to image both organellar viscosity and membrane fluidity, using a combination of chemical targeting and organelle extraction. For demonstration, we image matrix viscosity and membrane fluidity of mitochondria, which have been linked to human diseases, including Alzheimer's Disease and Leigh's syndrome. We find that both are highly dynamic and responsive to small environmental and physiological changes, even under non-pathological conditions. This shows that neither viscosity nor fluidity can be assumed to be fixed and underlines the need for single-cell, and now even single-organelle, imaging.	[Steinmark, Ida Emilie; James, Arjuna L.; Chung, Pei-Hua; Lorenz, Christian D.; Suhling, Klaus] Kings Coll London, Dept Phys, London, England; [Morton, Penny E.; Parsons, Maddy] Kings Coll London, Randall Ctr Cell & Mol Biophys, London, England; [Dreiss, Cecile A.] Kings Coll London, Inst Pharmaceut Sci, London, England; [Yahioglu, Gokhan] Imperial Coll London, Dept Chem, London, England; [Yahioglu, Gokhan] Antikor Biopharma, Stevenage, Herts, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Imperial College London	Suhling, K (corresponding author), Kings Coll London, Dept Phys, London, England.; Yahioglu, G (corresponding author), Imperial Coll London, Dept Chem, London, England.; Yahioglu, G (corresponding author), Antikor Biopharma, Stevenage, Herts, England.	ida.steinmark@kcl.ac.uk; g.yahioglu@antikor.co.uk; klaus.suhling@kcl.ac.uk	; Lorenz, Christian/A-6996-2017; Parsons, Maddy/B-2203-2013	suhling, klaus/0000-0001-8797-5430; Steinmark, Ida Emilie/0000-0002-7024-8736; Lorenz, Christian/0000-0003-1028-4804; Parsons, Maddy/0000-0002-2021-8379	King's College London through a LIDo PhD studentship; EPSRC [EP/L000202, EP/P020194/1]; BBSRC [BB/R004803/1] Funding Source: UKRI	King's College London through a LIDo PhD studentship; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the King's College London through a LIDo PhD studentship for author IES, and by EPSRC (EP/L000202 and EP/P020194/1) to author CDL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Budin I, 2018, SCIENCE, V362, P1186, DOI 10.1126/science.aat7925; Carisey A, 2011, METHODS MOL BIOL, V769, P387, DOI 10.1007/978-1-61779-207-6_26; Chambers JE, 2018, ACS NANO, V12, P4398, DOI 10.1021/acsnano.8b00177; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Cheng NS, 2008, IND ENG CHEM RES, V47, P3285, DOI 10.1021/ie071349z; Chung PH, 2012, ADV FLUORESCENCE LIF; Clayton David A, 2014, Cold Spring Harb Protoc, V2014, DOI 10.1101/pdb.prot080010; Dean KM, 2014, NAT CHEM BIOL, V10, P512, DOI [10.1038/NCHEMBIO.1556, 10.1038/nchembio.1556]; Demicheli V, 2016, BIOCHEMISTRY-US, V55, P3403, DOI 10.1021/acs.biochem.6b00045; Dieteren CEJ, 2011, P NATL ACAD SCI USA, V108, P8657, DOI 10.1073/pnas.1017581108; Domaille DW, 2008, NAT CHEM BIOL, V4, P168, DOI 10.1038/nchembio.69; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Eckmann J, 2013, INT J BIOCHEM CELL B, V45, P76, DOI 10.1016/j.biocel.2012.06.009; FEINSTEIN MB, 1975, BIOCHIM BIOPHYS ACTA, V413, P354, DOI 10.1016/0005-2736(75)90121-2; Fornace ME, 2015, J CHEM THEORY COMPUT, V11, P568, DOI 10.1021/ct5011032; Guyer MF, 1942, CANCER RES, V2, P16; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koopman WJH, 2008, AM J PHYSIOL-CELL PH, V294, pC1124, DOI 10.1152/ajpcell.00079.2008; Kuimova MK, 2008, J AM CHEM SOC, V130, P6672, DOI 10.1021/ja800570d; Kuimova MK, 2012, PHYS CHEM CHEM PHYS, V14, P12671, DOI 10.1039/c2cp41674c; Kuimova MK, 2009, NAT CHEM, V1, P69, DOI [10.1038/nchem.120, 10.1038/NCHEM.120]; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Le Marois A, 2017, J BIOPHOTONICS, V10, P1124, DOI 10.1002/jbio.201600160; Levitt JA, 2011, CHEMPHYSCHEM, V12, P662, DOI 10.1002/cphc.201000782; Lopez-Duarte I, 2014, CHEM COMMUN, V50, P5282, DOI 10.1039/c3cc47530a; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160; NORTHRUP SH, 1988, SCIENCE, V241, P67, DOI 10.1126/science.2838904; Pal S, 2016, CHEM PHYS LIPIDS, V196, P69, DOI 10.1016/j.chemphyslip.2016.02.004; Ries J, 2012, BIOESSAYS, V34, P361, DOI 10.1002/bies.201100111; Rowley MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158404; Sbalzarini IF, 2005, BIOPHYS J, V89, P1482, DOI 10.1529/biophysj.104.057885; SCALETTAR BA, 1991, P NATL ACAD SCI USA, V88, P8057, DOI 10.1073/pnas.88.18.8057; Sniekers YH, 2005, BIOPHYS J, V89, P1302, DOI 10.1529/biophysj.104.053652; SOLTOFF SP, 1986, J MEMBRANE BIOL, V94, P153, DOI 10.1007/BF01871195; Song KC, 2011, J PHYS CHEM B, V115, P6157, DOI 10.1021/jp109629v; Song XB, 2017, J MATER CHEM B, V5, P360, DOI 10.1039/c6tb02524b; Sreenath K, 2012, J ORG CHEM, V77, P8268, DOI 10.1021/jo3016659; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Su DD, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091397; Suhaj A, 2018, PHYS CHEM CHEM PHYS, V20, P16060, DOI 10.1039/c8cp00543e; Tang R, 2017, J AM CHEM SOC, V139, P8547, DOI 10.1021/jacs.7b02801; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Valeur B, 2001, MOL FLUORESCENCE PRI, V2nd; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vinegoni C, 2019, ADV DRUG DELIVER REV, V151, P262, DOI 10.1016/j.addr.2018.01.019; Visagie MH, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0030-1; Volk A, 2018, EXP FLUIDS, V59, DOI 10.1007/s00348-018-2527-y; Vysniauskas A, 2017, PHYS CHEM CHEM PHYS, V19, P25252, DOI 10.1039/c7cp03571c; Vysniauskas A, 2015, CHEM SCI, V6, P5773, DOI 10.1039/c5sc02248g; Wang L, 2013, J AM CHEM SOC, V135, P2903, DOI 10.1021/ja311688g; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Wu YL, 2013, PHYS CHEM CHEM PHYS, V15, P14986, DOI 10.1039/c3cp51953h; Yang Z, 2013, J AM CHEM SOC, V135, P9181, DOI 10.1021/ja403851p; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7; Zheng KY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42022	60	38	38	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0211165	10.1371/journal.pone.0211165	http://dx.doi.org/10.1371/journal.pone.0211165			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763333	gold, Green Published, Green Submitted			2022-12-26	WOS:000458763900011
J	Fazaeli, A; Golestani, A; Lakzaei, M; Varaei, SSR; Aminian, M				Fazaeli, Aliakbar; Golestani, Abolfazl; Lakzaei, Mostafa; Varaei, Samaneh Sadat Rasi; Aminian, Mahdi			Expression optimization, purification, and functional characterization of cholesterol oxidase from Chromobacterium sp. DS1	PLOS ONE			English	Article							ACTIVE EUKARYOTIC PROTEINS; ESCHERICHIA-COLI; STREPTOMYCES-LIVIDANS; BREVIBACTERIUM-STEROLICUM; RECOMBINANT PROTEINS; GENE; CLONING; STRATEGIES; STABILITY; BACTERIA	Cholesterol oxidase is a bifunctional bacterial flavoenzyme which catalyzes oxidation and isomerization of cholesterol. This valuable enzyme has attracted a great deal of attention because of its wide application in the clinical laboratory, synthesis of steroid derived drugs, food industries, and its potentially insecticidal activity. Therefore, development of an efficient protocol for overproduction of cholesterol oxidase could be valuable and beneficial in this regard. The present study examined the role of various parameters (host strain, culture media, induction time, isopropyl B-D-1-thiogalactopyranoside concentration, as well as post-induction incubation time and temperature) on over-expression of cholesterol oxidase from Chromobacterium sp. DS1. Applying the optimized protocol, the yield of recombinant cholesterol oxidase significantly increased from 92 U/L to 2115 U/L. Under the optimized conditions, the enzyme was produced on a large-scale, and overexpressed cholesterol oxidase was purified from cell lysate by column nickel affinity chromatography. K-m and V-max values of the purified enzyme for cholesterol were estimated using Lineweaver-Burk plot. Further, the optimum pH and optimum temperature for the enzyme activity were determined. This study reports a straightforward protocol for cholesterol oxidase production which can be performed in any laboratory.	[Fazaeli, Aliakbar] Ardabil Univ Med Sci, Sch Med, Dept Clin Biochem, Ardebil, Iran; [Golestani, Abolfazl; Lakzaei, Mostafa; Varaei, Samaneh Sadat Rasi; Aminian, Mahdi] Univ Tehran Med Sci, Sch Med, Dept Biochem, Ardebil, Iran; [Aminian, Mahdi] Univ Tehran Med Sci, Recombinant Vaccine Res Ctr, Tehran, Iran	Ardabil University of Medical Sciences; Tehran University of Medical Sciences	Aminian, M (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Biochem, Ardebil, Iran.; Aminian, M (corresponding author), Univ Tehran Med Sci, Recombinant Vaccine Res Ctr, Tehran, Iran.	amminian@tums.ac.ir	Fazaeli, Aliakbar/AAL-7819-2020	Fazaeli, Aliakbar/0000-0001-7860-3950; Golestani, Abolfazl/0000-0003-0347-7309	Tehran University of Medical Sciences [30859]	Tehran University of Medical Sciences(Tehran University of Medical Sciences)	This study was funded by Tehran University of Medical Sciences (grant number 30859).	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Aminian M, 2013, ANAL BIOCHEM, V434, P287, DOI 10.1016/j.ab.2012.11.014; Basu AK, 2007, BIOELECTROCHEMISTRY, V70, P375, DOI 10.1016/j.bioelechem.2006.05.006; BENTLEY WE, 1990, BIOTECHNOL BIOENG, V35, P668, DOI 10.1002/bit.260350704; BRIGIDI P, 1993, LETT APPL MICROBIOL, V17, P61, DOI 10.1111/j.1472-765X.1993.tb00371.x; Caspeta L, 2009, BIOTECHNOL BIOENG, V102, P468, DOI 10.1002/bit.22084; Cho HJ, 1995, APPL MICROBIOL BIOT, V44, P133, DOI 10.1007/BF00164492; Collins T, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-21; CORBIN DR, 1994, APPL ENVIRON MICROB, V60, P4239, DOI 10.1128/AEM.60.12.4239-4244.1994; Doukyu N, 2008, APPL MICROBIOL BIOT, V80, P59, DOI 10.1007/s00253-008-1526-y; Doukyu N, 2015, J BIOSCI BIOENG, V120, P24, DOI 10.1016/j.jbiosc.2014.12.003; Doukyu N, 2009, APPL MICROBIOL BIOT, V83, P825, DOI 10.1007/s00253-009-2059-8; Doukyu N, 2009, APPL MICROBIOL BIOT, V82, P479, DOI 10.1007/s00253-008-1775-9; El-Naggar NEA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20786-3; El-Naggar NEA, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0830-4; FUJISHIRO K, 1990, BIOCHEM BIOPH RES CO, V172, P721, DOI 10.1016/0006-291X(90)90734-5; HORII M, 1990, J BACTERIOL, V172, P3644, DOI 10.1128/jb.172.7.3644-3653.1990; Jevsevar S, 2005, BIOTECHNOL PROGR, V21, P632, DOI 10.1021/bp0497839; Jin DJ, 2012, FEMS MICROBIOL REV, V36, P269, DOI 10.1111/j.1574-6976.2011.00279.x; Kanwar SS, 2012, ADV MICROBIOLOGY, V2, P49, DOI DOI 10.4236/AIM.2012.22007; Kaur J, 2018, INT J BIOL MACROMOL, V106, P803, DOI 10.1016/j.ijbiomac.2017.08.080; Khow Orawan, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P159, DOI 10.1016/S2221-1691(11)60213-X; KIEFHABER T, 1991, BIO-TECHNOL, V9, P825, DOI 10.1038/nbt0991-825; Kim R, 1998, BIOTECHNOL LETT, V20, P207, DOI 10.1023/A:1005305330517; Lammertyn E, 1996, MOL GEN GENET, V250, P223, DOI 10.1007/s004380050070; LIU WH, 1988, AGR BIOL CHEM TOKYO, V52, P413; Low C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038244; Lv CF, 2002, PROCESS BIOCHEM, V37, P901, DOI 10.1016/S0032-9592(01)00296-5; Ma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076913; MacLachlan J, 2000, J STEROID BIOCHEM, V72, P169, DOI 10.1016/S0960-0760(00)00044-3; MIZUKAMI T, 1986, BIOTECHNOL LETT, V8, P605, DOI 10.1007/BF01025964; MOLNAR I, 1991, J FERMENT BIOENG, V72, P368, DOI 10.1016/0922-338X(91)90089-Y; MUROOKA Y, 1986, APPL ENVIRON MICROB, V52, P1382, DOI 10.1128/AEM.52.6.1382-1385.1986; Nishiya Y, 1997, PROTEIN ENG, V10, P231, DOI 10.1093/protein/10.3.231; OHTA T, 1992, BIOSCI BIOTECH BIOCH, V56, P1786, DOI 10.1271/bbb.56.1786; Pollegioni L, 2009, FEBS J, V276, P6857, DOI 10.1111/j.1742-4658.2009.07379.x; PURCELL JP, 1993, BIOCHEM BIOPH RES CO, V196, P1406, DOI 10.1006/bbrc.1993.2409; Reiss R, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-46; Sahdev S, 2008, MOL CELL BIOCHEM, V307, P249, DOI 10.1007/s11010-007-9603-6; Saida Fakhri, 2007, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0519s50; Serajzadeh S, 2010, AUST J DAIRY TECHNOL, V65, P10; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Sodoyer R, 2004, BIODRUGS, V18, P51, DOI 10.2165/00063030-200418010-00005; SOLAIMAN DKY, 1992, PLASMID, V28, P25, DOI 10.1016/0147-619X(92)90033-7; SOLAIMAN DKY, 1995, J IND MICROBIOL, V15, P39, DOI 10.1007/BF01570011; SOLAIMAN DKY, 1991, J IND MICROBIOL, V8, P253, DOI 10.1007/BF01576063; Somkuti GA, 1997, CURR MICROBIOL, V35, P180, DOI 10.1007/s002849900235; SOMKUTI GA, 1991, BIOTECHNOL APPL BIOC, V13, P238; SOMKUTI GA, 1995, PLASMID, V33, P7, DOI 10.1006/plas.1995.1002; Sorensen HP, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-1; Yehia HM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0517-2; Zarychta B, 2015, ACTA CRYSTALLOGR D, V71, P954, DOI 10.1107/S1399004715002382	52	13	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0212217	10.1371/journal.pone.0212217	http://dx.doi.org/10.1371/journal.pone.0212217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759160	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300078
J	Francis, JM; Myers, B; Nkosi, S; Williams, PP; Carney, T; Lombard, C; Nel, E; Morojele, N				Francis, Joel Msafiri; Myers, Bronwyn; Nkosi, Sebenzile; Williams, Petal Petersen; Carney, Tara; Lombard, Carl; Nel, Elmarie; Morojele, Neo			The prevalence of religiosity and association between religiosity and alcohol use, other drug use, and risky sexual behaviours among grade 8-10 learners in Western Cape, South Africa	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; SUBSTANCE USE; YOUNG-PEOPLE; UNIVERSITY-STUDENTS; METHAMPHETAMINE USE; ADOLESCENT HEALTH; MENTAL-HEALTH; TOWN; RELIGIOSITY/SPIRITUALITY; INTERVENTIONS	Background Alcohol and other drug use (AOD) and risky sexual behaviours remain high among adolescents in South Africa and globally. Religiosity influences, mitigates and provides resilience against engaging in risky behaviours among young people but few South African studies have explored potential associations between religiosity, AOD use and risky sex. We report the prevalence of religiosity and association between religiosity and AOD use and risky sexual behaviours among learners in the Western Cape Province, South Africa. Methods Between May and August 2011, a cross sectional survey was conducted among 20 227 learners from 240 public schools randomly selected through a stratified multistage sampling design to determine the prevalence of AOD use and sexual risk behaviours. We performed univariate and multivariate logistic regression analyses to assess the association between religiosity, AOD use and risky sexual behaviours. Results The learners were aged 10-23 years. Almost three quarters (74%) of learners reported high religiosity (defined as attending religious services or activities at least 1-2 times a month). More female than male learners had high religiosity. The prevalence of past 30 day reported alcohol, tobacco and cannabis use was 23%, 19% and 8% respectively. Compared to learners with low religiosity, those with high religiosity were less likely to engage in AOD use: specifically alcohol use, (AOR = 0.86, 95%CI: 0.76-0.97), tobacco use (AOR = 0.76, 95%CI: 0.67-0.87), cannabis use (AOR = 0.57, 95%CI: 0.48-0.68) in the last 30 days. They were also less likely to engage in risky sexual behaviours (AOR = 0.90, 95%CI: 0.81-0.99). Conclusion Religiosity was associated with lower odds of reported AOD use and risky sexual behaviours among learners in the Western Cape. This calls for further exploration on how to incorporate religiosity into AOD use and risky sexual behaviour interventions.	[Francis, Joel Msafiri; Nkosi, Sebenzile; Nel, Elmarie; Morojele, Neo] South African Med Res Council, Alcohol Tobacco & Other Drug Res Unit, Pretoria, South Africa; [Francis, Joel Msafiri] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst WRHI, Johannesburg, South Africa; [Francis, Joel Msafiri] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Johannesburg, South Africa; [Francis, Joel Msafiri] Muhimbili Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania; [Myers, Bronwyn; Williams, Petal Petersen; Carney, Tara] South African Med Res Council, Alcohol Tobacco & Other Drug Res Unit, Cape Town, South Africa; [Myers, Bronwyn; Williams, Petal Petersen; Carney, Tara] Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [Lombard, Carl] South African Med Res Council, Biostat Unit, Cape Town, South Africa; [Morojele, Neo] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Morojele, Neo] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	South African Medical Research Council; University of Witwatersrand; University of Witwatersrand; Muhimbili University of Health & Allied Sciences; South African Medical Research Council; University of Cape Town; South African Medical Research Council; University of Cape Town; University of Witwatersrand	Francis, JM (corresponding author), South African Med Res Council, Alcohol Tobacco & Other Drug Res Unit, Pretoria, South Africa.; Francis, JM (corresponding author), Univ Witwatersrand, Wits Reprod Hlth & HIV Inst WRHI, Johannesburg, South Africa.; Francis, JM (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Johannesburg, South Africa.; Francis, JM (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania.	joelmfrancis@gmail.com	Myers, Bronwyn/AAT-7788-2021; Morojele, Neo/AAI-3372-2021; Morojele, Neo/AAS-1221-2021; Francis, Joel/B-1271-2019	Myers, Bronwyn/0000-0003-0235-6716; Francis, Joel/0000-0003-1902-2683; Lombard, Carl/0000-0002-2136-6533	Provincial Government of the Western Cape via the United Nations Office on Drugs & Crime (Pretoria); South African Medical Research Council	Provincial Government of the Western Cape via the United Nations Office on Drugs & Crime (Pretoria); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this survey was provided by the Provincial Government of the Western Cape via the United Nations Office on Drugs & Crime (Pretoria) and the South African Medical Research Council.	AbdAleati NS, 2016, J RELIG HEALTH, V55, P1929, DOI 10.1007/s10943-014-9896-1; [Anonymous], 2017, DUBL DRUG POL SUMM R; Aukst-Margetic B, 2005, COLLEGIUM ANTROPOL, V29, P365; Aziz G, 2017, VERBUM ECCLESIA, V38, pa1745, DOI [10.4102/ve.v38i1.1745, DOI 10.4102/VE.V38I1.1745]; Bauman A, 1999, DRUG ALCOHOL DEPEN, V55, P187, DOI 10.1016/S0376-8716(99)00016-2; Carney T, 2013, J ADOLESCENCE, V36, P447, DOI 10.1016/j.adolescence.2013.01.004; Casey BJ, 2013, CURR DIR PSYCHOL SCI, V22, P82, DOI 10.1177/0963721413480170; Christopher AJ, 2001, URBAN STUD, V38, P449, DOI 10.1080/00420980120027447; Cotton Sian, 2007, Adolesc Med State Art Rev, V18, P471; Dayan J, 2010, J PHYSIOL-PARIS, V104, P279, DOI 10.1016/j.jphysparis.2010.08.007; Degenhardt L, 2016, LANCET PSYCHIAT, V3, P251, DOI 10.1016/S2215-0366(15)00508-8; Foster DW, 2013, ADDICT BEHAV, V38, P2647, DOI 10.1016/j.addbeh.2013.06.019; Francis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140041; Francis JM, 2014, TROP MED INT HEALTH, V19, P476, DOI 10.1111/tmi.12267; FURBY L, 1992, DEV REV, V12, P1, DOI 10.1016/0273-2297(92)90002-J; Ganiel G, 2010, RELIG COMPASS, V4, P130, DOI 10.1111/j.1749-8171.2009.00203.x; Greenfield Emily A, 2007, Int J Psychol Relig, V17, P245; Griffith DM, 2010, PUBLIC HEALTH REP, V125, P4, DOI 10.1177/00333549101250S102; Gyimah SO, 2013, J BIOSOC SCI, V45, P13, DOI 10.1017/S0021932012000168; Heeren GA, 2014, AIDS BEHAV, V18, P1991, DOI 10.1007/s10461-014-0767-2; Jabbour S, 2004, B WORLD HEALTH ORGAN, V82, P923; Koenig Harold G, 2012, ISRN Psychiatry, V2012, P278730, DOI 10.5402/2012/278730; Kub J, 2013, J ADDICT NURS, V24, P247, DOI 10.1097/JAN.0000000000000006; Kuntsche S, 2016, CLIN PSYCHOL REV, V45, P89, DOI 10.1016/j.cpr.2016.02.004; Lara LAS, 2016, J PEDIATR ADOL GYNEC, V29, P417, DOI 10.1016/j.jpag.2015.11.012; Masuku Tobias M, 2014, Missionalia (Online), V42, P151, DOI 10.7832/42-3-66; Moreau C, 2013, EUR J CONTRACEP REPR, V18, P168, DOI 10.3109/13625187.2013.777829; Moreira-Almeida A, 2006, REV BRAS PSIQUIATR, V28, P242, DOI 10.1590/S1516-44462006000300018; Muhwava LS, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0807-1; Nicholas LJ, 2004, J SEX MARITAL THER, V30, P37, DOI 10.1080/00926230490247264; Nkosi, 2013, SURVEY SUBSTANCE USE; Palmer RHC, 2009, DRUG ALCOHOL DEPEN, V102, P78, DOI 10.1016/j.drugalcdep.2009.01.012; Parry CDH, 2004, J ADOLESCENCE, V27, P369, DOI 10.1016/j.adolescence.2003.09.005; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Peltzer K, 2018, SAJP-S AFR J PSYCHI, V24, DOI 10.4102/sajpsychiatry.v24i0.1139; Peltzer K, 2016, J RELIG HEALTH, V55, P2131, DOI 10.1007/s10943-016-0260-5; Peltzer K, 2015, IRAN J PUBLIC HEALTH, V44, P1330; Peltzer K, 2010, SUBST USE MISUSE, V45, P2221, DOI 10.3109/10826084.2010.481594; Pinnock, 2016, GANG TOWN; Pluddemann A, 2008, DRUG ALCOHOL REV, V27, P687, DOI 10.1080/09595230802245253; Pluddemann A, 2010, DRUG ALCOHOL DEPEN, V109, P14, DOI 10.1016/j.drugalcdep.2009.11.021; Ponte S, 2007, DEV CHANGE, V38, P933, DOI 10.1111/j.1467-7660.2007.00440.x; Peres M, 2018, J RELIG HEALTH, V57, P1842, DOI 10.1007/s10943-017-0400-6; Reddy P.S., 2013, UMTHENTE UHLABA USAM; Rew L, 2006, J ADOLESCENT HEALTH, V38, P433, DOI 10.1016/j.jadohealth.2005.02.004; ROHRBAUGH J, 1975, J PERS, V43, P136, DOI 10.1111/j.1467-6494.1975.tb00577.x; Saban A, 2010, J PSYCHOACTIVE DRUGS, V42, P37, DOI 10.1080/02791072.2010.10399784; Shisana OR T, 2012, AFRICAN NATL HIV P, DOI [10.1177/00333549101250S102, DOI 10.1177/00333549101250S102]; Sommer J, 2017, ADDICT BEHAV, V64, P29, DOI 10.1016/j.addbeh.2016.08.008; Stats SA, 2012, S AFR STAT 2012; Stats SA, 2017, VICT CRIM SURV 2015; Storch EA, 2004, PSYCHOL REP, V94, P993; VanderWeele TJ, 2017, SOC PSYCH PSYCH EPID, V52, P1331, DOI 10.1007/s00127-017-1434-5; VanderWeele TJ, 2017, AM J EPIDEMIOL, V185, P515, DOI 10.1093/aje/kww179; Viljoen D, 2002, J STUD ALCOHOL, V63, P6; Ward CM, 2015, S AFRICAN CHILD GAUG, P70; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wong Y Joel, 2006, Issues Ment Health Nurs, V27, P161; Word Health Organisation, 2005, ALC US SEX RISK BEAH; World Health Organization, 2017, WHO REP GLOB TOB EP; Yonker JE, 2012, J ADOLESCENCE, V35, P299, DOI 10.1016/j.adolescence.2011.08.010	61	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211322	10.1371/journal.pone.0211322	http://dx.doi.org/10.1371/journal.pone.0211322			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5IX	30759112	Green Published, Green Submitted, gold			2022-12-26	WOS:000458761300038
J	Hawinkel, S; Kerckhof, FM; Bijnens, L; Thas, O				Hawinkel, Stijn; Kerckhof, Frederiek-Maarten; Bijnens, Luc; Thas, Olivier			A unified framework for unconstrained and constrained ordination of microbiome read count data	PLOS ONE			English	Article							LATENT VARIABLE MODELS; MULTIVARIATE ANALYSES	Explorative visualization techniques provide a first summary of microbiome read count datasets through dimension reduction. A plethora of dimension reduction methods exists, but many of them focus primarily on sample ordination, failing to elucidate the role of the bacterial species. Moreover, implicit but often unrealistic assumptions underlying these methods fail to account for overdispersion and differences in sequencing depth, which are two typical characteristics of sequencing data. We combine log-linear models with a dispersion estimation algorithm and flexible response function modelling into a framework for unconstrained and constrained ordination. The method is able to cope with differences in dispersion between taxa and varying sequencing depths, to yield meaningful biological patterns. Moreover, it can correct for observed technical confounders, whereas other methods are adversely affected by these artefacts. Unlike distance-based ordination methods, the assumptions underlying our method are stated explicitly and can be verified using simple diagnostics. The combination of unconstrained and constrained ordination in the same framework is unique in the field and facilitates microbiome data exploration. We illustrate the advantages of our method on simulated and real datasets, while pointing out flaws in existing methods. The algorithms for fitting and plotting are available in the R-package RCM.	[Hawinkel, Stijn; Thas, Olivier] Univ Ghent, Dept Data Anal & Math Modelling, Ghent, Belgium; [Kerckhof, Frederiek-Maarten] Univ Ghent, Ctr Microbial Ecol & Technol, Ghent, Belgium; [Bijnens, Luc] Johnson & Johnson, Janssen Pharmaceut Co, Quantitat Sci, Beerse, Belgium; [Bijnens, Luc; Thas, Olivier] Hasselt Univ, Ctr Stat, Hasselt, Belgium; [Thas, Olivier] Univ Wollongong, NIASRA, Wollongong, NSW, Australia	Ghent University; Ghent University; Johnson & Johnson; Janssen Pharmaceuticals; Hasselt University; University of Wollongong	Hawinkel, S (corresponding author), Univ Ghent, Dept Data Anal & Math Modelling, Ghent, Belgium.	stijn.hawinkel@ugent.be	Kerckhof, Frederiek-Maarten/E-5059-2011	Kerckhof, Frederiek-Maarten/0000-0002-4472-6810; Bijnens, Luc/0000-0002-4126-3152; Thas, Olivier/0000-0001-6442-4089	Janssen Pharmaceutical companies of Johnson and Johnson	Janssen Pharmaceutical companies of Johnson and Johnson	Stijn Hawinkel was funded by Janssen Pharmaceutical companies of Johnson and Johnson. The funder was kept informed about research progress and provided useful input.	AmericanGut org, 2015, AM GUT PROJ; Andelinovic M, 2017, PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON CURRENCY, BANKING AND INTERNATIONAL FINANCE, P1; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Benzecri JP, 1975, POPULATION, V30, P1190; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Costea PI, 2014, NAT METHODS, V11, P359, DOI 10.1038/nmeth.2897; Dray S, 2015, MOL ECOL RESOUR, V15, P242, DOI 10.1111/1755-0998.12300; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Fukuyama J, 2012, BIOCOMPUT-PAC SYM, P213; Gloor GB, 2016, CAN J MICROBIOL, V62, P692, DOI 10.1139/cjm-2015-0821; GOODMAN LA, 1979, J AM STAT ASSOC, V74, P537, DOI 10.2307/2286971; Gower J, 2011, UNDERSTANDING BIPLOT, V1, DOI [10.1002/9780470973196, DOI 10.1002/9780470973196]; Gower JC, 2005, PRINCIPAL COORDINATE; Hampel FR, 2011, ROBUST STAT APPROACH, V07; Hastie T., 1986, STAT SCI, V1986, P297, DOI [DOI 10.1214/SS/1177013604, 10.1214/ss/1177013604]; Hawinkel S, 2019, BRIEF BIOINFORM, V20, P210, DOI 10.1093/bib/bbx104; Hiergeist A, 2016, INT J MED MICROBIOL, V306, P334, DOI 10.1016/j.ijmm.2016.03.005; Hui FKC, 2017, J COMPUT GRAPH STAT, V26, P35, DOI 10.1080/10618600.2016.1164708; Hui FKC, 2015, METHODS ECOL EVOL, V6, P399, DOI 10.1111/2041-210X.12236; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, DEV ENV MODEL, P1, DOI DOI 10.1016/B978-0-444-53868-0.50001-0; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Niku J, 2018, GLLVM GEN LINEAR LAT; Niku J, 2017, J AGR BIOL ENVIR ST, V22, P498, DOI 10.1007/s13253-017-0304-7; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pledger S, 2014, COMPUT STAT DATA AN, V71, P241, DOI 10.1016/j.csda.2013.05.013; Props R, 2017, ISME J, V11, P584, DOI 10.1038/ismej.2016.117; R Core Team, 2021, R LANGUAGE ENV STAT; Rao R, 1995, QUESTIIO, V17, P23; Richardson Marion Webster, 1938, PSYCHOL BULL, V35, P659; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Ruokolainen L, 2006, ANN BOT FENN, V43, P269; Schmidt TSB, 2017, ISME J, V11, P791, DOI 10.1038/ismej.2016.139; Sohn MB, 2017, BIOMETRICS; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 1988, ADV ECOL RES, V18, P271; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; Warton DI, 2015, TRENDS ECOL EVOL, V30, P766, DOI 10.1016/j.tree.2015.09.007; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Wong RSY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151949; Xu LZ, 2017, GENET EPIDEMIOL, V41, P221, DOI 10.1002/gepi.22031; Yee TW, 2014, COMPUTATION STAT, V29, P1427, DOI 10.1007/s00180-014-0499-9; Yee TW, 2006, ECOLOGY, V87, P203, DOI 10.1890/05-0283; Yee TW, 2004, ECOL MONOGR, V74, P685, DOI 10.1890/03-0078; Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645; Zhang Y., 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0154079; Zhu M, 2005, ECOL MODEL, V187, P524, DOI 10.1016/j.ecolmodel.2005.01.049	63	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0205474	10.1371/journal.pone.0205474	http://dx.doi.org/10.1371/journal.pone.0205474			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759084	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300003
J	Weber, T; Green, DA; Attias, J; Sies, W; Frechette, A; Braunstein, B; Rittweger, J				Weber, Tobias; Green, David A.; Attias, Julia; Sies, Wolfram; Frechette, Alexandre; Braunstein, Bjoern; Rittweger, Joern			Hopping in hypogravity - A rationale for a plyometric exercise countermeasure in planetary exploration missions	PLOS ONE			English	Article							BED-REST; BONE LOSS; GRAVITY; ADAPTATIONS; PRESSURE; SPACE; MOON; JUMP	Moon and Mars are considered to be future targets for human space explorations. The gravity level on the Moon and Mars amount to 16% and 38%, respectively, of Earth's gravity. Mechanical loading during the anticipated habitual activities in these hypogravity environments will most likely not be sufficient to maintain physiological integrity of astronauts unless additional exercise countermeasures are performed. Current microgravity exercise countermeasures appear to attenuate but not prevent 'space deconditioning'. However, plyometric exercises (hopping and whole body vibration) have shown promise in recent analogue bed rest studies and may be options for space exploration missions where resources will be limited compared to the ISS. This paper therefore tests the hypothesis that plyometric hop exercise in hypogravity can generate sufficient mechanical stimuli to prevent musculoskeletal deconditioning. It has been suggested that hypogravity-induced reductions in peak ground reaction force (peak vertical GRF) can be offset by increases in hopping height. Therefore, this study investigated the effects of simulated hypogravity (0.16G, 0.27G, 0.38G, and 0.7G) upon sub-maximal plyometric hopping on the Verticalised Treadmill Facility, simulating different hypogravity levels. Results show that peak vertical GRF are negatively related to simulated gravity level, but positively to hopping height. Contact times decreased with increasing gravity level but were not influenced through hopping height. In contrast, flight time increased with decreasing gravity levels and increasing hopping height (P < 0.001). The present data suggest that the anticipated hypogravity-related reductions of musculoskeletal forces during normal walking can be compensated by performing hops and therefore support the idea of plyometric hopping as a robust and resourceful exercise countermeasure in hypogravity. As maximal hop height was constrained on the VTF further research is needed to determine whether similar relationships are evident during maximal hops and other forms of jumping.	[Weber, Tobias; Green, David A.; Frechette, Alexandre] European Space Agcy, European Astronaut Ctr, Space Med Team HRE, Cologne, Germany; [Weber, Tobias; Green, David A.; Frechette, Alexandre] KBRwyle GmbH, Cologne, Germany; [Attias, Julia] Kings Coll London, Ctr Appl Physiol Sci CHAPS, London, England; [Sies, Wolfram; Rittweger, Joern] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany; [Braunstein, Bjoern] German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany; [Braunstein, Bjoern] Ctr Hlth & Integrat Physiol Space CHIPS, Cologne, Germany; [Rittweger, Joern] Univ Cologne, Dept Pediat & Adolescent Med, Cologne, Germany	European Space Agency; University of London; King's College London; Helmholtz Association; German Aerospace Centre (DLR); German Sport University Cologne; University of Cologne	Weber, T (corresponding author), European Space Agcy, European Astronaut Ctr, Space Med Team HRE, Cologne, Germany.; Weber, T (corresponding author), KBRwyle GmbH, Cologne, Germany.	tobias.weber@esa.int	Braunstein, Bjoern/D-7142-2013; Rittweger, Jörn/A-4308-2009	Braunstein, Bjoern/0000-0002-5173-8916; Rittweger, Jörn/0000-0002-2223-8963; Weber, Tobias/0000-0002-3015-3468	ESA's Space Medicine Team (HRE-OM)	ESA's Space Medicine Team (HRE-OM)	The study has been funded by ESA's Space Medicine Team (HRE-OM) and is part of the 'Moon Gym Project'.	Astrobotic, PER LUN LAND PAYL US; Belavy DL, 2011, J MUSCULOSKEL NEURON, V11, P215; Belavy DL, 2011, OSTEOPOROSIS INT, V22, P1581, DOI 10.1007/s00198-010-1371-6; CAVAGNA GA, 1972, AEROSPACE MED, V43, P408; Clement G, 2011, SPACE TECHNOL LIB, V23, P1, DOI 10.1007/978-1-4419-9905-4; Cochrane DJ, 2011, J SPORT SCI MED, V10, P19; Cutuk A, 2006, J APPL PHYSIOL, V101, P771, DOI 10.1152/japplphysiol.00644.2005; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Genc KO, 2010, J BIOMECH, V43, P3020, DOI 10.1016/j.jbiomech.2010.06.028; Goodman CA, 2015, BONE, V80, P24, DOI 10.1016/j.bone.2015.04.014; Gosseye TP, 2010, EUR J APPL PHYSIOL, V110, P709, DOI 10.1007/s00421-010-1549-9; Jones H., 2017, 47 INT C ENV SYST, P16; Korth DW, 2015, AEROSP MED HUM PERF, V86, pA7, DOI 10.3357/AMHP.EC02.2015; Kramer A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13659-8; Larson WJ, 1999, HUMAN SPACEFLIGHT MI, DOI [10.1016/j.bone.2009.08.051, DOI 10.1016/J.BONE.2009.08.051]; Markovic G, 2010, SPORTS MED, V40, P859, DOI 10.2165/11318370-000000000-00000; Mosley JR, 1998, BONE, V23, P313, DOI 10.1016/S8756-3282(98)00113-6; Petersen N, 2016, EXTREME PHYSIOL MED, V5, DOI 10.1186/s13728-016-0050-4; Richter K, 2017, FRONT PSYCHOL, V8, DOI [10.3389/fphys.2017.00583, 10.3389/fpsyg.2017.00575]; Rittweger J, 2010, BONE, V46, P137, DOI 10.1016/j.bone.2009.08.051; Ritzmann R, 2016, J APPL PHYSIOL, V121, P1187, DOI 10.1152/japplphysiol.00692.2016; Salles AS, 2011, EUR J APPL PHYSIOL, V111, P441, DOI 10.1007/s00421-010-1665-6; Smith SM, 2008, BONE, V42, P572, DOI 10.1016/j.bone.2007.11.015; Vanrenterghem J, 2004, HUM MOVEMENT SCI, V22, P713, DOI 10.1016/j.humov.2003.11.001; Whitley R, 2017, GLOBAL EXPLORATION R; Witzke KA, 2000, MED SCI SPORT EXER, V32, P1051, DOI 10.1097/00005768-200006000-00003; Woerner J., 2016, MOON VILLAGE VISION; Yang PF, 2014, MED ENG PHYS, V36, P1041, DOI 10.1016/j.medengphy.2014.05.005; Yang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094525	29	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211263	10.1371/journal.pone.0211263	http://dx.doi.org/10.1371/journal.pone.0211263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759113	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000458761300035
J	Park, KM; Sung, JM; Kim, WJ; An, SK; Namkoong, K; Lee, E; Chang, HJ				Park, Kyung Mee; Sung, Ji Min; Kim, Woo Jung; An, Suk Kyoon; Namkoong, Kee; Lee, Eun; Chang, Hyuk-Jae			Population-based dementia prediction model using Korean public health examination data: A cohort study	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; LATE-LIFE; SCORE; MIDLIFE; PREVENTION	The early identification and prevention of dementia is important for reducing its worldwide burden and increasing individuals' quality of life. Although several dementia prediction models have been developed, there remains a need for a practical and precise model targeted to middle-aged and Asian populations. Here, we used national Korean health examination data from adults (331,126 individuals, 40-69 years of age, mean age: 52 years) from 2002-2003 to predict the incidence of dementia after 10 years. We divided the dataset into two cohorts to develop and validate of our prediction model. Cox proportional hazards models were used to construct dementia prediction models for the total group and sex-specific subgroups. Receiver operating characteristics curves, C-statistics, calibration plots, and cumulative hazards were used to validate model performance. Discriminative accuracy as measured by C-statistics was 0.81 in the total group (95% confidence interval (CI) = 0.81 to 0.82), 0.81 in the male subgroup (CI = 0.80 to 0.82), and 0.81 in the female subgroup (CI = 0.80 to 0.82). Significant risk factors for dementia in the total group were age; female sex; underweight; current hypertension; comorbid psychiatric or neurological disorder; past medical history of cardio-vascular disease, diabetes mellitus, or hypertension; current smoking; and no exercise. All identified risk factors were statistically significant in the sex-specific subgroups except for low body weight and current hypertension in the female subgroup. These results suggest that public health examination data can be effectively used to predict dementia and facilitate the early identification of dementia within a middle-aged Asian population.	[Park, Kyung Mee; An, Suk Kyoon; Namkoong, Kee; Lee, Eun] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Park, Kyung Mee; Kim, Woo Jung; An, Suk Kyoon; Namkoong, Kee; Lee, Eun] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea; [Sung, Ji Min; Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea; [Kim, Woo Jung] Myongji Hosp, Dept Psychiat, Goyang, Gyeonggi, South Korea; [Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Myongji Hospital; Yonsei University; Yonsei University Health System	Lee, E (corresponding author), Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea.; Lee, E (corresponding author), Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea.	leeeun@yuhs.ac	Kim, Woo Jung/AAG-1822-2019	Kim, Woo Jung/0000-0002-4963-4819; Lee, Eun/0000-0002-7462-0144; Chang, Hyuk-Jae/0000-0002-6139-7545; An, Suk Kyoon/0000-0003-4576-6184; NAMKOONG, KEE/0000-0003-1400-8057; park, kyungmee/0000-0002-2416-2683	National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [2012027176, 2017R1A2B3008214]; Korean Mental Health Technology R&Project, Ministry of Health & Welfare, Republic of Korea [HM15C0995]	National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning; Korean Mental Health Technology R&Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by the Leading Foreign Research Institute Recruitment Program (No. 2012027176 to H. Chang) and the Basic Science Research Program (No. 2017R1A2B3008214 to E. Lee) through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning, and the Korean Mental Health Technology R&Project, Ministry of Health & Welfare, Republic of Korea [HM15C0995 to E. Lee]. The funders plays no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese Emiliano, 2017, Alzheimers Dement (Amst), V8, P165, DOI 10.1016/j.dadm.2017.05.007; [Anonymous], 2016, MEAN BODY MASS INDEX; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Anstey KJ, 2013, PREV SCI, V14, P411, DOI 10.1007/s11121-012-0313-2; Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2; Barnes DE, 2009, NEUROLOGY, V73, P173, DOI 10.1212/WNL.0b013e3181a81636; Barnes DE, 2014, ALZHEIMERS DEMENT, V10, P656, DOI 10.1016/j.jalz.2013.11.006; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Exalto LG, 2014, ALZHEIMERS DEMENT, V10, P562, DOI 10.1016/j.jalz.2013.05.1772; Exalto LG, 2013, LANCET DIABETES ENDO, V1, P183, DOI 10.1016/S2213-8587(13)70048-2; Fenlon C, 2018, PREV VET MED, V149, P107, DOI 10.1016/j.prevetmed.2017.11.018; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hayden KM, 2006, ALZ DIS ASSOC DIS, V20, P93, DOI 10.1097/01.wad.0000213814.43047.86; Hou XH, 2018, J NEUROL NEUROSUR PS, V2018, DOI [10.1136/jnnp-2018-2018/06/30, DOI 10.1136/JNNP-2018-2018/06/30]; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Launer LJ, 2011, ANN NEUROL, V70, P774, DOI 10.1002/ana.22520; Mangialasche F, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt104; Meng XF, 2014, J ALZHEIMERS DIS, V42, P1295, DOI 10.3233/JAD-140954; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Ohara T, 2011, J AM GERIATR SOC, V59, P1074, DOI 10.1111/j.1532-5415.2011.03405.x; Pan WH, 2008, ASIA PAC J CLIN NUTR, V17, P370; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Rawtaer I, 2016, DEMENT GERIATR COGN, V41, P348, DOI 10.1159/000447448; Ritchie CW, 2016, LANCET PSYCHIAT, V3, P179, DOI 10.1016/S2215-0366(15)00454-X; Roman GC, 2012, ALZ DIS ASSOC DIS, V26, P295, DOI 10.1097/WAD.0b013e31825cbc4b; SAS Institute Inc, SAS STAT 14 1 US GUI; Schneider JA, 2010, STROKE, V41, pS144, DOI 10.1161/STROKEAHA.110.598326; Seong SC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016640; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Stephan BCM, 2010, NAT REV NEUROL, V6, P318, DOI 10.1038/nrneurol.2010.54; Szeto JYY, 2016, CURR NEUROPHARMACOL, V14, P326, DOI 10.2174/1570159X14666151208112754; Szklo M, 1998, EPIDEMIOL REV, V20, P81, DOI 10.1093/oxfordjournals.epirev.a017974; Tang EYH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136181; Vuk M., 2006, METODOLOSKI ZVEZKI, V3, P89; Vuoksimaa Eero, 2016, Alzheimers Dement (Amst), V4, P118; Wagner M, 2018, JAMA PSYCHIAT, V75, P1033, DOI 10.1001/jamapsychiatry.2018.2004; ZWEIG MH, 1993, CLIN CHEM, V39, P561	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211957	10.1371/journal.pone.0211957	http://dx.doi.org/10.1371/journal.pone.0211957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753205	Green Published, gold, Green Submitted			2022-12-26	WOS:000458395600033
J	Diretto, G; Jin, X; Capell, T; Zhu, CF; Gomez-Gomez, L				Diretto, Gianfranco; Jin, Xin; Capell, Teresa; Zhu, Changfu; Gomez-Gomez, Lourdes			Differential accumulation of pelargonidin glycosides in petals at three different developmental stages of the orange-flowered gentian (Gentiana lutea L. var. aurantiaca)	PLOS ONE			English	Article							ANTHOCYANIN 5-AROMATIC ACYLTRANSFERASE; RED-PURPLE FLOWERS; UDP-GLUCOSE; ENGINEERING ANTHOCYANIN; ACYLATED ANTHOCYANINS; BIOSYNTHESIS GENES; EXPRESSION; FRUITS; 5-O-GLUCOSYLTRANSFERASE; IDENTIFICATION	Corolla color in Gentiana lutea L. exhibits a yellow/orange variation. We previously demonstrated that the orange petal color of G. lutea L. var. aurantiaca is predominantly caused by newly synthesized pelargonidin glycosides that confer a reddish hue to the yellow background color, derived from the carotenoids. However, the anthocyanin molecules of these pelargonidin glycosides are not yet fully identified and characterized. Here, we investigated the regulation, content and type of anthocyanins determining the petal coloration of the orange-flowered G. lutea L. var. aurantiaca. Anthocyanins from the petals of G. lutea L. var. aurantiaca were characterized and quantified by HPLC-ESI-MS/MS (High-performance liquid chromatography-electrospray ionization-tandem mass spectrometry) coupled with a diode array detector in flowers at three different stages of development (S1, S3 and S5). Eleven pelargonidin derivatives were identified in the petals of G. lutea L. var. aurantiaca for the first time, but quantitative and qualitative differences were observed at each developmental stage. The highest levels of these pelargonidin derivatives were reached at the fully open flower stage (S5) where all anthocyanins were detected. In contrast, not all the anthocyanins were detected at the budlet stage (S1) and mature bud stage (S3) and those corresponded to more complex pelargonidin derivatives. The major pelargonidin derivatives found at all the stages were pelargonidin 3-O-glucoside, pelargonidin 3,5-O-diglucoside and pelargonidin 3-O-rutinoside. Furthermore, the expression of DFR (dihydroflavonol 4-reductase), ANS (anthocyanidin synthase), 3GT (UDP-glucose: flavonoid 3-O-glucosyltransferase), 5GT (UDP-glucose: flavonoid 5-O-glucosyltransferase) and 5AT (anthocyanin 5-aromatic acyltransferase) genes was analyzed in the petals of three developmental stages, showing that the expression level of DFR, ANS and 3GT parallels the accumulation of the pelargonidin glucosides. Overall, this study enhances the knowledge of the biochemical basis of flower coloration in Gentiana species, and lays a foundation for breeding of flower color and genetic variation studies on Gentiana varieties.	[Diretto, Gianfranco] Italian Natl Agcy New Technol Energy & Sustainabl, Casaccia Res Ctr, Rome, Italy; [Jin, Xin; Capell, Teresa; Zhu, Changfu] Univ Lleida, Agrotecnio Ctr, Dept Prod Vegetal & Ciencia Forestal, Lleida, Spain; [Zhu, Changfu] Changchun Normal Univ, Sch Life Sci, Changchun, Jilin, Peoples R China; [Gomez-Gomez, Lourdes] Univ Castilla La Mancha, Fac Farm, Inst Bot, Dept Ciencia & Tecnol Agroforestal & Genet, Campus Univ, Albacete, Spain	Italian National Agency New Technical Energy & Sustainable Economics Development; Universitat de Lleida; Changchun Normal University; Universidad de Castilla-La Mancha	Zhu, CF (corresponding author), Univ Lleida, Agrotecnio Ctr, Dept Prod Vegetal & Ciencia Forestal, Lleida, Spain.; Zhu, CF (corresponding author), Changchun Normal Univ, Sch Life Sci, Changchun, Jilin, Peoples R China.; Gomez-Gomez, L (corresponding author), Univ Castilla La Mancha, Fac Farm, Inst Bot, Dept Ciencia & Tecnol Agroforestal & Genet, Campus Univ, Albacete, Spain.	zhu@pvcf.udl.cat; marialourdes.gomez@uclm.es	Capell, Teresa/AAD-8609-2022; Gomez-Gomez, Lourdes/AAF-2371-2020; Diretto, Gianfranco/L-9279-2017; Capell, Teresa/B-2757-2011; Zhu, Changfu/C-8446-2011	Gomez-Gomez, Lourdes/0000-0003-2586-4457; Diretto, Gianfranco/0000-0002-1441-0233; Capell, Teresa/0000-0002-6436-4538; Zhu, Changfu/0000-0003-2834-2742	National Natural Science Foundation of China [31270344]; MICINN, Spain [BIO2014-54441-P]; Jilin Provincial Science & Technology Department, China [20190201013JC]; PROGRAMA ESTATAL DE INVESTIGACION CIENTIFICA Y TECNICA DE EXCELENCIA, Spain [BIO2015-71703-REDT, BIO2017-90877-REDT]; European Cooperation in Science and Technology (EUROCAROTEN) [OC-2015-1-19780]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Jilin Provincial Science & Technology Department, China; PROGRAMA ESTATAL DE INVESTIGACION CIENTIFICA Y TECNICA DE EXCELENCIA, Spain; European Cooperation in Science and Technology (EUROCAROTEN)	This work was supported by the National Natural Science Foundation of China (31270344); MICINN, Spain (BIO2014-54441-P); International Science & Technology Cooperation Project supported by Jilin Provincial Science & Technology Department, China (20190201013JC); PROGRAMA ESTATAL DE INVESTIGACION CIENTIFICA Y TECNICA DE EXCELENCIA, Spain (BIO2015-71703-REDT, BIO2017-90877-REDT); European Cooperation in Science and Technology (EUROCAROTEN, OC-2015-1-19780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrazem O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21225-z; Barnes JS, 2011, INT J MASS SPECTROM, V308, P71, DOI 10.1016/j.ijms.2011.07.026; Berman J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162410; Blount JW, 2000, PLANT PHYSIOL, V122, P107, DOI 10.1104/pp.122.1.107; Diretto G, 2010, PLANT PHYSIOL, V154, P899, DOI 10.1104/pp.110.159368; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fujiwara H, 1998, PLANT J, V16, P421, DOI 10.1046/j.1365-313x.1998.00312.x; Fukuchi-Mizutani M, 2003, PLANT PHYSIOL, V132, P1652, DOI 10.1104/pp.102.018242; Giusti MM, 2003, BIOCHEM ENG J, V14, P217, DOI 10.1016/S1369-703X(02)00221-8; Gomez-Gomez L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010076; HARBORNE J B, 1962, Fortschr Chem Org Naturst, V20, P165; HARBORNE JB, 1958, BIOCHEM J, V70, P22, DOI 10.1042/bj0700022; Harborne JB, 2001, NAT PROD REP, V18, P310, DOI 10.1039/b006257j; HARBORNE JB, 1957, EXPERIENTIA, V13, P486, DOI 10.1007/BF02159411; Harborne JB, 1958, J CHOMATOGR, V1, P210; Holton Timothy A., 1995, Drug Metabolism and Drug Interactions, V12, P359; HONG V, 1990, J AGR FOOD CHEM, V38, P708, DOI 10.1021/jf00093a026; HOSOKAWA K, 1995, PHYTOCHEMISTRY, V40, P941, DOI 10.1016/0031-9422(95)00242-Y; HOSOKAWA K, 1995, PHYTOCHEMISTRY, V38, P1293, DOI 10.1016/0031-9422(94)00778-R; Justesen H, 1997, ANN BOT-LONDON, V79, P355, DOI 10.1006/anbo.1996.0371; KAMSTEEG J, 1978, BIOCHEM GENET, V16, P1059, DOI 10.1007/BF00484526; Kim HW, 2012, FOOD CHEM, V130, P966, DOI 10.1016/j.foodchem.2011.08.031; Kohlein F, 1991, GENTIANS, P25, DOI 10.1104/pp.102.018242; Koshioka M, 2015, NAT PROD COMMUN, V10, P453; Lai YS, 2012, PLANT SCI, V193, P136, DOI 10.1016/j.plantsci.2012.05.013; Lou Q, 2017, MOLECULES, V22, DOI 10.3390/molecules22050688; LU TS, 1992, PHYTOCHEMISTRY, V31, P289, DOI 10.1016/0031-9422(91)83056-Q; Maloney GS, 2014, PLANT PHYSIOL, V166, P614, DOI 10.1104/pp.114.240507; MARTIN C, 1993, PLANT CELL, V5, P1253, DOI 10.1105/tpc.5.10.1253; Matsuba Y, 2010, PLANT CELL, V22, P3374, DOI 10.1105/tpc.110.077487; Mu JP, 2017, ECOL EVOL, V7, P2947, DOI 10.1002/ece3.2899; Nakatsuka T, 2006, MOL GENET GENOMICS, V275, P231, DOI 10.1007/s00438-005-0083-7; Nakatsuka T, 2005, PLANT SCI, V169, P949, DOI 10.1016/j.plantsci.2005.06.013; Nakatsuka T, 2005, PLANT SCI, V168, P1309, DOI 10.1016/j.plantsci.2005.01.009; Nakatsuka T, 2008, J EXP BOT, V59, P1241, DOI 10.1093/jxb/ern031; Ohno S, 2011, J EXP BOT, V62, P5105, DOI 10.1093/jxb/err216; Rambla JL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01619; Renobales G., 2003, ANALES JARD BOT MADR, V60, P461; Rodriguez-Saona LE, 1998, J FOOD SCI, V63, P458, DOI 10.1111/j.1365-2621.1998.tb15764.x; Saito N, 1996, PHYTOCHEMISTRY, V41, P1613, DOI 10.1016/0031-9422(95)00824-1; Saito N, 1996, PHYTOCHEMISTRY, V43, P1365, DOI 10.1016/S0031-9422(96)00501-8; Sasaki N, 2015, PLANT CELL PHYSIOL, V56, P28, DOI 10.1093/pcp/pcu097; Sasaki N, 2014, MOLECULES, V19, P18747, DOI 10.3390/molecules191118747; Shi Ming-Zhu, 2014, Recent Pat Biotechnol, V8, P47, DOI 10.2174/1872208307666131218123538; Shim YS, 2015, J CHROMATOGR SCI, V53, P1646, DOI 10.1093/chromsci/bmv064; Sulli M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184143; Sun JH, 2012, RAPID COMMUN MASS SP, V26, P1123, DOI 10.1002/rcm.6209; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tanaka Y, 2008, CURR OPIN BIOTECH, V19, P190, DOI 10.1016/j.copbio.2008.02.015; TOKI K, 1995, PHYTOCHEMISTRY, V40, P939, DOI 10.1016/0031-9422(95)00371-D; Wu XL, 2005, J AGR FOOD CHEM, V53, P2589, DOI 10.1021/jf048068b; Yabuya T, 2002, PLANT SCI, V162, P779, DOI 10.1016/S0168-9452(02)00021-3; Yamagishi M, 2010, PLANT CELL PHYSIOL, V51, P463, DOI 10.1093/pcp/pcq011; Yildirim S, 2016, J SEP SCI, V39, P3927, DOI 10.1002/jssc.201600661; Yonekura-Sakakibara Keiko, 2009, P169, DOI 10.1007/978-0-387-77335-3_6; Yoshida K, 2009, NAT PROD REP, V26, P884, DOI 10.1039/b800165k; Zhang Y, 2014, CURR OPIN PLANT BIOL, V19, P81, DOI 10.1016/j.pbi.2014.05.011; Zhao DQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-689	60	19	20	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0212062	10.1371/journal.pone.0212062	http://dx.doi.org/10.1371/journal.pone.0212062			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742659	Green Submitted, Green Published, gold			2022-12-26	WOS:000458393400044
J	Ricciotti, E; Sarantopoulou, D; Grant, GR; Sanzari, JK; Krigsfeld, GS; Kiliti, AJ; Kennedy, AR; Grosser, T				Ricciotti, Emanuela; Sarantopoulou, Dimitra; Grant, Gregory R.; Sanzari, Jenine K.; Krigsfeld, Gabriel S.; Kiliti, Amber J.; Kennedy, Ann R.; Grosser, Tilo			Distinct vascular genomic response of proton and gamma radiation-A pilot investigation	PLOS ONE			English	Article							INFLAMMATORY PLAQUE PHENOTYPE; IONIZING-RADIATION; GENE-EXPRESSION; LONG-TERM; CARDIOVASCULAR COMPLICATIONS; BIOLOGICAL MECHANISMS; ENDOTHELIAL-CELLS; APOE(-/-) MICE; HEART-DISEASE; IRRADIATION	The cardiovascular biology of proton radiotherapy is not well understood. We aimed to compare the genomic dose-response to proton and gamma radiation of the mouse aorta to assess whether their vascular effects may diverge. We performed comparative RNA sequencing of the aorta following (4 hrs) total-body proton and gamma irradiation (0.5-200 cGy whole body dose, 10 dose levels) of conscious mice. A trend analysis identified genes that showed a dose response. While fewer genes were dose-responsive to proton than gamma radiation (29 vs. 194 genes; q-value <= 0.1), the magnitude of the effect was greater. Highly responsive genes were enriched for radiation response pathways (DNA damage, apoptosis, cellular stress and inflammation; p-value <= 0.01). Gamma, but not proton radiation induced additionally genes in vasculature specific pathways. Genes responsive to both radiation types showed almost perfectly superimposable dose-response relationships. Despite the activation of canonical radiation response pathways by both radiation types, we detected marked differences in the genomic response of the murine aorta. Models of cardiovascular risk based on photon radiation may not accurately predict the risk associated with proton radiation.	[Ricciotti, Emanuela; Kiliti, Amber J.; Grosser, Tilo] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ricciotti, Emanuela; Sarantopoulou, Dimitra; Grant, Gregory R.; Grosser, Tilo] Univ Penn, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Grant, Gregory R.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sanzari, Jenine K.; Krigsfeld, Gabriel S.; Kennedy, Ann R.] Univ Penn, Dept Radiat Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Grosser, T (corresponding author), Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA.; Grosser, T (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA.	tilo@pennmedicine.upenn.edu	Grosser, Tilo/A-1057-2007; Grant, Gregory Robert/I-3599-2019; Ricciotti, Emanuela/AAH-2729-2019	Grosser, Tilo/0000-0001-8569-8396; Grant, Gregory Robert/0000-0002-0139-7658; Kiliti, Amber/0000-0002-8581-6222; Sarantopoulou, Dimitra/0000-0002-1972-8865	National Institutes of Health [HL117798, UL1TR000003]; Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania	This work was supported by National Institutes of Health Grants HL117798 (TG), UL1TR000003 (TG), and in part by the Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania (TG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2004, J CLIN ONCOL, V22, P3139, DOI 10.1200/JCO.2004.09.109; Aleman BMP, 2007, BLOOD, V109, P1878, DOI 10.1182/blood-2006-07-034405; Aleman BMP, 2003, J CLIN ONCOL, V21, P3431, DOI 10.1200/JCO.2003.07.131; Antoccia A, 2009, J RADIAT RES, V50, P457, DOI 10.1269/jrr.09008; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Boerma M, 2010, CARDIOL RES PRACT, V2011, P1; Borghini A, 2013, ATHEROSCLEROSIS, V230, P40, DOI 10.1016/j.atherosclerosis.2013.06.010; Broustas CG, 2017, RADIAT RES, V187, P433, DOI 10.1667/RR0005.1; Broustas CG, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3436-1; Cervelli T, 2014, ATHEROSCLEROSIS, V235, P510, DOI 10.1016/j.atherosclerosis.2014.05.932; Chang PY, 2005, RADIAT RES, V164, P531, DOI 10.1667/RR3368.1; Chen JJ, 2017, INT J RADIAT ONCOL, V98, P775, DOI 10.1016/j.ijrobp.2017.03.017; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Efstathiou JA, 2012, RADIOTHER ONCOL, V103, P12, DOI 10.1016/j.radonc.2012.01.012; Finch W, 2014, REV CARDIOVASC MED, V15, P232, DOI 10.3909/ricm0689; Finnberg N, 2008, CANCER BIOL THER, V7, P2023, DOI 10.4161/cbt.7.12.7417; Gabriels K, 2012, RADIOTHER ONCOL, V105, P358, DOI 10.1016/j.radonc.2012.08.002; Gagliardi G, 2010, INT J RADIAT ONCOL, V76, pS77, DOI 10.1016/j.ijrobp.2009.04.093; Ganapathy V, 2004, PFLUG ARCH EUR J PHY, V447, P641, DOI 10.1007/s00424-003-1068-1; Girdhani S, 2013, RADIAT RES, V179, P257, DOI 10.1667/RR2839.1; Girdhani S, 2012, RADIAT RES, V178, P33, DOI 10.1667/RR2724.1; Gori T, 2012, EUR HEART J, V33, P292, DOI 10.1093/eurheartj/ehr288; Grabham P, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-19; Grabham P, 2012, INT J RADIAT BIOL, V88, P493, DOI 10.3109/09553002.2012.679382; Grabham P, 2011, RADIAT RES, V175, P21, DOI 10.1667/RR2289.1; Henson KE, 2013, BRIT J CANCER, V108, P179, DOI 10.1038/bjc.2012.575; Hoving S, 2008, INT J RADIAT ONCOL, V71, P848, DOI 10.1016/j.ijrobp.2008.02.031; Hughson RL, 2018, NAT REV CARDIOL, V15, P167, DOI 10.1038/nrcardio.2017.157; Kajioka EH, 2000, RADIAT RES, V153, P587, DOI 10.1667/0033-7587(2000)153[0587:AEOWBP]2.0.CO;2; Kantemiris I, 2011, MED PHYS, V38, P6585, DOI 10.1118/1.3662911; Kim EJ, PORT PIPELINE RNA SE; Kumar P, 2004, J BIOL CHEM, V279, P43352, DOI 10.1074/jbc.M405777200; Lancellotti P, 2013, EUR HEART J-CARD IMG, V14, P721, DOI 10.1093/ehjci/jet123; Lee CL, 2013, TRANSL CANCER RES, V2, P412, DOI 10.3978/j.issn.2218-676X.2013.09.01; Lee JH, 2005, BIOCHEM BIOPH RES CO, V337, P39, DOI 10.1016/j.bbrc.2005.08.264; Lee KF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/834087; Lee MO, 2012, ARTERIOSCL THROM VAS, V32, P343, DOI 10.1161/ATVBAHA.111.237651; Lee Peter J, 2005, Cardiol Rev, V13, P80, DOI 10.1097/01.crd.0000131188.41589.c5; Lin LL, 2015, ACTA ONCOL, V54, P1032, DOI 10.3109/0284186X.2015.1011756; Little MP, 2013, RADIAT ENVIRON BIOPH, V52, P435, DOI 10.1007/s00411-013-0484-7; Luo-Owen X, 2012, RADIAT RES, V177, P251, DOI 10.1667/RR2785.1; Maier P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010102; Maks CJ, 2011, RADIAT RES, V176, P170, DOI 10.1667/RR2413.1; Mayer C, 2011, CANCER LETT, V302, P20, DOI 10.1016/j.canlet.2010.12.006; Mitteer RA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13961; Nam SY, 1998, BIOCHEM PHARMACOL, V56, P1295, DOI 10.1016/S0006-2952(98)00203-2; Nayak S, 2018, ISO RELEVANCE FUNCTI; Ossetrova NI, 2014, RADIAT PROT DOSIM, V159, P61, DOI 10.1093/rpd/ncu165; Panganiban RAM, 2013, INT J RADIAT BIOL, V89, P656, DOI 10.3109/09553002.2012.711502; Roelofs E, 2012, J THORAC ONCOL, V7, P165, DOI 10.1097/JTO.0b013e31823529fc; Romero-Weaver AL, 2013, RADIAT RES, V180, P177, DOI 10.1667/RR3055.1; Romero-Weaver AL, 2013, ASTROBIOLOGY, V13, P570, DOI 10.1089/ast.2012.0916; Russo GL, 2012, EUR HEART J, V33, P408, DOI 10.1093/eurheartj/ehr263; Sanzari JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071757; Sardaro A, 2012, RADIOTHER ONCOL, V103, P133, DOI 10.1016/j.radonc.2012.02.008; Sasi SP, 2014, J BIOL CHEM, V289, P14178, DOI 10.1074/jbc.M114.567743; Schiller NK, 2001, ARTERIOSCL THROM VAS, V21, P1674, DOI 10.1161/hq1001.096724; Seemann I, 2012, RADIOTHER ONCOL, V103, P143, DOI 10.1016/j.radonc.2011.10.011; Sefer E, 2016, CELL SYST, V3, P35, DOI 10.1016/j.cels.2016.06.007; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Soucy KG, 2007, RADIAT ENVIRON BIOPH, V46, P179, DOI 10.1007/s00411-006-0090-z; Stewart FA, 2010, RADIAT RES, V174, P865, DOI 10.1667/RR1862.1; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Streeter PR, 2003, EXP HEMATOL, V31, P1119, DOI 10.1016/j.exphem.2003.07.003; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Tilton SC, 2016, RADIAT RES, V186, P531, DOI 10.1667/RR14471.1; Tiwana GS, 2015, ONCOTARGET, V6, P5978, DOI 10.18632/oncotarget.3468; Tommasino F, 2015, CANCERS, V7, P353, DOI 10.3390/cancers7010353; Trott KR, 2012, RADIOTHER ONCOL, V105, P79, DOI 10.1016/j.radonc.2012.05.008; Tukenova M, 2010, J CLIN ONCOL, V28, P1308, DOI 10.1200/JCO.2008.20.2267; van de Water TA, 2011, INT J RADIAT ONCOL, V79, P1216, DOI 10.1016/j.ijrobp.2010.05.012; van de Water TA, 2011, ONCOLOGIST, V16, P366, DOI 10.1634/theoncologist.2010-0171; Vodovotz Y, 1999, CIRCULATION, V100, P2527, DOI 10.1161/01.CIR.100.25.2527; Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463; Zastre JA, 2013, J NUTR BIOCHEM, V24, P1616, DOI 10.1016/j.jnutbio.2013.02.002	77	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0207503	10.1371/journal.pone.0207503	http://dx.doi.org/10.1371/journal.pone.0207503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742630	Green Published, gold, Green Submitted			2022-12-26	WOS:000458393400004
J	Ushigome, H; Fukunaga, Y; Nagasaki, T; Akiyoshi, T; Konishi, T; Fujimoto, Y; Nagayama, S; Ueno, M				Ushigome, Hajime; Fukunaga, Yosuke; Nagasaki, Toshiya; Akiyoshi, Takashi; Konishi, Tsuyoshi; Fujimoto, Yoshiya; Nagayama, Satoshi; Ueno, Masashi			Difficulty of predicting lymph node metastasis on CT in patients with rectal neuroendocrine tumors	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; CONSENSUS GUIDELINES; COMPUTED-TOMOGRAPHY; CANCER; CARCINOIDS; SIZE; MANAGEMENT; EPIDEMIOLOGY; SURVEILLANCE; EFFICACY	Background Surgical indications for rectal neuroendocrine tumors with potential lymph node metastasis remain controversial. Although accurate preoperative diagnosis of nodal status may be helpful for treatment strategy, scant data about clinical values of lymph node size have been reported. The aim of this retrospective study was to investigate the relationship between lymph node size and lymph node metastasis. Methods Participants comprised 102 patients who underwent rectal resection with total mesenteric excision or tumor-specific mesenteric excision and in some cases additional lateral pelvic lymph node dissection for rectal neuroendocrine tumor between June 2005 and September 2016. All lymph nodes from specimens were checked and measured. Results Pathological lymph node metastasis was confirmed in 37 patients (36%), including 6 patients (5.8%) with lateral pelvic lymph node metastasis. A total of 1169 lymph nodes in the mesorectum were retrieved from all specimens, with 78 lymph nodes (6.7%) showing metastasis. Mean length (long-axis diameter) of metastatic lymph nodes in the mesorectum was 4.31 mm, significantly larger than that of non-metastatic lymph nodes (2.39 mm, P<0.01). The optimal cut-off of major axis length for predicting mesorectal lymph node metastasis was 3 mm. We could predict lymph node metastasis in only 7 patients (21%) from preoperative multidetector-row computed tomography. Conclusions Metastatic lymph nodes were small, so predicting lymph node metastasis from preoperative computed tomography is difficult. Alternative modalities with a scan width less than 3 mm may be needed to predict lymph node metastasis of rectal NET with low cost and labour requirements.	[Ushigome, Hajime; Fukunaga, Yosuke; Nagasaki, Toshiya; Akiyoshi, Takashi; Konishi, Tsuyoshi; Fujimoto, Yoshiya; Nagayama, Satoshi; Ueno, Masashi] Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Dept Surg Gastroenterol,Koto Ku, Tokyo, Japan	Japanese Foundation for Cancer Research	Fukunaga, Y (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Dept Surg Gastroenterol,Koto Ku, Tokyo, Japan.	yosuke.fukunaga@jfcr.or.jp	Fukunaga, Yosuke/AAR-8933-2021; nagasaki, toshiya/AAE-6844-2020	Fukunaga, Yosuke/0000-0002-6397-0907; nagasaki, toshiya/0000-0001-5853-314X; Akiyoshi, Takashi/0000-0002-2321-1412				Akiyoshi T, 2014, ANN SURG ONCOL, V21, P189, DOI 10.1245/s10434-013-3216-y; Anthony LB, 2010, PANCREAS, V39, P767, DOI 10.1097/MPA.0b013e3181ec1261; Bajetta E, 2002, ANN ONCOL, V13, P614, DOI 10.1093/annonc/mdf064; Bajetta Emilio, 2003, Expert Rev Anticancer Ther, V3, P631, DOI 10.1586/14737140.3.5.631; Caplin M, 2012, NEUROENDOCRINOLOGY, V95, P88, DOI 10.1159/000335594; Cserni G, 2002, J CLIN PATHOL, V55, P386, DOI 10.1136/jcp.55.5.386; de Mestier L, 2013, ENDOSCOPY, V45, P1039, DOI 10.1055/s-0033-1344794; Eggenberger John Carl, 2011, Clin Colon Rectal Surg, V24, P129, DOI 10.1055/s-0031-1285996; FISHER KS, 1990, AM SURGEON, V56, P339; FT B. World Health Organization. International Agency for Research on Cancer, 2010, WHO CLASSIFICATION O; Kasuga A, 2012, J GASTROEN HEPATOL, V27, P1801, DOI 10.1111/j.1440-1746.2012.07218.x; Kim BC, 2016, COLORECTAL DIS, V18, pO243, DOI 10.1111/codi.13377; Kobayashi H, 2015, ANN SURG ONCOL, V22, P203, DOI 10.1245/s10434-014-3972-3; Konishi T, 2007, GUT, V56, P863, DOI 10.1136/gut.2006.109157; Kono Y, 2015, AM SURGEON, V81, P1263; Kulke MH, 2015, J NATL COMPR CANC NE, V13, P78, DOI 10.6004/jnccn.2015.0011; Langman G, 2015, DIS COLON RECTUM, V58, P406, DOI 10.1097/DCR.0000000000000321; Lowry AC, 2001, DIS COLON RECTUM, V44, P915, DOI 10.1007/BF02235475; Markl B, 2012, MODERN PATHOL, V25, P1413, DOI 10.1038/modpathol.2012.92; McConnell YJ, 2016, AM J SURG, V211, P877, DOI 10.1016/j.amjsurg.2016.01.008; Niederhuber JE, 2006, SURG ONCOL CLIN N AM, V15, P511, DOI 10.1016/j.soc.2006.05.004; RodriguezBigas MA, 1996, ANN SURG ONCOL, V3, P124, DOI 10.1007/BF02305790; Shields CJ, 2010, ANN SURG, V252, P750, DOI 10.1097/SLA.0b013e3181fb8df6; Soga J, 2003, J EXP CLIN CANC RES, V22, P517; Taghavi S, 2013, DIS COLON RECTUM, V56, P952, DOI 10.1097/DCR.0b013e318291f512; Takatsu Y, 2017, DIS COLON RECTUM, V60, P284, DOI 10.1097/DCR.0000000000000745; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Zhou X, 2013, J GASTROINTEST SURG, V17, P1689, DOI 10.1007/s11605-013-2249-7	28	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211675	10.1371/journal.pone.0211675	http://dx.doi.org/10.1371/journal.pone.0211675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742649	Green Submitted, Green Published, gold			2022-12-26	WOS:000458393400016
J	Ojha, CR; Rodriguez, M; Karuppan, MKM; Lapierre, J; Kashanchi, F; El-Hage, N				Ojha, Chet Raj; Rodriguez, Myosotys; Karuppan, Mohan Kumar Muthu; Lapierre, Jessica; Kashanchi, Fatah; El-Hage, Nazira			Toll-like receptor 3 regulates Zika virus infection and associated host inflammatory response in primary human astrocytes	PLOS ONE			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM STRESS; DENGUE VIRUS; AUTOPHAGY; AXL; PATHOGENESIS; ACTIVATION; DEFENSE; DISEASE; BRAZIL	The connection between Zika virus (ZIKV) and neurodevelopmental defects is widely recognized, although the mechanisms underlying the infectivity and pathology in primary human glial cells are poorly understood. Here we show that three isolated strains of ZIKV, an African strain MR766 (Uganda) and two closely related Asian strains R103451 (Honduras) and PRVABC59 (Puerto Rico) productively infect primary human astrocytes, although Asian strains showed a higher infectivity rate and increased cell death when compared to the African strain. Inhibition of AXL receptor significantly attenuated viral entry of MR766 and PRVABC59 and to a lesser extend R103451, suggesting an important role of TAM receptors in ZIKV cell entry, irrespective of lineage. Infection by PRVABC59 elicited the highest release of inflammatory molecules, with a 8-fold increase in the release of RANTES, 10-fold increase in secretion of IP-10 secretion and a 12-fold increase in IFN-beta secretion when compared to un-infected human astrocytes. Minor changes in the release of several growth factors, endoplasmic reticulum (ER)-stress response factors and the transcription factor, NF-kappa B were detected with the Asian strains, while significant increases in FOXO6, MAPK10 and JNK were detected with the African strain. Activation of the autophagy pathway was evident with increased expression of the autophagy related proteins Beclin1, LC3B and p62/SQSTM1 with all three strains of ZIKV. Pharmacological inhibition of the autophagy pathway and genetic inhibition of the Beclin1 showed minimal effects on ZIKV replication. The expression of toll-like receptor 3 (TLR3) was significantly increased with all three strains of ZIKV; pharmacological and genetic inhibition of TLR3 caused a decrease in viral titers and in viral-induced inflammatory response in infected astrocytes. We conclude that TLR3 plays a vital role in both ZIKV replication and viral-induced inflammatory responses, irrespective of the strains, while the autophagy protein Beclin1 influences host inflammatory responses.	[Ojha, Chet Raj; Rodriguez, Myosotys; Karuppan, Mohan Kumar Muthu; Lapierre, Jessica; El-Hage, Nazira] Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA	State University System of Florida; Florida International University; George Mason University	El-Hage, N (corresponding author), Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA.	nelhage@fiu.edu		Ojha, Chet Raj/0000-0002-6816-8892; Rodriguez, Myosotys/0000-0002-3925-9023	Florida Department of Health [7ZK09, R01 DA036154]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036154] Funding Source: NIH RePORTER	Florida Department of Health; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Nazira El-Hage received funding from the Florida Department of Health award number 7ZK09 and R01 DA036154 grant. (http://www.floridahealth.gov/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbulos Darrell S, 2016, Curr Protoc Microbiol, V43, DOI 10.1002/cpmc.19; Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157; Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/msphere.00292-17, 10.1128/mSphere.00292-17]; [Anonymous], 2017, VIRUSES BASEL, DOI DOI 10.3390/V9080201; Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Blackburn D, 2009, GLIA, V57, P1251, DOI 10.1002/glia.20848; Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]; Boasso A, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/580968; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; Breckpot K, 2010, J VIROL, V84, P5627, DOI 10.1128/JVI.00014-10; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4; Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006; Chiramel Abhilash I, 2013, Cells, V2, P83, DOI 10.3390/cells2010083; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; Darling NJ, 2014, BBA-MOL CELL RES, V1843, P2150, DOI 10.1016/j.bbamcr.2014.01.009; de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; DETER RL, 1967, J CELL BIOL, V33, P437, DOI 10.1083/jcb.33.2.437; Dever S. M., 2015, MICROBIOL, V6, P1, DOI DOI 10.3389/FMICB.2015.00001; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dong XY, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-173; El-Hage N, 2015, J VIROL, V89, P1024, DOI 10.1128/JVI.02022-14; FAYE O, 2014, PLOS NEGLECT TROP D, V0008; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Fukunaga K, 2009, ADV EXP MED BIOL, V665, P130; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4; Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Huang YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0017-2; Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/blt.16.178608, 10.2471/BLT.16.178608]; Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019; Liu WJ, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0031-z; Liu Y, 2016, J MED VIROL, V88, P1596, DOI 10.1002/jmv.24504; Marinelli C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0458-6; Marziale M, 2017, P TEX A M MED STUD G; Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045; Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI [10.1523/jneurosci.3124-16.2017, 10.1523/JNEUROSCI.3124-16.2017]; Naveca FG, 2017, BIORXIV, DOI [10.1101/185041, DOI 10.1101/185041]; Neidhart S, 2001, FEBS LETT, V508, P259, DOI 10.1016/S0014-5793(01)03090-3; Nozaki S, 2001, ONCOGENE, V20, P2178, DOI 10.1038/sj.onc.1204292; Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564; Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893; Rodriguez M, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080201; Routhu NK, 2017, J NEUROIMMUNE PHARM, V12, P219, DOI 10.1007/s11481-017-9736-7; Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020; Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685; SMITHBURN KC, 1952, J IMMUNOL, V69, P223; Sreekanth GP, 2018, CELL SIGNAL, V48, P64, DOI 10.1016/j.cellsig.2018.05.002; Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7; Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258; Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x; VanMarle G, 2007, W NILE VIRUS INDUCED, DOI [10.1128/JVI.02422-06, DOI 10.1128/JVI.02422-06]; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886; Willy JA, 2015, MOL BIOL CELL, V26, P2190, DOI 10.1091/mbc.E15-01-0036; Ferreira RAX, 2015, ACTA TROP, V149, P138, DOI 10.1016/j.actatropica.2015.04.023; Xu J, 2017, J IMMUNOLOGY S, V198; Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206	74	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0208543	10.1371/journal.pone.0208543	http://dx.doi.org/10.1371/journal.pone.0208543			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735502	gold, Green Published, Green Submitted			2022-12-26	WOS:000458181200007
J	Zhao, YF; Pan, BR; Zhang, ML				Zhao, Yanfen; Pan, Borong; Zhang, Mingli			Phylogeography and conservation genetics of the endangered Tugarinovia mongolica (Asteraceae) from Inner Mongolia, Northwest China	PLOS ONE			English	Article							ALLOPATRIC DIVERGENCE; POPULATION-GROWTH; MITOCHONDRIAL; DESERT; SHRUB; CHLOROPLAST; DISPERSAL; PATTERNS; HISTORY; CLIMATE	Tugarinovia (Family Asteraceae) is a monotypic genus. It's sole species, Tugarinovia mongolica Iljin, is distributed in the northern part of Inner Mongolia, with one additional variety, Tugarinovia mongolica var ovatifolia, which is distributed in the southern part of Inner Mongolia. The species has a limited geographical range and declining populations. To understand the phylogeographic structure of T. mongolica, we sequenced two chloroplast DNA regions (psbA-trnH and psbK-psbI) from 219 individuals of 16 populations, and investigated the genetic variation and phylogeographic patterns of T. mongolica. The results identified a total of 17 (H1-H17) chloroplast haplotypes. There were no haplotypes shared between the northern (T. mongolica) and southern groups (T. mongolica var. ovatifolia), and they formed two distinct lineages. The regional split was also supported by AMOVA and BEAST analyses. AMOVA showed the main variation that occurred between the two geographic groups. The time of divergence of the two groups can be dated to the early Pleistocene epoch, when climate fluctuations most likely resulted in the allopatric divergence of T. mongolica. The formation of the desert blocked genetic flow and enhanced the divergence of the northern and southern groups. Our results indicate that the genetic differences between T. mongolica and T. mongolica var. ovatifolia are consistent with previously proposed morphological differences. We speculate that the dry, cold climate and the expansion of the desert during the Quaternary resulted in the currently observed distribution of extant populations of T. mongolica. In the northern group, the populations Chuanjinsumu, Wuliji and Yingen displayed the highest genetic diversity and should be given priority protection. The southern group showed a higher genetic drift (F-ST = 1, G(ST) = 1), and the inbreeding load (H-S = 0) required protection for each population. Our results propose that the protection of T. mongolica should be implemented through in situ and ex situ conservation practices to increase the effective population size and genetic diversity.	[Zhao, Yanfen; Pan, Borong; Zhang, Mingli] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China; [Zhao, Yanfen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Mingli] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Pan, BR (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China.	brpan@ms.xjb.ac.cn			Biodiversity Conservation Strategy Program of Chinese Academy of Sciences [ZSSD-012]; China National Key Basic Research Program [2014CB954201]	Biodiversity Conservation Strategy Program of Chinese Academy of Sciences; China National Key Basic Research Program(National Basic Research Program of China)	This study is financially supported by Biodiversity Conservation Strategy Program of Chinese Academy of Sciences (ZSSD-012), and China National Key Basic Research Program (2014CB954201).	Aoki K, 2004, J PLANT RES, V117, P77, DOI 10.1007/s10265-003-0132-4; Bai WN, 2016, NEW PHYTOL, V209, P1757, DOI 10.1111/nph.13711; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beatty GE, 2013, J BIOGEOGR, V40, P335, DOI 10.1111/j.1365-2699.2012.02789.x; Bevill RL, 1999, CONSERV BIOL, V13, P493, DOI 10.1046/j.1523-1739.1999.97369.x; Chen LY, 2015, SCI BULL, V60, P1184, DOI 10.1007/s11434-015-0832-x; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Dong G., 1983, ACTA GEOGRAPHIC SINI, V38, P341; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankel O.H., 1995, CONSERVATION PLANT B; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fu LG, 1992, RED BOOK CHINESE PLA, P236; Fu XQ, 1992, FLORA INTRAMONGOLICA, VII, P704; Fu YX, 1997, GENETICS, V147, P915; Ge XJ, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-1; Guu YP, 2010, J SYST EVOL, V48, P153, DOI 10.1111/j.1759-6831.2010.00073.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Huang SC, 2005, J PLANT RES, V118, P1, DOI 10.1007/s10265-004-0185-z; Jia DR, 2012, NEW PHYTOL, V194, P1123, DOI 10.1111/j.1469-8137.2012.04115.x; Jia DR, 2011, BIOL J LINN SOC, V102, P37, DOI 10.1111/j.1095-8312.2010.01553.x; Jia J, 2016, PLANT MOL BIOL REP, V34, P327, DOI 10.1007/s11105-015-0924-4; Lande R, 1998, RES POPUL ECOL, V40, P259, DOI 10.1007/BF02763457; Li BF, 2017, QUATERNARY SCI REV, V156, P69, DOI 10.1016/j.quascirev.2016.11.023; Li ZH, 2012, J SYST EVOL, V50, P351, DOI 10.1111/j.1759-6831.2012.00201.x; Liu JQ, 2012, J SYST EVOL, V50, P267, DOI 10.1111/j.1759-6831.2012.00214.x; Ma H, 2000, ACTA BOT BOREALI-OCC, V20, P461; Ma SM, 2011, DISTRIBUTION PATTERN; Ma SM, 2012, CONSERV GENET, V13, P1531, DOI 10.1007/s10592-012-0397-z; Meng HH, 2015, J SYST EVOL, V53, P33, DOI 10.1111/jse.12088; Meng HH, 2013, MOL PHYLOGENET EVOL, V68, P398, DOI 10.1016/j.ympev.2013.04.012; Meng HH, 2011, BIOCHEM SYST ECOL, V39, P787, DOI 10.1016/j.bse.2011.07.015; Pons O, 1996, GENETICS, V144, P1237; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Santiso X, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01264; Schneider S, 1999, GENETICS, V152, P1079; Shi XJ, 2015, J PLANT RES, V128, P269, DOI 10.1007/s10265-014-0699-y; Shi Z, 1979, FLORA REIPUBLICAE PO, V75, P246; Shi Z., 2011, FLORA CHINA, P41; Su ZH, 2016, CONSERV GENET, V17, P485, DOI 10.1007/s10592-015-0798-x; Su ZH, 2016, BOT J LINN SOC, V180, P334, DOI 10.1111/boj.12376; Su ZH, 2011, CONSERV GENET, V12, P1525, DOI 10.1007/s10592-011-0250-9; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang He-Sheng, 1994, Acta Botanica Yunnanica, V16, P209; Wang P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159790; Wang Q, 2013, NEW PHYTOL, V199, P277, DOI 10.1111/nph.12241; Wang Y, 1996, ARID ZONE RES, V13, P20; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Xu Z, 2015, J HERED, V106, P184, DOI 10.1093/jhered/esu078; Zhang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061954, 10.1371/journal.pone.0069046]; Zhang HX, 2012, J SYST EVOL, V50, P295, DOI 10.1111/j.1759-6831.2012.00198.x; Zhang LX, 2001, CHINA POPULATION RES, V11, P98; Zhang YH, 2017, PLANT SYST EVOL, V303, P451, DOI 10.1007/s00606-016-1383-6; Zhao YZ, 1997, ACTA SCI NATURALIUM, V28, P547; Zhao YZ., 2000, ACTA BOT BOR OCCID S, V20, P873; Zhou Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155495; Zhu XM, 2008, STUDY ORIGIN MIGRATI; Zhu Z, 1999, J ARID LAND RESOURCE, V13, P1	63	11	14	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211696	10.1371/journal.pone.0211696	http://dx.doi.org/10.1371/journal.pone.0211696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730930	Green Published, Green Submitted, gold			2022-12-26	WOS:000458026000046
J	Kiskaddon, E; Chernicky, K; Bell, S				Kiskaddon, Erin; Chernicky, Kiley; Bell, Susan			Resource use by and trophic variability of Armases cinereum (Crustacea, Brachyura) across human-impacted mangrove transition zones	PLOS ONE			English	Article							ISOTOPE MIXING MODELS; FOOD-WEB STRUCTURE; SALT-MARSH CRAB; STABLE-ISOTOPES; CLIMATE-CHANGE; PLANT; CONSEQUENCES; PALATABILITY; HABITAT; CONNECTIVITY	In Florida, resource use patterns by Armases cinereum (Armases), a highly abundant crab in coastal habitats, may serve as important indicators of habitat condition. Here we investigated feeding patterns of Armases in coastal palm scrub forest to intertidal mangrove forest transition zones (transitions) as well as the relationship between habitat disturbance and Armases' trophic position across three pairs of geographically separated populations in Tampa FL, USA. Each pair of sites represented an unmodified "natural" location as well as a "disturbed" location lacking upland terrestrial palm scrub forested habitat. Laboratory experiments established a baseline understanding of feeding preference of Armases offered strictly mangrove material as well as sources abundant at the transition. In-situ feeding behavior was examined using MixSIAR mixing models with delta C-13 and delta N-15 stable isotope tracers. Armases showed a strong preference for consuming partially-decomposed mangrove material from Avicennia germinans and an equally strong preference for Iva frutescens. Armases also displayed predatory behavior under laboratory conditions, confirming omnivory in the presence of mangrove material. Stable isotopes revealed a pattern of elevated trophic position of Armases in disturbed habitats over paired natural locations. Diet reconstruction provided coarse resolution of in-situ feeding and results show high spatial variation: in natural habitats, Armases appears to rely heavily upon upland plant material compared to disturbed habitats where it may consume more animal prey. Combined, these findings support that Armases trophic position and diet may indicate habitat quality in mangrove transitions in the southeastern United States.	[Kiskaddon, Erin; Chernicky, Kiley; Bell, Susan] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Kiskaddon, E (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA.	ekiskaddon@gmail.com		Kiskaddon, Erin/0000-0003-1133-0390	St. Petersburg Audubon Society from a 2016 SPAS Student Grant	St. Petersburg Audubon Society from a 2016 SPAS Student Grant	Funding was secured for EK from the St. Petersburg Audubon Society from a 2016 SPAS Student Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele Lawrence G., 1992, Smithsonian Contributions to Zoology, V527, P1; Adams P, 1993, SALTMARSH ECOLOGY; Bertness MD, 2008, CONSERV BIOL, V22, P618, DOI 10.1111/j.1523-1739.2008.00962.x; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bosire JO, 2008, AQUAT BOT, V89, P251, DOI 10.1016/j.aquabot.2008.03.010; Bouillon S, 2008, J SEA RES, V59, P44, DOI 10.1016/j.seares.2007.05.001; Buck TL, 2003, J EXP MAR BIOL ECOL, V292, P103, DOI 10.1016/S0022-0981(03)00146-1; Bui THH, 2015, COMP BIOCHEM PHYS B, V179, P27, DOI 10.1016/j.cbpb.2014.09.004; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Cadenasso ML, 2003, BIOSCIENCE, V53, P717, DOI 10.1641/0006-3568(2003)053[0717:AIASAT]2.0.CO;2; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; COHEN JE, 1988, ECOLOGY, V69, P1655, DOI 10.2307/1941142; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Demopoulos AWJ, 2007, OECOLOGIA, V153, P675, DOI 10.1007/s00442-007-0751-x; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Enwright NM, 2016, FRONT ECOL ENVIRON, V14, P307, DOI 10.1002/fee.1282; Erickson AA, 2004, BIOTROPICA, V36, P333; Ewel KC, 2001, ECOSYSTEMS, V4, P452, DOI 10.1007/s10021-001-0106-0; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Fry B., 2006, STABLE ISOTOPE ECOLO; Gehman ALM, 2017, ESTUAR COAST, P1; Gilman EL, 2008, AQUAT BOT, V89, P237, DOI 10.1016/j.aquabot.2007.12.009; Giri C, 2016, SENSORS, V16, P1; Granek E, 2008, ESTUAR COAST SHELF S, V80, P555, DOI 10.1016/j.ecss.2008.09.012; Harada Y, 2016, ESTUAR COAST SHELF S, V174, P41, DOI 10.1016/j.ecss.2016.03.017; Herbon CM, 2013, MAR ECOL PROG SER, V490, P91, DOI 10.3354/meps10421; Ho CK, 2008, ECOLOGY, V89, P1714, DOI 10.1890/07-1069.1; Hubner L, 2015, OECOLOGIA, V178, P999, DOI 10.1007/s00442-015-3271-0; Huxel GR, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P434; Jack L, 2011, MAR ECOL PROG SER, V443, P129, DOI 10.3354/meps09468; Kelleway JJ, 2017, GLOBAL CHANGE BIOL, V23, P3967, DOI 10.1111/gcb.13727; Kennish MJ, 2001, J COASTAL RES, V17, P731; Kon K, 2010, J EXP MAR BIOL ECOL, V383, P171, DOI 10.1016/j.jembe.2009.11.015; Krauss KW, 2011, J COAST CONSERV, V15, P629, DOI 10.1007/s11852-011-0153-4; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Kristensen DK, 2010, ESTUAR COAST SHELF S, V87, P583, DOI 10.1016/j.ecss.2010.02.016; Kruitwagen G, 2010, ESTUAR COAST SHELF S, V88, P464, DOI 10.1016/j.ecss.2010.05.002; Levin L. A., 2012, STABLE ISOTOPE PROTO; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; MANLY BFJ, 1974, BIOMETRICS, V30, P281, DOI 10.2307/2529649; MANLY BFJ, 1995, BIOMETRICS, V51, P709, DOI 10.2307/2532956; Marczak LB, 2011, ECOLOGY, V92, P276, DOI 10.1890/10-0760.1; Martinuzzi S, 2009, FOREST ECOL MANAG, V257, P75, DOI 10.1016/j.foreco.2008.08.037; McCann MJ, 2017, FRONT ECOL ENVIRON, V15, P142, DOI 10.1002/fee.1474; Meixler MS, 2018, ESTUAR COAST, V41, P52, DOI 10.1007/s12237-017-0296-0; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Morrow K, 2014, MAR ECOL PROG SER, V502, P197, DOI 10.3354/meps10728; NEILSON MJ, 1986, MAR ECOL PROG SER, V34, P185, DOI 10.3354/meps034185; Nobbs M, 2003, J EXP MAR BIOL ECOL, V284, P41, DOI 10.1016/S0022-0981(02)00488-4; Nordhaus I, 2011, J SEA RES, V65, P414, DOI 10.1016/j.seares.2011.03.006; Nordstrom MC, 2015, J APPL ECOL, V52, P1343, DOI 10.1111/1365-2664.12473; NOSS RF, 1995, 28 NAT BIOL SERV; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Page HM, 2013, OCEANOGRAPHY, V26, P180, DOI 10.5670/oceanog.2013.61; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pennings SC, 1998, ECOLOGY, V79, P1968; Pennings SC, 2001, ECOLOGY, V82, P1344, DOI 10.1890/0012-9658(2001)082[1344:LDIPPI]2.0.CO;2; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; R Core Team, 2013, R LANG ENV STAT COMP; Rooney N, 2008, ECOL LETT, V11, P867, DOI 10.1111/j.1461-0248.2008.01193.x; Saintilan N, 2013, ESTUAR COAST SHELF S, V128, P84, DOI 10.1016/j.ecss.2013.05.010; SEIPLE W, 1982, J EXP MAR BIOL ECOL, V62, P1, DOI 10.1016/0022-0981(82)90213-1; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Sheaves M, 2005, MAR ECOL PROG SER, V302, P293, DOI 10.3354/meps302293; Sheaves M, 2009, MAR ECOL PROG SER, V391, P107, DOI 10.3354/meps08121; Siska EL, 2002, ECOLOGY, V83, P3369, DOI 10.1890/0012-9658(2002)083[3369:LVIPOS]2.0.CO;2; Smith JA, 2013, METHODS ECOL EVOL, V4, P612, DOI 10.1111/2041-210X.12048; Tewfik A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147759; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Walsh G. E., 1974, Ecology of halophytes ed. R.J. Reimold and W.H. Queen., P51; Wedge M, 2017, WETLANDS, V37, P715, DOI 10.1007/s13157-017-0902-8; Winkler G, 2007, MAR ECOL PROG SER, V332, P171, DOI 10.3354/meps332171; Yando ES, 2016, METHODS ECOL EVOL, P1; Zarnetske PL., 2017, CURR LANDSC ECOL REP, V2, P12, DOI DOI 10.1007/S40823-017-0021-5; Zimmer M, 2004, ESTUARIES, V27, P753, DOI 10.1007/BF02912038	82	5	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212448	10.1371/journal.pone.0212448	http://dx.doi.org/10.1371/journal.pone.0212448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768634	gold, Green Published, Green Submitted			2022-12-26	WOS:000458766300040
J	Biasiolli, L; Hann, E; Lukaschuk, E; Carapella, V; Paiva, JM; Aung, N; Rayner, JJ; Werys, K; Fung, K; Puchta, H; Sanghvi, MM; Moon, NO; Thomson, RJ; Thomas, KE; Robson, MD; Grau, V; Petersen, SE; Neubauer, S; Piechnik, SK				Biasiolli, Luca; Hann, Evan; Lukaschuk, Elena; Carapella, Valentina; Paiva, Jose M.; Aung, Nay; Rayner, Jennifer J.; Werys, Konrad; Fung, Kenneth; Puchta, Henrike; Sanghvi, Mihir M.; Moon, Niall O.; Thomson, Ross J.; Thomas, Katharine E.; Robson, Matthew D.; Grau, Vicente; Petersen, Steffen E.; Neubauer, Stefan; Piechnik, Stefan K.			Automated localization and quality control of the aorta in cine CMR can significantly accelerate processing of the UK Biobank population data	PLOS ONE			English	Article							WALL THICKNESS; MR-IMAGES; QUANTIFICATION	Introduction Aortic distensibility can be calculated using semi-automated methods to segment the aortic lumen on cine CMR (Cardiovascular Magnetic Resonance) images. However, these methods require visual quality control and manual localization of the region of interest (ROI) of ascending (AA) and proximal descending (PDA) aorta, which limit the analysis in large-scale population-based studies. Using 5100 scans from UK Biobank, this study sought to develop and validate a fully automated method to 1) detect and locate the ROIs of AA and PDA, and 2) provide a quality control mechanism. Methods The automated AA and PDA detection-localization algorithm followed these steps: 1) fore-ground segmentation; 2) detection of candidate ROIs by Circular Hough Transform (CHT); 3) spatial, histogram and shape feature extraction for candidate ROIs; 4) AA and PDA detection using Random Forest (RF); 5) quality control based on RF detection probability. To provide the ground truth, overall image quality (IQ = 0-3 from poor to good) and aortic locations were visually assessed by 13 observers. The automated algorithm was trained on 1200 scans and Dice Similarity Coefficient (DSC) was used to calculate the agreement between ground truth and automatically detected ROIs. Results The automated algorithm was tested on 3900 scans. Detection accuracy was 99.4% for AA and 99.8% for PDA. Aorta localization showed excellent agreement with the ground truth, with DSC >= 0.9 in 94.8% of AA (DSC = 0.97 +/- 0.04) and 99.5% of PDA cases (DSC = 0.98 +/- 0.03). AAxPDA detection probabilities could discriminate scans with IQ >= 1 from those severely corrupted by artefacts (AUC = 90.6%). If scans with detection probability < 0.75 were excluded (350 scans), the algorithm was able to correctly detect and localize AA and PDA in all the remaining 3550 scans (100% accuracy). Conclusion The proposed method for automated AA and PDA localization was extremely accurate and the automatically derived detection probabilities provided a robust mechanism to detect low quality scans for further human review. Applying the proposed localization and quality control techniques promises at least a ten-fold reduction in human involvement without sacrificing any accuracy.	[Biasiolli, Luca; Hann, Evan; Lukaschuk, Elena; Carapella, Valentina; Rayner, Jennifer J.; Werys, Konrad; Puchta, Henrike; Moon, Niall O.; Thomas, Katharine E.; Robson, Matthew D.; Neubauer, Stefan; Piechnik, Stefan K.] Univ Oxford, Oxford Ctr Clin Magnet Resonance Res OCMR, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England; [Paiva, Jose M.; Aung, Nay; Fung, Kenneth; Sanghvi, Mihir M.; Thomson, Ross J.; Petersen, Steffen E.] Queen Mary Univ London, William Harvey Res Inst, NIHR Barts Biomed Res Ctr, London, England; [Grau, Vicente] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England	University of Oxford; University of London; Queen Mary University London; University of Oxford	Biasiolli, L (corresponding author), Univ Oxford, Oxford Ctr Clin Magnet Resonance Res OCMR, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England.	luca.biasiolli@cardiov.ox.ac.uk	Thomson, Ross/GXV-0334-2022; Petersen, Steffen E/A-8389-2011; Thomson, Ross/AAU-6636-2020	Petersen, Steffen E/0000-0003-4622-5160; Thomson, Ross/0000-0002-8229-8060; Aung, Nay/0000-0001-5095-1611; Biasiolli, Luca/0000-0002-0452-8756; Grau, Vicente/0000-0001-8139-3480; Neubauer, Stefan/0000-0001-9017-5645; Sanghvi, Mihir/0000-0002-1914-4149; Hann, Evan/0000-0002-8911-923X	British Heart Foundation (BHF) [PG/15/74/31747]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre at The Oxford University Hospitals, University of Oxford, UK; BHF [PG/14/89/31194]; British Heart Foundation Centre of Research Excellence, Oxford, UK; National Institute for Health Research Barts Biomedical Research Centre	British Heart Foundation (BHF)(British Heart Foundation); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre at The Oxford University Hospitals, University of Oxford, UK; BHF(British Heart Foundation); British Heart Foundation Centre of Research Excellence, Oxford, UK; National Institute for Health Research Barts Biomedical Research Centre	LB was supported by the British Heart Foundation (BHF PG/15/74/31747). This study was funded in part by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre at The Oxford University Hospitals, University of Oxford, UK. The authors acknowledge the BHF for funding the manual analysis to create a cardiovascular magnetic resonance imaging reference standard for the UK Biobank imaging resource in 5000 CMR scans (PG/14/89/31194). SN, SKP acknowledge support from the British Heart Foundation Centre of Research Excellence, Oxford, UK. SEP was directly funded by the National Institute for Health Research Barts Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame IM, 2006, J MAGN RESON IMAGING, V24, P595, DOI 10.1002/jmri.20662; Bai WJ, 2018, LECT NOTES COMPUT SC, V11073, P586, DOI 10.1007/978-3-030-00937-3_67; Biasiolli L, 2010, P SPIE MED IM IM POS; Biasiolli L, 2011, J MAGN RESON IMAGING, V33, P1136, DOI 10.1002/jmri.22569; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carapella V, 2016, LECT NOTES COMPUT SC, V10008, P238, DOI 10.1007/978-3-319-46976-8_25; Gao S, 2017, J MAGN RESON IMAGING, V45, P215, DOI 10.1002/jmri.25332; Goel A, 2014, J MAGN RESON IMAGING, V40, P221, DOI 10.1002/jmri.24338; Herment A, 2011, MAGN RESON MED, V65, P986, DOI 10.1002/mrm.22678; Jackson CE, 2009, INT J CARDIOVAS IMAG, V25, P797, DOI 10.1007/s10554-009-9495-5; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; Petersen SE, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0227-4; Redheuil A, 2014, J AM COLL CARDIOL, V64, P2619, DOI 10.1016/j.jacc.2014.09.060; Robinson R, P MED IM COMP COMP A, P720; Vedaldi A, 2010, P 18 ACM INT C MULT, P1469, DOI DOI 10.1145/1873951.1874249; Zhang L, 2016, LECT NOTES COMPUT SC, V9968, P138, DOI 10.1007/978-3-319-46630-9_14	17	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212272	10.1371/journal.pone.0212272	http://dx.doi.org/10.1371/journal.pone.0212272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763349	Green Published, gold, Green Submitted			2022-12-26	WOS:000458763900057
J	Ul-Hasan, S; Bowers, RM; Figueroa-Montiel, A; Licea-Navarro, AF; Beman, JM; Woyke, T; Nobile, CJ				Ul-Hasan, Sabah; Bowers, Robert M.; Figueroa-Montiel, Andrea; Licea-Navarro, Alexei F.; Beman, J. Michael; Woyke, Tanja; Nobile, Clarissa J.			Community ecology across bacteria, archaea and microbial eukaryotes in the sediment and seawater of coastal Puerto Nuevo, Baja California	PLOS ONE			English	Article							GUERRERO-NEGRO; CLIMATE-CHANGE; LYNGBYA-SP; MATS; DIVERSITY; BIOGEOCHEMISTRY; PATTERNS; BIOGEOGRAPHY; ENVIRONMENT; DYNAMICS	Microbial communities control numerous biogeochemical processes critical for ecosystem function and health. Most analyses of coastal microbial communities focus on the characterization of bacteria present in either sediment or seawater, with fewer studies characterizing both sediment and seawater together at a given site, and even fewer studies including information about non-bacterial microbial communities. As a result, knowledge about the ecological patterns of microbial biodiversity across domains and habitats in coastal communities is limited-despite the fact that archaea, bacteria, and microbial eukaryotes are present and known to interact in coastal habitats. To better understand microbial biodiversity patterns in coastal ecosystems, we characterized sediment and seawater microbial communities for three sites along the coastline of Puerto Nuevo, Baja California, Mexico using both 16S and 18S rRNA gene amplicon sequencing. We found that sediment hosted approximately 500-fold more operational taxonomic units (OTUs) for bacteria, archaea, and microbial eukaryotes than seawater (p < 0.001). Distinct phyla were found in sediment versus seawater samples. Of the top ten most abundant classes, Cytophagia (bacterial) and Chromadorea (eukaryal) were specific to the sediment environment, whereas Cyanobacteria and Bacteroidia (bacterial) and Chlorophyceae (eukaryal) were specific to the seawater environment. A total of 47 unique genera were observed to comprise the core taxa community across environment types and sites. No archaeal taxa were observed as part of either the abundant or core taxa. No significant differences were observed for sediment community composition across domains or between sites. For seawater, the bacterial and archaeal community composition was statistically different for the Major Outlet site (p < 0.05), the site closest to a residential area, and the eukaryal community composition was statistically different between all sites (p < 0.05). Our findings highlight the distinct patterns and spatial heterogeneity in microbial communities of a coastal region in Baja California, Mexico.	[Ul-Hasan, Sabah; Woyke, Tanja; Nobile, Clarissa J.] Univ Calif Merced, Sch Nat Sci, Dept Mol & Cell Biol, Merced, CA 95343 USA; [Ul-Hasan, Sabah] Univ Calif Merced, Quantitat & Syst Biol Grad Program, Merced, CA 95343 USA; [Bowers, Robert M.; Woyke, Tanja] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Figueroa-Montiel, Andrea; Licea-Navarro, Alexei F.] CICESE, Dept Biomed Innovat, Ensenada, Baja California, Mexico; [Beman, J. Michael] Univ Calif Merced, Sch Nat Sci, Dept Life & Environm Sci, Merced, CA USA	University of California System; University of California Merced; University of California System; University of California Merced; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; University of California System; University of California Merced	Ul-Hasan, S; Nobile, CJ (corresponding author), Univ Calif Merced, Sch Nat Sci, Dept Mol & Cell Biol, Merced, CA 95343 USA.; Ul-Hasan, S (corresponding author), Univ Calif Merced, Quantitat & Syst Biol Grad Program, Merced, CA 95343 USA.	bysabahulhasan@gmail.com; cnobile@ucmerced.edu	Navaro, Alexei Fedorovish Licea/B-4106-2016; Nobile, Clarissa/C-2407-2015	Navaro, Alexei Fedorovish Licea/0000-0003-4022-7405; Nobile, Clarissa/0000-0003-0799-6499	U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility [DE-AC02-05CH11231]; University of California Mexus Small Grant; Eugene Cota-Robles Fellowship from the University of California, Merced; National Institutes of Health [R35GM124594]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124594] Funding Source: NIH RePORTER	U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility(United States Department of Energy (DOE)); University of California Mexus Small Grant; Eugene Cota-Robles Fellowship from the University of California, Merced; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work conducted by the U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, was supported under Contract No. DE-AC02-05CH11231. Travel and sampling costs were supported by the University of California Mexus Small Grant with SU and AFM listed as contributors in collaboration with ALN. Labor costs were additionally supported by the Eugene Cota-Robles Fellowship from the University of California, Merced to SU. CJN acknowledges funding from the National Institutes of Health grant R35GM124594. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Valdivieso-Ojeda JA, 2014, CHEM GEOL, V363, P341, DOI 10.1016/j.chemgeo.2013.11.021; Aleklett K, 2018, ISME J, V12, P312, DOI 10.1038/ismej.2017.184; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Huerta-Diaz MA, 2011, AQUAT GEOCHEM, V17, P603, DOI 10.1007/s10498-011-9126-3; Angell JH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00170; Bakun A, 2015, CURR CLIM CHANGE REP, V1, P85, DOI 10.1007/s40641-015-0008-4; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Barberan A, 2010, AQUAT MICROB ECOL, V59, P1, DOI 10.3354/ame01389; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bauer JE, 2013, NATURE, V504, P61, DOI 10.1038/nature12857; Bokulich N. A., 2017, PEERJ PREPRINTS, DOI [10.7287/peerj.preprints.3208v1, DOI 10.7287/PEERJ.PREPRINTS.3208V1]; Bolhuis H, 2014, FEMS MICROBIOL ECOL, V90, P335, DOI 10.1111/1574-6941.12408; Bowen JL, 2015, MICROB ECOL, V70, P311, DOI 10.1007/s00248-015-0582-y; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brussaard CPD, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.255; Camanocha A, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.25468; Campbell AM, 2015, MICROBIOLOGYOPEN, V4, P390, DOI 10.1002/mbo3.245; Capone DG, 2013, NAT GEOSCI, V6, P711, DOI 10.1038/NGEO1916; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chen WD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01912; Core R Team D, 2011, LANG ENV STAT COMP; Cowan MK, 2018, MICROBIOLOGY SYSTEMS; Daly NL, 2014, FUTURE MED CHEM, V6, P1715, DOI [10.4155/FMC.14.108, 10.4155/fmc.14.108]; DOWNING JA, 1988, LIMNOL OCEANOGR, V33, P447, DOI 10.4319/lo.1988.33.3.0447; Franco DC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00153; Fuhrman JA, 2015, NAT REV MICROBIOL, V13, P133, DOI 10.1038/nrmicro3417; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gao Y, 2014, LIMNOL OCEANOGR, V59, P959, DOI 10.4319/lo.2014.59.3.0959; Ghaisas S, 2016, PHARMACOL THERAPEUT, V158, P52, DOI 10.1016/j.pharmthera.2015.11.012; Gradoville MR, 2017, LIMNOL OCEANOGR, V62, P1895, DOI 10.1002/lno.10542; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Hao YQ, 2016, ENVIRON MICROBIOL, V18, P1730, DOI 10.1111/1462-2920.12858; Haskell WZ, 2017, GLOBAL BIOGEOCHEM CY, V31, P357, DOI 10.1002/2016GB005561; He YD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01579; Hedges JI, 1997, ORG GEOCHEM, V27, P319, DOI 10.1016/S0146-6380(97)00056-9; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hollibaugh JT, 2014, ISME J, V8, P685, DOI 10.1038/ismej.2013.171; Huerta-Diaz MA, 2012, GEOBIOLOGY, V10, P531, DOI 10.1111/gbi.12008; Hunt DE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01182; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kaestli M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01313; Kavagutti VS, 2016, BIOTIC FACTORS DRIVE; Kirchman DL, 2016, ANNU REV MAR SCI, V8, P285, DOI 10.1146/annurev-marine-122414-033938; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Langenheder S, 2007, ECOLOGY, V88, P2154, DOI 10.1890/06-2098.1; Li H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01763; Lopez-Cortes A., 2001, International Microbiology, V4, P227; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lu XM, 2017, MICROB ECOL, V73, P791, DOI 10.1007/s00248-016-0868-8; Machado RJA, 2016, TOXICON, V119, P362, DOI 10.1016/j.toxicon.2016.06.002; Makhalanyane TP, 2015, BIODIVERS CONSERV, V24, P819, DOI 10.1007/s10531-015-0902-z; Martini AM, 2002, GEOL SOC AM BULL, V114, P1055; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; McFall-Ngai MJ, 2014, ANNU REV MICROBIOL, V68, P177, DOI 10.1146/annurev-micro-091313-103654; Moulton OM, 2016, FRONT ECOL ENVIRON, V14, P200, DOI 10.1002/fee.1262; Nielsen LP, 2015, ANNU REV MAR SCI, V7, P425, DOI 10.1146/annurev-marine-010814-015708; O'Brien SL, 2016, ENVIRON MICROBIOL, V18, P2039, DOI 10.1111/1462-2920.13231; Omoregie EO, 2004, APPL ENVIRON MICROB, V70, P2119, DOI 10.1128/AEM.70.4.2119-2128.2004; Omoregie EO, 2004, FEMS MICROBIOL ECOL, V47, P305, DOI 10.1016/S0168-6496(03)00301-5; Orphan VJ, 2008, GEOBIOLOGY, V6, P376, DOI 10.1111/j.1472-4669.2008.00166.x; Paerl H., 2017, F1000RESEARCH, V6; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Petro C, 2017, AQUAT MICROB ECOL, V79, P177, DOI 10.3354/ame01826; Prober SM, 2015, ECOL LETT, V18, P85, DOI 10.1111/ele.12381; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Reimer JJ, 2011, ESTUAR COAST, V34, P514, DOI 10.1007/s12237-010-9308-z; Richa K, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00494-17; Cleary DFR, 2018, MAR BIODIVERS, V48, P1889, DOI 10.1007/s12526-017-0697-0; Roling WFM, 2010, CURR OPIN BIOTECH, V21, P532, DOI 10.1016/j.copbio.2010.06.007; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Stoyan H, 2000, PLANT SOIL, V222, P203, DOI 10.1023/A:1004757405147; Sun MY, 2013, ENVIRON MICROBIOL, V15, P2517, DOI 10.1111/1462-2920.12133; Thompson L., 18S ILLUMINA AMPLICO, DOI [10.17504/protocols.io.nuvdew6, DOI 10.17504/PROTOCOLS.IO.NUVDEW6]; Tremblay J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00771; Wallenstein MD, ECOL APPL, V16, P2143, DOI [10.1890/1051-0761(2006)016[2143:ECODCA]2.0.CO;2, DOI 10.1890/1051-0761(2006)0162143:ECODCA2.0.CO;2]; Walsh EA, 2016, ISME J, V10, P979, DOI 10.1038/ismej.2015.175; Wasmund K, 2016, MBIO, V7, DOI 10.1128/mBio.00266-16; Weber L, 2018, EMP 16S ILLUMINA AMP, DOI [10.17504/protocols.io.nuudeww, DOI 10.17504/PROTOCOLS.IO.NUUDEWW]; Whitton B. A., 2007, ECOLOGY CYANOBACTERI; Won NI, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020130; Zhang HJ, 2018, SCI TOTAL ENVIRON, V635, P618, DOI 10.1016/j.scitotenv.2018.04.142	86	31	32	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212355	10.1371/journal.pone.0212355	http://dx.doi.org/10.1371/journal.pone.0212355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763377	Green Submitted, Green Published, gold			2022-12-26	WOS:000458763900074
J	Schulte, FA; Christen, P; Badilatti, SD; Parkinson, I; Khosla, S; Goldhahn, J; Muller, R				Schulte, Friederike A.; Christen, Patrik; Badilatti, Sandro D.; Parkinson, Ian; Khosla, Sundeep; Goldhahn, Jorg; Mueller, Ralph			Virtual supersampling as post-processing step preserves the trabecular bone morphometry in human peripheral quantitative computed tomography scans	PLOS ONE			English	Article							RESOLUTION DEPENDENCE; MECHANICAL-PROPERTIES; CANCELLOUS BONE; REPRODUCIBILITY; MICROARCHITECTURE; PRECISION; PQCT; PARAMETERS; ACCURACY; FOREARM	In the clinical field of diagnosis and monitoring of bone diseases, high-resolution peripheral quantitative computed tomography (HR-pQCT) is an important imaging modality. It provides a resolution where quantitative bone morphometry can be extracted in vivo on patients. It is known that HR-pQCT provides slight differences in morphometric indices compared to the current standard approach micro-computed tomography (micro-CT). The most obvious reason for this is the restriction of the radiation dose and with this a lower image resolution. With advances in micro-CT evaluation techniques such as patient-specific remodeling simulations or dynamic bone morphometry, a higher image resolution would potentially also allow the application of such novel evaluation techniques to clinical HR-pQCT measurements. Virtual supersampling as post-processing step was considered to increase the image resolution of HR-pQCT scans. The hypothesis was that this technique preserves the structural bone morphometry. Supersampling from 82 mu m to virtual 41 mu m by trilinear interpolation of the grayscale values of 42 human cadaveric forearms resulted in strong correlations of structural parameters (R-2: 0.96-1.00). BV/TV was slightly overestimated (4.3%, R-2: 1.00) compared to the HR-pQCT resolution. Tb.N was overestimated (7.47%; R-2: 0.99) and Tb.Th was slightly underestimated (-4.20%; R-2: 0.98). The technique was reproducible with PE yocv between 1.96% (SMI) and 7.88% (Conn.D). In a clinical setting with 205 human forearms with or without fracture measured at 82 mu m resolution HR-pQCT, the technique was sensitive to changes between groups in all parameters (p < 0.05) except trabecular thickness. In conclusion, we demonstrated that supersampling preserves the bone morphometry from HR-pQCT scans and is reproducible and sensitive to changes between groups. Super-sampling can be used to investigate on the resolution dependency of HR-pQCT images and gain more insight into this imaging modality.	[Schulte, Friederike A.; Christen, Patrik; Badilatti, Sandro D.; Goldhahn, Jorg; Mueller, Ralph] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Parkinson, Ian] SA Pathol, Adelaide, SA, Australia; [Parkinson, Ian] Univ Adelaide, Adelaide, SA, Australia; [Khosla, Sundeep] Mayo Clin, Dept Internal Med, Div Endocrinol Diabet Metab & Nutr, Rochester, MN USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; SA Pathology; University of Adelaide; Mayo Clinic	Muller, R (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	ram@ethz.ch	Khosla, Sundeep/AAE-6170-2020; Goldhahn, Jörg/A-8302-2008; Müller, Ralph/A-1198-2008	Khosla, Sundeep/0000-0002-2936-4372; Goldhahn, Jörg/0000-0003-0012-0494; Müller, Ralph/0000-0002-5811-7725; Christen, Patrik/0000-0001-8854-0682	AO Foundation Clinical Priority Program "Fracture Fixation in Osteoporotic Bone" [CF2009_01]; NIH [R01 AR027065]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027065] Funding Source: NIH RePORTER	AO Foundation Clinical Priority Program "Fracture Fixation in Osteoporotic Bone"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded from the AO Foundation Clinical Priority Program "Fracture Fixation in Osteoporotic Bone" (CF2009_01) as well as NIH R01 AR027065 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; BRADBEER JN, 1994, J BONE MINER RES, V9, P1679; Burghardt AJ, 2013, J BONE MINER RES, V28, P524, DOI 10.1002/jbmr.1795; Christen P, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.0991; Christen P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5855; Christen P, 2012, BIOMECH MODEL MECHAN, V11, P483, DOI 10.1007/s10237-011-0327-x; De Kooter M., 2011, QUANTIFICATION REPRO; Ellouz R, 2014, BONE, V63, P147, DOI 10.1016/j.bone.2014.03.001; Engelke K, 2012, OSTEOPOROSIS INT, V23, P2151, DOI 10.1007/s00198-011-1829-1; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Isaksson H, 2011, OSTEOPOROSIS INT, V22, P167, DOI 10.1007/s00198-010-1219-0; Kohler T, 2005, CALCIFIED TISSUE INT, V77, P281, DOI 10.1007/s00223-005-0039-2; Kohler T, 2007, BONE, V41, P659, DOI 10.1016/j.bone.2007.05.018; Krause M, 2014, OSTEOPOROSIS INT, V25, P1595, DOI 10.1007/s00198-014-2650-4; Laib A, 1999, COMPUT MED IMAG GRAP, V23, P69, DOI 10.1016/S0895-6111(98)00071-8; Levchuk A, 2014, CLIN BIOMECH, V29, P355, DOI 10.1016/j.clinbiomech.2013.12.019; Liu XS, 2010, J BONE MINER RES, V25, P746, DOI 10.1359/jbmr.090822; MacNeil JA, 2008, MED ENG PHYS, V30, P792, DOI 10.1016/j.medengphy.2007.11.003; MacNeil JA, 2007, MED ENG PHYS, V29, P1096, DOI 10.1016/j.medengphy.2006.11.002; Manske SL, 2015, BONE, V79, P213, DOI 10.1016/j.bone.2015.06.006; Melton LJ, 2010, OSTEOPOROSIS INT, V21, P1161, DOI 10.1007/s00198-009-1047-2; Metcalf LM, 2018, BONE, V106, P69, DOI 10.1016/j.bone.2017.09.013; Mueller TL, 2009, BONE, V44, P364, DOI 10.1016/j.bone.2008.10.045; Muller R, 1996, BONE, V18, P215, DOI 10.1016/8756-3282(95)00489-0; Muller R, 1996, Technol Health Care, V4, P113; R Development Core Team, 2007, R LANG ENV STAT COMP; Schulte FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062172; Schulte FA, 2011, BONE, V48, P433, DOI 10.1016/j.bone.2010.10.007; Sode M, 2008, BONE, V42, P728, DOI 10.1016/j.bone.2007.12.004; Sugiyama T, 2012, J BONE MINER RES, V27, P1784, DOI 10.1002/jbmr.1599; Tjong W, 2012, MED PHYS, V39, P1893, DOI 10.1118/1.3689813; Zhou B, 2016, BONE, V86, P58, DOI 10.1016/j.bone.2016.02.016	32	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0212280	10.1371/journal.pone.0212280	http://dx.doi.org/10.1371/journal.pone.0212280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759159	Green Submitted, Green Published, gold			2022-12-26	WOS:000458761300080
J	Inoue, K				Inoue, Kentaro			Sensitivity analysis for reproducible candidate values of model parameters in signaling hub model	PLOS ONE			English	Article								Mathematical models for signaling pathways are helpful for understanding molecular mechanism in the pathways and predicting dynamic behavior of the signal activity. To analyze the robustness of such models, local sensitivity analysis has been implemented. However, such analysis primarily focuses on only a certain parameter set, even though diverse parameter sets that can recapitulate experiments may exist. In this study, we performed sensitivity analysis that investigates the features in a system considering the reproducible and multiple candidate values of the model parameters to experiments. The results showed that although different reproducible model parameter values have absolute differences with respect to sensitivity strengths, specific trends of some relative sensitivity strengths exist between reactions regardless of parameter values. It is suggested that (i) network structure considerably influences the relative sensitivity strength and (ii) one might be able to predict relative sensitivity strengths specified in the parameter sets employing only one of the reproducible parameter sets.	[Inoue, Kentaro] Univ Miyazaki, Fac Engn, Dept Comp Sci & Syst Engn, Miyazaki, Japan	University of Miyazaki	Inoue, K (corresponding author), Univ Miyazaki, Fac Engn, Dept Comp Sci & Syst Engn, Miyazaki, Japan.	inoue@cs.miyazaki-u.ac.jp	Inoue, Kentaro/P-4920-2016	Inoue, Kentaro/0000-0002-7447-5856				Ashyraliyev M, 2009, FEBS J, V276, P886, DOI 10.1111/j.1742-4658.2008.06844.x; Behar M, 2013, CELL, V155, P448, DOI 10.1016/j.cell.2013.09.018; Behar M, 2013, BIOPHYS J, V105, P231, DOI 10.1016/j.bpj.2013.05.013; Degasperi A, 2017, NPJ SYST BIOL APPL, V3, DOI 10.1038/s41540-017-0023-2; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Goldstein B, 2004, NAT REV IMMUNOL, V4, P445, DOI 10.1038/nri1374; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Inoue K, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.24; Iwamoto K, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005222; Ji ZW, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5958321; Kent E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079244; Kimura S., 2011, SICE J CONTROL MEASU, V4, P105, DOI DOI 10.9746/JCMSI.4.105-4889; Klipp E, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S10; Maeda K., 2018, IPSJ T BIOINFORM, V11, P31, DOI [10.2197/ipsjtbio.11.31, DOI 10.2197/IPSJTBIO.11.31]; Okada T, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.022322; Schoeberl B, 2017, NPJ SYST BIOL APPL, V3, DOI 10.1038/npjsba.2016.34; Shinohara H, 2016, SCI REP-UK, V6, DOI 10.1038/srep27706; Shinohara H, 2014, SCIENCE, V344, P760, DOI 10.1126/science.1250020; Villaverde AF, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0144-4; Zi Z, 2011, IET SYST BIOL, V5, P336, DOI 10.1049/iet-syb.2011.0015	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211654	10.1371/journal.pone.0211654	http://dx.doi.org/10.1371/journal.pone.0211654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753191	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600018
J	Choi, SH; Ryu, TH; Kim, JI; Lee, S; Lee, SS; Kim, JH				Choi, Seung Hee; Ryu, Tae Ho; Kim, Jeong-Il; Lee, Sungbeom; Lee, Seung Sik; Kim, Jin-Hong			Mutation in DDM1 inhibits the homology directed repair of double strand breaks	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; CHROMATIN-REMODELING FACTORS; COMET ASSAY; ARABIDOPSIS-THALIANA; DIFFERENT PATHWAYS; RAD51 PARALOGS; RECOMBINATION; GENE; PROTEIN; SWI/SNF	In all organisms, DNA damage must be repaired quickly and properly, as it can be lethal for cells. Because eukaryotic DNA is packaged into nucleosomes, the structural units of chromatin, chromatin modification is necessary during DNA damage repair and is achieved by histone modification and chromatin remodeling. Chromatin remodeling proteins therefore play important roles in the DNA damage response (DDR) by modifying the accessibility of DNA damage sites. Here, we show that mutation in a SWI2/SNF2 chromatin remodeling protein (DDM1) causes hypersensitivity in the DNA damage response via defects in single-strand annealing (SSA) repair of double-strand breaks (DSBs) as well as in the initial steps of homologous recombination (HR) repair. ddm1 mutants such as ddm1-1 and ddm1-2 exhibited increased root cell death and higher DSB frequency compared to the wild type after gamma irradiation. Although the DDM1 mutation did not affect the expression of most DDR genes, it did cause substantial decrease in the frequency of SSA as well as partial inhibition in the gamma-H2AX and Rad51 induction, the initial steps of HR. Furthermore, global chromatin structure seemed to be affected by DDM1 mutations. These results suggest that DDM1 is involved in the homology directed repair such as SSA and HR, probably by modifying chromatin structure.	[Choi, Seung Hee; Ryu, Tae Ho; Lee, Sungbeom; Lee, Seung Sik; Kim, Jin-Hong] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Jeongeup Si, Jeollabuk Do, South Korea; [Ryu, Tae Ho; Kim, Jeong-Il] Chonnam Natl Univ, Dept Biotechnol, Gwangju, South Korea; [Kim, Jeong-Il; Lee, Sungbeom; Lee, Seung Sik] Univ Sci & Technol, Dept Radiat Biotechnol & Appl Radioisotope Sci, Daejeon, South Korea	Korea Atomic Energy Research Institute (KAERI); Chonnam National University; University of Science & Technology (UST)	Kim, JH (corresponding author), Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Jeongeup Si, Jeollabuk Do, South Korea.	jhongkim@kaeri.re.kr			Ministry of Science and ICT, Republic of Korea	Ministry of Science and ICT, Republic of Korea	This research was supported by the Ministry of Science and ICT, Republic of Korea.	Abe K, 2005, PLANT PHYSIOL, V139, P896, DOI 10.1104/pp.105.065243; Aklilu BB, 2014, NUCLEIC ACIDS RES, V42, P3104, DOI 10.1093/nar/gkt1292; Bennett G, 2015, DNA REPAIR, V30, P38, DOI 10.1016/j.dnarep.2015.03.006; Biedermann S, 2017, EMBO J, V36, P1279, DOI 10.15252/embj.201694571; Bleuyard JY, 2005, PLANT J, V41, P533, DOI 10.1111/j.1365-313X.2004.02318.x; Bleuyard JY, 2004, EMBO J, V23, P439, DOI 10.1038/sj.emboj.7600055; Brzeski J, 2003, J BIOL CHEM, V278, P823, DOI 10.1074/jbc.M209260200; Burrage J, 2012, J CELL SCI, V125, P5524, DOI 10.1242/jcs.111252; Calini V, 2002, CELL BIOL TOXICOL, V18, P369, DOI 10.1023/A:1020811522100; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Esnault MA, 2010, ENVIRON EXP BOT, V68, P231, DOI 10.1016/j.envexpbot.2010.01.007; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Fritsch O, 2004, MOL CELL, V16, P479, DOI 10.1016/j.molcel.2004.09.034; Furukawa T, 2010, DNA REPAIR, V9, P940, DOI 10.1016/j.dnarep.2010.06.006; Gao J, 2012, PLANT CELL, V24, P1437, DOI 10.1105/tpc.112.096792; Gao M, 2014, CELL RES, V24, P532, DOI 10.1038/cr.2014.36; Giglia-Mari G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000745; Grimme JM, 2010, NUCLEIC ACIDS RES, V38, P2917, DOI 10.1093/nar/gkp1249; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huertas D, 2009, EPIGENETICS-US, V4, P31, DOI 10.4161/epi.4.1.7733; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Knizewski L, 2008, TRENDS PLANT SCI, V13, P557, DOI 10.1016/j.tplants.2008.08.004; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Kurzbauer MT, 2012, PLANT CELL, V24, P2058, DOI 10.1105/tpc.112.098459; Lans H, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-4; Lee HS, 2010, EMBO J, V29, P1434, DOI 10.1038/emboj.2010.27; LEWIS J, 1991, FEBS LETT, V285, P155, DOI 10.1016/0014-5793(91)80795-5; Li WX, 2005, PLANT PHYSIOL, V138, P965, DOI 10.1104/pp.104.058347; Liu BH, 2012, CURR GENOMICS, V13, P533, DOI 10.2174/138920212803251373; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Mazon G, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.006; Menke M, 2001, MUTAT RES-GEN TOX EN, V493, P87, DOI 10.1016/S1383-5718(01)00165-6; Monari A, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00054; Moreno-Romero J, 2012, PLANT J, V71, P627, DOI 10.1111/j.1365-313X.2012.05019.x; Muchardt C, 1999, SEMIN CELL DEV BIOL, V10, P189, DOI 10.1006/scdb.1999.0300; Nikitaki Z, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00035; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Orel N, 2003, PLANT J, V35, P604, DOI 10.1046/j.1365-313X.2003.01832.x; Osakabe K, 2006, PLANT J, V48, P827, DOI 10.1111/j.1365-313X.2006.02927.x; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; Pai CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5091; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Polo SE, 2015, DNA REPAIR, V36, P114, DOI 10.1016/j.dnarep.2015.09.014; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Probst AV, 2003, PLANT J, V33, P743, DOI 10.1046/j.1365-313X.2003.01667.x; Questa JI, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00420; Ravanat JL, 2016, RADIAT PHYS CHEM, V128, P92, DOI 10.1016/j.radphyschem.2016.07.007; Reyes JC, 2014, MOL PLANT, V7, P454, DOI 10.1093/mp/sst147; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rosa M, 2013, PLANT CELL, V25, P1990, DOI 10.1105/tpc.112.104067; Roth N, 2012, PLANT J, V72, P781, DOI 10.1111/j.1365-313X.2012.05119.x; Roy S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00487; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Sellou H, 2016, MOL BIOL CELL, V27, P3791, DOI 10.1091/mbc.E16-05-0269; Shaked H, 2006, GENETICS, V173, P985, DOI 10.1534/genetics.105.051664; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Song JQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004030; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Tan TLR, 1999, CURR BIOL, V9, P325, DOI 10.1016/S0960-9822(99)80142-0; Taylor MRG, 2015, CELL, V162, P271, DOI 10.1016/j.cell.2015.06.015; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wang S, 2010, P NATL ACAD SCI USA, V107, P22716, DOI 10.1073/pnas.1005978107; Weimer AK, 2016, EMBO J, V35, P2068, DOI 10.15252/embj.201593083; Yao YL, 2012, PLANT CELL REP, V31, P1549, DOI 10.1007/s00299-012-1269-1; Yoshiyama Kaoru Okamoto, 2013, Biology (Basel), V2, P1338, DOI 10.3390/biology2041338; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033	72	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211878	10.1371/journal.pone.0211878	http://dx.doi.org/10.1371/journal.pone.0211878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742642	gold, Green Published, Green Submitted			2022-12-26	WOS:000458393400029
J	Grajales-Muniz, C; Borja-Aburto, VH; Cabrera-Gaytan, DA; Rojas-Mendoza, T; Arriaga-Nieto, L; Vallejos-Paras, A				Grajales-Muniz, Concepcion; Hugo Borja-Aburto, Victor; Alejandro Cabrera-Gaytan, David; Rojas-Mendoza, Teresita; Arriaga-Nieto, Lumumba; Vallejos-Paras, Alfonso			Zika virus: Epidemiological surveillance of the Mexican Institute of Social Security	PLOS ONE			English	Article							DENGUE VIRUS; INFECTION; ANTIBODIES	Introduction At the end of 2015, the first cases of Zika were identified in southern Mexico. During 2016, Zika spread as an outbreak to a large part of the country's coastal zones. Methodology The Zika epidemiological surveillance system records cases with clinical symptoms of Zika virus disease (ZVD) and those confirmed by means of a reverse polymerase chain reaction (RT-PCR) assay. This report includes the suspected and confirmed cases from 2016. Incidence rates were estimated by region and in pregnant women based on the proportion of confirmed cases. Results In total, 43,725 suspected cases of ZVD were reported. The overall incidence of suspected cases of ZVD was 82.0 per 100,000 individuals and 25.3 per 100,000 Zika cases. There were 4,168 pregnant women with suspected symptoms of ZVD, of which infection was confirmed in 1,082 (26%). The estimated incidence rate of ZVD for pregnant women nationwide was 186.1 positive Zika cases per 100,000 pregnant women. Conclusions The incidence of Zika in Mexico is higher than that reported previously in the National System of Epidemiological Surveillance. Positive cases of Zika must be estimated and reported.	[Grajales-Muniz, Concepcion; Alejandro Cabrera-Gaytan, David; Rojas-Mendoza, Teresita; Arriaga-Nieto, Lumumba; Vallejos-Paras, Alfonso] IMSS, Div Epidemiol Surveillance Communicable Dis, Mexico City, DF, Mexico; [Hugo Borja-Aburto, Victor] IMSS, Unit Primary Hlth Care, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social	Vallejos-Paras, A (corresponding author), IMSS, Div Epidemiol Surveillance Communicable Dis, Mexico City, DF, Mexico.	alfonso.vallejos@imss.gob.mx	amsalu, ribka/G-8780-2019; ARRIAGA-NIETO, LUMUMBA/B-7697-2019	ARRIAGA-NIETO, LUMUMBA/0000-0003-0243-768X; Vallejos Paras, Alfonso/0000-0003-0972-8295; Rojas Mendoza, Teresita/0000-0002-6658-1739	CONACyT (Mexico's National Science and Research Council); Technical Committee and Fund Management International Cooperation in Science and Technology CONACYT (FONCICYT) [274386]	CONACyT (Mexico's National Science and Research Council); Technical Committee and Fund Management International Cooperation in Science and Technology CONACYT (FONCICYT)	This work was supported by CONACyT (Mexico's National Science and Research Council). Through the Technical Committee and Fund Management International Cooperation in Science and Technology CONACYT (FONCICYT) number 274386 to VHBA. This work is part of "The Global Alliance to Control and Prevent the Zika Virus". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0; Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Colon-Gonzalez FJ, 2011, AM J TROP MED HYG, V84, P757, DOI 10.4269/ajtmh.2011.10-0609; Comision Nacional de Agua Mexico, REUM TEMP PRES MENS; Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Hernandez-Avila JE, 2018, B WORLD HEALTH ORGAN, V96, P306, DOI 10.2471/BLT.17.201004; Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472; Haque U, 2016, ACTA TROP, V162, P5, DOI 10.1016/j.actatropica.2016.06.010; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lee CT, 2016, MMWR-MORBID MORTAL W, V65, P629, DOI 10.15585/mmwr.mm6524e3; Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8; Pacheco O, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMoa1604037; Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073; Pan American Health Organization, ZIK CAS CONG SYNDR A; Pan American Health Organization, 2017, ZIK CAS CONG SYNDR A; Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72; Peterson A Townsend, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.a832cf06c4bf89fb2e15cb29d374f9de; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; Secretaria de Salud, 2015, CAS CONF INF VIR ZIK; Secretaria de Salud, MAN PROC EST VIG EP; Secretaria de Salud, SEMANA EPIDEMIOLOGIC; Secretaria de Salud Direccion General de Epidemiologia, DESGL CAS SINDR CONG; Secretaria de Salud Direccion General de Epidemiologia, CAS CONF SINDR GUILL; Secretaria de Salud. Direccion General de Epidemiologia, 2016, MAN PROC EST VIG EP; Subissi L, 2017, INT J INFECT DIS, V65, P116, DOI 10.1016/j.ijid.2017.10.009; Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X; Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044; World Health Organization, FACT SHEETS ZIK VIR	39	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0212114	10.1371/journal.pone.0212114	http://dx.doi.org/10.1371/journal.pone.0212114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742671	gold, Green Published, Green Submitted			2022-12-26	WOS:000458393400050
J	Nierwinska, K; Nowacka-Chmielewska, M; Bernacki, J; Jagsz, S; Chalimoniuk, M; Langfort, J; Malecki, A				Nierwinska, Katarzyna; Nowacka-Chmielewska, Marta; Bernacki, Jacek; Jagsz, Slawomir; Chalimoniuk, Malgorzata; Langfort, Jozef; Malecki, Andrzej			The effect of endurance training and testosterone supplementation on the expression of blood spinal cord barrier proteins in rats	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; BRAIN-BARRIER; ENDOTHELIAL-CELLS; PERMEABILITY; EXERCISE; ANDROGENS; DISEASE; CANCER; HEAT	The present study aimed to estimate the effect of endurance training, two doses of testosterone, and the combination of these stimuli on the level of the endothelial proteins claudin, occludin, JAM-1, VE-cadherin, ZO-1, ZO-2, and P-glycoprotein in rat spinal cords. Adult male Wistar rats were trained using a motor-driven treadmill for 6 weeks (40-60 min, 5 times per week) and/or were treated for 6 weeks with two doses of testosterone (i.m.; 8 mg/kg or 80 mg/kg body weight). Spinal cords were collected 48 hours after the last training cycle and stored at -80 degrees C. The levels of selected proteins in whole tissue lysates of the spinal cord were measured by western blot. Testosterone-treated trained rats had significantly lower claudin levels than vehicle-treated trained rats. High doses of testosterone resulted in a significant decrease in claudin-5 in untrained rats compared to the control group. Both doses of testosterone significantly reduced occludin levels compared to those in vehicle-treated untrained rats. The JAM-1 level in the spinal cords of both trained and untrained animals receiving testosterone was decreased in a dose-dependent manner. The JAM-1 level in the trained group treated with high doses of testosterone was significantly higher than that in the untrained rats treated with 80 mg/kg of testosterone. VE-cadherin levels were decreased in all groups receiving testosterone regardless of endurance training and were also diminished in the vehicle-treated group compared to the control group. Testosterone treatment did not exert a significant effect on ZO-1 protein levels. Testosterone and/or training had no significant effects on ZO-2 protein levels in the rat spinal cords. Endurance training increased P-glycoprotein levels in the rat spinal cords. The results suggest that an excessive supply of testosterone may adversely impact the expression of endothelial proteins in the central nervous system, which, in turn, may affect the blood-brain barrier function.	[Nierwinska, Katarzyna] Jerzy Kukuczka Acad Phys Educ, Dept Physiol, Katowice, Poland; [Nowacka-Chmielewska, Marta; Malecki, Andrzej] Jerzy Kukuczka Acad Phys Educ, Lab Mol Biol, Katowice, Poland; [Bernacki, Jacek] Med Univ Silesia, Dept Pharmacol, Katowice, Poland; [Jagsz, Slawomir] Jerzy Kukuczka Acad Phys Educ, Dept Biochem, Katowice, Poland; [Chalimoniuk, Malgorzata] Pilsudski Univ Phys Educ Warsaw, Dept Tourism & Hlth Biala Podlaska, Warsaw, Poland; [Langfort, Jozef] Jerzy Kukuczka Acad Phys Educ Katowice, Dept Sports Training, Katowice, Poland	Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach; Medical University Silesia; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach	Nierwinska, K (corresponding author), Jerzy Kukuczka Acad Phys Educ, Dept Physiol, Katowice, Poland.	k.nierwinska@awf.katowice.pl	Nowacka-Chmielewska, Marta/AAQ-1179-2020; Nierwińska, Katarzyna/X-2633-2018; JOZEF, LANGFORT/X-2550-2018; Chalimoniuk, Malgorzata/Y-4440-2018	Nowacka-Chmielewska, Marta/0000-0001-8668-8878; Nierwińska, Katarzyna/0000-0003-2958-783X; JOZEF, LANGFORT/0000-0001-5710-5100; Chalimoniuk, Malgorzata/0000-0003-0361-8626	Jerzy Kukuczka Academy of Physical Education in Katowice [UP/F/5/2015]	Jerzy Kukuczka Academy of Physical Education in Katowice	This work was supported by the Statuatory Grants from The Jerzy Kukuczka Academy of Physical Education in Katowice UP/F/5/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Brown RC, 2003, J CELL SCI, V116, P693, DOI 10.1242/jcs.00264; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Coles LD, 2009, MOL PHARMACEUT, V6, P1816, DOI 10.1021/mp900077q; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; Esposito P, 2001, BRAIN RES, V888, P117, DOI 10.1016/S0006-8993(00)03026-2; Freeman LR, 2012, BBA-MOL BASIS DIS, V1822, P822, DOI 10.1016/j.bbadis.2011.12.009; Ge SJ, 2006, J NEUROIMMUNOL, V177, P209, DOI 10.1016/j.jneuroim.2006.05.012; Gonzales RJ, 2004, AM J PHYSIOL-HEART C, V286, pH552, DOI 10.1152/ajpheart.00663.2003; Hambrecht R, 2003, CIRCULATION, V107, P3152, DOI 10.1161/01.CIR.0000074229.93804.5C; Haorah J, 2005, J LEUKOCYTE BIOL, V78, P1223, DOI 10.1189/jlb.0605340; Haseloff RF, 2015, SEMIN CELL DEV BIOL, V38, P16, DOI 10.1016/j.semcdb.2014.11.004; Herr D, 2015, REPRODUCTION, V149, pR71, DOI 10.1530/REP-13-0296; Ibrahim AA, 2016, NEURONS COGNITION, VVI, P1; Jahromi AS, 2014, AM J IMMUNOLOGY, V10, P10; Kiyatkin EA, 2007, EUR J NEUROSCI, V26, P1242, DOI 10.1111/j.1460-9568.2007.05741.x; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Krizbai IA, 2005, CELL MOL NEUROBIOL, V25, P129, DOI 10.1007/s10571-004-1378-7; Langfort J, 1996, BIOCHEM MOL MED, V59, P28, DOI 10.1006/bmme.1996.0060; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; Lochhead JJ, 2011, J CEREBR BLOOD F MET, V31, P790, DOI 10.1038/jcbfm.2010.177; Mazzon E, 2002, MOL MED, V8, P353, DOI 10.1007/BF03402016; McCabe MJ, 2016, HUM REPROD, V31, P875, DOI 10.1093/humrep/dew009; Morgan SV, 2018, EUR J NEUROSCI, V47, P1444, DOI 10.1111/ejn.13933; Mutoh K, 2006, CANCER SCI, V97, P1198, DOI 10.1111/j.1349-7006.2006.00300.x; Nheu L, 2011, STEROIDS, V76, P1590, DOI 10.1016/j.steroids.2011.09.015; Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652, DOI 10.1016/S0735-1097(96)00393-2; Ohtsuki S, 2005, J CELL PHYSIOL, V204, P896, DOI 10.1002/jcp.20352; Ovadia H, 2001, BRAIN RES, V905, P21, DOI 10.1016/S0006-8993(01)02361-7; Pan WH, 1997, J NEUROIMMUNOL, V76, P105, DOI 10.1016/S0165-5728(97)00034-9; Papadopoulos D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150143; Pedersen BK, 2007, TRENDS PHARMACOL SCI, V28, P152, DOI 10.1016/j.tips.2007.02.002; Poletti A, 2004, FRONT NEUROENDOCRIN, V25, P1, DOI 10.1016/j.yfrne.2004.03.001; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Radu BM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/648268; Romanitan MO, 2010, J CELL MOL MED, V14, P1088, DOI 10.1111/j.1582-4934.2009.00999.x; Sadowska-Krepa E, 2011, CARDIOVASC TOXICOL, V11, P118, DOI 10.1007/s12012-011-9105-3; Sharma HS, 2007, PROG BRAIN RES, V162, P459, DOI 10.1016/S0079-6123(06)62023-2; Sumanasekera WK, 2007, TOXICOL LETT, V174, P61, DOI 10.1016/j.toxlet.2007.08.014; Toborek M, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-22; Torres-Estay V, 2015, J ENDOCRINOL, V224, pR131, DOI 10.1530/JOE-14-0611; Watson P, 2005, AM J PHYSIOL-REG I, V288, pR1689, DOI 10.1152/ajpregu.00676.2004; Watson P, 2006, MED SCI SPORT EXER, V38, P2118, DOI 10.1249/01.mss.0000235356.31932.0a; WIJSMAN JA, 1993, ACTA NEUROPATHOL, V86, P49, DOI 10.1007/BF00454898; Willson AC, 2008, BIOCHIM BIOPHYS ACTA, V6, P401; Witt KA, 2003, AM J PHYSIOL-HEART C, V285, pH2820, DOI 10.1152/ajpheart.00589.2003; Wolff G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097033; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Yu HC, 2013, INT J BIOL SCI, V9, P966, DOI 10.7150/ijbs.6996; Zhu WH, 2017, UROL INT, V98, P79, DOI 10.1159/000448691; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016; Zuloaga KL, 2012, ENDOCRINOLOGY, V153, P5949, DOI 10.1210/en.2012-1316	53	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211818	10.1371/journal.pone.0211818	http://dx.doi.org/10.1371/journal.pone.0211818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742658	gold, Green Submitted, Green Published			2022-12-26	WOS:000458393400025
J	Bakeng, JBL; Hofstad, EF; Solberg, OV; Eiesland, J; Tangen, GA; Amundsen, T; Lango, T; Reinertsen, I; Selbekk, T; Leira, HO				Bakeng, Janne Beate Lervik; Hofstad, Erlend Fagertun; Solberg, Ole Vegard; Eiesland, Jon; Tangen, Geir Arne; Amundsen, Tore; Lango, Thomas; Reinertsen, Ingerid; Selbekk, Tormod; Leira, Hakon Olav			Using the CustusX toolkit to create an image guided bronchoscopy application: Fraxinus	PLOS ONE			English	Article							RESEARCH PLATFORM	Purpose The aim of this paper is to show how a specialized planning and guidance application called Fraxinus, can be built on top of the CustusX platform (www. custusx. org), which is an open source image-guided intervention software platform. Fraxinus has been customized to meet the clinical needs in navigated bronchoscopy. Methods The application requirements for Fraxinus were defined in close collaboration between research scientists, software developers and clinicians (pulmonologists), and built on top of CustusX. Its superbuild system downloads specific versions of the required libraries and builds them for the application in question, including the selected plugins. New functionality is easily added through the plugin framework. The build process enables the creation of specialized applications, adding additional documentation and custom configurations. The toolkit's libraries offer building blocks for image-guided applications. An iterative development process was applied, where the clinicians would test and provide feedback during the entire process. Results Fraxinus has been developed and is released as an open source planning and guidance application built on top of CustusX. It is highly specialized for bronchoscopy. The proposed workflow is adapted to the different steps in this procedure. The user interface of CustusX has been modified to enhance information, quality assurance and user friendliness with the intention to increase the overall yield for the patient. As the workflow of the procedure is relatively constant, some actions are predicted and automatically performed by the application, according to the requirements from the clinicians. Conclusions The CustusX platform facilitates development of new and specialized applications. The toolkit supports the process and makes important extension and injection points available for customization.	[Bakeng, Janne Beate Lervik; Hofstad, Erlend Fagertun; Solberg, Ole Vegard; Eiesland, Jon; Tangen, Geir Arne; Lango, Thomas; Reinertsen, Ingerid; Selbekk, Tormod] SINTEF Technol & Soc, Dept Hlth, Res Grp Med Technol, Trondheim, Norway; [Amundsen, Tore; Leira, Hakon Olav] St Olavs Hosp, Dept Thorac Med, Trondheim, Norway; [Amundsen, Tore; Leira, Hakon Olav] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, Trondheim, Norway; [Lango, Thomas] St Olavs Hosp, Norwegian Natl Advisory Unit Ultrasound & Image G, Trondheim, Norway	SINTEF; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Bakeng, JBL (corresponding author), SINTEF Technol & Soc, Dept Hlth, Res Grp Med Technol, Trondheim, Norway.	janne.beate.lervik.bakeng@sintef.no	Reinertsen, Ingerid/AAD-1948-2022	Reinertsen, Ingerid/0000-0003-0999-3849	Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); EEA Financial Mechanism 2009 -2014 under the project Navigation System For Confocal Laser Endomicroscopy To Improve Optical Biopsy Of Peripheral Lesions In The Lungs (NAVICAD) [EEA-JRP-RO-NO-2013-1-0123, 3SEE/30.06.2014]; Ministry of Health and Social Affairs of Norway through the Norwegian National Advisory Unit for Ultrasound and Image-Guided Therapy (St. Olavs hospital, Trondheim, Norway); SINTEF	Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); EEA Financial Mechanism 2009 -2014 under the project Navigation System For Confocal Laser Endomicroscopy To Improve Optical Biopsy Of Peripheral Lesions In The Lungs (NAVICAD); Ministry of Health and Social Affairs of Norway through the Norwegian National Advisory Unit for Ultrasound and Image-Guided Therapy (St. Olavs hospital, Trondheim, Norway); SINTEF(SINTEF)	The research leading to these results has received funding from The Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU); EEA Financial Mechanism 2009 -2014 under the project EEA-JRP-RO-NO-2013-1-0123 - Navigation System For Confocal Laser Endomicroscopy To Improve Optical Biopsy Of Peripheral Lesions In The Lungs (NAVICAD), contract no. 3SEE/30.06.2014; The Ministry of Health and Social Affairs of Norway through the Norwegian National Advisory Unit for Ultrasound and Image-Guided Therapy (St. Olavs hospital, Trondheim, Norway); SINTEF.	[Anonymous], 2015, MASTERING CMAKE CROS; Askeland C, 2016, INT J COMPUT ASS RAD, V11, P505, DOI 10.1007/s11548-015-1292-0; Baaklini WA, 2000, CHEST, V117, P1049, DOI 10.1378/chest.117.4.1049; Bradski G., 2008, LEARNING OPENCV COMP; Dingsoyr T, 2012, J SYST SOFTWARE, V85, P1213, DOI 10.1016/j.jss.2012.02.033; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Heckel F., 2009, LECT NOTES INFORM, V154, P1338; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Leira HO, 2011, MINIM INVASIV THER, V20, P30, DOI 10.3109/13645706.2010.518747; Nardelli P, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0060-2; Nolden M, 2013, INT J COMPUT ASS RAD, V8, P607, DOI 10.1007/s11548-013-0840-8; Osgi Alliance, 2009, OSGI SERVICE PLATFOR; Pieper S, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P632; Reynisson PJ, 2014, J BRONCHOL INTERN PU, V21, P242, DOI 10.1097/LBR.0000000000000064; Schreiber G, 2003, CHEST, V123, p115S, DOI 10.1378/chest.123.1_suppl.115S; Smistad E, 2012, NORSK INFORMATIKKONF, V2012; Smistad E, 2014, INT J COMPUT ASS RAD, V9, P561, DOI 10.1007/s11548-013-0956-x; Sorger H, 2015, INT J COMPUTER ASSIS; Tokuda J, 2009, INT J MED ROBOT COMP, V5, P423, DOI 10.1002/rcs.274; Yung Rex C W, 2003, Respir Care Clin N Am, V9, P51, DOI 10.1016/S1078-5337(02)00083-7	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211772	10.1371/journal.pone.0211772	http://dx.doi.org/10.1371/journal.pone.0211772			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735513	gold, Green Published, Green Submitted			2022-12-26	WOS:000458181200025
J	Cho, YJ; Kim, WS; Choi, YH; Ha, JY; Lee, S; Park, SJ; Cheon, JE; Kang, HJ; Shin, HY; Kim, IO				Cho, Yeon Jin; Kim, Woo Sun; Choi, Young Hun; Ha, Ji Young; Lee, SeungHyun; Park, Sang Joon; Cheon, Jung-Eun; Kang, Hyoung Jin; Shin, Hee Young; Kim, In-One			Computerized texture analysis of pulmonary nodules in pediatric patients with osteosarcoma: Differentiation of pulmonary metastases from non-metastatic nodules	PLOS ONE			English	Article							CHILDREN; BENIGN; CT	Objective To retrospectively evaluate the value of computerized 3D texture analysis for differentiating pulmonary metastases from non-metastatic lesions in pediatric patients with osteosarcoma. Materials and methods This retrospective study was approved by the institutional review board. The study comprised 42 pathologically confirmed pulmonary nodules in 16 children with osteosarcoma who had undergone preoperative computed tomography between January 2009 and December 2014. Texture analysis was performed using an in-house program. Multivariate logistic regression analysis was performed to identify factors for differentiating metastatic nodules from non-metastases. A subgroup analysis was performed to identify differentiating parameters in small non-calcified pulmonary nodules. The receiver operator characteristic curve was created to evaluate the discriminating performance of the established model. Results There were 24 metastatic and 18 non-metastatic lesions. Multivariate analysis revealed that higher mean attenuation (adjusted odds ratio [OR], 1.014, P = 0.003) and larger effective diameter (OR, 1.745, P = 0.012) were significant differentiators. The analysis with small non-calcified pulmonary nodules (7 metastases and 18 non-metastases) revealed significant inter-group differences in various parameters. Logistic regression analysis revealed that higher mean attenuation (OR, 1.007, P = 0.008) was a significant predictor of non-calcified pulmonary metastases. The established logistic regression model of subgroups showed excellent discriminating performance in the ROC analysis (area under the curve, 0.865). Conclusion Pulmonary metastases from osteosarcoma could be differentiated from non-metastases by using computerized texture analysis. Higher mean attenuation and larger diameter were significant predictors for pulmonary metastases, while higher mean attenuation was a significant predictor for small non-calcified pulmonary metastases.	[Cho, Yeon Jin; Kim, Woo Sun; Choi, Young Hun; Lee, SeungHyun; Park, Sang Joon; Cheon, Jung-Eun; Kim, In-One] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Cho, Yeon Jin; Kim, Woo Sun; Choi, Young Hun; Lee, SeungHyun; Cheon, Jung-Eun; Kim, In-One] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Woo Sun; Cheon, Jung-Eun; Kim, In-One] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Ha, Ji Young] Gyeongsang Natl Univ, Changwon Hosp, Dept Radiol, Chang Won, South Korea; [Park, Sang Joon; Kang, Hyoung Jin; Shin, Hee Young] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Kang, Hyoung Jin; Shin, Hee Young] Seoul Natl Univ Hosp, Dept Pediat, Seoul, South Korea; [Kang, Hyoung Jin; Shin, Hee Young] Seoul Natl Univ, Dept Pediat, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Gyeongsang National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, WS (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Kim, WS (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.; Kim, WS (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.	kimws@snu.ac.kr		Ha, Ji Young/0000-0001-5769-3045; Lee, Seunghyun/0000-0003-1858-0640; Cho, Yeon Jin/0000-0001-9820-3030				Brader P, 2011, J PEDIATR SURG, V46, P729, DOI 10.1016/j.jpedsurg.2010.11.027; Briccoli A, 2010, SURG ONCOL, V19, P193, DOI 10.1016/j.suronc.2009.05.002; Chae HD, 2014, RADIOLOGY, V273, P285, DOI 10.1148/radiol.14132187; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; GOORIN AM, 1984, J CLIN ONCOL, V2, P425, DOI 10.1200/JCO.1984.2.5.425; Huang Z, 2015, THORAC CANCER, V6, P180, DOI 10.1111/1759-7714.12161; MAILE CW, 1982, BRIT J RADIOL, V55, P108, DOI 10.1259/0007-1285-55-650-108; McCarville M, 2001, CANCER, V91, P1170, DOI 10.1002/1097-0142(20010315)91:6<1170::AID-CNCR1114>3.0.CO;2-B; McCarville MB, 2006, RADIOLOGY, V239, P514, DOI 10.1148/radiol.2392050631; PEUCHOT M, 1987, RADIOLOGY, V164, P719, DOI 10.1148/radiology.164.3.3615867; Rasalkar DD, 2011, PEDIATR RADIOL, V41, P227, DOI 10.1007/s00247-010-1809-1; ROSENFIELD NS, 1992, J PEDIATR SURG, V27, P459, DOI 10.1016/0022-3468(92)90336-6; She YL, 2018, EUR RADIOL, V28, P5121, DOI 10.1007/s00330-018-5509-9; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; You SK, 2015, J ULTRAS MED, V34, P1931, DOI 10.7863/ultra.15.01031; Zwaga T, 2008, RADIOGRAPHICS, V28, P277, DOI 10.1148/rg.281075015	16	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211969	10.1371/journal.pone.0211969	http://dx.doi.org/10.1371/journal.pone.0211969			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735557	gold, Green Published, Green Submitted			2022-12-26	WOS:000458181200052
J	Carter, KL; Treurnicht, A; Davis, KL; Kumar, RB; Feldman, BJ				Carter, Kaylene L.; Treurnicht, Anckia; Davis, Kara L.; Kumar, Rajiv B.; Feldman, Brian J.			A novel platform for isotype-specific testing of autoantibodies	PLOS ONE			English	Article								The objective of this study was to test if a novel platform could be used for isotype-specific autoantibody testing in humans. Further, we evaluated if testing with this novel platform enables earlier detection of insulin autoantibodies in individuals that have first-degree relatives with type-1 diabetes than currently used approaches. Longitudinal serum samples from participants were collected before and after they converted to become positive for insulin autoantibodies by the current standardly used assays. Using a novel plasmonic gold chip platform, we tested these samples for IgM isotype-specific autoantibodies. Serial serum samples from individuals without diabetes were also tested as a comparison control cohort. Our results demonstrate proof-of-concept that a plasmonic gold chip can specifically detect the IgM insulin autoantibody. Five out of the six individuals that converted to being positive for insulin autoantibodies by standard testing had significant IgM autoantibodies on the plasmonic chip platform. The plasmonic chip platform detected IgM autoantibodies earlier than standard testing by up to 4 years. Our results indicate that the plasmonic gold platform can specifically detect the IgM isotype autoantibodies and suggest that combining isotype-specific testing with currently used approaches enables earlier detection of insulin autoantibodies in individuals that have first-degree relatives with type 1 diabetes.	[Carter, Kaylene L.; Treurnicht, Anckia; Davis, Kara L.; Kumar, Rajiv B.; Feldman, Brian J.] Stanford Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Feldman, Brian J.] Stanford Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Feldman, Brian J.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	Stanford University; Stanford University; University of California System; University of California San Francisco	Feldman, BJ (corresponding author), Stanford Sch Med, Dept Pediat, Stanford, CA 94305 USA.; Feldman, BJ (corresponding author), Stanford Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.; Feldman, BJ (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	Brian.Feldman@ucsf.edu			Juvenile Diabetes Research Foundation (JDRF); Stanford Medical Scholars Research Program; Type 1 Diabetes TrialNet Pathway to Prevention Study Group; National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01 DK061010, U01 DK061034, U01 DK061042, U01 DK061058, U01 DK085465, U01 DK085453, U01 DK085461, U01 DK085466, U01 DK085499, U01 DK085504, U01 DK085509, U01 DK103180, U01 DK103153, U01 DK085476, U01 DK103266, U01 DK103282, U01 DK106984, U01 DK106994, U01 DK107013, U01 DK107014, UC4 DK106993]; JDRF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085499, U01DK085509, U01DK103180, U01DK085461, U01DK061010, U01DK103153, U01DK061058, U01DK085466, U01DK103282, U01DK061042, U01DK106984, U01DK103266, U01DK106994, R01DK114217, U01DK107013, U01DK107014, U01DK085476, U01DK085465, U01DK061034] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Stanford Medical Scholars Research Program; Type 1 Diabetes TrialNet Pathway to Prevention Study Group; National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by a grant from the Juvenile Diabetes Research Foundation (JDRF) to BJF. The Stanford Medical Scholars Research Program provided support for KLC. We acknowledge the support of the Type 1 Diabetes TrialNet Pathway to Prevention Study Group, which identified study participants and provided samples for this study. The Type 1 Diabetes TrialNet Pathway to Prevention Study Group is a clinical trials network funded by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, through cooperative agreements U01 DK061010, U01 DK061034, U01 DK061042, U01 DK061058, U01 DK085465, U01 DK085453, U01 DK085461, U01 DK085466, U01 DK085499, U01 DK085504, U01 DK085509, U01 DK103180, U01 DK103153, U01 DK085476, U01 DK103266, U01 DK103282, U01 DK106984, U01 DK106994, U01 DK107013, U01 DK107014, UC4 DK106993, and the JDRF. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or the JDRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingley PJ, 2010, J CLIN ENDOCR METAB, V95, P25, DOI 10.1210/jc.2009-1365; BOUGNERES PF, 1988, NEW ENGL J MED, V318, P663, DOI 10.1056/NEJM198803173181103; Forlenza GP, 2011, CURR OPIN ENDOCRINOL, V18, P248, DOI 10.1097/MED.0b013e32834872ce; Greenbaum CJ, 2012, DIABETES, V61, P1323, DOI 10.2337/db11-1452; Insel RA, 2015, DIABETES CARE, V38, P1964, DOI 10.2337/dc15-1419; Kumar RB, 2015, EXPERT REV MOL DIAGN, V15, P291, DOI 10.1586/14737159.2015.1002468; Ma WT, 2017, J AUTOIMMUN, V83, P95, DOI 10.1016/j.jaut.2017.07.003; Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1; Thomas HR, 2013, PEDIATR DIABETES, V14, P311, DOI 10.1111/pedi.12040; Tsokos GC, 2016, NAT REV RHEUMATOL, V12, P716, DOI 10.1038/nrrheum.2016.186; Wyatt R, 2016, METHODS MOL BIOL, V1433, P57, DOI 10.1007/7651_2015_292; Zhang B, 2014, NAT MED, V20, P948, DOI 10.1038/nm.3619	14	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211596	10.1371/journal.pone.0211596	http://dx.doi.org/10.1371/journal.pone.0211596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730939	gold, Green Published, Green Submitted			2022-12-26	WOS:000458026000037
J	Coulthard, MG; Varghese, V; Harvey, LP; Gillen, TC; Kimble, RM; Ware, RS				Coulthard, Mark G.; Varghese, Vanil; Harvey, Lauren P.; Gillen, Tona C.; Kimble, Roy M.; Ware, Robert S.			A review of children with severe trauma admitted to pediatric intensive care in Queensland, Australia	PLOS ONE			English	Review							GLOBAL BURDEN; BRAIN-INJURY; MORTALITY; DISEASE	Background The aim of this study is to review patient characteristics, injury patterns, and outcomes of trauma cases admitted to pediatric intensive care in Children's Health Queensland, Brisbane, Queensland, Australia. Methods Routinely recorded data collected prospectively from the Children's Health Queensland Trauma Service registry from November 2008 to October 2015 were reviewed. Demographic and clinical characteristics of trauma cases in children under 16 years of age are described, and their association with age and mortality analyzed. Results There were 542 cases of pediatric trauma identified and 66.4% were male. The overall mortality since January 2012 was 11.1%. The median injury severity score (ISS) was 11 (IQR = 9-22), 48.2% (n = 261) had an ISS > 12 and 41.7% (n = 226) patients had an ISS > 15. The most common injury patterns were isolated head injury (29.7%; n = 161) and multiple trauma (31.2%; n = 169). In 28.4% of cases (n = 154) surgery was required. The home was reported to be the most common place of injury (37.6%; n = 204). Children aged 0-4 years were least likely to survive their injury (15.3% mortality) compared with the 5-9 (5.6% mortality) and 10-15 (9.0% mortality) age groups. Higher mortality was associated with more severe injuries, abdomen/spine/thorax injuries, inflicted injuries, drowning and hanging. Conclusion This description of major pediatric trauma cases admitted to pediatric intensive care in Children's Health Queensland, Australia, will inform future pediatric major trauma service requirements as it identifies injury patterns and profiles, injury severity, management and mortality across different age groups.	[Coulthard, Mark G.; Varghese, Vanil] Queensland Childrens Hosp, Paediat Intens Care Unit, Brisbane, Qld, Australia; [Coulthard, Mark G.; Kimble, Roy M.] Univ Queensland, Queensland Childrens Hosp, Sch Clin Med, Acad Discipline Paediat & Child Hlth, South Brisbane, Australia; [Harvey, Lauren P.; Gillen, Tona C.; Kimble, Roy M.] Queensland Childrens Hosp, Paediat Trauma Serv, Brisbane, Qld, Australia; [Harvey, Lauren P.; Kimble, Roy M.] Childrens Hlth Queensland, Ctr Childrens Burns & Trauma Res, Brisbane, Qld, Australia; [Ware, Robert S.] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia	University of Queensland; Griffith University; Menzies Health Institute Queensland	Coulthard, MG (corresponding author), Queensland Childrens Hosp, Paediat Intens Care Unit, Brisbane, Qld, Australia.; Coulthard, MG (corresponding author), Univ Queensland, Queensland Childrens Hosp, Sch Clin Med, Acad Discipline Paediat & Child Hlth, South Brisbane, Australia.	Mark.Coulthard@health.qld.gov.au	Coulthard, Mark G/AAT-7735-2021; Coulthard, Mark Graeme/E-9444-2010; Ware, Robert/B-2024-2014	Coulthard, Mark G/0000-0001-7400-5582; Coulthard, Mark Graeme/0000-0001-7400-5582; Ware, Robert/0000-0002-6129-6736				Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; COMMITTEE ON PEDIATRIC EMERGENCY MEDICINE COUNCIL ON INJURY, 2016, Pediatrics, V138, DOI 10.1542/peds.2016-1569; Davies FC, 2015, EMERG MED J, V32, P921, DOI 10.1136/emermed-2015-205285; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; Deasy C, 2012, INJURY, V43, P2006, DOI 10.1016/j.injury.2011.08.032; Densmore JC, 2006, J PEDIATR SURG, V41, P92, DOI 10.1016/j.jpedsurg.2005.10.013; Foster K, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0693-8; Franzen L, 2007, INJURY, V38, P91, DOI 10.1016/j.injury.2006.07.042; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Herman BE, 2011, PEDIATR EMERG CARE, V27, P65, DOI 10.1097/PEC.0b013e31820349db; Holland AJA, 2005, ANZ J SURG, V75, P878, DOI 10.1111/j.1445-2197.2005.03553.x; Holland AJA, 2002, J PAEDIATR CHILD H, V38, P487, DOI 10.1046/j.1440-1754.2002.00034.x; Kelly P, 2015, ARCH DIS CHILD, V100, P1123, DOI 10.1136/archdischild-2014-306960; KLEM SA, 1990, J TRAUMA, V30, P32, DOI 10.1097/00005373-199001000-00005; Kristiansen T, 2012, INJURY, V43, P1865, DOI 10.1016/j.injury.2011.08.011; Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Lee KJ, 2015, AM J CRIT CARE, V24, P422, DOI 10.4037/ajcc2015720; Miller TR, 2000, FUTURE CHILD, V10, P137, DOI 10.2307/1602828; Osterman MJK, 2015, PEDIATRICS, V135, P1115, DOI 10.1542/peds.2015-0434; Patel N, 2017, PEDIATR SURG INT, V33, P1013, DOI 10.1007/s00383-017-4125-0; Powell EC, 2002, PEDIATRICS, V110, P792, DOI 10.1542/peds.110.4.792; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sharar Sam R, 2012, Int J Crit Illn Inj Sci, V2, P111, DOI 10.4103/2229-5151.100886; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; Stelfox HT, 2008, J TRAUMA, V65, P1488, DOI 10.1097/TA.0b013e3181568cfc; Tracy ET, 2013, J PEDIATR SURG, V48, P1384, DOI 10.1016/j.jpedsurg.2013.03.041; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wohlgemut JM, 2013, J PEDIATR SURG, V48, P1593, DOI 10.1016/j.jpedsurg.2013.03.060	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211530	10.1371/journal.pone.0211530	http://dx.doi.org/10.1371/journal.pone.0211530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730910	gold, Green Submitted, Green Published			2022-12-26	WOS:000458026000032
J	Latten, GHP; Claassen, L; Jonk, M; Cals, JWL; Muris, JWM; Stassen, PM				Latten, Gideon H. P.; Claassen, Lieke; Jonk, Marnix; Cals, Jochen W. L.; Muris, Jean W. M.; Stassen, Patricia M.			Characteristics of the prehospital phase of adult emergency department patients with an infection: A prospective pilot study	PLOS ONE			English	Article							SEPTIC SHOCK; SEPSIS; EPIDEMIOLOGY; DEFINITIONS; MORTALITY	Objective Research on serious infections/sepsis has focused on the hospital environment, while potentially the most delay, and therefore possibly the best opportunity to improve quality of care, lies in the prehospital setting. In this study we investigated the prehospital phase of adult emergency department (ED) patients with an infection. Methods In this prospective pilot study all adult (>= 18y) patients with a suspected/proven infection, based on the notes in the patient's ED chart, were included during a 4-week period in 2017. Prehospital course, ED findings, presence of sepsis and 30-day outcomes were registered. Results A total of 440 patients were identified, with a median symptom duration before ED visit of 3 days (IQR 1-7 days). Before arrival in the ED, 23.9% of patients had used antibiotics. Most patients (83.0%) had been referred by a general practitioner (GP), while 41.1% of patients had visited their GP previously during the current disease episode. Patients referred by a GP were triaged as high-urgency less often, while vital parameters were similar. Emergency Medical Services (EMS) transported 268 (60.9%) of patients. Twenty-two patients (5.0%) experienced an adverse outcome (30-day all-cause mortality and/or admission to intensive care). Conclusions Patients with a suspected infection had symptoms for 3 (IQR 1-7) days at the moment of presentation to the ED. During this prehospital phase patients often had consulted, and were treated by, their GP. Many were transported to the ED by EMS. Future research on severe infections should focus on the prehospital phase, targeting patients and primary care professionals.	[Latten, Gideon H. P.; Claassen, Lieke; Jonk, Marnix] Zuyderland Med Ctr, Emergency Dept, Heerlen, Netherlands; [Cals, Jochen W. L.; Muris, Jean W. M.] Maastricht Univ, Sch CAPHRI, Dept Family Med, Maastricht, Netherlands; [Stassen, Patricia M.] Maastricht Univ, Sch CAPHRI, Sect Acute Med, Dept Internal Med,Div Gen Med, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Latten, GHP (corresponding author), Zuyderland Med Ctr, Emergency Dept, Heerlen, Netherlands.	g.latten@zuyderland.nl	Cals, Jochen/A-1262-2007	Cals, Jochen/0000-0001-9550-5674; Muris, Jean/0000-0002-8780-476X				Alam N, 2017, LANCET RESP MED; Alam Nadia, 2016, Acute Med, V15, P168; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Faust S, 2016, SEPSIS RECOGNITION A; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Finkelsztein EJ, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1658-5; Freund Y, 2017, JAMA-J AM MED ASSOC, V317, P301, DOI 10.1001/jama.2016.20329; Gilham C, 2016, BRIT J GEN PRACT, V66, P120, DOI 10.3399/bjgp16X683905; Hunter CL, 2018, AM J EMERG MED; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Loots FJ, 2017, BJGP OPEN; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; van der Wekken LCW, 2016, PREHOSP EMERG CARE, V20, P90, DOI 10.3109/10903127.2015.1037476; Veen van M, 2009, WETENSCHAPPELIJK OND; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Williams JM, 2017, CHEST, V151, P586, DOI 10.1016/j.chest.2016.10.057; Zachariasse JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170811	19	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0212181	10.1371/journal.pone.0212181	http://dx.doi.org/10.1371/journal.pone.0212181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730990	gold, Green Submitted, Green Published			2022-12-26	WOS:000458026000101
J	Naqvi, RZ; Zaidi, SSEA; Mukhtar, MS; Amin, I; Mishra, B; Strickler, S; Mueller, LA; Asif, M; Mansoor, S				Naqvi, Rubab Zahra; Zaidi, Syed Shan-e-Ali; Mukhtar, M. Shahid; Amin, Imran; Mishra, Bharat; Strickler, Susan; Mueller, Lukas A.; Asif, Muhammad; Mansoor, Shahid			Transcriptomic analysis of cultivated cotton Gossypium hirsutum provides insights into host responses upon whitefly-mediated transmission of cotton leaf curl disease	PLOS ONE			English	Article							RNA-SEQ EXPERIMENTS; ABSCISIC-ACID; EXPRESSION ANALYSIS; GLOBAL ANALYSIS; VIRUS; TOMATO; RESISTANCE; GENE; INFECTION; REVEALS	Cotton is a commercial and economically important crop that generates billions of dollars in annual revenue worldwide. However, cotton yield is affected by a sap-sucking insect Bemisia tabaci (whitefly), and whitefly-borne cotton leaf curl disease (CLCuD). The causative agent of devastating CLCuD is led by the viruses belonging to the genus Begomovirus (family Geminiviridae), collectively called cotton leaf curl viruses. Unfortunately, the extensively cultivated cotton (Gossypium hirsutum) species are highly susceptible and vulnerable to CLCuD. Yet, the concomitant influence of whitefly and CLCuD on the susceptible G. hirsutum transcriptome has not been interpreted. In the present study we have employed an RNA Sequencing (RNA-Seq) transcriptomics approach to explore the differential gene expression in susceptible G. hirsutum variety upon infection with viruliferous whiteflies. Comparative RNA-Seq of control and CLCuD infected plants was done using Illumina HiSeq 2500. This study yielded 468 differentially expressed genes (DEGs). Among them, we identified 220 up and 248 downregulated DEGs involved in disease responses and pathogen defense. We selected ten genes for downstream RT-qPCR analyses on two cultivars, Karishma and MNH 786 that are susceptible to CLCuD. We observed a similar expression pattern of these genes in both susceptible cultivars that was also consistent with our transcriptome data further implying a wider application of our global transcription study on host susceptibility to CLCuD. We next performed weighted gene co-expression network analysis that revealed six modules. This analysis also identified highly co-expressed genes as well as 55 hub genes that co-express with >= 50 genes. Intriguingly, most of these hub genes are shown to be downregulated and enriched in cellular processes. Under-expression of such highly co-expressed genes suggests their roles in favoring the virus and enhancing plant susceptibility to CLCuD. We also discuss the potential mechanisms governing the establishment of disease susceptibility. Overall, our study provides a comprehensive differential gene expression analysis of G. hirsutum under whitefly-mediated CLCuD infection. This vital study will advance the understanding of simultaneous effect of whitefly and virus on their host and aid in identifying important G. hirsutum genes which intricate in its susceptibility to CLCuD.	[Naqvi, Rubab Zahra; Zaidi, Syed Shan-e-Ali; Amin, Imran; Asif, Muhammad; Mansoor, Shahid] NIBGE, Agr Biotechnol Div, Faisalabad, Punjab, Pakistan; [Naqvi, Rubab Zahra; Zaidi, Syed Shan-e-Ali] PIEAS, Islamabad, Pakistan; [Naqvi, Rubab Zahra; Zaidi, Syed Shan-e-Ali; Strickler, Susan; Mueller, Lukas A.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [Mukhtar, M. Shahid; Mishra, Bharat] Univ Alabama Birmingham, Dept Biol, Birmingham, AL USA; [Zaidi, Syed Shan-e-Ali] Univ Liege, Gembloux Agrobio Tech, AgroBioChem Dept, Gembloux, Belgium	Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; Cornell University; Boyce Thompson Institute for Plant Research; University of Alabama System; University of Alabama Birmingham; University of Liege	Mansoor, S (corresponding author), NIBGE, Agr Biotechnol Div, Faisalabad, Punjab, Pakistan.	shahidmansoor7@gmail.com	Zaidi, Syed Shan-e-Ali/M-3084-2016; Mishra, Bharat/ABG-2832-2021; Mishra, Bharat/ABK-3168-2022	Zaidi, Syed Shan-e-Ali/0000-0002-2976-4624; Mishra, Bharat/0000-0002-7505-5722; Mansoor, Shahid/0000-0001-7418-1826	USDA-ICARDA cotton productivity Enhancement Project; International Research Support Initiative Program of Higher Education Commission (HEC) of Pakistan	USDA-ICARDA cotton productivity Enhancement Project; International Research Support Initiative Program of Higher Education Commission (HEC) of Pakistan	This research was supported by grants from the USDA-ICARDA cotton productivity Enhancement Project and International Research Support Initiative Program of Higher Education Commission (HEC) of Pakistan.	Adhikari BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034954; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Agudelo-Romero P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002397; Ahmad A, 2014, PAK J AGR SCI, V51, P685; Akhtar K. P., 2002, Tropical Agricultural Research and Extension, V5, P29; Alazem M, 2015, MOL PLANT PATHOL, V16, P529, DOI 10.1111/mpp.12204; Andrews S, FASTQC QUALITY CONTR; Anjum Z. I., 2014, Pakistan Journal of Phytopathology, V26, P25; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Bhattacharyya D, 2015, J EXP BOT, V66, P5881, DOI 10.1093/jxb/erv299; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Briddon RW, 2000, VIRUS RES, V71, P151, DOI 10.1016/S0168-1702(00)00195-7; Castillo-Gonzalez C, 2015, ELIFE, V4, DOI 10.7554/eLife.06671; Chen JY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0508-3; Chen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080879; Czosnek H, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100273; Divol F, 2005, PLANT MOL BIOL, V57, P517, DOI 10.1007/s11103-005-0338-z; Dubey NK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-241; FRASER RSS, 1989, PHYSIOL MOL PLANT P, V34, P215, DOI 10.1016/0885-5765(89)90045-3; Garbutt CC, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00312; Hagberg A., 2008, EXPLORING NETWORK ST; Hamann T, 2015, PLANT CELL PHYSIOL, V56, P215, DOI 10.1093/pcp/pcu164; Hassinen VH, 2011, PLANT BIOLOGY, V13, P225, DOI 10.1111/j.1438-8677.2010.00398.x; HEDIN PA, 1992, J CHEM ECOL, V18, P105, DOI 10.1007/BF00993746; Henry E, 2013, NEW PHYTOL, V199, P908, DOI 10.1111/nph.12214; Howden AJM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00160; Huang P-Y, 2015, J EXPT BOT; Idris AM, 2004, PHYTOPATHOLOGY, V94, P1068, DOI 10.1094/PHYTO.2004.94.10.1068; Juturu VN, 2015, PLANT CELL TISS ORG, V120, P813, DOI 10.1007/s11240-014-0640-z; Kang WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33332; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Kim NH, 2013, PLANT PHYSIOL, V162, P2067, DOI 10.1104/pp.113.217372; Kodama Y, 2010, P NATL ACAD SCI USA, V107, P19591, DOI 10.1073/pnas.1007836107; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li JY, 2016, PLANT BIOTECHNOL J, V14, P1956, DOI 10.1111/pbi.12554; Li K, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1044-1; Lima ATM, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex005; Lin M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0433-5; Liu Y, 2017, NUCLEIC ACIDS RES; Mansoor S, 2006, TRENDS PLANT SCI, V11, P209, DOI 10.1016/j.tplants.2006.03.003; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Melgarejo TA, 2013, J VIROL, V87, P5397, DOI 10.1128/JVI.00234-13; Mesirov, 2014, F1000RESEARCH, V3; Miozzi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089951; Mishra B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08073-z; Mukhtar MS, 2016, CURR BIOL, V26, pR608, DOI 10.1016/j.cub.2016.02.051; Mukhtar MS, 2013, TRENDS PLANT SCI, V18, P469, DOI 10.1016/j.tplants.2013.08.005; Naqvi RZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15963-9; Nie XZ, 2015, VIRUSES-BASEL, V7, P680, DOI 10.3390/v7020680; Niu EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145725; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Park W, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-90; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pierce EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067534; Razaq M, 2014, PAK J ZOOL, V46, P661; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Sade D, 2015, METABOLOMICS, V11, P81, DOI 10.1007/s11306-014-0670-x; Sahu PP, 2012, PROTOPLASMA, V249, P1017, DOI 10.1007/s00709-012-0421-7; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Satoh K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018094; Seebacher J, 2011, CELL, V144, P1000, DOI 10.1016/j.cell.2011.02.025; Selth LA, 2005, PLANT CELL, V17, P311, DOI 10.1105/tpc.104.027235; Sempruch C, 2014, J PLANT INTERACT, V9, P825, DOI 10.1080/17429145.2014.954014; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen W, 2006, PLANT PHYSIOL, V142, P1642, DOI 10.1104/pp.106.088476; Shukla AK, 2016, NAT BIOTECHNOL, V34, P1046, DOI 10.1038/nbt.3665; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trouvelot S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00592; Tully JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-421; van Loon LC, 2016, TRENDS PLANT SCI, V21, P286, DOI 10.1016/j.tplants.2015.11.009; Van Verk MC, 2013, TRENDS PLANT SCI, V18, P175, DOI 10.1016/j.tplants.2013.02.001; Wang JX, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S10; Wang JY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1249-2; Wang L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-169; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wegier A, 2016, TRADITIONAL MODERN U, P439; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Zaidi SSEA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01673; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang C, 2017, PLANT BIOTECHNOL J, V15, P39, DOI 10.1111/pbi.12589; Zhang JF, 2008, PLANT CELL ENVIRON, V31, P562, DOI 10.1111/j.1365-3040.2008.01786.x; Zhong S, 2011, COLD SPRING HARB PRO, V2011, P5652, DOI DOI 10.1101/PDB.PR0T5652; Zubair M, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100280	90	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0210011	10.1371/journal.pone.0210011	http://dx.doi.org/10.1371/journal.pone.0210011			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730891	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000007
J	Ishikawa, M; Osaki, M; Yamagishi, M; Onuma, K; Ito, H; Okada, F; Endo, H				Ishikawa, Mizuho; Osaki, Mitsuhiko; Yamagishi, Makoto; Onuma, Kunishige; Ito, Hisao; Okada, Futoshi; Endo, Hideya			Correlation of two distinct metastasis-associated proteins, MTA1 and S100A4, in angiogenesis for promoting tumor growth	ONCOGENE			English	Article							BREAST-CANCER METASTASIS; HUMAN ENDOTHELIAL-CELLS; HEAVY-CHAIN; EXPRESSION; HYPOXIA; GENE; MTS1; OVEREXPRESSION; MOTILITY; BINDING	Extensive studies on metastasis-associated proteins, S100A4 and MTA1, have been carried out for over two decades, but correlation of both proteins remains obscure. Here we show evidence for the correlation in angiogenesis. First, silencing of each protein by siRNA-mediated knockdown in mouse endothelial MSS31 cells resulted in the inhibition of tube formation. Unexpectedly, the knockdown of MTA1 affected not only its own expression but also the expression of S100A4, whereas silencing of S100A4 did not affect the MTA1 expression. Additionally, non-muscle myosin IIA (NMIIA) phosphorylation, which was partly controlled by S100A4, was found to be upregulated by knockdown of both proteins in MSS31 cells. Moreover, cycloheximide treatment of MSS31 cells revealed that the rate of S100A4 degradation was accelerated by MTA1 knockdown. This finding, together with our observation that cytoplasmic MTA1, but not nuclear MTA1, was colocalized with S100A4, suggested the involvement of MTA1 in S100A4 stability. The direct in vivo angiogenesis assay showed that both protein siRNAs provoked a significant inhibition of new blood vessel formation induced by angiogenic factors, indicating their anti-angiogenic activities. Treatment of human pancreatic tumor (PANC-1) xenograft in mice with mMTA1 siRNA resulted in tumor regression via suppression of angiogenesis in vivo, as also observed in the case of human prostate cancer xenograft treated with mS100A4 siRNA. Taken together, these data led us to conclude that the MTA1-S100A4-NMIIA axis exists in endothelial cells as a novel pathway in promoting tumor vascular formation and could be a target for suppressing tumor growth and metastasis.	[Ishikawa, Mizuho; Osaki, Mitsuhiko; Onuma, Kunishige; Ito, Hisao; Okada, Futoshi] Tottori Univ, Fac Med, Dept Biomed Sci, Div Pathol Biochem, 86 Nishi Cho, Yonago, Tottori 6838503, Japan; [Osaki, Mitsuhiko; Okada, Futoshi] Tottori Univ, Chromosome Engn Res Ctr, 86 Nishi Cho, Yonago, Tottori 6838503, Japan; [Yamagishi, Makoto] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Lab Tumor Cell Biol,Minato Ku, Tokyo 1088639, Japan; [Endo, Hideya] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Cellular & Mol Biol,Minato Ku, Tokyo 1088639, Japan	Tottori University; Tottori University; University of Tokyo; University of Tokyo	Endo, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Cellular & Mol Biol,Minato Ku, Tokyo 1088639, Japan.	endoh@ims.u-tokyo.ac.jp		Onuma, Kunishige/0000-0002-1034-5796; Okada, Futoshi/0000-0003-4733-1037	Arteriosclerosis Research Foundation, Tokyo, Japan	Arteriosclerosis Research Foundation, Tokyo, Japan	We are grateful to Dr. K. Takenaga (Chiba Cancer Center Research Institute, Chiba, Japan) for valuable comments and critical reading of the manuscript. We also thank to Dr. Y. Toh (National Kyushu Cancer Center, Fukuoka, Japan) for valuable information on the MTA1 studies. This work was supported by a grant from the Arteriosclerosis Research Foundation, Tokyo, Japan.	Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636; Bartoszewska S, 2015, FASEB J, V29, P1467, DOI 10.1096/fj.14-267054; Dannenmann C, 2008, CANCER BIOL THER, V7, P1462, DOI 10.4161/cbt.7.9.6427; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; EBRALIDZE A, 1989, GENE DEV, V3, P1086, DOI 10.1101/gad.3.7.1086; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; FORD HL, 1995, ONCOGENE, V11, P2067; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hunter K, 2006, NAT REV CANCER, V6, P141, DOI 10.1038/nrc1803; Jang KS, 2006, CANCER SCI, V97, P374, DOI 10.1111/j.1349-7006.2006.00186.x; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kriajevska M, 2000, BBA-MOL CELL RES, V1498, P252, DOI 10.1016/S0167-4889(00)00100-2; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Liu TL, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0084-x; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Meinert C, 2017, DATA BRIEF, V10, P354, DOI 10.1016/j.dib.2016.12.004; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moon HE, 2006, ONCOL REP, V16, P929; Ochiya T, 2014, ANGIOGENESIS, V17, P17, DOI 10.1007/s10456-013-9372-7; Oida Y, 2006, ONCOL REP, V16, P457; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rudland SDS, 2006, CLIN CANCER RES, V12, P1192, DOI 10.1158/1078-0432.CCR-05-1580; Schmidt-Hansen B, 2004, ONCOGENE, V23, P5487, DOI 10.1038/sj.onc.1207720; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Takenaga K, 1997, CLIN CANCER RES, V3, P2309; TAKENAGA K, 1994, JPN J CANCER RES, V85, P831, DOI 10.1111/j.1349-7006.1994.tb02955.x; Toh Y, 2000, J EXP CLIN CANC RES, V19, P105; Toh Y, 1999, BRIT J CANCER, V79, P1723, DOI 10.1038/sj.bjc.6690274; TOH Y, 1994, J BIOL CHEM, V269, P22958; Wang YY, 2010, ANN SURG ONCOL, V17, P89, DOI 10.1245/s10434-009-0722-z; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yoo YG, 2006, EMBO J, V25, P1231, DOI 10.1038/sj.emboj.7601025; Zhu XX, 2010, J THORAC ONCOL, V5, P1159, DOI 10.1097/JTO.0b013e3181e04d98	38	11	11	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2019	38	24					4715	4728		10.1038/s41388-019-0748-z	http://dx.doi.org/10.1038/s41388-019-0748-z			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IC7ND	30745574	Green Submitted			2022-12-26	WOS:000471160500005
J	Kumar, P; Becker, JC; Gao, KW; Carney, RP; Lankford, L; Keller, BA; Herout, K; Lam, KS; Farmer, DL; Wang, AJ				Kumar, Priyadarsini; Becker, James C.; Gao, Kewa; Carney, Randy P.; Lankford, Lee; Keller, Benjamin A.; Herout, Kyle; Lam, Kit S.; Farmer, Diana L.; Wang, Aijun			Neuroprotective effect of placenta-derived mesenchymal stromal cells: role of exosomes	FASEB JOURNAL			English	Article						spina bifida; galectin 1; apoptosis; mesenchymal stromal cells; neuroprotection	EXTRACELLULAR VESICLES; CHORIONIC VILLI; IN-VITRO; FETAL; GALECTIN-1; PROTEIN; PROLIFERATION; ANGIOGENESIS; GROWTH; MODEL	We have established early-gestation chorionic villus-derived placenta mesenchymal stromal cells (PMSCs) as a potential treatment for spina bifida (SB), a neural tube defect. Our preclinical studies demonstrated that PMSCs have the potential to cure hind limb paralysis in the fetal lamb model of SB via a paracrine mechanism. PMSCs exhibit neuroprotective function by increasing cell number and neurites, as shown by indirect coculture and direct addition of PMSC-conditioned medium to the staurosporine-induced apoptotic human neuroblastoma cell line, SH-SY5Y. PMSC-conditioned medium suppressed caspase activity in apoptotic SH-SY5Y cells, suggesting that PMSC secretome contributes to neuronal survival after injury. As a part of PMSC secretome, PMSC exosomes were isolated and extensively characterized; their addition to apoptotic SH-SY5Y cells mediated an increase in neurites, suggesting that they exhibit neuroprotective function. Proteomic and RNA sequencing analysis revealed that PMSC exosomes contain several proteins and RNAs involved in neuronal survival and development. Galectin 1 was highly expressed on the surface of PMSCs and PMSC exosomes. Preincubation of exosomes with anti-galectin 1 antibody decreased their neuroprotective effect, suggesting that PMSC exosomes likely impart their effect via binding of galectin 1 to cells. Future studies will include in-depth analyses of the role of PMSC exosomes on neuroprotection and their clinical applications.Kumar, P., Becker, J. C., Gao, K., Carney, R. P., Lankford, L., Keller, B. A., Herout, K., Lam, K. S., Farmer, D. L., Wang, A. Neuroprotective effect of placenta-derived mesenchymal stromal cells: role of exosomes.	[Kumar, Priyadarsini; Becker, James C.; Gao, Kewa; Lankford, Lee; Keller, Benjamin A.; Herout, Kyle; Farmer, Diana L.; Wang, Aijun] Univ Calif Davis, Sch Med, Dept Surg, Surg Bioengn Lab, Sacramento, CA 95817 USA; [Lam, Kit S.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Gao, Kewa] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Carney, Randy P.; Wang, Aijun] Cent South Univ, Dept Burns & Plast Surg, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Farmer, Diana L.; Wang, Aijun] Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Central South University	Wang, AJ (corresponding author), Univ Calif Davis Hlth, Dept Surg, Surg Bioengn Lab, Res 2,Suite 3005,4625 2nd Ave, Sacramento, CA 95817 USA.	aawang@ucdavis.edu	Wang, Aijun/C-7559-2013; Carney, Randy/ABB-8530-2020; kumar, priyadarsini/AAG-7494-2019	Wang, Aijun/0000-0002-2985-3627; Carney, Randy/0000-0001-8193-1664; kumar, priyadarsini/0000-0001-6800-9632; Farmer, Diana/0000-0002-3530-5993	California Institute for Regenerative Medicine [PC1-08103]; Craig H. Neilsen Foundation Research Grant [546558]; Shriners Hospital for Children Research Grants [85120-NCA-16, 87410-NCA-17, 85119-NCA-18]; U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant [5R01NS100761-02]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [R03HD091601-01]; March of Dimes Foundation Grant [5FY1682]; University of California-Davis Center for Biophotonics Pilot grant; California Institute for Regenerative Medicine (CIRM) Training Grant [TG2-01163]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100761] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Craig H. Neilsen Foundation Research Grant; Shriners Hospital for Children Research Grants; U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; March of Dimes Foundation Grant; University of California-Davis Center for Biophotonics Pilot grant; California Institute for Regenerative Medicine (CIRM) Training Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part, by the California Institute for Regenerative Medicine (PC1-08103 to D.L.F. and A.W.), Craig H. Neilsen Foundation Research Grant 546558 (to D.L.F.), Shriners Hospital for Children Research Grants 85120-NCA-16 (to D.L.F.), 87410-NCA-17 and 85119-NCA-18 (to A.W.), U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant 5R01NS100761-02 (to A.W.), NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R03HD091601-01 (to A.W.), March of Dimes Foundation Grant 5FY1682 (to A.W.), a University of California-Davis Center for Biophotonics Pilot grant (to A.W.), and California Institute for Regenerative Medicine (CIRM) Training Grant TG2-01163 (to B.A.K.). The authors acknowledge Nicole Kreutzberg (University of California-Davis) for her help with manuscript editing and submission. The authors declare no conflicts of interest.	Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; Ahn Jee-Yin, 2014, Exp Neurobiol, V23, P200, DOI 10.5607/en.2014.23.3.200; Anderson JD, 2016, STEM CELLS, V34, P601, DOI 10.1002/stem.2298; Antoniadou E, 2016, BEST PRACT RES CL OB, V31, P13, DOI 10.1016/j.bpobgyn.2015.08.014; Beretti F, 2018, BIOFACTORS, V44, P158, DOI 10.1002/biof.1407; Bjorge IM, 2017, BIOMATER SCI-UK, V6, P60, DOI 10.1039/c7bm00479f; Brady K, 2014, STEM CELLS DEV, V23, P541, DOI 10.1089/scd.2013.0301; Calzarossa C, 2013, NEUROSCIENCE, V234, P158, DOI 10.1016/j.neuroscience.2012.12.038; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Carney RP, 2017, ADV BIOSYST, V1, DOI 10.1002/adbi.201600038; Carney RP, 2017, ANAL CHEM, V89, P5357, DOI 10.1021/acs.analchem.7b00017; Chen YJ, 2018, J PEDIATR SURG, V53, P183, DOI 10.1016/j.jpedsurg.2017.10.040; Colao IL, 2018, TRENDS MOL MED, V24, P242, DOI 10.1016/j.molmed.2018.01.006; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Doeppner TR, 2015, STEM CELL TRANSL MED, V4, P1131, DOI 10.5966/sctm.2015-0078; Fais S, 2016, ACS NANO, V10, P3886, DOI 10.1021/acsnano.5b08015; Fan YN, 2016, NUCLEIC ACIDS RES, V44, pW135, DOI 10.1093/nar/gkw288; Farmer DL, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.12.001; Ham O, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0134-x; He XT, 2018, J CELL MOL MED, V22, P1302, DOI 10.1111/jcmm.13431; Horie H, 1999, J NEUROSCI, V19, P9964; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kabagambe S, 2018, J PEDIATR SURG, V53, P178, DOI 10.1016/j.jpedsurg.2017.10.032; Keshtkar S, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0791-7; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; Kramer-Albers EM, 2016, CURR OPIN NEUROBIOL, V39, P101, DOI 10.1016/j.conb.2016.04.016; Lamichhane TN, 2015, TISSUE ENG PART B-RE, V21, P45, DOI [10.1089/ten.TEB.2014.0300, 10.1089/ten.teb.2014.0300]; Lankford KL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190358; Lankford L, 2017, CYTOTHERAPY, V19, P680, DOI 10.1016/j.jcyt.2017.03.003; Lankford L, 2015, WORLD J STEM CELLS, V7, P195, DOI 10.4252/wjsc.v7.i1.195; Li H, 2014, CYTOTHERAPY, V16, P319, DOI 10.1016/j.jcyt.2013.10.005; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Lopes FM, 2012, NEUROTOX RES, V22, P138, DOI 10.1007/s12640-012-9311-1; Mead B, 2017, STEM CELL TRANSL MED, V6, P1273, DOI 10.1002/sctm.16-0428; Meuli M, 2014, PEDIATR SURG INT, V30, P689, DOI 10.1007/s00383-014-3524-8; Peng X, 2011, CURR PROTEIN PEPT SC, V12, P52, DOI 10.2174/138920311795659452; Phan J, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1522236; Popa SJ, 2018, SEMIN CELL DEV BIOL, V83, P42, DOI 10.1016/j.semcdb.2018.02.022; Safford KA, 2005, CURR DRUG TARGETS, V6, P57, DOI 10.2174/1389450053345028; Sakaguchi M, 2006, P NATL ACAD SCI USA, V103, P7112, DOI 10.1073/pnas.0508793103; Shabbir A, 2015, STEM CELLS DEV, V24, P1635, DOI 10.1089/scd.2014.0316; Smith ZJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28533; Szekiova E, 2018, NEUROL RES, V40, P258, DOI 10.1080/01616412.2018.1432266; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang Ho Man, 2017, F1000Res, V6, P43, DOI 10.12688/f1000research.10568.2; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wagenaar N, 2018, PEDIATR RES, V83, P372, DOI 10.1038/pr.2017.243; Wang AJ, 2015, STEM CELL TRANSL MED, V4, P659, DOI 10.5966/sctm.2014-0296; Wang L, 2017, MINERAL MET MAT SER, P109, DOI 10.1007/978-3-319-51580-9_11; Willis GR, 2017, METHODS MOL BIOL, V1660, P409, DOI 10.1007/978-1-4939-7253-1_34	53	34	37	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5836	5849		10.1096/fj.201800972R	http://dx.doi.org/10.1096/fj.201800972R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30753093	Green Published, Bronze			2022-12-26	WOS:000466932600004
J	Werner, M; Jordan, PM; Romp, E; Czapka, A; Rao, ZG; Kretzer, C; Koeberle, A; Garscha, U; Pace, S; Claesson, HE; Serhan, CN; Werz, O; Gerstmeier, J				Werner, Markus; Jordan, Paul M.; Romp, Erik; Czapka, Anna; Rao, Zhigang; Kretzer, Christian; Koeberle, Andreas; Garscha, Ulrike; Pace, Simona; Claesson, Hans-Erik; Serhan, Charles N.; Werz, Oliver; Gerstmeier, Jana			Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome	FASEB JOURNAL			English	Article						resolution; macrophages; inflammation; leukotrienes; prostaglandins	CYTOSOLIC PHOSPHOLIPASE A(2); INFLAMMATION; MEDIATORS; INHIBITION; RESOLUTION; ACID; 15-LIPOXYGENASE-1; CYCLOOXYGENASE; IDENTIFICATION; POLARIZATION	Nonsteroidal anti-inflammatory drugs interfere with the metabolism of arachidonic acid to proinflammatory prostaglandins and leukotrienes by targeting cyclooxygenases (COXs), 5-lipoxygenase (LOX), or the 5-LOX-activating protein (FLAP). These and related enzymes act in conjunction with marked crosstalk within a complex lipid mediator (LM) network where also specialized proresolving LMs (SPMs) are formed. Here, we present how prominent LM pathways can be differentially modulated in human proinflammatory M1 and proresolving M2 macrophage phenotypes that, upon exposure to Escherichia coli, produce either abundant prostaglandins and leukotrienes (M1) or SPMs (M2). Targeted liquid chromatography-tandem mass spectrometry-based metabololipidomics was applied to analyze and quantify the specific LM profiles. Besides expected on-target actions, we found that: 1) COX or 15-LOX-1 inhibitors elevate inflammatory leukotriene levels, 2) FLAP and 5-LOX inhibitors reduce leukotrienes in M1 but less so in M2 macrophages, 3) zileuton blocks resolution-initiating SPM biosynthesis, whereas FLAP inhibition increases SPM levels, and 4) that the 15-LOX-1 inhibitor 3887 suppresses SPM formation in M2 macrophages. Conclusively, interference with discrete LM biosynthetic enzymes in different macrophage phenotypes considerably affects the LM metabolomes with potential consequences for inflammation-resolution pharmacotherapy. Our data may allow better appraisal of the therapeutic potential of these drugs to intervene with inflammatory disorders.Werner, M., Jordan, P. M., Romp, E., Czapka, A., Rao, Z., Kretzer, C., Koeberle, A., Garscha, U., Pace, S., Claesson, H.-E., Serhan, C. N., Werz, O., Gerstmeier, J. Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome.	[Werner, Markus; Jordan, Paul M.; Romp, Erik; Czapka, Anna; Rao, Zhigang; Kretzer, Christian; Koeberle, Andreas; Garscha, Ulrike; Pace, Simona; Werz, Oliver; Gerstmeier, Jana] Friedrich Schiller Univ Jena, Dept Pharmaceut Med Chem, Inst Pharm, Philosophenweg 14, D-07743 Jena, Germany; [Claesson, Hans-Erik] Karolinska Univ Hosp Solna, Div Hematol, Dept Med, Stockholm, Sweden; [Serhan, Charles N.] Harvard Med Sch, Dept Anesthesia Perioperat & Pain, Ctr Expt Therapeut & Reperfus Injury, Brigham & Womens Hosp, Boston, MA 02115 USA	Friedrich Schiller University of Jena; Karolinska Institutet; Karolinska University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Werz, O; Gerstmeier, J (corresponding author), Friedrich Schiller Univ Jena, Dept Pharmaceut Med Chem, Inst Pharm, Philosophenweg 14, D-07743 Jena, Germany.	oliver.werz@uni-jena.de; jana.gerstmeier@uni-jena.de	Koeberle, Andreas/ABB-2356-2020; Garscha, Ulrike/G-3559-2018	Koeberle, Andreas/0000-0001-6269-5088; Jordan, Paul Mike/0000-0002-8364-4236; Rao, Zhigang/0000-0002-9918-9100; Garscha, Ulrike/0000-0002-3645-7833	Deutsche Forschungsgemeinschaft [SFB1127, SFB1278]; Carl-Zeiss stipend; U.S. National Institutes of Health, National Institute of General Medical Sciences Grant [P01GM095467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Carl-Zeiss stipend; U.S. National Institutes of Health, National Institute of General Medical Sciences Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB1127, ChemBioSys, and SFB1278, Polytarget). J.G. received a Carl-Zeiss stipend, and C.N.S. was supported by U.S. National Institutes of Health, National Institute of General Medical Sciences Grant P01GM095467. The authors declare no conflicts of interest.	Ajuebor MN, 2000, AM J PHYSIOL-GASTR L, V279, pG238; Andersson CK, 2008, AM J RESP CELL MOL, V39, P648, DOI 10.1165/rcmb.2007-0443OC; Archambault AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202424; Aursnes M, 2015, J NAT PROD, V78, P2924, DOI 10.1021/acs.jnatprod.5b00574; Bhavsar PK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-71; Burnett BP, 2012, ADV THER, V29, P79, DOI 10.1007/s12325-011-0100-7; CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Claesson HE, 2009, PROSTAG OTH LIPID M, V89, P120, DOI 10.1016/j.prostaglandins.2008.12.003; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Conte MS, 2018, J CLIN INVEST, V128, P3727, DOI 10.1172/JCI97947; Dalli J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01940; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Fischer L, 2004, BRIT J PHARMACOL, V142, P861, DOI 10.1038/sj.bjp.0705860; Fischer L, 2003, FASEB J, V17, P949, DOI 10.1096/fj.02-0815fje; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; Fukunaga K, 2005, J IMMUNOL, V174, P5033, DOI 10.4049/jimmunol.174.8.5033; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gerstmeier J, 2016, FASEB J, V30, P276, DOI 10.1096/fj.15-278010; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; GILLARD J, 1989, CAN J PHYSIOL PHARM, V67, P456, DOI 10.1139/y89-073; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Han HY, 2017, FASEB J, V31, P491, DOI 10.1096/fj.201600679RR; He C, 2012, MOL BIOSYST, V8, P1585, DOI 10.1039/c2mb05503a; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Kim SN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27221-7; Kutzner L, 2017, BBA-MOL CELL BIOL L, V1862, P666, DOI 10.1016/j.bbalip.2017.04.001; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lehmann C, 2015, FASEB J, V29, P5029, DOI 10.1096/fj.15-275487; Leslie CC, 2015, J LIPID RES, V56, P1386, DOI 10.1194/jlr.R057588; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Mazaleuskaya LL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87031; Meng H, 2016, J MED CHEM, V59, P4202, DOI 10.1021/acs.jmedchem.5b01011; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Motwani MP, 2015, SEMIN IMMUNOL, V27, P257, DOI 10.1016/j.smim.2015.07.002; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Pace S, 2017, J CLIN INVEST, V127, P3167, DOI 10.1172/JCI92885; Primdahl KG, 2017, ORG BIOMOL CHEM, V15, P8606, DOI [10.1039/c7ob02113ersc.li/obc, 10.1039/c7ob02113e]; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Rainsford K. D., 2007, V42, P3; RAINSFORD KD, 1993, AGENTS ACTIONS, V39, pC24, DOI 10.1007/BF01972709; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SHIKANO M, 1994, BBA-LIPID LIPID MET, V1212, P211, DOI 10.1016/0005-2760(94)90255-0; Snodgrass RG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01906; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Sugimoto MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00160; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Titos E, 2005, J LEUKOCYTE BIOL, V78, P871, DOI 10.1189/jlb.1204747; Wallace JL, 2000, GASTROENTEROLOGY, V119, P706, DOI 10.1053/gast.2000.16510; Werz O, 2005, BIOCHEM PHARMACOL, V70, P327, DOI 10.1016/j.bcp.2005.04.018; Werz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02538-5; Werz O, 2017, EXPERT OPIN THER PAT, V27, P607, DOI 10.1080/13543776.2017.1276568; Yang K, 2007, PLOS COMPUT BIOL, V3, P523, DOI 10.1371/journal.pcbi.0030055	63	54	55	3	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6140	6153		10.1096/fj.201802509R	http://dx.doi.org/10.1096/fj.201802509R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30735438	Bronze, Green Accepted, Green Published			2022-12-26	WOS:000466932600028
J	Garcia, A; Lev, B; Hossain, KR; Gorman, A; Diaz, D; Pham, THN; Cornelius, F; Allen, TW; Clarke, RJ				Garcia, Alvaro; Lev, Bogdan; Hossain, Khondker R.; Gorman, Amy; Diaz, Dil; Thi Hanh Nguyen Pham; Cornelius, Flemming; Allen, Toby W.; Clarke, Ronald J.			Cholesterol depletion inhibits Na+,K+-ATPase activity in a near-native membrane environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid-protein interaction; molecular dynamics; Na+; K+-ATPase; pre-steady-state kinetics; cholesterol; lipid-protein interactions; methyl--cyclodextrin; molecular dynamics; partial reaction kinetics; steady-state activity	LIPID-PROTEIN INTERACTIONS; NA+/K+-ATPASE ACTIVITY; CRYSTAL-STRUCTURE; CONFORMATIONAL TRANSITIONS; MOLECULAR-DYNAMICS; STEADY-STATE; SODIUM-PUMP; K+-ATPASE; NA,K-ATPASE; MODULATION	Cholesterol's effects on Na , K -ATPase reconstituted in phospholipid vesicles have been extensively studied. However, previous studies have reported both cholesterol-mediated stimulation and inhibition of Na , K -ATPase activity. Here, using partial reaction kinetics determined via stopped-flow experiments, we studied cholesterol's effect on Na , K -ATPase in a near-native environment in which purified membrane fragments were depleted of cholesterol with methyl- -cyclodextrin (m CD). Them CD-treated Na , K -ATPase had significantly reduced overall activity and exhibited decreased observed rate constants forATPphosphorylation(ENa 3 3E2P, i. e. phosphorylation by ATP and Na occlusion from the cytoplasm) and K deocclusion with subsequent intracellular Na binding (E2K 2 3E1Na 3 ). However, cholesterol depletion did not affect the observed rate constant for K occlusion by phosphorylated Na , K -ATPase on the extracellular face and subsequent dephosphorylation (E2P3E2K 2 ). Thus, partial reactions involving cation binding and release at the protein's intracellular side were most dependent on cholesterol. Fluorescence measurements with the probe eosin indicated that cholesterol depletion stabilizes the unphosphorylated E2 state relative to E1, and the cholesterol depletion-induced slowing of ATP phosphorylation kinetics was consistent with partial conversion of Na , K ATPase into the E2 state, requiring a slow E2 3 E1 transition before the phosphorylation. Molecular dynamics simulations of Na , K -ATPase in membranes with 40 mol % cholesterol revealed cholesterol interaction sites that differ markedly among protein conformations. They further indicated state-dependent effects on membrane shape, with the E2 state being likely disfavored in cholesterol-rich bilayers relative to the E1P state because of a greater hydrophobic mismatch. In summary, cholesterol extraction from membranes significantly decreases Na , K -ATPase steady-state activity.	[Garcia, Alvaro; Hossain, Khondker R.; Gorman, Amy; Diaz, Dil; Thi Hanh Nguyen Pham; Clarke, Ronald J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Garcia, Alvaro; Clarke, Ronald J.] Univ Sydney, Nano Inst, Sydney, NSW 2006, Australia; [Lev, Bogdan; Allen, Toby W.] RMIT Univ, Sch Sci, Melbourne, Vic 3001, Australia; [Gorman, Amy] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Cornelius, Flemming] Univ Aarhus, Dept Biomed, DK-8000 Aarhus C, Denmark; [Allen, Toby W.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Garcia, Alvaro] Univ Technol Sydney, Sch Life Sci, Ultimo, NSW 2007, Australia	University of Sydney; University of Sydney; Royal Melbourne Institute of Technology (RMIT); University of York - UK; Aarhus University; University of California System; University of California Davis; University of Technology Sydney	Clarke, RJ (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	ronald.clarke@sydney.edu.au	Hossain, Khondker/C-1814-2019; Hossain, Khondker Rufaka/AAR-6301-2020; Clarke, Ronald J/L-5259-2016; Garcia, Alvaro/E-6573-2015	Hossain, Khondker/0000-0003-4506-1491; Hossain, Khondker Rufaka/0000-0003-4506-1491; Clarke, Ronald J/0000-0002-0950-8017; Garcia, Alvaro/0000-0002-1159-4567; allen, toby/0000-0002-3521-7950; Gorman, Amy/0000-0002-6039-9100; Lev, Bogdan/0000-0002-7631-9400	Australian Research Council [DP121003548, DP150101112, DP170101732]; NHMRC [App1104259]; National Institutes of Health [U01-HL126273-02]; Medical Advances Without Animals Trust; Danish Medical Research Council; Novo Nordisk Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL126273] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Advances Without Animals Trust; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Australian Research Council Discovery Grants DP121003548 (to R. J. C. and T. W. A.), DP150101112 (to R. J. C. and F. C.), and DP170101732 (to R. J. C., T. W. A., and F. C.), NHMRC Grant App1104259 (to T. W. A.), National Institutes of Health Grant U01-HL126273-02, the Medical Advances Without Animals Trust, the Danish Medical Research Council, and The Novo Nordisk Foundation (to F. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alwarawrah M, 2010, J PHYS CHEM B, V114, P7516, DOI 10.1021/jp101415g; Asano S, 2000, JPN J PHYSIOL, V50, P419, DOI 10.2170/jjphysiol.50.419; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Balut C, 2006, AM J PHYSIOL-CELL PH, V290, pC87, DOI 10.1152/ajpcell.00184.2005; CLARET M, 1978, J PHYSIOL-LONDON, V274, P247, DOI 10.1113/jphysiol.1978.sp012145; Clarke RJ, 2015, BIOPHYS J, V109, P1513, DOI 10.1016/j.bpj.2015.08.022; Clarke RJ, 2013, BBA-BIOENERGETICS, V1827, P1205, DOI 10.1016/j.bbabio.2013.06.010; Cornelius F, 2005, BIOCHEMISTRY-US, V44, P13051, DOI 10.1021/bi0504456; Cornelius F, 2015, BBA-BIOMEMBRANES, V1848, P1729, DOI 10.1016/j.bbamem.2015.03.012; Cornelius F, 2003, BIOCHEMISTRY-US, V42, P8541, DOI 10.1021/bi034532e; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; Cornelius F, 2003, BIOPHYS J, V84, P1690, DOI 10.1016/S0006-3495(03)74977-7; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Cornelius F, 1999, BIOPHYS J, V77, P934, DOI 10.1016/S0006-3495(99)76944-4; Cornelius F, 1998, BIOCHEMISTRY-US, V37, P16686, DOI 10.1021/bi981571v; Cornelius F, 2008, BIOCHEMISTRY-US, V47, P1652, DOI 10.1021/bi702128x; Cuevas FJ, 2006, BIOCHEMISTRY-US, V45, P13855, DOI 10.1021/bi061351e; Daly SE, 1996, J BIOL CHEM, V271, P23683, DOI 10.1074/jbc.271.39.23683; DEPONT JJHHM, 1978, BIOCHIM BIOPHYS ACTA, V508, P464, DOI 10.1016/0005-2736(78)90092-5; ESMANN M, 1985, BIOCHEMISTRY-US, V24, P1386, DOI 10.1021/bi00327a016; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FORBUSH B, 1991, SOC GEN PHY, V46, P211; Garcia A, 2017, BBA-BIOMEMBRANES, V1859, P813, DOI 10.1016/j.bbamem.2017.01.022; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; Grossfield A, 2006, P NATL ACAD SCI USA, V103, P4888, DOI 10.1073/pnas.0508352103; Habeck M, 2017, P NATL ACAD SCI USA, V114, P2904, DOI 10.1073/pnas.1620799114; Habeck M, 2015, J BIOL CHEM, V290, P4829, DOI 10.1074/jbc.M114.611384; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; Han M, 2017, SCI REP-UK, V7, DOI 10.1038/srep39829; Humphrey PA, 2002, BIOCHEMISTRY-US, V41, P9496, DOI 10.1021/bi025836o; Hung WC, 2007, BIOPHYS J, V92, P3960, DOI 10.1529/biophysj.106.099234; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; Jiang QC, 2017, BIOPHYS J, V112, P288, DOI 10.1016/j.bpj.2016.12.008; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN PL, 1982, BIOCHIM BIOPHYS ACTA, V694, P27, DOI 10.1016/0304-4157(82)90013-2; JORGENSEN PL, 1986, BIOCHIM BIOPHYS ACTA, V860, P570, DOI 10.1016/0005-2736(86)90555-9; JORGENSEN PL, 1982, ANN NY ACAD SCI, V402, P207, DOI 10.1111/j.1749-6632.1982.tb25743.x; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; JORGENSEN PL, 1975, BIOCHIM BIOPHYS ACTA, V401, P399, DOI 10.1016/0005-2736(75)90239-4; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kane DJ, 1997, BIOCHEMISTRY-US, V36, P13406, DOI 10.1021/bi970598w; Khalid M, 2010, BIOPHYS J, V98, P2290, DOI 10.1016/j.bpj.2010.01.038; KIMELBERG HK, 1974, J BIOL CHEM, V249, P1071; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Klodos I, 2002, KIDNEY INT, V62, P2097, DOI 10.1046/j.1523-1755.2002.00654.x; Lambropoulos N, 2016, J MEMBRANE BIOL, V249, P251, DOI 10.1007/s00232-015-9864-z; Lauger P., 1991, ELECTROGENIC ION PUM; Lopez CA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUCIO FJ, 1991, EXP PHYSIOL, V76, P437, DOI 10.1113/expphysiol.1991.sp003510; LUNDKATZ S, 1988, BIOCHEMISTRY-US, V27, P3416, DOI 10.1021/bi00409a044; Lupfert C, 2001, BIOPHYS J, V81, P2069, DOI 10.1016/S0006-3495(01)75856-0; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MARIN R, 1985, BIOCHEM PHARMACOL, V34, P4197, DOI 10.1016/0006-2952(85)90274-6; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Myers SL, 2011, BIOPHYS J, V100, P70, DOI 10.1016/j.bpj.2010.11.038; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Pan J, 2008, BIOPHYS J, V94, P117, DOI 10.1529/biophysj.107.115691; PETERS WHM, 1981, BIOCHIM BIOPHYS ACTA, V649, P541, DOI 10.1016/0005-2736(81)90158-9; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pilotelle-Bunner A, 2009, BIOPHYS J, V96, P3753, DOI 10.1016/j.bpj.2009.01.042; Pucadyil TJ, 2004, BBA-BIOMEMBRANES, V1663, P188, DOI 10.1016/j.bbamem.2004.03.010; Pytel M, 2006, BRIT J PHARMACOL, V148, P413, DOI 10.1038/sj.bjp.0706747; Razavi AM, 2017, J BIOL CHEM, V292, P12412, DOI 10.1074/jbc.M117.779090; Reddy ST, 2016, BBA-BIOMEMBRANES, V1858, P2611, DOI 10.1016/j.bbamem.2016.07.007; ROBINSON JD, 1993, BIOCHIM BIOPHYS ACTA, V1154, P83, DOI 10.1016/0304-4157(93)90018-J; Sarkar P, 2016, CHEM PHYS LIPIDS, V195, P34, DOI 10.1016/j.chemphyslip.2015.11.005; Sarkar P, 2015, CHEM PHYS LIPIDS, V191, P91, DOI 10.1016/j.chemphyslip.2015.08.016; Scanzano R, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705899200; SCHVARTZ PG, 2005, J GEN PHYSIOL, V31, pA32; Schwartz A. K., 1971, METHOD PHARMACOL, V1, P361; SHIN YK, 1990, BIOPHYS J, V57, P445, DOI 10.1016/S0006-3495(90)82561-3; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; SKOU JC, 1983, BIOCHIM BIOPHYS ACTA, V746, P101, DOI 10.1016/0167-4838(83)90016-X; SKOU JC, 1981, BIOCHIM BIOPHYS ACTA, V647, P232, DOI 10.1016/0005-2736(81)90251-0; Sotomayor CP, 2000, BIOCHEMISTRY-US, V39, P10928, DOI 10.1021/bi000717z; Starke-Peterkovic T, 2006, BIOPHYS J, V90, P4060, DOI 10.1529/biophysj.105.074666; STURMER W, 1991, J MEMBRANE BIOL, V121, P163, DOI 10.1007/BF01870530; YEAGLE PL, 1983, BIOCHIM BIOPHYS ACTA, V727, P39, DOI 10.1016/0005-2736(83)90366-8; YEAGLE PL, 1988, BIOCHEMISTRY-US, V27, P6449, DOI 10.1021/bi00417a037; Yu HB, 2011, NAT STRUCT MOL BIOL, V18, P1159, DOI 10.1038/nsmb.2113; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	87	18	18	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5956	5969		10.1074/jbc.RA118.006223	http://dx.doi.org/10.1074/jbc.RA118.006223			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30770471	Green Published, hybrid			2022-12-26	WOS:000465077500027
J	Gunaratnam, P; Heywood, AE; McGregor, S; Jamil, MS; McManus, H; Mao, L; Lobo, R; Brown, G; Hellard, M; Marukutira, T; Bretana, NA; Lang, C; Medland, N; Bavinton, B; Grulich, A; Guy, R				Gunaratnam, Praveena; Heywood, Anita Elizabeth; McGregor, Skye; Jamil, Muhammad Shahid; McManus, Hamish; Mao, Limin; Lobo, Roanna; Brown, Graham; Hellard, Margaret; Marukutira, Tafireyi; Bretana, Neil Arvin; Lang, Carolyn; Medland, Nicholas; Bavinton, Benjamin; Grulich, Andrew; Guy, Rebecca			HIV diagnoses in migrant populations in Australia-A changing epidemiology	PLOS ONE			English	Article							MIGRATION; NORTHERN	Introduction We conducted a detailed analysis of trends in new HIV diagnoses in Australia by country of birth, to understand any changes in epidemiology, relationship to migration patterns and implications for public health programs. Methods Poisson regression analyses were performed, comparing the age-standardised HIV diagnosis rates per 100,000 estimated resident population between 2006-2010 and 2011-2015 by region of birth, with stratification by exposure (male-to-male sex, heterosexual sex-males and females). Correlation between the number of permanent and long-term arrivals was also explored using linear regression models. Results Between 2006 and 2015, there were 6,741 new HIV diagnoses attributed to male-to-male sex and 2,093 attributed to heterosexual sex, with the proportion of diagnoses attributed to male-to-male sex who were Australian-born decreasing from 72.5% to 66.5%. Compared with 2006-2010, the average annual HIV diagnosis rate per 100,000 in 2011-15 attributed to male-to-male sex was significantly higher in men born in South-East Asia (summary rate ratio (SRR) = 1.37, p = 0.001), North-East Asia (SRR = 2.18, p<0.001) and the Americas (SRR = 1.37, p = 0.025), but significantly lower as a result of heterosexual sex in men born in South-East Asia (SRR = 0.49, p = 0.002), Southern and Central Asia (SRR = 0.50, p = 0.014) and Sub-Saharan Africa (SRR = 0.39, p<0.001) and women born in South-East Asia (SRR = 0.61, p = 0.002) and Sub-Saharan Africa (SRR = 0.61, p<0.001). Positive associations were observed between the number of permanent and long-term arrivals and HIV diagnoses particularly in relation to diagnoses associated with male-to-male sex in men from North Africa and the Middle East, North Asia, Southern and Central Asia and the Americas. Conclusion The epidemiology of HIV in Australia is changing, with an increase in HIV diagnosis rates attributed to male-to-male sex amongst men born in Asia and the Americas. Tailored strategies must be developed to increase access to, and uptake of, prevention, testing and treatment in this group.	[Gunaratnam, Praveena; McGregor, Skye; Jamil, Muhammad Shahid; McManus, Hamish; Bretana, Neil Arvin; Bavinton, Benjamin; Grulich, Andrew; Guy, Rebecca] UNSW Sydney, Kirby Inst Infect & Immun, Sydney, NSW, Australia; [Heywood, Anita Elizabeth] UNSW Sydney, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Mao, Limin] UNSW Sydney, Ctr Social Res Hlth, Sydney, NSW, Australia; [Lobo, Roanna] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Brown, Graham] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Hellard, Margaret; Marukutira, Tafireyi] Burnet Inst, Melbourne, Vic, Australia; [Lang, Carolyn] Queensland Dept Hlth, Communicable Dis Branch, Brisbane, Qld, Australia; [Medland, Nicholas] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Medland, Nicholas] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; University of New South Wales Sydney; Curtin University; La Trobe University; Burnet Institute; Queensland Health; Monash University	Gunaratnam, P (corresponding author), UNSW Sydney, Kirby Inst Infect & Immun, Sydney, NSW, Australia.	praveenagunaratnam@gmail.com	Marukutira, Tafireyi/AAE-3518-2020; Lobo, Roanna C/E-4287-2013; Mao, Limin/B-2049-2013	Marukutira, Tafireyi/0000-0003-1142-6114; Lobo, Roanna C/0000-0002-8335-3017; Mao, Limin/0000-0003-0995-5789; Brown, Graham/0000-0003-4901-0974; McManus, Hamish/0000-0002-7264-8848; Bretana, Neil Arvin/0000-0003-4743-348X; Bavinton, Benjamin Robert/0000-0001-5834-8278; Jamil, Muhammad/0000-0001-9637-7838	Australian Department of Health	Australian Department of Health(Australian GovernmentDepartment of Health & Ageing)	The Kirby Institute and the Centre for Social Research in Health receive funding from the Australian Department of Health for national HIV surveillance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-del Arco D, 2017, AIDS, V31, P1979, DOI 10.1097/QAD.0000000000001571; Aung E, 2017, AIDS BEHAV, V21, P2844, DOI 10.1007/s10461-017-1833-3; Australian Bureau of Statistics, STAND POP US AG STAN; Australian Bureau of Statistics, TABL 2 TOT MOV LONG; Australian Bureau of Statistics, 2017, 34010 AUSTR BUR STAT; Australian Bureau of Statistics, 2015, 3412 0 MIGR; Australian Bureau of Statistics, EST RES POP COUNTR B; Australian Bureau of Statistics, 2016, 12690 MAJ GROUPS STA; Australian Bureau of Statistics, TABL 1 TOT MOV PERM; Australian Bureau of Statistics, 2016, 2940055002 AUSTR BUR; Australian Government Department of Education and Training, 2016, END YEAR SUMM INT ST; Australian Government Department of Health, 2014, 7 NAT HIV STRAT 2014; Chu JJ, 2013, EUR J PUBLIC HEALTH, V23, P642, DOI 10.1093/eurpub/cks067; Communicable Diseases Network of Australia, 2014, HUM IMM VIR HIV CDNA; Fakoya I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1852-9; Fish J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3418-x; Grulich A., 2017, AUSTRALASIAN HIV AID; Guy RJ, 2007, MED J AUSTRALIA, V187, P437, DOI 10.5694/j.1326-5377.2007.tb01353.x; Hanway A, 2016, TUBERCULOSIS, V101, P67, DOI 10.1016/j.tube.2016.07.019; Hernando V, 2015, JAIDS-J ACQ IMM DEF, V70, P204, DOI 10.1097/QAI.0000000000000717; Kenyon C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-350; Mao L WT, 2017, AUSTR SEX HLTH C 6 8; Medland NA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3325-0; Rice B, 2014, SEX TRANSM DIS, V41, P257, DOI 10.1097/OLQ.0000000000000111; The Kirby Institute, 2016, HIV VIR HEP SEX TRAN; UNAIDS, KEY POP ATL; Xiridou M, 2011, SEX TRANSM INFECT, V87, P289, DOI 10.1136/sti.2010.048512	27	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212268	10.1371/journal.pone.0212268	http://dx.doi.org/10.1371/journal.pone.0212268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763366	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000458763900055
J	Redman, W				Redman, William			An O(n) method of calculating Kendall correlations of spike trains	PLOS ONE			English	Article								The ability to record from increasingly large numbers of neurons, and the increasing attention being paid to large scale neural network simulations, demands computationally fast algorithms to compute relevant statistical measures. We present an O(n) algorithm for calculating the Kendall correlation of spike trains, a correlation measure that is becoming especially recognized as an important tool in neuroscience. We show that our method is around 50 times faster than the O(n ln n) method which is a current standard for quickly computing the Kendall correlation. In addition to providing a faster algorithm, we emphasize the role that taking the specific nature of spike trains had on reducing the run time. We imagine that there are many other useful algorithms that can be even more significantly sped up when taking this into consideration. A MATLAB function executing the method described here has been made freely available on-line.	[Redman, William] UC Santa Barbara, Dynam Neurosci Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Redman, W (corresponding author), UC Santa Barbara, Dynam Neurosci Program, Santa Barbara, CA 93106 USA.	wredman@ucsb.edu		Redman, William/0000-0002-4147-2026				Agresti A., 2010, ANAL ORDINAL CATEGOR, DOI [10.1002/9780470594001, DOI 10.1002/9780470594001]; Christensen D., FAST ALGORITHMS CALC, P51, DOI [10.1007/BF02736122, DOI 10.1007/BF02736122]; Giraudet AL, 2008, EUR J ENDOCRINOL, V158, P239, DOI 10.1530/EJE-07-0667; Kelder T, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.18; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; KNIGHT WR, 1966, J AM STAT ASSOC, V61, P436, DOI 10.2307/2282833; Neymotin SA, 2017, J NEUROSCI METH, V275, P1, DOI 10.1016/j.jneumeth.2016.10.009; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Soletta JH, 2015, IEEE LAT AM T, V13, P3743, DOI 10.1109/TLA.2015.7404902	10	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212190	10.1371/journal.pone.0212190	http://dx.doi.org/10.1371/journal.pone.0212190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763350	Green Published, gold, Green Submitted			2022-12-26	WOS:000458763900050
J	Boycott, TJ; Gao, JY; Gall, MD				Boycott, Timothy J.; Gao, Jingyi; Gall, Megan D.			Deer browsing alters sound propagation in temperate deciduous forests	PLOS ONE			English	Article							WHITE-TAILED DEER; VEGETATION STRUCTURE; BIRD POPULATIONS; PLANT DIVERSITY; WOODLAND BIRDS; VOCAL SIGNALS; NOISE; SONG; TRANSMISSION; EVOLUTION	The efficacy of animal signals is strongly influenced by the structure of the habitat in which they are propagating. In recent years, the habitat structure of temperate forests has been increasingly subject to modifications from foraging by white-tailed deer (Odocoileus virginianus). Increasing deer numbers and the accompanying browsing have been shown to alter vegetation structure and thus the foraging, roosting, and breeding habitats of many species. However, despite a large body of literature on the effects of vegetation structure on sound propagation, we do not yet know what impact deer browsing may have on acoustic communication. Here we used playback experiments to determine whether sound fidelity and amplitude of white noise, pure tones, and trills differed between deer-browsed and deer-excluded plots. We found that sound fidelity, but not amplitude, differed between habitats, with deer-browsed habitats having greater sound fidelity than deer-excluded habitats. Difference in sound propagation characteristics between the two habitats could alter the efficacy of acoustic communication through plasticity, cultural evolution or local adaptation, in turn influencing vocally-mediated behaviors (e.g. agonistic, parent-offspring, mate selection). Reduced signal degradation suggests vocalizations may retain more information, improving the transfer of information to both intended and unintended receivers. Overall, our results suggest that deer browsing impacts sound propagation in temperate deciduous forest, although much work remains to be done on the potential impacts on communication.	[Boycott, Timothy J.; Gao, Jingyi; Gall, Megan D.] Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA	Vassar College	Gall, MD (corresponding author), Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA.	megall@vassar.edu		Gall, Megan/0000-0003-0032-8164; Boycott, Timothy/0000-0002-8026-3032	Vassar College	Vassar College	Funding was provided by Vassar College.	ALLISON TD, 1990, OECOLOGIA, V83, P523, DOI 10.1007/BF00317204; Anderson RC, 2008, ETHOLOGY, V114, P662, DOI 10.1111/j.1439-0310.2008.01518.x; Attenborough K, 2002, ANNU REV FLUID MECH, V34, P51, DOI 10.1146/annurev.fluid.34.081701.143541; AYLOR D, 1972, J ACOUST SOC AM, V51, P411, DOI 10.1121/1.1912852; Baker MC, 2002, WILSON BULL, V114, P510, DOI 10.1676/0043-5643(2002)114[0510:MCOBCC]2.0.CO;2; Baker MC, 2006, BEHAVIOUR, V143, P1473, DOI 10.1163/156853906779366991; Baker TM, 2012, ANIM BEHAV, V84, P965, DOI 10.1016/j.anbehav.2012.07.022; Bakker ES, 2004, OECOLOGIA, V138, P91, DOI 10.1007/s00442-003-1402-5; Begemann M, 2015, DEER MANAGEMENT VASS, DOI [10.1038/nature09492, DOI 10.1038/NATURE09492]; Betts MG, 2008, P ROY SOC B-BIOL SCI, V275, P2257, DOI 10.1098/rspb.2008.0217; Blumenrath SH, 2004, BEHAVIOUR, V141, P935, DOI 10.1163/1568539042360152; Borer ET, 2012, ECOL LETT, V15, P1457, DOI 10.1111/ele.12006; Bradbury Jack W., 1998, pi; Brown TJ, 1996, CONDOR, V98, P608, DOI 10.2307/1369573; Brown TJ, 2000, CONDOR, V102, P81, DOI 10.1650/0010-5422(2000)102[0081:SDFVQI]2.0.CO;2; Brown TL, 2000, WILDLIFE SOC B, V28, P797; Cardinal E, 2012, ECOSCIENCE, V19, P38, DOI 10.2980/19-1-3441; Chollet S, 2013, DIVERS DISTRIB, V19, P481, DOI 10.1111/ddi.12003; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; DABELSTEEN T, 1993, J ACOUST SOC AM, V93, P2206, DOI 10.1121/1.406682; Dabelsteen Torben, 1998, Bioacoustics, V9, P89; Derryberry EP, 2017, ECOL EVOL, V7, P4991, DOI 10.1002/ece3.3037; Derryberry EP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154456; Derryberry EP, 2009, AM NAT, V174, P24, DOI 10.1086/599298; Embleton TFW, 1996, J ACOUST SOC AM, V100, P31, DOI 10.1121/1.415879; Eycott AE, 2004, LANDSCAPE ECOLOGY OF TREES AND FORESTS, P50; FORREST TG, 1994, AM ZOOL, V34, P644; Fotheringham JR, 1997, ANIM BEHAV, V53, P1271, DOI 10.1006/anbe.1996.0361; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Fuller RA, 2007, BIOLOGY LETT, V3, P368, DOI 10.1098/rsbl.2007.0134; Fuller RJ, 2001, FORESTRY, V74, P289, DOI 10.1093/forestry/74.3.289; Fuller Robert J., 2005, British Birds, V98, P116; Gall MD, 2012, J ACOUST SOC AM, V132, P4053, DOI 10.1121/1.4764512; Gil D, 2015, BEHAV ECOL, V26, P435, DOI 10.1093/beheco/aru207; Gill RMA, 2001, FORESTRY, V74, P209, DOI 10.1093/forestry/74.3.209; Gill RMA, 2007, IBIS, V149, P119, DOI 10.1111/j.1474-919X.2007.00731.x; Gorissen L, 2005, BEHAVIOUR, V142, P489, DOI 10.1163/1568539054012056; Graham BA, 2017, BIOACOUSTICS, V26, P37, DOI 10.1080/09524622.2016.1181574; HANSEN P, 1979, ANIM BEHAV, V27, P1270, DOI 10.1016/0003-3472(79)90073-3; Haven Wiley R., 1982, P131; Heckel CD, 2010, ECOLOGY, V91, P319, DOI 10.1890/09-0628.1; HENWOOD K, 1979, AM NAT, V114, P260, DOI 10.1086/283473; Hewson CM, 2007, IBIS, V149, P14, DOI 10.1111/j.1474-919X.2007.00745.x; Holland J, 1998, J ACOUST SOC AM, V103, P2154, DOI 10.1121/1.421361; Hughes M, 1998, ETHOLOGY, V104, P232; Isler ML, 1998, AUK, V115, P577, DOI 10.2307/4089407; Kirby KJ, 2001, FORESTRY, V74, P219, DOI 10.1093/forestry/74.3.219; Kleist NJ, 2017, ECOL APPL, V27, P260, DOI 10.1002/eap.1437; Larom D, 1997, J EXP BIOL, V200, P421; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Luther D, 2010, P R SOC B, V277, P469, DOI 10.1098/rspb.2009.1571; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; MARTENS MJM, 1980, J ACOUST SOC AM, V67, P66, DOI 10.1121/1.383790; Mathevon N, 1997, BEHAV PROCESS, V39, P77, DOI 10.1016/S0376-6357(96)00046-0; McShea WJ, 2000, CONSERV BIOL, V14, P1161, DOI 10.1046/j.1523-1739.2000.99210.x; MORGAN S, 1992, J ACOUST SOC AM, V92, P1180, DOI 10.1121/1.404049; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Mougeot F, 2000, ANIM BEHAV, V60, P647, DOI 10.1006/anbe.2000.1491; Naguib M, 2003, J ACOUST SOC AM, V113, P1749, DOI 10.1121/1.1539050; Nordt A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071476; Olofsson J, 2002, OIKOS, V96, P507, DOI 10.1034/j.1600-0706.2002.960312.x; Peake TM, 2002, P ROY SOC B-BIOL SCI, V269, P1925, DOI 10.1098/rspb.2002.2112; Peters S, 2012, BIOL LETTERS, V8, P736, DOI 10.1098/rsbl.2012.0446; PIERCY JE, 1977, J ACOUST SOC AM, V61, P1403, DOI 10.1121/1.381455; Pohl NU, 2012, ANIM BEHAV, V83, P711, DOI 10.1016/j.anbehav.2011.12.019; Proppe DS, 2010, CAN J ZOOL, V88, P788, DOI 10.1139/Z10-047; Radford AN, 2008, ANIM BEHAV, V75, P519, DOI 10.1016/j.anbehav.2007.05.016; Reichard DG, 2013, BEHAVIOUR, V150, P1183, DOI 10.1163/1568539X-00003090; RICHARDS DG, 1980, AM NAT, V115, P381, DOI 10.1086/283568; Ripple WJ, 2003, FOREST ECOL MANAG, V184, P299, DOI 10.1016/S0378-1127(03)00154-3; ROMER H, 1992, BEHAV ECOL SOCIOBIOL, V29, P437, DOI 10.1007/BF00170174; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schutz M, 2003, FOREST ECOL MANAG, V181, P177, DOI 10.1016/S0378-1127(03)00131-2; Seddon N, 2005, EVOLUTION, V59, P200; Slabbekoorn H, 2002, CONDOR, V104, P564, DOI 10.1650/0010-5422(2002)104[0564:BASTTB]2.0.CO;2; Stewart AJA, 2001, FORESTRY, V74, P259, DOI 10.1093/forestry/74.3.259; Tennessen JB, 2016, ANIM BEHAV, V114, P53, DOI 10.1016/j.anbehav.2016.01.021; TILGHMAN NG, 1989, J WILDLIFE MANAGE, V53, P524, DOI 10.2307/3809172; Underwood HB, 1997, SCI OVERABUNDANCE DE; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; WILEY RH, 1991, AM NAT, V138, P973, DOI 10.1086/285263	82	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211569	10.1371/journal.pone.0211569	http://dx.doi.org/10.1371/journal.pone.0211569			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759129	gold, Green Submitted, Green Published			2022-12-26	WOS:000458761300052
J	Semasaka, JPS; Krantz, G; Nzayirambaho, M; Munyanshongore, C; Edvardsson, K; Mogren, I				Semasaka, Jean Paul Sengoma; Krantz, Gunilla; Nzayirambaho, Manasse; Munyanshongore, Cyprien; Edvardsson, Kristina; Mogren, Ingrid			"Not taken seriously"-A qualitative interview study of postpartum Rwandan women who have experienced pregnancy-related complications	PLOS ONE			English	Article							SEVERE OBSTETRIC COMPLICATIONS; BURKINA-FASO; MISS; HEALTH; BIRTH; CARE; HEMORRHAGE; MORTALITY; BENIN; DEATH	Background There is limited knowledge on the women's experiences of pregnancy-related complications in Rwanda. This study aimed to investigate women's experiences and perceptions of specific complications during pregnancy and delivery and the consequences of these complications on postpartum health and family situation. Methods Data were collected through individual in-depth interviews (N = 15). Participants who experienced complications such as postpartum haemorrhage, caesarean section due to prolonged labour/dystocia, pre-eclampsia, or fistula and who were 13-24 months postpartum were invited to participate in the study in July 2015. Interviews were held in Kinyarwanda, digitally recorded, transcribed verbatim, translated into English, and analysed using qualitative content analysis. Results Most participants reported that they were previously unaware of the complications they had developed, and they claimed that at discharge they should have been better informed about the potential consequences of these complications. Most participants blamed the health care system as the cause of their problems due to the provision of inadequate care. Participants elaborated different strategies for coping with persistent health problems. Pregnancy-related complications negatively affected participants' economic situation due to increased health care expenses and lowered income because of impaired working capacity, and participants expressed fear of encountering the same pregnancy-related health problems during future pregnancies. Conclusions The findings of this study demonstrate how participants felt that inadequate health care provision during pregnancy, delivery, and the postpartum period was the source of their problems. Participants reported different coping strategies to improve their respective life situation despite persistent health problems. Women's individual postpartum experiences need to be considered and actions taken at the policy level and also by the local community, in terms of the quality of antenatal and postpartum care services, and in sensitizing the local community about the existence of these complications and preparing the community to support the affected women.	[Semasaka, Jean Paul Sengoma; Edvardsson, Kristina; Mogren, Ingrid] Umea Univ, Dept Clin Sci Obstet & Gynaecol, Umea, Sweden; [Semasaka, Jean Paul Sengoma; Nzayirambaho, Manasse; Munyanshongore, Cyprien] Univ Rwanda, Coll Med & Hlth Sci, Sch Publ Hlth, Kigali, Rwanda; [Krantz, Gunilla] Univ Gothenburg, Sahlgrenska Acad, Dept Community Med & Publ Hlth, Gothenburg, Sweden; [Edvardsson, Kristina; Mogren, Ingrid] La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia	Umea University; University of Rwanda; University of Gothenburg; La Trobe University	Semasaka, JPS (corresponding author), Umea Univ, Dept Clin Sci Obstet & Gynaecol, Umea, Sweden.; Semasaka, JPS (corresponding author), Univ Rwanda, Coll Med & Hlth Sci, Sch Publ Hlth, Kigali, Rwanda.	jeanpaul.semasaka.sengoma@umu.se	Edvardsson, Kristina/AAX-4810-2020; Edvardsson, Kristina/GOP-2054-2022	Edvardsson, Kristina/0000-0001-6883-3664; Edvardsson, Kristina/0000-0001-6883-3664	Swedish International Development Agency (SIDA) [51160027-04]	Swedish International Development Agency (SIDA)	This study was conducted as part of the first author's PhD studies that were sponsored by the Swedish International Development Agency (SIDA) grant award - 51160027-04. SIDA did not play any role in the study design, data collection, data analysis, interpretation of data, or in the writing of the manuscript.	Alio AP, 2011, ARCH GYNECOL OBSTET, V284, P371, DOI 10.1007/s00404-010-1652-5; Bangser M, 2011, INT UROGYNECOL J, V22, P91, DOI 10.1007/s00192-010-1236-8; Bashah DT, 2018, CONSEQUENCES OBSTETR, V18, P106, DOI [10.1186/s12905-018-0605-1, DOI 10.1186/S12905-018-0605-1]; Blum LS, 2012, FISTULA CARE; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; Dunning T, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0870-7; Elmir R, 2012, MIDWIFERY, V28, P228, DOI 10.1016/j.midw.2010.11.008; Essendi H, 2011, J URBAN HEALTH, V88, P356, DOI 10.1007/s11524-010-9481-1; Falconer AD:, 2010, OBSTET GYNAECOL REPR, V20, P369; Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8; Foreman M, 2012, MATERNAL MORTALITY S; Fottrell E, 2010, BRIT J PSYCHIAT, V196, P18, DOI 10.1192/bjp.bp.108.062489; Furuta M, 2014, MIDWIFERY, V30, P158, DOI 10.1016/j.midw.2013.09.001; Fusch PI, 2015, QUAL REP, V20, P1408; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Graneheim UH, 2017, NURS EDUC TODAY, V56, P29, DOI 10.1016/j.nedt.2017.06.002; Kaye DK, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-31; Kealy MA, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-47; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Mselle LT, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-174; Mselle LT, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-49; Mukamurigo J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189371; Mwini-Nyaledzigbor PP, 2013, HEALTH CARE WOMEN IN, V34, P440, DOI 10.1080/07399332.2012.755981; Nathan LM, 2015, MATERN CHILD HLTH J, V19, P1949, DOI 10.1007/s10995-015-1702-5; Norhayati MN, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1377-6; Pafs J, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1051-4; Rowan C, 2007, WORLDV EVID-BASED NU, V4, P97, DOI 10.1111/j.1741-6787.2007.00088.x; Rwanda National Institute of Statistics Rwandan Ministry of Health International I, 2015, RWAND DEM HLTH SURV; Semasaka JPS, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1138-y; Souza JP, 2009, BIRTH-ISS PERINAT C, V36, P149, DOI 10.1111/j.1523-536X.2009.00313.x; Storeng KT, 2012, B WORLD HEALTH ORGAN, V90, P418, DOI 10.2471/BLT.11.094011; Storeng KT, 2010, SOC SCI MED, V71, P1749, DOI 10.1016/j.socscimed.2010.03.056; United Nations Economic Commission of Africa, 2015, MDG REP 2015 ASS PRO; van den Broek NR, 2011, BRIT MED BULL, V99, P25, DOI 10.1093/bmb/ldr033; Wahl K, 2011, J BEHAV THER EXP PSY, V42, P454, DOI 10.1016/j.jbtep.2011.03.002; World Health Organization, 1999, PUTT WOM 1 ETH SAF R	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0212001	10.1371/journal.pone.0212001	http://dx.doi.org/10.1371/journal.pone.0212001			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5IX	30759136	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300067
J	Castillo, D; Galvez, JM; Herrera, LJ; Rojas, F; Valenzuela, O; Caba, O; Prados, J; Rojas, I				Castillo, Daniel; Manuel Galvez, Juan; Herrera, Luis J.; Rojas, Fernando; Valenzuela, Olga; Caba, Octavio; Prados, Jose; Rojas, Ignacio			Leukemia multiclass assessment and classification from Microarray and RNA-seq technologies integration at gene expression level	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; READ ALIGNMENT; PROTEIN; EVOLUTION; AML; DIFFERENTIATION; PROLIFERATION; PROGRESSION; OMICS	In more recent years, a significant increase in the number of available biological experiments has taken place due to the widespread use of massive sequencing data. Furthermore, the continuous developments in the machine learning and in the high performance computing areas, are allowing a faster and more efficient analysis and processing of this type of data. However, biological information about a certain disease is normally widespread due to the use of different sequencing technologies and different manufacturers, in different experiments along the years around the world. Thus, nowadays it is of paramount importance to attain a correct integration of biologically-related data in order to achieve genuine benefits from them. For this purpose, this work presents an integration of multiple Microarray and RNA-seq platforms, which has led to the design of a multiclass study by collecting samples from the main four types of leukemia, quantified at gene expression. Subsequently, in order to find a set of differentially expressed genes with the highest discernment capability among different types of leukemia, an innovative parameter referred to as coverage is presented here. This parameter allows assessing the number of different pathologies that a certain gen is able to discern. It has been evaluated together with other widely known parameters under assessment of an ANOVA statistical test which corroborated its filtering power when the identified genes are subjected to a machine learning process at multiclass level. The optimal tuning of gene extraction evaluated parameters by means of this statistical test led to the selection of 42 highly relevant expressed genes. By the use of minimum-Redundancy Maximum-Relevance (mRMR) feature selection algorithm, these genes were reordered and assessed under the operation of four different classification techniques. Outstanding results were achieved by taking exclusively the first ten genes of the ranking into consideration. Finally, specific literature was consulted on this last subset of genes, revealing the occurrence of practically all of them with biological processes related to leukemia. At sight of these results, this study underlines the relevance of considering a new parameter which facilitates the identification of highly valid expressed genes for simultaneously discerning multiple types of leukemia.	[Castillo, Daniel; Manuel Galvez, Juan; Herrera, Luis J.; Rojas, Fernando; Rojas, Ignacio] Univ Granada, Dept Comp Architecture & Comp Technol, Granada, Spain; [Valenzuela, Olga] Univ Granada, Dept Appl Math, Granada, Spain; [Caba, Octavio; Prados, Jose] Univ Granada, Inst Biopathol & Regenerat Med IBIMER, Ctr Biomed Res CIBM, Granada, Spain; [Castillo, Daniel] Univ Granada, Res Ctr Informat & Commun Technol CITIC, C Periodista Rafael Gomez Montero 2,D1-7 Off, E-18071 Granada, Spain	University of Granada; University of Granada; University of Granada; University of Granada	Castillo, D (corresponding author), Univ Granada, Dept Comp Architecture & Comp Technol, Granada, Spain.; Castillo, D (corresponding author), Univ Granada, Res Ctr Informat & Commun Technol CITIC, C Periodista Rafael Gomez Montero 2,D1-7 Off, E-18071 Granada, Spain.	cased@ugr.es	Herrera, Luis/GMW-6727-2022; Galvez, Juan Manuel/AAB-9172-2019; Rojas, Fernando/AAL-4976-2020; Herrera, Luis J/L-2392-2014; Gálvez, Juan M./J-6149-2018; Caba, Octavio/H-1918-2015	Herrera, Luis/0000-0003-3220-9389; Galvez, Juan Manuel/0000-0003-2139-0565; Rojas, Fernando/0000-0002-4377-6744; Herrera, Luis J/0000-0003-3220-9389; Gálvez, Juan M./0000-0003-2139-0565; Castillo-Secilla, Daniel/0000-0002-7380-1023; Caba, Octavio/0000-0003-3426-8294	Spanish Ministry of Economy and Competitiveness -MINECO [TIN2015-71873-R]; European Regional Development Fund -ERDF [TIN2015-71873-R]; Junta de Andalucia [P12-TIC-2082]	Spanish Ministry of Economy and Competitiveness -MINECO; European Regional Development Fund -ERDF; Junta de Andalucia(Junta de Andalucia)	This work was supported by Project TIN2015-71873-R (Spanish Ministry of Economy and Competitiveness -MINECO- and the European Regional Development Fund -ERDF) and Junta de Andalucia (P12-TIC-2082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Asnafi AA, 2018, J CELL PHYSL; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Nunez-Enriquez JC, 2016, ARCH MED RES, V47, P644, DOI 10.1016/j.arcmed.2016.12.005; Castillo D, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1925-0; Cavallari Maurizio, 2018, Oncotarget, V9, P34398, DOI 10.18632/oncotarget.26146; Cha K, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0194-5; Chen Y, 2010, LEUKEMIA, V24, P1545, DOI 10.1038/leu.2010.143; Chiaretti S, 2019, CANCER-AM CANCER SOC, V125, P194, DOI 10.1002/cncr.31848; Cho S.-B., 2003, P 1 AS PAC BIOINF C, V19, P189; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crivellaro S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2346-6; Daigo K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015073; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dimitrakopoulos L, 2017, CRIT REV CL LAB SCI, V54, P414, DOI 10.1080/10408363.2017.1384446; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Dobbin KK, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-31; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunne J, 2006, ONCOGENE, V25, P6067, DOI 10.1038/sj.onc.1209638; Exiqon, 2009, EX GEN EXPR ARR; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goh W.W.B., 2017, BMC BIOINF, V6, P191; Gohlmann H, GENE EXPRESSION STUD; Goldin LR, 2004, BLOOD, V104, P1850, DOI 10.1182/blood-2004-01-0341; Grimwade D, 2016, BLOOD, V127, P29, DOI 10.1182/blood-2015-07-604496; Hackl H, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0416-0; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hasan MK, 2018, BLOOD, V132, P170, DOI 10.1182/blood-2017-12-819383; Haseeb M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02720; Huang L, 2012, INT J HEMATOL, V96, P234, DOI 10.1007/s12185-012-1115-9; Huang Yi, 2012, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V20, P835; Huygens C, 2015, J BIOL CHEM, V290, P20105, DOI 10.1074/jbc.M115.655340; Illumina, 2009, ILL GEN EXPR ARR; Imoto N, 2016, J BIOL CHEM, V291, P4723, DOI 10.1074/jbc.M115.637835; Kan ZY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04129-4; Karczewski KJ, 2018, NAT REV GENET, V19, P299, DOI 10.1038/nrg.2018.4; Karjalainen E, 2016, PROG MOL BIOL TRANSL, V144, P383, DOI 10.1016/bs.pmbts.2016.09.005; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim E, 2017, BLOOD, V129, P1155, DOI 10.1182/blood-2016-06-722900; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Lewis D. D., 1998, Machine Learning: ECML-98. 10th European Conference on Machine Learning. Proceedings, P4, DOI 10.1007/BFb0026666; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ljungstrom V, 2016, BLOOD, V127, P1007, DOI 10.1182/blood-2015-10-674572; Galvez JM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196836; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Nakayama J, 2009, BLOOD, V113, P1483, DOI 10.1182/blood-2008-07-166355; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Onskog J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-390; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Parry RM, 2010, PHARMACOGENOMICS J, V10, P292, DOI 10.1038/tpj.2010.56; Paul S, 2016, MAYO CLIN PROC, V91, P1645, DOI 10.1016/j.mayocp.2016.09.010; Peng YZ, 2017, J BIOL CHEM, V292, P12285, DOI 10.1074/jbc.M117.794834; RCore Team, 2020, R LANG ENV STAT COMP; Reif K, 2002, TRENDS CELL BIOL, V12, P368, DOI 10.1016/S0962-8924(02)02330-9; Roloff GW, 2018, BLOOD ADV, V2, P3070, DOI 10.1182/bloodadvances.2018020206; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Short NJ, 2018, LANCET, V392, P593, DOI 10.1016/S0140-6736(18)31041-9; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spina V, 2018, MOL ONCOL; Statnikov Alexander, 2007, AMIA Annu Symp Proc, P686; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Taqman, 2009, TAQM GEN EXPR ARR; Tarazona S., 2011, EMBNET J, V17, P18, DOI [10.14806/ej.17.B.265, DOI 10.14806/EJ.17.B.265]; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu M, 2017, ONCOTARGET, V8, P88253, DOI 10.18632/oncotarget.21390; Wu W, TRENDS BIOTECHNOLOGY, V35, P498; Xue K, 2016, MOL IMMUNOL, V73, P1, DOI 10.1016/j.molimm.2016.03.007; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zhang HJ, 2012, NAT GENET, V44, P861, DOI 10.1038/ng.2350	80	17	17	7	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212127	10.1371/journal.pone.0212127	http://dx.doi.org/10.1371/journal.pone.0212127			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753220	Green Submitted, gold, Green Published			2022-12-26	WOS:000458395600046
J	Rodrigues, F; Christensen, H; Morales-Aza, B; Sikora, P; Oliver, E; Oliver, J; Lucidarme, J; Marlow, R; Januario, L; Finn, A				Rodrigues, Fernanda; Christensen, Hannah; Morales-Aza, Begonia; Sikora, Paulina; Oliver, Elizabeth; Oliver, Jennifer; Lucidarme, Jay; Marlow, Robin; Januario, Luis; Finn, Adam			Viable Neisseria meningitidis is commonly present in saliva in healthy young adults: Non-invasive sampling and enhanced sensitivity of detection in a follow-up carriage study in Portuguese students	PLOS ONE			English	Article							SEROGROUP W; MENINGOCOCCUS; CHILDREN; ENGLAND; DISEASE; PCR	Introduction and aims Improved sensitivity and efficiency of detection and quantification of carriage of Neisseria meningitidis (Nm) in young people is important for evaluation of the impact of vaccines upon transmission and associated population-wide effects. Saliva collection is quick, non-invasive and facilitates frequent sampling, but has been reported to yield low sensitivity by culture. We re-evaluated this approach in a follow-up cross sectional study using direct and culture-amplified PCR. Material/Methods In April 2016 we collected paired oropharyngeal swabs (OPS) and saliva samples from 1005 healthy students in Portugal into STGG broth and stored them at -80 degrees C until DNA extraction and batched qPCR analysis. Samples were also cultured on GC agar plates for 72h and PCR done on DNA extracts from overall growth. Nm isolates were also sought from a selection of 50 samples. qPCR amplification targets were superoxide dismutase sodC and capsular locus/genogroup-specific genes (B, C, W, X and Y) and, for cultured isolates only, porA. Cycle threshold values of. 36 were considered positive. Results 556 tests (460 samples, 363 subjects, 36.1%) were positive for Nm (sodC) and 65 (45, 36, 3.6%) for MenB. More salivas were positive by direct sodC qPCR (211, 21.0%) than OPS (126, 12.5%) but fewer were positive by culture-amplified qPCR (94 vs. 125). For both sample types, many that were negative on direct qPCR came positive on culture-amplification and Nm was consistently isolated from salivas in which culture amplified the PCR signal. Using both methods on both samples yielded 36.1% Nm and 5.5% encapsulated Nm carriage rates while direct qPCR on OPS alone detected 12.5% and 2.2%. Conclusions Detectable MenB carriage rates (2.9%) were lower than 4 years earlier (6.8%) in this population (p = 0.0003). Viable meningococci were often present in saliva. Although evidence of encapsulated Nm was less frequent in saliva than OPS, collection is more acceptable to subjects allowing more frequent sampling. Use of culture-amplification increases detection sensitivity in both sample types, especially when combined with direct PCR. Combining these samples and/or methodologies could greatly enhance the power of carriage studies to detect the impact of vaccines upon carriage and transmission.	[Rodrigues, Fernanda; Januario, Luis] Ctr Hosp & Univ Coimbra, Hosp Pediat, Coimbra, Portugal; [Rodrigues, Fernanda] Univ Coimbra, Fac Med, Coimbra, Portugal; [Christensen, Hannah; Oliver, Jennifer; Marlow, Robin; Finn, Adam] Univ Bristol, Sch Populat Hlth Sci, Bristol, Avon, England; [Morales-Aza, Begonia; Sikora, Paulina; Oliver, Elizabeth; Finn, Adam] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Lucidarme, Jay] Publ Hlth England, Meningococcal Reference Unit, Manchester, Lancs, England	Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; University of Bristol; University of Bristol; Public Health England	Rodrigues, F (corresponding author), Ctr Hosp & Univ Coimbra, Hosp Pediat, Coimbra, Portugal.; Rodrigues, F (corresponding author), Univ Coimbra, Fac Med, Coimbra, Portugal.	rodriguesfmp@gmail.com	Rodrigues, Fernanda/AAW-4615-2021	Finn, Adam/0000-0003-1756-5668; Marlow, Robin/0000-0002-3192-3102; Oliver, Elizabeth/0000-0002-1211-1942	Pfizer; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at the University of Bristol; Public Health England	Pfizer(Pfizer); National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at the University of Bristol; Public Health England	This work was supported by an investigator-led project grant from Pfizer. HC is supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at the University of Bristol in partnership with Public Health England. The funders had no role in study design, data collection and analysis nor preparation of the manuscript.	Broad J, 2017, LANCET PUBLIC HEALTH, V2, pE443, DOI 10.1016/S2468-2667(17)30163-9; Diallo K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3789-0; Diene SM, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.03.022; Finn A, 2016, PEDIATR INFECT DIS J, V35, P1080, DOI 10.1097/INF.0000000000001237; Gunnarsson RK, 1998, SCAND J PRIM HEALTH, V16, P13; Hong E, 2018, J INFECTION, V76, P149, DOI 10.1016/j.jinf.2017.10.015; Jordens JZ, 2005, J MED MICROBIOL, V54, P463, DOI 10.1099/jmm.0.45847-0; Knol MJ, 2017, LANCET PUBLIC HEALTH, V2, pE473, DOI 10.1016/S2468-2667(17)30157-3; Kroll JS, 1998, P NATL ACAD SCI USA, V95, P12381, DOI 10.1073/pnas.95.21.12381; Ladhani SN, 2015, CLIN INFECT DIS, V60, P578, DOI 10.1093/cid/ciu881; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; Manigart O, 2016, J CLIN MICROBIOL, V54, P2743, DOI 10.1128/JCM.01428-16; Marlow R, 2017, PAEDIAT CHILD HLTH, V27, P102; Orr HJ, 2003, EMERG INFECT DIS, V9, P1314, DOI 10.3201/eid0910.030344; Rodrigues F, 2015, PEDIATR INFECT DIS J, V34, P1267, DOI 10.1097/INF.0000000000000860; Simoes MJ, 2016, INVASIVE MENINGOCOCC; Thomas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019361; Thors V, 2016, HUM VACC IMMUNOTHER, V12, P375, DOI 10.1080/21645515.2015.1090069; Wyllie AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102045; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	22	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0209905	10.1371/journal.pone.0209905	http://dx.doi.org/10.1371/journal.pone.0209905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742640	Green Published, Green Submitted, gold			2022-12-26	WOS:000458393400006
J	Kimura, Y; Kato, T; Miyata, H; Sasaki, I; Minamino-Muta, E; Nagasawa, Y; Numao, S; Nagano, T; Higuchi, T; Inoko, M				Kimura, Yuki; Kato, Takao; Miyata, Hiromi; Sasaki, Issei; Minamino-Muta, Eri; Nagasawa, Yoshinori; Numao, Shigeharu; Nagano, Tadayoshi; Higuchi, Toshihiro; Inoko, Moriaki			Factors associated with increased levels of brain natriuretic peptide and cardiac troponin I during the peripartum period	PLOS ONE			English	Article							HEMODYNAMIC-CHANGES; EUROPEAN-SOCIETY; PREGNANCY; CARDIOMYOPATHY; PREECLAMPSIA; VOLUME; BLOOD; PUERPERIUM; DOPPLER; OUTPUT	Background We aimed to investigate the values and the changes of brain natriuretic peptide (BNP) and cardiac troponin in pregnant women. Methods and results We prospectively collected the data of 405 pregnant women who were treated at Japanese general hospital between 2012 and 2013. We analyzed their laboratory data and echocardiographic findings during the third trimester (28-30 weeks' gestation) and within 4 days of delivery. In addition, we evaluated the factors associated with elevation of BNP and cardiac troponin I (cTnI) levels. The pregnant women were 33.8 +/- 5.0 years old and the prevalence of pregnancy induced hypertension (PIH) and placental abnormality was 4.2% and 2.5%, respectively. BNP levels increased after delivery (13.2 pg/mL vs. 23.5 pg/mL; P < 0.001), correlated with increased left ventricular diastolic dimension (P = 0.035), left atrial dimension (P < 0.001), and decreased hemoglobin (P < 0.001). Moreover, cTnI levels increased to over 0.015 ng/mL after delivery in 4.0% of pregnant women. In multivariate analysis, PIH (OR: 18.71, P = 0.003), placental abnormality (OR: 26.78, P = 0.007), and decreased hemoglobin after delivery (OR: 2.59, P < 0.001) were the factors associated with elevated cTnI. Conclusions BNP levels increased in association with cardiac chamber enlargement and decreased hemoglobin after delivery. Additionally, the factors affecting elevated cTnI levels were related to labor and delivery.	[Kimura, Yuki; Minamino-Muta, Eri; Inoko, Moriaki] Kitano Hosp, Tazuke Kofukai Med Res Inst, Cardiovasc Ctr, Kita Ku, Ogimachi, Osaka, Japan; [Kato, Takao] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto, Japan; [Miyata, Hiromi; Nagano, Tadayoshi; Higuchi, Toshihiro] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Obstet & Gynecol, Kita Ku, Ogimachi, Osaka, Japan; [Sasaki, Issei; Nagasawa, Yoshinori; Numao, Shigeharu] Kyoto Pharmaceut Univ, Dept Hlth & Sports Sci, Kyoto, Japan	Kitano Hospital; Kyoto University; Kitano Hospital; Kyoto Pharmaceutical University	Kato, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto, Japan.	tkato75@kuhp.kyoto-u.ac.jp		Kimura, Yuki/0000-0003-2191-8577; Kato, Takao/0000-0001-8213-7999				Ananth CV, 2001, AM J EPIDEMIOL, V153, P771, DOI 10.1093/aje/153.8.771; Armaly Z, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00973; Bello N, 2013, J AM COLL CARDIOL, V62, P1715, DOI 10.1016/j.jacc.2013.08.717; Bhattacharyya A, 2012, TEX HEART I J, V39, P8; CAMPOS O, 1993, INT J CARDIOL, V40, P265, DOI 10.1016/0167-5273(93)90010-E; Chapman AB, 1998, KIDNEY INT, V54, P2056, DOI 10.1046/j.1523-1755.1998.00217.x; Clapp JF, 1997, AM J CARDIOL, V80, P1469, DOI 10.1016/S0002-9149(97)00738-8; De Haas S, 2017, ULTRASOUND OBST GYN, V49, P177, DOI 10.1002/uog.17360; Elkayam U, 2005, CIRCULATION, V111, P2050, DOI 10.1161/01.CIR.0000162478.36652.7E; Fleming SM, 2000, BRIT J OBSTET GYNAEC, V107, P1417, DOI 10.1111/j.1471-0528.2000.tb11658.x; Forster O, 2008, EUR J HEART FAIL, V10, P861, DOI 10.1016/j.ejheart.2008.07.005; Ghaheh HS, 2013, J RES MED SCI, V18, P422; Giuliani I, 1999, CLIN CHEM, V45, P213; Granger JP, 2001, AM J HYPERTENS, V14, p178S, DOI 10.1016/S0895-7061(01)02086-6; Hameed Afshan Batool, 2009, Clin Cardiol, V32, pE60, DOI 10.1002/clc.20391; Jaffe AS, 2011, J AM COLL CARDIOL, V58, P1819, DOI 10.1016/j.jacc.2011.08.026; Kamiya CA, 2011, CIRC J, V75, P1975, DOI 10.1253/circj.CJ-10-1214; KATZ R, 1978, CIRCULATION, V58, P434, DOI 10.1161/01.CIR.58.3.434; KINNUNEN P, 1993, ENDOCRINOLOGY, V132, P1961, DOI 10.1210/en.132.5.1961; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; MCLENNAN CE, 1950, AM J OBSTET GYNECOL, V59, P662; Meah VL, 2016, HEART, V102, P518, DOI 10.1136/heartjnl-2015-308476; Metivier F, 2000, NEPHROL DIAL TRANSPL, V15, P14, DOI 10.1093/oxfordjournals.ndt.a027970; PRITCHAR.JA, 1965, ANESTHESIOLOGY, V26, P393, DOI 10.1097/00000542-196507000-00004; Riise HKR, 2018, J AM HEART ASSOC, V7, DOI [10.1161/jaha.117.008337, 10.1161/JAHA.117.008337]; Roberts JM, 2000, SEMIN PERINATOL, V24, P24, DOI 10.1016/S0146-0005(00)80050-6; ROBSON SC, 1987, BRIT J OBSTET GYNAEC, V94, P1028, DOI 10.1111/j.1471-0528.1987.tb02286.x; ROBSON SC, 1989, AM J PHYSIOL, V256, pH1060, DOI 10.1152/ajpheart.1989.256.4.H1060; Saha P, 2009, BJOG-INT J OBSTET GY, V116, P1602, DOI 10.1111/j.1471-0528.2009.02295.x; Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120; Troisi R, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.030	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211982	10.1371/journal.pone.0211982	http://dx.doi.org/10.1371/journal.pone.0211982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730993	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000085
J	La, TM; Choi, EJ; Lee, JB; Park, SY; Song, CS; Choi, IS; Lee, SW				La, Tae-Min; Choi, Eun-Jung; Lee, Joong-Bok; Park, Seung-Yong; Song, Chang-Seon; Choi, In-Soo; Lee, Sang-Won			Comparative genome analysis of Korean field strains of infectious laryngotracheitis virus	PLOS ONE			English	Article							LIVE ATTENUATED VACCINES; NUCLEOTIDE-SEQUENCE; DNA-SEQUENCE; GENE; HERPESVIRUS-1; IDENTIFICATION; ORGANIZATION; VIRULENCE; PROTEINS; REGION	Attenuated live infectious laryngotracheitis (ILT) virus (ILTV) vaccines have been used to prevent and control the outbreak of ILT worldwide. Recent studies using high-throughput sequencing technology have increased the number of complete genome sequences of ILTVs, enabling comparative genome analysis. Although 37 complete genome sequences of ILTV, including vaccine strains, have been reported, the complete genome sequence of any field strain of ILTV in South Korea is yet to be published. In this study, we determined and analyzed the complete genome sequences of three virulent Korean field strains of ILTV (40798/10/Ko, 0206/14/Ko, and 30678/14/Ko). Two of the Korean field strains (40798/10/Ko and 0206/14/Ko) displayed fewer non-synonymous single nucleotide polymorphisms than those of the Serva vaccine strain, indicating that these Korean field strains of ILTV most likely originated from the vaccine strain. The third ILTV strain, 307678/14/Ko, had two regions in the genome showing recombination between the Serva vaccine-like strain and the Australian A20 vaccine-like strain. Comparative genome analysis of ILTV using the Korean field strains with variable virulence can shed light on the recent trend of the emergence of virulent ILTV strains in the field. A few amino acid changes in the genome of ILTV vaccines could enhance the virulence in the vaccine strain, and natural recombination should be considered one of the major risks for the generation of revertant strains of ILTV under field conditions.	[La, Tae-Min; Choi, Eun-Jung; Lee, Joong-Bok; Park, Seung-Yong; Song, Chang-Seon; Choi, In-Soo; Lee, Sang-Won] Konkuk Univ, Coll Vet Med, Seoul, South Korea	Konkuk University	Lee, SW (corresponding author), Konkuk Univ, Coll Vet Med, Seoul, South Korea.	odssey@konkuk.ac.kr			Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry(IPET) through AgriBio industry Technology Development Program - Ministry of Agriculture, Food and Rural Affairs(MAFRA) [314012-3]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry(IPET) through AgriBio industry Technology Development Program - Ministry of Agriculture, Food and Rural Affairs(MAFRA)	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry(IPET) through AgriBio industry Technology Development Program funded by Ministry of Agriculture, Food and Rural Affairs(MAFRA)(314012-3) http://www.fris.go.kr/.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew-Crumpton R, 2016, INFECT GENET EVOL, V43, P67, DOI 10.1016/j.meegid.2016.05.023; Bagust TJ, 2000, REV SCI TECH OIE, V19, P483, DOI 10.20506/rst.19.2.1229; Brideau AD, 2000, J VIROL, V74, P834, DOI 10.1128/JVI.74.2.834-845.2000; Chandra YG, 2012, VIRUS GENES, V44, P470, DOI 10.1007/s11262-012-0728-7; CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125; Choi CO, 1985, OUTBREAKS INFECT LAR; Choi EJ, GENOTYPING INFECT LA; Choi EJ, 2016, AVIAN PATHOL, V45, P443, DOI 10.1080/03079457.2016.1155692; Davison AJ, 2010, VET MICROBIOL, V143, P52, DOI 10.1016/j.vetmic.2010.02.014; Dufour-Zavala L, 2008, AVIAN DIS, V52, P1, DOI 10.1637/8018-051007-Review; Fuchs W, 1996, J GEN VIROL, V77, P2221, DOI 10.1099/0022-1317-77-9-2221; Fuchs W, 2000, J GEN VIROL, V81, P627, DOI 10.1099/0022-1317-81-3-627; Fuchs W, 1999, J GEN VIROL, V80, P2173, DOI 10.1099/0022-1317-80-8-2173; Garcia M, 2013, VIROLOGY, V440, P64, DOI 10.1016/j.virol.2013.02.007; GELENCZEI EF, 1964, AVIAN DIS, V8, P105, DOI 10.2307/1587827; GRIFFIN AM, 1990, J GEN VIROL, V71, P841, DOI 10.1099/0022-1317-71-4-841; GUY JS, 1991, AVIAN DIS, V35, P348, DOI 10.2307/1591188; Han MG, 2001, VET MICROBIOL, V83, P321, DOI 10.1016/S0378-1135(01)00423-0; JOHNSON MA, 1995, VIRUS RES, V35, P193, DOI 10.1016/0168-1702(94)00096-U; Johnson MA, 1997, ARCH VIROL, V142, P1903, DOI 10.1007/s007050050209; JOHNSON MA, 1995, ARCH VIROL, V140, P623, DOI 10.1007/BF01309954; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim HR, 2013, POULTRY SCI, V92, P2053, DOI 10.3382/ps.2013-03134; Kirkpatrick NC, 2006, AVIAN PATHOL, V35, P449, DOI 10.1080/03079450601028803; Klupp BG, 2005, VIROLOGY, V334, P224, DOI 10.1016/j.virol.2005.01.032; Kratchmarov R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058776; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055121; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Lee SW, 2011, VACCINE, V29, P9583, DOI 10.1016/j.vaccine.2011.10.055; Lee SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-197; Lee SW, PHYLOGENETIC AND MOL; Menendez KR, 2014, AVIAN PATHOL, V43, P108, DOI 10.1080/03079457.2014.886004; Mundt A, 2011, J GEN VIROL, V92, P2586, DOI 10.1099/vir.0.031443-0; Pavlova S, 2013, AVIAN DIS, V57, P416, DOI 10.1637/10332-082612-Reg.1; Piccirillo A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149529; POULSEN DJ, 1991, VIRUS GENES, V5, P335, DOI 10.1007/BF00271532; RUSSELL RG, 1983, CAN J COMP MED, V47, P163; Spatz SJ, 2012, VIRUS GENES, V44, P273, DOI 10.1007/s11262-011-0696-3; Thureen DR, 2006, J VIROL, V80, P7863, DOI 10.1128/JVI.00134-06; Wild MA, 1996, VIRUS GENES, V12, P107, DOI 10.1007/BF00572949; Zhao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132747; Ziemann K, 1998, J VIROL, V72, P847, DOI 10.1128/JVI.72.1.847-852.1998; Ziemann K, 1998, J VIROL, V72, P6867, DOI 10.1128/JVI.72.8.6867-6874.1998	45	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211158	10.1371/journal.pone.0211158	http://dx.doi.org/10.1371/journal.pone.0211158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730935	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000016
J	Xie, QQ; Wang, Z; Ni, FY; Chen, XR; Ma, JP; Patel, N; Lu, HX; Liu, Y; Tian, JH; Flyer, D; Massare, MJ; Ellingsworth, L; Glenn, G; Smith, G; Wang, QH				Xie, Qingqing; Wang, Zhao; Ni, Fengyun; Chen, Xiaorui; Ma, Jianpeng; Patel, Nita; Lu, Hanxin; Liu, Ye; Tian, Jing-Hui; Flyer, David; Massare, Michael J.; Ellingsworth, Larry; Glenn, Gregory; Smith, Gale; Wang, Qinghua			Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein	PLOS ONE			English	Article							HUMANIZED MONOCLONAL-ANTIBODY; ANTIGENIC SITE; RSV F; YOUNG-CHILDREN; G-GLYCOPROTEIN; INFECTION; STRAINS; HOSPITALIZATION; PALIVIZUMAB; PREVENTION	Globally, human respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in newborns, young children, and the elderly for which there is no vaccine. The RSV fusion (F) glycoprotein is a major target for vaccine development. Here, we describe a novel monoclonal antibody (designated as R4.C6) that recognizes both prefusion and post-fusion RSV F, and binds with nanomole affinity to a unique neutralizing site comprised of antigenic sites II and IV on the globular head. A 3.9 A-resolution structure of RSV F-R4.C6 Fab complex was obtained by single particle cryo-electron microscopy and 3D reconstruction. The structure unraveled detailed interactions of R4.C6 with antigenic site II on one protomer and site IV on a neighboring protomer of post-fusion RSV F protein. These findings significantly further our understanding of the antigenic complexity of the F protein and provide new insights into RSV vaccine design.	[Xie, Qingqing; Ma, Jianpeng] Rice Univ, Dept Bioengn, Houston, TX USA; [Xie, Qingqing; Wang, Zhao; Ni, Fengyun; Chen, Xiaorui; Ma, Jianpeng; Wang, Qinghua] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Patel, Nita; Lu, Hanxin; Liu, Ye; Tian, Jing-Hui; Flyer, David; Massare, Michael J.; Ellingsworth, Larry; Glenn, Gregory; Smith, Gale] Novavax Inc, Gaithersburg, MD 20878 USA; [Chen, Xiaorui] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Liu, Ye] Regenxbio Inc, Rockville, MD USA	Rice University; Baylor College of Medicine; Academia Sinica - Taiwan	Wang, QH (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Smith, G (corresponding author), Novavax Inc, Gaithersburg, MD 20878 USA.	GSmith@Novavax.com; qinghuaw@bcm.edu	wang, zhao/E-7013-2015	Wang, Zhao/0000-0003-4897-9986	Novavax, Inc.; National Institutes of Health [R01-GM127628, R01-GM116280]; Welch Foundation [Q-1826, Q-1512, Q-1967]; Keck Center Computational Cancer Biology Training Program of the Gulf Coast Consortia (CPRIT Grant) [RP101489]; Baylor College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM127628, R01GM116280] Funding Source: NIH RePORTER	Novavax, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Keck Center Computational Cancer Biology Training Program of the Gulf Coast Consortia (CPRIT Grant); Baylor College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Q.W. acknowledges support from a Contract from Novavax, Inc., and grants from the National Institutes of Health (R01-GM127628, R01-GM116280), and the Welch Foundation (Q-1826). J.M. thanks support from the National Institutes of Health (R01-GM127628, R01-GM116280), and the Welch Foundation (Q-1512). Z.W. thanks support from the Welch Foundation (Q-1967). F.N. was partially supported for postdoctoral training fellowships from the Keck Center Computational Cancer Biology Training Program of the Gulf Coast Consortia (funded by CPRIT Grant No. RP101489). Cryo-EM ATC core is funded by Baylor College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Apiratmateekul N, 2009, CYTOTECHNOLOGY, V60, P45, DOI [10.1007/s10616-009-9213-0, 10.1007/s10616-009-9222-z]; ARBIZA J, 1992, J GEN VIROL, V73, P2225, DOI 10.1099/0022-1317-73-9-2225; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Borchers AT, 2013, CLIN REV ALLERG IMMU, V45, P331, DOI 10.1007/s12016-013-8368-9; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Bukreyev A, 2008, J VIROL, V82, P12191, DOI 10.1128/JVI.01604-08; Burmester J, 2001, J MOL BIOL, V309, P671, DOI 10.1006/jmbi.2001.4663; Collins PL, 2013, CURR TOP MICROBIOL, V372, P3, DOI 10.1007/978-3-642-38919-1_1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Everitt DE, 1996, J INFECT DIS, V174, P463, DOI 10.1093/infdis/174.3.463; Gimferrer L, 2015, J CLIN VIROL, V66, P27, DOI 10.1016/j.jcv.2015.02.018; Gonzalez-Reyes L, 2001, P NATL ACAD SCI USA, V98, P9859, DOI 10.1073/pnas.151098198; Griffiths C, 2017, CLIN MICROBIOL REV, V30, P277, DOI 10.1128/CMR.00010-16; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hause AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175792; Haynes AK, 2014, MMWR-MORBID MORTAL W, V63, P1133; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/NMETH.2727, 10.1038/nmeth.2727]; Kulkarni PS, 2018, VIRAL IMMUNOL, V31, P195, DOI 10.1089/vim.2017.0147; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Liu HQ, 2015, J STRUCT BIOL, V192, P14, DOI 10.1016/j.jsb.2015.09.001; McLellan JS, 2015, CURR OPIN VIROL, V11, P70, DOI 10.1016/j.coviro.2015.03.002; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2010, J VIROL, V84, P12236, DOI 10.1128/JVI.01579-10; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Melero JA, 2017, VACCINE, V35, P461, DOI 10.1016/j.vaccine.2016.09.045; Meng J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004016; Mousa JJ, 2016, P NATL ACAD SCI USA, V113, pE6849, DOI 10.1073/pnas.1609449113; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ni FY, 2018, VIROLOGY, V513, P98, DOI 10.1016/j.virol.2017.10.010; Ni F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134576; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raghunandan R, 2014, VACCINE, V32, P6485, DOI 10.1016/j.vaccine.2014.09.030; Rossey I, 2018, TRENDS MICROBIOL, V26, P209, DOI 10.1016/j.tim.2017.09.009; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Smith G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050852; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051439; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Walsh Edward E., 2012, Infectious Disorders - Drug Targets, V12, P98; WALSH EE, 1983, J VIROL, V47, P171, DOI 10.1128/JVI.47.1.171-177.1983; WALSH EE, 1987, J GEN VIROL, V68, P2169, DOI 10.1099/0022-1317-68-8-2169; Wu H, 2007, J MOL BIOL, V368, P652, DOI 10.1016/j.jmb.2007.02.024; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou HY, 2011, BIOPHYS J, V101, P2043, DOI 10.1016/j.bpj.2011.09.012	59	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0210749	10.1371/journal.pone.0210749	http://dx.doi.org/10.1371/journal.pone.0210749			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730999	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000010
J	John, B; Naczki, C; Patel, C; Ghoneum, A; Qasem, S; Salih, Z; Said, N				John, Bincy; Naczki, Christine; Patel, Chirayu; Ghoneum, Alia; Qasem, Shadi; Salih, Ziyan; Said, Neveen			Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC	ONCOGENE			English	Article							BINDING PROTEIN BETA; ADIPOSE TRIGLYCERIDE LIPASE; C/EBP-BETA; CHEMOKINE GENES; EXPRESSION; INFLAMMATION; METASTASIS; LIPOLYSIS; PATHWAYS; SURVIVAL	Ovarian cancer (OvCa) exhibits a specific predilection for metastasis to the omentum. Our earlier studies highlighted the tumour-suppressor effect of secreted protein acidic and rich in cysteine (SPARC) in OvCa through multi-faceted roles inhibiting cancer cell interactions within the peritoneal milieu. The goal of this study is to investigate the role of SPARC in OvCa interactions with omental adipocytes and its role in OvCa colonization in the omentum. We employed multi-pronged approach using primary omental adipocytes from Sparc knockout mice, genetically engineered human omental adipocytes in 3D co-cultures with OvCa cells, as well as treatment with recombinant SPARC protein. We show that SPARC suppresses multistep cascade in OvCa omental metastasis. SPARC inhibited in vivo and adipocyte-induced homing, proliferation, and invasion of OvCa cells. SPARC suppressed metabolic programming of both adipocytes and OvCa cells and exerted an inhibitory effect of adipocyte differentiation and their phenotypic switch to cancer-associated phenotype. Mechanistic studies revealed that this effect is mediated through inhibition of cEBP beta-NFkB-AP-1 transcription machinery. These findings define a novel and functionally important role of SPARC in OvCa and not only bridge the knowledge gap but highlight the need to consider SPARC protein expression in therapeutic development.	[John, Bincy; Naczki, Christine; Patel, Chirayu; Ghoneum, Alia; Said, Neveen] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27109 USA; [Qasem, Shadi; Salih, Ziyan; Said, Neveen] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27103 USA; [Said, Neveen] Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, Winston Salem, NC 27103 USA; [Qasem, Shadi] Univ Kentucky, Coll Med, Surg Pathol, Lexington, KY USA; [Salih, Ziyan] Univ Louisville, Sch Med, Dept Pathol & Lab Med, Louisville, KY 40202 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of Kentucky; University of Louisville	Said, N (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27109 USA.; Salih, Z; Said, N (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27103 USA.; Said, N (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, Winston Salem, NC 27103 USA.; Salih, Z (corresponding author), Univ Louisville, Sch Med, Dept Pathol & Lab Med, Louisville, KY 40202 USA.	ziyan.salih@louisville.edu; nsaid@wakehealth.edu		Patel, Chirayu/0000-0003-0649-0090	Marsha Rivkin Pilot Award; WFBMC Department of Pathology Research Pilot Funds;  [R01 CA193437];  [P30CA012197]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA193437] Funding Source: NIH RePORTER	Marsha Rivkin Pilot Award; WFBMC Department of Pathology Research Pilot Funds; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Marsha Rivkin Pilot Award, WFBMC Department of Pathology Research Pilot Funds and R01 CA193437 (NS) and P30CA012197 to the Wake Forest Baptist Comprehensive Cancer Center (WFBCCC).	Al-Hassan NN, 2012, NEOPLASIA, V14, P259, DOI 10.1593/neo.12442; Barbolina MV, 2009, CANCER TREAT RES, V149, P319, DOI 10.1007/978-0-387-98094-2_15; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Cheville NF, 2014, VET PATHOL, V51, P28, DOI 10.1177/0300985813505114; Chinnaiyan P, 2012, CANCER RES, V72, P5878, DOI 10.1158/0008-5472.CAN-12-1572-T; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Delany AM, 2009, J CELL COMMUN SIGNAL, V3, P227, DOI 10.1007/s12079-009-0076-0; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Doerstling SS, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00216; Ebadi M, 2014, NUTRIENTS, V6, P5280, DOI 10.3390/nu6115280; Esteves CL, 2014, J CLIN ENDOCR METAB, V99, pE160, DOI 10.1210/jc.2013-1708; Ewing SJ, 2008, CELL DEATH DIFFER, V15, P1734, DOI 10.1038/cdd.2008.105; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Gharpure KM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04987-y; Grisouard J, 2012, INNATE IMMUN-LONDON, V18, P25, DOI 10.1177/1753425910386632; Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Harjes U, 2017, ONCOGENE, V36, P912, DOI 10.1038/onc.2016.256; Hein S, 2009, ONCOL REP, V22, P177, DOI 10.3892/or_00000422; Hernandez L, 2010, CANCER RES, V70, P4005, DOI 10.1158/0008-5472.CAN-09-3912; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; House CD, 2017, CANCER RES, V77, P6927, DOI 10.1158/0008-5472.CAN-17-0366; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Jakobs A, 2016, J BIOL CHEM, V291, P26098, DOI 10.1074/jbc.M116.748129; Ji CB, 2011, J BIOENERG BIOMEMBR, V43, P367, DOI 10.1007/s10863-011-9361-8; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Ladanyi A, 2018, ONCOGENE, V37, P2285, DOI 10.1038/s41388-017-0093-z; Lengyel E, 2014, ONCOGENE, V33, P3619, DOI 10.1038/onc.2013.321; Liu D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03590-5; Miranda F, 2016, CANCER CELL, V30, P273, DOI 10.1016/j.ccell.2016.06.020; Naczki C, 2018, CANCERS, V10, DOI 10.3390/cancers10100385; Nie J, 2011, CONNECT TISSUE RES, V52, P99, DOI 10.3109/03008207.2010.483747; Nie J, 2009, J CELL COMMUN SIGNAL, V3, P247, DOI 10.1007/s12079-009-0064-4; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Oyesanya RA, 2008, FASEB J, V22, P2639, DOI 10.1096/fj.07-101428; Piconese S, 2011, J AUTOIMMUN, V37, P300, DOI 10.1016/j.jaut.2011.09.002; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rozenberg JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078179; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; Said N, 2013, J CARCINOGENE MUTAGE, V4, P151; Said N, 2007, MOL CANCER RES, V5, P1015, DOI 10.1158/1541-7786.MCR-07-0001; Said N, 2007, AM J PATHOL, V170, P1054, DOI 10.2353/ajpath.2007.060903; Said N, 2013, J CLIN INVEST, V123, P4089, DOI 10.1172/JCI71241; Said N, 2012, J CLIN INVEST, V122, P1503, DOI 10.1172/JCI61392; Said N, 2011, J CLIN INVEST, V121, P132, DOI 10.1172/JCI42912; Said NA, 2008, NEOPLASIA, V10, P1092, DOI 10.1593/neo.08672; Said NA, 2007, NEOPLASIA, V9, P23, DOI 10.1593/neo.06658; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Tucker SL, 2014, CLIN CANCER RES, V20, P3280, DOI 10.1158/1078-0432.CCR-14-0445; Vaysse C, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0015-9; Yeung TL, 2015, AM J PHYSIOL-CELL PH, V309, pC444, DOI 10.1152/ajpcell.00188.2015; Zhang WL, 2014, J BIOL CHEM, V289, P32178, DOI 10.1074/jbc.M114.601096; Zhang ZQ, 2010, J BIOL CHEM, V285, P33092, DOI 10.1074/jbc.M110.130377; Zhang ZJ, 2014, INT J MOL SCI, V15, P17242, DOI 10.3390/ijms151017242	64	27	29	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4366	4383		10.1038/s41388-019-0728-3	http://dx.doi.org/10.1038/s41388-019-0728-3			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30765860	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000469339100012
J	Grimsey, NJ; Lin, Y; Narala, R; Rada, CC; Mejia-Pena, H; Trejo, J				Grimsey, Neil J.; Lin, Ying; Narala, Rachan; Rada, Cara C.; Mejia-Pena, Hilda; Trejo, JoAnn			G protein-coupled receptors activate p38 MAPK via a non-canonical TAB1-TAB2-and TAB1-TAB3-dependent pathway in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenosine; endothelial dysfunction; histamine; inflammation; prostaglandin; purinergic receptor; thrombin; protease-activated receptor	KINASE ACTIVATION; INDEPENDENT ACTIVATION; BARRIER FUNCTION; P38-ALPHA; MECHANISM; BINDING; PERMEABILITY; MIGRATION; INHIBIT; ROLES	Endothelial dysfunction is induced by inflammatory mediators including multiple G protein-coupled receptor (GPCR) agonists. However, the GPCR signaling pathways that promote endothelial dysfunction are incompletely understood. We previously showed that thrombin promotes endothelial barrier disruption through autophosphorylation and activation of p38 mitogen-activated protein kinase (MAPK) via a non-canonical transforming growth factor--activated protein kinase-1-binding protein-1 (TAB1) and TAB2-dependent pathway rather than the canonical three-tiered kinase cascade. Here, we sought to determine whether other GPCR agonists stimulate p38 MAPK activation via this non-canonical pathway in human endothelial cells derived from different vascular beds. Using primary human umbilical vein endothelial cells (HUVECs), HUVEC-derived EA.hy926 cells, and human dermal microvascular endothelial cells (HDMECs), we found that both non-canonical and canonical p38 activation pathways components are expressed in these various endothelial cell types, including TAB3, a structurally-related TAB2 homolog. Moreover, multiple GPCRs agonists, including thrombin, histamine, prostaglandin E-2, and ADP, stimulated robust p38 autophosphorylation, whereas phosphorylation of the upstream MAPKs MAP kinase kinase 3 (MKK3) and MKK6, was virtually undetectable, indicating that non-canonical p38 activation may exist for other GPCRs. Indeed, in EA.hy926 cells, thrombin- and histamine-stimulated p38 activation depended on TAB1-TAB2, whereas in primary HUVECs, both TAB1-TAB2 and TAB1-TAB3 were required for p38 activation. In HDMECs, thrombin-induced p38 activation depended on TAB1-TAB3, but histamine-induced p38 activation required TAB1-TAB2. Moreover, thrombin- and histamine-stimulated interleukin-6 production required both TAB1-TAB2 and TAB1-TAB3 in HUVEC. We conclude that multiple GPCR agonists utilize non-canonical TAB1-TAB2 and TAB1-TAB3-dependent p38 activation to promote endothelial inflammatory responses.	[Grimsey, Neil J.; Lin, Ying; Narala, Rachan; Rada, Cara C.; Mejia-Pena, Hilda; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Rada, Cara C.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Grimsey, Neil J.] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Georgia; University of Georgia	Trejo, J (corresponding author), Biomed Sci Bldg 3044A,9500 Gilman Dr, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu	Grimsey, Neil/AAB-9153-2020	Grimsey, Neil/0000-0002-0481-4920; Lin, Ying/0000-0002-5619-1104; TREJO, JOANN/0000-0003-4405-6228	University of California Tobacco-related Disease Research Program Predoctoral Fellowship; National Institutes of Health, NIGMS Initiative for Maximizing Student Development Grant [R25 GM083275]; National Institutes of Health NIGMS Grant [R35 GM127121]; University of California [TRDRP 26IP-0050]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM127121, R25GM083275, T32GM007752] Funding Source: NIH RePORTER	University of California Tobacco-related Disease Research Program Predoctoral Fellowship; National Institutes of Health, NIGMS Initiative for Maximizing Student Development Grant; National Institutes of Health NIGMS Grant; University of California(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a University of California Tobacco-related Disease Research Program Predoctoral Fellowship (to C. C. R.), National Institutes of Health, NIGMS Initiative for Maximizing Student Development Grant R25 GM083275 (to H. M.-P.), National Institutes of Health NIGMS Grant R35 GM127121 (to J. T.), and a University of California TRDRP 26IP-0050 High Impact Pilot Award (to J. T.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adderley SP, 2015, MICROCIRCULATION, V22, P237, DOI 10.1111/micc.12189; Bernatchez PN, 2001, BRIT J PHARMACOL, V134, P1253, DOI 10.1038/sj.bjp.0704367; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; De Nicola GF, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121144; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Ge BX, 2003, J BIOL CHEM, V278, P2286, DOI 10.1074/jbc.M210918200; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Goddard LM, 2013, THROMB HAEMOSTASIS, V109, P407, DOI 10.1160/TH12-09-0678; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Grimsey NJ, 2018, CELL REP, V24, P3312, DOI 10.1016/j.celrep.2018.08.061; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Gupta J, 2015, FEBS J, V282, P1841, DOI 10.1111/febs.13250; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Jean-Charles PY, 2016, PROG MOL BIOL TRANSL, V141, P1, DOI 10.1016/bs.pmbts.2016.05.001; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Konya V, 2013, J ALLERGY CLIN IMMUN, V131, P532, DOI 10.1016/j.jaci.2012.05.008; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Li HG, 2003, CIRCULATION, V107, P2348, DOI 10.1161/01.CIR.0000066697.19571.AF; Li Y, 2001, MICROVASC RES, V61, P253, DOI 10.1006/mvre.2001.2304; Marin V, 2001, BLOOD, V98, P667, DOI 10.1182/blood.V98.3.667; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Perrot CY, 2018, FASEB J; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Remy G, 2010, CELL SIGNAL, V22, P660, DOI 10.1016/j.cellsig.2009.11.020; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Shen JZ, 2008, CIRC RES, V102, P448, DOI 10.1161/CIRCRESAHA.107.165795; Stolwijk JA, 2016, J BIOL CHEM, V291, P22894, DOI 10.1074/jbc.M116.756114; Stolwijk JA, 2015, PFLUG ARCH EUR J PHY, V467, P2193, DOI 10.1007/s00424-014-1674-0; Sun L, 2012, ACTA PHARMACOL SIN, V33, P342, DOI 10.1038/aps.2011.200; Tanno M, 2003, CIRC RES, V93, P254, DOI 10.1161/01.RES.0000083490.43943.85; Theivanthiran B, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005903; Wang QY, 2013, MOL THER, V21, P1668, DOI 10.1038/mt.2013.90; Weis SM, 2008, CURR OPIN HEMATOL, V15, P243, DOI 10.1097/MOH.0b013e3282f97d86; Yamauchi J, 2001, J BIOL CHEM, V276, P23362, DOI 10.1074/jbc.M011752200; Zhou XM, 2008, P NATL ACAD SCI USA, V105, P5620, DOI 10.1073/pnas.0801453105	44	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5867	5878		10.1074/jbc.RA119.007495	http://dx.doi.org/10.1074/jbc.RA119.007495			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30760523	hybrid, Green Published			2022-12-26	WOS:000465077500018
J	Ries, LK; Sander, B; Deol, KK; Letzelter, MA; Strieter, ER; Lorenz, S				Ries, Lena K.; Sander, Bodo; Deol, Kirandeep K.; Letzelter, Marie-Annick; Strieter, Eric Robert; Lorenz, Sonja			Analysis of ubiquitin recognition by the HECT ligase E6AP provides insight into its linkage specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; ubiquitin ligase; ubiquitylation (ubiquitination); post-translational modification; enzyme mechanism	E3 LIGASE; STRUCTURAL BASIS; CHAIN ELONGATION; MOLECULAR-BASIS; POLYUBIQUITIN; MECHANISM; REVEALS; DOMAIN; COMPLEX; BINDING	Deregulation of the HECT-type ubiquitin ligase E6AP (UBE3A) is implicated in human papilloma virus-induced cervical tumorigenesis and several neurodevelopmental disorders. Yet the structural underpinnings of activity and specificity in this crucial ligase are incompletely understood. Here, we unravel the determinants of ubiquitin recognition by the catalytic domain of E6AP and assign them to particular steps in the catalytic cycle. We identify a functionally critical interface that is specifically required during the initial formation of a thioester-linked intermediate between the C terminus of ubiquitin and the ligase-active site. This interface resembles the one utilized by NEDD4-type enzymes, indicating that it is widely conserved across HECT ligases, independent of their linkage specificities. Moreover, we uncover surface regions in ubiquitin and E6AP, both in the N- and C-terminal portions of the catalytic domain, that are important for the subsequent reaction step of isopeptide bond formation between two ubiquitin molecules. We decipher key elements of linkage specificity, including the C-terminal tail of E6AP and a hydrophilic surface region of ubiquitin in proximity to the acceptor site Lys-48. Intriguingly, mutation of Glu-51, a single residue within this region, permits formation of alternative chain types, thus pointing to a key role of ubiquitin in conferring linkage specificity to E6AP. We speculate that substrate-assisted catalysis, as described previously for certain RING-associated ubiquitin-conjugating enzymes, constitutes a common principle during linkage-specific ubiquitin chain assembly by diverse classes of ubiquitination enzymes, including HECT ligases.	[Ries, Lena K.; Sander, Bodo; Letzelter, Marie-Annick; Lorenz, Sonja] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Deol, Kirandeep K.; Strieter, Eric Robert] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Strieter, Eric Robert] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Wurzburg; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Lorenz, S (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany.	sonja.lorenz@virchow.uni-wuerzburg.de	Lorenz, Sonja/AAL-4499-2020	Lorenz, Sonja/0000-0002-9639-2381	National Institutes of Health [1S10OD010645-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Lorenz laboratory for insightful discussions; Julia Haubenreisser for technical assistance; and Kristian Schweimer at the Northern Bavaria NMR Center for excellent support. Data collected on the Orbitrap Fusion mass spectrometer were funded by National Institutes of Health Grant 1S10OD010645-01A1.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Al-Maawali A, 2013, J CHILD NEUROL, V28, P392, DOI 10.1177/0883073812443591; Attali I, 2017, EMBO J, V36, P425, DOI 10.15252/embj.201694314; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Brown NG, 2016, CELL, V165, P1440, DOI 10.1016/j.cell.2016.05.037; Brown NG, 2014, MOL CELL, V56, P246, DOI 10.1016/j.molcel.2014.09.009; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen D, 2018, CHEMBIOCHEM, V19, P2123, DOI 10.1002/cbic.201800321; Chen Z, 2017, MOL CELL, V66, P345, DOI 10.1016/j.molcel.2017.03.020; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Fajner V, 2017, FEBS LETT, V591, P2636, DOI 10.1002/1873-3468.12775; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; French ME, 2017, J BIOL CHEM, V292, P10398, DOI 10.1074/jbc.M117.789479; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hong JH, 2015, PROTEOMICS, V15, P2910, DOI 10.1002/pmic.201500058; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Jackl M, 2018, J MOL BIOL, V430, P3218, DOI 10.1016/j.jmb.2018.06.044; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kathman SG, 2015, J AM CHEM SOC, V137, P12442, DOI 10.1021/jacs.5b06839; Kelly A, 2014, MOL CELL, V56, P232, DOI 10.1016/j.molcel.2014.09.010; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Koch JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4041; Kristariyanto YA, 2015, BIOCHEM J, V467, P345, DOI 10.1042/BJ20141502; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Lee YS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1469; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lorenz S, 2018, BIOL CHEM, V399, P127, DOI 10.1515/hsz-2017-0184; Lorenz S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147550; Lorenz S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-65; Martinez-Noel G, 2018, J MOL BIOL, V430, P1024, DOI 10.1016/j.jmb.2018.01.021; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; Mevissen TET, 2016, NATURE, V538, P402, DOI 10.1038/nature19836; Michel MA, 2017, MOL CELL, V68, P233, DOI 10.1016/j.molcel.2017.08.020; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Middleton AJ, 2017, J MOL BIOL, V429, P3430, DOI 10.1016/j.jmb.2017.06.008; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Mortensen F, 2015, P NATL ACAD SCI USA, V112, P9872, DOI 10.1073/pnas.1505923112; Ogunjimi AA, 2010, J BIOL CHEM, V285, P6308, DOI 10.1074/jbc.M109.044537; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Phu LL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003756; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Ronchi VP, 2017, J BIOL CHEM, V292, P18006, DOI 10.1074/jbc.M117.813477; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Sadikovic B, 2014, HUM MUTAT, V35, P1407, DOI 10.1002/humu.22687; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Sander B, 2017, ELIFE, V6, DOI 10.7554/eLife.21036; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Scialpi F, 2008, BIOCHEM PHARMACOL, V76, P1515, DOI 10.1016/j.bcp.2008.07.028; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Stieglitz B, 2013, NATURE, V503, P422, DOI 10.1038/nature12638; Streich FC, 2016, NATURE, V536, P304, DOI 10.1038/nature19071; TAYLOR WR, 1995, NATURE, V375, P372, DOI 10.1038/375372a0; Todaro DR, 2018, J BIOL CHEM, V293, P18192, DOI 10.1074/jbc.RA118.003716; Todaro DR, 2017, J BIOL CHEM, V292, P19521, DOI 10.1074/jbc.M117.817882; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu YS, 2001, J BIOMOL NMR, V21, P285, DOI 10.1023/A:1012916731276; Yang Y, 2013, P NATL ACAD SCI USA, V110, P5115, DOI 10.1073/pnas.1220271110; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhu K, 2017, EMBO REP, V18, P1618, DOI 10.15252/embr.201744454	94	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6113	6129		10.1074/jbc.RA118.007014	http://dx.doi.org/10.1074/jbc.RA118.007014			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30737286	Green Published, hybrid			2022-12-26	WOS:000465077500040
J	Beliakova-Bethell, N; Mukim, A; White, CH; Deshmukh, S; Abewe, H; Richman, DD; Spina, CA				Beliakova-Bethell, Nadejda; Mukim, Amey; White, Cory H.; Deshmukh, Savitha; Abewe, Hosiana; Richman, Douglas D.; Spina, Celsa A.			Histone deacetylase inhibitors induce complex host responses that contribute to differential potencies of these compounds in HIV reactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug action; human immunodeficiency virus (HIV); gene expression; transcriptomics; histone deacetylase inhibitor (HDAC inhibitor) (HDI); T cell; transcription regulation; latency reversal; maturation phenotypes; primary CD4+T cell; romidepsin; SAHA	HYDROXAMIC ACID SAHA; B P-TEFB; GENE-EXPRESSION; LATENT HIV; TRANSCRIPTION; RNA; DEPSIPEPTIDE; ACETYLATION; PATHWAY; CELLS	Histone deacetylase (HDAC) inhibitors (HDACis) have been widely tested in clinical trials for their ability to reverse HIV latency but have yielded only limited success. One HDACi, suberoylanilide hydroxamic acid (SAHA), exhibits off-target effects on host gene expression predicted to interfere with induction of HIV transcription. Romidepsin (RMD) has higher potency and specificity for class I HDACs implicated in maintaining HIV provirus in the latent state. More robust HIV reactivation has indeed been achieved with RMD use ex vivo than with SAHA; however, reduction of viral reservoir size has not been observed in clinical trials. Therefore, using RNA-Seq, we sought to compare the effects of SAHA and RMD on gene expression in primary CD4(+) T cells. Among the genes whose expression was modulated by both HDACi agents, we identified genes previously implicated in HIV latency. Two genes, SMARCB1 and PARP1, whose modulation by SAHA and RMD is predicted to inhibit HIV reactivation, were evaluated in the major maturation subsets of CD4(+) T cells and were consistently either up- or down-regulated by both HDACi compounds. Our results indicate that despite having different potencies and HDAC specificities, SAHA and RMD modulate an overlapping set of genes, implicated in HIV latency regulation. Some of these genes merit exploration as additional targets to improve the therapeutic outcomes of shock and kill strategies. The overall complexity of HDACi-induced responses among host genes with predicted stimulatory or inhibitory effects on HIV expression likely contributes to differential HDACi potencies and dictates the outcome of HIV reactivation.	[Beliakova-Bethell, Nadejda; Mukim, Amey; Deshmukh, Savitha; Abewe, Hosiana; Richman, Douglas D.; Spina, Celsa A.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Beliakova-Bethell, Nadejda; Mukim, Amey; Deshmukh, Savitha; Abewe, Hosiana; Richman, Douglas D.; Spina, Celsa A.] Vet Med Res Fdn, San Diego, CA 92161 USA; [Beliakova-Bethell, Nadejda; White, Cory H.; Abewe, Hosiana; Richman, Douglas D.; Spina, Celsa A.] Univ Calif San Diego, Stein Clin Res Bldg,Rm 304,9500 Gilman Dr,0679, La Jolla, CA 92093 USA; [White, Cory H.] Merck Res Labs, Merck Exploratory Sci Ctr, Cambridge, MA 02141 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Veterans Medical Research Foundation; University of California System; University of California San Diego; Merck & Company	Beliakova-Bethell, N (corresponding author), Univ Calif San Diego, Stein Clin Res Bldg,Rm 304,9500 Gilman Dr,0679, La Jolla, CA 92093 USA.	nbeliako@ucsd.edu		Mukim, Amey/0000-0002-7777-3728	NIAID, National Institutes of Health, San Diego CFAR Developmental Grant [AI036214]; Office of Research and Development, Veterans Health Administration, Career Developmental Award [II IK2 BX002731]; NIAID, National Institutes of Health, CARE Collaboratory for AIDS Research on Eradication Grants [U19 AI096113, 1UM1 AI126619]; James B. Pendleton Charitable Trust; Molecular Biology Program, University of Utah, Salt Lake City, UT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI126619, P30AI036214] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002731] Funding Source: NIH RePORTER	NIAID, National Institutes of Health, San Diego CFAR Developmental Grant; Office of Research and Development, Veterans Health Administration, Career Developmental Award; NIAID, National Institutes of Health, CARE Collaboratory for AIDS Research on Eradication Grants; James B. Pendleton Charitable Trust; Molecular Biology Program, University of Utah, Salt Lake City, UT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIAID, National Institutes of Health, San Diego CFAR Developmental Grant AI036214 (to N. B.-B.); Office of Research and Development, Veterans Health Administration, Career Developmental Award-II IK2 BX002731 (to N. B.-B.); NIAID, National Institutes of Health, CARE Collaboratory for AIDS Research on Eradication Grants U19 AI096113 and 1UM1 AI126619 (to D. D. R.) and U19 AI096113 (to C. A. S.); and the James B. Pendleton Charitable Trust. D. D. R. has consulted for Gilead, Inc., Antiva Biosciences, Inc., and Monogram Biosciences, Inc. C. H. W. is currently employed by Merck, Inc. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. The sponsors of this research were not involved in the study design, collection or interpretation of the data, manuscript preparation, or the decision to submit the article for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a merit-based scholarship from H. E. president of Rwanda, Paul Kagame. Present address: Molecular Biology Program, University of Utah, Salt Lake City, UT 84112.	Abdel-Mohsen M, 2015, AIDS, V29, P411, DOI 10.1097/QAD.0000000000000572; Ako-Adjei D, 2015, NUCLEIC ACIDS RES, V43, pD566, DOI 10.1093/nar/gku1126; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson I, 2014, P NATL ACAD SCI USA, V111, pE1528, DOI 10.1073/pnas.1320178111; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2014, J INFECT DIS, V210, P728, DOI 10.1093/infdis/jiu155; Beliakova-Bethell N, 2014, CYTOM PART A, V85A, P94, DOI 10.1002/cyto.a.22352; Beliakova-Bethell N, 2013, AIDS, V27, P29, DOI 10.1097/QAD.0b013e32835b3e26; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blagosklonny MV, 2002, MOL CANCER THER, V1, P937; Chavez L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004955; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Das B, 2018, P NATL ACAD SCI USA, V115, pE7795, DOI 10.1073/pnas.1803468115; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Furumai R, 2002, CANCER RES, V62, P4916; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hlubek F, 2001, J BIOCHEM-TOKYO, V129, P635, DOI 10.1093/oxfordjournals.jbchem.a002901; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; LaBonte MJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-67; Lada SM, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01158-18; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauffer BEL, 2013, J BIOL CHEM, V288, P26926, DOI 10.1074/jbc.M113.490706; Leth S, 2016, LANCET HIV, V3, pE463, DOI 10.1016/S2352-3018(16)30055-8; Li ZC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007012; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; Mensah AA, 2015, ONCOTARGET, V6, P5059; Michaels KK, 2015, J IMMUNOL, V194, P3267, DOI 10.4049/jimmunol.1402581; Mohammadi P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004156; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Pan XY, 2016, J BIOL CHEM, V291, P26177, DOI 10.1074/jbc.M116.743906; Parent M, 2005, J BIOL CHEM, V280, P448, DOI 10.1074/jbc.M408435200; Park J, 2014, AIDS, V28, P1719, DOI 10.1097/QAD.0000000000000309; Rajgolikar G, 1998, BREAST CANCER RES TR, V51, P29, DOI 10.1023/A:1006091014092; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruiz A, 2014, J BIOL CHEM, V289, P27665, DOI 10.1074/jbc.M114.570341; Shirakawa K, 2013, TRENDS MICROBIOL, V21, P277, DOI 10.1016/j.tim.2013.02.005; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Sung JA, 2017, EBIOMEDICINE, V23, P52, DOI 10.1016/j.ebiom.2017.07.019; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2007, BIOCHEM BIOPH RES CO, V356, P998, DOI 10.1016/j.bbrc.2007.03.076; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; White CH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006026; White CH, 2015, ANTIVIR RES, V123, P78, DOI 10.1016/j.antiviral.2015.09.002; Wightman F, 2013, AIDS, V27, P2853, DOI 10.1097/QAD.0000000000000067; Wozniak MB, 2010, HAEMATOL-HEMATOL J, V95, P613, DOI 10.3324/haematol.2009.013870; Wu GX, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92901; Yang XA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002350; Yu D, 2018, CELL REP, V23, P3741, DOI 10.1016/j.celrep.2018.05.084; Yucha RW, 2017, EBIOMEDICINE, V20, P217, DOI 10.1016/j.ebiom.2017.05.006; Yukl SA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9927; Zaikos TD, 2018, J VIROL, V92, DOI 10.1128/JVI.02110-17	59	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5576	5589		10.1074/jbc.RA118.005185	http://dx.doi.org/10.1074/jbc.RA118.005185			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30745362	Green Published, hybrid			2022-12-26	WOS:000464517500027
J	Camacho, L; Silva, CS; Hanig, JP; Schleimer, RP; George, NI; Bowyer, JF				Camacho, Luisa; Silva, Camila S.; Hanig, Joseph P.; Schleimer, Robert P.; George, Nysia I.; Bowyer, John F.			Identification of whole blood mRNA and microRNA biomarkers of tissue damage and immune function resulting from amphetamine exposure or heat stroke in adult male rats	PLOS ONE			English	Article							SUBSTITUTED AMPHETAMINES; POTENTIAL BIOMARKERS; HIV-1 REPLICATION; GENE-EXPRESSION; METHAMPHETAMINE; NEUROTOXICITY; HYPERTHERMIA; BIOGENESIS; CYTOKINES; PROFILES	This work extends the understanding of how toxic exposures to amphetamine (AMPH) adversely affect the immune system and lead to tissue damage. Importantly, it determines which effects of AMPH are and are not due to pronounced hyperthermia. Whole blood messenger RNA (mRNA) and whole blood and serum microRNA (miRNA) transcripts were identified in adult male Sprague-Dawley rats after exposure to toxic AMPH under normothermic conditions, AMPH when it produces pronounced hyperthermia, or environmentally-induced hyperthermia (EIH). mRNA transcripts with large increases in fold-change in treated relative to control rats and very low expression in the control group were a rich source of organ-specific transcripts in blood. When severe hyperthermia was produced by either EIH or AMPH, significant increases in circulating organ-specific transcripts for liver (Alb, Fbg, F2), pancreas (Spink1), bronchi/lungs (F3, Cyp4b1), bone marrow (Np4, RatNP-3b), and kidney (Cesl1, Slc22a8) were observed. Liver damage was suggested also by increased miR-122 levels in the serum. Increases in muscle/heart-enriched transcripts were produced by AMPH even in the absence of hyperthermia. Expression increases in immune-related transcripts, particularly Cd14 and Vcan, indicate that AMPH can activate the innate immune system in the absence of hyperthermia. Most transcripts specific for T-cells decreased 50-70% after AMPH exposure or EIH, with the noted exception of Ccr5 and Chst12. This is probably due to T-cells leaving the circulation and down-regulation of these genes. Transcript changes specific for B-cells or B-lymphoblasts in the AMPH and EIH groups ranged widely from decreasing approximate to 40% (Cd19, Cd180) to increasing 30 to 100% (Tk1, Ahsa1) to increasing >= 500% (Stip1, Ackr3). The marked increases in Ccr2, Ccr5, Pld1, and Ackr3 produced by either AMPH or EIH observed in vivo provide further insight into the initial immune system alterations that result from methamphetamine and AMPH abuse and could modify risk for HIV and other viral infections.	[Camacho, Luisa; Silva, Camila S.] US FDA, Natl Ctr Toxicol Res, Div Biochem Toxicol, Jefferson, AR 72079 USA; [Hanig, Joseph P.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Schleimer, Robert P.] Northwestern Feinberg Sch Med, Div Allergy & Immunol, Chicago, IL USA; [George, Nysia I.] US FDA, NCTR, Div Bioinformat & Biostat, Jefferson, AR USA; [Bowyer, John F.] US FDA, NCTR, Div Neurotoxicol, Jefferson, AR 72079 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Northwestern University; Feinberg School of Medicine; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Bowyer, JF (corresponding author), US FDA, NCTR, Div Neurotoxicol, Jefferson, AR 72079 USA.	john.bowyer@fda.hhs.gov		Silva, Camila/0000-0001-7079-9979; Camacho, Luisa/0000-0002-3300-3895	NCTR/FDA [E7295, E7519]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL068546] Funding Source: NIH RePORTER	NCTR/FDA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research animals, their housing, and reagents were funded under NCTR/FDA protocols E7295 and E7519.	Akira S, 2013, DIABETES OBES METAB, V15, P10, DOI 10.1111/dom.12151; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; BOWYER JF, 1994, J PHARMACOL EXP THER, V268, P1571; BOWYER JF, 1992, J PHARMACOL EXP THER, V260, P817; Bowyer JF, 2006, SYNAPSE, V60, P521, DOI 10.1002/syn.20324; Bowyer John F, 2014, Temperature (Austin), V1, P172, DOI 10.4161/23328940.2014.982049; Bowyer JF, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0526-6; Bowyer JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133315; Bowyer JF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-147; Bowyer JF, 2008, ANN NY ACAD SCI, V1139, P127, DOI 10.1196/annals.1432.005; Chang L, 2005, AM J PSYCHIAT, V162, P361, DOI 10.1176/appi.ajp.162.2.361; Correia CN, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00118; Crabtree NM, 2017, BIODATA MIN, V10, DOI 10.1186/s13040-017-0134-8; DAVIS WM, 1978, TOXICOL APPL PHARM, V45, P49, DOI 10.1016/0041-008X(78)90027-3; DAVIS WM, 1978, RES COMMUN CHEM PATH, V21, P27; Di Santo JP, 2014, IMMUNOL REV, V261, P169, DOI 10.1111/imr.12202; Gauvin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155868; George NI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125224; Gomez Camilo R, 2014, Handb Clin Neurol, V120, P947, DOI 10.1016/B978-0-7020-4087-0.00062-0; Gottschalk C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00379; Halpin LE, 2012, J NEUROSCI, V32, P13155, DOI 10.1523/JNEUROSCI.2530-12.2012; Heled Yuval, 2013, Journal of Basic and Clinical Physiology and Pharmacology, V24, P85, DOI 10.1515/jbcpp-2012-0040; HESS A, 1990, J NEUROCYTOL, V19, P338, DOI 10.1007/BF01188403; Hirsiger S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/315941; Huang JJ, 2015, AM J MED, V128, P1140, DOI 10.1016/j.amjmed.2015.05.016; Jiang JJ, 2016, DRUG ALCOHOL DEPEN, V159, P246, DOI 10.1016/j.drugalcdep.2015.12.027; KALANT H, 1975, CAN MED ASSOC J, V112, P299; Kang R, 2014, MOL MED, V20, P466, DOI 10.2119/molmed.2014.00117; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lacour Sandrine, 2005, Cancer Biomarkers, V1, P29; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Leon LR, 2015, COMPR PHYSIOL, V5, P611, DOI 10.1002/cphy.c140017; Levi MS, 2013, NEUROTOXICOLOGY, V37, P40, DOI 10.1016/j.neuro.2013.04.003; Levi MS, 2012, NEUROTOXICOL TERATOL, V34, P253, DOI 10.1016/j.ntt.2012.01.007; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liang H, 2008, AM J PATHOL, V172, P1617, DOI 10.2353/ajpath.2008.070971; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mantri CK, 2014, AM J PATHOL, V184, P92, DOI 10.1016/j.ajpath.2013.09.011; Martinez LR, 2009, J INFECT DIS, V200, P131, DOI 10.1086/599328; Maruta T, 1997, Nihon Arukoru Yakubutsu Igakkai Zasshi, V32, P122; Nair MPN, 2009, J NEUROIMMUNE PHARM, V4, P129, DOI 10.1007/s11481-008-9128-0; O'Callaghan JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102003; O'Callaghan JP, 2008, ANN NY ACAD SCI, V1139, P318, DOI 10.1196/annals.1432.032; OCALLAGHAN JP, 1994, J PHARMACOL EXP THER, V270, P741; Pankratz F, 2018, CIRC RES, V122, P417, DOI 10.1161/CIRCRESAHA.117.311428; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Saito M, 2008, EXP ANIM TOKYO, V57, P35, DOI 10.1538/expanim.57.35; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Siddeek B, 2014, MUTAT RES-GEN TOX EN, V764, P46, DOI 10.1016/j.mrgentox.2014.01.010; Soontornniyomkij V, 2016, J NEUROVIROL, V22, P650, DOI 10.1007/s13365-016-0441-8; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Taylor HE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004864; Thomas DM, 2004, J NEUROCHEM, V88, P380, DOI 10.1046/j.1471-4159.2003.02182.x; Thomas DM, 2004, J PHARMACOL EXP THER, V311, P1, DOI 10.1124/jpet.104.070961; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Unlu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038899; Wilkinson D, 1996, CURR BIOL, V6, P1051, DOI 10.1016/S0960-9822(02)70661-1; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xiao J, 2015, BIOCHEM J, V471, P281, DOI 10.1042/BJ20131510; Yu HW, 2015, ARCH TOXICOL, V89, P319, DOI 10.1007/s00204-014-1440-2; ZALIS EG, 1967, J PHARMACOL EXP THER, V158, P115; ZALIS EG, 1963, ARCH INTERN MED, V112, P822, DOI 10.1001/archinte.1963.03860060060004; Zhao SF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00271	68	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0210273	10.1371/journal.pone.0210273	http://dx.doi.org/10.1371/journal.pone.0210273			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779732	Green Published, Green Submitted, gold			2022-12-26	WOS:000459062900007
J	Nannoni, E; Martelli, G; Rubini, G; Sardi, L				Nannoni, Eleonora; Martelli, Giovanna; Rubini, Giulia; Sardi, Luca			Effects of increased space allowance on animal welfare, meat and ham quality of heavy pigs slaughtered at 160Kg	PLOS ONE			English	Article							GROWTH-PERFORMANCE; SPATIAL REQUIREMENTS; STOCKING DENSITY; FINISHING PIGS; GROUP-SIZE; BEHAVIOR; PRODUCTIVITY; ENRICHMENT; CARCASS	Sixty barrows (Body Weight-BW- range: 23.9-160 kg) were allotted to two experimental groups (6 pens of 5 pigs each): the control group was kept at a space allowance of 1 m(2)/head; the second group was kept at 1.3m(2)/head. Behaviour, growth parameters, carcass and meat quality were assessed, as well as fat and cured ham quality. Results showed that pigs raised at 1.3m(2)/head spent more time laying (particularly in lateral recumbency, P<0.01 and P<0.001, respectively) compared to pigs kept at lower space allowance. They also reduced the aimless exploration of the slatted pen floor (P<0.001) and increased overall expression of other, mainly active, behaviors (e.g., drinking, walking and standing, P<0.01). Pigs raised at 1.3m(2)/head showed higher final BW (P = 0.02), more favourable Average Daily Gain (ADG) and gain-to-Feed ratio (G:F) both during the last period of the trial (P<0.05 for both parameters) and over the entire trial (P = 0.01 for both parameters). No significant difference was observed between groups for carcass traits and the main meat quality attributes. Subcutaneous fat from green hams had higher alpha-linolenic acid content (P<0.01) in the group reared at greater space allowance. Green hams from this group lost less weight at trimming (P<0.01) and the resulting cured hams received better sensory evaluations (P<0.05). No difference was observed in fatty acid composition and unsaturation levels of the subcutaneous fat from cured hams. Our data suggest that heavy pigs intended for Parma ham would benefit from the adoption of higher individual floor space allowances, both in terms of animal welfare (increased possibility to rest) and of productive parameters, without having any detrimental effect on the suitability of the thighs for dry-curing or on the quality of the final product.	[Nannoni, Eleonora; Martelli, Giovanna; Rubini, Giulia; Sardi, Luca] Univ Bologna, Dept Vet Med Sci, Ozzano Dell Emilia, Italy	University of Bologna	Martelli, G (corresponding author), Univ Bologna, Dept Vet Med Sci, Ozzano Dell Emilia, Italy.	giovanna.martelli@unibo.it	Martelli, Giovanna/J-6826-2012; Nannoni, Eleonora/R-8693-2017	Martelli, Giovanna/0000-0002-3137-6700; Nannoni, Eleonora/0000-0002-5431-6807; SARDI, LUCA/0000-0003-0937-8088				[Anonymous], 2005, EFSA J; [Anonymous], 1992, PROTECTED DESIGNATIO; AOAC, 2006, OFFICIAL METHODS ANA; AOAC, 2000, OFFICIAL METHODS ANA; BALDINI P, 1992, IND CONSERVE, V67, P149; CARERI M, 1993, J FOOD SCI, V58, P968, DOI 10.1111/j.1365-2621.1993.tb06090.x; CIE (Commission Internationale de l'Eclairage), 1976, CIE COL PUBBL; Cornale P, 2015, J VET BEHAV, V10, P569, DOI 10.1016/j.jveb.2015.05.002; Di Pasquale J, 2014, ITAL J ANIM SCI, V13, DOI 10.4081/ijas.2014.3582; Flohr JR, 2016, J ANIM SCI, V94, P4388, DOI 10.2527/jas.2016-0407; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frankel EN, 2014, LIPID OXIDATION, P99; Gonyou HW, 1998, J ANIM SCI, V76, P1326; Honikel KO, 1998, MEAT SCI, V49, P447, DOI 10.1016/S0309-1740(98)00034-5; Jensen MB, 2010, APPL ANIM BEHAV SCI, V123, P87, DOI 10.1016/j.applanim.2010.01.002; Jensen T, 2012, LIVEST SCI, V149, P33, DOI 10.1016/j.livsci.2012.06.018; Kim KH, 2017, ANIMAL, V11, P78, DOI [10.1017/S1751731116001361, DOI 10.1017/S1751731116001361]; Klont RE, 2001, J ANIM SCI, V79, P2835; Kornegay E. T., 1984, Pig News and Information, V5, P23; Martelli G, 2010, BERL MUNCH TIERARZTL, V123, P457, DOI 10.2376/0005-9366-123-457; Nannoni E, 2019, ITAL J ANIM SCI, V18, P45, DOI 10.1080/1828051X.2018.1472531; Pastorelli G, 2006, LIVEST SCI, V105, P260, DOI 10.1016/j.livsci.2006.05.022; Patton BS, 2008, ANIMAL, V2, P471, DOI 10.1017/S1751731107001280; PEARCE GP, 1993, APPL ANIM BEHAV SCI, V36, P11, DOI 10.1016/0168-1591(93)90095-7; Pena-Ramos EA, 2003, MEAT SCI, V64, P259, DOI 10.1016/S0309-1740(02)00187-0; Petherick J.C., 1981, MODELLING DESIGN EVA; Petherick JC, 2007, J VET BEHAV, V2, P197, DOI 10.1016/j.jveb.2007.10.001; Rossi R, 2008, J SWINE HEALTH PROD, V16, P304; Sardi L, 2012, BERL MUNCH TIERARZTL, V125, P463, DOI 10.2376/0005-9366-125-463; Schivazappa C, 2002, MEAT SCI, V60, P77, DOI 10.1016/S0309-1740(01)00109-7; Scipioni R, 2009, ITAL J ANIM SCI, V8, P117, DOI 10.4081/ijas.2009.s1.117; Serrano MP, 2013, SPAN J AGRIC RES, V11, P89, DOI 10.5424/sjar/2013111-2869; Spoolder HAM, 2000, LIVEST PROD SCI, V64, P167, DOI 10.1016/S0301-6226(99)00152-9; StatSoft Inc, 2013, EL STAT TXB; Street BR, 2008, J ANIM SCI, V86, P982, DOI 10.2527/jas.2007-0449; Terlouw C, 2005, LIVEST PROD SCI, V94, P125, DOI 10.1016/j.livprodsci.2004.11.032; Van de Weerd HA, 2005, ANIM SCI, V80, P289, DOI 10.1079/ASC40450289; Vermeer HM, 2014, LIVEST SCI, V159, P79, DOI 10.1016/j.livsci.2013.10.021; Weng RC, 1998, APPL ANIM BEHAV SCI, V59, P307, DOI 10.1016/S0168-1591(97)00143-3	39	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212417	10.1371/journal.pone.0212417	http://dx.doi.org/10.1371/journal.pone.0212417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768620	Green Published, gold, Green Submitted			2022-12-26	WOS:000458766300037
J	Chen, YT; Tseng, PH; Tseng, FY; Chi, YC; Han, DS; Yang, WS				Chen, Yen-Ting; Tseng, Ping-Huei; Tseng, Fen-Yu; Chi, Yu-Chiao; Han, Der-Sheng; Yang, Wei-Shiung			The serum level of a novel lipogenic protein Spot 14 was reduced in metabolic syndrome	PLOS ONE			English	Article							HEPATIC GENE-EXPRESSION; THYROID-HORMONE; ADIPOSE-TISSUE; BREAST-CANCER; S14; OBESITY; ADIPONECTIN; DEFINITION; INCREASES; DIET	Spot 14 (S14) protein is primarily expressed in adipogenic tissues. Compared to wild type, S14 knockout mice had better resistance to diet-induced obesity and glucose tolerance. However, the association between serum S14 level and metabolic variables in humans has never been investigated. The objectives of this study were to evaluate the associations between serum S14 concentrations with components of metabolic syndrome (MetS). A total of 327 subjects were recruited in this cross-sectional study and categorized by presence of MetS. The mean serum levels of S14 were significantly lower in subjects with MetS than those without (87.1 +/- 26.3 mu g/L vs. 107.3 +/- 40.2 mu g/L, p<0.001). In addition, the subjects with central obesity, low high density lipoprotein-C (HDL-C) or hypertriglyceridemia also had significantly lower S14 levels in comparison to those without. Adjusted with age and sex, diagnosis of MetS (beta = -0.227, p<0.001), central obesity (beta = -0.176, p = 0.001), low HDL-C (beta = -0.149, p = 0.005), and high triglyceride (TG) (beta = -0.198, p<0.001) were negatively associated with log transformation of serum S14 levels (logS14). With 25% logS14 increased, the risk of MetS (OR 0.65, 95% CI, 0.51-0.82, p<0.001), central obesity (OR 0.72, 95% CI, 0.58-0.89, p = 0.002), low HDL-C (OR 0.76, 95% CI, 0.61-0.95, p = 0.015) or high TG (OR 0.65, 95% CI, 0.51-0.83, p = 0.001) was reduced with a dose response trend. Our analysis revealed that patients with MetS had lower serum S14 levels than those without. Negative associations existed between MetS, central obesity, high TG, low HDL-C and logS14.	[Chen, Yen-Ting; Yang, Wei-Shiung] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Tseng, Ping-Huei] Natl Taiwan Univ Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan; [Tseng, Fen-Yu; Chi, Yu-Chiao; Yang, Wei-Shiung] Natl Taiwan Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Taipei, Taiwan; [Han, Der-Sheng] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Bei Hu Branch, Taipei, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ Hosp, Ctr Obes Lifestyle & Metab Surg, Taipei, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ, Grad Inst Med Genom & Prote, Coll Med, Taipei, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Yang, WS (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.; Yang, WS (corresponding author), Natl Taiwan Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Taipei, Taiwan.; Yang, WS (corresponding author), Natl Taiwan Univ Hosp, Ctr Obes Lifestyle & Metab Surg, Taipei, Taiwan.; Yang, WS (corresponding author), Natl Taiwan Univ, Grad Inst Med Genom & Prote, Coll Med, Taipei, Taiwan.; Yang, WS (corresponding author), Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan.	wsyang@ntu.edu.tw	Tseng, Ping-Huei/GZA-8772-2022; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Tseng, Fen-Yu/0000-0003-1571-5255	Ministry of Science and Technology of Taiwan [105-2314-B-002-173-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan [grant numbers 105-2314-B-002-173-MY3]. WSY acquired the grants. The funder website is https://www.most.gov.tw/.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GW, 2009, MOL CELL ENDOCRINOL, V302, P99, DOI 10.1016/j.mce.2009.01.005; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Brown SB, 1997, J BIOL CHEM, V272, P2163, DOI 10.1074/jbc.272.4.2163; Chen YT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005036; Chou WY, 2007, BIOCHEM BIOPH RES CO, V357, P133, DOI 10.1016/j.bbrc.2007.03.103; Colbert CL, 2010, P NATL ACAD SCI USA, V107, P18820, DOI 10.1073/pnas.1012736107; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Harvatine KJ, 2006, J NUTR, V136, P2468, DOI 10.1093/jn/136.10.2468; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Hung CS, 2018, RADIOLOGY, V287, P853, DOI 10.1148/radiol.2018170331; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; JUMP DB, 1985, ENDOCRINOLOGY, V117, P2259, DOI 10.1210/endo-117-6-2259; JUMP DB, 1984, J BIOL CHEM, V259, P2789; JUMP DB, 1990, MOL ENDOCRINOL, V4, P1655, DOI 10.1210/mend-4-11-1655; Katzmarzyk PT, 2005, DIABETES CARE, V28, P391, DOI 10.2337/diacare.28.2.391; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; KINLAW WB, 1995, J BIOL CHEM, V270, P16615, DOI 10.1074/jbc.270.28.16615; KINLAW WB, 1992, ENDOCRINOLOGY, V131, P3120, DOI 10.1210/en.131.6.3120; Kinlaw WB, 2006, ENDOCRINOLOGY, V147, P4048, DOI 10.1210/en.2006-0463; Kirschner LS, 1999, THYROID, V9, P143, DOI 10.1089/thy.1999.9.143; Li L, 2012, CLIN EXP PHARMACOL P, V39, P393, DOI 10.1111/j.1440-1681.2012.05684.x; Lu JY, 2008, J BIOMED SCI, V15, P565, DOI 10.1007/s11373-008-9261-z; Martel PM, 2006, EXP CELL RES, V312, P278, DOI 10.1016/j.yexcr.2005.10.022; Moncur JT, 1998, P NATL ACAD SCI USA, V95, P6989, DOI 10.1073/pnas.95.12.6989; Ortega FJ, 2010, INT J OBESITY, V34, P487, DOI 10.1038/ijo.2009.263; Otero M, 2006, DRUG NEWS PERSPECT, V19, P21, DOI 10.1358/dnp.2006.19.1.966243; Pitsavos Christos, 2006, Review of Diabetic Studies, V3, P118, DOI 10.1900/RDS.2006.3.118; Ren JX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08452-6; SEELIG S, 1981, P NATL ACAD SCI-BIOL, V78, P4733, DOI 10.1073/pnas.78.8.4733; Stelmanska E, 2013, J STEROID BIOCHEM, V134, P37, DOI 10.1016/j.jsbmb.2012.10.006; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Wang YT, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0522-x; Yang WS, 2002, OBES RES, V10, P1104, DOI 10.1038/oby.2002.150; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212341	10.1371/journal.pone.0212341	http://dx.doi.org/10.1371/journal.pone.0212341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763384	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900071
J	Hertz, JT; Madut, DB; Tesha, RA; William, G; Simmons, RA; Galson, SW; Sakita, FM; Maro, VP; Bloomfield, GS; Crump, JA; Rubach, MP				Hertz, Julian T.; Madut, Deng B.; Tesha, Revogatus A.; William, Gwamaka; Simmons, Ryan A.; Galson, Sophie W.; Sakita, Francis M.; Maro, Venance P.; Bloomfield, Gerald S.; Crump, John A.; Rubach, Matthew P.			Perceptions of chest pain and healthcare seeking behavior for chest pain in northern Tanzania: A community-based survey	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; HEART-DISEASE	Background Little is known about community perceptions of chest pain and healthcare seeking behavior for chest pain in sub-Saharan Africa. Methods A two-stage randomized population-based cluster survey with selection proportional to population size was performed in northern Tanzania. Self-identified household healthcare decision-makers from randomly selected households were asked to list all possible causes of chest pain in an adult and asked where they would go if an adult household member had chest pain. Results Of 718 respondents, 485 (67.5%) were females. The most commonly cited causes of chest pain were weather and exercise, identified by 342 (47.6%) and 318 (44.3%) respondents. Two (0.3%) respondents identified 'heart attack' as a possible cause of chest pain. A hospital was selected as the preferred healthcare facility for an adult with chest pain by 277 (38.6%) respondents. Females were less likely to prefer a hospital than males (OR 0.65, 95% CI 0.47-0.90, p = 0.008). Conclusions There is little community awareness of cardiac causes of chest pain in northern Tanzania, and most adults reported that they would not present to a hospital for this symptom. There is an urgent need for educational interventions to address this knowledge deficit and guide appropriate care-seeking behavior.	[Hertz, Julian T.; Galson, Sophie W.] Duke Univ, Med Ctr, Div Emergency Med, Durham, NC 27708 USA; [Madut, Deng B.; Rubach, Matthew P.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Tesha, Revogatus A.] Duke Univ, Dept Stat Sci, Durham, NC USA; [William, Gwamaka] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Simmons, Ryan A.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Sakita, Francis M.] Kilimanjaro Christian Med Ctr, Dept Emergency Med, Moshi, Tanzania; [Maro, Venance P.] Kilimanjaro Christian Med Ctr, Dept Med, Moshi, Tanzania; [Bloomfield, Gerald S.] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA; [Crump, John A.] Univ Otago, Otago Global Hlth Inst, Dunedin, New Zealand	Duke University; Duke University; Duke University; Kilimanjaro Christian Medical Centre; Duke University; Kilimanjaro Christian Medical Centre; Kilimanjaro Christian Medical Centre; Duke University; University of Otago	Hertz, JT (corresponding author), Duke Univ, Med Ctr, Div Emergency Med, Durham, NC 27708 USA.	julian.hertz@duke.edu	Crump, John A./AAZ-6412-2020; Crump, John A./AAZ-6289-2020	Crump, John A./0000-0002-4529-102X; Crump, John A./0000-0002-4529-102X; Sakita, Francis/0000-0001-5879-6564; Simmons, Ryan/0000-0003-0855-4334; Hertz, Julian/0000-0002-7396-4789; Rubach, Matthew/0000-0001-5262-1421; Madut, Deng/0000-0003-4023-3928	Bill & Melinda Gates Foundation [OPP1158210]; US National Institutes of Health Fogarty International Center [D43TW009337]; US National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) [R01AI121378]; US National Institutes of Health NIAID [K23AI116869]; FOGARTY INTERNATIONAL CENTER [D43TW009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121378, K23AI116869, T32AI007392] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); US National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID); US National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by Bill & Melinda Gates Foundation (www.gatesfoundation.org) grant OPP1158210 (Awarded to JAC). JTH and DBM received support from US National Institutes of Health Fogarty International Center grant D43TW009337; JAC from US National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) grant R01AI121378; and MPR from US National Institutes of Health NIAID grant K23AI116869. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson J, 2008, BRIT J GEN PRACT, V58, P318, DOI 10.3399/bjgp08X279670; Brieger D, 2004, CHEST, V126, P461, DOI 10.1378/chest.126.2.461; Campbell NRC, 2015, CARDIOVASC J AFR, V26, P152; Chaturvedi N, 1997, LANCET, V350, P1578, DOI 10.1016/S0140-6736(97)06243-0; Chibwana AI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-219; Galson SW, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018829; Hertz JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096688; Hertz JT, 2013, TROP MED INT HEALTH, V18, P1406, DOI 10.1111/tmi.12191; IHME, 2016, TANZ SEATTL; Liao L, 2004, AM HEART J, V147, P630, DOI 10.1016/j.ahj.2003.10.006; Pastorius Benziger C, 2011, CRIT PATHW CARDIOL, V10, P99, DOI DOI 10.1097/HPC.0B013E318223E375; Sarr M, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-118; Shavadia J, 2012, CARDIOVASC J AFR, V23, P318, DOI 10.5830/CVJA-2012-002; Song L, 2010, CHINESE MED J-PEKING, V123, P1840, DOI 10.3760/cma.j.issn.0366-6999.2010.14.003; Stanifer JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164428; SWAI ABM, 1993, INT J EPIDEMIOL, V22, P651, DOI 10.1093/ije/22.4.651; Tanzania National Bureau of Statistics, 2013, 2012 POP HOUS CENS P; Tibazarwa K, 2009, INT J CARDIOL, V132, P233, DOI 10.1016/j.ijcard.2007.11.067; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Walker ARP, 2004, J R SOC PROMO HEALTH, V124, P40, DOI 10.1177/146642400312400112; WHO, 2018, WHO VACC COV CLUST S; Zucker DR, 1997, J GEN INTERN MED, V12, P79, DOI 10.1046/j.1525-1497.1997.00011.x	22	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212139	10.1371/journal.pone.0212139	http://dx.doi.org/10.1371/journal.pone.0212139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753216	gold, Green Submitted, Green Published			2022-12-26	WOS:000458395600048
J	Jin, B; Sheng, ZL; Muhammad, I; Chen, JQ; Yang, HL				Jin, Bo; Sheng, Zunlai; Muhammad, Ishfaq; Chen, Jianqing; Yang, Hongliang			Cloning and functional analysis of the promoter of a stress-inducible gene (Zmap) in maize	PLOS ONE			English	Article							TEMPERATURE-RESPONSIVE GENE; ERWINIA-AMYLOVORA; IDENTIFICATION; EXPRESSION; PROTEIN; REGION; ELEMENTS; DROUGHT	The anionic peroxidases play an important role in a variety of plant physiological processes. We characterized and isolated the Zmap promoter (PZmap) at the 50 flanking region in order to better understand the regulatory mechanisms of Zmap gene expression. A series of PZmap deletion derivatives, termed a1-a6, at positions -1694, -1394, -1138, -784, -527 and -221 from the translation start site were blended to the beta-glucuronidase reporter gene. Agrobacterium-mediated transformation method was used to study each deletion construct in tobaccos. Sequence analysis showed that several cis-acting elements (MYB binding site, Box-II, a TGACG-element, a CGTCA-element and a low temperature responsive element) were located within the promoter. Deletion analysis suggested the sequence between -1,694 and -1394bp may contain cis-elements associated with GUS up regulation. The MYB binding site (-757) might act as a negative drought-responsive element. There might be repressor elements located in the region (-1,694 to -1394bp) to repress Zmap expression under 4 degrees C. The characterized promoter would be an ideal candidate for genetic engineering for improving the resistance of maize to different stressors.	[Jin, Bo; Sheng, Zunlai; Muhammad, Ishfaq; Chen, Jianqing; Yang, Hongliang] Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China; [Sheng, Zunlai; Chen, Jianqing; Yang, Hongliang] Heilongjiang Key Lab Anim Dis Control & Pharmaceu, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Yang, HL (corresponding author), Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China.; Yang, HL (corresponding author), Heilongjiang Key Lab Anim Dis Control & Pharmaceu, Harbin, Heilongjiang, Peoples R China.	hongl_yang@126.com	Ishfaq, Muhammad/HGD-1422-2022; Ishfaq, Muhammad/U-9965-2019	Ishfaq, Muhammad/0000-0003-1376-8986	University Nursing Programs for Young Scholars with Creative Talents in Heilongjiang Province [UNPYSCT-2017003]; "Young Talents" Project of Northeast Agricultural University [17QC13]	University Nursing Programs for Young Scholars with Creative Talents in Heilongjiang Province; "Young Talents" Project of Northeast Agricultural University	This work was supported by the University Nursing Programs for Young Scholars with Creative Talents in Heilongjiang Province (UNPYSCT-2017003) and "Young Talents" Project of Northeast Agricultural University (17QC13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER CJ, 1993, PLANT PHYSIOL, V102, P1341, DOI 10.1104/pp.102.4.1341; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Dunn MA, 1998, PLANT MOL BIOL, V38, P551, DOI 10.1023/A:1006098132352; ECKES P, 1986, MOL GEN GENET, V205, P14, DOI 10.1007/BF02428027; Hou LX, 2016, SCI BULL, V61, P1171, DOI 10.1007/s11434-016-1128-5; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiu ST, 2016, FUNCT INTEGR GENOMIC, V16, P595, DOI 10.1007/s10142-016-0516-x; KALDENHOFF R, 1993, PLANT MOL BIOL, V23, P1187, DOI 10.1007/BF00042352; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; KWON HB, 1994, PLANT PHYSIOL, V105, P357, DOI 10.1104/pp.105.1.357; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malnoy M, 2006, TRANSGENIC RES, V15, P83, DOI 10.1007/s11248-005-2943-7; Mehrotra R, 2011, PLANT MOL BIOL, V75, P527, DOI 10.1007/s11103-011-9755-3; Nishiuchi T, 1995, PLANT MOL BIOL, V29, P599, DOI 10.1007/BF00020987; PERISIC O, 1992, PLANT CELL, V4, P831, DOI 10.1105/tpc.4.7.831; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; SHEEN J, 1993, EMBO J, V12, P3497, DOI 10.1002/j.1460-2075.1993.tb06024.x; SIMPSON J, 1986, NATURE, V323, P551, DOI 10.1038/323551a0; Sun QH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-90; Tao Y, 2015, PLANT MOL BIOL REP, V33, P200, DOI 10.1007/s11105-014-0741-1; Teichmann T, 1997, EUR J BIOCHEM, V247, P826, DOI 10.1111/j.1432-1033.1997.00826.x; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Vaucheret H, 1998, PLANT J, V16, P651, DOI 10.1046/j.1365-313x.1998.00337.x; WHITE TC, 1994, PLANT PHYSIOL, V106, P917, DOI 10.1104/pp.106.3.917; Xu YY, 2016, J INTEGR AGR, V15, P763, DOI 10.1016/S2095-3119(15)61295-3; Zhou YL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-78	28	9	9	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211941	10.1371/journal.pone.0211941	http://dx.doi.org/10.1371/journal.pone.0211941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735543	gold, Green Published, Green Submitted			2022-12-26	WOS:000458181200046
J	Thissen, JB; Be, NA; McLoughlin, K; Gardner, S; Rack, PG; Shapero, MH; Rowland, RRR; Slezak, T; Jaing, CJ				Thissen, James B.; Be, Nicholas A.; McLoughlin, Kevin; Gardner, Shea; Rack, Paul G.; Shapero, Michael H.; Rowland, Raymond R. R.; Slezak, Tom; Jaing, Crystal J.			Axiom Microbiome Array, the next generation microarray for high-throughput pathogen and microbiome analysis	PLOS ONE			English	Article							SYNDROME VIRUS PRRSV; PIGS; COINFECTION; INFECTION; BACTERIA; TIME	Microarrays have proven to be useful in rapid detection of many viruses and bacteria. Pathogen detection microarrays have been used to diagnose viral and bacterial infections in clinical samples and to evaluate the safety of biological drug materials. In this study, the Axiom Microbiome Array was evaluated to determine its sensitivity, specificity and utility in microbiome analysis of veterinary clinical samples. The array contains probes designed to detect more than 12,000 species of viruses, bacteria, fungi, protozoa and archaea, yielding the most comprehensive microbial detection platform built to date. The array was able to detect Shigella and Aspergillus at 100 genome copies, and vaccinia virus DNA at 1,000 genome copies. The Axiom Microbiome Array made correct species- level calls in mock microbial community samples. When tested against serum, tissue, and fecal samples from pigs experimentally co-infected with porcine reproductive and respiratory syndrome virus and porcine circovirus type 2, the microarray correctly detected these two viruses and other common viral and bacterial microbiome species. This cost-effective and high-throughput microarray is an efficient tool to rapidly analyze large numbers of clinical and environmental samples for the presence of multiple viral and bacterial pathogens.	[Thissen, James B.; Be, Nicholas A.; Jaing, Crystal J.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [McLoughlin, Kevin; Gardner, Shea; Slezak, Tom] Lawrence Livermore Natl Lab, Computat Directorate, Livermore, CA USA; [Rack, Paul G.; Shapero, Michael H.] Thermo Fisher Sci, Santa Clara, CA USA; [Rowland, Raymond R. R.] Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Thermo Fisher Scientific; Kansas State University	Jaing, CJ (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.	jaing2@llnl.gov		Rack, Philip/0000-0002-9964-3254; Thissen, James/0000-0002-4693-5886; Jaing, Crystal/0000-0001-9933-3005	Lawrence Livermore Laboratory Derived Research and Development effort	Lawrence Livermore Laboratory Derived Research and Development effort	This research work was supported by the Lawrence Livermore Laboratory Derived Research and Development effort. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2011, NAT REV MICROBIOL, V9, P628, DOI 10.1038/nrmicro2644; Be NA, 2014, J CLIN MICROBIOL, V52, P2583, DOI 10.1128/JCM.00556-14; Be NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073455; CHAPELA MJ, 2015, COGENT FOOD AGR, V1, DOI DOI 10.1080/23311932.2015.1013771; Devault AM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04245; Erlandsson L, 2013, MICROARRAY USED TOOL; Erlandsson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022631; Gardner SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-668; Henderson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074787; Hewitson L, 2014, ADV VIROL, V2014, DOI 10.1155/2014/720585; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Hogfeldt T, 2016, ONCOL LETT, V12, P2782, DOI 10.3892/ol.2016.5012; Jaing C, 2015, DIS AQUAT ORGAN, V116, P83, DOI 10.3354/dao02917; Jaing Crystal, 2011, PDA J Pharm Sci Technol, V65, P668, DOI 10.5731/pdajpst.2011.00838; Jaing CJ, 2015, J VET DIAGN INVEST, V27, P313, DOI 10.1177/1040638715578484; Jiang LX, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030223; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Lee YG, 2015, PLANT J, V81, P625, DOI 10.1111/tpj.12755; McLoughlin KS, 2011, BRIEF FUNCT GENOMICS, V10, P342, DOI 10.1093/bfgp/elr027; Navidad JF, 2013, J CLIN MICROBIOL, V51, P3018, DOI 10.1128/JCM.00896-13; Niederwerder MC, 2016, VET MICROBIOL, V188, P1, DOI 10.1016/j.vetmic.2016.03.008; Ober RA, 2017, VET MICROBIOL, V208, P203, DOI 10.1016/j.vetmic.2017.06.023; Pal N, 2011, TRANSBOUND EMERG DIS, V58, P344, DOI 10.1111/j.1865-1682.2011.01210.x; Paradzik M, 2014, TUMOR BIOL, V35, P567, DOI 10.1007/s13277-013-1079-2; Robinson LA, 2016, BRIT J CANCER, V115, P497, DOI 10.1038/bjc.2016.213; Tellez J, 2014, BIOMARK RES, V2, DOI 10.1186/s40364-014-0024-x; Thissen JB, 2014, J VIROL METHODS, V201, P73, DOI 10.1016/j.jviromet.2014.01.024; Vesty A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169877; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; Wu ZW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-503; You Q, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00104	31	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0212045	10.1371/journal.pone.0212045	http://dx.doi.org/10.1371/journal.pone.0212045			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735540	gold, Green Published, Green Submitted			2022-12-26	WOS:000458181200055
J	Kandeel, M; Kitade, Y; Al-Taher, A; Al-Nazawi, M				Kandeel, Mahmoud; Kitade, Yukio; Al-Taher, Abdulla; Al-Nazawi, Mohammed			The structural basis of unique substrate recognition by Plasmodium thymidylate kinase: Molecular dynamics simulation and inhibitory studies	PLOS ONE			English	Article							THYMIDINE ANALOGS; DISCOVERY; ALPHA	Plasmodium falciparum thymidylate kinase (PfTMK) showed structural and catalytic distinctions from the host enzyme rendering it a hopeful antiprotozoal drug target. Despite the comprehensive enzymologic, structural, inhibitory and chemical synthesis approaches targeting this enzyme, the elucidation of the exact mechanism underlying the recognition of the atypical purine substrates remains to be determined. In this study, molecular dynamics (MD) simulation of a broad range of substrates and inhibitors as well as the inhibitory properties of deoxyguanosine (dG) derivatives were used to assess the PfTMK substructure molecular rearrangements. The estimated changes during the favourable binding of high affinity substrate (TMP) include lower interaction with P-loop, free residue fluctuations of the lid domain and the average RMSD value. The RMSD of TMP complex was higher and more rapidly stabilized than the dGMP complex. The lid domain flexibility is severely affected by dGMP and beta-thymidine derivatives, while being partially fluctuating with other thymidine derivatives. The TMK-purine (dGMP) complex was slowly and gradually stabilized with lower over all structure flexibility and residue fluctuations especially at the lid domain, which closes the active site during its catalytic state. Thymidine derivatives allow structure flexibility of the lid domain being highly fluctuating in alpha- and beta-thymidine derivatives and TMP. dG derivatives remains less efficient than thymidine derivatives in inhibiting TMK. The variations in the structural dynamics of the P-loop and lid domain in response to TMP or dGMP might favour thymidine-based compounds. The provided MD simulation strategy can be used for predicating structural changes in PfTMK during lead optimization.	[Kandeel, Mahmoud; Al-Taher, Abdulla; Al-Nazawi, Mohammed] King Faisal Univ, Dept Physiol Biochem & Pharmacol, Fac Vet Med, Al Hufuf, Alahsa, Saudi Arabia; [Kandeel, Mahmoud] Kafrelsheikh Univ, Fac Vet Med, Dept Pharmacol, Kafrelsheikh, Kafrelsheikh, Egypt; [Kitade, Yukio] Aichi Inst Technol, Fac Engn, Dept Appl Chem, Toyota, Japan; [Kitade, Yukio] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu, Japan	King Faisal University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Gifu University	Kandeel, M (corresponding author), King Faisal Univ, Dept Physiol Biochem & Pharmacol, Fac Vet Med, Al Hufuf, Alahsa, Saudi Arabia.; Kandeel, M (corresponding author), Kafrelsheikh Univ, Fac Vet Med, Dept Pharmacol, Kafrelsheikh, Kafrelsheikh, Egypt.	mkandeel@kfu.edu.sa	Kandeel, Mahmoud/G-3636-2016; Al-Taher, Abdulla/P-6246-2016	Kandeel, Mahmoud/0000-0003-3668-5147; Al-Taher, Abdulla/0000-0002-0831-6486	King Faisal University, Deanship of Scientific Research (DSR) [180039]	King Faisal University, Deanship of Scientific Research (DSR)	MA and MK received financial support from King Faisal University, Deanship of Scientific Research (DSR) grant number 180039 (https://www.kfu.edu.sa/en/Deans/Research/Pages/Home-new.aspx).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONE R, 1986, J BIOL CHEM, V261, P6410; Chen MS, 2018, BIOCHEMISTRY-US, V57, P2868, DOI 10.1021/acs.biochem.8b00162; Cui HQ, 2012, J MED CHEM, V55, P10948, DOI 10.1021/jm301328h; Georlette D, 2003, J BIOL CHEM, V278, P37015, DOI 10.1074/jbc.M305142200; Goncalves AD, 2014, J BIOMOL STRUCT DYN, V32, P301, DOI 10.1080/07391102.2013.765361; Goncalves MA, 2016, THEOR CHEM ACC, V136, DOI 10.1007/s00214-016-2037-z; Guimaraes AP, 2014, J BIOMOL STRUCT DYN, V32, P1601, DOI 10.1080/07391102.2013.830578; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kandeel M, 2009, PARASITOLOGY, V136, P11, DOI 10.1017/S0031182008005301; Kandeel M, 2008, J BIOCHEM, V144, P245, DOI 10.1093/jb/mvn062; Kandeel Mahmoud, 2009, Nucleic Acids Symp Ser (Oxf), P39, DOI 10.1093/nass/nrp020; Kandeel M, 2011, BIOL PHARM BULL, V34, P173, DOI 10.1248/bpb.34.173; Kato A, 2012, PARASITOL INT, V61, P501, DOI 10.1016/j.parint.2012.03.001; Kawatkar SP, 2014, J MED CHEM, V57, P4584, DOI 10.1021/jm500463c; Martinez-Botella G, 2012, J MED CHEM, V55, P10010, DOI 10.1021/jm3011806; Naik M, 2015, J MED CHEM, V58, P753, DOI 10.1021/jm5012947; Noguchi Y, 2013, PARASITOL INT, V62, P368, DOI 10.1016/j.parint.2013.03.009; Ojha PK, 2013, BIOSYSTEMS, V113, P177, DOI 10.1016/j.biosystems.2013.07.005; Soares FV, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041257; Song LJ, 2018, J MED CHEM, V61, P2753, DOI 10.1021/acs.jmedchem.7b01570; Whittingham JL, 2010, BIOCHEM J, V428, P499, DOI 10.1042/BJ20091880	21	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0212065	10.1371/journal.pone.0212065	http://dx.doi.org/10.1371/journal.pone.0212065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730992	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000092
J	Nascimento, JD; da Rosa, JA; Salgado-Roa, FC; Hernandez, C; Pardo-Diaz, C; Alevi, KCC; Ravazi, A; de Oliveira, J; Oliveira, MTVD; Salazar, C; Ramirez, JD				Nascimento, Juliana Damieli; da Rosa, Joao Aristeu; Salgado-Roa, Fabian C.; Hernandez, Carolina; Pardo-Diaz, Carolina; Chaboli Alevi, Kaio Cesar; Ravazi, Amanda; de Oliveira, Jader; Vilela de Azeredo Oliveira, Maria Tercilia; Salazar, Camilo; Ramirez, Juan David			Taxonomical over splitting in the Rhodnius prolixus (Insecta: Hemiptera: Reduviidae) clade: Are R. taquarussuensis (da Rosa et al., 2017) and R. neglectus (Lent, 1954) the same species?	PLOS ONE			English	Article							CHAGAS-DISEASE VECTOR; TRIATOMINAE HEMIPTERA; CHROMOSOMAL EVOLUTION; CRYPTIC SPECIATION; COMPLEX HEMIPTERA; BUGS HEMIPTERA; BRASILIENSIS; DIFFERENTIATION; BIOGEOGRAPHY; VARIABILITY	The use of subtle features as species diagnostic traits in taxa with high morphological similarity sometimes fails in discriminating intraspecific variation from interspecific differences, leading to an incorrect species delimitation. A clear assessment of species boundaries is particularly relevant in disease vector organisms in order to understand epidemiological and evolutionary processes that affect transmission capacity. Here, we assess the validity of the recently described Rhodnius taquarussuensis (da Rosa et al., 2017) using interspecific crosses and molecular markers. We did not detect differences in hatching rates in interspecific crosses between R. taquarussuensis and R. neglectus (Lent, 1954). Furthermore, genetic divergence and species delimitation analyses show that R. taquarussuensis is not an independent lineage in the R. prolixus group. These results suggest that R. taquarussuensis is a phenotypic form of R. neglectus instead of a distinct species. We would like to stress that different sources of evidence are needed to correctly delimit species. We consider this is an important step in understanding vectorial Chagas disease spread and transmission.	[Nascimento, Juliana Damieli] Univ Estadual Campinas UNICAMP, Inst Biol, Campinas, SP, Brazil; [da Rosa, Joao Aristeu; Chaboli Alevi, Kaio Cesar; de Oliveira, Jader] Univ Estadual Paulista Julio de Mesquita Filho UN, Fac Ciencias Farmaceut, Dept Ciencias Biol, Lab Parasitol, Araraquara, SP, Brazil; [Salgado-Roa, Fabian C.; Pardo-Diaz, Carolina; Salazar, Camilo] Univ Rosario, Fac Ciencias Nat & Matemat, Programa Biol, Grp Genet Evolut Filogeog & Ecol Biodiversidad Ne, Bogota, Colombia; [Salgado-Roa, Fabian C.] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Hernandez, Carolina; Ramirez, Juan David] Univ Rosario, Fac Ciencias Nat & Matemat, Programa Biol, GIMUR, Bogota, Colombia; [Chaboli Alevi, Kaio Cesar; Ravazi, Amanda; Vilela de Azeredo Oliveira, Maria Tercilia] Univ Estadual Paulista Julio de Mesquita Filho UN, Inst Biociencias Letras & Ciencias Exatas, Dept Biol, Lab Biol Celular, Sao Jose Do Rio Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidad del Rosario; Universidad de los Andes (Colombia); Universidad del Rosario; Universidade Estadual Paulista	Ramirez, JD (corresponding author), Univ Rosario, Fac Ciencias Nat & Matemat, Programa Biol, GIMUR, Bogota, Colombia.	juand.ramirez@urosario.edu.co	de Oliveira, Jader/C-6416-2017; da Rosa, João Aristeu/AAP-6781-2020; Alevi, Kaio Cesar Chaboli/F-9529-2013; C, Salazar/A-1647-2010; Salgado Roa, Fabian Camilo/GSN-5001-2022; Nascimento, Juliana Damieli/AAO-1060-2020; Pardo-Diaz, Carolina/C-7936-2016; da Rosa, Joao Aristeu/U-9885-2017	de Oliveira, Jader/0000-0002-2588-1911; C, Salazar/0000-0001-9217-6588; Nascimento, Juliana Damieli/0000-0002-6892-2453; Salgado-Roa, Fabian Camilo/0000-0002-7266-4055; Azeredo-Oliveira, Maria Tercilia/0000-0003-2111-638X; Pardo-Diaz, Carolina/0000-0002-7259-1183; Alevi, Kaio/0000-0001-8333-3764; da Rosa, Joao Aristeu/0000-0001-6318-3025	DIRECCION DE INVESTIGACION UNIVERSIDAD DEL ROSARIO	DIRECCION DE INVESTIGACION UNIVERSIDAD DEL ROSARIO	This word was funded by DIRECCION DE INVESTIGACION UNIVERSIDAD DEL ROSARIO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2013, MEM I OSWALDO CRUZ, V108, P92, DOI 10.1590/0074-0276130434; Abad-Franch F, 2009, ACTA TROP, V110, P159, DOI 10.1016/j.actatropica.2008.06.005; Alevi KCC, 2015, GENET MOL RES, V14, P12654, DOI 10.4238/2015.October.19.9; Almeida F.B., 1973, Acta amazon, V3, P43; Barata J M, 1981, Rev Saude Publica, V15, P490; Bardella VB, 2016, MEM I OSWALDO CRUZ, V111, P614, DOI 10.1590/0074-02760160044; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650; Bouckaert RR, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0890-6; Ceccarelli S, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.71; Costa J, 2003, MEM I OSWALDO CRUZ, V98, P637, DOI 10.1590/S0074-02762003000500009; Crossa RP, 2002, INFECT GENET EVOL, V2, P47, DOI 10.1016/S1567-1348(02)00063-1; da Rosa JA, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.675.12024; Da Rosa JA, 2012, ZOOTAXA, P62; da Rosa JA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-17; DAROSA JA, 1992, MEM I OSWALDO CRUZ, V87, P257, DOI 10.1590/S0074-02761992000200014; Meneguetti DUD, 2014, REV SOC BRAS MED TRO, V47, P374, DOI 10.1590/0037-8682-0179-2013; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galvao C., 2014, VETORES DOENCA CHAGA, DOI DOI 10.7476/9788598203096; Gomez-Palacio A, 2008, MEM I OSWALDO CRUZ, V103, P160, DOI 10.1590/S0074-02762008000200006; Heitzmann-Fontenelle T, 1967, MEM I BUTANTAN, V47, P175; Hypsa V, 2002, MOL PHYLOGENET EVOL, V23, P447, DOI 10.1016/S1055-7903(02)00023-4; Jiggins CD, 2001, EVOLUTION, V55, P1631, DOI 10.1111/j.0014-3820.2001.tb00682.x; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Justi SA, 2017, TRENDS PARASITOL, V33, P42, DOI 10.1016/j.pt.2016.11.002; Justi SA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004527; Justi SA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-149; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kumar V, 2018, SPRING TEXT BUS ECON, P1, DOI 10.1007/978-3-662-55381-7; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; LENT H, 1993, MEM I OSWALDO CRUZ, V88, P605, DOI 10.1590/S0074-02761993000400019; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lyman DE, 1999, AM J TROP MED HYG, V60, P377, DOI 10.4269/ajtmh.1999.60.377; Maddison, 2018, MESQUITE MODULAR SYS; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Martinez-Ibarra JA, 2011, J MED ENTOMOL, V48, P705, DOI 10.1603/ME10159; Mendonca VJ, 2016, ZOOTAXA, V4107, P239, DOI 10.11646/zootaxa.4107.2.6; Mendonca VJ, 2014, INFECT GENET EVOL, V26, P123, DOI 10.1016/j.meegid.2014.05.015; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Minard G, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2202-9; Monteiro FA, 2004, MOL PHYLOGENET EVOL, V32, P46, DOI 10.1016/j.ympev.2003.12.011; Monteiro FA, 2003, MOL ECOL, V12, P997, DOI 10.1046/j.1365-294X.2003.01802.x; Monteiro FA, 2018, ADV PARASIT, V99, P265, DOI 10.1016/bs.apar.2017.12.002; Neiva A., 1923, Brazil Medico, V37, P20; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Noireau F, 1998, TROP MED INT HEALTH, V3, P364; Panzera F, 1997, AM J TROP MED HYG, V57, P732, DOI 10.4269/ajtmh.1997.57.732; Panzera F, 2006, TROP MED INT HEALTH, V11, P1092, DOI 10.1111/j.1365-3156.2006.01656.x; Panzera F, 2004, EMERG INFECT DIS, V10, P438, DOI 10.3201/eid1003.020812; Panzera F, 2014, INFECT GENET EVOL, V27, P105, DOI 10.1016/j.meegid.2014.07.006; Panzera Y, 2012, CYTOGENET GENOME RES, V138, P56, DOI 10.1159/000341888; Pavan MG, 2007, TROP MED INT HEALTH, V12, P751, DOI 10.1111/j.1365-3156.2007.01845.x; Pavan MG, 2013, INFECT GENET EVOL, V14, P426, DOI 10.1016/j.meegid.2012.10.018; Perez R, 2005, GENETICA, V125, P261, DOI 10.1007/s10709-005-0369-z; Pinto C., 1931, Boletim Biologico Rio de Janeiro fasc, V19, P45; Pita S, 2013, MEM I OSWALDO CRUZ, V108, P376, DOI 10.1590/S0074-02762013000300017; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Ravazi A, 2018, BRAZ J BIOL, V78, P183, DOI 10.1590/1519-6984.167196; Roux C, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000234; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Skoracka A, 2015, EXP APPL ACAROL, V67, P165, DOI 10.1007/s10493-015-9954-8; UESHIMA N, 1966, CHROMOSOMA, V18, P97, DOI 10.1007/BF00326447; VALENTE VC, 2001, ENTOMOL VECTORES, V8, P65, DOI DOI 10.4238/2015.OCTOBER.19.9; Velasquez NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087732; Zapata F, 2012, SYST BIOL, V61, P179, DOI 10.1093/sysbio/syr084; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	68	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211285	10.1371/journal.pone.0211285	http://dx.doi.org/10.1371/journal.pone.0211285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730919	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000019
J	Schmidt, P; Kempin, R; Langner, S; Beule, A; Kindler, S; Koppe, T; Volzke, H; Ittermann, T; Jurgens, C; Tost, F				Schmidt, Patrick; Kempin, Robert; Langner, Soenke; Beule, Achim; Kindler, Stefan; Koppe, Thomas; Voelzke, Henry; Ittermann, Till; Juergens, Clemens; Tost, Frank			Association of anthropometric markers with globe position: A population-based MRI study	PLOS ONE			English	Article							EYEBALL POSITION; ORBITAL VOLUME; EXOPHTHALMOMETRY; HEALTH	Purpose Exophthalmometry is a common examination in ophthalmology. For example it is relevant for diagnosis or follow-up of thyroid eye disease. However, exophthalmometry is affected by several factors such as ethnicity, sex and age. The purpose of this study was to determine the globe position by magnetic resonance imaging (MRI) and to investigate its correlates among the general Northeast German adult population. Methods A total of 3030 subjects aged between 20 and 89 from the population-based Study of Health in Pomerania (SHIP) underwent a standardised whole-body MRI. Axial length and globe position were determined in axial T1-weighted images of the orbit. The image had to include the corneal apex as well as the optic nerve head. Study participants were excluded from imaging analysis if there was no plane available that included both structures. Further exclusion criterion was a lateral deviation of the subject's viewing direction. Images with inadequate quality due to motion artefacts or other technical reasons were excluded as well. Globe position was defined as the perpendicular distance between the interzygomatic line and the posterior surface of the cornea (exophthalmometric value). The distance between the posterior surface of the cornea and the posterior pole of the eyeball, at the boundary with orbital fat, was defined as axial length. We used posterior surface of the cornea for our measurements, because it seemed to be less vulnerable for motion artefacts than the anterior one. Moreover body measurements including body mass index (BMI), waist and hip circumferences were determined. Associations between anthropometric measurements with exophthalmometric outcomes were analysed by linear regressions adjusted for age and stratified by sex. P-values <0.05 were considered as statistically significant. To assess intra-reader variability intra-class correlation coefficients (ICC) were computed for repeated measurements of the MRI scans of 25 subjects. Results After considering the exclusion criteria 1926 evaluable subjects remained. There was no significant difference between means of right and left eyes. The mean exophthalmometric value was significantly higher in men (16.5 +/- 2.2 mm) than in women (15.3 +/- 2.1 mm). The mean MRI-axial length was 23.4 +/- 0.8 mm for men and 22.8 +/- 0.9 mm for women. BMI, waist and hip circumferences were positively correlated with exophthalmometric value (p<0.001). Difference of mean MRI-based exophthalmometric value for obese subjects (BMI >= 30 kg/m(2)) and non-overweight (BMI <25 kg/m(2)) was 2.1 mm for men and 1.6 mm for women. ICC between 0.97 and 0.99 indicate excellent repeatability of our method. Conclusion We conclude that MRI-based exophthalmometric values are positively correlated with BMI, waist-and hip-circumference among the general Northeast German adult population. This association is independent from age and axial length. Consequently bodyweight of patients should be regarded to interpret exophthalmometric values correctly. MRI-exophthalmometry seems to be a suitable method to determine globe position. Considering the large number of study participants, exophthalmometric values of our study could be used as comparative values for exophthalmometry of people of Western European descent in future.	[Schmidt, Patrick; Kempin, Robert; Tost, Frank] Univ Med Greifswald, Dept Ophthalmol, Greifswald, Mecklenburg Wes, Germany; [Langner, Soenke] Univ Med Rostock, Inst Diagnost Radiol & Neuroradiol, Rostock, Mecklenburg Wes, Germany; [Beule, Achim] Univ Clin Munster, Dept Otorhinolaryngol, Munster, North Rhine Wes, Germany; [Kindler, Stefan] Univ Med Greifswald, Dept Oral & Maxillofacial Surg Plast Surg, Greifswald, Mecklenburg Wes, Germany; [Koppe, Thomas] Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Mecklenburg Wes, Germany; [Voelzke, Henry; Ittermann, Till; Juergens, Clemens] Univ Med Greifswald, Inst Community Med, Greifswald, Mecklenburg Wes, Germany	Greifswald Medical School; University of Rostock; University of Munster; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Tost, F (corresponding author), Univ Med Greifswald, Dept Ophthalmol, Greifswald, Mecklenburg Wes, Germany.	tost@uni-greifswald.de	Beule, Achim/J-3525-2019; Langner, Soenke/ABB-6744-2021	Beule, Achim/0000-0002-1622-6077; Langner, Soenke/0000-0001-7241-1173	Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 01ZZ0701, 03ZIK012]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; German Federal Ministry of Education and Research (BMBF) [01ZZ0701, 01ZZ96030]; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; DFG (German Research Foundation) [393148499]; Open Access Publication Fund of the University of Greifswald	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; DFG (German Research Foundation)(German Research Foundation (DFG)); Open Access Publication Fund of the University of Greifswald	SHIP is part of the Community Medicine Research network of the University of Greifswald which is funded by the Federal Ministry of Education and Research (www.bmbf.de/en/index.html, 01ZZ9603, 01ZZ0103, 01ZZ0403, 01ZZ0701, 03ZIK012), the Ministry of Cultural Affairs (www.regierung-mv.de/Landesregierung/bm) as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania (www.regierung-mv.de/Landesregierung/sm) and the German Federal Ministry of Education and Research (BMBF, grant 01ZZ96030, 01ZZ0701). Wholebody MR imaging was supported by a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. We also acknowledge support for the Article Processing Charge from the DFG (German Research Foundation, 393148499) and the Open Access Publication Fund of the University of Greifswald. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beden U, 2008, EUR J OPHTHALMOL, V18, P165, DOI 10.1177/112067210801800201; Bingham CM, 2016, OPHTHAL PLAST RECONS, V32, P106, DOI 10.1097/IOP.0000000000000437; Chan WO, 2009, CLIN EXP OPHTHALMOL, V37, P496, DOI 10.1111/j.1442-9071.2009.02087.x; Cole HP, 1997, OPHTHALMIC PLAST REC, V13, P189, DOI 10.1097/00002341-199709000-00005; de Montes FBG, 1999, REV INVEST CLIN, V51, P341; Delmas J, 2018, EUR J OPHTHALMOL, V28, P144, DOI 10.5301/ejo.5001049; Detorakis ET, 2010, BRIT J OPHTHALMOL, V94, P135, DOI 10.1136/bjo.2008.150532; Detorakis ET, 2010, ORBIT, V29, P244, DOI 10.3109/01676831003664319; Erkoc MF, 2015, EXP THER MED, V9, P1991, DOI 10.3892/etm.2015.2313; Frueh WT, 2007, OPHTHAL PLAST RECONS, V23, P197, DOI 10.1097/IOP.0b013e3180500d70; Genders SW, 2015, ORBIT, V34, P23, DOI 10.3109/01676830.2014.963877; Hegenscheid K, 2009, ROFO-FORTSCHR RONTG, V181, P748, DOI 10.1055/s-0028-1109510; Ibraheem WA, 2013, AFR J MED HLTH SCI, V12, P74; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Lazarus JH, 2012, BEST PRACT RES CL EN, V26, P273, DOI 10.1016/j.beem.2011.10.005; Li YW, 2017, MED SCI MONITOR, V23, P57, DOI 10.12659/MSM.902551; Ozgen A, 2000, J COMPUT ASSIST TOMO, V24, P493, DOI 10.1097/00004728-200005000-00025; Ramli N, 2015, ORBIT, V34, P257, DOI 10.3109/01676830.2015.1057291; Segni M, 2002, AM J OPHTHALMOL, V133, P813, DOI 10.1016/S0002-9394(02)01429-0; Sleep TJ, 2002, OPHTHAL PLAST RECONS, V18, P254, DOI 10.1097/00002341-200207000-00004; Smolders MH, 2004, OPHTHALMIC RES, V36, P78, DOI 10.1159/000076885; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Yoo JH, 2013, J CRANIOFAC SURG, V24, P822, DOI 10.1097/SCS.0b013e3182802600	23	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211817	10.1371/journal.pone.0211817	http://dx.doi.org/10.1371/journal.pone.0211817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730926	Green Submitted, gold, Green Published			2022-12-26	WOS:000458026000062
J	Phillipps, HR; Rand, CJ; Brown, RSE; Kokay, IC; Stanton, JA; Grattan, DR				Phillipps, Hollian R.; Rand, Christy J.; Brown, Rosemary S. E.; Kokay, Ilona C.; Stanton, Jo-Ann; Grattan, David R.			Prolactin regulation of insulin-like growth factor 2 gene expression in the adult mouse choroid plexus	FASEB JOURNAL			English	Article						nanoString; RNA-seq; transcriptome	RECEPTOR MESSENGER-RNA; FACTOR-II GENE; LONG-FORM; SUBVENTRICULAR ZONE; PLACENTAL-LACTOGEN; EPITHELIAL-CELLS; BRAIN; PREGNANCY; TRANSCRIPTION; ISOFORM	There is clear evidence for carrier-mediated transport of prolactin into the brain, and it has been widely assumed that prolactin receptors (PRLRs) in the choroid plexus (ChP) might mediate this transport. Using PRLR knockout mice, we recently showed that PRLRs in ChP are not required for prolactin transport into the brain. Hence, the function of PRLR in the ChP remains unknown. PRLR expression is increased in the ChP during lactation, suggesting a possible role in adaptive function of prolactin at this time. To gain insight into prolactin function in the ChP, we have utilized RNA sequencing and NanoString techniques to characterize transcriptional changes in response to differing levels of prolactin at diestrus, during pregnancy, and in lactation. We have observed opposing transcriptional effects of prolactin on the ChP in different physiologic states, being primarily inhibitory during diestrus but stimulatory in lactation. Insulin-like growth factor 2 (Igf2), a highly expressing transcript found in the ChP, showed a 6-fold increase at lactation that returned to baseline on suppression of prolactin levels. These results indicate that Igf2 may be an important downstream mediator of prolactin-induced signaling in the ChP.Phillipps, H. R., Rand, C. J., Brown, R. S. E., Kokay, I. C., Stanton, J.-A., Grattan, D. R. Prolactin regulation of insulin-like growth factor 2 gene expression in the adult mouse choroid plexus.	[Phillipps, Hollian R.; Brown, Rosemary S. E.; Kokay, Ilona C.; Grattan, David R.] Univ Otago, Ctr Neuroendocrinol, 270 Great King St,POB 913, Dunedin 9054, New Zealand; [Phillipps, Hollian R.; Rand, Christy J.; Brown, Rosemary S. E.; Kokay, Ilona C.; Stanton, Jo-Ann; Grattan, David R.] Univ Otago, Sch Med Sci, Dept Anat, 270 Great King St,POB 913, Dunedin 9054, New Zealand	University of Otago; University of Otago	Phillipps, HR (corresponding author), Univ Otago, Ctr Neuroendocrinol, 270 Great King St,POB 913, Dunedin 9054, New Zealand.; Phillipps, HR (corresponding author), Univ Otago, Sch Med Sci, Dept Anat, 270 Great King St,POB 913, Dunedin 9054, New Zealand.	holly.phillipps@otago.ac.nz	Stanton, Jo-Ann L/C-6621-2009; Grattan, David/M-4307-2019	Stanton, Jo-Ann L/0000-0001-8139-4694; Grattan, David/0000-0001-5606-2559; Brown, Rosemary/0000-0001-6775-3072	Marsden Fund; Health Research Council (HRC) of New Zealand; Ministry of Business, Innovation, and Employment (MBIE) Grant [000X1507]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council (HRC) of New Zealand(Health Research Council of New Zealand); Ministry of Business, Innovation, and Employment (MBIE) Grant	The authors thank staff at New Zealand Genomics Limited (NZGL) for their NanoString expertise. This work was funded by grants from the Marsden Fund, administered by the Royal Society of New Zealand and the Health Research Council (HRC) of New Zealand. C.J.R. and J.-A.S. were supported by Ministry of Business, Innovation, and Employment (MBIE) Grant 000X1507. The authors declare no conflicts of interest.	Augustine RA, 2003, J MOL ENDOCRINOL, V31, P221, DOI 10.1677/jme.0.0310221; Bakowska JC, 1997, J COMP NEUROL, V386, P161, DOI 10.1002/(SICI)1096-9861(19970922)386:2<161::AID-CNE1>3.0.CO;2-#; Benarroch EE, 2012, NEUROLOGY, V79, P2148, DOI 10.1212/WNL.0b013e3182752eef; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Blume A, 2009, ENDOCRINOLOGY, V150, P1841, DOI 10.1210/en.2008-1023; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; BOUTIN JM, 1989, MOL ENDOCRINOL, V3, P1455, DOI 10.1210/mend-3-9-1455; Breves JP, 2014, GEN COMP ENDOCR, V203, P21, DOI 10.1016/j.ygcen.2013.12.014; Breves JP, 2013, MOL CELL ENDOCRINOL, V369, P98, DOI 10.1016/j.mce.2013.01.021; Brisken C, 2002, DEV CELL, V3, P877, DOI 10.1016/S1534-5807(02)00365-9; Brooker GJF, 2000, J NEUROSCI RES, V59, P332, DOI 10.1002/(SICI)1097-4547(20000201)59:3<332::AID-JNR6>3.0.CO;2-2; Brown RSE, 2017, P NATL ACAD SCI USA, V114, P10779, DOI 10.1073/pnas.1708025114; Brown RSE, 2016, FASEB J, V30, P1002, DOI 10.1096/fj.15-276519; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; CHIU SF, 1994, J NEUROENDOCRINOL, V6, P191, DOI 10.1111/j.1365-2826.1994.tb00572.x; CLARKE DL, 1993, ENDOCRINOLOGY, V133, P224, DOI 10.1210/en.133.1.224; DAVIS JA, 1989, MOL ENDOCRINOL, V3, P674, DOI 10.1210/mend-3-4-674; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Devi YS, 2009, ENDOCRINOLOGY, V150, P3327, DOI 10.1210/en.2008-1719; Dziegielewska KM, 2001, MICROSC RES TECHNIQ, V52, P5, DOI 10.1002/1097-0029(20010101)52:1<5::AID-JEMT3>3.3.CO;2-A; Ferron SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9265; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Goffin V, 1996, ENDOCR REV, V17, P385, DOI 10.1210/er.17.4.385; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Halperin J, 2008, MOL ENDOCRINOL, V22, P513, DOI 10.1210/me.2007-0399; Hong-Goka BC, 2004, NEUROSCI LETT, V360, P113, DOI 10.1016/j.neulet.2004.01.075; Hovey RC, 2003, MOL ENDOCRINOL, V17, P460, DOI 10.1210/me.2002-0214; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kline JB, 1999, J BIOL CHEM, V274, P35461, DOI 10.1074/jbc.274.50.35461; Kokay Ilona C, 2018, J Neuroendocrinol, V30, pe12634, DOI 10.1111/jne.12634; Larsen CM, 2010, ENDOCRINOLOGY, V151, P3805, DOI 10.1210/en.2009-1385; Lee CL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037897, 10.1371/journal.pone.0030077]; MARKOFF E, 1981, BIOL REPROD, V24, P846, DOI 10.1095/biolreprod24.4.846; Marques F, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-10; Mayr S, 1998, EUR J BIOCHEM, V258, P784, DOI 10.1046/j.1432-1327.1998.2580784.x; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; MOLLGARD K, 1976, NATURE, V264, P293, DOI 10.1038/264293a0; MOORE RC, 1993, GENE, V134, P263, DOI 10.1016/0378-1119(93)90104-B; NAGANO M, 1994, J BIOL CHEM, V269, P13337; OHLSSON R, 1994, DEVELOPMENT, V120, P361; OUHTIT A, 1993, ENDOCRINOLOGY, V133, P135, DOI 10.1210/en.133.1.135; Phillipps HR, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.162; Pi XJ, 1999, J NEUROENDOCRINOL, V11, P693; Pi XJ, 2003, NEUROENDOCRINOLOGY, V77, P187, DOI 10.1159/000069510; PICKFORD GE, 1959, SCIENCE, V130, P454, DOI 10.1126/science.130.3373.454; Quadros PS, 2007, J COMP NEUROL, V504, P42, DOI 10.1002/cne.21427; Quintela T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060199; Sakamoto T, 2006, GEN COMP ENDOCR, V147, P24, DOI 10.1016/j.ygcen.2005.10.008; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Shu YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18597; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; SPECTOR R, 1989, SCI AM, V261, P68, DOI 10.1038/scientificamerican1189-68; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; Tabata H, 2012, J MOL ENDOCRINOL, V48, P169, DOI 10.1530/JME-11-0122; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trott JF, 2003, J MOL ENDOCRINOL, V30, P31, DOI 10.1677/jme.0.0300031; WALSH RJ, 1987, ENDOCRINOLOGY, V120, P1846, DOI 10.1210/endo-120-5-1846; WALSH RJ, 1984, ENDOCRINOLOGY, V114, P1496, DOI 10.1210/endo-114-5-1496; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Ye XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141078; Ziegler AN, 2012, STEM CELLS, V30, P1265, DOI 10.1002/stem.1095	65	6	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6115	6128		10.1096/fj.201802262R	http://dx.doi.org/10.1096/fj.201802262R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30735445	Bronze			2022-12-26	WOS:000466932600026
J	Eisa, NH; Jilani, Y; Kainth, K; Redd, P; Lu, S; Bougrine, O; Sater, HA; Patwardhan, CA; Shull, A; Shi, HD; Liu, KB; Elsherbiny, NM; Eissa, LA; El-Shishtawy, MM; Horuzsko, A; Bollag, R; Maihle, N; Roig, J; Korkaya, H; Cowell, JK; Chadli, A				Eisa, Nada H.; Jilani, Yasmeen; Kainth, Kashish; Redd, Priscilla; Lu, Su; Bougrine, Oulia; Sater, Houssein Abdul; Patwardhan, Chaitanya A.; Shull, Austin; Shi, Huidong; Liu, Kebin; Elsherbiny, Nehal M.; Eissa, Laila A.; El-Shishtawy, Mamdouh M.; Horuzsko, Anatolij; Bollag, Roni; Maihle, Nita; Roig, Joan; Korkaya, Hasan; Cowell, John K.; Chadli, Ahmed			The co-chaperone UNC45A is essential for the expression of mitotic kinase NEK7 and tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; mitosis; molecular chaperone; centrosome; glucocorticoid receptor; Heat shock protein 90; Hsp90; KEK7; UNC-45A; UNC45A	NIMA-FAMILY KINASE; MYOSIN CHAPERONE; UNC-45 CHAPERONE; KINESIN EG5; UCS DOMAIN; CANCER; PROLIFERATION; CENTROSOMES; SEPARATION; PROTEINS	Cumulative evidence suggests that the heat shock protein 90 (Hsp90) co-chaperone UNC-45 myosin chaperone A (UNC45A) contributes to tumorigenesis and that its expression in cancer cells correlates with proliferation and metastasis of solid tumors. However, the molecular mechanism by which UNC45A regulates cancer cell proliferation remains largely unknown. Here, using siRNA-mediated gene silencing and various human cells, we report that UNC45A is essential for breast cancer cell growth, but is dispensable for normal cell proliferation. Immunofluorescence microscopy, along with gene microarray and RT-quantitative PCR analyses, revealed that UNC45A localizes to the cancer cell nucleus, where it up-regulates the transcriptional activity of the glucocorticoid receptor and thereby promotes expression of the mitotic kinase NIMA-related kinase 7 (NEK7). We observed that UNC45A-deficient cancer cells exhibit extensive pericentrosomal material disorganization, as well as defects in centrosomal separation and mitotic chromosome alignment. Consequently, these cells stalled in metaphase and cytokinesis and ultimately underwent mitotic catastrophe, phenotypes that were rescued by heterologous NEK7 expression. Our results identify a key role for the co-chaperone UNC45A in cell proliferation and provide insight into the regulatory mechanism. We propose that UNC45A represents a promising new therapeutic target to inhibit cancer cell growth in solid tumor types.	[Eisa, Nada H.; Jilani, Yasmeen; Kainth, Kashish; Redd, Priscilla; Lu, Su; Patwardhan, Chaitanya A.; Shull, Austin; Shi, Huidong; Horuzsko, Anatolij; Bollag, Roni; Maihle, Nita; Korkaya, Hasan; Cowell, John K.; Chadli, Ahmed] Augusta Univ, Georgia Canc Ctr, 1410 Laney Walker Blvd,CN-3151, Augusta, GA 30912 USA; [Bougrine, Oulia; Sater, Houssein Abdul] Augusta Univ, Dept Pathol, CN-3151, Augusta, GA 30912 USA; [Liu, Kebin; Elsherbiny, Nehal M.; Eissa, Laila A.; El-Shishtawy, Mamdouh M.; Bollag, Roni] Mansoura Univ, Biochem Dept, Fac Pharm, Mansoura 35516, Egypt; [Bollag, Roni] Augusta Univ, Georgia Canc Ctr, Biorepository, Augusta, GA 30912 USA; [Roig, Joan] CSIC, IBMB, Parc Cient Barcelona,C Baldiri & Reixac 10-12, E-08028 Barcelona, Spain	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Egyptian Knowledge Bank (EKB); Mansoura University; University System of Georgia; Augusta University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Chadli, A (corresponding author), Augusta Univ, Georgia Canc Ctr, 1410 Laney Walker Blvd,CN-3151, Augusta, GA 30912 USA.	achadli@augusta.edu	Eisa, Nada H./AAR-4359-2021; El-Shishtawy, Mamdouh M./O-6626-2018; Elsherbiny, Nehal/AAF-9206-2019; Korkaya, Hasan/GRY-1016-2022; Eissa, Laila Ahmed/O-3010-2018; Korkaya, Hasan/ABD-6282-2020; Eisa, Nada H./N-5111-2018; Roig, Joan/E-2836-2017	El-Shishtawy, Mamdouh M./0000-0002-7888-354X; Elsherbiny, Nehal/0000-0001-5167-3377; Eissa, Laila Ahmed/0000-0003-4470-0263; Korkaya, Hasan/0000-0002-0719-5862; Shi, Huidong/0000-0003-1137-3390; Abdul Sater, Houssein/0000-0003-1975-3726; Eisa, Nada H./0000-0001-8630-0693; Roig, Joan/0000-0002-3872-4712; Shull, Austin/0000-0001-5111-2908	National Institutes of Health [R01 GM102443-01]; Augusta University Startup Funds; Egyptian Cultural and Educational Bureau	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Augusta University Startup Funds; Egyptian Cultural and Educational Bureau(Egyptian Cultural & Educational Bureau)	This work was supported by National Institutes of Health Grant R01 GM102443-01 and Augusta University Startup Funds (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the government scholarship fund from the Egyptian Cultural and Educational Bureau.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bazzaro M, 2007, AM J PATHOL, V171, P1640, DOI 10.2353/ajpath.2007.070325; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; BRENNER S, 1974, GENETICS, V77, P71; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chadli A, 2006, MOL CELL BIOL, V26, P1722, DOI 10.1128/MCB.26.5.1722-1730.2006; Chadli A, 2008, J BIOL CHEM, V283, P9509, DOI 10.1074/jbc.C800017200; Cohen S, 2013, BBA-MOL CELL RES, V1833, P1104, DOI 10.1016/j.bbamcr.2012.12.021; Comyn SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048861; Cullati SN, 2017, J CELL BIOL, V216, P2339, DOI 10.1083/jcb.201512055; Epping MT, 2009, MOL CANCER RES, V7, P1861, DOI 10.1158/1541-7786.MCR-09-0187; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Feige E, 2002, MECH DEVELOP, V110, P219, DOI 10.1016/S0925-4773(01)00573-1; Ferenz NP, 2010, SEMIN CELL DEV BIOL, V21, P255, DOI 10.1016/j.semcdb.2010.01.019; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Fu JY, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015800; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gazda L, 2013, CELL, V152, P183, DOI 10.1016/j.cell.2012.12.025; GILMORE TD, 1986, CELL, V44, P791, DOI 10.1016/0092-8674(86)90845-7; Godinho SA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0467; Guo W, 2011, J MOL BIOL, V412, P365, DOI 10.1016/j.jmb.2011.07.012; Gupta A, 2017, MOL BIOL CELL, V28, P2123, DOI 10.1091/mbc.E16-09-0643; Iizuka Y, 2017, MOL BIOL CELL, V28, P1337, DOI 10.1091/mbc.E16-06-0381; Iizuka Y, 2015, J IMMUNOL, V195, P4760, DOI 10.4049/jimmunol.1500979; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Jilani Y, 2015, CANCER LETT, V357, P114, DOI 10.1016/j.canlet.2014.11.009; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kim S, 2007, BIOCHEM BIOPH RES CO, V360, P56, DOI 10.1016/j.bbrc.2007.05.206; Kim S, 2011, J CELL SCI, V124, P3760, DOI 10.1242/jcs.078089; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Lee CF, 2011, STRUCTURE, V19, P397, DOI 10.1016/j.str.2011.01.002; Lehtimaki JI, 2017, J CELL BIOL, V216, P4053, DOI 10.1083/jcb.201703107; Minoguchi S, 2003, BIOCHEM BIOPH RES CO, V301, P899, DOI 10.1016/S0006-291X(03)00049-4; Mooneyham A, 2019, MOL CANCER RES, V17, P370, DOI 10.1158/1541-7786.MCR-18-0670; Ni WM, 2011, J CELL SCI, V124, P3164, DOI 10.1242/jcs.087320; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202; Salem H, 2010, ONCOGENE, V29, P4046, DOI 10.1038/onc.2010.162; Sampson J, 2017, CANCER RES, V77, P4785, DOI 10.1158/0008-5472.CAN-16-3233; Sdelci S, 2011, CELL CYCLE, V10, P3816, DOI 10.4161/cc.10.22.18226; Shi H, 2010, P NATL ACAD SCI USA, V107, P21382, DOI 10.1073/pnas.1013038107; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Walker Michael G., 2001, Mini-Reviews in Medicinal Chemistry, V1, P197, DOI 10.2174/1389557013407034; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069	49	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5246	5260		10.1074/jbc.RA118.006597	http://dx.doi.org/10.1074/jbc.RA118.006597			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30737284	Green Published, hybrid			2022-12-26	WOS:000464517500002
J	Wang, HB; Lu, J; Kulkarni, S; Zhang, WQ; Gorka, JE; Mandel, JA; Goetzman, ES; Prochownik, EV				Wang, Huabo; Lu, Jie; Kulkarni, Sucheta; Zhang, Weiqi; Gorka, Joanna E.; Mandel, Jordan A.; Goetzman, Eric S.; Prochownik, Edward V.			Metabolic and oncogenic adaptations to pyruvate dehydrogenase inactivation in fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Myc (c-Myc); fatty acid oxidation; pyruvate carboxylase (PC); Warburg effect; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); glutaminolysis; reverse carboxylation	GREEN FLUORESCENT PROTEIN; C-MYC; LACTATE-DEHYDROGENASE; REDUCTIVE CARBOXYLATION; DNA-DAMAGE; DEFICIENT CELLS; RAT-LIVER; CANCER; GLUTAMINE; INHIBITION	Eukaryotic cell metabolism consists of processes that generate available energy, such as glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation (Oxphos), and those that consume it, including macromolecular synthesis, the maintenance of ionic gradients, and cellular detoxification. By converting pyruvate to acetyl-CoA (AcCoA), the pyruvate dehydrogenase (PDH) complex (PDC) links glycolysis and the TCA cycle. Surprisingly, disrupting the connection between glycolysis and the TCA cycle by inactivation of PDC has only minor effects on cell replication. However, the molecular basis for this metabolic re-equilibration is unclear. We report here that CRISPR/Cas9-generated PDH-knockout (PDH-KO) rat fibroblasts reprogrammed their metabolism and their response to short-term c-Myc (Myc) oncoprotein overexpression. PDH-KO cells replicated normally but produced surprisingly little lactate. They also exhibited higher rates of glycolysis and Oxphos. In addition, PDH-KO cells showed altered cytoplasmic and mitochondrial pH, redox states, and mitochondrial membrane potential (M). Conditionally activated Myc expression affected some of these parameters in a PDH-dependent manner. PDH-KO cells had increased oxygen consumption rates in response to glutamate, but not to malate, and were depleted in all TCA cycle substrates between -ketoglutarate and malate despite high rates of glutaminolysis, as determined by flux studies with isotopically labeled glutamine. Malate and pyruvate were diverted to produce aspartate, thereby potentially explaining the failure to accumulate lactate. We conclude that PDH-KO cells maintain proliferative capacity by utilizing glutamine to supply high rates of AcCoA-independent flux through the bottom portion of the TCA cycle while accumulating pyruvate and aspartate that rescue their redox defects.	[Wang, Huabo; Lu, Jie; Kulkarni, Sucheta; Zhang, Weiqi; Gorka, Joanna E.; Mandel, Jordan A.; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Sect Hematol Oncol, Pittsburgh, PA 15224 USA; [Goetzman, Eric S.] UPMC, Childrens Hosp Pittsburgh, Div Med Genet, Pittsburgh, PA USA; [Prochownik, Edward V.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15219 USA; [Prochownik, Edward V.] UPMC, Hillman Canc Ctr, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), UPMC, Hillman Canc Ctr, Pittsburgh, PA 15232 USA.; Prochownik, EV (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Hematol Oncol, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	procev@chp.edu		Gorka, Joanna/0000-0001-9871-7664	National Institutes of Health [DK090242, RO1CA174713]; Hyundai Hope on Wheels Scholar Grant; NATIONAL CANCER INSTITUTE [R01CA174713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Hope on Wheels Scholar Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1CA174713, Hyundai Hope on Wheels Scholar Grant (to E. V. P.), and National Institutes of Health Grant DK090242 (to E. S. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alberghina L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.513; Augoff K, 2015, CANCER LETT, V358, P1, DOI 10.1016/j.canlet.2014.12.035; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; BURTON BK, 1984, PEDIATR RES, V18, P1242, DOI 10.1203/00006450-198412000-00003; BUSTO F, 1984, INT J BIOCHEM, V16, P171, DOI 10.1016/0020-711X(84)90068-5; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Cardaci S, 2015, NAT CELL BIOL, V17, P1317, DOI 10.1038/ncb3233; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COULSON CJ, 1969, FEBS LETT, V3, P333, DOI 10.1016/0014-5793(69)80171-7; Covarrubias L, 2008, DEV BIOL, V320, P1, DOI 10.1016/j.ydbio.2008.04.041; Damaghi M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00370; Dang CV, 2010, CELL CYCLE, V9, P3884, DOI 10.4161/cc.9.19.13302; Dean JM, 2018, PROTEIN CELL, V9, P196, DOI 10.1007/s13238-017-0423-5; DESANCHEZ VC, 1977, FEBS LETT, V83, P321, DOI 10.1016/0014-5793(77)81032-6; Dolezal JM, 2017, J BIOL CHEM, V292, P10068, DOI 10.1074/jbc.M117.782052; Edmunds LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134049; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Eszes CM, 1996, FEBS LETT, V399, P193, DOI 10.1016/S0014-5793(96)01317-8; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Green K, 2004, DIABETES, V53, pS110, DOI 10.2337/diabetes.53.2007.S110; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; HASLAM JM, 1968, BIOCHEM J, V109, P921, DOI 10.1042/bj1090921; Hsieh AL, 2015, SEMIN CELL DEV BIOL, V43, P11, DOI 10.1016/j.semcdb.2015.08.003; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Idelchik MDS, 2017, SEMIN CANCER BIOL, V47, P57, DOI 10.1016/j.semcancer.2017.04.005; Indo HP, 2017, HANDB EXP PHARMACOL, V240, P439, DOI 10.1007/164_2016_117; Jackson LE, 2017, CANCER RES, V77, P5795, DOI 10.1158/0008-5472.CAN-17-1325; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Jiang K, 2006, PLANT PHYSIOL, V141, P397, DOI 10.1104/pp.106.078246; Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Johnson MT, 2001, MOL GENET METAB, V74, P293, DOI 10.1006/mgme.2001.3249; Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; KLEFSTROM J, 1994, EMBO J, V13, P5442, DOI 10.1002/j.1460-2075.1994.tb06879.x; Kulkarni S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182705; Landay M, 2000, CELL DEATH DIFFER, V7, P697, DOI 10.1038/sj.cdd.4400701; Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Li M, 2012, ARCH BIOCHEM BIOPHYS, V519, P69, DOI 10.1016/j.abb.2011.10.015; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Lindsay DP, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00058; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; MAFTAH A, 1989, BIOCHEM BIOPH RES CO, V164, P185, DOI 10.1016/0006-291X(89)91700-2; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Moloney JN, 2018, SEMIN CELL DEV BIOL, V80, P50, DOI 10.1016/j.semcdb.2017.05.023; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nakae Y, 1997, J HISTOCHEM CYTOCHEM, V45, P1427, DOI 10.1177/002215549704501011; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Obrosova IG, 2005, ANTIOXID REDOX SIGN, V7, P1543, DOI 10.1089/ars.2005.7.1543; Patel KP, 2012, MOL GENET METAB, V105, P34, DOI 10.1016/j.ymgme.2011.09.032; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Pelletier J, 2018, NAT REV CANCER, V18, P51, DOI 10.1038/nrc.2017.104; Perez-Escuredo J, 2016, CELL CYCLE, V15, P72, DOI 10.1080/15384101.2015.1120930; Perl A, 2004, TRENDS IMMUNOL, V25, P360, DOI 10.1016/j.it.2004.05.001; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Sarin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.201; Scalise M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00306; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001; Shirmanova MV, 2015, BBA-GEN SUBJECTS, V1850, P1905, DOI 10.1016/j.bbagen.2015.05.001; Sofou K, 2017, J INHERIT METAB DIS, V40, P237, DOI 10.1007/s10545-016-0011-5; Stacpoole PW, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx071; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Swietach P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0099; Talaiezadeh A, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0171-7; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Van Vranken JG, 2015, CELL, V162, P471, DOI 10.1016/j.cell.2015.07.027; VANANTWERP ME, 1992, P NATL ACAD SCI USA, V89, P9010, DOI 10.1073/pnas.89.19.9010; Wahlstrom T, 2015, BBA-GENE REGUL MECH, V1849, P563, DOI 10.1016/j.bbagrm.2014.07.004; Wang HB, 2016, J BIOL CHEM, V291, P26241, DOI 10.1074/jbc.M116.754218; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Whitaker AM, 2017, FRONT BIOSCI-LANDMRK, V22, P1493, DOI 10.2741/4555; White C, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00171; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; WOJTCZAK L, 1969, BIOCHIM BIOPHYS ACTA, V191, P10, DOI 10.1016/0005-2744(69)90310-6; Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yang LF, 2017, ANNU REV BIOMED ENG, V19, P163, DOI 10.1146/annurev-bioeng-071516-044546; Yao CH, 2016, CELL CHEM BIOL, V23, P483, DOI 10.1016/j.chembiol.2016.03.007; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yin XY, 2001, CANCER RES, V61, P6487; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	114	10	11	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5466	5486		10.1074/jbc.RA118.005200	http://dx.doi.org/10.1074/jbc.RA118.005200			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30755479	Green Published, hybrid			2022-12-26	WOS:000464517500019
J	Piwetz, S				Piwetz, Sarah			Common bottlenose dolphin (Tursiops truncatus) behavior in an active narrow seaport	PLOS ONE			English	Article							SCALE HABITAT SELECTION; MOVEMENT PATTERNS; DUSKY DOLPHIN; LAGENORHYNCHUS-OBSCURUS; IMPACT ASSESSMENT; DOUBTFUL SOUND; TOUR BOATS; RESPONSES; WHALES; ISLAND	The Galveston Ship Channel (GSC) is a narrow, congested waterway that supports largescale shipping, commercial fishing, dolphin tourism, and recreation. Human activity and common bottlenose dolphins (Tursiops truncatus) converge in the GSC with potentially negative consequences on the dolphins. Elevated land-based tracking and behavioral observation of dolphins and vessels were conducted along the GSC in June-August 2013 using a digital theodolite. Positional information was used to calculate dolphin movement patterns and proximity to vessels. Log-likelihood ratio and Chi-square contingency tests were used to assess behavioral states, and generalized additive models were used to analyze movement patterns (i. e., swimming speed, reorientation rate, and linearity) relative to endogenous and exogenous factors and vessel presence. Dolphins regularly use the GSC to forage (57% of observed behavioral states) and socialize (27%), and it is not a travel corridor for accessing other favorable sites (traveling = 5%). Dolphin behavior varied significantly based on time of day, group size, calf presence, and general boat presence. When boats were present, the proportion of time dolphins spent socializing and foraging was significantly less than expected by chance. Swimming speeds increased significantly in the presence of small recreational boats, dolphin-watching tour boats, shrimp trawlers, and when tour boats and shrimp trawlers were both present. Reorientation rate increased significantly in the presence of tour boats and trawlers. Dolphin behavioral responses to vessel presence may result in decreased energy consumption due to disrupted foraging activity. Without proper management, the observed behavioral changes may be detrimental to individuals within this population in the short term, with potential long-term consequences to health and survivorship.	[Piwetz, Sarah] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	Texas A&M University System	Piwetz, S (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	sarahpiwetz@hotmail.com			Texas Institute of Oceanography Graduate Research Fellowship Program	Texas Institute of Oceanography Graduate Research Fellowship Program	S. P. received funding support through the Texas Institute of Oceanography Graduate Research Fellowship Program (http://tamug.edu/research/tio/tio.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MC, 2001, MAR ECOL PROG SER, V222, P253, DOI 10.3354/meps222253; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson M, 2011, 19 BIENN C BIOL MAR; [Anonymous], 2009, YARMOUTH MA US PREP; [Anonymous], 2004, ECOL SOC; Arcangeli Antonella, 2009, Journal of Marine Animals and their Ecology, V2, P3; Bailey H, 2006, J ANIM ECOL, V75, P456, DOI 10.1111/j.1365-2656.2006.01066.x; Ban NC, 2012, AQUAT CONSERV, V22, P262, DOI 10.1002/aqc.2224; Beale C. M., 2007, INT J COMP PSYCHOL, V20, P111; Bejder L, 1999, MAR MAMMAL SCI, V15, P738, DOI 10.1111/j.1748-7692.1999.tb00840.x; Bejder L., 2005, LINKING SHORT LONG T; Bejder L, 2006, ANIM BEHAV, V72, P1149, DOI 10.1016/j.anbehav.2006.04.003; Bejder Lars, 2003, P229; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Berger-Tal O, 2011, BEHAV ECOL, V22, P236, DOI 10.1093/beheco/arq224; Bishop YM., 2007, DISCRETE MULTIVARIAT; BRAGER S, 1993, MAR MAMMAL SCI, V9, P434, DOI 10.1111/j.1748-7692.1993.tb00477.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Christiansen F., 2014, WHALE WATCHING SUSTA, P177, DOI [10.1017/CBO9781139018166.016, DOI 10.1017/CBO9781139018166.016]; Christiansen Fredrik, 2010, Endangered Species Research, V11, P91, DOI 10.3354/esr00265; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Dans SL, 2008, MAR ECOL PROG SER, V369, P287, DOI 10.3354/meps07629; Dray S, 2010, ECOL RES, V25, P673, DOI 10.1007/s11284-010-0701-7; Fertl D., 1997, Journal of Northwest Atlantic Fishery Science, V22, P219; FERTL D, 1994, TEX J SCI, V46, P299; Fertl D., 1994, THESIS; Foroughirad V, 2013, BIOL CONSERV, V160, P242, DOI 10.1016/j.biocon.2013.01.001; Gailey G, 2007, ENVIRON MONIT ASSESS, V134, P75, DOI 10.1007/s10661-007-9812-1; Gailey Glenn, 2002, Journal of Cetacean Research and Management, V4, P213; Gailey G, 2016, ENDANGER SPECIES RES, V30, P53, DOI 10.3354/esr00713; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; Gottman J. M., 1990, SEQUENTIAL ANAL GUID; Gowans S, 2008, ADV MAR BIOL, V53, P195, DOI 10.1016/S0065-2881(07)53003-8; Guilherme-Silveira F. R., 2009, Marine Biodiversity Records, V2, pe122, DOI 10.1017/S1755267209000906; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Hastie GD, 2004, MAR BIOL, V144, P397, DOI 10.1007/s00227-003-1195-4; Hastie GD, 2003, MAR MAMMAL SCI, V19, P74, DOI 10.1111/j.1748-7692.2003.tb01093.x; Hastie T., 1986, STAT SCI, V1, P297; Hegar G., 2015, PORT ENTRY GALVESTON; Henderson EE, 2004, BEHAV ASS PATTERNS H; Henningsen T, 1991, P 5 ANN C EUR CET S; Higham JES, 2011, TOURISM MANAGE, V32, P1290, DOI 10.1016/j.tourman.2010.12.006; Higham JES, 2008, ENVIRON CONSERV, V35, P294, DOI 10.1017/S0376892908005249; Hung SK, 2008, HABITAT USE INDO PAC; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jefferson TA, 2000, WILDLIFE MONOGR, P1; Jefferson TA, 2009, MAR POLICY, V33, P305, DOI 10.1016/j.marpol.2008.07.011; Latusek JN, 2002, IMPACT BOAT TRAFFIC; Leatherwood A., 2016, HDB TEXAS ONLINE; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lundquist D, 2013, NEW ZEAL J MAR FRESH, V47, P430, DOI 10.1080/00288330.2013.778301; Lundquist D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041969; Lusseau D, 2003, MAR ECOL PROG SER, V257, P267, DOI 10.3354/meps257267; Lusseau D, 2006, MAR MAMMAL SCI, V22, P802, DOI 10.1111/j.1748-7692.2006.00052.x; Mann J, 1999, MAR MAMMAL SCI, V15, P102, DOI 10.1111/j.1748-7692.1999.tb00784.x; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mann J, 1999, BEHAVIOUR, V136, P529, DOI 10.1163/156853999501469; Meissner AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116962; Moore JE, 2009, MAR POLICY, V33, P435, DOI 10.1016/j.marpol.2008.09.003; Moreno MPT, 2005, ENV PREDICTORS BOTTL; NOAA, 2017, SE REG MAR MAMM SEA; Noren SR, 2002, J ZOOL, V258, P105, DOI 10.1017/S0952836902001243; Nowacek SM, 2001, MAR MAMMAL SCI, V17, P673, DOI 10.1111/j.1748-7692.2001.tb01292.x; Parra GJ, 2006, J ANIM ECOL, V75, P862, DOI 10.1111/j.1365-2656.2006.01104.x; Parra GJ, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P576; Pearson HC, 2012, NEW ZEAL J MAR FRESH, V46, P567, DOI 10.1080/00288330.2012.712977; Phillips NM, 2014, NMFSSEFSC665; Piwetz S, 2012, AQUAT MAMM, V38, P325, DOI 10.1578/AM.38.3.2012.325; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ribeiro S, 2007, J MAR BIOL ASSOC UK, V87, P119, DOI 10.1017/S0025315407051594; Rohr JJ, 2002, MAR MAMMAL SCI, V18, P1, DOI 10.1111/j.1748-7692.2002.tb01014.x; Sallese CW., 2013, HOUSTON GALVESTON NA; Scott M.D., 1990, P235; Shane S.H., 1990, P245; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Srinivasan M, 2010, ECOL MODEL, V221, P2687, DOI 10.1016/j.ecolmodel.2010.07.010; Stensland E, 2007, MAR ECOL PROG SER, V332, P225, DOI 10.3354/meps332225; STEWARTOATEN A, 1986, ECOLOGY, V67, P929, DOI 10.2307/1939815; Stockin KA, 2008, MAR ECOL PROG SER, V355, P287, DOI 10.3354/meps07386; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; USACE, 2014, WAT COMM US 5; USCG, 2009, PORTS WAT SAF ASS WO; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; WALTERS CJ, 1978, ANNU REV ECOL SYST, V9, P157, DOI 10.1146/annurev.es.09.110178.001105; Weir CR, 2013, MAMMAL REV, V43, P258, DOI 10.1111/j.1365-2907.2012.00222.x; Williams R, 2007, J ZOOL, V272, P390, DOI 10.1111/j.1469-7998.2006.00280.x; Williams R, 2002, J ZOOL, V256, P255, DOI 10.1017/S0952836902000298; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Wursig B., 1991, P79; WURSIG B, 1989, SCIENCE, V244, P1550, DOI 10.1126/science.2662403; WURSIG B, 1980, FISH B-NOAA, V77, P871	97	9	10	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211971	10.1371/journal.pone.0211971	http://dx.doi.org/10.1371/journal.pone.0211971			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779764	gold, Green Published, Green Submitted			2022-12-26	WOS:000459062900023
J	De Gaetano, A; Gaz, C; Panunzi, S				De Gaetano, Andrea; Gaz, Claudio; Panunzi, Simona			Consistency of compact and extended models of glucose-insulin homeostasis: The role of variable pancreatic reserve	PLOS ONE			English	Article							BETA-CELL FUNCTION; TOLERANCE TEST; MINIMAL MODEL; SECRETION; TESTS; MEAL	Published compact and extended models of the glucose-insulin physiologic control system are compared, in order to understand why a specific functional form of the compact model proved to be necessary for a satisfactory representation of acute perturbation experiments such as the Intra Venous Glucose Tolerance Test (IVGTT). A spectrum of IVGTT's of virtual subjects ranging from normal to IFG to IGT to frank T2DM were simulated using an extended model incorporating the population-of-controllers paradigm originally hypothesized by Grodsky, and proven to be able to capture a wide array of experimental results from heterogeneous perturbation procedures. The simulated IVGTT's were then fitted with the Single-Delay Model (SDM), a compact model with only six free parameters, previously shown to be very effective in delivering precise estimates of insulin sensitivity and secretion during an IVGTT. Comparison of the generating, extended-model parameter values with the obtained compact model estimates shows that the functional form of the nonlinear insulin secretion term, empirically found to be necessary for the compact model to satisfactorily fit clinical observations, captures the pancreatic reserve level of the simulated virtual patients. This result supports the validity of the compact model as a meaningful analysis tool for the clinical assessment of insulin sensitivity.	[De Gaetano, Andrea; Gaz, Claudio; Panunzi, Simona] Italian Natl Res Council, Inst Syst Anal & Comp Sci, Biomath Lab,Lab Biomatemat, CNR IASI BioMatLab,Consiglio Nazl Ric,Ist Anal Si, UCSC Largo A Gemelli 8, Rome, Italy; [Gaz, Claudio] Sapienza Univ Roma, Dipartimento Ingn Informat Automat & Gest DIAG, Dept Comp Control & Management Engn, Via Ariosto 25, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Sapienza University Rome	Gaz, C (corresponding author), Italian Natl Res Council, Inst Syst Anal & Comp Sci, Biomath Lab,Lab Biomatemat, CNR IASI BioMatLab,Consiglio Nazl Ric,Ist Anal Si, UCSC Largo A Gemelli 8, Rome, Italy.; Gaz, C (corresponding author), Sapienza Univ Roma, Dipartimento Ingn Informat Automat & Gest DIAG, Dept Comp Control & Management Engn, Via Ariosto 25, Rome, Italy.	gaz@diag.uniroma1.it	De Gaetano, Andrea/AAC-4805-2021; Panunzi, Simona/AAK-9337-2020	GAZ, CLAUDIO ROBERTO/0000-0003-4659-5831; De Gaetano, Andrea/0000-0001-7712-056X; Panunzi, Simona/0000-0003-0956-8578				BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; BOLIE VW, 1961, J APPL PHYSIOL, V16, P783, DOI 10.1152/jappl.1961.16.5.783; Breda E, 2001, DIABETES, V50, P150, DOI 10.2337/diabetes.50.1.150; Cobelli C, 2011, DIABETES, V60, P2672, DOI 10.2337/db11-0654; Dalla Man C, 2014, J DIABETES SCI TECHN; De Fronzo RA, 1979, AM J PHYSL, V237; De Gaetano A, 2000, J MATH BIOL, V40, P136, DOI 10.1007/s002850050007; De Gaetano A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142344; De Gaetano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070875; De Gaetano A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1462, DOI 10.1152/ajpendo.90444.2008; Gaz C, 2017, IFAC PAPERSONLINE, V50, P13526, DOI 10.1016/j.ifacol.2017.08.2345; GRODSKY GM, 1972, J CLIN INVEST, V51, P2047, DOI 10.1172/JCI107011; Hahn RG, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-12; Hovorka R, 2011, NAT REV ENDOCRINOL, V7, P385, DOI 10.1038/nrendo.2011.32; Kovacs Levente, 2013, J Diabetes Sci Technol, V7, P708; Kovatchev Boris P, 2009, J Diabetes Sci Technol, V3, P44; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Marchetti L, 2016, SCI REP-UK, V6, DOI 10.1038/srep36029; Mari A, 2002, CURR OPIN CLIN NUTR, V5, P495, DOI 10.1097/00075197-200209000-00007; Mari A, 2002, DIABETES, V51, pS221, DOI 10.2337/diabetes.51.2007.S221; Mari A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1159, DOI 10.1152/ajpendo.00093.2002; Martin EC, 2017, J PHARM PHARMACOL, V69, P1275, DOI 10.1111/jphp.12759; Othman Nor Azlan, 2018, J Diabetes Sci Technol, V12, P665, DOI 10.1177/1932296817750402; Palumbo P, 2014, MATH BIOSCI, V257, P2, DOI 10.1016/j.mbs.2014.09.003; Palumbo P, 2007, DISCRETE CONT DYN-B, V7, P399; Palumbo P, 2010, J MATH BIOL, V61, P171, DOI 10.1007/s00285-009-0297-0; Panunzi S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-35; Panunzi S, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-9; Pedersen MG, 2008, PHILOS T R SOC A, V366, P3525, DOI 10.1098/rsta.2008.0120; Polyzogopoulou EV, 2003, DIABETES, V52, P1098, DOI 10.2337/diabetes.52.5.1098; Porksen N., 2000, AM J PHYSL ENDOCRINO, V278; SIMON C, 1987, J CLIN ENDOCR METAB, V64, P669, DOI 10.1210/jcem-64-4-669; Sorensen J. T, 1985, PHYSL MODEL GLUCOSE; STURIS J, 1994, AM J PHYSIOL, V267, pE250, DOI 10.1152/ajpendo.1994.267.2.E250; STURIS J, 1991, J CLIN INVEST, V87, P439, DOI 10.1172/JCI115015; Toffolo G, 2006, AM J PHYSIOL-ENDOC M, V290, pE169, DOI 10.1152/ajpendo.00473.2004; Toghaw P, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-16; Toschi E, 2002, DIABETES, V51, pS130, DOI 10.2337/diabetes.51.2007.S130; Ward GM, 2001, METABOLISM, V50, P512, DOI 10.1053/meta.2001.21029	40	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0211331	10.1371/journal.pone.0211331	http://dx.doi.org/10.1371/journal.pone.0211331			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768604	Green Published, gold, Green Submitted			2022-12-26	WOS:000458766300006
J	Kawakami, R; Kashino, I; Kasai, H; Kawai, K; Li, YS; Nanri, A; Higuchi, M; Mizoue, T				Kawakami, Ryoko; Kashino, Ikuko; Kasai, Hiroshi; Kawai, Kazuaki; Li, Yun-Shan; Nanri, Akiko; Higuchi, Mitsuru; Mizoue, Tetsuya			Leisure-time physical activity and DNA damage among Japanese workers	PLOS ONE			English	Article							DIET HISTORY QUESTIONNAIRES; OXIDATIVE STRESS BIOMARKERS; CANCER PREVENTION; URINARY-EXCRETION; LIFE-STYLE; EXERCISE; 8-HYDROXYDEOXYGUANOSINE; MARKER; 7-METHYLGUANINE; METHYLATION	Background It remains unclear whether daily physical activity is associated with DNA damage. This cross-sectional study examined the association between leisure-time physical activity and urinary 8-hydroxydeoxyguanosine (8-OH-dG), a biomarker of oxidative DNA damage, or urinary 7-methylguanine (m(7)Gua), a biomarker of methylating DNA damage. Methods Participants included 501 workers (294 men and 207 women), aged 20-65 years, from municipal offices in Japan. Urinary 8-OH-dG and m(7) Gua were measured using column-switching HPLC. Physical activity was evaluated using a self-reported questionnaire. The associations between leisure-time physical activity and urinary DNA damage markers were assessed by multiple linear regression analysis, with stratification by occupational physical activity. Results After adjusting for covariates, leisure-time physical activity showed a suggestive inverse correlation with urinary 8-OH-dG levels (P for trend = 0.06), and a significant inverse association with urinary m(7)Gua levels (P for trend = 0.03). In analysis stratified by occupation, inverse correlations were observed in sedentary workers (walking < 30 min/day at work: P for trend = 0.06 and = 0.03 for urinary 8-OH-dG and m(7)Gua, respectively), but not in physically active workers (walking >= 30 min/day at work). In analysis for each intensity of leisure-time physical activity, light-intensity exercise was associated with lower levels of urinary 8-OH-dG (P for trend = 0.03), whereas moderate-to-high-intensity exercise was associated with lower levels of urinary m(7)Gua (P for trend = 0.02). Conclusions Our results suggest that high levels of leisure-time physical activity are associated with decreased levels of DNA damage in individuals with low physical activity at work.	[Kawakami, Ryoko; Higuchi, Mitsuru] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Kawakami, Ryoko; Kashino, Ikuko; Nanri, Akiko; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Tokyo, Japan; [Kasai, Hiroshi; Kawai, Kazuaki; Li, Yun-Shan] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Environm Oncol, Fukuoka, Fukuoka, Japan; [Nanri, Akiko] Fukuoka Womens Univ, Int Coll Arts & Sci, Dept Food & Hlth Sci, Fukuoka, Fukuoka, Japan	Waseda University; National Center for Global Health & Medicine - Japan; University of Occupational & Environmental Health - Japan	Kawakami, R (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.; Kawakami, R (corresponding author), Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Tokyo, Japan.	r.kawakami@aoni.waseda.jp	KASHINO, IKUKO/AAS-4008-2020; Kawakami, Ryoko/K-8149-2019	Kawakami, Ryoko/0000-0001-8211-1553	Ministry of Education, Culture, Sports, Science and Technology of Japan [21390213]; Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus from the Japan Agency for Medical Research and Development [15ek0210021h0002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by a Grant-in-Aid for Scientific Research (B) (21390213, T. Mizoue) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus (15ek0210021h0002, T. Mizoue) from the Japan Agency for Medical Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bloomer RJ, 2008, GENDER MED, V5, P218, DOI 10.1016/j.genm.2008.07.002; Chiou CC, 2003, CLIN CHIM ACTA, V334, P87, DOI 10.1016/S0009-8981(03)00191-8; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Grazioli E, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4193-5; Hara M, 2016, CANCER SCI, V107, P1653, DOI 10.1111/cas.13070; Holtermann A, 2012, BRIT J SPORT MED, V46, P291, DOI 10.1136/bjsm.2010.079582; Holtermann A, 2018, BRIT J SPORT MED, V52, P149, DOI 10.1136/bjsports-2017-097965; Hori A, 2010, CANCER SCI, V101, P517, DOI 10.1111/j.1349-7006.2009.01394.x; Horsburgh S, 2015, EXERC IMMUNOL REV, V21, P26; Kasai H, 2001, JPN J CANCER RES, V92, P9, DOI 10.1111/j.1349-7006.2001.tb01041.x; Kasai H, 2005, IND HEALTH, V43, P333, DOI 10.2486/indhealth.43.333; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Kasai H., 2008, GENES ENVIRON, V30, P33, DOI [10.3123/jemsge.30.33, DOI 10.3123/JEMSGE.30.33]; Kashino I, 2018, NUTRITION, V47, P63, DOI 10.1016/j.nut.2017.10.004; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; Li TT, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-094927; Li YJ, 2016, INT J CANCER, V138, P818, DOI 10.1002/ijc.29828; Loft S, 2007, INT J CANCER, V121, P1579, DOI 10.1002/ijc.22863; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Na HK, 2011, ANN NY ACAD SCI, V1229, P176, DOI 10.1111/j.1749-6632.2011.06105.x; Nojima H, 2008, METABOLISM, V57, P170, DOI 10.1016/j.metabol.2007.08.021; Orhan H, 2004, FREE RADICAL RES, V38, P1269, DOI 10.1080/10715760400013763; Porcelli B, 1997, RAPID COMMUN MASS SP, V11, P398, DOI 10.1002/(SICI)1097-0231(19970228)11:4<398::AID-RCM807>3.0.CO;2-M; Radak Z, 2003, LIFE SCI, V72, P1627, DOI 10.1016/S0024-3205(02)02476-1; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Radak Z, 2009, FREE RADICAL BIO MED, V46, P238, DOI 10.1016/j.freeradbiomed.2008.10.022; Rezapour S, 2018, BIOTECHNOL APPL BIOC, V65, P761, DOI 10.1002/bab.1689; Rogers CJ, 2008, SPORTS MED, V38, P271, DOI 10.2165/00007256-200838040-00002; Sakano N, 2009, J CLIN BIOCHEM NUTR, V44, P185, DOI 10.3164/jcbn.08-252; Sakano N, 2009, FREE RADICAL RES, V43, P183, DOI 10.1080/10715760802663124; Sato Y, 2003, BIOCHEM BIOPH RES CO, V305, P333, DOI 10.1016/S0006-291X(03)00774-5; Svoboda P, 2004, ANAL BIOCHEM, V334, P239, DOI 10.1016/j.ab.2004.08.021; TAGESSON C, 1995, EUR J CANCER, V31A, P934, DOI 10.1016/0959-8049(94)00490-0; Tamae K, 2009, CANCER SCI, V100, P715, DOI 10.1111/j.1349-7006.2009.01088.x; Tsai K, 2001, FREE RADICAL BIO MED, V31, P1465, DOI 10.1016/S0891-5849(01)00729-8; Voisin S, 2015, ACTA PHYSIOL, V213, P39, DOI 10.1111/apha.12414; Westerlind KC, 2003, MED SCI SPORT EXER, V35, P1834, DOI 10.1249/01.MSS.0000093619.37805.B7; Yuasa Y, 2009, INT J CANCER, V124, P2677, DOI 10.1002/ijc.24231; Zeng HM, 2012, BREAST CANCER RES TR, V133, P127, DOI 10.1007/s10549-011-1716-7	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212499	10.1371/journal.pone.0212499	http://dx.doi.org/10.1371/journal.pone.0212499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768632	gold, Green Published, Green Submitted			2022-12-26	WOS:000458766300045
J	Weinstein, G; Davis-Plourde, KL; Conner, S; Himali, JJ; Beiser, AS; Lee, A; Rawlings, AM; Sedaghat, S; Ding, J; Moshier, E; van Duijn, CM; Beeri, MS; Selvin, E; Ikram, MA; Launer, LJ; Haan, MN; Seshadri, S				Weinstein, Galit; Davis-Plourde, Kendra L.; Conner, Sarah; Himali, Jayandra J.; Beiser, Alexa S.; Lee, Anne; Rawlings, Andreea M.; Sedaghat, Sanaz; Ding, Jie; Moshier, Erin; van Duijn, Cornelia M.; Beeri, Michal S.; Selvin, Elizabeth; Ikram, M. Arfan; Launer, Lenore J.; Haan, Mary N.; Seshadri, Sudha			Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; INTRANASAL INSULIN; OLDER-ADULTS; SEVERE HYPOGLYCEMIA; ANTIDIABETIC DRUGS; DIABETES-MELLITUS; TYPE-2; DESIGN; AGE; HYPERGLYCEMIA	Objective To determine whether classes of diabetes medications are associated with cognitive health and dementia risk, above and beyond their glycemic control properties. Research design and methods Findings were pooled from 5 population-based cohorts: the Framingham Heart Study, the Rotterdam Study, the Atherosclerosis Risk in Communities (ARIC) Study, the Aging Gene Environment Susceptibility-Reykjavik Study (AGES) and the Sacramento Area Latino Study on Aging (SALSA). Differences between users and non-users of insulin, metformin and sulfonylurea were assessed in each cohort for cognitive and brain MRI measures using linear regression models, and cognitive decline and dementia/AD risk using mixed effect models and Cox regression analyses, respectively. Findings were then pooled using meta-analytic techniques, including 3,590 individuals with diabetes for the prospective analysis. Results After adjusting for potential confounders including indices of glycemic control, insulin use was associated with increased risk of new-onset dementia (pooled HR (95% CI) = 1.58 (1.18, 2.12);p = 0.002) and with a greater decline in global cognitive function (beta = -0.014 +/- 0.007;p = 0.045). The associations with incident dementia remained similar after further adjustment for renal function and excluding persons with diabetes whose treatment was lifestyle change only. Insulin use was not related to cognitive function nor to brain MRI measures. No significant associations were found between metformin or sulfonylurea use and outcomes of brain function and structure. There was no evidence of significant between study heterogeneity. Conclusions Despite its advantages in controlling glycemic dysregulation and preventing complications, insulin treatment may be associated with increased adverse cognitive outcomes possibly due to a greater risk of hypoglycemia.	[Weinstein, Galit] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Davis-Plourde, Kendra L.; Conner, Sarah; Himali, Jayandra J.; Beiser, Alexa S.; Seshadri, Sudha] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Davis-Plourde, Kendra L.; Conner, Sarah; Himali, Jayandra J.; Beiser, Alexa S.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Himali, Jayandra J.; Beiser, Alexa S.; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Lee, Anne; Haan, Mary N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Rawlings, Andreea M.; Selvin, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Sedaghat, Sanaz; van Duijn, Cornelia M.; Ikram, M. Arfan] Erasmus MC Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Ding, Jie; Launer, Lenore J.] NIA, Lab Epidemiol & Populat Sci, NIH, Bethesda, MD 20892 USA; [Moshier, Erin; Beeri, Michal S.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Beeri, Michal S.] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Tel Hashomer, Israel; [Selvin, Elizabeth] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD USA; [Ikram, M. Arfan] Erasmus Univ, Dept Radiol, Med Ctr, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus Univ, Dept Neurol, Med Ctr, Rotterdam, Netherlands	University of Haifa; Framingham Heart Study; Boston University; Boston University; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Icahn School of Medicine at Mount Sinai; Chaim Sheba Medical Center; Johns Hopkins University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Weinstein, G (corresponding author), Univ Haifa, Sch Publ Hlth, Haifa, Israel.	gweinstei@univ.haifa.ac.il	Ikram, M. Arfan/AAM-5225-2021	Sedaghat, Sanaz/0000-0002-8296-1811; Van Duijn, Cornelia/0000-0002-2374-9204; Seshadri, Sudha/0000-0001-6135-2622; Conner, Sarah/0000-0002-0929-9948; /0000-0003-1391-9481; Weinstein, Galit/0000-0002-1316-4448; Davis-Plourde, Kendra/0000-0001-6654-0710	Alzheimer's Drug Discovery Foundation [20150702]; NIA [AG12975]; Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN2682017000041]; NHLBI [R01-HL70825]; NIH/NIDDK [K24DK106414, R01DK089174]; NIH/NHLBI grant [T32HL007024]; National Institutes of Health (NIH) [N01-AG-12100]; Intramural Research Program of the National Institute on Aging; Icelandic Heart Association; Icelandic Parliament; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; National Institute on Aging [R01 AG054076, AG016495, AG049505, AG049607, AG033193, R01 AG034087, R01 AG 051545]; National Institute of Neurological Disorders and Stroke [NS017950]; National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK-HL081572]; National Heart, Lung, and Blood Institute's Framingham Heart Study [N01 -HC-25195, HHSN2682015000011]; LeRoy Schecter Foundation; Bader Philanthropies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL096902, U01HL096814, U01HL096812, T32HL007024, U01HL096899, U01HL096917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089174, K24DK106414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [UH3NS100605, R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007380, R01AG051545, R01AG054076, U01AG052409, ZIAAG007420] Funding Source: NIH RePORTER	Alzheimer's Drug Discovery Foundation; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NHLBI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Icelandic Heart Association; Icelandic Parliament; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); LeRoy Schecter Foundation; Bader Philanthropies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the Alzheimer's Drug Discovery Foundation (contract number 20150702). Work on the SALSA study for this was supported by NIA AG12975. The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. (HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN2682017000041). Neurocognitive data is collected by U01 2U01HL096812, 2U01HL096814, 2U01HL096899, 2U01HL096902, 2U01HL096917 from the NIH (NHLBI, NINDS, NIA and NIDCD), and with previous brain MRI examinations funded by R01-HL70825 from the NHLBI. The authors thank the staff and participants of the ARIC study for their important contributions. Dr. Selvin was supported by NIH/NIDDK grants K24DK106414 and R01DK089174. Dr. Rawlings was supported by NIH/NHLBI grant T32HL007024 during the time of her contributions to this project. The AGES Reykjavik Study was funded by National Institutes of Health (NIH) (contract N01-AG-12100); the Intramural Research Program of the National Institute on Aging; the Icelandic Heart Association and the Icelandic Parliament. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The authors are grateful to the study participants, the staff from the Rotterdam Study and the participating general practitioners, pharmacists and the Erasmus Epidemiology data management team. The Framingham Study received grants from the National Institute on Aging (R01 AG054076, AG016495, AG049505, AG049607, and AG033193), the National Institute of Neurological Disorders and Stroke (NS017950), and the National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-HL081572) and support from the National Heart, Lung, and Blood Institute's Framingham Heart Study (contracts no. N01 -HC-25195 and HHSN2682015000011). The Israel Diabetes and Cognitive Decline study received funding from the National Institute on Aging (R01 AG034087 and R01 AG 051545) and from the LeRoy Schecter Foundation and the Bader Philanthropies.	Alagiakrishnan K, 2013, DISCOV MED, V16, P277; [Anonymous], 2014, DIABETES RES CLIN PR, V104, P1, DOI 10.1016/j.diabres.2012.10.001; [Anonymous], 1994, DIAGN STAT MAN MENT, Vxxvii; Beeri MS, 2014, ALZHEIMERS DEMENT, V10, P769, DOI 10.1016/j.jalz.2014.06.002; Bis JC, 2012, NAT GENET, V44, P545, DOI 10.1038/ng.2237; Bohlken J, 2018, J ALZHEIMERS DIS, V66, P725, DOI 10.3233/JAD-180808; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Bruce DG, 2009, DIABETOLOGIA, V52, P1808, DOI 10.1007/s00125-009-1437-1; Cardoso S, 2013, NEUROBIOL DIS, V49, P1, DOI 10.1016/j.nbd.2012.08.008; Cardoso S, 2011, SYNAPSE, V65, P457, DOI 10.1002/syn.20863; Cardoso S, 2010, BBA-MOL BASIS DIS, V1802, P942, DOI 10.1016/j.bbadis.2010.07.001; Chauhan G, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.028; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; Cheng C, 2014, J GERONTOL A-BIOL, V69, P1299, DOI 10.1093/gerona/glu073; Cholerton B, 2013, EUR J PHARMACOL, V719, P170, DOI 10.1016/j.ejphar.2013.08.008; Claxton A, 2013, J ALZHEIMERS DIS, V35, P789, DOI 10.3233/JAD-122308; Correia S, 2008, MED CHEM, V4, P358, DOI 10.2174/157340608784872299; Dacks PA, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0200-3; Dacks Penny A, 2014, J Prev Alzheimers Dis, V1, P117; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Falvey CM, 2013, DIABETES CARE, V36, P677, DOI 10.2337/dc12-0814; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fornage M, 2011, ANN NEUROL, V69, P928, DOI 10.1002/ana.22403; Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8; Genuth S, 2007, NEW ENGL J MED, V356, P1842; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Gudala K, 2013, J DIABETES INVEST, V4, P640, DOI 10.1111/jdi.12087; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Haan MN, 2003, J AM GERIATR SOC, V51, P169, DOI 10.1046/j.1532-5415.2003.51054.x; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Herath PM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7208429; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hsu CC, 2011, J ALZHEIMERS DIS, V24, P485, DOI 10.3233/JAD-2011-101524; Ikram MA, 2017, EUR J EPIDEMIOL, V32, P807, DOI 10.1007/s10654-017-0321-4; Imfeld P, 2012, J AM GERIATR SOC, V60, P916, DOI 10.1111/j.1532-5415.2012.03916.x; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Johnson W, 2008, INTELLIGENCE, V36, P81, DOI 10.1016/j.intell.2007.06.001; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kern W, 2001, NEUROENDOCRINOLOGY, V74, P270, DOI 10.1159/000054694; Launer LJ, 2011, LANCET NEUROL, V10, P969, DOI 10.1016/S1474-4422(11)70188-0; Lee AK, 2018, DIABETOLOGIA; Lee AK, 2017, DIABETES CARE, V40, P1661, DOI 10.2337/dc17-0819; Li J, 2010, STROKE, V41, P2645, DOI 10.1161/STROKEAHA.110.589697; Luchsinger JA, 2017, DIABETES CARE, V40, P958, DOI 10.2337/dc16-2376; Luchsinger JA, 2016, J ALZHEIMERS DIS, V51, P501, DOI 10.3233/JAD-150493; Maimaiti S, 2016, J GERONTOL A-BIOL, V71, P30, DOI 10.1093/gerona/glu314; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mehta HB, 2017, J GERONTOL A-BIOL, V72, P1110, DOI 10.1093/gerona/glw217; Moreira PI, 2012, J ALZHEIMERS DIS, V30, pS199, DOI 10.3233/JAD-2011-111127; Ng TP, 2014, J ALZHEIMERS DIS, V41, P61, DOI 10.3233/JAD-131901; Nunes AP, 2016, DIABETES RES CLIN PR, V121, P192, DOI 10.1016/j.diabres.2016.09.012; Orkaby AR, 2017, NEUROLOGY, V89, P1877, DOI [10.1212/WNL.0000000000004586, 10.1212/wnl.0000000000004586]; Qiu CX, 2014, ANN NEUROL, V75, P138, DOI 10.1002/ana.24063; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rawlings AM, 2014, ANN INTERN MED, V161, P785, DOI 10.7326/M14-0737; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Sebastiao I, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00110; Tondelli M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.018; Vagelatos NT, 2013, EPIDEMIOL REV, V35, P152, DOI 10.1093/epirev/mxs012; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu CC, 2002, NEUROLOGY, V59, P383, DOI 10.1212/WNL.59.3.383; Yaffe K, 2013, JAMA INTERN MED, V173, P1300, DOI 10.1001/jamainternmed.2013.6176; Zoppini G, 2012, CLIN J AM SOC NEPHRO, V7, P401, DOI 10.2215/CJN.07650711	66	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212293	10.1371/journal.pone.0212293	http://dx.doi.org/10.1371/journal.pone.0212293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5KT	30768625	Green Published, Green Submitted, gold			2022-12-26	WOS:000458766300027
J	Brander, RW; Warton, N; Franklin, RC; Shaw, WS; Rijksen, EJT; Daw, S				Brander, Robert W.; Warton, Nicola; Franklin, Richard C.; Shaw, Wendy S.; Rijksen, Eveline J. T.; Daw, Shane			Characteristics of aquatic rescues undertaken by bystanders in Australia	PLOS ONE			English	Article							RESUSCITATION; SYSTEMS; SAFETY	An issue of growing importance within the field of drowning prevention is the undertaking of aquatic rescues by bystanders, who sometimes drown in the process. The main objectives of this study were to describe characteristics of bystanders making rescues in different Australian aquatic environments, identify the role of prior water safety training in conducting bystander rescues and provide insights into future public education strategies relating to bystander rescue scenarios. An online survey was disseminated via various social media platforms in 2017 and gathered a total of 243 complete responses. The majority of bystander rescues described took place in coastal waterways (76.5%; n = 186), particularly beaches (n = 67), followed by pools (17.3%; n = 42) and inland waterways (6.2%; n = 15). The majority of respondents were males (64.2%; n = 156) who rescued on average approximately twice as many people in their lifetime (6.5) than female respondents (3.6). Most rescues occurred more than 1 km from lifeguard/lifesaver services (67%; n = 163), but in the presence of others (94.2%; n = 229). The majority of bystander rescuers had water safety training (65.8%; n = 160), self-rated as strong swimmers (68.3%; n = 166), conducted the rescue without help from others (60%; n = 146), did not use a flotation device to assist (63%; n = 153), but were confident in their ability to make the rescue (76.5%; n = 186). However, most considered the situation to be very serious (58%; n = 141) and felt they had saved a life (70.1%; n = 172). With the exception of pools, most bystanders rescued strangers (76.1%; n = 185). While Australia clearly benefits from having a strong water safety culture, there is no clear consensus on the most appropriate actions bystanders should take when confronted with a potential aquatic rescue scenario. In particular, more research is needed to gather information regarding bystander rescues undertaken by those without prior water safety training.	[Brander, Robert W.; Warton, Nicola; Shaw, Wendy S.] UNSW Sydney, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Franklin, Richard C.] James Cook Univ, Townsville, Qld, Australia; [Franklin, Richard C.] Royal Life Saving Soc Australia, Ultimo, NSW, Australia; [Rijksen, Eveline J. T.; Daw, Shane] Surf Life Saving Australia, Bondi Beach, NSW, Australia	University of New South Wales Sydney; James Cook University	Brander, RW (corresponding author), UNSW Sydney, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	rbrander@unsw.edu.au	Brander, Robert/GZH-3081-2022; Franklin, Richard Charles/H-1731-2012	Franklin, Richard Charles/0000-0003-1864-4552; Brander, Robert/0000-0002-7268-2587; Shaw, Wendy S./0000-0003-1520-7250; Daw, Shane/0000-0003-0904-3632	Surf Life Saving Australia (SLSA)	Surf Life Saving Australia (SLSA)	This study was supported financially by a Surf Life Saving Australia (SLSA; https://sls.com.au) Internal Research Project Grant awarded to UNSW Sydney (RB, WS) and JCU (RF). Authors ER and SD are affiliated with SLSA and were directly involved in the study design, data collection, decision to publish and preparation of the manuscript.	Attard A, 2015, ACCIDENT ANAL PREV, V82, P70, DOI 10.1016/j.aap.2015.05.017; Australia SLS., 2017, NAT COAST SAF REP 20; Barcala-Furelos R, 2016, AM J EMERG MED, V34, P480, DOI 10.1016/j.ajem.2015.12.006; BBC News, 2017, BBC NEWS        0711; Booth Douglas, 2001, AUSTR BEACH CULTURES; Branche CM, 2001, LIFEGUARD EFFECTIVEN; Brighton B, 2013, NAT HAZARD EARTH SYS, V13, P1069, DOI 10.5194/nhess-13-1069-2013; Castelle B, 2016, EARTH-SCI REV, V163, P1, DOI 10.1016/j.earscirev.2016.09.008; Franklin RC, 2010, INJURY PREV, V16, pA81, DOI 10.1136/ip.2010.029215.294; Franklin RC, 2015, P WORLD C DROWN PREV, P35; Franklin RC, 2011, J PAEDIATR CHILD H, V47, P44, DOI 10.1111/j.1440-1754.2010.01889.x; Gilchrist J, 2016, SCIENCE OF BEACH LIFEGUARDING, P29; GOMEZ DA, 1992, J SAFETY RES, V23, P1, DOI 10.1016/0022-4375(92)90034-7; Hall L., 2017, GOOD SAMARITAN S OLI; Houghton J., 2016, EMOTIONAL SCENES FIN; Jaggard E, 2006, FLAGS 100 SUMMERS AU; MacCool J., 2008, INT J AQUAT RES ED, V2, DOI [10.25035/ijare.02.01.02, DOI 10.25035/IJARE.02.01.02]; Menard AD, 2018, NAT HAZARDS, V94, P953, DOI 10.1007/s11069-018-3424-7; Moran K., 2013, INT J AQUAT RES ED, V7, P290; Moran K, 2017, INT J INJ CONTROL SA, V24, P396, DOI 10.1080/17457300.2016.1224904; Moran K, 2011, ANN LEIS RES, V14, P260, DOI 10.1080/11745398.2011.615719; News CBS, 2017, NEWS CBS        0720; Omnipoll, 2017, SURF LIF SAV AUSTR N; Pearn JH, 2012, INT J AQUATIC RES ED, V6, P315; Pearn JH, 2009, INT J AQUATIC RES ED, V3, P325; Peden A, 2018, HEALTH PROMOT J AUST, P1; Peden AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160709; Peden AE, 2016, INJURY PREV, V22, P202, DOI 10.1136/injuryprev-2015-041750; Pia F., 1974, J PHYS ED YMCA SOC N, V71, P164; Royal Life Saving Society Australia (RLSSA), 2017, NAT DROWN REP 2017; Scarr, 2017, 13 YEAR NATL STUDY N; Sherker S, 2008, J SCI MED SPORT, V11, P81, DOI 10.1016/j.jsams.2006.08.007; Short AD, 2007, J COASTAL RES, P7; Short A.D., 1994, J COASTAL RES, V12, P197; Short AD, 2006, J COASTAL RES, V22, P11, DOI 10.2112/05A-0002.1; Surf Life Saving Australia, 2018, NAT COAST SAF REP 20; Szpilman D, 2016, AM J EMERG MED, V34, P2224, DOI 10.1016/j.ajem.2016.07.063; Szpilman D, 2014, RESUSCITATION, V85, P1149, DOI 10.1016/j.resuscitation.2014.05.034; Turgut A, 2012, J SAFETY RES, V43, P129, DOI 10.1016/j.jsr.2012.05.001; Venema AM, 2010, RESUSCITATION, V81, P434, DOI 10.1016/j.resuscitation.2010.01.005; Walton T, 2017, SOC CULT GEOGR, V18, P869, DOI 10.1080/14649365.2016.1239755; Warton NM, 2017, TOURISM MANAGE, V63, P187, DOI 10.1016/j.tourman.2017.06.017; Wigginton J, 2006, HDB DROWNING PREVENT, P323; World Health Organization (WHO), 2014, GLOB REP DROWN PREV; Zhu YC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2010-0	45	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212349	10.1371/journal.pone.0212349	http://dx.doi.org/10.1371/journal.pone.0212349			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5JX	30763388	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000458763900073
J	Lyng, FM; Traynor, D; Nguyen, TNQ; Meade, AD; Rakib, F; Al-Saady, R; Goormaghtigh, E; Al-Saad, K; Ali, MH				Lyng, Fiona M.; Traynor, Damien; Thi Nguyet Que Nguyen; Meade, Aidan D.; Rakib, Fazle; Al-Saady, Rafif; Goormaghtigh, Erik; Al-Saad, Khalid; Ali, Mohamed H.			Discrimination of breast cancer from benign tumours using Raman spectroscopy	PLOS ONE			English	Article							IDENTIFICATION; TRANSLATION; SURGERY	Breast cancer is the most common cancer among women worldwide, with an estimated 1.7 million cases and 522,000 deaths in 2012. Breast cancer is diagnosed by histopathological examination of breast biopsy material but this is subjective and relies on morphological changes in the tissue. Raman spectroscopy uses incident radiation to induce vibrations in the molecules of a sample and the scattered radiation can be used to characterise the sample. This technique is rapid and non-destructive and is sensitive to subtle biochemical changes occurring at the molecular level. This allows spectral variations corresponding to disease onset to be detected. The aim of this work was to use Raman spectroscopy to discriminate between benign lesions (fibrocystic, fibroadenoma, intraductal papilloma) and cancer (invasive ductal carcinoma and lobular carcinoma) using formalin fixed paraffin preserved (FFPP) tissue. Haematoxylin and Eosin stained sections from the patient biopsies were marked by a pathologist. Raman maps were recorded from parallel unstained tissue sections. Immunohistochemical staining for estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2/neu) was performed on a further set of parallel sections. Both benign and cancer cases were positive for ER while only the cancer cases were positive for HER2. Significant spectral differences were observed between the benign and cancer cases and the benign cases could be differentiated from the cancer cases with good sensitivity and specificity. This study has shown the potential of Raman spectroscopy as an aid to histopathological diagnosis of breast cancer, in particular in the discrimination between benign and malignant tumours.	[Lyng, Fiona M.; Traynor, Damien; Thi Nguyet Que Nguyen; Meade, Aidan D.] Technol Univ Dublin, FOCAS Res Inst, Ctr Radiat & Environm Sci, Dublin, Ireland; [Rakib, Fazle; Al-Saad, Khalid] Qatar Univ, Dept Chem & Earth Sci, Doha, Qatar; [Al-Saady, Rafif] Al Ahli Hosp, Pathol & Lab Med, Doha, Qatar; [Goormaghtigh, Erik] Univ Libre Bruxelles, Lab Struct & Funct Biol Membranes, Ctr Struct Biol & Bioinformat, Brussels, Belgium; [Ali, Mohamed H.] Qatar Biomed Res Inst, Doha, Qatar	Qatar University; Al Ahli Hospital; Universite Libre de Bruxelles; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI)	Lyng, FM (corresponding author), Technol Univ Dublin, FOCAS Res Inst, Ctr Radiat & Environm Sci, Dublin, Ireland.	fiona.lyng@dit.ie; mohamali@hbku.edu.qa	Meade, Aidan/A-5092-2013; Lyng, Fiona/AAD-2842-2020	Meade, Aidan/0000-0003-0353-9768; Lyng, Fiona/0000-0002-9876-963X; Goormaghtigh, Erik/0000-0002-2071-2262; Nguyen, Thi Nguyet Que/0000-0002-7103-6049; , rafif/0000-0001-7797-9614	Qatar National Research Fund (Qatar Foundation) [7 - 1267 - 3 - 328]	Qatar National Research Fund (Qatar Foundation)	This article was made possible by a NPRP Award [7 - 1267 - 3 - 328] from the Qatar National Research Fund (a member of The Qatar Foundation). The statements made herein are solely the responsibility of the authors.	Abramczyk H, 2016, ANAL CHIM ACTA, V909, P91, DOI 10.1016/j.aca.2015.12.038; Brozek-Pluska B, 2015, ANALYST, V140, P2134, DOI 10.1039/c4an01877j; Brozek-Pluska B, 2012, ANALYST, V137, P3773, DOI 10.1039/c2an16179f; Depciuch J, 2016, APPL SPECTROSC, V70, P251, DOI 10.1177/0003702815620127; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FRANK CJ, 1994, ANAL CHEM, V66, P319, DOI 10.1021/ac00075a002; FRANK CJ, 1995, ANAL CHEM, V67, P777, DOI 10.1021/ac00101a001; Haka AS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3247154; Haka AS, 2005, P NATL ACAD SCI USA, V102, P12371, DOI 10.1073/pnas.0501390102; Jermyn M, 2016, PHYS MED BIOL, V61, pR370, DOI 10.1088/0031-9155/61/23/R370; Kendall C, 2003, J PATHOL, V200, P602, DOI 10.1002/path.1376; Kong K, 2015, ADV DRUG DELIVER REV, V89, P121, DOI 10.1016/j.addr.2015.03.009; Kong K, 2014, PHYS MED BIOL, V59, P6141, DOI 10.1088/0031-9155/59/20/6141; Liu C. H., 1991, C LAS EL OPT P CWF51; MCGUIRE WL, 1977, CANCER-AM CANCER SOC, V39, P2934, DOI 10.1002/1097-0142(197706)39:6<2934::AID-CNCR2820390680>3.0.CO;2-P; Molavi D. W., 2017, PRACTICE SURG PATHOL; O Faolain E, 2005, VIB SPECTROSC, V38, P121, DOI 10.1016/j.vibspec.2005.02.013; REDD DCB, 1993, APPL SPECTROSC, V47, P787, DOI 10.1366/0003702934067072; Santos IP, 2017, ANALYST, V142, P3025, DOI 10.1039/c7an00957g; Surmacki J, 2015, ANALYST, V140, P2121, DOI 10.1039/c4an01876a; Verdonck M, 2013, ANALYST, V138, P4083, DOI 10.1039/c3an00246b; Verma S, 2010, CURR ONCOL, V17, P20	22	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212376	10.1371/journal.pone.0212376	http://dx.doi.org/10.1371/journal.pone.0212376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763392	Green Published, gold, Green Submitted			2022-12-26	WOS:000458763900078
J	Venables, E; Casteels, I; Sumbi, EM; Goemaere, E				Venables, Emilie; Casteels, Ilse; Sumbi, Elysee Manziasi; Goemaere, Eric			"Even if she's really sick at home, she will pretend that everything is fine.": Delays in seeking care and treatment for advanced HIV disease in Kinshasa, Democratic Republic of Congo	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ART ADHERENCE; STABLE PATIENTS; SOUTH-AFRICA; AIDS; CHALLENGES; PATIENT; BURDEN; IMPACT	Introduction HIV prevalence in the Democratic Republic of Congo (DRC) is estimated to be 1.2%, and access to HIV testing and treatment remains low across the country. Despite advances in treatment, HIV continues to be one of the main reasons for hospitalisation and death in low- and middle-income countries, including DRC, but the reasons why people delay seeking health-care when they are extremely sick remain little understood. People in Kinshasa, DRC, continue to present to health-care facilities in an advanced stage of HIV when they are close to death and needing intensive treatment. Methods This qualitative study was conducted in one health-care facility in Kinshasa. A total of 24 indepth interviews with purposively selected health-care workers, patients and care-givers were conducted. Patients were currently or previously hospitalised with advanced HIV, defined as CD4 count <200 cells/pl. Patients included those who had previously started anti-retroviral treatment (ART), and those who had not. Participant observation was also carried out. Interviews were audio-recorded, translated from French and Lingala into English, transcribed, coded and thematically analysed using NVivo. Results The main reasons for delaying access to health-care were stigmatisation, religious beliefs and limited economic resources. Stigmatisation meant that people feared disclosing their HIV status and thus did not receive support from their families. Religious leaders were reported to have encouraged people not to take ART. Patients delayed seeking treatment as they could not afford it, and health-care workers believed that staff at other facilities in Kinshasa were delaying HIV diagnoses for economic benefit. Conclusions Delays in accessing care and treatment linked to stigma, religious beliefs and economic factors contribute to explaining the persistence of advanced HIV within this context. Access to free HIV-testing, ART and treatment of opportunistic infections; counselling; training of health-care workers; support for care-givers and stigma reduction strategies are urgently needed to prevent unnecessary deaths.	[Venables, Emilie; Goemaere, Eric] SAMU, Medecins Sans Frontieres, Cape Town, South Africa; [Venables, Emilie] Univ Cape Town, Div Social & Behav Sci, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Casteels, Ilse; Sumbi, Elysee Manziasi] Medecins Sans Frontieres, Kinshasa, DEM REP CONGO; [Goemaere, Eric] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Sch Publ Hlth & Family Med, Cape Town, South Africa	University of Cape Town; University of Cape Town	Venables, E (corresponding author), SAMU, Medecins Sans Frontieres, Cape Town, South Africa.; Venables, E (corresponding author), Univ Cape Town, Div Social & Behav Sci, Sch Publ Hlth & Family Med, Cape Town, South Africa.	emilie.venables@brussels.msf.org						Ahmed S, 2018, SOC SCI MED, V213, P72, DOI 10.1016/j.socscimed.2018.05.048; [Anonymous], 2014, DEUXIEME ENQUETE DEM, P113; Calmy A, 2018, CLIN INFECT DIS, V66, pS103, DOI 10.1093/cid/cix1138; Carmona S, 2018, CLIN INFECT DIS, V66, pS111, DOI 10.1093/cid/ciy045; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kagee A, 2011, GLOB PUBLIC HEALTH, V6, P83, DOI 10.1080/17441691003796387; Kaplan SR, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002407; Katz IT, 2015, AIDS BEHAV, V19, P704, DOI 10.1007/s10461-014-0920-y; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Lindgren T, 2013, J ASSOC NURSE AIDS C, V24, P227, DOI 10.1016/j.jana.2012.05.004; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; MacPherson P, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.18020; Mashako M., 2015, THESIS; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; MSF, 2017, WAIT ISNT OPT PREV S; Musheke M, 2013, AIDS PATIENT CARE ST, V27, P231, DOI 10.1089/apc.2012.0341; Osler M, 2018, CLIN INFECT DIS, V66, pS118, DOI 10.1093/cid/cix1140; Ousley J, 2018, CLIN INFECT DIS, V66, pS126, DOI 10.1093/cid/ciy103; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Programme National de la Lutte contre le SIDA et les IST en RDC, 2016, PROGRAMME NATL LUTTE; Ramjan R, 2014, TROP MED INT HEALTH, V19, P501, DOI 10.1111/tmi.12297; Rankin SH, 2008, JOGNN-J OBST GYN NEO, V37, P596, DOI 10.1111/j.1552-6909.2008.00280.x; Rankin WW, 2005, PLOS MED, V2, P702, DOI 10.1371/journal.pmed.0020247; Scanlon ML, 2013, HIV AIDS-RES PALLIAT, V5, P1, DOI 10.2147/HIV.S28912; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNICEF, 2002, ACT CHILDR YOUNG PEO; Waldrop G, 2016, TROP MED INT HEALTH, V21, P1124, DOI 10.1111/tmi.12746; Wilkinson LS, 2013, S AFR J HIV MED, V14, P48, DOI [10.7196/SAJHIVMED.924, 10.7196/sajhivmed.924]; World Health Organization, 2017, GUID MAN ADV HIV DIS	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211619	10.1371/journal.pone.0211619	http://dx.doi.org/10.1371/journal.pone.0211619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5IX	30759138	Green Submitted, Green Published, gold			2022-12-26	WOS:000458761300053
J	Hartley, T				Hartley, Tilman			The continuing evolution of ownership	PLOS ONE			English	Article							FISSION-FUSION DYNAMICS; PROPERTY-RIGHTS; COEVOLUTION; INEQUALITY; ORIGINS; EXCLUDABILITY; INSTITUTIONS; AGRICULTURE; COOPERATION; COMPETITION	The evolution in animals of a first possession convention, in which individuals retain what they are the first to acquire, has often been taken as a foundation for the evolution of human ownership institutions. However, among humans, individuals actually only seldom retain an item they have acquired from the environment, instead typically transferring what they possess to other members of the community, to those in command, or to those who hold a contractual title. This paper presents a novel game-theoretic model of the evolution of ownership institutions as rules governing resource transfers. Integrating existing findings, the model contributes a new perspective on the emergence of communal transfers among hominin large game hunters around 200,000 years ago, of command ownership among sedentary humans in the millennia prior to the transition to agriculture, and of titled property ownership around 5,500 years ago. Since today's property institutions motivate transfers through the promise of future returns, the analysis presented here suggests that these institutions may be placed under considerable pressure should resources become significantly constrained.	[Hartley, Tilman] Univ Bristol, Sch Sociol Polit & Int Studies, Bristol, Avon, England	University of Bristol	Hartley, T (corresponding author), Univ Bristol, Sch Sociol Polit & Int Studies, Bristol, Avon, England.	tilmanhartley@protonmail.com		Hartley, Tilman/0000-0001-8080-7303				Abbott FF, 1911, HIST DESCRIPTION ROM; Acemoglu D, 2012, NEW YORK REV BOOKS, V59, P85; Adams R. M., 2006, J ECON SOC HIST ORIE, V49, P133, DOI DOI 10.1163/156852006777502090; Afshar M, 2014, ANIM BEHAV, V96, P167, DOI 10.1016/j.anbehav.2014.07.022; Ahmed N. M., 2017, FAILING STATES COLLA; Allen R. C, 2009, BRIT IND REVOLUTION; Allen RC, 2003, WAS THERE TIMBER CRI, VXIII- XVIII, P469; Alston L, 2015, IOWA LAW REV, V100, P2255; Ames K., 2007, HDB ARCHAEOLOGICAL T, P487; ANDERSON TL, 1975, J LAW ECON, V18, P163, DOI 10.1086/466809; [Anonymous], 1980, EARLY GREECE; Araujo B., 2015, QUATERNARY INT B, V431, P216; Astin AE, 1989, CAMBRIDGE ANCIENT HI, V7; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; BAILEY MJ, 1992, J LAW ECON, V35, P183, DOI 10.1086/467249; BARNARD CJ, 1981, ANIM BEHAV, V29, P543, DOI 10.1016/S0003-3472(81)80117-0; Bartlett LJ, 2016, ECOGRAPHY, V39, P152, DOI 10.1111/ecog.01566; Bavel Bas van, 2016, INVISIBLE HAND MARKE; Bettinger RL, 2007, DEV QUATER SCI, V9, P83, DOI 10.1016/S1571-0866(07)09008-2; Bisin A, 2017, J ECON LIT, V55, P1122, DOI 10.1257/jel.20151352; Boix C, 2014, AM POLIT SCI REV, V108, P1, DOI 10.1017/S0003055413000555; Bowles S, 2003, J THEOR BIOL, V223, P135, DOI 10.1016/S0022-5193(03)00060-2; Bowles S, 2013, P NATL ACAD SCI USA, V110, P8830, DOI 10.1073/pnas.1212149110; Bowles S, 2012, SCIENCE, V336, P876, DOI 10.1126/science.1217336; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Brook Barry W., 2012, P179; Byrd B., 2002, LIFE NEOLITHIC FARMI, P63; Canny N., 1998, OXFORD HIST BRIT EMP; CARACO T, 1991, J THEOR BIOL, V153, P559, DOI 10.1016/S0022-5193(05)80156-0; Clay CGA, 2005, ECONOMIC EXPANSION S, V1; Cole D. H, 2010, SSRN ELECT J, DOI [10.2139/ssrn.1656418, DOI 10.2139/SSRN.1656418]; CORNELL T., 1995, BEGINNINGS ROME ITAL; Currie TE, 2016, STRUNGMANN FORUM REP, P201; de Heinzelin J, 1999, SCIENCE, V284, P625; De Soto H., 2000, MYSTERY CAPITAL; Demsetz H, 1967, AM ECON REV, V57, P347; Dionisio F, 2006, EVOL ECOL RES, V8, P321; Dionisio F, 2007, EVOL ECOL RES, V9, P365; Dow GK, 2013, J POLIT ECON, V121, P609, DOI 10.1086/670741; DYSONHUDSON R, 1978, AM ANTHROPOL, V80, P21, DOI 10.1525/aa.1978.80.1.02a00020; Eswaran M, 2014, AM ECON J-MICROECON, V6, P203, DOI 10.1257/mic.6.3.203; Feinman G.M., 1998, ARCHAIC STATES; Ferraro JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062174; FIELD BC, 1989, KYKLOS, V42, P319; Fischer- Kowalski M, 2015, MRS ENERGY SUSTAIN R, P2; Fischer-Kowalski Marina, 2013, LONG TERM SOCIO ECOL, P77, DOI DOI 10.1007/978-94-007-1177-8_4; Flaig Egon, 2011, ROMAN EMPIRE CONTEXT, P67; Flannery K., 2012, CREATION INEQUALITY; Foragers Morris I., 2015, HUMAN VALUES EVOLVE; Fouquet R, 1998, ENERGY J, V19, P1; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Fuller DQ, 2015, ARCHAEOL INT, V18, P61, DOI 10.5334/ai.1808; Fuller DQ, 2014, P NATL ACAD SCI USA, V111, P6147, DOI 10.1073/pnas.1308937110; Gabba E., 1989, CAMBRIDGE ANCIENT HI, P197; Garfinkle S. J., 2004, J ECON SOC HIST ORIE, V47, P1, DOI DOI 10.1163/156852004323069385; Gerber JD, 2017, ECOL ECON, V131, P551, DOI 10.1016/j.ecolecon.2016.08.030; GETTY T, 1981, AM NAT, V118, P426, DOI 10.1086/283834; Gintis H, 2015, CURR ANTHROPOL, V56, P327, DOI 10.1086/681217; Gintis Herbert, 2009, BOUNDS REASON GAME T; Graeber, 2011, DEBT 1 5000 YEARS; Guns Diamond J., 1997, GERMS STEEL FATE HUM; Gurven M, 2004, RES ECON ANTHROPOL, V23, P19, DOI 10.1016/S0190-1281(04)23001-3; Gurven M., 2015, EMERGING TRENDS SOCI, P1, DOI DOI 10.1002/9781118900772.ETRDS0133; Hardin Garrett, 1991, COMMONS TRAGEDY PROT, P162; Hare D, 2016, J EVOLUTION BIOL, V29, P1178, DOI 10.1111/jeb.12859; Hartley T, 2018, J POLIT ECOL, V25, P602; Hatcher J., 1993, HIST BRIT COAL IND V; Hawkes K., 2001, MEAT EATING HUMAN EV, P219; Heinsohn G, 2013, OWNERSHIP EC; HELMHOLZ RH, 1986, SPECULUM, V61, P364, DOI 10.2307/2854044; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Henrich J, 2008, CURR ANTHROPOL, V49, P715, DOI 10.1086/587889; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; HIGASHI M, 1993, AM NAT, V142, P553, DOI 10.1086/285555; Hodgson GM, 2017, J I ECON, V13, P79, DOI 10.1017/S1744137416000266; Holman S., 2001, HUNGRY ARE DYING BEG; Homer S., 2005, HIST INTEREST RATES, V4; Hudson M, 2002, DEBT AND ECONOMIC RENEWAL IN THE ANCIENT NEAR EAST, VOL 3, P7; Hudson M., 1992, GREECE E W 10 8 CENT, P128; Hudson Michael, 2000, J ECON SOC HIST ORIE, V43, P132, DOI DOI 10.1163/156852000511259; International Energy Agency, 2017, EN US KG OIL EQ CAP; Jaeggi AV, 2013, EVOL ANTHROPOL, V22, P186, DOI 10.1002/evan.21364; Jones David J., 2004, REFORMING MORALITY U; Kaplan H.S., 2005, MORAL SENTIMENTS MAT, P75; Kelly R., 1995, FORAGING SPECTRUM; Kirch Patrick V., 2010, CHIEFS BECAME KINGS; Kohler T. A., 1993, J ARCHAEOL RES, V1, P267, DOI DOI 10.1007/BF01418108; Krier JE, 2009, CORNELL LAW REV, V95, P139; Kuijt I, 2009, MACROEVOLUTION IN HUMAN PREHISTORY, P253, DOI 10.1007/978-1-4419-0682-3_10; Levmore S., J LEGAL STUDIES, V31, P421; Lewis HM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6789; MATTESSICH R, 1989, ABACUS-J ACCOUNT BUS, V25, P74, DOI 10.1111/j.1467-6281.1989.tb00222.x; Mattison SM, 2016, EVOL ANTHROPOL, V25, P184, DOI 10.1002/evan.21491; Maynard Smith J., 1982, pi; McCloskey D.N., 2010, BOURGEOIS DIGNITY WH; McElreath R., 2008, MATH MODELS SOCIAL E; MELITZ J, 1971, KYKLOS, V24, P473, DOI 10.1111/j.1467-6435.1971.tb00615.x; Millett P., 2002, LENDING BORROWING AN; Moore AMT, 2000, VILLAGE EUPHRATES FO; Morris I, 2004, J INST THEOR ECON, V160, P709, DOI 10.1628/0932456042776050; Mulder MB, 2009, SCIENCE, V326, P682, DOI 10.1126/science.1178336; Nicolet C., 1994, CAH, Vix, P599; Noonan John T., 1957, SCHOLASTIC ANAL USUR; Noonan Jt Jr, 1965, Nat Law Forum, V10, P215; North D., 1973, RISE W WORLD NEW EC; NORTH DC, 1977, ECON HIST REV, V30, P229; North DC, 2009, VIOLENCE AND SOCIAL ORDERS: A CONCEPTUAL FRAMEWORK FOR INTERPRETING RECORDED HUMAN HISTORY, pXI, DOI 10.1017/CBO9780511575839.001; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Price TD, 2010, FUND ISSUE ARCHAEOL, P147, DOI 10.1007/978-1-4419-6300-0_6; Purugganan MD, 2011, EVOLUTION, V65, P171, DOI 10.1111/j.1558-5646.2010.01093.x; Raaflaub K. A., 1986, SOCIAL STRUGGLES ARC; Richerson P.J., 1998, INDOCTRINABILITY IDE, P71; Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241; Richerson PJ., 2001, P BR ACAD, V110, P197; ROSE CM, 1985, U CHICAGO LAW REV, V52, P73, DOI 10.2307/1599571; Rosenstein N., 2004, ROME WAR FARMS FAMIL; Rowthorn R, 2010, 10207 TSE; Scheidel Walter, 2017, GREAT LEVELER VIOLEN; Schmandt- Besserat D., 1992, WRITING COUNTING CUN, V1; SCHMANDTBESSERAT D, 1986, WRIT COMMUN, V3, P31, DOI 10.1177/0741088386003001003; Sherratt TN, 2015, J EVOLUTION BIOL, V28, P1185, DOI 10.1111/jeb.12648; Sherratt TN, 2017, ELS, P1, DOI [10.1002/9780470015902.a0027503, DOI 10.1002/9780470015902.A0027503]; Smil V., 2010, ENERGY TRANSITIONS H; Smil Vaclav, 2008, ENERGY NATURE SOC GE; Smith EA, 2010, CURR ANTHROPOL, V51, P85, DOI 10.1086/649029; Smith JE, 2008, ANIM BEHAV, V76, P619, DOI 10.1016/j.anbehav.2008.05.001; Smith JE, 2012, CURR ANTHROPOL, V53, pS436, DOI 10.1086/667653; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Stake JE, 2004, PHILOS T R SOC B, V359, P1763, DOI 10.1098/rstb.2004.1551; Stamps JA, 2001, AM NAT, V157, P154, DOI 10.1086/318634; Steppacher R., 2008, PROPERTY EC PROPERTY, P323; Stiner MC, 2009, P NATL ACAD SCI USA, V106, P13207, DOI 10.1073/pnas.0900564106; Stiner MC, 2002, J ARCHAEOL RES, V10, P1, DOI 10.1023/A:1014588307174; Strassmann JE, 2014, ANIM BEHAV, V92, P305, DOI 10.1016/j.anbehav.2014.02.011; Sugden R, 2005, ECONOMICS OF RIGHTS, COOPERATION AND WELFARE, P1, DOI 10.1057/9780230536791; Taagepera R, 1997, INT STUD QUART, V41, P475, DOI 10.1111/0020-8833.00053; Tomasello M, 2012, CURR ANTHROPOL, V53, P673, DOI 10.1086/668207; Trainer T., 2011, REAL WORLD EC REV, V57, P71; Trainer T, 2014, ENERG POLICY, V64, P168, DOI 10.1016/j.enpol.2013.06.008; Turchin P, 2013, P NATL ACAD SCI USA, V110, P16384, DOI 10.1073/pnas.1308825110; Van de Velde RF, 1956, ANTHROPOLOGICA, P5; van den Bergh JCJM, 2003, J EVOL ECON, V13, P289, DOI 10.1007/s00191-003-0158-8; van Griethuysen P, 2012, ECOL ECON, V84, P262, DOI 10.1016/j.ecolecon.2012.02.018; Wallace RW, 2007, ORIGINS OF DEMOCRACY IN ANCIENT GREECE, P49; Warde P., 2007, ENERGY CONSUMPTION E; Willems EP, 2017, J HUM EVOL, V109, P11, DOI 10.1016/j.jhevol.2017.05.003; Winterhalder B., 2001, MEAT EATING HUMAN EV, P279	147	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211871	10.1371/journal.pone.0211871	http://dx.doi.org/10.1371/journal.pone.0211871			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL0PE	30753234	Green Published, gold, Green Submitted			2022-12-26	WOS:000458395600027
J	Hu, L; Zhang, ST; Wen, HY; Liu, TF; Cai, J; Du, DS; Zhu, DN; Chen, FX; Xia, CM				Hu, Li; Zhang, Shutian; Wen, Haoyu; Liu, Tianfeng; Cai, Jian; Du, Dongshu; Zhu, Danian; Chen, Fuxue; Xia, Chunmei			Melatonin decreases M1 polarization via attenuating mitochondrial oxidative damage depending on UCP2 pathway in prorenin-treated microglia	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2; STRESS; BIOGENESIS; BRAIN; CELLS	Accumulating evidence suggests that neuroinflammation and oxidative stress in cardiovascular center contribute to the pathological processes underlying hypertension. Microglia activation triggers the inflammation and oxidative stress. Melatonin is a documented potent anti-inflammatory regent and antioxidant, the underlying roles of melatonin in regulating microglia activation via mitochondria remain unclear. In present study, we investigated the protective role of melatonin in decreasing M1 phenotype switching via attenuating mitochondrial oxidative damage in dependence on uncoupling protein 2 (UCP2) pathway in microglia. Prorenin (20 nmol/L; 24 hr) was used to induce inflammation in cultured microglia. Mitochondrial morphology was detected by transmission electron microscope. The reactive oxygen species (ROS) production by using DCFH-DA fluorescence imaging and mitochondrial membrane potential (MMP, Delta Psi m) was evaluated by JC-1 staining. The indicator of the redox status as the ratio of the amount of total NADP(+) to total NADPH, and the expression of 6 subunits of NADPH oxidase is measured. The pro-inflammatory cytokines releasing was measured by qPCR. UCP2 and activated AMPK alpha (p-AMPK alpha) expression were examined by immunoblot. Melatonin (100 mu M) markedly alleviated the M1 microglia phenotype shifting and abnormal mitochondria morphology. Melatonin attenuated prorenin-induced Delta Psi m increasing and ROS overproduction. Melatonin decreased the redox ratio (NADP(+)/NADPH) and the p47phox and gp91phox subunits of NADPH oxidase expression in prorenin-treated microglia. These effects were reversed in the presence of UCP2 siRNA. Our results suggested that the protective effect of melatonin against prorenin-induced M1 phenotype switching via attenuating mitochondrial oxidative damage depending on UCP2 upregulation in prorenin-treated microglia.	[Hu, Li; Liu, Tianfeng; Du, Dongshu; Chen, Fuxue] Shanghai Univ, Lab Neuropharmacol & Neurotoxicol, Shanghai Key Lab Bioenergy Crops, Coll Life Sci, Shanghai, Peoples R China; [Zhang, Shutian; Wen, Haoyu; Zhu, Danian; Xia, Chunmei] Fudan Univ, Dept Physiol & Pathophysiol, Basic Med Coll, Shanghai, Peoples R China; [Cai, Jian] Shanghai Jiao Tong Univ, Dept Neurol, Renji Hosp, Shanghai, Peoples R China	Shanghai University; Fudan University; Shanghai Jiao Tong University	Chen, FX (corresponding author), Shanghai Univ, Lab Neuropharmacol & Neurotoxicol, Shanghai Key Lab Bioenergy Crops, Coll Life Sci, Shanghai, Peoples R China.; Xia, CM (corresponding author), Fudan Univ, Dept Physiol & Pathophysiol, Basic Med Coll, Shanghai, Peoples R China.	chenfuxue@staff.shu.edu.cn; cmxia@fudan.edu.cn			Chinese National Natural Science Foundation [31571171]; Shanghai Municipal Natural Science Foundation [13ZR1403400]; 49th Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry)	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation; 49th Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry)(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the Chinese National Natural Science Foundation 31571171 to CMX; and Shanghai Municipal Natural Science Foundation 13ZR1403400 to CMX; The 49th Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry) to CMX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Castroviejo N, 2017, CELLULAR MOL LIFE SC, V74, P3985; Alonso-Alconada D, 2012, HISTOL HISTOPATHOL, V27, P771, DOI 10.14670/HH-27.771; Baker J, 2018, CLINICAL EXPERIMENTA; Barnstable CJ, 2016, J MOL NEUROSCI, V58, P1, DOI [10.1007/s12031-015-0694-3, DOI 10.1007/S12031-015-0694-3]; Bremer K, 2016, COMP BIOCHEM PHYS B, V199, P4, DOI 10.1016/j.cbpb.2015.09.005; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Chen ZB, 2018, BIOCHEM BIOPH RES CO, V504, P13, DOI 10.1016/j.bbrc.2018.08.027; Correa-da-Silva F, 2018, CELL BIOL INT, V42, P651, DOI 10.1002/cbin.10921; De Simone R, 2015, J NEUROCHEM, V135, P147, DOI 10.1111/jnc.13244; Du DS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0942-2; Dun-Xian T, 2010, J PINEAL RES, V42, P28; Galley HF, 2014, J PINEAL RES, V56, P427, DOI 10.1111/jpi.12134; Haspula D, 2018, AUTONOMIC NEUROSCIEN, V210; Hass DT, 2016, NEURAL REGEN RES, V11, P1197, DOI 10.4103/1673-5374.189159; Jimenez-Aranda A, 2013, J PINEAL RES, V55, P416, DOI 10.1111/jpi.12089; Kapoor K, 2016, RESP PHYSIOL NEUROBI, V226, P51, DOI 10.1016/j.resp.2015.11.015; Kaur C, 2010, J PINEAL RES, V48, P185, DOI 10.1111/j.1600-079X.2009.00740.x; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Li HB, 2018, CELL PHYSIOL BIOCHEM, V48, P1369, DOI 10.1159/000492095; Li N, 2010, J CARDIOVASC PHARM, V55, P161, DOI 10.1097/01.fjc.0000365898.92719.f0; Liu D, 2018, FREE RADICAL BIO MED, V129, P59, DOI 10.1016/j.freeradbiomed.2018.08.032; Marvar PJ, 2011, CURR OPIN PHARMACOL, V11, P156, DOI 10.1016/j.coph.2010.12.001; Mi Y, 2018, AUTON NEUROSCI-BASIC, V213, P71, DOI 10.1016/j.autneu.2018.06.003; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Ozyener F, 2012, RESTOR NEUROL NEUROS, V30, P435, DOI 10.3233/RNN-2012-120217; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Pechanova O, 2014, INT J MOL SCI, V15, P17920, DOI 10.3390/ijms151017920; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pei HF, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12371; Pei HF, 2016, FREE RADICAL BIO MED, V97, P408, DOI 10.1016/j.freeradbiomed.2016.06.015; Peruzzotti-Jametti L, 2018, TRENDS MOL MED, V24, P838, DOI 10.1016/j.molmed.2018.07.007; Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006; Reiter RJ, 2003, ACTA BIOCHIM POL, V50, P1129; Sang-Ho C, 2015, J NEUROCHEM, V120, P292; Shi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092937; Shi P, 2010, CLIN EXP PHARMACOL P, V37, pE52, DOI 10.1111/j.1440-1681.2009.05234.x; Slusarczyk J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071965; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Suwanjang W, 2016, NEUROCHEM INT, V97, P34, DOI 10.1016/j.neuint.2016.05.003; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Tsai CF, 2015, INT J MOL SCI, V16, P5572, DOI 10.3390/ijms16035572; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Villena JA, 2015, FEBS J, V282, P647, DOI 10.1111/febs.13175; Xia CM, 2010, CLIN EXP PHARM PHYSL, V35, P1258; Xia YY, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12547; Yao K, 2016, BIOCHEM BIOPH RES CO, V470, P961, DOI 10.1016/j.bbrc.2016.01.089; Yeh TC, 2018, J APPL PHYSIOL, V125, P40, DOI 10.1152/japplphysiol.00686.2017; Yu LM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41337; Yu XX, 2000, AM J PHYSIOL-ENDOC M, V279, pE433, DOI 10.1152/ajpendo.2000.279.2.E433; Zhong MF, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/3256325	51	21	23	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0212138	10.1371/journal.pone.0212138	http://dx.doi.org/10.1371/journal.pone.0212138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742657	Green Submitted, Green Published, gold			2022-12-26	WOS:000458393400053
J	Won, JH; Kim, M; Park, BY; Youn, J; Park, H				Won, Ji Hye; Kim, Mansu; Park, Bo-yong; Youn, Jinyoung; Park, Hyunjin			Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson's disease	PLOS ONE			English	Article							MAJOR DEPRESSION; SYMPTOMS; BRAIN; DISORDER; EPIDEMIOLOGY; ASSOCIATIONS; THICKNESS; DOPAMINE; PATHWAYS; SOCIETY	Depression is one of the most common and important neuropsychiatric symptoms in Parkinson's disease and often becomes worse as Parkinson's disease progresses. However, the underlying mechanisms of depression in Parkinson's disease are not clear. The aim of our study was to find genetic features related to depression in Parkinson's disease using an imaging genetics approach and to construct an analytical model for predicting the degree of depression in Parkinson's disease. The neuroimaging and genotyping data were obtained from an openly accessible database. We computed imaging features through connectivity analysis derived from tractography of diffusion tensor imaging. The imaging features were used as intermediate phenotypes to identify genetic variants according to the imaging genetics approach. We then constructed a linear regression model using the genetic features from imaging genetics approach to describe clinical scores indicating the degree of depression. As a comparison, we constructed other models using imaging features and genetic features based on references to demonstrate the effectiveness of our imaging genetics model. The models were trained and tested in a five-fold cross-validation. The imaging genetics approach identified several brain regions and genes known to be involved in depression, with the potential to be used as meaningful biomarkers. Our proposed model using imaging genetic features predicted and explained the degree of depression in Parkinson's disease appropriately (adjusted R-2 larger than 0.6 over five training folds) and with a lower error and higher correlation than with other models over five test folds.	[Won, Ji Hye; Kim, Mansu; Park, Bo-yong] Sungkyunkwan Univ, Dept Elect & Comp Engn, Suwon, South Korea; [Won, Ji Hye; Kim, Mansu; Park, Bo-yong; Park, Hyunjin] Inst Basic Sci, Ctr Neurosci Imaging Res, Suwon, South Korea; [Youn, Jinyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Youn, Jinyoung] Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea; [Park, Hyunjin] Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea	Sungkyunkwan University (SKKU); Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Park, H (corresponding author), Inst Basic Sci, Ctr Neurosci Imaging Res, Suwon, South Korea.; Park, H (corresponding author), Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea.	hyunjinp@skku.edu	Youn, Jinyoung/ABD-4588-2020; Park, Hyunjin/A-1164-2007; Kim, Mansu/AAI-4977-2021; Park, Bo-yong/AAM-8094-2020; WON, JI HYE/GXG-8525-2022	Park, Hyunjin/0000-0001-5681-8918; Park, Bo-yong/0000-0001-7096-337X	Institute for Basic Science [IBS-R015-D1]; National Research Foundation of Korea [NRF-2016R1A2B4008545, NRF-2017H1A2A1043075]; Ministry of Science and ICT of Korea under the ITRC Program [IITP-2018-2018-0-01798]; Michael J. Fox Foundation for Parkinson's Research; Abbott; Avid Pharmaceuticals; Biogen Idec; Bristol-Myers Squibb; Covance; Elan; GE Healthcare; Genentech; GlaxoSmithKline; Lilly; Merck; Meso Scale Discovery; Pfizer; Roche; UCB	Institute for Basic Science; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science and ICT of Korea under the ITRC Program(Ministry of Science, ICT & Future Planning, Republic of Korea); Michael J. Fox Foundation for Parkinson's Research; Abbott(Abbott Laboratories); Avid Pharmaceuticals; Biogen Idec(Biogen); Bristol-Myers Squibb(Bristol-Myers Squibb); Covance; Elan; GE Healthcare(General ElectricGE Healthcare); Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Lilly(Eli Lilly); Merck(Merck & Company); Meso Scale Discovery; Pfizer(Pfizer); Roche(Roche Holding); UCB(UCB Pharma SA)	This study was supported by the Institute for Basic Science (http://www.ibs.re.kr/, grant number IBS-R015-D1, recipient: N/A). This work was also supported by the National Research Foundation of Korea (http://www.nrf.re.kr/, grant numbers NRF-2016R1A2B4008545 [recipient: HP] and NRF-2017H1A2A1043075 [recipient: MK]). This study was also supported by the Ministry of Science and ICT of Korea under the ITRC Program (grant number IITP-2018-2018-0-01798). Imaging data were obtained from the PPMI. The PPMI is a public-private partnership funded by The Michael J. Fox Foundation for Parkinson's Research, Abbott, Avid Pharmaceuticals, Biogen Idec, Bristol-Myers Squibb, Covance, Elan, GE Healthcare, Genentech, GlaxoSmithKline, Lilly, Merck, Meso Scale Discovery, Pfizer, Roche, and UCB (www.ppmi-info.org/fundingpartners).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2012, NAT REV NEUROL, V8, P35, DOI 10.1038/nrneurol.2011.189; Aarsland D, 2009, MOVEMENT DISORD, V24, P2175, DOI 10.1002/mds.22589; Abe O, 2010, PSYCHIAT RES-NEUROIM, V181, P64, DOI 10.1016/j.pscychresns.2009.07.007; Baquero M, 2015, WORLD J CLIN CASES, V3, P682, DOI 10.12998/wjcc.v3.i8.682; Barbagallo G, 2017, HUM BRAIN MAPP, V38, P4716, DOI 10.1002/hbm.23697; Benes FM, 2010, NEUROPSYCHOPHARMACOL, V35, P239, DOI 10.1038/npp.2009.116; Bergstrom HC, 2017, J NEUROSCI RES, V95, P795, DOI 10.1002/jnr.24006; Brown SM, 2006, COGN AFFECT BEHAV NE, V6, P44, DOI 10.3758/CABN.6.1.44; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chagas MHN, 2017, J PSYCHIATR RES, V90, P40, DOI 10.1016/j.jpsychires.2017.02.010; Chagas MHN, 2013, INT PSYCHOGERIATR, V25, P1953, DOI 10.1017/S1041610213001427; CUMMINGS JL, 1992, AM J PSYCHIAT, V149, P443; D'Ostilio K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00161; Ding SL, 2009, J COMP NEUROL, V514, P595, DOI 10.1002/cne.22053; Duman R. S., 2002, European Psychiatry, V17, P306, DOI 10.1016/S0924-9338(02)00654-5; ENIGMA2 Genetics Support Team, 2013, ENH NEUR GEN METAANA; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gillan CM, 2017, PSYCHOL MED, V47, P1528, DOI 10.1017/S0033291716002786; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Guo T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00334; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Hardy MA, 1993, REGRESSION WITH DUMM; Hashimoto R, 2015, CURR MOL MED, V15, P168, DOI 10.2174/1566524015666150303104159; Huang PY, 2016, PSYCHIAT RES-NEUROIM, V250, P24, DOI 10.1016/j.pscychresns.2016.03.002; Ishihara L, 2006, ACTA NEUROL SCAND, V113, P211, DOI 10.1111/j.1600-0404.2006.00579.x; Kim M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46700; KNIGHT RG, 1983, BRIT J CLIN PSYCHOL, V22, P245, DOI 10.1111/j.2044-8260.1983.tb00610.x; Korgaonkar MS, 2012, NEUROREPORT, V23, P566, DOI 10.1097/WNR.0b013e3283546264; Krug A, 2010, NEUROIMAGE, V49, P1831, DOI 10.1016/j.neuroimage.2009.09.028; Lee M, 2015, SYNAPSE, V69, P453, DOI 10.1002/syn.21834; Lemke MR, 2008, EUR J NEUROL, V15, P21, DOI 10.1111/j.1468-1331.2008.02058.x; Li W, 2010, AM J NEURORADIOL, V31, P1861, DOI 10.3174/ajnr.A2195; Liang PP, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004222; MacQueen G, 2011, MOL PSYCHIATR, V16, P252, DOI 10.1038/mp.2010.80; Marek K, 2011, PROG NEUROBIOL, V95, P629, DOI 10.1016/j.pneurobio.2011.09.005; McDonald WA, 2003, BIOL PSYCHIAT, V54, P363, DOI 10.1016/S0006-3223(03)00530-4; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Nalls MA, 2016, MOVEMENT DISORD, V31, P79, DOI 10.1002/mds.26374; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nguyen LS, 2012, MOL PSYCHIATR, V17, P1103, DOI 10.1038/mp.2011.163; Nutt David, 2008, Dialogues Clin Neurosci, V10, P329; Oquendo MA, 2007, ARCH GEN PSYCHIAT, V64, P201, DOI 10.1001/archpsyc.64.2.201; Pandya M, 2012, CURR PSYCHIAT REP, V14, P634, DOI 10.1007/s11920-012-0322-7; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002142; Plaschkes I., 2016, CURR PROTOC BIOINFOR, V54, DOI DOI 10.1002/CPBI.5; Politis M, 2010, NEUROLOGY, V75, P1920, DOI 10.1212/WNL.0b013e3181feb2ab; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ravina B, 2007, NEUROLOGY, V69, P342, DOI 10.1212/01.wnl.0000268695.63392.10; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Santana-Casiano JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep25686; Sartorius N, 1996, BRIT J PSYCHIAT, V168, P38, DOI 10.1192/S0007125000298395; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; Shimizu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123524; Singh I, 2008, NAT REV NEUROSCI, V9, P957, DOI 10.1038/nrn2514; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Storch A, 2008, FORTSCHR NEUROL PSYC, V76, P715, DOI 10.1055/s-2008-1038293; Stuhrmann A, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-10; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Weintraub D, 2009, MOVEMENT DISORD, V24, P1461, DOI 10.1002/mds.22571; Wu YH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192050; Wu YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130282; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zanigni S, 2017, NEURODEGENER DIS, V17, P97, DOI 10.1159/000450614; Zhang L, 2015, GENET MOL RES, V14, P7218, DOI 10.4238/2015.June.29.15	70	5	5	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211699	10.1371/journal.pone.0211699	http://dx.doi.org/10.1371/journal.pone.0211699			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL0OI	30742647	Green Submitted, Green Published, gold			2022-12-26	WOS:000458393400019
J	Cross, EW; Blain, TJ; Mathew, D; Kedl, RM				Cross, Eric W.; Blain, Trevor J.; Mathew, Divij; Kedl, Ross M.			Anti-CD8 monoclonal antibody-mediated depletion alters the phenotype and behavior of surviving CD8+T cells	PLOS ONE			English	Article							FC-GAMMA-RECEPTORS; T-CELLS; TRANSCRIPTION FACTOR; LYMPHOCYTE DEPLETION; MEMORY; EFFECTOR; ACTIVATION; SUBSETS; BINDING; DIFFERENTIATION	It is common practice for researchers to use antibodies to remove a specific cell type to infer its function. However, it is difficult to completely eliminate a cell type and there is often limited or no information as to how the cells which survive depletion are affected. This is particularly important for CD8+ T cells for two reasons. First, they are more resistant to mAb-mediated depletion than other lymphocytes. Second, targeting either the CD8 alpha or CD8 beta chain could induce differential effects. We show here that two commonly used mAbs, against either the CD8 alpha or CD8 beta subunit, can differentially affect cellular metabolism. Further, in vivo treatment leaves behind a population of CD8+ T cells with different phenotypic and functional attributes relative to each other or control CD8+ T cells. The impact of anti-CD8 antibodies on CD8+ T cell phenotype and function indicates the need to carefully consider the use of these, and possibly other "depleting" antibodies, as they could significantly complicate the interpretation of results or change the outcome of an experiment. These observations could impact how immunotherapy and modulation of CD8+ T cell activation is pursued.	[Cross, Eric W.; Blain, Trevor J.; Mathew, Divij; Kedl, Ross M.] Univ Colorado, Dept Immunol & Microbiol, Denver, CO 80202 USA; [Blain, Trevor J.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Colorado System; University of Colorado Denver; University of Alabama System; University of Alabama Birmingham	Cross, EW (corresponding author), Univ Colorado, Dept Immunol & Microbiol, Denver, CO 80202 USA.	eric.cross@ucdenver.edu			National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) [RO1 AI066121, RO1 AI117918, RO1 AI101205]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101205, R01AI126899, R01AI066121, R01AI117918] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID; https://www.niaid.nih.gov) grants RO1 AI066121, RO1 AI117918, and RO1 AI101205 to RMK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Artyomov MN, 2010, P NATL ACAD SCI USA, V107, P16916, DOI 10.1073/pnas.1010568107; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Biburger M, 2011, IMMUNITY, V35, P932, DOI 10.1016/j.immuni.2011.11.009; Burchill MA, 2013, VACCINE, V31, P297, DOI 10.1016/j.vaccine.2012.10.096; Clement M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35332; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Devine L, 2004, IMMUNOL LETT, V93, P123, DOI 10.1016/j.imlet.2004.02.002; GOLDSCHMIDT TJ, 1988, J IMMUNOL METHODS, V111, P219, DOI 10.1016/0022-1759(88)90130-5; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Hoffmann MM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500415; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jones JL, 2013, P NATL ACAD SCI USA, V110, P20200, DOI 10.1073/pnas.1313654110; Jung YW, 2010, J IMMUNOL, V185, P5315, DOI 10.4049/jimmunol.1001948; Kallies A, 2017, TRENDS IMMUNOL, V38, P287, DOI 10.1016/j.it.2017.02.003; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Kishton RJ, 2017, CELL METAB, V26, P94, DOI 10.1016/j.cmet.2017.06.016; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; Lei J, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12798; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Maltby S, 2018, J IMMUNOL, V200, P632, DOI 10.4049/jimmunol.1700927; Martin AJ, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87636; Matsuzaki J, 2003, CELL IMMUNOL, V224, P98, DOI 10.1016/j.cellimm.2003.08.009; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Morillon YM, 2016, J IMMUNOL, V197, P3504, DOI 10.4049/jimmunol.1501600; Muller-Durovic B, 2016, J IMMUNOL, V197, P2891, DOI 10.4049/jimmunol.1600590; Nishikado H, 2011, J IMMUNOL, V186, P5766, DOI 10.4049/jimmunol.1100370; Parish N, 2005, AUTOIMMUNITY, V38, P597, DOI 10.1080/08916930500438241; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearl JP, 2005, AM J TRANSPLANT, V5, P465, DOI 10.1111/j.1600-6143.2005.00759.x; Pennock ND, 2014, P NATL ACAD SCI USA, V111, P16472, DOI 10.1073/pnas.1407393111; Raposo BR, 2010, ARTHRITIS RHEUM-US, V62, P2953, DOI 10.1002/art.27729; Robbins SH, 2003, J IMMUNOL, V170, P5876, DOI 10.4049/jimmunol.170.12.5876; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sanchez PJ, 2007, J IMMUNOL, V178, P1564, DOI 10.4049/jimmunol.178.3.1564; Sanchez PJ, 2012, VACCINE, V30, P1154, DOI 10.1016/j.vaccine.2011.12.017; Scharping NE, 2016, IMMUNITY, V45, P701, DOI 10.1016/j.immuni.2016.08.009; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Shore DA, 2008, J MOL BIOL, V384, P1190, DOI 10.1016/j.jmb.2008.09.069; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Thompson EA, 2015, J IMMUNOL, V195, P1015, DOI 10.4049/jimmunol.1500078; Van den Steen PE, 2010, AM J RESP CRIT CARE, V181, P957, DOI 10.1164/rccm.200905-0786OC; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Victorino F, 2015, J IMMUNOL, V195, P4973, DOI 10.4049/jimmunol.1500651; Wang QH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00892-y; Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z; Wieland A, 2015, IMMUNITY, V42, P367, DOI 10.1016/j.immuni.2015.01.009; Yamada DH, 2015, IMMUNITY, V42, P379, DOI 10.1016/j.immuni.2015.01.005; Yi ZA, 2012, DIABETES, V61, P2871, DOI 10.2337/db12-0098; Zwang NA, 2014, CURR OPIN ORGAN TRAN, V19, P357, DOI 10.1097/MOT.0000000000000096	56	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211446	10.1371/journal.pone.0211446	http://dx.doi.org/10.1371/journal.pone.0211446			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735510	gold, Green Published, Green Submitted			2022-12-26	WOS:000458181200019
J	Ashbrook, AR; Scharf, ME; Bennett, GW; Gondhalekar, AD				Ashbrook, Aaron R.; Scharf, Michael E.; Bennett, Gary W.; Gondhalekar, Ameya D.			Bed bugs (Cimex lectularius L.) exhibit limited ability to develop heat resistance	PLOS ONE			English	Article							HEMIPTERA CIMICIDAE; HETEROPTERA CIMICIDAE; SHOCK PROTEINS; METABOLIC-RATE; TOLERANCE; COLD; DEHYDRATION; ACTIVATION; EXPRESSION; RESPONSES	The global population growth of the bed bug, Cimex lectularius (L.), is attributed to their cryptic behavior, diverse insecticide resistance mechanisms, and lack of public awareness. Bed bug control can be challenging and typically requires chemical and non-chemical treatments. One common non-chemical method for bed bug management is thermal remediation. However, in certain instances, bed bugs are known to survive heat treatments. Bed bugs may be present after a heat treatment due to (i) abiotic factors associated with the inability to achieve lethal temperatures in harborage areas for a sufficient time period, (ii) re-infestation from insects that escaped to cooler areas during a heat treatment or (iii) development of physiological resistance that allows them to survive heat exposure. Previous research has investigated the optimal temperature and exposure time required for either achieving complete mortality or sublethally affecting their growth and development. However, no research has examined bed bug populations for their ability to develop resistance to heat exposure and variation in thermo-tolerance between different bed bug strains. The goals of this study were: i) to determine if bed bugs could be selected for heat resistance under a laboratory selection regime, and ii) to determine if bed bug populations with various heat exposure histories, insecticide resistance profiles, and geographic origins have differential temperature tolerances using two heat exposure techniques (step-function and rampfunction). Selection experiments found an initial increase in bed bug survivorship; however, survivorship did not increase past the fourth generation. Sublethal exposure to heat significantly reduced bed bug feeding and, in some cases, inhibited development. The step-function exposure technique revealed non-significant variation in heat tolerance between populations and the ramp-function exposure technique provided similar results. Based on these study outcomes, the ability of bed bugs to develop heat resistance appears to be limited.	[Ashbrook, Aaron R.; Scharf, Michael E.; Bennett, Gary W.; Gondhalekar, Ameya D.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Gondhalekar, AD (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	ameyag@purdue.edu		Gondhalekar, Ameya/0000-0003-4002-0914	Pest Management Foundation [208527]; US Department of Housing and Development [INHHU0026-14]; ADG; Gerald Leep Family; J. T. Eaton and Company; Pi Chi Omega; National Pest Management Foundation	Pest Management Foundation; US Department of Housing and Development; ADG; Gerald Leep Family; J. T. Eaton and Company; Pi Chi Omega; National Pest Management Foundation	This research was funded by a grant award from the Pest Management Foundation (#208527) to ADG, MES and GWB. MES received a grant award from US Department of Housing and Development (INHHU0026-14); and ADG supported the graduate assistantship for the first author, ARA. Additionally, ARA was supported by merit-based scholarships from Gerald Leep Family, J. T. Eaton and Company, Pi Chi Omega, National Pest Management Foundation and R. O. William. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026228; Ashbrook AR, 2017, J ECON ENTOMOL, V110, P1195, DOI 10.1093/jee/tox070; Bahrndorff S, 2009, FUNCT ECOL, V23, P233, DOI 10.1111/j.1365-2435.2009.01541.x; Balvin O, 2015, SYST ENTOMOL, V40, P652, DOI 10.1111/syen.12127; Bennett GW, 2016, PEST MANAG SCI, V72, P8, DOI 10.1002/ps.4084; Benoit JB, 2009, MED VET ENTOMOL, V23, P418, DOI 10.1111/j.1365-2915.2009.00832.x; Benoit JB, 2007, AM J TROP MED HYG, V76, P987, DOI 10.4269/ajtmh.2007.76.987; Benoit JB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10165; Benoit JB, 2011, P NATL ACAD SCI USA, V108, P8026, DOI 10.1073/pnas.1105195108; Benoit JB, 2009, COMP BIOCHEM PHYS A, V152, P518, DOI 10.1016/j.cbpa.2008.12.009; Boase C, 2014, URBAN INSECT PESTS: SUSTAINABLE MANAGEMENT STRATEGIES, P8, DOI 10.1079/9781780642758.0008; Booth W, 2012, J MED ENTOMOL, V49, P535, DOI 10.1603/ME11256; BRISCOE DA, 1992, CONSERV BIOL, V6, P416, DOI 10.1046/j.1523-1739.1992.06030416.x; Campbell BE, 2016, FLA ENTOMOL, V99, P549, DOI 10.1653/024.099.0333; CHANG KP, 1974, J INVERTEBR PATHOL, V23, P333, DOI 10.1016/0022-2011(74)90098-6; Chin-Heady E, 2013, PEST MANAG SCI, V69, P1115, DOI 10.1002/ps.3482; Clarke K.U., 1967, THERMOBIOLOGY, P293; Cooper R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136462; DeVries ZC, 2016, J EXP BIOL, V219, P3773, DOI 10.1242/jeb.143487; DeVries ZC, 2016, COMP BIOCHEM PHYS A, V197, P52, DOI 10.1016/j.cbpa.2016.03.003; DeVries ZC, 2015, PHYSIOL BIOCHEM ZOOL, V88, P53, DOI 10.1086/679499; Doggett SL, 2006, J ECON ENTOMOL, V99, P2132, DOI 10.1603/0022-0493-99.6.2132; Doggett SL, 2012, CLIN MICROBIOL REV, V25, P164, DOI 10.1128/CMR.05015-11; Drijfhout F, 2009, BEHAV CHEM ECOLOGY, P2; Edney E.B., 1977, WATER BALANCE LAND A, P17; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feng HZ, 2012, J ZHEJIANG U SCI, V2, P159; Gapon D. A., 2016, ZOOSYSTEMATICA ROSSICA, V25, P239; Gray EM, 2013, J INSECT PHYSIOL, V59, P1001, DOI 10.1016/j.jinsphys.2013.08.001; How YF, 2014, J ECON ENTOMOL, V6, P987; HUEY RB, 1992, FUNCT ECOL, V6, P489, DOI 10.2307/2389288; HUEY RB, 1991, EVOLUTION, V45, P751, DOI 10.1111/j.1558-5646.1991.tb04343.x; Kells S.A., 2018, ADV BIOL MANAGEMENT, P257; Kells Stephen A, 2011, Insects, V2, P412, DOI 10.3390/insects2030412; Kim KS, 2007, ENVIRON ENTOMOL, V36, P637, DOI 10.1603/0046-225X(2007)36[637:GDILCO]2.0.CO;2; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Koganemaru R, 2013, PESTIC BIOCHEM PHYS, V106, P190, DOI 10.1016/j.pestbp.2013.01.001; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Liu K L, 2007, CHINESE AGR SCI B, V1, P249; Loudon C, 2017, PEST MANAG SCI, V73, P64, DOI 10.1002/ps.4409; Mukhopadhyay J, 1997, AM J TROP MED HYG, V57, P216, DOI 10.4269/ajtmh.1997.57.216; Neven LG, 1998, J ECON ENTOMOL, V91, P297, DOI 10.1093/jee/91.1.297; NEWBERRY K, 1989, MED VET ENTOMOL, V3, P407, DOI 10.1111/j.1365-2915.1989.tb00248.x; Okada Y, 2014, PHYSIOL ENTOMOL, V39, P304, DOI 10.1111/phen.12076; Omori N, 1941, J FORMOS MED ASSOC, V40, P129; Pereira RM, 2009, J ECON ENTOMOL, V102, P1182, DOI 10.1603/029.102.0342; Raab RW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0117805; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Robertson JL, 2008, BIOASSAYS ARTHROPODS; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Rukke BA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193788; Rukke BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127555; Schrader G, 2011, PERSONAL EPISTEMOLOG, P265; Steelman CD, 2008, J AGR URBAN ENTOMOL, V25, P41, DOI 10.3954/1523-5475-25.1.41; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; van Dooremalen C, 2011, J INSECT PHYSIOL, V57, P1267, DOI 10.1016/j.jinsphys.2011.05.017; Vinnersten Thomas Persson, 2017, Entomologisk Tidskrift, V138, P67; Wagner D, 2001, J CHEM ECOL, V27, P1805, DOI 10.1023/A:1010408725464; Wang DS, 2018, J MED ENTOMOL, V55, P1536, DOI 10.1093/jme/tjy113; Yocum GD, 1993, J INSECT PHYSIOL, V40, P13; Zizzari ZV, 2011, J INSECT PHYSIOL, V57, P421, DOI 10.1016/j.jinsphys.2011.01.002	61	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211677	10.1371/journal.pone.0211677	http://dx.doi.org/10.1371/journal.pone.0211677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30731005	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000042
J	Besser, TE; Levy, J; Ackerman, M; Nelson, D; Manlove, K; Potter, KA; Busboom, J; Benson, M				Besser, Thomas E.; Levy, Jessica; Ackerman, Melissa; Nelson, Danielle; Manlove, Kezia; Potter, Kathleen A.; Busboom, Jan; Benson, Margaret			A pilot study of the effects of Mycoplasma ovipneumoniae exposure on domestic lamb growth and performance	PLOS ONE			English	Article							CHRONIC NONPROGRESSIVE PNEUMONIA; NEW-ZEALAND; SHEEP	Mycoplasma ovipneumoniae is a globally distributed pathogen that has been associated with pneumonia in both domestic and wild Caprinae. It is closely related to M. hyopneumoniae, a respiratory pathogen of swine that is associated with decreased growth rates of pigs as well as clinical respiratory disease. In order to assess the effects of M. ovipneumoniae on lamb performance, we generated a cohort of lambs free of M. ovipneumoniae by segregation of test negative ewes after lambing, then compared the growth and carcass quality traits of M. ovipneumoniae-free and -colonized lambs from weaning to harvest. Some signs of respiratory disease were observed during the feeding trial in both lamb groups, but the M. ovipneumoniae-exposed group included more affected lambs and higher average disease scores. At harvest, lungs of lambs in both groups showed few grossly visible lesions, although the M. ovipneumoniae-exposed group did exhibit increased microscopic lung lesions (P<0.05). In addition, M. ovipneumoniae exposed lambs produced lower average daily gains (P<0.05), and lower yield grade carcasses (P<0.05) compared to those of non-exposed lambs. The results demonstrated the feasibility of test and segregation for elimination of M. ovipneumoniae from groups of sheep and suggested that this pathogen may impair lamb growth and productivity even in the absence of overt respiratory disease.	[Besser, Thomas E.; Levy, Jessica; Nelson, Danielle; Potter, Kathleen A.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Ackerman, Melissa] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Manlove, Kezia] Utah State Univ, Coll Nat Resources, Dept Wildland Resources, Logan, UT 84322 USA; [Busboom, Jan; Benson, Margaret] Washington State Univ, Dept Anim Sci, Coll Agr Human & Nat Resource Sci, Pullman, WA 99164 USA	Washington State University; Washington State University; Utah System of Higher Education; Utah State University; Washington State University	Besser, TE (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	tbesser@wsu.edu	Nelson, Danielle D/X-8743-2019	Besser, Thomas/0000-0003-0449-1989	Wild Sheep Foundation/Foundation [WSU003366]	Wild Sheep Foundation/Foundation	This work was supported by the Wild Sheep Foundation/Foundation for North American Wild Sheep (https://www.wildsheepfoundation.org/) Grant-in-Aid #WSU003366 to TEB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKAISSI A, 1983, VET MICROBIOL, V8, P571, DOI 10.1016/0378-1135(83)90006-8; ALLEY MR, 1987, NEW ZEAL VET J, V35, P163, DOI 10.1080/00480169.1987.35429; Alley MR, 1999, NEW ZEAL VET J, V47, P155, DOI 10.1080/00480169.1999.36135; Besser TE, 2013, PREV VET MED, V108, P85, DOI 10.1016/j.prevetmed.2012.11.018; Cassirer EF, 2018, J WILDLIFE MANAGE, V82, P32, DOI 10.1002/jwmg.21309; Goodwin KA, 2004, NEW ZEAL VET J, V52, P175, DOI 10.1080/00480169.2004.36425; Goodwin-Ray KA, 2008, NEW ZEAL VET J, V56, P107, DOI 10.1080/00480169.2008.36818; Goodwin-Ray KA, 2008, PREV VET MED, V85, P136, DOI 10.1016/j.prevetmed.2008.01.010; JONES GE, 1982, VET REC, V110, P168, DOI 10.1136/vr.110.8.168; Kirton A H, 1976, N Z Vet J, V24, P59, DOI 10.1080/00480169.1976.34284; Martin WB, 1996, COMP IMMUNOL MICROB, V19, P171, DOI 10.1016/0147-9571(96)00002-1; McAuliffe L, 2003, VET REC, V153, P687, DOI 10.1136/vr.153.22.687; Nicholas R, 2008, MYCOPLASMA DISEASES OF RUMINANTS, P1, DOI 10.1079/9780851990125.0000; Roos LR, 2016, VET MICROBIOL, V184, P51, DOI 10.1016/j.vetmic.2016.01.008; SCHEIDT AB, 1990, J AM VET MED ASSOC, V196, P881; STGEORGE TD, 1975, VET REC, V97, P205, DOI 10.1136/vr.97.11.205; Switzer W. P., 1975, Diseases of swine,, P741; USDA, 1992, OFF US STAND GRAD LA; USDA-APHIS, 2015, MYC OV US SHEEP OP; Volokhov DV, 2012, MOL PHYLOGENET EVOL, V62, P515, DOI 10.1016/j.ympev.2011.11.002; Ziegler JC, 2014, PLOS ONE, V9; Zimmermann W, 2001, TIERAERZTL UMSCHAU, V56, P339	22	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0207420	10.1371/journal.pone.0207420	http://dx.doi.org/10.1371/journal.pone.0207420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730893	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000002
J	Hung, JJ; Peng, SH; Chen, CTA; Wei, TP; Hwang, JS				Hung, Jia-Jang; Peng, Shao-Hung; Chen, Chen-Tung Arthur; Wei, Tsui-Ping; Hwang, Jiang-Shiou			Reproductive adaptations of the hydrothermal vent crab Xenograpus testudinatus: An isotopic approach	PLOS ONE			English	Article							SEDIMENTS; DELTA-N-15; DELTA-C-13; SEA	The vent crab Xenograpsus testudinatus was firstly discovered in 2000 at the hydrothermal vent field off the coast of Kueishan Island. The present study attempts to understand the adaptive reproduction of this crab living in an extreme environment by examining its spatial and temporal distribution and isotopic signatures. The seasonal variation of the female-male ratio suggests that ovigerous females may migrate from beneath the vent orifice to the vent-periphery region to release their larvae to avoid the larvae contacting high toxic plumes, and then returns to the vent orifice habitat. We used variation of the isotopic crab signatures as indicators for this unique female migration. Our results showed that this vent crab evolved an adaptive modulation of reproductive behavior to successfully survive and propagate in an oceanic shallow hydrothermal vent field.	[Hung, Jia-Jang; Peng, Shao-Hung; Chen, Chen-Tung Arthur] Natl Sun Yat Sen Univ, Asian Pacific Ocean Res Ctr, Dept Oceanog, Kaohsiung, Taiwan; [Peng, Shao-Hung] Natl Cheng Kung Univ, Ctr Res Water Sci & Technol, Tainan, Taiwan; [Wei, Tsui-Ping] Natl Taiwan Univ, Inst Fisheries Sci, Taipei, Taiwan; [Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan	National Sun Yat Sen University; National Cheng Kung University; National Taiwan University; National Taiwan Ocean University; National Taiwan Ocean University	Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan.; Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan.	jshwang@mail.ntou.edu.tw	Chen, Chen-Tung Arthur/C-8901-2011; chen, chen/GRY-7085-2022; CHEN, CHEN/HDM-6657-2022	Chen, Chen-Tung Arthur/0000-0002-5170-6471; Hung, Jia-Jang/0000-0003-3432-2107	National Sun Yat-sen University; Ministry of Education, Taiwan, ROC ("Aim for the Top University Plan) [99C030302, 00C030203]; Ministry of Science and Technology (MOST) of Taiwan [MOST 105-2611-M-110-016, MOST 104-2611-M-019-004, MOST 105-2621-M-019-001, MOST 105-2918-I-019-001, MOST 106-2621-M-019-001, MOST 107-2621-M-019-001]; Ministry of Education; Ministry of Science and Technology of Taiwan	National Sun Yat-sen University; Ministry of Education, Taiwan, ROC ("Aim for the Top University Plan); Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Sun Yat-sen University and the Ministry of Education, Taiwan, ROC ("Aim for the Top University Plan" 99C030302 and 00C030203); Ministry of Science and Technology (MOST) of Taiwan grant nos. MOST 105-2611-M-110-016(JJH), MOST 104-2611-M-019-004, MOST 105-2621-M-019-001, MOST 105-2918-I-019-001 and MOST 106-2621-M-019-001, MOST 107-2621-M-019-001 (JSH). The funders are the Ministry of Education and Ministry of Science and Technology of Taiwan, they had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodin N, 2007, J EXP MAR BIOL ECOL, V343, P149, DOI 10.1016/j.jembe.2006.09.024; Chang NN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204753; Dahms HU, 2018, HYDROBIOLOGIA, V818, P1, DOI 10.1007/s10750-018-3598-8; Dahms HU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182649; Galkin SV, 1997, MAR GEOL, V142, P197, DOI 10.1016/S0025-3227(97)00051-0; Hu MYA, 2012, AQUAT BIOL, V15, P11, DOI 10.3354/ab00396; Hung JJ, 2018, MAR CHEM, V198, P88, DOI 10.1016/j.marchem.2017.12.004; Hung JJ, 2009, J MARINE SYST, V76, P479, DOI 10.1016/j.jmarsys.2008.03.022; Hung JJ, 2008, MAR ENVIRON RES, V65, P1, DOI 10.1016/j.marenvres.2007.07.003; Jeng MS, 2004, NATURE, V432, P969, DOI 10.1038/432969a; Liu XD, 2006, EARTH PLANET SC LETT, V243, P424, DOI 10.1016/j.epsl.2006.01.018; Peng SH, 2011, MAR POLLUT BULL, V63, P396, DOI 10.1016/j.marpolbul.2011.05.013; Perovich GM, 2003, MAR ECOL PROG SER, V251, P211, DOI 10.3354/meps251211; Riera P, 2000, MAR ECOL PROG SER, V199, P205, DOI 10.3354/meps199205; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021	15	5	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211516	10.1371/journal.pone.0211516	http://dx.doi.org/10.1371/journal.pone.0211516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730900	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000030
J	Liao, XY; Hao, YS; Zhang, XF; Ward, S; Houldsworth, J; Polydorides, AD; Harpaz, N				Liao, Xiaoyan; Hao, Yansheng; Zhang, Xiaofei; Ward, Stephen; Houldsworth, Jane; Polydorides, Alexandros D.; Harpaz, Noam			Clinicopathological characterization of SMAD4-mutated intestinal adenocarcinomas: A case-control study	PLOS ONE			English	Article							COLORECTAL-CANCER; SMAD4; MUTATION; EXPRESSION; PROGNOSIS; CETUXIMAB; PREDICTS; GRADE	The SMAD4 tumor suppressor gene product inhibits transforming growth factor-beta-mediated signaling and is mutated in similar to 10% of colorectal carcinomas. The prognostic significance of SMAD4 mutations has been controversial. We studied the pathological and clinical characteristics of SMAD4-mutated intestinal adenocarcinomas using a retrospective case-control study design. Cases and controls were identified among 443 primary adenocarcinomas that had undergone next generation DNA sequencing (NGS) with the Ion AmpliSeq Cancer Hotspot Panel v2, which evaluates 50 cancer-related genes. Twenty-eight SMAD4-mutated (SMAD4m) patients were matched 1:2 with 56 consecutive SMAD4 wild-type (SMAD4wt) control patients from the same analysis stream. Compared with the SMAD4wt controls, the SMAD4m tumors were of higher stage (P = 0.026) and were more likely to feature mucinous differentiation (P = 0.0000), to occur in the setting of Crohn's disease (P = 0.0041), and to harbor concurrent RAS mutations (P = 0.0178). Tumor mucin content was significantly correlated with mutations involving the MH2 domain of the SMAD4 protein (P = 0.0338). Correspondence between mutation sites and morphology was demonstrated directly in a mixed adenocarcinoma and neuroendocrine tumor where SMAD4 mutations involving different protein domains were found in histologically disparate tumor regions despite both containing identical KRAS and TP53 mutations.	[Liao, Xiaoyan; Hao, Yansheng; Zhang, Xiaofei; Ward, Stephen; Houldsworth, Jane; Polydorides, Alexandros D.; Harpaz, Noam] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Liao, Xiaoyan] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA	Icahn School of Medicine at Mount Sinai; University of Rochester	Liao, XY (corresponding author), Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA.; Liao, XY (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA.	Xiaoyan_liao@urmc.rochester.edu	hao, yan/HGB-0465-2022; Harpaz, Noam/L-3411-2017	Harpaz, Noam/0000-0003-4923-2200				Aaltonen LA, 2000, PATHOLOGY GENETICS T; Alazzouzi H, 2005, CLIN CANCER RES, V11, P2606, DOI 10.1158/1078-0432.CCR-04-1458; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chacko BM, 2001, NAT STRUCT BIOL, V8, P248, DOI 10.1038/84995; Chang SC, 2016, ANN SURG ONCOL, V23, P849, DOI 10.1245/s10434-015-4899-z; Chung Y, 2018, J PATHOL TRANSL MED, V52, P37, DOI 10.4132/jptm.2017.10.20; Davison JM, 2014, AM J SURG PATHOL, V38, P583, DOI 10.1097/PAS.0000000000000194; Felsenstein M, 2018, GUT, V67, P1652, DOI 10.1136/gutjnl-2017-315062; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Goswami RS, 2015, CLIN CANCER RES, V21, P2644, DOI 10.1158/1078-0432.CCR-14-2391; Houlston R, 1998, HUM MOL GENET, V7, P1907, DOI 10.1093/hmg/7.12.1907; Itatani Y, 2013, GASTROENTEROLOGY, V145, P1064, DOI 10.1053/j.gastro.2013.07.033; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khan M, 2018, CLIN COLORECTAL CANC, V17, pE699, DOI 10.1016/j.clcc.2018.07.005; Klausen P, 2018, GASTROENTEROLOGY RES, V2018, P1; Kozak MM, 2015, J CLIN PATHOL, V68, P341, DOI 10.1136/jclinpath-2014-202660; Li WB, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1345-3; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Mizuno T, 2018, EJSO-EUR J SURG ONC, V44, P684, DOI 10.1016/j.ejso.2018.02.247; Sarshekeh AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173345; Schrock AB, 2017, JAMA ONCOL, V3, P1546, DOI 10.1001/jamaoncol.2017.1051; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Yaeger R, 2016, GASTROENTEROLOGY, V151, P278, DOI 10.1053/j.gastro.2016.04.001; Yoshioka Y, 2015, CANCER-AM CANCER SOC, V121, P4359, DOI 10.1002/cncr.29676	25	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0212142	10.1371/journal.pone.0212142	http://dx.doi.org/10.1371/journal.pone.0212142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730996	gold, Green Submitted, Green Published			2022-12-26	WOS:000458026000100
J	Lima, LP; Leite, HR; de Matos, MA; Neves, CDC; Lage, VKD; da Silva, GP; Lopes, GS; Chaves, MGA; Santos, JNV; Camargos, ACR; Figueiredo, PHS; Lacerda, ACR; Mendonca, VA				Lima, Liliana Pereira; Leite, Hercules Ribeiro; de Matos, Mariana Aguiar; Cunha Neves, Camila Danielle; da Silva Lage, Vanessa Kelly; da Silva, Guilherme Pinto; Lopes, Gladson Salomao; Abreu Chaves, Maria Gabriela; Vitor Santos, Joyce Noelly; Resende Camargos, Ana Cristina; Scheidt Figueiredo, Pedro Henrique; Rodrigues Lacerda, Ana Cristina; Mendonca, Vanessa Amaral			Cardiorespiratory fitness assessment and prediction of peak oxygen consumption by Incremental Shuttle Walking Test in healthy women	PLOS ONE			English	Article							REFERENCE VALUES; HEART-RATE; VALIDITY; RELIABILITY; EQUATION; ADULTS	Introduction Preliminary studies have showed that the Incremental Shuttle Walking Test (ISWT) is a maximal test, however comparison between ISWT with the cardiopulmonary exercise test (CEPT) has not yet performed in the healthy woman population. Furthermore, there is no regression equation available in the current literature to predict oxygen peak consumption (VO2 peak). Thus, this study aimed to compare the ISWT with CEPT and to develop an equation to predict peak oxygen uptake (VO2 peak) in healthy women participants. Methods First, the VO2 peak, respiratory exchange ratio (R peak), heart rate max (HR max) and percentage of predicted HR max (% predicted HR max) were evaluated in the CEPT and ISWT (n = 40). Then, an equation was developed to predict the VO2 peak (n = 54) and its validation was performed (n = 20). Results There were no significant differences between the ISWT and CEPT of VO2 peak, HR max and % predicted HR max values (P>0.05), except for R peak measure in the ISWT (1.22 +/- 0.13) and CEPT (1.18 +/- 0.1) (P = 0.022). Therefore, both tests showed a moderate positive correlation of VO2 peak (r = 0.51; P = 0.0007), HR max (r = 0.65; P<0.0001) and R peak (r = 0.55; P = 0.0002) and the Bland-Altman analysis showed agreement of VO2 peak (bias = -0.14). The distance walked on ISWT and age explained 36.3% (R-2 Adjusted = 0.363) of the variance in VO2 peak. The equation developed was VO2 peak (predicted) = 19.793 + (0.02 x distance walked)-(0.236 x age). There was no statistically significant difference between the VO2 peak measured directly and the predicted, and the Bland-Altman analysis showed agreement (bias = 1.5 ml/kg/min). Conclusion ISWT is a maximal test showing similar results compared to the CEPT, and the predicted equation was valid and applicable for VO2 peak assessing in young adult healthy women.	[Lima, Liliana Pereira; Leite, Hercules Ribeiro; da Silva, Guilherme Pinto; Resende Camargos, Ana Cristina; Scheidt Figueiredo, Pedro Henrique; Rodrigues Lacerda, Ana Cristina; Mendonca, Vanessa Amaral] Univ Fed Vales Jequitinhonha & Mucuri, Programa Posgrad Reabilitacao & Desempenho Func, Dept Fisioterapia, Diamantina, MG, Brazil; [Lima, Liliana Pereira; Leite, Hercules Ribeiro; de Matos, Mariana Aguiar; Cunha Neves, Camila Danielle; da Silva Lage, Vanessa Kelly; da Silva, Guilherme Pinto; Lopes, Gladson Salomao; Abreu Chaves, Maria Gabriela; Vitor Santos, Joyce Noelly; Resende Camargos, Ana Cristina; Scheidt Figueiredo, Pedro Henrique; Rodrigues Lacerda, Ana Cristina; Mendonca, Vanessa Amaral] Univ Fed Vales Jequitinhonha & Mucuri, CIPq Saude, LIM, Diamantina, MG, Brazil	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM)	Mendonca, VA (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Programa Posgrad Reabilitacao & Desempenho Func, Dept Fisioterapia, Diamantina, MG, Brazil.; Mendonca, VA (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, CIPq Saude, LIM, Diamantina, MG, Brazil.	vaafisio@hotmail.com	Lacerda, Ana Cristina/J-2181-2012; Leite, Hércules Ribeiro/GVT-1268-2022; Pereira Lima, Liliana/AAY-4860-2021; Lage, Vanessa/AAE-6639-2019; Mendonça, Vanessa Amaral/T-7958-2019; Figueiredo, Pedro Henrique/AAP-2158-2020; Leite, Hércules Ribeiro/T-8366-2019; Camargos, Ana Cristina/O-5993-2016	Lacerda, Ana Cristina/0000-0001-5366-3754; Leite, Hércules Ribeiro/0000-0001-8977-8131; Pereira Lima, Liliana/0000-0002-6839-4363; Lage, Vanessa/0000-0002-0381-5622; Mendonça, Vanessa Amaral/0000-0002-1696-6091; Leite, Hércules Ribeiro/0000-0001-8977-8131; Camargos, Ana Cristina/0000-0003-2719-4231				Agarwal B, 2016, LUNG INDIA, V33, P36, DOI 10.4103/0970-2113.173056; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Balady Gary J, 2014, DIR ACSM TEST EST SU; Bradley J, 1999, THORAX, V54, P437, DOI 10.1136/thx.54.5.437; Despres JP, 2016, CAN J CARDIOL, V32, P505, DOI 10.1016/j.cjca.2015.12.006; Dourado VZ, 2013, BRAZ J MED BIOL RES, V46, P194, DOI 10.1590/1414-431X20122376; Dourado VZ, 2013, J BRAS PNEUMOL, V39, P190, DOI 10.1590/S1806-37132013000200010; Dourado VZ, 2011, J BRAS PNEUMOL, V37, P607, DOI 10.1590/S1806-37132011000500007; Goncalves CG, 2015, PHYSIOTHERAPY, V101, P141, DOI 10.1016/j.physio.2014.11.002; Harrison SL, 2013, J CARDIOPULM REHABIL, V33, P309, DOI 10.1097/HCR.0b013e3182a0297e; Hawkins SA, 2003, SPORTS MED, V33, P877, DOI 10.2165/00007256-200333120-00002; Herdy AH, 2016, ARQ BRAS CARDIOL, V106, P389, DOI 10.5935/abc.20160070; Jurgensen SP, 2015, CLIN PHYSIOL FUNCT I, V35, P120, DOI 10.1111/cpf.12135; Jurgensen SP, 2011, RESPIRATION, V81, P223, DOI 10.1159/000319037; Jurgensen SP, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165229; Jurio-Iriarte B, 2017, J AM SOC HYPERTENS, V11, P186, DOI 10.1016/j.jash.2017.01.008; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Lanza FD, 2015, J PEDIATR-US, V167, P1057, DOI 10.1016/j.jpeds.2015.07.068; Lewis ME, 2001, HEART, V86, P183, DOI 10.1136/heart.86.2.183; Lima VP, 2018, PHYSIOTHER THEOR PR, V34, P806, DOI 10.1080/09593985.2018.1425786; Morales FJ, 1999, AM HEART J, V138, P291, DOI 10.1016/S0002-8703(99)70114-6; Neves CDC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117563; Nici L, 2006, AM J RESP CRIT CARE, V173, P1390, DOI 10.1164/rccm.200508-1211ST; Nunes RA, 2005, FITNESS PERFORMANCE, V4, P27, DOI DOI 10.3900/fpj.4.1.27.e; Onorati P, 2003, EUR J APPL PHYSIOL, V89, P331, DOI 10.1007/s00421-003-0803-9; Palange P, 2000, J APPL PHYSIOL, V88, P1715, DOI 10.1152/jappl.2000.88.5.1715; Pascatello LS., 2018, DIRETRIZES ACSM TEST, V10th; Pinho TMP., 2015, PREDICTIVE EQUATION; Probst VS, 2012, RESP MED, V106, P243, DOI 10.1016/j.rmed.2011.07.023; Robergs RA, 2010, SPORTS MED, V40, P95, DOI 10.2165/11319670-000000000-00000; Robles P, 2017, J CARDIOPULM REHABIL, V37, P356, DOI 10.1097/HCR.0000000000000282; Sawyer BJ, 2010, MED SCI SPORT EXER, V42, P2122, DOI 10.1249/MSS.0b013e3181de2da7; SINGH SJ, 1994, EUR RESPIR J, V7, P2016; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; Vardhan V, 2017, INT J PHARM BIO SCI, V8, P478	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211327	10.1371/journal.pone.0211327	http://dx.doi.org/10.1371/journal.pone.0211327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730949	Green Published, Green Submitted, gold			2022-12-26	WOS:000458026000021
J	Lin, Y; Wu, CC; Wang, XY; Liu, S; Kemper, T; Li, FH; Squire, A; Zhu, Y; Zhang, JM; Chen, XW; Lu, MJ				Lin, Yong; Wu, Chunchen; Wang, Xueyu; Liu, Shi; Kemper, Thekla; Li, Fahong; Squire, Anthony; Zhu, Ying; Zhang, Jiming; Chen, Xinwen; Lu, Mengji			Synaptosomal-associated protein 29 is required for the autophagic degradation of hepatitis B virus	FASEB JOURNAL			English	Article						HBV; SNAP29; VAMP8; autophagy	LYSOSOME FUSION; REPLICATION; COMPLEX; SUPPRESSION; ACTIVATION; INFECTION	Hepatitis B virus (HBV) replication and envelopment is dependent on cellular autophagy. Previously, we have provided evidence for the extensive lysosomal degradation of HBV virions and the hepatitis B surface antigen (HBsAg), which is likely controlled by autophagosome-lysosome fusion. Synaptosomal-associated protein 29 (SNAP29) has been identified as a protein specifically mediating autophagosome-lysosome fusion. Thus, in the present study, we addressed the hypothesis that SNAP29 is required for the autophagic degradation of HBV virions and HBsAg. We found that silencing SNAP29 significantly increased the number of autophagosomes and concomitantly promoted HBV replication and HBsAg production. Conversely, SNAP29 overexpression decreased HBV production. Consistent with this, SNAP29 modulated HBV production by interacting with vesicle-associated membrane protein 8 (VAMP8) and synergistically regulated HBV replication with Rab7 complexes. Moreover, the production and release of the small HBsAg is strongly regulated by SNAP29 expression, suggesting that its export occurs partly through the autophagic pathway. Our findings provide new evidence, strongly suggesting that autophagic degradation critically determines the production of HBV virions and HBsAg and that this is controlled by the SNAP29-VAMP8 interaction.Lin, Y., Wu, C., Wang, X., Liu, S., Kemper, T., Li, F., Squire, A., Zhu, Y., Zhang, J., Chen, X., Lu, M. Synaptosomal-associated protein 29 is required for the autophagic degradation of hepatitis B virus.	[Lin, Yong; Wang, Xueyu; Liu, Shi; Kemper, Thekla; Li, Fahong; Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Squire, Anthony] Univ Duisburg Essen, Univ Hosp Essen, Inst Expt Immunol & Imaging, Essen, Germany; [Wu, Chunchen; Chen, Xinwen] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Liu, Shi; Zhu, Ying] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Li, Fahong; Zhang, Jiming] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China	University of Duisburg Essen; University of Duisburg Essen; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Wuhan University; Fudan University	Lu, MJ (corresponding author), Univ Hosp Essen, Inst Virol, Hufelandstr 55, D-45122 Essen, Germany.	mengji.lu@uni-due.de	Lu, Mengji/ABF-9410-2020		Deutsche Forschungsgemeinschaft [RTG1949/2, Transregio TRR60]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (RTG1949/2 and Transregio TRR60). The authors declare no conflicts of interest.	Arasaki K, 2018, EMBO REP, V19, DOI 10.15252/embr.201745584; Carman WF, 1997, HEPATOLOGY, V26, P1658, DOI 10.1002/hep.510260640; Chua CEL, 2012, J CELL PHYSIOL, V227, P3722, DOI 10.1002/jcp.24082; Diao JJ, 2015, NATURE, V520, P563, DOI 10.1038/nature14147; Ding BB, 2014, CELL HOST MICROBE, V15, P564, DOI 10.1016/j.chom.2014.04.004; Doring T, 2018, J VIROL, V92, DOI 10.1128/JVI.01513-17; Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066; Inoue J, 2015, J CELL SCI, V128, P1696, DOI 10.1242/jcs.158097; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jiang P, 2014, MOL BIOL CELL, V25, P1327, DOI 10.1091/mbc.E13-08-0447; Kimura T, 2017, EMBO J, V36, P42, DOI 10.15252/embj.201695081; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Li M, 2013, J BIOL CHEM, V288, P35769, DOI 10.1074/jbc.M113.511212; Lin Y, 2019, PROTEIN CELL, V10, P60, DOI 10.1007/s13238-018-0555-2; Lin Y, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12709; Liu B, 2014, AUTOPHAGY, V10, P416, DOI 10.4161/auto.27286; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mohamud Y, 2018, CELL REP, V22, P3292, DOI 10.1016/j.celrep.2018.02.090; Pellegrini P, 2014, AUTOPHAGY, V10, P562, DOI 10.4161/auto.27901; SCHIRMBECK R, 1995, J VIROL, V69, P5929, DOI 10.1128/JVI.69.10.5929-5934.1995; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Selzer L, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021394; Sir D, 2010, AUTOPHAGY, V6, P548, DOI 10.4161/auto.6.4.11669; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Szatmari Z, 2014, AUTOPHAGY, V10, P1154, DOI 10.4161/auto.29395; Tang LSY, 2018, JAMA-J AM MED ASSOC, V319, P1802, DOI 10.1001/jama.2018.3795; Tian YJ, 2011, J VIROL, V85, P13453, DOI 10.1128/JVI.06064-11; Tong SP, 2016, J HEPATOL, V64, pS4, DOI 10.1016/j.jhep.2016.01.027; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Xie N, 2016, AUTOPHAGY, V12, P1507, DOI 10.1080/15548627.2016.1191857; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11; Zhou TH, 2016, BIOSCI TRENDS, V10, P244, DOI 10.5582/bst.2016.01049	34	16	16	6	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6023	6034		10.1096/fj.201801995RR	http://dx.doi.org/10.1096/fj.201801995RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30742775	Bronze			2022-12-26	WOS:000466932600019
J	Wang, QJ; Hassan, BH; Lou, NJ; Merritt, J; Feng, YJ				Wang, Qingjing; Hassan, Bachar H.; Lou, Ningjie; Merritt, Justin; Feng, Youjun			Functional definition of NrtR, a remnant regulator of NAD(+) homeostasis in the zoonotic pathogen Streptococcus suis	FASEB JOURNAL			English	Article						NAD(+) salvage; Nudix-related transcriptional regulator; ADP-ribose; SS2; virulence	DEPENDENT TRANSCRIPTIONAL REGULATOR; ADP-RIBOSE; NADR REGULATOR; METABOLISM; VIRULENCE; BIOSYNTHESIS; REPRESSOR; BINDING; FAMILY; DOMAIN	NAD(+) is an enzyme cofactor required for the 3 domains of life. However, little is known about the NAD(+) biosynthesis and salvage pathways in the opportunistic pathogen Streptococcus suis. A genome-wide search allows us to identify the NAD(+) salvage pathway encoded by an operon of nadR-pnuC-nrtR (from SSU05_1973 to SSU05_1971 on the reverse strand) in the S. suis 05ZYH33 that causes streptococcal toxin shock-like syndrome. The regulator of this pathway is Nudix-related transcriptional regulator (NrtR), a transcription regulator of the Nudix family comprising an N-terminal Nudix-like effector domain, and a C-terminal DNA-binding winged helix-turn-helix-like domain. Intriguingly, the S. suis NrtR naturally contains a single amino acid substitution (K92E) in the catalytic site of its Nudix domain that renders it catalytically inactive but does not influence its ability to bind DNA. Despite its lack of enzymatic activity, DNA-binding activity of NrtR is antagonized by the effector ADP-ribose. Furthermore, nrtR knockout in S. suis serotype 2 reduces its capacity to form biofilms and attenuates its virulence in a mouse infection model. Genome mining indicates that nrtR appears in a strain-specific manner whose occupancy is correlated to bacterial infectivity. Unlike the paradigmatic member of NrtR family having 2 unrelated functions (Nudix hydrolase and DNA binding), S. suis 2 retains a single regulatory role in the modulation of NAD(+) salvage. This control of NAD(+) homeostasis contributes to S. suis virulence.Wang, Q., Hassan, B. H., Lou, N., Merritt, J., Feng, Y. Functional definition of NrtR, a remnant regulator of NAD(+) homeostasis in the zoonotic pathogen Streptococcus suis.	[Wang, Qingjing; Lou, Ningjie; Feng, Youjun] Zhejiang Univ, Dept Pathogen Biol & Microbiol, Affiliated Hosp 2, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Qingjing; Lou, Ningjie; Feng, Youjun] Zhejiang Univ, Dept Gen Intens Care Unit, Affiliated Hosp 2, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Hassan, Bachar H.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Merritt, Justin] Oregon Hlth & Sci Univ, Dept Restorat Dent, Portland, OR 97201 USA	Zhejiang University; Zhejiang University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Oregon Health & Science University	Feng, YJ (corresponding author), Zhejiang Univ, Dept Pathogen Biol & Microbiol, Affiliated Hosp 2, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.; Feng, YJ (corresponding author), Zhejiang Univ, Dept Gen Intens Care Unit, Affiliated Hosp 2, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.	fengyj@zju.edu.cn			National Natural Science Foundation of China [81772142, 31830001]; National Key R&D Program of China [2017YFD0500202]; national Thousand Talents Program of China; National Institutes of Health; National Institute of Dental and Craniofacial Research Grants [DE018893, DE022083, DE028252]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; national Thousand Talents Program of China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research Grants	This work was supported by the National Natural Science Foundation of China (81772142 and 31830001, to Y.F.) and the National Key R&D Program of China (2017YFD0500202, to Y.F.). Y.F. is a recipient of the national Thousand Talents Program of China. J.M. is supported by National Institutes of Health and National Institute of Dental and Craniofacial Research Grants (DE018893, DE022083, and DE028252). The authors declare no conflicts of interest.	Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Chen C, 2018, NUCLEIC ACIDS RES, V46, pD640, DOI 10.1093/nar/gkx1043; DOM P, 1992, J VET MED B, V39, P303, DOI 10.1111/j.1439-0450.1992.tb01173.x; Feng Y, 2009, ZOONOSES PUBLIC HLTH, V56, P506, DOI 10.1111/j.1863-2378.2008.01225.x; Feng YJ, 2014, VIRULENCE, V5, P477, DOI 10.4161/viru.28595; Feng YJ, 2014, MOL MICROBIOL, V91, P300, DOI 10.1111/mmi.12460; Feng YJ, 2011, MOL MICROBIOL, V80, P195, DOI 10.1111/j.1365-2958.2011.07564.x; Feng YJ, 2010, J BACTERIOL, V192, P4289, DOI 10.1128/JB.00516-10; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Calixto GMF, 2018, INT J NANOMED, V13, P31, DOI 10.2147/IJN.S147553; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Gerasimova Anna V., 2005, Journal of Bioinformatics and Computational Biology, V3, P1007, DOI 10.1142/S0219720005001387; Grose JH, 2005, J BACTERIOL, V187, P2774, DOI 10.1128/JB.187.8.2774-2782.2005; Huang N, 2008, STRUCTURE, V16, P196, DOI 10.1016/j.str.2007.11.017; Huang N, 2009, STRUCTURE, V17, P939, DOI 10.1016/j.str.2009.05.012; Johnson MDL, 2015, MICROBIOL-SGM, V161, P2127, DOI 10.1099/mic.0.000164; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Krapp AR, 2002, J BACTERIOL, V184, P1474, DOI 10.1128/JB.184.5.1474-1480.2002; Kurnasov OV, 2002, J BACTERIOL, V184, P6906, DOI 10.1128/JB.184.24.6906-6917.2002; Li Q, 2018, VET MICROBIOL, V216, P198, DOI 10.1016/j.vetmic.2018.02.013; Mushegian Arcady, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P127; Okon E, 2017, INT J MED MICROBIOL, V307, P83, DOI 10.1016/j.ijmm.2016.09.007; Okuda K, 2005, J BACTERIOL, V187, P4984, DOI 10.1128/JB.187.14.4984-4991.2005; Penfound T, 1999, J BACTERIOL, V181, P648, DOI 10.1128/JB.181.2.648-655.1999; Raffaelli N, 1999, J BACTERIOL, V181, P5509, DOI 10.1128/JB.181.17.5509-5511.1999; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2032, DOI 10.1093/nar/gkn046; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Rossolillo P, 2005, J BACTERIOL, V187, P7155, DOI 10.1128/JB.187.20.7155-7160.2005; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Tang JQ, 2006, PLOS MED, V3, P1439, DOI 10.1371/journal.pmed.0030377; Teramoto H, 2012, MICROBIOL-SGM, V158, P975, DOI 10.1099/mic.0.057513-0; Vu CQ, 1997, ADV EXP MED BIOL, V419, P381; Ye HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26479; Zhang HM, 2015, MICROBIOLOGYOPEN, V4, P983, DOI 10.1002/mbo3.307	36	8	8	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6055	6068		10.1096/fj.201802179RR	http://dx.doi.org/10.1096/fj.201802179RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30759348	Bronze, Green Published			2022-12-26	WOS:000466932600022
J	Nakariyakul, S				Nakariyakul, Songyot			A hybrid gene selection algorithm based on interaction information for microarray-based cancer classification	PLOS ONE			English	Article							PREDICTION; RELEVANCE; PATTERNS; TUMOR	We address gene selection and machine learning methods for cancer classification using microarray gene expression data. Due to the high dimensionality of microarray data, traditional gene selection algorithms are filter-based, focusing on intrinsic properties of the data such as distance, dependency, and correlation. These methods are fast but select far too many genes to use for the classification task. In this work, we present a new hybrid filter wrapper gene subset selection algorithm that is an improved modification of our prior algorithm. Our proposed method employs interaction information to rank candidate genes to add into a gene subset. It then conditionally adds one gene at a time into the current subset and verifies whether the resultant subset improves the classification performance significantly. Only significant genes are selected, and the candidate gene list is updated every time a gene is added to the subset. Thus, our gene selection algorithm is very dynamic. Experimental results on ten public cancer microarray data sets show that our method consistently outperforms prior gene selection algorithms in terms of classification accuracy, while requiring a small number of selected genes.	[Nakariyakul, Songyot] Thammasat Univ, Dept Elect & Comp Engn, Khlongluang, Pathumthani, Thailand	Thammasat University	Nakariyakul, S (corresponding author), Thammasat Univ, Dept Elect & Comp Engn, Khlongluang, Pathumthani, Thailand.	nsongyot@engr.tu.ac.th	Nakariyakul, Songyot/I-9051-2015	Nakariyakul, Songyot/0000-0002-1545-1942	Thailand Research Fund (TRF); Thammasat University [RSA6080052]	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Thammasat University	This work was financially supported by the joint grant from the Thailand Research Fund (TRF) and Thammasat University under Grant No. RSA6080052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Bermejo P, 2012, KNOWL-BASED SYST, V25, P35, DOI 10.1016/j.knosys.2011.01.015; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bo TH, 2002, GENOME BIOL, V3; Bolon-Canedo V, 2014, INFORM SCIENCES, V282, P111, DOI 10.1016/j.ins.2014.05.042; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Li JY, 2002, BIOINFORMATICS, V18, P725, DOI 10.1093/bioinformatics/18.5.725; Maldonado S, 2011, INFORM SCIENCES, V181, P115, DOI 10.1016/j.ins.2010.08.047; McGill WJ., 1954, PSYCHOMETRIKA, V19, P97, DOI 10.1007/BF02289159; Nakano S., 2016, 20155 WAS U FAC SOC, P1; Nakariyakul S, 2018, KNOWL-BASED SYST, V145, P59, DOI 10.1016/j.knosys.2018.01.002; Nakariyakul S, 2014, PATTERN RECOGN LETT, V45, P62, DOI 10.1016/j.patrec.2014.03.002; Nakariyakul S, 2014, BBA-PROTEINS PROTEOM, V1844, P165, DOI 10.1016/j.bbapap.2013.04.008; Nakariyakul S, 2012, AMINO ACIDS, V42, P1947, DOI 10.1007/s00726-011-0923-1; Nakariyakul S, 2009, 2009 EIGHTH INTERNATIONAL SYMPOSIUM ON NATURAL LANGUAGE PROCESSING, PROCEEDINGS, P147, DOI 10.1109/SNLP.2009.5340930; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Pikman Y, 2017, CLIN CANCER RES, V23, P1012, DOI 10.1158/1078-0432.CCR-15-2869; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ruiz R, 2012, EXPERT SYST APPL, V39, P11094, DOI 10.1016/j.eswa.2012.03.061; Tarca AL, 2006, AM J OBSTET GYNECOL, V195, P373, DOI 10.1016/j.ajog.2006.07.001; Thalheimer W., 2002, CALCULATE EFFECT SIZ; Wong TT, 2011, EXPERT SYST APPL, V38, P14065, DOI 10.1016/j.eswa.2011.04.215; Yang HH, 2000, ADV NEUR IN, V12, P687; Yu L, 2004, J MACH LEARN RES, V5, P1205; Zhu ZX, 2007, PATTERN RECOGN, V40, P3236, DOI 10.1016/j.patcog.2007.02.007	34	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212333	10.1371/journal.pone.0212333	http://dx.doi.org/10.1371/journal.pone.0212333			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768654	Green Published, Green Submitted, gold			2022-12-26	WOS:000458766300031
J	Mareze, M; Benitez, AD; Brandao, APD; Pinto-Ferreira, F; Miura, AC; Martins, FDC; Caldart, ET; Biondo, AW; Freire, RL; Mitsuka-Bregano, R; Navarro, IT				Mareze, Marcelle; Benitez, Aline do Nascimento; Drulla Brandao, Ana Perola; Pinto-Ferreira, Fernanda; Miura, Ana Carolina; Cardoso Martins, Felippe Danyel; Caldart, Eloiza Teles; Biondo, Alexander Welker; Freire, Roberta Lemos; Mitsuka-Bregano, Regina; Navarro, Italmar Teodorico			Socioeconomic vulnerability associated to Toxoplasma gondii exposure in southern Brazil	PLOS ONE			English	Article							RIO-DE-JANEIRO; PREVALENCE; INFECTION; SEROPREVALENCE; POPULATION; BURDEN	Human toxoplasmosis, a protozoonosis caused by Toxoplasma gondii, has been described as a worldwide foodborne disease with important public health impact. Despite infection has reportedly varied due to differences in alimentary, cultural and hygienic habits and geographic region, social vulnerability influence on toxoplasmosis distribution remains to be fully established. Accordingly, the present study has aimed to assess T. gondii seroprevalence and factors associated to social vulnerability for infection in households of Ivaipora, southern Brazil, with 33.6% population making half minimum wage or less, ranked 1,055th in population (31,816 habitants), 1,406th in per capita income (U$ 211.80 per month) and 1,021st in HDI (0.764) out of 5,570 Brazilian cities. Serum samples and epidemiological questionnaires were obtained from citizen volunteers with official City Secretary of Health assistance in 2015 and 2016. In overall, serosurvey has revealed 526/715 (73.57%) positive samples for anti-T. gondii antibodies by Indirect Fluorescent Antibody Test. Logistic regression has shown a significant increase associated to adults (p = 0.021) and elderly (p = 0.014) people, illiterates (p = 0.025), unemployment (p < 0.001) and lack of household water tank (p = 0.039). On the other hand, sex (male or female), living area (urban or rural), yard hygiene, meat ingestion, sand or land contact, owning pets (dog, cat or both) were not significant variables of positivity for anti-T. gondii antibodies in the surveyed population. Although no significant spatial cluster was found, high intensity areas of seropositive individuals were located in the Kernel map where the suburban neighborhoods are located. In conclusion, socioeconomic vulnerability determinants may be associated to Toxoplasma gondii exposure. The increased risk due to illiteracy, adult or elderly age, unemployment and lack of household water tank were confirmed by multivariate analysis and the influence of low family income for seropositivity by the spatial analysis.	[Mareze, Marcelle; Pinto-Ferreira, Fernanda; Miura, Ana Carolina; Cardoso Martins, Felippe Danyel; Caldart, Eloiza Teles; Freire, Roberta Lemos; Mitsuka-Bregano, Regina; Navarro, Italmar Teodorico] Univ Estadual Londrina, Lab Zoonoses & Publ Hlth, Dept Vet Prevent Med, Londrina, Parana, Brazil; [Benitez, Aline do Nascimento] Sao Paulo State Univ, Dept Anim Prod & Hlth, Sao Paulo, Brazil; [Drulla Brandao, Ana Perola] Univ Sao Paulo, Dept Vet Prevent Med, Sao Paulo, Brazil; [Biondo, Alexander Welker] Univ Fed Parana, Dept Vet Med, Curitiba, Parana, Brazil; [Biondo, Alexander Welker] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Universidade Estadual de Londrina; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Federal do Parana; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Navarro, IT (corresponding author), Univ Estadual Londrina, Lab Zoonoses & Publ Hlth, Dept Vet Prevent Med, Londrina, Parana, Brazil.	italmar@uel.br	Benitez, Aline N/M-1677-2017; Bregano, Regina Mitsuka/AAX-3103-2020; Martins, Felippe Danyel Cardoso/T-5710-2019; BIONDO, ALEXANDER WELKER W/E-8823-2018; BIONDO, ALEXANDER WELKER/AAU-8955-2021; Mareze, Marcelle/R-2144-2018; Martins, felippe danyel cardoso/E-8522-2019	Benitez, Aline N/0000-0002-0770-9552; BIONDO, ALEXANDER WELKER W/0000-0002-4182-5821; BIONDO, ALEXANDER WELKER/0000-0002-4182-5821; Drulla Brandao, Ana Perola/0000-0001-6783-0242; Mareze, Marcelle/0000-0001-7266-5851; Caldart, Eloiza/0000-0002-0475-2010; Martins, felippe danyel cardoso/0000-0002-9162-1536				Afonso Eve, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P278, DOI 10.1016/j.ijppaw.2013.09.006; Alvarado-Esquivel C, 2014, EUR J MICROBIOL IMMU, V4, P76, DOI 10.1556/EuJMI.4.2014.1.7; [Anonymous], 2008, WHO IN EST GLOB BURD; Avelar JB, 2018, REV SOC BRAS MED TRO, V51, P57, DOI 10.1590/0037-8682-0112-2017; Avelar MV, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759090, 10.1590/s1678-9946201759090]; Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55; Belluco S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153856; Benitez A do N, 2017, SEROEPIDEMIOLOGY TOX, V18, P1, DOI [10.1590/1089-6891v18e-42102, DOI 10.1590/1089-6891V18E-42102]; Benitez AD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180906; Bittencourt LHF de B, 2012, BRAZILIAN J GYNECOLO, V34, P63; Bresciani KDS, 2013, RES J INFECT DISEASE, V1, P7, DOI [10.7243/2052-5958-1-7, DOI 10.7243/2052-5958-1-7]; CamargO M. E., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P117; Capobiango JD, 2014, BRAZ J INFECT DIS, V18, P364, DOI 10.1016/j.bjid.2013.11.009; Coryell W, 2016, ARCH SUICIDE RES, V20, P605, DOI 10.1080/13811118.2016.1158677; Dard C, 2018, EXPERT REV ANTI-INFE, V16, P447, DOI 10.1080/14787210.2018.1483721; Daryani A, 2014, ACTA TROP, V137, P185, DOI 10.1016/j.actatropica.2014.05.015; de Moura FL, 2016, EPIDEMIOL SERV SAUDE, V25, P655, DOI [10.5123/s1679-49742016000300022, 10.5123/S1679-49742016000300022]; Dean A.G., 1994, EPI INFO VERSION 6 W; do Carmo ME, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00101417, 10.1590/0102-311X00101417]; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005; Egorov AI, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3343-y; Engroff P, 2014, CIENC SAUDE COLETIVA, V19, P3385, DOI 10.1590/1413-81232014198.12402013; Fallahi S, 2018, J GYNECOL OBSTET HUM, V47, P133, DOI 10.1016/j.jogoh.2017.12.003; Ferreira FP, 2018, BRAZILIAN J VET PARA, V2961, P1; Flegr J, 2017, EUR PSYCHIAT, V40, P82, DOI 10.1016/j.eurpsy.2016.09.001; Flegr J, 2014, FOLIA PARASIT, V61, P485, DOI 10.14411/fp.2014.061; Gao X, 2016, SCI TOTAL ENVIRON, V568, P1086, DOI 10.1016/j.scitotenv.2016.06.165; Gilbert RE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000277; Gotteland C, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-45; IPEA, 2015, ATL VULN SOC NOS MUN, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; IPEA, 2018, PER ORG SOC CIV BRAS; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lange AE, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0966-0; Liu L, 2017, ACTA TROP, V176, P162, DOI 10.1016/j.actatropica.2017.08.001; Carellos EVM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088588; Mangot Ajish G, 2016, J Parasit Dis, V40, P1636, DOI 10.1007/s12639-015-0684-y; Mitsuka-Bregan R., 2010, TOXOPLASMOSE ADQUIRI; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Pearce BD, 2014, SOC PSYCH PSYCH EPID, V49, P1001, DOI 10.1007/s00127-014-0820-5; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Sugden K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148435; Team QD, 2016, QGIS GEOGR INF SYST; Vaudaux JD, 2010, J INFECT DIS, V202, P1226, DOI 10.1086/656397; Wang ZD, 2017, LANCET HIV, V4, pE177, DOI 10.1016/S2352-3018(17)30005-X; WHO, 2017, ONE HLTH; Wilking H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22551	47	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212375	10.1371/journal.pone.0212375	http://dx.doi.org/10.1371/journal.pone.0212375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763391	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900077
J	Santiago, Z; Loustau, J; Meretzky, D; Rawal, D; Brazill, D				Santiago, Zully; Loustau, John; Meretzky, David; Rawal, Devarshi; Brazill, Derrick			Advances in geometric techniques for analyzing blebbing in chemotaxing Dictyostelium cells	PLOS ONE			English	Article							ACTIN CYTOSKELETON; MIGRATION; CONTRACTION; PROBES; BLEBS	We present a technical platform that allows us to monitor and measure cortex and membrane dynamics during bleb-based chemotaxis. Using D. discoideum cells expressing LifeAct-GFP and crawling under agarose containing RITC-dextran, we were able to simultaneously visualize the actin cortex and the cell membrane throughout bleb formation. Using these images, we then applied edge detect to generate points on the cell boundary with coordinates in a coordinate plane. Then we fitted these points to a curve with known x and y coordinate functions. The result was to parameterize the cell outline. With the parameterization, we demonstrate how to compute data for geometric features such as cell area, bleb area and edge curvature. This allows us to collect vital data for the analysis of blebbing.	[Santiago, Zully; Brazill, Derrick] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Santiago, Zully; Brazill, Derrick] CUNY, Grad Ctr, PhD Program Biol, New York, NY 10016 USA; [Loustau, John; Meretzky, David; Rawal, Devarshi] CUNY Hunter Coll, Dept Math & Stat, New York, NY 10021 USA; [Brazill, Derrick] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10016 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System	Brazill, D (corresponding author), CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA.; Brazill, D (corresponding author), CUNY, Grad Ctr, PhD Program Biol, New York, NY 10016 USA.; Loustau, J (corresponding author), CUNY Hunter Coll, Dept Math & Stat, New York, NY 10021 USA.; Brazill, D (corresponding author), CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10016 USA.	jloustau@msn.com; brazill@genectr.hunter.cuny.edu			National Institutes of Health - National Institute on Minority Health and Health Disparities [8 G12 MD007599]; National Science Foundation, Division of Molecular and Cellular Biosciences [MCB-1244162]; Professional Staff Congress-City University of New York [69271 00 47]; National Institutes of Health - National Institute of General Medical Sciences (RISE) [GM060665]; National Science Foundation [MCB-1244162]; PSC-CUNY grant [69271 00 47]; Research Centers in Minority Institutions Program grants from the National Institute on Minority Health and Health Disparities from the National Institutes of Health [8 G12 MD007599]; Research Inititaive for Scientific Enhancement (RISE) at Hunter College - NIH grant [GM060665]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060665] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Institutes of Health - National Institute on Minority Health and Health Disparities; National Science Foundation, Division of Molecular and Cellular Biosciences(National Science Foundation (NSF)); Professional Staff Congress-City University of New York; National Institutes of Health - National Institute of General Medical Sciences (RISE); National Science Foundation(National Science Foundation (NSF)); PSC-CUNY grant; Research Centers in Minority Institutions Program grants from the National Institute on Minority Health and Health Disparities from the National Institutes of Health; Research Inititaive for Scientific Enhancement (RISE) at Hunter College - NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health - National Institute on Minority Health and Health Disparities, 8 G12 MD007599 (https://www.nimhd.nih.gov/); National Science Foundation, Division of Molecular and Cellular Biosciences, MCB-1244162 (https://www.nsf.gov/div/index.jsp? div=MCB); The Professional Staff Congress-City University of New York, 69271 00 47 (https://www.rfcuny.org/RFWebsite/research/content. aspx? catID=1190); and National Institutes of Health - National Institute of General Medical Sciences (RISE), GM060665 (https://www.nigms.nih.gov/Training/RISE).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants to Derrick Brazill from the National Science Foundation (MCB-1244162), a PSC-CUNY grant (69271 00 47), as well as Research Centers in Minority Institutions Program grants from the National Institute on Minority Health and Health Disparities (8 G12 MD007599) from the National Institutes of Health. Z.S. is supported by the Research Inititaive for Scientific Enhancement (RISE) at Hunter College funded by NIH grant GM060665.	Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Catrina IE, 2012, ACS CHEM BIOL, V7, P1586, DOI 10.1021/cb300178a; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Choi CH, 2010, MOL BIOL CELL, V21, P3162, DOI 10.1091/mbc.E09-12-1058; Collier S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06875-9; Diz-Munoz A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0294-x; Guy R, 2010, BIOPHYS J, V110, P1168; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Landau L.D., 1987, PHYS TODAY; Lemieux MG, 2014, CYTOSKELETON, V71, P157, DOI 10.1002/cm.21160; Loustau J., 2017, ELEMENTS NUMERICAL A; Markela I, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0163866, DOI 10.1371/JOURNAL.PONE.0163866]; Maugis B, 2010, J CELL SCI, V123, P3884, DOI 10.1242/jcs.065672; Nichols JME, 2015, CURR OPIN CELL BIOL, V36, P7, DOI 10.1016/j.ceb.2015.06.005; Otto A, 2011, REJUV RES, V14, P249, DOI 10.1089/rej.2010.1151; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Pang M, 2009, PLASMID, V41, P187, DOI [10.1006/plas.1999.1391, DOI 10.1006/PLAS.1999.1391]; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Strychalski W, 2015, J COMPUT PHYS, V282, P77, DOI 10.1016/j.jcp.2014.10.004; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Tyson RA, 2014, P NATL ACAD SCI USA, V111, P11703, DOI 10.1073/pnas.1322291111; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Woolley TE, 2015, J THEOR BIOL, V380, P83, DOI 10.1016/j.jtbi.2015.04.023; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zatulovskiy E, 2014, J CELL BIOL, V204, P1027, DOI 10.1083/jcb.201306147	26	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0211975	10.1371/journal.pone.0211975	http://dx.doi.org/10.1371/journal.pone.0211975			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763409	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900032
J	Wang, H; Tian, D; Li, C; Tian, Y; Zhou, HY				Wang, Hu; Tian, Di; Li, Chu; Tian, Yan; Zhou, Haoyu			Plant leaf tooth feature extraction	PLOS ONE			English	Article							ARCHITECTURE; LEAVES; THRESHOLD; EVOLUTION; CLIMATE	Leaf tooth can indicate several systematically informative features and is extremely useful for circumscribing fossil leaf taxa. Moreover, it can help discriminate species or even higher taxa accurately. Previous studies extract features that are not strictly defined in botany; therefore, a uniform standard to compare the accuracies of various feature extraction methods cannot be used. For efficient and automatic retrieval of plant leaves from a leaf database, in this study, we propose an image-based description and measurement of leaf teeth by referring to the leaf structure classification system in botany. First, image preprocessing is carried out to obtain a binary map of plant leaves. Then, corner detection based on the curvature scale-space (CSS) algorithm is used to extract the inflection point from the edges; next, the leaf tooth apex is extracted by screening the convex points; then, according to the definition of the leaf structure, the characteristics of the leaf teeth are described and measured in terms of number of orders of teeth, tooth spacing, number of teeth, sinus shape, and tooth shape. In this manner, data extracted from the algorithm can not only be used to classify plants, but also provide scientific and standardized data to understand the history of plant evolution. Finally, to verify the effectiveness of the extraction method, we used simple linear discriminant analysis and multiclass support vector machine to classify leaves. The results show that the proposed method achieves high accuracy that is superior to that of other methods.	[Wang, Hu; Li, Chu; Zhou, Haoyu] China Shipbldg Ind Corp, Res Inst 722, Wuhan, Hubei, Peoples R China; [Tian, Di] Wenhua Coll, Fac Informat Sci & Technol, Wuhan, Hubei, Peoples R China; [Tian, Yan] Huazhong Univ Sci & Technol, Elect & Informat Engn Dept, Wuhan, Hubei, Peoples R China	China Shipbuilding Industry Corporation; Huazhong University of Science & Technology	Tian, D (corresponding author), Wenhua Coll, Fac Informat Sci & Technol, Wuhan, Hubei, Peoples R China.	tiandi_2015@foxmail.com		Wang, Hu/0000-0002-6558-847X	China Shipbuilding Industry Corporation [722]	China Shipbuilding Industry Corporation	The work was supported by China Shipbuilding Industry Corporation, no. 722 Research Institute. The funder provided support in the form of salaries for authors [WH LC ZHY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ash A., 1999, MANUAL LEAF ARCHITEC; Bailey IW, 1916, AM J BOT, V3, P24, DOI 10.2307/2435109; Bailey IW, 1915, SCIENCE, V41, P831, DOI 10.1126/science.41.1066.831; Bruno OM, 2008, INFORM SCIENCES, V178, P2722, DOI 10.1016/j.ins.2008.01.023; Chen Y, 2014, THESIS; Corney DPA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042112; Doyle JA, 2007, COUR FOR SEKENBG, V258, P21; Espinosa D, 2006, J BIOGEOGR, V33, P1945, DOI 10.1111/j.1365-2699.2006.01566.x; Gonzalez RC, 2007, QIU QIUQI DIGITAL IM; He XC, 2004, INT C PATT RECOG, P791, DOI 10.1109/ICPR.2004.1334377; HICKEY LJ, 1991, ANN MO BOT GARD, V78, P105, DOI 10.2307/2399596; Huff PM, 2003, PALAIOS, V18, P266, DOI 10.1669/0883-1351(2003)018<0266:DFFPEF>2.0.CO;2; Jin TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139482; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li L., 2017, THESIS; MERRILL EK, 1978, BOT GAZ, V139, P447, DOI 10.1086/337020; Mokhtarian F, 1998, IEEE T PATTERN ANAL, V20, P1376, DOI 10.1109/34.735812; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Powers DMW, 2007, SIE07001 FED U; Rahmani M.E., 2015, ALLDATA, V82, P75; Rizve M., ABS06329 ARXIV, V2021; Royer DL, 2006, INT J PLANT SCI, V167, P11, DOI 10.1086/497995; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Sajo MG, 2015, BOT J LINEAN SOC, V138, P339; Sun W, 2008, OPT ENG, V47, DOI 10.1117/1.2896537; Tsolakidis DG, 2014, LECT NOTES ARTIF INT, V8445, P406, DOI 10.1007/978-3-319-07064-3_33; Utescher T, 2000, PALAIOS, V15, P430, DOI 10.2307/3515514; WALKER JW, 1975, ANN MO BOT GARD, V62, P664, DOI 10.2307/2395271; [王晓峰 Wang Xiaofeng], 2006, [计算机工程与应用, Computer Engineering and Application], V42, P190; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; WOLFE JA, 1971, PALAEOGEOGR PALAEOCL, V9, P27, DOI 10.1016/0031-0182(71)90016-2; Yang L., 2003, STUDY ECOLOGICAL PLA; Zhang Y., 2012, IMAGE ENG, P304; [郑小东 Zheng Xiaodong], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P174	35	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0204714	10.1371/journal.pone.0204714	http://dx.doi.org/10.1371/journal.pone.0204714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759085	gold, Green Published, Green Submitted			2022-12-26	WOS:000458761300002
J	Wilde, S; Jiang, YL; Tafoya, AM; Horsman, J; Yousif, M; Vazquez, LA; Roland, KL				Wilde, Shyra; Jiang, Yanlong; Tafoya, Amanda M.; Horsman, Jamie; Yousif, Miranda; Vazquez, Luis Armando; Roland, Kenneth L.			Salmonella-vectored vaccine delivering three Clostridium perfringens antigens protects poultry against necrotic enteritis	PLOS ONE			English	Article							BROILER-CHICKENS; ALPHA-TOXIN; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; IMMUNE-RESPONSES; IMMUNIZATION; STRAINS; PATHOGENESIS; IDENTIFICATION; CHALLENGE; BACTERIA	Necrotic enteritis is an economically important poultry disease caused by the bacterium Clostridium perfringens. There are currently no necrotic enteritis vaccines commercially available for use in broiler birds, the most important target population. Salmonella-vectored vaccines represent a convenient and effective option for controlling this disease. We used a single attenuated Salmonella vaccine strain, engineered to lyse within the host, to deliver up to three C. perfringens antigens. Two of the antigens were toxoids, based on C. perfringens alpha-toxin and NetB toxin. The third antigen was fructose-1,6-bisphosphate aldolase (Fba), a metabolic enzyme with an unknown role in virulence. Oral immunization with a single Salmonella vaccine strain producing either Fba, alpha-toxoid and NetB toxoid, or all three antigens, was immunogenic, inducing serum, cellular and mucosal responses against Salmonella and the vectored C. perfringens antigens. All three vaccine strains were partially protective against virulent C. perfringens challenge. The strains delivering Fba only or all three antigens provided the best protection. We also demonstrate that both toxins and Fba are present on the C. perfringens cell surface. The presence of Fba on the cell surface suggests that Fba may function as an adhesin.	[Wilde, Shyra; Jiang, Yanlong; Tafoya, Amanda M.; Horsman, Jamie; Yousif, Miranda; Vazquez, Luis Armando; Roland, Kenneth L.] Arizona State Univ, Ctr Immunotherapy Vaccines & Virotherapy, Biodesign Inst, Tempe, AZ 85281 USA; [Wilde, Shyra] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Jiang, Yanlong] Jilin Agr Univ, Jilin Prov Engn Res Ctr Anim Probiot, Key Lab Anim Prod & Prod Qual Safety, Coll Anim Sci & Technol,Minist Educ, Changchun, Jilin, Peoples R China	Arizona State University; Arizona State University-Tempe; Emory University; Jilin Agricultural University	Roland, KL (corresponding author), Arizona State Univ, Ctr Immunotherapy Vaccines & Virotherapy, Biodesign Inst, Tempe, AZ 85281 USA.	kenneth.roland@asu.edu		Wilde, Shyra/0000-0003-4909-5816; Roland, Kenneth/0000-0002-4684-1257	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2016-67016-24947]; Arizona State University	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; Arizona State University	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2016-67016-24947 from the USDA National Institute of Food and Agriculture, https://nifa.usda.gov/, and startup funds from Arizona State University to KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 1991, CURRENT PROTOCOLS MO; Barbara AJ, 2008, VET MICROBIOL, V126, P377, DOI 10.1016/j.vetmic.2007.07.019; Blau K, 2007, J INFECT DIS, V195, P1828, DOI 10.1086/518038; Cheung JK, 2010, INFECT IMMUN, V78, P3064, DOI 10.1128/IAI.00123-10; Cooper KK, 2009, VET MICROBIOL, V133, P92, DOI 10.1016/j.vetmic.2008.06.001; Coursodon CF, 2012, ANAEROBE, V18, P117, DOI 10.1016/j.anaerobe.2011.10.001; da Costa SPF, 2016, AVIAN PATHOL, V45, P381, DOI 10.1080/03079457.2015.1129663; da Costa SPF, 2013, VACCINE, V31, P4003, DOI 10.1016/j.vaccine.2013.05.063; Gogal RM, 1997, AVIAN DIS, V41, P714, DOI 10.2307/1592166; Haghighi HR, 2005, CLIN DIAGN LAB IMMUN, V12, P1387, DOI 10.1128/CDLI.12.12.1387-1392.2005; Jiang YL, 2015, AVIAN DIS, V59, P475, DOI 10.1637/11094-041715-Reg; Jiang YL, 2014, INT J MED MICROBIOL, V304, P431, DOI 10.1016/j.ijmm.2014.02.006; Kang HY, 2002, INFECT IMMUN, V70, P1739, DOI 10.1128/IAI.70.4.1739-1749.2002; Kawsar HI, 2004, FEMS MICROBIOL LETT, V235, P289, DOI 10.1016/j.femsle.2004.04.047; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Kong W, 2008, P NATL ACAD SCI USA, V105, P9361, DOI 10.1073/pnas.0803801105; Kulkarni RR, 2008, VACCINE, V26, P4194, DOI 10.1016/j.vaccine.2008.05.079; Kulkarni RR, 2007, CLIN VACCINE IMMUNOL, V14, P1070, DOI 10.1128/CVI.00162-07; Kulkarni RR, 2006, CLIN VACCINE IMMUNOL, V13, P1358, DOI 10.1128/CVI.00292-06; Lepp D, 2013, J BACTERIOL, V195, P1152, DOI 10.1128/JB.01032-12; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Moore RJ, 2016, AVIAN PATHOL, V45, P275, DOI 10.1080/03079457.2016.1150587; Prescott JF, 2016, AVIAN PATHOL, V45, P288, DOI 10.1080/03079457.2016.1139688; Rood JI, 2018, ANAEROBE, V53, P5, DOI 10.1016/j.anaerobe.2018.04.011; Shams F, 2014, BIOCHEM SOC T, V42, P1792, DOI 10.1042/BST20140203; Shimizu T, 2002, J BACTERIOL, V184, P2587, DOI 10.1128/JB.184.10.2587-2594.2002; Shojadoost B, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-74; Sizemore Donata R, 2012, Hum Vaccin Immunother, V8, P371, DOI 10.4161/hv.18670; Sun ZY, 2015, FISH SHELLFISH IMMUN, V46, P638, DOI 10.1016/j.fsi.2015.08.001; Terao Y, 2005, J INFECT DIS, V192, P2081, DOI 10.1086/498162; Thompson DR, 2006, VET MICROBIOL, V113, P25, DOI 10.1016/j.vetmic.2005.10.015; Timbermont L, 2011, AVIAN PATHOL, V40, P341, DOI 10.1080/03079457.2011.590967; Tunio SA, 2010, MOL MICROBIOL, V76, P605, DOI 10.1111/j.1365-2958.2010.07098.x; Van Immerseel F, 2009, TRENDS MICROBIOL, V17, P32, DOI 10.1016/j.tim.2008.09.005; Wade B., 2015, World Poultry, V31, P16; Wade B, 2016, VET MICROBIOL, V197, P53, DOI 10.1016/j.vetmic.2016.10.028; Xolalpa W, 2007, PROTEOMICS, V7, P3332, DOI 10.1002/pmic.200600876; Zekarias B, 2008, CLIN VACCINE IMMUNOL, V15, P805, DOI 10.1128/CVI.00457-07	38	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0197721	10.1371/journal.pone.0197721	http://dx.doi.org/10.1371/journal.pone.0197721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753181	Green Published, Green Submitted, gold			2022-12-26	WOS:000458395600001
J	El-Fiqi, H; Petraki, E; Abbass, HA				El-Fiqi, Heba; Petraki, Eleni; Abbass, Hussein A.			Network motifs for translator stylometry identification	PLOS ONE			English	Article							COMPLEX NETWORKS; AUTHORSHIP ATTRIBUTION; MODAL PARTICLES; ALGORITHM	Despite the extensive literature investigating stylometry analysis in authorship attribution research, translator stylometry is an understudied research area. The identification of translator stylometry contributes to many fields including education, intellectual property rights and forensic linguistics. In a two stage process, this paper first evaluates the use of existing lexical measures for the translator stylometry problem. Similar to previous research we found that using vocabulary richness in its traditional form as it has been used in the literature could not identify translator stylometry. This encouraged us to design an approach with the aim of identifying the distinctive patterns of a translator by employing network-motifs. Networks motifs are small sub-graphs which aim at capturing the local structure of a complex network. The proposed approach achieved an average accuracy of 83% in three-way classification. These results demonstrate that classic tools based on lexical features can be used for identifying translator stylometry if they get augmented with appropriate non-parametric scaling. Moreover, the use of complex network analysis and network motifs mining provided made it possible to design features that can solve translator stylometry analysis problems.	[El-Fiqi, Heba; Abbass, Hussein A.] Univ New South Wales, Sch Engn & Informat Technol, Canberra, ACT, Australia; [Petraki, Eleni] Univ Canberra, Fac Educ, Canberra, ACT, Australia	University of New South Wales Sydney; University of Canberra	El-Fiqi, H (corresponding author), Univ New South Wales, Sch Engn & Informat Technol, Canberra, ACT, Australia.	h.el-fiqi@adfa.edu.au	El-Fiqi, Heba/U-2041-2017; Abbass, Hussein A/C-9563-2009	El-Fiqi, Heba/0000-0001-8146-0110; Abbass, Hussein A/0000-0002-8837-0748				Abbasi A, 2008, IEEE T KNOWL DATA EN, V20, P1168, DOI 10.1109/TKDE.2008.51; Abbasi A, 2011, IEEE T KNOWL DATA EN, V23, P447, DOI 10.1109/TKDE.2010.110; Aharoni R, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 2, P289; Akimushkin C, 2018, PHYSICA A, V495, P49, DOI 10.1016/j.physa.2017.12.054; Akimushkin C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170527; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Alwazna R. Y., 2013, U SHARJAH J HUMANITI, V10, P45, DOI [10.12816/0004515, DOI 10.12816/0004515]; Amancio DR, 2012, PHYSICA A, V391, P1855, DOI 10.1016/j.physa.2011.10.015; Amancio DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136076; Amancio DR, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123024; Antiqueira L, 2007, PHYSICA A, V373, P811, DOI 10.1016/j.physa.2006.06.002; Arase Y., 2013, P 51 ANN M ASS COMP, V1, P1597; Argamon S., 2003, TEXT TALK, V23, P321, DOI [10.1515/text.2003.014, DOI 10.1515/TEXT.2003.014]; Argamon S., 2003, ACM SIGKDD, V9, P475, DOI DOI 10.1145/956750.956805; Argamon S, 2008, LIT LINGUIST COMPUT, V23, P131, DOI 10.1093/llc/fqn003; Baker M., 2000, TARGETS, V12, P2, DOI [10.1075/target.12.2.04bak, DOI 10.1075/TARGET.12.2.04BAK]; Biemann C, 2016, NETWORK MOTIFS ARE P, P83, DOI [10.1007/978-3-662-47238-5_4, DOI 10.1007/978-3-662-47238-5_4]; Brennan M, 2012, ACM T INFORM SYST SE, V15, DOI 10.1145/2382448.2382450; Burrows J., 2002, Literary & Linguistic Computing, V17, P267, DOI 10.1093/llc/17.3.267; Castagnoli S, 2009, REGULARITIES VARIATI; Cooperman A, 2009, MAPPING GLOBAL MUSLI; Corney M, 2002, 18TH ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE, PROCEEDINGS, P282, DOI 10.1109/CSAC.2002.1176299; Daelemans Walter, 2013, Computational Linguistics and Intelligent Text Processing. 14th International Conference, CICLing 2013. Proceedings, P451, DOI 10.1007/978-3-642-37256-8_37; Domedel-Puig N, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-18; El-Fiqi H, 2011, IEEE INT CONF FUZZY, P2039; Garcia Antonio Miranda, 2007, Literary & Linguistic Computing, V22. no 1, P49, DOI 10.1093/llc/fql048; Ghoneim A, 2008, IEEE T SYST MAN CY B, V38, P682, DOI 10.1109/TSMCB.2008.918570; Goh WP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203025; Hedegaard S., 2011, P 49 ANN M ASS COMPU, P65; Heydel M, 2012, DIGITAL HUMANITIES; Holmes D. I., 1991, Literary & Linguistic Computing, V6, P259, DOI 10.1093/llc/6.4.259; Holmes D. I., 1995, LIT LINGUIST COMPUT, V10, P111, DOI DOI 10.1093/LLC/10.2.111; Holmes J, 2008, LEARNING LANGUAGE; Hoover D. L., 2004, Literary & Linguistic Computing, V19, P453, DOI 10.1093/llc/19.4.453; Hoover D. L., 2004, Literary & Linguistic Computing, V19, P477, DOI 10.1093/llc/19.4.477; Ivir V., 1987, INDIAN J APPL LINGUI, P35; Kamenicka Renata., 2008, TRANSLATION RES PROJ, V1, P117; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Kashtan N, 2004, NETWORK MOTIF DETECT; Katzner K., 2002, LANGUAGES WORLD; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kestemont M., 2012, J DUTCH LIT, V2, P46; Layton R., 2010, Proceedings Second Cybercrime and Trustworthy Computing Workshop (CTC 2010), P1, DOI 10.1109/CTC.2010.17; LEONARD Vanessa, 2007, GENDER IDEOLOGY TRAN; Li DF, 2011, LIT LINGUIST COMPUT, V26, P153, DOI 10.1093/llc/fqr001; Liu HT, 2009, CHINESE SCI BULL, V54, P2781, DOI 10.1007/s11434-009-0467-x; Marinho VQ, 2016, PROCEEDINGS OF 2016 5TH BRAZILIAN CONFERENCE ON INTELLIGENT SYSTEMS (BRACIS 2016), P355, DOI [10.1109/BRACIS.2016.071, 10.1109/BRACIS.2016.71]; Martins AFT, 2007, LIT SURVEY LANGUAGE; McMenamin GR, 2002, ADV FORENSIC STYLIST; Mehri A, 2012, PHYSICA A, V391, P2429, DOI 10.1016/j.physa.2011.12.011; Mikkhailov Mikhail, 2001, P CORP LING LANC UK, P378; Moradi M, 2014, THEORY PRACTICE LANG, V4; Mustafa TK, 2009, INT J COMPUT SCI NET, V9, P262; Newman M.E.J., 2010, NETWORKS INTRO; Ordudari, 2008, GOOD TRANSLATION ART; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Prochazka S, 2006, ENCY LANGUAGE LINGUI, P423; Quinlan J. R, 1993, C4 5 PROGRAMS MACHIN, V240; RAbeie Ati, 2011, J TEACHING LANGUAGE, V3, P143, DOI DOI 10.22099/JTLS.2012.381; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rybicki J., 2006, Literary & Linguistic Computing, V21, P91, DOI 10.1093/llc/fqh051; Rybicki J., 2011, DIGITAL HUMANITIES; Rybicki J, 2012, STUD CORPUS LINGUIST, V51, P231; Smith PWH, 2011, J QUANT LINGUIST, V18, P63, DOI 10.1080/09296174.2011.533591; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Valverde S, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026107; Wang Q, 2011, LIT LINGUISTIC COMPU; Wardhaugh R., 2009, INTRO SOCIOLINGUISTI; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Winters M., 2004, LANG MATTERS, V35, P248, DOI DOI 10.1080/10228190408566215; Winters M, 2007, META, V52, P412, DOI 10.7202/016728ar; Winters M, 2010, TRANSL INTERPRET STU, V5, P163, DOI 10.1075/tis.5.2.02win; Winters M, 2009, TARGET-NETH, V21, P74, DOI 10.1075/target.21.1.04win; Xiumei X., 2006, BABEL, V52, P334, DOI [10.1075/babel.52.4.04xiu, DOI 10.1075/BABEL.52.4.04XIU]	75	6	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211809	10.1371/journal.pone.0211809	http://dx.doi.org/10.1371/journal.pone.0211809			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735512	Green Submitted, gold, Green Published			2022-12-26	WOS:000458181200033
J	Hansen, C; Drinkwater, KF; Jahkel, A; Fulton, EA; Gorton, R; Skern-Mauritzen, M				Hansen, Cecilie; Drinkwater, Kenneth F.; Jahkel, Anne; Fulton, Elizabeth A.; Gorton, Rebecca; Skern-Mauritzen, Mette			Sensitivity of the Norwegian and Barents Sea Atlantis end-to-end ecosystem model to parameter perturbations of key species	PLOS ONE			English	Article							CAPELIN MALLOTUS-VILLOSUS; HERRING CLUPEA-HARENGUS; MARINE ECOSYSTEMS; FEEDING-HABITS; UNCERTAINTY; FISH; CLIMATE; MANAGEMENT	Using end-to-end models for ecosystem-based management requires knowledge of the structure, uncertainty and sensitivity of the model. The Norwegian and Barents Seas (NoBa) Atlantis model was implemented for use in 'what if' scenarios, combining fisheries management strategies with the influences of climate change and climate variability. Before being used for this purpose, we wanted to evaluate and identify sensitive parameters and whether the species position in the foodweb influenced their sensitivity to parameter perturbation. Perturbing recruitment, mortality, prey consumption and growth by +/-25% for nine biomass-dominating key species in the Barents Sea, while keeping the physical climate constant, proved the growth rate to be the most sensitive parameter in the model. Their trophic position in the ecosystem (lower trophic level, mid trophic level, top predators) influenced their responses to the perturbations. Top-predators, being generalists, responded mostly to perturbations on their individual life-history parameters. Mid-level species were the most vulnerable to perturbations, not only to their own individual life-history parameters, but also to perturbations on other trophic levels (higher or lower). Perturbations on the lower trophic levels had by far the strongest impact on the system, resulting in biomass changes for nearly all components in the system. Combined perturbations often resulted in non-additive model responses, including both dampened effects and increased impact of combined perturbations. Identifying sensitive parameters and species in end-to-end models will not only provide insights about the structure and functioning of the ecosystem in the model, but also highlight areas where more information and research would be useful-both for model parameterization, but also for constraining or quantifying model uncertainty.	[Hansen, Cecilie; Drinkwater, Kenneth F.; Jahkel, Anne; Skern-Mauritzen, Mette] Inst Marine Res, Bergen, Norway; [Fulton, Elizabeth A.] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Fulton, Elizabeth A.; Gorton, Rebecca] Univ Tasmania, Ctr Marine Socioecol, Hobart, Tas, Australia; [Jahkel, Anne] UFZ Helmholtz Ctr Environm Res, Leipzig, Germany	Institute of Marine Research - Norway; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Hansen, C (corresponding author), Inst Marine Res, Bergen, Norway.	Cecilie.hansen@hi.no	Skern-Mauritzen, Mette/ABA-8173-2020; Fulton, Beth/A-2871-2008	Fulton, Beth/0000-0002-5904-7917; Hansen, Cecilie/0000-0003-0291-2428	Norwegian Research Council through Comparison of Marine Ecosystems of NORWAY; Norwegian Research Council through US II (MENU II); Atlantis: socioECOnomics and ECOsystem-based fisheries management (@ECO); COFASP through Process integration into multispecies and ecosystem Models for realistic evaluation of eccological, economic and social tradeoffs (PRIME tradeoffs)	Norwegian Research Council through Comparison of Marine Ecosystems of NORWAY; Norwegian Research Council through US II (MENU II); Atlantis: socioECOnomics and ECOsystem-based fisheries management (@ECO); COFASP through Process integration into multispecies and ecosystem Models for realistic evaluation of eccological, economic and social tradeoffs (PRIME tradeoffs)	This work was supported by the Norwegian Research Council, www.forsningsradet.no, through Comparison of Marine Ecosystems of NORWAY and the US II (MENU II); and Atlantis: socioECOnomics and ECOsystem-based fisheries management (@ECO); and through COFASP, www.cofasp.eu, through Process integration into multispecies and ecosystem Models for realistic evaluation of eccological, economic and social tradeoffs (PRIME tradeoffs).	Allen JI, 2007, J MARINE SYST, V64, P3, DOI 10.1016/j.jmarsys.2006.02.010; Asta Audzijonyte, 2017, ATLANTISUSERGUIDE 1, P215; Bogstad B, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00029; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; Dalpadado P, 2001, ICES J MAR SCI, V58, P876, DOI 10.1006/jmsc.2001.1078; Dalpadado P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095273; Eriksen E, 2017, PROG OCEANOGR, V151, P206, DOI 10.1016/j.pocean.2016.12.009; Eriksen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033050; Fossheim M, 2015, NAT CLIM CHANGE, V5, P673, DOI 10.1038/NCLIMATE2647; Fuller E.A., 2004, ECOLOGICAL INDICATOR; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Fulton EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084242; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Gjosaeter H, 2016, ICES J MAR SCI, V73, P182, DOI 10.1093/icesjms/fsv177; Gjosaeter H, 2009, MAR BIOL RES, V5, P40, DOI 10.1080/17451000802454866; Hansen C., 2016, FISKEN HAVET NR; Hjermann DO, 2010, CAN J FISH AQUAT SCI, V67, P1363, DOI 10.1139/F10-064; Holsman KK, 2016, DEEP-SEA RES PT II, V134, P360, DOI 10.1016/j.dsr2.2015.08.001; Horne P. J., DESIGN PARAMETERIZAT, P140; Howell D, 2013, MAR BIOL RES, V9, P920, DOI 10.1080/17451000.2013.775452; Huse G, 1996, SARSIA, V81, P143, DOI 10.1080/00364827.1996.10413618; ICES, 2017, REP WORK GROUP WID D, P994; ICES, 2018, REP ARCT FISH WORK G, P534; Jahkel A, 2013, TUNING DIET N E ARCT, P87; Johannesen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034924; Johannesen E, 2012, ICES J MAR SCI, V69, P880, DOI 10.1093/icesjms/fss046; Kortsch S, 2015, P ROY SOC B-BIOL SCI, V282, P31, DOI 10.1098/rspb.2015.1546; Lehuta S, 2016, AQUAT LIVING RESOUR, V29, DOI 10.1051/alr/2016022; Lindstrom U, 2009, DEEP-SEA RES PT II, V56, P2068, DOI 10.1016/j.dsr2.2008.11.017; Link JS, 2012, PROG OCEANOGR, V102, P102, DOI 10.1016/j.pocean.2012.03.008; Link JS, 2010, PROG OCEANOGR, V87, P214, DOI 10.1016/j.pocean.2010.09.020; LOENG H, 1991, POLAR RES, V10, P5, DOI 10.1111/j.1751-8369.1991.tb00630.x; Mork KA, 2010, OCEAN SCI, V6, P901, DOI 10.5194/os-6-901-2010; Morris DJ, 2014, ECOL MODEL, V273, P251, DOI 10.1016/j.ecolmodel.2013.11.019; Nottestad L, 2014, MAR ECOL PROG SER, V499, P275, DOI 10.3354/meps10638; NTIBA MJ, 1993, NETH J SEA RES, V31, P189, DOI 10.1016/0077-7579(93)90009-H; Nye JA, 2013, ECOL MODEL, V264, P157, DOI 10.1016/j.ecolmodel.2012.08.019; Olsen E, 2007, ICES J MAR SCI, V64, P599, DOI 10.1093/icesjms/fsm005; Olsen E, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00064; Olsen E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146467; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Ortega-Cisneros K, 2017, ECOL MODEL, V355, P49, DOI 10.1016/j.ecolmodel.2017.04.009; Ottersen G, 2014, ICES J MAR SCI, V71, P2064, DOI 10.1093/icesjms/fsu037; Pantus FJ, 2006, SENSITIVITY ANAL COM, P261; Patrick WS, 2015, FISHERIES, V40, P155, DOI 10.1080/03632415.2015.1024308; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Plaganyi E.E., 2007, FAO FISH TECH PAP; Punt AE, 2014, ICES J MAR SCI, V71, P2208, DOI 10.1093/icesjms/fst057; Refsgaard JC, 2007, ENVIRON MODELL SOFTW, V22, P1543, DOI 10.1016/j.envsoft.2007.02.004; Robinson KL, 2014, OCEANOGRAPHY, V27, P104, DOI 10.5670/oceanog.2014.90; Rose GA, 2005, ICES J MAR SCI, V62, P1524, DOI 10.1016/j.icesjms.2005.05.008; Rose KA, 2010, MAR COAST FISH, V2, P115, DOI 10.1577/C09-059.1; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Skogen MD, 1998, USERS GUIDE NORVECOM; Skogen MD, 2007, ICES J MAR SCI, V64, P889, DOI 10.1093/icesjms/fsm063; Stow CA, 2009, J MARINE SYST, V76, P4, DOI 10.1016/j.jmarsys.2008.03.011; Toresen R, 2000, FISH FISH, V1, P231, DOI 10.1111/j.1467-2979.2000.00022.x; Uye S, 2011, HYDROBIOLOGIA, V666, P71, DOI 10.1007/s10750-010-0208-9; Wgibar I, 2018, INT REP WORK GROUP I, P210; Wiedmann MA, 2014, ECOL EVOL, V4, P3596, DOI 10.1002/ece3.1203; Yaragina NA, 2009, DEEP-SEA RES PT II, V56, P2141, DOI 10.1016/j.dsr2.2008.11.025	61	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0210419	10.1371/journal.pone.0210419	http://dx.doi.org/10.1371/journal.pone.0210419			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735534	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000458181200015
J	Hong, JY; Wang, ZP; Niu, W				Hong, Jieying; Wang, Zhipeng; Niu, Wei			A simple approximation algorithm for the diameter of a set of points in an Euclidean plane	PLOS ONE			English	Article							HYPERSPHERE	Approximation algorithms with linear complexities are required in the treatments of big data, however, present algorithms cannot output the diameter of a set of points with arbitrary accuracy and near-linear complexity. By introducing the partition technique, we introduce a very simple approximation algorithm with arbitrary accuracy epsilon and a complexity of O(N + epsilon(-1) log epsilon(-1)) for the cases that all points are located in an Euclidean plane. The error bounds are proved strictly, and are verified by numerical tests. This complexity is better than existing algorithms, and the present algorithm is also very simple to be implemented in applications.	[Hong, Jieying] ESSEC Business Sch, ESSEC Asia Pacific, Singapore, Singapore; [Wang, Zhipeng; Niu, Wei] Beihang Univ, Ecole Cent Pekin, Beijing, Peoples R China; [Niu, Wei] Beihang Univ, Beijing Adv Innovat Ctr Big Data & Brain Comp, Beijing, Peoples R China	ESSEC Business School; Beihang University; Beihang University	Niu, W (corresponding author), Beihang Univ, Ecole Cent Pekin, Beijing, Peoples R China.; Niu, W (corresponding author), Beihang Univ, Beijing Adv Innovat Ctr Big Data & Brain Comp, Beijing, Peoples R China.	wei.niu@buaa.edu.cn			National Natural Science Foundation of China [11601023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant Nos. 11601023). The website of the funder is http://www.nsfc.gov.cn/.The author Wei Niu received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P. K., 1992, Computational Geometry: Theory and Applications, V1, P189, DOI 10.1016/0925-7721(92)90001-9; Alipour S, 2014, ARXIV14102195; [Anonymous], 2014, P 30 ANN S COMP GEOM, P416; Barequet G, 1999, PROCEEDINGS OF THE TENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P82; BENTLEY JL, 1982, COMMUN ACM, V25, P64, DOI 10.1145/358315.358392; Chan T. M., 2000, P 16 ANN S COMP GEOM, P300; COOPER PW, 1962, INFORM CONTROL, V5, P324, DOI 10.1016/S0019-9958(62)90641-1; EGECIOGLU O, 1989, INFORM PROCESS LETT, V32, P205, DOI 10.1016/0020-0190(89)90045-8; Fang L, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4936140; KATSUKI S, 1994, J ENG MECH-ASCE, V120, P2405, DOI 10.1061/(ASCE)0733-9399(1994)120:11(2405); Knuth D.E., 1968, ART COMPUTER PROGRAM, V2; Malandain G, 2002, INT J COMPUT GEOM AP, V12, P489, DOI 10.1142/S0218195902001006; Preparatat FP, 1985, COMPUTATIONAL GEOMET; Sato K, 2006, J STRUCT GEOL, V28, P972, DOI 10.1016/j.jsg.2006.03.007; YAO ACC, 1982, SIAM J COMPUT, V11, P721, DOI 10.1137/0211059	15	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211201	10.1371/journal.pone.0211201	http://dx.doi.org/10.1371/journal.pone.0211201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735522	Green Published, gold, Green Submitted			2022-12-26	WOS:000458181200018
J	Huang, XX; Urosevic, N; Inglis, TJJ				Huang, Xiao Xuan; Urosevic, Nadezda; Inglis, Timothy J. J.			Accelerated bacterial detection in blood culture by enhanced acoustic flow cytometry (AFC) following peptide nucleic acid fluorescence in situ hybridization (PNA-FISH)	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; RAPID IDENTIFICATION; BACTEREMIA; POSITIVITY; MICROORGANISMS; PNEUMONIAE; PREDICTOR; PROGNOSIS	Bacteraemia is a risk factor for subsequent clinical deterioration and death. Current reliance on culture-based methods for detection of bacteraemia delays identification and assessment of this risk until after the optimal period for positively impacting treatment decisions has passed. Therefore, a method for rapid detection and identification of bacterial infection in the peripheral bloodstream in acutely ill patients is crucial for improved patient survival through earlier targeted antibiotic treatment. The turnaround time for current clinical laboratory methods ranges from 12 to 48 hours, emphasizing the need for a faster diagnostic test. Here we describe a novel assay for accelerated generic detection of bacteria in blood culture (BC) using peptide nucleic acid fluorescence in situ hybridization enhanced acoustic flow cytometry (PNA-FISH-AFC). For assay development, we used simulated blood cultures (BCs) spiked with one of three bacterial species at a low starting concentration of 10 CFU/mL: Escherichia coli, Klebsiella pneumoniae or Pseudomonas aeruginosa. Under current clinical settings, it takes a minimum of 12 hours incubation to reach positivity on the BacTEC system, corresponding to a bacterial concentration of 10(7)-10(9) CFU/mL optimal for further analyses. In contrast, our PNA-FISH-AFC assay detected 10(3)-10(4) CFU/mL bacteria in BC following a much shorter culture incubation of 5 to 10 hours. Using either PCR-based FilmArray assay or MALDI-TOF for bacterial detection, it took 7-10 and 12-24 hours of incubation, respectively, to reach the positive result. These findings indicate a potential time advantage of PNA-FISH-AFC assay for rapid bacterial detection in BC with significantly improved turnaround time over currently used laboratory techniques.	[Huang, Xiao Xuan; Urosevic, Nadezda; Inglis, Timothy J. J.] QEII Med Ctr, Dept Microbiol, PathWest Lab Med, Nedlands, WA, Australia; [Huang, Xiao Xuan; Urosevic, Nadezda; Inglis, Timothy J. J.] Univ Western Australia, Sch Biomed Sci, Fac Hlth & Med Sci, Nedlands, WA, Australia; [Inglis, Timothy J. J.] Univ Western Australia, Sch Med, Fac Hlth Med Sci, Nedlands, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Inglis, TJJ (corresponding author), QEII Med Ctr, Dept Microbiol, PathWest Lab Med, Nedlands, WA, Australia.; Inglis, TJJ (corresponding author), Univ Western Australia, Sch Biomed Sci, Fac Hlth & Med Sci, Nedlands, WA, Australia.; Inglis, TJJ (corresponding author), Univ Western Australia, Sch Med, Fac Hlth Med Sci, Nedlands, WA, Australia.	Tim.Inglis@health.wa.gov.au		Urosevic, Nadia/0000-0002-2081-1172	PathWest Laboratory Medicine WA	PathWest Laboratory Medicine WA	XXH receives a PhD scholarship from PathWest Laboratory Medicine WA; TJJI received in-kind support from Thermo Fisher Scientific in the form of loan equipment (acoustic flow cytometer): http://corporate.thermofisher.com/en/home.html.	Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; [Anonymous], 2000, INTRO FLOW CYTOMETRY; Bowers DR, 2013, ANTIMICROB AGENTS CH, V57, P1270, DOI 10.1128/AAC.02235-12; Calderaro A, 2014, CLIN MICROBIOL INFEC, V20, pO468, DOI 10.1111/1469-0691.12490; Christner M, 2010, J CLIN MICROBIOL, V48, P1584, DOI 10.1128/JCM.01831-09; Drancourt M, 2010, CLIN MICROBIOL INFEC, V16, P1620, DOI 10.1111/j.1469-0691.2010.03290.x; Faron ML, 2017, J CLIN MICROBIOL, V55, P3328, DOI 10.1128/JCM.00868-17; Ferroni A, 2010, J CLIN MICROBIOL, V48, P1542, DOI 10.1128/JCM.02485-09; Forrest GN, 2008, ANTIMICROB AGENTS CH, V52, P3558, DOI 10.1128/AAC.00283-08; Fredricks DN, 1999, CLIN INFECT DIS, V29, P475, DOI 10.1086/598618; Heintzelman DL, 2000, PHOTOCHEM PHOTOBIOL, V71, P327, DOI 10.1562/0031-8655(2000)071<0327:COTAOP>2.0.CO;2; Hilty M, 2013, INT J ANTIMICROB AG, V41, P236, DOI 10.1016/j.ijantimicag.2012.10.022; Hsu MS, 2014, CLIN MICROBIOL INFEC, V20, P892, DOI 10.1111/1469-0691.12608; Kohlmann R, 2015, INT J MED MICROBIOL, V305, P469, DOI 10.1016/j.ijmm.2015.04.004; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Leli C, 2013, INT J MED MICROBIOL, V303, P205, DOI 10.1016/j.ijmm.2013.03.002; Liu HH, 2007, APPL ENVIRON MICROB, V73, P1899, DOI 10.1128/AEM.02391-06; Marra AR, 2006, J CLIN MICROBIOL, V44, P1342, DOI 10.1128/JCM.44.4.1342-1346.2006; Martinez JA, 2006, J CLIN MICROBIOL, V44, P1468, DOI 10.1128/JCM.44.4.1468-1474.2006; Mulroney KT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02009-3; Neuman MI, 2001, CLIN INFECT DIS, V33, P1324, DOI 10.1086/322699; Nielsen P E, 1999, Curr Issues Mol Biol, V1, P89; Nielsen PE, 2002, PEPTIDE NUCL ACID ME; Peralta G, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-79; Prod'hom G, 2010, J CLIN MICROBIOL, V48, P1481, DOI 10.1128/JCM.01780-09; Saffert RT, 2012, DIAGN MICR INFEC DIS, V73, P21, DOI 10.1016/j.diagmicrobio.2012.01.010; Saunderson RB, 2015, CLIN MICROBIOL INFEC, V21, P779, DOI 10.1016/j.cmi.2015.05.026; Sogaard M, 2007, J MED MICROBIOL, V56, P914, DOI 10.1099/jmm.0.46829-0; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P444, DOI 10.1128/JCM.01541-09; Wang MC, 2015, J MICROBIOL IMMUNOL, V48, P419, DOI 10.1016/j.jmii.2013.10.006; WRIGHT AJ, 1982, AM J CLIN PATHOL, V78, P173, DOI 10.1093/ajcp/78.2.173	31	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0201332	10.1371/journal.pone.0201332	http://dx.doi.org/10.1371/journal.pone.0201332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735489	Green Published, gold, Green Submitted			2022-12-26	WOS:000458181200003
J	Schmider, AB; Vaught, M; Bauer, NC; Elliott, HL; Godin, MD; Ellis, GE; Nigrovic, PA; Soberman, RJ				Schmider, Angela B.; Vaught, Melissa; Bauer, Nicholas C.; Elliott, Hunter L.; Godin, Matthew D.; Ellis, Giorgianna E.; Nigrovic, Peter A.; Soberman, Roy J.			The organization of leukotriene biosynthesis on the nuclear envelope revealed by single molecule localization microscopy and computational analyses	PLOS ONE			English	Article							AFFINITY IGE RECEPTOR; PROTEIN-PROTEIN INTERACTIONS; BASOPHILIC LEUKEMIA-CELLS; SLOW-REACTING SUBSTANCE; HIGHER-ORDER ASSEMBLIES; FC-EPSILON-RI; MAST-CELLS; MEMBRANE ORGANIZATION; TYROSINE KINASES; 5-LIPOXYGENASE	The initial steps in the synthesis of leukotrienes are the translocation of 5-lipoxygenase (5-LO) to the nuclear envelope and its subsequent association with its scaffold protein 5-lipoxygenase-activating protein (FLAP). A major gap in our understanding of this process is the knowledge of how the organization of 5-LO and FLAP on the nuclear envelope regulates leukotriene synthesis. We combined single molecule localization microscopy with Clus-DoC cluster analysis, and also a novel unbiased cluster analysis to analyze changes in the relationships between 5-LO and FLAP in response to activation of RBL-2H3 cells to generate leukotriene C-4. We identified the time-dependent reorganization of both 5-LO and FLAP into higher-order assemblies or clusters in response to cell activation via the IgE receptor. Clus-DoC analysis identified a subset of these clusters with a high degree of interaction between 5-LO and FLAP that specifically correlates with the time course of LTC4 synthesis, strongly suggesting their role in the initiation of leukotriene biosynthesis.	[Schmider, Angela B.; Vaught, Melissa; Bauer, Nicholas C.; Godin, Matthew D.; Ellis, Giorgianna E.; Soberman, Roy J.] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; [Schmider, Angela B.; Vaught, Melissa; Bauer, Nicholas C.; Godin, Matthew D.; Ellis, Giorgianna E.; Nigrovic, Peter A.; Soberman, Roy J.] Harvard Med Sch, Boston, MA 02115 USA; [Elliott, Hunter L.] Harvard Med Sch, Dept Cell Biol, Image & Data Anal Core, Boston, MA USA; [Nigrovic, Peter A.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Soberman, RJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA.; Soberman, RJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	rsoberman@mgh.harvard.edu		Bauer, Nicholas/0000-0002-8513-4467	National Institutes of Health [1R01AR065538, 1R01CA193520, R01DK062472, S10RR027931, K01DK089145, T32 DK007540-32]; NATIONAL CANCER INSTITUTE [R01CA193520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062472, T32DK007540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	RJS was supported by National Institutes of Health - 1R01AR065538, 1R01CA193520, R01DK062472, and S10RR027931. ABS was supported by National Institutes of Health-K01DK089145 and R01DK062472, MVT, T32 DK007540-32. None of these funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair AM, 2012, MOL BIOL CELL, V23, P4456, DOI 10.1091/mbc.E12-06-0489; BROCK TG, 1994, J BIOL CHEM, V269, P22059; BROCK TG, 1995, J BIOL CHEM, V270, P21652, DOI 10.1074/jbc.270.37.21652; CHEN XS, 1995, J BIOL CHEM, V270, P17993, DOI 10.1074/jbc.270.30.17993; Christmas P, 2002, J BIOL CHEM, V277, P28902, DOI 10.1074/jbc.M203074200; Comaniciu D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P438, DOI 10.1109/ICCV.2001.937550; Dempsey GT, 2013, METHOD CELL BIOL, V114, P561, DOI 10.1016/B978-0-12-407761-4.00024-5; Ester M., 1996, P KDD 96, P1; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gerstmeier J, 2016, FASEB J, V30, P1892, DOI 10.1096/fj.201500210R; Gerstmeier J, 2016, FASEB J, V30, P276, DOI 10.1096/fj.15-278010; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; Hafner AK, 2015, BBA-MOL CELL BIOL L, V1851, P1465, DOI 10.1016/j.bbalip.2015.08.010; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lundeen KA, 2006, J IMMUNOL, V177, P3439, DOI 10.4049/jimmunol.177.5.3439; Mandal AK, 2004, P NATL ACAD SCI USA, V101, P6587, DOI 10.1073/pnas.0308523101; Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106; MENCIAHUERTA JM, 1983, J IMMUNOL, V130, P1885; Monachino E, 2017, J CELL BIOL, V216, P41, DOI 10.1083/jcb.201610025; Moore TI, 2018, CELL REP, V22, P1903, DOI 10.1016/j.celrep.2018.01.062; MURPHY RC, 1979, P NATL ACAD SCI USA, V76, P4275, DOI 10.1073/pnas.76.9.4275; ORANGE RP, 1968, J EXP MED, V127, P767, DOI 10.1084/jem.127.4.767; Pageon SV, 2016, MOL BIOL CELL, V27, P3627, DOI 10.1091/mbc.E16-07-0478; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Phong BL, 2015, J EXP MED, V212, P2289, DOI 10.1084/jem.20150388; Rius M, 2008, J PHARMACOL EXP THER, V324, P86, DOI 10.1124/jpet.107.131342; SCHARENBERG AM, 1995, EMBO J, V14, P3385, DOI 10.1002/j.1460-2075.1995.tb07344.x; Spiess M, 2018, J CELL BIOL, V217, P1929, DOI 10.1083/jcb.201707075; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Subbotin RI, 2014, MOL CELL PROTEOMICS, V13, P2824, DOI 10.1074/mcp.M114.041095; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Weller CL, 2005, J EXP MED, V201, P1961, DOI 10.1084/jem.20042407; WOODS JW, 1995, J CLIN INVEST, V95, P2035, DOI 10.1172/JCI117889; Wu H, 2016, CELL, V165, P1055, DOI 10.1016/j.cell.2016.05.004; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211943	10.1371/journal.pone.0211943	http://dx.doi.org/10.1371/journal.pone.0211943			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735559	Green Published, Green Submitted, gold			2022-12-26	WOS:000458181200047
J	Akombi, BJ; Agho, KE; Renzaho, AM; Hall, JJ; Merom, DR				Akombi, Blessing J.; Agho, Kingsley E.; Renzaho, Andre M.; Hall, John J.; Merom, Dafna R.			Trends in socioeconomic inequalities in child undernutrition: Evidence from Nigeria Demographic and Health Survey (2003-2013)	PLOS ONE			English	Article							PRENATAL-CARE; RURAL-AREAS; LOW-INCOME; MALNUTRITION; URBAN; COUNTRIES; HEIGHT; WOMEN; FOOD	Objective The aim of this study was to examine the trend in socioeconomic inequalities in child undernutrition in Nigeria. Methods The study analysed cross-sectional data from the Nigeria Demographic and Health Survey (NDHS) 2003 to 2013. The outcome variables were stunting, wasting and underweight among children under-five years. The magnitude of child undernutrition in Nigeria was estimated via a concentration index, and the socioeconomic factors contributing to child undernutrition over time were determined using the decomposition method. Results The concentration index showed an increase in childhood wasting and underweight in Nigeria over time. The socioeconomic factors contributing to the increase in child undernutrition were: child's age (0-23 months), maternal education (no education), household wealth index (poorest household), type of residence (rural) and geopolitical zone (North East, North West). Conclusions To address child undernutrition, there is a need to improve maternal education and adopt effective social protection policies especially in rural communities in Nigeria.	[Akombi, Blessing J.; Renzaho, Andre M.] Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia; [Agho, Kingsley E.; Merom, Dafna R.] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia; [Hall, John J.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	Western Sydney University; Western Sydney University; University of New South Wales Sydney	Akombi, BJ (corresponding author), Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia.	B.Akombi@westernsydney.edu.au	Renzaho, Andre M.N./AAH-7679-2021; Agho, Kingsley/AAE-9971-2020; Agho, Kingsley/AAW-5622-2021; Merom, Dafna/AAW-5357-2021; Akombi-Inyang, Blessing/AAT-6507-2020	Agho, Kingsley/0000-0003-4111-3207; Merom, Dafna/0000-0001-6459-8628; Akombi-Inyang, Blessing/0000-0002-6410-4154; RENZAHO, ANDRE/0000-0002-6844-0833				Adebami OJ, 2007, INTERNET J 3 WORLD M, V4, P1; Aheto JMK, 2015, PAEDIATR PERINAT EP, V29, P552, DOI 10.1111/ppe.12222; Akombi BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177338; Akombi BJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010044; Akombi BJ, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0770-z; [Anonymous], 2014, PAN AFR MED J, DOI DOI 10.11604/pamj.2014.17.161.2389; [Anonymous], 2008, ANAL HLTH EQUITY USI; Bain LE, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.120.2535; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Braveman P, 2002, SOC SCI MED, V54, P1621, DOI 10.1016/S0277-9536(01)00331-8; Burchi F, 2010, ECON HUM BIOL, V8, P331, DOI 10.1016/j.ehb.2010.05.010; Cherop C, 2009, E AFRICAN J PUBLIC H, V6; Erreygers G, 2009, J HEALTH ECON, V28, P504, DOI 10.1016/j.jhealeco.2008.02.003; Fotso JC, 2005, HEALTH PLACE, V11, P205, DOI 10.1016/j.healthplace.2004.06.004; Fotso JC, 2007, HEALTH PLACE, V13, P205, DOI 10.1016/j.healthplace.2006.01.004; Hackett M, 2009, REV PANAM SALUD PUBL, V25, P506, DOI 10.1590/S1020-49892009000600006; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; KISTIN N, 1990, PEDIATRICS, V86, P741; Ku CM, 2010, J CLIN NURS, V19, P2434, DOI 10.1111/j.1365-2702.2010.03302.x; Leroy JL, 2014, J NUTR, V144, P1460, DOI 10.3945/jn.114.191981; Masiye F., 2010, ZAMB SOC SCI J, V1, P4; Masuku Mfundo, 2017, Journal of Human Ecology, V58, P57, DOI 10.1080/09709274.2017.1305615; Matsumura M., 2001, ASIA PAC POPULAT J, V16, P23, DOI DOI 10.18356/E8A4C9ED-EN; Mutisya M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2403-0; National Population Commission, 2003, NIG DEM HLTH SURV; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Novignon J, 2015, HEALTH ECON REV, V5, DOI 10.1186/s13561-015-0072-4; O'Donnell O, 2016, STATA J, V16, P112, DOI 10.1177/1536867X1601600112; Pathak PK, 2011, SOC SCI MED, V73, P576, DOI 10.1016/j.socscimed.2011.06.024; Pritchett L.Z, 1998, POLICY RES WORKING P; Pulok MH, 2016, INT J SOC ECON, V43, P1439, DOI 10.1108/IJSE-03-2015-0065; Restrepo-Mendez MC, 2015, REV PANAM SALUD PUBL, V38, P9; Save the Children UK, 2010, NUTR ANTHR SURV DAUR; Saxena N.C., 2018, POVERTY CHRONIC POVE, P55, DOI 10.1007/978-981-13-0677-8_4; Shin H, 2007, J HEALTH SOC BEHAV, V48, P418, DOI 10.1177/002214650704800406; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; Sparks CS, 2011, AM J HUM BIOL, V23, P80, DOI 10.1002/ajhb.21104; Stewart CP, 2013, MATERN CHILD NUTR, V9, P27, DOI 10.1111/mcn.12088; Teitler JO, 2012, PERSPECT SEX REPRO H, V44, P13, DOI 10.1363/4401312; The World Bank, 2013, NIG EC REP; Thurman Sara Elizabeth, 2008, Pediatr Nurs, V34, P419; U.S. Department of Health and Human Services, 1989, A REPORT OF THE PUBL; Unicef, 2013, IMPR CHILD NUTR ACH, P1; UNICEF WHO World Bank, 2017, JOINT CHILD MALN EST; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Kien VD, 2016, GLOBAL HEALTH ACTION, V9, P29, DOI 10.3402/gha.v9.29263; Wambua BN, 2014, ASIAN J AGR FOOD SCI, V2; Wehby GL, 2009, ECON HUM BIOL, V7, P84, DOI 10.1016/j.ehb.2008.10.001; WHO, 2006, WHO CHILD GROWTH STA; Williams L., 2006, Proceedings. 16th IEEE International Symposium on Software Reliability Engineering; World Bank, 2014, NIG EC REP; World Bank, 2015, NIG EC REP	54	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211883	10.1371/journal.pone.0211883	http://dx.doi.org/10.1371/journal.pone.0211883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5RX	30730946	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000071
J	Sim, YS; Kwon, JW; Jee, D; Choi, JA; Ko, SH; Park, CK				Sim, Yoon Seop; Kwon, Jin-Woo; Jee, Donghyun; Choi, Jin A.; Ko, Seung-Hyun; Park, Chan Kee			Increased prelaminar tissue thickness in patients with open-angle glaucoma and type 2 diabetes	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; RETROGRADE AXONAL-TRANSPORT; VISUAL-FIELD DEFECTS; LAMINA-CRIBROSA; INTRAOCULAR-PRESSURE; HEAD CHANGES; DYSFUNCTION; MELLITUS; GLUCOSE	Background The characteristics of the optic nerve head (ONH) in open angle glaucoma (OAG) patients with diabetes have not been reported. This study aimed to characterize the ONH structures and glaucomatous damage in diabetic OAG patients, using age-matched non-diabetic OAG patients and control subjects. Methods The locations of visual field defects of OAG patients were classified and the prelaminar thickness and lamina cribrosa depth were measured in 64 OAG patients with type 2 diabetes (OAG+DM), 68 OAG patients without diabetes (OAG-DM), and 36 controls. All participants were scanned by spectral domain-optical coherence tomography. The anterior prelaminar depth and lamina cribrosa depth were measured at the center of the reference line (the Bruch's membrane opening plane). The prelaminar tissue thickness was obtained by subtracting the anterior prelaminar depth from the anterior lamina cribrosa depth. Results The visual field defects in the OAG+DM group were more commonly found in the inferior hemifield (P = 0.010), and tended to involve the central visual field compared to the OAG-DM group (P = 0.044). In the comparison of ONH parameters, the prelaminar thickness was highest in the OAG+DM group, followed by the control subjects and the OAG-DM group (P = 0.035). Post-hoc testing showed that prelaminar thickness was significantly greater in the OAG+DM group than in the OAG-DM group (P = 0.033). The lamina cribrosa depth was deepest in the OAG+DM group, followed by the OAG-DM group and the control subjects (P = 0.006). Conclusions Diabetic and non-diabetic OAG patients exhibit different characteristics of glaucoma, particularly increased prelaminar thickening in diabetics.	[Sim, Yoon Seop; Kwon, Jin-Woo; Jee, Donghyun; Choi, Jin A.] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Ko, Seung-Hyun] Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, St Vincent Hosp,Coll Med, Seoul, South Korea; [Park, Chan Kee] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Jee, D; Choi, JA (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	donghyunjee@catholic.ac.kr; jinah616@catholic.ac.kr		Choi, Jin A/0000-0002-9107-2565; Kwon, Jin-woo/0000-0003-2093-4284	National Research Foundation of Korea - Korean government [NRF-2016R1C1B1011287]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea [HC16C2299]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government); Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea	The authors wish to acknowledge the financial support of the National Research Foundation of Korea funded by the Korean government (No. NRF-2016R1C1B1011287 to JAC) and a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (No. HC16C2299 to DHJ).	Agoumi Y, 2011, OPHTHALMOLOGY, V118, P52, DOI 10.1016/j.ophtha.2010.05.016; Akkaya S, 2018, DIABETES VASC DIS RE, V15, P442, DOI 10.1177/1479164118782091; Amano S, 2001, BRIT J OPHTHALMOL, V85, P52, DOI 10.1136/bjo.85.1.52; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Beotra MR, 2018, INVEST OPHTH VIS SCI, V59, P260, DOI 10.1167/iovs.17-21982; Blackwell B, 2002, AM J OPHTHALMOL, V134, P499; Cheng HC, 2015, JAMA OPHTHALMOL, V133, P269, DOI 10.1001/jamaophthalmol.2014.4908; Choi JA, 2015, OPHTHALMOLOGY, V122, P976, DOI 10.1016/j.ophtha.2015.01.001; Cohen E, 2017, J GLAUCOMA, V26, P652, DOI 10.1097/IJG.0000000000000700; de Faria JML, 2002, BRIT J OPHTHALMOL, V86, P725; de Voogd S, 2006, OPHTHALMOLOGY, V113, P1827, DOI 10.1016/j.ophtha.2006.03.063; Ferreira JT, 2016, INVEST OPHTH VIS SCI, V57, P6455, DOI 10.1167/iovs.16-20215; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; He L, 2014, INVEST OPHTH VIS SCI, V55, P574, DOI 10.1167/iovs.13-13245; Ino-ue M, 2000, INVEST OPHTH VIS SCI, V41, P4055; Jeganathan VSE, 2008, DIABETES CARE, V31, P1905, DOI 10.2337/dc08-0342; Jeon SJ, 2016, INVEST OPHTH VIS SCI, V57, P4008, DOI 10.1167/iovs.16-19525; Jiang R, 2015, OPHTHALMOLOGY, V122, P730, DOI 10.1016/j.ophtha.2014.11.008; Jung KI, 2016, INVEST OPHTH VIS SCI, V57, P420, DOI 10.1167/iovs.15-18256; Keltner JL, 2003, ARCH OPHTHALMOL-CHIC, V121, P643, DOI 10.1001/archopht.121.5.643; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim DW, 2016, INVEST OPHTH VIS SCI, V57, P1662, DOI 10.1167/iovs.15-18453; Kim YW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159663; Lasta M, 2013, INVEST OPHTH VIS SCI, V54, P842, DOI 10.1167/iovs.12-10873; Lee E, 2014, EUR J OPHTHALMOL, V24, P542, DOI 10.5301/ejo.5000419; Lee EJ, 2015, OPHTHALMOLOGY, V122, P2234, DOI 10.1016/j.ophtha.2015.07.020; Lee EJ, 2015, OPHTHALMOLOGY, V122, P721, DOI 10.1016/j.ophtha.2014.10.007; Li LE, 2016, ACTA OPHTHALMOL, V94, pE492, DOI 10.1111/aos.13012; Ly A, 2011, INVEST OPHTH VIS SCI, V52, P9316, DOI 10.1167/iovs.11-7879; Min Seong Hee, 2006, Korean J Ophthalmol, V20, P162; Ochiai Y, 2002, JPN J OPHTHALMOL, V46, P249, DOI 10.1016/S0021-5155(01)00523-8; Ozdek S, 2002, EYE, V16, P761, DOI 10.1038/sj.eye.6700207; Park HYL, 2011, BRIT J OPHTHALMOL, V95, P1223, DOI 10.1136/bjo.2010.191841; Park HYL, 2012, AM J OPHTHALMOL, V154, P466, DOI 10.1016/j.ajo.2012.03.028; Park SC, 2015, INVEST OPHTH VIS SCI, V56, P2059, DOI 10.1167/iovs.14-15540; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; Reis ASC, 2012, INVEST OPHTH VIS SCI, V53, P5819, DOI 10.1167/iovs.12-9924; Sato T, 2002, INVEST OPHTH VIS SCI, V43, P170; Sawada H, 2014, J GLAUCOMA, V23, P81, DOI 10.1097/IJG.0b013e318265bbdc; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Sugimoto M, 2005, OPHTHALMOLOGICA, V219, P379, DOI 10.1159/000088382; Terai N, 2012, OPHTHALMIC RES, V47, P189, DOI 10.1159/000331990; Verma A, 2009, EYE, V23, P1824, DOI 10.1038/eye.2009.184; ZEITER JH, 1994, GRAEF ARCH CLIN EXP, V232, P205, DOI 10.1007/BF00184006; ZEITER JH, 1991, AM J OPHTHALMOL, V111, P581, DOI 10.1016/S0002-9394(14)73702-X; Zhang LX, 2000, CURR EYE RES, V20, P131, DOI 10.1076/0271-3683(200002)20:2;1-D;FT131; Zhao D, 2015, OPHTHALMOLOGY, V122, P72, DOI 10.1016/j.ophtha.2014.07.051	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211641	10.1371/journal.pone.0211641	http://dx.doi.org/10.1371/journal.pone.0211641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730917	gold, Green Published, Green Submitted			2022-12-26	WOS:000458026000039
J	Eyre, DR; Weis, M; Rai, J				Eyre, David R.; Weis, MaryAnn; Rai, Jyoti			Analyses of lysine aldehyde cross-linking in collagen reveal that the mature cross-link histidinohydroxylysinonorleucine is an artifact	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; cornea; protein cross-linking; lysyl oxidase; mass spectrometry (MS); skin; tendon; connective tissue; allysine aldol	I COLLAGEN; PEPTIDYL ALDEHYDES; BONE-COLLAGEN; HISTIDINE; HYDROXYLATION; CHEMISTRY; TELOPEPTIDES; QUANTITATION; SPECIFICITY; INHIBITORS	Lysyl oxidase-generated intermolecular cross-links are essential for the tensile strength of collagen fibrils. Two cross-linking pathways can be defined, one based on telopeptide lysine aldehydes and another on telopeptide hydroxylysine aldehydes. Since the 1970s it has been accepted that the mature cross-linking structures on the lysine aldehyde pathway, which dominates in skin and cornea, incorporate histidine residues. Here, using a range of MS-based methods, we re-examined this conclusion and found that telopeptide aldol dimerization is the primary mechanism for stable cross-link formation. The C-telopeptide aldol dimers formed labile addition products with glucosylgalactosyl hydroxylysine at 1(I)K87 in adjacent collagen molecules that resisted borohydride reduction and after acid hydrolysis produced histidinohydroxylysinonorleucine (HHL), but only from species with a histidine in their 1(I) C-telopeptide sequence. Peptide MS analyses and the lack of HHL formation in rat and mouse skin, species that lack an 1(I) C-telopeptide histidine, revealed that HHL is a laboratory artifact rather than a natural cross-linking structure. Our experimental results also establish that histidinohydroxymerodesmosine is produced by borohydride reduction of N-telopeptide allysine aldol dimers in aldimine intermolecular linkage to nonglycosylated 1(I) K930. Borohydride reduction of the aldimine promotes an accompanying base-catalyzed Michael addition of 1(I) H932 imidazole to the ,-unsaturated aldol. These aldehydes are intramolecular at the N terminus but at the C terminus they can be both intramolecular and intermolecular according to present and earlier findings.	[Eyre, David R.; Weis, MaryAnn; Rai, Jyoti] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eyre, DR (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	deyre@uw.edu			National Institutes of Health NIAMS [AR037318, AR036794]; NICHD [HD070394]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318] Funding Source: NIH RePORTER	National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in whole or in part by National Institutes of Health NIAMS Grants AR037318 and AR036794 (to D. E.) and NICHD Grant HD070394 (to D. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amar A, 2010, CR CHIM, V13, P553, DOI 10.1016/j.crci.2009.11.009; BAILEY AJ, 1970, BIOCHEM J, V117, P819, DOI 10.1042/bj1170819; BAILEY AJ, 1976, BIOCHEM J, V153, P211, DOI 10.1042/bj1530211; BAILEY AJ, 1969, BIOCHEM J, V111, pP12, DOI 10.1042/bj1110012Pb; Belin MW, 2018, CORNEA, V37, P1218, DOI 10.1097/ICO.0000000000001707; Bella J, 2017, SUBCELL BIOCHEM, V82, P457, DOI 10.1007/978-3-319-49674-0_14; BERNSTEIN PH, 1980, J BIOL CHEM, V255, P414; BORNSTEIN P, 1966, P NATL ACAD SCI USA, V55, P417, DOI 10.1073/pnas.55.2.417; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; EYRE DR, 1973, BIOCHIM BIOPHYS ACTA, V295, P301, DOI 10.1016/0005-2795(73)90097-4; FAIRWEATHER RB, 1972, BIOCHEM BIOPH RES CO, V48, P1311, DOI 10.1016/0006-291X(72)90854-6; Giger L, 2013, NAT CHEM BIOL, V9, P494, DOI 10.1038/nchembio.1276; Gjaltema RAF, 2017, CRIT REV BIOCHEM MOL, V52, P74, DOI 10.1080/10409238.2016.1269716; HANSON DA, 1992, J BONE MINER RES, V7, P1251; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Heard ME, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006002; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; HENKEL W, 1976, EUR J BIOCHEM, V69, P223, DOI 10.1111/j.1432-1033.1976.tb10877.x; Holmes DF, 2018, CURR TOP DEV BIOL, V130, P107, DOI 10.1016/bs.ctdb.2018.02.004; HOUSLEY T, 1975, BIOCHEM BIOPH RES CO, V67, P824, DOI 10.1016/0006-291X(75)90887-6; Hudson DM, 2017, J BIOL CHEM, V292, P3877, DOI 10.1074/jbc.M116.762245; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Inani H, 2017, CHEMISTRYSELECT, V2, P11666, DOI 10.1002/slct.201702502; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; KANG AH, 1970, P NATL ACAD SCI USA, V67, P1307, DOI 10.1073/pnas.67.3.1307; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malone JP, 2004, BIOCHEMISTRY-US, V43, P15358, DOI 10.1021/bi048304b; McCall AS, 2010, INVEST OPHTH VIS SCI, V51, P129, DOI 10.1167/iovs.09-3738; MECHANIC GL, 1987, BIOCHEMISTRY-US, V26, P3500, DOI 10.1021/bi00386a038; Naffa R, 2016, J CHROMATOGR A, V1478, P60, DOI 10.1016/j.chroma.2016.11.060; Park J, 2004, BIOORG MED CHEM LETT, V14, P685, DOI 10.1016/j.bmcl.2003.11.027; Park JU, 2003, BIOCHEMISTRY-US, V42, P5159, DOI 10.1021/bi034076u; Paul RG, 1997, INT J BIOCHEM CELL B, V29, P211, DOI 10.1016/S1357-2725(96)00134-3; REISER KM, 1994, J GERONTOL, V49, pB71, DOI 10.1093/geronj/49.2.B71; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; ROBINS SP, 1973, BIOCHEM J, V135, P657, DOI 10.1042/bj1350657; ROBINS SP, 1977, BIOCHIM BIOPHYS ACTA, V492, P408, DOI 10.1016/0005-2795(77)90092-7; Rodriguez-Pascual F, 2016, SCI REP-UK, V6, DOI 10.1038/srep37374; ROJKIND M, 1966, J BIOL CHEM, V241, P1530; SIMS TJ, 1992, J CHROMATOGR-BIOMED, V582, P49, DOI 10.1016/0378-4347(92)80301-6; TANZER ML, 1973, J BIOL CHEM, V248, P393; TANZER ML, 1973, SCIENCE, V180, P561, DOI 10.1126/science.180.4086.561; WOODLEY DT, 1991, J INVEST DERMATOL, V97, P580, DOI 10.1111/1523-1747.ep12481920; YAMAUCHI M, 1988, BIOCHEM BIOPH RES CO, V152, P898, DOI 10.1016/S0006-291X(88)80124-4; YAMAUCHI M, 1987, J BIOL CHEM, V262, P11428; Yamauchi M, 2018, METHOD CELL BIOL, V143, P115, DOI 10.1016/bs.mcb.2017.08.006; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/BSE0520113, 10.1042/bse0520113]; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200	51	26	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6578	6590		10.1074/jbc.RA118.007202	http://dx.doi.org/10.1074/jbc.RA118.007202			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30733334	Green Published, hybrid			2022-12-26	WOS:000468402000031
J	Luu, K; Rajagopalan, N; Ching, JCH; Loewen, MC; Loewen, ME				Luu, Khanh; Rajagopalan, Nandhakishore; Ching, John C. H.; Loewen, Michele C.; Loewen, Matthew E.			The malate-activated ALMT12 anion channel in the grass Brachypodium distachyon is co-activated by Ca2+/calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; patch clamp; isothermal titration calorimetry (ITC); calmodulin (CaM); calcium; plant physiology; protein-protein interaction; structure-function; stomatal function	ABSCISIC-ACID ACTIVATION; GUARD-CELLS; STOMATAL MOVEMENT; ION CHANNELS; CALMODULIN; ARABIDOPSIS; KINASE; SLAC1; EXPRESSION; CALCIUM	In plants, strict regulation of stomatal pores is critical for modulation of CO2 fixation and transpiration. Under certain abiotic and biotic stressors, pore closure is initiated through anionic flux, with calcium (Ca2+) playing a central role. The aluminum-activated malate transporter 12 (ALMT12) is a malate-activated, voltage-dependent member of the aluminum-activated malate transporter family that has been implicated in anionic flux from guard cells controlling the stomatal aperture. Herein, we report the characterization of the regulatory mechanisms mediating channel activities of an ALMT from the grass Brachypodium distachyon (BdALMT12) that has the highest sequence identity to Arabidopsis thaliana ALMT12. Electrophysiological studies in a heterologous cell system confirmed that this channel is malate- and voltage-dependent. However, this was shown to be true only in the presence of Ca2+. Although a general kinase inhibitor increased the current density of BdALMT12, a calmodulin (CaM) inhibitor reduced the Ca2+-dependent channel activation. We investigated the physiological relevance of the CaM-based regulation in planta, where stomatal closure, induced by exogenous Ca2+ ionophore and malate, was shown to be inhibited by exogenous application of a CaM inhibitor. Subsequent analyses revealed that the double substitutions R335A/R338A and R335A/K342A, within a predicted BdALMT12 CaM-binding domain (CBD), also decreased the channels' ability to activate. Using isothermal titration calorimetry and CBD-mimetic peptides, as well as CaM-agarose affinity pulldown of full-length recombinant BdALMT12, we confirmed the physical interaction between the CBD and CaM. Together, these findings support a co-regulatory mechanism of BdALMT12 activation by malate, and Ca2+/CaM, emphasizing that a complex regulatory network modulates BdALMT12 activity.	[Luu, Khanh; Ching, John C. H.; Loewen, Matthew E.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK S7N 1B8, Canada; [Rajagopalan, Nandhakishore; Loewen, Michele C.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada; [Loewen, Michele C.] Natl Res Council Canada, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada; [Loewen, Michele C.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 0N6, Canada	University of Saskatchewan; National Research Council Canada; National Research Council Canada; Queens University - Canada	Loewen, MC (corresponding author), Natl Res Council Canada, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	michele.loewen@nrc.ca			Natural Sciences and Engineering Discovery Grants [261683-2012, 371364-2010]; National Research Council of Canada	Natural Sciences and Engineering Discovery Grants; National Research Council of Canada	This work was supported by Natural Sciences and Engineering Discovery Grants 261683-2012 (to M.C.L.) and 371364-2010 (to M.E.L.) and by a grant from the National Research Council of Canada, Wheat Flagship Program to M.C.L. This manuscript is NRCC no. 53630. The authors declare that they have no conflicts of interest with the contents of this article.	Alaimo A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13811-4; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Berger D, 2000, GENE DEV, V14, P1119; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; CAO YW, 1995, PLANT PHYSIOL, V109, P1093, DOI 10.1104/pp.109.3.1093; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COUSSON A, 1995, PLANT PHYSIOL, V109, P491, DOI 10.1104/pp.109.2.491; DESILVA DLR, 1985, NEW PHYTOL, V101, P555, DOI 10.1111/j.1469-8137.1985.tb02861.x; DONOVAN N, 1985, J PLANT PHYSIOL, V118, P177, DOI 10.1016/S0176-1617(85)80146-2; Dreyer I, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00263; Edlund M, 1996, J BIOL CHEM, V271, P1393, DOI 10.1074/jbc.271.3.1393; ERDAHL WL, 1994, BIOPHYS J, V66, P1678, DOI 10.1016/S0006-3495(94)80959-2; Geiger D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001346; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Hedrich R, 2012, PHYSIOL REV, V92, P1777, DOI 10.1152/physrev.00038.2011; HIDAKA H, 1983, METHOD ENZYMOL, V102, P185; HILU KW, 1984, TAXON, V33, P413, DOI 10.2307/1220980; Imes D, 2013, PLANT J, V74, P372, DOI 10.1111/tpj.12133; Ivashikina N, 2005, J GEN PHYSIOL, V125, P483, DOI 10.1085/jgp.200409211; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Leng Q, 1999, PLANT PHYSIOL, V121, P753, DOI 10.1104/pp.121.3.753; Leng Q, 2002, PLANT PHYSIOL, V128, P400, DOI 10.1104/pp.010832; Ligaba A, 2009, PLANT J, V60, P411, DOI 10.1111/j.1365-313X.2009.03964.x; LINDER B, 1992, FEBS LETT, V313, P27, DOI 10.1016/0014-5793(92)81176-M; Maierhofer T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005703; Mann DGJ, 2012, PLANT BIOTECHNOL J, V10, P226, DOI 10.1111/j.1467-7652.2011.00658.x; Marten H, 2007, PLANT PHYSIOL, V143, P28, DOI 10.1104/pp.106.092643; Medeiros DB, 2016, PLANT PHYSIOL, V170, P86, DOI 10.1104/pp.15.01053; Meyer S, 2010, PLANT J, V63, P1054, DOI 10.1111/j.1365-313X.2010.04302.x; Minhas FUA, 2012, BIOINFORMATICS, V28, pI416, DOI 10.1093/bioinformatics/bts416; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Mruk K, 2014, J GEN PHYSIOL, V144, P103, DOI 10.1085/jgp.201311140; Mumm P, 2013, MOL PLANT, V6, P1550, DOI 10.1093/mp/sst008; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Palmer AJ, 2016, BIOCHEM SOC T, V44, P856, DOI 10.1042/BST20160027; Peterson FC, 2010, NAT STRUCT MOL BIOL, V17, P1109, DOI 10.1038/nsmb.1898; Pilot G, 2001, J BIOL CHEM, V276, P3215, DOI 10.1074/jbc.M007303200; Reichow SL, 2013, NAT STRUCT MOL BIOL, V20, P1085, DOI 10.1038/nsmb.2630; Reisser S, 2014, BIOPHYS J, V106, P2385, DOI 10.1016/j.bpj.2014.04.020; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Sasaki T, 2010, PLANT CELL PHYSIOL, V51, P354, DOI 10.1093/pcp/pcq016; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; Scherzer S, 2012, MOL PLANT, V5, P1409, DOI 10.1093/mp/sss084; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHROEDER JI, 1992, P NATL ACAD SCI USA, V89, P5025, DOI 10.1073/pnas.89.11.5025; SHIMAZAKI K, 1992, PLANT PHYSIOL, V99, P1416, DOI 10.1104/pp.99.4.1416; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Szabo I, 2000, BIOCHEM BIOPH RES CO, V274, P130, DOI 10.1006/bbrc.2000.3095; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Weiner SA, 2018, GENOME, V61, P266, DOI 10.1139/gen-2017-0066; Zhou YP, 2012, PLANT MOL BIOL, V79, P333, DOI 10.1007/s11103-012-9915-0; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	58	7	7	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6142	6156		10.1074/jbc.RA118.005301	http://dx.doi.org/10.1074/jbc.RA118.005301			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30770467	hybrid, Green Published			2022-12-26	WOS:000465077500042
J	Summers, KC; Bogard, AS; Tavalin, SJ				Summers, Kyle C.; Bogard, Amy S.; Tavalin, Steven J.			Preferential generation of Ca2+-permeable AMPA receptors by AKAP79-anchored protein kinase C proceeds via GluA1 subunit phosphorylation at Ser-831	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						A-kinase anchoring protein (AKAP); alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA receptor; AMPAR); phosphorylation; synaptic plasticity; protein kinase C (PKC); calcineurin; protein kinase A (PKA); calcium; ion channel; subunit composition	LONG-TERM POTENTIATION; SYNAPTIC INCORPORATION; AKAP150-ANCHORED PKA; GLUR1 SUBUNIT; CINGULATE CORTEX; TRAFFICKING; PLASTICITY; MEMBRANE; AKAP79; NMDA	AMPA-type glutamate receptors (AMPARs) mediate fast excitatory neurotransmission in the mammalian central nervous system. Preferential AMPAR subunit assembly favors heteromeric GluA1/GluA2 complexes. The presence of the GluA2 subunit generates Ca2+-impermeable (CI) AMPARs that have linear current-voltage (I-V) relationships. However, diverse forms of synaptic plasticity and pathophysiological conditions are associated with shifts from CI to inwardly rectifying, GluA2-lacking, Ca2+-permeable (CP) AMPARs on time scales ranging from minutes to days. These shifts have been linked to GluA1 phosphorylation at Ser-845, a protein kinase A (PKA)-targeted site within its intracellular C-terminal tail, often in conjunction with protein kinase A anchoring protein 79 (AKAP79; AKAP150 in rodents), which targets PKA to GluA1. However, AKAP79 may impact GluA1 phosphorylation at other sites by interacting with other signaling enzymes. Here, we evaluated the ability of AKAP79, its signaling components, and GluA1 phosphorylation sites to induce CP-AMPARs under conditions in which CI-AMPARs normally predominate. We found that GluA1 phosphorylation at Ser-831 is sufficient for the appearance of CP-AMPARs and that AKAP79-anchored protein kinase C (PKC) primarily drives the appearance of these receptors via this site. In contrast, other AKAP79-signaling components and C-terminal tail GluA1 phosphorylation sites exhibited a permissive role, limiting the extent to which AKAP79 promotes CP-AMPARs. This may reflect the need for these sites to undergo active phosphorylation/dephosphorylation cycles that control their residency within distinct subcellular compartments. These findings suggest that AKAP79, by orchestrating phosphorylation, represents a key to a GluA1 phosphorylation passcode, which allows the GluA1 subunit to escape GluA2 dominance and promote the appearance of CP-AMPARs.	[Summers, Kyle C.; Bogard, Amy S.; Tavalin, Steven J.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, 71 S Manassas St, Memphis, TN 38103 USA	University of Tennessee System; University of Tennessee Health Science Center	Tavalin, SJ (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, 71 S Manassas St, Memphis, TN 38103 USA.	stavalin@uthsc.edu			National Institutes of Health [NS076637]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant NS076637 (to S. J. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee B, 2013, NEUROGASTROENT MOTIL, V25, P973, DOI 10.1111/nmo.12233; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Brooks IM, 2011, J BIOL CHEM, V286, P6697, DOI 10.1074/jbc.M110.183558; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chen T, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0076-8; Chung HJ, 2000, J NEUROSCI, V20, P7258; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Clem RL, 2010, J NEUROSCI, V30, P6360, DOI 10.1523/JNEUROSCI.6276-09.2010; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Diering GH, 2018, NEURON, V100, P314, DOI 10.1016/j.neuron.2018.10.018; Diering GH, 2016, P NATL ACAD SCI USA, V113, pE4920, DOI 10.1073/pnas.1610631113; Diering GH, 2014, NEURON, V84, P790, DOI 10.1016/j.neuron.2014.09.024; Dittmer PJ, 2014, CELL REP, V7, P1410, DOI 10.1016/j.celrep.2014.04.039; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ferrario CR, 2011, NEUROPHARMACOLOGY, V61, P1141, DOI 10.1016/j.neuropharm.2011.01.021; Goel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018264; Gray EE, 2014, J BIOL CHEM, V289, P14600, DOI 10.1074/jbc.M114.553537; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Hanley JG, 2014, SEMIN CELL DEV BIOL, V27, P14, DOI 10.1016/j.semcdb.2013.12.002; Hosokawa T, 2015, NEURON, V85, P60, DOI 10.1016/j.neuron.2014.11.026; Huie JR, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0091-15.2015; Incontro S, 2013, BBA-MOL CELL RES, V1833, P1820, DOI 10.1016/j.bbamcr.2013.03.021; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jenkins MA, 2014, MOL PHARMACOL, V85, P618, DOI 10.1124/mol.113.091488; Jenkins MA, 2012, CHANNELS, V6, P60, DOI 10.4161/chan.18648; Jones TL, 2005, PAIN, V117, P259, DOI 10.1016/j.pain.2005.06.003; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Keith DJ, 2012, J NEUROSCI, V32, P7119, DOI 10.1523/JNEUROSCI.0784-12.2012; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; Kim S, 2015, P NATL ACAD SCI USA, V112, P3122, DOI 10.1073/pnas.1417498112; Kim S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001900; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Lee HK, 2007, MOL CELL NEUROSCI, V36, P86, DOI 10.1016/j.mcn.2007.06.003; Lee HK, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00017; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee S, 2013, NAT NEUROSCI, V16, P1436, DOI 10.1038/nn.3491; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Lussier MP, 2015, J BIOL CHEM, V290, P28596, DOI 10.1074/jbc.R115.652750; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Man HY, 2011, CURR OPIN NEUROBIOL, V21, P291, DOI 10.1016/j.conb.2011.01.001; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Martinez-Rivera A, 2017, MOL PSYCHIATR, V22, P1735, DOI 10.1038/mp.2017.9; McDonald BJ, 2001, NEUROPHARMACOLOGY, V41, P672, DOI 10.1016/S0028-3908(01)00129-0; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Park K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100108; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Purkey AM, 2018, CELL REP, V25, P974, DOI 10.1016/j.celrep.2018.09.085; Qiu S, 2014, J NEUROSCI, V34, P13505, DOI 10.1523/JNEUROSCI.1431-14.2014; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sanderson JL, 2018, J NEUROSCI, V38, P2863, DOI 10.1523/JNEUROSCI.2362-17.2018; Sanderson JL, 2016, NEURON, V89, P1000, DOI 10.1016/j.neuron.2016.01.043; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shen GF, 2009, BIOCHEM SOC T, V37, P1394, DOI 10.1042/BST0371394; Shukla K, 2007, J BIOL CHEM, V282, P18100, DOI 10.1074/jbc.M702906200; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tang YY, 2018, NEUROPHARMACOLOGY, V133, P462, DOI 10.1016/j.neuropharm.2018.02.026; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Toda AMA, 2015, P NATL ACAD SCI USA, V112, P6712, DOI 10.1073/pnas.1507229112; Tukey DS, 2013, J BIOL CHEM, V288, P35297, DOI 10.1074/jbc.M113.516690; Weisenhaus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010325; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Whitcomb DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10934; Whitehead G, 2013, BRAIN, V136, P3753, DOI 10.1093/brain/awt293; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wigerblad G, 2017, EXP NEUROL, V293, P144, DOI 10.1016/j.expneurol.2017.04.004; Yi ES, 2017, BIOCHEM BIOPH RES CO, V486, P671, DOI 10.1016/j.bbrc.2017.03.093; Yoo SW, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.254	82	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5521	5535		10.1074/jbc.RA118.004340	http://dx.doi.org/10.1074/jbc.RA118.004340			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30737285	Green Published, hybrid			2022-12-26	WOS:000464517500023
J	Jarry, AC; Merah, N; Cisse, F; Cayetanot, F; Fiamma, MN; Willemetz, A; Gueddouri, D; Barka, B; Valet, P; Guilmeau, S; Bado, A; Le Beyec, J; Bodineau, L; Le Gall, M				Jarry, Anne-Charlotte; Merah, Nadir; Cisse, Fanta; Cayetanot, Florence; Fiamma, Marie-Noelle; Willemetz, Alexandra; Gueddouri, Dalale; Barka, Besma; Valet, Philippe; Guilmeau, Sandra; Bado, Andre; Le Beyec, Johanne; Bodineau, Laurence; Le Gall, Maude			Neuromedin U is a gut peptide that alters oral glucose tolerance by delaying gastric emptying via direct contraction of the pylorus and vagal-dependent mechanisms	FASEB JOURNAL			English	Article						enteropeptide; decretin; vagus nerve	CENTRAL-NERVOUS-SYSTEM; GASTROINTESTINAL MOTILITY; INSULIN-SECRETION; BRAIN; IDENTIFICATION; EXPRESSION; ENERGY; FOOD; NMU	The gut-brain peptide neuromedin U (NMU) decreases food intake and body weight and improves glucose tolerance. Here, we characterized NMU as an enteropeptide and determined how it impacts glucose excursion. NMU was expressed predominantly in the proximal small intestine, and its secretion was triggered by ingestion of a mixed meal. Although a single peripheral injection of NMU in C57BL/6NRj mice prevented the rise of glycemia upon an oral but not an intraperitoneal load of glucose, it unexpectedly prevented insulin secretion, only slightly improved peripheral insulin sensitivity, and barely reduced intestinal glucose absorption. Interestingly, peripheral administration of NMU abrogated gastric emptying. NMU receptors 1 and 2 were detected in pyloric muscles and NMU was able to directly induce pyloric contraction in a dose-dependent manner ex vivo in isometric chambers. Using a modified glucose tolerance test, we demonstrate that improvement of oral glucose tolerance by NMU was essentially, if not exclusively, because of its impact on gastric emptying. Part of this effect was abolished in vagotomized (VagoX) mice, suggesting implication of the vagus tone. Accordingly, peripheral injection of NMU was associated with increased number of c-FOS-positive neurons in the nucleus of the solitary tract, which was partly prevented in VagoX mice. Finally, NMU kept its ability to improve oral glucose tolerance in obese and diabetic murine models. Together, these data demonstrate that NMU is an enteropeptide that prevents gastric emptying directly by triggering pylorus contraction and indirectly through vagal afferent neurons. This blockade consequently reduces intestinal nutrient absorption and thereby results in an apparent improved tolerance to oral glucose challenge.	[Jarry, Anne-Charlotte; Merah, Nadir; Cisse, Fanta; Willemetz, Alexandra; Bado, Andre; Le Beyec, Johanne; Le Gall, Maude] Univ Paris Diderot, AP HP, INSERM, UMR 1149, Paris, France; [Cayetanot, Florence; Fiamma, Marie-Noelle; Barka, Besma; Bodineau, Laurence] Sorbonne Univ, INSERM, UMR Neurophysiol Resp Expt & Clin S1158, Paris, France; [Gueddouri, Dalale; Guilmeau, Sandra] Univ Paris 05, CNRS, INSERM, Unite 1016,UMR 8104,Inst Cochin, Paris, France; [Valet, Philippe] Univ Toulouse III Paul Sabatier, INSERM, Unite 1048, I2MC, Toulouse, France; [Le Beyec, Johanne] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Endocrine & Oncol Biochem, Paris, France	Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Le Gall, M (corresponding author), Univ Paris Diderot Paris 7, Fac Med Site Bichat, Gastrointestinal & Metab Dysfunct Nutr Pathol, Ctr Rech Inflammat Paris Montmartre,INSERM,UMRS 1, 16 Rue Henri Huchard, F-75890 Paris 18, France.	maude.le-gall@inserm.fr	Le Gall, Maude/W-2593-2019; Le Gall, Maude/C-3917-2017; BADO, Andre/G-3408-2013; Valet, Philippe/N-7472-2017	Le Gall, Maude/0000-0002-5372-4585; Le Gall, Maude/0000-0002-5372-4585; Valet, Philippe/0000-0001-6520-7393; Le Beyec - Le Bihan, johanne/0000-0002-5647-2002; BODINEAU, Laurence/0000-0002-0085-9021; BADO, Andre/0000-0002-8007-1460; CAYETANOT, Florence/0000-0003-0441-0720	INSERM; Universite Paris Diderot; Universite Paris Descartes; Sorbonne Universite; Ministry for Research and Education; Societe Francophone du Diabete; Institut Benjamin Delessert; Fondation pour la Recherche Medicale; European Association for the Study of Diabetes	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Diderot; Universite Paris Descartes; Sorbonne Universite; Ministry for Research and Education; Societe Francophone du Diabete; Institut Benjamin Delessert; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Association for the Study of Diabetes	The authors thank R. Ducroc (UMRS1149, Paris, France) for help in setting up the Ussing chamber experiments, and B. Eto (UMRS1149, Paris) for assistance in the measurement of pyloric contractions. The authors are grateful to Nicholas Nguyen (UMRS1149, Paris) and Sara Zaat (UMRS 1149, Paris) for English editing, Prof. F. Gribble (University of Cambridge, Cambridge, United Kingdom) for discussing and sharing unpublished data, and Prof. J. Hommel (University of Texas-Galveston, Galveston, TX, USA) for advice with NMU receptor antibodies and immunostaining. This work was supported by INSERM, Universite Paris Diderot, Universite Paris Descartes, and Sorbonne Universite. A.-C.J. and D.G. received funding from the Ministry for Research and Education. M.L.G. received research grants from Societe Francophone du Diabete and Institut Benjamin Delessert. D.G. and S.G. received funding from Fondation pour la Recherche Medicale, Societe Francophone du Diabete, and European Association for the Study of Diabetes. The authors declare no conflicts of interest.	Alfa RW, 2015, CELL METAB, V21, P323, DOI 10.1016/j.cmet.2015.01.006; AUGOOD SJ, 1988, REGUL PEPTIDES, V20, P281, DOI 10.1016/0167-0115(88)90063-8; AUSTIN C, 1995, J MOL ENDOCRINOL, V14, P157, DOI 10.1677/jme.0.0140157; BALLESTA J, 1988, NEUROSCIENCE, V25, P797, DOI 10.1016/0306-4522(88)90037-1; BENITOORFILA MA, 1991, EUR J PHARMACOL, V193, P329, DOI 10.1016/0014-2999(91)90147-I; Brighton PJ, 2008, J PHARMACOL EXP THER, V325, P154, DOI 10.1124/jpet.107.132803; Browning KN, 2014, COMPR PHYSIOL, V4, P1339, DOI 10.1002/cphy.c130055; Dalboge LS, 2015, PEPTIDES, V69, P56, DOI 10.1016/j.peptides.2015.04.010; Dass NB, 2007, BRIT J PHARMACOL, V150, P502, DOI 10.1038/sj.bjp.0707004; Gage G. J., 2012, JOVE-J VIS EXP, V65, P3562; Gevaert B, 2016, NEUROPHARMACOLOGY, V107, P460, DOI 10.1016/j.neuropharm.2016.03.051; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Ingallinella P, 2012, BIOORGAN MED CHEM, V20, P4751, DOI 10.1016/j.bmc.2012.06.003; Joubert F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00609; Kaczmarek P, 2006, INT J MOL MED, V18, P951; Kaczmarek P, 2009, PANCREAS, V38, P208, DOI 10.1097/MPA.0b013e31818d9095; Kaplan JM, 1997, AM J PHYSIOL-REG I, V273, pR1786, DOI 10.1152/ajpregu.1997.273.5.R1786; Kowalski TJ, 2005, J ENDOCRINOL, V185, P151, DOI 10.1677/joe.1.05948; Kuhre RE, 2019, CELL METAB, V29, P719, DOI 10.1016/j.cmet.2018.10.008; Martinez VG, 2015, CLIN CHEM, V61, P471, DOI 10.1373/clinchem.2014.231753; McCue DL, 2017, INT J OBESITY, V41, P120, DOI 10.1038/ijo.2016.178; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P1078, DOI 10.1016/0006-291X(85)91726-7; Mondal MS, 2003, AM J PHYSIOL-GASTR L, V284, pG963, DOI 10.1152/ajpgi.00218.2002; Nakashima Y, 2010, ANN NY ACAD SCI, V1200, P104, DOI 10.1111/j.1749-6632.2010.05504.x; Nakazato M, 2000, BIOCHEM BIOPH RES CO, V277, P191, DOI 10.1006/bbrc.2000.3669; Peier A, 2009, ENDOCRINOLOGY, V150, P3101, DOI 10.1210/en.2008-1772; Peier AM, 2011, ENDOCRINOLOGY, V152, P2644, DOI 10.1210/en.2010-1463; Szekeres PG, 2000, J BIOL CHEM, V275, P20247, DOI 10.1074/jbc.C000244200; Takayama K, 2016, BIOPOLYMERS, V106, P440, DOI 10.1002/bip.22770; Wren AM, 2002, ENDOCRINOLOGY, V143, P4227, DOI 10.1210/en.2002-220308; Zeng HK, 2006, MOL CELL BIOL, V26, P9352, DOI 10.1128/MCB.01148-06; Zhang WD, 2017, BIOCHEM BIOPH RES CO, V493, P677, DOI 10.1016/j.bbrc.2017.08.132	33	11	11	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5377	5388		10.1096/fj.201801718R	http://dx.doi.org/10.1096/fj.201801718R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30753087	Bronze			2022-12-26	WOS:000462888500060
J	Gok, A; Fagerholm, CL; French, RH; Bruckman, LS				Gok, Abdulkerim; Fagerholm, Cara L.; French, Roger H.; Bruckman, Laura S.			Temporal evolution and pathway models of poly(ethylene-terephthalate) degradation under multi-factor accelerated weathering exposures	PLOS ONE			English	Article							PHOTOCHEMICAL DEGRADATION; HYDROLYSIS; IDENTIFICATION; TEREPHTHALATE; MECHANISMS; ANALYTICS; FILMS; IR	Photolytic and hydrolytic degradation of poly(ethylene-terephthalate) (PET) polymers with different stabilizers were performed under multiple accelerated weathering exposures and changes in the polymers were monitored by various evaluation techniques. Yellowing was caused by photolytic degradation and haze formation was induced by combined effects of photolytic and hydrolytic degradation. The formation of light absorbing chromophores and bleaching of the UV stabilizer additive were recorded through optical spectroscopy. Chain scission and crystallization were found to be common mechanisms under both photolytic and hydrolytic conditions, based on the infrared absorption of the carbonyl (C = O) band and the trans ethylene glycol unit, respectively. The degradation mechanisms determined from these evaluations were then used to construct a set of degradation pathway network models using the network structural equation modeling (netSEM) approach. This method captured the temporal evolution of degradation by assessing statistically significant relationships between applied stressors, mechanistic variables, and performance level responses. Quantitative pathway equations provided the contributions from mechanistic variables to the response changes.	[Gok, Abdulkerim] Gebze Tech Univ, Dept Mat Sci & Engn, Gebze, Kocaeli, Turkey; [Fagerholm, Cara L.; French, Roger H.; Bruckman, Laura S.] Case Western Reserve Univ, Dept Mat Sci & Engn, SDLE Res Ctr, Cleveland, OH 44106 USA	Gebze Technical University; Case Western Reserve University	Gok, A (corresponding author), Gebze Tech Univ, Dept Mat Sci & Engn, Gebze, Kocaeli, Turkey.; Bruckman, LS (corresponding author), Case Western Reserve Univ, Dept Mat Sci & Engn, SDLE Res Ctr, Cleveland, OH 44106 USA.	agok@gtu.edu.tr; laura.bruckman@case.edu	Gok, Abdulkerim/Y-8830-2019; French, Roger H/E-1986-2011; Bruckman, Laura/X-4067-2019	Gok, Abdulkerim/0000-0003-3433-7106; French, Roger H/0000-0002-6162-0532; Bruckman, Laura/0000-0003-1271-1072	Ohio Third Frontier, Wright Project Program Award Tech [12-004]; 3M Corporate Research Laboratory [1401945]; Ohio Third Frontier, Wright Project Program Award [12-004]	Ohio Third Frontier, Wright Project Program Award Tech; 3M Corporate Research Laboratory(3M); Ohio Third Frontier, Wright Project Program Award	This research was performed at the SDLE Center (funded through Ohio Third Frontier, Wright Project Program Award Tech 12-004) at Case Western Reserve University. The authors would like to acknowledge the support from 3M Corporate Research Laboratory (Agreement Control Number: 1401945). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was performed at the SDLE Research Center (funded through Ohio Third Frontier, Wright Project Program Award Tech 12-004) at Case Western Reserve University. The authors would like to acknowledge the support from 3M Corporate Research Laboratory (Agreement Control Number: 1401945). The authors would like to thank Dr. Nicholas Wheeler, Dr. Wei-Heng Huang, and other SDLE Research Center researchers who have contributed to the netSEM package development, David Burns of 3M for providing NMR analysis, Brad Smith of Auriga Polymers for providing ICP-MS analysis, David Schiraldi of CWRU for his suggestions to improve this work, and Tekra for providing samples.	Allen NS, 2000, POLYM DEGRAD STABIL, V67, P325, DOI 10.1016/S0141-3910(99)00134-2; Andanson JM, 2008, MACROMOL SYMP, V265, P195, DOI 10.1002/masy.200850521; [Anonymous], 2010, G172022010E1 ASTM; [Anonymous], 2013, D100313 ASTM; [Anonymous], 2016, TRENDS 2016 PHOT APP; [Anonymous], 2010, G166002011 ASTM; [Anonymous], WK57612 ASTM; [Anonymous], WK55620 ASTM; ASTM, 2015, E31315E1 ASTM; BALLARA A, 1989, POLYM DEGRAD STABIL, V26, P361, DOI 10.1016/0141-3910(89)90114-6; Beleites C. S., 2016, HYPERSPEC PACKAGE HA; Bruckman LS, 2013, PROC SPIE, V8825, DOI 10.1117/12.2024717; Bruckman LS, 2013, IEEE ACCESS, V1, P384, DOI 10.1109/ACCESS.2013.2267611; BUXBAUM LH, 1968, ANGEW CHEM INT EDIT, V7, P182, DOI 10.1002/anie.196801821; Cole KC, 2002, MACROMOLECULES, V35, P770, DOI 10.1021/ma011492i; DAY M, 1971, J POLYM SCI POL LETT, V9, P665, DOI 10.1002/pol.1971.110090906; DAY M, 1972, J APPL POLYM SCI, V16, P191, DOI 10.1002/app.1972.070160117; DAY M, 1972, J APPL POLYM SCI, V16, P203, DOI 10.1002/app.1972.070160118; DAY M, 1972, J APPL POLYM SCI, V16, P175, DOI 10.1002/app.1972.070160116; Dunlop ED, 2005, IEEE PHOT SPEC CONF, P1593, DOI 10.1109/PVSC.2005.1488449; EDGE M, 1995, POLYMER, V36, P227, DOI 10.1016/0032-3861(95)91308-T; Edge M, 1996, POLYM DEGRAD STABIL, V53, P141, DOI 10.1016/0141-3910(96)00081-X; Escobar LA, 2006, STAT SCI, V21, P552, DOI 10.1214/088342306000000321; Felder TC, 2014, PROC SPIE, V9179, DOI 10.1117/12.2062063; French RH, 2015, CURR OPIN SOLID ST M, V19, P212, DOI 10.1016/j.cossms.2014.12.008; G03 Committee, 2016, G15416 ASTM, DOI 10.1520/G0154-06; Gok Abdulkerim, 2015, 2015 IEEE 42nd Photovoltaic Specialist Conference (PVSC). Proceedings, P1, DOI 10.1109/PVSC.2015.7355601; Gok A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177614; Gok Abdulkerim, 2016, DEGRADATION PATHWAY; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P1, DOI 10.1002/pip.2573; Huang WH, 2018, NETWORK STRUCTURAL E; International Electrotechnical Commission (IEC), 2016, 6121522016 IEC; James G., 2017, INTRO STAT LEARNING, V8th ed.; Jones-Albertus R, 2016, PROG PHOTOVOLTAICS, V24, P1272, DOI 10.1002/pip.2755; Jordan DC, 2013, PROG PHOTOVOLTAICS, V21, P12, DOI 10.1002/pip.1182; Jordan DC, 2017, PROG PHOTOVOLTAICS, V25, P318, DOI 10.1002/pip.2866; Kirov KR, 2005, MACROMOLECULES, V38, P9258, DOI 10.1021/ma050495i; Klinke AG, 2018, POLYM DEGRAD STABIL, V153, P244, DOI 10.1016/j.polymdegradstab.2018.05.008; Klinke AG, 2017, DEGRADATION PHOTOVOL; Kontges M, 2017, T13092017 IEAPVPS; Kontges M, 2014, PERFORMANCE RELIABIL; LAUNAY A, 1994, POLYM DEGRAD STABIL, V46, P319, DOI 10.1016/0141-3910(94)90148-1; Luque A., 2011, HDB PHOTOVOLTAIC SCI, Vsecond, P1012, DOI [10.1002/9780470974704, DOI 10.1002/9780470974704]; McMahon W., 1959, J CHEM ENG DATA, V4, P57, DOI DOI 10.1021/JE60001A009; Murray MP, 2012, MRS ONLINE P LIB, V1391, DOI [10.1557/opl.2012.1241, DOI 10.1557/OPL.2012.1241]; Murray MP, 2012, J PHOTON ENERGY, V2, DOI 10.1117/1.JPE.2.022004; Novoa FD, 2014, SOL ENERG MAT SOL C, V120, P87, DOI 10.1016/j.solmat.2013.08.020; Oreski G, 2005, SOL ENERGY, V79, P612, DOI 10.1016/j.solener.2005.02.008; Osterwald CR, 2009, PROG PHOTOVOLTAICS, V17, P11, DOI 10.1002/pip.861; Peshek TJ, 2016, J VAC SCI TECHNOL B, V34, DOI 10.1116/1.4960628; Pickett J. E., 2015, SERVICE LIFE PREDICT, P41, DOI [DOI 10.1007/978-3-319-06034-7_3, 10.1007/978-3-319-06034-7_3]; Pickett JE, 2013, POLYM DEGRAD STABIL, V98, P1311, DOI 10.1016/j.polymdegradstab.2013.04.001; PICKETT JE, 1993, POLYM DEGRAD STABIL, V42, P231, DOI 10.1016/0141-3910(93)90219-9; RAVINDRANATH K, 1986, CHEM ENG SCI, V41, P2197, DOI 10.1016/0009-2509(86)85070-9; Ross RG, 2014, IEEE J PHOTOVOLT, V4, P291, DOI 10.1109/JPHOTOV.2013.2281102; Sammon C, 2000, POLYM DEGRAD STABIL, V67, P149, DOI 10.1016/S0141-3910(99)00104-4; Standard A., 2012, ANN BOOK ASTM STAND, P14; Thompson S.K., 2012, SAMPLING, V3; Trentin A, 2013, IEEE ENER CONV, P1, DOI 10.1109/ECCE.2013.6646673; Turnbull L, 2012, J APPL POLYM SCI, V124, P4517, DOI 10.1002/app.35476; Vazquez M, 2008, PROG PHOTOVOLTAICS, V16, P419, DOI 10.1002/pip.825; Wheeler NR, 2015, PROC SPIE, V9563, DOI 10.1117/12.2209204; Wheeler NR, IEEE PVSC 40; Wohlgemuth JH, 2006, 2006 IEEE 4 WORLD C, V2; Wohlgemuth JH, 2011, 2011 IEEE INTERNATIONAL RELIABILITY PHYSICS SYMPOSIUM (IRPS)	65	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212258	10.1371/journal.pone.0212258	http://dx.doi.org/10.1371/journal.pone.0212258			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768646	gold, Green Published, Green Submitted			2022-12-26	WOS:000458766300026
J	Alghamdi, F; Alhussien, A; Alohali, M; Alatawi, A; Almusned, T; Fecteau, S; Habib, SS; Bashir, S				Alghamdi, Faisal; Alhussien, Ahmed; Alohali, Meshal; Alatawi, Abdullah; Almusned, Tariq; Fecteau, Shirley; Habib, Syed Shahid; Bashir, Shahid			Effect of transcranial direct current stimulation on the number of smoked cigarettes in tobacco smokers	PLOS ONE			English	Article							PREFRONTAL CORTEX MODULATION; MAGNETIC STIMULATION; CORTICAL STIMULATION; PLACEBO-RESPONSE; DOUBLE-BLIND; SMOKING; TDCS; SCHIZOPHRENIA; METAANALYSIS; ACTIVATION	Background Recent studies reported that transcranial direct current stimulation (tDCS) applied over the dorsolateral prefrontal cortex (DLPFC) reduced craving and cigarette smoking. We aimed to evaluate whether 3 sessions of tDCS over the DLPFC modulate cigarette smoking which is a critical factor in tobacco smokers. Methods In a double-blinded, sham-controlled, parallel experimental study, 22 participants who wished to quit smoking received tDCS with the cathodal over the right DLPFC and anodal over the left DLPFC based on the 10-20 EEG international system (F4, F3) at an intensity of 1.5 mA for 20 minutes during three consecutive days. For sham stimulation, the electrodes placement was the same as for the active stimulation. Results For the short time interval (8 days after the end of the tDCS regimen), the number of smoked cigarettes was reduced similarly in the active and sham groups (p < 0.001). Also, at the long time-interval (4 months after the end of the tDCS regimen) as compared to pre-tDCS, there was no significant difference in the number of smoked cigarettes in the active (p = 0.806) or the sham (p = 0.573) groups. Overall, there were no statistically significant differences between the active and sham tDCS groups on cigarette smoking. Conclusion These findings suggested that 3 sessions of tDCS over the right and left DLPFC may reduce number of smoked cigarettes for short-time period but might not be significantly more effective than sham to decrease cigarette smoking.	[Alghamdi, Faisal; Alhussien, Ahmed; Alohali, Meshal; Alatawi, Abdullah; Almusned, Tariq; Habib, Syed Shahid] King Saud Univ, Fac Med, Riyadh, Saudi Arabia; [Fecteau, Shirley] Laval Univ, Lab Canada Res Chair Cognit Neurosci, CERVO Brain Res Ctr, Sch Med, Quebec City, PQ, Canada; [Bashir, Shahid] King Fahad Specialist Hosp Dammam, Neurosci Ctr, Dammam, Saudi Arabia; [Bashir, Shahid] Harvard Med Sch, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02115 USA	King Saud University; Laval University; Harvard University; Harvard Medical School	Bashir, S (corresponding author), King Fahad Specialist Hosp Dammam, Neurosci Ctr, Dammam, Saudi Arabia.; Bashir, S (corresponding author), Harvard Med Sch, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02115 USA.	sbashir10@gmail.com	Habib, Syed/ABD-2283-2020; Alhussien, Ahmed/GRS-9857-2022; Bashir, Shahid/N-3031-2019	Habib, Syed/0000-0001-5944-8406; Bashir, Shahid/0000-0001-6286-6895; Alhussien, Ahmed/0000-0003-4754-0293				Ayo-Yusuf OA, 2014, NIGER J CLIN PRACT, V17, P174, DOI 10.4103/1119-3077.127542; Baker TB, 2004, ANNU REV PSYCHOL, V55, P463, DOI 10.1146/annurev.psych.55.090902.142054; Batista EK, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv066; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bikson M, 2009, CLIN NEUROPHYSIOL, V120, P1033, DOI 10.1016/j.clinph.2009.03.018; Boggio PS, 2008, DRUG ALCOHOL DEPEN, V92, P55, DOI 10.1016/j.drugalcdep.2007.06.011; Boggio PS, 2009, NEUROSCI LETT, V463, P82, DOI 10.1016/j.neulet.2009.07.041; Brunoni AR, 2014, EXPERT REV MED DEVIC, V11, P383, DOI 10.1586/17434440.2014.911082; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Camprodon JA, 2007, DRUG ALCOHOL DEPEN, V86, P91, DOI 10.1016/j.drugalcdep.2006.06.002; Dollfus S, 2016, SCHIZOPHRENIA BULL, V42, P301, DOI 10.1093/schbul/sbv076; Eichhammer P, 2003, J CLIN PSYCHIAT, V64, P951, DOI 10.4088/JCP.v64n0815; Ekpu VU, 2015, TOB USE INSIGHTS, V8, P1, DOI 10.4137/TUI.S15628; Ellison-Loschmann L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181581; Engelmann JM, 2012, NEUROIMAGE, V60, P252, DOI 10.1016/j.neuroimage.2011.12.024; Fagerstrom K O, 1996, Tob Control, V5, P52, DOI 10.1136/tc.5.1.52; Falcone M, 2016, BRAIN STIMUL, V9, P191, DOI 10.1016/j.brs.2015.10.004; Fecteau S, 2014, DRUG ALCOHOL DEPEN, V140, P78, DOI 10.1016/j.drugalcdep.2014.03.036; Fraser Paige E, 2012, Front Psychiatry, V3, P79, DOI 10.3389/fpsyt.2012.00079; Fregni F, 2006, BIPOLAR DISORD, V8, P203, DOI 10.1111/j.1399-5618.2006.00291.x; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2008, J CLIN PSYCHIAT, V69, P32, DOI 10.4088/JCP.v69n0105; Fregni F, 2006, DEPRESS ANXIETY, V23, P482, DOI 10.1002/da.20201; Gallus S, 2015, PREV MED, V70, P76, DOI 10.1016/j.ypmed.2014.11.015; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; George MS, 2001, ARCH GEN PSYCHIAT, V58, P345, DOI 10.1001/archpsyc.58.4.345; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Hyland ME, 2011, PHILOS T R SOC B, V366, P1828, DOI 10.1098/rstb.2010.0391; Isa MM, 2014, INT J SCI RES PUBL, V4, P2250; Jansen JM, 2013, NEUROSCIENCE BIOBEHA; Kincses TZ, 2004, NEUROPSYCHOLOGIA, V42, P113, DOI 10.1016/S0028-3932(03)00124-6; Klauss J, 2014, INT J NEUROPSYCHOPH, V17, P1793, DOI 10.1017/S1461145714000984; Koks G, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4590-3; LEEWAHNHEE, 2017, Epidemiology and Health, V39, P1, DOI 10.4178/epih.e2017026; Li J, 2015, ONCOTARGET; Mahapatra S, 2015, J CANCER RES THER, V11, P199, DOI 10.4103/0973-1482.143332; Mcbride D., 2006, NEUROPSYCHOPHARMACOL; Meron D, 2015, NEUROSCI BIOBEHAV R, V57, P46, DOI 10.1016/j.neubiorev.2015.07.012; Miller FG, 2006, J CLIN EPIDEMIOL, V59, P331, DOI 10.1016/j.jclinepi.2005.12.001; Moore RA, 2012, INT J ENV RES PUB HE, V9, P192, DOI 10.3390/ijerph9010192; Olbrich HM, 2006, AUST NZ J PSYCHIAT, V40, P171, DOI 10.1111/j.1440-1614.2006.01765.x; Pripfl J, 2014, BRAIN STIMUL, V7, P226, DOI 10.1016/j.brs.2013.11.003; Shahbabaie A, 2014, INT J NEUROPSYCHOPH, V17, P1591, DOI 10.1017/S1461145714000686; Stead LF, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub3; Uher R, 2005, BIOL PSYCHIAT, V58, P840, DOI 10.1016/j.biopsych.2005.05.043; WHO, 2017, TOBACCO; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Xu Jiansong, 2013, Front Psychiatry, V4, P112, DOI 10.3389/fpsyt.2013.00112; Zellweger JP, 2005, AM J HEALTH BEHAV, V29, P240, DOI 10.5993/AJHB.29.3.5; Zhao HC, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00685; Zwar NA, 2014, BMJ-BRIT MED J, P348	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212312	10.1371/journal.pone.0212312	http://dx.doi.org/10.1371/journal.pone.0212312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763404	gold, Green Published, Green Submitted			2022-12-26	WOS:000458763900066
J	Pareja, MEM; Gauron, MC; Robledo, E; Aguilera, MO; Colombo, MI				Mansilla Pareja, Maria Eugenia; Celeste Gauron, Maria; Robledo, Esteban; Osmar Aguilera, Milton; Isabel Colombo, Maria			The cAMP effectors, Rap2b and EPAC, are involved in the regulation of the development of the Coxiella burnetii containing vacuole by altering the fusogenic capacity of the vacuole	PLOS ONE			English	Article							AUTOPHAGY; PROTEINS; INTERPLAY; MEMBRANE; PATHWAY	Cyclic Adenosine 3',5'-monophosphate (cAMP) is a key second messenger known to directly regulate not only the protein kinase A (PKA) activity but also other important molecules such as the exchange protein activated by cAMP (EPAC), which is as a guanine nucleotide exchange factor (GEF) of the low molecular weight GTPase, Rap2. Coxiella burnetii is a Gram negative bacterium that survives and grows in a large Coxiella replicative vacuole (CRV), which displays lysosomal and autophagic features. In this report, we present evidence that both, EPAC and its downstream effector Rap2b, were recruited to the CRV. The transient over-expression of the Rap2b wt protein, but not its inactive mutant Rap2b Delta AAX, markedly inhibited the development of the large CRV. Additionally, Rap2b wtinhibited the fusion of early Coxiella phagosomes with the fully developed CRV, indicating that homotypic fusion events are altered in the presence of high levels of Rap2b wt. Likewise, the fusion of endosome/lysosomal compartments (heterotypic fusions) with the large CRV was also affected by the over-expression of this GTPase. Interestingly, cell overexpression of Rap2b wt markedly decreased the levels of the v-SNARE, Vamp7, suggesting that this down-regulation impairs the homotypic and heterotypic fusions events of the Coxiella vacuole.	[Mansilla Pareja, Maria Eugenia; Celeste Gauron, Maria; Robledo, Esteban; Osmar Aguilera, Milton; Isabel Colombo, Maria] Univ Nacl Cuyo, Inst Histol & Embriol IHEM, Lab Biol Celular & Mol, Mendoza, Argentina; [Mansilla Pareja, Maria Eugenia; Celeste Gauron, Maria; Isabel Colombo, Maria] Fac Ciencias Med, Mendoza, Argentina; [Mansilla Pareja, Maria Eugenia] Univ Juan Agustin Maza, Fac Farm & Bioquim, Mendoza, Argentina; [Osmar Aguilera, Milton] UNCuyo, Fac Odontol, Mendoza, Argentina	University Nacional Cuyo Mendoza	Colombo, MI (corresponding author), Univ Nacl Cuyo, Inst Histol & Embriol IHEM, Lab Biol Celular & Mol, Mendoza, Argentina.; Colombo, MI (corresponding author), Fac Ciencias Med, Mendoza, Argentina.	mcolombo@fcm.uncu.edu.ar			Agencia Nacional de Investigacion Cientifica y Tecnologica [PICT2013-0305, PICT2016-0443]; SeCTyP [06/J432]	Agencia Nacional de Investigacion Cientifica y Tecnologica; SeCTyP	This work was supported by SeCTyP 06/J432 to MIC; Agencia Nacional de Investigacion Cientifica y Tecnologica (PICT2013-0305) to MIC and Agencia Nacional de Investigacion Cientifica y Tecnologica (PICT2016-0443) to MIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mestre MB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002664; Beron W, 2002, INFECT IMMUN, V70, P5816, DOI 10.1128/IAI.70.10.5816-5821.2002; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; Bruurs LJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106687; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Kalamidas SA, 2006, J CELL SCI, V119, P3686, DOI 10.1242/jcs.03091; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Kohler L, 2016, EFFECTOR PROTEIN CIG, V7, P1, DOI [10.1128/mBio.01127-16, DOI 10.1128/MBIO.01127-16]; Lai Shu-Chin, 2012, Cells, V1, P396, DOI 10.3390/cells1030396; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Pareja MEM, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00112; Pareja MEM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00054; Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011; Campoy EM, 2013, CELL MICROBIOL, V15, P922, DOI 10.1111/cmi.12087; Campoy EM, 2011, INFECT IMMUN, V79, P402, DOI 10.1128/IAI.00688-10; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; Mcdonough JA, 2013, HOST PATHWAYS IMPORT, P1, DOI [10.1128/mBio.00606-12, DOI 10.1128/MBIO.00606-12]; Militello RD, 2011, CURR MOL MED, V11, P197; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Newton HJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004286; Newton HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054566; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Pizon V, 1994, ASS RAP1A RAP1B PROT, V1670, P1661; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Roscioni SS, 2008, EPAC EFFECTORS BIOL, P345; Uechi Y, 2009, BIOCHEM BIOPH RES CO, V378, P732, DOI 10.1016/j.bbrc.2008.11.107; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Weber MM, 2013, J BACTERIOL, V195, P3914, DOI 10.1128/JB.00071-13; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Winchell CG, 2014, INFECT IMMUN, V82, P2229, DOI 10.1128/IAI.01236-13	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212202	10.1371/journal.pone.0212202	http://dx.doi.org/10.1371/journal.pone.0212202			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763357	gold, Green Submitted, Green Published			2022-12-26	WOS:000458763900051
J	Zumaquero, A; Martinez-Ferri, E; Matas, AJ; Reeksting, B; Olivier, NA; Pliego-Alfaro, F; Barcelo, A; van den Berg, N; Pliego, C				Zumaquero, Adela; Martinez-Ferri, Elsa; Matas, Antonio J.; Reeksting, Bianca; Olivier, Nicholas A.; Pliego-Alfaro, Fernando; Barcelo, Araceli; van den Berg, Noelani; Pliego, Clara			Rosellinia necatrix infection induces differential gene expression between tolerant and susceptible avocado rootstocks	PLOS ONE			English	Article							PROTEASE INHIBITORS; ROOT-ROT; DISEASE; OVEREXPRESSION; PHOTOSYNTHESIS; RESPONSES; PLANTS; TOOLS	Rosellinia necatrix is the causal agent of avocado white root rot (WRR). Control of this soilborne disease is difficult, and the use of tolerant rootstocks may present an effective method to lessen its impact. To date, no studies on the molecular mechanisms regulating the avocado plant response towards this pathogen have been undertaken. To shed light on the mechanisms underpinning disease susceptibility and tolerance, molecular analysis of the gene's response in two avocado rootstocks with a contrasting disease reaction was assessed. Gene expression profiles against R. necatrix were carried out in the susceptible 'Dusa' and the tolerant selection BG83 avocado genotypes by micro-array analysis. In 'Dusa', the early response was mainly related to redox processes and cell-wall degradation activities, all becoming enhanced after disease progression affected photosynthetic capacity, whereas tolerance to R. necatrix in BG83 relied on the induction of protease inhibitors and their negative regulators, as well as genes related to tolerance to salt and osmotic stress such as aspartic peptidase domain-containing proteins and gdsl esterase lipase proteins. In addition, three protease inhibitors were identified, glu protease, trypsin and endopeptidase inhibitors, which were highly overexpressed in the tolerant genotype when compared to susceptible 'Dusa', after infection with R. necatrix, reaching fold change values of 52, 19 and 38, respectively. The contrasting results between 'Dusa' and BG83 provide new insights into the different mechanisms involved in avocado tolerance to Phytophthora cinnamomi and R. necatrix, which are consistent with their biotrophic and necrotrophic lifestyles, respectively. The differential induction of genes involved in salt and osmotic stress in BG83 could indicate that R. necatrix penetration into the roots is associated with osmotic effects, suggesting that BG83's tolerance to R. necatrix is related to the ability to withstand osmotic imbalance. In addition, the high expression of protease inhibitors in tolerant BG83 compared to susceptible 'Dusa' after infection with the pathogen suggests the important role that these proteins may play in the defence of avocado rootstocks against R. necatrix.	[Zumaquero, Adela; Barcelo, Araceli; Pliego, Clara] Unidad Asociada I D I CSIC, Dept Genom & Biotechnol Fruticultura Subtrop & Me, Malaga, Spain; [Martinez-Ferri, Elsa] Unidad Asociada I D I CSIC, Dept Crop Ecophysiol Fruticultura Subtrop & Medit, Malaga, Spain; [Matas, Antonio J.; Pliego-Alfaro, Fernando] Univ Malaga, Dept Plant Physiol, Inst Hortofruticultura Subtrop & Mediterranea La, Unidad Asociada IHSM IFAPA, Malaga, Spain; [Reeksting, Bianca; van den Berg, Noelani] Univ Pretoria, Dept Biochem Genet & Microbiol, Pretoria, South Africa; [Reeksting, Bianca; Olivier, Nicholas A.; van den Berg, Noelani] Univ Pretoria, Forestry & Agr Biotechnol Inst, Pretoria, South Africa; [Olivier, Nicholas A.] Univ Pretoria, Dept Plant & Soil Sci, Pretoria, South Africa	Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); University of Pretoria; University of Pretoria; University of Pretoria	Pliego, C (corresponding author), Unidad Asociada I D I CSIC, Dept Genom & Biotechnol Fruticultura Subtrop & Me, Malaga, Spain.	mclara.pliego@juntadeandalucia.es	PLIEGO-ALFARO, FERNANDO/L-6089-2014; Prieto, Clara M Pliego/J-7295-2017; Martinez-Ferri, Elsa/S-1591-2019; Reeksting, Bianca/ABF-8312-2020; Matas, Antonio J./A-9325-2008	PLIEGO-ALFARO, FERNANDO/0000-0001-8176-072X; Prieto, Clara M Pliego/0000-0003-1203-6740; Martinez-Ferri, Elsa/0000-0002-9700-6307; Matas, Antonio J./0000-0003-4348-3930; Reeksting, Bianca/0000-0003-1219-9574; Olivier, Nicholas/0000-0002-1719-7319	INIA-AEI [RTA2017-00040-00-00]; Junta de Andalucia [AVA201601.14]; FEDER [AVA201601.14]; (Ministerio de Ciencia e Innovacion), Spain [AGL 2014-52518-C2-1-R]; INIA-CCAA; INIA	INIA-AEI; Junta de Andalucia(Junta de Andalucia); FEDER(European Commission); (Ministerio de Ciencia e Innovacion), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); INIA-CCAA(Instituto de Investigacion Agropecuaria (INIA)); INIA(Instituto de Investigacion Agropecuaria (INIA))	This research was supported by grants RTA2017-00040-00-00 (INIA-AEI) to CPP, AVA201601.14 to EMF (20% Junta de Andalucia, 80% FEDER) and AGL 2014-52518-C2-1-R (Ministerio de Ciencia e Innovacion), Spain to FPA. MC. Pliego is currently supported by an INIA-CCAA contract, co-financed by INIA (20%) and FEDER (80%).	Ali S, 2018, MICROBIOL RES, V212, P29, DOI 10.1016/j.micres.2018.04.008; [Anonymous], 2021, LANG ENV STAT COMP; BarceluE-Muuoz A., 2007, PROGRAMA SELECCION P; Boyle P, 2009, PLANT CELL, V21, P3700, DOI 10.1105/tpc.109.069971; Budic M, 2013, PLANT PHYSIOL BIOCH, V62, P79, DOI 10.1016/j.plaphy.2012.10.022; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Clemenz C, 2008, TREE PHYSIOL, V28, P1703, DOI 10.1093/treephys/28.11.1703; COFFEY MD, 1987, PLANT DIS, V71, P1046; Coram TE, 2008, MOL PLANT PATHOL, V9, P157, DOI 10.1111/J.1364-3703.2007.00453.X; Desjardins AE, 2000, APPL ENVIRON MICROB, V66, P1020, DOI 10.1128/AEM.66.3.1020-1025.2000; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dunaevsky YE, 1998, J PLANT PHYSIOL, V152, P696, DOI 10.1016/S0176-1617(98)80032-1; Dunaevsky YE, 2005, MOL BIOL+, V39, P702; Engelbrecht J, 2013, S AFR J SCI, V109, DOI 10.1590/sajs.2013/20120058; Fleischmann F, 2005, PLANT BIOLOGY, V7, P650, DOI 10.1055/s-2005-872891; Frolich E.F., 1972, CALIFORNIA AVOCADO S, V55, P97; Garcia-Pineda E, 2010, PLANT SOIL, V331, P45, DOI 10.1007/s11104-009-0225-5; Giblin F, 2005, P NZ AUSTR AV GROW C; Guo ML, 2019, J PLANT INTERACT, V14, P21, DOI 10.1080/17429145.2018.1551581; Howell JT, 2005, CAN J PLANT PATHOL, DOI [10.1080/07060660509507188, DOI 10.1080/07060660509507188]; Huma Habib, 2007, Biotechnology and Molecular Biology Reviews, V2, P068; Kim JY, 2009, INT J MOL SCI, V10, P2860, DOI 10.3390/ijms10062860; Lawrence PK, 2002, ELECTRON J BIOTECHN, V5, DOI 10.2225/vol5-issue1-fulltext-3; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leyva-Perez MD, 2018, NEW PHYTOL, V217, P671, DOI 10.1111/nph.14833; Li R, 2015, ELECTRON J BIOTECHN, V18, P368, DOI 10.1016/j.ejbt.2015.08.002; Lopez-Herrera CJ, 2007, CROP PROT, DOI [10.1016/j.cropro.2007.01.008, DOI 10.1016/J.CROPRO.2007.01.008]; Mandelc S, 2013, PLANT PHYSIOL BIOCH, V68, P23, DOI 10.1016/j.plaphy.2013.03.017; Martinez-Ferri E, 2000, TREE PHYSIOL, V20, P131; Martinez-Ferri E, 2016, PLANT DIS, V100, P49, DOI 10.1094/PDIS-01-15-0062-RE; Matic S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2925-6; Naranjo MA, 2006, PLANT CELL ENVIRON, V29, P1890, DOI 10.1111/j.1365-3040.2006.01565.x; Perez-Jimenez RM, 2006, J PHYTOPATHOL, V154, P257, DOI 10.1111/j.1439-0434.2006.01101.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pliego C, 2009, FUNGAL GENET BIOL, V46, P137, DOI 10.1016/j.fgb.2008.11.009; Pliego C, 2012, MOL PLANT PATHOL, V13, P226, DOI 10.1111/j.1364-3703.2011.00753.x; Pliego C, 2011, PLANT SOIL, V340, P505, DOI 10.1007/s11104-010-0615-8; Pliego-Alfaro F, 2013, AVOCADO: BOTANY, PRODUCTION AND USES, 2ND EDITION, P268, DOI 10.1079/9781845937010.0268; Pogany M, 2015, INT J MOL SCI, V16, P23177, DOI 10.3390/ijms161023177; Reeksting BJ, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0893-2; Reeksting BJ, 2014, S AFR J BOT, V95, P40, DOI 10.1016/j.sajb.2014.08.004; Reeksting BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086399; Rodrigues FA, 2009, PLANT SCI, V176, P286, DOI 10.1016/j.plantsci.2008.11.007; Rodríguez-Henao Eberto, 2017, Acta Agron., V66, P128, DOI 10.15446/acag.v66n1.50705; Sharma N., 2011, Asian Journal of Biochemistry, V6, P29, DOI 10.3923/ajb.2011.29.37; Srinivasan T., 2012, FUNCT PLANT SCI BIOT, V6, P59; SZTEJNBERG A, 1980, Plant Disease, V64, P662, DOI 10.1094/PD-64-662; Thomas SW, 2002, MOL PLANT MICROBE IN, V15, P847, DOI 10.1094/MPMI.2002.15.8.847; van den Berg N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205705; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Warnes G, 2016, R PACKAGE VERSION 3; Xia YJ, 2004, EMBO J, V23, P980, DOI 10.1038/sj.emboj.7600086; Xu J, 2015, J INTEGR AGR, V14, P1673, DOI 10.1016/S2095-3119(14)60980-1; Zainal Z., 2009, American Journal of Plant Physiology, V4, P70, DOI 10.3923/ajpp.2009.70.79	55	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212359	10.1371/journal.pone.0212359	http://dx.doi.org/10.1371/journal.pone.0212359			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763398	gold, Green Submitted, Green Published			2022-12-26	WOS:000458763900075
J	Alonso, F; Teran, GE; Aguilera, G; Rican, O; Casciotta, J; Serra, WS; Almiron, A; Benitez, MF; Garcia, I; Mirande, JM				Alonso, Felipe; Teran, Guillermo E.; Aguilera, Gaston; Rican, Oldrich; Casciotta, Jorge; Sebastian Serra, Wilson; Almiron, Adriana; Benitez, Mauricio F.; Garcia, Ignacio; Marcos Mirande, Juan			Description of a new species of the Neotropical cichlid genus Gymnogeophagus Miranda Ribeiro, 1918 (Teleostei: Cichliformes) from the Middle Parana basin, Misiones, Argentina	PLOS ONE			English	Article							DELIMITATION; COALESCENT; BIOGEOGRAPHY; PERCIFORMES	Gymnogeophagus jaryi, new species, is described from Southern tributaries of the Middle Parana basin in Misiones. It can be distinguished from all other members of the genus, except from G. australis and G. caaguazuensis, by the presence of a hyaline to grey anterior portion of the dorsal fin. Gymnogeophagus jaryi differs from G. caaguazuensis by a longer caudal peduncle, caudal fin not lyrate, central portion of scales on dorsal portion of trunk light iridescent blue and by white spots in soft portion of dorsal fin in adult males, and from G. australis by the light iridescent blue coloration of central portion of scales on the dorsal portion of trunk and tail, and by the lack of scales on the soft portion of the dorsal fin. Additionally, it can be diagnosed by the following unique combination of characters: 10-11 dorsal-fin branched rays, 27-30 E1 scales, absence of lips thickening, and, in males, by the possession of a hump in adults, caudal fin not lyrate, presence of large white spots forming transversal stripes distally and in anterior area of the dorsal fin's soft portion, central area of scales on the dorsal portion of the trunk light iridescent blue, lack of scales on the base of the dorsal fin's soft portion, absence of a conspicuous and oblique dark band from the eye to the anterior border of the head, anterior portion of dorsal fin hyaline to grey, scales of the midlateral spot each bearing a semicircular light blue blotch, head hump starting at the horizontal through the eyes, concave anterior profile in lateral view, base of unpaired fins yellow, and whitish hyaline spots on caudal fin. The new species, based on mtDNA phylogeny, is the sister species of G. caaguazuensis from the Paraguay basin and is closely related to G. australis.	[Alonso, Felipe] CCT Salta, CONICET, IBIGEO, Inst Bio & Geociencias,NOA, Rosario De Lerma, Salta, Argentina; [Teran, Guillermo E.; Aguilera, Gaston; Marcos Mirande, Juan] Fdn Miguel Lillo, CONICET, Unidad Ejecutora Lillo, San Miguel De Tucuman, Tucuman, Argentina; [Rican, Oldrich] Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic; [Casciotta, Jorge; Almiron, Adriana] Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Zool Vertebrados, Buenos Aires, DF, Argentina; [Casciotta, Jorge] Comis Invest Cient Prov Buenos Aires, Buenos Aires, DF, Argentina; [Sebastian Serra, Wilson] Museo Nacl Hist Nat, Secc Ictiol, Dept Zool, Montevideo, Uruguay; [Sebastian Serra, Wilson] Ctr Univ Reg Este CURE Sede Rocha, Rocha, Uruguay; [Sebastian Serra, Wilson] UdelaR, Fac Ciencias, Secc Zool Vertebrados, Montevideo, Uruguay; [Benitez, Mauricio F.] UNAM, CONICET, Inst Biol Subtrop, Posadas, Argentina; [Garcia, Ignacio] Consejo Nacl Invest Cient & Tecn, Inst Limnol Dr Raul A Ringuelet ILPLA, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miguel Lillo Foundation; University of South Bohemia Ceske Budejovice; National University of La Plata; Comision de Investigaciones Cientificas; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Alonso, F (corresponding author), CCT Salta, CONICET, IBIGEO, Inst Bio & Geociencias,NOA, Rosario De Lerma, Salta, Argentina.	felipealonso@gmail.com	Alonso, Felipe/AAA-5717-2020; Serra Alanis, Wilson Sebastian/B-9857-2017	Alonso, Felipe/0000-0001-7227-2732; Garcia, Ignacio/0000-0002-0454-2603; Teran, Guillermo/0000-0002-3795-3345; Serra Alanis, Wilson Sebastian/0000-0003-0032-9335; Aguilera, Gaston/0000-0002-5486-2787; Mirande, Juan Marcos/0000-0003-4370-3526				Aguilera G, 2009, ZOOTAXA, P68, DOI 10.11646/zootaxa.2220.1.4; Azpelicueta M. de la Mercedes, 2003, Revista del Museo de La Plata Seccion Zoologia, V15, P1; Azpelicueta MD, 2002, REV SUISSE ZOOL, V109, P243, DOI 10.5962/bhl.part.79588; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Casciotta Jorge, 2017, Historia Natural (Corrientes), V7, P5; Climate-Data. org, 2018, CLIM DAT CIT WORLDW; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Teran GE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179594; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fricke R., 2018, SPECIES FAMILY SUBFA; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff PA, 2014, CLADISTICS, V30, P260, DOI 10.1111/cla.12047; IUCN Red List, 2001, CAT CRIT VERS 3 1; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kullander Sven O., 1996, Ichthyological Exploration of Freshwaters, V7, P149; Loureiro M, 2016, NEOTROP ICHTHYOL, V14, DOI 10.1590/1982-0224-20150082; Malabarba LR, 2015, NEOTROP ICHTHYOL, V13, P637, DOI 10.1590/1982-0224-20140188; Malabarba MC, 2010, J VERTEBR PALEONTOL, V30, P341, DOI 10.1080/02724631003618348; Mirande JM, 2019, CLADISTICS, V35, P282, DOI 10.1111/cla.12345; Miquelarena Amalia M., 2002, Aqua (Miradolo Terme), V6, P69; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Musilova Z, 2015, VERTEBR ZOOL, V65, P333; Nylander JAA., 2004, MRMODELTEST 2 2; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Powell JR, 2012, METHODS ECOL EVOL, V3, P1, DOI 10.1111/j.2041-210X.2011.00122.x; Reid N.M, 2012, TRACER, P1; REIS R E, 1988, Revista Brasileira de Zoologia, V4, P259; Reis R. E., 1992, ICHTHYOL EXPLOR FRES, V3, P265; Rican O, 2019, HYDROBIOLOGIA, V832, P331, DOI 10.1007/s10750-018-3691-z; Staeck Wolfgang, 2006, Zoologische Abhandlungen (Dresden), V56, P99; TAYLOR W R, 1985, Cybium, V9, P107; Turcati A, 2018, NEOTROP ICHTHYOL, V16, DOI 10.1590/1982-0224-20180118; Vuataz L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019728; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	38	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0210166	10.1371/journal.pone.0210166	http://dx.doi.org/10.1371/journal.pone.0210166			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759109	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300014
J	Shimamoto, K; Gipson, JD				Shimamoto, Kyoko; Gipson, Jessica D.			Investigating pathways linking women's status and empowerment to skilled attendance at birth in Tanzania: A structural equation modeling approach	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; GENDER INEQUALITY; HEALTH-SERVICES; COUNTRIES; FERTILITY; AUTONOMY; MOTHERS; POWER	Maternal and newborn mortality remain unacceptably high in sub-Saharan Africa where use of a skilled birth attendant (SBA) at delivery has remained low. Despite the recognized importance of women's empowerment as a key determinant of maternal and newborn health, evidence from sub-Saharan Africa is more limited. Using data from the 2010 Tanzania Demographic and Health Survey (n = 4,340), this study employs a robust method structural equation modeling (SEM) to investigate the complex and multidimensional pathways through which women's empowerment affects SBA use. The results show that women's education and household decision-making are positively associated with SBA use. However, not all empowerment dimensions have similar effects. Attitudes towards sex negotiation and violence as well as early marriage are not significant factors in Tanzania. Mediation analysis also confirms the indirect effect of education on SBA use only through household decision-making. The findings underscore the utility of structural equation modeling when examining complex and multidimensional constructs, such as empowerment, and demonstrate potential causal inference to better inform policy and programmatic recommendations.	[Shimamoto, Kyoko; Gipson, Jessica D.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Shimamoto, K (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA 90024 USA.	kyoko0517@ucla.edu			Joint Japan/World Bank Graduate Scholarship Program; UCLA graduate division fellowship; UCLA Bixby doctoral fellowship; National Institutes of Child Health (NICHD) [K01HD06767704]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R24-HD041022]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041022] Funding Source: NIH RePORTER	Joint Japan/World Bank Graduate Scholarship Program; UCLA graduate division fellowship; UCLA Bixby doctoral fellowship; National Institutes of Child Health (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors acknowledge the input and helpful suggestions of Peter M. Bentler, Anne R. Pebley, Linda B. Bourque, and Patrick Heuveline; the UCLA Institute for Digital Research and Education; the Macro International that conducted the Senegal Demographic and Health Surveys. Shimamoto acknowledges financial support from the Joint Japan/World Bank Graduate Scholarship Program, the UCLA graduate division fellowship, and the UCLA Bixby doctoral fellowship. Gipson acknowledges financial support from the National Institutes of Child Health (NICHD) Grant# K01HD06767704. The authors benefited from facilities and resources provided by the California Center for Population Research at UCLA (CCPR), which receives core support (R24-HD041022) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).	Agarwala R, 2006, SOC FORCES, V84, P2077, DOI 10.1353/sof.2006.0079; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; [Anonymous], 2002, WORLD BANK WORKSH PO; Anthony D., 2017, GENERATION 2030 AFRI; Austin A, 2015, INT J WOMENS HEALTH, V7, P345, DOI 10.2147/IJWH.S79573; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Bank World, 2012, WORLD DEV REP 2012 G; Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Blumberg R.L., 1984, SOCIOL THEOR, V2, P23, DOI DOI 10.2307/223343; Bollen KA, 2011, P NATL ACAD SCI USA, V108, P15639, DOI 10.1073/pnas.1010661108; Bongaarts J, 2001, POP STUD-J DEMOG, V55, P263, DOI 10.1080/00324720127697; BOYE AE, 1991, STUD FAMILY PLANN, V22, P343, DOI 10.2307/1966448; COLLINS R, 1993, SOCIOL PERSPECT, V36, P185, DOI 10.2307/1389242; Do M, 2012, INT PERSPECT SEX R H, V38, P23, DOI 10.1363/3802312; Fuse K., 2008, DHS WORKING PAPERS, V44; Hindin M., 2012, INT CTR RES WOMEN FE; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Interagency Gender Working Group, 2011, SUMM REP NEW EV GEND; Jayaraman A, 2008, DHS WORKING PAPERS F; Kabeer N, 1997, DEV CHANGE, V28, P261, DOI 10.1111/1467-7660.00043; Kabeer N, 2001, SIDA STUDIES, V3; Kishor S., 2008, DHS COMP REPORTS; Kitui J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-40; Kline R.B., 2011, PRINCIPLES PRACTICE; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Larsen U, 2003, SOC SCI MED, V57, P1099, DOI 10.1016/S0277-9536(02)00488-4; Lee-Rife S, 2012, STUD FAMILY PLANN, V43, P287, DOI 10.1111/j.1728-4465.2012.00327.x; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Magadi MA, 2007, SOC SCI MED, V64, P1311, DOI 10.1016/j.socscimed.2006.11.004; Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9; McCloskey LA, 2005, INT FAM PLAN PERSPEC, V31, P124, DOI 10.1363/3112405; National Bureau of Statistics (NBS) Tanzania and ICF Macro, 2016, TANZ DEM HLTH SURV 2; National Bureau of Statistics (NBS) Tanzania and ICF Macro, 2011, TANZ DEM HLTH SURV 2; Neal S, 2012, ACTA OBSTET GYN SCAN, V91, P1114, DOI 10.1111/j.1600-0412.2012.01467.x; Ochako R, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-1; Pallitto CC, 2005, SOC SCI MED, V60, P2205, DOI 10.1016/j.socscimed.2004.10.017; Pandey S, 2012, INT SOC WORK, V55, P554, DOI 10.1177/0020872811408575; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Pulerwitz J, 2008, MEN MASC, V10, P322, DOI 10.1177/1097184X06298778; Requejo JH, 2014, LANCET; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Safilios-Rothschild C., 1982, WOMENS ROLES POPULAT; Shiffman J, 2000, STUD FAMILY PLANN, V31, P274, DOI 10.1111/j.1728-4465.2000.00274.x; Shimamoto K, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1499-x; Shimamoto K, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0591-3; Singh K, 2011, 66 MEASURE; Singh K, 2015, HEALTH CARE WOMEN IN, V36, P57, DOI 10.1080/07399332.2013.824971; Singh Kavita, 2012, Afr J Reprod Health, V16, P123; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tuncalp O, 2014, BJOG-INT J OBSTET GY, V121, P57, DOI 10.1111/1471-0528.12634; UN (United Nations), 2015, MIL DEV GOALS REP 20; UNFPA, 2013, STAT WORLD POP 2013; United Nations, 2018, SUST DEV GOALS REP 2; Upadhyay U. D, 2010, DHS WORKING PAPERS, V80; Upadhyay UD, 2014, SOC SCI MED, V115, P111, DOI 10.1016/j.socscimed.2014.06.014; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; WHO (World Health Organization), 2015, STRAT END PREV MAT M; Woldemicael G, 2010, MATERN CHILD HLTH J, V14, P988, DOI 10.1007/s10995-009-0535-5; Woldemicael G, 2010, HEALTH CARE WOMEN IN, V31, P599, DOI 10.1080/07399331003599555; World Health Organization, 2011, WHO GUID PREV EARL P; World Health Organization, 2015, EST WHO UNICEF UNFPA; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; Yu CY, 2002, ANN C AM ED RES ASS; Zere E, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-34	65	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0212038	10.1371/journal.pone.0212038	http://dx.doi.org/10.1371/journal.pone.0212038			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5IX	30759174	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300072
J	Weller, ZD; Yang, DK; von Fischer, JC				Weller, Zachary D.; Yang, Duck Keun; von Fischer, Joseph C.			An open source algorithm to detect natural gas leaks from mobile methane survey data	PLOS ONE			English	Article							AIR-POLLUTION; EMISSIONS; SYSTEM	The data collected by mobile methane (CH4) sensors can be used to find natural gas (NG) leaks in urban distribution systems. Extracting actionable insights from the large volumes of data collected by these sensors requires several data processing steps. While these survey platforms are commercially available, the associated data processing software largely constitute a black box due to their proprietary nature. In this paper we describe a step-by-step algorithm for developing leak indications using data from mobile CH4 surveys, providing an under-the-hood look at the choices and challenges associated with data analysis. We also describe how our algorithm has evolved over time, and the data-driven insights that have prompted these changes. Applying our algorithm to data collected in 15 cities produced more than 6100 leak indications and estimates of the leaks' size. We use these results to characterize the distribution of leak sizes in local NG distribution systems. Mobile surveys are already an effective and necessary tool for managing NG distribution systems, but improvements in the technology and software will continue to increase its value.	[Weller, Zachary D.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Yang, Duck Keun] Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA; [von Fischer, Joseph C.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Weller, ZD (corresponding author), Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA.	zdweller@rams.colostate.edu	von Fischer, Joe/AAC-6977-2019	Weller, Zachary/0000-0001-7940-8305; von Fischer, Joseph/0000-0001-5508-6073	Alfred P Sloan Foundation; Robertson Foundations; Environmental Defense Fund	Alfred P Sloan Foundation(Alfred P. Sloan Foundation); Robertson Foundations; Environmental Defense Fund	This work was funded by grants from the Alfred P Sloan Foundation and Robertson Foundations to the Environmental Defense Fund. Authors ZW, DKY, and JvF were funded by the Environmental Defense Fund through aforementioned grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABB, 2018, ABB AB MOB GAS LEAK; Aberer K, 2010, P ACM SIGSPATIAL INT, P39, DOI DOI 10.1145/1878500.1878509; Alerma, 2018, AL MOUNT; Apte JS, 2017, ENVIRON SCI TECHNOL, V51, P6999, DOI 10.1021/acs.est.7b00891; Cresnar G, 2018, DRIVE; Environmental Protection Agency, 2018, GREENH GAS EQ CALC; Gongora HA, 2018, DAT AGGR; Graul C., 2015, LEAFLETR INTERACTIVE; Gulliver J, 2004, ATMOS ENVIRON, V38, P1, DOI 10.1016/j.atmosenv.2003.09.036; Hendrick MF, 2016, ENVIRON POLLUT, V213, P710, DOI 10.1016/j.envpol.2016.01.094; Hung PDP, 2018, FLUT; Jaakkola A, 2010, ISPRS J PHOTOGRAMM, V65, P514, DOI 10.1016/j.isprsjprs.2010.08.002; jai, 2018, JAI PEAK; Kemp CE, 2016, ENVIRON SCI TECHNOL, V50, P4546, DOI 10.1021/acs.est.5b06068; Kharismayadi IP, 2018, SOFTW QUAL; Kirma A, 2018, RESIZE; Kozin N, 2018, MAP; leak B. Q., 2018, LEAK; Mayle J, 2018, GOOGL CAR; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Arias-Nicolas JP, 2015, ENTROPY-SWITZ, V17, P3656, DOI 10.3390/e17063656; Palacios V, INTEGRATING LEAK QUA; Picarro, 2018, PIC SURV OV; ProSymbols, 2018, PROSYMBOLS DAT FILT; R Core Team, 2018, R LANG ENV STAT COMP; Reed M., 2017, PIPELINE GAS J, V243; Shuster E, 2018, ROAD; U. S. Census Bureau, 2018, TIGER LIN GEOGR; Upop, 2018, UP POINT MAP; US Census Bureau, 2017, AM COMMUNITY SURVEY; Villa TF, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16071072; von Fischer JC, 2017, ENVIRON SCI TECHNOL, V51, P4091, DOI 10.1021/acs.est.6b06095; Wang WH, 2017, PROCESS SAF ENVIRON, V111, P678, DOI 10.1016/j.psep.2017.08.040; Weller ZD, 2018, ENVIRONMETRICS, V29, DOI 10.1002/env.2519; Weller ZD, 2018, ENV SCI TECHNOL; Zimmerle DJ, 2015, ENVIRON SCI TECHNOL, V49, P9374, DOI 10.1021/acs.est.5b01669	36	18	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0212287	10.1371/journal.pone.0212287	http://dx.doi.org/10.1371/journal.pone.0212287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759153	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300081
J	Schoenherr, D; Paulick, J; Strauss, BM; Deisenhofer, AK; Schwartz, B; Rubel, JA; Lutz, W; Stangier, U; Altmann, U				Schoenherr, Desiree; Paulick, Jane; Strauss, Bernhard M.; Deisenhofer, Anne-Katharina; Schwartz, Brian; Rubel, Julian A.; Lutz, Wolfgang; Stangier, Ulrich; Altmann, Uwe			Identification of movement synchrony: Validation of windowed cross-lagged correlation and -regression with peak-picking algorithm	PLOS ONE			English	Article							NONVERBAL SYNCHRONY; COMMUNICATION; MOTION; MIMICRY	In psychotherapy, movement synchrony seems to be associated with higher patient satisfaction and treatment outcome. However, it remains unclear whether movement synchrony rated by humans and movement synchrony identified by automated methods reflect the same construct. To address this issue, video sequences showing movement synchrony of patients and therapists (N = 10) or not (N = 10), were analyzed using motion energy analysis. Three different synchrony conditions with varying levels of complexity (naturally embedded, naturally isolated, and artificial) were generated for time series analysis with windowed cross-lagged correlation/ -regression (WCLC, WCLR). The concordance of ratings (human rating vs. automatic assessment) was computed for 600 different parameter configurations of the WCLC/WCLR to identify the parameter settings that measure movement synchrony best. A parameter configuration was rated as having a good identification rate if it yields high concordance with human-rated intervals (Cohen's kappa) and a low amount of over-identified data points. Results indicate that 76 configurations had a good identification rate (IR) in the least complex condition (artificial). Two had an acceptable IR with regard to the naturally isolated condition. Concordance was low with regard to the most complex (naturally embedded) condition. A valid identification of movement synchrony strongly depends on parameter configuration and goes beyond the identification of synchrony by human raters. Differences between human-rated synchrony and nonverbal synchrony measured by algorithms are discussed.	[Schoenherr, Desiree; Strauss, Bernhard M.; Altmann, Uwe] Jena Univ Hosp, Inst Psychosocial Med & Psychotherapy, Jena, Germany; [Paulick, Jane; Deisenhofer, Anne-Katharina; Schwartz, Brian; Rubel, Julian A.; Lutz, Wolfgang] Trier Univ, Dept Clin Psychol & Psychotherapy, Trier, Germany; [Stangier, Ulrich] Goethe Univ Frankfurt Main, Dept Clin Psychol & Psychotherapy, Frankfurt, Germany	Friedrich Schiller University of Jena; Universitat Trier; Goethe University Frankfurt	Schoenherr, D (corresponding author), Jena Univ Hosp, Inst Psychosocial Med & Psychotherapy, Jena, Germany.	desiree.schoenherr@med.uni-jena.de	Rubel, Julian/B-8461-2013; Lutz, Wolfgang/Q-6125-2017; Rubel, Julian/M-7448-2013	Rubel, Julian/0000-0002-9625-6611; Lutz, Wolfgang/0000-0002-5141-3847; Rubel, Julian/0000-0002-9625-6611; Schwartz, Brian/0000-0003-4695-4953; Schoenherr, Desiree/0000-0001-8919-6908; Altmann, Uwe/0000-0002-3429-2895	German Research Foundation (DFG) [STR 306/28-1, LU 660/8-1]; German Federal Ministry of Education and Research (BMBF) [FKZ 01GV0607]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Research Foundation (DFG project "Timing of nonverbal patient-therapist-interaction and therapeutic success of social phobic patients (TIMPATHIN) -http://www.dfg.de/en/index.jsp", under funding number GZ BMS: STR 306/28-1 and WL: LU 660/8-1) and uses video recordings from the SOPHO-NET treatment study funded by the German Federal Ministry of Education and Research (BMBF, FKZ 01GV0607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann U, 2011, ANAL VERBAL NONVERBA, P344; Altmann U., 2019, INTRO PRACTICAL GUID; Altmann U., 2013, SYNCHRONISATION NONV, V188; Altorfer A, 1997, Z PSYCHOL, V205, P83; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.1093/biomet/35.3-4.246; Anvsoft Inc, 2009, ANY VIDEO CONVERTER; Ashenfelter KT, 2009, J EXP PSYCHOL HUMAN, V35, P1072, DOI 10.1037/a0015017; Bailenson JN, 2005, PSYCHOL SCI, V16, P814, DOI 10.1111/j.1467-9280.2005.01619.x; BERNIERI FJ, 1988, J PERS SOC PSYCHOL, V54, P243, DOI 10.1037/0022-3514.54.2.243; Bernieri FJ, 1991, FUNDAMENTALS NONVERB, P511; Bilakhia S, 2015, PATTERN RECOGN LETT, V66, P52, DOI 10.1016/j.patrec.2015.03.005; Boker S.M., 2002, MIRROR NEURONS EVOLU, VVol. 42, P163, DOI [DOI 10.1075/AICR.42.14BOK, 10.1075/aicr.42.14bok]; Boker SM, 2002, PSYCHOL METHODS, V7, P338, DOI 10.1037//1082-989X.7.3.338; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bozkurt E, 2016, SPEECH COMMUN, V85, P29, DOI 10.1016/j.specom.2016.10.004; Campbell N, 2009, AUDIO VISUAL APPROAC; Chetouani M., 2017, SOCIAL SIGNAL PROCES, P202, DOI 10.1017/9781316676202.015; Dean RT, 2016, BEHAV RES METHODS, V48, P783, DOI 10.3758/s13428-015-0611-2; Delaherche E, 2010, P 2 INT WORKSH SOC S; Dionisio A, 2004, PHYSICA A, V344, P326, DOI 10.1016/j.physa.2004.06.144; Feldman R, 2007, J CHILD PSYCHOL PSYC, V48, P329, DOI 10.1111/j.1469-7610.2006.01701.x; Galbusera L, 2018, PSYCHOTHER RES, V28, P457, DOI 10.1080/10503307.2016.1216624; GOTTMAN JM, 1981, CHILD DEV, V52, P393, DOI 10.2307/1129157; Grammer K, 1999, J PERS SOC PSYCHOL, V77, P487, DOI 10.1037/0022-3514.77.3.487; Grammer K, 1998, J NONVERBAL BEHAV, V22, P3, DOI 10.1023/A:1022986608835; GREENE MG, 1994, SOC SCI MED, V38, P1279, DOI 10.1016/0277-9536(94)90191-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leichsenring F, 2014, AM J PSYCHIAT; Leichsenring F, 2013, AM J PSYCHIAT, V170, P759, DOI [10.1176/appi.ajp.2013.13060744r, 10.1176/appi.ajp.2013.12081125]; Louwerse MM, 2012, COGNITIVE SCI, V36, P1404, DOI 10.1111/j.1551-6709.2012.01269.x; Messinger DS, 2009, INFANCY, V14, P285, DOI 10.1080/15250000902839963; Michelet Stephane, 2012, Human Behavior Understanding. Proceedings of the Third International Workshop, HBU 2012, P161, DOI 10.1007/978-3-642-34014-7_14; Moulder RG, 2018, PSYCHOL METHODS, V23, P757, DOI 10.1037/met0000172; Nagaoka C, 2008, IEICE T INF SYST, VE91D, P1634, DOI 10.1093/ietisy/e91-d.6.1634; Namy LL, 2002, J LANG SOC PSYCHOL, V21, P422, DOI 10.1177/026192702237958; Paulick J, 2017, J PSYCHOTHERAPY INTE; Paxton A, 2013, BEHAV RES METHODS, V45, P329, DOI 10.3758/s13428-012-0249-2; Ramseyer F., 2008, SIMULTANEITY TEMPORA, P329, DOI DOI 10.1142/9789812792426_0020; Ramseyer F, 2016, NONLIN DYNAM PSYCHOL, V20, P145; Ramseyer F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00979; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Ramseyer F, 2010, LECT NOTES COMPUT SC, V5967, P182, DOI 10.1007/978-3-642-12397-9_15; Safran JD, 2011, PSYCHOTHERAPY, V48, P80, DOI 10.1037/a0022140; Schonbrodt FD, 2013, J RES PERS, V47, P609, DOI 10.1016/j.jrp.2013.05.009; Schoenherr D, 2018, BEHAV RES METHODS, P1; Stel M, 2008, PSYCHOL SCI, V19, P984, DOI 10.1111/j.1467-9280.2008.02188.x; Sun X, 2011, AUTOMATIC VISUAL MIM; Tonti M, 2016, RES PSYCHOTHER-PSYCH, V19, P102, DOI 10.4081/ripppo.2016.232; TRONICK ED, 1977, J COMMUN, V27, P74, DOI 10.1111/j.1460-2466.1977.tb01829.x; Tschacher W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01323; WATANABE T, 1983, B JSME, V26, P2244, DOI 10.1299/jsme1958.26.2244; Yang N, 2016, IEEE INT CONF CON AU, P611, DOI 10.1109/ICCA.2016.7505345	53	21	21	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211494	10.1371/journal.pone.0211494	http://dx.doi.org/10.1371/journal.pone.0211494			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL0OI	30742651	Green Published, gold, Green Submitted			2022-12-26	WOS:000458393400014
J	Clarke, D; Idris, A; McMillan, NAJ				Clarke, Daniel; Idris, Adi; McMillan, Nigel A. J.			Development of novel lipidic particles for siRNA delivery that are highly effective after 12 months storage	PLOS ONE			English	Article							LIPOSOMES	Liposomes are versatile and well-proven as a means to deliver nucleic acids into cells. Most of the formulation procedures used are labour intensive and result in unstable end products. We have previously reported on the development of a simple, yet efficient, hydration-of-freeze-dried-matrix (HFDM) method to entrap siRNA within lipid particles. Here we show that the particles are stable up to 12 months after storage at room temperature (RT), 4 degrees C or -20 degrees C. While RT storage results in changes in particle size and polydispersity, gene silencing of all particles was similar to freshly prepared particles following storage for 3, 6, 9 or 12 months at all temperatures. This is the first report of such long-term stability in siRNA-loaded liposomes.	[Clarke, Daniel; Idris, Adi; McMillan, Nigel A. J.] Griffith Univ, Sch Med Sci, Menzies Hlth Inst Queensland, Southport, Qld, Australia	Griffith University	Idris, A (corresponding author), Griffith Univ, Sch Med Sci, Menzies Hlth Inst Queensland, Southport, Qld, Australia.	a.idris@griffith.edu.au	McMillan, Nigel/AAQ-5416-2021; Idris, Adi/N-3500-2016	McMillan, Nigel/0000-0002-9471-1406; Idris, Adi/0000-0002-0562-1549				Anchordoquy TJ, 1997, ARCH BIOCHEM BIOPHYS, V348, P199, DOI 10.1006/abbi.1997.0385; Bishop CJ, 2015, ACTA BIOMATER, V11, P393, DOI 10.1016/j.actbio.2014.09.020; Clement J, 2005, EUR J PHARM BIOPHARM, V59, P35, DOI 10.1016/j.ejpb.2004.06.001; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gabrielli B, 2015, MOL CANCER THER, V14, P2753, DOI 10.1158/1535-7163.MCT-15-0506; Jeffs LB, 2005, PHARM RES-DORDR, V22, P362, DOI 10.1007/s11095-004-1873-z; Li CL, 2004, J PHARM SCI-US, V93, P1403, DOI 10.1002/jps.20055; Li SD, 2006, MOL PHARMACEUT, V3, P579, DOI 10.1021/mp060039w; Maurer N, 2001, BIOPHYS J, V80, P2310, DOI 10.1016/S0006-3495(01)76202-9; McCaskill J, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.22; Merkel OM, 2009, J CONTROL RELEASE, V138, P148, DOI 10.1016/j.jconrel.2009.05.016; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Payton NM, 2014, J PHARM SCI-US, V103, P3869, DOI 10.1002/jps.24171; Sato A, 2007, BIOMATERIALS, V28, P1434, DOI 10.1016/j.biomaterials.2006.11.010; Sheng YH, 2016, ONCOGENE; Singhania A, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/192562; Stuart DD, 2000, BBA-BIOMEMBRANES, V1463, P219, DOI 10.1016/S0005-2736(99)00209-6; Wheeler JJ, 1999, GENE THER, V6, P271, DOI 10.1038/sj.gt.3300821; Wu SY, 2011, GENE THER, V18, P14, DOI 10.1038/gt.2010.113; Wu SY, 2011, J CONTROL RELEASE, V155, P418, DOI 10.1016/j.jconrel.2011.02.002; Wu SY, 2009, PHARM RES-DORDR, V26, P512, DOI 10.1007/s11095-008-9766-1; Wyrozumska P, 2015, CANCER BIOL THER, V16, P66, DOI 10.4161/15384047.2014.987009; Yu JX, 2009, J PHARM SCI-US, V98, P3278, DOI 10.1002/jps.21846; Zelphati O, 1998, GENE THER, V5, P1272, DOI 10.1038/sj.gt.3300707	24	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211954	10.1371/journal.pone.0211954	http://dx.doi.org/10.1371/journal.pone.0211954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735545	Green Published, gold, Green Submitted			2022-12-26	WOS:000458181200050
J	Ozdemir, O; Egemen, E; Iseri, SAU; Sezerman, OU; Bebek, N; Baykan, B; Ozbek, U				Ozdemir, Ozkan; Egemen, Ece; Iseri, Sibel Aylin Ugur; Sezerman, Osman Ugur; Bebek, Nerses; Baykan, Betul; Ozbek, Ugur			Identification of epilepsy related pathways using genome-wide DNA methylation measures: A trio-based approach	PLOS ONE			English	Article							DENSITY; MODEL; KEGG	Genetic generalized epilepsies (GGE) are genetically determined, as their name implies and they are clinically characterized by generalized seizures involving both sides of the brain in the absence of detectable brain lesions or other known causes. GGEs are yet complex and are influenced by many different genetic and environmental factors. Methylation specific epigenetic marks are one of the players of the complex epileptogenesis scenario leading to GGE. In this study, we have set out to perform genome-wide methylation profiling to analyze GGE trios each consisting of an affected parent-offspring couple along with an unaffected parent. We have developed a novel scoring scheme within trios to categorize each locus analyzed as hypo or hypermethylated. This stringent approach classified differentially methylated genes in each trio and helped us to produce trio specific and pooled gene lists with inherited and aberrant methylation levels. In order to analyze the methylation differences from a boarder perspective, we performed enrichment analysis with these lists using the PANOGA software. This collective effort has led us to detect pathways associated with the GGE phenotype, including the neurotrophin signaling pathway. We have demonstrated a trio based approach to genome-wide DNA methylation analysis that identified individual and possibly minor changes in methylation marks that could be involved in epileptogenesis leading to GGE.	[Ozdemir, Ozkan; Iseri, Sibel Aylin Ugur; Ozbek, Ugur] Istanbul Univ, Aziz Sancar Inst Expt Med, Dept Genet, Istanbul, Turkey; [Egemen, Ece] Sabanci Univ, Fac Engn & Nat Sci, Dept Comp Engn, Istanbul, Turkey; [Sezerman, Osman Ugur] Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Med Stat & Bioinformat, Istanbul, Turkey; [Bebek, Nerses; Baykan, Betul] Istanbul Univ, Dept Neurol, Istanbul Fac Med, Istanbul, Turkey; [Ozbek, Ugur] Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Med Genet, Istanbul, Turkey; [Ozdemir, Ozkan] Genet Diagnost Ctr Labgen, Acibadem Labmed Labs, Istanbul, Turkey	Istanbul University; Sabanci University; Acibadem University; Istanbul University; Acibadem University	Iseri, SAU (corresponding author), Istanbul Univ, Aziz Sancar Inst Expt Med, Dept Genet, Istanbul, Turkey.	sibel.ugur@istanbul.edu.tr	bebek, nerses/W-7266-2019; Ozbek, Ugur/C-9513-2017; SEZERMAN, OSMAN U/X-6441-2018; ozdemir, ozkan/AAI-9947-2021; Iseri, Sibel Aylin Ugur/AAD-6099-2020; Baykan, Betul/J-5307-2014	Ozbek, Ugur/0000-0001-5319-0547; ozdemir, ozkan/0000-0002-2647-6416; Sezerman, Osman Ugur/0000-0003-0905-6783; Ugur Iseri, Sibel Aylin/0000-0002-5790-6853	Scientific and Technology Research Council of Turkey (TUBITAK) [IntenC-109S218]; Scientific Research Projects Coordination Unit of Istanbul University [ONAP-11021]; Istanbul Development Agency [TR10/15/YNK/0093]	Scientific and Technology Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Scientific Research Projects Coordination Unit of Istanbul University(Istanbul University); Istanbul Development Agency(Turkiye Cumhuriyeti Kalkinma Bakanligi)	This work was supported by the grants of The Scientific and Technology Research Council of Turkey (TUBITAK) Project Number: IntenC-109S218 and Scientific Research Projects Coordination Unit of Istanbul University, Project Number: ONAP-11021. Biobanking support was given by Istanbul Development Agency (Project Number: TR10/15/YNK/0093). OO, EE and SAUI had been fellows of TUBITAK-IntenC project.	Adams B, 1997, J NEUROSCI, V17, P5288; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Bakir-Gungor B, 2014, BIOINFORMATICS, V30, P1287, DOI 10.1093/bioinformatics/btt743; Bakir-Gungor B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026277; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Davis S, METHYLUMI HANDLE ILL; Fan W, 2016, SCI REP-UK, V6, DOI 10.1038/srep19430; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Henshall DC, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022731; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jallon P, 2005, EPILEPSIA, V46, P10, DOI 10.1111/j.1528-1167.2005.00309.x; Jankowsky JL, 2001, PROG NEUROBIOL, V63, P125, DOI 10.1016/S0301-0082(00)00022-8; Kandratavicius L, 2013, J NEUROPATH EXP NEUR, V72, DOI 10.1097/NEN.0000000000000002; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kobow K, 2012, EPILEPSIA, V53, P11, DOI 10.1111/epi.12031; Lemire M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7326; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Nordli DR, 2005, EPILEPSIA, V46, P48, DOI 10.1111/j.1528-1167.2005.00313.x; Pandolfo M, 2013, CURR OPIN NEUROL, V26, P137, DOI 10.1097/WCO.0b013e32835f19da; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Shetty AK, 2003, J NEUROCHEM, V87, P147, DOI 10.1046/j.1471-4159.2003.01979.x; Stricker SH, 2017, NAT REV GENET, V18, P51, DOI 10.1038/nrg.2016.138	24	5	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211917	10.1371/journal.pone.0211917	http://dx.doi.org/10.1371/journal.pone.0211917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735541	Green Published, Green Submitted, gold			2022-12-26	WOS:000458181200042
J	Xu, TS; Gu, LH; Yu, HP; Jiang, XF; Zhang, YS; Zhang, XH; Rong, G; Zhou, ZK; Schachtschneider, KM; Hou, SS				Xu, Tieshan; Gu, Lihong; Yu, Haopeng; Jiang, Xuefei; Zhang, Yunsheng; Zhang, Xiaohui; Rong, Guang; Zhou, Zhengkui; Schachtschneider, Kyle M.; Hou, Shuisheng			Analysis of Anasplatyrhynchos genome resequencing data reveals genetic signatures of artificial selection	PLOS ONE			English	Article							PROVIDE INSIGHT; GROWTH; EXPRESSION; ALIGNMENT; RECEPTOR; ADAPTATION; PHENOTYPE; EVOLUTION; MUTATION; MEF2A	Three artificially selected duck populations (AS), higher lean meat ratios (LTPD), higher fat ratios (FTPD) and higher quality meat (CMD), have been developed in China, providing excellent populations for investigation of artificial selection effects. However, the genetic signatures of artificial selection are unclear. In this study, we sequenced the genome sequences of these three artificially selected populations and their ancestral population (mallard, M). We then compared the genome sequences between AS and M and between LTPD and FTPD using integrated strategies such as anchoring scaffolds to pseudo-chromosomes, mutation detection, selective screening, GO analysis, qRT-PCR, and protein multiple sequences alignment to uncover genetic signatures of selection. We anchored duck scaffolds to pseudo-chromosomes and obtained 28 pseudo-chromosomes, accounting for 84% of duck genome in length. Totally 78 and 99 genes were found to be under selection between AS and M and between LTPD and FTPD. Genes under selection between AS and M mainly involved in pigmentation and heart rates, while genes under selection between LTPD and FTPD involved in muscle development and fat deposition. A heart rate regulator (HCN1), the strongest selected gene between AS and M, harbored a GC deletion in AS and displayed higher mRNA expression level in M than in AS. IGF2R, a regulator of skeletal muscle mass, was found to be under selection between FTPD and LTPD. We also found two nonsynonymous substitutions in IGF2R, which might lead to higher IGF2R mRNA expression level in FTPD than LTPD, indicating the two nonsynonymous substitutions might play a key role for the regulation of duck skeletal muscle mass. Taken together, these results of this study provide valuable insight for the genetic basis of duck artificial selection.	[Xu, Tieshan; Zhang, Yunsheng; Zhou, Zhengkui; Hou, Shuisheng] Chinese Acad Trop Agr Sci, Trop Crop Genet Resource Res Inst, Danzhou, Peoples R China; [Xu, Tieshan; Rong, Guang] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Gu, Lihong] Hainan Acad Agr Sci, Inst Anim Sci & Vet, Haikou, Hainan, Peoples R China; [Yu, Haopeng] Sichuan Univ, West China Sch Med, West China Hosp, West China Biomed Big Data Ctr, Chengdu, Sichuan, Peoples R China; [Jiang, Xuefei] Hainan Univ, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China; [Zhang, Xiaohui] Henan Univ Sci & Technol, Coll Anim Sci, Luoyang, Peoples R China; [Schachtschneider, Kyle M.] Univ Illinois, Dept Radiol, Chicago, IL USA	Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Sichuan University; Hainan University; Henan University of Science & Technology; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hou, SS (corresponding author), Chinese Acad Trop Agr Sci, Trop Crop Genet Resource Res Inst, Danzhou, Peoples R China.	houss2010@163.com	zhang, yunsheng/AAP-8347-2021	Schachtschneider, Kyle/0000-0002-7293-8642	Key Research and Development Programs of Hainan Province [ZDYF2018224]; Chinese Modern Technology System of Agricultural Industry [CARS-42-1, CARS-42-50]; Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences Grant [1630032017034]	Key Research and Development Programs of Hainan Province; Chinese Modern Technology System of Agricultural Industry; Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences Grant	This work was financial supported by Key Research and Development Programs of Hainan Province (Grant no. ZDYF2018224), Chinese Modern Technology System of Agricultural Industry (Grant no. CARS-42-1 and CARS-42-50) and Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences Grant (no. 1630032017034).	Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107; Andersson L, 2009, COLD SH Q B, V74, P319, DOI 10.1101/sqb.2009.74.039; Andersson L, 2013, INTERNATIONAL PLANT; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Burga A, 2017, SCIENCE, V356, DOI 10.1126/science.aal3345; Carneiro M, 2014, SCIENCE, V345, P1074, DOI 10.1126/science.1253714; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clark DL, 2015, GROWTH HORM IGF RES, V25, P207, DOI 10.1016/j.ghir.2015.06.007; De Summa S, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1537-8; Devi GR, 1998, MOL ENDOCRINOL, V12, P1661, DOI 10.1210/me.12.11.1661; Duggan BM, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0166-9; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Farmer WT, 2013, ANIM REPROD SCI, V138, P64, DOI 10.1016/j.anireprosci.2013.01.009; Fenske S, 2013, CIRCULATION, V128, P2585, DOI 10.1161/CIRCULATIONAHA.113.003712; Fisher R.A, 1930, GENETIC THEORY NATUR; Goding CR, 2000, GENE DEV, V14, P1712; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gutierrez-Gil B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-56; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hansen NF, 2016, METHODS MOL BIOL, V1418, P209, DOI 10.1007/978-1-4939-3578-9_11; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KAUSHAL S, 1994, SCIENCE, V266, P1236, DOI 10.1126/science.7973707; Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419; Kofler R, 2011, BIOINFORMATICS, V27, P3435, DOI 10.1093/bioinformatics/btr589; Konkel MK, 2015, GENOME BIOL EVOL, V7, P2608, DOI 10.1093/gbe/evv167; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Lei MM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-70; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li HF, 2010, MOL PHYLOGENET EVOL, V57, P634, DOI 10.1016/j.ympev.2010.07.011; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054; Loehr J, 2007, J EVOLUTION BIOL, V20, P818, DOI 10.1111/j.1420-9101.2006.01272.x; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Micke GC, 2011, MOL CELL ENDOCRINOL, V332, P234, DOI 10.1016/j.mce.2010.10.018; MORGAN DO, 1987, NATURE, V329, P301, DOI 10.1038/329301a0; Murray GGR, 2017, SCIENCE, V358, P951, DOI 10.1126/science.aao0960; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Radzimirska M, 2010, MORPHOLOGY TOPOGRAPH, P405; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Runkel F, 2006, MAMM GENOME, V17, P203, DOI 10.1007/s00335-005-0015-1; Schiavo G, 2016, ANIM GENET, V47, P181, DOI 10.1111/age.12392; Senapati MR, 2015, EXPLOR ANIM MED RES, V5, P73; Shi WM, 1999, CIRC RES, V85, pE1; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Wang LY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04178-7; Wang YM, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1036-6; Wojcik E, 2007, FOLIA BIOL-KRAKOW, V55, P115, DOI 10.3409/173491607781492588; Wu Y, 2008, ANIM GENET, V39, P564, DOI 10.1111/j.1365-2052.2008.01761.x; Xu TS, 2015, GENET MOL RES, V14, P4448, DOI 10.4238/2015.May.4.2; Xu TS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174612; Xu TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107574; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zicha S, 2005, CARDIOVASC RES, V66, P472, DOI 10.1016/j.cardiores.2005.02.011	60	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211908	10.1371/journal.pone.0211908	http://dx.doi.org/10.1371/journal.pone.0211908			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735526	Green Published, gold, Green Submitted			2022-12-26	WOS:000458181200041
J	Frasconi, C; Martelloni, L; Antichi, D; Raffaelli, M; Fontanelli, M; Peruzzi, A; Benincasa, P; Tosti, G				Frasconi, Christian; Martelloni, Luisa; Antichi, Daniele; Raffaelli, Michele; Fontanelli, Marco; Peruzzi, Andrea; Benincasa, Paolo; Tosti, Giacomo			Combining roller crimpers and flaming for the termination of cover crops in herbicide-free no-till cropping systems	PLOS ONE			English	Article							ROW WEED-CONTROL; VETCH; MAIZE; RYE; ROLLER/CRIMPER; MACHINES	The termination of cover crops in conventional no-till systems is mostly conducted mechanically in combination with herbicides. Combining flaming and roller crimpers could be a viable solution to avoid using herbicides for cover crop termination in farming systems where herbicides are banned, or at least to reduce their use in an integrated management approach. This research tested the effects of flaming used in combination with three different types of roller crimpers to terminate a fall-sown cover crop mixture of winter pea and barley. The cover crop termination rate was visually assessed in terms of percentage of green cover provided by cover crop plants at different intervals from the termination date, and estimated using a log-logistic non-linear regression model with four parameters. Machine performance data are also reported. The results show that, irrespective of the roller type, flaming significantly boosted the effect of the roller crimpers. In fact, an economic threshold for cover crop suppression of 85% was reached only when the rollers were used in combination with flaming. Nevertheless, none of the methods were able to reach the 100% of cover crop suppression. In some case, the combined use of flaming and roller crimpers allowed reaching the 90% of cover crop devitalisation, which happened six weeks after the termination date. More importantly, the use of flaming in combination with rollers shortened the time needed to achieve the estimated levels of devitalisation, compared with the rollers used alone. We conclude that flaming is an effective tool to increase the effectiveness of roller crimpers. Nevertheless, further research is needed to identify solutions to overcome the barrier of the high operational costs of flaming, which is constraining its wider adoption by farmers. Future studies could focus, for instance, on the development of a new prototype of combined machine for crimping and flaming the cover crops simultaneously, which could potentially reduce the operational costs.	[Frasconi, Christian; Martelloni, Luisa; Antichi, Daniele; Raffaelli, Michele; Fontanelli, Marco; Peruzzi, Andrea] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy; [Benincasa, Paolo; Tosti, Giacomo] Univ Perugia, Dept Agr Food & Environm Sci DSA3, Perugia, Italy	University of Pisa; University of Perugia	Martelloni, L (corresponding author), Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.	lmartelloni@agr.unipi.it	FRASCONI, CHRISTIAN/AAL-4963-2021; Frasconi, Christian/AAL-9955-2021; Raffaelli, Michele/H-4280-2013; Antichi, Daniele/AAX-3430-2020	Frasconi, Christian/0000-0001-6339-341X; Antichi, Daniele/0000-0002-5520-2510; TOSTI, GIACOMO/0000-0003-4649-3018; Martelloni, Luisa/0000-0001-6721-0027	Italian Ministry of University and Research (MIUR) [RBFR13L8J6]	Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministry of University and Research (MIUR) under the project "Integration and comparison of innovative technical approaches with different 'ecological intensification' finalized to a smart management of conservative agricultural systems." (Project code: RBFR13L8J6). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, NEWS SHEET DEUT PLAN; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2018, IMAGING CROP RESPONS; Ashford D. L., 2003, American Journal of Alternative Agriculture, V18, P37, DOI 10.1079/AJAA2003037; Bavougian CM, 2019, BIOL AGRIC HORTIC, V35, P1, DOI 10.1080/01448765.2018.1455607; Bedoussac L, 2010, PLANT SOIL, V330, P37, DOI 10.1007/s11104-010-0303-8; Benincasa P, 2010, J SUSTAIN AGR, V34, P705, DOI 10.1080/10440046.2010.507452; Benincasa P, ADV RES FERTILIZATIO; Brady N.C., 1999, NATURE PROPERTIES SO; Cornell S.C.U., 2008, STATNEWS CORNELL U S, V73, P3; Dhima KV, 2007, FIELD CROP RES, V100, P249, DOI 10.1016/j.fcr.2006.07.008; Frasconi C, 2017, APPL ENG AGRIC, V33, P345, DOI 10.13031/aea.11529; Guiducci M, 2018, AGRON SUSTAIN DEV, V38, DOI 10.1007/s13593-018-0509-3; Hauggaard-Nielsen H, 2005, PLANT SOIL, V274, P237, DOI 10.1007/s11104-004-1305-1; Hunt D, 2001, FARM POWER MACHINERY, P75; Kornecki TS, 2009, APPL ENG AGRIC, V25, P819; Kornecki TS, 2009, RENEW AGR FOOD SYST, V24, P165, DOI 10.1017/S1742170509002580; Kornecki TS, 2010, J COTTON SCI, V14, P212; Martelloni L, 2016, APPL ENG AGRIC, V32, P569, DOI 10.13031/aea.32.11114; Martelloni L, 2017, SPAN J AGRIC RES, V15, DOI 10.5424/sjar/2017152-10668; Marusiak M, 2018, CROAT J FOR ENG, V39, P233; Mazzoncini M, 2011, SOIL TILL RES, V114, P165, DOI 10.1016/j.still.2011.05.001; Meier U., 2001, GROWTH STAGES MONOAN, V2nd ed, P14; Mirsky SB, 2009, AGRON J, V101, P1589, DOI 10.2134/agronj2009.0130; Miville D, 2018, WEED TECHNOL, V32, P251, DOI 10.1017/wet.2018.9; Miyata ES, 1983, 238 US DEP AGR FOR S; Mojzis M., 2002, Research in Agricultural Engineering, V48, P94; Peruzzi A, 2017, J AGRIC ENG, V48, P57, DOI 10.4081/jae.2017.583; Raffaelli M, 2013, APPL ENG AGRIC, V29, P663; Raper RL, 2005, US patent, Patent No. [6,968,907 B1, 6968907]; Rasmussen J, 2007, WEED RES, V47, P299, DOI 10.1111/j.1365-3180.2007.00565.x; Reeves DW, 1994, ADV SOIL SCI CROPS R; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Rodale Institute, 2018, FREE PLANS; SNAYDON RW, 1991, J APPL ECOL, V28, P930, DOI 10.2307/2404218; Teasdale JR, 2012, AGRON J, V104, P621, DOI 10.2134/agronj2011.0317; Tennakoon SB, 2006, IRRIGATION SCI, V25, P45, DOI 10.1007/s00271-006-0033-0; Tosti G, 2014, EUR J AGRON, V54, P34, DOI 10.1016/j.eja.2013.11.012; Tosti G, 2012, EUR J AGRON, V43, P136, DOI 10.1016/j.eja.2012.06.004	39	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211573	10.1371/journal.pone.0211573	http://dx.doi.org/10.1371/journal.pone.0211573			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730925	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000035
J	Ladele, JI; Fajolu, IB; Ezeaka, VC				Ladele, Jejelola I.; Fajolu, Iretiola Bamikeolu; Ezeaka, Veronica Chinyere			Determination of lead levels in maternal and umbilical cord blood at birth at the Lagos University Teaching Hospital, Lagos	PLOS ONE			English	Article							METAL CONTAMINATION; PREGNANT-WOMEN; EXPOSURE; NIGERIA; CHILDREN; SOIL; POPULATION; INCREASES; POLLUTION; AFRICA	Background Lead toxicity is a cause of intellectual disability in children and majority of affected children live in developing countries. Its adverse effect on pregnancy outcome has also been documented. Objectives To assess the relationship between maternal blood lead levels and umbilical cord blood lead levels in their corresponding newborn infants; to determine factors associated with high blood lead levels and the pregnancy outcome in participants. Materials and methods This was a cross-sectional descriptive study carried out at a tertiary Teaching Hospital, Lagos, Nigeria. Four hundred and forty pregnant women and their respective newborns delivered at the study centre. Blood samples were obtained from the mothers and umbilical cord of the newborns at delivery and analysed by atomic absorption spectrophotometry. Socio-demographic and obstetric data was obtained by questionnaires administered to the mothers. The anthropometric measurements of the babies were taken at birth and clinical data recorded. Main outcome measures were blood lead levels in mother and baby pair, socio-demographic factors, birth weight, gestational age, length, occipito-frontal circumference. Results The median maternal and umbilical blood lead level was 64.3 mu g/dl and 39.2 mu g/dl respectively. The levels were above 5 mu g/dl in 75.6% and 66.8% of mothers and umbilical cord respectively. There was a strong positive correlation between the maternal and umbilical cord blood lead levels (r(s) = 0.80). Use of calcium supplements during pregnancy was significantly associated with a lower maternal blood lead level (p = 0.010) while recent painting and renovation of residential accommodation were associated with a higher umbilical cord blood lead level (p = 0.025). There were no statistically significant associations between the maternal and umbilical cord blood lead levels and the gestational age and anthropometry of the newborns at birth. Conclusions The blood lead levels in newborns of women residing in Lagos, Nigeria are high and administration of antenatal calcium is associated with lower blood lead levels.	[Ladele, Jejelola I.; Fajolu, Iretiola Bamikeolu; Ezeaka, Veronica Chinyere] Lagos Univ, Teaching Hosp, Dept Paediat, Lagos, Nigeria; [Fajolu, Iretiola Bamikeolu; Ezeaka, Veronica Chinyere] Univ Lagos, Coll Med, Dept Paediat, Lagos, Nigeria	University of Lagos	Ladele, JI (corresponding author), Lagos Univ, Teaching Hosp, Dept Paediat, Lagos, Nigeria.	jeje_ladele@yahoo.com	Fajolu, Iretiola Bamikeolu/P-5759-2019	Fajolu, Iretiola Bamikeolu/0000-0003-3045-9616; Ezeaka, Veronica Chinyere/0000-0003-1880-4616; ladele, jejelola/0000-0002-3202-4977				Adebamowo EO, 2007, SCI TOTAL ENVIRON, V388, P116, DOI 10.1016/j.scitotenv.2007.07.061; Adekunle IM, 2010, ENVIRON MONIT ASSESS, V170, P467, DOI 10.1007/s10661-009-1247-4; Adekunle IM, 2004, FOOD CHEM TOXICOL, V42, P1463, DOI 10.1016/j.fct.2004.04.007; Adogame  Leslie, 2017, NATL REPORT LEAD SOL; Ahamefuna N, 2014, S AM J PUBLIC HLTH, V2, P135; Anuforo E, 2015, THEGUARDIAN; Arowolo T.A., 2012, RES J ENVIRON EARTH, V4, P460; Barltrop D, 1969, MINERAL METABOLISM P, P135; Bellinger DC, 2005, BIRTH DEFECTS RES A, V73, P409, DOI 10.1002/bdra.20127; Borja-Aburto VH, 1999, AM J EPIDEMIOL, V150, P590, DOI 10.1093/oxfordjournals.aje.a010057; Chelchowska M, 2013, BIOL TRACE ELEM RES, V155, P169, DOI 10.1007/s12011-013-9775-8; CLARK ARL, 1977, POSTGRAD MED J, V53, P674, DOI 10.1136/pgmj.53.625.674; Committee on Measuring Lead in Critical Population NRC, 1993, MEAS LEAD INF CHILDR; de Caceres M L, 1995, Behav Neurol, V8, P39, DOI 10.3233/BEN-1995-8105; DIETRICH KN, 1987, PEDIATRICS, V80, P721; Dooyema CA, 2012, ENVIRON HEALTH PERSP, V120, P601, DOI 10.1289/ehp.1103965; El Sawi I., 2013, J PHARMACOL TOX MET, V8, P98, DOI [10.3923/jpt.2013.98.104, DOI 10.3923/JPT.2013.98.104]; Ettinger AS, 2009, ENVIRON HEALTH PERSP, V117, P26, DOI [10.1289/ehp.11868, 10.1289/ehp.1171c26]; Ettinger Adrienne S., 2010, BREAST FEEDING; Fakayode SO, 2003, ENVIRON GEOL, V44, P150, DOI 10.1007/s00254-002-0739-0; Galadima A., 2012, ELIXIR POLLUTION, V43, P6893; Garcia-Esquinas E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-841; Gomaa A, 2002, PEDIATRICS, V110, P110, DOI 10.1542/peds.110.1.110; GonzalezCossio T, 1997, PEDIATRICS, V100, P856, DOI 10.1542/peds.100.5.856; GOYER RA, 1990, ENVIRON HEALTH PERSP, V89, P101, DOI 10.2307/3430905; GRAZIANO JH, 1990, ENVIRON HEALTH PERSP, V89, P95, DOI 10.2307/3430904; Harville EW, 2005, OCCUP ENVIRON MED, V62, P263, DOI 10.1136/oem.2003.012492; Hernandez-Avila M, 2003, EPIDEMIOLOGY, V14, P206, DOI 10.1097/00001648-200303000-00015; Hu H, 2006, ENVIRON HEALTH PERSP, V114, P1730, DOI 10.1289/ehp.9067; Ibukun A, 2010, SCI RES ESSAYS, V5, P813; IPCS, 1995, IN LEAD; Irgens A, 1998, AM J IND MED, V34, P431, DOI 10.1002/(SICI)1097-0274(199811)34:5<431::AID-AJIM3>3.0.CO;2-T; Jedrychowski W, 2009, NEUROEPIDEMIOLOGY, V32, P270, DOI 10.1159/000203075; Kakulu SE, 2003, ENVIRON MONIT ASSESS, V89, P233, DOI 10.1023/A:1026149914428; Kirel B, 2005, TURKISH J PEDIATR, V47, P125; LANDRIGAN PJ, 1987, PEDIATRICS, V79, P582; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Maduabuchi JMU, 2006, SCI TOTAL ENVIRON, V366, P621, DOI 10.1016/j.scitotenv.2005.12.015; Momodu M. A., 2010, Research Journal of Environmental and Earth Sciences, V2, P39; Naicker N, 2010, ENVIRON RES, V110, P355, DOI 10.1016/j.envres.2010.02.006; Nduka JKC, 2008, TOXICOL IND HEALTH, V24, P539, DOI 10.1177/0748233708098125; Nduka JK, 2010, INT J ENV RES PUB HE, V7, P2501, DOI 10.3390/ijerph7062501; Nduka JKC, 2006, ARCH ENVIRON OCCUP H, V61, P197, DOI 10.3200/AEOH.61.5.197-204; Njoku CO, 2012, OCCUP ENVIRON MED, V69, P850, DOI 10.1136/oemed-2012-100947; Nnorom IC, 2005, AFR J BIOTECHNOL, V4, P1133; Nriagu J, 1997, SCI TOTAL ENVIRON, V197, P13, DOI 10.1016/S0048-9697(96)05408-3; Nriagu J, 2008, INT J HYG ENVIR HEAL, V211, P591, DOI 10.1016/j.ijheh.2008.05.001; Obi Ejeatuluchukwu, 2014, Journal of UOEH, V36, P159, DOI 10.7888/juoeh.36.159; Oguntona T. S., 2012, TRANSNATIONAL J SCI, V2, P69; Oke S.A., 2008, PACIFIC J SCI TECH, V9, P263; OKOYE COB, 1994, B ENVIRON CONTAM TOX, V52, P825; OLOWE SA, 1981, J PEDIATR-US, V99, P489, DOI 10.1016/S0022-3476(81)80358-7; Olubomehin O. O., 2012, RES HUMANITIES SOCIA, V2, P231; Omolaoye J.A., 2010, ARCH APPL SCI RES, V2, P76; Organization WH, 2009, GLOB HLTH RISKS MORT; Orisakwe OE, 2004, ARCH ENVIRON HEALTH, V59, P31, DOI 10.3200/AEOH.59.1.31-36; Orisakwe OE, 2009, INT J OCCUP ENV HEAL, V15, P315, DOI 10.1179/oeh.2009.15.3.315; Patel AB, 2009, INDIAN PEDIATR, V46, P791; Pfitzner M.A., 2000, AMBULATORY CHILD HLT, V6, P115, DOI [10.1046/j.1467-0658.2000.00069.x, DOI 10.1046/J.1467-0658.2000.00069.X]; Rahman A., 2003, JPMA Journal of the Pakistan Medical Association, V53, P529; Rhainds M, 1997, AM J EPIDEMIOL, V145, P250, DOI 10.1093/oxfordjournals.aje.a009098; Rothenberg SJ, 2002, AM J EPIDEMIOL, V156, P1079, DOI 10.1093/aje/kwf163; SATIN KP, 1991, ARCH ENVIRON HEALTH, V46, P167, DOI 10.1080/00039896.1991.9937445; Schell LM, 2009, AM J HUM BIOL, V21, P180, DOI 10.1002/ajhb.20842; Schmidt CW, 2006, ENVIRON HEALTH PERSP, V114, pA232, DOI 10.1289/ehp.114-a232; Schnaas L, 2006, ENVIRON HEALTH PERSP, V114, P791, DOI 10.1289/ehp.8552; Sharma R, 2014, INT J PHARM SCI RES, V5, P636, DOI 10.13040/IJPSR.097-8232.(3).63-42; Sridhar K, 2010, LEAD NIGERIAN ENV; Tong S, 2000, B WORLD HEALTH ORGAN, V78, P1068; Ugwuja EI, 2011, INT J OCCUP ENV MED, V2, P143; Ugwuja EI, 2013, ENVIRON MONIT ASSESS, V185, P3795, DOI 10.1007/s10661-012-2828-1; Wells EM, 2011, ENVIRON RES, V111, P411, DOI 10.1016/j.envres.2010.12.009; World Health Organization, 2010, CHILDH LEAD POIS; World Health Organization, 2019, LEAD POIS HLTH; World Health Organization, 2011, BRIEF GUIDE ANAL MET; Wright JP, 2008, PLOS MED, V5, P732, DOI 10.1371/journal.pmed.0050101; Wright NJ, 2005, ARCH DIS CHILD, V90, P262, DOI 10.1136/adc.2003.043562; Yazbeck C, 2009, ENVIRON HEALTH PERSP, V117, P1526, DOI 10.1289/ehp.0800488; Zhu MT, 2010, ENVIRON HEALTH PERSP, V118, P1471, DOI 10.1289/ehp.0901561	79	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211535	10.1371/journal.pone.0211535	http://dx.doi.org/10.1371/journal.pone.0211535			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730916	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000033
J	Horsthemke, M; Nutter, LMJ; Bachg, AC; Skryabin, BV; Honnert, U; Zobel, T; Bogdan, S; Stoll, M; Seidl, MD; Muller, FU; Ravens, U; Unger, A; Linke, WA; van Gorp, PRR; de Vries, AAF; Bahler, M; Hanley, PJ				Horsthemke, Markus; Nutter, Lauryl M. J.; Bachg, Anne C.; Skryabin, Boris V.; Honnert, Ulrike; Zobel, Thomas; Bogdan, Sven; Stoll, Monika; Seidl, Matthias D.; Mueller, Frank U.; Ravens, Ursula; Unger, Andreas; Linke, Wolfgang A.; van Gorp, Pim R. R.; de Vries, Antoine A. F.; Baehler, Martin; Hanley, Peter J.			A novel isoform of myosin 18A (Myo18A) is an essential sarcomeric protein in mouse heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene knockout; myosin; molecular motor; heart; macrophage	PDZ-CONTAINING MYOSIN; GENOME-WIDE; F-ACTIN; GENE; EXPRESSION; GOLGI; MICE; ACTOMYOSIN; RESOLUTION; RESOURCE	Whereas myosin 18B (Myo18B) is known to be a critical sarcomeric protein, the function of myosin 18A (Myo18A) is unclear, although it has been implicated in cell motility and Golgi shape. Here, we show that homozygous deletion (homozygous tm1a, tm1b, or tm1d alleles) of Myo18a in mouse is embryonic lethal. Reminiscent of Myo18b, Myo18a was highly expressed in the embryo heart, and cardiac-restricted Myo18a deletion in mice was embryonic lethal. Surprisingly, using Western blot analysis, we were unable to detect the known isoforms of Myo18A, Myo18A and Myo18A, in mouse heart using a custom C-terminal antibody. However, alternative anti-Myo18A antibodies detected a larger than expected protein, and RNA-Seq analysis indicated that a novel Myo18A transcript is expressed in mouse ventricular myocytes (and human heart). Cloning and sequencing revealed that this cardiac isoform, denoted Myo18A, lacks the PDZ-containing N terminus of Myo18A but includes an alternative N-terminal extension and a long serine-rich C terminus. EGFP-tagged Myo18A expressed in ventricular myocytes localized to the level of A-bands in sarcomeres, and Myo18a knockout embryos at day 10.5 exhibited disorganized sarcomeres with wavy thick filaments. We additionally generated myeloid-restricted Myo18a knockout mice to investigate the role of Myo18A in nonmuscle cells, exemplified by macrophages, which express more Myo18A than Myo18A, but no defects in cell shape, motility, or Golgi shape were detected. In summary, we have identified a previously unrecognized sarcomere component, a large novel isoform (denoted Myo18A) of Myo18A. Thus, both members of class XVIII myosins are critical components of cardiac sarcomeres.	[Horsthemke, Markus; Bachg, Anne C.; Honnert, Ulrike; Baehler, Martin; Hanley, Peter J.] Westfalische Wilhelms Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany; [Skryabin, Boris V.] Westfalische Wilhelms Univ Munster, Dept Med Transgen Anim & Genet Engn Models TRAM, D-48149 Munster, Germany; [Stoll, Monika] Westfalische Wilhelms Univ Munster, Inst Humangenet, D-48149 Munster, Germany; [Seidl, Matthias D.; Mueller, Frank U.] Westfalische Wilhelms Univ Munster, Inst Pharmakol & Toxikol, D-48149 Munster, Germany; [Nutter, Lauryl M. J.] Hosp Sick Children, Ctr Phenogen, Toronto, ON M5T 3H7, Canada; [Zobel, Thomas] Heinrich Heine Univ Dusseldorf, Ctr Adv Imaging, D-40225 Dusseldorf, Germany; [Bogdan, Sven] Philipps Univ Marburg, Inst Physiol & Pathophysiol, Abt Mol Zellphysiol, D-35037 Marburg, Germany; [Ravens, Ursula] Univ Klinikum Freiburg, Inst Expt Kardiovaskulare Med, D-79110 Freiburg, Germany; [Unger, Andreas; Linke, Wolfgang A.] Westfalische Wilhelms Univ Munster, Inst Physiol 2, Robert Koch Str 27b, D-48149 Munster, Germany; [van Gorp, Pim R. R.; de Vries, Antoine A. F.] Leiden Univ, Med Ctr, Dept Cardiol, Lab Expt Cardiol, Albinusdreef 2, NL-2300 RC Leiden, Netherlands	University of Munster; University of Munster; University of Munster; University of Munster; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Heinrich Heine University Dusseldorf; Philipps University Marburg; University of Freiburg; University of Munster; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hanley, PJ (corresponding author), Westfalische Wilhelms Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany.	hanley@uni-muenster.de	de Vries, Antoine/ABG-5787-2021; Skryabin, Boris/AAL-3100-2020	Skryabin, Boris/0000-0002-4392-185X; Nutter, Lauryl/0000-0001-9619-146X; Linke, Wolfgang/0000-0003-0801-3773	Deutsche Forschungsgemeinschaft (DFG) [Mu1376/11-3, HA 3271/3-1, HA 3271/4-1, EXC 1003]; Cells in Motion (CiM); Genome Canada; Ontario Genomics Institute [OGI-059]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cells in Motion (CiM); Genome Canada(Genome Canada); Ontario Genomics Institute	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants Mu1376/11-3 (to F. U. M.), HA 3271/3-1 (to P. J. H.), HA 3271/4-1 (to P. J. H.), and EXC 1003 (Cluster of Excellence 1003), Cells in Motion (CiM), and the NorCOMM2 project was funded by Genome Canada and Ontario Genomics Institute Grant OGI-059. The authors declare that they have no conflicts of interest with the contents of this article.	Adams NC, 2006, PRIN PRACT, P131; Ajima R, 2008, GENES CELLS, V13, P987, DOI 10.1111/j.1365-2443.2008.01226.x; Askar SFA, 2011, CARDIOVASC RES, V90, P295, DOI 10.1093/cvr/cvr011; Berger J, 2017, HUM MOL GENET, V26, P1146, DOI 10.1093/hmg/ddx025; Billington N, 2015, CURR BIOL, V25, P942, DOI 10.1016/j.cub.2015.02.012; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Birling MC, 2012, GENESIS, V50, P482, DOI 10.1002/dvg.20826; Bruun K, 2017, CYTOSKELETON, V74, P205, DOI 10.1002/cm.21364; Cao JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep36768; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cole RW, 2011, NAT PROTOC, V6, P1929, DOI 10.1038/nprot.2011.407; Desgrange A, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.162776; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Engels MC, 2015, CARDIOVASC RES, V107, P601, DOI 10.1093/cvr/cvv191; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Furusawa T, 2000, BIOCHEM BIOPH RES CO, V270, P67, DOI 10.1006/bbrc.2000.2377; Guzik-Lendrum S, 2013, J BIOL CHEM, V288, P9532, DOI 10.1074/jbc.M112.441238; Guzik-Lendrum S, 2011, J BIOL CHEM, V286, P21755, DOI 10.1074/jbc.M111.218669; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Isfort K, 2011, J BIOL CHEM, V286, P44776, DOI 10.1074/jbc.M111.289793; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Katz Y, 2015, BIOINFORMATICS, V31, P2400, DOI 10.1093/bioinformatics/btv034; Kronlage M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000588; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lee I, 2014, P NATL ACAD SCI USA, V111, P1849, DOI 10.1073/pnas.1323895111; Maravillas-Montero JL, 2012, J LEUKOCYTE BIOL, V91, P35, DOI 10.1189/jlb.0711335; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Mori K, 2003, J BIOCHEM, V133, P405, DOI 10.1093/jb/mvg053; Nenoi M, 1996, GENE, V175, P179, DOI 10.1016/0378-1119(96)00145-X; Nishioka M, 2002, P NATL ACAD SCI USA, V99, P12269, DOI 10.1073/pnas.192445899; Perez-Garcia V, 2018, NATURE, V555, P463, DOI 10.1038/nature26002; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Taft MH, 2013, J BIOL CHEM, V288, P30029, DOI 10.1074/jbc.M113.497180; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Tuck E, 2015, DIS MODEL MECH, V8, P1467, DOI 10.1242/dmm.021238; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Yang CH, 2005, J BIOL CHEM, V280, P34447, DOI 10.1074/jbc.M505229200; Yu ZY, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003439; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	46	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7202	7218		10.1074/jbc.RA118.004560	http://dx.doi.org/10.1074/jbc.RA118.004560			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30737279	hybrid, Green Published			2022-12-26	WOS:000468402900010
J	Barbosa, TD; Alm, PS; Krook, A; Barres, R; Zierath, JR				Barbosa, Thais de Castro; Alm, Petter S.; Krook, Anna; Barres, Romain; Zierath, Juleen R.			Paternal high-fat diet transgenerationally impacts hepatic immunometabolism	FASEB JOURNAL			English	Article						metabolism; epigenetics; cytokines; liver	NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; GENE-EXPRESSION; PARENTAL BMI; TNF-ALPHA; OBESITY; LIVER; MICE	Paternal preconceptional high-fat diet (HFD) alters whole-body glucose and energy homeostasis over several generations, which may be mediated by altered transcriptomic profiles of metabolic organs. We investigated the effect of paternal HFD on the hepatic transcriptomic and metabolic signatures of female grand-offspring. Paternal HFD strongly impacted the liver transcriptome of the second-generation offspring. Gene set enrichment analysis (GSEA) revealed grandpaternal-HFD altered the TNF- signaling via NFB pathway, independent of the grand-offspring's diet. Reduction in the hepatic cytokine levels, including the TNF-, as well as NFB content and activity, suggest that the basal inflammatory response in F2 rats is disturbed. GSEA also show altered expression of various genes annotated to the fatty acid metabolism. Grandpaternal-HFD reduced G(0)/G(1) switch gene 2 (G0S2) expression, concomitant with reduced hepatic triglyceride content in F2 rats. In conclusion, the hepatic transcriptome is altered in grand-offspring from HFD-fed grandfathers. Altered TNF-/NFB signaling and levels of inflammatory cytokines indicate grandpaternal HFD impacts hepatic immunometabolism. Overall, our findings indicate that paternal exposure to environmental factors transgenerationally reprograms metabolism in a tissue-specific manner, affecting the development and health of future generations.De Castro Barbosa, T., Alm, P. S., Krook, A., Barres, R., Zierath, J. R. Paternal high-fat diet transgenerationally impacts hepatic immunometabolism.	[Barbosa, Thais de Castro; Alm, Petter S.; Krook, Anna; Zierath, Juleen R.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Krook, Anna; Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Barres, Romain; Zierath, Juleen R.] Univ Copenhagen, Novo Nord Fdn, Fac Hlth & Med Sci, Ctr Basic Metab Res, Copenhagen, Denmark	Karolinska Institutet; Karolinska Institutet; University of Copenhagen	Zierath, JR (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Sect Integrat Physiol, Solnavagen 9, S-17765 Stockholm, Sweden.	juleen.zierath@ki.se	BARRES, Romain/N-2501-2016	BARRES, Romain/0000-0002-0158-519X; Zierath, Juleen/0000-0001-6891-7497	Novo Nordisk Foundation [NNF14OC0011493, NNF14OC0009941, NNF18CC0034900]; Swedish Research Council [2011-3550, 2015-00165]; Diabetes Wellness Sweden [783_2015PG]; Swedish Diabetes Foundation [DIA2012-082, DIA2015-052]; Swedish Foundation for Strategic Research [SRL10-0027]; Torsten Soderbergs Stiftelse [M69/17]; Fredrik and Ingrid Thurings Foundation; Strategic Research Program in Diabetes at Karolinska Institutet [2009-1068]; Erik and Edith Fernstroms; Karolinska Institutet Fonder	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Research Council(Swedish Research CouncilEuropean Commission); Diabetes Wellness Sweden; Swedish Diabetes Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Torsten Soderbergs Stiftelse; Fredrik and Ingrid Thurings Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; Erik and Edith Fernstroms; Karolinska Institutet Fonder(Karolinska Institutet)	This work was funded by the Novo Nordisk Foundation (NNF14OC0011493; NNF14OC0009941), Swedish Research Council (2011-3550; 2015-00165), Diabetes Wellness Sweden (783_2015PG), Swedish Diabetes Foundation (DIA2012-082; DIA2015-052), Swedish Foundation for Strategic Research (SRL10-0027), Torsten Soderbergs Stiftelse (M69/17), Fredrik and Ingrid Thurings Foundation, Erik and Edith Fernstroms, Karolinska Institutet Fonder, and the Strategic Research Program in Diabetes at Karolinska Institutet (2009-1068). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (NNF18CC0034900). The transcriptome data set is publically available at Gene Ontology Omnibus GSE107066. The remaining data are available upon request from the corresponding author. The authors declare no conflicts of interest.	AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Alm PS, 2017, MOL METAB, V6, P621, DOI 10.1016/j.molmet.2017.05.009; Anderson ER, 2013, COMPR PHYSIOL, V3, P315, DOI 10.1002/cphy.c120016; Sanchez-Garrido MA, 2018, ENDOCRINOLOGY, V159, P1005, DOI 10.1210/en.2017-00705; Barbosa TD, 2016, MOL METAB, V5, P184, DOI 10.1016/j.molmet.2015.12.002; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Borghi A, 2016, BIOCHEM PHARMACOL, V116, P1, DOI 10.1016/j.bcp.2016.03.009; Bundred P, 2001, BMJ-BRIT MED J, V322, P326, DOI 10.1136/bmj.322.7282.326; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cho H, 2008, AM J PHYSIOL-ENDOC M, V295, pE1142, DOI 10.1152/ajpendo.90298.2008; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Dandona P, 1998, J CLIN ENDOCR METAB, V83, P2907, DOI 10.1210/jc.83.8.2907; Danielzik S, 2002, EUR J NUTR, V41, P132, DOI 10.1007/s00394-002-0367-1; Dias C, 2014, NATURE, V516, P51, DOI 10.1038/nature13976; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Golden-Mason L, 2004, CLIN EXP IMMUNOL, V138, P94, DOI 10.1111/j.1365-2249.2004.02586.x; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Heckmann BL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88735; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jager J, 2016, J INTERN MED, V280, P209, DOI 10.1111/joim.12483; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kelly AM, 2006, CYTOKINE, V35, P171, DOI 10.1016/j.cyto.2006.07.019; Kirchner H, 2016, MOL METAB, V5, P171, DOI 10.1016/j.molmet.2015.12.004; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murashov AK, 2016, FASEB J, V30, P775, DOI 10.1096/fj.15-274274; Ng SF, 2014, FASEB J, V28, P1830, DOI 10.1096/fj.13-244046; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svensson V, 2011, INT J OBESITY, V35, P46, DOI 10.1038/ijo.2010.189; Terashima M, 2015, EPIGENETICS-US, V10, P861, DOI 10.1080/15592294.2015.1075691; Tyrrell JS, 2013, INT J EPIDEMIOL, V42, P1714, DOI 10.1093/ije/dyt220; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang YP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057085, 10.1371/journal.pone.0065634]; Wu Q, 2006, OBES REV, V7, P201, DOI 10.1111/j.1467-789X.2006.00232.x; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003	52	10	10	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6269	6280		10.1096/fj.201801879RR	http://dx.doi.org/10.1096/fj.201801879RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30768368	Bronze			2022-12-26	WOS:000466932600037
J	Mun, D; Kim, H; Kang, JY; Park, H; Park, H; Lee, SH; Yun, N; Joung, B				Mun, Dasom; Kim, Hyoeun; Kang, Ji-Young; Park, Hyelim; Park, Hyewon; Lee, Seung-Hyun; Yun, Nuri; Joung, Boyoung			Expression of miRNAs in circulating exosomes derived from patients with persistent atrial fibrillation	FASEB JOURNAL			English	Article						microRNA; biomarkers; pathway	MICRORNAS; HEART; BIOMARKERS; PROTEINS; VESICLES; CONTRIBUTES; SIGNATURES; ROLES	Atrial fibrillation (AF), the most common type of cardiac arrhythmia, is thought to be regulated by changes in microRNA (miRNA) expression. However, the evidence for this is inconsistent. The high stability and expression of circulating exosomal miRNAs may allow their use as candidate biomarkers. For the discovery phase, exosomes were isolated from the serum of patients with supraventricular tachycardia (SVT) as the controls (n = 5) and with paroxysmal AF (n = 4) and persistent AF (n = 5) for microarray analysis of miRNAs. Forty-five miRNAs were expressed significantly higher (>1.5-fold) in patients with persistent AF, but not in patients with paroxysmal AF, relative to the levels in patients with SVT control. Notably, expression of 5 miRNAs (miRNA-103a, -107, -320d, -486, and let-7b) was elevated by more than 4.5-fold in patients with persistent AF. For the validation phase, miRNAs were analyzed using quantitative RT-PCR analysis in exosomes from the serum of patients with SVT control (n = 20) and patients with persistent AF (n = 40). These miRNAs and their target genes were involved in atrial function and structure, oxidative stress, and fibrosis pathways. These findings suggest that serum exosomal miRNAs might be used as novel biomarkers to reflect the progression of AF.Mun, D., Kim, H., Kang, J.-Y., Park, H., Park, H., Lee, S.-H., Yun, N., Joung, B. Expression of miRNAs in circulating exosomes derived from patients with persistent atrial fibrillation.	[Mun, Dasom; Kim, Hyoeun; Kang, Ji-Young; Park, Hyelim; Park, Hyewon; Joung, Boyoung] Yonsei Univ, Coll Med, Div Cardiol, Seoul, South Korea; [Lee, Seung-Hyun] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Yun, Nuri] Yonsei Univ, Inst Life Sci & Biotechnol, 50 Yonsei Ro, Seoul SEOUL, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Yun, N (corresponding author), Yonsei Univ, Inst Life Sci & Biotechnol, 50 Yonsei Ro, Seoul SEOUL, South Korea.; Joung, B (corresponding author), Univ Coll Med, 250 Seungsanno, Seoul 120752, South Korea.	yunnuri@hanmail.net; cby6908@yuhs.ac		Yun, Nuri/0000-0003-1853-1304; Joung, Boyoung/0000-0001-9036-7225; Lee, Seung-Hyun/0000-0001-7549-9430	Brain Korea21 PLUS Project for Medical Science by the Yonsei University; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2017R1A2B3003303]; Korean Healthcare Technology Research and Development Project - Ministry of Health and Welfare [HI16C0058]	Brain Korea21 PLUS Project for Medical Science by the Yonsei University; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Korean Healthcare Technology Research and Development Project - Ministry of Health and Welfare	This study was supported by research grants from the Brain Korea21 PLUS Project for Medical Science by the Yonsei University, the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2017R1A2B3003303), and the Korean Healthcare Technology Research and Development Project funded by the Ministry of Health and Welfare (HI16C0058). The authors declare no conflicts of interest.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Busk PK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-29; Cvjetkovic A, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23111; Dawson K, 2013, CIRCULATION, V127, P1466, DOI 10.1161/CIRCULATIONAHA.112.001207; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Ebrahimkhani S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14301-3; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goren Y, 2014, AM J CARDIOL, V113, P976, DOI 10.1016/j.amjcard.2013.11.060; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; Ham O, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0134-x; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Hucker WJ, 2017, J AM COLL CARDIOL, V69, P2088, DOI 10.1016/j.jacc.2017.02.043; Iwasaki YK, 2011, CIRCULATION, V124, P2264, DOI 10.1161/CIRCULATIONAHA.111.019893; Karagkouni D, 2018, NUCLEIC ACIDS RES, V46, pD239, DOI 10.1093/nar/gkx1141; Kim H, 2018, BIOCHEM BIOPH RES CO, V499, P803, DOI 10.1016/j.bbrc.2018.03.227; Koga Y, 2011, J GASTROINTEST ONCOL, V2, P215, DOI 10.3978/j.issn.2078-6891.2011.015; Kojima R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03733-8; Kuosmanen SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119646; Ling TY, 2013, HEART RHYTHM, V10, P1001, DOI 10.1016/j.hrthm.2013.03.005; Liu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044906; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Luo XB, 2015, NAT REV CARDIOL, V12, P80, DOI 10.1038/nrcardio.2014.178; McManus DD, 2014, HEART RHYTHM, V11, P663, DOI 10.1016/j.hrthm.2014.01.018; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Natsume Y, 2018, CIRC J, V82, P965, DOI 10.1253/circj.CJ-17-1194; Sanz-Rubio D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28748-5; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; Shin M, 2018, NAT BIOMED ENG, V2, P304, DOI 10.1038/s41551-018-0227-9; Siegel SR, 2012, MOL BIOL REP, V39, P6219, DOI 10.1007/s11033-011-1441-7; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Statello L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195969; Sun YH, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0549-7; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van den Berg NWE, 2017, CARDIOVASC DRUG THER, V31, P345, DOI 10.1007/s10557-017-6736-z; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Wang ZG, 2011, CARDIOVASC RES, V89, P710, DOI 10.1093/cvr/cvq350; Xu GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166235; Yim N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12277	52	29	31	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5979	5989		10.1096/fj.201801758R	http://dx.doi.org/10.1096/fj.201801758R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30753098	Bronze			2022-12-26	WOS:000466932600015
J	Dierschke, SK; Miller, WP; Favate, JS; Shah, P; Kawasawa, YI; Salzberg, AC; Kimball, SR; Jefferson, LS; Dennis, MD				Dierschke, Sadie K.; Miller, William P.; Favate, John S.; Shah, Premal; Kawasawa, Yuka Imamura; Salzberg, Anna C.; Kimball, Scot R.; Jefferson, Leonard S.; Dennis, Michael D.			O-GlcNAcylation alters the selection of mRNAs for translation and promotes 4E-BP1-dependent mitochondrial dysfunction in the retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-linked N-acetylglucosamine (O-GlcNAc); eukaryotic translation initiation factor 4E-binding protein 1 (EIF4EBP1); eukaryotic translation initiation; diabetes; retina; oxidative stress; post-translational modification (PTM); RiboSeq; ribosome foot printing	LINKED N-ACETYLGLUCOSAMINE; PROTEIN-SYNTHESIS; GENE-EXPRESSION; SUPEROXIDE-DISMUTASE; DIABETIC-RETINOPATHY; DNA-DAMAGE; CELL-DEATH; GLCNAC; BINDING; PHOSPHORYLATION	Diabetes promotes the posttranslational modification of proteins by O-linked addition of GlcNAc (O-GlcNAcylation) to Ser/Thr residues of proteins and thereby contributes to diabetic complications. In the retina of diabetic mice, the repressor of mRNA translation, eIF4E-binding protein 1 (4E-BP1), is O-GlcNAcylated, and sequestration of the cap-binding protein eukaryotic translation initiation factor (eIF4E) is enhanced. O-GlcNAcylation has also been detected on several eukaryotic translation initiation factors and ribosomal proteins. However, the functional consequence of this modification is unknown. Here, using ribosome profiling, we evaluated the effect of enhanced O-GlcNAcylation on retinal gene expression. Mice receiving thiamet G (TMG), an inhibitor of the O-GlcNAc hydrolase O-GlcNAcase, exhibited enhanced retinal protein O-GlcNAcylation. The principal effect of TMG on retinal gene expression was observed in ribosome-associated mRNAs (i.e. mRNAs undergoing translation), as less than 1% of mRNAs exhibited changes in abundance. Remarkably, approximate to 19% of the transcriptome exhibited TMG-induced changes in ribosome occupancy, with 1912 mRNAs having reduced and 1683 mRNAs having increased translational rates. In the retina, the effect of O-GlcNAcase inhibition on translation of specific mitochondrial proteins, including superoxide dismutase 2 (SOD2), depended on 4E-BP1/2. O-GlcNAcylation enhanced cellular respiration and promoted mitochondrial superoxide levels in WT cells, and 4E-BP1/2 deletion prevented O-GlcNAcylation-induced mitochondrial superoxide in cells in culture and in the retina. The retina of diabetic WT mice exhibited increased reactive oxygen species levels, an effect not observed in diabetic 4E-BP1/2-deficient mice. These findings provide evidence for a mechanism whereby diabetes-induced O-GlcNAcylation promotes oxidative stress in the retina by altering the selection of mRNAs for translation.	[Dierschke, Sadie K.; Miller, William P.; Kimball, Scot R.; Jefferson, Leonard S.; Dennis, Michael D.] Penn State Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA; [Favate, John S.; Shah, Premal] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Kawasawa, Yuka Imamura] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Salzberg, Anna C.] Penn State Coll Med, Dept Biochem & Mol Biol, Inst Personalized Med, Hershey, PA 17033 USA; [Salzberg, Anna C.] Ipsen Biosci Inc, 650 E Kendall St, Cambridge, MA 02142 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Dennis, MD (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	mdennis@psu.edu		Favate, John/0000-0001-6344-4854; MILLER, WILLIAM PHILLIP/0000-0003-0157-6389; Shah, Premal/0000-0002-8424-4218; Dennis, Michael/0000-0002-0645-6864	American Diabetes Association Pathway to Stop Diabetes Grant [1-14-INI-04]; NEI, National Institutes of Health [EY023612]; Penn State Eye Center Frontiers in Eye and Vision Research Award; Human Genetics Institute of New Jersey; NIGMS, National Institutes of Health Grant [GM124976]; NIDDK, National Institute of Health Grants [DK13499, DK15658]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002016, UL1TR002014] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R00EY023612] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015658, R01DK013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124976] Funding Source: NIH RePORTER	American Diabetes Association Pathway to Stop Diabetes Grant; NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Penn State Eye Center Frontiers in Eye and Vision Research Award; Human Genetics Institute of New Jersey; NIGMS, National Institutes of Health Grant; NIDDK, National Institute of Health Grants; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Diabetes Association Pathway to Stop Diabetes Grant 1-14-INI-04; NEI, National Institutes of Health Grant EY023612 and the Penn State Eye Center Frontiers in Eye and Vision Research Award (to M. D. D.); startup funds from the Human Genetics Institute of New Jersey and NIGMS, National Institutes of Health Grant GM124976 (to P. S.); and NIDDK, National Institute of Health Grants DK13499 and DK15658 (to S. R. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; Benard G, 2008, ANTIOXID REDOX SIGN, V10, P1313, DOI 10.1089/ars.2007.2000; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; Dai WW, 2018, BBA-MOL BASIS DIS, V1864, P3568, DOI 10.1016/j.bbadis.2018.09.006; Dennis MD, 2015, J BIOL CHEM, V290, P3865, DOI 10.1074/jbc.M114.623058; Dennis MD, 2013, DIABETES, V62, P2204, DOI 10.2337/db12-1453; Dennis MD, 2011, J BIOL CHEM, V286, P34286, DOI 10.1074/jbc.M111.259457; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Duverger E, 1996, GLYCOBIOLOGY, V6, P381, DOI 10.1093/glycob/6.4.381; Fort PE, 2014, DIABETES, V63, P3077, DOI 10.2337/db14-0235; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Gurel Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095561; Gurel Z, 2013, MOL VIS, V19, P1047; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Issad T, 2010, DIABETES METAB, V36, P423, DOI 10.1016/j.diabet.2010.09.001; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; Kern TS, 2000, INVEST OPHTH VIS SCI, V41, P3972; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Kim SJ, 2016, CURR EYE RES, V41, P249, DOI 10.3109/02713683.2015.1006372; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kowluru RA, 2006, INVEST OPHTH VIS SCI, V47, P1594, DOI 10.1167/iovs.05-1276; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; Kowluru RA, 2006, FREE RADICAL BIO MED, V41, P1191, DOI 10.1016/j.freeradbiomed.2006.01.012; Lee R, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0026-2; Li WZ, 2017, BIOINFORMATICS, V33, P1735, DOI 10.1093/bioinformatics/btx047; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma JF, 2016, J PROTEOME RES, V15, P2254, DOI 10.1021/acs.jproteome.6b00250; Ma JF, 2015, J BIOL CHEM, V290, P29141, DOI 10.1074/jbc.M115.691741; MADER S, 1995, MOL CELL BIOL, V15, P4990; Madsen-Bouterse SA, 2010, ANTIOXID REDOX SIGN, V13, P797, DOI 10.1089/ars.2009.2932; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Rodriguez JM, 2013, NUCLEIC ACIDS RES, V41, pD110, DOI 10.1093/nar/gks1058; Miller WP, 2016, INVEST OPHTH VIS SCI, V57, P1327, DOI 10.1167/iovs.15-18719; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Nandi A, 2006, ANAL CHEM, V78, P452, DOI 10.1021/ac051207j; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Ptushkina M, 1999, EMBO J, V18, P4068, DOI 10.1093/emboj/18.14.4068; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schrufer TL, 2010, DIABETES, V59, P2107, DOI 10.2337/db10-0148; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Semba RD, 2014, PROTEOM CLIN APPL, V8, P218, DOI 10.1002/prca.201300076; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Tan EP, 2017, J BIOL CHEM, V292, P14940, DOI 10.1074/jbc.M117.797944; Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Young TA, 2002, ARCH BIOCHEM BIOPHYS, V405, P65, DOI 10.1016/S0003-9861(02)00338-7; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhong Q, 2011, INVEST OPHTH VIS SCI, V52, P8739, DOI 10.1167/iovs.11-8045; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	68	14	14	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5508	5520		10.1074/jbc.RA119.007494	http://dx.doi.org/10.1074/jbc.RA119.007494			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30733333	Green Published, hybrid			2022-12-26	WOS:000464517500022
J	Liu, XH; Chen, Z; Han, ZL; Liu, Y; Wu, X; Peng, YZ; Di, WC; Lan, RF; Sun, BG; Xu, B; Xu, W				Liu, Xuehua; Chen, Zheng; Han, Zhonglin; Liu, Yu; Wu, Xiang; Peng, Yuzhu; Di, Wencheng; Lan, Rongfang; Sun, Bugao; Xu, Biao; Xu, Wei			AMPK-mediated degradation of Nav1.5 through autophagy	FASEB JOURNAL			English	Article						sodium channel; protein degradation; SCN5A; ischemia and reperfusion injury; phosphorylation	CARDIAC SODIUM-CHANNEL; UBIQUITIN-PROTEASOME SYSTEM; HEART; MUTATIONS; PROTEIN; ISCHEMIA; NA(V)1.5; MYOCYTES; INJURY; REPERFUSION	The voltage-gated cardiac sodium channel, Nav1.5, is the key component that controls cardiac excitative electrical impulse and propagation. However, the dynamic alterations of Nav1.5 during cardiac ischemia and reperfusion (I/R) are seldom reported. We found that the protein levels of rat cardiac Nav1.5 were significantly decreased in response to cardiac I/R injury. By simulating I/R injury in cells through activating AMPK by glucose deprivation, AMPK activator treatment, or hypoxia and reoxygenation (H/R), we found that Nav1.5 was down-regulated by AMPK-mediated autophagic degradation. Furthermore, AMPK was found to phosphorylate Nav1.5 at threonine (T) 101, which then regulates the interaction between Nav1.5 and the autophagic adaptor protein, microtubule-associated protein 1 light chain 3 (LC3), by exposing the LC3-interacting region adjacent to T101 in Nav1.5. This study highlights an instrumental role of AMPK in mediating the autophagic degradation of Nav1.5 during cardiac I/R injury.	[Liu, Xuehua; Sun, Bugao] Nanjing Univ, Drum Tower Hosp, Med Sch, Dept Ultrasound Diag, Nanjing, Jiangsu, Peoples R China; [Liu, Xuehua; Chen, Zheng; Han, Zhonglin; Liu, Yu; Wu, Xiang; Peng, Yuzhu; Di, Wencheng; Lan, Rongfang; Xu, Biao; Xu, Wei] Nanjing Univ, Drum Tower Hosp, Med Sch, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Xu, W (corresponding author), Nanjing Univ, Med Sch, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	13390900868@163.com			National Natural Science Foundation of China [81600267]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 81600267). The authors declare no conflicts of interest.	Beltran-Alvarez P, 2014, J MOL CELL CARDIOL, V76, P126, DOI 10.1016/j.yjmcc.2014.08.014; Beltran-Alvarez P, 2011, J PROTEOME RES, V10, P3712, DOI 10.1021/pr200339n; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bezzina CR, 2003, CIRC RES, V92, P159, DOI 10.1161/01.RES.0000052672.97759.36; Boccalini G, 2015, FASEB J, V29, P239, DOI 10.1096/fj.14-254854; Bonuccelli G, 2003, AM J PATHOL, V163, P1663, DOI 10.1016/S0002-9440(10)63523-7; Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082; BUERKE M, 1995, P NATL ACAD SCI USA, V92, P8031, DOI 10.1073/pnas.92.17.8031; Calise J, 2013, AM J PHYSIOL-HEART C, V304, pH337, DOI 10.1152/ajpheart.00604.2012; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; COHEN SA, 1993, CIRC RES, V73, P735, DOI 10.1161/01.RES.73.4.735; Genereux P, 2014, J AM COLL CARDIOL, V64, P2605, DOI 10.1016/j.jacc.2014.08.052; Golden HB, 2012, METHODS MOL BIOL, V843, P205, DOI 10.1007/978-1-61779-523-7_20; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hamacher-Brady A, 2006, AUTOPHAGY, V2, P307, DOI 10.4161/auto.2947; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Huang WQ, 2018, J CELL PHYSIOL, V233, P6669, DOI 10.1002/jcp.26320; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kraft LJ, 2014, AUTOPHAGY, V10, P861, DOI 10.4161/auto.28175; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Luo L, 2017, ACTA PHYSIOL, V221, P44, DOI 10.1111/apha.12872; Ma S, 2015, BBA-MOL BASIS DIS, V1852, P271, DOI 10.1016/j.bbadis.2014.05.010; Makiyama T, 2008, J AM COLL CARDIOL, V52, P1326, DOI 10.1016/j.jacc.2008.07.013; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Murphy BJ, 1996, J BIOL CHEM, V271, P28837, DOI 10.1074/jbc.271.46.28837; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Qi D, 2015, TRENDS ENDOCRIN MET, V26, P422, DOI 10.1016/j.tem.2015.05.010; Qian X, 2017, MOL CELL, V65, P917, DOI 10.1016/j.molcel.2017.01.027; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Remme CA, 2009, BASIC RES CARDIOL, V104, P511, DOI 10.1007/s00395-009-0012-8; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Shy D, 2013, BBA-MOL CELL RES, V1833, P886, DOI 10.1016/j.bbamcr.2012.10.026; Tang HX, 2017, MOL MED REP, V15, P3747, DOI 10.3892/mmr.2017.6424; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Valentim L, 2006, J MOL CELL CARDIOL, V40, P846, DOI 10.1016/j.yjmcc.2006.03.428; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Wang C, 2016, PHARMACOL RES, V105, P164, DOI 10.1016/j.phrs.2016.01.028; Wei X, 2016, J CARDIOVASC PHARM, V68, P269; WEISS J, 1985, J CLIN INVEST, V75, P436, DOI 10.1172/JCI111718; Xiao J, 2016, MOL MED, V22, P643, DOI 10.2119/molmed.2016.00034; Xie M, 2011, CURR OPIN CARDIOL, V26, P216, DOI 10.1097/HCO.0b013e328345980a	45	8	9	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5366	5376		10.1096/fj.201801583RR	http://dx.doi.org/10.1096/fj.201801583RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30759345	Bronze			2022-12-26	WOS:000462888500059
J	Monmai, C; You, S; Park, WJ				Monmai, Chaiwat; You, SangGuan; Park, Woo Jung			Immune-enhancing effects of anionic macromolecules extracted from Codium fragile on cyclophosphamide-treated mice	PLOS ONE			English	Article							NF-KAPPA-B; IMMUNOMODULATORY ACTIVITY; IN-VITRO; INDUCED IMMUNOSUPPRESSION; SULFATED POLYSACCHARIDES; BIOLOGICAL-ACTIVITIES; PROTECTS; ACTIVATION; EXPRESSION; ANTITUMOR	Immune-regulation and homeostasis are critical in cancer therapy and immunomodulatory biomaterials have been used to decrease side effects of immunosuppressant drugs. Anionic macromolecules (CFAMs) were isolated from the seaweed Codium fragile, and its immune-enhancing biological activities were examined in CY-induced immunosuppressed mice. CFAMs improved the splenic lymphocyte proliferation, NK cell activity, and spleen index. The expression of immune-associated genes was highly upregulated in splenic lymphocytes, and gene expression was differently regulated according to mitogens such as T-cell (Con A) and B-cell (LPS) mitogens. Additionally, CFAMs boosted the proliferation, NO production, and phagocytosis of peritoneal macrophages. CFAMs also considerably stimulated immune-associated gene expression in peritoneal macrophages. Moreover, our results showed CFAMs mediated its immune-enhancing effects via the MAPK pathway. These suggested CFAMs can be used as a potent immunomodulatory material under immune-suppressive condition. Furthermore, CFAMs may also be used as a bio-functional and pharmaceutical material for improving human health and immunity.	[Monmai, Chaiwat; You, SangGuan; Park, Woo Jung] Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Kangnung, Gangwon, South Korea	Kangnung Wonju National University	Park, WJ (corresponding author), Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Kangnung, Gangwon, South Korea.	pwj0505@gwnu.ac.kr		Monmai, Chaiwat/0000-0002-9267-3047	Marine Bio-Regional Specialization Leading Technology Development Program - Ministry of Oceans and Fisheries in Korea [D11413914H480000100]; University Emphasis Research Institute Support Program from the National Research Foundation of Korea [2018R1A6A1A03023584]	Marine Bio-Regional Specialization Leading Technology Development Program - Ministry of Oceans and Fisheries in Korea; University Emphasis Research Institute Support Program from the National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by the Marine Bio-Regional Specialization Leading Technology Development Program (D11413914H480000100) funded by the Ministry of Oceans and Fisheries in Korea. This research project also is supported by the University Emphasis Research Institute Support Program (2018R1A6A1A03023584) from the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAR HD, 1986, CANCER RES, V46, P1805; Bhattacharyya S, 2010, BLOOD, V115, P1921, DOI 10.1182/blood-2009-06-224782; Cao RA, 2017, INT J BIOL MACROMOL, V99, P539, DOI 10.1016/j.ijbiomac.2017.03.026; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen JR, 2010, FITOTERAPIA, V81, P1117, DOI 10.1016/j.fitote.2010.07.009; Chen XM, 2012, CARBOHYD POLYM, V90, P1114, DOI 10.1016/j.carbpol.2012.06.052; Cho CW, 2015, INT J BIOL MACROMOL, V72, P519, DOI 10.1016/j.ijbiomac.2014.09.010; Choi JH, 2013, BIOCHIMIE, V95, P1266, DOI 10.1016/j.biochi.2013.01.023; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Daien CI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00548; Iida Y, 2017, CANCER SCI, V108, P1974, DOI 10.1111/cas.13337; Jesenak M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070779; Kang CH, 2012, J MED FOOD, V15, P44, DOI 10.1089/jmf.2010.1540; Kim JK, 2011, INT J BIOL MACROMOL, V49, P1051, DOI 10.1016/j.ijbiomac.2011.08.032; Kim JB, 2007, BIOL PHARM BULL, V30, P2345, DOI 10.1248/bpb.30.2345; Lee EJ, 2004, INT IMMUNOPHARMACOL, V4, P235, DOI 10.1016/j.intimp.2003.12.007; Lee JB, 2010, CARBOHYD RES, V345, P1452, DOI 10.1016/j.carres.2010.02.026; Liu XH, 2017, CURR PHARM BIOTECHNO, V18, P1106, DOI 10.2174/1389201019666180226145427; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lori A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061216; Manosroi A, 2003, J ETHNOPHARMACOL, V89, P155, DOI 10.1016/S0378-8741(03)00278-2; MOSMANN TR, 1989, ADV IMMUNOL, V46, P111, DOI 10.1016/S0065-2776(08)60652-5; Narayanan BA, 2003, CANCER RES, V63, P972; Park HR, 2013, INT J MOL MED, V31, P361, DOI 10.3892/ijmm.2012.1224; Pass GJ, 2005, CANCER RES, V65, P4211, DOI 10.1158/0008-5472.CAN-04-4103; Patel S, 2017, INT J BIOL MACROMOL, V97, P331, DOI 10.1016/j.ijbiomac.2017.01.042; Prendergast GC, 2007, CANCER RES, V67, P3500, DOI 10.1158/0008-5472.CAN-06-4626; Quakyi EK, 1999, J INFECT DIS, V180, P747, DOI 10.1086/314927; Rahat MA, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00144; Raj S, 2015, FOOD CHEM TOXICOL, V81, P151, DOI 10.1016/j.fct.2015.04.026; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Ren Z, 2014, J ETHNOPHARMACOL, V155, P769, DOI 10.1016/j.jep.2014.06.021; Sarangi I, 2006, INT IMMUNOPHARMACOL, V6, P1287, DOI 10.1016/j.intimp.2006.04.002; Sevag MG, 1938, J BIOL CHEM, V124, P0425; SINGH KP, 1993, IMMUNOPHARM IMMUNOT, V15, P525, DOI 10.3109/08923979309019729; Sun YX, 2011, CARBOHYD POLYM, V85, P490, DOI 10.1016/j.carbpol.2011.03.033; Surayot U, 2017, INT J BIOL MACROMOL, V98, P117, DOI 10.1016/j.ijbiomac.2017.01.108; Tabarsa M, 2015, MAR BIOTECHNOL, V17, P266, DOI 10.1007/s10126-015-9615-2; Tabarsa M, 2013, INT J BIOL MACROMOL, V59, P1, DOI 10.1016/j.ijbiomac.2013.04.022; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tu J, 2008, J ETHNOPHARMACOL, V119, P266, DOI 10.1016/j.jep.2008.07.007; Tzianabos AO, 2000, CLIN MICROBIOL REV, V13, P523, DOI 10.1128/CMR.13.4.523-533.2000; Umesue M, 1996, TRANSPLANTATION, V61, P116, DOI 10.1097/00007890-199601150-00023; Walls J, 2016, SEMIN IMMUNOL, V28, P396, DOI 10.1016/j.smim.2016.09.001; Wang H, 2011, INT IMMUNOPHARMACOL, V11, P1946, DOI 10.1016/j.intimp.2011.06.006; Wang JX, 2012, J ETHNOPHARMACOL, V139, P788, DOI 10.1016/j.jep.2011.12.019; WEEKS BA, 1987, DEV COMP IMMUNOL, V11, P117, DOI 10.1016/0145-305X(87)90013-9; Yu ZD, 2016, CARBOHYD POLYM, V148, P318, DOI 10.1016/j.carbpol.2016.04.068; Zheng Y, 2017, INT J BIOL MACROMOL, V95, P1216, DOI 10.1016/j.ijbiomac.2016.11.013	50	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211570	10.1371/journal.pone.0211570	http://dx.doi.org/10.1371/journal.pone.0211570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779763	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900016
J	Afshar, B; Carless, J; Roche, A; Balasegaram, S; Anderson, C				Afshar, Baharak; Carless, Jacqueline; Roche, Anita; Balasegaram, Sooria; Anderson, Charlotte			Surveillance of tuberculosis (TB) cases attributable to relapse or reinfection in London, 2002-2015	PLOS ONE			English	Article								Recurrence of TB in an individual can occur due to relapse of the same strain or reinfection by a different strain. The contribution of reinfection and relapse to TB incidence, and the factors associated with each are unknown. We aimed to quantify and describe cases attributable to relapse or reinfection, and identify associated risk factors in order to reduce recurrence. We categorised recurrent TB cases from notifications in London (2002-2015) as relapse or reinfection using molecular (MIRU VNTR strain type) and epidemiological information (hierarchical approach using time since notification, site of disease and method of case finding). Factors associated with each outcome were determined using logistic regression in Stata Version 13.1 (2009-2015 only). Of 43,465 TB cases, 1.4% (618) were classified as relapse and 3.8% (1,637) as reinfection. The proportion with relapse decreased from 2002 (2.3%) to 2015 (1.3%), while the proportion of reinfection remained around 4%. Relapse was more common among recent migrants (<1 year, odds ratio (OR) = 1.99, p = 0.005), those with a social risk factor (OR = 1.51, p = 0.033) and those with central nervous system, spinal, miliary or disseminated TB (OR = 1.75, p = 0.001). Reinfection was more common among long term migrants (>11 years, OR = 1.67, p = <0.001), those with a social risk factor (OR = 1.96, p = <0.001) and within specific areas in London. Patients with social risk factors were at increased risk of both relapse and reinfection. Characterising those with relapsed disease highlights patients at risk and factors associated with reinfection suggest groups where transmission is occurring. This will inform TB control programs to target appropriate treatment and interventions in order to reduce the risk of recurrence.	[Afshar, Baharak; Carless, Jacqueline; Roche, Anita; Balasegaram, Sooria; Anderson, Charlotte] Publ Hlth England, Field Serv, Natl Infect Serv, London, England; [Afshar, Baharak] European Ctr Dis Prevent & Control ECDC, European Publ Hlth Microbiol Programme EUPHEM, Stockholm, Sweden	Public Health England; European Centre for Disease Prevention & Control	Anderson, C (corresponding author), Publ Hlth England, Field Serv, Natl Infect Serv, London, England.	charlotte.anderson@phe.gov.uk						[Anonymous], 2012, NICE PUBLIC HLTH GUI; [Anonymous], TUBERCULOSIS LONDON; de Vries G, 2014, EUROSURVEILLANCE, V6; Guerra-Assuncao JA, 2015, J INFECT DIS, V211, P1154, DOI 10.1093/infdis/jiu574; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Lee PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092623; Millet JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064898; Rosser A, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-017-2933-4; Schiroli C, 2015, INFECTION, V43, P647, DOI 10.1007/s15010-015-0759-9; WHO, 2016, GLOB TUB REP; Wyllie DH, 2018, EBIOMEDICINE, V34, P122, DOI 10.1016/j.ebiom.2018.07.019	11	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0211972	10.1371/journal.pone.0211972	http://dx.doi.org/10.1371/journal.pone.0211972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768624	Green Submitted, Green Published, gold			2022-12-26	WOS:000458766300018
J	Das, A; Pramanik, K; Sharma, R; Gantait, S; Banerjee, J				Das, Arpita; Pramanik, Krishnendu; Sharma, Rishu; Gantait, Saikat; Banerjee, Joydeep			In-silico study of biotic and abiotic stress-related transcription factor binding sites in the promoter regions of rice germin-like protein genes	PLOS ONE			English	Article							DISEASE RESISTANCE; SALT TOLERANCE; REGULATORY ELEMENTS; FUNCTIONAL-ANALYSIS; DROUGHT RESISTANCE; FREEZING TOLERANCE; MULTIGENE FAMILY; GRAIN-YIELD; EXPRESSION; DEFENSE	Germin-like proteins (GLPs) are involved in biotic and abiotic stress tolerance in different plant species. Rice (Oryza sativa L.) genome contains about 40 GLP family member proteins in nine chromosomes. Although some of the rice GLP (OsGLP) promoters have been studied through in silico analysis as well as experimentally, studies regarding the distribution pattern of the biotic and abiotic stress associated transcription factor binding sites (TFbs) in the promoter regions of OsGLP genes have not been attempted thoroughly. Several transcription factors (TFs) namely NAC, WRKY, bHLH, bZIP, MYB and AP2/ERF act as major TFs concerned with biotic as well as abiotic stress responses across various plant species. In the present study the in silico analysis was carried out using the 1.5 kilobases (kb) promoter regions from 40 different OsGLP genes for the presence of NAC, WRKY, bHLH, bZIP, MYB and AP2/ERF TFbs in it. Among various OsGLP gene promoters, OsGLP8-11 was found to contain highest number of tested TFbs in the promoter region whereas the promoter region of OsGLP5-1 depicted least amount of TFbs. Phylogenetic study of promoter regions of different OsGLP genes revealed four different clades. Our analyses could reveal the evolutionary significance of different OsGLP gene promoters. It can be presumed from the present findings as well as previous reports that OsGLP gene duplications and subsequent variations in the TFbs in OsGLP gene promoter regions might be the consequences of neofunctionalization of OsGLP genes and their promoters for biotic and abiotic stress tolerance in rice.	[Das, Arpita] Bidhan Chandra Krishi Viswavidyalaya, RRS Chakdah, Genet & Plant Breeding, Nadia, W Bengal, India; [Pramanik, Krishnendu] Bidhan Chandra Krishi Viswavidyalaya, Agr Biotechnol, Nadia, W Bengal, India; [Sharma, Rishu] Bidhan Chandra Krishi Viswavidyalaya, Plant Pathol, Nadia, W Bengal, India; [Gantait, Saikat] Bidhan Chandra Krishi Viswavidyalaya, Directorate Res, Crop Res Unit, Nadia, W Bengal, India; [Banerjee, Joydeep] Indian Inst Technol Kharagpur, Dept Agr & Food Engn, Paschim Medinipur, W Bengal, India	Bidhan Chandra Agricultural University; Bidhan Chandra Agricultural University; Bidhan Chandra Agricultural University; Bidhan Chandra Agricultural University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Banerjee, J (corresponding author), Indian Inst Technol Kharagpur, Dept Agr & Food Engn, Paschim Medinipur, W Bengal, India.	jbanerjeebiotech@gmail.com	Banerjee, Joydeep/AAF-2786-2020; Gantait, Saikat/L-7422-2016	Gantait, Saikat/0000-0001-5059-2428; Banerjee, Joydeep/0000-0003-3856-8876				Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Ali I, 2015, TURK J BOT, V39, P389, DOI 10.3906/bot-1405-48; Alves MS, 2014, PROTEOMES, V2, DOI 10.3390/proteomes2010085; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Banerjee J, 2017, PLANT CELL TISS ORG, V131, P127, DOI 10.1007/s11240-017-1270-z; Banerjee J, 2010, BIOCHEM BIOPH RES CO, V402, P637, DOI 10.1016/j.bbrc.2010.10.073; Banerjee J, 2010, BIOCHEM BIOPH RES CO, V394, P178, DOI 10.1016/j.bbrc.2010.02.142; Barman AR, 2015, FUNCT INTEGR GENOMIC, V15, P533, DOI 10.1007/s10142-015-0454-z; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Breen J, 2010, FUNCT INTEGR GENOMIC, V10, P463, DOI 10.1007/s10142-010-0184-1; Carrillo MGC, 2009, RICE, V2, P67, DOI 10.1007/s12284-009-9024-0; Chang AT, 2015, GENE DEV, V29, P603, DOI 10.1101/gad.242842.114; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Faktor O, 1997, PLANT SCI, V124, P175, DOI 10.1016/S0168-9452(97)04615-3; Fujita Yasunari, 2014, CLIMATE CHANGE PLANT, P521; Godfrey D, 2007, MOL PLANT MICROBE IN, V20, P1112, DOI 10.1094/MPMI-20-9-1112; Himmelbach A, 2010, PLANT CELL, V22, P937, DOI 10.1105/tpc.109.067934; Hosoda K, 2002, PLANT CELL, V14, P2015, DOI 10.1105/tpc.002733; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang XS, 2013, PLANT PHYSIOL, V162, P1178, DOI 10.1104/pp.112.210740; Ilyas M, 2016, ARCH BIOL SCI, V68, P863, DOI 10.2298/ABS151116076I; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Kankainen M, 2004, NUCLEIC ACIDS RES, V32, pW222, DOI 10.1093/nar/gkh463; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; KARATHANASIS SK, 1985, P NATL ACAD SCI USA, V82, P6374, DOI 10.1073/pnas.82.19.6374; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kugelberg E, 2010, GENETICS, V185, P65, DOI 10.1534/genetics.110.114074; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LANE BG, 1991, FASEB J, V5, P2893, DOI 10.1096/fasebj.5.14.1752357; Li L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101622; Li SJ, 2009, PLANT CELL REP, V28, P683, DOI 10.1007/s00299-008-0666-y; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Liu XQ, 2005, CELL RES, V15, P593, DOI 10.1038/sj.cr.7290329; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; Mahmood T, 2013, GENET MOL RES, V12, P360, DOI 10.4238/2013.February.7.6; Mahmood T, 2007, DNA SEQUENCE, V18, P26, DOI 10.1080/10425170600986688; Mahmood T, 2010, AFR J BIOTECHNOL, V9, P1871; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; Mathieu M, 2003, PHYSIOL PLANTARUM, V117, P425, DOI 10.1034/j.1399-3054.2003.00050.x; Munir F, 2016, FUNCT INTEGR GENOMIC, V16, P19, DOI 10.1007/s10142-015-0463-y; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Ogo Y, 2006, J EXP BOT, V57, P2867, DOI 10.1093/jxb/erl054; Ohta T, 2010, GENES-BASEL, V1, P349, DOI 10.3390/genes1030349; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Rahaie M., 2011, Iranian Journal of Crop Sciences, V13, P580; Redillas MCFR, 2012, PLANT BIOTECHNOL J, V10, P792, DOI 10.1111/j.1467-7652.2012.00697.x; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Sakamoto W, 2001, PLANT CELL PHYSIOL, V42, P982, DOI 10.1093/pcp/pce128; Saleh A., 2003, GENETIKA+, V35, P37, DOI DOI 10.2298/GENSR0301037S; Santino A, 2013, PLANT CELL REP, V32, P1085, DOI 10.1007/s00299-013-1441-2; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; TAYLOR KM, 1977, AM J MED GENET, V1, P3, DOI 10.1002/ajmg.1320010103; Tripathi P, 2014, PLANTA, V239, P255, DOI 10.1007/s00425-013-1985-y; Tsuda K, 2015, NEW PHYTOL, V206, P932, DOI 10.1111/nph.13286; Yang SJ, 2010, MOL PLANT, V3, P469, DOI 10.1093/mp/ssq016; Yasmin T, 2008, PAK J BOT, V40, P1627; Zhou ML, 2010, AFR J BIOTECHNOL, V9, P9255; Zhu Y, 2011, PLANT PHYSIOL, V155, P580, DOI 10.1104/pp.110.169466; Zimmermann G, 2006, PLANT PHYSIOL, V142, P181, DOI 10.1104/pp.106.083824	72	28	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0211887	10.1371/journal.pone.0211887	http://dx.doi.org/10.1371/journal.pone.0211887			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763346	Green Published, gold, Green Submitted			2022-12-26	WOS:000458763900027
J	Ndichu, ET; Ohiri, K; Sekoni, O; Makinde, O; Schulman, K				Ndichu, Elizabeth Thithi; Ohiri, Kelechi; Sekoni, Oluwafemi; Makinde, Olasunmbo; Schulman, Kevin			Evaluating the quality of antihypertensive drugs in Lagos State, Nigeria	PLOS ONE			English	Article							MEDICINES; PREVALENCE	Background As the burden of noncommunicable diseases grows, access to safe medical therapy is increasing in importance. The aim of this study was to develop a method for evaluating the quality of antihypertensive drugs and to examine whether this prevalence varies by socioeconomic variables. Methods We conducted a cross-sectional survey of registered pharmacies in 6 local government areas (LGAs) in Lagos State, Nigeria. In each LGA, we sampled 17 pharmacies from a list of all registered pharmacies derived from the Pharmacists Council of Nigeria. We assessed drug quality based on (1) the level of active pharmaceutical ingredients (APIs), which identified falsely labeled drug samples; and (2) the amount of impurities, which revealed substandard drug samples in accordance with the international pharmacopoeia guidelines. Good-quality drugs met specifications for both API and impurity. Results Of the 102 drug samples collected, 30 (29.3%) were falsely labeled, 76 (74.5%) were substandard,78 (76.5%) were of poor quality and 24 (23.5%) were of good quality. Among the falsely labeled drugs, 2 samples met standards set for purity while 28 did not. Among the 76 substandard drug samples, 28 were also falsely labeled. Of the falsely labeled drugs, 17 (56.7%) came from LGAs with low socioeconomic status, and 40 (52.6%) of the substandard drug samples came from LGAs with high socioeconomic status. Most of the good-quality drug samples, 14 (58.3%), were from LGAs with low socioeconomic status. Eighteen (60%) of the falsely labeled samples, 37 (48.7%) of the substandard samples, and 15 (62.5%) of the good-quality drug samples were from manufacturers based in Asia. The average price was 375.67 Nigerian naira (NGN) for falsely labeled drugs, 383.33 NGN for substandard drugs, and 375.67 NGN for good-quality drugs. The prevalence of falsely labeled and substandard drug samples did not differ by LGA-level socioeconomic status (P=.39) or region of manufacturer (P=.24); however, there was a trend for a difference by price (P=.06). Conclusion The prevalence of falsely labeled and substandard drug samples was high in Lagos. Treatment of noncommunicable diseases in this setting will require efforts to monitor and assure drug quality.	[Ndichu, Elizabeth Thithi] Duke Global Hlth Inst, Durham, NC USA; [Ohiri, Kelechi; Sekoni, Oluwafemi; Makinde, Olasunmbo] Hlth Strategy & Delivery Fdn, Lagos, Nigeria; [Schulman, Kevin] Stanford Univ, Dept Med, Clin Excellence Res Ctr, Stanford, CA 94305 USA	Duke University; Stanford University	Schulman, K (corresponding author), Stanford Univ, Dept Med, Clin Excellence Res Ctr, Stanford, CA 94305 USA.	KevinSchulman2018@gmail.com			Duke Global health Institute	Duke Global health Institute	This project was funded by the Duke Global health Institute (url:https://www.globalhealth.duke.edu). The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript.	Alfadl AA, 2013, RES SOC ADMIN PHARM, V9, P302, DOI 10.1016/j.sapharm.2012.05.002; [Anonymous], 2018, REV EXISTING EMERGIN; Antignac M, 2017, INT J CARDIOL, V243, P523, DOI 10.1016/j.ijcard.2017.04.099; Bate R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-157; Degardin K, 2014, J PHARMACEUT BIOMED, V87, P167, DOI 10.1016/j.jpba.2013.01.009; Delepierre A, 2012, MED MALADIES INFECT, V42, P247, DOI 10.1016/j.medmal.2012.04.007; El-Jardali F, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006290; Falase AO, 2015, NIGERIAN J CARDIOLOG, V12, P158, DOI [10.4103/0189-7969.161791, DOI 10.4103/0189-7969.161791]; Hollein L, 2016, TRAC-TREND ANAL CHEM, V76, P60, DOI 10.1016/j.trac.2015.11.009; International Workshop on Counterfeit Drugs, 1997, INT WORKSH COUNT DRU; Koczwara A, 2017, J PHARM SCI-US, V106, P2921, DOI 10.1016/j.xphs.2017.05.018; Nayyar GML, 2015, AM J TROP MED HYG, V92, P2, DOI 10.4269/ajtmh.15-0221; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; Nsimba SE, E AFR J PUBLIC HLTH, V5, P205; Redfern J, BMJ GLOB HLTH; Ryan Winters R., 2018, STAT BRIEF OVERVIEW; Sani M U, 2008, Niger J Med, V17, P270; United States Food and Drug Administration, COUNT MED; WHO, DEF SUBST FALS SF ME; WHO, SUBST FALS SF MED PR; WHO, SUBST SPUR FALS LAB; World Health Organization, WHO MED PROD AL BACK; Zou WB, 2018, J PHARMACEUT BIOMED, V147, P81, DOI 10.1016/j.jpba.2017.08.016	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211567	10.1371/journal.pone.0211567	http://dx.doi.org/10.1371/journal.pone.0211567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759124	Green Submitted, Green Published, gold			2022-12-26	WOS:000458761300051
J	Oniszczuk, T; Combrzynski, M; Matwijczuk, A; Oniszczuk, A; Gladyszewska, B; Podlesny, J; Czernel, G; Karcz, D; Niemczynowicz, A; Wojtowicz, A				Oniszczuk, Tomasz; Combrzynski, Maciej; Matwijczuk, Arkadiusz; Oniszczuk, Anna; Gladyszewska, Bozena; Podlesny, Janusz; Czernel, Grzegorz; Karcz, Dariusz; Niemczynowicz, Agnieszka; Wojtowicz, Agnieszka			Physical assessment, spectroscopic and chemometric analysis of starch-based foils with selected functional additives	PLOS ONE			English	Article							THERMOPLASTIC STARCH; MECHANICAL-PROPERTIES; MIXED PLASTICIZER; BLENDS; FIBERS; FILMS; FTIR; UREA	The paper presents the results of studies related to the impact of functional additives in the form of polylactide (PLA), polyvinyl alcohol (PVA), and keratin hydrolysate (K) on the physical characteristics of biopolymer foils. TPS granulate was obtained using a TS-45 single-screw extruder with LID = 16. Foil was produced with the use of an LID = 36 extruder with film-blowing section. The impact of the quantity and type of the functional additives on the processing efficiency and energy consumption of granulate extrusion, as well as the physical characteristics of the foil produced: thickness, basis weight, and colour were determined. By measuring the FTIR spectra it was determined the type and origin of the respective functional groups. It was observed that foils produced from granulates with the addition of 3% PVA were characterised by the lowest thickness and basis weight. Addition of 2 and 3% of PLA increased thickness and basis weight of starch-based foils significantly. Increasing the content of keratin in SG/K samples resulted in a decrease of brightness and intensify the yellow tint of foils, especially when 2 and 3% of keratin was used. In terms of the other samples, it was observed that the colour remained almost unchanged irrespective of the percentage content of the additive used. Infrared analyses conducted on foil containing PVA, PLA, and K revealed a change in spectra intensity in the frequency range associated with OH groups originating from the forming free, intra- and intermolecular hydrogen bonds. Based on an analysis of the respective bands within the IR range it was also concluded that considerable structural changes took place with respect to the glycosidic bonds of starch itself. The application of the mentioned additives had a significant structural impact on the produced starch-based foils. Furthermore, the conducted UV-Vis analyses revealed a substantial increase in absorbance and a related reduction of the permeability (colour change) of the obtained materials in the range of ultraviolet and visible light.	[Oniszczuk, Tomasz; Combrzynski, Maciej; Wojtowicz, Agnieszka] Univ Life Sci Lublin, Dept Thermal Technol & Food Proc Engn, Lublin, Poland; [Matwijczuk, Arkadiusz; Gladyszewska, Bozena; Czernel, Grzegorz] Univ Life Sci Lublin, Dept Phys, Lublin, Poland; [Oniszczuk, Anna] Med Univ Lublin, Dept Inorgan Chem, Lublin, Poland; [Podlesny, Janusz] Inst Soil Sci & Plant Cultivat State Res Inst, Pulawy, Poland; [Karcz, Dariusz] Cracow Univ Technol, Fac Chem Engn & Technol, Dept Analyt Chem, Krakow, Poland; [Niemczynowicz, Agnieszka] Univ Warmia & Mazury, Fac Math & Comp Sci, Dept Anal & Differential Equat, Olsztyn, Poland	University of Life Sciences in Lublin; University of Life Sciences in Lublin; Medical University of Lublin; Institute of Soil Science & Plant Cultivation; Cracow University of Technology; University of Warmia & Mazury	Combrzynski, M (corresponding author), Univ Life Sci Lublin, Dept Thermal Technol & Food Proc Engn, Lublin, Poland.; Matwijczuk, A (corresponding author), Univ Life Sci Lublin, Dept Phys, Lublin, Poland.	maciej.combrzynski@up.lublin.pl; arkadiusz.matwijczuk@up.lublin.pl	Czernel, Grzegorz/U-3472-2018; Niemczynowicz, Agnieszka/W-4957-2017; Wójtowicz, Agnieszka/V-4525-2018; Czernel, Grzegorz/AAO-3004-2020; Matwijczuk, Arkadiusz/AAU-8881-2021; Gładyszewska, Bożena/T-2830-2019; Niemczynowicz, Agnieszka/K-3481-2019; Combrzynski, Maciej/V-5893-2018; Oniszczuk, Tomasz/Z-1941-2018; Oniszczuk, Anna/A-2397-2019	Czernel, Grzegorz/0000-0002-2094-4039; Niemczynowicz, Agnieszka/0000-0002-4370-3326; Wójtowicz, Agnieszka/0000-0001-5981-6109; Matwijczuk, Arkadiusz/0000-0003-2630-120X; Gładyszewska, Bożena/0000-0002-8473-1403; Niemczynowicz, Agnieszka/0000-0002-4370-3326; Combrzynski, Maciej/0000-0001-7161-9589; Oniszczuk, Tomasz/0000-0002-1061-6541; Karcz, Dariusz/0000-0002-9848-2508; PODLESNY, JANUSZ/0000-0001-6757-8331; Oniszczuk, Anna/0000-0002-5109-3302				Carvalho AJF, 2003, CARBOHYD POLYM, V53, P95, DOI 10.1016/S0144-8617(03)00005-5; Chen Y, 2008, CARBOHYD POLYM, V73, P8, DOI 10.1016/j.carbpol.2007.10.015; Chocyk D, 2015, INT AGROPHYS, V29, P267, DOI 10.1515/intag-2015-0031; Combrzynski M, 2018, PRZEM CHEM, V97, P682, DOI 10.15199/62.2018.5.4; Cyras VP, 2008, CARBOHYD POLYM, V73, P55, DOI 10.1016/j.carbpol.2007.11.014; Elizondo NJ, 2009, CARBOHYD POLYM, V75, P592, DOI 10.1016/j.carbpol.2008.08.020; Fan MC, 2017, FOOD CHEM, V218, P221, DOI 10.1016/j.foodchem.2016.09.068; Follain N, 2005, CARBOHYD POLYM, V60, P185, DOI 10.1016/j.carbpol.2004.12.003; Gaurav S, 2003, DIGITAL COLOR IMAGIN, DOI [10.1016/J.CARBPOL.2007.10.015, DOI 10.1016/J.CARBPOL.2007.10.015]; GOHEEN SM, 1991, J APPL POLYM SCI, V42, P2691, DOI 10.1002/app.1991.070421007; Hoyos-Leyva JD, 2017, LWT-FOOD SCI TECHNOL, V83, P150, DOI 10.1016/j.lwt.2017.05.019; Huang MF, 2004, POLYMER, V45, P7017, DOI 10.1016/j.polymer.2004.07.068; Jaiswal P, 2015, INT J BIOL MACROMOL, V79, P256, DOI 10.1016/j.ijbiomac.2015.04.050; Kapanen A, 2008, J POLYM ENVIRON, V16, P109, DOI 10.1007/s10924-008-0091-x; Kaushik A, 2010, CARBOHYD POLYM, V82, P337, DOI 10.1016/j.carbpol.2010.04.063; Khanoonkon N, 2016, EUR POLYM J, V76, P266, DOI 10.1016/j.eurpolymj.2016.02.001; Kizil R, 2002, J AGR FOOD CHEM, V50, P3912, DOI 10.1021/jf011652p; La Mantia FP, 2011, COMPOS PART A-APPL S, V42, P579, DOI 10.1016/j.compositesa.2011.01.017; Lancuski A, 2017, CARBOHYD POLYM, V158, P68, DOI 10.1016/j.carbpol.2016.12.003; Li JW, 2013, STARCH-STARKE, V65, P831, DOI 10.1002/star.201200260; Liu P, 2011, CARBOHYD POLYM, V85, P180, DOI 10.1016/j.carbpol.2011.02.006; Ma XF, 2006, CARBOHYD POLYM, V64, P267, DOI 10.1016/j.carbpol.2005.11.042; Ma XF, 2004, POLYM INT, V53, P1780, DOI 10.1002/pi.1580; Mano JF, 2003, J MATER SCI-MATER M, V14, P127, DOI 10.1023/A:1022015712170; Matysiak A., 2018, Agricultural Engineering, V22, P49, DOI 10.1515/agriceng-2018-0015; Moscicki L, 2012, FOOD RES INT, V47, P291, DOI 10.1016/j.foodres.2011.07.017; Muszynski S, 2017, PRZEM CHEM, V96, P891, DOI 10.15199/62.2017.4.32; Oniszczuk T, 2014, ZESZYTY PROBLEMOWE P, V578, P89; Oniszczuk T, 2016, INT AGROPHYS, V30, P211, DOI 10.1515/intag-2015-0080; Oniszczuk T, 2015, PRZEM CHEM, V94, P1748; Oniszczuk T, 2013, PRZEM CHEM, V92, P265; Pandey JK, 2005, POLYM DEGRAD STABIL, V88, P234, DOI 10.1016/j.polymdegradstab.2004.09.013; Raquez JM, 2008, CARBOHYD POLYM, V74, P159, DOI 10.1016/j.carbpol.2008.01.027; Rejak A., 2012, TEKA KOMISJI MOTORYZ, V12, P219; Rubens P, 1999, CARBOHYD POLYM, V39, P231, DOI 10.1016/S0144-8617(99)00005-3; Shi R, 2007, CARBOHYD POLYM, V69, P748, DOI 10.1016/j.carbpol.2007.02.010; Sreedhar B, 2005, J APPL POLYM SCI, V96, P1313, DOI 10.1002/app.21439; Swanson C. L., 1993, J ENVIRON POLYM DEGR, V1, P155; Wang SJ, 2005, POLYM DEGRAD STABIL, V87, P395, DOI 10.1016/j.polymdegradstab.2004.08.012; Wojtowicz A, 2017, J FOOD SCI TECH MYS, V54, P3218, DOI 10.1007/s13197-017-2765-7; Zhang YR, 2013, CARBOHYD POLYM, V96, P358, DOI 10.1016/j.carbpol.2013.03.093; Zhang YR, 2009, CARBOHYD POLYM, V78, P157, DOI 10.1016/j.carbpol.2009.04.023; Zullo R, 2009, CARBOHYD POLYM, V77, P376, DOI 10.1016/j.carbpol.2009.01.007	43	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0212070	10.1371/journal.pone.0212070	http://dx.doi.org/10.1371/journal.pone.0212070			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759170	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300073
J	de Azevedo, KRV; Lopes, CB; Andrade, RHTLR; da Costa, FFNP; Goncalves, LS; dos Santos, RM; Alves, FRF				Vaz de Azevedo, Katia R.; Lopes, Cristiane B.; Andrade, Rosana H. T. L. R.; Pacheco da Costa, Fernanda F. N.; Goncalves, Lucio S.; dos Santos, Rachel Medeiros; Alves, Flavio R. F.			C-shaped canals in first and second mandibular molars from Brazilian individuals: A prevalence study using cone-beam computed tomography	PLOS ONE			English	Article							ROOT CANALS; MORPHOLOGY; POPULATION; 2ND-MOLARS; MAXILLARY; FEATURES; SYSTEM; IDENTIFICATION; SUBPOPULATION; CONFIGURATION	Introduction The study aimed to evaluate, through in vivo tomographic analysis, the prevalence of C-shaped canals in mandibular first and second molars of Brazilian individuals, analyzing its frequency by thirds of the roots, and in contralateral teeth. Methods Images of 801 mandibular molars (379 first molars and 422 second molars) from 334 Brazilian individuals (142 men and 192 women) were identified through 1544 cone beam computed tomography (CBCT) exams, obtained from a private oral radiologic clinic. The cross-sectional configurations were analyzed to determine the frequency of C-shaped canals at three different axial levels and classified in categories by three experienced endodontists independently. Results The incidence of C-shaped canals was 181 (23%). Considering the type of tooth, 91 (24.01%) were identified in the first molars, and 90 (21.32%) were found in the second molars. The incidence was significantly higher in female individuals (P < 0.05) for both first and second molars. The most common C-shaped canal configurations were: C1 (89.01% for first molars and 90% second molars), followed by C2 (8.79% for first molars and 6.66% for second molars) and C4 (2.19% for the first molars and 3.33% for the second molars). Bilateral C-shaped canals were significantly higher than unilateral for both first and second molars (P < 0.01). Conclusions The prevalence of C-shaped canals in mandibular molars of the Brazilian individuals was higher than previously reported for both mandibular first (24.01%) and second molars (21.32%). The incidence was significantly higher in female individuals and the coronal portion of the roots. The classic C-shaped format "C1" was the most frequent anatomical configuration. Furthermore, the prevalence of bilateral C-shaped canals was higher for the first molar (61.70%) and lower for the second molar (38.29%).	[Vaz de Azevedo, Katia R.; Lopes, Cristiane B.; Andrade, Rosana H. T. L. R.; Pacheco da Costa, Fernanda F. N.; Goncalves, Lucio S.; Alves, Flavio R. F.] Estacio de Sa Univ, Fac Dent, Dept Endodont, Rio De Janeiro, RJ, Brazil; [dos Santos, Rachel Medeiros] Private Oral Radiol Clin, Rio De Janeiro, RJ, Brazil		Alves, FRF (corresponding author), Estacio de Sa Univ, Fac Dent, Dept Endodont, Rio De Janeiro, RJ, Brazil.	flavioferreiraalves@gmail.com	Gonçalves, Lucio Souza/E-4552-2014	Gonçalves, Lucio Souza/0000-0002-4388-6310; Alves, Flavio/0000-0002-9922-8202	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazilian Governmental Institution	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazilian Governmental Institution(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazilian Governmental Institution. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qudah AA, 2009, INT ENDOD J, V42, P775, DOI 10.1111/j.1365-2591.2009.01578.x; Amoroso-Silva PA, 2015, J ENDODONT, V41, P890, DOI 10.1016/j.joen.2015.01.021; Buhrley LJ, 2002, J ENDODONT, V28, P324, DOI 10.1097/00004770-200204000-00016; Chai WL, 2004, J ENDODONT, V30, P509, DOI 10.1097/00004770-200407000-00012; Choi MR, 2015, IMAGNG SCI DENT, V45, P221, DOI 10.5624/isd.2015.45.4.221; Cleghorn BM, 2008, INT ENDOD J, V41, P1005, DOI 10.1111/j.1365-2591.2008.01451.x; COOKE HG, 1979, J AM DENT ASSOC, V99, P836, DOI 10.14219/jada.archive.1979.0402; Fan B, 2004, J ENDODONT, V30, P904, DOI 10.1097/01.don.0000136206.73115.93; Fan W, 2008, J ENDODONT, V34, P1187, DOI 10.1016/j.joen.2008.06.013; Fan W, 2007, J ENDODONT, V33, P806, DOI 10.1016/j.joen.2007.04.007; Farman AG, 2005, ORAL SURG ORAL MED O, V100, P395, DOI 10.1016/j.tripleo.2005.05.055; Fayad MI, 2015, OR SURG OR MED OR PA, V120, P508, DOI 10.1016/j.oooo.2015.07.033; Haddad GY, 1999, J ENDODONT, V25, P268, DOI 10.1016/S0099-2399(99)80157-5; Helvacioglu-Yigit D, 2013, INT ENDOD J, V46, P1032, DOI 10.1111/iej.12094; Jerome Charles E., 1994, General Dentistry, V42, P424; Jin GC, 2006, J ENDODONT, V32, P10, DOI 10.1016/j.joen.2005.10.007; Kato A, 2014, INT ENDOD J, V47, P1012, DOI 10.1111/iej.12256; Khalighinejad N, 2017, J ENDODONT, V43, P728, DOI 10.1016/j.joen.2017.01.015; Kim SY, 2016, INT ENDOD J, V49, P136, DOI 10.1111/iej.12437; Lyroudia K, 1997, J ENDODONT, V23, P101, DOI 10.1016/S0099-2399(97)80254-3; MANNING SA, 1990, INT ENDOD J, V23, P40, DOI 10.1111/j.1365-2591.1990.tb00801.x; Martins JNR, 2016, J ENDODONT, V42, P383, DOI 10.1016/j.joen.2015.12.013; Silva EJNL, 2013, J ENDODONT, V39, P849, DOI 10.1016/j.joen.2013.04.030; Peiris HRD, 2008, INT ENDOD J, V41, P828, DOI 10.1111/j.1365-2591.2008.01428.x; Portoles CA, 2015, J ENDODONT, V41, P1903, DOI 10.1016/j.joen.2015.08.001; Seo MS, 2004, INT ENDOD J, V37, P139, DOI 10.1111/j.0143-2885.2004.00772.x; Shemesh A, 2017, CLIN ORAL INVEST, V21, P2039, DOI 10.1007/s00784-016-1993-y; Sidow SJ, 2000, J ENDODONT, V26, P675, DOI 10.1097/00004770-200011000-00011; Ladeira DBS, 2014, BRAZ ORAL RES, V28, P39, DOI 10.1590/S1806-83242013005000027; Solomonov M, 2012, J ENDODONT, V38, P209, DOI 10.1016/j.joen.2011.10.022; Torres A, 2015, IMAGNG SCI DENT, V45, P95, DOI 10.5624/isd.2015.45.2.95	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211948	10.1371/journal.pone.0211948	http://dx.doi.org/10.1371/journal.pone.0211948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759126	Green Published, Green Submitted, gold			2022-12-26	WOS:000458761300063
J	Elmarakby, A; Faulkner, J; Pati, P; Rudic, RD; Bergson, C				Elmarakby, Ahmed; Faulkner, Jessica; Pati, Paramita; Rudic, R. Dan; Bergson, Clare			Increased arterial pressure in mice with overexpression of the ADHD candidate gene calcyon in forebrain	PLOS ONE			English	Article							OXIDATIVE STRESS; EPOXYEICOSATRIENOIC ACIDS; RENAL DENERVATION; UP-REGULATION; RAT MODELS; HYPERTENSION; ANGIOTENSIN; EXPRESSION; HYPERACTIVITY; NATRIURESIS	The link between blood pressure (BP) and cerebral function is well established. However, it is not clear whether a common mechanism could underlie the relationship between elevated BP and cognitive deficits. The expression of calcyon, a gene abundant in catecholaminergic and hypothalamic nuclei along with other forebrain regions, is increased in the brain of the spontaneously hypertensive rat (SHR) which is a widely accepted animal model of essential hypertension and attention deficit hyperactivity disorder (ADHD). Previous studies demonstrated that mice with up-regulation of calcyon in forebrain (CalOE) exhibit deficits in working memory. To date, there is no evidence directly connecting calcyon to BP regulation. Here, we investigated whether forebrain up-regulation of calcyon alters BP using radiotelemetry. We found that CalOE mice exhibited higher mean arterial pressure (MAP) compared to tTA controls. Plasma norepinephrine levels were significantly higher in CalOE mice compared to tTA controls. Silencing the transgene with doxycycline normalized BP in CalOE mice, whereas challenging the mice with 4% high salt diet for 12 days exacerbated the MAP differences between CalOE and tTA mice. High salt diet challenge also increased proteinuria and urinary thiobarbituric acid reactive substances (TBARs) in tTA and CalOE; and the increases were more prominent in CalOE mice. Taken together, our data suggest that upregulation of calcyon in forebrain could increase BP via alterations in noradrenergic transmission and increased oxidative stress during high salt challenge. Overall, this study reveals that calcyon could be a novel neural regulator of BP raising the possibility that it could play a role in the development of vascular abnormalities.	[Elmarakby, Ahmed; Faulkner, Jessica] Augusta Univ, Dept Oral Biol & Diagnost Sci, Augusta, GA 30912 USA; [Elmarakby, Ahmed; Pati, Paramita; Rudic, R. Dan; Bergson, Clare] Augusta Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Elmarakby, A (corresponding author), Augusta Univ, Dept Oral Biol & Diagnost Sci, Augusta, GA 30912 USA.; Elmarakby, A (corresponding author), Augusta Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	aelmarakby@augusta.edu	Elmarakby, Ahmed/ABF-5055-2021; Rudic, Dan/B-3432-2016	Rudic, Dan/0000-0001-9122-3127	Augusta University Pilot Study Research Program Award; NIH [R21MH109280]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL136191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH109280] Funding Source: NIH RePORTER	Augusta University Pilot Study Research Program Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	These studies were supported by intramural grant award from Augusta University Pilot Study Research Program Award (PSRP) to A. Elmarakby and C. Bergson and an extramural NIH R21MH109280 award to C. Bergson.	Adams HR, 2010, PEDIATRICS, V126, pE1425, DOI 10.1542/peds.2010-1899; Armando I, 2015, CURR HYPERTENS REV, V11, P49, DOI 10.2174/1573402111999150521102331; Capdevila JH, 2014, J BIOL CHEM, V289, P4377, DOI 10.1074/jbc.M113.508416; Chao YM, 2013, HYPERTENSION, V61, P1270, DOI 10.1161/HYPERTENSIONAHA.111.00469; Chen WS, 2014, CELL PHYSIOL BIOCHEM, V33, P1663, DOI 10.1159/000362950; Combe R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153472; DasBanerjee T, 2008, AM J MED GENET B, V147B, P1554, DOI 10.1002/ajmg.b.30877; de Cavanagh EMV, 2010, AM J HYPERTENS, V23, P1318, DOI 10.1038/ajh.2010.167; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Elmarakby AA, 2006, HYPERTENSION, V47, P557, DOI 10.1161/01.HYP.0000198545.01860.90; Elmarakby AA, 2007, HYPERTENSION, V50, P1069, DOI 10.1161/HYPERTENSIONAHA.107.098806; GOLDSTEIN DS, 1983, HYPERTENSION, V5, P86, DOI 10.1161/01.HYP.5.1.86; GOLDSTEIN DS, 1983, HYPERTENSION, V5, P552, DOI 10.1161/01.HYP.5.4.552; Grassi G, 2010, AM J HYPERTENS, V23, P1052, DOI 10.1038/ajh.2010.154; GREENBERG S, 1994, J HYPERTENS, V12, P1359; Grisaru S, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/419208; Heijtz RD, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-33; Hyndman KA, 2013, HYPERTENSION, V62, P91, DOI 10.1161/HYPERTENSIONAHA.113.01291; Iadecola C, 2016, HYPERTENSION, V68, pE67, DOI 10.1161/HYP.0000000000000053; Imig JD, 2015, HYPERTENSION, V65, P476, DOI 10.1161/HYPERTENSIONAHA.114.03585; Imig JD, 2013, PROSTAG OTH LIPID M, V104, P2, DOI 10.1016/j.prostaglandins.2013.01.002; Jiang HL, 2011, AM J PHYSIOL-HEART C, V300, pH1990, DOI 10.1152/ajpheart.01267.2010; Katayama T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000197; Kawarazaki H, 2011, AM J PHYSIOL-RENAL, V300, pF1402, DOI 10.1152/ajprenal.00691.2010; Kolar Dusan, 2008, Neuropsychiatr Dis Treat, V4, P107; Koroshi A, 2007, Hippokratia, V11, P105; Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39; KUBOTA J, 1993, JPN CIRC J, V57, P1097, DOI 10.1253/jcj.57.1097; Lara LS, 2012, AM J PHYSIOL-RENAL, V302, pF85, DOI 10.1152/ajprenal.00351.2011; Laurin N, 2005, MOL PSYCHIATR, V10, P1117, DOI 10.1038/sj.mp.4001737; Leib DE, 2017, NEURON, V96, P1272, DOI 10.1016/j.neuron.2017.11.041; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Loria AS, 2013, AM J PHYSIOL-RENAL, V305, pF390, DOI 10.1152/ajprenal.00008.2013; Manolis AJ, 2014, CURR VASC PHARMACOL, V12, P4; Maranon RO, 2014, AM J PHYSIOL-REG I, V306, pR248, DOI 10.1152/ajpregu.00490.2013; Meneses A, 2011, REV NEUROSCIENCE, V22, P365, DOI 10.1515/RNS.2011.024; Muthusamy N, 2015, J NEUROCHEM, V132, P20, DOI 10.1111/jnc.12989; Oakman SA, 2004, J COMP NEUROL, V468, P264, DOI 10.1002/cne.10993; Odeh F, 2011, NEUROIMAGE, V54, P2603, DOI 10.1016/j.neuroimage.2010.11.032; OPARIL S, 1986, KIDNEY INT, V30, P437, DOI 10.1038/ki.1986.204; Persu A, 2013, J HUM HYPERTENS, DOI [10.1038/jhh.2013.88jhh201388, DOI 10.1038/JHH.2013.88JHH201388]; Pinto YM, 1998, CARDIOVASC RES, V39, P77, DOI 10.1016/S0008-6363(98)00077-7; Russell VA, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-9; Schlaich MP, 2012, CURR HYPERTENS REP, V14, P247, DOI 10.1007/s11906-012-0264-9; Schlaich MP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00010; Shi L, 2018, MOL BIOL CELL, V29, P2055, DOI 10.1091/mbc.E18-01-0007; Susic D, 2011, J HYPERTENS, V29, P716, DOI 10.1097/HJH.0b013e3283440683; Tadic M, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0386-0; Tian N, 2007, AM J PHYSIOL-HEART C, V293, pH3388, DOI 10.1152/ajpheart.00981.2007; Trantham-Davidson H, 2008, BEHAV BRAIN RES, V189, P244, DOI 10.1016/j.bbr.2007.12.031; Vazdarjanova A, 2011, MOL PSYCHIATR, V16, P672, DOI 10.1038/mp.2011.14; Vitiello B, 2008, CHILD ADOL PSYCH CL, V17, P459, DOI 10.1016/j.chc.2007.11.010; Wilens TE, 2010, POSTGRAD MED, V122, P97, DOI 10.3810/pgm.2010.09.2206; Williams JM, 2010, J CARDIOVASC PHARM, V56, P336, DOI 10.1097/FJC.0b013e3181f04b1c; Xiao JP, 2006, J BIOL CHEM, V281, P15182, DOI 10.1074/jbc.M600265200; YOSHIDA M, 1991, AM J PHYSIOL, V260, pF81, DOI 10.1152/ajprenal.1991.260.1.F81; Zelenin S, 2002, J COMP NEUROL, V446, P37, DOI 10.1002/cne.10198; Zhao XY, 2003, HYPERTENSION, V42, P775, DOI [10.1161/01.HYP.0000085649.28268.DF, 10.1161/01.HYP.000008549.28268.DF]; Zhao XY, 2003, HYPERTENSION, V41, P709, DOI 10.1161/01.HYP.0000047877.36743.FA	59	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211903	10.1371/journal.pone.0211903	http://dx.doi.org/10.1371/journal.pone.0211903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753204	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600030
J	Lai, CC; Huang, PH; Wang, FN; Shen, SH; Wang, HK; Liu, HT; Chung, HJ; Lin, TP; Chang, YH; Pan, CC; Peng, SL				Lai, Chih-Ching; Huang, Pin-Hsun; Wang, Fu-Nien; Shen, Shu-Huei; Wang, Hsin-Kai; Liu, Hsian-Tzu; Chung, Hsiao-Jen; Lin, Tzu-Ping; Chang, Yen-Hwa; Pan, Chin-Chen; Peng, Shin-Lei			Histogram analysis of prostate cancer on dynamic contrast-enhanced magnetic resonance imaging: A preliminary study emphasizing on zonal difference	PLOS ONE			English	Article							COMPUTER-AIDED DIAGNOSIS; NORMAL PERIPHERAL ZONE; QUANTITATIVE-ANALYSIS; MULTIPARAMETRIC MRI; TISSUE; AGGRESSIVENESS; HETEROGENEITY; SPECTROSCOPY	Background This study evaluated the performance of histogram analysis in the time course of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for differentiating cancerous tissues from benign tissues in the prostate. Methods We retrospectively analyzed the histograms of DCE-MRI of 30 patients. Histograms within regions of interest(ROI) in the peripheral zone (PZ) and transitional zone (TZ) were separately analyzed. The maximum difference wash-in slope (MWS) and delay phase slope (DPS) were defined for each voxel. Differences in histogram parameters, namely the mean, standard deviation (SD), the coefficient of variation (CV), kurtosis, skewness, interquartile range (IQR), percentile (P10, P25, P75, P90, and P90P10), Range, and modified full width at half-maximum (mFWHM) between cancerous and benign tissues were assessed. Results In the TZ, CV for ROIs of 7.5 and 10mm was the only significantly different parameter of the MWS (P = 0.034 and P = 0.004, respectively), whereas many parameters of the DPS (mean, skewness, P10, P25, P50, P75 and P90) differed significantly (P = < 0.001-0.016 and area under the curve [AUC] = 0.73-0.822). In the PZ, all parameters of the MWS exhibited significant differences, except kurtosis and skewness in the ROI of 7.5mm(P = < 0.001-0.017 and AUC = 0.865-0.898). SD, IQR, mFWHM, P90P10 and Range were also significant differences in the DPS (P = 0.001-0.035). Conclusion The histogram analysis of DCE-MRI is a potentially useful approach for differentiating prostate cancer from normal tissues. Different histogram parameters of the MWS and DPS should be applied in the TZ and PZ.	[Lai, Chih-Ching; Huang, Pin-Hsun; Wang, Fu-Nien] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Shen, Shu-Huei; Wang, Hsin-Kai; Liu, Hsian-Tzu] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Shen, Shu-Huei; Wang, Hsin-Kai; Liu, Hsian-Tzu; Chung, Hsiao-Jen; Lin, Tzu-Ping; Chang, Yen-Hwa; Pan, Chin-Chen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chung, Hsiao-Jen; Lin, Tzu-Ping; Chang, Yen-Hwa] Taipei Vet Gen Hosp, Dept Urol, Taipei, Taiwan; [Pan, Chin-Chen] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan; [Peng, Shin-Lei] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan	National Tsing Hua University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; China Medical University Taiwan	Shen, SH (corresponding author), Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.; Shen, SH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	shshen@vghtpe.gov.tw		Shen, Shu-Huei/0000-0002-2776-4671	Taiwan Ministry of Science and Technology [104-2314-B-075-052, 106-2314-B-075-012]; Taipei Veterans General Hospital [V107D31-001-MY3-2]	Taiwan Ministry of Science and Technology; Taipei Veterans General Hospital(Taipei Veterans General Hospital)	The project was supported by research grant of Taiwan Ministry of Science and Technology (104-2314-B-075-052, 106-2314-B-075-012) and research grant of Taipei Veterans General Hospital (V107D31-001-MY3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Radiology, 2015, PI RADS V2; Chen YJ, 2012, J MAGN RESON IMAGING, V36, P912, DOI 10.1002/jmri.23723; Engelbrecht MR, 2003, RADIOLOGY, V229, P248, DOI 10.1148/radiol.2291020200; Fan XB, 2004, MAGNET RESON MED, V51, P487, DOI 10.1002/mrm.10737; Fusco R, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0168-z; Fusco R, 2016, MAGN RESON IMAGING, V34, P839, DOI 10.1016/j.mri.2016.04.001; Hambrock T, 2013, RADIOLOGY, V266, P521, DOI 10.1148/radiol.12111634; Isebaert S, 2012, EUR J RADIOL, V81, pE217, DOI 10.1016/j.ejrad.2011.01.107; Jackson A, 2007, CLIN CANCER RES, V13, P3449, DOI 10.1158/1078-0432.CCR-07-0238; Just N, 2014, BRIT J CANCER, V111, P2205, DOI 10.1038/bjc.2014.512; Kim JY, 2014, RADIOLOGY, V271, P435, DOI 10.1148/radiol.13130801; Noworolski SM, 2005, MAGN RESON MED, V53, P249, DOI 10.1002/mrm.20374; Padhani AR, 2000, CLIN RADIOL, V55, P99, DOI 10.1053/crad.1999.0327; Peng SL, 2013, NMR BIOMED, V26, P443, DOI 10.1002/nbm.2882; Peng YH, 2013, RADIOLOGY, V267, P787, DOI 10.1148/radiol.13121454; Perdona S, 2013, UROL ONCOL-SEMIN ORI, V31, P761, DOI 10.1016/j.urolonc.2011.07.010; Petrillo A, 2014, J MAGN RESON IMAGING, V39, P1206, DOI 10.1002/jmri.24269; Preziosi P, 2003, EUR RADIOL, V13, P925, DOI 10.1007/s00330-002-1703-9; Rouviere O, 2003, EUR RADIOL, V13, P931, DOI 10.1007/s00330-002-1617-6; Siegel RL, 2015, CA-CANCER J CLIN, V65, P457, DOI 10.3322/caac.21314; Turkbey B, 2010, RADIOLOGY, V255, P89, DOI 10.1148/radiol.09090475; van Niekerk CG, 2013, PROSTATE, V73, P467, DOI 10.1002/pros.22588; Vos EK, 2013, EUR UROL, V64, P448, DOI 10.1016/j.eururo.2013.05.045; Yang XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/732848; Zelhof B, 2009, BJU INT, V104, P621, DOI 10.1111/j.1464-410X.2009.08457.x	25	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212092	10.1371/journal.pone.0212092	http://dx.doi.org/10.1371/journal.pone.0212092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753222	gold, Green Submitted, Green Published			2022-12-26	WOS:000458395600042
J	Escasa, SR; Harrison, RL; Mowery, JD; Bauchan, GR; Cory, JS				Escasa, Shannon R.; Harrison, Robert L.; Mowery, Joseph D.; Bauchan, Gary R.; Cory, Jenny S.			The complete genome sequence of an alphabaculovirus from Spodoptera exempta, an agricultural pest of major economic significance in Africa	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; PHYLOGENETIC ANALYSIS; DNA; IDENTIFICATION; BACULOVIRUSES; VARIANTS; ARMYWORM; EXIGUA; TRANSCRIPTION; TRANSMISSION	Spodoptera exempta nucleopolyhedrovirus (SpexNPV) is a viral pathogen of the African armyworm, Spodoptera exempta (Lepidoptera: Noctuidae), a significant agricultural pest of cereal crops in Africa. SpexNPV has been evaluated as a potential insecticide for control of this pest and has served as the subject of research on baculovirus pathology and transmission. Occlusion bodies (OBs) of SpexNPV isolate 244.1 were examined, and the nucleotide sequence of the genome was determined and characterized. SpexNPV-244.1 OBs consisted of irregular polyhedra with a size and appearance typical for alphabaculoviruses. Virions within the polyhedra contained 1-8 nucleocapsids per unit envelope. The SpexNPV-244.1 genome was comprised of a 129,528 bp circular sequence, in which 139 ORFs were annotated. Five homologous regions (hrs) consisting of a variable number of 28-bp imperfect palindromes were identified in the genome. The genome sequence contained the 38 core genes of family Baculoviridae, as well as three ORFs unique to the SpexNPV sequence and one ORF that was apparently acquired by horizontal gene transfer with a betabaculovirus ancestor. Phylogenetic inference with core gene amino acid sequence alignments placed SpexNPV-244.1 in a lineage containing alphabaculoviruses of Spodoptera frugiperda and Spodopotera exigua which in turn is part of a larger group of alphabaculoviruses from the subfamily Noctuinae in the lepidopteran family Noctuidae. Kimura-2-parameter pairwise nucleotide distances indicated that SpexNPV-244.1 represented a different and previously unlisted species in the genus Alphabaculovirus. Gene parity plots indicated that the gene order of SpexNPV-244. I was extensively collinear with that of Spodoptera exigua NPV (SeMNPV). These plots also revealed a group of 17 core genes whose order was conserved in other alpha-and betabaculoviruses.	[Escasa, Shannon R.] Algoma Univ, Great Lakes Forestry Ctr, Lab Mol Ecol, Marie, ON, Canada; [Escasa, Shannon R.] Algoma Univ, Biol Dept, Marie, ON, Canada; [Harrison, Robert L.] ARS, USDA, Beltsville Agr Res Ctr, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA; [Mowery, Joseph D.; Bauchan, Gary R.] ARS, USDA, Beltsville Agr Res Ctr, Electron & Confocal Microscopy Unit, Beltsville, MD USA; [Cory, Jenny S.] Simon Fraser Univ, Dept Biol Sci, Univ Blvd, Burnaby, BC, Canada	Algoma University; Algoma University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Simon Fraser University	Harrison, RL (corresponding author), ARS, USDA, Beltsville Agr Res Ctr, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA.; Cory, JS (corresponding author), Simon Fraser Univ, Dept Biol Sci, Univ Blvd, Burnaby, BC, Canada.	Robert.L.Harrison@ars.usda.gov; jennifer_cory@sfu.ca	Bauchan, Gary/ABH-3800-2020	Bauchan, Gary/0000-0003-3060-7666; Harrison, Robert/0000-0002-8348-3874				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Applebaum SW, 1999, ANNU REV ENTOMOL, V44, P317, DOI 10.1146/annurev.ento.44.1.317; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Breitenbach JE, 2013, VIRUS RES, V171, P194, DOI 10.1016/j.virusres.2012.11.016; BROWN ES, 1965, B ENTOMOL RES, V56, P95, DOI 10.1017/S0007485300057072; BROWN SE, 1984, VIROLOGY, V136, P235, DOI 10.1016/0042-6822(84)90262-9; BROWN SE, 1985, J GEN VIROL, V66, P2431, DOI 10.1099/0022-1317-66-11-2431; Dumas P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122407; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Escasa SR, 2006, J GEN VIROL, V87, P1917, DOI 10.1099/vir.0.81792-0; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Graham RI, 2015, INSECTS, V6, P746, DOI 10.3390/insects6030746; Graham RI, 2012, ECOL LETT, V15, P993, DOI 10.1111/j.1461-0248.2012.01820.x; Grzywacz D, 2008, CROP PROT, V27, P17, DOI 10.1016/j.cropro.2007.04.005; Habib S, 1996, J BIOL CHEM, V271, P28250, DOI 10.1074/jbc.271.45.28250; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARRAP KA, 1977, VIROLOGY, V79, P14, DOI 10.1016/0042-6822(77)90330-0; Harrison RL, 2008, J GEN VIROL, V89, P775, DOI 10.1099/vir.0.83566-0; Harrison RL, 2018, J GEN VIROL, V99, P1185, DOI 10.1099/jgv.0.001107; Harrison RL, 2018, VIRUS GENES, V54, P297, DOI 10.1007/s11262-017-1525-0; Harrison RL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170510; Heldens JGM, 1997, J GEN VIROL, V78, P1497, DOI 10.1099/0022-1317-78-6-1497; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Hu ZH, 1998, J GEN VIROL, V79, P2841, DOI 10.1099/0022-1317-79-11-2841; IJkel WFJ, 1999, J GEN VIROL, V80, P3289, DOI 10.1099/0022-1317-80-12-3289; Javed MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02115-16; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Kabaluk JT, 2010, THE USE AND REGULATI; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009; Lauzon HAM, 2004, J VIROL, V78, P7023, DOI 10.1128/JVI.78.13.7023-7035.2004; Luque T, 2001, J GEN VIROL, V82, P2531, DOI 10.1099/0022-1317-82-10-2531; MAEDA S, 1990, J GEN VIROL, V71, P2631, DOI 10.1099/0022-1317-71-11-2631; Miele Solange Ana Belen, 2011, Int J Evol Biol, V2011, P379424, DOI 10.4061/2011/379424; Mitchell JK, 2013, J VIROL, V87, P12592, DOI 10.1128/JVI.02501-13; Murillo R, 2003, INT J PEST MANAGE, V49, P147, DOI 10.1080/0967087021000043102; Pang Y, 2001, VIROLOGY, V287, P391, DOI 10.1006/viro.2001.1056; Barrera GP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2218-5; PERSSON B, 1981, B ENTOMOL RES, V71, P289, DOI 10.1017/S0007485300008312; Pogue M., 2002, WORLD REVISION GENUS; Popham HJR, 2004, J GEN VIROL, V85, P2255, DOI 10.1099/vir.0.79965-0; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Redman EM, 2016, J ANIM ECOL, V85, P1200, DOI 10.1111/1365-2656.12547; Redman EM, 2010, J INVERTEBR PATHOL, V105, P190, DOI 10.1016/j.jip.2010.06.008; Reeson AF, 2000, OECOLOGIA, V124, P373, DOI 10.1007/s004420000397; Reeson AF, 1998, P ROY SOC B-BIOL SCI, V265, P1787, DOI 10.1098/rspb.1998.0503; Rose DJW, 2000, THE AFRICAN ARMYWORM; Saejeng A, 2010, J INSECT PHYSIOL, V56, P1232, DOI 10.1016/j.jinsphys.2010.03.025; Shikano I, 2010, BASIC APPL ECOL, V11, P15, DOI 10.1016/j.baae.2009.06.008; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Theze J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070366; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; Vilaplana L, 2008, OECOLOGIA, V155, P237, DOI 10.1007/s00442-007-0914-9; Vilaplana L, 2010, EVOL ECOL, V24, P147, DOI 10.1007/s10682-009-9296-2; Viswanathan P, 2003, J BIOL CHEM, V278, P52564, DOI 10.1074/jbc.M309351200; Wang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155134; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Williams T, 2017, J INVERTEBR PATHOL, V147, P4, DOI 10.1016/j.jip.2016.08.001; Yanase T, 2000, VIRUS GENES, V21, P167, DOI 10.1023/A:1008183329145; Yuan CF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006645	64	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0209937	10.1371/journal.pone.0209937	http://dx.doi.org/10.1371/journal.pone.0209937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735528	Green Published, gold, Green Submitted			2022-12-26	WOS:000458181200012
J	Chen, YL; Wu, WL; Jang, CW; Yen, YC; Wang, SH; Tsai, FY; Shen, YY; Chen, YW				Chen, Yu-Lin; Wu, Wan-Lin; Jang, Chuan-Wei; Yen, Yi-Chen; Wang, Ssu-Han; Tsai, Fang-Yu; Shen, Ying-Ying; Chen, Ya-Wen			Interferon-stimulated gene 15 modulates cell migration by interacting with Rac1 and contributes to lymph node metastasis of oral squamous cell carcinoma cells	ONCOGENE			English	Article							BREAST-CANCER; RHO FAMILY; ISG15; EXPRESSION; PROTEIN; BINDING; TUMORIGENESIS; ISGYLATION; PROTEOMICS; INVASION	In an effort to understand the underlying mechanisms of lymph node metastasis in oral squamous cell carcinoma (OSCC), through in vivo selection, LN1-1 cells were previously established from OEC-M1 cells and showed enhanced lymphangiogenesis and lymphatic metastasis capabilities. In the current study, we use a stable isotope labeling with amino acids in cell culture (SILAC) and liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomic platform to compare LN1-1 to OEC-M1 cells. Interferon-stimulated gene 15 (ISG15) was found highly expressed in LN1-1 cells Immunohistochemical analysis and meta-analysis of publicly available microarray datasets revealed that the ISG15 level was increased in human OSCC tissues and associated with poor disease outcome. Knockdown of ISG15 had minimal effects on tumor growth but did decrease tumor lymphangiogenesis and lymphatic metastasis of LN1-1 cells. Consistent with the in vivo assay, ISG15 knockdown did not impair cell growth but diminished cell migration, invasion, and transendothelial migration in vitro. ISG15-induced cell migration was independent of ISGylation and associated with membrane protrusion. Ectopic expression of ISG15 increased Rac1 activity and knockdown of Rac1 impaired ISG15-enhanced migration. Furthermore, Rac1 colocalized with ISG15 to a region of membrane protrusion and ISG15 coimmunoprecipitated with Rac1, especially with the Rac1-GDP form. Importantly, as shown by proximity ligation assays, ISG15 and Rac1 physically interacted with each other. Our results indicated that ISG15 affects cell migration by interacting with Rac1 and regulating Rac1 activity and contributes to lymphatic metastasis in OSCC.	[Chen, Yu-Lin; Wu, Wan-Lin; Jang, Chuan-Wei; Yen, Yi-Chen; Wang, Ssu-Han; Tsai, Fang-Yu; Chen, Ya-Wen] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Shen, Ying-Ying] Natl Hlth Res Inst, Pathol Core Lab, Miaoli, Taiwan; [Chen, Ya-Wen] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan	Chen, YW (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan.; Chen, YW (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.	ywc@nhri.org.tw	Chen, Ya-Wen/AAG-7549-2019	Chen, Ya-Wen/0000-0002-6080-8859; Chen, Yu-Lin/0000-0001-9564-3997	National Health Research Institutes, Taiwan [NHRI CA-107-PP-04, MOST 106-2314-B-400-026-MY3]; Ministry of Science and Technology, Taiwan [NHRI CA-107-PP-04, MOST 106-2314-B-400-026-MY3]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants NHRI CA-107-PP-04 and MOST 106-2314-B-400-026-MY3 from National Health Research Institutes and Ministry of Science and Technology, Taiwan.	Ahmad Y, 2014, TRENDS CELL BIOL, V24, P257, DOI 10.1016/j.tcb.2013.10.010; Andersen JB, 2006, CYTOKINE GROWTH F R, V17, P411, DOI 10.1016/j.cytogfr.2006.10.001; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Burks J, 2015, ONCOTARGET, V6, P7221, DOI 10.18632/oncotarget.3372; Cajee UF, 2012, INT J MOL SCI, V13, P11804, DOI 10.3390/ijms130911804; Castillo-Lluva S, 2013, ONCOGENE, V32, P1735, DOI 10.1038/onc.2012.189; Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Chen RH, 2016, ONCOTARGET, V7, P16910, DOI 10.18632/oncotarget.7626; Chen YW, 2008, CANCER RES, V68, P476, DOI 10.1158/0008-5472.CAN-07-1960; Chen YW, 2007, CANCER RES, V67, P7589, DOI 10.1158/0008-5472.CAN-07-0381; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069389; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Desai SD, 2012, EXP BIOL MED, V237, P38, DOI 10.1258/ebm.2011.011236; dos Santos PF, 2017, J INTERF CYTOK RES, V37, P246, DOI 10.1089/jir.2016.0103; Durfee LA, 2012, METHODS MOL BIOL, V832, P141, DOI 10.1007/978-1-61779-474-2_9; Estilo CL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-11; Festing Michael F W, 2002, ILAR J, V43, P244; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Graziano BR, 2014, CURR OPIN CELL BIOL, V30, P60, DOI 10.1016/j.ceb.2014.06.007; Hermann MR, 2016, J CELL SCI, V129, P1391, DOI 10.1242/jcs.177592; Hishiki T, 2014, BIOCHEM BIOPH RES CO, V448, P95, DOI 10.1016/j.bbrc.2014.04.081; Jeon YJ, 2010, BBA-MOL BASIS DIS, V1802, P485, DOI 10.1016/j.bbadis.2010.02.006; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; Kuriakose MA, 2004, CELL MOL LIFE SCI, V61, P1372, DOI 10.1007/s00018-004-4069-0; Laljee RP, 2013, ASIAN PAC J CANCER P, V14, P1147, DOI 10.7314/APJCP.2013.14.2.1147; Lee CH, 2013, J PATHOL, V230, P298, DOI 10.1002/path.4173; Li C, 2014, ONCOTARGET, V5, P8429, DOI 10.18632/oncotarget.2316; Liao CT, 2009, INT J RADIAT ONCOL, V73, P764, DOI 10.1016/j.ijrobp.2008.05.004; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Qin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034132; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Sainz B, 2014, CANCER RES, V74, P7309, DOI 10.1158/0008-5472.CAN-14-1354; Sgorbissa A, 2012, CYTOKINE GROWTH F R, V23, P307, DOI 10.1016/j.cytogfr.2012.07.003; Spano D, 2012, SEMIN CANCER BIOL, V22, P234, DOI 10.1016/j.semcancer.2012.03.006; Symons M, 2000, TRENDS CELL BIOL, V10, P415, DOI 10.1016/S0962-8924(00)01832-8; Talbot SG, 2005, CANCER RES, V65, P3063, DOI 10.1158/0008-5472.CAN-04-1985; Toruner GA, 2004, CANCER GENET CYTOGEN, V154, P27, DOI 10.1016/j.cancergencyto.2004.01.026; Tyanova S, 2014, METHODS MOL BIOL, V1188, P351, DOI 10.1007/978-1-4939-1142-4_24; UEDA T, 1990, J BIOL CHEM, V265, P9373; Um K, 2014, DEV CELL, V29, P701, DOI 10.1016/j.devcel.2014.05.011; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Wang SH, 2018, INT J CANC; Wong TY, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2809192; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Yeh YH, 2013, CLIN CANCER RES, V19, P5927, DOI 10.1158/1078-0432.CCR-13-0018; Yen YC, 2015, ONCOTARGET, V6, P41837, DOI 10.18632/oncotarget.5995; Yen YC, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-6; Zhang QM, 2017, EXP THER MED, V14, P2329, DOI 10.3892/etm.2017.4720; Zhang X, 2002, CANCER-AM CANCER SOC, V95, P1663, DOI 10.1002/cncr.10837; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801	58	19	19	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2019	38	23					4480	4495		10.1038/s41388-019-0731-8	http://dx.doi.org/10.1038/s41388-019-0731-8			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB4KM	30765861				2022-12-26	WOS:000470240300004
J	Fernandes, VC; Golubeva, VA; Di Pietro, G; Shields, C; Amankwah, K; Nepomuceno, TC; de Gregoriis, G; Abreu, RBV; Harro, C; Gomes, TT; Silva, RF; Suarez-Kurtz, G; Couch, FJ; Iversen, ES; Monteiro, ANA; Carvalho, MA				Fernandes, Vanessa C.; Golubeva, Volha A.; Di Pietro, Giuliano; Shields, Cara; Amankwah, Kwabena; Nepomuceno, Thales C.; de Gregoriis, Giuliana; Abreu, Renata B. V.; Harro, Carly; Gomes, Thiago T.; Silva, Ricceli F.; Suarez-Kurtz, Guilherme; Couch, Fergus J.; Iversen, Edwin S.; Monteiro, Alvaro N. A.; Carvalho, Marcelo A.			Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BRCA1; cancer prevention; human genetics; protein conformation; breast cancer; BRCT domains; breast cancer risk; clinical annotation; clinical risk assessment; VarCall	SEQUENCE VARIANTS; MISSENSE VARIANTS; FUNCTIONAL-ANALYSIS; CLASSIFICATION; BREAST; TRANSCRIPTION; MUTATIONS; PROTEIN; ASSAY; REGION	Genetic testing for BRCA1, a DNA repair protein, can identify carriers of pathogenic variants associated with a substantially increased risk for breast and ovarian cancers. However, an association with increased risk is unclear for a large fraction of BRCA1 variants present in the human population. Most of these variants of uncertain clinical significance lead to amino acid changes in the BRCA1 protein. Functional assays are valuable tools to assess the potential pathogenicity of these variants. Here, we systematically probed the effects of substitutions in the C terminus of BRCA1: the N- and C-terminal borders of its tandem BRCT domain, the BRCT-[N-C] linker region, and the 1 and 1 helices in BRCT-[N] and -[C]. Using a validated transcriptional assay based on a fusion of the GAL4 DNA-binding domain to the BRCA1 C terminus (amino acids 1396-1863), we assessed the functional impact of 99 missense variants of BRCA1. We include the data obtained for these 99 missense variants in a joint analysis to generate the likelihood of pathogenicity for 347 missense variants in BRCA1 using VarCall, a Bayesian integrative statistical model. The results from this analysis increase our understanding of BRCA1 regions less tolerant to changes, identify functional borders of structural domains, and predict the likelihood of pathogenicity for 98% of all BRCA1 missense variants in this region recorded in the population. This knowledge will be critical for improving risk assessment and clinical treatment of carriers of BRCA1 variants.	[Fernandes, Vanessa C.; Nepomuceno, Thales C.; de Gregoriis, Giuliana; Abreu, Renata B. V.; Suarez-Kurtz, Guilherme; Carvalho, Marcelo A.] Inst Nacl Canc, Programa Pesquisa Clin, BR-20231050 Rio De Janeiro, Brazil; [Golubeva, Volha A.; Di Pietro, Giuliano; Shields, Cara; Amankwah, Kwabena; Nepomuceno, Thales C.; Harro, Carly; Monteiro, Alvaro N. A.] H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA; [Di Pietro, Giuliano] Univ Fed Sergipe, Campus Sao Cristovao, BR-49100000 Sao Cristovao, Brazil; [Harro, Carly] Univ S Florida, Canc Biol PhD Program, Coll Arts & Sci, Dept Cell Biol,Microbiol, Tampa, FL 33612 USA; [Couch, Fergus J.] Mayo Clin, Dept Lab Med, Rochester, MN 55905 USA; [Iversen, Edwin S.] Duke Univ, Dept Stat, Durham, NC 27710 USA; [Gomes, Thiago T.; Silva, Ricceli F.] Inst Fed Rio de Janeiro, BR-20270021 Rio De Janeiro, Brazil	National Cancer Institute (Inca); H Lee Moffitt Cancer Center & Research Institute; Universidade Federal de Sergipe; State University System of Florida; University of South Florida; Mayo Clinic; Duke University; Instituto Federal do Rio de Janeiro (IFRJ)	Carvalho, MA (corresponding author), Inst Fed Rio de Janeiro, BR-20270021 Rio De Janeiro, Brazil.; Monteiro, ANA (corresponding author), 12902 Magnolia Dr, Tampa, FL 33612 USA.	alvaro.monteiro@moffitt.org; marcelo.carvalho@ifrj.edu.br	De Gregoriis, Giuliana/AAC-9864-2022; Carvalho, Marcelo A/J-7144-2012; Carvalho, Marcelo/T-2014-2019; Torres Gomes, Thiago/GRR-2203-2022; Monteiro, Alvaro N. A./A-7566-2009; Suarez-Kurtz, Guilherme/J-6648-2012; Nepomuceno, Thales/Y-8018-2019; Barbosa Vahia de Abreu, Renata/V-5594-2018	Carvalho, Marcelo A/0000-0002-7053-0053; Monteiro, Alvaro N. A./0000-0002-8448-4801; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Nepomuceno, Thales/0000-0002-1171-1030; Fernandes, Vanessa C./0000-0003-4130-8215; Harro, Carly/0000-0002-0683-217X; Shields, Cara/0000-0002-3791-8259; Golubeva, Volha/0000-0001-5430-3507; Barbosa Vahia de Abreu, Renata/0000-0002-3183-1195; Torres Gomes, Thiago/0000-0001-7669-3980	National Institutes of Health [U01 CA116167]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao do Cancer (Programa de Oncobiologia); Molecular Genomics Core Facilities at the Moffitt Cancer Center through National Institutes of Health NCI CCSG Grant [P30-CA76292]; NATIONAL CANCER INSTITUTE [P30CA076292, U01CA116167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao do Cancer (Programa de Oncobiologia); Molecular Genomics Core Facilities at the Moffitt Cancer Center through National Institutes of Health NCI CCSG Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant U01 CA116167, the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao do Cancer (Programa de Oncobiologia), and in part by the Molecular Genomics Core Facilities at the Moffitt Cancer Center through National Institutes of Health NCI CCSG Grant P30-CA76292. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anantha RW, 2017, ELIFE, V6, DOI 10.7554/eLife.21350; Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Bouwman P, 2013, CANCER DISCOV, V3, P1142, DOI 10.1158/2159-8290.CD-13-0094; Brzovic PS, 2001, J BIOL CHEM, V276, P41399, DOI 10.1074/jbc.M106551200; Carvalho MA, 2002, CANCER BIOL THER, V1, P502, DOI 10.4161/cbt.1.5.165; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Cline MS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007752; Coyne RS, 2004, CANCER BIOL THER, V3, P453, DOI 10.4161/cbt.3.5.809; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Goldgar DE, 2008, HUM MUTAT, V29, P1265, DOI 10.1002/humu.20897; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Hayes F, 2000, CANCER RES, V60, P2411; Iversen ES, 2011, CANCER EPIDEM BIOMAR, V20, P1078, DOI 10.1158/1055-9965.EPI-10-1214; Karchin R, 2007, PLOS COMPUT BIOL, V3, P268, DOI 10.1371/journal.pcbi.0030026; Kleiman FE, 1999, SCIENCE, V285, P1576, DOI 10.1126/science.285.5433.1576; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Lindor NM, 2012, HUM MUTAT, V33, P8, DOI 10.1002/humu.21627; Lu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10086; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Nadeau G, 2000, EMBO REP, V1, P260, DOI 10.1093/embo-reports/kvd059; Petitalot A., 2018, MOL CANCER RES, V17, P54, DOI [10.1186/s12943-018-0790-4, DOI 10.1186/S12943-018-0790-4]; Phelan CM, 2005, J MED GENET, V42, P138, DOI 10.1136/jmg.2004.024711; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Starita LM, 2017, AM J HUM GENET, V101, P315, DOI 10.1016/j.ajhg.2017.07.014; Starita LM, 2015, GENETICS, V200, P413, DOI 10.1534/genetics.115.175802; Thouvenot P, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006096; Toland AE, 2017, J MED GENET, V54, P721, DOI 10.1136/jmedgenet-2017-104707; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Woods NT, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.1; Worley T, 2002, CANCER BIOL THER, V1, P497, DOI 10.4161/cbt.1.5.164	42	19	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5980	5992		10.1074/jbc.RA118.005274	http://dx.doi.org/10.1074/jbc.RA118.005274			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30765603	Green Published, hybrid			2022-12-26	WOS:000465077500029
J	Katayama, K; Gulati, S; Ortega, JT; Alexander, NS; Sun, WY; Shenouda, MM; Palczewski, K; Jastrzebska, B				Katayama, Kota; Gulati, Sahil; Ortega, Joseph T.; Alexander, Nathan S.; Sun, Wenyu; Shenouda, Marina M.; Palczewski, Krzysztof; Jastrzebska, Beata			Specificity of the chromophore-binding site in human cone opsins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); membrane protein; photoreceptor; retinoid; rhodopsin; 11-cis-6mr-retinal; protein structure; retinal pigment; vision	CRYSTAL-STRUCTURE; VISUAL PIGMENTS; RECEPTOR ACTIVATION; WATER-MOLECULES; SCHIFF-BASE; RHODOPSIN; ISOMERIZATION; GREEN; ROD; PHOTOSENSITIVITIES	The variable composition of the chromophore-binding pocket in visual receptors is essential for vision. The visual phototransduction starts with the cis-trans isomerization of the retinal chromophore upon absorption of photons. Despite sharing the common 11-cis-retinal chromophore, rod and cone photoreceptors possess distinct photochemical properties. Thus, a detailed molecular characterization of the chromophore-binding pocket of these receptors is critical to understanding the differences in the photochemistry of vision between rods and cones. Unlike for rhodopsin (Rh), the crystal structures of cone opsins remain to be determined. To obtain insights into the specific chromophore-protein interactions that govern spectral tuning in human visual pigments, here we harnessed the unique binding properties of 11-cis-6-membered-ring-retinal (11-cis-6mr-retinal) with human blue, green, and red cone opsins. To unravel the specificity of the chromophore-binding pocket of cone opsins, we applied 11-cis-6mr-retinal analog-binding analyses to human blue, green, and red cone opsins. Our results revealed that among the three cone opsins, only blue cone opsin can accommodate the 11-cis-6mr-retinal in its chromophore-binding pocket, resulting in the formation of a synthetic blue pigment (B6mr) that absorbs visible light. A combination of primary sequence alignment, molecular modeling, and mutagenesis experiments revealed the specific amino acid residue 6.48 (Tyr-262 in blue cone opsins and Trp-281 in green and red cone opsins) as a selectivity filter in human cone opsins. Altogether, the results of our study uncover the molecular basis underlying the binding selectivity of 11-cis-6mr-retinal to the cone opsins.	[Katayama, Kota; Ortega, Joseph T.; Alexander, Nathan S.; Shenouda, Marina M.; Jastrzebska, Beata] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Gulati, Sahil; Palczewski, Krzysztof] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92697 USA; [Gulati, Sahil; Palczewski, Krzysztof] Univ Calif Irvine, Dept Ophthalmol, Irvine, CA 92697 USA; [Katayama, Kota] Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi 4668555, Japan; [Katayama, Kota] Nagoya Inst Technol, OptoBio Technol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan; [Sun, Wenyu; Palczewski, Krzysztof] Polgenix Inc, Cleveland, OH 44106 USA	Case Western Reserve University; University of California System; University of California Irvine; University of California System; University of California Irvine; Nagoya Institute of Technology; Nagoya Institute of Technology	Palczewski, K (corresponding author), Gavin Herbert Eye Inst, Dept Ophthalmol, 850 Hlth Sci Rd, Irvine, CA 92697 USA.; Palczewski, K (corresponding author), Gavin Herbert Eye Inst, Dept Physiol & Biophys, 850 Hlth Sci Rd, Irvine, CA 92697 USA.; Jastrzebska, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kpalczewski@uci.edu; bxj27@case.edu	Ortega, Joseph/AFN-8883-2022	Katayama, Kota/0000-0001-8498-4374; Shenouda, Marina/0000-0002-6074-2327; Jastrzebska, Beata/0000-0001-5209-8685	National Institutes of Health [EY025214, EY027283, EY024864, EY009339, EY025451, P30EY011373]; CORE grant for Vision Research; Research to Prevent Blindness (RPB) grant; Canadian Institute for Advanced Research (CIFAR); Alcon Research Institute (ARI); NATIONAL EYE INSTITUTE [R24EY024864, U01EY025451, P30EY011373, R01EY009339, R24EY027283, R01EY025214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CORE grant for Vision Research; Research to Prevent Blindness (RPB) grant(Research to Prevent Blindness (RPB)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Alcon Research Institute (ARI); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grants EY025214 (to B. J.), EY027283, EY024864, EY009339, EY025451 (all to K. P.), and P30EY011373, CORE grant for Vision Research awarded to the Visual Sciences Research Center (VSRC) at Case Western Reserve University; a Research to Prevent Blindness (RPB) grant (to the Department of Ophthalmology at University of California Irvine); the Canadian Institute for Advanced Research (CIFAR); and Alcon Research Institute (ARI). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahuja S, 2009, J AM CHEM SOC, V131, P15160, DOI 10.1021/ja9034768; Alexander NS, 2017, J BIOL CHEM, V292, P10983, DOI 10.1074/jbc.M117.780478; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; BHATTACHARYA S, 1992, J BIOL CHEM, V267, P6763; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brown MF, 2010, BBA-BIOMEMBRANES, V1798, P177, DOI 10.1016/j.bbamem.2009.08.013; Chen Yuanyuan, 2015, Methods Mol Biol, V1271, P369, DOI 10.1007/978-1-4939-2330-4_24; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DARTNALL HJ, 1968, VISION RES, V8, P339, DOI 10.1016/0042-6989(68)90104-1; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Fasick JI, 1999, BIOCHEMISTRY-US, V38, P11593, DOI 10.1021/bi991600h; Furutani Y, 2003, BIOCHEMISTRY-US, V42, P9619, DOI 10.1021/bi034592k; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Gulati S, 2017, P NATL ACAD SCI USA, V114, pE2608, DOI 10.1073/pnas.1617446114; Heck M, 2003, J BIOL CHEM, V278, P3162, DOI 10.1074/jbc.M209675200; Imamoto Y, 2013, BIOCHEMISTRY-US, V52, P3010, DOI 10.1021/bi3015967; Isayama T, 2006, VISUAL NEUROSCI, V23, P899, DOI 10.1017/S0952523806230256; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Katayama K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05177-4; Katayama K, 2015, J PHYS CHEM LETT, V6, P1130, DOI 10.1021/acs.jpclett.5b00291; Katayama K, 2012, BIOCHEMISTRY-US, V51, P1126, DOI 10.1021/bi201676y; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kim JE, 2003, BIOCHEMISTRY-US, V42, P5169, DOI 10.1021/bi030026d; Kim JE, 2001, BIOCHEMISTRY-US, V40, P13774, DOI 10.1021/bi0116137; Kono M, 2011, J NAT PROD, V74, P391, DOI 10.1021/np100749j; Kuksa V, 2002, J BIOL CHEM, V277, P42315, DOI 10.1074/jbc.M206014200; Kuwayama S, 2002, BIOCHEMISTRY-US, V41, P15245, DOI 10.1021/bi026444k; Lee J, 2010, PROTEINS, V78, P3428, DOI 10.1002/prot.22849; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; Mertz B, 2012, BBA-BIOMEMBRANES, V1818, P241, DOI 10.1016/j.bbamem.2011.08.003; NAKANISHI K, 1976, J AM CHEM SOC, V98, P236, DOI 10.1021/ja00417a040; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; OKANO T, 1992, PHOTOCHEM PHOTOBIOL, V56, P995, DOI 10.1111/j.1751-1097.1992.tb09722.x; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, VISION RES, V46, P4425, DOI 10.1016/j.visres.2006.10.009; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pope A, 2014, BBA-BIOENERGETICS, V1837, P683, DOI 10.1016/j.bbabio.2013.10.007; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; SHICHIDA Y, 1988, BIOCHEMISTRY-US, V27, P6495, DOI 10.1021/bi00417a044; SPALINK JD, 1983, P NATL ACAD SCI-BIOL, V80, P1887, DOI 10.1073/pnas.80.7.1887; Stenkamp RE, 2002, BBA-BIOMEMBRANES, V1565, P168, DOI 10.1016/S0005-2736(02)00567-9; Stenkamp RE, 2002, CHEMBIOCHEM, V3, P963, DOI 10.1002/1439-7633(20021004)3:10<963::AID-CBIC963>3.0.CO;2-9; Tsutsui K, 2007, BIOCHEMISTRY-US, V46, P6437, DOI 10.1021/bi7003763; Van Hooser JP, 2000, METHOD ENZYMOL, V316, P565; Vogel R, 2000, CURR OPIN CHEM BIOL, V4, P518, DOI 10.1016/S1367-5931(00)00125-3; Vogel R, 2005, BIOCHEMISTRY-US, V44, P11684, DOI 10.1021/bi0508587; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Yan ECY, 2004, BIOCHEMISTRY-US, V43, P10867, DOI 10.1021/bi0400148; Yuan SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5733	61	7	8	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6082	6093		10.1074/jbc.RA119.007587	http://dx.doi.org/10.1074/jbc.RA119.007587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30770468	Green Published, hybrid			2022-12-26	WOS:000465077500038
J	Iwama, R; Ohsumi, Y				Iwama, Ryo; Ohsumi, Yoshinori			Analysis of autophagy activated during changes in carbon source availability in yeast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; physiology; yeast; glucose; mitophagy; autophagy-related protein 8 (Atg8); diauxie; ER-phagy; ethanol; nutrient starvation	SACCHAROMYCES-CEREVISIAE; TRIACYLGLYCEROL LIPASE; TAGS PEROXISOMES; DIAUXIC SHIFT; DEGRADATION; GENES; STARVATION; RECEPTOR; PROTEIN; MECHANISMS	Autophagy is a conserved intracellular degradation system in eukaryotes. Recent studies have revealed that autophagy can be induced not only by nitrogen starvation but also by many other stimuli. However, questions persist regarding the types of conditions that induce autophagy, as well as the particular kinds of autophagy that are induced under these specific conditions. In experimental studies, abrupt nutrient changes are often used to induce autophagy. In this study, we investigated autophagy induction in batch culture on low-glucose medium, in which growth of yeast (Saccharomyces cerevisiae) cells is clearly reflected exclusively by carbon source state. In this medium, cells pass sequentially through three stages: glucose-utilizing, ethanol-utilizing, and ethanol-depleted phases. Using GFP cleavage assay by immunoblotting methods, fluorescence microscopy, and transmission electron microscopy ultrastructural analysis, we found that bulk autophagy and endoplasmic reticulum-phagy are induced starting at the ethanol-utilizing phase, and bulk autophagy is activated to a greater extent in the ethanol-depleted phase. Furthermore, we found that mitophagy is induced by ethanol depletion. Microautophagy occurred after glucose depletion and involved incorporation of cytosolic components and lipid droplets into the vacuolar lumen. Moreover, we observed that autophagy-deficient cells grow more slowly in the ethanol-utilizing phase and exhibit a delay in growth resumption when they are shifted to fresh medium from the ethanol-depleted phase. Our findings suggest that distinct types of autophagy are induced in yeast cells undergoing gradual changes in carbon source availability.	[Iwama, Ryo; Ohsumi, Yoshinori] Tokyo Inst Technol, Inst Innovat Res, Ctr Cell Biol, Midori Ku, 4259-S2-12 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Ohsumi, Y (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Ctr Cell Biol, Midori Ku, 4259-S2-12 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	yohsumi@iri.titech.ac.jp	Ohsumi, Yoshinori/C-6449-2009; IWAMA, Ryo/AAY-4462-2021; Iwama, Ryo/W-2769-2017	Ohsumi, Yoshinori/0000-0003-2384-2166; IWAMA, Ryo/0000-0002-0466-6593; Iwama, Ryo/0000-0002-0466-6593	JSPS KAKENHI [JP23000015, JP16H06375, JP17K15245]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grants JP23000015, JP16H06375, and JP17K15245. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi A, 2017, J BIOL CHEM, V292, P19905, DOI 10.1074/jbc.M117.817510; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Dickinson J. R., 1999, METABOLISM MOL PHYSL; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; FIECHTER A, 1981, ADV MICROB PHYSIOL, V22, P123, DOI 10.1016/S0065-2911(08)60327-6; Frankel D. G., 2011, YEAST INTERMEDIARY M; Fukuda T, 2018, MOL CELLS, V41, P35, DOI 10.14348/molcells.2018.2214; Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; Haurie V, 2003, J BIOL CHEM, V278, P45391, DOI 10.1074/jbc.M307447200; Horie T, 2017, J BIOL CHEM, V292, P8533, DOI 10.1074/jbc.M116.762963; Huang HH, 2015, EMBO J, V34, P154, DOI 10.15252/embj.201489083; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kawamata T, 2017, J BIOL CHEM, V292, P8520, DOI 10.1074/jbc.M116.762948; Kayikci O, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov068; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Medeiros TC, 2018, J CELL BIOL, V217, P1601, DOI 10.1083/jcb.201801168; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; MOELLER CH, 1979, J ULTRA MOL STRUCT R, V68, P38, DOI 10.1016/S0022-5320(79)90140-0; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Murphy JP, 2015, MOL CELL PROTEOMICS, V14, P2454, DOI 10.1074/mcp.M114.045849; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2015, ANNU REV BIOPHYS, V44, P101, DOI 10.1146/annurev-biophys-060414-034248; Noda T, 2008, METHOD ENZYMOL, V451, P27, DOI 10.1016/S0076-6879(08)03202-3; Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Oku M, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201800008; Oku M, 2017, J CELL BIOL, V216, P3263, DOI 10.1083/jcb.201611029; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Ploier B, 2013, J BIOL CHEM, V288, P36061, DOI 10.1074/jbc.M113.509927; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Sibirny AA, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow038; Stahl G, 2004, EUKARYOT CELL, V3, P331, DOI 10.1128/EC.3.2.331-338.2004; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2013, CELL DEATH DIFFER, V20, P43, DOI 10.1038/cdd.2012.73; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Tsuji T, 2017, ELIFE, V6, DOI 10.7554/eLife.25960; VANDIJKEN JP, 1993, ANTON LEEUW INT J G, V63, P343, DOI 10.1007/BF00871229; Yokota H, 2017, BIOCHEM BIOPH RES CO, V483, P522, DOI 10.1016/j.bbrc.2016.12.112	53	16	16	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5590	5603		10.1074/jbc.RA118.005698	http://dx.doi.org/10.1074/jbc.RA118.005698			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30755486	hybrid, Green Published			2022-12-26	WOS:000464517500028
J	Chen, JE; Barbrook, AC; Cui, GX; Howe, CJ; Aranda, M				Chen, Jit Ern; Barbrook, Adrian C.; Cui, Guoxin; Howe, Christopher J.; Aranda, Manuel			The genetic intractability of Symbiodinium microadriaticum to standard algal transformation methods	PLOS ONE			English	Article							NUCLEAR TRANSFORMATION; DNA; 5-HYDROXYMETHYLURACIL; EXPRESSION; KAWAGUTII; GENOME	Modern transformation and genome editing techniques have shown great success across a broad variety of organisms. However, no study of successfully applied genome editing has been reported in a dinoflagellate despite the first genetic transformation of Symbiodinium being published about 20 years ago. Using an array of different available transformation techniques, we attempted to transform Symbiodinium microadriaticum (CCMP2467), a dinoflagellate symbiont of reef-building corals, with the view to performing subsequent CRISPR-Cas9 mediated genome editing. Plasmid vectors designed for nuclear transformation containing the chloramphenicol resistance gene under the control of the CaMV p35S promoter as well as several putative endogenous promoters were used to test a variety of transformation techniques including biolistics, electroporation and agitation with silicon carbide whiskers. Chloroplast-targeted transformation was attempted using an engineered Symbiodinium chloroplast minicircle encoding a modified PsbA protein expected to confer atrazine resistance. We report that we have been unable to confer chloramphenicol or atrazine resistance on Symbiodinium microadriaticum strain CCMP2467.	[Chen, Jit Ern; Cui, Guoxin; Aranda, Manuel] KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Chen, Jit Ern] Sunway Univ, Dept Biol Sci, Bandar Sunway, Malaysia; [Chen, Jit Ern] Sunway Univ, Jeffrey Sachs Ctr Sustainable Dev, Bandar Sunway, Malaysia; [Barbrook, Adrian C.; Howe, Christopher J.] Univ Cambridge, Dept Biochem, Cambridge, England	King Abdullah University of Science & Technology; Sunway University; Sunway University; University of Cambridge	Aranda, M (corresponding author), KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia.	manuel.aranda@kaust.edu.sa	Cui, Guoxin/Q-9504-2017; Cui, Guoxin/Y-3028-2019; Aranda Lastra, Manuel/D-9530-2011	Cui, Guoxin/0000-0003-4951-1883; Cui, Guoxin/0000-0003-4951-1883; Aranda Lastra, Manuel/0000-0001-6673-016X; Chen, Jit Ern/0000-0003-4779-7275; Barbrook, Adrian/0000-0002-6209-7413	King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR) [URF/1/1705-01]; King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research. (OSR) [OCRF-2014-CRG3-2216]	King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR); King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research. (OSR)	Funded by King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR). https://www.kaust.edu.sa/en/research/sponsored-research URF/1/1705-01. MA. King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research. (OSR). https://www.kaust.edu.sa/en/research/sponsored-research OCRF-2014-CRG3-2216. MA, CJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39734; BLANK RJ, 1988, ARCH MICROBIOL, V149, P515, DOI 10.1007/BF00446754; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Chen JE, 2018, ISME J, V12, P639, DOI 10.1038/ismej.2017.179; Dong XL, 2004, NUCLEIC ACIDS RES, V32, pW660, DOI 10.1093/nar/gkh410; Ortiz-Matamoros MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132693; Ortiz-Matamoros MF, 2015, CIENC MAR, V41, P21, DOI 10.7773/cm.v41i1.2449; Gornik SG, 2012, CURR BIOL, V22, P2303, DOI 10.1016/j.cub.2012.10.036; HERZOG M, 1984, ORIGINS LIFE EVOL B, V13, P205, DOI 10.1007/BF00927172; Howe CJ, 2008, J EXP BOT, V59, P1035, DOI 10.1093/jxb/erm292; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Kawasaki F, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1150-1; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Lajeunesse TC, 2015, EUR J PHYCOL, V50, P223, DOI 10.1080/09670262.2015.1025857; Levin RA, 2017, J EUKARYOT MICROBIOL, V64, P588, DOI 10.1111/jeu.12393; Lin SJ, 2015, SCIENCE, V350, P691, DOI 10.1126/science.aad0408; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Nimmo I, 2018, GENETIC TRANSFORMATI; Pfaffeneder T, 2014, NAT CHEM BIOL, V10, P574, DOI [10.1038/NCHEMBIO.1532, 10.1038/nchembio.1532]; RAE PMM, 1973, P NATL ACAD SCI USA, V70, P1141, DOI 10.1073/pnas.70.4.1141; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Smith DM, 2007, SCIENCE, V317, P796, DOI 10.1126/science.1139540; ten Lohuis MR, 1998, PLANT J, V13, P427; Yu M, 2012, NAT PROTOC, V7, P2159, DOI 10.1038/nprot.2012.137; Zhang CY, 2014, MAR GENOM, V16, P63, DOI 10.1016/j.margen.2013.10.003; Zhang H, 2013, PROTIST, V164, P510, DOI 10.1016/j.protis.2013.04.002	31	10	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211936	10.1371/journal.pone.0211936	http://dx.doi.org/10.1371/journal.pone.0211936			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779749	Green Published, Green Submitted, gold			2022-12-26	WOS:000459062900022
J	Diong, J; Heroux, ME; Gandevia, SC; Herbert, RD				Diong, Joanna; Heroux, Martin E.; Gandevia, Simon C.; Herbert, Robert D.			Minimal force transmission between human thumb and index finger muscles under passive conditions	PLOS ONE			English	Article							HUMAN SOLEUS; LENGTH; FLEXOR; GASTROCNEMIUS	It has been hypothesized that force can be transmitted between adjacent muscles. Inter muscle force transmission violates the assumption that muscles act in mechanical isolation, and implies that predictions from biomechanical models are in error due to mechanical interactions between muscles, but the functional relevance of intermuscle force transmission is unclear. To investigate intermuscle force transmission between human flexor pollicis longus and the index finger part of flexor digitorum profundus, we compared finger flexion force produced by passive thumb flexion after one of three conditioning protocols: passive thumb flexion-extension cycling, thumb flexion maximal voluntary contraction (MVC), and thumb extension stretch. Finger flexion force increased after all three conditions. Compared to passive thumb flexion-extension cycling, change in finger flexion force was less after thumb extension stretch (mean difference 0.028 N, 95% CI 0.005 to 0.051 N), but not after thumb flexion MVC (0.007 N, 95% CI -0.020 to 0.033 N). As muscle conditioning changed finger flexion force produced by passive thumb flexion, the change in force is likely due to inter muscle force transmission. Thus, intermuscle force transmission resulting from passive stretch of an adjacent muscle is probably small enough to be ignored.	[Diong, Joanna] Univ Sydney, Fac Med & Hlth, Sch Med Sci, Sydney, NSW, Australia; [Diong, Joanna; Heroux, Martin E.; Gandevia, Simon C.; Herbert, Robert D.] Neurosci Res Australia NeuRA, Randwick, NSW, Australia; [Heroux, Martin E.; Gandevia, Simon C.; Herbert, Robert D.] Univ New South Wales, Randwick, NSW, Australia	University of Sydney; Neuroscience Research Australia; University of New South Wales Sydney	Diong, J (corresponding author), Univ Sydney, Fac Med & Hlth, Sch Med Sci, Sydney, NSW, Australia.; Diong, J (corresponding author), Neurosci Res Australia NeuRA, Randwick, NSW, Australia.	joanna.diong@sydney.edu.au	Diong, Joanna/S-6717-2019; Heroux, Martin/AAD-7694-2021	Diong, Joanna/0000-0002-0077-3869; Heroux, Martin/0000-0002-3354-7104; Herbert, Rob/0000-0003-4188-9195	National Stroke Foundation Small Project Grant [S14/317]; National Health and Medical Research Council [APP1055084]	National Stroke Foundation Small Project Grant; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by a National Stroke Foundation Small Project Grant (https://strokefoundation.org.au/), S14/317. RDH, MEH and SCG are supported by the National Health and Medical Research Council (https://www.nhmrc.gov.au/), APP1055084	Bernabei M, 2017, J EXP BIOL, V220, P537, DOI 10.1242/jeb.143545; Bernabei M, 2015, J APPL PHYSIOL, V118, P427, DOI 10.1152/japplphysiol.00703.2014; Bojsen-Moller J, 2010, J APPL PHYSIOL, V109, P1608, DOI 10.1152/japplphysiol.01381.2009; DAVIES TW, 1989, J ANAT, V162, P169; de Bruin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101038; Diong JA, 2015, J APPL BIOMECH, V31, P13, DOI [10.1123/JAB.2014-0064, 10.1123/jab.2014-0064]; Diong JHL, 2012, MUSCLE NERVE, V46, P237, DOI 10.1002/mus.23356; Carvalhais VOD, 2013, J BIOMECH, V46, P1003, DOI 10.1016/j.jbiomech.2012.11.044; Field A., 2012, DISCOVERING STAT USI; HAGBARTH KE, 1985, J PHYSIOL-LONDON, V368, P323, DOI 10.1113/jphysiol.1985.sp015860; Hamitouche K, 2000, Chir Main, V19, P109, DOI 10.1016/S1297-3203(00)73468-8; Higham TE, 2011, PHILOS T R SOC B, V366, P1477, DOI 10.1098/rstb.2010.0359; Huijing PA, 2009, J BIOMECH, V42, P9, DOI 10.1016/j.jbiomech.2008.09.027; Krause F, 2016, J ANAT, V228, P910, DOI 10.1111/joa.12464; Lieber RL, 2010, SKELETAL MUSCLE STRU; Linburg R M, 1979, J Hand Surg Am, V4, P79; Maas H, 2008, J APPL PHYSIOL, V104, P1557, DOI 10.1152/japplphysiol.01208.2007; Maas H, 2018, EXERC SPORT SCI REV, V46, P26, DOI 10.1249/JES.0000000000000132; Maas H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/575672; Meijer HJM, 2006, ACTA PHYSIOL, V186, P185, DOI 10.1111/j.1748-1716.2006.01528.x; Motulsky H., 2014, INTUITIVE BIOSTATIST; NARICI MV, 1992, EUR J APPL PHYSIOL O, V65, P438, DOI 10.1007/BF00243511; Proske U, 2014, EXP BRAIN RES, V232, P3397, DOI 10.1007/s00221-014-4088-5; Sandercock TG, 2009, MED SCI SPORT EXER, V41, P184, DOI 10.1249/MSS.0b013e318183c0c3; SCHUIND F, 1992, J HAND SURG-AM, V17A, P291, DOI 10.1016/0363-5023(92)90408-H; Smeulders MJC, 2005, MUSCLE NERVE, V32, P208, DOI 10.1002/mus.20360; Tian MY, 2012, J APPL PHYSIOL, V113, P517, DOI 10.1152/japplphysiol.00111.2012; Tijs C, 2016, J BIOMECH, V49, P2953, DOI 10.1016/j.jbiomech.2016.07.005; Tijs C, 2015, J EXP BIOL, V218, P2935, DOI 10.1242/jeb.122747; Walsh LD, 2013, J PHYSIOL-LONDON, V591, P6103, DOI 10.1113/jphysiol.2013.259127; Yu WS, 2007, J PHYSIOL-LONDON, V583, P1145, DOI 10.1113/jphysiol.2007.135640; ZAJAC FE, 1989, EXERCISE SPORT SCI R, V17, P187	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212496	10.1371/journal.pone.0212496	http://dx.doi.org/10.1371/journal.pone.0212496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768639	Green Published, Green Submitted, gold			2022-12-26	WOS:000458766300044
J	Lumenta, DB; Sendlhofer, G; Pregartner, G; Hart, M; Tiefenbacher, P; Kamolz, LP; Brunner, G				Lumenta, David Benjamin; Sendlhofer, Gerald; Pregartner, Gudrun; Hart, Marlies; Tiefenbacher, Peter; Kamolz, Lars Peter; Brunner, Gernot			Quality of teamwork in multidisciplinary cancer team meetings: A feasibility study	PLOS ONE			English	Article							CLINICAL DECISION-MAKING; PERFORMANCE; CARE; IMPLEMENTATION; STRATEGIES; VALIDATION	Background Tumor boards (TB) play an important role to formulate a management plan for the treatment of patients with a malignancy. Recent evidence suggests that optimally functioning teams (teamwork, communication and decision making) are major prerequisites to conduct efficient TB meetings. The aims of this study were i) to use a readily published tool as a template for the development of a teamwork perspective extended assessment tool and ii) to evaluate the tool in a feasibility study by clinical and non-clinical observers. Methods A systematic literature search in four databases revealed the "Metric for the Observation of Decision-making (MODe)" to be consistently used. MODe served as a template for the clinical evaluation, additional, notably teamwork items were integrated, and the resulting tool was tested in a feasibility study in TBs by clinical and non-clinical observers. The percentage of agreement between observers was assessed in a two-step approach: first, agreement of raters on discussion of items by TB members, and second, agreement of raters based on ordinal scale. Results In total, 244 patients were discussed in 27 TB sessions, thereof 136 (56%) fast track cases and 108 (44%) complex cases. In 228 (93%) of all cases an agreement for recommendation of a treatment plan was reached. Observers showed in general high agreement on discussion of the items. For the majority of items, the percentage of agreement between the different pairs of rater was similar and mostly high. Conclusion A newly developed TB team performance tool using MODe as a template was piloted in a German-speaking country and enabled the assessment of specialized multidisciplinary teams with a special focus on teamwork patterns. The developed assessment tool requires evaluation in a larger collective for validation, and additional assessment whether it can be applied equally by non-clinicians and clinicians.	[Lumenta, David Benjamin; Sendlhofer, Gerald; Kamolz, Lars Peter; Brunner, Gernot] Med Univ Graz, Div Plast Aesthet & Reconstruct Surg, Dept Surg, Res Unit Safety Hlth, Graz, Austria; [Lumenta, David Benjamin; Sendlhofer, Gerald; Hart, Marlies; Tiefenbacher, Peter; Kamolz, Lars Peter; Brunner, Gernot] Med Univ Graz, Comprehens Canc Ctr Graz, Graz, Austria; [Lumenta, David Benjamin; Sendlhofer, Gerald; Hart, Marlies; Tiefenbacher, Peter; Kamolz, Lars Peter; Brunner, Gernot] Univ Hosp Graz, Graz, Austria; [Sendlhofer, Gerald; Hart, Marlies; Tiefenbacher, Peter; Kamolz, Lars Peter] Univ Hosp Graz, Execut Dept Qual & Risk Management, Graz, Austria; [Pregartner, Gudrun] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Sendlhofer, G (corresponding author), Med Univ Graz, Div Plast Aesthet & Reconstruct Surg, Dept Surg, Res Unit Safety Hlth, Graz, Austria.; Sendlhofer, G (corresponding author), Med Univ Graz, Comprehens Canc Ctr Graz, Graz, Austria.; Sendlhofer, G (corresponding author), Univ Hosp Graz, Graz, Austria.; Sendlhofer, G (corresponding author), Univ Hosp Graz, Execut Dept Qual & Risk Management, Graz, Austria.	gerald.sendlhofer@medunigraz.at	Lumenta, David Benjamin/AAD-5935-2019	Lumenta, David Benjamin/0000-0003-0903-252X; Sendlhofer, Gerald/0000-0002-6538-3116				Engel D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115212; Fleissig A, 2006, LANCET ONCOL, V7, P935, DOI 10.1016/S1470-2045(06)70940-8; Hahlweg P, PROCESS QUALITY DECI; Hahlweg P, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3768-5; Jalil R, 2014, J UROLOGY, V192, P891, DOI 10.1016/j.juro.2014.03.002; Jalil R, 2013, INT J SURG, V11, P389, DOI 10.1016/j.ijsu.2013.02.026; Kesson EM, 2012, EFFECTS MULTIDISCIPL; Kidger J, 2009, BJOG-INT J OBSTET GY, V116, P511, DOI 10.1111/j.1471-0528.2008.02066.x; Lamb B, 2011, SURG ONCOL, V20, P163, DOI 10.1016/j.suronc.2010.07.007; Lamb BW, 2013, ANN SURG ONCOL, V20, P1408, DOI 10.1245/s10434-012-2676-9; Lamb BW, 2013, ANN SURG ONCOL, V20, P715, DOI 10.1245/s10434-012-2691-x; Lamb BW, 2012, ANN SURG ONCOL, V19, P1759, DOI 10.1245/s10434-011-2187-0; Lamb BW, 2011, ANN SURG ONCOL, V18, P3535, DOI 10.1245/s10434-011-1773-5; Lamb BW, 2013, J AM COLL SURGEONS, V217, P412, DOI 10.1016/j.jamcollsurg.2013.04.035; Lamb BW, 2011, BMJ QUAL SAF, V20, P849, DOI 10.1136/bmjqs.2010.048660; Lamb BW, 2011, ANN SURG ONCOL, V18, P2116, DOI 10.1245/s10434-011-1675-6; Muller E, 2016, ACTA ONCOL, V55, P1484, DOI 10.1080/0284186X.2016.1227087; Scholl I, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0740-y; Scholl I, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0731-z; Shah S, 2014, SURG ENDOSC, V28, P2783, DOI 10.1007/s00464-014-3545-3; Taylor C, 2012, ANN SURG ONCOL, V19, P4019, DOI 10.1245/s10434-012-2493-1; Taylor C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-202; Woolley AW, 2007, SOC NEUROSCI, V2, P96, DOI 10.1080/17470910701363041; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147	24	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212556	10.1371/journal.pone.0212556	http://dx.doi.org/10.1371/journal.pone.0212556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768645	gold, Green Published, Green Submitted			2022-12-26	WOS:000458766300048
J	Abiy, AZ; Melesse, AM; Abtew, W; Whitman, D				Abiy, Anteneh Z.; Melesse, Assefa M.; Abtew, Wossenu; Whitman, Dean			Rainfall trend and variability in Southeast Florida: Implications for freshwater availability in the Everglades	PLOS ONE			English	Article							STANDARDIZED PRECIPITATION INDEX; MIAMI-DADE COUNTY; ECOSYSTEM; MANAGEMENT; HYDROLOGY	Freshwater demand in Southeast Florida is predicted to increase over the next few decades. However, shifting patterns in the intensity and frequency of drought create considerable pressure on local freshwater availability. Well-established water resources management requires evaluating and understanding long-term rainfall patterns, drought intensity and cycle, and related rainfall deficit. In this study, the presence of rainfall monotonic trends was analyzed using linear regression and Mann-Kendal trend tests. Pettit's single point detection test examined the presence of an abrupt change of rainfall. Drought in Southeast Florida is assessed using the Standardized Precipitation Index (SPI) in 3-, 6-, 12-, and 24-months scale; and the Fast Fourier Transform is applied to evaluate the frequency of each drought intensity. There was an increase of rainfall in most of the wet season months, the total wet season, and the annual total. The wet season duration showed a decrease driven by a decrease in October rainfall. Since 1990, wet season and total annual rainfall exhibited an abrupt increase. The SPI analysis has indicated that extended wetness characterizes the contemporary rainfall regime since 1995, except for the incidence of intermittent dry spells. Short-term droughts have 3-year to 5-year recurrence intervals, and sustained droughts have a 10-year and 20-year recurrence intervals. In Southeast Florida, prolonged drought limits freshwater availability by decreasing recharge, resulting in a longer hydro-period to maintain the health of the Everglades Ecosystem, and to control saltwater intrusion. The increasing dry season duration suggests the growing importance of promoting surface water storage and demand-side management practices.	[Abiy, Anteneh Z.; Melesse, Assefa M.; Abtew, Wossenu; Whitman, Dean] Florida Int Univ, Dept Earth & Environm, Miami, FL 33199 USA; [Abtew, Wossenu] Water & Environm Consulting, Boynton Beach, FL USA; [Melesse, Assefa M.] Florida Int Univ, SERC, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Abiy, AZ (corresponding author), Florida Int Univ, Dept Earth & Environm, Miami, FL 33199 USA.	aabiy001@fiu.edu	Melesse, Assefa/F-9931-2013	Melesse, Assefa/0000-0003-4724-9367	Everglades Foundation; FIU for Everglades's fellowship; Department of Earth and Environment; NSF CREST-CACHE; Institute of Water & Environment of Florida International University; NSF CREST-CACHE project; Southeast Environmental Research Center (SERC)	Everglades Foundation; FIU for Everglades's fellowship; Department of Earth and Environment; NSF CREST-CACHE; Institute of Water & Environment of Florida International University; NSF CREST-CACHE project; Southeast Environmental Research Center (SERC)	This research is partially supported by the Everglades Foundation, FIU for Everglades's fellowship, the Department of Earth and Environment, the NSF CREST-CACHE, Southeast Environmental Research Center (SERC), and Institute of Water & Environment of Florida International University. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; This research is partially supported by the Everglades Foundation, FIU for Everglades fellowship, the Department of Earth and Environment, and the NSF CREST-CACHE project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to acknowledge our data sources the Florida Climate Center and the South Florida Water Management District. The manuscript was proof read and polished in Center for Excellence in Writing at Florida International University; specifically, we are grateful to Charles A. Donate, Kay-Ann L., and Manny for arranging extra time to proofreading the manuscript. The authors are thankful to the journal editor and anonymous reviewers for providing substantial comments. This is contribution number 898 from the Southeast Environmental Research Center in the Institute of Water & Environment at Florida International University.	Abdi H., 2007, ENCY MEASUREMENT STA, P508; ABTEW W, 1993, WATER RESOUR BULL, V29, P179; Abtew W, 2007, HYDROLOGY S FLORIDA, V1; Abtew W, 2010, S FLORIDA ENV REPORT; Abtew W, 2010, WATER RESOUR MANAG, V24, P4255, DOI 10.1007/s11269-010-9656-2; Ali A, 2000, J AM WATER RESOUR AS, V36, P833, DOI 10.1111/j.1752-1688.2000.tb04310.x; D'Odorico P, 2012, PHILOS T R SOC B, V367, P3145, DOI 10.1098/rstb.2012.0016; DeAngelis DL, 1998, ECOSYSTEMS, V1, P64, DOI 10.1007/s100219900006; Edward DC, 1997, CHARACTERISTICS 20 C, P1; Fleming SW, 2002, HYDROL PROCESS, V16, P565, DOI 10.1002/hyp.523; Gentile JH, 2001, SCI TOTAL ENVIRON, V274, P231, DOI 10.1016/S0048-9697(01)00746-X; Guttman NB, 1999, J AM WATER RESOUR AS, V35, P311, DOI 10.1111/j.1752-1688.1999.tb03592.x; Harvey JW, 2009, HYDROGEOL J, V17, P185, DOI 10.1007/s10040-008-0379-x; Irizarry-Ortiz MM, 2013, HYDROL PROCESS, V27, P2225, DOI 10.1002/hyp.8259; Katz RW, 2002, ADV WATER RESOUR, V25, P1287, DOI 10.1016/S0309-1708(02)00056-8; Kendall MG, 1990, RANK CORRELATION MET, V3; KOHOUT FA, 1960, J GEOPHYS RES, V65, P2133, DOI 10.1029/JZ065i007p02133; Krivoruchko K, 2012, ARCUSER FALL, V6; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Marella RL, 2005, WATER WITHDRAWALS TR; Mayowa OO, 2015, J EARTH SYST SCI, V124, P1609; MCKEE TB, 1993, P 8 C APPL CLIM AN C; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Mishra AK, 2011, J HYDROL, V403, P157, DOI 10.1016/j.jhydrol.2011.03.049; Obeysekera J., 1999, URBAN ECOSYST, V3, P223, DOI DOI 10.1023/A:1009552500448; Palmer W.C., 1965, 45 US DEP COMM WEATH, P45; Perry WB, 2008, ECOTOXICOLOGY, V17, P569, DOI 10.1007/s10646-008-0240-y; Pettitt A. N., 1979, Applied Statistics, V28, P126, DOI 10.2307/2346729; Press WH, 1992, NUMERICAL RECIPES C, V29; RENKEN RA, 2005, US GEOL SURV CIRC, P1; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Sklar F., 1999, EVERGLADES INTERIM R, V2, P1; Storch H. V., 1999, J AM STAT ASSOC, V95, P1375, DOI [10.1017/CBO9780511612336, DOI 10.1017/CBO9780511612336]; Swain E, 2012, J ENVIRON MANAGE, V113, P15, DOI 10.1016/j.jenvman.2012.08.033; Tallaksen L.M., 2004, HYDROLOGICAL DROUGHT, V48; Theil H., 1950, RANK INVARIANT METHO, V53, P386, DOI DOI 10.1007/978-94-011-2546-8_20; Vujica Yevjevich, 1972, PROBABILITY STAT HYD; Wilcox WM, 2004, J HYDROL, V293, P1, DOI [10.1016/j.jhyrol.2003.12.041, 10.1016/j.jhydrol.2003.12.041]; Wilhite D. A., 1985, Water International, V10, P111, DOI 10.1080/02508068508686328; Wu H, 2007, INT J CLIMATOL, V27, P65, DOI 10.1002/joc.1371	40	28	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212008	10.1371/journal.pone.0212008	http://dx.doi.org/10.1371/journal.pone.0212008			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753221	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600036
J	Busch, G; Gauly, S; von Meyer-Hofer, M; Spiller, A				Busch, Gesa; Gauly, Sarah; von Meyer-Hoefer, Marie; Spiller, Achim			Does picture background matter? People's evaluation of pigs in different farm settings	PLOS ONE			English	Article							PUBLIC-ATTITUDES; CONSUMER ATTITUDES; ANIMAL WELFARE; CONSISTENCY; IDENTIFICATION; PERCEPTIONS; PREFERENCES; SYSTEMS; OBJECTS	Pictures of farm animals and their husbandry systems are frequently presented in the media and are mostly connected to discussions surrounding farm animal welfare. How such pictures are perceived by the broader public is not fully understood thus far. It is presumable that the animals' expressions and body languages as well as their depicted environment or husbandry systems affect public perception. Therefore, the aim of this study is to test how the evaluation of a picture showing a farmed pig is influenced by portrayed attributes, as well as participants' perceptions of pigs' abilities in general, and if connection to agriculture has an influence. In an online survey, 1,019 German residents were shown four modified pictures of a pig in a pen. The pictures varied with regards to facial expression and body language of the pig ('happy' versus 'unhappy' pig) and the barn setting (straw versus slatted floor pen). Respondents were asked to evaluate both the pen and the welfare of the pig. Two Linear Mixed Models were calculated to analyze effects on pig and pen evaluation. For the pictures, the pen had the largest influence on both pig and pen evaluation, followed by the pig's appearance and participants' beliefs in pigs' mental and emotional abilities, as well as their connection to agriculture. The welfare of both the 'happy' and the 'unhappy' pig was assessed to be higher in the straw setting compared to the slatted floor setting in our study, and even the 'unhappy pig' on straw was perceived more positively than the 'happy pig' on slatted floor. The straw pen was evaluated as being better than the slatted floor pen on the pictures we presented but the pens also differed in level of dirt on the walls (more dirt in the slatted floor pen), which might have influenced the results. Nevertheless, the results suggest that enduring aspects of pictures such as the husbandry system influence perceptions more than a momentary body expression of the pig, at least in the settings tested herein.	[Busch, Gesa] Free Univ Bozen Bolzano, Fac Sci & Technol, Agr & Food Econ, Bozen Bolzano, Italy; [Gauly, Sarah; von Meyer-Hoefer, Marie; Spiller, Achim] Univ Goettingen, Fac Agr Sci, Dept Agr Econ & Rural Dev, Gottingen, Germany	Free University of Bozen-Bolzano; University of Gottingen	Busch, G (corresponding author), Free Univ Bozen Bolzano, Fac Sci & Technol, Agr & Food Econ, Bozen Bolzano, Italy.; Spiller, A (corresponding author), Univ Goettingen, Fac Agr Sci, Dept Agr Econ & Rural Dev, Gottingen, Germany.	gesabusch@web.de; a.spiller@agr.uni-goettingen.de	Spiller, Achim/CAJ-5518-2022; Busch, Gesa/AAI-1529-2020	von Meyer-Hofer, Marie/0000-0002-2853-2522	project "Social Lab - Livestock farming as mirrored by society" (Social Lab - Nutztierhaltung im Spiegel der Gesellschaft"); Federal Ministry of Food and Agriculture (BMEL) of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE) under the innovation support program [2817203213]; German Research Foundation; Gottingen University	project "Social Lab - Livestock farming as mirrored by society" (Social Lab - Nutztierhaltung im Spiegel der Gesellschaft"); Federal Ministry of Food and Agriculture (BMEL) of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE) under the innovation support program; German Research Foundation(German Research Foundation (DFG)); Gottingen University	The study is funded by the project "Social Lab - Livestock farming as mirrored by society" (Social Lab - Nutztierhaltung im Spiegel der Gesellschaft", grant recipient AS). It is supported by funds of the Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE) under the innovation support program. The grant number is 2817203213, the funder's web site can be accessed via: http://www.sociallab-nutztiere.de/.We acknowledge support from the German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bitgood S, 1985, AAZPA C P, P419; Boissy A, 2011, ANIM WELFARE, V20, P47; Boogaard BK, 2006, LIVEST SCI, V104, P13, DOI 10.1016/j.livsci.2006.02.010; Boogaard BK, 2011, LIVEST SCI, V140, P189, DOI 10.1016/j.livsci.2011.03.028; Boogaard BK, 2011, ANIMAL, V5, P1458, DOI 10.1017/S1751731111000371; Busch G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174013; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; Clark B, 2016, J AGR ENVIRON ETHIC, V29, P455, DOI 10.1007/s10806-016-9615-x; Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; Davenport JL, 2007, MEM COGNITION, V35, P393, DOI 10.3758/BF03193280; Ekman P., 1982, EMOTION HUMAN FACE; FINLAY T, 1988, ENVIRON BEHAV, V20, P508, DOI 10.1177/0013916588204008; Frewer LJ, 2005, J AGR ENVIRON ETHIC, V18, P345, DOI 10.1007/s10806-005-1489-2; Hall C, 2007, ANIM WELFARE, V16, P499; Hills AM, 1995, ANTHROZOOS, V8, P132, DOI 10.2752/089279395787156347; Janssen M, 2016, J AGR ENVIRON ETHIC, V29, P1071, DOI 10.1007/s10806-016-9647-2; Kano F, 2009, P R SOC B, V276, P1949, DOI 10.1098/rspb.2008.1811; Knight S, 2008, ANTHROZOOS, V21, P31, DOI 10.2752/089279308X274047; Konok V, 2014, APPL ANIMAL BEHAV SC, V162, P37; Krystallis A, 2009, LIVEST SCI, V126, P46, DOI 10.1016/j.livsci.2009.05.016; Kujala MV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170730; Kuleshov Lev Vladimirovich, 1974, KULESHOV FILM WRITIN; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Lassen J, 2006, LIVEST SCI, V103, P221, DOI 10.1016/j.livsci.2006.05.008; Malhotra N.K., 2008, REV MARKETING RES, P123, DOI DOI 10.1108/S1548-6435(2008)0000004009; MAPLE TL, 1983, INT J STUD ANIM PROB, V4, P295; MCFARLAND SG, 1981, PUBLIC OPIN QUART, V45, P208, DOI 10.1086/268651; Mobbs D, 2006, SOC COGN AFFECT NEUR, V1, P95, DOI 10.1093/scan/nsl014; Myers Olin Eugene Jr, 2004, Curator, V47, P299; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; RHOADS DL, 1979, INT J ENVIRON STUD, V13, P283, DOI 10.1080/00207237908709834; Roosen J., 2008, P SYST DYN INN FOOD, V0, P260, DOI DOI 10.18461/PFSD.2016.1630; Rousing T, 2006, APPL ANIM BEHAV SCI, V101, P40, DOI 10.1016/j.applanim.2005.12.009; Ryan EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141878; Schirmer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074591; SOMMER R, 1972, NAT HIST, V81, P26; Sorensen BT, 2012, APPETITE, V59, P885, DOI 10.1016/j.appet.2012.08.021; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; TOURANGEAU R, 1988, PSYCHOL BULL, V103, P299, DOI 10.1037/0033-2909.103.3.299; TROPE Y, 1986, PSYCHOL REV, V93, P239, DOI 10.1037/0033-295X.93.3.239; Vanhonacker F, 2008, LIVEST SCI, V116, P126, DOI 10.1016/j.livsci.2007.09.017; Verbeke W, 2010, MEAT SCI, V84, P284, DOI 10.1016/j.meatsci.2009.05.001; Wemelsfelder F, 2012, J ANIM SCI, V90, P3652, DOI 10.2527/jas.2011-4691; Wemelsfelder F, 2009, ANIM BEHAV, V78, P477, DOI 10.1016/j.anbehav.2009.06.005; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Zhang C, 2014, SURV RES METHODS-GER, V8, P127	48	15	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211256	10.1371/journal.pone.0211256	http://dx.doi.org/10.1371/journal.pone.0211256			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL0PE	30753189	Green Published, Green Submitted, gold			2022-12-26	WOS:000458395600008
J	Meneguetti, GP; Santos, JHPM; Obreque, KMT; Barbosa, CMV; Monteiro, G; Farsky, SHP; de Oliveira, AM; Angeli, CB; Palmisano, G; Ventura, SPM; Pessoa, A; Rangel-Yagui, CD				Meneguetti, Giovanna Pastore; Picado Madalena Santos, Joao Henrique; Torres Obreque, Karin Mariana; Vaz Barbosa, Christiano Marcello; Monteiro, Gisele; Poliselli Farsky, Sandra Helena; de Oliveira, Adriano Marim; Angeli, Claudia Blanes; Palmisano, Giuseppe; Marques Ventura, Sonia Patricia; Pessoa-Junior, Adalberto; Rangel-Yagui, Carlota de Oliveira			Novel site-specific PEGylated L-asparaginase	PLOS ONE			English	Article							ESCHERICHIA-COLI ASPARAGINASE; SUBSTRATE-SPECIFICITY; PURIFICATION; PROTEINS; LEUKEMIA; PEGASPARGASE; SYNTHETASE; EXPRESSION; RESISTANCE; CHILDREN	L-asparaginase (ASNase) from Escherichia coli is currently used in some countries in its PEGylated form (ONCASPAR, pegaspargase) to treat acute lymphoblastic leukemia (ALL). PEGylation refers to the covalent attachment of poly(ethylene) glycol to the protein drug and it not only reduces the immune system activation but also decreases degradation by plasmatic proteases. However, pegaspargase is randomly PEGylated and, consequently, with a high degree of polydispersity in its final formulation. In this work we developed a site-specific N-terminus PEGylation protocol for ASNase. The monoPEG-ASNase was purified by anionic followed by size exclusion chromatography to a final purity of 99%. The highest yield of monoPEG-ASNase of 42% was obtained by the protein reaction with methoxy polyethylene glycol-carboxymethyl N-hydroxysuccinimidyl ester (10kDa) in 100 mM PBS at pH 7.5 and PEG: ASNase ratio of 25:1. The monoPEG-ASNase was found to maintain enzymatic stability for more days than ASNase, also was resistant to the plasma proteases like asparaginyl endopeptidase and cathepsin B. Additionally, monoPEG-ASNase was found to be potent against leukemic cell lines (MOLT-4 and REH) in vitro like polyPEG-ASNase. monoPEG-ASNase demonstrates its potential as a novel option for ALL treatment, being an inventive novelty that maintains the benefits of the current enzyme and solves challenges.	[Meneguetti, Giovanna Pastore; Picado Madalena Santos, Joao Henrique; Torres Obreque, Karin Mariana; Monteiro, Gisele; Pessoa-Junior, Adalberto; Rangel-Yagui, Carlota de Oliveira] Univ Sao Paulo, Dept Biochem & Pharmaceut Technol, Sao Paulo, Brazil; [Picado Madalena Santos, Joao Henrique; Marques Ventura, Sonia Patricia] Univ Aveiro, Dept Chem, CICECO Aveiro Inst Mat, Aveiro, Portugal; [Vaz Barbosa, Christiano Marcello; Poliselli Farsky, Sandra Helena] Univ Sao Paulo, Dept Clin & Toxicol Anal, Sao Paulo, Brazil; [de Oliveira, Adriano Marim] Technol Res Inst, Dept Bionanomanufacture, Sao Paulo, Brazil; [Angeli, Claudia Blanes; Palmisano, Giuseppe] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Aveiro; Universidade de Sao Paulo; Universidade de Sao Paulo	Rangel-Yagui, CD (corresponding author), Univ Sao Paulo, Dept Biochem & Pharmaceut Technol, Sao Paulo, Brazil.	corangel@usp.br	Farsky, Sandra HP/C-4044-2012; Angeli, Claudia B/M-1282-2016; Monteiro, Gisele/E-5897-2012; RANGEL-YAGUI, CARLOTA/AAE-3084-2021; de Oliveira, Adriano Marim/F-1115-2013; RANGEL-YAGUI, CARLOTA O/B-2560-2013; Pessoa-Junior, Adalberto/B-7963-2012; Palmisano, Giuseppe/N-3602-2013; Obreque, Karin Torres/X-7920-2019; Santos, João H. P. M./G-8387-2017; Ventura, Sonia/D-3992-2012	Angeli, Claudia B/0000-0002-3906-1973; Monteiro, Gisele/0000-0002-3385-047X; RANGEL-YAGUI, CARLOTA/0000-0003-4221-9505; RANGEL-YAGUI, CARLOTA O/0000-0003-4221-9505; Pessoa-Junior, Adalberto/0000-0002-5268-8690; Palmisano, Giuseppe/0000-0003-1336-6151; Obreque, Karin Torres/0000-0003-1911-385X; Santos, João H. P. M./0000-0002-1897-7501; Ventura, Sonia/0000-0001-9049-4267	State of Sao Paulo Research Foundation (FAPESP-Brazil) [2013/08617-7, 2016/22065-5]; National Council for Scientific and Technological Development (CNPq-Brazil); Coordination of Improvement of Higher Education Personnel (CAPES-Brazil) [001]; Technological Research Institute Foundation (FIPT, Brazil); national funds through the FCT/MEC - FEDER [POCI-01-0145-FEDER-007679, UID/CTM/50011/2013]; FEDER under the PT2020 Partnership Agreement; Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/102915/2014]; FCT [IF/00402/2015]	State of Sao Paulo Research Foundation (FAPESP-Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Improvement of Higher Education Personnel (CAPES-Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Technological Research Institute Foundation (FIPT, Brazil); national funds through the FCT/MEC - FEDER; FEDER under the PT2020 Partnership Agreement; Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was supported by grants from the State of Sao Paulo Research Foundation (FAPESP-Brazil, processes number 2013/08617-7 and 2016/22065-5), the National Council for Scientific and Technological Development (CNPq-Brazil), the Coordination of Improvement of Higher Education Personnel (CAPES-Brazil, Project 001) and Technological Research Institute Foundation (FIPT, Brazil). This work was also developed within scope of the project CICECO-Aveiro Institute of Materials, POCI-01-0145-FEDER-007679 (FCT Ref. UID/CTM/50011/2013), financed by national funds through the FCT/MEC and when appropriate co-financed by FEDER under the PT2020 Partnership Agreement. The authors are grateful for the financial support of the Portuguese Foundation for Science and Technology (FCT) for the doctoral grant of SFRH/BD/102915/2014 of Joao H. P. M. Santos. S. P. M. Ventura acknowledges FCT for the contract IF/00402/2015.	Abe M, 2010, BIOTECHNOL J, V5, P477, DOI 10.1002/biot.201000013; ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578; Aghaiypour K, 2001, BIOCHEMISTRY-US, V40, P5655, DOI 10.1021/bi0029595; Akbarzadehlaleh P, 2016, ADV PHARM BULL, V6, P309, DOI 10.15171/apb.2016.043; Anishkin A, 2015, J MOL BIOL, V427, P2867, DOI 10.1016/j.jmb.2015.06.017; Aslanian AM, 2001, BIOCHEM J, V357, P321, DOI 10.1042/0264-6021:3570321; Avramis VI, 2002, BLOOD, V99, P1986, DOI 10.1182/blood.V99.6.1986; Balcao VM, 2001, BIOTECHNOL PROGR, V17, P537, DOI 10.1021/bp000163r; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Costa IM, 2016, SCI REP-UK, V6, DOI 10.1038/srep36239; Derst C, 2000, PROTEIN SCI, V9, P2009, DOI 10.1110/ps.9.10.2009; Dinndorf PA, 2007, ONCOLOGIST, V12, P991, DOI 10.1634/theoncologist.12-8-991; Douer D, 2007, BLOOD, V109, P2744, DOI 10.1182/blood-2006-07-035006; Ebbing D., 1993, GEN CHEM; European Medicine Agency EMA, 2005, EPAR HUM PROD INF; European Medicine Agency EMA. Oncaspar- pegaspargase, 2015, EMACHMP7349822015; Fernandes LR, 2017, J PROTEOMICS, V151, P12, DOI 10.1016/j.jprot.2016.06.011; Glasstone S., 2007, INTRO ELECTROCHEMIST; Gokarn YR, 2012, MOL PHARMACEUT, V9, P762, DOI 10.1021/mp200470c; Hagel Lars, 2011, Methods Biochem Anal, V54, P51; Hermanova I, 2012, EXP HEMATOL, V40, P657, DOI 10.1016/j.exphem.2012.04.005; Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P1; IMADA A, 1973, J GEN MICROBIOL, V76, P85, DOI 10.1099/00221287-76-1-85; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Jin MJ, 2013, ACTA PHARM SIN B, V3, P123, DOI 10.1016/j.apsb.2013.01.003; Knott SRV, 2018, NATURE, V554, P378, DOI 10.1038/nature25465; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee S, 2000, US, Patent No. [7052686B2, 7052686]; Lopez-Fernandez H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0752-4; Loureiro C. B., 2012, ADV MICROBIOL, V02, P138, DOI [10.4236/aim.2012.22019, DOI 10.4236/AIM.2012.22019]; Mattos A, 2012, J CONTROL RELEASE, V162, P84, DOI 10.1016/j.jconrel.2012.05.041; MESAS JM, 1990, J GEN MICROBIOL, V136, P515, DOI 10.1099/00221287-136-3-515; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nelson D.L., 2005, LEHNINGER PRINCIPLES, DOI DOI 10.1002/BMB.2005.494033010419; Offman MN, 2011, BLOOD, V117, P1614, DOI 10.1182/blood-2010-07-298422; Pabst TM, 2007, J CHROMATOGR A, V1147, P172, DOI 10.1016/j.chroma.2007.02.051; Pasut G, 2008, ADV DRUG DELIVER REV, V60, P69, DOI 10.1016/j.addr.2007.04.018; Pasut G, 2012, J CONTROL RELEASE, V161, P461, DOI 10.1016/j.jconrel.2011.10.037; Patel N, 2009, J CLIN INVEST, V119, P1964, DOI 10.1172/JCI37977; Pfister D, 2016, BIOTECHNOL BIOENG, V113, P1711, DOI 10.1002/bit.25932; Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054; Rashband WS, 1997, IMAGEJ; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Santos JHPM, 2017, GREEN CHEM, V19, P5800, DOI 10.1039/c7gc02600e; Sigma- Aldrich, 2013, M6768 SIGMA METH GLY; Sigma-Tau, 1994, PHARMACEUTICALS; Soares AL, 2002, INT J PHARMACEUT, V237, P163, DOI 10.1016/S0378-5173(02)00046-7; Subramanian G, 2015, CONTINUOUS PROCESSING IN PHARMACEUTICAL MANUFACTURING, pXXIII; van der Meer LT, 2014, BLOOD, V124, P3027, DOI 10.1182/blood-2014-06-582627; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Yu DQ, 2010, J PHARM SCI-US, V99, P3326, DOI 10.1002/jps.22103; Zalipsky S, 1998, CHEM COMMUN, P69, DOI 10.1039/a706713e	53	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211951	10.1371/journal.pone.0211951	http://dx.doi.org/10.1371/journal.pone.0211951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753228	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600031
J	Novak, P; Felsenstein, D; Mao, C; Octavien, NR; Zubcevik, N				Novak, Peter; Felsenstein, Donna; Mao, Charlotte; Octavien, Nadlyne R.; Zubcevik, Nevena			Association of small fiber neuropathy and post treatment Lyme disease syndrome	PLOS ONE			English	Article							HUMAN GRANULOCYTIC ANAPLASMOSIS; SKIN BIOPSY; NEUROBORRELIOSIS; DIAGNOSIS; VASOREACTIVITY; EPIDEMIOLOGY; PREVENTION; BABESIOSIS; INFECTION; ARTHRITIS	Objectives To examine whether post-treatment Lyme disease syndrome (PTLDS) defined by fatigue, cognitive complaints and widespread pain following the treatment of Lyme disease is associated with small fiber neuropathy (SFN) manifesting as autonomic and sensory dysfunction. Methods This single center, retrospective study evaluated subjects with PTLDS. Skin biopsies for assessment of epidermal nerve fiber density (ENFD), sweat gland nerve fiber density (SGNFD) and functional autonomic testing (deep breathing, Valsalva maneuver and tilt test) were performed to assess SFN, severity of dysautonomia and cerebral blood flow abnormalities. Heart rate, end tidal CO2, blood pressure, and cerebral blood flow velocity (CBFv) from middle cerebral artery using transcranial Doppler were monitored. Results 10 participants, 5/5 women/men, age 51.3 +/- 14.7 years, BMI 27.6 +/- 7.3 were analyzed. All participants were positive for Lyme infection by CDC criteria. At least one skin biopsy was abnormal in all ten participants. Abnormal ENFD was found in 9 participants, abnormal SGNFD in 5 participants, and both abnormal ENFD and SGNFD were detected in 4 participants. Parasympathetic failure was found in 7 participants and mild or moderate sympathetic adrenergic failure in all participants. Abnormal total CBFv score was found in all ten participants. Low orthostatic CBFv was found in 7 participants, three additional participants had abnormally reduced supine CBFv. Conclusions SFN appears to be associated with PTLDS and may be responsible for certain sensory symptoms. In addition, dysautonomia related to SFN and abnormal CBFv also seem to be linked to PTLDS. Reduced orthostatic CBFv can be associated with cerebral hypoperfusion and may lead to cognitive dysfunction. Autonomic failure detected in PTLDS is mild to moderate. SFN evaluation may be useful in PTLDS.	[Novak, Peter] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Felsenstein, Donna] Harvard Med Sch, Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA USA; [Mao, Charlotte] Spaulding Rehabil Hosp, Dean Ctr Tick Borne Illness, Boston, MA USA; [Octavien, Nadlyne R.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Zubcevik, Nevena] Harvard Med Sch, Spaulding Rehabil Hosp, Dean Ctr Tick Borne Illness, Dept Phys Med & Rehabil, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital	Novak, P (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA.	pnovak2@bwh.harvard.edu			Department of Neurology, Brigham and Women's Faulkner Hospital, Harvard Medical School and Superior Biologics	Department of Neurology, Brigham and Women's Faulkner Hospital, Harvard Medical School and Superior Biologics	This study was funded by Department of Neurology, Brigham and Women's Faulkner Hospital, Harvard Medical School and Superior Biologics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaedini A, 2005, J NEUROIMMUNOL, V159, P192, DOI 10.1016/j.jneuroim.2004.10.014; [Anonymous], 2002, J INTERN MED, V251, P361, DOI 10.1046/j.1365-2796.2002.00967.x; Aucott JN, 2016, CLIN VACCINE IMMUNOL, V23, P757, DOI 10.1128/CVI.00071-16; Aucott JN, 2015, INFECT DIS CLIN N AM, V29, P309, DOI 10.1016/j.idc.2015.02.012; Aucott JN, 2013, INT J INFECT DIS, V17, pE443, DOI 10.1016/j.ijid.2013.01.008; Bastyr EJ, 2005, CLIN THER, V27, P1278, DOI 10.1016/j.clinthera.2005.08.002; Biesiada G, 2009, POL ARCH MED WEWN, V119, P200, DOI 10.20452/pamw.652; Birnbaum J, 2014, SEMIN ARTHRITIS RHEU, V43, P638, DOI 10.1016/j.semarthrit.2013.10.007; Cairns V, 2005, INT J EPIDEMIOL, V34, P1340, DOI 10.1093/ije/dyi129; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Chung CC, 2015, NEUROLOGY, V85, P450, DOI 10.1212/WNL.0000000000001820; de Greef BTA, 2018, EUR J NEUROL, V25, P348, DOI 10.1111/ene.13508; DURAY PH, 1989, REV INFECT DIS, V11, pS1487; DURAY PH, 1989, RHEUM DIS CLIN N AM, V15, P691; England JD, 2009, NEUROLOGY, V72, P177, DOI 10.1212/01.wnl.0000336345.70511.0f; Fallon BA, 2008, NEUROLOGY, V70, P992, DOI 10.1212/01.WNL.0000284604.61160.2d; Gibbons CH, 2010, MUSCLE NERVE, V42, P112, DOI 10.1002/mus.21626; Grill MF, 2011, BRIT J CLIN PHARMACO, V72, P381, DOI 10.1111/j.1365-2125.2011.03991.x; Kanjwal K, 2011, CARDIOL J, V18, P63; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Koedel U, 2015, NAT REV NEUROL, V11, P446, DOI 10.1038/nrneurol.2015.121; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; LENGLJANSSEN B, 1994, J EXP MED, V180, P2069, DOI 10.1084/jem.180.6.2069; LOW PA, 1983, ANN NEUROL, V14, P573, DOI 10.1002/ana.410140513; Mead PS, 2015, INFECT DIS CLIN N AM, V29, P187, DOI 10.1016/j.idc.2015.02.010; Melia MT, 2016, NEW ENGL J MED, V374, P1277, DOI 10.1056/NEJMe1502350; Moore A, 2016, EMERG INFECT DIS, V22, P1169, DOI 10.3201/eid2207.151694; Novak P., 2015, J NEUROLOGICAL DISOR, DOI [10.4172/2329-6895.1000196, DOI 10.4172/2329-6895.1000196]; Novak P, 2019, AM J MED, V132, P420, DOI 10.1016/j.amjmed.2018.09.027; Novak P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204419; Novak P, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00199; Novak P, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00022; Novak P, 2011, JOVE-J VIS EXP, DOI 10.3791/2502; Novak V, 1998, STROKE, V29, P1876, DOI 10.1161/01.STR.29.9.1876; Novak V, 1998, STROKE, V29, P104, DOI 10.1161/01.STR.29.1.104; Novak V, 2011, DIABETES CARE, V34, P2438, DOI 10.2337/dc11-0969; Pachner AR, 2007, LANCET NEUROL, V6, P544, DOI 10.1016/S1474-4422(07)70128-X; Paules CI, 2018, NEW ENGL J MED, V379, P701, DOI 10.1056/NEJMp1807870; Peter Novak, 2019, AUTONOMIC TESTING; Rauer S, 2018, DTSCH ARZTEBL INT, V115, P751, DOI 10.3238/arztebl.2018.0751; Ross AJ, 2013, CLIN AUTON RES, V23, P305, DOI 10.1007/s10286-013-0212-z; Rupprecht TA, 2008, MOL MED, V14, P205, DOI 10.2119/2007-00091.Rupprecht; Sanchez E, 2016, JAMA-J AM MED ASSOC, V315, P1767, DOI 10.1001/jama.2016.2884; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Shapiro ED, 2000, CLIN INFECT DIS, V31, P533, DOI 10.1086/313982; Steere AC, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.90; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Zilliox L, 2011, NEUROLOGY, V76, P1099, DOI 10.1212/WNL.0b013e3182120147	48	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212222	10.1371/journal.pone.0212222	http://dx.doi.org/10.1371/journal.pone.0212222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753241	Green Published, Green Submitted, gold			2022-12-26	WOS:000458395600054
J	Hernandez, M; Martin, MV; Herrador-Gomez, PM; Jimenez, S; Hernandez-Gonzalez, C; Barreiro, S; Sarralde, R; van Zyl, BJ; Gamatham, JC; Almeida, T; Lopez-Abellan, LJ				Hernandez, Mariano; Virginia Martin, M.; Herrador-Gomez, Pedro M.; Jimenez, Sebastian; Hernandez-Gonzalez, Carlos; Barreiro, Santiago; Sarralde, Roberto; van Zyl, Barend Johannes; Gamatham, Johny Charles; Almeida, Teresa; Lopez-Abellan, Luis J.			Mitocondrial COI and 16S rDNA sequences support morphological identification and biogeography of deep-sea red crabs of the genus Chaceon (Crustacea, Decapoda, Geryonidae) in the Eastern Central and South Atlantic Ocean	PLOS ONE			English	Article							AFFINIS MILNE-EDWARDS; BRACHYURA; POPULATIONS; BOUVIER; BIOLOGY; GENERA; DNA	The geographical spreading of new fishing activities and the increasingly deeper locations of these activities have shown the worldwide distribution of gerionid crabs and new descriptions of Chaceon taxa. However, incomplete penetrance, variable expressivity, and phenotypic overlap make the morphometric identification of these species difficult. In this study, partial sequences of the cytochrome c oxidase subunit 1 (COI) and 16S mitochondrial ribosomal RNA (16S rRNA) genes have been analyzed in Chaceon species from the Eastern Central and South Atlantic and compared with sequences of species from Western Atlantic. Our results corroborate the proposed morphological species and highlight the significant separation of the Eastern Atlantic species and those from Atlantic coasts of South America for both markers (97% Bayesian posterior probability, BPP / 83% Bootstrap replicates, BT). Interestingly, Chaceon sanctaehelenae shows a closer relationship with the species of the American coast than with those from the Eastern Atlantic. On the other hand, while COI marker clearly separates Chaceon atopus and Chaceon erytheiae species (99 BPP / 91% BT), these species share haplotypes for the 16S rRNA marker, pointing to a recent speciation process. Moreover, a close relationship was observed between Chaceon maritae and Chaceon affinis (94% BPP / 77% BT). The topologies of the trees obtained indicate that the ancestor of this genus was closer related to those species from South America than to those from the Eastern Atlantic.	[Hernandez, Mariano; Herrador-Gomez, Pedro M.; Almeida, Teresa] Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, Dept Bioquim Microbiol Biol Celular & Genet, San Cristobal la Laguna, Santa Cruz De T, Spain; [Virginia Martin, M.; Jimenez, Sebastian; Hernandez-Gonzalez, Carlos; Barreiro, Santiago; Sarralde, Roberto; Lopez-Abellan, Luis J.] Inst Espanol Oceanog, Ctr Oceanog Canarias, Santa Cruz De Tenerife, Spain; [van Zyl, Barend Johannes] SEAFO, Swakopmund, Namibia; [Gamatham, Johny Charles] Minist Fisheries & Marine Resources, Swakopmund, Namibia	Universidad de la Laguna; Spanish Institute of Oceanography	Hernandez, M (corresponding author), Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, Dept Bioquim Microbiol Biol Celular & Genet, San Cristobal la Laguna, Santa Cruz De T, Spain.; Martin, MV; Lopez-Abellan, LJ (corresponding author), Inst Espanol Oceanog, Ctr Oceanog Canarias, Santa Cruz De Tenerife, Spain.	mnhdez@ull.edu.es; virginia.martin@ieo.es; luis.lopez@ieo.es	Almeida, Teresa A/S-1166-2018; Martín, M. Virginia M.V. Martín/J-1630-2012; Hernandez, Mariano/AAK-3143-2020; Hernandez, Mariano/K-6679-2015	Almeida, Teresa A/0000-0002-7644-3436; Martín, M. Virginia M.V. Martín/0000-0003-4435-2414; Hernandez, Mariano/0000-0003-1219-0246; Hernandez, Mariano/0000-0003-1219-0246; Herrador Gomez, Pedro Manuel/0000-0002-6831-4415	Spanish Institute of Oceanography	Spanish Institute of Oceanography	MV Martin, S. Jimenez, C. Hernandez-Gonzalez, S. Barreiro, R. Sarralde and L Lopez-Abellan received funds from Spanish Institute of Oceanography (www.ieo.es).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan LJL, 2002, FISH RES, V58, P231, DOI 10.1016/S0165-7836(01)00384-8; Gonzalez JA, 2016, SCI MAR, V80, P89, DOI 10.3989/scimar.04350.10A; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Biscoito M, 2015, DEEP-SEA RES PT I, V95, P99, DOI 10.1016/j.dsr.2014.10.010; CUNNINGHAM CW, 1992, NATURE, V355, P539, DOI 10.1038/355539a0; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davie P, 1989, CHACEON MANNING HOLT; Gonzalez J. A., 1995, CATALOGO CRUSTACEOS; Gonzalez JA, 2009, OLHAR BIODIVERSIDADE; Hastie LC, 1995, OCEANOGR MAR BIOL, V33, P561; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holthuis LB., 1981, SMITHSONIAN CONTRIB, V306, P1, DOI [10.5479/si.00810282.306, DOI 10.5479/SI.00810282.306]; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Karasawa H, 2008, J CRUSTACEAN BIOL, V28, P82, DOI 10.1651/07-2882R.1; KNOWLTON N, 1993, SCIENCE, V260, P1629, DOI 10.1126/science.8503007; Lopez-Abellan LJ, 1992, INF TEC I ESP OCEANO, V119; Lopez-Abellan LJ, 1990, INF TEC I ESP OCEANO, V89; Lopez-Abellan LJ, 2008, PRELIMINARY REPORT M; Macpherson E., 1984, JUNTA CONSULTIVA INV, V12, P39; MANNING R B, 1988, Annals of the South African Museum, V98, P77; MANNING RB, 1989, P BIOL SOC WASH, V102, P50; Mantelatto FL, 2014, DEEP-SEA RES PT I, V84, P29, DOI 10.1016/j.dsr.2013.10.001; Martin JW, 2005, ZOOL J LINN SOC-LOND, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; MELVILLESMITH R, 1988, S AFR J MARINE SCI, V6, P79, DOI 10.2989/025776188784480681; Monacell JT, 2014, BIOINFORMATICS, V30, P1488, DOI 10.1093/bioinformatics/btu055; Ne-Edwards A, 1894, RESULT CAMP SCI MONA, V7, P1; Ng Peter K.L., 2008, Raffles Bulletin of Zoology Supplement, V17, P1; Palumbi SR, 1991, SIMPLE FOOLS GUIDE P, P46; Pinho MR, 2001, FISH RES, V51, P283, DOI 10.1016/S0165-7836(01)00252-1; RAMBAUT A, 2003, TRACER VERSION 1 3 C; Robinson M, 2008, ICES J MAR SCI, V65, P148, DOI 10.1093/icesjms/fsm189; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sampedro MP, 2001, 01139 NAFO SCR; Schubart CD, 2006, B FR PECHE PISCIC, P1019, DOI 10.1051/kmae:2006008; Schubart Christoph D., 2009, Crustacean Issues, V18, P47; Sobrino I, 1992, INF TEC I ESP OCEANO, V112; Sobrino I, 1992, INF TEC I ESP OCEANO, V125; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Stramma L, 1999, DEEP-SEA RES PT II, V46, P279, DOI 10.1016/S0967-0645(98)00109-X; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Weinberg JR, 2003, BIOL BULL-US, V204, P318, DOI 10.2307/1543602; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; [No title captured]	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211717	10.1371/journal.pone.0211717	http://dx.doi.org/10.1371/journal.pone.0211717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742637	gold, Green Published, Green Submitted			2022-12-26	WOS:000458393400020
J	Kedzierski, M; Villain, J; Falcou-Prefol, M; Kerros, ME; Henry, M; Pedrotti, ML; Bruzaud, S				Kedzierski, Mikael; Villain, Jonathan; Falcou-Prefol, Mathilde; Kerros, Marie Emmanuelle; Henry, Maryvonne; Pedrotti, Maria Luiza; Bruzaud, Stephane			Microplastics in Mediterranean Sea: A protocol to robustly assess contamination characteristics	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; IDENTIFICATION METHODS; ENVIRONMENTAL-SAMPLES; MARINE-ENVIRONMENT; COASTAL SEDIMENTS; ABUNDANCE; POLLUTION; BEHAVIOR; ELEMENTS; DEBRIS	The study of microplastic pollution involves multidisciplinary analyses on a large number of microplastics. Therefore, providing an overview of plastic pollution is time consuming and, despite high throughput analyses, remains a major challenge. The objective of this study is to propose a protocol to determine how many microplastics must be analyzed to give a representative view of the particle size distribution and chemical nature, and calculate the associated margin error. Based on microplastic data from Tara Mediterranean campaign, this approach is explained through different examples. In this particular case, the results show that only 3% of the collected microplastics need to be analyzed to give a precise view on the scale of the North West Mediterranean Basin (error <5%), and 17.7% to give an overview manta per manta (error <10%). This approach could be an important practical contribution to microplastic studies.	[Kedzierski, Mikael; Falcou-Prefol, Mathilde; Bruzaud, Stephane] Univ Bretagne Sud, CNRS, UMR, Inst Rech Dupuy de Lome, Lorient, France; [Villain, Jonathan] Univ Lille, Inst Mines Telecom Lille Douai, Unite Rech Informat & Automat, Lille, France; [Kerros, Marie Emmanuelle; Pedrotti, Maria Luiza] Sorbonne Univ, CNRS, UMR, Lab Oceanog Villefranche Sur Mer, Villefranche Sur Mer, France; [Henry, Maryvonne] IFREMER, LER PAC, La Seine Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Ifremer	Kedzierski, M (corresponding author), Univ Bretagne Sud, CNRS, UMR, Inst Rech Dupuy de Lome, Lorient, France.	mikael.kedzierski@univ-ubs.fr	Kedzierski, Mikaël/U-1013-2019	Kedzierski, Mikaël/0000-0003-2855-4593; BRUZAUD, STEPHANE/0000-0002-4576-7681	CNRS; UPMC; LOV; Genoscope/CEA; Tara Expeditions Foundation; Romain Trouble; Veolia Environment Foundation; Lorient Agglomeration; Serge Ferrari; Foundation Prince Albert II de Monaco; IDEC; French Ministry of Foreign Affairs	CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC; LOV; Genoscope/CEA; Tara Expeditions Foundation; Romain Trouble; Veolia Environment Foundation; Lorient Agglomeration; Serge Ferrari; Foundation Prince Albert II de Monaco; IDEC; French Ministry of Foreign Affairs	We thank the commitment of the following institutions, persons and sponsors: CNRS, UPMC, LOV, Genoscope/CEA, the Tara Expeditions Foundation and its founders: agnes b.(R), Etienne Bourgois, Romain Trouble, the Veolia Environment Foundation, Lorient Agglomeration, Serge Ferrari, the Foundation Prince Albert II de Monaco, IDEC, the "Tara" schooner and teams. We thank MERCATOR-CORIOLIS and ACRI-ST for providing daily satellite data during the expedition. We are also grateful to the French Ministry of Foreign Affairs for supporting the expedition and to the countries that graciously granted sampling permission.	Akhbarizadeh R, 2017, ENVIRON POLLUT, V220, P720, DOI 10.1016/j.envpol.2016.10.038; Amaral-Zettler LA, 2015, FRONT ECOL ENVIRON, V13, P541, DOI 10.1890/150017; Barboza LGA, 2015, MAR POLLUT BULL, V97, P5, DOI 10.1016/j.marpolbul.2015.06.008; Antunes JC, 2013, ESTUAR COAST SHELF S, V130, P62, DOI 10.1016/j.ecss.2013.06.016; Bakir A, 2016, ENVIRON POLLUT, V219, P56, DOI 10.1016/j.envpol.2016.09.046; Bakir A, 2014, ESTUAR COAST SHELF S, V140, P14, DOI 10.1016/j.ecss.2014.01.004; Bakir A, 2014, ENVIRON POLLUT, V185, P16, DOI 10.1016/j.envpol.2013.10.007; Bakir A, 2012, MAR POLLUT BULL, V64, P2782, DOI 10.1016/j.marpolbul.2012.09.010; Boucher C, 2016, REG STUD MAR SCI, V3, P1, DOI 10.1016/j.rsma.2015.11.009; Brennecke D, 2016, ESTUAR COAST SHELF S, V178, P189, DOI 10.1016/j.ecss.2015.12.003; Cozar A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600582; Cozar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121762; Dris R, 2017, ENVIRON POLLUT, V221, P453, DOI 10.1016/j.envpol.2016.12.013; Dumichen E, 2015, WATER RES, V85, P451, DOI 10.1016/j.watres.2015.09.002; Dussud C, 2018, ENVIRON POLLUT, V236, P807, DOI 10.1016/j.envpol.2017.12.027; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Eriksen M, 2013, MAR POLLUT BULL, V77, P177, DOI 10.1016/j.marpolbul.2013.10.007; Eriksen M, 2013, MAR POLLUT BULL, V68, P71, DOI 10.1016/j.marpolbul.2012.12.021; Frere L, 2016, MAR POLLUT BULL, V113, P461, DOI 10.1016/j.marpolbul.2016.10.051; Frere L, 2018, ENVIRON POLLUT, V242, P614, DOI 10.1016/j.envpol.2018.07.023; Frias JPGL, 2016, MAR ENVIRON RES, V114, P24, DOI 10.1016/j.marenvres.2015.12.006; Guven O, 2017, ENVIRON POLLUT, V223, P286, DOI 10.1016/j.envpol.2017.01.025; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; Imhof HK, 2016, WATER RES, V98, P64, DOI 10.1016/j.watres.2016.03.015; Kanhai LK, 2017, MAR POLLUT BULL, V115, P307, DOI 10.1016/j.marpolbul.2016.12.025; Kedzierski M, 2018, MAR POLLUT BULL, V127, P684, DOI 10.1016/j.marpolbul.2017.12.059; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lebreton LCM, 2012, MAR POLLUT BULL, V64, P653, DOI 10.1016/j.marpolbul.2011.10.027; Lobelle D, 2011, MAR POLLUT BULL, V62, P197, DOI 10.1016/j.marpolbul.2010.10.013; Loder MGJ, 2015, MARINE ANTHROPOGENIC LITTER, P201, DOI 10.1007/978-3-319-16510-3_8; Majewsky M, 2016, SCI TOTAL ENVIRON, V568, P507, DOI 10.1016/j.scitotenv.2016.06.017; McCormick A, 2014, ENVIRON SCI TECHNOL, V48, P11863, DOI 10.1021/es503610r; Moore CJ, 2002, MAR POLLUT BULL, V44, P1035, DOI 10.1016/S0025-326X(02)00150-9; Moore CJ, 2001, MAR POLLUT BULL, V42, P1297, DOI 10.1016/S0025-326X(01)00114-X; Ng KL, 2006, MAR POLLUT BULL, V52, P761, DOI 10.1016/j.marpolbul.2005.11.017; Ogata Y, 2009, MAR POLLUT BULL, V58, P1437, DOI 10.1016/j.marpolbul.2009.06.014; Pedrotti ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161581; Qiu QX, 2016, ESTUAR COAST SHELF S, V176, P102, DOI 10.1016/j.ecss.2016.04.012; Rocha-Santos T, 2015, TRAC-TREND ANAL CHEM, V65, P47, DOI 10.1016/j.trac.2014.10.011; Sadri SS, 2014, MAR POLLUT BULL, V81, P55, DOI 10.1016/j.marpolbul.2014.02.020; Schlitzer R., 2015, CMOS B SCMO, V43, P9; Song YK, 2015, MAR POLLUT BULL, V93, P202, DOI 10.1016/j.marpolbul.2015.01.015; Sussarellu R, 2016, P NATL ACAD SCI USA, V113, P2430, DOI 10.1073/pnas.1519019113; Turner A, 2016, MAR POLLUT BULL, V111, P136, DOI 10.1016/j.marpolbul.2016.07.020; van Sebille E, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124006; Wang JD, 2017, CHEMOSPHERE, V171, P248, DOI 10.1016/j.chemosphere.2016.12.074; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	47	33	33	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0212088	10.1371/journal.pone.0212088	http://dx.doi.org/10.1371/journal.pone.0212088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742663	Green Submitted, Green Published, gold			2022-12-26	WOS:000458393400047
J	Suwarganda, EK; Diamond, LE; Lloyd, DG; Besier, TF; Zhang, J; Killen, BA; Savage, TN; Saxby, DJ				Suwarganda, Edin K.; Diamond, Laura E.; Lloyd, David G.; Besier, Thor F.; Zhang, Ju; Killen, Bryce A.; Savage, Trevor N.; Saxby, David J.			Minimal medical imaging can accurately reconstruct geometric bone models for musculoskeletal models	PLOS ONE			English	Article							HIP-JOINT CENTER; DYNAMIC SIMULATIONS; SHAPE MODELS; REGISTRATION; STRESSES; CREATE; FEMUR	Accurate representation of subject-specific bone anatomy in lower-limb musculoskeletal models is important for human movement analyses and simulations. Mathematical methods can reconstruct geometric bone models using incomplete imaging of bone by morphing bone model templates, but the validity of these methods has not been fully explored. The purpose of this study was to determine the minimal imaging requirements for accurate reconstruction of geometric bone models. Complete geometric pelvis and femur models of 14 healthy adults were reconstructed from magnetic resonance imaging through segmentation. From each complete bone segmentation, three sets of incomplete segmentations (set 1 being the most incomplete) were created to test the effect of imaging incompleteness on reconstruction accuracy. Geometric bone models were reconstructed from complete sets, three incomplete sets, and two motion capture-based methods. Reconstructions from (in) complete sets were generated using statistical shape modelling, followed by host-mesh and local-mesh fitting through the Musculoskeletal Atlas Project Client. Reconstructions from motion capture-based methods used positional data from skin surface markers placed atop anatomic landmarks and estimated joint centre locations as target points for statistical shape modelling and linear scaling. Accuracy was evaluated with distance error (mm) and overlapping volume similarity (%) between complete bone segmentation and reconstructed bone models, and statistically compared using a repeated measure analysis of variance (p<0.05). Motion capture-based methods produced significantly higher distance error than reconstructions from (in) complete sets. Pelvis volume similarity reduced significantly with the level of incompleteness: complete set (92.70 +/- 1.92%), set 3 (85.41 +/- 1.99%), set 2 (81.22 +/- 3.03%), set 1 (62.30 +/- 6.17%), motion capture-based statistical shape modelling (41.18 +/- 9.54%), and motion capture-based linear scaling (26.80 +/- 7.19%). A similar trend was observed for femur volume similarity. Results indicate that imaging two relevant bone regions produces overlapping volume similarity >80% compared to complete segmented bone models, and improve analyses and simulation over current standard practice of linear scaling musculoskeletal models.	[Suwarganda, Edin K.; Diamond, Laura E.; Lloyd, David G.; Killen, Bryce A.; Savage, Trevor N.; Saxby, David J.] Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia; [Suwarganda, Edin K.; Diamond, Laura E.; Lloyd, David G.; Killen, Bryce A.; Savage, Trevor N.; Saxby, David J.] Griffith Univ, Gold Coast Orthopaed Res Engn & Educ Alliance, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Besier, Thor F.; Zhang, Ju] Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand; [Besier, Thor F.; Zhang, Ju] Univ Auckland, Dept Engn Sci, Auckland, New Zealand; [Savage, Trevor N.] Univ Sydney, Dept Rheumatol, Kolling Inst Med Res, Inst Bone & Joint Res, Sydney, NSW, Australia	Griffith University; Griffith University; Menzies Health Institute Queensland; University of Auckland; University of Auckland; University of Sydney; Kolling Institute of Medical Research	Suwarganda, EK; Saxby, DJ (corresponding author), Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia.; Suwarganda, EK; Saxby, DJ (corresponding author), Griffith Univ, Gold Coast Orthopaed Res Engn & Educ Alliance, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia.	edin.suwarganda@griffithuni.edu.au; david.saxby@griffithuni.edu.au	Savage, Trevor N/C-5709-2019; Besier, Thor F/P-6425-2019; Saxby, David John/T-4036-2019; Lloyd, David Gavin/AAH-6066-2020	Savage, Trevor N/0000-0001-6608-8664; Lloyd, David Gavin/0000-0002-0824-9682; Saxby, David John/0000-0002-0874-7518; Besier, Thor/0000-0003-0818-7554; Killen, Bryce/0000-0001-6389-2497; Diamond, Laura/0000-0002-2197-1856; Suwarganda, Edin/0000-0002-5467-8760	Australian National Health and Medical Research Council [APP ID 1069278]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study is funded by an Australian National Health and Medical Research Council (https://www.nhmrc.gov.au/) grant (APP ID 1069278) awarded to prof. D.G.L.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barratt DC, 2008, MED IMAGE ANAL, V12, P358, DOI 10.1016/j.media.2007.12.006; Besier TF, 2003, J BIOMECH, V36, P1159, DOI 10.1016/S0021-9290(03)00087-3; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bradley CP, 1997, ANN BIOMED ENG, V25, P96, DOI 10.1007/BF02738542; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; da Luz SB, 2017, J BIOMECH, V53, P45, DOI 10.1016/j.jbiomech.2016.12.018; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Falisse A, 2018, J APPL BIOMECH, V34, P496, DOI 10.1123/jab.2017-0156; Fernandez JW, 2004, BIOMECH MODEL MECHAN, V2, P139, DOI [10.1007/s10237-003-0036-1, 10.1007/S10237-003-0036-1]; Fernandez J, 2014, INT J NUMER METH BIO, V30, P28, DOI 10.1002/cnm.2586; Gerus P, 2013, J BIOMECH, V46, P2778, DOI 10.1016/j.jbiomech.2013.09.005; Handsfield GG, 2014, J BIOMECH, V47, P631, DOI 10.1016/j.jbiomech.2013.12.002; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Jones B, 2016, J KNEE SURG, V29, P92, DOI 10.1055/s-0035-1568989; Kainz H, 2017, J APPL BIOMECH, V33, P354, DOI 10.1123/jab.2016-0282; Lenaerts G, 2009, J BIOMECH, V42, P1246, DOI 10.1016/j.jbiomech.2009.03.037; LEVANDOWSKY M, 1971, NATURE, V234, P34, DOI 10.1038/234034a0; Ng KCG, 2017, CLIN ORTHOP RELAT R, V475, P998, DOI 10.1007/s11999-016-5038-2; Nolte D, 2016, J BIOMECH, V49, P3576, DOI 10.1016/j.jbiomech.2016.09.005; Roelker SA, 2017, ANN BIOMED ENG, V45, P2635, DOI 10.1007/s10439-017-1894-5; Satopaa V., 2011, Proceedings of the 2011 31st International Conference on Distributed Computing Systems Workshops (ICDCS Workshops), P166, DOI 10.1109/ICDCSW.2011.20; Shim VB, 2014, J BIOMECH, V47, P3598, DOI 10.1016/j.jbiomech.2014.10.001; TERZOPOULOS D, 1986, IEEE T PATTERN ANAL, V8, P413, DOI 10.1109/TPAMI.1986.4767807; Zhang J, 2017, COMPUT METHOD BIOMEC, V20, P566, DOI 10.1080/10255842.2016.1263301; Zhang J, 2016, J BIOMECH, V49, P3875, DOI 10.1016/j.jbiomech.2016.10.021; Zhang J, 2014, COMP M BIO BIO E-IV, V2, P176, DOI 10.1080/21681163.2013.878668; Zhang J, 2016, MED ENG PHYS, V38, P450, DOI 10.1016/j.medengphy.2016.02.003; Zhang J, 2014, LECT NOTES COMPUT SC, V8789, P182, DOI 10.1007/978-3-319-12057-7_21	28	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0205628	10.1371/journal.pone.0205628	http://dx.doi.org/10.1371/journal.pone.0205628			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742643	Green Published, Green Submitted, gold			2022-12-26	WOS:000458393400001
J	Verma, K; Patel, A				Verma, Kirtika; Patel, Ashok			Pyruvate Kinase M2 serves as blockade for nucleosome repositioning and abrogates Chd7 remodeling activity	PLOS ONE			English	Article							RECOMBINANT HISTONES; DNA TRANSLOCATION; CHROMATIN; PKM2; BINDING; RECONSTITUTION; METABOLISM; MECHANISM; ISOFORM; OCTAMER	Pyruvate Kinase M2 (PKM2) mediates metabolic reshuffling and is ubiquitously upregulated in several cancer types. The non-metabolic function of PKM2 as key nuclear kinase and modulator of gene expression is instrumental in cancer progression and tumorigenesis. Here, we attempt to discern the non-canonical function of PKM2 as an epigenetic modulator and the underlying implication of this activity. Using 5'-FAM labelled reconstituted mononucleosome we have shown that PKM2 interacts with the complex through Histone H3 and possibly obstruct the access to DNA binding factors. Subsequently, the interaction negatively impacts the ATP dependent remodeling activity of Chromodomain Helicase DNA binding protein-7 (Chd7). Chd7 remodeling activity is required to ameliorate DNA damage and is crucial to genome stability. Our study shows that PKM2 blocks the Chd7 mediated sliding of nucleosome. It can be conjectured that stalling Chd7 may lead to impaired DNA damage and increased genomic instability. We propose a mechanism in which PKM2 negatively regulate nucleosome repositioning in chromatin and may exacerbate cancer by altering the nucleosome architecture. This research is imperative to our understanding of how altered cancer metabolism can potentially modulate the gene expression and sustain incessant proliferation by tweaking the chromatin topography.	[Verma, Kirtika; Patel, Ashok] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Patel, A (corresponding author), Indian Inst Technol Delhi, Kusuma Sch Biol Sci, Delhi, India.	ashokpatel@bioschool.iitd.ac.in		PATEL, ASHOK/0000-0001-6134-7794	Department of Biotechnology, India [BT/57/2012]; University Grant Commission, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); University Grant Commission, India(University Grants Commission, India)	This work received support from the Department of Biotechnology, India, BT/57/2012, AP University Grant Commission, India, KV.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Chen L, 2014, JOVE-J VIS EXP, DOI 10.3791/51721; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Chu XF, 2017, MOL ONCOL, V11, P1348, DOI 10.1002/1878-0261.12104; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eberharter A, 2004, METHOD ENZYMOL, V377, P344; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao X, 2012, MOL CELL, P45; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gottesfeld JM, 2001, BIOCHEMISTRY-US, V40, P10927, DOI 10.1021/bi0109966; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Keller KE, 2014, MOL CELL, V53, P700, DOI 10.1016/j.molcel.2014.02.015; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; Li XJ, 2018, NAT REV MOL CELL BIO, V19, P563, DOI 10.1038/s41580-018-0029-7; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1999, METH MOL B, V119, P1; Lusser A, 2004, NAT METHODS, V1, P19, DOI 10.1038/nmeth709; Manning BJ, 2017, J BIOL CHEM, V292, P11927, DOI 10.1074/jbc.M117.779470; Matsuda S., 2016, NUCLEIC ACIDS RES, P44; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mitogenic Lv L, 2013, MOL CELL, P52; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Park Sang-Hyun, 2004, Methods Mol Biol, V261, P155; Patel A, 2013, NUCLEIC ACIDS RES, V41, P1637, DOI 10.1093/nar/gks1440; Patel A, 2011, J BIOL CHEM, V286, P43984, DOI 10.1074/jbc.M111.282970; PRUNELL A, 1982, J MOL BIOL, V154, P515, DOI 10.1016/S0022-2836(82)80010-7; Rother MB, DNA REPAIR GOES HIP, DOI [10.1098/rstb.2016.0285, DOI 10.1098/RSTB.2016.0285]; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Sharma P, 2018, INT J BIOL MACROMOL, V107, P2026, DOI 10.1016/j.ijbiomac.2017.10.075; Singh J, 2017, RSC ADV, V7, P493, DOI 10.1039/c6ra26313e; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wong N, 2015, CANCER LETT, V356, P184, DOI 10.1016/j.canlet.2014.01.031; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yang W, 2012, NAT CELL BIOL, P14; Yang WW, 2015, PROTEIN CELL, V6, P238, DOI 10.1007/s13238-015-0146-4; Yang WW, 2013, CELL CYCLE, V12, P3154, DOI 10.4161/cc.26182; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	50	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211515	10.1371/journal.pone.0211515	http://dx.doi.org/10.1371/journal.pone.0211515			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735509	gold, Green Submitted, Green Published			2022-12-26	WOS:000458181200022
J	Foster, AD				Foster, Adam D.			The impact of bipedal mechanical loading history on longitudinal long bone growth	PLOS ONE			English	Article							RAT; PLATE; COMPRESSION; LOCOMOTION; MODULATION; WALKING; YOUNG	Longitudinal bone growth is accomplished through a process where proliferating chondrocytes produce cartilage in the growth plate, which ultimately ossifies. Environmental influences, like mechanical loading, can moderate the growth of this cartilage, which can alter bone length. However, little is known about how specific behaviors like bipedalism, which is characterized by a shift in body mass (mechanical load), to the lower limbs, may impact bone growth. This study uses an experimental approach to induce bipedal behaviors in a rodent model (Rattus norvegicus) over a 12-week period using a treadmill-mounted harness system to test how rat hindlimbs respond to the following loading conditions: 1) fully loaded bipedal walking, 2) partially loaded bipedal walking, 3) standing, 4) quadrupedal walking, and 5) no exercise control. These experimental conditions test whether mechanical loading from 1) locomotor or postural behaviors, and 2) a change in the magnitude of load can moderate longitudinal bone growth in the femur and tibia, relative to controls. The results demonstrate that fully loaded bipedal walking and bipedal standing groups showed significant differences in the percentage change in length for the tibia and femur. When comparing the change from baseline, which control for body mass, all bipedal groups showed significant differences in tibia length compared to control groups. However, there were no absolute differences in bone length, which suggests that mechanical loads from bipedal behaviors may instead be moderating changes in growth velocity. Implications for the relationship between bipedal behaviors and longitudinal bone growth are discussed.	[Foster, Adam D.] Campbell Univ, Dept Anat, Sch Osteopath Med, Buies Creek, NC 27506 USA	Campbell University	Foster, AD (corresponding author), Campbell Univ, Dept Anat, Sch Osteopath Med, Buies Creek, NC 27506 USA.	afoster@campbell.edu		Foster, Adam/0000-0002-1265-8171	National Science Foundation [BCS 1153863]; Force & Motion Foundation; School of Anthropology at the University of Arizona	National Science Foundation(National Science Foundation (NSF)); Force & Motion Foundation; School of Anthropology at the University of Arizona	I would like to thank the National Science Foundation (BCS 1153863; https://www.nsf.gov/), the Force & Motion Foundation http://www.forceandmotion.org/), and the School of Anthropology at the University of Arizona (https://anthropology.arizona.edu/) for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bailey AS, 2001, SPINE, V26, P308; BOURRIN S, 1994, J APPL PHYSIOL, V76, P1999, DOI 10.1152/jappl.1994.76.5.1999; Colton HS, 1929, J EXP ZOOL, V53, P1, DOI 10.1002/jez.1400530102; Cowgill LW, 2010, AM J PHYS ANTHROPOL, V143, P52, DOI 10.1002/ajpa.21289; Currey J.D., 2002, BONES STRUCTURE MECH; Geiger M, 2014, J EVOLUTION BIOL, V27, P98, DOI 10.1111/jeb.12279; Giszter SF, 2008, EXP BRAIN RES, V190, P53, DOI 10.1007/s00221-008-1451-4; Goff WC, 1957, J BONE JT SURG, V39, P616; Hammond AS, 2010, ANAT REC, V293, P658, DOI 10.1002/ar.21136; Horton JA, 2008, ANAT REC, V291, P283, DOI 10.1002/ar.20650; Ireland A, 2017, J BONE MINER RES, V32, P1209, DOI 10.1002/jbmr.3099; Kelly PM, 2008, J CHILD ORTHOP, V2, P407, DOI 10.1007/s11832-008-0119-8; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; LI KC, 1991, J APPL PHYSIOL, V70, P554, DOI 10.1152/jappl.1991.70.2.554; MOSS ML, 1961, AM J PHYS ANTHROPOL, V19, P301, DOI 10.1002/ajpa.1330190311; Niehoff A, 2004, BONE, V35, P899, DOI 10.1016/j.bone.2004.06.006; Pratt LW, 1943, B JOHNS HOPKINS HOSP, V72, P265; Raichlen DA, 2015, J HUM EVOL, V81, P1, DOI 10.1016/j.jhevol.2015.01.003; RIESENFE.A, 1966, ACTA ANAT, V65, P449; RIESENFELD A, 1972, AM J PHYS ANTHROPOL, V36, P229, DOI 10.1002/ajpa.1330360211; Robling AG, 2001, BONE, V29, P105, DOI 10.1016/S8756-3282(01)00488-4; Rolian C, 2008, EVOL DEV, V10, P15, DOI 10.1111/j.1525-142X.2008.00211.x; Russo GA, 2020, ANAT REC, V303, P150, DOI 10.1002/ar.24003; SIMON MR, 1982, ACTA ANAT, V114, P321; Stokes IAF, 2006, J ORTHOP RES, V24, P1327, DOI 10.1002/jor.20189; Stokes IAF, 2007, BONE, V41, P197, DOI 10.1016/j.bone.2007.04.180; Ueki M, 2008, ANN BIOMED ENG, V36, P793, DOI 10.1007/s10439-008-9462-7; UMEMURA Y, 1995, INT J SPORTS MED, V16, P364, DOI 10.1055/s-2007-973021; Vickers A J, 2001, BMC Med Res Methodol, V1, P6, DOI 10.1186/1471-2288-1-6; Villemure I, 2009, J BIOMECH, V42, P1793, DOI 10.1016/j.jbiomech.2009.05.021; Wada N, 2008, BRAIN RES, V1243, P70, DOI 10.1016/j.brainres.2008.09.034; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Zhang P, 2012, J BONE MINER METAB, V30, P31, DOI 10.1007/s00774-011-0292-6; Zhang P, 2010, J BONE MINER METAB, V28, P268, DOI 10.1007/s00774-009-0135-x; Zhang P, 2008, BONE, V43, pS42, DOI 10.1016/j.bone.2008.08.015	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211692	10.1371/journal.pone.0211692	http://dx.doi.org/10.1371/journal.pone.0211692			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5RX	30730948	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000045
J	Murphy, CA; Arismendi, I; Taylor, GA; Johnson, SL				Murphy, Christina A.; Arismendi, Ivan; Taylor, Gregory A.; Johnson, Sherri L.			Evidence for lasting alterations to aquatic food webs with short-duration reservoir draining	PLOS ONE			English	Article							LARGEMOUTH BASS; DAMS; RIVER; PREY; FISH; DIET; TEMPERATURE; DELTA-N-15; INVASIONS; PISCIVORY	Large dams and their respective reservoirs provide renewable energy and water security, but also can profoundly alter riverine ecosystems. Here, we present evidence of changing aquatic food web structure in the seasons following short-duration, extreme manipulation of water levels in a reservoir (i.e., draining of the reservoir to the original riverbed during fall to assist outmigration of juvenile Chinook Salmon). We find unintended and lagged consequences of transitioning from a lake to a river, even temporarily, that resulted in trophic shifts away from piscivory and towards feeding at lower trophic levels for two common piscivorous fishes in reservoirs. Using natural abundances of nitrogen stable isotopes, we observed lower trophic level of feeding for invasive Largemouth Bass (Micropterus salmoides) and native Rainbow Trout (Oncorhynchus mykiss) during the summers following reservoir refilling than in nearby reference reservoirs that were not temporarily drained during fall. Declines in trophic levels of aquatic top predators have been rarely documented outside of controlled laboratory conditions. While useful for assisting outmigration of juvenile salmonids, the temporary draining of a reservoir to riverbed can also result in novel shifts in food-web dynamics including reduced piscivory. As large dams continue to be operated and constructed worldwide, increased understanding of the community and ecosystem-level effects of reservoir management will be critical to evaluating trade-offs between human water needs, conservation of high value species, and ecosystem services impacted by river fragmentation.	[Murphy, Christina A.; Arismendi, Ivan] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Taylor, Gregory A.] US Army, Willamette Valley Project, Corps Engn, Lowell, OR USA; [Johnson, Sherri L.] US Forest Serv, Pacific Northwest Res Stn, Corvallis, OR 97331 USA	Oregon State University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; United States Department of Agriculture (USDA); United States Forest Service	Murphy, CA (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.	Christina.Murphy@oregonstate.edu	Arismendi, Ivan/B-3144-2010; Murphy, Christina/O-4941-2019	Arismendi, Ivan/0000-0002-8774-9350; Murphy, Christina/0000-0002-3467-6610	US Army Corps of Engineers [JPL 14-02-SYS]; USDA Forest Service Pacific Northwest Research Station (SLJ); Oregon State University; U.S. Environmental Protection Agency (EPA) [FP-91782401-1]	US Army Corps of Engineers(United States Department of DefenseUnited States Army); USDA Forest Service Pacific Northwest Research Station (SLJ); Oregon State University; U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency)	This research was primarily supported by funding from US Army Corps of Engineers (JPL 14-02-SYS) in collaboration with USDA Forest Service Pacific Northwest Research Station (SLJ) and Oregon State University (IA). This publication was developed under STAR Fellowship Assistance Agreement no. FP-91782401-1 awarded by the U.S. Environmental Protection Agency (EPA) to CAM.	Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; BEAUCHAMP DA, 1990, T AM FISH SOC, V119, P475, DOI 10.1577/1548-8659(1990)119<0475:SADFHO>2.3.CO;2; BRECK JE, 1993, T AM FISH SOC, V122, P902, DOI 10.1577/1548-8659(1993)122<0902:FTAPFA>2.3.CO;2; Chao BF, 2008, SCIENCE, V320, P212, DOI 10.1126/science.1154580; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; Dibble ED, 1997, J AQUAT PLANT MANAGE, V35, P74; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Garcia-Berthou E, 2002, INT REV HYDROBIOL, V87, P353, DOI 10.1002/1522-2632(200207)87:4<353::AID-IROH353>3.0.CO;2-N; Gulati RD, 2008, LIMNOLOGICA, V38, P233, DOI 10.1016/j.limno.2008.05.008; Havel JE, 2005, BIOSCIENCE, V55, P518, DOI 10.1641/0006-3568(2005)055[0518:DRFIIL]2.0.CO;2; Heady WN, 2013, OECOLOGIA, V172, P21, DOI 10.1007/s00442-012-2483-9; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Kareiva PM, 2012, P NATL ACAD SCI USA, V109, P5553, DOI 10.1073/pnas.1203263109; Keefer ML, 2013, RIVER RES APPL, V29, P483, DOI 10.1002/rra.1613; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Lovett RA, 2014, NATURE, V511, P521, DOI 10.1038/511521a; Murphy C, 2018, WILLAMETTE FISHERIES; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; O'Connor JE, 2015, SCIENCE, V348, P496, DOI 10.1126/science.aaa9204; Oregon Department of Environmental Quality, 2012, 12778 FERC OR DEP EN; Persson A, 2002, ECOLOGY, V83, P3014; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Poff NL, 2016, SCIENCE, V353, P1099, DOI 10.1126/science.aah4926; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Sanderson BL, 2009, BIOSCIENCE, V59, P245, DOI 10.1525/bio.2009.59.3.9; SCRIMGEOUR CM, 1995, ISOT ENVIRON HEALT S, V31, P107, DOI 10.1080/10256019508036256; Sherwood GD, 2002, CAN J FISH AQUAT SCI, V59, P229, DOI 10.1139/F02-001; Shoup DE, 2015, N AM J FISH MANAGE, V35, P913, DOI 10.1080/02755947.2015.1067260; Stanford JA, 2001, REGUL RIVER, V17, P303, DOI 10.1002/rrr.659; Stone R, 2011, SCIENCE, V333, P814, DOI 10.1126/science.333.6044.814; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Vander Zanden MJ, 2015, CONSERVATION BIOL CO, DOI [10.1017/CBO9781139627085.009, DOI 10.1017/CBO9781139627085.009]; Warburton K, 1998, ENVIRON BIOL FISH, V51, P445, DOI 10.1023/A:1007489100809; Whitmore MM, 2017, RIVER RES APPL, V33, P1052, DOI 10.1002/rra.3150; Williams JE, 2014, HABITAT RELATIONSHIP; Yard MD, 2011, T AM FISH SOC, V140, P471, DOI 10.1080/00028487.2011.572011	37	13	13	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211870	10.1371/journal.pone.0211870	http://dx.doi.org/10.1371/journal.pone.0211870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730968	Green Published, Green Submitted, gold			2022-12-26	WOS:000458026000069
J	Raw, RK; Wilkie, RM; Allen, RJ; Warburton, M; Leonetti, M; Williams, JHG; Mon-Williams, M				Raw, Rachael K.; Wilkie, Richard M.; Allen, Richard J.; Warburton, Matthew; Leonetti, Matteo; Williams, Justin H. G.; Mon-Williams, Mark			Skill acquisition as a function of age, hand and task difficulty: Interactions between cognition and action	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; OLDER-ADULTS; MOTOR; MOVEMENT; COORDINATION; BRAIN; SEGMENTATION; ASYMMETRY; SEQUENCES; DEMENTIA	Some activities can be meaningfully dichotomised as 'cognitive' or 'sensorimotor' in naturebut many cannot. This has radical implications for understanding activity limitation in disability. For example, older adults take longer to learn the serial order of a complex sequence but also exhibit slower, more variable and inaccurate motor performance. So is their impaired skill acquisition a cognitive or motor deficit? We modelled sequence learning as a process involving a limited capacity buffer (working memory), where reduced performance restricts the number of elements that can be stored. To test this model, we examined the relationship between motor performance and sequence learning. Experiment 1 established that older adults were worse at learning the serial order of a complex sequence. Experiment 2 found that participants showed impaired sequence learning when the non-preferred hand was used. Experiment 3 confirmed that serial order learning is impaired when motor demands increase (as the model predicted). These results can be captured by reinforcement learning frameworks which suggest sequence learning will be constrained both by an individual's sensorimotor ability and cognitive capacity.	[Raw, Rachael K.; Wilkie, Richard M.; Allen, Richard J.; Warburton, Matthew; Mon-Williams, Mark] Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England; [Leonetti, Matteo] Univ Leeds, Sch Comp, Leeds, W Yorkshire, England; [Williams, Justin H. G.] Univ Aberdeen, Med Sch, Inst Med Sci, Aberdeen, Scotland; [Mon-Williams, Mark] Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Mon-Williams, Mark] Univ Southeast Norway, Natl Ctr Vis, Kongsberg, Norway	University of Leeds; University of Leeds; University of Aberdeen	Wilkie, RM (corresponding author), Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England.	R.M.Wilkie@leeds.ac.uk	Williams, Justin/AAE-5903-2020; Wilkie, Richard M./G-5977-2012; Raw, Rachael/AGT-7704-2022	Wilkie, Richard M./0000-0003-4299-7171; Mon-Williams, Mark/0000-0001-7595-8545; Raw, Rachael/0000-0001-7593-3436; Warburton, Matthew/0000-0001-5309-4424	Medical Research Council (MRC) PhD studentship; Magstim Company Ltd.; MRC Centenary Early Career Post-Doctoral Fellowship; MRC-ESRC grant [MR/N024397/1]; Engineering and Physical Sciences Research Council (EPSRC) grant [EP/R031193/1]; Medical Research Council (MRC, UK) PhD studentship; MRC- Economic and Social Research Council (ESRC, UK) [MR/N024397/1]; Engineering and Physical Sciences Research Council (EPSRC) [EP/R031193/1]; EPSRC [EP/R031193/1] Funding Source: UKRI; MRC [MR/N024397/1] Funding Source: UKRI	Medical Research Council (MRC) PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Magstim Company Ltd.; MRC Centenary Early Career Post-Doctoral Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC-ESRC grant(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council (EPSRC) grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (MRC, UK) PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC- Economic and Social Research Council (ESRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Rachael Raw was initially funded by a Medical Research Council (MRC) PhD studentship and The Magstim Company Ltd. Analysis and publication was further supported by an MRC Centenary Early Career Post-Doctoral Fellowship awarded to Rachael Raw. The production of this manuscript was also supplemented by an MRC-ESRC grant awarded to Mark Mon-Williams (MR/N024397/1) and an Engineering and Physical Sciences Research Council (EPSRC) grant awarded to Mark Mon-Williams and Matteo Leonetti (EP/R031193/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Rachael Raw was initially funded by a Medical Research Council (MRC, UK) PhD studentship and The Magstim Company Ltd. Analyses and publication was further supported by an MRC Centenary Early Career Post-Doctoral Fellowship awarded to Rachael Raw. The production of this manuscript was also supplemented by an MRC- Economic and Social Research Council (ESRC, UK) grant awarded to Mark Mon-Williams (MR/N024397/1) and an Engineering and Physical Sciences Research Council (EPSRC) grant awarded to Mark Mon-Williams and Matteo Leonetti (EP/R031193/1). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript. We would like to thank Oscar Giles, Emma Morton and Felix Mann for their assistance with recruitment and data collection, as well as Ian Flatters and Liam Hill for their contributions to data analysis.	Allen R. J., 2013, WORKING MEMORY DEV D, P83; Allen RJ, 2015, J EXP PSYCHOL LEARN, V41, P820, DOI 10.1037/xlm0000058; Allen RJ, 2015, MEM COGNITION, V43, P555, DOI 10.3758/s13421-014-0481-3; Baddeley A. D, 1986, WORKING MEMORY; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; BARNETT CH, 1968, ANN RHEUM DIS, V27, P175, DOI 10.1136/ard.27.2.175; Bassett DS, 2015, NAT NEUROSCI, V18, P744, DOI 10.1038/nn.3993; Bo J, 2009, J NEUROPHYSIOL, V102, P2744, DOI 10.1152/jn.00393.2009; Bo J, 2009, J NEUROPHYSIOL, V101, P3116, DOI 10.1152/jn.00006.2009; Boyd LA, 2008, PHYS THER, V88, P351, DOI 10.2522/ptj.20070131; BRADSHAW JL, 1981, BEHAV BRAIN SCI, V4, P51, DOI 10.1017/S0140525X00007548; Castel AD, 2003, PSYCHOL AGING, V18, P873, DOI 10.1037/0882-7974.18.4.873; Chalfonte BL, 1996, MEM COGNITION, V24, P403, DOI 10.3758/BF03200930; Clark Brian C, 2011, Curr Aging Sci, V4, P192; Contreras-Vidal JL, 1998, ACTA PSYCHOL, V100, P25, DOI 10.1016/S0001-6918(98)00023-7; COOKE JD, 1989, NEUROBIOL AGING, V10, P159, DOI 10.1016/0197-4580(89)90025-0; Culmer PR, 2009, J NEUROSCI METH, V184, P184, DOI 10.1016/j.jneumeth.2009.07.025; Delbono O, 2003, AGING CELL, V2, P21, DOI 10.1046/j.1474-9728.2003.00011.x; DESROSIERS J, 1995, AGE AGEING, V24, P108, DOI 10.1093/ageing/24.2.108; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Fitts PM., 1967, HUM PERFORM; GARRETT SV, 1976, J CREATIVE BEHAV, V10, P239, DOI 10.1002/j.2162-6057.1976.tb00145.x; Gathercole S., 2006, WORKING MEMORY ED, P219, DOI DOI 10.1016/B978-012554465-8/50010-7; Gathercole S. E., 2003, EDUC CHILD PSYCHOL, V20, P109, DOI DOI 10.1037/A0036633; Gershon R C, 2013, NEUROLOGY S3, V80; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; HARPAZ I, 1990, J CREATIVE BEHAV, V24, P161, DOI 10.1002/j.2162-6057.1990.tb00538.x; HARRINGTON DL, 1992, PSYCHOL AGING, V7, P425, DOI 10.1037/0882-7974.7.3.425; HOWARD DV, 1991, J EXP PSYCHOL LEARN, V17, P779, DOI 10.1037/0278-7393.17.4.779; Korkman M, 2001, DEV NEUROPSYCHOL, V20, P331, DOI 10.1207/S15326942DN2001_2; LIGHT LL, 1985, J GERONTOL, V40, P737, DOI 10.1093/geronj/40.6.737; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; MORGAN M, 1994, J GERONTOL, V49, pM133, DOI 10.1093/geronj/49.3.M133; Naveh-Benjamin M, 2000, J EXP PSYCHOL LEARN, V26, P1170, DOI 10.1037/0278-7393.26.5.1170; Naveh-Benjamin M, 2007, MEM COGNITION, V35, P724, DOI 10.3758/BF03193310; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Plamondon R, 1997, BEHAV BRAIN SCI, V20, P279, DOI 10.1017/S0140525X97001441; Pohl PS, 1995, J GERONTOL B-PSYCHOL, V51B, P94, DOI DOI 10.1093/GERONB/51B.2.P94; Raw RK, 2012, J EXP PSYCHOL HUMAN, V38, P735, DOI 10.1037/a0026568; Raw RK, 2012, EXP BRAIN RES, V217, P35, DOI 10.1007/s00221-011-2971-x; Raw RK, 2016, GERIATRICS, V1, P1; Raw RK, 2015, PLOS ONE, V10, P1; Rhodes BJ, 2004, HUM MOVEMENT SCI, V23, P699, DOI 10.1016/j.humov.2004.10.008; SAHAKIAN BJ, 1988, BRAIN, V111, P695, DOI 10.1093/brain/111.3.695; Sakai K, 2003, EXP BRAIN RES, V152, P229, DOI 10.1007/s00221-003-1548-8; Sakai K, 1998, J NEUROSCI, V18, P1827; SCHWARTZ GE, 1975, SCIENCE, V190, P286, DOI 10.1126/science.1179210; Shea CH, 2006, PHYS THER, V86, P478, DOI 10.1093/ptj/86.4.478; Shumway-Cook A., 2001, MOTOR CONTROL THEORY, V2nd; Springer SP, 1997, LEFT BRAIN RIGHT BRA; Talelli P, 2008, NEUROIMAGE, V40, P1772, DOI 10.1016/j.neuroimage.2008.01.039; Tresilian J., 2012, SENSORIMOTOR CONTROL; Unsworth N, 2005, MEM COGNITION, V33, P213, DOI 10.3758/BF03195310; van Swieten LM, 2010, J EXP PSYCHOL HUMAN, V36, P493, DOI 10.1037/a0017177; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; Verwey WB, 2003, J MOTOR BEHAV, V35, P171, DOI 10.1080/00222890309602131; Verwey WB, 1996, J EXP PSYCHOL HUMAN, V22, P544, DOI 10.1037/0096-1523.22.3.544; Verwey WB, 1999, J EXP PSYCHOL HUMAN, V25, P1693, DOI 10.1037/0096-1523.25.6.1693; Verwey WB, 2010, ACTA PSYCHOL, V134, P206, DOI 10.1016/j.actpsy.2010.02.001; Verwey WB, 2009, HUM MOVEMENT SCI, V28, P348, DOI 10.1016/j.humov.2008.10.004; Voelcker-Rehage C, 2008, EUR REV AGING PHYS A, V5, P5, DOI 10.1007/s11556-008-0030-9; Voelcker-Rehage C, 2010, EUR J NEUROSCI, V31, P167, DOI 10.1111/j.1460-9568.2009.07014.x; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; WELFORD AT, 1969, ACTA PSYCHOL, V30, P3, DOI 10.1016/0001-6918(69)90034-1; Wilson AD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00058; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	69	12	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211706	10.1371/journal.pone.0211706	http://dx.doi.org/10.1371/journal.pone.0211706			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5RX	30730947	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000051
J	Tanaka, M; Hashimoto, K				Tanaka, Mami; Hashimoto, Kenji			Impact of consuming green and yellow vegetables on the depressive symptoms of junior and senior high school students in Japan	PLOS ONE			English	Article							DIETARY PATTERNS; MENTAL-HEALTH; ACADEMIC-PERFORMANCE; BREAKFAST; MIDDLE; RISK; CONSUMPTION; DISORDERS; QUALITY; ADULTS	Adolescent depression is a significant public health concern. Although skipping breakfast is associated with depressive symptoms in adolescents, the effects of dietary patterns on their depressive symptoms remain unknown. Therefore, this study aims to determine whether dietary patterns are associated with depressive symptoms among junior and senior high school students in Japan. A total of 441 junior high school students and 417 senior high school students participated in this study. The Center for Epidemiologic Studies Depression scale (CES-D) was used to measure the participants' depressive symptoms. We surveyed the participants' breakfast consumption pattern, as well as their general dietary patterns (meat, fish, green and yellow vegetables, milk and dairy products, and fruits), using a self-report questionnaire. The results indicated that the senior high school students had a significantly higher CES-D score than the junior high school students. We found negative and significant partial correlations between regular consumption of breakfast and depressive symptoms, and between regular consumption of green and yellow vegetables and depressive symptoms in both junior and senior high school students, after controlling for age, sex, and sleep duration. Furthermore, a one-way analysis of covariance (ANCOVA) revealed that adolescents who consumed green and yellow vegetables every day (one or more times per day) had significantly lower depressive symptoms than those from the "Never/1-2 times a week" group. The findings of this study reveal that the regular consumption of green and yellow vegetables is associated with lower depressive symptoms in adolescents, that is, the consumption of green and yellow vegetables may be vital in the context of adolescents' mental health.	[Tanaka, Mami; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Chiba, Japan	Chiba University	Tanaka, M (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Chiba, Japan.	tanaka.mami@chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	Japan Society for the Promotion of Science (JSPS) KAKENHI [15K04112, 17H04243]; Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED [JP17dm0107119]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was partly supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (to MT, 15K04112, to KH, 17H04243), the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED (to KH, JP17dm0107119).	Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Avenevoli S, 2008, HDB DEPRESSION CHILD, P6, DOI [10.1176/ajp.153.6.836, DOI 10.1176/AJP.153.6.836]; Das JK, 2016, J ADOLESCENT HEALTH, V59, pS49, DOI 10.1016/j.jadohealth.2016.06.020; Finan PH, 2013, SLEEP MED REV, V17, P173, DOI 10.1016/j.smrv.2012.03.003; Frojd SA, 2008, J ADOLESCENCE, V31, P485, DOI 10.1016/j.adolescence.2007.08.006; Fujii A, 2016, JAPANESE J HLTH HUMA, V82, P217; Hines AR, 2006, ADOLESCENCE, V41, P597; Itani O, 2016, J CLIN PSYCHIAT, V77, pE860, DOI 10.4088/JCP.15m10044; Jacka FN, 2011, PSYCHOSOM MED, V73, P483, DOI 10.1097/PSY.0b013e318222831a; Jenni OG, 2008, HDB DEV COGNITIVE NE, V2, P807; La Greca AM, 2005, J CLIN CHILD ADOLESC, V34, P49, DOI 10.1207/s15374424jccp3401_5; Lai JS, 2014, AM J CLIN NUTR, V99, P181, DOI 10.3945/ajcn.113.069880; Li Y, 2017, PSYCHIAT RES, V253, P373, DOI 10.1016/j.psychres.2017.04.020; Lien L, 2007, PUBLIC HEALTH NUTR, V10, P422, DOI 10.1017/S1368980007258550; Lucas M, 2014, BRAIN BEHAV IMMUN, V36, P46, DOI 10.1016/j.bbi.2013.09.014; Marin O, 2016, NAT MED, V22, P1229, DOI 10.1038/nm.4225; National Institute of Mental Health, 2017, MENT HLTH INF STAT M; NOLENHOEKSEMA S, 1994, PSYCHOL BULL, V115, P424, DOI 10.1037/0033-2909.115.3.424; O'Sullivan TA, 2009, PUBLIC HEALTH NUTR, V12, P249, DOI 10.1017/S1368980008003935; Oellingrath IM, 2014, PUBLIC HEALTH NUTR, V17, P2554, DOI 10.1017/S1368980013002747; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Raaijmakers LGM, 2010, EUR J PUBLIC HEALTH, V20, P318, DOI 10.1093/eurpub/ckp191; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rahe C, 2014, EUR J NUTR, V53, P997, DOI 10.1007/s00394-014-0652-9; Sampasa-Kanyinga H, 2017, PUBLIC HEALTH, V145, P120, DOI 10.1016/j.puhe.2016.12.027; Sampasa-Kanyinga H, 2014, APPETITE, V79, P76, DOI 10.1016/j.appet.2014.04.007; Shaw ME, 1998, ADOLESCENCE, V33, P851; Shima S., 1985, PSYCHIATRY, V27, P717, DOI DOI 10.11477/MF.1405203967; Smith AP, 1998, INT J FOOD SCI NUTR, V49, P397, DOI 10.3109/09637489809089415; Smith AP, 2003, NUTR NEUROSCI, V6, P59, DOI 10.1080/1028415021000042820; Smith AP, 2002, NUTR NEUROSCI, V5, P141, DOI 10.1080/10284150290018946; Tanaka H, 2002, PSYCHIAT CLIN NEUROS, V56, P235, DOI 10.1046/j.1440-1819.2002.00997.x; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Toyomaki A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181057; WEISSMAN MM, 1977, ARCH GEN PSYCHIAT, V34, P98; World Health Organization (WHO), 2017, MAT NEWB CHILD AD HL; Yao W, 2016, SCI REP-UK, V6, DOI 10.1038/srep30659; Yoshiike N, 2007, NUTR REV, V65, P149, DOI 10.1301/nr.2007.apr.149-154; Zhang JC, 2017, J NUTR BIOCHEM, V39, P134, DOI 10.1016/j.jnutbio.2016.10.004	39	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211323	10.1371/journal.pone.0211323	http://dx.doi.org/10.1371/journal.pone.0211323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5RX	30730901	Green Submitted, gold, Green Published			2022-12-26	WOS:000458026000020
J	Toledano, MN; Vera, P; Tilly, H; Jardin, F; Becker, S				Toledano, Mathieu N.; Vera, Pierre; Tilly, Herve; Jardin, Fabrice; Becker, Stephanie			Comparison of therapeutic evaluation criteria in FDG-PET/CT in patients with diffuse large-cell B-cell lymphoma: Prognostic impact of tumor/liver ratio	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; LIVER-BASED INTERPRETATION; METABOLIC TUMOR VOLUME; NON-HODGKIN-LYMPHOMA; SUV-BASED ASSESSMENT; EARLY F-18-FDG PET; RESPONSE ASSESSMENT; TARGET LESION; INTERIM; CHEMOTHERAPY	Purpose The study objective was to compare the prognostic value of interim and end-of-treatment FDG PET/CT using five therapeutic evaluation criteria in patients with diffuse large B cell lymphoma (DLBCL). Methods 181 patients were retrospectively analysed. All patients underwent FDG-PET at baseline and after four cycles (iPET4) of first-line chemotherapy and 165 at the end-of-treatment (PET-eot). Ratio Deauville score (rDS) (SUVmax-target residual lesion/SUVmax-liver) was measured in iPET4 and PET-eot, and its optimal threshold was determined using receiver operating characteristic (ROC) curve analysis. Deauville score (DS) (iPET4 and PET-eot), Delta SUVmax, Delta SUVmax determined according to Menton 2011 criteria (Delta SUVmax+DS) and Delta SUVmax+rDS were also evaluated (iPET4 only). Median follow-up was 44 months. Results ROC analysis revealed the optimal cut-off value was 1.4-fold of SUVmax-liver on iPET4 and PET-eot. On iPET4, positive predictive value (PPV) of rDS was significantly better than DS: 81.58% vs. 67.79%. In univariate analysis, the five interpretation methods were statistically significant (p<0.0001 for progression-free survival [PFS] and overall survival [OS]). In multivariate analysis, only rDS was an independent prognostic factor (p = 0.0002 and p<0.0001 for PFS and OS, respectively). On PET-eot, similarly, the two therapeutic evaluation criteria analysed (rDS and DS) were statistically significant at the univariate level (p<0.0001). rDS was the only significant prognostic factor in multivariate analysis (p<0.0001). PPV and accuracy of rDS were also better than DS. Conclusions rDS with a tumor/liver ratio of 1.4 is a robust prognostic factor in patients with DLBCL on iPET4 and PET-eot.	[Toledano, Mathieu N.; Vera, Pierre; Becker, Stephanie] Henri Becquerel Canc Ctr, Nucl Med Dept, Rouen, France; [Toledano, Mathieu N.; Vera, Pierre; Becker, Stephanie] Univ Rouen, Fac Med, QuantIF LITIS, CNRS,EA 4108,FR 3638, Rouen, France; [Tilly, Herve; Jardin, Fabrice] INSERM, U1245, Ctr Henri Becquerel, Rouen, France; [Tilly, Herve; Jardin, Fabrice] Ctr Henri Becquerel, Hematol Dept, Rouen, France	UNICANCER; Centre Henri Becquerel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Information Sciences & Technologies (INS2I); Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Henri Becquerel; UNICANCER; Centre Henri Becquerel	Becker, S (corresponding author), Henri Becquerel Canc Ctr, Nucl Med Dept, Rouen, France.; Becker, S (corresponding author), Univ Rouen, Fac Med, QuantIF LITIS, CNRS,EA 4108,FR 3638, Rouen, France.	stephanie.becker@chb.unicancer.fr						Annunziata S, 2018, ANN NUCL MED, V32, P372, DOI 10.1007/s12149-018-1243-2; Annunziata S, 2016, ANN NUCL MED, V30, P588, DOI 10.1007/s12149-016-1092-9; Barrington SF, 2014, J CLIN ONCOL, V32, P3048, DOI 10.1200/JCO.2013.53.5229; Boellaard R, 2015, EUR J NUCL MED MOL I, V42, P328, DOI 10.1007/s00259-014-2961-x; Casasnovas RO, 2017, BLOOD, V130, P1315, DOI 10.1182/blood-2017-02-766691; Casasnovas RO, 2011, BLOOD, V118, P37, DOI 10.1182/blood-2010-12-327767; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Coiffier B, 2010, BLOOD, V116, P2040, DOI 10.1182/blood-2010-03-276246; Cottereau AS, 2016, ANN ONCOL, V27, P719, DOI 10.1093/annonc/mdw011; Fan Y, 2017, LEUKEMIA LYMPHOMA, V58, P2065, DOI 10.1080/10428194.2016.1277384; Friedberg JW, 2011, HEMATOL-AM SOC HEMAT, P498, DOI 10.1182/asheducation-2011.1.498; Hasenclever D, 2014, EUR J NUCL MED MOL I, V41, P1301, DOI 10.1007/s00259-014-2715-9; Huttmann A, 2019, ANN HEMATOL; Itti E, 2013, EUR J NUCL MED MOL I, V40, P1312, DOI 10.1007/s00259-013-2435-6; Itti E, 2010, J NUCL MED, V51, P1857, DOI 10.2967/jnumed.110.080556; Itti E, 2009, J NUCL MED, V50, P527, DOI 10.2967/jnumed.108.057703; Kanoun S, 2014, EUR J NUCL MED MOL I, V41, P1735, DOI 10.1007/s00259-014-2783-x; Le Gouill S, 2017, BLOOD, V129, P3059, DOI 10.1182/blood-2016-05-672196; Lin C, 2007, J NUCL MED, V48, P1626, DOI 10.2967/jnumed.107.042093; Mamot C, 2015, J CLIN ONCOL, V33, P2523, DOI 10.1200/JCO.2014.58.9846; Meignan M, 2012, LEUKEMIA LYMPHOMA, V53, P1876, DOI 10.3109/10428194.2012.677535; Mylam KJ, 2015, LEUKEMIA LYMPHOMA, V56, P2005, DOI 10.3109/10428194.2014.975800; Nols N, 2014, LEUKEMIA LYMPHOMA, V55, P773, DOI 10.3109/10428194.2013.831848; Pregno P, 2012, BLOOD, V119, P2066, DOI 10.1182/blood-2011-06-359943; Quak E, 2014, HAEMATOLOGICA, V99, pE84, DOI 10.3324/haematol.2014.104125; Recher C, 2011, LANCET, V378, P1858, DOI 10.1016/S0140-6736(11)61040-4; Zhang YW, 2018, LEUKEMIA LYMPHOMA, V59, P660, DOI 10.1080/10428194.2017.1357171	27	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211649	10.1371/journal.pone.0211649	http://dx.doi.org/10.1371/journal.pone.0211649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730936	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000040
J	Tsai, FJ; Tseng, WL; Yang, LK; Gau, SSF				Tsai, Fang-Ju; Tseng, Wan-Ling; Yang, Li-Kuang; Gau, Susan Shur-Fen			Psychiatric comorbid patterns in adults with attention-deficit hyperactivity disorder: Treatment effect and subtypes	PLOS ONE			English	Article							PROSPECTIVE FOLLOW-UP; SUBSTANCE USE DISORDERS; OPPOSITIONAL-DEFIANT DISORDER; DEFICIT/HYPERACTIVITY DISORDER; STIMULANT TREATMENT; METHYLPHENIDATE TREATMENT; EXECUTIVE FUNCTION; CHILD-RELATIONSHIP; BIPOLAR DISORDER; CONDUCT DISORDER	Psychiatric comorbidities are common in individuals with attention-deficit/hyperactivity disorder (ADHD). In this study, we sought to evaluate the effects of medication and childhood ADHD subtypes on psychiatric comorbidities among adults with ADHD as compared to healthy adult controls. We assessed 121 drug-naive adults with ADHD, 93 treated adults with ADHD, and 145 healthy controls (age 18-36 years) using semi-structured psychiatric interviews, intelligence tests, and medical records. Drug-naive adults with ADHD had more comorbidities than treated adults with ADHD and controls. Childhood ADHD-combined subtype, relative to ADHD-inattentive subtype, was associated with higher risks of comorbidities. Current medication treatment was associate with a higher risk for anxiety disorders, and longer treatment duration was associated with lower risks of mood disorders and sleep disorders. Our results indicate that no medication treatment, short treatment duration, and childhood ADHD-combined subtype are associated with increased risks for psychiatric comorbidities among adults with ADHD.	[Tsai, Fang-Ju; Yang, Li-Kuang; Gau, Susan Shur-Fen] Natl Taiwan Univ, Dept Psychiat, Taipei, Taiwan; [Tsai, Fang-Ju; Yang, Li-Kuang; Gau, Susan Shur-Fen] Coll Med, Taipei, Taiwan; [Tsai, Fang-Ju] En Chu Kong Hosp, Dept Psychiat, New Taipei, Taiwan; [Tseng, Wan-Ling] NIMH, Emot & Dev Branch, NIH, Dept Hlth & Human Sev, Bethesda, MD 20892 USA; [Yang, Li-Kuang] Tri Serv Gen Hosp, Beitou Branch, Natl Def Med Ctr, Taipei, Taiwan; [Gau, Susan Shur-Fen] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei, Taiwan; [Gau, Susan Shur-Fen] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	National Taiwan University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Taiwan University	Gau, SSF (corresponding author), Natl Taiwan Univ, Dept Psychiat, Taipei, Taiwan.; Gau, SSF (corresponding author), Coll Med, Taipei, Taiwan.; Gau, SSF (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei, Taiwan.; Gau, SSF (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.	gaushufe@ntu.edu.tw	GAU, SUSAN SHUR-FEN/P-4726-2017	GAU, SUSAN SHUR-FEN/0000-0002-2718-8221	National Health Research Institute [NHRI-EX100-10008PI, NHRI-EX101-10008PI, NHRI-EX102-10008PI, NHRI-EX103-10008PI]	National Health Research Institute(National Health Research Institutes - Taiwan)	This work was supported by National Health Research Institute (NHRI-EX100-10008PI, NHRI-EX101-10008PI, NHRI-EX102-10008PI; NHRI-EX103-10008PI), Taiwan. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Acosta MT, 2008, J AM ACAD CHILD PSY, V47, P797, DOI 10.1097/CHI.0b013e318173f70b; Adewuya AO, 2007, EUR CHILD ADOLES PSY, V16, P10, DOI 10.1007/s00787-006-0569-9; Barbaresi WJ, 2013, PEDIATRICS, V131, P637, DOI 10.1542/peds.2012-2354; Biederman J, 2008, PSYCHOL MED, V38, P1027, DOI 10.1017/S0033291707002668; Biederman J, 2012, ACTA PSYCHIAT SCAND, V125, P147, DOI 10.1111/j.1600-0447.2011.01797.x; Biederman J, 2008, AM J PSYCHIAT, V165, P597, DOI 10.1176/appi.ajp.2007.07091486; Biederman J, 2010, AM J PSYCHIAT, V167, P409, DOI 10.1176/appi.ajp.2009.09050736; Bleck JR, 2015, J BEHAV HEALTH SER R, V42, P437, DOI 10.1007/s11414-014-9422-y; Caci H, 2009, J ATTEN DISORD, V13, P36, DOI 10.1177/1087054708320439; Chang LR, 2013, COMPR PSYCHIAT, V54, P128, DOI 10.1016/j.comppsych.2012.07.008; Chang Z, 2014, J CHILD PSYCHOL PSYC, V55, P878, DOI 10.1111/jcpp.12164; Chiang HL, 2016, PSYCHOL MED, V46, P1225, DOI 10.1017/S0033291715002767; Chiang HL, 2013, RES DEV DISABIL, V34, P2986, DOI 10.1016/j.ridd.2013.06.020; Chiang HL, 2010, J SLEEP RES, V19, P535, DOI 10.1111/j.1365-2869.2010.00832.x; Chronis-Tuscano A, 2010, ARCH GEN PSYCHIAT, V67, P1044, DOI 10.1001/archgenpsychiatry.2010.127; Conners CK., 1999, CONNERS ADULT ADHD R, DOI DOI 10.1038/s41588-018-0269-7; Cumyn L, 2009, CAN J PSYCHIAT, V54, P673, DOI 10.1177/070674370905401004; Daviss WB, 2008, J CHILD ADOL PSYCHOP, V18, P257, DOI 10.1089/cap.2007.0100; Donfrancesco R, 2017, J ATTEN DISORD, V21, P715, DOI 10.1177/1087054714539999; Drimmer EJ, 2003, NUTRITION, V19, P76, DOI 10.1016/S0899-9007(02)01045-6; Dukarm CP, 2005, J WOMENS HEALTH, V14, P345, DOI 10.1089/jwh.2005.14.345; Elkins IJ, 2007, ARCH GEN PSYCHIAT, V64, P1145, DOI 10.1001/archpsyc.64.10.1145; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Gau SS, 2015, PSYCHOL MED, V45, P529, DOI 10.1017/S0033291714001664; Gau SSF, 2014, PSYCHOL MED, V44, P435, DOI 10.1017/S0033291713000640; Gau SF, 1999, AUST NZ J PSYCHIAT, V33, P734, DOI 10.1080/j.1440-1614.1999.00610.x; Gau SSF, 2005, AM J PSYCHIAT, V162, P1344, DOI 10.1176/appi.ajp.162.7.1344; Gau SSF, 2007, BRIT J PSYCHIAT, V190, P42, DOI 10.1192/bjp.bp.106.022871; Gau SSF, 2007, SLEEP, V30, P195, DOI 10.1093/sleep/30.2.195; Gau SSF, 2008, J CLIN PSYCHIAT, V69, P131, DOI 10.4088/JCP.v69n0118; Gau SSF, 2013, RES DEV DISABIL, V34, P1581, DOI 10.1016/j.ridd.2013.02.002; Gau SSF, 2010, AUST NZ J PSYCHIAT, V44, P135, DOI 10.3109/00048670903282733; Golubchik P, 2014, INT CLIN PSYCHOPHARM, V29, P274, DOI 10.1097/YIC.0000000000000034; Golubchik P, 2014, INT CLIN PSYCHOPHARM, V29, P212, DOI 10.1097/YIC.0000000000000029; Grizenko N, 2010, J ATTEN DISORD, V13, P649, DOI 10.1177/1087054709347200; Groenman AP, 2013, BRIT J PSYCHIAT, V203, P112, DOI 10.1192/bjp.bp.112.124784; Gurkan K, 2010, J PSYCHOPHARMACOL, V24, P1810, DOI 10.1177/0269881109348172; Humphreys KL, 2013, JAMA PSYCHIAT, V70, P740, DOI 10.1001/jamapsychiatry.2013.1273; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Klein RG, 2012, ARCH GEN PSYCHIAT, V69, P1295, DOI 10.1001/archgenpsychiatry.2012.271; Kollins SH, 2008, CURR MED RES OPIN, V24, P1345, DOI [10.1185/030079908X280707, 10.1185/030079908X280707 ]; Lensing MB, 2013, J CLIN PSYCHIAT, V74, pE87, DOI 10.4088/JCP.12m07714; Levy F, 2005, J AM ACAD CHILD PSY, V44, P368, DOI 10.1097/01.chi.0000153232.64968.c1; Lin YJ, 2014, PSYCHOL MED, V44, P1765, DOI 10.1017/S0033291713002390; Lin YJ, 2017, J FORMOS MED ASSOC, V116, P946, DOI 10.1016/j.jfma.2017.02.009; Lin YJ, 2016, AUST NZ J PSYCHIAT, V50, P548, DOI 10.1177/0004867415609423; Lin YJ, 2015, RES DEV DISABIL, V47, P48, DOI 10.1016/j.ridd.2015.07.026; Mannuzza S, 1998, AM J PSYCHIAT, V155, P493, DOI 10.1176/ajp.155.4.493; Mannuzza S, 2003, J CHILD ADOL PSYCHOP, V13, P273, DOI 10.1089/104454603322572606; Mannuzza S, 2008, PSYCHIAT RES, V160, P237, DOI 10.1016/j.psychres.2007.11.003; Mannuzza S, 2008, AM J PSYCHIAT, V165, P604, DOI 10.1176/appi.ajp.2008.07091465; Mayes SD, 2009, J PEDIATR PSYCHOL, V34, P328, DOI 10.1093/jpepsy/jsn083; Meinzer MC, 2013, DEPRESS ANXIETY, V30, P546, DOI 10.1002/da.22082; Merikangas KR, 1998, ADDICT BEHAV, V23, P893, DOI 10.1016/S0306-4603(98)00076-8; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; Moshe K, 2012, ADHD-ATTEND DEFICIT, V4, P153, DOI 10.1007/s12402-012-0078-2; Murphy KR, 2002, J NERV MENT DIS, V190, P147, DOI 10.1097/00005053-200203000-00003; Ni HC, 2015, COMPR PSYCHIAT, V57, P85, DOI 10.1016/j.comppsych.2014.11.002; Ni HC, 2017, J ATTEN DISORD, V21, P27, DOI 10.1177/1087054713476549; Ni HC, 2013, INT J NEUROPSYCHOPH, V16, P1959, DOI 10.1017/S1461145713000357; Oner O, 2012, CHILD PSYCHIAT HUM D, V43, P523, DOI 10.1007/s10578-012-0281-6; Pineiro-Dieguez B, 2016, J ATTEN DISORD, V20, P1066, DOI 10.1177/1087054713518240; Purgato M, 2014, EPIDEMIOL PSYCH SCI, V23, P133, DOI 10.1017/S2045796014000146; Rucklidge JJ, 2016, J ATTEN DISORD, V20, P1030, DOI 10.1177/1087054714529457; Sciberras E, 2014, PEDIATRICS, V133, P801, DOI 10.1542/peds.2013-3686; Shang CY, 2016, PSYCHOL MED, V46, P3173, DOI 10.1017/S0033291716001938; Shang CY, 2018, BRAIN IMAGING BEHAV, V12, P882, DOI 10.1007/s11682-017-9749-0; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Sivakumar T, 2013, ASIAN J PSYCHIATR, V6, P235, DOI 10.1016/j.ajp.2012.12.011; Sobanski E, 2008, EUR PSYCHIAT, V23, P142, DOI 10.1016/j.eurpsy.2007.09.007; Soendergaard HM, 2016, J ATTEN DISORD, V20, P925, DOI 10.1177/1087054713517544; Staikova E, 2010, J CHILD ADOL PSYCHOP, V20, P387, DOI 10.1089/cap.2009.0107; Tamm L, 2012, AM J DRUG ALCOHOL AB, V38, P93, DOI 10.3109/00952990.2011.600395; Vansickel AR, 2011, PSYCHOPHARMACOLOGY, V218, P381, DOI 10.1007/s00213-011-2328-y; Wilens TE, 2009, J CLIN PSYCHIAT, V70, P1557, DOI 10.4088/JCP.08m04785pur; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Winters KC, 2011, J CHILD ADOLES SUBST, V20, P314, DOI 10.1080/1067828X.2011.598834; Yang PC, 2007, J DEV BEHAV PEDIATR, V28, P369, DOI 10.1097/DBP.0b013e3181131f8e; Yeh CB, 2008, INT J METH PSYCH RES, V17, P45, DOI 10.1002/mpr.241; Yuce M, 2013, NEUROPSYCH DIS TREAT, V9, P1791, DOI 10.2147/NDT.S54283	81	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211873	10.1371/journal.pone.0211873	http://dx.doi.org/10.1371/journal.pone.0211873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5RX	30730956	Green Published, Green Submitted, gold			2022-12-26	WOS:000458026000070
J	Zhang, J; Jia, L; Liu, TF; Yip, YL; Tang, WC; Lin, WT; Deng, W; Lo, KW; You, CP; Lung, ML; Lung, HL; Cheung, ALM; Tsao, SW; Tsang, CM				Zhang, Jun; Jia, Lin; Liu, Tengfei; Yip, Yim Ling; Tang, Wing Chung; Lin, Weitao; Deng, Wen; Lo, Kwok Wai; You, Chanping; Lung, Maria Li; Lung, Hong Lok; Cheung, Annie Lai-Man; Tsao, Sai Wah; Tsang, Chi Man			mTORC2-mediated PDHE1 alpha nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma	ONCOGENE			English	Article							EPSTEIN-BARR-VIRUS; EPITHELIAL-CELLS; EXPRESSION; SNAIL; IMMORTALIZATION; TRANSCRIPTION; GLYCOLYSIS; ACTIVATION; INFECTION; GROWTH	EBV infection of preinvasive nasopharyngeal epithelium is believed to be an initiation step during pathogenesis of nasopharyngeal carcinoma (NPC), but the mechanisms remain poorly understood. Here we report a novel mechanism driving NPC metastasis through the EBV-encoded LMP1-mediated metabolic reprogramming, via activation of IGF1-mTORC2 signaling and nuclear acetylation of the Snail promoter by the PDHE1 alpha, an enzyme involved in glucose metabolism. Mechanistically, EBV-LMP1 increases the cellular secretion of IGF1 which promotes phosphorylation of IGF1R to activate mTORC2/AKT signaling linking glucose metabolism to cell motility. LMP1 expression facilitates translocation of mitochondrial PDHE1a into the nucleus in a phosphorylation-dependent manner at Ser(293) residue. Functionally, nuclear PDHE1a promotes H3K9 acetylation on the Snail promoter to enhance cell motility, thereby driving cancer metastasis. Importantly, the IGF1/mTORC2/PDHE1 alpha/Snail axis correlates significantly with disease progression and poor prognosis in NPC patients. This study highlights the functional importance of IGF1-mTORC2-PDHE1 alpha signaling mediated by EBV-LMP1 in NPC pathogenesis.	[Zhang, Jun; Jia, Lin; Liu, Tengfei; Yip, Yim Ling; Tang, Wing Chung; Lin, Weitao; Deng, Wen; You, Chanping; Cheung, Annie Lai-Man; Tsao, Sai Wah; Tsang, Chi Man] Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Deng, Wen] Univ Hong Kong, Sch Nursing, Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Lo, Kwok Wai] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, State Key Lab Translat Oncol, Hong Kong, Peoples R China; [Lung, Maria Li] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Peoples R China; [Lung, Maria Li; Tsao, Sai Wah] Univ Hong Kong, Ctr Canc Res, Hong Kong, Peoples R China; [Lung, Hong Lok] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong; University of Hong Kong; Hong Kong Baptist University	Tsao, SW; Tsang, CM (corresponding author), Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, Hong Kong, Peoples R China.; Tsao, SW (corresponding author), Univ Hong Kong, Ctr Canc Res, Hong Kong, Peoples R China.	gswtsao@hku.hk; annatsan@hku.hk	ZHANG, Jun/V-5275-2018	ZHANG, Jun/0000-0002-6523-7573; Lin, Weitao/0000-0003-4385-9897	Research Grants Council, Area of Excellence NPC [AoE/M 06/08]; Theme-Based Research Scheme [T12-401/13-R]; Collaborative Research Fund [C7027-16G, C4001-18GF, C1013-15G]; General Research Fund [14117316, 17161116, 17120814, 779713, 779312, 17110315, 17111516]; Health and Medical Research Fund [04151726, 05162386, 13142201]	Research Grants Council, Area of Excellence NPC; Theme-Based Research Scheme; Collaborative Research Fund; General Research Fund; Health and Medical Research Fund	We acknowledge the Faculty Core Facility members of HKU and Mr. Tony Chan for technical supports. SWT and KWL are funded by the Research Grants Council, Area of Excellence NPC (Grant No. AoE/M 06/08), Theme-Based Research Scheme (T12-401/13-R), Collaborative Research Fund (C7027-16G, C4001-18GF and C1013-15G), General Research Fund (14117316, 17161116, 17120814, 779713, and 779312), and Health and Medical Research Fund (04151726). CMT is funded by the Health and Medical Research Fund (05162386 and 13142201) and General Research Fund (17110315 and 17111516).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cai TT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006503; Chae YC, 2016, CANCER CELL, V30, P257, DOI 10.1016/j.ccell.2016.07.004; Chua MLK, 2016, LANCET, V387, P1012, DOI 10.1016/S0140-6736(15)00055-0; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hamabe A, 2014, P NATL ACAD SCI USA, V111, P15526, DOI 10.1073/pnas.1407717111; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hecht I, 2015, SCI REP-UK, V5, DOI 10.1038/srep13538; Horikawa T, 2011, BRIT J CANCER, V104, P1160, DOI 10.1038/bjc.2011.38; Levy P, 2016, ONCOGENE, V35, P4155, DOI 10.1038/onc.2015.479; Li HM, 2006, INT J CANCER, V119, P1567, DOI 10.1002/ijc.22032; Li Y., 2017, NAT COMMUN, V8; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lin WT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06889-5; Liu HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002690; Lo AKF, 2018, J PATHOL, V246, P180, DOI 10.1002/path.5130; Lo AKF, 2015, J PATHOL, V237, P238, DOI 10.1002/path.4575; McFadden K, 2016, P NATL ACAD SCI USA, V113, pE782, DOI 10.1073/pnas.1517141113; MILARSKI KL, 1986, P NATL ACAD SCI USA, V83, P9517, DOI 10.1073/pnas.83.24.9517; Nagaraj R, 2017, CELL, V168, P210, DOI 10.1016/j.cell.2016.12.026; Niedobitek G, 1992, Diagn Mol Pathol, V1, P103, DOI 10.1097/00019606-199203000-00016; PATHMANATHAN R, 1995, NEW ENGL J MED, V333, P693, DOI 10.1056/NEJM199509143331103; Ren XY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14053; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shair KHY, 2009, CANCER RES, V69, P5734, DOI 10.1158/0008-5472.CAN-09-0468; Sommermann TG, 2011, CANCER RES, V71, P7291, DOI 10.1158/0008-5472.CAN-11-1715; Stacpoole PW, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx071; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Tsang CM, 2012, P NATL ACAD SCI USA, V109, pE3473, DOI 10.1073/pnas.1202637109; Tsang CM, 2010, INT J CANCER, V127, P1570, DOI 10.1002/ijc.25173; Tsao SW, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0270; Tsao SW, 2015, J PATHOL, V235, P323, DOI 10.1002/path.4448; Tsao SW, 2002, SEMIN CANCER BIOL, V12, P473, DOI 10.1016/S1044579X02000901; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Tworkoski K, 2015, J VIROL, V89, P2590, DOI 10.1128/JVI.02921-14; Wang XM, 2016, CELL RES, V26, P1, DOI 10.1038/cr.2015.134; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Xiao L, 2014, ONCOGENE, V33, P4568, DOI 10.1038/onc.2014.32; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhang D, 2017, ONCOGENE, V36, P2900, DOI 10.1038/onc.2016.446; Zhang J, 2017, ADV EXP MED BIOL, V1018, P75, DOI 10.1007/978-981-10-5765-6_6; Zhang J, 2017, J VIROL, V91, DOI 10.1128/JVI.02168-16; Zhu DD, 2016, INT J CANCER, V138, P1175, DOI 10.1002/ijc.29850	46	24	25	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2019	38	24					4669	4684		10.1038/s41388-019-0749-y	http://dx.doi.org/10.1038/s41388-019-0749-y			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IC7ND	30745576	Green Published, hybrid			2022-12-26	WOS:000471160500002
J	Zhao, GX; Xu, YY; Weng, SQ; Zhang, S; Chen, Y; Shen, XZ; Dong, L; Chen, S				Zhao, Guang-Xi; Xu, Ying-Ying; Weng, Shu-Qiang; Zhang, Si; Chen, Ying; Shen, Xi-Zhong; Dong, Ling; Chen, She			CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation	ONCOGENE			English	Article							CA2+-DEPENDENT ACTIVATOR PROTEIN; E-CADHERIN; CELLS REVEALS; TUMOR-CELLS; SECRETION; TRANSITION; EXPRESSION; INVASION; SYSTEM; EMT	Colorectal cancer (CRC) is a common gastrointestinal cancer with high mortality rate mostly due to metastasis. Ca2+-dependent activator protein for secretion 1 (CAPS1) was originally identified as a soluble factor that reconstitutes Ca2+-dependent secretion. In this study, we discovered a novel role of CAPS1 in CRC metastasis. CAPS1 is frequently up-regulated in CRC tissues. Increased CAPS1 expression is associated with frequent metastasis and poor prognosis of CRC patients. Overexpression of CAPS1 promotes CRC cell migration and invasion in vitro, as well as liver metastasis in vivo, without affecting cell proliferation. CAPS1 induces epithelial-mesenchymal transition (EMT), including decreased E-cadherin and ZO-1, epithelial marker expression, and increased N-cadherin and Snail, mesenchymal marker expression. Snail knockdown reversed CAPS1-induced EMT, cell migration and invasion. This result indicates that Snail is required for CAPS1-mediated EMT process and metastasis in CRC. Furthermore, CAPS1 can bind with Septin2 and p85 (subunit of PI3K). LY294002 and wortmanin, PI3K/Akt inhibitors, can abolish CAPS1-induced increase of Akt/GSK3 beta activity, as well as increase of Snail protein level. Taken together, CAPS1 promotes colorectal cancer metastasis through PI3K/Akt/GSK3 beta/Snail signal pathway-mediated EMT process.	[Zhao, Guang-Xi; Weng, Shu-Qiang; Shen, Xi-Zhong; Dong, Ling] Fudan Univ, Zhongshan Hosp, Shanghai Inst Liver Dis, Dept Gastroenterol & Hepatol, Shanghai 200032, Peoples R China; [Zhao, Guang-Xi; Xu, Ying-Ying; Zhang, Si; Chen, She] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Glycoconjugate Res,Minist Publ Hlth, Shanghai 200032, Peoples R China; [Chen, Ying] Fudan Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Shen, XZ; Dong, L (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai Inst Liver Dis, Dept Gastroenterol & Hepatol, Shanghai 200032, Peoples R China.; Chen, S (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Glycoconjugate Res,Minist Publ Hlth, Shanghai 200032, Peoples R China.	shen.xizhong@zs-hospital.sh.cn; dong.ling@zs-hospital.sh.cn; shechen@fudan.edu.cn	zhang, si/AAG-9094-2021	zhang, Si/0000-0002-5682-4995	National Natural Science Foundation of China (NSFC) [81672334, 81772615, 81572686, 81772968, 81573423, 81770137, 81672720]; Shanghai Science and Technology Commission [15410710100, 16ZR1406100]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (NSFC) (81672334, 81772615, 81572686, 81772968, 81573423, 81770137, 81672720) and Shanghai Science and Technology Commission (15410710100, 16ZR1406100).	Abbey M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20007; Agarwal E, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-145; Angelis D, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00122; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Tang BL, 2015, MOL MEMBR BIOL, V32, P120, DOI 10.3109/09687688.2015.1079934; Cao H, 2015, PATHOL RES PRACT, V211, P557, DOI 10.1016/j.prp.2015.05.010; Cao LQ, 2015, CANCER LETT, V359, P127, DOI 10.1016/j.canlet.2015.01.004; Chen L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0534-9; Chen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01024-2; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Garcia Z, 2006, EMBO J, V25, P4740, DOI 10.1038/sj.emboj.7601324; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hahn S, 2013, EMBO J, V32, P3079, DOI 10.1038/emboj.2013.236; Hawk ET, 2005, J CLIN ONCOL, V23, P378, DOI 10.1200/JCO.2005.08.097; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; Hosono M, 2016, NEUROSCI LETT, V617, P232, DOI 10.1016/j.neulet.2016.02.035; Huang XT, 2018, CELL PHYSIOL BIOCHEM, V47, P590, DOI 10.1159/000490015; Huang YW, 2006, FEBS J, V273, P3248, DOI 10.1111/j.1742-4658.2006.05333.x; Im HJ, 2016, CANCER RES, V76, P1698, DOI 10.1158/0008-5472.CAN-15-2114; James DJ, 2009, P NATL ACAD SCI USA, V106, P17308, DOI 10.1073/pnas.0900755106; Do K, 2015, INVEST NEW DRUG, V33, P720, DOI 10.1007/s10637-015-0212-z; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Liu TT, 2011, ACTA BIOCH BIOPH SIN, V43, P542, DOI 10.1093/abbs/gmr044; Lu LL, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5874127; Luo W, 2018, PHYTOTHER RES, V32, P2009, DOI 10.1002/ptr.6132; Mali AV, 2018, CANCER BIOL MED, V15, P137, DOI 10.20892/j.issn.2095-3941.2018.0012; Mathias RA, 2009, J PROTEOME RES, V8, P2827, DOI 10.1021/pr8010974; Miller S, 2011, NEURO-ONCOLOGY, V13, P866, DOI 10.1093/neuonc/nor070; Mundade Rasika, 2014, Oncoscience, V1, P400; Nagano K, 2015, INT J BIOCHEM CELL B, V62, P62, DOI 10.1016/j.biocel.2015.02.013; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pemberton JG, 2014, GEN COMP ENDOCR, V205, P268, DOI 10.1016/j.ygcen.2014.03.011; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Price TJ, 2014, LANCET ONCOL, V15, P569, DOI 10.1016/S1470-2045(14)70118-4; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Sadakata T, 2007, J HISTOCHEM CYTOCHEM, V55, P301, DOI 10.1369/jhc.6A7033.2006; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Shiozaki H, 1996, CANCER, V77, P1605, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1605::AID-CNCR4>3.3.CO;2-R; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Tanaka T, 2017, J CELL PHYSIOL, V232, P939, DOI 10.1002/jcp.25619; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Vu T, 2017, CANCERS, V9, DOI 10.3390/cancers9120171; VanSaun MN, 2009, AM J PATHOL, V175, P355, DOI 10.2353/ajpath.2009.080703; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wang JM, 2015, ONCOTARGET, V6, P27427, DOI 10.18632/oncotarget.4861; Wang YD, 2018, EUR J PHARMACOL, V834, P45, DOI 10.1016/j.ejphar.2018.07.006; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Xu DC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0547-4; Xue RY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101626; Zhang Y, 2017, MOL CARCINOGEN, V56, P272, DOI 10.1002/mc.22491; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	57	17	19	0	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2019	38	23					4574	4589		10.1038/s41388-019-0740-7	http://dx.doi.org/10.1038/s41388-019-0740-7			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB4KM	30742066				2022-12-26	WOS:000470240300010
J	Lu, YY; Li, XD; Zhou, HD; Shao, S; He, S; Hong, MN; Liu, JC; Xu, YL; Wu, YJ; Zhu, DL; Wang, JG; Gao, PJ				Lu, Yuan-Yuan; Li, Xiao-Dong; Zhou, Han-Dan; Shao, Shuai; He, Shun; Hong, Mo-Na; Liu, Jia-Chen; Xu, Ying-Le; Wu, Yong-Jie; Zhu, Ding-Liang; Wang, Ji-Guang; Gao, Ping-Jin			Transactivation domain of Kruppel-like factor 15 negatively regulates angiotensin II-induced adventitial inflammation and fibrosis	FASEB JOURNAL			English	Article						KLF15; Ang II; vascular remodeling; adenovirus; macrophage	PHOSPHOLIPASE C-GAMMA-1; PROTEIN; FIBROBLASTS; EXPRESSION; KLF15; DIFFERENTIATION; CONTRIBUTE; MIGRATION; DISEASE; INJURY	Kruppel-like factor (KLF) 15 has emerged as a critical regulator of fibrosis in cardiovascular diseases. However, the precise role that KLF15 and its functional domain played in adventitial inflammation and fibrosis remains unclear. This study aims to investigate the role of the transactivation domain (TAD) of KLF15 in angiotensin II (Ang II)-induced adventitial pathologic changes. KLF15 expression was decreased in the vascular adventitia of Ang II-infused mice (1000 ng/kg/min, 14 d) and in adventitial fibroblasts (AFs) stimulated by Ang II (10(-7) M). Adenovirus-mediated KLF15 overexpression normalized Ang II-induced vascular hypertrophy, increased collagen deposition, macrophage infiltration, and CCL2 and VCAM-1 expression. Interestingly, KLF15-TAD (KLF15 with deletion of TAD at amino acids 132-152) overexpression showed no effect on the above pathologic changes. Similarly, perivascularly overexpression of KLF15 but not KLF15-TAD in carotid arteries also attenuated Ang II-induced vascular inflammation and fibrosis. Furthermore, KLF15 overexpression after Ang II infusion rescued Ang II-induced vascular remodeling. CCL2 or VCAM-1-mediated monocyte and macrophage migration or adhesion to AFs in response to Ang II was negatively regulated by KLF15 through TAD. Ang II-enhanced Smad2/3 activation and adventitial migration, proliferation, and differentiation of AFs were suppressed by KLF15 but not KLF15-TAD overexpression. Conversely, small interfering RNA knockdown of KLF15 aggravated Ang II-induced Smad2/3 activation and dysfunction of AFs. Luciferase, coimmunoprecipitation, and chromatin immunoprecipitation assay were used to demonstrate that interaction of KLF15 with Smad2/3 suppressed CCL2 expression through TAD. Mechanistically, activation of Ang II type 1 receptor/phospholipase C 1/ERK1/2 signaling resulted in a decrease of KLF15 expression. In conclusion, these results demonstrate that KLF15 negatively regulates activation of AFs through TAD, which plays an important role in Ang II-induced adventitial inflammation and fibrosis.Lu, Y.-Y., Li, X.-D., Zhou, H.-D., Shao, S., He, S., Hong, M.-N., Liu, J.-C., Xu, Y.-L., Wu, Y.-J., Zhu, D.-L., Wang, J.-G., Gao, P.-J. Transactivation domain of Kruppel-like factor 15 negatively regulates angiotensin II-induced adventitial inflammation and fibrosis.	[Lu, Yuan-Yuan; Li, Xiao-Dong; Zhou, Han-Dan; Shao, Shuai; He, Shun; Hong, Mo-Na; Liu, Jia-Chen; Xu, Ying-Le; Wu, Yong-Jie; Zhu, Ding-Liang; Wang, Ji-Guang; Gao, Ping-Jin] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Shanghai Key Lab Hypertens, Ruijin Hosp,Dept Hypertens,Sch Med, Shanghai, Peoples R China; [Li, Xiao-Dong; Xu, Ying-Le; Wu, Yong-Jie; Zhu, Ding-Liang; Wang, Ji-Guang; Gao, Ping-Jin] Shanghai Res Inst Hypertens, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University	Li, XD (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Hypertens, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.; Li, XD (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Sch Med, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.	flylxd@163.com	Wang, Ji Guang/AAP-4045-2021	Wang, Ji Guang/0000-0001-8511-1524; Li, Xiaodong/0000-0002-3771-6286	Shanghai Sailing Program of Talented Youth in Science and Technology [15YF1409800]; Key Project of National Natural Science Foundation of China [91539202, 91639203, 91739303]; National Natural Science Foundation of China [81770415]; Natural Science Foundation of Shanghai [18ZR1431800]	Shanghai Sailing Program of Talented Youth in Science and Technology; Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This study was supported by the Shanghai Sailing Program of Talented Youth in Science and Technology (15YF1409800), the Key Project of National Natural Science Foundation of China (91539202, 91639203, and 91739303), the National Natural Science Foundation of China (81770415), and the Natural Science Foundation of Shanghai (18ZR1431800). The authors declare no conflicts of interest.	Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bersi MR, 2016, HYPERTENSION, V67, P890, DOI 10.1161/HYPERTENSIONAHA.115.06262; Chen WD, 2009, BIOCHEM BIOPH RES CO, V389, P217, DOI 10.1016/j.bbrc.2009.08.104; Coen M, 2011, ARTERIOSCL THROM VAS, V31, P2391, DOI 10.1161/ATVBAHA.111.231548; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gao PJ, 2003, J MOL CELL CARDIOL, V35, P1105, DOI 10.1016/S0022-2828(03)00207-4; Gao XA, 2011, KIDNEY INT, V79, P987, DOI 10.1038/ki.2010.539; Gu XC, 2017, KIDNEY INT, V92, P1178, DOI 10.1016/j.kint.2017.03.037; Hong MN, 2016, ONCOTARGET, V7, P67828, DOI 10.18632/oncotarget.12182; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Jin X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023558; Karnik SS, 2015, PHARMACOL REV, V67, P754, DOI 10.1124/pr.114.010454; Kuang SQ, 2013, ARTERIOSCL THROM VAS, V33, P2172, DOI 10.1161/ATVBAHA.113.301624; Kuwabara JT, 2017, ARTERIOSCL THROM VAS, V37, P1598, DOI 10.1161/ATVBAHA.117.308199; Lehoux S, 2016, HYPERTENSION, V67, P836, DOI 10.1161/HYPERTENSIONAHA.116.06375; Li GH, 2000, CIRCULATION, V101, P1362, DOI 10.1161/01.CIR.101.12.1362; Li XD, 2012, ARTERIOSCL THROM VAS, V32, P2250, DOI 10.1161/ATVBAHA.112.255216; Lin JR, 2015, ARTERIOSCL THROM VAS, V35, P1413, DOI 10.1161/ATVBAHA.115.305706; Liu HW, 2006, LIFE SCI, V79, P475, DOI 10.1016/j.lfs.2006.01.031; Liu ZY, 2012, CIRC RES, V111, P1261, DOI [10.1161/CIRCRESAHA.112.270520, 10.1161/circresaha.112.270520]; Lu Y, 2013, J CLIN INVEST, V123, P4232, DOI 10.1172/JCI68552; Lu YA, 2010, ARTERIOSCL THROM VAS, V30, P1550, DOI 10.1161/ATVBAHA.110.207050; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Majesky MW, 2015, ARTERIOSCL THROM VAS, V35, pE31, DOI 10.1161/ATVBAHA.115.306088; Mas C, 2011, P NATL ACAD SCI USA, V108, P10484, DOI 10.1073/pnas.1017029108; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Meijles DN, 2016, HYPERTENSION, V67, P14, DOI 10.1161/HYPERTENSIONAHA.115.03622; Noack C, 2012, EMBO MOL MED, V4, P992, DOI 10.1002/emmm.201101043; Ohki R, 2007, CANCER SCI, V98, P189, DOI 10.1111/j.1349-7006.2006.00375.x; Pandey D, 2018, ARTERIOSCL THROM VAS, V38, P913, DOI 10.1161/ATVBAHA.117.310660; Patel SK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051303; Poduri A, 2015, ARTERIOSCL THROM VAS, V35, P1995, DOI 10.1161/ATVBAHA.115.305995; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Ruan CC, 2010, ARTERIOSCL THROM VAS, V30, P2568, DOI 10.1161/ATVBAHA.110.215525; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Schmitz U, 1997, CIRC RES, V81, P550, DOI 10.1161/01.RES.81.4.550; Shannon LA, 2010, J BIOL CHEM, V285, P38781, DOI 10.1074/jbc.M110.152173; Shen WL, 2006, BIOCHEM BIOPH RES CO, V339, P337, DOI 10.1016/j.bbrc.2005.10.207; Stenmark KR, 2013, ANNU REV PHYSIOL, V75, P23, DOI 10.1146/annurev-physiol-030212-183802; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Venema RC, 1998, J BIOL CHEM, V273, P7703, DOI 10.1074/jbc.273.13.7703; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; Wang YL, 2011, KIDNEY INT, V79, P933, DOI 10.1038/ki.2011.8; Xu SQ, 2011, HYPERTENSION, V58, P310, DOI 10.1161/HYPERTENSIONAHA.111.172031; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Yu Y, 2015, CARDIOLOGY, V130, P143, DOI 10.1159/000369382; Zhang GN, 2016, NITRIC OXIDE-BIOL CH, V61, P20, DOI 10.1016/j.niox.2016.09.006	48	10	10	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6254	6268		10.1096/fj.201801809R	http://dx.doi.org/10.1096/fj.201801809R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30776250	Bronze			2022-12-26	WOS:000466932600036
J	Wang, WL; Geng, XQ; Lei, L; Jia, YL; Li, YJ; Zhou, H; Verkman, AS; Yang, BX				Wang, Weiling; Geng, Xiaoqiang; Lei, Lei; Jia, Yingli; Li, Yingjie; Zhou, Hong; Verkman, Alan S.; Yang, Baoxue			Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease	FASEB JOURNAL			English	Article						water channel; ADPKD; glucose metabolism; AMPK; mTOR signaling; HIF1-	HYDROGEN-PEROXIDE TRANSPORT; CELL PROLIFERATION; GLUCOSE-METABOLISM; MITOCHONDRIAL ROS; INHIBITION; GROWTH; ACTIVATION; EXPRESSION; PATHWAY; KINASE	Human autosomal dominant polycystic kidney disease (ADPKD) is characterized by bilateral renal cysts that lead to a decline in kidney function. Previous studies reported aquaporin (AQP)-3 expression in cysts derived from collecting ducts in ADPKD. To study the role of AQP3 in cyst development, we generated 2 polycystic kidney disease (PKD) mouse models: kidney-specific Pkd1 knockout mice and inducible Pkd1 knockout mice, each without and with AQP3 deletion. In both models, kidney sizes and cyst indexes were significantly reduced in AQP3-null PKD mice compared with AQP3-expressing PKD mice, with the difference seen mainly in collecting duct cysts. AQP3-deficient kidneys showed significantly reduced ATP content, increased phosphorylated (p)-AMPK, and decreased p-ERK and p-mammalian target of rapamycin (mTOR). In a matrix-grown Madin-Darby canine kidney cyst model, AQP3 expression promoted cyst enlargement and was associated with increased expression of hypoxia-inducible factor 1- and glucose transporter 1 and increased glucose uptake. Our data suggest that the slowed renal cyst enlargement in AQP3 deficiency involves impaired energy metabolism in the kidney through AMPK and mTOR signaling and impaired cellular glucose uptake. These findings implicate AQP3 as a novel determinant of renal cyst enlargement and hence a potential drug target in ADPKD.Wang, W., Geng, X., Lei, L., Jia, Y., Li, Y., Zhou, H., Verkman, A. S., Yang, B. Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease.	[Wang, Weiling; Geng, Xiaoqiang; Lei, Lei; Jia, Yingli; Li, Yingjie; Zhou, Hong; Yang, Baoxue] Peking Univ, Dept Pharmacol, Sch Basic Med Sci, 38 Xueyuan Lu,211 Bldg Physiol, Beijing 100191, Peoples R China; [Wang, Weiling; Geng, Xiaoqiang; Lei, Lei; Jia, Yingli; Li, Yingjie; Zhou, Hong; Yang, Baoxue] State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Yang, Baoxue] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Wang, Weiling] Beijing Univ Chinese Med, Beijing Res Inst Chinese Med, Beijing, Peoples R China; [Verkman, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Verkman, Alan S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Peking University; Beijing University of Chinese Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yang, BX (corresponding author), Peking Univ, Dept Pharmacol, Sch Basic Med Sci, 38 Xueyuan Lu,211 Bldg Physiol, Beijing 100191, Peoples R China.	baoxue@bjmu.edu.cn			National Natural Science Foundation of China [81620108029, 81261160507, 81330074, 81170632, 81370783]; Beijing Natural Science Foundation [7172113]; 111 Project; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK101373]; Fundamental Research Funds for the Central Universities [2018-JYBZZ-XJSJJ012]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101373] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); 111 Project(Ministry of Education, China - 111 Project); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Peter Igarashi (Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA) and Stefan Somlo (Section of Nephrology, Yale School of Medicine, New Haven, CT, USA) for the Ksp-Cre and Pkd1<SUP>flox/flox</SUP> mice. This work was supported by National Natural Science Foundation of China Grants 81620108029, 81261160507, 81330074, 81170632, and 81370783; Beijing Natural Science Foundation Grant 7172113; the 111 Project; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK101373; and the Fundamental Research Funds for the Central Universities (2018-JYBZZ-XJSJJ012). The authors declare no conflicts of interest.	Bland ML, 2011, SCIENCE, V332, P1387, DOI 10.1126/science.1208444; Brookes ZLS, 2013, AM J PHYSIOL-HEART C, V304, pH33, DOI 10.1152/ajpheart.01102.2011; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Byun YJ, 2009, NEUROSCI LETT, V461, P131, DOI 10.1016/j.neulet.2009.06.011; Chiaravalli M, 2016, J AM SOC NEPHROL, V27, P1958, DOI 10.1681/ASN.2015030231; Cinq-Frais C, 2013, BBA-MOL CELL BIOL L, V1831, P1344, DOI 10.1016/j.bbalip.2013.04.014; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; Dalla Sega FV, 2014, BBA-MOL CELL RES, V1843, P806, DOI 10.1016/j.bbamcr.2014.01.011; Damm E, 2012, MOL ENDOCRINOL, V26, P643, DOI 10.1210/me.2011-1218; Deubzer B, 2010, CELL PHYSIOL BIOCHEM, V25, P767, DOI 10.1159/000315098; Gattone VH, 1999, DEV GENET, V24, P309, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<309::AID-DVG14>3.0.CO;2-5; Grandjean G, 2016, CANCER RES, V76, P4259, DOI 10.1158/0008-5472.CAN-16-0401; GRANTHAM JJ, 1987, KIDNEY INT, V31, P1145, DOI 10.1038/ki.1987.121; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; Hara-Chikuma M, 2016, BIOCHEM BIOPH RES CO, V471, P603, DOI 10.1016/j.bbrc.2016.02.010; Hara-Chikuma M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8454; Hardie DG, 2011, NATURE, V472, P176, DOI 10.1038/472176a; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hayashi M, 1997, NEPHRON, V75, P321, DOI 10.1159/000189556; Kim J, 2001, J BIOL CHEM, V276, P19102, DOI 10.1074/jbc.M011579200; Laforenza U, 2016, BBA-BIOMEMBRANES, V1858, P1, DOI 10.1016/j.bbamem.2015.10.004; Lei L, 2017, BBA-MOL BASIS DIS, V1863, P1231, DOI 10.1016/j.bbadis.2017.03.012; Li Z, 2016, TUMOR BIOL, V37, P9169, DOI 10.1007/s13277-015-4753-8; Liu CX, 2016, ONCOTARGET, V7, P7534, DOI 10.18632/oncotarget.7183; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Maekawa Y, 2015, NAT MED, V21, P55, DOI 10.1038/nm.3758; Maser RL, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134991; Menezes LF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003053; Metheni M, 2014, CELL MICROBIOL, V16, P269, DOI 10.1111/cmi.12218; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Nagaraju GP, 2016, CANCER LETT, V373, P12, DOI 10.1016/j.canlet.2016.01.003; Pema M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10786; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Radisavljevic ZM, 2004, J CELL BIOCHEM, V91, P1293, DOI 10.1002/jcb.20037; Riwanto M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146654; Rossi A, 2013, APOPTOSIS, V18, P1469, DOI 10.1007/s10495-013-0893-8; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Schneider A, 2003, AM J PHYSIOL-RENAL, V284, pF411, DOI 10.1152/ajprenal.00235.2002; Shi WW, 2018, MOL CELL BIOCHEM, V449, P219, DOI 10.1007/s11010-018-3358-0; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shukla SK, 2017, CANCER CELL, V32, P71, DOI 10.1016/j.ccell.2017.06.004; Takakura A, 2008, J AM SOC NEPHROL, V19, P2351, DOI 10.1681/ASN.2007101139; Takiar V, 2011, BBA-MOL BASIS DIS, V1812, P1337, DOI 10.1016/j.bbadis.2010.11.014; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2010, CLIN J AM SOC NEPHRO, V5, P1312, DOI 10.2215/CJN.01360210; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Wang W, 2017, ONCOTARGET, V8, P3344, DOI 10.18632/oncotarget.13763; Wang WL, 2015, FASEB J, V29, P1551, DOI 10.1096/fj.14-260828; Wang XQ, 2013, KIDNEY INT, V84, P962, DOI 10.1038/ki.2013.199; Warner G, 2016, J AM SOC NEPHROL, V27, P1437, DOI 10.1681/ASN.2015020132; Yuajit C, 2014, BIOCHEM PHARMACOL, V88, P412, DOI 10.1016/j.bcp.2014.01.038; Zhang JQ, 2016, INT J BIOCHEM CELL B, V70, P76, DOI 10.1016/j.biocel.2015.11.009; Zhao SM, 2016, ONCOTARGET, V7, P84839, DOI 10.18632/oncotarget.13321; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	59	11	11	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6185	6196		10.1096/fj.201801338RRR	http://dx.doi.org/10.1096/fj.201801338RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30768374	Green Published, Bronze			2022-12-26	WOS:000466932600031
J	Tang, TC; Kienlen-Campard, P; Hu, Y; Perrin, F; Opsomer, R; Octave, JN; Constantinescu, SN; Smith, SO				Tang, Tzu-Chun; Kienlen-Campard, Pascal; Hu, Yi; Perrin, Florian; Opsomer, Remi; Octave, Jean-Noel; Constantinescu, Stefan N.; Smith, Steven O.			Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and -secretase processing of the C99 peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid-beta (A); amyloid precursor protein (APP); secretase; nuclear magnetic resonance (NMR); Fourier transform IR (FTIR); fluorescence; neurodegeneration; A42; A40 ratio; membrane interaction	AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; INTRAMEMBRANE PROTEOLYSIS; CEREBRAL-HEMORRHAGE; FLEMISH MUTATION; CLEAVAGE SITE; APP; DOMAIN; GENE; HOMODIMERIZATION	Extracellular deposition of -amyloid (A) peptides in the brain is a hallmark of Alzheimer's disease (AD). Upon -secretase-mediated cleavage of the C-terminal fragment (-CTF) from the A precursor protein, the -secretase complex produces the A peptides associated with AD. The familial T43I mutation within the transmembrane domain of the -CTF (also referred to as C99) increases the ratio between the A42 and A40 peptides largely due to a decrease in A40 formation. A42 is the principal component of amyloid deposits within the brain parenchyma, and an increase in the A42/A40 ratio is correlated with early-onset AD. Using NMR and FTIR spectroscopy, here we addressed how the T43I substitution influences the structure of C55, the minimal sequence containing the entire extracellular and transmembrane (TM) domains of C99 needed for -secretase processing. C-13 NMR chemical shifts indicated that the T43I substitution increases helical structure within the TM domain of C55. These structural changes were associated with a shift of the C55 dimer to the monomer and an increase in the tilt of the TM helix relative to the membrane normal in the T43I mutant compared with that of WT C55. The A21G (Flemish) mutation was previously found to increase secreted A40 levels; here, we combined this mutation in the extracellular domain of C99 with T43I and observed that the T43I/A21G double mutant decreases A40 formation. We discuss how the observed structural changes in the T43I mutant may decrease A40 formation and increase the A42/A40 ratio.	[Tang, Tzu-Chun; Hu, Yi; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Kienlen-Campard, Pascal; Opsomer, Remi; Octave, Jean-Noel] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Perrin, Florian; Constantinescu, Stefan N.] Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Perrin, Florian; Constantinescu, Stefan N.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain	Smith, SO (corresponding author), SUNY Stony Brook, Ctr Struct Biol Z 5215, Stony Brook, NY 11794 USA.	steven.o.smith@stonybrook.edu	Smith, Steven/HDM-9496-2022	Smith, Steven/0000-0003-1861-7159	National Institutes of Health [S10 RR13889, DBI-9977553, AG 27317]; National Science Foundation [S10 RR13889, DBI-9977553]; Foundation for Research on Alzheimer's Disease; Interuniversity Attraction Pole Programme-Belgian State-Belgian Science Policy [IAP-P7/16]; Fondation Medicale Reine Elisabeth (FMRE); Fonds National de la Recherche Scientifique (FNRS) [PDRT. 0177.18]; Action de Recherche Concertee [14/19-059, 16/21-073]; Ludwig Institute for Cancer Research; Fondation contre le Cancer [F/2014/266]; Salus Sanguinis; Fondation "Les Avions de Sebastien"; FNRS-WELBIO [WELBIO-CR-2017A-02]; NATIONAL INSTITUTE ON AGING [RF1AG027317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Foundation for Research on Alzheimer's Disease; Interuniversity Attraction Pole Programme-Belgian State-Belgian Science Policy; Fondation Medicale Reine Elisabeth (FMRE); Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Action de Recherche Concertee; Ludwig Institute for Cancer Research; Fondation contre le Cancer; Salus Sanguinis; Fondation "Les Avions de Sebastien"; FNRS-WELBIO(Fonds de la Recherche Scientifique - FNRSWELBIO); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health and National Science Foundation Instrumentation Grants S10 RR13889 and DBI-9977553 and National Institutes of Health Grant AG 27317 (to S. O. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Foundation for Research on Alzheimer's Disease, the Interuniversity Attraction Pole Programme-Belgian State-Belgian Science Policy (IAP-P7/16), the Fondation Medicale Reine Elisabeth (FMRE), Fonds National de la Recherche Scientifique (FNRS, PDRT. 0177.18), and Action de Recherche Concertee (convention 14/19-059).; Supported by the Ludwig Institute for Cancer Research, Fondation contre le Cancer Grant F/2014/266, Salus Sanguinis, Fondation "Les Avions de Sebastien," Action de Recherche Concertee (convention 16/21-073), and the FNRS-WELBIO (convention WELBIO-CR-2017A-02).	Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Bolduc DM, 2016, ELIFE, V5, DOI 10.7554/eLife.17578; BURDICK D, 1992, J BIOL CHEM, V267, P546; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Chen WL, 2014, ACS SYM SER, V1174, P5; Cruts M, 2003, J NEUROL, V250, P1374, DOI 10.1007/s00415-003-0182-5; De Jonghe C, 2001, HUM MOL GENET, V10, P1665, DOI 10.1093/hmg/10.16.1665; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Fukumori A, 2016, EMBO J, V35, P1628, DOI 10.15252/embj.201694151; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hoos MD, 2007, J BIOL CHEM, V282, P9952, DOI 10.1074/jbc.M603494200; Hu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17144-0; Itkin A, 2017, ACS OMEGA, V2, P6525, DOI 10.1021/acsomega.7b00619; KAMINO K, 1992, AM J HUM GENET, V51, P998; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; Kumar-Singh S, 2000, HUM MOL GENET, V9, P2589, DOI 10.1093/hmg/9.18.2589; Kwok JBJ, 2000, ANN NEUROL, V47, P249, DOI 10.1002/1531-8249(200002)47:2<249::AID-ANA18>3.3.CO;2-#; Langosch D, 2015, TRENDS BIOCHEM SCI, V40, P318, DOI 10.1016/j.tibs.2015.04.001; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Murrell JR, 2000, ARCH NEUROL-CHICAGO, V57, P885, DOI 10.1001/archneur.57.6.885; Nadezhdin KD, 2012, FEBS LETT, V586, P1687, DOI 10.1016/j.febslet.2012.04.062; Pasalar P, 2002, NEUROLOGY, V58, P1574, DOI 10.1212/WNL.58.10.1574; Pester O, 2013, J AM CHEM SOC, V135, P1317, DOI 10.1021/ja3112093; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Smith SO, 2002, BIOPHYS J, V82, P2476, DOI 10.1016/S0006-3495(02)75590-2; Song YL, 2013, BIOCHEMISTRY-US, V52, P5051, DOI 10.1021/bi400735x; Szaruga M, 2017, CELL, V170, P443, DOI 10.1016/j.cell.2017.07.004; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tang TC, 2014, STRUCTURE, V22, P387, DOI 10.1016/j.str.2013.12.012; Tian Y, 2010, NAT STRUCT MOL BIOL, V17, P151, DOI 10.1038/nsmb.1743; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WANG R, 1991, J BIOL CHEM, V266, P16960; Winkler E, 2015, BIOCHEMISTRY-US, V54, P6149, DOI 10.1021/acs.biochem.5b00986; Xu TH, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.26; Yan Y, 2017, J BIOL CHEM, V292, P15826, DOI 10.1074/jbc.M117.789669; Yang GH, 2019, NATURE, V565, P192, DOI 10.1038/s41586-018-0813-8; Zhou R, 2019, SCIENCE, V363, P708, DOI 10.1126/science.aaw0930	46	5	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5854	5866		10.1074/jbc.RA118.006061	http://dx.doi.org/10.1074/jbc.RA118.006061			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30755484	Green Published, hybrid			2022-12-26	WOS:000465077500017
J	Adnan, AA; Diels, J; Jibrin, JM; Kamara, AY; Craufurd, P; Shaibu, AS; Mohammed, IB; Tonnang, ZEH				Adnan, A. A.; Diels, J.; Jibrin, J. M.; Kamara, A. Y.; Craufurd, P.; Shaibu, A. S.; Mohammed, I. B.; Tonnang, Z. E. H.			Options for calibrating CERES-maize genotype specific parameters under data-scarce environments	PLOS ONE			English	Article							CROP MODEL; CULTIVAR COEFFICIENTS; GENETIC COEFFICIENTS; SOYBEAN MODEL; NITROGEN; METHODOLOGY; STRATEGIES; PHENOLOGY; GENCALC; SEASON	Most crop simulation models require the use of Genotype Specific Parameters (GSPs) which provide the Genotype component of GxExMinteractions. Estimation of GSPs is the most difficult aspect of most modelling exercises because it requires expensive and time-consuming field experiments. GSPs could also be estimated using multi-year and multi locational data from breeder evaluation experiments. This research was set up with the following objectives: i) to determine GSPs of 10 newly released maize varieties for the Nigerian Savannas using data from both calibration experiments and by using existing data from breeder varietal evaluation trials; ii) to compare the accuracy of the GSPs generated using experimental and breeder data; and iii) to evaluate CERES-Maize model to simulate grain and tissue nitrogen contents. For experimental evaluation, 8 different experiments were conducted during the rainy and dry seasons of 2016 across the Nigerian Savanna. Breeder evaluation data were also collected for 2 years and 7 locations. The calibrated GSPs were evaluated using data from a 4-year experiment conducted under varying nitrogen rates (0, 60 and 120kg N ha(-1)). For the model calibration using experimental data, calculated model efficiency (EF) values ranged between 0.88-0.94 and coefficient of determination (d-index) between 0.93-0.98. Calibration of time-series data produced nRMSE below 7% while all prediction deviations were below 10% of the mean. For breeder experiments, EF (0.58-0.88) and d-index (0.56-0.86) ranges were lower. Prediction deviations were below 17% of the means for all measured variables. Model evaluation using both experimental and breeder trials resulted in good agreement (low RMSE, high EF and d-index values) between observed and simulated grain yields, and tissue and grain nitrogen contents. It is concluded that higher calibration accuracy of CERES-Maize model is achieved from detailed experiments. If unavailable, data from breeder experimental trials collected from many locations and planting dates can be used with lower but acceptable accuracy.	[Adnan, A. A.; Shaibu, A. S.] Bayero Univ Kano, Dept Agron, Kano, Nigeria; [Adnan, A. A.; Diels, J.] Katholieke Univ Leuven, Div Soil & Water Management, Dept Earth & Environm Sci, Leuven, Belgium; [Adnan, A. A.; Jibrin, J. M.; Shaibu, A. S.] Bayero Univ Kano, CDA, Kano, Nigeria; [Kamara, A. Y.; Mohammed, I. B.; Tonnang, Z. E. H.] Int Inst Trop Agr, Ibadan, Nigeria; [Kamara, A. Y.; Mohammed, I. B.; Tonnang, Z. E. H.] Carolyn House, Croydon, England; [Craufurd, P.; Tonnang, Z. E. H.] World Agroforestry Ctr ICRAF, Int Maize & Wheat Improvement Ctr CIMMYT, House United Nations Ave, Nairobi, Kenya	Bayero University; KU Leuven; Bayero University; CGIAR; International Institute of Tropical Agriculture (IITA); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); World Agroforestry (ICRAF)	Adnan, AA (corresponding author), Bayero Univ Kano, Dept Agron, Kano, Nigeria.; Adnan, AA (corresponding author), Katholieke Univ Leuven, Div Soil & Water Management, Dept Earth & Environm Sci, Leuven, Belgium.; Adnan, AA (corresponding author), Bayero Univ Kano, CDA, Kano, Nigeria.	aaadnan.agr@buk.edu.ng	TONNANG, Henri/AAQ-2206-2021; Diels, Jan/R-5564-2019	TONNANG, Henri/0000-0002-9424-9186; Diels, Jan/0000-0002-0317-8280; Jibrin, Jibrin/0000-0003-3757-289X; Shaibu, Abdulwahab Saliu/0000-0002-8538-3690	International Maize and Wheat Improvement Centre (CIMMYT) [OPP1113374]	International Maize and Wheat Improvement Centre (CIMMYT)(CGIAR)	International Maize and Wheat Improvement Centre (CIMMYT), contract OPP1113374, funding received by JMJ.	Adnan AA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01118; Adnan AA, 2017, J PLANT NUTR, V40, P1066, DOI 10.1080/01904167.2016.1263330; Angulo C, 2013, AGR FOREST METEOROL, V170, P32, DOI 10.1016/j.agrformet.2012.11.017; [Anonymous], [No title captured]; Anothai J, 2008, FIELD CROP RES, V108, P169, DOI 10.1016/j.fcr.2008.04.012; Anothai J, 2008, AGR SYST, V96, P195, DOI 10.1016/j.agsy.2007.08.002; Badu- Apraku B, 2009, IMPROVEMENT YIELD OT, DOI [10.2134/agronj2008.0089x, DOI 10.2134/AGRONJ2008.0089X]; Bannayan M, 2009, FIELD CROP RES, V111, P290, DOI 10.1016/j.fcr.2009.01.007; Batchelor WD, 2002, EUR J AGRON, V18, P141, DOI 10.1016/S1161-0301(02)00101-6; Buddhaboon C, 2018, J AGR SCI-CAMBRIDGE, V156, P482, DOI 10.1017/S0021859618000527; Chisanga CB, 2015, J AGR SCI, V7, P1, DOI [10.5539/jas.v7n3pxx, DOI 10.5539/JAS.V7N3PXX]; du Toit A. S., 2002, South African Journal of Plant and Soil, V19, P208; FAOSTAT, 2017, DAT FOOD AGR ORG FAO; Fensterseifer CA, 2017, FIELD CROP RES, V204, P146, DOI 10.1016/j.fcr.2017.01.007; Gungula DT, 2003, AGRON J, V95, P892, DOI 10.2134/agronj2003.0892; He JQ, 2010, AGR SYST, V103, P256, DOI 10.1016/j.agsy.2010.01.006; HUNT LA, 1993, AGRON J, V85, P1090, DOI 10.2134/agronj1993.00021962008500050025x; IBSNAT, 1994, DEC SUPP SYST AGR TR, P1776; Iyanda R. A., 2014, International Journal of Agricultural Policy and Research, V2, P69; Jagtap SS, 1999, AGR SYST, V60, P77, DOI 10.1016/S0308-521X(99)00019-0; Jibrin J. M., 2012, African Journal of Agricultural Research, V7, P5530; Jones C., 1986, SIMULATION MODEL MAI; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Kumudini S, 2014, AGRON J, V106, P2087, DOI 10.2134/agronj14.0200; Lamsal A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195841; Lamsal A, 2017, AGR SYST, V157, P170, DOI 10.1016/j.agsy.2017.07.016; LOAGUE K, 1991, Journal of Contaminant Hydrology, V7, P51, DOI 10.1016/0169-7722(91)90038-3; MacCarthy DS, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00031; Mavromatis T, 2001, CROP SCI, V41, P40, DOI 10.2135/cropsci2001.41140x; Roman-Paoli E, 2000, AGR SYST, V65, P29, DOI 10.1016/S0308-521X(00)00024-X; Ruiz-Nogueira B, 2001, AGR SYST, V68, P151, DOI 10.1016/S0308-521X(01)00008-7; Seidel SJ, 2018, EUR J AGRON, V94, P25, DOI 10.1016/j.eja.2018.01.006; Soler CMT, 2007, EUR J AGRON, V27, P165, DOI 10.1016/j.eja.2007.03.002; Suriharn B, 2007, CROP SCI, V47, P607, DOI 10.2135/cropsci2006.01.0050; Thorp KR, 2008, COMPUT ELECTRON AGR, V64, P276, DOI 10.1016/j.compag.2008.05.022; WALLACH D, 1989, ECOL MODEL, V44, P299, DOI 10.1016/0304-3800(89)90035-5; Welch S. M., 2001, P 3 INT S SYST APPR; Welch SM, 2002, T ASAE, V45, P1163, DOI 10.13031/2013.9925; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2; Xiong W, 2014, ECOL MODEL, V273, P128, DOI 10.1016/j.ecolmodel.2013.10.026; Zinyengere Nkulumo, 2015, South African Journal of Plant and Soil, V32, P95, DOI 10.1080/02571862.2015.1006271	41	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0200118	10.1371/journal.pone.0200118	http://dx.doi.org/10.1371/journal.pone.0200118			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779756	Green Published, Green Submitted, gold			2022-12-26	WOS:000459062900002
J	Hassing, B; Winter, D; Becker, Y; Mesarich, CH; Eaton, CJ; Scott, B				Hassing, Berit; Winter, David; Becker, Yvonne; Mesarich, Carl H.; Eaton, Carla J.; Scott, Barry			Analysis of Epichloe festucae small secreted proteins in the interaction with Lolium perenne	PLOS ONE			English	Article							REPEAT TRANSPOSABLE ELEMENTS; PATHOGEN ZYMOSEPTORIA-TRITICI; POINT MUTATION RIP; FUNGAL EFFECTOR; GENE-CLUSTER; SACCHAROMYCES-CEREVISIAE; PHYTOPHTHORA-INFESTANS; LACCARIA-BICOLOR; HOST-SPECIFICITY; BLAST FUNGUS	Epichloe festucae is an endophyte of the agriculturally important perennial ryegrass. This species systemically colonises the aerial tissues of this host where its growth is tightly regulated thereby maintaining a mutualistic symbiotic interaction. Recent studies have suggested that small secreted proteins, termed effectors, play a vital role in the suppression of host defence responses. To date only a few effectors with important roles in mutualistic interactions have been described. Here we make use of the fully assembled E. festucae genome and EffectorP to generate a suite of 141 effector candidates. These were analysed with respect to their genome location and expression profiles in planta and in several symbiosis-defective mutants. We found an association between effector candidates and a class of transposable elements known as MITEs, but no correlation with other dynamic features of the E. festucae genome, such as transposable element-rich regions. Three effector candidates and a small GPI-anchored protein were chosen for functional analysis based on their high expression in planta compared to in culture and their differential regulation in symbiosis defective E. festucae mutants. All three candidate effector proteins were shown to possess a functional signal peptide and two could be detected in the extracellular medium by western blotting. Localization of the effector candidates in planta suggests that they are not translocated into the plant cell, but rather, are localized in the apoplastic space or are attached to the cell wall. Deletion and overexpression of the effector candidates, as well as the putative GPI-anchored protein, did not affect the plant growth phenotype or restrict growth of E. festucae mutants in planta. These results indicate that these proteins are either not required for the interaction at the observed life stages or that there is redundancy between effectors expressed by E. festucae.	[Hassing, Berit; Winter, David; Mesarich, Carl H.; Eaton, Carla J.; Scott, Barry] Massey Univ, Sch Fundamental Sci, Palmerston North, New Zealand; [Hassing, Berit; Winter, David; Eaton, Carla J.; Scott, Barry] Massey Univ, Bioprotect Res Ctr, Palmerston North, New Zealand; [Becker, Yvonne] Fed Res Ctr Cultivated Plants, Inst Epidemiol & Pathogen Diagnost, Julius Kuehn Inst, Braunschweig, Germany; [Mesarich, Carl H.] Massey Univ, Sch Agr & Environm, Palmerston North, New Zealand	Massey University; Massey University; Julius Kuhn-Institut; Massey University	Scott, B (corresponding author), Massey Univ, Sch Fundamental Sci, Palmerston North, New Zealand.; Scott, B (corresponding author), Massey Univ, Bioprotect Res Ctr, Palmerston North, New Zealand.	d.b.scott@massey.ac.nz	Mesarich, Carl H/E-4304-2015; Becker, Yvonne E/N-7031-2016	Mesarich, Carl H/0000-0002-5207-4074; Hassing, Berit/0000-0002-2920-1055; Eaton, Carla/0000-0002-0633-1535; Winter, David/0000-0002-6165-0029; Scott, Barry/0000-0002-2224-2946	Tertiary Education Commission [RM19009]; CE Royal Society of New Zealand Marsden Fund [MAU1301]	Tertiary Education Commission; CE Royal Society of New Zealand Marsden Fund	BS received funding from Tertiary Education Commission to the Bio-Protection Research Centre (RM19009) and CE Royal Society of New Zealand Marsden Fund (MAU1301).	[Anonymous], 2006, NEW PHYTOL, V171, P699, DOI [10.1111/j.1469-8137.2006.01829.x, DOI 10.1111/J.1469-8137.2006.01829.X]; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Becker M, 2016, NEW PHYTOL, V211, P240, DOI 10.1111/nph.13931; Becker Y, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2990; Becker Y, 2015, MOL PLANT MICROBE IN, V28, P69, DOI 10.1094/MPMI-06-14-0183-R; Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Brefort T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003866; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Bultman Thomas L., 2008, Fungal Biology Reviews, V22, P131, DOI 10.1016/j.fbr.2009.04.003; BYRD AD, 1990, CURR GENET, V18, P347, DOI 10.1007/BF00318216; CAMBARERI EB, 1991, GENETICS, V127, P699; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; Christensen MJ, 2008, FUNGAL GENET BIOL, V45, P84, DOI 10.1016/j.fgb.2007.07.013; Chujo T, 2014, MOL MICROBIOL, V92, P413, DOI 10.1111/mmi.12567; Chung KR, 1997, PHYTOPATHOLOGY, V87, P599, DOI 10.1094/PHYTO.1997.87.6.599; Chung KR, 1997, MYCOL RES, V101, P295, DOI 10.1017/S0953756296002602; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; Derevnina L, 2016, NEW PHYTOL, V212, P888, DOI 10.1111/nph.14137; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Doehlemann G, 2011, MOL MICROBIOL, V81, P751, DOI 10.1111/j.1365-2958.2011.07728.x; Du J, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.34, 10.1038/nplants.2015.34]; Dupont PY, 2015, NEW PHYTOL, V208, P1227, DOI 10.1111/nph.13614; Eaton CJ, 2015, MOL PLANT MICROBE IN, V28, P218, DOI 10.1094/MPMI-09-14-0293-FI; Eaton CJ, 2010, PLANT PHYSIOL, V153, P1780, DOI 10.1104/pp.110.158451; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Fattash I, 2013, GENOME, V56, P475, DOI 10.1139/gen-2012-0174; Feschotte C, 2000, MOL BIOL EVOL, V17, P730, DOI 10.1093/oxfordjournals.molbev.a026351; Fleetwood DJ, 2007, APPL ENVIRON MICROB, V73, P2571, DOI 10.1128/AEM.00257-07; Fleetwood DJ, 2011, GENOME BIOL EVOL, V3, P1253, DOI 10.1093/gbe/evr098; Florea S, 2015, CURRENT PROTOCOLS MI, V38; Fudal I, 2009, MOL PLANT MICROBE IN, V22, P932, DOI 10.1094/MPMI-22-8-0932; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gladyshev E, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0042-2017; Grove TZ, 2008, CURR OPIN STRUC BIOL, V18, P507, DOI 10.1016/j.sbi.2008.05.008; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Hirsch CD, 2017, BBA-GENE REGUL MECH, V1860, P157, DOI 10.1016/j.bbagrm.2016.05.010; Houterman PM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000061; Hurlburt NK, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007263; Inoue Y, 2017, SCIENCE, V357, P80, DOI 10.1126/science.aam9654; ITOH Y, 1994, CURR GENET, V25, P508, DOI 10.1007/BF00351670; Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2; Johnson RD, 2015, FUNGAL GENET BIOL, V85, P14, DOI 10.1016/j.fgb.2015.10.005; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Joosten MHAJ, 1997, PLANT CELL, V9, P367; Jorda J, 2009, BIOINFORMATICS, V25, P2632, DOI 10.1093/bioinformatics/btp482; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kettles GJ, 2017, NEW PHYTOL, V213, P338, DOI 10.1111/nph.14215; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Kleemann Jochen, 2012, PLoS Pathog, V8, pe1002643, DOI 10.1371/journal.ppat.1002643; Kloppholz S, 2011, CURR BIOL, V21, P1204, DOI 10.1016/j.cub.2011.06.044; Koncz C, 1994, PLANT MOL BIOL MANUA, VB2, P1, DOI DOI 10.1007/978-94-011-0511-8_4; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lanver D, 2018, PLANT CELL, V30, P300, DOI 10.1105/tpc.17.00764; LATCH GCM, 1985, ANN APPL BIOL, V107, P17, DOI 10.1111/j.1744-7348.1985.tb01543.x; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; LEUCHTMANN A, 1994, MYCOLOGIA, V86, P802, DOI 10.2307/3760595; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; Luderer R, 2002, MOL PLANT PATHOL, V3, P91, DOI 10.1046/j.1464-6722.2001.00095.x; Lukito Y, 2015, FUNGAL GENET BIOL, V85, P25, DOI 10.1016/j.fgb.2015.10.008; Ma LS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04149-0; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mesarich CH, 2018, MOL PLANT MICROBE IN, V31, P145, DOI 10.1094/MPMI-05-17-0114-FI; Mesarich CH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00872; Miller JH., 1972, EXPT MOL GENETICS; Moon CD, 1999, APPL ENVIRON MICROB, V65, P1268; Moon CD, 2000, MYCOLOGIA, V92, P1103, DOI 10.2307/3761478; Mueller AN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003177; Orbach MJ, 2000, PLANT CELL, V12, P2019, DOI 10.1105/tpc.12.11.2019; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plett JM, 2014, P NATL ACAD SCI USA, V111, P8299, DOI 10.1073/pnas.1322671111; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; R Core Team, 2021, R LANGUAGE ENV STAT; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Rehmeyer C, 2006, NUCLEIC ACIDS RES, V34, P4685, DOI 10.1093/nar/gkl588; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Rittenour WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081603; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez-Vallet A, 2013, ELIFE, V2, DOI 10.7554/eLife.00790; Schardl C.L., 2009, PLANT RELATIONSHIPS, V5, P275, DOI [10.1007/978-3-540-87407-2_15, DOI 10.1007/978-3-540-87407-2_15]; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; SCHARDL CL, 1994, GENETICS, V136, P1307; Schmidt SM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-119; Scott B, 1993, Trends Microbiol, V1, P196, DOI 10.1016/0966-842X(93)90091-5; Selin C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00600; Shabab M, 2008, PLANT CELL, V20, P1169, DOI 10.1105/tpc.107.056325; Soyer JL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004227; Sperschneider J, 2016, NEW PHYTOL, V210, P743, DOI 10.1111/nph.13794; SPIERS AG, 1993, EUR J FOREST PATHOL, V23, P92; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Stewart EL, 2016, PHYTOPATHOLOGY, V106, P782, DOI 10.1094/PHYTO-01-16-0018-R; Stewart EL, 2014, PHYTOPATHOLOGY, V104, P985, DOI 10.1094/PHYTO-11-13-0328-R; Takemoto D, 2006, PLANT CELL, V18, P2807, DOI 10.1105/tpc.106.046169; Takemoto D, 2011, P NATL ACAD SCI USA, V108, P2861, DOI 10.1073/pnas.1017309108; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Tanaka A, 2008, MOL MICROBIOL, V68, P1165, DOI 10.1111/j.1365-2958.2008.06217.x; Tanaka A, 2013, MOL MICROBIOL, V90, P551, DOI 10.1111/mmi.12385; Teertstra WR, 2009, J BIOL CHEM, V284, P9153, DOI 10.1074/jbc.M900095200; van Dam P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07995-y; van Dam P, 2016, ENVIRON MICROBIOL, V18, P4087, DOI 10.1111/1462-2920.13445; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; van Esse HP, 2008, PLANT CELL, V20, P1948, DOI 10.1105/tpc.108.059394; Vargas WA, 2016, MOL PLANT MICROBE IN, V29, P83, DOI 10.1094/MPMI-09-15-0209-R; Voisey Christine R., 2010, Fungal Biology Reviews, V24, P123, DOI 10.1016/j.fbr.2010.12.001; Wawra S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13188; Weigel D., 2006, CSH PROTOC, V2006, DOI 10.1101/pdb.prot4665; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Win J, 2012, Cold Spring Harb Symp Quant Biol, V77, P235, DOI 10.1101/sqb.2012.77.015933; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Winter DJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007467; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; Wosten HAB, 1996, EMBO J, V15, P4274, DOI 10.1002/j.1460-2075.1996.tb00802.x; Yoshida K, 2009, PLANT CELL, V21, P1573, DOI 10.1105/tpc.109.066324; Young CA, 2005, MOL GENET GENOMICS, V274, P13, DOI 10.1007/s00438-005-1130-0; Zamioudis C, 2012, MOL PLANT MICROBE IN, V25, P139, DOI 10.1094/MPMI-06-11-0179; Zhu WJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01807; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	125	18	19	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0209463	10.1371/journal.pone.0209463	http://dx.doi.org/10.1371/journal.pone.0209463			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759164	gold, Green Published, Green Submitted			2022-12-26	WOS:000458761300007
J	Wang, JC; Chien, WC; Chu, PL; Chung, CH; Lin, CY; Tsai, SH				Wang, Jen-Chun; Chien, Wu-Chien; Chu, Pauling; Chung, Chi-Hsiang; Lin, Chih-Yuan; Tsai, Shih-Hung			The association between heat stroke and subsequent cardiovascular diseases	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; SHOCK PROTEINS; RISK; HOSPITALIZATION; ILLNESS; PNEUMONIA; OUTCOMES; MARKERS; STRESS; SEPSIS	Background Recent studies have indicated that several critical illnesses are associated with an increased risk of cardiovascular diseases (CVDs). Nonetheless, studies of the association between heat-related illnesses (HRIs) and subsequent CVDs are still limited. We sought to evaluate whether heat stroke (HS) was associated with an increased CVD incidence. Methods The data from the nationwide, population-based, retrospective, cohort study described herein were obtained from the National Health Insurance Research Database in Taiwan. The outcome evaluated in this study was the cumulative incidence of CVDs, which was compared between patients with HS, patients with other HRIs and a control group during a 14-year follow-up period. Results Our analyses included 150 HS cases, 150 patients with other HRIs and 150 patients without HRIs. The HS patients had a significantly higher incidence of developing CVDs than the other HRI and control patients (32.67% vs. 23.33% vs. 16.67%, p = 0.005). Patients with HS had an increased incidence of acute myocardial infarction (AMI) compared with that of the controls (6% vs. 2.67%, p = 0.042) and an increased incidence of acute ischemic stroke (AIS) compared with those of the other HRI and control patients (12% vs. 6% vs. 4.67%, p = 0.038). An increased risk of chronic kidney disease (CKD) was also found in the patients with HS and other HRIs compared to that in the controls (17.33% vs. 14.67% vs. 6.67%, p = 0.016). Conclusion Prior HS was associated with an increased incidence of CVDs, particularly AMI and AIS, and an increased incidence of CKD.	[Wang, Jen-Chun; Tsai, Shih-Hung] Triserv Gen Hosp, Dept Emergency Med, Natl Def Med Ctr, Taipei, Taiwan; [Wang, Jen-Chun] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Triserv Gen Hosp, Dept Med Res, Natl Def Med Ctr, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Chu, Pauling] Triserv Gen Hosp, Div Nephrol, Dept Med, Natl Def Med Ctr, Taipei, Taiwan; [Lin, Chih-Yuan] Triserv Gen Hosp, Div Cardiovasc Surg, Dept Surg, Natl Def Med Ctr, Taipei, Taiwan; [Tsai, Shih-Hung] Natl Def Med Ctr, Grad Inst Physiol, Dept Physiol & Biophys, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Tsai, SH (corresponding author), Triserv Gen Hosp, Dept Emergency Med, Natl Def Med Ctr, Taipei, Taiwan.; Chien, WC (corresponding author), Triserv Gen Hosp, Dept Med Res, Natl Def Med Ctr, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Chien, WC (corresponding author), Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan.; Tsai, SH (corresponding author), Natl Def Med Ctr, Grad Inst Physiol, Dept Physiol & Biophys, Taipei, Taiwan.	chienwu@mail.ndmctsgh.edu.tw; tsaishihung@yahoo.com.tw	Chung, Chi-Hsiang/AAY-3386-2021	Tsai, Shih-Hung/0000-0003-0215-3193	Tri-Service General Hospital [TSGH-C107-004, TSGH-C107-045, TSGH-C107-047, MAB-107-013]; Ministry of Science and Technology, Taiwan [MOST 106-2314-B-016-008-MY3, MOST 107-2314-B-016-061 -]; Tri-Service General Hospital of the National Defense Medical Center in Taipei, Taiwan [TSGH-C107-004, TSGH-C107-045, TSGH-C107-047, MAB-107-013]; Ministry of Science and Technology [MOST 106-2314-B-016-008 -MY3, MOST 107-2314-B-016-061-]	Tri-Service General Hospital; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital of the National Defense Medical Center in Taipei, Taiwan; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was funded by the Tri-Service General Hospital (grants TSGH-C107-004 to Prof. Wu-Chien Chien, TSGH-C107-045 to Dr. Jen-Chun Wang, TSGH-C107-047 to Dr. Shih-Hung Tsai, and MAB-107-013 to Dr. Shih-Hung Tsai), Ministry of Science and Technology, Taiwan (grant MOST 106-2314-B-016-008-MY3 to Dr. Jen-Chun Wang), and the Ministry of Science and Technology, Taiwan (grant MOST 107-2314-B-016-061 - to Dr. Shih-Hung Tsai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Tri-Service General Hospital of the National Defense Medical Center in Taipei, Taiwan (TSGH-C107-004, TSGH-C107-045, TSGH-C107-047 and MAB-107-013) and the Ministry of Science and Technology (MOST 106-2314-B-016-008 -MY3 and MOST 107-2314-B-016-061-).	Abdel-Kader K, 2018, CRIT CARE MED, V46, pE380, DOI 10.1097/CCM.0000000000003003; Boehme AK, 2017, STROKE, V48, P574, DOI 10.1161/STROKEAHA.116.016162; CHAO TC, 1981, PATHOLOGY, V13, P145, DOI 10.3109/00313028109086837; Chen WT, 2012, ANN EMERG MED, V60, P63, DOI 10.1016/j.annemergmed.2011.11.005; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Dad T, 2015, SEMIN NEPHROL, V35, P311, DOI 10.1016/j.semnephrol.2015.06.003; Gammelager H, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0492-2; GARCIARUBIRA JC, 1995, INT J CARDIOL, V47, P297, DOI 10.1016/0167-5273(94)02204-V; Goldberg A, 2009, KIDNEY INT, V76, P900, DOI 10.1038/ki.2009.295; Hansen MK, 2013, CRIT CARE, V17, DOI 10.1186/cc13158; Hess JJ, 2014, ENVIRON HEALTH PERSP, V122, P1209, DOI 10.1289/ehp.1306796; Iguchi M, 2012, J ATHL TRAINING, V47, P184; James MT, 2011, CIRCULATION, V123, P409, DOI 10.1161/CIRCULATIONAHA.110.970160; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Lawton EM, 2018, EMERG MED AUSTRALAS, V47, P20; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Li MM, 2015, INT J ENV RES PUB HE, V12, P5256, DOI 10.3390/ijerph120505256; Lindsay J, 2003, CATHETER CARDIO INTE, V59, P338, DOI 10.1002/ccd.10534; Nelson DA, 2018, MED SCI SPORT EXER, V50, P1603, DOI 10.1249/MSS.0000000000001623; Rebholz CM, 2015, CLIN J AM SOC NEPHRO, V10, P941, DOI 10.2215/CJN.10101014; Rowat A, 2014, INT J STROKE, V9, P633, DOI 10.1111/ijs.12264; Saleem Syed Ghazanfar, 2017, J Ayub Med Coll Abbottabad, V29, P320; Sankoff J, 2015, AUST FAM PHYSICIAN, V44, P22; Satirapoj B, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0268-9; Singer DE, 2018, MIL MED, V183, pE310, DOI 10.1093/milmed/usx085; Tustin AW, 2018, J OCCUP ENVIRON MED, V60, pE383, DOI 10.1097/JOM.0000000000001365; Wallace RF, 2007, ENVIRON RES, V104, P290, DOI 10.1016/j.envres.2007.01.003; Walter EJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1376-4; Wang XW, 2014, AGE AGEING, V43, P839, DOI 10.1093/ageing/afu090; WILD P, 1995, EPIDEMIOLOGY, V6, P243, DOI 10.1097/00001648-199505000-00009; Xu QB, 2002, ARTERIOSCL THROM VAS, V22, P1547, DOI 10.1161/01.ATV.0000029720.59649.50; Yahalom G, 2009, STROKE, V40, P1296, DOI 10.1161/STROKEAHA.108.520882; Yu TM, 2016, LANCET ONCOL, V17, P1419, DOI 10.1016/S1470-2045(16)30250-9	34	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211386	10.1371/journal.pone.0211386	http://dx.doi.org/10.1371/journal.pone.0211386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759128	gold, Green Published, Green Submitted			2022-12-26	WOS:000458761300042
J	Khuluza, F; Haefele-Abah, C				Khuluza, Felix; Haefele-Abah, Christine			The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study	PLOS ONE			English	Article								Introduction The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere. Before the government implements a payment policy in other areas of health care, it is important to investigate the prices, affordability and availability of essential medicines in Malawi. Methods Data on availability and prices of 50 essential medicines were collected in 44 health facilities in two major cities and two districts. These included 12 public facilities, 11 facilities of the Christian Health Association of Malawi (CHAM), nine retail pharmacies, eight wholesalers and four private clinics/hospitals. Price, availability and affordability were assessed based on the methodology developed by the World Health Organization and Health Action International, which compares local prices to international reference prices. Results and discussion The overall availability of medicines was 48.5% in public facilities, 71.1% in retail pharmacies, 62.9% in CHAM facilities and 57.5% in private clinics. The availability of essential medicines varied from 0% for ethosuximide to 100% for amoxicillin and cotrimoxazole tablets. Antibiotic formulations for adults were widely available, in contrast to the low availability of pediatric formulations. Several medicines for non-communicable diseases like sodium valproate, phenytoin, paraldehyde, captopril and simvastatin showed poor availability and affordability. The overall median price ratio compared to the international reference price was 1.11 for wholesalers, 2.54 in CHAM facilities, 2.70 in retail pharmacies, and 4.01 in private clinics, which is low compared to other countries. But nevertheless, for 18 out of 32 medicines assessed, the cost of one course exceeded the statutory minimum daily wage, making them unaffordable to a majority of the population. Therefore, continued provision of free public health care is still of critical importance for the foreseeable future until other financing mechanisms have been explored.	[Khuluza, Felix] Univ Malawi, Pharm Dept, Coll Med, Blantyre, Malawi; [Haefele-Abah, Christine] Eberhard Karls Univ Tuebingen, Pharmaceut Inst, Tubingen, Germany	University of Malawi; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Khuluza, F (corresponding author), Univ Malawi, Pharm Dept, Coll Med, Blantyre, Malawi.	fkhuluza@medcol.mw	Khuluza, Felix/HGC-0661-2022	Khuluza, Felix/0000-0002-8334-0160	German Medical Aid Organization action medeor e.V. Germany [7000129]; Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK) [087547/Z/08/Z]; Carnegie Corporation of New York [B8606.R02]; Sida [54100029]; Deutsche Forschungsgemeinschaft; University of Tuebingen	German Medical Aid Organization action medeor e.V. Germany; Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK)(Wellcome Trust); Carnegie Corporation of New York; Sida; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tuebingen	This study was financially supported by grant number 7000129 of the German Medical Aid Organization action medeor e.V. Germany. The contribution by FK was supported by the Consortium for Advanced Research Training in Africa (CARTA) during the draft of this manuscript. CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Wellcome Trust (UK) (Grant No. 087547/Z/08/Z), the Carnegie Corporation of New York (Grant No. B8606.R02) and Sida (Grant No. 54100029). We furthermore acknowledge support for open access publication by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tuebingen. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abiiro GA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-234; Alba S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-163; [Anonymous], 2015, ESAPWP241; [Anonymous], 2018, BURD DIS MAL; Babar ZUD, 2013, PHARMACOECONOMICS, V31, P1063, DOI 10.1007/s40273-013-0095-9; Babigumira JB, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2530-7; Bazargani YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087576; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A, 2012, EPILEPSIA, V53, P962, DOI 10.1111/j.1528-1167.2012.03446.x; Chinele J., 2016, UNREGULATED SALE DRU; Choi Y, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-266; Coates ARM, 2011, BRIT J PHARMACOL, V163, P184, DOI 10.1111/j.1476-5381.2011.01250.x; Ewen M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171284; Freye JE, 2014, INT DRUG PRICE INDIC; Government of Malawi, 2017, MAL GROWTH DEV STRAT, DOI [10.1093/heapol/czw050, DOI 10.1093/HEAPOL/CZW050]; Hamer J., 2016, ACHIEVING UNIVERSAL; Health Policy Project, 2016, HLTH FIN PROF MAL; Khuluza F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175399; Kumwenda K., 2018, K100 000 FINE SELLIN; Kwan P, 2004, EPILEPSIA, V45, P1141, DOI 10.1111/j.0013-9580.2004.12704.x; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Management Sciences for Health, 2012, MDS 3 MAN ACC MED HL; Manthalu G, 2016, HEALTH POLICY PLANN, V31, P1184, DOI 10.1093/heapol/czw050; Ministry of Health Malawi, 2015, INC MAL ESS MED LIST; Ministry of Health. National Medicine Policy, 2015, NAT MED POL PROM EQ; Ministry of Health-Malawi, 2012, NAT HLTH RES AG 2012; National Statistical Office ICF Macro., 2011, MAL DEM HLTH SURV 20; National Statistical Office Malawi ICF, 2017, MAL DEM HLTH SURV 20; National- Statistical- Office, 2018, SUMM PROJ POP GROWTH; Nkhulembe LG, 2017, MAL C TRAD UN PLEAS; Pisani E., 2015, ANTIMICROBIAL RESIST; Ravinetto RM, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3618; Reserve- Bank- of- Malawi, 2017, RES BANK MAL EXCH RA; Sado E, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0572-3; Thomas SV, 2011, ANN INDIAN ACAD NEUR, V14, P158, DOI 10.4103/0972-2327.85873; United Nations Development Programme, 2016, SUST DEV GOALS; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; WHO Health Action International, 2008, MEAS MED PRIC AV AFF, V2nd; Wong-Beringer A, 2009, PHARMACOTHERAPY, V29, P736, DOI 10.1592/phco.29.6.736; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization WHO, 2012, RECOMMENDATIONS PREV; World- Health-Organization, 2018, METH WCCFDS; Yin XX, 2013, J ANTIMICROB CHEMOTH, V68, P2445, DOI 10.1093/jac/dkt223; Zaheer Ud Din Babar MIMI, 2007, PLOS MED, DOI [10.1186/s12913-017-2530-7, DOI 10.1186/S12913-017-2530-7]	44	29	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212125	10.1371/journal.pone.0212125	http://dx.doi.org/10.1371/journal.pone.0212125			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753219	Green Published, gold			2022-12-26	WOS:000458395600044
J	Kim, EK; Kim, S; Maeng, YS				Kim, Eung Kweon; Kim, Seunghyuk; Maeng, Yong-Sun			Generation of TGFBI knockout ABCG2+/ABCB5+double-positive limbal epithelial stem cells by CRISPR/Cas9-mediated genome editing	PLOS ONE			English	Article							MATRIX PROTEIN BETA-IG-H3; CORNEAL DYSTROPHIES; GENE-MUTATIONS; EXTRACELLULAR-MATRIX; BETA IG-H3; IN-VITRO; EXPRESSION; ADHESION; DIFFERENTIATION; FIBROBLASTS	Corneal dystrophy is an autosomal dominant disorder caused by mutations of the transforming growth factor beta-induced (TGFBI) gene on chromosome 5q31.8. This disease is therefore ideally suited for gene therapy using genome-editing technology. Here, we isolated human limbal epithelial stem cells (ABCG2+/ABCB5+ double-positive LESCs) and established a TGFBI knockout using RNA-guided clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 genome editing. An LESC clone generated with a single-guide RNA (sgRNA) targeting exon 4 of the TGFBI gene was sequenced in order to identify potential genomic insertions and deletions near the Cas9/sgRNA-target sites. A detailed analysis of the differences between wild type LESCs and the single LESC clone modified by the TGFBI-targeting sgRNA revealed two distinct mutations, an 8 bp deletion and a 14 bp deletion flanked by a single point mutation. These mutations each lead to a frameshift missense mutation and generate premature stop codons downstream in exon 4. To validate the TGFBI knockout LESC clone, we used single cell culture to isolate four individual sub-clones, each of which was found to possess both mutations present in the parent clone, indicating that the population is homogenous. Furthermore, we confirmed that TGFBI protein expression is abolished in the TGFBI knockout LESC clone using western blot analysis. Collectively, our results suggest that genome editing of TGFBI in LESCs by CRISPR/Cas9 may be useful strategy to treat corneal dystrophy.	[Kim, Eung Kweon; Maeng, Yong-Sun] Yonsei Univ, Coll Med, Corneal Dystrophy Res Inst, Dept Ophthalmol, Seoul, South Korea; [Kim, Eung Kweon; Kim, Seunghyuk] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Inst Vis Res, Seoul, South Korea; [Maeng, Yong-Sun] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Dept Obstet & Gynecol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Maeng, YS (corresponding author), Yonsei Univ, Coll Med, Corneal Dystrophy Res Inst, Dept Ophthalmol, Seoul, South Korea.; Maeng, YS (corresponding author), Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Dept Obstet & Gynecol, Seoul, South Korea.	maengmatthew@gmail.com		Kim, Eung Kweon/0000-0002-1453-8042	National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1D1A1B03933337]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C1009]	National Research Foundation of Korea (NRF) - Ministry of Education; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1D1A1B03933337) awared to YSM and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI16C1009) awarded to EKK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpitha P, 2005, INVEST OPHTH VIS SCI, V46, P3631, DOI 10.1167/iovs.05-0343; Bojic S, 2018, STEM CELLS, V36, P1723, DOI 10.1002/stem.2903; Carson DD, 2002, MOL HUM REPROD, V8, P871, DOI 10.1093/molehr/8.9.871; CHEN JJY, 1991, INVEST OPHTH VIS SCI, V32, P2219; Cho KJ, 2012, MOL VIS, V18, P2012; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choi SI, 2016, BIOCHEM BIOPH RES CO, V472, P150, DOI 10.1016/j.bbrc.2016.02.086; Choi SI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119561; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courtney DG, 2014, INVEST OPHTH VIS SCI, V55, P977, DOI 10.1167/iovs.13-13279; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; de Bruin LO, 2016, ONCOTARGET, V7, P12962, DOI 10.18632/oncotarget.7341; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; ESCRIBANO J, 1994, J CELL PHYSIOL, V160, P511, DOI 10.1002/jcp.1041600314; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Ferguson JW, 2003, CELL TISSUE RES, V313, P93, DOI 10.1007/s00441-003-0743-z; Fujiki K, 2001, J HUM GENET, V46, P431, DOI 10.1007/s100380170041; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gibson MA, 1997, J HISTOCHEM CYTOCHEM, V45, P1683, DOI 10.1177/002215549704501212; Hirano K, 1996, CURR EYE RES, V15, P965, DOI 10.3109/02713689609017642; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim EK, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/7678637; Kim HJ, 2008, INT J BIOCHEM CELL B, V40, P991, DOI 10.1016/j.biocel.2007.11.001; Kim JE, 2002, J BIOL CHEM, V277, P46159, DOI 10.1074/jbc.M207055200; Kim MO, 2003, NEUROSCI LETT, V336, P93, DOI 10.1016/S0304-3940(02)01260-0; KINOSHITA S, 1981, INVEST OPHTH VIS SCI, V21, P434; Kitahama S, 2000, BONE, V27, P61, DOI 10.1016/S8756-3282(00)00292-1; Klintworth GK, 1998, AM J PATHOL, V152, P743; Klintworth GK, 1999, AM J OPHTHALMOL, V128, P747, DOI 10.1016/S0002-9394(99)00358-X; Ksander BR, 2014, NATURE, V511, P353, DOI 10.1038/nature13426; Lee JH, 2010, OPHTHAL EPIDEMIOL, V17, P160, DOI 10.3109/09286581003624939; Lee SH, 2003, KIDNEY INT, V64, P1012, DOI 10.1046/j.1523-1755.2003.00158.x; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Liu L, 2018, STEM CELLS, V36, P1411, DOI 10.1002/stem.2857; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Maeng YS, 2016, ONCOGENE, V35, P196, DOI 10.1038/onc.2015.73; Maeng YS, 2017, YONSEI MED J, V58, P423, DOI 10.3349/ymj.2017.58.2.423; Maeng YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20739; Maeng YS, 2015, STEM CELLS, V33, P2052, DOI 10.1002/stem.2003; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mariappan I, 2010, NAT PROTOC, V5, P1470, DOI 10.1038/nprot.2010.115; Mashima Y, 2000, AM J OPHTHALMOL, V130, P516, DOI 10.1016/S0002-9394(00)00571-7; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mort RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-4; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; Nam EJ, 2006, ARTHRITIS RHEUM-US, V54, P2734, DOI 10.1002/art.22076; Nam JO, 2005, CANCER RES, V65, P4153, DOI 10.1158/0008-5472.CAN-04-2705; Notara M, 2010, EXP EYE RES, V90, P188, DOI 10.1016/j.exer.2009.09.023; Ohno S, 1999, BBA-MOL CELL RES, V1451, P196, DOI 10.1016/S0167-4889(99)00093-2; Osei-Bempong C, 2013, BIOESSAYS, V35, P211, DOI 10.1002/bies.201200086; Park SY, 2009, FEBS LETT, V583, P1375, DOI 10.1016/j.febslet.2009.03.046; Park SW, 2004, EXP MOL MED, V36, P211, DOI 10.1038/emm.2004.29; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2013, REGEN MED, V8, P553, DOI 10.2217/rme.13.43; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Rawe IM, 1997, INVEST OPHTH VIS SCI, V38, P893; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Sun TT, 2010, NATURE, V463, pE10, DOI 10.1038/nature08805; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Xie HT, 2012, INVEST OPHTH VIS SCI, V53, P279, DOI 10.1167/iovs.11-8441; Yang JH, 2010, MOL VIS, V16, P1186; Yuan C, 2007, MOL VIS, V13, P2083; Yuan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22024	68	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211864	10.1371/journal.pone.0211864	http://dx.doi.org/10.1371/journal.pone.0211864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753226	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600026
J	Roe, WD; Lenting, B; Kokosinska, A; Hunter, S; Duignan, PJ; Gartrell, B; Rogers, L; Collins, DM; de Lisle, GW; Gedye, K; Price-Carter, M				Roe, Wendi D.; Lenting, Baukje; Kokosinska, Anna; Hunter, Stuart; Duignan, Padraig J.; Gartrell, Brett; Rogers, Lynn; Collins, Desmond M.; de Lisle, Geoffrey W.; Gedye, Kristene; Price-Carter, Marian			Pathology and molecular epidemiology of Mycobacterium pinnipedii tuberculosis in native New Zealand marine mammals	PLOS ONE			English	Article							MIRU-VNTRPLUS; SEA LIONS; COMPLEX; BOVIS; TRANSMISSION; CATTLE	Mycobacterium pinnipedii causes tuberculosis in a number of pinniped species, and transmission to cattle and humans has been reported. The aims of this study were to: characterize the pathology and prevalence of tuberculosis in New Zealand marine mammals; use molecular diagnostic methods to confirm and type the causal agent; and to explore relationships between type and host characteristics. Tuberculosis was diagnosed in 30 pinnipeds and one cetacean. Most affected pinnipeds had involvement of the pulmonary system, supporting inhalation as the most common route of infection, although ingestion was a possible route in the cetacean. PCR for the RD2 gene confirmed M. pinnipedii as the causal agent in 23/31 (74%) cases (22 using DNA from cultured organisms, and one using DNA from formalin-fixed paraffin-embedded (FFPE) tissue), including the first published report in a cetacean. RD2 PCR results were compared for 22 cases where both cultured organisms and FFPE tissues were available, with successful identification of M. pinnipedii in 7/22 (31.8%). In cases with moderate to large numbers of acid-fast bacilli, RD2 PCR on FFPE tissue provided a rapid, inexpensive method for confirming M. pinnipedii infection without the need for culture. VNTR typing distinguished New Zealand M. pinnipedii isolates from M. pinnipedii isolated from Australian pinnipeds and from common types of M. bovis in New Zealand. Most (16/18) M. pinnipedii isolates from New Zealand sea lions were one of two common VNTR types whereas the cetacean isolate was a type detected previously in New Zealand cattle.	[Roe, Wendi D.; Lenting, Baukje; Kokosinska, Anna; Hunter, Stuart; Gartrell, Brett; Rogers, Lynn; Gedye, Kristene] Massey Univ, Sch Vet Sci, Palmerston North, New Zealand; [Duignan, Padraig J.] Marine Mammal Ctr, Sausalito, CA USA; [Collins, Desmond M.; de Lisle, Geoffrey W.; Price-Carter, Marian] AgResearch, Palmerston North, New Zealand; [Lenting, Baukje] Wellington Zoo, Wellington, New Zealand; [Kokosinska, Anna] Univ Georgia, Coll Vet Med, Athens, GA USA	Massey University; AgResearch - New Zealand; University System of Georgia; University of Georgia	Roe, WD (corresponding author), Massey Univ, Sch Vet Sci, Palmerston North, New Zealand.	w.d.roe@massey.ac.nz		Gartrell, Brett/0000-0002-8062-9313	Lewis Fitch Veterinary Research Fund	Lewis Fitch Veterinary Research Fund	This study was funded by the Lewis Fitch Veterinary Research Fund (WR, KG, MP-C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahlstrom C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1387-6; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Baird SJ., 2011, NZ AQUATIC ENV BIODI; Barbier E, 2016, J APPL MICROBIOL, V120, P1193, DOI 10.1111/jam.13090; Barbier E, 2016, VET MICROBIOL, V186, P1, DOI 10.1016/j.vetmic.2016.01.025; Blair WR, 1913, 17 ANN REPORT NEW YO; Boardman WSJ, 2014, J ZOO WILDLIFE MED, V45, P970, DOI 10.1638/2014-0054.1; COUSINS DV, 1993, AUST VET J, V70, P92, DOI 10.1111/j.1751-0813.1993.tb03284.x; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; de Amorim DB, 2014, J WILDLIFE DIS, V50, P419, DOI 10.7589/2013-05-124; de Lisle GW, 2002, REV SCI TECH OIE, V21, P317, DOI 10.20506/rst.21.2.1339; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Hunter JEB, 1998, NEW ZEAL MED J, V111, P130; Jurczynski K, 2012, AQUAT MAMM, V38, P43, DOI 10.1578/AM.38.1.2012.43; Jurczynski K, 2011, J ZOO WILDLIFE MED, V42, P222, DOI 10.1638/2009-0207.1; Kao RR, 2016, REV SCI TECH OIE, V35, P241, DOI 10.20506/rst.35.1.2430; Kriz P, 2011, VET MED-CZECH, V56, P307, DOI 10.17221/1549-VETMED; Loeffler SH, 2014, J WILDLIFE DIS, V50, P180, DOI 10.7589/2013-09-237; Medie FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020499; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; Price-Carter M, 2011, VET MICROBIOL, V150, P107, DOI 10.1016/j.vetmic.2011.01.012; Roe WD, 2006, NZ VET J, V54, P51, DOI [10.1080/00480169.2006.36610, DOI 10.1080/00480169.2006.36610]; Roe WD, 2010, J WILDLIFE DIS, V46, P1295, DOI 10.7589/0090-3558-46.4.1295; Sakamoto K, 2012, VET PATHOL, V49, P423, DOI 10.1177/0300985811429313; THOMPSON PJ, 1993, AM REV RESPIR DIS, V147, P164, DOI 10.1164/ajrccm/147.1.164; Warren RM, 2006, INT J TUBERC LUNG D, V10, P818; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351	27	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212363	10.1371/journal.pone.0212363	http://dx.doi.org/10.1371/journal.pone.0212363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753243	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600059
J	Wallmeroth, N; Jeschke, D; Slane, D; Nagele, J; Veerabagu, M; Mira-Rodado, V; Berendzen, KW				Wallmeroth, Niklas; Jeschke, Daniel; Slane, Daniel; Naegele, Janine; Veerabagu, Manikandan; Mira-Rodado, Virtudes; Berendzen, Kenneth Wayne			ARR22 overexpression can suppress plant Two-Component Regulatory Systems	PLOS ONE			English	Article							ARABIDOPSIS RESPONSE REGULATOR; TO-ASP PHOSPHORELAY; CYTOKININ-SIGNALING PATHWAY; B RESPONSE; SHOOT DEVELOPMENT; ACQUIRING COMPETENCE; PROTEIN INTERACTIONS; NEGATIVE REGULATOR; MERISTEM FUNCTION; STRESS-RESPONSE	In plants, several developmental processes are co-coordinated by cytokinins via phosphorylation dependent processes of the Two-Component System (TCS). An outstanding challenge is to track phosphorelay flow from cytokinin perception to its molecular outputs, of which gene activation plays a major role. To address this issue, a kinetic-based reporter system was expounded to track TCS phosphorelay activity in vivo that can distinguish between basal and cytokinin dependent effects of overexpressed TCS members. The TCS phosphorelay can be positively activated by cytokinin and inhibited by pharmaceuticals or naturally interfering components. In this case we took advantage of the phosphohistidine-phosphatase Arabidopsis Response Regulator (ARR) 22 and investigated its phosphocom-petition with other TCS members in regulating promoters of ARR5 and WUS in Arabidopsis thaliana cell culture protoplasts. In congruency with the proposed function of ARR22, overexpression of ARR22 blocked the activation of all B-type ARRs in this study in a TCS dependent manner. Furthermore, this effect could not be mimicked by A-type response regulator overexpression or compensated by AHP overexpression. Compared to other reporter assays, ours mimicked effects previously observed only in transgenic plants for all of the TCS proteins studied, suggesting that it is possible to expose phosphocompetition. Thus, our approach can be used to investigate gene signaling networks involving the TCS by leveraging ARR22 as a TCS inhibitor along with B-type ARR overexpression.	[Wallmeroth, Niklas; Jeschke, Daniel; Naegele, Janine; Veerabagu, Manikandan; Mira-Rodado, Virtudes; Berendzen, Kenneth Wayne] Univ Tubingen, Ctr Plant Mol Biol ZMBP, Dept Plant Physiol, Tubingen, Germany; [Slane, Daniel] Max Planck Inst Dev Biol, Tubingen, Germany; [Berendzen, Kenneth Wayne] Univ Tubingen, Ctr Plant Mol Biol ZMBP, Dept Cent Facil, Tubingen, Germany; [Veerabagu, Manikandan] Norwegian Univ Life Sci, Dept Plant Sci, As, Norway	Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; Norwegian University of Life Sciences	Berendzen, KW (corresponding author), Univ Tubingen, Ctr Plant Mol Biol ZMBP, Dept Plant Physiol, Tubingen, Germany.; Berendzen, KW (corresponding author), Univ Tubingen, Ctr Plant Mol Biol ZMBP, Dept Cent Facil, Tubingen, Germany.	kenneth.berendzen@zmbp.uni-tuebingen.de		Slane, Daniel/0000-0003-2948-8188	German Research Foundation [CRC 1101]; Eberhard Karls Universitat Tubingen	German Research Foundation(German Research Foundation (DFG)); Eberhard Karls Universitat Tubingen	This work was partially supported by the German Research Foundation (CRC 1101) and both the German Research Foundation and Eberhard Karls Universitat Tubingen (DE) offered support in the form of publication fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendzen KW, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-25; BOURRET RB, 1990, P NATL ACAD SCI USA, V87, P41, DOI 10.1073/pnas.87.1.41; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Cary AJ, 2002, PLANT J, V32, P867, DOI 10.1046/j.1365-313X.2002.01479.x; Che P, 2007, PLANTA, V226, P1183, DOI 10.1007/s00425-007-0565-4; Che P, 2008, PLANT SIGNAL BEHAV, V3, P99, DOI 10.4161/psb.3.2.4958; Cheng CY, 2013, PLANT J, V73, P929, DOI 10.1111/tpj.12084; Cheng ZJ, 2010, PLANT CELL REP, V29, P927, DOI 10.1007/s00299-010-0879-8; Choi J, 2010, DEV CELL, V19, P284, DOI 10.1016/j.devcel.2010.07.011; Cortleven A, 2014, PLANT PHYSIOL, V164, P1470, DOI 10.1104/pp.113.224667; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; Desikan R, 2006, PLANT J, V47, P907, DOI 10.1111/j.1365-313X.2006.02842.x; Dettmer J, 2005, PLANT J, V41, P117, DOI 10.1111/j.1365-313X.2004.02282.x; Dortay H, 2006, FEBS J, V273, P4631, DOI 10.1111/j.1742-4658.2006.05467.x; Ehlert A, 2006, PLANT J, V46, P890, DOI 10.1111/j.1365-313X.2006.02731.x; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gattolin S, 2006, J EXP BOT, V57, P4225, DOI 10.1093/jxb/erl205; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Hill K, 2013, PLANT PHYSIOL, V162, P212, DOI 10.1104/pp.112.208736; Horak J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-77; Hutchison CE, 2002, PLANT CELL, V14, pS47, DOI 10.1105/tpc.010444; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Imamura A, 2003, PLANT CELL PHYSIOL, V44, P122, DOI 10.1093/pcp/pcg014; Ishida K, 2008, BIOSCI BIOTECH BIOCH, V72, P3025, DOI 10.1271/bbb.80402; Jenal U, 2009, CURR OPIN MICROBIOL, V12, P152, DOI 10.1016/j.mib.2009.01.010; Jeon J, 2010, J BIOL CHEM, V285, P23369, DOI 10.1074/jbc.M109.096644; Jia H, 2007, PLANT BIOTECHNOL J, V5, P477, DOI 10.1111/j.1467-7652.2007.00255.x; Kang NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079248; Kiba T, 2004, PLANT CELL PHYSIOL, V45, P1063, DOI 10.1093/pcp/pch128; Kiba T, 2003, PLANT CELL PHYSIOL, V44, P868, DOI 10.1093/pcp/pcg108; Kiba T, 2002, PLANT CELL PHYSIOL, V43, P1059, DOI 10.1093/pcp/pcf121; Kieber Joseph J, 2014, Arabidopsis Book, V12, pe0168, DOI 10.1199/tab.0168; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kim HJ, 2013, P NATL ACAD SCI USA, V110, P10028, DOI 10.1073/pnas.1300403110; Kim K, 2012, PLANT J, V69, P934, DOI 10.1111/j.1365-313X.2011.04843.x; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Lee DJ, 2008, PLANTA, V227, P577, DOI 10.1007/s00425-007-0640-x; Lee DJ, 2007, MOL GENET GENOMICS, V277, P115, DOI 10.1007/s00438-006-0177-x; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lohar DP, 2004, PLANT J, V38, P203, DOI 10.1111/j.1365-313X.2004.02038.x; Lohrmann J, 2001, MOL GENET GENOMICS, V265, P2, DOI 10.1007/s004380000400; Mahonen AP, 2006, CURR BIOL, V16, P1116, DOI 10.1016/j.cub.2006.04.030; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; Meng WJ, 2017, PLANT CELL, V29, P1357, DOI 10.1105/tpc.16.00640; Mira-Rodado V, 2007, J EXP BOT, V58, P2595, DOI 10.1093/jxb/erm087; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Pekarova B, 2016, MOL PLANT, V9, P71, DOI 10.1016/j.molp.2015.11.008; Punwani JA, 2010, PLANT J, V62, P473, DOI 10.1111/j.1365-313X.2010.04165.x; Romanov GA, 2002, FEBS LETT, V515, P39, DOI 10.1016/S0014-5793(02)02415-8; Sablowski R, 2009, P NATL ACAD SCI USA, V106, P16016, DOI 10.1073/pnas.0909300106; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Schaller GE, 2015, PLANT CELL, V27, P44, DOI 10.1105/tpc.114.133595; Schaller G Eric, 2008, Arabidopsis Book, V6, pe0112, DOI 10.1199/tab.0112; Schaumberg KA, 2016, NAT METHODS, V13, P94, DOI [10.1038/NMETH.3659, 10.1038/nmeth.3659]; Shi YT, 2012, PLANT CELL, V24, P2578, DOI 10.1105/tpc.112.098640; Shull Timothy E, 2016, Plant Signal Behav, V11, pe1169354, DOI 10.1080/15592324.2016.1169354; Siligato R, 2016, PLANT PHYSIOL, V170, P627, DOI 10.1104/pp.15.01246; Sprenger-Haussels M, 2000, PLANT J, V22, P1, DOI 10.1046/j.1365-313x.2000.00687.x; Stolz A, 2011, PLANT J, V67, P157, DOI 10.1111/j.1365-313X.2011.04584.x; Street IH, 2016, DEVELOPMENT, V143, P3982, DOI 10.1242/dev.132035; Suzuki T, 1998, PLANT CELL PHYSIOL, V39, P1258, DOI 10.1093/oxfordjournals.pcp.a029329; Suzuki T, 2002, PLANT CELL PHYSIOL, V43, P123, DOI 10.1093/pcp/pcf007; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P37, DOI 10.1093/pcp/pce011; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Tajima Y, 2004, PLANT CELL PHYSIOL, V45, P28, DOI 10.1093/pcp/pcg154; Takahashi N, 2013, CURR BIOL, V23, P1812, DOI 10.1016/j.cub.2013.07.051; Tanaka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P462, DOI 10.1271/bbb.68.462; Taniguchi M, 2007, PLANT CELL PHYSIOL, V48, P263, DOI 10.1093/pcp/pcl063; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Veerabagu M, 2012, PLANT J, V72, P721, DOI 10.1111/j.1365-313X.2012.05101.x; Wallmeroth N, 2017, PROTOPLASMA, V254, P597, DOI 10.1007/s00709-016-0944-4; Wang J, 2017, PLANT CELL, V29, P1373, DOI 10.1105/tpc.16.00579; Zhang TQ, 2017, PLANT CELL, V29, P1073, DOI 10.1105/tpc.16.00863; Zhang WJ, 2011, PLANT J, V68, P1, DOI 10.1111/j.1365-313X.2011.04668.x; Zubo YO, 2017, P NATL ACAD SCI USA, V114, pE5995, DOI 10.1073/pnas.1620749114; Zurcher E, 2013, PLANT PHYSIOL, V161, P1066, DOI 10.1104/pp.112.211763; Zundel CJ, 1998, FEBS LETT, V441, P242, DOI 10.1016/S0014-5793(98)01556-7	80	8	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0212056	10.1371/journal.pone.0212056	http://dx.doi.org/10.1371/journal.pone.0212056			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742656	Green Published, gold, Green Submitted			2022-12-26	WOS:000458393400042
J	Weil, IA; Kumar, P; Seicean, S; Neuhauser, D; Seicean, A				Weil, Isabel A.; Kumar, Prateek; Seicean, Sinziana; Neuhauser, Duncan; Seicean, Andreea			Platelet count abnormalities and perioperative outcomes in adults undergoing elective, non-cardiac surgery	PLOS ONE			English	Article							PREOPERATIVE ANEMIA; POSTOPERATIVE OUTCOMES; BLOOD-TRANSFUSION; PROPENSITY-SCORE; IMPACT; THROMBOCYTOSIS; MORTALITY; TESTS; NSQIP	Background Anemia and transfusion of blood in the peri-operative period have been shown to be associated with increased morbidity and mortality across a wide variety of non-cardiac surgeries. While tests of coagulation, including the platelet count, have frequently been used to identify patients with an increased risk of peri-operative bleeding, results have been equivocal. The aim of this study was to assess the effect of platelet level on outcomes in patients undergoing elective surgery. Materials and methods Retrospective cohort analysis of prospectively-collected clinical data from American College of Surgeons National Surgical Quality Improvement Program (NSQIP) between 2006-2016. Results We identified 3,884,400 adult patients who underwent elective, non-cardiac surgery from 2006-2016 at hospitals participating in NSQIP, a prospectively-collected, national clinical database with established reproducibility and validity. After controlling for all peri-and intraoperative factors by matching on propensity scores, patients with all levels of thrombocytopenia or thrombocytosis had higher odds for perioperative transfusion. All levels of thrombocytopenia were associated with higher mortality, but there was no association with complications or other morbidity after matching. On the other hand, thrombocytosis was not associated with mortality; but odds for postoperative complications and 30-day return to the operating room remained slightly increased after matching. Conclusions These findings may guide surgeons in the appropriate use and appreciation of the utility of pre-operative screening of the platelet count prior to an elective, non-cardiac surgery.	[Weil, Isabel A.] Columbia Univ, Fu Fdn Sch Engn & Appl Sci, New York, NY USA; [Kumar, Prateek; Seicean, Andreea] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Seicean, Sinziana] Univ Hosp Case Med Ctr, Dept Med, Cleveland, OH USA; [Neuhauser, Duncan] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Columbia University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University	Seicean, A (corresponding author), Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA.	andreea.seicean@gmail.com		Seicean, Andreea/0000-0002-4361-2600				Alan N, 2015, J CLIN NEUROSCI, V22, P1413, DOI 10.1016/j.jocn.2015.03.009; Alan N, 2015, J NEUROINTERV SURG, V7, P431, DOI 10.1136/neurintsurg-2014-011135; Alan N, 2014, J NEUROSURG, V120, P764, DOI 10.3171/2013.10.JNS131028; Amer Soc Anesthesiolgists, 2012, ANESTHESIOLOGY, V116, P522, DOI 10.1097/ALN.0b013e31823c1067; American College of Surgeons National Surgical Quality Improvement Program, NON TRADITIONAL REF; Austin PC, 2005, STAT MED, V24, P1563, DOI 10.1002/sim.2053; Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Beer PA, 2011, BLOOD, V117, P1472, DOI 10.1182/blood-2010-08-270033; Bernard AC, 2009, J AM COLL SURGEONS, V208, P931, DOI 10.1016/j.jamcollsurg.2008.11.019; Hernandez-Boluda JC, 2015, EUR J HAEMATOL, V94, P4, DOI 10.1111/ejh.12381; Diz-Kucukkaya R, 2010, WILLIAMS HEMATOLOGY, P1891; Elixhauser A, 2010, ARCH SURG-CHICAGO, V145, P1201, DOI 10.1001/archsurg.2010.269; Garcia-Miguel FJ, 2003, LANCET, V362, P1749, DOI 10.1016/S0140-6736(03)14857-X; Glance LG, 2014, JAMA SURG, V149, P439, DOI 10.1001/jamasurg.2014.4; Glance LG, 2014, ANESTHESIOLOGY, V120, P62, DOI 10.1097/ALN.0b013e3182a4441f; Glance LG, 2011, ANESTHESIOLOGY, V114, P283, DOI 10.1097/ALN.0b013e3182054d06; HCUP Cost-to-Charge Ratio Files (CCR), 2001, HCUP COST TO CHARG R; HOURY S, 1995, AM J SURG, V170, P19, DOI 10.1016/S0002-9610(99)80245-1; Huffman KM, 2015, ANN SURG, V261, P1108, DOI 10.1097/SLA.0000000000000913; Izak Marina, 2014, F1000Prime Rep, V6, P45, DOI 10.12703/P6-45; KAPLAN EB, 1985, JAMA-J AM MED ASSOC, V253, P3576, DOI 10.1001/jama.253.24.3576; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Khuri SF, 2005, SURGERY, V138, P837, DOI 10.1016/j.surg.2005.08.016; Khuri SF, 2007, J AM COLL SURGEONS, V204, P1089, DOI 10.1016/j.jamcollsurg.2007.03.028; Moschini M, 2014, ANTICANCER RES, V34, P3225; Musallam KM, 2011, LANCET, V378, P1396, DOI 10.1016/S0140-6736(11)61381-0; Ng KFJ, 2002, WORLD J SURG, V26, P515, DOI 10.1007/s00268-001-0260-8; Qaseem A, 2012, ANN INTERN MED, V156, P147, DOI 10.7326/0003-4819-156-2-201201170-00011; ROHRER MJ, 1988, ANN SURG, V208, P554, DOI 10.1097/00000658-198811000-00002; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Salim A, 2009, J TRAUMA, V66, P1349, DOI 10.1097/TA.0b013e318191b8af; Seicean A, 2015, J NEUROSURG, V123, P91, DOI 10.3171/2014.10.JNS14551; Seicean A, 2014, SPINE, V39, P1605, DOI 10.1097/BRS.0000000000000489; Seicean A, 2014, SPINE, V39, P1520, DOI 10.1097/BRS.0000000000000435; Seicean A, 2014, J CLIN NEUROSCI, V21, P1579, DOI 10.1016/j.jocn.2014.03.003; Seicean A, 2013, SPINE, V38, P1331, DOI 10.1097/BRS.0b013e3182912c6b; Seicean A, 2013, SPINE, V38, P1294, DOI 10.1097/BRS.0b013e31828e2747; Seicean A, 2012, J NEUROSURG, V116, P1097, DOI 10.3171/2012.1.JNS111760; Shiloach M, 2010, J AM COLL SURGEONS, V210, P6, DOI 10.1016/j.jamcollsurg.2009.09.031; Wu WC, 2007, JAMA-J AM MED ASSOC, V297, P2481, DOI 10.1001/jama.297.22.2481	40	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0212191	10.1371/journal.pone.0212191	http://dx.doi.org/10.1371/journal.pone.0212191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742687	Green Submitted, Green Published, gold			2022-12-26	WOS:000458393400058
J	Kim, M; Gwak, J; Hwang, S; Yang, S; Jeong, SM				Kim, Minjoong; Gwak, Jihye; Hwang, Sunsook; Yang, Seungyeon; Jeong, Seung Min			Mitochondrial GPT2 plays a pivotal role in metabolic adaptation to the perturbation of mitochondrial glutamine metabolism	ONCOGENE			English	Article							PANCREATIC-CANCER GROWTH; UP-REGULATION; SUPPRESSION; INHIBITION; SURVIVAL; PATHWAY	Cancer cells exhibit metabolic dependence on mitochondrial glutamine metabolism that provides them with the substrates required for rapid proliferation. Despite the extensive efforts to target this glutamine addiction for therapeutic purposes, the adaptive metabolic responses and the mechanisms whereby cells maintain their unlimited growth remain areas of active investigation. Here we report that mitochondrial glutamate-pyruvate transaminase 2 (GPT2) contributes to cell survival and growth by sustaining the tricarboxylic acid (TCA) cycle anaplerosis after the inhibition of glutaminase (GLS), the first enzyme for mitochondrial glutamine metabolism. We found that elevated reactive oxygen species upon GLS inhibition induce GPT2 expression via activating transcription factor 4. Moreover, inhibition of GPT2 synergized with suppression of GLS activity to induce a pronounced reduction in proliferation and an increase in cell death of cancer cells. Our data uncover GPT2 as an important component of the adaptive metabolic response for glutamine deprivation and indicate that targeting this pathway in combination with GLS inhibition may be an effective therapeutic approach for cancer treatment.	[Kim, Minjoong; Gwak, Jihye; Hwang, Sunsook; Yang, Seungyeon; Jeong, Seung Min] Catholic Univ Korea, Coll Med, Dept Biochem, 222 Banpo Daero, Seoul 06591, South Korea; [Kim, Minjoong; Gwak, Jihye; Hwang, Sunsook; Yang, Seungyeon; Jeong, Seung Min] Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, 222 Banpo Daero, Seoul 06591, South Korea; [Kim, Minjoong; Gwak, Jihye; Hwang, Sunsook; Yang, Seungyeon; Jeong, Seung Min] Catholic Univ Korea, Coll Med, Inst Aging & Metab Dis, 222 Banpo Daero, Seoul 06591, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Jeong, SM (corresponding author), Catholic Univ Korea, Coll Med, Dept Biochem, 222 Banpo Daero, Seoul 06591, South Korea.; Jeong, SM (corresponding author), Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, 222 Banpo Daero, Seoul 06591, South Korea.; Jeong, SM (corresponding author), Catholic Univ Korea, Coll Med, Inst Aging & Metab Dis, 222 Banpo Daero, Seoul 06591, South Korea.	smjeong@catholic.ac.kr		Kim, Minjoong/0000-0003-1065-7914	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1C1A1A01052548, 2018R1D1A1B07040961]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1C1A1A01052548 and 2018R1D1A1B07040961).	Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Biancur DE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15965; Byun JK, 2017, CELL REP, V20, P586, DOI 10.1016/j.celrep.2017.06.066; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Ferguson J, 2017, ONCOTARGET, V8, P32946, DOI 10.18632/oncotarget.16514; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hao YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11971; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jeong SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep30767; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Patel D, 2016, J BIOL CHEM, V291, P9322, DOI 10.1074/jbc.M115.710145; Polet F, 2016, ONCOTARGET, V7, P1765, DOI 10.18632/oncotarget.6426; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Salgado MC, 2014, BBA-GENE REGUL MECH, V1839, P288, DOI 10.1016/j.bbagrm.2014.01.005; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sun LC, 2015, CELL RES, V25, P429, DOI 10.1038/cr.2015.33; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Toda K, 2016, NEOPLASIA, V18, P654, DOI 10.1016/j.neo.2016.09.004; Wang SF, 2016, ONCOTARGET, V7, P74132, DOI 10.18632/oncotarget.12356; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wong D T, 1973, Adv Enzyme Regul, V11, P139, DOI 10.1016/0065-2571(73)90013-7; Yang S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0089-1; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Zhang J, 2014, MOL CELL, V56, P205, DOI 10.1016/j.molcel.2014.08.018	28	21	21	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2019	38	24					4729	4738		10.1038/s41388-019-0751-4	http://dx.doi.org/10.1038/s41388-019-0751-4			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IC7ND	30765862				2022-12-26	WOS:000471160500006
J	Partearroyo, T; Murillo-Cuesta, S; Vallecillo, N; Bermudez-Munoz, JM; Rodriguez-de la Rosa, L; Mandruzzato, G; Celaya, AM; Zeisel, SH; Pajares, MA; Varela-Moreiras, G; Varela-Nieto, I				Partearroyo, Teresa; Murillo-Cuesta, Silvia; Vallecillo, Nestor; Bermudez-Munoz, Jose M.; Rodriguez-de la Rosa, Lourdes; Mandruzzato, Giacomo; Celaya, Adelaida M.; Zeisel, Steven H.; Pajares, Maria A.; Varela-Moreiras, Gregorio; Varela-Nieto, Isabel			Betaine-homocysteine S-methyltransferase deficiency causes increased susceptibility to noise-induced hearing loss associated with plasma hyperhomocysteinemia	FASEB JOURNAL			English	Article						ARHL; cochlear injury; methionine cycle; NIHL	FOLIC-ACID; OXIDATIVE STRESS; RAT-LIVER; EXPRESSION; FOLATE; GLUTATHIONE; RISK; MICE; VITAMIN-B-12; INHIBITION	Betaine-homocysteine S-methyltransferases (BHMTs) are methionine cycle enzymes that remethylate homocysteine; hence, their malfunction leads to hyperhomocysteinemia. Epidemiologic and experimental studies have revealed a correlation between hyperhomocysteinemia and hearing loss. Here, we have studied the expression of methionine cycle genes in the mouse cochlea and the impact of knocking out the Bhmt gene in the auditory receptor. We evaluated age-related changes in mouse hearing by recording auditory brainstem responses before and following exposure to noise. Also, we measured cochlear cytoarchitecture, gene expression by RNA-arrays and quantitative RT-PCR, and metabolite levels in liver and plasma by HPLC. Our results indicate that there is an age-dependent strain-specific expression of methionine cycle genes in the mouse cochlea and a further regulation during the response to noise damage. Loss of Bhmt did not cause an evident impact in the hearing acuity of young mice, but it produced higher threshold shifts and poorer recovery following noise challenge. Hearing loss was associated with increased cochlear injury, outer hair cell loss, altered expression of cochlear methionine cycle genes, and hyperhomocysteinemia. Our results suggest that BHMT plays a central role in the homeostasis of cochlear methionine metabolism and that Bhmt2 up-regulation could carry out a compensatory role in cochlear protection against noise injury in the absence of BHMT.Partearroyo, T., Murillo-Cuesta, S., Vallecillo, N., Bermudez-Munoz, J. M., Rodriguez-de la Rosa, L., Mandruzzato, G., Celaya, A. M., Zeisel, S. H., Pajares, M. A., Varela-Moreiras, G., Varela-Nieto, I. Betaine-homocysteine S-methyltransferase deficiency causes increased susceptibility to noise-induced hearing loss associated with plasma hyperhomocysteinemia.	[Partearroyo, Teresa; Varela-Moreiras, Gregorio] Univ Ctr Estudios Univ CEU San Pablo, Fac Farm, Dept Ciencias Farmaceut & Salud, Madrid, Spain; [Partearroyo, Teresa; Murillo-Cuesta, Silvia; Vallecillo, Nestor; Bermudez-Munoz, Jose M.; Rodriguez-de la Rosa, Lourdes; Celaya, Adelaida M.; Pajares, Maria A.; Varela-Moreiras, Gregorio; Varela-Nieto, Isabel] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Murillo-Cuesta, Silvia; Bermudez-Munoz, Jose M.; Rodriguez-de la Rosa, Lourdes; Celaya, Adelaida M.; Pajares, Maria A.; Varela-Nieto, Isabel] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Murillo-Cuesta, Silvia; Rodriguez-de la Rosa, Lourdes; Varela-Nieto, Isabel] Inst Invest Sanitaria La Paz IdiPAZ, Madrid, Spain; [Mandruzzato, Giacomo] MED EL, Res & Dev, Innsbruck, Austria; [Zeisel, Steven H.] Univ North Carolina Chapel Hill, Nutr Res Inst, Kannapolis, NC USA; [Pajares, Maria A.] CSIC, Ctr Invest Biol, Madrid, Spain	San Pablo CEU University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of North Carolina; University of North Carolina Chapel Hill; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Murillo-Cuesta, S (corresponding author), CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.	smurillo@iib.uam.es	de la Rosa, Lourdes Rodríguez/K-3037-2017; Partearroyo, Teresa/J-7322-2017; Murillo-Cuesta, Silvia/C-3557-2016; Varela-Moreiras, Gregorio/AAA-7153-2019; Celaya, Adelaida M./L-1577-2018; Varela-Nieto, Isabel/G-5289-2015; Pajares, Maria Angeles/I-5952-2012; Bermudez-Munoz, Jose M/K-5565-2018	de la Rosa, Lourdes Rodríguez/0000-0002-7518-6036; Partearroyo, Teresa/0000-0002-4401-1233; Murillo-Cuesta, Silvia/0000-0002-8706-4327; Varela-Moreiras, Gregorio/0000-0001-5158-4999; Celaya, Adelaida M./0000-0002-0757-6163; Varela-Nieto, Isabel/0000-0003-3077-0500; Pajares, Maria Angeles/0000-0002-4714-9051; Bermudez-Munoz, Jose M/0000-0002-6034-9285	Spanish Ministerio de Economia y Competitividad (MINECO)/FEDER [SAF2017-86107-R]; U.S. National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases [DK056350]; CEU-Banco Santander precompetitive project [MUSPB047]; CEU-Banco Santander consolidation project [MBS18C12]; Puleva BioFoods; TARGEAR (FP7 PEOPLE 2013) [IAPP-612261]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	Spanish Ministerio de Economia y Competitividad (MINECO)/FEDER; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CEU-Banco Santander precompetitive project; CEU-Banco Santander consolidation project; Puleva BioFoods; TARGEAR (FP7 PEOPLE 2013); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Tania Jareno (Centro de Investigacion Biomedica en Red de Enfermedades Raras, CIBERER) for technical support and colleagues at the Neurobiology of Hearing group for sharing data and helpful discussions. The authors thank the Non-invasive Neurofunctional Evaluation and the Genomics facilities [Instituto de Investigaciones Biomedicas Alberto Sols (IIBM), CSIC-UAM] and Histology [Centro Nacional de Biotecnologia (CNB), CSIC] for the technical support provided. This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO)/FEDER SAF2017-86107-R to I.V.-N., U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (Grant DK056350 to S.H.Z.), CEU-Banco Santander precompetitive project (MUSPB047) and CEU-Banco Santander consolidation project (MBS18C12) to T.P., and Puleva BioFoods (to I.V.-N., G.V.-M., and M.A.P.). G.M. was supported by TARGEAR (FP7 PEOPLE 2013 IAPP-612261). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Attias J, 2012, AUDIOL NEURO-OTOL, V17, P309, DOI 10.1159/000339356; Bowl MR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00595-4; Cadoni G, 2004, ACTA OTO-LARYNGOL, V124, P608, DOI 10.1080/00016480410016216; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; Rodriguez RD, 2015, CELL MOL LIFE SCI, V72, P3983, DOI 10.1007/s00018-015-1919-x; Durga J, 2007, ANN INTERN MED, V146, P1, DOI 10.7326/0003-4819-146-1-200701020-00003; Emmett SD, 2014, MED HYPOTHESES, V82, P6, DOI 10.1016/j.mehy.2013.09.028; FELL D, 1985, J CHROMATOGR, V345, P150, DOI 10.1016/0378-4347(85)80146-8; Feng QP, 2011, MOL GENET METAB, V102, P126, DOI 10.1016/j.ymgme.2010.10.010; Garcia-Alcantara F, 2018, HEARING RES, V358, P10, DOI 10.1016/j.heares.2017.12.004; Givvimani S, 2012, AM J PHYSIOL-GASTR L, V303, pG281, DOI 10.1152/ajpgi.00423.2011; Gok U, 2004, AURIS NASUS LARYNX, V31, P19, DOI 10.1016/j.anl.2003.09.001; Gonzalez B, 2003, BIOCHEM J, V370, P945, DOI 10.1042/BJ20021510; Gopinath B, 2010, AM J CLIN NUTR, V92, P416, DOI 10.3945/ajcn.2010.29370; Gross J, 2005, HEARING RES, V204, P183, DOI 10.1016/j.heares.2005.02.001; Houston DK, 1999, AM J CLIN NUTR, V69, P564; Hume CR, 2007, GENE EXPR PATTERNS, V7, P798, DOI 10.1016/j.modgep.2007.05.002; Iacobazzi V, 2013, MOL GENET METAB, V110, P25, DOI 10.1016/j.ymgme.2013.07.012; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; JENCKS DA, 1987, J BIOL CHEM, V262, P2485; Jhee KH, 2005, ANTIOXID REDOX SIGN, V7, P813, DOI 10.1089/ars.2005.7.813; JOHNSSON LG, 1972, ANN OTO RHINOL LARYN, V81, P364, DOI 10.1177/000348947208100307; Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118; Kamath AF, 2006, BLOOD, V107, P591, DOI 10.1182/blood-2005-06-2506; Kane KL, 2012, HEARING RES, V283, P80, DOI 10.1016/j.heares.2011.11.007; Karli R, 2013, ACTA OTORHINOLARYNGO, V33, P243; Koller A, 2018, CURR PHARM DESIGN, V24, P2911, DOI 10.2174/1381612824666180625125450; Kundu S, 2012, HEARING RES, V284, P42, DOI 10.1016/j.heares.2011.12.006; Lai D, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0164164; Lasisi AO, 2010, OTOLARYNG HEAD NECK, V143, P826, DOI 10.1016/j.otohns.2010.08.031; Lehotsky J, 2015, CELL MOL NEUROBIOL, V35, P7, DOI 10.1007/s10571-014-0112-3; Li F, 2008, MOL GENET METAB, V94, P326, DOI 10.1016/j.ymgme.2008.03.013; Liberman MC, 2014, J NEUROSCI, V34, P4599, DOI 10.1523/JNEUROSCI.4923-13.2014; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Liu HH, 2010, GENOME RES, V20, P28, DOI 10.1101/gr.097212.109; Liu ZG, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0140839, 10.1371/journal.pone.0128274]; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; MAKISHIMA K, 1978, OTOLARYNG HEAD NECK, V86, P322, DOI 10.1177/019459987808600225; Martinez-Vega R, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00209; Martinez-Vega R, 2015, FASEB J, V29, P418, DOI 10.1096/fj.14-259283; Murillo-Cuesta S, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3389/fnagi.2015.00032, 10.5589/fnagi.2015.00032]; Ou XP, 2007, BIOCHEM J, V401, P87, DOI 10.1042/BJ20061119; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; Pan HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06600-6; Partearroyo T, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00107; Pearson RD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-211; Perna AF, 2016, NEPHROL DIAL TRANSPL, V31, P860, DOI 10.1093/ndt/gfv409; ROSEN S, 1965, B NEW YORK ACAD MED, V41, P1052; Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; Sanchez JT, 2015, NEUROSCIENCE, V285, P248, DOI 10.1016/j.neuroscience.2014.11.027; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Savoy-Burke G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108160; Schalinske KL, 2012, ADV NUTR, V3, P755, DOI 10.3945/an.112.002758; Steevens AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04315-2; Sudduth TL, 2017, NEUROSCIENCE, V341, P42, DOI 10.1016/j.neuroscience.2016.11.024; Teng YW, 2012, J NUTR, V142, P1964, DOI 10.3945/jn.112.166835; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Wang J, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00043; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wu XY, 2017, NOISE HEALTH, V19, P245, DOI 10.4103/nah.NAH_56_16; Yamasoba T, 1998, BRAIN RES, V804, P72, DOI 10.1016/S0006-8993(98)00660-X; Yamasoba T, 1998, BRAIN RES, V784, P82, DOI 10.1016/S0006-8993(97)01156-6; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	64	5	7	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5942	5956		10.1096/fj.201801533R	http://dx.doi.org/10.1096/fj.201801533R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30753104	Green Published, Green Submitted			2022-12-26	WOS:000466932600012
J	Pike, CM; Boyer-Andersen, R; Kinch, LN; Caplan, JL; Neunuebel, MR				Pike, Colleen M.; Boyer-Andersen, Rebecca; Kinch, Lisa N.; Caplan, Jeffrey L.; Neunuebel, M. Ramona			The Legionella effector RavD binds phosphatidylinositol-3-phosphate and helps suppress endolysosomal maturation of the Legionella-containing vacuole	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						host-pathogen interaction; phosphoinositide; infection; virulence factor; bacterial pathogenesis; bacterial effectors; cellular localization; immune evasion; Legionella pneumophila; Legionnaires' disease	LEGIONNAIRES-DISEASE; ALVEOLAR MACROPHAGES; INTRACELLULAR GROWTH; PNEUMOPHILA; PHAGOSOME; PHOSPHOINOSITIDES	Upon phagocytosis into macrophages, the intracellular bacterial pathogen Legionella pneumophila secretes effector proteins that manipulate host cell components, enabling it to evade lysosomal degradation. However, the bacterial proteins involved in this evasion are incompletely characterized. Here we show that the L. pneumophila effector protein RavD targets host membrane compartments and contributes to the molecular mechanism the pathogen uses to prevent encounters with lysosomes. Protein-lipid binding assays revealed that RavD selectively binds phosphatidylinositol-3-phosphate (PI(3)P) in vitro. We further determined that a C-terminal RavD region mediates the interaction with PI(3)P and that this interaction requires Arg-292. In transiently transfected mammalian cells, mCherry-RavD colocalized with the early endosome marker EGFP-Rab5 as well as the PI(3)P biosensor EGFP-2xFYVE. However, treatment with the phosphoinositide 3-kinase inhibitor wortmannin did not disrupt localization of mCherry-RavD to endosomal compartments, suggesting that RavD's interaction with PI(3)P is not necessary to anchor RavD to endosomal membranes. Using superresolution and immunogold transmission EM, we observed that, upon translocation into macrophages, RavD was retained onto the Legionella-containing vacuole and was also present on small vesicles adjacent to the vacuole. We also report that despite no detectable effects on intracellular growth of L. pneumophila within macrophages or amebae, the lack of RavD significantly increased the number of vacuoles that accumulate the late endosome/lysosome marker LAMP-1 during macrophage infection. Together, our findings suggest that, although not required for intracellular replication of L. pneumophila, RavD is a part of the molecular mechanism that steers the Legionella-containing vacuole away from endolysosomal maturation pathways.	[Pike, Colleen M.; Boyer-Andersen, Rebecca; Caplan, Jeffrey L.; Neunuebel, M. Ramona] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA; [Caplan, Jeffrey L.] Univ Delaware, Dept Biol Sci, 105 Green, Newark, DE 19716 USA; [Caplan, Jeffrey L.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA; [Kinch, Lisa N.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Delaware; University of Delaware; University of Delaware; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Neunuebel, MR (corresponding author), Univ Delaware, Dept Biol Sci, 105 Green, Newark, DE 19716 USA.	neunr@udel.edu		Caplan, Jeffrey/0000-0002-3991-0912; Kinch, Lisa/0000-0003-3041-2615	NIAID, National Institutes of Health [1R21AI142317-01]; Delaware COBRE Program, NIGMS, National Institutes of Health [P20GM104316]; Delaware INBRE Program, NIGMS, National Institutes of Health [P20GM103446]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI142317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446, P20GM104316] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Delaware COBRE Program, NIGMS, National Institutes of Health; Delaware INBRE Program, NIGMS, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIAID, National Institutes of Health grant 1R21AI142317-01 (to M.R.N.), Delaware COBRE Program, NIGMS, National Institutes of Health Grant P20GM104316 (to M.R.N.), and Delaware INBRE Program, NIGMS, National Institutes of Health Grant P20GM103446 (to J.L.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; CHANDLER FW, 1977, NEW ENGL J MED, V297, P1218, DOI 10.1056/NEJM197712012972206; Chen DQ, 2006, MICROBIOL RES, V161, P246, DOI 10.1016/j.micres.2005.09.001; Clemens DL, 2000, INFECT IMMUN, V68, P2671, DOI 10.1128/IAI.68.5.2671-2684.2000; Copenhaver AM, 2014, INFECT IMMUN, V82, P4325, DOI 10.1128/IAI.01891-14; Del Campo CM, 2014, STRUCTURE, V22, P397, DOI 10.1016/j.str.2013.12.018; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dong N, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.236; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Hammond GRV, 2015, BBA-MOL CELL BIOL L, V1851, P746, DOI 10.1016/j.bbalip.2015.02.013; Hilbi H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00091; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Kubori T, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12840; Levin R, 2017, MOL BIOL CELL, V28, P128, DOI 10.1091/mbc.E16-06-0451; Levin R, 2015, BBA-MOL CELL BIOL L, V1851, P805, DOI 10.1016/j.bbalip.2014.09.005; Luo X, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004965; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; NASH TW, 1984, J CLIN INVEST, V74, P771, DOI 10.1172/JCI111493; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Pauwels AM, 2017, TRENDS IMMUNOL, V38, P407, DOI 10.1016/j.it.2017.03.006; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Segal G, 1999, INFECT IMMUN, V67, P2117, DOI 10.1128/IAI.67.5.2117-2124.1999; Segal Gil, 2013, Methods Mol Biol, V954, P595, DOI 10.1007/978-1-62703-161-5_37; Toulabi L, 2013, J BIOL CHEM, V288, P24518, DOI 10.1074/jbc.M113.474239; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; WEBER S, 2014, LEGIONELLA, V5, pe0083, DOI DOI 10.1128/MBIO.00839-13; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x; Yu XB, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-017-1147-7	40	15	17	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6405	6415		10.1074/jbc.RA118.007086	http://dx.doi.org/10.1074/jbc.RA118.007086			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30733336	Green Published, hybrid			2022-12-26	WOS:000468402000018
J	Guo, T; Nan, Z; Miao, C; Jin, XY; Yang, WW; Wang, ZH; Tu, YQ; Bao, HC; Lyu, JL; Zheng, HM; Deng, QN; Guo, PF; Xi, YM; Yang, XH; Ge, WZ				Guo, Ting; Nan, Zi; Miao, Chen; Jin, Xiaoye; Yang, Weiwei; Wang, Zehua; Tu, Yinqi; Bao, Hongcun; Lyu, Jialan; Zheng, Huimei; Deng, Qiannan; Guo, Pengfei; Xi, Yongmei; Yang, Xiaohang; Ge, Wanzhong			The autophagy-related gene Atg101 in Drosophila regulates both neuron and midgut homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; neuron; cell differentiation; homeostasis; aging; neurogenesis; Atg101; insect development; intracellular degradation; midgut	STEM-CELLS; INTERACTS; ULK1; ACTIVATION; LONGEVITY; DISEASE; PROTEIN	Atg101 is an autophagy-related gene identified in worms, flies, mice, and mammals, which encodes a protein that functions in autophagosome formation by associating with the ULK1-Atg13-Fip200 complex. In the last few years, the critical role of Atg101 in autophagy has been well-established through biochemical studies and the determination of its protein structure. However, Atg101's physiological role, both during development and in adulthood, remains less understood. Here, we describe the generation and characterization of an Atg101 loss-of-function mutant in Drosophila and report on the roles of Atg101 in maintaining tissue homeostasis in both adult brains and midguts. We observed that homozygous or hemizygous Atg101 mutants were semi-lethal, with only some of them surviving into adulthood. Both developmental and starvation-induced autophagy processes were defective in the Atg101 mutant animals, and Atg101 mutant adult flies had a significantly shorter lifespan and displayed a mobility defect. Moreover, we observed the accumulation of ubiquitin-positive aggregates in Atg101 mutant brains, indicating a neuronal defect. Interestingly, Atg101 mutant adult midguts were shorter and thicker and exhibited abnormal morphology with enlarged enterocytes. Detailed analysis also revealed that the differentiation from intestinal stem cells to enterocytes was impaired in these midguts. Cell type-specific rescue experiments disclosed that Atg101 had a function in enterocytes and limited their growth. In summary, the results of our study indicate that Drosophila Atg101 is essential for tissue homeostasis in both adult brains and midguts. We propose that Atg101 may have a role in age-related processes.	[Guo, Ting; Nan, Zi; Miao, Chen; Jin, Xiaoye; Yang, Weiwei; Wang, Zehua; Tu, Yinqi; Bao, Hongcun; Lyu, Jialan; Zheng, Huimei; Deng, Qiannan; Guo, Pengfei; Xi, Yongmei; Yang, Xiaohang; Ge, Wanzhong] Zhejiang Univ, Div Human Reprod & Dev Genet, Womens Hosp, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Guo, Ting; Nan, Zi; Miao, Chen; Jin, Xiaoye; Yang, Weiwei; Wang, Zehua; Tu, Yinqi; Bao, Hongcun; Lyu, Jialan; Zheng, Huimei; Deng, Qiannan; Guo, Pengfei; Xi, Yongmei; Yang, Xiaohang; Ge, Wanzhong] Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Guo, Ting; Nan, Zi; Wang, Zehua; Tu, Yinqi; Bao, Hongcun; Deng, Qiannan; Guo, Pengfei] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Miao, Chen; Jin, Xiaoye; Yang, Weiwei; Lyu, Jialan; Zheng, Huimei; Xi, Yongmei; Yang, Xiaohang; Ge, Wanzhong] Zhejiang Univ, Sch Med, Dept Genet, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Ge, WZ (corresponding author), Zhejiang Univ, Div Human Reprod & Dev Genet, Womens Hosp, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.; Ge, WZ (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China.; Ge, WZ (corresponding author), Zhejiang Univ, Sch Med, Dept Genet, Hangzhou 310058, Zhejiang, Peoples R China.	wanzhongge@zju.edu.cn	席, 咏梅/AAE-1909-2022; guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022; Lyu, Jialan/AAO-3620-2021	Ge, Wanzhong/0000-0003-1334-2723; ZHENG, HUIMEI/0000-0001-7129-8412	National Key Research and Development Program of China [2018YFC1003200]; National Natural Science Foundation of China [31371319]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 2018YFC1003200 from the National Key Research and Development Program of China and Grant 31371319 from the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Chang YY, 2010, FEBS LETT, V584, P1342, DOI 10.1016/j.febslet.2010.01.006; Chen HY, 2014, CELL, V159, P829, DOI 10.1016/j.cell.2014.10.028; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Foronda D, 2014, GENE DEV, V28, P2421, DOI 10.1101/gad.241588.114; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Hale AN, 2013, AUTOPHAGY, V9, P951, DOI 10.4161/auto.24273; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hegedus K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470482; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kim M, 2013, AUTOPHAGY, V9, P1201, DOI 10.4161/auto.24811; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Levine B, 2009, CELL DEATH DIFFER, V16, P1, DOI 10.1038/cdd.2008.139; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang J, 2017, NATURE, V548, P588, DOI 10.1038/nature23678; Liang QQ, 2012, AUTOPHAGY, V8, P1426, DOI 10.4161/auto.21163; Mauvezin C, 2014, METHODS, V68, P134, DOI 10.1016/j.ymeth.2014.03.014; McPhee CK, 2009, BBA-MOL CELL RES, V1793, P1452, DOI 10.1016/j.bbamcr.2009.02.009; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Michel M, 2015, AUTOPHAGY, V11, P2300, DOI 10.1080/15548627.2015.1076605; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mulakkal NC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/273473; Nagy P, 2014, AUTOPHAGY, V10, P453, DOI 10.4161/auto.27442; Noda NN, 2016, CELL STRUCT FUNCT, V41, P13, DOI 10.1247/csf.15013; Noda NN, 2015, ANNU REV BIOPHYS, V44, P101, DOI 10.1146/annurev-biophys-060414-034248; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Popelka H, 2015, AUTOPHAGY, V11, P1953, DOI 10.1080/15548627.2015.1087635; Qi SQ, 2015, STRUCTURE, V23, P1848, DOI 10.1016/j.str.2015.07.011; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Stanley RE, 2014, TRENDS CELL BIOL, V24, P73, DOI 10.1016/j.tcb.2013.07.008; Suzuki H, 2015, AUTOPHAGY, V11, P2123, DOI 10.1080/15548627.2015.1091144; Suzuki H, 2015, NAT STRUCT MOL BIOL, V22, P572, DOI 10.1038/nsmb.3036; Tang HW, 2013, DEV CELL, V27, P489, DOI 10.1016/j.devcel.2013.10.017; Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006; Wang LF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005220; Wen JK, 2017, ELIFE, V6, DOI 10.7554/eLife.29338; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhao GL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004984	52	14	15	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5666	5676		10.1074/jbc.RA118.006069	http://dx.doi.org/10.1074/jbc.RA118.006069			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30760524	Green Published, hybrid			2022-12-26	WOS:000464517500034
J	Chu, MX; Liu, XP; Gong, RF; Zhao, J				Chu, Maoxiang; Liu, Xiaoping; Gong, Rongfen; Zhao, Jie			Support vector machine with quantile hyper-spheres for pattern classification	PLOS ONE			English	Article							MAXIMUM MARGIN; TSVH	This paper formulates a support vector machine with quantile hyper-spheres (QHSVM) for pattern classification. The idea of QHSVM is to build two quantile hyper-spheres with the same center for positive or negative training samples. Every quantile hyper-sphere is constructed by using pinball loss instead of hinge loss, which makes the new classification model be insensitive to noise, especially the feature noise around the decision boundary. Moreover, the robustness and generalization of QHSVM are strengthened through maximizing the margin between two quantile hyper-spheres, maximizing the inner-class clustering of samples and optimizing the independent quadratic programming for a target class. Besides that, this paper proposes a novel local center-based density estimation method. Based on it, rho-QHSVM with surrounding and clustering samples is given. Under the premise of high accuracy, the execution speed of rho-QHSVM can be adjusted. The experimental results in artificial, benchmark and strip steel surface defects datasets show that the QHSVM model has distinct advantages in accuracy and the rho-QHSVM model is fit for large-scale datasets.	[Chu, Maoxiang; Gong, Rongfen] Univ Sci & Technol Liaoning, Sch Elect & Informat Engn, Anshan, Liaoning, Peoples R China; [Chu, Maoxiang; Liu, Xiaoping] Lakehead Univ, Dept Elect Engn, Thunder Bay, ON, Canada; [Zhao, Jie] State Key Lab Robot & Syst HIT, Harbin, Heilongjiang, Peoples R China	University of Science & Technology Liaoning; Lakehead University	Chu, MX (corresponding author), Univ Sci & Technol Liaoning, Sch Elect & Informat Engn, Anshan, Liaoning, Peoples R China.; Chu, MX (corresponding author), Lakehead Univ, Dept Elect Engn, Thunder Bay, ON, Canada.	chu52_2004@163.com	Liu, Xiaoping/Z-1619-2019; Liu, Xiaoping/ABA-8379-2020	Liu, Xiaoping/0000-0003-1808-4233; Chu, Maoxiang/0000-0003-2358-9455	Liaoning Province PhD Start-up Fund [201601291]; Natural Science Foundation of Liaoning Province of China [20180550067]; Liaoning Province Ministry of Education Scientific Study Project [2017LNQN11, 2016TSPY13]; State Key Laboratory of Robotics and System (HIT) [SKLRS-2016-KF-08]	Liaoning Province PhD Start-up Fund; Natural Science Foundation of Liaoning Province of China(Natural Science Foundation of Liaoning Province); Liaoning Province Ministry of Education Scientific Study Project; State Key Laboratory of Robotics and System (HIT)	This work was supported by Liaoning Province PhD Start-up Fund (No. 201601291 to MC), Natural Science Foundation of Liaoning Province of China (20180550067 to MC), Liaoning Province Ministry of Education Scientific Study Project (No. 2017LNQN11 to MC and No. 2016TSPY13 to RG) and State Key Laboratory of Robotics and System (HIT) (No. SKLRS-2016-KF-08 to MC).	Cawley GC, 2006, IEEE IJCNN, P1661; Cheng LL, 2008, ICICSE: 2008 INTERNATIONAL CONFERENCE ON INTERNET COMPUTING IN SCIENCE AND ENGINEERING, PROCEEDINGS, P106; Chu MX, 2015, ISIJ INT, V55, P1956, DOI 10.2355/isijinternational.ISIJINT-2015-201; Chu MX, 2014, ISIJ INT, V54, P119, DOI 10.2355/isijinternational.54.119; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dua D., 2017, MACHINE LEARNING REP; Everingham M, 2012, PASCAL VISUAL OBJECT; Fung G., 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P77, DOI 10.1145/502512.502527; Gong RF, 2016, CHIN CONT DECIS CONF, P6551, DOI 10.1109/CCDC.2016.7532177; Gu ZF, 2017, NEUROCOMPUTING, V223, P1, DOI 10.1016/j.neucom.2016.10.008; Hao PY, 2009, APPL INTELL, V30, P98, DOI 10.1007/s10489-007-0101-z; Huang XL, 2014, IEEE T PATTERN ANAL, V36, P984, DOI 10.1109/TPAMI.2013.178; Jayadeva, 2007, IEEE T PATTERN ANAL, V29, P905, DOI 10.1109/TPAMI.2007.1068; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Kumar MA, 2009, EXPERT SYST APPL, V36, P7535, DOI 10.1016/j.eswa.2008.09.066; Lin CF, 2002, IEEE T NEURAL NETWOR, V13, P464, DOI 10.1109/72.991432; Mangasarian OL, 2006, IEEE T PATTERN ANAL, V28, P69, DOI 10.1109/TPAMI.2006.17; Maulik U, 2012, INT J MACH LEARN CYB, V3, P247, DOI 10.1007/s13042-011-0059-3; Peng XJ, 2014, NEURAL COMPUT APPL, V24, P1207, DOI 10.1007/s00521-012-1306-6; Peng XJ, 2013, INFORM SCIENCES, V221, P12, DOI 10.1016/j.ins.2012.09.009; Peng XJ, 2013, NEUROCOMPUTING, V99, P134, DOI 10.1016/j.neucom.2012.06.012; Peng XJ, 2011, PATTERN RECOGN, V44, P2678, DOI 10.1016/j.patcog.2011.03.031; Peng XJ, 2010, EXPERT SYST APPL, V37, P8371, DOI 10.1016/j.eswa.2010.05.045; Qi ZQ, 2012, NEURAL NETWORKS, V35, P46, DOI 10.1016/j.neunet.2012.07.011; Shao YH, 2011, IEEE T NEURAL NETWOR, V22, P962, DOI 10.1109/TNN.2011.2130540; Song KC, 2013, APPL SURF SCI, V285, P858, DOI 10.1016/j.apsusc.2013.09.002; Steinwart I, 2011, BERNOULLI, V17, P211, DOI 10.3150/10-BEJ267; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Tax DMJ, 2004, MACH LEARN, V54, P45, DOI 10.1023/B:MACH.0000008084.60811.49; Xu H, 2009, J MACH LEARN RES, V10, P1485; Xu YT, 2017, IEEE T NEUR NET LEAR, V28, P359, DOI 10.1109/TNNLS.2015.2513006; Xu YT, 2016, KNOWL-BASED SYST, V95, P75, DOI 10.1016/j.knosys.2015.12.005; Ye QL, 2014, PATTERN RECOGN LETT, V42, P91, DOI 10.1016/j.patrec.2014.02.006; Ye QL, 2012, NEURAL NETWORKS, V35, P31, DOI 10.1016/j.neunet.2012.06.010; Yoon M, 2003, IEEE IJCNN, P2049; Zhang Z, 2012, EXPERT SYST APPL, V39, P849, DOI 10.1016/j.eswa.2011.07.083	37	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212361	10.1371/journal.pone.0212361	http://dx.doi.org/10.1371/journal.pone.0212361			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768635	Green Submitted, gold, Green Published			2022-12-26	WOS:000458766300035
J	Guaraldi, G; Zona, S; Silva, AR; Menozzi, M; Dolci, G; Milic, J; Carli, F; Mussini, C				Guaraldi, Giovanni; Zona, Stefano; Silva, Ana Rita; Menozzi, Marianna; Dolci, Giovanni; Milic, Jovana; Carli, Federica; Mussini, Cristina			The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV	PLOS ONE			English	Article							T-CELL-ACTIVATION; IMMUNE ACTIVATION; INFECTED PERSONS; DISEASE; ADULTS; AGE; INFLAMMATION; COMORBIDITIES; PHENOTYPE; MARKERS	Objective To investigate the association between current CD4+ T-cell count and CD4/CD8+ ratio with severity of frailty among people aging with HIV. Methods Cross-sectional observational study analysing data from all study visits in the ongoing prospective Modena HIV Metabolic Clinic Cohort between 2006 and 2015. Frailty severity was assessed using a frailty index (FI). We visualized the relationships between frailty index score and current CD4 cell count and CD4/CD8 ratio on two different curves adjusted for age, sex, and duration of HIV infection. Results Frailty index scores exhibited an inverse relationship with current CD4 count, up to 900 cells/mu L. The CD4/CD8 ratio was inversely correlated with frailty index both below and above the cut-off of 900 CD4 cells/mu L. Conclusions Frailty in PLWH is inversely associated with both immune-activation, depicted by CD4/CD8 ratio and immune-deficit depicted by CD4 count. The first association shows a linear shape while the second shows a hook-shape with a turning point at 900 cells. Above this cut off level CD4 do not represent a significant risk factor for frailty.	[Guaraldi, Giovanni; Zona, Stefano; Menozzi, Marianna; Dolci, Giovanni; Carli, Federica; Mussini, Cristina] Univ Modena & Reggio Emilia, Infect Dis Clin, Modena, Italy; [Silva, Ana Rita] Hosp Beatriz Angelo, Dept Infect Dis, Loures, Portugal; [Milic, Jovana] Univ Modena & Reggio Emilia, Clin & Expt Med PhD Program, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Guaraldi, G (corresponding author), Univ Modena & Reggio Emilia, Infect Dis Clin, Modena, Italy.	giovanni.guaraldi@unimore.it	Mussini, Cristina/K-8672-2016; Guaraldi, Giovanni/J-9467-2018	Mussini, Cristina/0000-0002-6615-4198; Zona, Stefano/0000-0003-3451-2744; Dolci, Giovanni/0000-0001-9948-652X; Silva, Ana Rita/0000-0003-0277-9751				Adeyemi O, 2013, JAIDS-J ACQ IMM DEF, V63, pE78, DOI 10.1097/QAI.0b013e318291854b; Althoff KN, 2014, J GERONTOL A-BIOL, V69, P189, DOI 10.1093/gerona/glt148; Bouillon K, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-64; Brothers TD, 2014, J INFECT DIS, V210, P1170, DOI 10.1093/infdis/jiu258; Brothers TD, 2014, CURR OPIN HIV AIDS, V9, P412, DOI 10.1097/COH.0000000000000070; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Desquilbet L, 2009, JAIDS-J ACQ IMM DEF, V50, P299, DOI 10.1097/QAI.0b013e3181945eb0; Erlandson KM, 2013, J INFECT DIS, V208, P249, DOI 10.1093/infdis/jit147; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Guaraldi G, 2017, HIV MED, V18, P764, DOI 10.1111/hiv.12527; Guaraldi G, 2006, HIV CLIN TRIALS, V7, P97, DOI 10.1310/EYWJ-8B5K-X7VQ-9CPE; Guaraldi G, 2015, AIDS, V29, P1633, DOI 10.1097/QAD.0000000000000753; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Ianas Voichita, 2013, J Int Assoc Provid AIDS Care, V12, P62, DOI 10.1177/1545109712457241; Kooij KW, 2016, AIDS, V30, P241, DOI 10.1097/QAD.0000000000000910; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; Mitnitski A, 2015, INTERD T GERONT GERI, V40, P85, DOI 10.1159/000364933; Mocroft A, 2013, CLIN INFECT DIS, V57, P1038, DOI 10.1093/cid/cit423; Onen NF, 2009, J INFECTION, V59, P346, DOI 10.1016/j.jinf.2009.08.008; Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168; Pathai S, 2013, JAIDS-J ACQ IMM DEF, V62, P43, DOI 10.1097/QAI.0b013e318273b631; Piggott DA, 2015, J GERONTOL A-BIOL, V70, P1542, DOI 10.1093/gerona/glv107; Piggott DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054910; Rodriguez-Manas L, 2015, LANCET, V385, pE7, DOI 10.1016/S0140-6736(14)61595-6; Ryom L, 2014, AIDS, V28, P187, DOI 10.1097/QAD.0000000000000042; Sabin CA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-251; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Serrano-Villar S, 2014, HIV MED, V15, P40, DOI 10.1111/hiv.12081; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Serrano-Villar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085798; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Terzian AS, 2009, J WOMENS HEALTH, V18, P1965, DOI 10.1089/jwh.2008.1090; Zhang WY, 2015, J GERONTOL A-BIOL, V70, P1533, DOI 10.1093/gerona/glv132	41	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212283	10.1371/journal.pone.0212283	http://dx.doi.org/10.1371/journal.pone.0212283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5JX	30763363	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900060
J	Bocanegra-Ibarias, P; Garza-Gonzalez, E; Padilla-Orozco, M; Mendoza-Olazaran, S; Perez-Alba, E; Flores-Trevino, S; Garza-Ramos, U; Silva-Sanchez, J; Camacho-Ortiz, A				Bocanegra-Ibarias, Paola; Garza-Gonzalez, Elvira; Padilla-Orozco, Magaly; Mendoza-Olazaran, Soraya; Perez-Alba, Eduardo; Flores-Trevino, Samantha; Garza-Ramos, Ulises; Silva-Sanchez, Jesus; Camacho-Ortiz, Adrian			The successful containment of a hospital outbreak caused by NDM-1-producing Klebsiella pneumoniae ST307 using active surveillance	PLOS ONE			English	Article							ESCHERICHIA-COLI; RAPID DETECTION; ENTEROBACTERIACEAE; PCR; CARBAPENEMASES; PLASMIDS; DNA	The worldwide dissemination of high-risk carbapenemase-producing Klebsiella pneumoniae clones has become a major threat to healthcare facilities. This study describes the successful containment of a hospital outbreak caused by NDM-1-producing K. pneumoniae Sequence Type (ST) 307 using active surveillance. The outbreak began when a patient was transferred from a local hospital. After 48 hours in our hospital, a tracheal aspirate was positive for a meropenem resistant and carbapenemase-producing K. pneumoniae. All patients in the medical intensive care unit (ICU) and the neurology wards were subject to contact precautions. The hospital surfaces and devices, healthcare workers, and patients from these wards were screened by cultures. Fecal swabs were placed into broth and PCR for bla(KPC), bla(OXA-48), bla(IMP), bla(VIM), and bla(NDM), which were performed directly from the broth after 12 hours. PCRs were also performed on DNA extracted from carbapenemase-producing species from subcultured broths. Five and nine days later, two more patients' rectal swabs tested positive. Molecular assays identified K. pneumoniae bla(NDM-1) onto a 130-kb conjugative plasmid (IncY, IncFIIs, and IncFIIY), ST307. After the three patients were discharged, monitoring continued, and after three weeks with negative results, rectal swabbing ended. In conclusion, it was possible to contain a hospital outbreak caused by NDM-1-producing K. pneumoniae ST307 through epidemiological and microbiological surveillance. With the methodology used, the detection of NDM-type genes in fecal samples was obtained in approximately 15 hours after obtaining the fecal sample.	[Bocanegra-Ibarias, Paola; Garza-Gonzalez, Elvira; Padilla-Orozco, Magaly; Mendoza-Olazaran, Soraya; Perez-Alba, Eduardo; Flores-Trevino, Samantha; Camacho-Ortiz, Adrian] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Garza-Ramos, Ulises; Silva-Sanchez, Jesus] Inst Nacl Salud Publ, Lab Resistencia Bacteriana, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Instituto Nacional de Salud Publica	Camacho-Ortiz, A (corresponding author), Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico.	acamacho_md@yahoo.com	Pérez-Alba, Eduardo/AAB-6864-2019; Flores-Treviño, Samantha/AAB-4537-2020; Flores-Treviño, Samantha M/E-8601-2019	Pérez-Alba, Eduardo/0000-0002-6642-2770; Flores-Treviño, Samantha/0000-0003-1259-7425; Flores-Treviño, Samantha M/0000-0003-1259-7425; Garza Ramos, Ulises/0000-0002-5013-3050; Bocanegra-Ibarias, Paola/0000-0003-4602-3817; Mendoza-Olazaran, Soraya/0000-0001-5649-4810				Baroud M, 2013, INT J ANTIMICROB AG, V41, P75, DOI 10.1016/j.ijantimicag.2012.08.010; Barrios H, 2014, PEDIATR INFECT DIS J, V33, P335, DOI 10.1097/INF.0000000000000173; Barrios H, 2013, J ANTIMICROB CHEMOTH, V68, P1934, DOI 10.1093/jac/dkt124; Bocanegra-Ibarias P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179651; Bocanegra-Ibarias P, 2015, INT J ANTIMICROB AG, V45, P309, DOI 10.1016/j.ijantimicag.2014.10.022; Bonnin RA, 2012, J CLIN MICROBIOL, V50, P1419, DOI 10.1128/JCM.06276-11; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Castanheira M, 2013, MICROB DRUG RESIST, V19, P295, DOI 10.1089/mdr.2012.0238; Chen CJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0089305, 10.1371/journal.pone.0105414, 10.1371/journal.pone.0104899]; Clinical and Laboratory Standards Institute, 2018, M100 CLIN LAB STAND, V28th, DOI DOI 10.1108/08876049410065598; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Dortet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249856; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; European Committee on Antimicrobial Susceptibility Testing EUCAST, 2018, CLIN BREAKP BACT V 8, V80; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Hamprecht A, 2013, J ANTIMICROB CHEMOTH, V68, P558, DOI 10.1093/jac/dks447; Hamzaoui Z, 2018, MICROB DRUG RESIST, V24, P1137, DOI 10.1089/mdr.2017.0165; Jean SS, 2015, FUTURE MICROBIOL, V10, P407, DOI [10.2217/FMB.14.135, 10.2217/fmb.14.135]; Kaufmann Mary Elizabeth, 1998, V15, P33; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016/0147-619X(84)90063-5; Kim JO, 2017, DIAGN MICR INFEC DIS, V87, P343, DOI 10.1016/j.diagmicrobio.2016.12.012; Lovleva A, 2017, CLIN LAB MED, V37, P303, DOI 10.1016/j.cll.2017.01.005; Miller JH, 1972, EXPT MOL GENETICS, Vxvi; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Rozales FP, 2014, INT J INFECT DIS, V25, P79, DOI 10.1016/j.ijid.2014.01.005; Schaufler K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00150; Swayne RL, 2011, INT J ANTIMICROB AG, V38, P35, DOI 10.1016/j.ijantimicag.2011.03.010; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Torres-Gonzalez P, 2015, ANTIMICROB AGENTS CH, V59, P7080, DOI 10.1128/AAC.00055-15; Villa L, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000110; Wei WJ, 2015, CHINESE MED J-PEKING, V128, P1969, DOI 10.4103/0366-6999.160566; Wyres KL, 2016, TRENDS MICROBIOL, V24, P944, DOI 10.1016/j.tim.2016.09.007; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09	33	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0209609	10.1371/journal.pone.0209609	http://dx.doi.org/10.1371/journal.pone.0209609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759100	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000458761300010
J	Gomez, AI; Cruz, M; Lopez-Gimenez, JF				Gomez, Ana I.; Cruz, Marcos; Lopez-Gimenez, Juan F.			Evaluating the pharmacological response in fluorescence microscopy images: The Delta m algorithm	PLOS ONE			English	Article							RECEPTOR INTERNALIZATION; QUANTIFICATION; SELECTION	Current drug discovery procedures require fast and effective quantification of the pharmacological response evoked in living cells by agonist compounds. In the case of G-protein coupled receptors (GPCRs), the efficacy of a particular drug to initiate the endocytosis process is related to the formation of endocytic vesicles or endosomes and their subsequent internalisation within intracellular compartments that can be observed with high spatial and temporal resolution by fluorescence microscopy techniques. Recently, an algorithm has been proposed to evaluate the pharmacological response by estimating the number of endosomes per cell on time series of images. However, the algorithm was limited by the dependence on some manually set parameters and in some cases the quality of the image does not allow a reliable detection of the endosomes. Here we propose a simple, fast and automated image analysis method-the Delta m algorithm- to quantify a pharmacological response with data obtained from fluorescence microscopy experiments. This algorithm does not require individual object detection and computes the relative increment of the third order moment in fluorescence microscopy images after filtering with the Laplacian of Gaussian function. It was tested on simulations demonstrating its ability to discriminate different experimental situations according to the number and the fluorescence signal intensity of the simulated endosomes. Finally and in order to validate this methodology with real data, the algorithm was applied to several time-course experiments based on the endocytosis of the mu opioid receptor (MOP) initiated by different agonist compounds. Each drug displayed a different Am sigmoid time-response curve and statistically significant differences were observed among drugs in terms of efficacy and kinetic parameters.	[Gomez, Ana I.; Cruz, Marcos] Univ Cantabria, Dept Math Stat & Comp Sci, Santander, Spain; [Lopez-Gimenez, Juan F.] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Gomez, AI (corresponding author), Univ Cantabria, Dept Math Stat & Comp Sci, Santander, Spain.	gomezanab@gmail.com	Cruz, Marcos/N-3429-2014; Lopez-Gimenez, Juan F./K-5823-2014	Cruz, Marcos/0000-0002-4767-530X; Gomez, Ana Isabel/0000-0002-8561-2991; Lopez-Gimenez, Juan F./0000-0003-3021-6200	MINECO/FEDER [AYA2015-66357-R 288]	MINECO/FEDER	The authors acknowledge financial support from the Spanish Project AYA2015-66357-R 288 (MINECO/FEDER).	Basset A, 2015, IEEE T IMAGE PROCESS, V24, P4512, DOI 10.1109/TIP.2015.2450996; Campa VM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122604; Conway BR, 1999, J BIOMOL SCREEN, V4, P75, DOI 10.1177/108705719900400207; Ghosh RN, 2000, BIOTECHNIQUES, V29, P170, DOI 10.2144/00291pf01; Gonzalez-Nuevo J, 2006, MON NOT R ASTRON SOC, V369, P1603, DOI 10.1111/j.1365-2966.2006.10442.x; HUERTAS A, 1986, IEEE T PATTERN ANAL, V8, P651, DOI 10.1109/TPAMI.1986.4767838; Kayser K, 2015, DIAGNOSTIC PATHOLOGY; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; Ruusuvuori P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-248; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Sanz JL, 2001, ASTROPHYS J, V552, P484, DOI 10.1086/320550; Serge A, 2011, INTEGR BIOL-UK, V3, P675, DOI 10.1039/c0ib00121j; Smal I, 2010, IEEE T MED IMAGING, V29, P282, DOI 10.1109/TMI.2009.2025127; Smith A, 2002, NATURE, V418, P453, DOI 10.1038/418453a; Usaj MM, 2016, TRENDS CELL BIOL, V26, P598, DOI 10.1016/j.tcb.2016.03.008	17	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211330	10.1371/journal.pone.0211330	http://dx.doi.org/10.1371/journal.pone.0211330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759168	Green Published, Green Submitted, gold			2022-12-26	WOS:000458761300039
J	Zhao, J; Feng, QP; Wu, P; Warner, JL; Denny, JC; Wei, WQ				Zhao, Juan; Feng, QiPing; Wu, Patrick; Warner, Jeremy L.; Denny, Joshua C.; Wei, Wei-Qi			Using topic modeling via non-negative matrix factorization to identify relationships between genetic variants and disease phenotypes: A case study of Lipoprotein(a) (LPA)	PLOS ONE			English	Article							RISK; ASSOCIATION; MULTIPLE	Genome-wide and phenome-wide association studies are commonly used to identify important relationships between genetic variants and phenotypes. Most studies have treated diseases as independent variables and suffered from the burden of multiple adjustment due to the large number of genetic variants and disease phenotypes. In this study, we used topic modeling via non-negative matrix factorization (NMF) for identifying associations between disease phenotypes and genetic variants. Topic modeling is an unsupervised machine learning approach that can be used to learn patterns from electronic health record data. We chose the single nucleotide polymorphism (SNP) rs10455872 in LPA as the predictor since it has been shown to be associated with increased risk of hyperlipidemia and cardiovascular diseases (CVD). Using data of 12,759 individuals with electronic health records (EHR) and linked DNA samples at Vanderbilt University Medical Center, we trained a topic model using NMF from 1,853 distinct phenotypes and identified six topics. We tested their associations with rs10455872 in LPA. Topics enriched for CVD and hyperlipidemia had positive correlations with rs10455872 (P < 0.001), replicating a previous finding. We also identified a negative correlation between LPA and a topic enriched for lung cancer (P < 0.001) which was not previously identified via phenome-wide scanning. We were able to replicate the top finding in a separate dataset. Our results demonstrate the applicability of topic modeling in exploring the relationship between genetic variants and clinical diseases.	[Zhao, Juan; Wu, Patrick; Warner, Jeremy L.; Denny, Joshua C.; Wei, Wei-Qi] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37232 USA; [Feng, QiPing] Vanderbilt Univ, Med Ctr, Div Clin Pharmacol, Nashville, TN USA; [Wu, Patrick] Vanderbilt Univ, Sch Med, Med Scientist Training Program, Nashville, TN 37212 USA; [Warner, Jeremy L.; Denny, Joshua C.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Wei, WQ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37232 USA.	wei-qi.wei@vumc.org	Denny, Josh/AAL-3359-2021; Wu, Patrick/GPG-1125-2022	Denny, Josh/0000-0002-3049-7332; Wu, Patrick/0000-0002-1437-6688; Warner, Jeremy/0000-0002-2851-7242	NIH from the National Institute of General Medical Studies [P50 GM115305, R01 HL133786, R01 GM120523, T32 GM007347]; NIH from the American Heart Association [18AMTG34280063]; NIH from the National Library of Medicine [T15 LM007450]; CTSA from NCATS/NIH [ULTR000445, UL1TR000445]; NIH from NIGMS/OD [RC2GM092618]; NIH from NHGRI/NIGMS [U01HG004603]; Vanderbilt Ingram Cancer Center [P30 CA068485]; Vanderbilt Vision Center [P30 EY08126]; Rheumatology Research Foundation; American Heart Association [18AMTG34280063, 16SDG27490014, 15MCPRP25620006]; Vanderbilt Faculty Research Scholar Fund; Vanderbilt National Center for Advancing Translational Science from NCATS/NIH [2UL1 TR000445-06];  [1S10RR025141-01];  [GM120523];  [GM109145];  [HL133786];  [5T32GM080178-09];  [K23AR064768];  [HG008672];  [R01 LM010685];  [GM115305]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR064768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM115305, T32GM080178, R01GM120523, T32GM007347] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007450, R01LM010685] Funding Source: NIH RePORTER	NIH from the National Institute of General Medical Studies; NIH from the American Heart Association; NIH from the National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); CTSA from NCATS/NIH; NIH from NIGMS/OD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from NHGRI/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Ingram Cancer Center; Vanderbilt Vision Center; Rheumatology Research Foundation; American Heart Association(American Heart Association); Vanderbilt Faculty Research Scholar Fund; Vanderbilt National Center for Advancing Translational Science from NCATS/NIH; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The project was supported NIH grant P50 GM115305, R01 HL133786, R01 GM120523, T32 GM007347 from the National Institute of General Medical Studies for the Vanderbilt Medical -Scientist Training Program, 18AMTG34280063 from American Heart Association and T15 LM007450 from the National Library of Medicine for the Vanderbilt Biomedical Informatics Training Program. The dataset used in the analyses described were obtained from Vanderbilt University Medical Centers BioVU which is supported by institutional funding and by the CTSA grant ULTR000445 from NCATS/NIH. Genome-wide genotyping was funded by NIH grants RC2GM092618 from NIGMS/OD and U01HG004603 from NHGRI/NIGMS. The dataset (s) used for the analyses described were obtained from Vanderbilt University Medical Center's BioVU which is supported by institutional funding, the 1S10RR025141-01 instrumentation award, and by the CTSA grant UL1TR000445 from NCATS/NIH. The authors wish to acknowledge the expert technical support of the VANTAGE and VANGARD core facilities, supported in part by the Vanderbilt Ingram Cancer Center (P30 CA068485) and Vanderbilt Vision Center (P30 EY08126). This study was supported by GM120523, GM109145, HL133786, 5T32GM080178-09, K23AR064768, Rheumatology Research Foundation (k-supplement), American Heart Association (18AMTG34280063, 16SDG27490014 and 15MCPRP25620006), HG008672, R01 LM010685, GM115305 and Vanderbilt Faculty Research Scholar Fund. The dataset used for the analyses described were obtained from Vanderbilt University Medical Center's resources, BioVU and the Synthetic Derivative, which are supported by institutional funding and by the Vanderbilt National Center for Advancing Translational Science grant 2UL1 TR000445-06 from NCATS/NIH. Existing genotypes in BioVU were funded by NIH grants RC2GM092618 from NIGMS/OD and U01HG004603 from NHGRI/NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Backenroth D, 2018, AM J HUM GENET, V102, P920, DOI 10.1016/j.ajhg.2018.03.026; Barlera S, 2007, EUR J HUM GENET, V15, P221, DOI 10.1038/sj.ejhg.5201732; Berglund L, 2004, ARTERIOSCL THROM VAS, V24, P2219, DOI 10.1161/01.ATV.0000144010.55563.63; Bioucas-Dias JM, 2005, INT SOC OPTICS PHOTO, DOI [10.1117/12.620061, DOI 10.1117/12.620061]; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Cha YC, 2012, SIGIR 2012: PROCEEDINGS OF THE 35TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P565, DOI 10.1145/2348283.2348360; Chan KR, 2013, INT CONF DAT MIN WOR, P56, DOI 10.1109/ICDMW.2013.91; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Denny JC, 2018, CLIN PHARMACOL THER, V103, P409, DOI 10.1002/cpt.951; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Greene Derek, 2014, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2014. Proceedings: LNCS 8724, P498, DOI 10.1007/978-3-662-44848-9_32; Huang ZX, 2015, J BIOMED INFORM, V58, P28, DOI 10.1016/j.jbi.2015.09.005; Kanagal B, RANK SELECTION LOW R, P5; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Kim H, 2007, BIOINFORMATICS, V23, P1495, DOI 10.1093/bioinformatics/btm134; Limestone, HIGH THROUGHPUT CAND; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; Liu L, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3252-8; MacMillan K, 2017, ARXIV170605084CSSTAT; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; MARTIN PA, 1970, CYTOGENETICS, V9, P360, DOI 10.1159/000130105; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McCoy TH, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.201; McCoy TH, 2017, MOL MED, V23, P285, DOI 10.2119/molmed.2017.00100; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; O'Callaghan D, 2015, EXPERT SYST APPL, V42, P5645, DOI 10.1016/j.eswa.2015.02.055; Pinoli P., 2013, 2013 IEEE 13 INT C B, V92, P1, DOI DOI 10.1109/BIBE.2013.6701702; SANDHOLZER C, 1991, HUM GENET, V86, P607; Sra S., 2006, ADV NEURAL INFORM PR, V18, P283; Stevens K., 2012, P 2012 JOINT C EMP M; Tan VYF, 2013, IEEE T PATTERN ANAL, V35, P1592, DOI 10.1109/TPAMI.2012.240; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vosecky J, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P879, DOI 10.1145/2505515.2505593; Wahabzada M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22482; Warner JL, 2015, J AM MED INFORM ASSN, V22, P324, DOI 10.1136/amiajnl-2014-002965; Wei WQ, 2018, CIRCULATION, V138, P1839, DOI 10.1161/CIRCULATIONAHA.117.031356; Wei WQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175508; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Ye SY, 2014, CANCER INFORM, V13, P85, DOI [10.4137/CIN.s16354, 10.4137/CIN.S16354]; Zhao WNX, 2011, LECT NOTES COMPUT SC, V6611, P338, DOI 10.1007/978-3-642-20161-5_34	46	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0212112	10.1371/journal.pone.0212112	http://dx.doi.org/10.1371/journal.pone.0212112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759150	gold, Green Submitted, Green Published			2022-12-26	WOS:000458761300074
J	Vignani, R; Lio, P; Scali, M				Vignani, Rita; Lio, Pietro; Scali, Monica			How to integrate wet lab and bioinformatics procedures for wine DNA admixture analysis and compositional profiling: Case studies and perspectives	PLOS ONE			English	Article							VITIS-VINIFERA; COMMERCIAL WINES; FOOD; GRAPE; EXTRACTION; MARKERS; PCR; IDENTIFICATION; ANTHOCYANINS; TECHNOLOGY	The varietal authentication of wines is fundamental for assessing wine quality, and it is part of its compositional profiling. The availability of historical, cultural and chemical composition information is extremely important for quality evaluation. DNA-based techniques are a powerful tool for proving the varietal composition of a wine. SSR-amplification of genomic residual Vitis vinifera DNA, namely Wine DNA Fingerprinting (WDF) is able to produce strong, analytical evidence concerning the monovarietal nature of a wine, and for blended wines by generating the probability of the presence/absence of a certain variety, all in association with a dedicated bioinformatics elaboration of genotypes associated with possible varietal candidates. Together with WDF we could exploit Bioinformatics techniques, due to the number of grape genomes grown. In this paper, the use of WDF and the development of a bioinformatics tool for allelic data validation, retrieved from the amplification of 7 to 10 SSRs markers in the Vitis vinifera genome, are reported. The wines were chosen based on increasing complexity; from monovarietal, experimental ones, to commercial monovarietals, to blended commercial wines. The results demonstrate that WDF, after calculation of different distance matrices and Neighbor-Joining input data, followed by Principal Component Analysis (PCA) can effectively describe the varietal nature of wines. In the unknown blended wines the WDF profiles were compared to possible varietal candidates (Merlot, Pinot Noir, Cabernet Sauvignon and Zinfandel), and the output graphs show the most probable varieties used in the blend as closeness to the tested wine. This pioneering work should be meant as to favor in perspective the multidisciplinary building-up of on-line databanks and bioinformatics toolkits on wine. The paper concludes with a discussion on an integrated decision support system based on bioinformatics, chemistry and cultural data to assess wine quality.	[Vignani, Rita; Scali, Monica] Univ Siena, Dept Life Sci, Siena, Italy; [Vignani, Rita] Serge Genom, Siena, Italy; [Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge, England	University of Siena; University of Cambridge	Vignani, R (corresponding author), Univ Siena, Dept Life Sci, Siena, Italy.; Vignani, R (corresponding author), Serge Genom, Siena, Italy.	rita.vignani@unisi.it	Scali, Monica/Q-7554-2016; P. Lió, Pietro Lio/AAV-3358-2021; vignani, rita/P-3829-2014	Scali, Monica/0000-0002-8551-8823; P. Lió, Pietro Lio/0000-0002-0540-5053; vignani, rita/0000-0002-7024-5965	Alcohol and Tobacco Tax and Trade Bureau (USA); Amministrazione Provinciale di Siena, Italy; Consorzio della Denominazione San Gimignano; Azienda Biologica Costa degli Ulivi, Fumane, Verona, Italy	Alcohol and Tobacco Tax and Trade Bureau (USA); Amministrazione Provinciale di Siena, Italy; Consorzio della Denominazione San Gimignano; Azienda Biologica Costa degli Ulivi, Fumane, Verona, Italy	The present work was co-funded by multiple public and private Entities and wine producers, depending on the wine type. The molecular analysis on wines from the American market was carried out with the essential and constant support offered by the Alcohol and Tobacco Tax and Trade Bureau (USA) under the research projects: "Wine varietal characterization by DNA analysis", part I, II, and III (2009-2016); by the Regione Toscana, under the Winefinger project: (2014-2016); by several Tuscan wine makers, namely: Case Basse, Caprili, Le Potazzine and Col D'Orcia, Montalcino, Siena, Italy that cooperated and supported the research done within the Winefinger actions. We are grateful to the Amministrazione Provinciale di Siena, Italy and to the Consorzio della Denominazione San Gimignano for their support and participation in the study. We also thank the Azienda Agricola Mantellassi, Magliano in Toscana, Grosseto, Italy for letting us characterize their Alicante collections and wines. Finally, the research was supported by the wine maker Azienda Biologica Costa degli Ulivi, Fumane, Verona, Italy. The Serge-genomics company contributed to the present work by supplying research materials, only. Serge-genomics did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adam-Blondon AF, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.56; Agrimonti C, 2018, EUR FOOD RES TECHNOL, V244, P2127, DOI 10.1007/s00217-018-3121-5; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Alonso A, 2004, FORENSIC SCI INT, V139, P141, DOI 10.1016/j.forsciint.2003.10.008; Angione C, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0912-1; [Anonymous], GUARDIAN; Arapitsas P, 2012, J AGR FOOD CHEM, V60, P10461, DOI 10.1021/jf302617e; Basalekou M, 2016, CURR RES NUTR FOOD S, V4, P54, DOI 10.12944/CRNFSJ.4.Special-Issue-October.08; Bessekri MW, 2015, FORENS SCI INT-GEN S, V5, pE360, DOI 10.1016/j.fsigss.2015.09.143; Bianconi G, 2018, MULTILAYER NETWORKS: STRUCTURE AND FUNCTION, DOI 10.1093/oso/9780198753919.001.0001; Bigliazzi J., 2011, THESIS; Bigliazzi J, 2012, AM J ENOL VITICULT, V63, P568, DOI 10.5344/ajev.2012.12014; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Bottero MT, 2011, VET J, V190, P34, DOI 10.1016/j.tvjl.2010.09.024; Bowers JE, 1999, AM J ENOL VITICULT, V50, P243; Carimi F, 2011, GENET RESOUR CROP EV, V58, P967, DOI 10.1007/s10722-011-9731-4; Catalano V, 2016, J AGR FOOD CHEM, V64, P6969, DOI 10.1021/acs.jafc.6b02560; Chen D-G, 2017, ICSA BOOK SERIES STA, DOI [10.1007/978-981-10-5194-4, DOI 10.1007/978-981-10-5194-4]; Chen ZD, 1999, AM J BOT, V86, P1168, DOI 10.2307/2656981; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Di Bernardo G, 2007, BIOTECHNOL PROGR, V23, P297, DOI 10.1021/bp060182m; Di Genova A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-7; Di Stefano A, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006714; Dimitri GM, 2017, COMPUT BIOL CHEM, V68, P204, DOI 10.1016/j.compbiolchem.2017.03.008; Estrada E, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042819; Faria MA, 2000, J AGR FOOD CHEM, V48, P1096, DOI 10.1021/jf990837h; Gambino G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17405-y; Garcia-Beneytez E, 2003, J AGR FOOD CHEM, V51, P5622, DOI 10.1021/jf0302207; Garcia-Beneytez E, 2002, J AGR FOOD CHEM, V50, P6090, DOI 10.1021/jf0202077; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; He F, 2012, MOLECULES, V17, P1571, DOI 10.3390/molecules17021571; Isci B, 2014, J I BREWING, V120, P238, DOI 10.1002/jib.129; Kalmar T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e67; Khalilia M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-51; Kingsford C, 2008, NAT BIOTECHNOL, V26, P1011, DOI 10.1038/nbt0908-1011; Laucou V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192540; Liepelt S, 2006, ANN BOT-LONDON, V98, P1107, DOI 10.1093/aob/mcl188; Lleixa J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00338; Madkour S, 2017, EGYPT J FORENSIC SCI, V7, DOI 10.1186/s41935-017-0008-8; Mangani S, 2011, AM J ENOL VITICULT, V62, P487, DOI 10.5344/ajev.2011.11047; Martinez-Lopez J, 2014, BLOOD, V123, P3073, DOI 10.1182/blood-2014-01-550020; Martinez-Rodriguez Adolfo J., 2009, P61, DOI 10.1007/978-0-387-74118-5_3; McCord B., 2011, INVESTIGATION EFFECT; Meyer R, 1996, Z LEBENSM UNTERS FOR, V203, P339, DOI 10.1007/BF01231072; Momcilovic D, 2000, J FOOD PROTECT, V63, P1602, DOI 10.4315/0362-028X-63.11.1602; Moreira L, 2016, SENSOR ACTUAT B-CHEM, V234, P92, DOI 10.1016/j.snb.2016.04.105; Moreno-Arribas M. V., 2009, WINE CHEM BIOCH; Munoz-Gonzalez C, 2011, ANAL BIOANAL CHEM, V401, P1497, DOI 10.1007/s00216-011-5078-0; Munsie JA, 2002, BRIEF HIST INT REGUL; Pennington N, 2007, ACS SYM SER, V952, P180, DOI [10.1021/bk-2007-0952.ch012, DOI 10.1021/BK-2007-0952.CH012]; Pereira L, 2018, FOOD RES INT, V103, P170, DOI 10.1016/j.foodres.2017.10.026; Perez-Jimenez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070507; Rodriguez-Bencomo J. J., 2012, HDB PLANT BASED FERM; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savazzini F, 2006, ANAL CHIM ACTA, V563, P274, DOI 10.1016/j.aca.2005.10.078; Scali M., 2014, Advances in Bioscience and Biotechnology, V5, P142, DOI 10.4236/abb.2014.52018; Scarano D., 2014, Diversity, V6, P579; Sefc KM, 1999, GENOME, V42, P367, DOI 10.1139/gen-42-3-367; Sefc KM, 2000, THEOR APPL GENET, V100, P498, DOI 10.1007/s001220050065; Siret R, 2002, J AGR FOOD CHEM, V50, P3822, DOI 10.1021/jf011462e; Spinger AE, 2014, J AGR FOOD CHEM, V62, P6844, DOI [10.1021/jf502042c, DOI 10.1021/JF502042C]; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tempere S, 2018, APPL MICROBIOL BIOT, V102, P3995, DOI 10.1007/s00253-018-8914-8; This P, 2006, ACS SYM SER, V952, P207, DOI [10.1021/bk-2007-0952.ch014, DOI 10.1021/BK-2007-0952.CH014]; THOMAS MR, 1993, THEOR APPL GENET, V86, P985, DOI 10.1007/BF00211051; Timothy W, REV CURRENT EMERGING; Velickovic P, 2016, J COMPLEX NETW, V4, P561, DOI 10.1093/comnet/cnv029; Vignani R, 2016, ACTA ITALUS HORTUS, V19, P209; Villano C, 2017, FOOD CONTROL, V80, P1, DOI 10.1016/j.foodcont.2017.04.020; Wagner H, 1999, IDENTITY 1 0 CENTRE; Welke JE, 2013, FOOD CHEM, V141, P3897, DOI 10.1016/j.foodchem.2013.06.100; Woods R, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110312; Woolfe M, 2004, TRENDS BIOTECHNOL, V22, P222, DOI 10.1016/j.tibtech.2004.03.010	73	7	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211962	10.1371/journal.pone.0211962	http://dx.doi.org/10.1371/journal.pone.0211962			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753217	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600035
J	Heine, V; Meinert-Berning, C; Luck, J; Mikowsky, N; Voigt, B; Riedel, K; Steinbuchel, A				Heine, Viktoria; Meinert-Berning, Christina; Lueck, Janina; Mikowsky, Nadine; Voigt, Birgit; Riedel, Katharina; Steinbuechel, Alexander			The catabolism of 3,3 '-thiodipropionic acid in Variovorax paradoxus strain TBEA6: A proteomic analysis	PLOS ONE			English	Article							ENOYL-COA HYDRATASE; RALSTONIA-EUTROPHA H16; COENZYME-A COA; ADVENELLA-MIMIGARDEFORDENSIS; MICROBIAL POLYTHIOESTERS; PHYSICAL-PROPERTIES; DEHYDROGENASE; TRANSFERASE; POLY(3-MERCAPTOPROPIONATE); IDENTIFICATION	Variovorax paradoxus strain TBEA6 is one of the few organisms known to utilize 3,3'-thiodipropionate (TDP) as the only source of carbon and energy. It cleaves TDP to 3-mercapto-propionate (3MP), which is a direct precursor for polythioester synthesis. To establish this process in V. paradoxus TBEA6, it is crucial to unravel its TDP metabolism. Therefore, a proteomic approach with subsequent deletion of interesting genes in the bacterium was chosen. Cells were cultivated with D-gluconate, TDP or 3-sulfinopropionate as the only carbon sources. Proteins with high abundances in gels of cells cultivated with either of the organic sulfur compounds were analyzed further. Thereby, we did not only confirm parts of the already postulated TDP metabolism, but also eight new protein candidates for TDP degradation were detected. Deletions of the corresponding genes (two enoyl-CoA hydratases (Ech-20 and Ech-30), an FK506-binding protein, a putative acetolactate synthase, a carnitinyl-CoA dehydratase, and a putative crotonase family protein) were obtained. Only the deletions of both Ech-20 and Ech-30 led to a TDP negative phenotype. The deletion mutant of VPARA_05510, which encodes the putative crotonase family protein showed reduced growth with TDP. The three genes are located in one cluster with genes proven to be involved in TDP metabolism. Thermal shift assays showed an increased stability of Ech-20 with TDP-CoA but not with TDP. These results indicate that Ech-20 uses TDP-CoA as a substrate instead of TDP. Hence, we postulate a new putative pathway for TDP metabolism. Ech-30 interacts with neither TDP-CoA nor TDP but might interact with other CoA-activated intermediates of the proposed pathway. Further enzyme characterization is necessary to unravel the complete pathway from TDP to 3MP.	[Heine, Viktoria; Meinert-Berning, Christina; Lueck, Janina; Mikowsky, Nadine; Steinbuechel, Alexander] Westfalische Wilhelms Univ, Inst Mol Mikrobiol & Biotechnol, Munster, Germany; [Voigt, Birgit; Riedel, Katharina] Ernst Moritz Arndt Univ Greifswald, Inst Mikrobiol, Greifswald, Germany; [Steinbuechel, Alexander] King Abdulaziz Univ, Environm Sci Dept, Jeddah, Saudi Arabia; [Heine, Viktoria] Rheinisch Westfalische Tech Hsch Aachen, Lehr & Forsch Gebiet Biomat, Aachen, Germany	University of Munster; Ernst Moritz Arndt Universitat Greifswald; King Abdulaziz University; RWTH Aachen University	Steinbuchel, A (corresponding author), Westfalische Wilhelms Univ, Inst Mol Mikrobiol & Biotechnol, Munster, Germany.; Steinbuchel, A (corresponding author), King Abdulaziz Univ, Environm Sci Dept, Jeddah, Saudi Arabia.	steinbu@uni-muenster.de	Heine, Viktoria/AAU-8052-2021	Heine, Viktoria/0000-0002-8667-3059; Meinert-Berning, Christina/0000-0002-4438-9447; Riedel, Katharina/0000-0002-4629-3019	Deutsche Forschungsgesellschaft DFG [STE386/1-12]; Open Access Publication Fund of the University of Muenster	Deutsche Forschungsgesellschaft DFG(German Research Foundation (DFG)); Open Access Publication Fund of the University of Muenster	The study was funded by the Deutsche Forschungsgesellschaft DFG (Grant Number: STE386/1-12 to AS) and the Open Access Publication Fund of the University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri G, 2003, BIOORGAN MED CHEM, V11, P9, DOI 10.1016/S0968-0896(02)00333-4; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; Baker-Malcolm JF, 1998, BIOCHEMISTRY-US, V37, P1383, DOI 10.1021/bi972415b; Baker-Malcolm JF, 2000, BIOCHEMISTRY-US, V39, P12007, DOI 10.1021/bi0010165; Brandt U, 2014, ENVIRON MICROBIOL, V16, P3370, DOI 10.1111/1462-2920.12340; Brandt U, 2014, APPL MICROBIOL BIOT, V98, P6039, DOI 10.1007/s00253-014-5811-7; Bruggeman C, 2004, MICROBIOL-SGM, V150, P805, DOI 10.1099/mic.0.26795-0; Bruland N, 2009, J BIOL CHEM, V284, P660, DOI 10.1074/jbc.M806762200; Dahl C, 2013, MICROBIOL-SGM, V159, P2626, DOI 10.1099/mic.0.071019-0; Doberstein C, 2014, J BIOTECHNOL, V184, P187, DOI 10.1016/j.jbiotec.2014.05.022; DORDINE RL, 1994, BIOCHEMISTRY-US, V33, P14733, DOI 10.1021/bi00253a011; Eggers J, 2013, J BACTERIOL, V195, P3213, DOI 10.1128/JB.00358-13; Elssner T, 2001, BIOCHEMISTRY-US, V40, P11140, DOI 10.1021/bi0108812; FITZSIMMONS ME, 1995, BIOCHEMISTRY-US, V34, P4276, DOI 10.1021/bi00013a017; FRIEDRICH B, 1981, J BACTERIOL, V147, P198, DOI 10.1128/JB.147.1.198-205.1981; Kawada J, 2003, BIOMACROMOLECULES, V4, P1698, DOI 10.1021/bm0341327; Kim DY, 2005, BIOMACROMOLECULES, V6, P897, DOI 10.1021/bm049334x; Lindenkamp N, 2013, APPL MICROBIOL BIOT, V97, P7699, DOI 10.1007/s00253-012-4624-9; Lutke-Eversloh T, 2004, MACROMOL BIOSCI, V4, P165, DOI 10.1002/mabi.200300084; Lutke-Eversloh T, 2003, FEMS MICROBIOL LETT, V221, P191, DOI 10.1016/S0378-1097(03)00185-X; Lutke-Eversloh T, 2002, BIOMACROMOLECULES, V3, P159, DOI 10.1021/bm015603x; Lutke-Eversloh T, 2001, BIOMACROMOLECULES, V2, P1061, DOI 10.1021/bm015564p; Meinert C, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny011; Meinert C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174256; Nolte JC, 2014, APPL ENVIRON MICROB, V80, P166, DOI 10.1128/AEM.03075-13; Potter M, 2005, MICROBIOL-SGM, V151, P825, DOI 10.1099/mic.0.27613-0; Rein U, 2005, MICROBIOL-SGM, V151, P737, DOI 10.1099/mic.0.27548-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHLEGEL HG, 1961, ARCH MIKROBIOL, V38, P209, DOI 10.1007/BF00422356; Schurmann M, 2014, J BACTERIOL, V196, P882, DOI 10.1128/JB.01265-13; Schurmann M, 2013, J BACTERIOL, V195, P3761, DOI 10.1128/JB.00456-13; Schurmann M, 2013, J BACTERIOL, V195, P1538, DOI 10.1128/JB.02105-12; Schurmann M, 2011, J BACTERIOL, V193, P3078, DOI 10.1128/JB.00049-11; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Steinbuchel A, 2005, CURR OPIN BIOTECH, V16, P607, DOI 10.1016/j.copbio.2005.10.011; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thakor N, 2005, APPL ENVIRON MICROB, V71, P835, DOI 10.1128/AEM.71.2.835-841.2005; Vivoli Mirella, 2014, J Vis Exp, P51809, DOI 10.3791/51809; Volodina E, 2014, APPL MICROBIOL BIOT, V98, P3579, DOI 10.1007/s00253-013-5222-1; WERBER FX, 1952, J AM CHEM SOC, V74, P532, DOI 10.1021/ja01122a075; WILLADSEN P, 1975, EUR J BIOCHEM, V54, P247, DOI 10.1111/j.1432-1033.1975.tb04134.x; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Wubbeler JH, 2015, J BIOTECHNOL, V209, P85, DOI 10.1016/j.jbiotec.2015.06.390; Wubbeler JH, 2014, CURR OPIN BIOTECH, V29, P85, DOI 10.1016/j.copbio.2014.02.017; Xia YZ, 2012, APPL ENVIRON MICROB, V78, P3286, DOI 10.1128/AEM.00007-12; Yang M, 2014, ACS CHEM BIOL, V9, P2632, DOI 10.1021/cb500232h	46	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211876	10.1371/journal.pone.0211876	http://dx.doi.org/10.1371/journal.pone.0211876			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742653	gold, Green Submitted, Green Published			2022-12-26	WOS:000458393400028
J	Pillai, N; Foster, N; Hanifa, Y; Ndlovu, N; Fielding, K; Churchyard, G; Chihota, V; Grant, AD; Vassall, A				Pillai, Natasha; Foster, Nicola; Hanifa, Yasmeen; Ndlovu, Nontobeko; Fielding, Katherine; Churchyard, Gavin; Chihota, Violet; Grant, Alison D.; Vassall, Anna			Patient costs incurred by people living with HIV/AIDS prior to ART initiation in primary healthcare facilities in Gauteng, South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; TUBERCULOSIS DIAGNOSIS; BARRIERS; THERAPY; ADHERENCE; ENABLERS; TIME	Purpose To quantify costs to patients of accessing HIV care prior to ART initiation. Materials and methods Using a cross-sectional study design, costs incurred by HIV-positive patients prior to ART initiation were estimated at urban primary healthcare facilities in South Africa. Costs included direct costs, indirect (productivity) costs, carer and coping costs (value of assets sold and money borrowed). The percentage of individual income spent on healthcare was calculated and compared by patient income tertiles and CD4 count strata. Results 289 patients (69% female, mean age 37 (SD: 10) years, median CD4 317 (IQR: 138-494) cells/mm(3)) were interviewed. The total mean monthly cost of pre-ART care was US$15.71. Indirect costs accounted for $2.59 (16.49%) of this when time was valued using the patient's reported income. The mean monthly patient costs were $31.61, $12.78, $12.65 and $11.93 for those with a CD4 count <100, 101-350, 351-500 and >500 cells/mm(3) respectively. The percentage of individual income spent on healthcare was 7.25% for those with a CD4 count <100 cells/mm(3) and 4.05% for those with a CD4 count >500 cells/mm(3). Conclusions Despite the provision of charge-free services at public clinics, care prior to ART initiation can be costly, particularly for the poor and unemployed. Our study adds to the growing body of evidence that highlights the need to consider policies to reduce the economic barriers to HIV service access, particularly for low income or unwell patient groups, such as improving access to disability grants.	[Pillai, Natasha; Vassall, Anna] London Sch Hyg & Trop Med, Social & Math Epidemiol, London, England; [Foster, Nicola] Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Econ Unit, Cape Town, South Africa; [Hanifa, Yasmeen; Grant, Alison D.] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Ndlovu, Nontobeko; Churchyard, Gavin; Chihota, Violet] Aurum Inst, Johannesburg, South Africa; [Fielding, Katherine; Churchyard, Gavin] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Fielding, Katherine; Churchyard, Gavin; Chihota, Violet; Grant, Alison D.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Grant, Alison D.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Africa Hlth Res Inst, Durban, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; Africa Health Research Institute; University of Kwazulu Natal	Vassall, A (corresponding author), London Sch Hyg & Trop Med, Social & Math Epidemiol, London, England.	Anna.Vassall@lshtm.ac.uk	Chihota, Violet/DWH-9372-2022; Foster, Nicola/AAA-9040-2020	Foster, Nicola/0000-0003-4630-6243; Chihota, Violet/0000-0003-1444-9266; Churchyard, Gavin/0000-0002-4269-3699; Vassall, Anna/0000-0002-2911-1375	Bill and Melinda Gates Foundation [OPP1034523]; Medical Research Council of South Africa; Public Health Enhancement Fund; MRC [MR/R010161/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council of South Africa(South African Medical Research Council); Public Health Enhancement Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This paper is part of the XPHACTOR study, funded by the Bill and Melinda Gates Foundation (Grant OPP1034523). In addition, NF is a PhD student, funded by the Medical Research Council of South Africa in terms of the National Health Scholars Programme from funds provided by the Public Health Enhancement Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspler A, 2008, INT J TUBERC LUNG D, V12, P928; Ataguba JEO, 2012, HEALTH ECON POLICY L, V7, P309, DOI 10.1017/S1744133110000356; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Bor J, 2012, HEALTH AFFAIR, V31, P1459, DOI 10.1377/hlthaff.2012.0407; C Arndt JDL, 2000, S AFRICAN J EC, V68, P857, DOI [10.1111/j.1813-6982.2000.tb01283.x, DOI 10.1111/J.1813-6982.2000.TB01283.X]; Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; Department of Labour Republic of South Africa, 2013, NON TRADITIONAL REF; Derek Yu AB, 2012, NON TRADITIONAL REF; du Toit E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096867; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Fox MP, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-8; Goudge J, 2007, SCAND J PUBLIC HEALT, V35, P181, DOI 10.1080/14034950701355551; Govender V, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0870-8; Hanifa Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181519; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Ingle SM, 2010, AIDS, V24, P2717, DOI 10.1097/QAD.0b013e32833fb71f; Kik SV, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-283; Mauch V, 2013, INT J TUBERC LUNG D, V17, P381, DOI 10.5588/ijtld.12.0368; Mauch V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-43; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Moshabela M, 2011, AIDS BEHAV, V15, P842, DOI 10.1007/s10461-010-9747-3; National Department of Health SA, 2015, NON TRADITIONAL REF; Onwujekwe O, 2010, TROP MED INT HEALTH, V15, P18, DOI 10.1111/j.1365-3156.2009.02418.x; Patcharanarumol W, 2012, SE ASIAN J TROP MED, V43, P1521; Peltzer K, 2011, AFR J TRADIT COMPLEM, V8, P337, DOI 10.4314/ajtcam.v8i4.1; Rosen S, 2008, AIDS, V22, pS131, DOI 10.1097/01.aids.0000327634.92844.91; Rosen S, 2007, SAMJ S AFR MED J, V97, P524; Russell S, 1996, HEALTH POLICY PLANN, V11, P219, DOI 10.1093/heapol/11.3.219; Sagbakken M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-11; Shisana O, 2014, S AFRICAN NATL HIV P; Sinanovic E, 2003, INT J TUBERC LUNG D, V7, pS56; Statistics South Africa, 2014, NON TRADITIONAL REF; van Loggerenberg F, 2015, AIDS PATIENT CARE ST, V29, P299, DOI 10.1089/apc.2014.0293; Vassall A, 2010, INT J TUBERC LUNG D, V14, P604; WHO, 2015, IMM PRACT PRACT GUID, P91	37	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0210622	10.1371/journal.pone.0210622	http://dx.doi.org/10.1371/journal.pone.0210622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL0OI	30742623	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000458393400010
J	Nelson, E; Fitzgerald, J; Tefft, N				Nelson, Erik; Fitzgerald, John; Tefft, Nathan			The distributional impact of a green payment policy for organic fruit	PLOS ONE			English	Article							CONSUMER PERCEPTIONS; CENSORED SYSTEM; DEMAND SYSTEMS; CONSUMPTION; FOODS; AGRICULTURE; INFORMATION; LIKELIHOOD; BEHAVIOR; FARMERS	Consumer spending on organic food products has grown rapidly. Some claim that organics have ecological, equity, and health advantages over conventional food and therefore should be subsidized. Here we explore the distributive impacts of an organic fruit subsidy that reduces the retail price of organic fruit in the US by 10 percent. We estimate the impact of the subsidy on organic fruit demand in a representative poor, middle income, and rich US household using three analytical methods; including two econometric and one machine learning. We do not find strong evidence of regressive redistribution due to our simulated organic fruit subsidy; the poor household's relative reaction to the subsidy is not much different than the reaction at the other two households. However, the infra-marginal savings from the subsidy tend to be larger in richer households.	[Nelson, Erik; Fitzgerald, John] Bowdoin Coll, Dept Econ, Brunswick, ME 04011 USA; [Tefft, Nathan] Bates Coll, Dept Econ, Lewiston, ME 04240 USA	Bowdoin College	Nelson, E (corresponding author), Bowdoin Coll, Dept Econ, Brunswick, ME 04011 USA.	enelson2@bowdoin.edu	Nelson, Erik J./J-4192-2019	Nelson, Erik J./0000-0002-7291-5192				Acemoglu D, 2016, J POLIT ECON, V124, P52, DOI 10.1086/684511; Allcott H, 2018, 3631 GRAD SCH BUS ST; American Public Health Association (APHA), 2007, TOWARD A HEALTHY SUS; Aschemann-Witzel J, 2017, J CONSUM AFF, V51, P211, DOI 10.1111/joca.12092; Bajari P., 2015, DEMAND ESTIMATION MA; Barbose GL, 2018, LBNL REPORT LBNL 200; Baudry J, 2018, JAMA INTERN MED, V178, P1597, DOI 10.1001/jamainternmed.2018.4357; Berentsen PBM, 2016, EUR J AGRON, V79, P100, DOI 10.1016/j.eja.2016.06.002; Biing-Hwan Lin, 2009, Sustainability, V1, P464, DOI 10.3390/su1030464; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Clark M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6cd5; Cotti C, 2016, AM ECON J-ECON POLIC, V8, P103, DOI 10.1257/pol.20150268; Crinnion WJ, 2010, ALTERN MED REV, V15, P4; Crowder DW, 2015, P NATL ACAD SCI USA, V112, P7611, DOI 10.1073/pnas.1423674112; Dangour AD, 2010, AM J CLIN NUTR, V92, P203, DOI 10.3945/ajcn.2010.29269; Delbridge T.A., 2017, CHOICES, V32, P1, DOI [DOI 10.22004/AG.ECON.267041, 10.22004/ag.econ.267041]; Delbridge TA, 2016, J AGR RESOUR ECON, V41, P481; Delbridge TA, 2011, AGRON J, V103, P1372, DOI 10.2134/agronj2011.0371; Dimitri C, 2002, USDA AGR INFORM B, P1; Dimitri C, 2006, AMBER WAVES; Dimitri C, 2017, J FOOD PROD MARK, V23, P221, DOI 10.1080/10454446.2015.1048023; El-Hage Scialabba N, 2013, CROP MANAGEMENT, V12; FABIOSA J.F, 2003, PAPER PRESENTED AT A; Fang C, 2002, J COMP ECON, V30, P732, DOI 10.1006/jcec.2002.1796; Gardebroek C, 2006, EUR REV AGRIC ECON, V33, P485, DOI 10.1093/erae/jbl029; Gattinger A, 2012, P NATL ACAD SCI USA, V109, P18226, DOI 10.1073/pnas.1209429109; Goodstein ES, 2014, ECONOMICS AND THE EN; Gorzelany, 2014, FORBES; Hallam D, 2003, ORGANIC AGRICULTURE: SUSTAINABILITY, MARKETS AND POLICIES, P179, DOI 10.1079/9780851997407.0179; Hastings J, 2010, AM ECON J-ECON POLIC, V2, P142, DOI 10.1257/pol.2.2.142; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Holzman DC, 2012, ENVIRON HEALTH PERSP, V120, pA458, DOI 10.1289/ehp.120-a458; Hsieh MF, 2012, AM J AGR ECON, V94, P307, DOI 10.1093/ajae/aar100; Hughner R.S., 2007, J CONSUM BEHAV, V6, P94, DOI 10.1002/cb.210; Jansson J, 2017, J CLEAN PROD, V154, P176, DOI 10.1016/j.jclepro.2017.03.186; Johansson E, 2014, INT J ENV RES PUB HE, V11, P3870, DOI 10.3390/ijerph110403870; Kasteridis P, 2012, AUST J AGR RESOUR EC, V56, P405, DOI 10.1111/j.1467-8489.2012.00589.x; Kilts Nielsen Center, KILTS NIELSEN CONSUM; Kotchen MJ, 2007, J ENVIRON ECON MANAG, V53, P1, DOI 10.1016/j.jeem.2006.06.003; Kuminoff NV, 2010, J AGR ECON, V61, P240, DOI 10.1111/j.1477-9552.2009.00235.x; LaFrance JT, 2002, J ECONOMETRICS, V107, P235, DOI 10.1016/S0304-4076(01)00122-1; LAFRANCE JT, 1989, AM J AGR ECON, V71, P262, DOI 10.2307/1241583; LAFRANCE JT, 1990, AUST J AGR ECON, V34, P118, DOI 10.1111/j.1467-8489.1990.tb00697.x; LAIRON D, 2010, AGRON SUSTAIN DEV, V30, P33, DOI DOI 10.1051/AGRO/2009019; Lam LT, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaab70; Lockeretz W, 2003, ORGANIC AGRICULTURE: SUSTAINABILITY, MARKETS AND POLICIES, P239, DOI 10.1079/9780851997407.0239; MacRae RJ, 2007, CAN J PLANT SCI, V87, P1037, DOI 10.4141/CJPS07135; Mauleon I, 2017, ENERGY, V137, P1054, DOI 10.1016/j.energy.2017.03.109; Meemken EM, 2018, ANNU REV RESOUR ECON, V10, P39, DOI 10.1146/annurev-resource-100517-023252; Monier S., 2009, Journal of Agricultural & Food Industrial Organization, V7, P12, DOI 10.2202/1542-0485.1269; Nelson T, 2011, ECON ANAL POLICY, V41, P113, DOI 10.1016/S0313-5926(11)50015-3; Pearson D, 2011, RENEW AGR FOOD SYST, V26, P171, DOI 10.1017/S1742170510000499; Seufert V, 2017, FOOD POLICY, V68, P10, DOI 10.1016/j.foodpol.2016.12.009; Shonkwiler JS, 1999, AM J AGR ECON, V81, P972, DOI 10.2307/1244339; Smith T. A., 2009, Journal of Agricultural and Applied Economics, V41, P731; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Sorensen O, 2015, STAT SINICA, V25, P809, DOI 10.5705/ss.2013.180; Sumane S, 2018, J RURAL STUD, V59, P232, DOI 10.1016/j.jrurstud.2017.01.020; Thompson GD, 1998, AM J AGR ECON, V80, P277, DOI 10.2307/1244500; Tuck SL, 2014, J APPL ECOL, V51, P746, DOI 10.1111/1365-2664.12219; U. S. Department of Agriculture-Economic Research Service (USDA-ERS), ORGANIC MARKET OVERV; Uematsu H, 2012, ECOL ECON, V78, P55, DOI 10.1016/j.ecolecon.2012.03.013; US Department of Agriculture-Economic Research Service (USDA-ERS), ORGANIC PRICES; US Department of Agriculture-National Agricultural Statistics Service (USDA-NASS), 2012, SPECIAL STUDIES PART, V3; US Department of Agriculture-National Agricultural Statistics Service (USDA-NASS), 2015, ORGANIC FARMING RESU; US Energy Information Administration (USEIA), 2018, TODAY IN ENERGY ELEC; USDA ERS, RURAL URBAN CONTINUU; USDA NASS Quick Stats, QUICK STATS; Varian HR, 2014, J ECON PERSPECT, V28, P3, DOI 10.1257/jep.28.2.3; Wilcox C, 2012, NY TIMES; Winter CK, 2006, J FOOD SCI, V71, pR117, DOI 10.1111/j.1750-3841.2006.00196.x; Yen ST, 2003, AM J AGR ECON, V85, P458, DOI 10.1111/1467-8276.00134; Yen ST, 2002, EUR REV AGRIC ECON, V29, P85, DOI 10.1093/erae/29.1.85; Yiridoe EK, 2005, RENEW AGR FOOD SYST, V20, P193, DOI 10.1079/RAF2005113; Zhang F, 2008, AGRIBUSINESS, V24, P510, DOI 10.1002/agr.20176; Zheng ZH, 2011, AGRIBUSINESS, V27, P99, DOI 10.1002/agr.20243	76	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211199	10.1371/journal.pone.0211199	http://dx.doi.org/10.1371/journal.pone.0211199			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5RX	30730913	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000017
J	Thompson, BJ				Thompson, Brennan J.			Does work-induced fatigue accumulate across three compressed 12 hour shifts in hospital nurses and aides?	PLOS ONE			English	Article							TORQUE CHARACTERISTICS; PATIENT SAFETY; HIP EXTENSORS; TIME; PLUG; PULL; ASSOCIATION; PERFORMANCE; VIGILANCE; SCHEDULE	Fatigue-related impairments in the nursing workforce contribute to a multitude of health, safety, and economic consequences at the individual, organizational and societal levels. Long and compressed work schedules are commonly worked in the healthcare industry, but more research is needed to understand the cumulative effects of multiple work shifts on physiology-based performance outcomes in nurses. The purpose of this study was to compare the effects of a single nursing work shift versus three compressed (one every 24 hours) 12 hour shifts on performance-based fatigue in nurses and aides. Twenty-six fulltime hospital working nurses and aides (age = 36.1 +/- 13.3 years) reported to the lab for testing before, immediately after working a single 12 hour shift, and after working three 12 hour shifts in a 72 hour period. Outcome measures included vigilance-based reaction time, lapses of attention, and muscle function assessments (lower and upper body muscle strength, explosive strength and vertical jump performance). All variables except hand grip strength showed a significant decline following the three work shifts. The psychomotor vigilance reaction time and lapses of attention variables also generally showed a significant decline from the end of shift one to the end of shift three, indicting an accumulation of fatigue in these metrics with increasing number of shifts worked. Muscle function variables responded early in the duty cycle, showing a significant decline after a single work shift, but did no further decline by the end of the third shift. These findings use objective measures to substantiate that fatigue impairments occur from working a single 12 hour shift, and in several instances, increase further with more successive work shifts. Caution should be employed by personnel and administrators with work schedules involving multiple compressed 12 hour shifts. Fatigue management strategies may be used to improve risks and consequences from fatigue-related mishaps, and this study reports several variables that appear sensitive to identifying and tracking fatigue in this population.	[Thompson, Brennan J.] Utah State Univ, Dept Kinesiol & Hlth Sci, Logan, UT 84322 USA; [Thompson, Brennan J.] Utah State Univ, Sorenson Legacy Fdn Ctr Clin Excellence, Movement Res Suite, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Thompson, BJ (corresponding author), Utah State Univ, Dept Kinesiol & Hlth Sci, Logan, UT 84322 USA.; Thompson, BJ (corresponding author), Utah State Univ, Sorenson Legacy Fdn Ctr Clin Excellence, Movement Res Suite, Logan, UT 84322 USA.	brennan.thompson@usu.edu						American Nurses Association, 2006, ASS PAT SAF REG NURS; American Nurses Association, 2014, ADDR NURS FAT PROM S; [Anonymous], 2011, Sentinel Event Alert, P1; Barger LK, 2006, PLOS MED, V3, P2440, DOI 10.1371/journal.pmed.0030487; Bultmann U, 2002, PSYCHOL MED, V32, P333, DOI 10.1017/S0033291701005098; Carayon P, 2006, QUAL SAF HEALTH CARE, V15, pI50, DOI 10.1136/qshc.2005.015842; Chen J, 2014, NURS HEALTH SCI, V16, P19, DOI 10.1111/nhs.12104; Conchola EC, 2013, EUR J APPL PHYSIOL, V113, P2391, DOI 10.1007/s00421-013-2675-y; Ellis JR, 2008, QUALITY CARE NURSES, P1; Folkard S, 2003, OCCUP MED-OXFORD, V53, P95, DOI 10.1093/occmed/kqg047; Geiger-Brown Jeanne, 2010, Annu Rev Nurs Res, V28, P191; Geiger-Brown J, 2010, J NURS ADMIN, V40, P357, DOI 10.1097/NNA.0b013e3181ee4295; Geiger-Brown J, 2010, J NURS ADMIN, V40, P100, DOI 10.1097/NNA.0b013e3181d0414e; Hanecke K, 1998, SCAND J WORK ENV HEA, V24, P43; Hinshaw Ada Sue, 2006, Nurs Adm Q, V30, P309; Hopcia K, 2012, WORKPLACE HEALTH SAF, V60, P437, DOI 10.3928/21650799-20120917-39; Huibers MJH, 2004, J OCCUP ENVIRON MED, V46, P1041, DOI 10.1097/01.jom.0000137714.46149.17; James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Khitrov MY, 2014, BEHAV RES METHODS, V46, P140, DOI 10.3758/s13428-013-0339-9; Lockley SW, 2007, JT COMM J QUAL PATIE, V33, P7, DOI 10.1016/S1553-7250(07)33109-7; Marras WS, 2009, APPL ERGON, V40, P15, DOI 10.1016/j.apergo.2008.01.018; Menzel NN, 2004, INT J NURS STUD, V41, P859, DOI 10.1016/j.ijnurstu.2004.03.012; Montgomery KL, 2010, J NURS ADMIN, V40, P147, DOI 10.1097/NNA.0b013e3181d40e63; Olds DM, 2010, J SAFETY RES, V41, P153, DOI 10.1016/j.jsr.2010.02.002; Palmer TB, 2017, J STRENGTH COND RES, V31, P480, DOI 10.1519/JSC.0000000000001503; Palmer TB, 2016, J GERIATR PHYS THER, V39, P102, DOI 10.1519/JPT.0000000000000060; Palmer TB, 2015, AGING CLIN EXP RES, V27, P431, DOI 10.1007/s40520-014-0305-0; Palmer TB, 2014, MUSCLE NERVE, V49, P69, DOI 10.1002/mus.23861; Patterson PD, 2018, PREHOSP EMERG CARE, V22, P89, DOI 10.1080/10903127.2017.1376137; Rech A, 2014, AGE, V36, DOI 10.1007/s11357-014-9708-2; Rosa RR, 1998, HUM FACTORS, V40, P150, DOI 10.1518/001872098779480523; Samra HA, 2015, ADV NEONAT CARE, V15, P311, DOI 10.1097/ANC.0000000000000230; Scott LD, 2006, AM J CRIT CARE, V15, P30; Smith-Miller CA, 2016, J NURS ADMIN, V46, P408, DOI 10.1097/NNA.0000000000000366; Stolt M, 2016, SCAND J PUBLIC HEALT, V44, P106, DOI 10.1177/1403494815602989; Surani S, 2015, J PATIENT SAF, V11, P215, DOI 10.1097/PTS.0000000000000089; Swaen G. M. H., 2003, Occupational and Environmental Medicine, V60, pi88, DOI 10.1136/oem.60.suppl_1.i88; Thompson BJ, 2018, J SPORT SCI, V36, P1749, DOI 10.1080/02640414.2017.1412245; Thompson BJ, 2018, INT J SPORTS MED, V39, P124, DOI 10.1055/s-0043-121149; Thompson BJ, 2017, HUM FACTORS, V59, P346, DOI 10.1177/0018720816677814; Thompson BJ, 2016, J OCCUP ENVIRON MED, V58, P737, DOI 10.1097/JOM.0000000000000766; Trinkoff AM, 2006, AM J IND MED, V49, P964, DOI 10.1002/ajim.20330	42	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211715	10.1371/journal.pone.0211715	http://dx.doi.org/10.1371/journal.pone.0211715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5RX	30730927	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000052
J	Mikkelsen, SA; Mogensen, LS; Vilsen, B; Molday, RS; Vestergaard, AL; Andersen, JP				Mikkelsen, Stine A.; Mogensen, Louise S.; Vilsen, Bente; Molday, Robert S.; Vestergaard, Anna L.; Andersen, Jens Peter			Asparagine 905 of the mammalian phospholipid flippase ATP8A2 is essential for lipid substrate-induced activation of ATP8A2 dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; membrane lipid; membrane transport; lipid binding protein; lipid transport; lipid-protein interaction; mutant; molecular modeling; membrane enzyme; transporter; CAMRQ syndrome; enzyme mechanism; mutagenesis; P4-ATPase; phosphatidylserine transport	CRYSTAL-STRUCTURE; TRANSPORT; ATPASE; GENE; CA2+-ATPASE; MECHANISM; RESIDUES; ACIDS; CA2+	The P-type ATPase protein family includes, in addition to ion pumps such as Ca2+-ATPase and Na+,K+-ATPase, also phospholipid flippases that transfer phospholipids between membrane leaflets. P-type ATPase ion pumps translocate their substrates occluded between helices in the center of the transmembrane part of the protein. The large size of the lipid substrate has stimulated speculation that flippases use a different transport mechanism. Information on the functional importance of the most centrally located helices M5 and M6 in the transmembrane domain of flippases has, however, been sparse. Using mutagenesis, we examined the entire M5-M6 region of the mammalian flippase ATP8A2 to elucidate its possible function in the lipid transport mechanism. This mutational screen yielded an informative map assigning important roles in the interaction with the lipid substrate to only a few M5-M6 residues. The M6 asparagine Asn-905 stood out as being essential for the lipid substrate-induced dephosphorylation. The mutants N905A/D/E/H/L/Q/R all displayed very low activities and a dramatic insensitivity to the lipid substrate. Strikingly, Asn-905 aligns with key ion-binding residues of P-type ATPase ion pumps, and N905D was recently identified as one of the mutations causing the neurological disorder cerebellar ataxia, mental retardation, and disequilibrium (CAMRQ) syndrome. Moreover, the effects of substitutions to the adjacent residue Val-906 (i.e. V906A/E/F/L/Q/S) suggest that the lipid substrate approaches Val-906 during the translocation. These results favor a flippase mechanism with strong resemblance to the ion pumps, despite a location of the translocation pathway in the periphery of the transmembrane part of the flippase protein.	[Mikkelsen, Stine A.; Mogensen, Louise S.; Vilsen, Bente; Vestergaard, Anna L.; Andersen, Jens Peter] Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark; [Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Molday, Robert S.] Univ British Columbia, Ctr Macular Res, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 3N9, Canada	Aarhus University; University of British Columbia; University of British Columbia	Andersen, JP (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark.	jpa@biomed.au.dk		Vilsen, Bente/0000-0002-4727-9382; Molday, Robert/0000-0002-4479-1831; Andersen, Jens Peter/0000-0003-0654-4300	Danish Council for Independent Research Grant [DFF 6110-00271]; Novo Nordisk Foundation [NNF16OC0022510]; Canadian Institutes of Health Research Grant [PJT-148649]; National Institutes of Health [EY002422]; NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER	Danish Council for Independent Research Grant; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by Danish Council for Independent Research Grant DFF 6110-00271 (to J. P. A.), Novo Nordisk Foundation Grant NNF16OC0022510 (to J. P. A.), Canadian Institutes of Health Research Grant PJT-148649 (to R. S. M.), and National Institutes of Health Grant EY002422 (to R. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 2018, NATURE, V556, P214, DOI 10.1038/s41586-018-0003-8; Alsahli S, 2018, J CENT NERV SYST DIS, V10, DOI 10.1177/1179573518759682; Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Halleck MS, 1998, GENOME RES, V8, P354, DOI 10.1101/gr.8.4.354; Jensen MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17742-y; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Martin-Hernandez E, 2016, NEUROGENETICS, V17, P259, DOI 10.1007/s10048-016-0496-y; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nielsen JM, 1998, BIOCHEMISTRY-US, V37, P1961, DOI 10.1021/bi972524q; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Stone Alex, 2012, J Chem Biol, V5, P131, DOI 10.1007/s12154-012-0078-x; Swarts HGP, 2005, J BIOL CHEM, V280, P11488, DOI 10.1074/jbc.M412321200; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111	27	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5970	5979		10.1074/jbc.RA118.007240	http://dx.doi.org/10.1074/jbc.RA118.007240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30760526	Green Published, hybrid			2022-12-26	WOS:000465077500028
J	Chen, CC; Breslin, MB; Guidry, JJ; Lan, MS				Chen, Chiachen; Breslin, Mary Beth; Guidry, Jessie J.; Lan, Michael S.			5-Iodotubercidin represses insulinoma-associated-1 expression, decreases cAMP levels, and suppresses human neuroblastoma cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenosine receptor; neuroblastoma; adenosine; adenylate kinase (ADK); cyclic AMP (cAMP); cell signaling; 5-iodotubercidin; insulinoma-associated-1 (INSM1); neuroblastoma; proto-oncogene BHLH transcription factor (N-Myc); transcriptional regulation	MYC GENE AMPLIFICATION; N-MYC; ADENOSINE RECEPTOR; HEPATOCELLULAR-CARCINOMA; INHIBITION; ACTIVATION; AGONIST; CF102; AMP; PROLIFERATION	Insulinoma-associated-1 (INSM1) is a key protein functioning as a transcriptional repressor in neuroendocrine differentiation and is activated by N-Myc in human neuroblastoma (NB). INSM1 modulates the phosphoinositide 3-kinase (PI3K)-AKT Ser/Thr kinase (AKT)-glycogen synthase kinase 3 (GSK3) signaling pathway through a positive-feedback loop, resulting in N-Myc stabilization. Accordingly, INSM1 has emerged as a critical player closely associated with N-Myc in facilitating NB cell growth. Here, an INSM1 promoter-driven luciferase-based screen revealed that the compound 5-iodotubercidin suppresses adenosine kinase (ADK), an energy pathway enzyme, and also INSM1 expression and NB tumor growth. Next, we sought to dissect how the ADK pathway contributes to NB tumor cell growth in the context of INSM1 expression. We also found that 5-iodotubercidin inhibits INSM1 expression and induces an intra- and extracellular adenosine imbalance. The adenosine imbalance, which triggers adenosine receptor-3 signaling that decreases cAMP levels and AKT phosphorylation and enhances GSK3 activity. We further observed that GSK3 then phosphorylates -catenin and promotes the cytoplasmic proteasomal degradation pathway. 5-Iodotubercidin treatment and INSM1 inhibition suppressed extracellular signal-regulated kinase 1/2 (ERK1/2) activity and the AKT signaling pathways required for NB cell proliferation. The 5-iodotubercidin treatment also suppressed -catenin, lymphoid enhancer-binding factor 1 (LEF-1), cyclin D1, N-Myc, and INSM1 levels, ultimately leading to apoptosis via caspase-3 and p53 activation. The identification of the signaling pathways that control the proliferation of aggressive NB reported here suggests new options for combination treatments of NB patients.	[Chen, Chiachen; Lan, Michael S.] Louisiana State Univ, Dept Genet, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Breslin, Mary Beth; Lan, Michael S.] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Guidry, Jessie J.] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Guidry, Jessie J.] Louisiana State Univ, LSUHSC Prote Core Facil, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Breslin, Mary Beth] Southwest Shadow, SWCTA 7050 W Shelbourne Ave, Las Vegas, NV 89113 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Lan, MS (corresponding author), Louisiana State Univ, Hlth Sci Ctr, 533 Bolivar St,CSRB Box 6-16, New Orleans, LA 70112 USA.	mlan@lsuhsc.edu	Lan, Michael/CAF-1839-2022	Guidry, Jessie/0000-0002-5601-0430; Lan, Michael/0000-0003-4596-5677	National Cancer Institute, National Institutes of Health [CA218764]; Louisiana State University Research Enhancement Program; Departments of Pediatrics/Genetics, Louisiana State University Health Sciences Center; Children's Hospital, New Orleans, LA; NATIONAL CANCER INSTITUTE [R21CA218764] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Louisiana State University Research Enhancement Program; Departments of Pediatrics/Genetics, Louisiana State University Health Sciences Center; Children's Hospital, New Orleans, LA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute, National Institutes of Health Grant CA218764, in part by the Louisiana State University Research Enhancement Program, the Departments of Pediatrics/Genetics, Louisiana State University Health Sciences Center, and the Children's Hospital, New Orleans, LA. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annes JP, 2012, P NATL ACAD SCI USA, V109, P3915, DOI 10.1073/pnas.1201149109; Bar-Yehuda S, 2008, INT J ONCOL, V33, P287, DOI 10.3892/ijo_00000008; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chen CC, 2018, CELL SIGNAL, V46, P83, DOI 10.1016/j.cellsig.2018.02.014; Chen CC, 2015, ONCOTARGET, V6, P36700, DOI 10.18632/oncotarget.5485; Cohen S, 2011, J CELL PHYSIOL, V226, P2438, DOI 10.1002/jcp.22593; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; FEOKTISTOV I, 1995, J CLIN INVEST, V96, P1979, DOI 10.1172/JCI118245; Fishman P, 2003, ANTICANCER RES, V23, P2077; Fishman P, 2002, ONCOGENE, V21, P4060, DOI 10.1038/sj.onc.1205531; Fishman P, 2012, DRUG DISCOV TODAY, V17, P359, DOI 10.1016/j.drudis.2011.10.007; Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0; KOHL NE, 1984, SCIENCE, V226, P1335, DOI 10.1126/science.6505694; Li QDQT, 2016, INT J ONCOL, V48, P2591, DOI 10.3892/ijo.2016.3478; LOOK AT, 1991, J CLIN ONCOL, V9, P581, DOI 10.1200/JCO.1991.9.4.581; Maira SM, 2009, BIOCHEM SOC T, V37, P265, DOI 10.1042/BST0370265; Marin RM, 2007, J SEP SCI, V30, P2473, DOI 10.1002/jssc.200700194; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Merighi S, 2005, J BIOL CHEM, V280, P19516, DOI 10.1074/jbc.M413772200; NISEN PD, 1988, J NATL CANCER I, V80, P1633, DOI 10.1093/jnci/80.20.1633; Peyton KJ, 2012, J PHARMACOL EXP THER, V342, P827, DOI 10.1124/jpet.112.194712; Saitoh M, 2004, BIOCHEM PHARMACOL, V67, P2005, DOI 10.1016/j.bcp.2004.01.020; SCHWAB M, 1991, ADV ENZYME REGUL, V31, P329, DOI 10.1016/0065-2571(91)90021-D; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SLAVC I, 1990, CANCER RES, V50, P1459; Stemmer SM, 2013, ONCOLOGIST, V18, P25, DOI 10.1634/theoncologist.2012-0211; VANCALKER D, 1979, J NEUROCHEM, V33, P999, DOI 10.1111/j.1471-4159.1979.tb05236.x; Wildner H, 2008, DEVELOPMENT, V135, P473, DOI 10.1242/dev.011783; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062527	30	6	7	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5456	5465		10.1074/jbc.RA118.006761	http://dx.doi.org/10.1074/jbc.RA118.006761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30755485	Green Published, hybrid			2022-12-26	WOS:000464517500018
J	Yu, DQ; Lv, PP; Yan, YS; Xu, GX; Sadhukhan, A; Dong, S; Shen, Y; Ren, J; Zhang, XY; Feng, C; Huang, YT; Tian, S; Zhou, Y; Cai, YT; Ming, ZH; Ding, GL; Zhu, H; Sheng, JZ; Jin, M; Huang, HF				Yu, Dan-Qing; Lv, Ping-Ping; Yan, Yi-Shang; Xu, Guan-Xin; Sadhukhan, Annapurna; Dong, Shan; Shen, Yan; Ren, Jun; Zhang, Xue-Ying; Feng, Chun; Huang, Yi-Ting; Tian, Shen; Zhou, Yin; Cai, Yi-Ting; Ming, Zhen-Hua; Ding, Guo-Lian; Zhu, Hong; Sheng, Jian-Zhong; Jin, Min; Huang, He-Feng			Intrauterine exposure to hyperglycemia retards the development of brown adipose tissue	FASEB JOURNAL			English	Article						gestational diabetes mellitus; mitochondrion; epigenetic modification	GESTATIONAL DIABETES-MELLITUS; DNA METHYLATION PROFILES; BETA-CELL PROLIFERATION; INSULIN SENSITIVITY; GLUCOSE-HOMEOSTASIS; CORD BLOOD; TRIGLYCERIDE; OBESITY; LEPTIN; RESISTANCE	Brown adipose tissue (BAT) is an exclusive tissue of nonshivering thermogenesis. It is fueled by lipids and glucose and involved in energy and metabolic homeostasis. Intrauterine exposure to hyperglycemia during gestational diabetes mellitus may result in abnormal fetal development and metabolic phenotypes in adulthood. However, whether intrauterine hyperglycemia influences the development of BAT is unknown. In this study, mouse embryos were exposed to the intrauterine hyperglycemia environment by injecting streptozocin into pregnant mice at 1 d post coitum (dpc). The structure of BAT was examined by hematoxylin and eosin staining and immunohistochemical analysis. The glucose uptake in BAT was measured in vivo by [F-18]-fluoro-2-deoxyglucose-micro-positron emission tomography. The gene expression in BAT was determined by real-time PCR, and the 5'-C-phosphate-G-3' site-specific methylation was quantitatively analyzed. Intrauterine hyperglycemia exposure resulted in the impaired structure of BAT and decreased glucose uptake function in BAT in adulthood. The expressions of the genes involved in thermogenesis and mitochondrial respiratory chain in BAT, such as Ucp1, Cox5b, and Elovl3, were down-regulated by intrauterine hyperglycemia exposure at 18.5 dpc and at 16 wk of age. Furthermore, higher methylation levels of Ucp1, Cox5b, and Elovl3 were found in offspring of mothers with streptozotocin-induced diabetes. Our results provide the evidence for enduring inhibitory effects of intrauterine hyperglycemia on BAT development in offspring. Intrauterine hyperglycemia is associated with increased DNA methylation of the BAT specific genes in offspring, which support an epigenetic involvement.	[Yu, Dan-Qing; Xu, Guan-Xin; Sadhukhan, Annapurna; Feng, Chun; Huang, Yi-Ting; Tian, Shen; Zhou, Yin; Cai, Yi-Ting; Jin, Min] Zhejiang Univ, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Yu, Dan-Qing; Lv, Ping-Ping; Yan, Yi-Shang; Dong, Shan; Shen, Yan; Ren, Jun; Feng, Chun; Huang, Yi-Ting; Tian, Shen; Zhou, Yin; Ming, Zhen-Hua; Zhu, Hong; Sheng, Jian-Zhong; Jin, Min; Huang, He-Feng] Zhejiang Univ, Minist Educ, Key Lab Reprod Genet, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Lv, Ping-Ping; Ren, Jun; Huang, He-Feng] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou, Zhejiang, Peoples R China; [Sheng, Jian-Zhong] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou, Zhejiang, Peoples R China; [Dong, Shan] Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China; [Shen, Yan] Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Zhang, Xue-Ying; Ding, Guo-Lian; Huang, He-Feng] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Zhang, Xue-Ying; Ding, Guo-Lian] Shanghai Jiao Tong Univ, Sch Med, Inst Embryofetal Original Adult Dis, Shanghai, Peoples R China; [Huang, He-Feng] Shanghai Jiao Tong Univ, Biox Inst, Shanghai, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Shandong University; Zhejiang Provincial People's Hospital; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Jin, M (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.; Huang, HF (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Reprod Genet, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	min_jin@zju.edu.cn; hhf57@zju.edu.cn	Huang, Hefeng/ABF-1117-2020; Huang, He-Feng/AAN-7985-2020; Ding, Guolian/GXG-7578-2022; huang, yiting/HDM-3648-2022; Huang, Hefeng/AAR-7184-2021	Huang, He-Feng/0000-0003-4344-8019; Ding, Guolian/0000-0002-0099-9980; 	National Natural Science Foundation of China [81671487, 81701461]; Zhejiang Provincial Natural Science Foundation of China [LY16H040007, LY17H040005]; Science and Technology Projects of the Competent Department [2017FZA7013]; National Key Basic Research Program [2013CB967404]; Medical and Health Science and Technology Plan of Zhejiang Province [2017KY078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Science and Technology Projects of the Competent Department; National Key Basic Research Program(National Basic Research Program of China); Medical and Health Science and Technology Plan of Zhejiang Province	This study was supported by the National Natural Science Foundation of China (Grants 81671487 and 81701461), Zhejiang Provincial Natural Science Foundation of China (Grants LY16H040007 and LY17H040005), Science and Technology Projects of the Competent Department (Grant 2017FZA7013), National Key Basic Research Program (Grant 2013CB967404), and Medical and Health Science and Technology Plan of Zhejiang Province (Grant 2017KY078). D.-Q.Y., P.-P.L, and Y.-S.Y. contributed equally to this work and should be considered joint first authors. The authors declare no conflicts of interest.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356; Blue EK, 2015, DIABETES, V64, P2664, DOI 10.2337/db14-1709; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen DQ, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0108-3; Chen P, 2017, DIABETOLOGIA, V60, P645, DOI 10.1007/s00125-016-4203-1; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305; Cote S, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0239-9; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; del Rosario MC, 2014, METABOLISM, V63, P654, DOI 10.1016/j.metabol.2014.01.007; Ding GL, 2012, DIABETES, V61, P1133, DOI 10.2337/db11-1314; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Dong HP, 2017, EUR REV MED PHARMACO, V21, P3658; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Finer S, 2015, HUM MOL GENET, V24, P3021, DOI 10.1093/hmg/ddv013; Fontes G, 2010, DIABETOLOGIA, V53, P2369, DOI 10.1007/s00125-010-1850-5; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Han JY, 2007, AM J PHYSIOL-ENDOC M, V293, pE228, DOI 10.1152/ajpendo.00479.2006; Hanssen MJW, 2016, DIABETES, V65, P1179, DOI 10.2337/db15-1372; Hanssen MJW, 2015, NAT MED, V21, P863, DOI 10.1038/nm.3891; HIMMSHAGEN J, 1990, FASEB J, V4, P2890, DOI 10.1096/fasebj.4.11.2199286; Horjales-Araujo E, 2014, NEUROSCIENCE, V277, P87, DOI 10.1016/j.neuroscience.2014.06.043; Houde AA, 2014, J DEV ORIG HLTH DIS, V5, P132, DOI 10.1017/S2040174414000038; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Kim E, 2017, EPIGENETICS-US, V12, P825, DOI 10.1080/15592294.2017.1370172; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Labbe SM, 2015, FASEB J, V29, P2046, DOI 10.1096/fj.14-266247; Li YG, 2018, CELL, V175, P1561, DOI 10.1016/j.cell.2018.10.016; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu L, 2014, CELL PHYSIOL BIOCHEM, V34, P1877, DOI 10.1159/000366386; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Nehring I, 2013, DIABETIC MED, V30, P1449, DOI 10.1111/dme.12286; Nilsson C, 2014, PEDIATR DIABETES, V15, P57, DOI 10.1111/pedi.12059; Oelkrug R, 2015, J COMP PHYSIOL B, V185, P587, DOI 10.1007/s00360-015-0907-7; Palou M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-69; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petitt D J, 1985, Diabetes, V34 Suppl 2, P119; Petropoulos S, 2015, ENDOCRINOLOGY, V156, P2222, DOI 10.1210/en.2014-1643; Phillips DIW, 1996, METABOLISM, V45, P947, DOI 10.1016/S0026-0495(96)90260-7; Potter VJV, 2012, ENDOCRINOLOGY, V153, P4266, DOI 10.1210/en.2011-2006; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Quevedo S, 1998, PFLUG ARCH EUR J PHY, V436, P689, DOI 10.1007/s004240050690; Quilter CR, 2014, FASEB J, V28, P4868, DOI 10.1096/fj.14-255240; Rahman TU, 2017, ONCOTARGET, V8, P53450, DOI 10.18632/oncotarget.18519; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Simpkin AJ, 2016, HUM MOL GENET, V25, P191, DOI 10.1093/hmg/ddv456; Soberanes S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00275; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Steculorum SM, 2011, ENDOCRINOLOGY, V152, P4171, DOI 10.1210/en.2011-1279; Su R, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4952801; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Tawfik SH, 2017, J ANIM SCI TECHNOL, V59, DOI 10.1186/s40781-016-0125-1; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Vila-Bedmar R, 2012, FASEB J, V26, P3503, DOI 10.1096/fj.11-202267; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang HH, 2018, ENDOCRINOLOGY, V159, P465, DOI 10.1210/en.2017-03017; Wang X., 2012, JOVE-J VIS EXP, V69, P4060, DOI [10.3791/4060, DOI 10.3791/4060]; West Nancy A, 2013, Immunometabolism, V1, P1; Wu D, 2018, NATURE, V559, P637, DOI 10.1038/s41586-018-0350-5; Xu LY, 2018, AGING CELL, V17, DOI 10.1111/acel.12721; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Yang IV, 2018, DIABETIC MED, V35, P612, DOI 10.1111/dme.13604; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zarrouki B, 2014, DIABETES, V63, P982, DOI 10.2337/db13-0425; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	70	10	10	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5425	5439		10.1096/fj.201801818R	http://dx.doi.org/10.1096/fj.201801818R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30759346	Bronze			2022-12-26	WOS:000462888500064
J	Topiwala, A; Suri, S; Allan, C; Valkanova, V; Filippini, N; Sexton, CE; Heise, V; Zsoldos, E; Mahmood, A; Singh-Manoux, A; Mackay, CE; Kivimaki, M; Ebmeier, KP				Topiwala, Anya; Suri, Sana; Allan, Charlotte; Valkanova, Vyara; Filippini, Nicola; Sexton, Claire E.; Heise, Verena; Zsoldos, Eniko; Mahmood, Abda; Singh-Manoux, Archana; Mackay, Clare E.; Kivimaki, Mika; Ebmeier, Klaus P.			Predicting cognitive resilience from midlife lifestyle and multi-modal MRI: A 30-year prospective cohort study	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; TEMPORAL-LOBE ATROPHY; ALZHEIMERS-DISEASE; OLDER-ADULTS; DEFAULT MODE; BRAIN; RESERVE; NETWORKS; CONNECTIVITY; DEMENTIA	Background There is significant heterogeneity in the clinical expression of structural brain abnormalities, including Alzheimer's disease biomarkers. Some individuals preserve their memory despite the presence of risk factors or pathological brain changes, indicating resilience. We aimed to test whether resilient individuals could be distinguished from those who develop cognitive impairment, using sociodemographic variables and neuroimaging. Methods We included 550 older adults participating in the Whitehall II study with longitudinal data, cognitive test results, and multi-modal MRI. Hippocampal atrophy was defined as Scheltens Scores >0. Resilient individuals (n = 184) were defined by high cognitive performance despite hippocampal atrophy (HA). Non- resilient participants (n = 133) were defined by low cognitive performance (>= 1.5 standard deviations (S.D.) below the group mean) in the presence of HA. Dynamic and static exposures were evaluated for their ability to predict later resilience status using multivariable logistic regression. In a brain-wide analysis we tested for group differences in the integrity of white matter (structural connectivity) and resting-state networks (functional connectivity). Findings Younger age (OR: 0.87, 95% CI: 0.83 to 0.92, p<0.001), higher premorbid FSIQ (OR: 1.06, 95% CI: 1.03 to 1.10, p<0.0001) and social class (OR 1 vs. 3: 4.99, 95% CI: 1.30 to 19.16, p = 0.02, OR 2 vs. 3: 8.43, 95% CI: 1.80 to 39.45, p = 0.007) were independently associated with resilience. Resilient individuals could be differentiated from non-resilient participants by higher fractional anisotropy (FA), and less association between anterior and posterior resting state networks. Higher FA had a significantly more positive effect on cognitive performance in participants with HA, compared to those without. Conclusions Resilient individuals could be distinguished from those who developed impairments on the basis of sociodemographic characteristics, brain structural and functional connectivity, but not midlife lifestyles. There was a synergistic deleterious effect of hippocampal atrophy and poor white matter integrity on cognitive performance. Exploiting and supporting neural correlates of resilience could offer a fresh approach to postpone or avoid the appearance of clinical symptoms.	[Topiwala, Anya; Suri, Sana; Allan, Charlotte; Valkanova, Vyara; Filippini, Nicola; Sexton, Claire E.; Heise, Verena; Zsoldos, Eniko; Mahmood, Abda; Mackay, Clare E.; Ebmeier, Klaus P.] Univ Oxford, Dept Psychiat, Oxford, England; [Suri, Sana] Wellcome Ctr Integrat Neuroimaging, Oxford, England; [Singh-Manoux, Archana] INSERM, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Singh-Manoux, Archana; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England	University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); University of London; University College London	Topiwala, A (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	anya.topiwala@psych.ox.ac.uk	Heise, Verena/AAE-2731-2021; Kivimaki, Mika/B-3607-2012; Sexton, Claire/W-3990-2019; Singh-Manoux, Archana/F-6804-2013; Filippini, Nicola/Q-5250-2019; Ebmeier, Klaus Peter/B-4789-2008	Kivimaki, Mika/0000-0002-4699-5627; Sexton, Claire/0000-0002-3846-2986; Singh-Manoux, Archana/0000-0002-1244-5037; Filippini, Nicola/0000-0003-1513-5269; Ebmeier, Klaus Peter/0000-0002-5190-7038; Zsoldos, Eniko/0000-0002-0478-6165; Topiwala, Anya/0000-0002-8408-0372; Mackay, Clare/0000-0001-6111-8318; Heise, Verena/0000-0002-5625-4128; Mahmood, Abda/0000-0002-3267-4590	UK Medical Research Council [G1001354]; Alzheimer's Research UK; HDH Wills 1965 Charitable Trust; NIH [R01AG013196, R01AG034454]; UK MRC [K013351]; NordForsk; National Institute Health Research at Oxford University Hospitals NHS Trust; University of Oxford; Wellcome Trust [203139/Z/16/Z]; MRC [MR/L023784/1, MR/R024227/1, MR/K013351/1, MR/M024962/1, MR/S011676/1, MC_EX_MR/N50192X/1, G1001354] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [RF1AG062553, R01AG056477] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); HDH Wills 1965 Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk; National Institute Health Research at Oxford University Hospitals NHS Trust; University of Oxford; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work on the Whitehall II Imaging Substudy was mainly funded by the UK Medical Research Council: G1001354. Other funding was from Alzheimer's Research UK (AT), HDH Wills 1965 Charitable Trust (SS, NF, EZ, AM), NIH (ASM, R01AG013196, R01AG034454), UK MRC (MK, K013351), NordForsk (MK), National Institute Health Research (CEM, CES) based at Oxford University Hospitals NHS Trust and University of Oxford. The Wellcome Centre for Integrative Neuroimaging is supported by core funding from the Wellcome Trust (203139/Z/16/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R., 2007, TR07JA2 FMRIB; Andreasen N, 1999, NEUROLOGY, V53, P1488, DOI 10.1212/WNL.53.7.1488; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Bastin C, 2012, NEUROIMAGE, V63, P713, DOI 10.1016/j.neuroimage.2012.06.074; Beckmann C., 2009, NEUROIMAGE, V47, pS148, DOI [10.1016/S1053-8119(09)71511-3, DOI 10.1016/S1053-8119(09)71511-3, 10.1016/s1053-8119(09)71511-3]; Bennett DA, 2018, JAMA-J AM MED ASSOC, V319, P123, DOI 10.1001/jama.2017.19700; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Chan MY, 2014, P NATL ACAD SCI USA, V111, pE4997, DOI 10.1073/pnas.1415122111; Crain B, 2005, MRI ATLAS HUMAN WHIT; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Filippini N, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-159; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Franzmeier N, 2018, BRAIN, V141, P1186, DOI 10.1093/brain/awy008; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; GOLOMB J, 1994, LEARN MEMORY, V1, P45; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Groot C, 2018, NEUROLOGY, V90, pE149, DOI 10.1212/WNL.0000000000004802; Harper Lorna, 2016, Brain, V139, P1211, DOI 10.1093/brain/aww005; Harrison TM, 2018, NEUROBIOL AGING, V67, P162, DOI 10.1016/j.neurobiolaging.2018.03.024; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jobke B, 2018, PUBLIC LIB SCI; Kaup AR, 2015, JAMA NEUROL, V72, P340, DOI 10.1001/jamaneurol.2014.3978; Korf ESC, 2004, NEUROLOGY, V63, P94, DOI 10.1212/01.WNL.0000133114.92694.93; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lyden H, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.21; Maillard P, 2012, LANCET NEUROL, V11, P1039, DOI 10.1016/S1474-4422(12)70241-7; Marstaller L, 2015, NEUROSCIENCE, V290, P369, DOI 10.1016/j.neuroscience.2015.01.049; McDermott KL, 2016, SEX EFFECTS PREDICTO; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mok VC, 2017, NATURE REV NEUROLOGY; Morbelli S, 2013, J NUCL MED, V54, P894, DOI 10.2967/jnumed.112.113928; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; Ng KK, 2016, NEUROIMAGE, V133, P321, DOI 10.1016/j.neuroimage.2016.03.029; Okonkwo OC, 2017, BRAIN IMAGING BEHAV, V11, P301, DOI 10.1007/s11682-017-9677-z; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; R Core Team, 2013, R LANG ENV STAT COMP; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raz N, 1998, NEUROPSYCHOLOGY, V12, P95, DOI 10.1037/0894-4105.12.1.95; Rentz DM, 2017, BRAIN IMAGING BEHAV, V11, P383, DOI 10.1007/s11682-016-9640-4; Rusmaully J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002334; SASS KJ, 1990, NEUROLOGY, V40, P1694, DOI 10.1212/WNL.40.11.1694; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Suri Sana, 2017, Neuroimage, V159, P122, DOI 10.1016/j.neuroimage.2017.07.049; Topiwala A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2353; Topiwala A, 2015, BRIT J PSYCHIAT, V207, P435, DOI 10.1192/bjp.bp.114.152363; Umarova RM, 2016, CORTEX; van Loenhoud AC, 2017, HUM BRAIN MAPP, V38, P4703, DOI 10.1002/hbm.23695; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Wahlund LO, 1999, PSYCHIAT RES-NEUROIM, V90, P193, DOI 10.1016/S0925-4927(99)00016-5; Wang HX, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002251; Wechsler D., 2011, TEST PREMORBID FUNCT; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	68	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211273	10.1371/journal.pone.0211273	http://dx.doi.org/10.1371/journal.pone.0211273			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779761	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900014
J	Urrestarazu, M; Gallegos-Cedillo, VM; Ferron-Carrillo, F; Guil-Guerrero, JL; Lao, MT; Alvaro, JE				Urrestarazu, Miguel; Manuel Gallegos-Cedillo, Victor; Ferron-Carrillo, Francisca; Luis Guil-Guerrero, Jose; Teresa Lao, Maria; Eugenio Alvaro, Juan			Effects of the electrical conductivity of a soilless culture system on gamma linolenic acid levels in borage seed oil	PLOS ONE			English	Article							NUTRIENT SOLUTION; POTENTIAL SOURCES; OFFICINALIS L.; SALINITY; BORAGINACEAE; YIELD; FERTILIZATION; TOMATO; CROP	Borage is a well-known plant of great importance in human nutrition and health. Expanding knowledge of particular plants that have anti-cancer products is a global concern. There is substantial information regarding the benefits, presence and extraction of gamma linolenic acid (GLA; 18:3n6) in different plants around the world, especially in borage seeds. However, there is little information concerning the effects of the salinity of the nutrient solution on the growth and presence of GLA in borage seeds. The objective of this work was to determine the optimal salinity of the nutrient solution for obtaining GLA in soilless cultivation systems. Borage plants were grown in coconut fibre and provided three treatments of nutrient solution of 2.20, 3.35 and 4.50 dS m(-1), increasing solution salinity with the standard nutrient solution of concentrated macronutrients as a reference. Vegetative growth, seed production and GLA ratio were measured. The results of vegetative development and GLA production doubled and tripled with the increase in salinity of the nutrient solution, respectively.	[Urrestarazu, Miguel; Manuel Gallegos-Cedillo, Victor; Ferron-Carrillo, Francisca; Luis Guil-Guerrero, Jose; Teresa Lao, Maria] Univ Almeria, Dept Agron, Almeria, Spain; [Eugenio Alvaro, Juan] Pontificia Univ Catolica Valparaiso, Escuela Agron, Quillota, Chile	Universidad de Almeria; Pontificia Universidad Catolica de Valparaiso	Urrestarazu, M (corresponding author), Univ Almeria, Dept Agron, Almeria, Spain.	mgavilan@ual.es	URRESTARAZU, MIGUEL/N-1927-2013; Gallegos-Cedillo, Victor M./I-7655-2018; Alvaro, Juan E./K-5994-2014; Gallegos-Cedillo, Victor M./G-6211-2015; Lao, Maria Teresa/G-7764-2016	URRESTARAZU, MIGUEL/0000-0003-4340-2184; Gallegos-Cedillo, Victor M./0000-0002-8046-8070; Alvaro, Juan E./0000-0001-9170-3681; Lao, Maria Teresa/0000-0002-1593-7328	Spanish Ministry of Education and Science Project (FEDER) [AGL2015-67528-R]; Mexican National Council for Science and Technology (CONACYT)	Spanish Ministry of Education and Science Project (FEDER); Mexican National Council for Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Spanish Ministry of Education and Science Project (FEDER AGL2015-67528-R). The authors gratefully acknowledge the support of the Mexican National Council for Science and Technology (CONACYT) for its financial support of this work.	ADAMS P, 1991, J HORTIC SCI, V66, P201, DOI 10.1080/00221589.1991.11516145; [Anonymous], [No title captured]; Aparicio C, 2014, HORTSCIENCE, V49, P901, DOI 10.21273/HORTSCI.49.7.901; BADI HN, 2011, AFR J BIOTECHNOL, V10, P146; Barceloux D.G., MED TOXICOLOGY NATUR; Beaubaire N. A., 1987, Acta Horticulturae, P101; Berti MT, 2010, CHIL J AGR RES, V70, P228, DOI 10.4067/S0718-58392010000200006; Castroviejo S, 1993, FLORA IBERICA, V11, P329; Cuartero J, 1999, SCI HORTIC-AMSTERDAM, V78, P83, DOI 10.1016/S0304-4238(98)00191-5; Dastborhan S., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V5, P313; del Rio-Celestino M, 2008, J SCI FOOD AGR, V88, P248, DOI 10.1002/jsfa.3080; El Hafid R, 2002, IND CROP PROD, V16, P193, DOI 10.1016/S0926-6690(02)00047-X; Alvaro JE, 2016, J PLANT NUTR, V39, P1057, DOI 10.1080/01904167.2015.1061552; Gilani AH, 2007, J ETHNOPHARMACOL, V114, P393, DOI 10.1016/j.jep.2007.08.032; Gilbertson PK, 2014, IND CROP PROD, V59, P202, DOI 10.1016/j.indcrop.2014.04.046; Grand View Research, BOR OIL MARK AN APPL; Guil-Guerrero JL, 2006, EUR J LIPID SCI TECH, V108, P43, DOI 10.1002/ejlt.200500251; Jaffel K, 2011, PLANT BIOSYST, V145, P362, DOI 10.1080/11263504.2011.558689; Jaffel-Hamza K, 2013, J PLANT GROWTH REGUL, V32, P200, DOI 10.1007/s00344-012-9290-8; Lpez, 2016, SERIE EC, V27; Guil-Guerrero JL, 2017, FOOD CHEM, V218, P435, DOI 10.1016/j.foodchem.2016.09.111; Guil-Guerrero JL, 2014, J AM OIL CHEM SOC, V91, P301, DOI 10.1007/s11746-013-2372-3; Guil-Guerrero JL, 2013, J FOOD COMPOS ANAL, V31, P20, DOI 10.1016/j.jfca.2013.02.007; Maas E. V., 1977, Journal of the Irrigation and Drainage Division, American Society of Civil Engineers, V103, P115; Ministry of Agriculture and Fisheries Food and Environment, SUP PROD AN CULT; Montaner C, 2001, THEOR APPL GENET, V102, P375, DOI 10.1007/s001220051656; Montgomery DC, 2004, DESING ANAL EXPT; Moya C, 2017, HORTSCIENCE, V52, P868, DOI 10.21273/HORTSCI12026-17; Rodriguez D, 2014, SCI HORTIC-AMSTERDAM, V179, P153, DOI 10.1016/j.scienta.2014.09.030; Signore A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00391; SIMPSON MJA, 1993, ANN APPL BIOL, V123, P187, DOI 10.1111/j.1744-7348.1993.tb04085.x; Sonneveld C, 2004, J PLANT NUTR, V27, P1931, DOI [10.1081/LPLA-200030053, 10.1081/PLN-200030053]; Sonneveld C., 1994, VOEDINGSPOLOSSINGEN, V8, P1; Tasset-Cuevas I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056986; Urrestarazu M., 2015, MANUAL PRACTICO CULT; Urrestarazu M, 2017, COMMUN SOIL SCI PLAN, V48, P1595, DOI 10.1080/00103624.2017.1374399	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0207106	10.1371/journal.pone.0207106	http://dx.doi.org/10.1371/journal.pone.0207106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779750	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900005
J	Yan, RL; Ye, YF; Fan, QY; Huang, YH; Wen, GC; Li, LM; Cai, YM; Feng, TJ; Huang, ZM				Yan, Rui-Lin; Ye, Yun-Feng; Fan, Qin-Ying; Huang, Yan-Hui; Wen, Gui-Chun; Li, Li-Mei; Cai, Yu-Mao; Feng, Tie-Jian; Huang, Zhi-Ming			Chlamydia trachomatis infection among patients attending sexual and reproductive health clinics: A cross-sectional study in Bao'an District, Shenzhen, China	PLOS ONE			English	Article							PELVIC-INFLAMMATORY-DISEASE; TRANSMITTED INFECTIONS; NEISSERIA-GONORRHOEAE; PREVALENCE; WOMEN; RISK; FEMALE; INFERTILITY; WORKERS; TRENDS	This study aimed to estimate the prevalence of chlamydial trachomatis (CT) infection and explore its risk factors among patients attending sexual and reproductive health clinics in Shenzhen, China. We collected demographic and clinical information from attendees (aged 18-49). CT and Neisseria gonorrhoeae (NG) infection was determined by nucleic acid amplification test (NAAT) on self-collected urine specimens. Of 1,938 participants recruited, 10.3% (95% confidence interval [CI]: 9.6%-11.0%) tested positive for CT. Prevalence was similar between men (10.6% [85/804]; 95% CI, 9.5%-11.7%) and women (10.1% [115/1134]; 95% CI: 9.2%-11.0%). Being 18-25 years old (adjusted odds ratio [aOR] = 2.52; 95% CI: 1.35-4.71), never tested for CT before (aOR = 2.42; 95% CI: 1.05-5.61) and infected with NG(aOR = 3.87; 95% CI: 2.10-7.10) were independently associated with CT infection. We found that CT infection is prevalent among patients attending sexual and reproductive health clinics in Shenzhen, China. A comprehensive program including CT screening, surveillance and treatment is urgently needed.	[Yan, Rui-Lin; Ye, Yun-Feng; Fan, Qin-Ying; Huang, Yan-Hui; Wen, Gui-Chun; Li, Li-Mei; Huang, Zhi-Ming] Shenzhen Baoan Ctr Chron Dis Control, Shenzhen, Peoples R China; [Cai, Yu-Mao; Feng, Tie-Jian] Shenzhen Ctr Chron Dis Control, Shenzhen, Peoples R China		Huang, ZM (corresponding author), Shenzhen Baoan Ctr Chron Dis Control, Shenzhen, Peoples R China.	hzm789@163.com			Health and Medical Project for Fundamental Research in Shenzhen [2018JD044]; Health and Family Planning Commission of Shenzhen Municipality; Health and Family Planning Commission of Baoan Municipality	Health and Medical Project for Fundamental Research in Shenzhen; Health and Family Planning Commission of Shenzhen Municipality; Health and Family Planning Commission of Baoan Municipality	This study was supported by Health and Medical Project for Fundamental Research in Shenzhen (2018JD044) to RLY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SGCIP was sponsored by the Health and Family Planning Commission of Shenzhen Municipality, and the Health and Family Planning Commission of Baoan Municipality. We thank all SGCIP collaborators, including Xiang-sheng Chen, Yue-ping Yin (National Center for STD Control); Fu-chang Hong, Li-na Lan, Chun-lai Zhang, Jian-bing Ye (Shenzhen Center for Chronic Disease Control); Ri-Dong Cai, Yan-Fang Guo (Shenzhen Baoan Center for Chronic Disease Control); and staff at the Hospital of Maternal and Child Care, the Baoan Hospital of Shenzhen, the Shajin Hospital of Shenzhen, and the Fuyong Hospital of Shenzhen. We are very grateful to all participants of this study for their cooperation. We also appreciate Dr. Yu Yu for providing English editorial assistance.	Casillas-Vega N, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0428-5; Chamani-Tabriz Leili, 2007, Pak J Biol Sci, V10, P4490, DOI 10.3923/pjbs.2007.4490.4494; Chen KT, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-120; Chen XS, 2006, SEX TRANSM INFECT, V82, P283, DOI 10.1136/sti.2006.019711; Chen XS, 2005, AIDS PATIENT CARE ST, V19, P853, DOI 10.1089/apc.2005.19.853; Cliffe SJ, 2008, SEX TRANSM DIS, V35, P801, DOI 10.1097/OLQ.0b013e318175d885; Creighton S, 2003, INT J STD AIDS, V14, P109, DOI 10.1258/095646203321156872; Davies B, 2016, LANCET INFECT DIS, V16, P1057, DOI 10.1016/S1473-3099(16)30092-5; Davies B, 2014, J INFECT DIS, V210, pS549, DOI 10.1093/infdis/jiu483; El Qouqa IA, 2009, INT J INFECT DIS, V13, P334, DOI 10.1016/j.ijid.2008.07.013; Silva LCF, 2012, BRAZ J INFECT DIS, V16, P335, DOI 10.1016/j.bjid.2012.06.023; Francis SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101221; French CE, 2011, SEX TRANSM DIS, V38, P158, DOI 10.1097/OLQ.0b013e3181f22f3e; Gimenes F, 2014, NAT REV UROL, V11, P672, DOI 10.1038/nrurol.2014.285; Hafner LM, 2014, VACCINE, V32, P1563, DOI 10.1016/j.vaccine.2013.08.020; Jensen IP, 2003, CLIN MICROBIOL INFEC, V9, P194, DOI 10.1046/j.1469-0691.2003.00483.x; Jin X, 2011, INT J STD AIDS, V22, P80, DOI 10.1258/ijsa.2010.010289; Kong FYS, 2011, MED J AUSTRALIA, V194, P249, DOI 10.5694/j.1326-5377.2011.tb02957.x; LaMontagne DS, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.022053; [蓝丽娜 Lan Lina], 2017, [中国艾滋病性病, Chinese JOurnal of Aids & STD], V23, P947; Lee KC, 2016, AM FAM PHYSICIAN, V94, P907; Li JH, 2011, JPN J INFECT DIS, V64, P143; Low N, 2009, INT J EPIDEMIOL, V38, P435, DOI 10.1093/ije/dyn222; Luo ZZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196516; Lyss SB, 2003, ANN INTERN MED, V139, P178, DOI 10.7326/0003-4819-139-3-200308050-00007; Marks M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007276; Menon S, 2015, CLIN MICROBIOL REV, V28, P969, DOI 10.1128/CMR.00035-15; Meyers D, 2008, AM FAM PHYSICIAN, V77, P819; Moore MS, 2016, SEX TRANSM DIS, V43, P2, DOI 10.1097/OLQ.0000000000000352; Nwankwo EO, 2014, AFR HEALTH SCI, V14, P672, DOI 10.4314/ahs.v14i3.24; O'Rourke KM, 2009, SEX TRANSM DIS, V36, P763, DOI 10.1097/OLQ.0b013e3181b12765; Ong JJ, 2016, BJOG-INT J OBSTET GY, V123, P1194, DOI 10.1111/1471-0528.13567; Price MJ, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20220; Price MJ, 2013, AM J EPIDEMIOL, V178, P484, DOI 10.1093/aje/kws583; Rekart ML, 2013, J INFECT DIS, V207, P30, DOI 10.1093/infdis/jis644; Repiso-Jimenez JB, 2014, ACTAS DERMO-SIFILOGR, V105, P774, DOI 10.1016/j.ad.2014.04.011; Rours GIJG, 2016, PATHOG GLOB HEALTH, V110, P292, DOI 10.1080/20477724.2016.1258162; Rours GIJG, 2011, EUR J EPIDEMIOL, V26, P493, DOI 10.1007/s10654-011-9586-1; Schoeman SA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8013; Scholes D, 2012, SEX TRANSM DIS, V39, P81, DOI 10.1097/OLQ.0b013e31823e3009; Shenzhen Staistics Bureau, 2017, SHENZH STAT YB 2017; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Tadesse E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168580; The Royal Australian College of General Practitioners (RACGP), 2018, GUID PREV ACT GEN PR, P23; Trojian TH, 2009, AM FAM PHYSICIAN, V79, P583; van den Broek IV, 2016, EUR J PUBLIC HEALTH, V26, P382, DOI 10.1093/eurpub/ckv196; van Rooijen MS, 2018, SEX TRANSM DIS, V45, P534, DOI [10.1097/OLQ.0000000000000794, 10.1097/olq.0000000000000794]; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wang HB, 2008, INT J STD AIDS, V19, P635, DOI 10.1258/ijsa.2008.008013; Wang QQ., 2014, GUIDELINES CLIN MANA; Wong WCW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172561; Workowski KA, 2015, CLIN INFECT DIS, V61, pS759, DOI 10.1093/cid/civ771; Yin YP, 2006, SEX TRANSM INFECT, V82, pV33, DOI 10.1136/sti.2006.022475; Yirenya-Tawiah Dzidzo, 2014, BMC Res Notes, V7, P349, DOI 10.1186/1756-0500-7-349; Yue XiaoLi, 2016, Chinese Journal of Dermatology, V49, P308; Zhang JJ, 2012, SEX TRANSM INFECT, V88, P272, DOI 10.1136/sextrans-2011-050163	56	6	6	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212292	10.1371/journal.pone.0212292	http://dx.doi.org/10.1371/journal.pone.0212292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779755	Green Submitted, Green Published, gold			2022-12-26	WOS:000459062900040
J	Murube, E; Campa, A; Ferreira, JJ				Murube, Ester; Campa, Ana; Jose Ferreira, Juan			Integrating genetic and physical positions of the anthracnose resistance genes described in bean chromosomes Pv01 and Pv04	PLOS ONE			English	Article							COLLETOTRICHUM-LINDEMUTHIANUM; PHASEOLUS-VULGARIS; COMMON; CULTIVAR; CLUSTER; SOFTWARE; MARKERS; IDENTIFICATION; DISSECTION; LINKAGE	A complex landscape of anthracnose resistance genes (Co-) located at the telomeric regions of the bean chromosomes Pv01 and Pv04 has been reported. The aim of this work was to investigate the genetic and physical positions of genes conferring resistance to races 6, 38, 39, 357, 65, and 73 as well as the relationships among the resistance genes identified herein and the previously described Co- genes in these telomeric regions. The linkage analysis using a genetic map of 497 SNPs from the recombinant inbred line population Xana/BAT93 revealed that the gene conferring resistance to race 65 in cultivar Xana (Co-1(65-X)) was located in the Co-1 cluster, at the distal end of chromosome Pv01. The fine mapping of Co-1(65-X) indicated that it was positioned between the physical positions 49,512,545 and 49,658,821 bp. This delimited physical position agrees with the positions of the previously mapped genes Co-1(4), Co-x, Co-14, Co-1(HY), and Co-Pa. Responses to races 6, 38, 39, and 357 in BAT93 exhibited co-segregation suggesting that the same gene, or very closely linked genes, were involved in the control. The linkage analysis showed that the resistance gene to race 38 in the genotype BAT93 (Co-3(38-B)) was located at the beginning of chromosome Pv04, in the genetic position of the Co-3 cluster, and was flanked by markers with physical positions between 1,286,490 and 2,047,754 bp. Thus, the genes Co-3, Co-9, Co-10, Co-16, and Co-3(38-B), found in this work, form part of the same anthracnose resistance cluster at the beginning of chromosome Pv04, which is consistent with the discontinuous distribution of typical R genes annotated in the underlying genomic region. Resistance loci involved in the response to race 73 in the genotypes Xana (R) and BAT93 (R) were mapped to the same positions on clusters Co-1 and Co-3, respectively. The positioning of the resistance genes in the bean genome based on fine linkage mapping should play an important role in the characterization and differentiation of the anthracnose resistance genes. The assignment of Co- genes to clusters of race specific genes can help simplify the current scenario of anthracnose resistance.	[Murube, Ester; Campa, Ana; Jose Ferreira, Juan] SERIDA, Plant Genet Grp, Area Hort & Forest Crops, Villaviciosa Asturias, Spain	Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA	Ferreira, JJ (corresponding author), SERIDA, Plant Genet Grp, Area Hort & Forest Crops, Villaviciosa Asturias, Spain.	jjferreira@serida.org	Ferreira, Juan Jose/J-9470-2016; Murube, Ester/K-5574-2017; Negrillo, Ana Campa/C-2768-2017	Ferreira, Juan Jose/0000-0002-8782-8868; Murube, Ester/0000-0003-4478-433X; Negrillo, Ana Campa/0000-0003-3970-9079; Murube Torcida., Ester/0000-0003-1652-416X	Ministerio de Economia y Competitividad [AGL2017-87050-R, RTA2011-0076-C02-01]; Spanish Government; European Regional Development Fund; Instituto de Investigacion y Tecnologia Agraria y Alimentaria (INIA, Spain) [DR13-0222]; European Regional Development's Funds (FEDER)	Ministerio de Economia y Competitividad(Spanish Government); Spanish Government(Spanish GovernmentEuropean Commission); European Regional Development Fund(European Commission); Instituto de Investigacion y Tecnologia Agraria y Alimentaria (INIA, Spain)(Instituto de Investigacion Agropecuaria (INIA)); European Regional Development's Funds (FEDER)	This work was supported in part by grants AGL2017-87050-R and RTA2011-0076-C02-01 from Ministerio de Economia y Competitividad, the Spanish Government, and the European Regional Development Fund. E. Murube (FPI-INIA) and A Campa (DR13-0222) are recipients of a salary from the Instituto de Investigacion y Tecnologia Agraria y Alimentaria (INIA, Spain) co-funding with European Regional Development's Funds (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by grants AGL2017-87050-R and RTA2011-0076-C02-01 from Ministerio de Economia y Competitividad, the Spanish Government, and the European Regional Development Fund. E. Murube (FPI-INIA) and A Campa (DR13-0222) are recipients of a salary from the Instituto de Investigacion y Tecnologia Agraria y Alimentaria (INIA, Spain) co-funding with European Regional Development's Funds (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank to M Bueno, F Diaz and JA Poladura for technical assistance.	Alzate-Marin AL, 2003, EUPHYTICA, V133, P165, DOI 10.1023/A:1025551006444; BANNEROT H, 1971, ANN AMELIOR PLANT, V21, P83; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Campa A, 2017, PHYTOPATHOLOGY, V107, P1515, DOI [10.1094/PHYTO-01-17-0012-R, 10.1094/phyto-01-17-0012-r]; Campa A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-115; Campa A, 2011, PHYTOPATHOLOGY, V101, P757, DOI 10.1094/PHYTO-11-10-0296; Campa A, 2009, THEOR APPL GENET, V119, P1, DOI 10.1007/s00122-009-1011-8; Castro SAD, 2017, BMC GENOMICS, V18, P12, DOI [10.1186/s12864-016-3419-2, DOI 10.1186/S12864-016-3419-2]; Chen ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169954; Coimbra-Goncalves GK, 2016, CROP SCI, V56, P2904, DOI 10.2135/cropsci2015.10.0651; David P, 2008, MOL GENET GENOMICS, V280, P521, DOI 10.1007/s00438-008-0384-8; David P, 2009, PLANT PHYSIOL, V151, P1048, DOI 10.1104/pp.109.142109; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Doerge RW, 1996, J QUANTITATIVE TRAIT, V2, P121, DOI DOI 10.1590/S1415-47572010005000033; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Feitoza L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183341; Ferreira J.J., 2013, TRANSLATIONAL GENOMI, VI, P151, DOI DOI 10.1002/9781118728475.CH9; Fouilloux G., 1979, DIS TROPICAL FOOD CR, P221; Geffroy V, 1999, MOL PLANT MICROBE IN, V12, P774, DOI 10.1094/MPMI.1999.12.9.774; Geffroy V, 2008, THEOR APPL GENET, V116, P407, DOI 10.1007/s00122-007-0678-y; Goncalves-Vidigal MC, 2013, THEOR APPL GENET, V126, P2245, DOI 10.1007/s00122-013-2131-8; Goncalves-Vidigal M.C., 2016, ANN REPORT BEAN IMPR, V59, P55; Goncalves-Vidigal MC, 2006, EUPHYTICA, V151, P411, DOI 10.1007/s10681-006-9164-x; Goncalves-Vidigal MC, 2012, PLANT BREEDING, V131, P423, DOI 10.1111/j.1439-0523.2011.01939.x; Goncalves-Vidigal MC, 2011, THEOR APPL GENET, V122, P893, DOI 10.1007/s00122-010-1496-1; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WT, 2010, THEOR APPL GENET, V121, P907, DOI 10.1007/s00122-010-1359-9; Margarido GRA, 2007, HEREDITAS, V144, P78, DOI 10.1111/j.2007.0018-0661.02000.x; Melotto M, 2000, EUPHYTICA, V116, P143, DOI 10.1023/A:1004005001049; Meziadi C, 2016, PLANT SCI, V242, P351, DOI 10.1016/j.plantsci.2015.09.006; Moghaddam SM, 2014, FRONT PLANT SCI, V5, P13, DOI [10.3389/fpls.2014.00013, DOI 10.3389/FPLS.2014.00013]; NODARI RO, 1993, THEOR APPL GENET, V85, P513, DOI 10.1007/BF00220907; Padder BA, 2017, J PLANT PATHOL, V99, P317; Padder BA, 2016, PLOS ONE, V11, DOI [10.1371/, DOI 10.1371/]; PASTOR-CORRALES M A, 1991, Phytopathology, V81, P694; R Development Core Team, 2017, LANG ENV STAT COMP R; Richard MMS, 2014, THEOR APPL GENET, V127, P1653, DOI 10.1007/s00122-014-2328-5; Rodriguez-Suarez C, 2008, THEOR APPL GENET, V116, P807, DOI 10.1007/s00122-008-0714-6; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Singh SP, 2010, CROP SCI, V50, P2199, DOI 10.2135/cropsci2009.03.0163; Sousa L. L., 2014, Australian Journal of Crop Science, V8, P317; Sousa LL, 2015, CROP SCI, V55, P1900, DOI 10.2135/cropsci2014.09.0604; Trabanco N, 2015, PLANT GENOME, V8, P11, DOI [10.3835/plantgenome2014100079, DOI 10.3835/PLANTGENOME2014100079]; Valentini G, 2017, THEOR APPL GENET, V130, P1705, DOI 10.1007/s00122-017-2920-6; Vlasova A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0883-6; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wu J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01398; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Young RA, 1997, CROP SCI, V37, P940, DOI 10.2135/cropsci1997.0011183X003700030039x; Young RA, 1998, THEOR APPL GENET, V96, P87, DOI 10.1007/s001220050713; Zuiderveen GH, 2016, PLOS ONE, V11, P17	52	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212298	10.1371/journal.pone.0212298	http://dx.doi.org/10.1371/journal.pone.0212298			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763410	Green Submitted, Green Published, gold			2022-12-26	WOS:000458763900064
J	Tamir, Z; Seid, A; Haileslassie, H				Tamir, Zemenu; Seid, Abdurahaman; Haileslassie, Haftay			Magnitude and associated factors of cytopenias among antiretroviral therapy naive Human Immunodeficiency Virus infected adults in Dessie, Northeast Ethiopia	PLOS ONE			English	Article							HEMATOLOGICAL ABNORMALITIES; IMMUNE-DEFICIENCY; HIV; THROMBOCYTOPENIA; PREVALENCE; ANEMIA; MANIFESTATIONS; COMPLICATIONS; NEUTROPENIA; CARE	Background Hematologic abnormalities involving peripheral blood cell cytopenias are strong predictors of morbidity, mortality and poor antiretroviral therapy (ART) outcomes of HIV infected individuals. However, limited studies are conducted in resource-limited settings of sub-Saharan Africa that have addressed the magnitude and associated factors of cytopenias. This study aimed to investigate the magnitude and associated factors of cytopenias among ART na ve HIV infected adult Ethiopians. Materials and methods A cross-sectional study was conducted among ART naive HIV infected individuals attending at ART unit of Dessie Referral Hospital between November 01, 2015 and April 30, 2016. A total of 402 adults were included using consecutive sampling. Socio-demographic, clinical and laboratory data of patients were collected. The data were entered to Epi Info version 3.4.3 and analyzed using SPSS version 20 software (SPSS INC, Chicago, IL, USA). Factors associated with cytopenias were analyzed first using bivariate and then multivariate logistic regression models. An odds ratio with 95% confidence interval was used to measure the strength of association. For all statistical significant tests, the cut-off value was set at P<0.05. Results In this study, the overall magnitude of any cytopenia, anemia, leucopenia and thrombocytopenia were 63.4%, 43.5%, 24.4% and 18.7%, respectively. In multivariate logistic regression analysis, severe immunosuppression and WHO clinical stage IV HIV disease were significantly associated with increased prevalence of cytopenias. In addition, older age and younger age showed significant association with increased prevalence of anemia and leucopenia, respectively. Conclusion Frequent occurrence of cytopenias was independently associated with severe immunosuppression and WHO clinical stage IV HIV disease. Further longitudinal multicenter studies are recommended to bolster the findings of this study in order to suggest the need of routine assessment and management of hematological abnormalities for optimal choice of initial antiretroviral agents and prevention of further morbidities.	[Tamir, Zemenu] Addis Ababa Univ, Dept Med Lab Sci, Coll Hlth Sci, Addis Ababa, Ethiopia; [Seid, Abdurahaman] Wollo Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Dessie, Ethiopia; [Haileslassie, Haftay] Mekelle Univ, Coll Hlth Sci, Dept Med Lab Sci, Mekelle, Ethiopia	Addis Ababa University; Mekelle University	Tamir, Z (corresponding author), Addis Ababa Univ, Dept Med Lab Sci, Coll Hlth Sci, Addis Ababa, Ethiopia.	zemenut266@gmail.com						Adane Asfaw, 2012, Ethiop Med J, V50, P13; Addis Z., 2014, INT BLOOD RES REV, V2, P270, DOI 10.9734/IBRR/2014/11137; Akinbami A, INFECT DIS RES TREAT; Anastos K, 2004, JAIDS-J ACQ IMM DEF, V35, P383, DOI 10.1097/00126334-200404010-00008; Assefa Muluken, 2015, BMC Hematol, V15, P6, DOI 10.1186/s12878-015-0024-6; Belperio PS, 2004, AM J MED, V116, P27, DOI 10.1016/j.amjmed.2003.12.010; CALENDA V, 1992, EUR J HAEMATOL, V48, P181; Choi Se Youn, 2011, Korean J Hematol, V46, P253, DOI 10.5045/kjh.2011.46.4.253; Coyle TE, 1997, MED CLIN N AM, V81, P449, DOI 10.1016/S0025-7125(05)70526-5; De Santis GC, 2011, INT J INFECT DIS, V15, pE808, DOI 10.1016/j.ijid.2011.08.001; Debarshi Saha, 2015, Journal of Medical Sciences, V35, P190; Denue BA, 2013, E MEDITERR HEALTH J, V19, P362, DOI 10.26719/2013.19.4.362; Dhurve SA, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.033; Dikshit Byomakesh, 2009, BMC Blood Disord, V9, P5, DOI 10.1186/1471-2326-9-5; Enawgaw Bamlaku, 2014, BMC Hematol, V14, P8, DOI 10.1186/2052-1839-14-8; Evans RH, 2000, BEST PRACT RES CL HA, V13, P215, DOI 10.1053/beha.1999.0069; Firnhaber C, 2010, INT J INFECT DIS, V14, pE1088, DOI 10.1016/j.ijid.2010.08.002; Gedefaw L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072202; Gunda DW, 2017, MALAWI MED J, V29, P43, DOI 10.4314/mmj.v29i1.9; Hekimoglu CH, 2017, TURK J MED SCI, V47, P69, DOI 10.3906/sag-1510-140; JOST J, 1988, SCHWEIZ MED WSCHR, V118, P206; KASLOW RA, 1987, ANN INTERN MED, V107, P474, DOI 10.7326/0003-4819-107-4-474; Kulkosky J, 2000, LEUKEMIA LYMPHOMA, V37, P497, DOI 10.3109/10428190009058502; Kyeyune R, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-496; Mathews Sujata E, 2013, J Lab Physicians, V5, P34, DOI 10.4103/0974-2727.115929; MURPHY MF, 1987, BRIT J HAEMATOL, V66, P337, DOI 10.1111/j.1365-2141.1987.tb06920.x; Opie J, 2012, SAMJ S AFR MED J, V102, P465, DOI 10.7196/SAMJ.5595; Patel KV, 2008, SEMIN HEMATOL, V45, P210, DOI 10.1053/j.seminhematol.2008.06.006; Prazeres F, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111097; SCADDEN DT, 1989, BLOOD, V74, P1455; Scaradavou A, 2002, BLOOD REV, V16, P73, DOI 10.1054/blre.2001.0188; Shen YZ, 2015, BIOSCI TRENDS, V9, P91, DOI 10.5582/bst.2015.01024; Shen YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073807; Taremwa IM, 2015, J BLOOD MED, V6, P109, DOI 10.2147/JBM.S80857; Vaughan JL, 2017, SAMJ S AFR MED J, V107, P264, DOI [10.7196/SAMJ.2017.v107i3.11206, 10.7196/samj.2017.v107i3.11206]; Wankah Paul Nji, 2014, BMC Hematol, V14, P15, DOI 10.1186/2052-1839-14-15; Wondimeneh Yitayih, 2014, BMC Res Notes, V7, P5, DOI 10.1186/1756-0500-7-5; World Health Organization, 2011, SER FERR CONC ASS IR; ZON LI, 1987, BRIT J HAEMATOL, V66, P251, DOI 10.1111/j.1365-2141.1987.tb01307.x	39	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211708	10.1371/journal.pone.0211708	http://dx.doi.org/10.1371/journal.pone.0211708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759131	gold, Green Published, Green Submitted			2022-12-26	WOS:000458761300055
J	Wheeler, DL; Scott, J; Dung, JKS; Johnson, DA				Wheeler, David Linnard; Scott, Jeness; Dung, Jeremiah Kam Sung; Johnson, Dennis Allen			Evidence of a trans-kingdom plant disease complex between a fungus and plant-parasitic nematodes	PLOS ONE			English	Article							VERTICILLIUM-DAHLIAE; PRATYLENCHUS-PENETRANS; POTATO; MANAGEMENT; MINT; WILT	Disease prediction tools improve management efforts for many plant diseases. Prediction and downstream prevention demand information about disease etiology, which can be complicated for some diseases, like those caused by soilborne microorganisms. Fortunately, the availability of machine learning methods has enabled researchers to elucidate complex relationships between hosts and pathogens without invoking difficult-to-satisfy assumptions. The etiology of a destructive plant disease, Verticillium wilt of mint, caused by the fungus Verticillium dahliae was reevaluated with several supervised machine learning methods. Specifically, the objective of this research was to identify drivers of wilt in commercial mint fields, describe the relationships between these drivers, and predict wilt. Soil samples were collected from commercial mint fields. Wilt foci, V. dahliae, and plant-parasitic nematodes that can exacerbate wilt were quantified. Multiple linear regression, a generalized additive model, random forest, and an artificial neural network were fit to the data, validated with 10 fold cross-validation, and measures of explanatory and predictive performance were compared. All models selected nematodes within the genus Pratylenchus as the most important predictor of wilt. The fungus after which this disease is named, V. dahliae, was the fourth most important predictor of wilt, after crop age and cultivar. All models explained around 50% of the total variation (R-2 <= 0.46), and exhibited comparable predictive error (RMSE <= 1.21). Collectively, these models revealed that the quantitative relationships between two pathogens, mint cultivars and age are required to explain wilt. The ascendance of Pratylenchus spp. in predicting symptoms of a disease assumed to primarily be caused by V. dahliae exposes the underestimated contribution of these nematodes to wilt. This research provides a foundation on which predictive forecasting tools can be developed for mint growers and reminds us of the lessons that can be learned by revisiting assumptions about disease etiology.	[Wheeler, David Linnard; Johnson, Dennis Allen] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Scott, Jeness; Dung, Jeremiah Kam Sung] Oregon State Univ, Dept Bot & Plant Pathol, Madras, OR USA	Washington State University; Oregon State University	Wheeler, DL (corresponding author), Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA.	david.wheeler@wsu.edu		Scott, Jeness/0000-0001-6395-3368	Mint Industry Research Council [3061 4682]; Washington Mint Commission [3061 6678]; Oregon Mint Commission; Natural Resource Sciences, Agricultural Research Center, Washington State University, Pullman, WA, USA [WNP00678]	Mint Industry Research Council; Washington Mint Commission; Oregon Mint Commission; Natural Resource Sciences, Agricultural Research Center, Washington State University, Pullman, WA, USA	This research was supported by grants obtained by the Mint Industry Research Council (http://www.usmintindustry.com/), grant number 3061 4682, the Washington Mint Commission, grant number 3061 6678, and the Oregon Mint Commission. The authors J.K.S.D and D.A.J received the grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful Dr. Randal Rowe for pre-submission review. To Nadine Wade and Russ Ingham of the Nematode Testing Service in the Department of Botany and Plant Pathology, Oregon State University, we are grateful for assistance in nematode sample processing. Additionally, we thank Darrin Walenta for collecting samples in Northeastern Oregon, PPNS #0769, Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center, Hatch Project No. WNP00678, Washington State University, Pullman, WA 99164-6430, USA.	ANNAS GJ, 1988, HASTINGS CENT REP, V18, P31, DOI 10.2307/3563046; [Anonymous], 2011, FUNG DIS EM THREAT H; [Anonymous], 2016, MEDIUM; Back MA, 2002, PLANT PATHOL, V51, P683, DOI 10.1046/j.1365-3059.2002.00785.x; Beckage B, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00211.1; BUTTERFIELD EJ, 1977, PHYTOPATHOLOGY, V67, P1073, DOI 10.1094/Phyto-67-1073; Byrd AL, 2016, SCIENCE, V351, P224, DOI 10.1126/science.aad6753; Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463; Dung JKS, 2013, PHYTOPATHOLOGY, V103, P445, DOI 10.1094/PHYTO-06-12-0133-R; Eshtiaghi H., 1975, THESIS; Eugster MJA, 2008, 302008 U MUN DEP STA; Evans AS, CAUSATION DIS, P1; FAULKNER LR, 1964, PHYTOPATHOLOGY, V54, P344; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Hastie T., 1986, STAT SCI, V1, P297; Heuer Jr R. J., 1999, PSYCHOL INTELLIGENCE; Holmes EC, 2018, NATURE, V558, P180, DOI 10.1038/d41586-018-05373-w; HORNER CE, 1954, PHYTOPATHOLOGY, V44, P239; Hothorn T, 2005, J COMPUT GRAPH STAT, V14, P675, DOI 10.1198/106186005X59630; Inderbitzin P, 2011, PLOS ONE, V6, P12, DOI [10.1371/journal.pone.0028341, DOI 10.1371/JOURNAL.PONE.0028341]; Inderbitzin P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065990; INGHAM R., 1994, METHODS SOIL ANAL 2, P459; Ingham RE, 1998, OSU NEMATODE TESTING; Ingham RE, 1996, IPPC PUBLICATION, V996, P39; James G., 2014, INTRO STAT LEARNING; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Johnson DA, 2001, PLANT DIS, V85, P1189, DOI 10.1094/PDIS.2001.85.11.1189; Johnson DA, 2006, PLANT DIS, V90, P789, DOI 10.1094/PD-90-0789; Kabir Z, 2004, PLANT DIS, V88, P49, DOI 10.1094/PDIS.2004.88.1.49; KABLE PF, 1968, NEMATOLOGICA, V14, P101, DOI 10.1163/187529268X00697; Kleynhans D, 1996, PLANT NEMATODES S AF; Koch R., 1890, 10 INT C MED BERL; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Larkin RP, 2011, PLANT DIS, V95, P568, DOI 10.1094/PDIS-09-10-0670; Lo C, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005915; MARTIN MJ, 1982, PHYTOPATHOLOGY, V72, P640, DOI 10.1094/Phyto-72-640; Merrifield KJ, 1996, J NEMATOL, V28, P557; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; POWELSON ML, 1993, ANNU REV PHYTOPATHOL, V31, P111, DOI 10.1146/annurev.py.31.090193.000551; ROWE RC, 1987, PLANT DIS, V71, P482, DOI 10.1094/PD-71-0482; Rowe RC, 2002, PLANT DIS, V86, P1184, DOI 10.1094/PDIS.2002.86.11.1184; Schultz OE, 1977, P BR CROP PROT C PES, V2, P491; Sciacca G, 2016, NEUROL SCI, V37, P541, DOI 10.1007/s10072-015-2450-4; Ulam SM, 1976, ADVENTURES MATH; WALLACE HR, 1978, ANNU REV PHYTOPATHOL, V16, P379, DOI 10.1146/annurev.py.16.090178.002115; Wei F, 2015, PHYTOPATHOLOGY, V105, P220, DOI 10.1094/PHYTO-05-14-0139-R; WHEELER TA, 1994, J NEMATOL, V26, P228; Wickham H., 2016, GGPLOT2 ELEGANT GRAP	48	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211508	10.1371/journal.pone.0211508	http://dx.doi.org/10.1371/journal.pone.0211508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759127	gold, Green Submitted, Green Published			2022-12-26	WOS:000458761300049
J	Cheng, X; Li, GH; Ma, CH; Abdullah, M; Zhang, JY; Zhao, H; Jin, Q; Cai, YP; Lin, Y				Cheng, Xi; Li, Guohui; Ma, Chenhui; Abdullah, Muhammad; Zhang, Jinyun; Zhao, Hai; Jin, Qing; Cai, Yongping; Lin, Yi			Comprehensive genome-wide analysis of the pear (Pyrus bretschneideri) laccase gene (PbLAC) family and functional identification of PbLAC1 involved in lignin biosynthesis	PLOS ONE			English	Article							STONE CELL; ARABIDOPSIS; LIGNIFICATION; POLYMERIZATION; EXPRESSION	The content and size of stone cell clusters affects the quality of pear fruit, and monolignol polymerization and deposition in the cell walls constitute a required step for stone cell formation. Laccase (LAC) is the key enzyme responsible for the polymerization of monolignols. However, there are no reports on the LAC family in pear (Pyrus bretschneideri), and the identity of the members responsible for lignin synthesis has not been clarified. Here, 41 LACs were identified in the whole genome of pear. All Pyrus bretschneideri LACs (PbLACs) were distributed on 13 chromosomes and divided into four phylogenetic groups (I-IV). In addition, 16 segmental duplication events were found, implying that segmental duplication was a primary reason for the expansion of the PbLAC family. LACs from the genomes of three Rosaceae species (Prunus mummer, Prunus persica, and Fragaria vesca) were also identified, and an interspecies collinearity analysis was performed. The phylogenetic analysis, sequence alignments and spatiotemporal expression pattern analysis suggested that PbLAC1, 5, 6, 29, 36 and 38 were likely associated with lignin synthesis and stone cell formation in fruit. The two target genes of Pyr-miR1890 (a microRNA identified from pear fruit that is associated with lignin and stone cell accumulation), PbLAC1 and PbLAC14, were selected for genetic transformation. Interfamily transfer of PbLAC1 into Arabidopsis resulted in a significant increase (approximately 17%) in the lignin content and thicker cell walls in interfascicular fibre and xylem cells, which demonstrated that PbLAC1 is involved in lignin biosynthesis and cell wall development. However, the lignin content and cell wall thickness were not changed significantly in the PbLAC14-overexpressing transgenic Arabidopsis plants. This study revealed the function of PbLAC1 in lignin synthesis and provides important insights into the characteristics and evolution of the PbLAC family.	[Cheng, Xi; Li, Guohui; Ma, Chenhui; Abdullah, Muhammad; Zhang, Jinyun; Zhao, Hai; Jin, Qing; Cai, Yongping; Lin, Yi] Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China; [Zhang, Jinyun] Anhui Acad Agr Sci, Hort Inst, Hefei, Anhui, Peoples R China	Anhui Agricultural University; Anhui Academy of Agricultural Sciences	Cai, YP; Lin, Y (corresponding author), Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China.	ypcaiah@163.com; linyi1957@126.com		Abdullah, Muhammad/0000-0001-6925-6192	National Natural Science Foundation of China (NSFC) [31640068]; Natural Science Foundation of Anhui Province; Department of Science and Technology of Anhui Province [1808085QC79]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Department of Science and Technology of Anhui Province	This work was supported by National Natural Science Foundation of China (NSFC) (http://www.nsfc.gov.cn/), Award Number: 31640068, Grant Recipient: Y.C.; Natural Science Foundation of Anhui Province, funder name: Department of Science and Technology of Anhui Province (http://www.ahkjt.gov.cn/), Award Number: 1808085QC79, Grant Recipient: X.C.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NA, 2015, PLANT CELL, V27, P2195, DOI 10.1105/tpc.15.00373; Balasubramanian VK, 2016, SCI REP, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Barros J, 2015, ANN BOT-LONDON, V115, P1053, DOI 10.1093/aob/mcv046; Berthet S, 2011, PLANT CELL, V23, P1124, DOI 10.1105/tpc.110.082792; Brahem M, 2017, CARBOHYD POLYM, V156, P152, DOI 10.1016/j.carbpol.2016.09.019; Cai XN, 2006, J EXP BOT, V57, P2563, DOI 10.1093/jxb/erl022; Cai YP, 2010, SCI HORTIC-AMSTERDAM, V125, P374, DOI 10.1016/j.scienta.2010.04.029; Cesarino I, 2013, J EXP BOT, V64, P1769, DOI 10.1093/jxb/ert045; CHEN XY, 2018, FRONT IMMUNOL, V9; Cheng X, 2017, BIOL OPEN, V6, P1602, DOI 10.1242/bio.026997; Cheng XQ, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/5389272; Choi J., 2007, HORTIC ENVIRON BIOTE, V48, P17; Choi JH, 2013, J APPL BOT FOOD QUAL, V86, P185, DOI 10.5073/JABFQ.2013.086.025; Chou EY, 2018, J EXP BOT, V69, P1849, DOI 10.1093/jxb/ery067; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Meester B, 2018, PLANT PHYSIOL, V176, P611, DOI 10.1104/pp.17.01462; Derksen H, 2013, PLANT SCI, V207, P79, DOI 10.1016/j.plantsci.2013.03.004; Dona M, 2013, PLANT CELL REP, V32, P1043, DOI 10.1007/s00299-013-1410-9; Dong HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067505; Huang JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22900; Jin Q, 2013, SCI HORTIC-AMSTERDAM, V155, P123, DOI 10.1016/j.scienta.2013.03.020; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li N, 2017, INT J AGRIC BIOL, V19, P610, DOI 10.17957/IJAB/15.0304; Lin YX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-76; Lin YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102825; Liu FG, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071117; Liu QQ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020209; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu GL, 2015, J PLANT GROWTH REGUL, V34, P251, DOI 10.1007/s00344-014-9461-x; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; McCaig BC, 2005, PLANTA, V221, P619, DOI 10.1007/s00425-004-1472-6; Mitra PP, 2014, JOVE-J VIS EXP, DOI 10.3791/51381; Pourcel L, 2005, PLANT CELL, V17, P2966, DOI 10.1105/tpc.105.035154; Schuetz M, 2014, PLANT PHYSIOL, V166, P798, DOI 10.1104/pp.114.245597; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang CY, 2014, PLANT BIOTECHNOL J, V12, P1132, DOI 10.1111/pbi.12222; Wang GD, 2004, NAT BIOTECHNOL, V22, P893, DOI 10.1038/nbt982; Wang J, 2008, PLANT CELL TISS ORG, V93, P303, DOI 10.1007/s11240-008-9377-x; Wang QQ, 2015, INT J MOL SCI, V16, P23517, DOI 10.3390/ijms161023517; Wang Y, 2015, PLANT PHYSIOL, V168, P192, DOI 10.1104/pp.114.255489; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Xue C, 2019, PLANT BIOTECHNOL J, V17, P103, DOI 10.1111/pbi.12950; Yan CC, 2014, SCI HORTIC-AMSTERDAM, V174, P142, DOI 10.1016/j.scienta.2014.05.018; Zhang JY, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0187114, 10.1371]; Zhang WL, 2014, MOL GENET GENOMICS, V289, P373, DOI 10.1007/s00438-014-0814-8; Zhao Q, 2013, PLANT CELL, V25, P3976, DOI 10.1105/tpc.113.117770; Zhao ShuGang, 2013, Journal of Food, Agriculture & Environment, V11, P937	47	16	20	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0210892	10.1371/journal.pone.0210892	http://dx.doi.org/10.1371/journal.pone.0210892			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753186	Green Submitted, gold, Green Published			2022-12-26	WOS:000458395600007
J	Varela, PF; Velours, C; Aumont-Nicaise, M; Pineau, B; Legrand, P; Poquet, I				Varela, Paloma Fernandez; Velours, Christophe; Aumont-Nicaise, Magali; Pineau, Blandine; Legrand, Pierre; Poquet, Isabelle			Biophysical and structural characterization of a zinc-responsive repressor of the MarR superfamily	PLOS ONE			English	Article							DNA-BINDING; STREPTOCOCCUS-PNEUMONIAE; CRYSTAL-STRUCTURE; FAMILY; REGULATOR; COMPETENCE; PROTEIN; RESISTANCE; VIRULENCE; SWITCH	The uptake of zinc, which is vital in trace amounts, is tightly controlled in bacteria. For this control, bacteria of the Streptococcaceae group use a Zn(II)-binding repressor named ZitR in lactococci and AdcR in streptococci, while other bacteria use a Zur protein of the Ferric uptake regulator (Fur) superfamily. ZitR and AdcR proteins, characterized by a winged helix-turn-helix DNA-binding domain, belong to the multiple antibiotic resistance (MarR) superfamily, where they form a specific group of metallo-regulators. Here, one such Zn(II)responsive repressor, ZitR of Lactococcus lactis subspecies cremoris strain MG1363, is characterized. Size Exclusion Chromatography-coupled to Multi Angle Light Scattering, Circular Dichroism and Isothermal Titration Calorimetry show that purified ZitR is a stable dimer complexed to Zn(II), which is able to bind its two palindromic operator sites on DNA fragments. The crystal structure of ZitR holo-form (Zn(II) 4-ZitR2), has been determined at 2.8 A resolution. ZitR is the fourth member of the MarR metallo-regulator subgroup whose structure has been determined. The folding of ZitR/ AdcR metallo-proteins is highly conserved between both subspecies (cremoris or lactis) in the Lactococcus lactis species and between species (Lactococcus lactis and Streptococcus pneumoniae or pyogenes) in the Streptococcaceae group. It is also similar to the folding of other MarR members, especially in the DNA-binding domain. Our study contributes to better understand the biochemical and structural properties of metallo-regulators in the MarR superfamily.	[Varela, Paloma Fernandez; Pineau, Blandine; Legrand, Pierre] Synchrotron SOLEIL, Gif Sur Yvette, France; [Varela, Paloma Fernandez] CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Velours, Christophe] CNRS, IMAGIF, Gif Sur Yvette, France; [Aumont-Nicaise, Magali] Univ Paris Sud, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France; [Poquet, Isabelle] Univ Paris Saclay, Micalis Inst, INRA, AgroParisTech, Jouy En Josas, France; [Varela, Paloma Fernandez; Velours, Christophe; Aumont-Nicaise, Magali] Univ Paris Saclay, Inst Integrat Biol Cell, CEA, CNRS, Gif Sur Yvette, France	SOLEIL Synchrotron; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Varela, PF (corresponding author), Synchrotron SOLEIL, Gif Sur Yvette, France.; Varela, PF (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France.; Varela, PF (corresponding author), Univ Paris Saclay, Inst Integrat Biol Cell, CEA, CNRS, Gif Sur Yvette, France.	paloma.fernandez-varela@i2bc.paris-saclay.fr	Isabelle, Poquet/AAA-7746-2021; Varela, Paloma/AFT-0478-2022; LEGRAND, Pierre/G-7709-2011	Isabelle, Poquet/0000-0003-3514-6520; Varela, Paloma/0000-0001-5078-7102; LEGRAND, Pierre/0000-0003-2431-2255; blandine, Pineau/0000-0003-0905-4796	French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]	French Infrastructure for Integrated Structural Biology (FRISBI)	This work was supported by the French Infrastructure for Integrated Structural Biology (FRISBI), ANR-10-INSB-05-01.	Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Capdevila DA, 2016, J BIOL CHEM, V291, P20858, DOI 10.1074/jbc.R116.742023; Chandrangsu P, 2017, NAT REV MICROBIOL, V15, P338, DOI 10.1038/nrmicro.2017.15; Choi SH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15812; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Deochand DK, 2017, CRIT REV BIOCHEM MOL, V52, P595, DOI 10.1080/10409238.2017.1344612; Dintilhac A, 1997, RES MICROBIOL, V148, P119, DOI 10.1016/S0923-2508(97)87643-7; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; Guerra AJ, 2011, J AM CHEM SOC, V133, P19614, DOI 10.1021/ja2080532; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lees JG, 2004, ANAL BIOCHEM, V15, P332; Llull D, 2004, APPL ENVIRON MICROB, V70, P5398, DOI 10.1128/AEM.70.9.5398-5406.2004; Llull D, 2011, J BACTERIOL, V193, P1919, DOI 10.1128/JB.01109-10; Ma Z, 2011, NUCLEIC ACIDS RES, V39, P9130, DOI 10.1093/nar/gkr625; Makthal N, 2017, EBIOMEDICINE, V21, P131, DOI 10.1016/j.ebiom.2017.05.030; Maret W, 2013, ADV NUTR, V4, P82, DOI 10.3945/an.112.003038; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Quade N, 2012, J BIOL CHEM, V19, P287; Reyes-Caballero H, 2010, J MOL BIOL, V403, P197, DOI 10.1016/j.jmb.2010.08.030; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saito K, 2003, J BACTERIOL, V185, P6195, DOI 10.1128/JB.185.20.6195-6198.2003; Sanson M, 2015, NUCLEIC ACIDS RES, V43, P418, DOI 10.1093/nar/gku1304; Shafeeq S, 2011, METALLOMICS, V3, P609, DOI 10.1039/c1mt00030f; Tubek S, 2008, BIOL TRACE ELEM RES, V121, P1, DOI 10.1007/s12011-007-8038-y; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhu RF, 2017, P NATL ACAD SCI USA, V114, P13661, DOI 10.1073/pnas.1708563115	37	4	4	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0210123	10.1371/journal.pone.0210123	http://dx.doi.org/10.1371/journal.pone.0210123			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753183	Green Published, Green Submitted, gold			2022-12-26	WOS:000458395600006
J	Mack, KML; Eppinga, MB; Bever, JD				Mack, Keenan M. L.; Eppinga, Maarten B.; Bever, James D.			Plant-soil feedbacks promote coexistence and resilience in multi-species communities	PLOS ONE			English	Article							DENSITY-DEPENDENCE; RELATIVE ABUNDANCE; FOOD WEBS; STABILITY; DYNAMICS; PATTERNS; INVASIVENESS; MAINTENANCE; POPULATION; COMPLEXITY	Both ecological theory and empirical evidence suggest that negative frequency dependent feedbacks structure plant communities, but integration of these findings has been limited. Here we develop a generic model of frequency dependent feedback to analyze coexistence and invasibility in random theoretical and real communities for which frequency dependence through plant-soil feedbacks (PSFs) was determined empirically. We investigated community stability and invasibility by means of mechanistic analysis of invasion conditions and numerical simulations. We found that communities fall along a spectrum of coexistence types ranging from strict pair-wise negative feedback to strict intransitive networks. Intermediate community structures characterized by partial intransitivity may feature "keystone competitors" which disproportionately influence community stability. Real communities were characterized by stronger negative feedback and higher robustness to species loss than randomly assembled communities. Partial intransitivity became increasingly likely in more diverse communities. The results presented here theoretically explain why more diverse communities are characterized by stronger negative frequency dependent feedbacks, a pattern previously encountered in observational studies. Natural communities are more likely to be maintained by strict negative plant-soil feedback than expected by chance, but our results also show that community stability often depends on partial intransitivity. These results suggest that plant-soil feedbacks can facilitate coexistence in multi-species communities, but that these feedbacks may also initiate cascading effects on community diversity following from single-species loss.	[Mack, Keenan M. L.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Eppinga, Maarten B.] Univ Utrecht, Copernicus Inst Sustainable Dev, Dept Environm Sci, Utrecht, Netherlands; [Eppinga, Maarten B.] Univ Zurich, Dept Geog, Zurich, Switzerland; [Bever, James D.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Bever, James D.] Univ Kansas, Kansas Biol Survey, Lawrence, KS 66045 USA; [Mack, Keenan M. L.] Illinois Coll, Dept Biol, Jacksonville, IL 62650 USA	Indiana University System; Indiana University Bloomington; Utrecht University; University of Zurich; University of Kansas; University of Kansas	Mack, KML (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.; Mack, KML (corresponding author), Illinois Coll, Dept Biol, Jacksonville, IL 62650 USA.	keenan.mack@mail.ic.edu			National Science Foundation [DEB -0919434, DEB -1050237, DEB-1556664, DEB-1738041, DEB - 1738041]; National Institute for Mathematical and Biological Synthesis - NSF; US Department of Homeland Security; US Department of Agriculture through NSF [EF-0832858]; University of Tennessee, Knoxville; National Institutes of Health [R01 GM092660]	National Science Foundation(National Science Foundation (NSF)); National Institute for Mathematical and Biological Synthesis - NSF; US Department of Homeland Security(United States Department of Homeland Security (DHS)); US Department of Agriculture through NSF(National Science Foundation (NSF)); University of Tennessee, Knoxville; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Science Foundation, grant no. DEB -0919434, DEB -1050237, DEB-1556664, DEB-1738041 (https://www.nsf.gov/) to KMLM and JDB; National Institute for Mathematical and Biological Synthesis, an Institute sponsored by the NSF; the US Department of Homeland Security; and the US Department of Agriculture through NSF award #EF-0832858, with additional support from the University of Tennessee, Knoxville to KMLM, MBE, JDB; National Institutes of Health, grant no. R01 GM092660, (https://www.nih.gov/) to JDB and National Science Foundation, grant no. DEB - 1738041, (https://www.nsf.gov/) to MBE and JDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Aguilera AG, 2011, ECOL MODEL, V222, P3413, DOI 10.1016/j.ecolmodel.2011.06.018; Allesina S, 2011, P NATL ACAD SCI USA, V108, P5638, DOI 10.1073/pnas.1014428108; Bardgett RD, 2014, NATURE, V515, P505, DOI 10.1038/nature13855; Bauer JT, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00480.1; Bever JD, 2015, ANNU REV ECOL EVOL S, V46, P305, DOI 10.1146/annurev-ecolsys-112414-054306; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Bonanomi G, 2005, OIKOS, V111, P311, DOI 10.1111/j.0030-1299.2005.13975.x; Bonanomi Giuliano, 2012, Biological Letters, V49, P35, DOI 10.2478/v10120-012-0007-2; Chawanya T, 2002, J PHYS SOC JPN, V71, P429, DOI 10.1143/JPSJ.71.429; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chisholm RA, 2011, THEOR ECOL-NETH, V4, P241, DOI 10.1007/s12080-011-0119-z; Chung YA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0608; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Cressman R, 2014, P NATL ACAD SCI USA, V111, P10810, DOI 10.1073/pnas.1400823111; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Eppinga MB, 2006, OIKOS, V114, P168, DOI 10.1111/j.2006.0030-1299.14625.x; Eppinga MB, 2018, NAT ECOL EVOL, V2, P1403, DOI 10.1038/s41559-018-0622-3; Eppstein MJ, 2007, ECOL LETT, V10, P253, DOI 10.1111/j.1461-0248.2007.01017.x; Fitzsimons MS, 2010, AM J BOT, V97, P1937, DOI 10.3732/ajb.0900237; Fowler MS, 2010, OIKOS, V119, P864, DOI 10.1111/j.1600-0706.2009.17817.x; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; Gustafson DJ, 2004, PLANT SOIL, V259, P9, DOI 10.1023/B:PLSO.0000020936.56786.a4; Hawkes CV, 2013, PLANT SOIL, V369, P141, DOI 10.1007/s11104-012-1557-0; Hemrova L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157800; Hendriks M, 2013, J ECOL, V101, P287, DOI 10.1111/1365-2745.12032; Hofbauer J., 1985, DYNAMICAL SYSTEMS, P70; Johnson DJ, 2012, SCIENCE, V336, P904, DOI 10.1126/science.1220269; Kardol P, 2007, ECOL MONOGR, V77, P147, DOI 10.1890/06-0502; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Kulmatiski A, 2011, J ECOL, V99, P542, DOI 10.1111/j.1365-2745.2010.01784.x; Leibold MA, 1996, AM NAT, V147, P784, DOI 10.1086/285879; Levine JM, 2006, ECOL LETT, V9, P1005, DOI 10.1111/j.1461-0248.2006.00949.x; Liang MX, 2015, ECOLOGY, V96, P562, DOI 10.1890/14-0871.1; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MacDougall AS, 2011, P ROY SOC B-BIOL SCI, V278, P2939, DOI 10.1098/rspb.2010.2730; Mack KML, 2014, J ECOL, V102, P1195, DOI 10.1111/1365-2745.12269; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Manning P, 2008, OECOLOGIA, V157, P661, DOI 10.1007/s00442-008-1104-0; Markham JH, 2009, ECOL RES, V24, P93, DOI 10.1007/s11284-008-0485-1; May RM, 1973, STABILITY AND COMPLE; McCarthy-Neumann S, 2010, J ECOL, V98, P396, DOI 10.1111/j.1365-2745.2009.01619.x; Montoya JM, 2009, ECOLOGY, V90, P2426, DOI 10.1890/08-0657.1; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Peltzer DA, 2009, OIKOS, V118, P1001, DOI 10.1111/j.1600-0706.2009.17244.x; Pendergast TH, 2013, NEW PHYTOL, V197, P1300, DOI 10.1111/nph.12105; PIMM SL, 1979, OIKOS, V33, P351, DOI 10.2307/3544322; Poisot T, 2011, ECOL LETT, V14, P841, DOI 10.1111/j.1461-0248.2011.01645.x; Revilla TA, 2013, THEOR ECOL-NETH, V6, P99, DOI 10.1007/s12080-012-0163-3; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tilman D., 1982, Monographs in Population Biology, pi; van der Putten WH, 2007, ECOLOGY, V88, P978, DOI 10.1890/06-1051; WILSON JB, 1992, ADV ECOL RES, V23, P263, DOI 10.1016/S0065-2504(08)60149-X	58	18	20	8	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211572	10.1371/journal.pone.0211572	http://dx.doi.org/10.1371/journal.pone.0211572			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742633	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000458393400015
J	Bown, D; Belli, A; Qureshi, K; Davies, D; Toman, E; Upthegrove, R				Bown, Dominic; Belli, Antonio; Qureshi, Kasim; Davies, David; Toman, Emma; Upthegrove, Rachel			Post-traumatic stress disorder and self-reported outcomes after traumatic brain injury in victims of assault	PLOS ONE			English	Article							QUALITY-OF-LIFE; RISK-FACTORS; HEALTH; EPIDEMIOLOGY; ASSOCIATIONS; SYMPTOMS; VETERANS; ETIOLOGY; MODERATE; VIOLENCE	Introduction Assault is the third most common cause of traumatic brain injury (TBI), after falls and road traffic collisions. TBI can lead to multiple long-term physical, cognitive and emotional sequelae, including post-traumatic stress disorder (PTSD). Intentional violence may further compound the psychological trauma of the event, in a way that conventional outcome measures, like the Glasgow Outcome Scale (GOS), fail to capture. This study aims to examine the influence of assault on self-reported outcomes, including quality of life and symptoms of PTSD. Methods Questionnaire were completed by 256 patients attending a TBI clinic, including Quality of Life after Brain Injury (QOLIBRI) and PTSD checklist (PCL-C). Medical records provided demographics, clinical data and aetiology of injury. Subjective outcomes were compared between assault and other causes. Results Of 202 patients analysed, 21% sustained TBI from assault. There was no difference in severity of injuries between assault and non-assault groups. No relationship was found between self-reported outcomes and TBI severity or GOS. The assault group scored worse in all self-reported questionnaires, with statistically significant differences for measures of PTSD and post-concussion symptoms. However, using threshold scores, the prevalence of PTSD in assaulted patients was not higher than non-assault. After adjusting for age, ethnicity and the presence of extra-cranial trauma, assault did not have a significant effect on questionnaire scores. Exploratory analysis showed that assault and road traffic accidents were associated with significantly worse outcomes compared to falls. Conclusion Quality of life is significantly related to functional and psychological outcomes after TBI. Assaulted patients suffer from worse self-reported outcomes than other patients, but these differences were insignificant when adjusted for demographic factors. Intentionality behind the traumatic event is likely more important than cause alone. Differences in quality of life and other self-reported outcomes are not reflected by the Glasgow Outcome Scale. This information is useful in arranging earlier and targeted review and support.	[Bown, Dominic; Qureshi, Kasim; Upthegrove, Rachel] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Belli, Antonio] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Belli, Antonio; Davies, David] Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Toman, Emma] Univ Cent Lancashire, Preston, Lancs, England; [Upthegrove, Rachel] Univ Birmingham, Inst Mental Hlth, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Central Lancashire; University of Birmingham	Upthegrove, R (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England.; Upthegrove, R (corresponding author), Univ Birmingham, Inst Mental Hlth, Birmingham, W Midlands, England.	r.upthegrove@bham.ac.uk	Belli, Antonio/I-3799-2015; Upthegrove, Rachel/AAD-9761-2022	Belli, Antonio/0000-0002-3211-9933; Upthegrove, Rachel/0000-0001-8204-5103; Bown, Dominic/0000-0002-2421-3196				Asmundson GJG, 2000, BEHAV RES THER, V38, P203, DOI 10.1016/S0005-7967(99)00061-3; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dagher JH, 2010, BRAIN INJURY, V24, P1389, DOI 10.3109/02699052.2010.523042; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Ghroubi S., 2016, ANN PHYS REHABIL M S, V59, pe135, DOI [10.1016/j.rehab.2016.07.304, DOI 10.1016/J.REHAB.2016.07.304]; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kaminer D, 2008, SOC SCI MED, V67, P1589, DOI 10.1016/j.socscimed.2008.07.023; Kim H, 2013, DISABIL REHABIL, V35, P2213, DOI 10.3109/09638288.2013.774063; Machamer JE, 2003, J HEAD TRAUMA REHAB, V18, P387, DOI 10.1097/00001199-200309000-00001; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mathias JL, 2014, J NEUROTRAUM, V31, P658, DOI 10.1089/neu.2013.3160; Motzkin Julian C, 2015, Handb Clin Neurol, V128, P633, DOI 10.1016/B978-0-444-63521-1.00039-X; Nachit-Ouinekh F, 2005, EUR J NEUROL, V12, P189, DOI 10.1111/j.1468-1331.2004.00934.x; National Institute for Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Patel MB, 2015, J NEUROTRAUM, V32, P984, DOI 10.1089/neu.2014.3652; Perkonigg A, 2000, ACTA PSYCHIAT SCAND, V101, P46, DOI 10.1034/j.1600-0447.2000.101001046.x; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schopp LH, 2006, J HEAD TRAUMA REHAB, V21, P213, DOI 10.1097/00001199-200605000-00002; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Trost Z, 2015, REHABIL PSYCHOL, V60, P213, DOI 10.1037/rep0000043; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	48	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211684	10.1371/journal.pone.0211684	http://dx.doi.org/10.1371/journal.pone.0211684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5RX	30730924	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000458026000043
J	Valtierra-de-Luis, D; Villanueva, M; Caballero, J; Matas, IM; Williams, T; Caballero, P				Valtierra-de-Luis, Daniel; Villanueva, Maite; Caballero, Javier; Matas, Isabel M.; Williams, Trevor; Caballero, Primitivo			Quantification of dose-mortality responses in adult Diptera: Validation using Ceratitis capitata and Drosophila suzukii responses to spinosad	PLOS ONE			English	Article							FRUIT-FLY DIPTERA; DIETARY RESTRICTION; NATURAL VARIATION; FEEDING-BEHAVIOR; TEPHRITIDAE; EFFICACY; INSECTICIDES; MELANOGASTER; PARAMETERS; MANAGEMENT	Quantitative laboratory bioassay methods are required to evaluate the toxicity of novel insecticidal compounds for pest control and to determine the presence of resistance traits. We used a radioactive tracer based on P-32-ATP to estimate the volume of a droplet ingested by two dipteran pests: Ceratitis capitata (Tephritidae) and Drosophila suzukii (Drosophilidae). Using blue food dye it was possible to distinguish between individuals that ingested the solution from those that did not. The average volume ingested by C. capitata adults was 1.968 mu l. Females ingested a similar to 20% greater volume of solution than males. Adults of D. suzukii ingested an average of 0.879 mu l and females ingested similar to 30% greater volume than males. The droplet feeding method was validated using the naturally-derived insecticide spinosad as the active ingredient (a.i.). For C. capitata, the concentration-mortality response did not differ between the sexes or among three different batches of insects. Lethal dose values were calculated based on mean ingested volumes. For C. capitata LD50 values were 1.462 and 1.502 ng a.i./insect for males and females, respectively, equivalent to 0.274 and 0.271 ng a.i./mg for males and females, respectively, when sex-specific variation in body weight was considered. Using the same process for D. suzukii, the LD50 value was estimated at 2.927 ng a.i./insect, or 1.994 ng a.i./mg based on a mean body weight of 1.67 mg for both sexes together. We conclude that this technique could be readily employed for determination of the resistance status and dose-mortality responses of insecticidal compounds in many species of pestiferous Diptera.	[Valtierra-de-Luis, Daniel; Villanueva, Maite; Caballero, Javier; Caballero, Primitivo] Univ Publ Navarra, Inst Multidisciplinary Appl Biol Res IMAB, Mutilva, Spain; [Matas, Isabel M.] Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental C, Matosinhos, Portugal; [Williams, Trevor] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Caballero, Primitivo] Univ Publ Navarra, Dept Agron Biotecnol & Alimentac, Pamplona, Spain	Universidad Publica de Navarra; Universidade do Porto; Instituto de Ecologia - Mexico; Universidad Publica de Navarra	Williams, T (corresponding author), Inst Ecol AC, Xalapa, Veracruz, Mexico.	trevor.inecol@gmail.com	Williams, Trevor/F-1447-2011; Villanueva, Maite/AAA-9550-2020; Williams, Trevor/ABG-3961-2020; Matas Casado, Isabel María/O-4495-2017; Caballero, Primitivo/D-5063-2009	Williams, Trevor/0000-0003-3414-3440; Villanueva, Maite/0000-0002-3894-0060; Matas Casado, Isabel María/0000-0002-2057-3485; Valtierra de Luis, Daniel/0000-0003-3965-7424; Caballero, Primitivo/0000-0003-0065-9625	Ministerio de Economia y Competitividad (MEC), Spain [AGL2014-57752-C2-1-R, AGL2017-83498-C2-1-R]; MEC [AGL2014-57752-C2-1-R]; Gobierno de Navarra, Spain [BTMOL-PI028]; Universidad Publica de Navarra, Spain	Ministerio de Economia y Competitividad (MEC), Spain(Spanish Government); MEC(European Commission); Gobierno de Navarra, Spain; Universidad Publica de Navarra, Spain	The study was funded by the Ministerio de Economia y Competitividad (MEC), Spain, projects AGL2014-57752-C2-1-R and AGL2017-83498-C2-1-R awarded to PC and TW. DDdL received a student scholarship from MEC project AGL2014-57752-C2-1-R. MV and IMM were funded by Gobierno de Navarra, Spain, project no. BTMOL-PI028. JC received a predoctoral scholarship from the Universidad Publica de Navarra, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Adan A, 1996, PESTIC SCI, V48, P261, DOI 10.1002/(SICI)1096-9063(199611)48:3&lt;261::AID-PS467&gt;3.0.CO;2-R; Baudier KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098949; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; BRODSGAARD HF, 1994, J ECON ENTOMOL, V87, P1141, DOI 10.1093/jee/87.5.1141; Bruck DJ, 2011, PEST MANAG SCI, V67, P1375, DOI 10.1002/ps.2242; Burns RE, 2001, FLA ENTOMOL, V84, P672, DOI 10.2307/3496400; Carvalho GB, 2006, CURR BIOL, V16, P692, DOI 10.1016/j.cub.2006.02.064; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Cini A, 2012, B INSECTOL, V65, P149; Cossentine J, 2016, J ECON ENTOMOL, V109, P1071, DOI 10.1093/jee/tow062; Cowles RS, 2015, J ECON ENTOMOL, V108, P640, DOI 10.1093/jee/tou100; CROWDER LA, 1979, J ECON ENTOMOL, V72, P1, DOI 10.1093/jee/72.1.1; Cuthbertson Andrew G.S., 2014, Insects, V5, P952, DOI 10.3390/insects5040952; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; Dyck V.A., 2006, STERILE INSECT TECHN; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; EPPO, 2020, EPPO A1 A2 LISTS PES; Epsky ND, 1999, J ECON ENTOMOL, V92, P156, DOI 10.1093/jee/92.1.156; GEER BW, 1970, J INSECT PHYSIOL, V16, P33, DOI 10.1016/0022-1910(70)90110-1; Gravot E, 2000, J INVERTEBR PATHOL, V75, P144, DOI 10.1006/jipa.1999.4913; Habayeb MS, 2009, J INVERTEBR PATHOL, V101, P29, DOI 10.1016/j.jip.2009.02.003; HENDRICHS J, 1990, ANN ENTOMOL SOC AM, V83, P632, DOI 10.1093/aesa/83.3.632; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jacome J, 1999, B ENTOMOL RES, V89, P165, DOI 10.1017/S0007485399000255; Jin T, 2011, PEST MANAG SCI, V67, P370, DOI 10.1002/ps.2076; Kaun KR, 2007, J EXP BIOL, V210, P3547, DOI 10.1242/jeb.006924; Lasa R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188350; Longley M, 1996, B ENVIRON CONTAM TOX, V57, P683, DOI 10.1007/s001289900244; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Manrakhan A, 2006, B ENTOMOL RES, V96, P259, DOI 10.1079/BER2006421; McPheron BA, 1996, FRUIT FLY PESTS WORL; Mishra R, 2017, INSECT SCI, V309, P764, DOI [10.1002/(SICI)1096-9063(199904)55:4<398::AID-PS925>3.0.CO;2-O, DOI 10.1002/(SICI)1096-9063(199904)55:4<398::AID-PS925>3.0.CO;2-O]; Mura ME, 2018, INSECTS, V9, DOI 10.3390/insects9030073; Nauen R, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, P935; Navarro-Llopis V, 2013, PEST MANAG SCI, V69, P478, DOI 10.1002/ps.3393; Navon A, 2000, BIOASSAYS ENTOMOPATO; Peck SL, 2000, J ECON ENTOMOL, V93, P280, DOI 10.1603/0022-0493-93.2.280; PENMAN DR, 1981, ENTOMOL EXP APPL, V30, P91, DOI 10.1007/BF00333916; Prompiboon P, 2010, APPL ENVIRON MICROB, V76, P994, DOI 10.1128/AEM.02424-09; ROBERTSON JL, 1995, J ECON ENTOMOL, V88, P1, DOI 10.1093/jee/88.1.1; Robertson JL, 2017, BIOASSAYS WITH ARTHR; Scott J.G., 1990, PESTICIDE RESISTANCE, P39, DOI DOI 10.1007/978-1-4684-6429-0_3; Shawer R, 2018, CROP PROT, V103, P73, DOI 10.1016/j.cropro.2017.09.010; Stark JD, 2004, J ECON ENTOMOL, V97, P911, DOI 10.1603/0022-0493(2004)097[0911:TOSIPB]2.0.CO;2; Stoffolano JG, 2013, ANNU REV ENTOMOL, V58, P205, DOI 10.1146/annurev-ento-120811-153653; Van Timmeren S, 2013, CROP PROT, V54, P126, DOI 10.1016/j.cropro.2013.08.003; Vidal-Quist JC, 2009, J MICROBIOL BIOTECHN, V19, P749, DOI 10.4014/jmb.0810.595; Voudouris CC, 2018, J PEST SCI, V91, P861, DOI 10.1007/s10340-017-0913-5; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; Williams T, 2003, BIOCONTROL SCI TECHN, V13, P459, DOI 10.1080/0958315031000140956; Wong R., 2009, PLOS ONE, V4; Zapata N, 2006, J ECON ENTOMOL, V99, P359, DOI 10.1603/0022-0493-99.2.359	53	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0210545	10.1371/journal.pone.0210545	http://dx.doi.org/10.1371/journal.pone.0210545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730908	gold, Green Submitted, Green Published			2022-12-26	WOS:000458026000008
J	Permata, TBM; Hagiwara, Y; Sato, H; Yasuhara, T; Oike, T; Gondhowiardjo, S; Held, KD; Nakano, T; Shibata, A				Permata, Tiara Bunga Mayang; Hagiwara, Yoshihiko; Sato, Hiro; Yasuhara, Takaaki; Oike, Takahiro; Gondhowiardjo, Soehartati; Held, Kathryn D.; Nakano, Takashi; Shibata, Atsushi			Base excision repair regulates PD-L1 expression in cancer cells	ONCOGENE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; STRAND BREAK REPAIR; MISMATCH-REPAIR; OXIDATIVE STRESS; NEOANTIGEN LOAD; PATHWAY CHOICE; DNA-DAMAGE; ASSOCIATION; DOCETAXEL; NIVOLUMAB	Programmed death-ligand 1 (PD-L1) is a key factor influencing cancer immunotherapy; however, the regulation of PD-L1 expression in cancer cells remains unclear, particularly regarding DNA damage, repair and its signalling. Herein, we demonstrate that oxidative DNA damage induced by exogenously applied hydrogen peroxide (H2O2) upregulates PD-L1 expression in cancer cells. Further, depletion of the base excision repair (BER) enzyme DNA glycosylase augments PD-L1 upregulation in response to H2O2. PD-L1 upregulation in BER-depleted cells requires ATR/Chkl kinase activities, demonstrating that PD-L1 upregulation is mediated by DNA damage signalling. Further analysis of The Cancer Genome Atlas revealed that the expression of PD-L1 is negatively correlated with that of the BER/single-strand break repair (SSBR) and tumours with low BER/SSBR gene expression show high microsatellite instability and neoantigen production. Hence, these results suggest that PD-L1 expression is regulated in cancer cells via the DNA damage signalling and neoantigen- interferon-gamma pathway under oxidative stress.	[Permata, Tiara Bunga Mayang; Hagiwara, Yoshihiko; Sato, Hiro; Oike, Takahiro; Nakano, Takashi] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma 3718511, Japan; [Permata, Tiara Bunga Mayang; Gondhowiardjo, Soehartati] Dr Cipto Mangunkusumo Natl Gen Hosp, Dept Radiotherapy, Jakarta, Indonesia; [Yasuhara, Takaaki] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Lab Mol Radiol,Bunkyo Ku, Tokyo 1138655, Japan; [Held, Kathryn D.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Held, Kathryn D.] Gunma Univ, Int Open Lab, Initiat Adv Res GIAR, Maebashi, Gunma 3718511, Japan; [Shibata, Atsushi] Gunma Univ, Grad Sch Med, Educ & Res Support Ctr, Maebashi, Gunma 3718511, Japan	Gunma University; University of Tokyo; Harvard University; Harvard Medical School; Massachusetts General Hospital; Gunma University; Gunma University	Shibata, A (corresponding author), Gunma Univ, Grad Sch Med, Educ & Res Support Ctr, Maebashi, Gunma 3718511, Japan.	shibata.at@gunma-u.ac.jp	Sato, Hiro/GWU-7659-2022; Shibata, Atsushi/AAX-1283-2021; Takaaki, Yasuhara/U-3345-2019	Shibata, Atsushi/0000-0001-8912-6977; Permata, Tiara Bunga Mayang/0000-0002-5890-5545; Yasuhara, Takaaki/0000-0002-6719-5709	Program of the network-type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University; Nagasaki University; Fukushima Medical University; Ministry of Education, Culture, Sports, Science and Technology of Japan	Program of the network-type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University; Nagasaki University; Fukushima Medical University; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Program of the network-type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University, Nagasaki University and Fukushima Medical University. This work was also supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan for programs for Leading Graduate Schools, Cultivating Global Leaders in Heavy Ion Therapeutics and Engineering.	Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937; AQUILINA G, 1994, P NATL ACAD SCI USA, V91, P8905, DOI 10.1073/pnas.91.19.8905; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Chen BPC, 2012, CANCER LETT, V327, P103, DOI 10.1016/j.canlet.2011.12.004; Chen MF, 2016, ONCOTARGET, V7, P7913, DOI 10.18632/oncotarget.6861; Cortes-Ciriano I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15180; Eggermont AMM, 2018, NEW ENGL J MED, V378, P1789, DOI 10.1056/NEJMoa1802357; Ensminger M, 2014, J CELL BIOL, V206, P29, DOI 10.1083/jcb.201312078; Feng WR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00634-0; Fiaschi Tania, 2012, Int J Cell Biol, V2012, P762825, DOI 10.1155/2012/762825; FISHEL R, 1994, SCIENCE, V266, P1403, DOI 10.1126/science.7973733; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hargadon KM, 2018, INT IMMUNOPHARMACOL, V62, P29, DOI 10.1016/j.intimp.2018.06.001; Howitt BE, 2015, JAMA ONCOL, V1, P1319, DOI 10.1001/jamaoncol.2015.2151; Hutter C, 2018, CELL, V173, P283, DOI 10.1016/j.cell.2018.03.042; Iwai Y, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0329-9; Karahalil B, 2012, HUM EXP TOXICOL, V31, P981, DOI 10.1177/0960327112444476; Kim ST, 2018, NAT MED, V24, P1449, DOI 10.1038/s41591-018-0101-z; Klein HL, 2002, MOL CELL, V9, P471, DOI 10.1016/S1097-2765(02)00493-8; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Mouw KW, 2018, BRIT J CANCER, V118, P933, DOI 10.1038/s41416-018-0017-x; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Qin Q, 2018, RADIAT RES, V190, P322, DOI 10.1667/RR15048.1; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Roger A, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1442166; Sato H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01883-9; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shen JF, 2018, NAT MED, V24, P556, DOI 10.1038/s41591-018-0012-z; Shibata A, 2017, MUTAT RES-FUND MOL M, V803, P51, DOI 10.1016/j.mrfmmm.2017.07.011; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Shin DS, 2017, CANCER DISCOV, V7, P188, DOI 10.1158/2159-8290.CD-16-1223; Strickland KC, 2016, ONCOTARGET, V7, P13587, DOI 10.18632/oncotarget.7277; Sunshine J, 2015, CURR OPIN PHARMACOL, V23, P32, DOI 10.1016/j.coph.2015.05.011; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tubbs A, 2017, CELL, V168, DOI 10.1016/j.cell.2017.01.002; UMAR A, 1994, J BIOL CHEM, V269, P14367; Vendetti FP, 2018, J CLIN INVEST, V128, P3926, DOI 10.1172/JCI96519; Wallace SS, 2012, CANCER LETT, V327, P73, DOI 10.1016/j.canlet.2011.12.038; Weren RDA, 2015, NAT GENET, V47, P668, DOI 10.1038/ng.3287	53	45	46	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2019	38	23					4452	4466		10.1038/s41388-019-0733-6	http://dx.doi.org/10.1038/s41388-019-0733-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB4KM	30755733				2022-12-26	WOS:000470240300002
J	Kwon, KW; Choi, HH; Han, SJ; Kim, JS; Kim, WS; Kim, H; Kim, LH; Kang, SM; Park, J; Shin, SJ				Kwon, Kee Woong; Choi, Hong-Hee; Han, Seung Jung; Kim, Jong-Seok; Kim, Woo Sik; Kim, Hongmin; Kim, Lee-Han; Kang, Soon Myung; Park, Jaehun; Shin, Sung Jae			Vaccine efficacy of a Mycobacterium tuberculosis Beijing-specific proline-glutamic acid (PE) antigen against highly virulent outbreak isolates	FASEB JOURNAL			English	Article						Beijing genotype; MTBK_20640; dendritic cells; subunit vaccine	T-CELL IMMUNITY; SECRETION SYSTEM; GENOME-SEQUENCE; DENDRITIC CELLS; LPRG RV1411C; ACTIVATION; PPE; RESPONSES; PROTEINS; MARINUM	Bacillus Calmette-Guerin vaccine confers insufficient pulmonary protection against tuberculosis (TB), particularly the Mycobacterium tuberculosis (Mtb) Beijing strain infection. Identification of vaccine antigens (Ags) by considering Mtb genetic diversity is crucial for the development of improved TB vaccine. MTBK_20640, a new Beijing genotype-specific proline-glutamic acid-family Ag, was identified by comparative genomic analysis. Its immunologic features were characterized by evaluating interactions with dendritic cells (DCs), and immunogenicity and vaccine efficacy were determined against highly virulent Mtb Beijing outbreak Korean Beijing (K) strain and HN878 strain in murine infection model. MTBK_20640 induced DCs via TLR2 and downstream MAPK and NF-B signaling pathways, effectively promoting naive CD4-positive (CD4(+)) T-cell proliferation and IFN- production. Different IFN- response was observed in mice infected with Mtb K or reference H37Rv strain. Significant induction of T helper type 1 cell-polarized Ag-specific multifunctional CD4(+) T cells and a marked Ag-specific IgG2c response were observed in mice immunized with MTBK_20640/glucopyranosyl lipid adjuvant-stable emulsion. The immunization conferred long-term protection against 2 Mtb Beijing outbreak strains, as evidenced by a significant reduction in colony-forming units in the lung and spleen and reduced lung inflammation. MTBK_20640 vaccination conferred long-term protection against highly virulent Mtb Beijing strains. MTBK_20640 may be developed into a novel Ag component in multisubunit TB vaccines in the future.Kwon, K. W., Choi, H.-H., Han, S. J., Kim, J.-S., Kim, W. S., Kim, H., Kim, L.-H., Kang, S. M., Park, J., Shin, S. J. Vaccine efficacy of a Mycobacterium tuberculosis Beijing-specific proline-glutamic acid (PE) antigen against highly virulent outbreak isolates.	[Kwon, Kee Woong; Choi, Hong-Hee; Han, Seung Jung; Kim, Jong-Seok; Kim, Woo Sik; Kim, Hongmin; Kim, Lee-Han; Kang, Soon Myung; Park, Jaehun; Shin, Sung Jae] Yonsei Univ, Coll Med, Dept Microbiol, Inst Immunol & Immunol Dis,Brain Korea 21 Program, Seoul, South Korea; [Kim, Jong-Seok] Konyang Univ, Coll Med, Myunggok Med Res Inst, Daejeon, South Korea; [Kim, Woo Sik] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Jeongeup, South Korea	Yonsei University; Yonsei University Health System; Konyang University; Konyang University Hospital; Korea Atomic Energy Research Institute (KAERI)	Shin, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol, 50-1 Yonsei Ro,ABMRC 304, Seoul 03722, South Korea.; Shin, SJ (corresponding author), Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Brain Korea 21 Program Leading Univ & Students PL, 50-1 Yonsei Ro,ABMRC 304, Seoul 03722, South Korea.	sjshin@yuhs.ac		Shin, Sung Jae/0000-0003-0854-4582	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of science, ICT & Future Planning [NRF-2016R1A2A1A05005263]; Korean Health Technology R&D Project of the Ministry of Health & Welfare, Republic of Korea [HI17C0175]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of science, ICT & Future Planning; Korean Health Technology R&D Project of the Ministry of Health & Welfare, Republic of Korea	The authors thank Professor Sang-Jun Ha from the College of Life Science and Biotechnology, Department of Biochemistry, Yonsei University, for his helpful advice on the experimental design and technical support. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of science, ICT & Future Planning (NRF-2016R1A2A1A05005263) and by a grant from the Korean Health Technology R&D Project of the Ministry of Health & Welfare (HI17C0175), Republic of Korea. The authors declare no conflicts of interest.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abebe F, 2006, CLIN EXP IMMUNOL, V145, P389, DOI 10.1111/j.1365-2249.2006.03162.x; Aguilo N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16085; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Bansal K, 2010, J BIOL CHEM, V285, P36511, DOI 10.1074/jbc.M110.158055; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Byun EH, 2012, FASEB J, V26, P2695, DOI 10.1096/fj.11-199588; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Chaitra MG, 2005, VACCINE, V23, P1265, DOI 10.1016/j.vaccine.2004.08.046; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Choi HG, 2017, ONCOTARGET, V8, P19947, DOI 10.18632/oncotarget.15256; Day CL, 2013, AM J RESP CRIT CARE, V188, P492, DOI 10.1164/rccm.201208-1385OC; Derrick SC, 2011, VACCINE, V29, P2902, DOI 10.1016/j.vaccine.2011.02.010; Drage MG, 2010, NAT STRUCT MOL BIOL, V17, P1088, DOI 10.1038/nsmb.1869; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gehring AJ, 2004, J IMMUNOL, V173, P2660, DOI 10.4049/jimmunol.173.4.2660; Goulding JN, 2000, J CLIN MICROBIOL, V38, P1121, DOI 10.1128/JCM.38.3.1121-1126.2000; Groschel MI, 2017, CELL REP, V18, P2752, DOI 10.1016/j.celrep.2017.02.057; Han SJ, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0071-4; Hanif SNM, 2011, SCAND J IMMUNOL, V74, P554, DOI 10.1111/j.1365-3083.2011.02604.x; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; Jeon BY, 2012, J MED MICROBIOL, V61, P1373, DOI 10.1099/jmm.0.047027-0; Jeon BY, 2011, MICROBES INFECT, V13, P284, DOI 10.1016/j.micinf.2010.11.002; Kaufmann SHE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4730; Kim JS, 2013, J LEUKOCYTE BIOL, V94, P733, DOI 10.1189/jlb.0912435; Kim WS, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00095; Kim WS, 2016, ONCOTARGET, V7, P24962, DOI 10.18632/oncotarget.8771; Kim WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145234; Kwon KW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44151; Le Moigne V, 2005, TUBERCULOSIS, V85, P213, DOI 10.1016/j.tube.2005.02.002; Li H, 2016, APOPTOSIS, V21, P795, DOI 10.1007/s10495-016-1249-y; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; Liu SQ, 2014, MOL IMMUNOL, V62, P227, DOI 10.1016/j.molimm.2014.06.026; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Okkels LM, 2003, INFECT IMMUN, V71, P6116, DOI 10.1128/IAI.71.11.6116-6123.2003; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Penn-Nicholson A, 2018, LANCET RESP MED, V6, P287, DOI [10.1016/S2213-2600(18)30077-8, 10.1016/s2213-2600(18)30077-8]; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; Qiu ZG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00216; Rachman H, 2006, J BIOTECHNOL, V126, P61, DOI 10.1016/j.jbiotec.2006.02.020; Reece ST, 2008, INT J MED MICROBIOL, V298, P143, DOI 10.1016/j.ijmm.2007.07.004; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; Sayes F, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005770; Su HB, 2018, J BIOL CHEM, V293, P10287, DOI 10.1074/jbc.RA118.001696; Su HB, 2015, ONCOTARGET, V6, P38517, DOI 10.18632/oncotarget.5956; Tiwari BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051686; Vani J, 2013, J INFECT DIS, V208, P1034, DOI 10.1093/infdis/jit281; Verwaerde C, 2014, VACCINE, V32, P6240, DOI 10.1016/j.vaccine.2014.09.024; Vipond J, 2006, TUBERCULOSIS, V86, P218, DOI 10.1016/j.tube.2006.01.014; Wang BL, 2007, CLIN VACCINE IMMUNOL, V14, P902, DOI 10.1128/CDLI.00077-07; Xu YW, 2015, IEEE 12TH INT CONF UBIQUITOUS INTELLIGENCE & COMP/IEEE 12TH INT CONF ADV & TRUSTED COMP/IEEE 15TH INT CONF SCALABLE COMP & COMMUN/IEEE INT CONF CLOUD & BIG DATA COMP/IEEE INT CONF INTERNET PEOPLE AND ASSOCIATED SYMPOSIA/WORKSHOPS, P93, DOI 10.1109/UIC-ATC-ScalCom-CBDCom-IoP.2015.37	55	7	7	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6483	6496		10.1096/fj.201802604R	http://dx.doi.org/10.1096/fj.201802604R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30753099	Bronze			2022-12-26	WOS:000466932600053
J	Sana, B; Chee, SMQ; Wongsantichon, J; Raghavan, S; Robinson, RC; Ghadessy, FJ				Sana, Barindra; Chee, Sharon M. Q.; Wongsantichon, Jantana; Raghavan, Sarada; Robinson, Robert C.; Ghadessy, Farid J.			Development and structural characterization of an engineered multi-copper oxidase reporter of protein-protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; enzyme mutation; enzyme oxidase; X-ray crystallography; structure-function; protein engineering; CueO; MDM2 proto-oncogene; protein-protein interaction; antibody; protein sensor; drug screening tool	GREEN FLUORESCENT PROTEINS; MULTICOPPER OXIDASE; ESCHERICHIA-COLI; BETA-GALACTOSIDASE; ENZYMATIC-ACTIVITY; FUNCTIONAL-ROLE; MDM2; CUEO; P53; BINDING	Protein-protein interactions (PPIs) are ubiquitous in almost all biological processes and are often corrupted in diseased states. A detailed understanding of PPIs is therefore key to understanding cellular physiology and can yield attractive therapeutic targets. Here, we describe the development and structural characterization of novel Escherichia coli CueO multi-copper oxidase variants engineered to recapitulate protein-protein interactions with commensurate modulation of their enzymatic activities. The fully integrated single-protein sensors were developed through modular grafting of ligand-specific peptides into a highly compliant and flexible methionine-rich loop of CueO. Sensitive detection of diverse ligand classes exemplified by antibodies, an E3 ligase, MDM2 proto-oncogene (MDM2), and protease (SplB from Staphylococcus aureus) was achieved in a simple mix and measure homogeneous format with visually observable colorimetric readouts. Therapeutic antagonism of MDM2 by small molecules and peptides in clinical development for treatment of cancer patients was assayed using the MDM2-binding CueO enzyme. Structural characterization of the free and MDM2-bound CueO variant provided functional insight into signal-transducing mechanisms of the engineered enzymes and highlighted the robustness of CueO as a stable and compliant scaffold for multiple applications.	[Sana, Barindra; Chee, Sharon M. Q.; Raghavan, Sarada; Ghadessy, Farid J.] p53 Lab, A STAR, 8A Biomed Grove, Singapore 138648, Singapore; [Wongsantichon, Jantana] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand; [Wongsantichon, Jantana; Robinson, Robert C.] ASTAR, Inst Mol & Cellular Biol, 61 Biopolis Dr, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Ghadessy, FJ (corresponding author), p53 Lab, A STAR, 8A Biomed Grove, Singapore 138648, Singapore.	fghadessy@p53Lab.a-star.edu.sg		Ghadessy, Farid/0000-0001-8559-903X; Wongsantichon, Jantana/0000-0002-4134-2248	Agency for Science Technology and Research (A*STAR), Singapore	Agency for Science Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science Technology and Research (A*STAR), Singapore. The authors declare that they have no conflicts of interest with the contents of this article.	Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BAUM EZ, 1990, P NATL ACAD SCI USA, V87, P10023, DOI 10.1073/pnas.87.24.10023; Beneyton T, 2014, ANALYST, V139, P3314, DOI 10.1039/c4an00228h; Benito A, 1996, J BIOL CHEM, V271, P21251, DOI 10.1074/jbc.271.35.21251; Bottger V, 1996, ONCOGENE, V13, P2141; BRENNAN C, 1994, PROTEIN ENG, V7, P509, DOI 10.1093/protein/7.4.509; BRENNAN CA, 1995, P NATL ACAD SCI USA, V92, P5783, DOI 10.1073/pnas.92.13.5783; Brown CJ, 2013, ACS CHEM BIOL, V8, P506, DOI 10.1021/cb3005148; Brown CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024122; Chee SMQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104914; Choi JH, 2016, PROTEIN SCI, V25, P1605, DOI 10.1002/pro.2962; Djoko KY, 2010, J AM CHEM SOC, V132, P2005, DOI 10.1021/ja9091903; Doi N, 1999, FEBS LETT, V453, P305, DOI 10.1016/S0014-5793(99)00732-2; Dubin G, 2008, J MOL BIOL, V379, P343, DOI 10.1016/j.jmb.2008.03.059; Edwards WR, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn363; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferraz RM, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-15; Ferrer-Miralles N, 2000, BIOCHEM BIOPH RES CO, V275, P360, DOI 10.1006/bbrc.2000.3309; Geddie ML, 2005, J BIOL CHEM, V280, P35641, DOI 10.1074/jbc.M508149200; Grass G, 2001, J BACTERIOL, V183, P2145, DOI 10.1128/JB.183.6.2145-2147.2001; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kataoka K, 2007, J MOL BIOL, V373, P141, DOI 10.1016/j.jmb.2007.07.041; Kataoka K, 2013, BIOCHEM BIOPH RES CO, V431, P393, DOI 10.1016/j.bbrc.2013.01.040; Kataoka K, 2011, BIOCHEMISTRY-US, V50, P558, DOI 10.1021/bi101107c; Kim C, 2001, J BACTERIOL, V183, P4866, DOI 10.1128/JB.183.16.4866-4875.2001; Kohn JE, 2005, P NATL ACAD SCI USA, V102, P10841, DOI 10.1073/pnas.0503055102; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lau SY, 2018, PROTEIN ENG DES SEL, V31, P301, DOI 10.1093/protein/gzy018; Legendre D, 1999, NAT BIOTECHNOL, V17, P67, DOI 10.1038/5243; London N, 2010, PROTEINS, V78, P3140, DOI 10.1002/prot.22785; MacDonald JT, 2016, BIOCHEM SOC T, V44, P1523, DOI 10.1042/BST20160155; Marvin JS, 2011, PROTEINS, V79, P3025, DOI 10.1002/prot.23118; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nadler DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12266; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nirantar SR, 2014, BIOSENS BIOELECTRON, V56, P250, DOI 10.1016/j.bios.2013.12.060; Nirantar SR, 2013, BIOSENS BIOELECTRON, V47, P421, DOI 10.1016/j.bios.2013.03.049; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Plainkum P, 2003, NAT STRUCT BIOL, V10, P115, DOI 10.1038/nsb884; Popowicz GM, 2011, ANGEW CHEM INT EDIT, V50, P2680, DOI 10.1002/anie.201003863; Roberts SA, 2003, J BIOL CHEM, V278, P31958, DOI 10.1074/jbc.M302963200; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Roxburgh P, 2012, CARCINOGENESIS, V33, P791, DOI 10.1093/carcin/bgs092; Singh SK, 2011, J BIOL CHEM, V286, P37849, DOI 10.1074/jbc.M111.293589; Stein V, 2017, ACS SYNTH BIOL, V6, P1337, DOI 10.1021/acssynbio.6b00370; Sun DQ, 2014, J MED CHEM, V57, P1454, DOI 10.1021/jm401753e; Vera A, 2005, BIOCHEM BIOPH RES CO, V329, P453, DOI 10.1016/j.bbrc.2005.01.147; Vu B, 2013, ACS MED CHEM LETT, V4, P466, DOI 10.1021/ml4000657; Wongso D, 2017, ANAL CHEM, V89, P6719, DOI 10.1021/acs.analchem.7b00959	54	4	4	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7002	7012		10.1074/jbc.RA118.007141	http://dx.doi.org/10.1074/jbc.RA118.007141			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30770473	hybrid, Green Published			2022-12-26	WOS:000467394700032
J	Raj, CJT; Croft, T; Venkatakrishnan, P; Groth, B; Dhugga, G; Cater, T; Lin, SJ				Raj, Christol James Theoga; Croft, Trevor; Venkatakrishnan, Padmaja; Groth, Benjamin; Dhugga, Gagandeep; Cater, Timothy; Lin, Su-Ju			The copper-sensing transcription factor Mac1, the histone deacetylase Hst1, and nicotinic acid regulate de novo NAD(+) biosynthesis in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NAD plus biosynthesis; gene regulation; nicotinamide adenine dinucleotide (NAD); yeast genetics; yeast metabolism; epigenetics; histone deacetylase; metabolic regulation; metal sensing; nicotinic acid; cell metabolism	LIFE-SPAN EXTENSION; SACCHAROMYCES-CEREVISIAE; KYNURENINE PATHWAY; GENE DISRUPTION; QUINOLINIC ACID; METABOLISM; PROTEIN; INHIBITION; DELETION; RIBOSIDE	NADH (NAD(+)) is an essential metabolite involved in various cellular biochemical processes. The regulation of NAD(+) metabolism is incompletely understood. Here, using budding yeast (Saccharomyces cerevisiae), we established an NAD(+) intermediate-specific genetic system to identify factors that regulate the de novo branch of NAD(+) biosynthesis. We found that a mutant strain (mac1) lacking Mac1, a copper-sensing transcription factor that activates copper transport genes during copper deprivation, exhibits increases in quinolinic acid (QA) production and NAD(+) levels. Similar phenotypes were also observed in the hst1 strain, deficient in the NAD(+)-dependent histone deacetylase Hst1, which inhibits de novo NAD(+) synthesis by repressing BNA gene expression when NAD(+) is abundant. Interestingly, the mac1 and hst1 mutants shared a similar NAD(+) metabolism-related gene expression profile, and deleting either MAC1 or HST1 de-repressed the BNA genes. ChIP experiments with the BNA2 promoter indicated that Mac1 works with Hst1-containing repressor complexes to silence BNA expression. The connection of Mac1 and BNA expression suggested that copper stress affects de novo NAD(+) synthesis, and we show that copper stress induces both BNA expression and QA production. Moreover, nicotinic acid inhibited de novo NAD(+) synthesis through Hst1-mediated BNA repression, hindered the reuptake of extracellular QA, and thereby reduced de novo NAD(+) synthesis. In summary, we have identified and characterized novel NAD(+) homeostasis factors. These findings will expand our understanding of the molecular basis and regulation of NAD(+) metabolism.	[Raj, Christol James Theoga; Croft, Trevor; Venkatakrishnan, Padmaja; Groth, Benjamin; Dhugga, Gagandeep; Cater, Timothy; Lin, Su-Ju] Univ Calif Davis, Dept Microbiol & Mol Genet, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Lin, SJ (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, One Shields Ave, Davis, CA 95616 USA.	slin@ucdavis.edu			NIGMS, National Institutes of Health [GM102297]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102297] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIGMS, National Institutes of Health, Grant GM102297. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amaral M, 2013, J MOL MED, V91, P705, DOI 10.1007/s00109-013-1046-9; Bedalov A, 2003, MOL CELL BIOL, V23, P7044, DOI 10.1128/MCB.23.19.7044-7054.2003; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Brachmann CB, 1998, YEAST, V14, P115; Braidy N, 2017, NEURAL REGEN RES, V12, P39, DOI 10.4103/1673-5374.198971; Breda C, 2016, P NATL ACAD SCI USA, V113, P5435, DOI 10.1073/pnas.1604453113; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Burke D., 2000, METHODS YEAST GENETI, P171; Cankorur-Cetinkaya A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2771-6; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chang KH, 2018, MOL NEUROBIOL, V55, P6319, DOI 10.1007/s12035-017-0845-3; Chini CCS, 2017, MOL CELL ENDOCRINOL, V455, P62, DOI 10.1016/j.mce.2016.11.003; Croft T, 2018, J BIOL CHEM, V293, P2927, DOI 10.1074/jbc.M117.807214; De Freitas JM, 2004, J BIOL CHEM, V279, P4450, DOI 10.1074/jbc.M212308200; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Emanuelli M, 1999, FEBS LETT, V455, P13, DOI 10.1016/S0014-5793(99)00852-2; FOSTER AC, 1985, J NEUROCHEM, V44, P446, DOI 10.1111/j.1471-4159.1985.tb05435.x; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gilmore JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011544; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Esquivel DG, 2017, NEUROPHARMACOLOGY, V112, P331, DOI 10.1016/j.neuropharm.2016.03.013; Graden JA, 1997, P NATL ACAD SCI USA, V94, P5550, DOI 10.1073/pnas.94.11.5550; Gross C, 2000, J BIOL CHEM, V275, P32310, DOI 10.1074/jbc.M005946200; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Iwai K, 1980, Methods Enzymol, V66, P96; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Jensen LT, 1998, J BIOL CHEM, V273, P23805, DOI 10.1074/jbc.273.37.23805; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; KALIKIN L, 1988, BIOCHEM BIOPH RES CO, V152, P559, DOI 10.1016/S0006-291X(88)80074-3; Kato M, 2014, DNA REPAIR, V23, P49, DOI 10.1016/j.dnarep.2014.07.009; Kato M, 2014, J BIOL CHEM, V289, P15577, DOI 10.1074/jbc.M114.558643; Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Li MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r48; Li MG, 2010, MOL CELL BIOL, V30, P3329, DOI 10.1128/MCB.01590-09; Lin JB, 2016, CELL REP, V17, P69, DOI 10.1016/j.celrep.2016.08.073; Liu HW, 2018, P NATL ACAD SCI USA, V115, P10654, DOI 10.1073/pnas.1809392115; Llorente B, 2000, FEBS LETT, V475, P237, DOI 10.1016/S0014-5793(00)01698-7; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu SP, 2011, J BIOL CHEM, V286, P14271, DOI 10.1074/jbc.M110.217885; Lu SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1567, DOI 10.1016/j.bbapap.2009.09.030; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Mehr AP, 2018, NAT MED, V24, P1351, DOI 10.1038/s41591-018-0138-z; Mole DJ, 2016, NAT MED, V22, P202, DOI 10.1038/nm.4020; Nikiforov A, 2015, CRIT REV BIOCHEM MOL, V50, P284, DOI 10.3109/10409238.2015.1028612; Ohashi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12392-6; Ohashi K, 2013, EUKARYOT CELL, V12, P648, DOI 10.1128/EC.00339-12; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Serpe M, 1999, J BIOL CHEM, V274, P29211, DOI 10.1074/jbc.274.41.29211; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sporty J, 2009, YEAST, V26, P363, DOI 10.1002/yea.1671; TOHE A, 1973, J BACTERIOL, V113, P727, DOI 10.1128/JB.113.2.727-738.1973; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; Yang Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1787, DOI 10.1016/j.bbapap.2016.06.014; Zhu ZW, 1998, J BIOL CHEM, V273, P1277, DOI 10.1074/jbc.273.3.1277	64	10	10	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5562	5575		10.1074/jbc.RA118.006987	http://dx.doi.org/10.1074/jbc.RA118.006987			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30760525	Green Published, hybrid			2022-12-26	WOS:000464517500026
J	Zhang, Y; Jiang, DS; Li, H; Sun, YF; Jiang, XH; Gong, S; Qian, ZY; Tao, J				Zhang, Yuan; Jiang, Dongsheng; Li, Hua; Sun, Yufang; Jiang, Xinghong; Gong, Shan; Qian, Zhiyuan; Tao, Jin			Melanocortin type 4 receptor-mediated inhibition of A-type K+ current enhances sensory neuronal excitability and mechanical pain sensitivity in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; patch clamp; potassium channel; signal transduction; G-protein-coupled receptor (GPCR); ion channel; pain; cell signaling; A-type K plus current; alpha-melanocyte-stimulating hormone; melanocortin type 4 receptor (MC4R); neuronal excitability; trigeminal ganglion neurons; pain perception; nociception; action potential	MELANOCYTE-STIMULATING HORMONE; KV4.2 POTASSIUM CHANNEL; PROTEIN-KINASE; NEUROPATHIC PAIN; PHOSPHATIDYLINOSITOL 3-KINASE; GANGLION NEURONS; CALCIUM-CHANNELS; P38 MAPK; ACTIVATION; EXPRESSION	alpha-Melanocyte-stimulating hormone (-MSH) has been shown to be involved in nociception, but the underlying molecular mechanisms remain largely unknown. In this study, we report that -MSH suppresses the transient outward A-type K+ current (I-A) in trigeminal ganglion (TG) neurons and thereby modulates neuronal excitability and peripheral pain sensitivity in rats. Exposing small-diameter TG neurons to -MSH concentration-dependently decreased I-A. This -MSH-induced I-A decrease was dependent on the melanocortin type 4 receptor (MC4R) and associated with a hyperpolarizing shift in the voltage dependence of A-type K+ channel inactivation. Chemical inhibition of phosphatidylinositol 3-kinase (PI3K) with wortmannin or of class I PI3Ks with the selective inhibitor CH5132799 prevented the MC4R-mediated I-A response. Blocking G(i/o)-protein signaling with pertussis toxin or by dialysis of TG neurons with the G-blocking synthetic peptide QEHA abolished the -MSH-mediated decrease in I-A. Further, -MSH increased the expression levels of phospho-p38 mitogen-activated protein kinase, and pharmacological or genetic inhibition of p38 abrogated the -MSH-induced I-A response. Additionally, -MSH significantly increased the action potential firing rate of TG neurons and increased the sensitivity of rats to mechanical stimuli applied to the buccal pad area, and both effects were abrogated by I-A blockade. Taken together, our findings suggest that -MSH suppresses I-A by activating MC4R, which is coupled sequentially to the G complex of the G(i/o)-protein and downstream class I PI3K-dependent p38 signaling, thereby increasing TG neuronal excitability and mechanical pain sensitivity in rats.	[Zhang, Yuan; Qian, Zhiyuan] Soochow Univ, Affiliated Hosp 2, Dept Geriatr, 1055 San Xiang Rd, Suzhou 215004, Peoples R China; [Zhang, Yuan; Jiang, Dongsheng; Sun, Yufang; Jiang, Xinghong; Gong, Shan; Tao, Jin] Soochow Univ, Coll Med, Dept Physiol & Neurobiol, 199 Ren Ai Rd, Suzhou 215123, Peoples R China; [Zhang, Yuan; Jiang, Dongsheng; Sun, Yufang; Jiang, Xinghong; Gong, Shan; Tao, Jin] Soochow Univ, Coll Med, Ctr Ion Channelopathy, 199 Ren Ai Rd, Suzhou 215123, Peoples R China; [Li, Hua] Natl Shanghai Ctr New Drug Safety Evaluat & Res, Shanghai 201203, Peoples R China; [Jiang, Dongsheng] Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr, D-81377 Munich, Germany; [Tao, Jin] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215123, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Soochow University - China	Qian, ZY (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Geriatr, 1055 San Xiang Rd, Suzhou 215004, Peoples R China.; Tao, J (corresponding author), Soochow Univ, Coll Med, Dept Physiol & Neurobiol, 199 Ren Ai Rd, Suzhou 215123, Peoples R China.; Tao, J (corresponding author), Soochow Univ, Coll Med, Ctr Ion Channelopathy, 199 Ren Ai Rd, Suzhou 215123, Peoples R China.	zhiyuanqian@suda.edu.cn; taoj@suda.edu.cn	Jiang, Dongsheng/AAG-1284-2020	Jiang, Dongsheng/0000-0003-0961-2671	National Natural Science Foundation of China [81873731, 81771187, 81622014, 81671080, 81571063, 81371229]; Innovation Project of Jiangsu Province Qing-Lan Project; Six Talent Peaks Project of Jiangsu Province [JY-065]; Jiangsu Key Laboratory of Neuropsychiatric Diseases [BM2013003]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of Jiangsu Province Qing-Lan Project; Six Talent Peaks Project of Jiangsu Province; Jiangsu Key Laboratory of Neuropsychiatric Diseases; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grants 81873731, 81771187, 81622014, 81671080, 81571063, and 81371229; the Innovation Project of Jiangsu Province Qing-Lan Project (to J. T.); Six Talent Peaks Project of Jiangsu Province Grant JY-065; Jiangsu Key Laboratory of Neuropsychiatric Diseases Grant BM2013003; and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Adan RAH, 2000, EUR J PHARMACOL, V405, P13, DOI 10.1016/S0014-2999(00)00537-9; Adan RAH, 1997, PEPTIDES, V18, P1279, DOI 10.1016/S0196-9781(97)00078-8; Agosti F, 2017, NEUROSCIENCE, V346, P102, DOI 10.1016/j.neuroscience.2017.01.007; Agosti F, 2014, EUR J NEUROSCI, V40, P2755, DOI 10.1111/ejn.12650; Beltramo M, 2003, MOL BRAIN RES, V118, P111, DOI 10.1016/j.molbrainres.2003.08.001; Bertolini A, 2009, PHARMACOL RES, V59, P13, DOI 10.1016/j.phrs.2008.10.005; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; Chen Y, 2013, PAIN, V154, P1295, DOI 10.1016/j.pain.2013.04.004; Chien LY, 2007, J NEUROSCI, V27, P9855, DOI 10.1523/JNEUROSCI.0604-07.2007; Chu HC, 2012, INT J NEUROSCI, V122, P74, DOI 10.3109/00207454.2011.630542; Coutts CA, 2009, ACTA PHYSIOL, V195, P259, DOI 10.1111/j.1748-1716.2008.01889.x; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dong YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111594; Duan KZ, 2012, PAIN, V153, P562, DOI 10.1016/j.pain.2011.11.020; Hagenacker T, 2010, BRAIN RES BULL, V83, P292, DOI 10.1016/j.brainresbull.2010.07.010; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Hu CL, 2009, J BIOL CHEM, V284, P7465, DOI 10.1074/jbc.M808049200; Hu HJ, 2003, J NEUROPHYSIOL, V90, P1671, DOI 10.1152/jn.00340.2003; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Klusa V, 2001, NEUROPEPTIDES, V35, P50, DOI 10.1054/npep.2000.0843; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Li N, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-21; Luo JL, 2011, J PAIN, V12, P600, DOI 10.1016/j.jpain.2010.11.005; Mountjoy KG, 2018, MOL METAB, V9, P207, DOI 10.1016/j.molmet.2017.11.008; Norris CA, 2012, J NEUROSCI, V32, P8865, DOI 10.1523/JNEUROSCI.0937-12.2012; Orestes P, 2013, DIABETES, V62, P3828, DOI 10.2337/db13-0813; Pieri M, 2010, NEUROPHARMACOLOGY, V58, P268, DOI 10.1016/j.neuropharm.2009.06.029; Popiolek-Barczyk K, 2014, PHARMACOL REP, V66, P845, DOI 10.1016/j.pharep.2014.05.001; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; Redman PT, 2009, J PHYSIOL-LONDON, V587, P4393, DOI 10.1113/jphysiol.2009.176321; Rodgers EW, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-143; Roepke TA, 2007, ENDOCRINOLOGY, V148, P4937, DOI 10.1210/en.2007-0605; SANDMAN CA, 1981, PEPTIDES, V2, P231, DOI 10.1016/S0196-9781(81)80040-X; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; Starowicz K, 2009, PHARMACOL REP, V61, P1086, DOI 10.1016/S1734-1140(09)70171-9; Takeda M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-5; Tanabe K, 2007, J NEUROCHEM, V101, P1145, DOI 10.1111/j.1471-4159.2006.04432.x; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; Tao J, 2012, J NEUROPHYSIOL, V107, P1666, DOI 10.1152/jn.00551.2011; Tolhurst DJ, 2009, J NEUROSCI, V29, P2355, DOI 10.1523/JNEUROSCI.3869-08.2009; van der Kraan M, 1999, MOL BRAIN RES, V63, P276, DOI 10.1016/S0169-328X(98)00291-5; Van Hoorick D, 2003, MOL CELL NEUROSCI, V24, P357, DOI 10.1016/S1044-7431(03)00174-X; Vrinten DH, 2001, ANESTH ANALG, V93, P1572, DOI 10.1097/00000539-200112000-00052; Vrinten DH, 2000, J NEUROSCI, V20, P8131; Vydyanathan A, 2005, J NEUROPHYSIOL, V93, P3401, DOI 10.1152/jn.01267.2004; Wang H, 2014, ENDOCRINOLOGY, V155, P168, DOI 10.1210/en.2013-1559; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; Winkelman DLB, 2005, J PHARMACOL EXP THER, V314, P1177, DOI 10.1124/jpet.105.087759; Wu RL, 1998, J NEUROSCI, V18, P6261; Xu YF, 2002, J NEUROSCI, V22, P9194; Yang YK, 2017, BBA-MOL BASIS DIS, V1863, P2436, DOI 10.1016/j.bbadis.2017.04.025; Yue JX, 2014, PHARMAZIE, V69, P804, DOI 10.1691/ph.2014.4650; Zhang Q, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0652-1; Zhang Y, 2018, ENDOCRINOLOGY, V159, P2253, DOI 10.1210/en.2018-00108; Zhang Y, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12476; Zhang Y, 2015, J BIOL CHEM, V290, P8644, DOI 10.1074/jbc.M114.615021; Zhang Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005283; Zhao XY, 2016, CELL SIGNAL, V28, P979, DOI 10.1016/j.cellsig.2016.05.004	60	7	8	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5496	5507		10.1074/jbc.RA118.006894	http://dx.doi.org/10.1074/jbc.RA118.006894			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30745360	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000464517500021
J	Bakhtavar, MA; Afzal, I; Basra, SMA				Bakhtavar, Muhammad Amir; Afzal, Irfan; Basra, Shahzad Maqsood Ahmed			Moisture adsorption isotherms and quality of seeds stored in conventional packaging materials and hermetic Super Bag	PLOS ONE			English	Article							SORPTION ISOTHERMS; SOYBEAN SEEDS; HUMIDITY	Seed moisture content (SMC) is an important attribute to seed quality. Maintaining seed dryness throughout supply chain (The Dry Chain) prevents seed germination and quality losses. Ambient relative humidity (RH) and temperature affect seed moisture and thereof seed moisture isotherm. Present study was conducted to compare the moisture adsorption isotherms of wheat, maize, cotton and quinoa seeds packed in hermetic Super Bag and traditional packaging materials including paper, polypropylene (PP), jute and cloth bags. Seeds were incubated at 60, 70, 80 and 90% static RH. Nearly straight line moisture isotherms for all crop seeds were obtained in Super Bag. Seed moisture contents increased in traditional packaging materials with increasing RH. At higher level of RH, moisture contents increased slightly (1-2%) in Super Bag, whereas this increase was much higher in traditional packaging materials (approximate to 9% higher than original SMC at 90% RH). In second study, seeds were dried to 8 and 14% initial seed moisture contents using zeolite drying beads and were stored in hermetic and conventional packaging materials for a period of 18 months. For all crop seeds, germination was severely affected in all packaging materials both at 8 and 14% initial SMC except storage in Super Bag at 8% SMC. Wheat seed stored in Super Bag at 8% SMC almost maintained initial germination while germination of cotton, maize and quinoa seeds declined 7%, 14% and 30% respectively in Super Bag at 8% SMC. Seed storage in Super Bag can help to prevent the significant increase in seed moisture at higher RH as is evident from moisture isotherm study, thus helps to preserve quality of maize, wheat, cotton and quinoa seeds by maintaining The Dry Chain throughout the storage period.	[Bakhtavar, Muhammad Amir; Afzal, Irfan; Basra, Shahzad Maqsood Ahmed] Univ Agr Faisalabad, Dept Agron, Seed Physiol Lab, Faisalabad, Punjab, Pakistan	University of Agriculture Faisalabad	Afzal, I (corresponding author), Univ Agr Faisalabad, Dept Agron, Seed Physiol Lab, Faisalabad, Punjab, Pakistan.	iafzal@uaf.edu.pk	afzal, irfan/D-1495-2019; Bakhtavar, Muhammad Amir/ABG-1421-2021; Afzal, Irfan/AAE-9266-2020	afzal, irfan/0000-0001-5942-7672; Bakhtavar, Muhammad Amir/0000-0001-5246-7663				Afzal I, 2017, J STORED PROD RES, V72, P49, DOI 10.1016/j.jspr.2017.04.001; Alhamdan AM, 2004, ACTA HORTIC, P63, DOI 10.17660/ActaHortic.2004.631.7; AOSA, 1983, ASS OFF SEED AN SEED; ASHWORTH EN, 1980, AGRON J, V72, P923, DOI 10.2134/agronj1980.00021962007200060015x; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Baoua IB, 2013, J STORED PROD RES, V54, P13, DOI 10.1016/j.jspr.2013.03.003; Barati M, 2016, J FOOD MEAS CHARACT, V10, P236, DOI 10.1007/s11694-015-9298-4; Barrozo MAS, 2001, INT J FOOD SCI TECH, V36, P393, DOI 10.1046/j.1365-2621.2001.00470.x; Ben D, 2006, INT RICE RES NOTES, V31; Bewley D., 2013, SEEDS PHYSL DEV GERM, V3; Bradford KJ, 2018, TRENDS FOOD SCI TECH, V71, P84, DOI 10.1016/j.tifs.2017.11.002; Chattha S.H., 2012, SCI TECHNOLOGY DEV, V31, P10; Don R., 2013, ISTA HDB SEEDLING EV; Duarte CR, 2004, BRAZ J CHEM ENG, V21, P59, DOI 10.1590/S0104-66322004000100007; GrainPro, 2018, PROD SPEC GRAINPRO S; GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011; ISTA, 2015, INT RULES SEED TEST; Khan Ikhtiar, 2007, Journal of Zhejiang University-Science B, V8, P555, DOI 10.1631/jzus.2007.B0555; Mbofung GCY, 2013, CROP SCI, V53, P1086, DOI 10.2135/cropsci2012.09.0530; McDonald M. B., 2007, Seed Technology, V29, P7; McDonald MB, 2001, PRINCIPLES SEED SCI; Royal Botanic Gardens Kew, 2018, SEED INF DAT SID VER; Siracusa V, 2012, INT J POLYM SCI, V2012, DOI 10.1155/2012/302029; Strelec I, 2010, POLJOPRIVREDA, V16, P20; Vertucci CW, SEED MOISTURE	25	24	28	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0207569	10.1371/journal.pone.0207569	http://dx.doi.org/10.1371/journal.pone.0207569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768633	Green Submitted, Green Published, gold			2022-12-26	WOS:000458766300002
J	Xie, R; Zhang, MR; Venkatraman, P; Zhang, XL; Zhang, GN; Carmer, R; Kantola, SA; Pang, CP; Ma, P; Zhang, MZ; Zhong, WX; Leung, YF				Xie, Rui; Zhang, Mengrui; Venkatraman, Prahatha; Zhang, Xinlian; Zhang, Gaonan; Carmer, Robert; Kantola, Skylar A.; Pang, Chi Pui; Ma, Ping; Zhang, Mingzhi; Zhong, Wenxuan; Leung, Yuk Fai			Normalization of large-scale behavioural data collected from zebrafish	PLOS ONE			English	Article							HIGH-THROUGHPUT; DRUGS	Many contemporary neuroscience experiments utilize high-throughput approaches to simultaneously collect behavioural data from many animals. The resulting data are often complex in structure and are subjected to systematic biases, which require new approaches for analysis and normalization. This study addressed the normalization need by establishing an approach based on linear-regression modeling. The model was established using a dataset of visual motor response (VMR) obtained from several strains of wild-type (WT) zebrafish collected at multiple stages of development. The VMR is a locomotor response triggered by drastic light change, and is commonly measured repeatedly from multiple larvae arrayed in 96-well plates. This assay is subjected to several systematic variations. For example, the light emitted by the machine varies slightly from well to well. In addition to the light-intensity variation, biological replication also created batch-batch variation. These systematic variations may result in differences in the VMR and must be normalized. Our normalization approach explicitly modeled the effect of these systematic variations on VMR. It also normalized the activity profiles of different conditions to a common baseline. Our approach is versatile, as it can incorporate different normalization needs as separate factors. The versatility was demonstrated by an integrated normalization of three factors: light-intensity variation, batch-batch variation and baseline. After normalization, new biological insights were revealed from the data. For example, we found larvae of TL strain at 6 days post-fertilization (dpf) responded to light onset much stronger than the 9-dpf larvae, whereas previous analysis without normalization shows that their responses were relatively comparable. By removing systematic variations, our model-based normalization can facilitate downstream statistical comparisons and aid detecting true biological differences in high-throughput studies of neurobehaviour.	[Xie, Rui; Zhang, Mengrui; Zhang, Xinlian; Ma, Ping; Zhong, Wenxuan] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Venkatraman, Prahatha; Zhang, Gaonan; Kantola, Skylar A.; Leung, Yuk Fai] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Carmer, Robert] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Pang, Chi Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Peoples R China; [Pang, Chi Pui; Zhang, Mingzhi] Joint Shantou Int Eye Ctr Shantou Univ & Chinese, Shantou, Peoples R China; [Leung, Yuk Fai] Indiana Univ Sch Med, Dept Biochem & Mol Biol, W Lafayette, IN USA; [Leung, Yuk Fai] Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA; [Leung, Yuk Fai] Purdue Univ, Purdue Inst Drug Discovery, W Lafayette, IN 47907 USA	University System of Georgia; University of Georgia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese University of Hong Kong; Indiana University System; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhong, WX (corresponding author), Univ Georgia, Dept Stat, Athens, GA 30602 USA.; Leung, YF (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.; Zhang, MZ (corresponding author), Joint Shantou Int Eye Ctr Shantou Univ & Chinese, Shantou, Peoples R China.; Leung, YF (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, W Lafayette, IN USA.; Leung, YF (corresponding author), Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA.; Leung, YF (corresponding author), Purdue Univ, Purdue Inst Drug Discovery, W Lafayette, IN 47907 USA.	zmz@jsiec.org; wenxuan@uga.edu; yfleung@purdue.edu	Ma, Ping/M-7746-2015	Ma, Ping/0000-0002-5728-3596; Xie, Rui/0000-0001-9769-8131; Xie, Rui/0000-0001-9300-7145	National Science Foundation [DMS-1440037, 1440038, 1438957]; NIH [1R01GM113242, 1R01GM122080]; Howard Hughes Medical Institute Undergraduate Research Experience Program from Purdue University; William H. Phillips Summer Research Internship from Purdue University; Faculty for the Future Fellowship by the Schlumberger Foundation; Direct grant from the Medical Panel [2041771]; Chinese University of Hong Kong; General Research Fund from the Research Grants Council of Hong Kong [2140694]; National Scientific Foundation of China [81486126]; Provincial Natural Scientific Foundation of China [8151503102000019]; Ministry of Health program of Public Welfare [201302015]; International Retinal Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113242, R01GM122080] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Undergraduate Research Experience Program from Purdue University; William H. Phillips Summer Research Internship from Purdue University; Faculty for the Future Fellowship by the Schlumberger Foundation(Schlumberger); Direct grant from the Medical Panel; Chinese University of Hong Kong(Chinese University of Hong Kong); General Research Fund from the Research Grants Council of Hong Kong; National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Scientific Foundation of China; Ministry of Health program of Public Welfare; International Retinal Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Rui Xie, Xinlian Zhang, Ping Ma and Wenxuan Zhong were partially supported by National Science Foundation (grant no. DMS-1440037, 1440038, 1438957) and NIH (1R01GM113242, 1R01GM122080). Robert Carmer was partially supported by a Howard Hughes Medical Institute Undergraduate Research Experience Program from Purdue University. Gaonan Zhang was partially supported by a William H. Phillips Summer Research Internship from Purdue University. Prahatha Venkatraman was partially supported by a Faculty for the Future Fellowship by the Schlumberger Foundation. Chi Pui Pang was partially supported by a Direct grant (grant no. 2041771) from the Medical Panel, The Chinese University of Hong Kong, and a General Research Fund (grant no. 2140694) from the Research Grants Council of Hong Kong. Mingzhi Zhang was partially supported by the National Scientific Foundation of China (grant no. 81486126), the Provincial Natural Scientific Foundation of China (grant no. 8151503102000019), and the Ministry of Health program of Public Welfare (grant no. 201302015). Yuk Fai Leung was partially supported by a Research Grant from the International Retinal Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov V, 2015, EUR J PHARMACOL, V750, P82, DOI 10.1016/j.ejphar.2014.11.047; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Bruni G, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00153; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P425, DOI 10.1016/j.ntt.2012.03.002; Emran F, 2008, J VIS EXP JOVE; Emran F, 2007, P NATL ACAD SCI USA, V104, P19126, DOI 10.1073/pnas.0709337104; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Ganzen L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061185; Gao Y, 2016, COMPUT BIOL MED, V69, P1, DOI 10.1016/j.compbiomed.2015.11.012; Gao Y, 2014, IEEE ACM T COMPUT BI, V11, P693, DOI 10.1109/TCBB.2014.2306829; Gu C., 2013, SMOOTHING SPLINE ANO; Kopp R, 2018, ENVIRON SCI POLLUT R, V25, P4085, DOI 10.1007/s11356-016-6704-3; Liu YW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02822-w; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Scott CA, 2016, DEV DYNAM, V245, P605, DOI [10.1002/DVDY.24398, 10.1002/dvdy.24398]; Shumway R.H., 2017, TIME SERIES ANAL ITS, Vfourth, DOI [DOI 10.1007/978-3-319-52452-8, 10.1007/978-3-319-52452-8]; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vignet C, 2013, ZEBRAFISH, V10, P365, DOI 10.1089/zeb.2013.0871; Zhang L, 2016, WORLD J PSYCHIATR, V6, P1, DOI 10.5498/wjp.v6.i1.1; Zhang LY, 2012, ASIA-PAC J OPHTHALMO, V1, P374, DOI 10.1097/APO.0b013e31827a9969; Zhou YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116095	23	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212234	10.1371/journal.pone.0212234	http://dx.doi.org/10.1371/journal.pone.0212234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768618	Green Submitted, Green Published, gold			2022-12-26	WOS:000458766300025
J	Kaji, DA; Zech, JR; Kim, JS; Cho, SK; Dangayach, NS; Costa, AB; Oermann, EK				Kaji, Deepak A.; Zech, John R.; Kim, Jun S.; Cho, Samuel K.; Dangayach, Neha S.; Costa, Anthony B.; Oermann, Eric K.			An attention based deep learning model of clinical events in the intensive care unit	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; HOSPITAL MORTALITY; PREDICTION; MANAGEMENT; LENGTH; STAY	This study trained long short-term memory (LSTM) recurrent neural networks (RNNs) incorporating an attention mechanism to predict daily sepsis, myocardial infarction (MI), and vancomycin antibiotic administration over two week patient ICU courses in the MIMIC-III dataset. These models achieved next-day predictive AUC of 0.876 for sepsis, 0.823 for MI, and 0.833 for vancomycin administration. Attention maps built from these models highlighted those times when input variables most influenced predictions and could provide a degree of interpretability to clinicians. These models appeared to attend to variables that were proxies for clinician decision-making, demonstrating a challenge of using flexible deep learning approaches trained with EHR data to build clinical decision support. While continued development and refinement is needed, we believe that such models could one day prove useful in reducing information overload for ICU physicians by providing needed clinical decision support for a variety of clinically important tasks.	[Kaji, Deepak A.; Zech, John R.; Kim, Jun S.; Cho, Samuel K.] Icahn Sch Med Mt Sinai, Dept Orthopaed, New York, NY 10029 USA; [Cho, Samuel K.; Dangayach, Neha S.; Costa, Anthony B.; Oermann, Eric K.] Icahn Sch Med Mt Sinai, Dept Neurol Surg, New York, NY 10029 USA; [Dangayach, Neha S.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Oermann, EK (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol Surg, New York, NY 10029 USA.	eric.oermann@mountsinai.org	Oermann, Eric/AAD-9729-2020; Kim, Jun Sup/ABB-5046-2021; Costa, Anthony/C-5471-2009	Oermann, Eric/0000-0002-1876-5963; Kim, Jun Sup/0000-0002-6114-2673; Kaji, Deepak/0000-0002-0470-3219; Costa, Anthony/0000-0002-2202-6450; Cho, Samuel/0000-0001-7511-2486				Ahmed A, 2011, CRIT CARE MED, V39, P1626, DOI 10.1097/CCM.0b013e31821858a0; Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b; [Anonymous], 2016, JAMA-J AM MED ASSOC, V315, P762, DOI [10.1001/jama.2016.0288, DOI 10.1001/JAMA.2016.0288]; Cabitza F, 2017, JAMA-J AM MED ASSOC, V318, P517, DOI 10.1001/jama.2017.7797; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; Choi E, 2016, ADV NEUR IN, V29; Choi Edward, 2016, JMLR Workshop Conf Proc, V56, P301; Clermont G, 2001, CRIT CARE MED, V29, P291, DOI 10.1097/00003246-200102000-00012; Dzmitry Bahdanau, 2016, Arxiv, DOI arXiv:1409.0473; Esteban C, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI), P93, DOI 10.1109/ICHI.2016.16; Futoma Joseph, 2017, MACH LEARN HEALTHC C, P243; Gandhi AA, 2017, INT J ADV MED, V2, P260; Gers FA, 2000, NEURAL COMPUT, V12, P2451, DOI 10.1162/089976600300015015; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Gruenberg DA, 2006, AM J CRIT CARE, V15, P502; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Henry KE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3719; Hsieh MH, 2018, J CLIN MED, V7; Hsieh YZ, 2014, COMPUT BIOL MED, V47, P13, DOI 10.1016/j.compbiomed.2013.12.012; Jansma G, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0035-7; Jo Y, 2017, CORR; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; LaFaro RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145395; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lipton Z. C., 2016, ARXIV160603490; Lipton Z.C., 2016, ICLR; Lipton ZC, 2016, PMLR, V56, P253; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Manaktala S, 2017, J AM MED INFORM ASSN, V24, P88, DOI 10.1093/jamia/ocw056; Mitchell S, 2016, 2016 IEEE SYSTEMS AND INFORMATION ENGINEERING DESIGN SYMPOSIUM (SIEDS), P107, DOI 10.1109/SIEDS.2016.7489280; Murdoch W James, 2018, INT C LEARN REPR; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Purushotham S, 2017, CORR; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Remy P., 2017, KERAS ATTENTION MECH; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sirio CA, 1999, CHEST, V115, P793, DOI 10.1378/chest.115.3.793; Six AJ, 2008, NETH HEART J, V16, P191, DOI 10.1007/BF03086144; Song H, 2017, CORR; Suistomaa M, 2002, INTENS CARE MED, V28, P479, DOI 10.1007/s00134-002-1214-9; Tanindi A, 2011, VASC HEALTH RISK MAN, V7, P597, DOI 10.2147/VHRM.S24509; Tieleman H, 2012, LECT 29 RMSPROP DIVI; Tran T., 1891, CEUR WORKSHOP PROC, P25; VanEperen AS, 2016, J INFECT CHEMOTHER, V22, P351, DOI 10.1016/j.jiac.2016.02.012; Vincent J-L, 1996, SOFA SEPSIS RELATED; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Xu K, 2015, PR MACH LEARN RES, V37, P2048; Xue Y, 2019, ARTIF INTELL MED, V95, P27, DOI 10.1016/j.artmed.2018.08.004; Zhang SH, 2018, ARCH ANIM NUTR, V72, P261, DOI 10.1080/1745039X.2018.1471185; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0; Zochios Vasileios, 2015, J Intensive Care Soc, V16, P52, DOI 10.1177/1751143714555303	55	54	55	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211057	10.1371/journal.pone.0211057	http://dx.doi.org/10.1371/journal.pone.0211057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759094	Green Submitted, Green Published, gold			2022-12-26	WOS:000458761300029
J	Meyer, SB; Foley, K; Olver, I; Ward, PR; McNaughton, D; Mwanri, L; Miller, ER				Meyer, Samantha B.; Foley, Kristen; Olver, Ian; Ward, Paul R.; McNaughton, Darlene; Mwanri, Lillian; Miller, Emma R.			Alcohol and breast cancer risk: Middle-aged women's logic and recommendations for reducing consumption in Australia	PLOS ONE			English	Article							PRIMARY-HEALTH-CARE; BRIEF INTERVENTIONS; LAY EPIDEMIOLOGY; PREVENTION; KNOWLEDGE; AWARENESS	Background We aimed to understand the factors shaping alcohol consumption patterns in middle-aged women (45-64), and to identify participant-driven population- and policy-level strategies that may be used to addresses alcohol consumption and reduce breast cancer risk. Methods Semi-structured interviews (n = 35) were conducted with 'middle-aged' women conversant in English and living in South Australia with no history of breast cancer diagnosis. Data were deductively coded using a co-developed framework including variables relevant to our study objectives. Women were asked about their current level of awareness of the association between alcohol and breast cancer risk, and their personal recommendations for how to decrease consumption in middle-aged Australian women. Results Women discussed their previous efforts to decrease consumption, which we drew on to identify preliminary recommendations for consumption reduction. We identified a low level of awareness of alcohol and breast cancer risk, and confusion related to alcohol as a risk for breast cancer, but not always causing breast cancer. Participants suggested that education and awareness, through various means, may help to reduce consumption. Conclusions Participants' description of strategies used to reduce their own consumption lead us to suggest that campaigns might focus on the more salient and immediate effects of alcohol (e.g. on physical appearance and mental health) rather than longer-term consequences. Critical considerations for messaging include addressing the personal, physical and social pleasures that alcohol provides, and how these may differ across socio-demographics.	[Meyer, Samantha B.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada; [Foley, Kristen; Ward, Paul R.; McNaughton, Darlene; Mwanri, Lillian; Miller, Emma R.] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Olver, Ian] Univ South Australia, Canc Res Inst, Adelaide, SA, Australia	University of Waterloo; Flinders University South Australia; University of South Australia	Meyer, SB (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada.	samantha.meyer@uwaterloo.ca	Miller, Emma/GXW-3128-2022; Miller, Emma R/G-9615-2018; Olver, Ian/I-1518-2015; Mwanri, Lillian/AGG-3711-2022	Miller, Emma R/0000-0002-6373-5720; Meyer, Samantha/0000-0002-2098-2828; Olver, Ian/0000-0001-5478-1576; Mwanri, Lillian/0000-0002-5792-7785; Ward, Paul/0000-0002-5559-9714; McNaughton, Darlene/0000-0002-0131-5966	Flinders University Seed Grant Competition, The Flinders Foundation	Flinders University Seed Grant Competition, The Flinders Foundation	This project was funded through the Flinders University Seed Grant Competition, The Flinders Foundation (EM as PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2007, NAT HLTH SURV SUMM R; Australian Institute of Health and Welfare, 2014, CANC AUSTR OV 2014; Australian Institute of Health and Welfare, 2017, CANC SER, V101; BABOR TF, 1994, ADDICTION, V89, P657, DOI 10.1111/j.1360-0443.1994.tb00944.x; Bagnardi V, 2015, BRIT J CANCER, V112, P580, DOI 10.1038/bjc.2014.579; Bates S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5581-8; Berry TR, 2018, BMC PSYCHOL, V6; Buykx P, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3855-6; Buykx P, 2015, INT J DRUG POLICY, V26, P371, DOI 10.1016/j.drugpo.2014.08.006; Cadmus-Bertram L, 2013, PSYCHO-ONCOLOGY, V22, P1821, DOI 10.1002/pon.3219; Campillo C., 1992, PROJECT IDENTIFICATI, P129; Clarke VA, 2000, J BEHAV MED, V23, P367, DOI 10.1023/A:1005500917875; Colditz GA, 2014, CA-CANCER J CLIN, V64, P186, DOI 10.3322/caac.21225; DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301; Dixon HG, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006511; Facione NC, 2002, CANCER PRACT, V10, P256, DOI 10.1046/j.1523-5394.2002.105005.x; FISCHHOFF B, 1993, ANNU REV PUBL HEALTH, V14, P183, DOI 10.1146/annurev.pu.14.050193.001151; Fleming MF, 2004, ALCOHOL RES HEALTH, V28, P57; Fleming MF, 2002, ALCOHOL CLIN EXP RES, V26, P36, DOI 10.1111/j.1530-0277.2002.tb02429.x; Fowler SL, 2017, MED DECIS MAKING, V37, P657, DOI 10.1177/0272989X17699835; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Go & Globe, 2021, ONL PIR NUMB FACTS S; Hay JL, 2015, MED DECIS MAKING, V35, P436, DOI 10.1177/0272989X15572827; Heather, 2006, WHO PHASE 4 COLLABOR, DOI DOI 10.1186/s12875-016-0461-8; Heather N, 2007, ADDICTION, V102, P679, DOI 10.1111/j.1360-0443.2007.01844.x; International Agency for Research on Cancer, 2009, 100E INT AG RES CANC, DOI [10.1016/j.amepre.2013.10.031, DOI 10.1016/J.AMEPRE.2013.10.031]; Iversen AC, 2006, HEALTH EDUC RES, V21, P601, DOI 10.1093/her/cyl014; Klein WMP, 2014, AM J PREV MED, V46, P303, DOI 10.1016/j.amepre.2013.10.004; Kraemer Kevin L, 2007, Subst Abus, V28, P67, DOI 10.1300/J465v28n03_07; Liu Y, 2015, WOMENS HEALTH, V11, P65, DOI [10.2217/WHE.14.62, 10.2217/whe.14.62]; Macdonald S, 2013, SOCIOL HEALTH ILL, V35, P575, DOI 10.1111/j.1467-9566.2012.01513.x; Martin N, 2018, ALCOHOL ALCOHOLISM, V53, P31, DOI 10.1093/alcalc/agx071; Miller ER, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013921; Miller ER, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2812-8; Mundt MP, 2006, ALCOHOL RES HEALTH, V29, P34; National Preventative Health Taskforce, 2009, 3 NAT PREV HLTH TASK; Nvivo, 2018, 12 QIPLV; Pandeya N, 2015, AUST NZ J PUBL HEAL, V39, P408, DOI 10.1111/1753-6405.12456; Park K, 2010, PSYCHO-ONCOLOGY, V19, P823, DOI 10.1002/pon.1618; Peacey V, 2006, EUR J CANCER, V42, P2585, DOI 10.1016/j.ejca.2006.03.017; Petticrew M, 2017, J EPIDEMIOL COMMUN H, V71, P308, DOI 10.1136/jech-2016-207644; Pettigrew S, 2016, ADDICTION RES THEORY, V24; Pettigrew S., 2002, QUAL MARK RES, V5, P112, DOI DOI 10.1108/13522750210423814; Pettigrew S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00217; Pettigrew S, 2016, HEALTH EDUC RES, V31, P60, DOI 10.1093/her/cyv067; Pettigrew S, 2012, DRUG ALCOHOL REV, V31, P797, DOI 10.1111/j.1465-3362.2012.00439.x; Sassi F., 2015, TACKLING HARMFUL ALC; Scoccianti C, 2014, AM J PREV MED, V46, pS16, DOI 10.1016/j.amepre.2013.10.031; Slovic P, 2005, HEALTH PSYCHOL, V24, pS35, DOI 10.1037/0278-6133.24.4.S35; Statistics Canada, 2016, HEAV DRINK; Swan A, 2008, ALCOHOL OTHER DRUG B; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Watling H., 2014, MEDIA RELEASE MIDDLE; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilk AI, 1997, J GEN INTERN MED, V12, P274; Winstanley MH, 2011, MED J AUSTRALIA, V194, P479, DOI 10.5694/j.1326-5377.2011.tb03067.x; World Health Organization, 2007, WHO EXP COMM PROBL R	57	16	16	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211293	10.1371/journal.pone.0211293	http://dx.doi.org/10.1371/journal.pone.0211293			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5IX	30759125	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000458761300036
J	Naito, A; Hiwasa, T; Tanabe, N; Sanada, TJ; Sugiura, T; Shigeta, A; Terada, J; Takizawa, H; Kashiwado, K; Sakao, S; Tatsumi, K				Naito, Akira; Hiwasa, Takaki; Tanabe, Nobuhiro; Sanada, Takayuki Jujo; Sugiura, Toshihiko; Shigeta, Ayako; Terada, Jiro; Takizawa, Hirotaka; Kashiwado, Koichi; Sakao, Seiichiro; Tatsumi, Koichiro			Elevated levels of autoantibodies against EXD2 and PHAX in the sera of patients with chronic thromboembolic pulmonary hypertension	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; DNA-DAMAGE; ANTIBODIES; MECHANISMS; SNRNA	While circulating autoantibodies have been detected in patients with several cardiovascular diseases, such studies have not been performed for chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Here we investigated the production of certain auto-antibodies in CTEPH patients. Initial screening was performed in 5 CTEPH patients and 5 healthy donors (HDs) using a ProtoArray Human Protein Micro array v5.1 containing 9,375 human proteins, and we selected 34 antigens recognized by IgG antibodies more strongly in the sera of CTEPH patients than in the sera of HDs. In subsequent second/third analyses, we validated the auto-antibody level using amplified luminescent proximity homogeneous assay-linked immunosorbent assay (AlphaLISA) in 96 CTEPH patients and 96 HDs as follows: At the second screening, we used 63 crude peptides derived from those selected 34 antigens and found that the serum levels of autoantibodies for 4 peptides seemed higher in CTEPH patients than in HDs. In third analysis, we used the purified peptides of those selected in second screening and found that serum antibodies against peptides derived from exonuclease 3'-5' domain-containing 2 (EXD2) and phosphorylated adaptor for RNA export (PHAX) were significantly higher in CTEPH patients than in HDs. The serum antibody levels to these antigens were also elevated in PAH patients. The titers against EXD2 peptide decreased after surgical treatment in CTEPH patients. These autoantibodies may be useful as biomarkers of CTEPH and PAH, and further investigations may provide novel insight into the etiology.	[Naito, Akira; Tanabe, Nobuhiro; Sanada, Takayuki Jujo; Sugiura, Toshihiko; Shigeta, Ayako; Terada, Jiro; Sakao, Seiichiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Japan; [Naito, Akira] Chiba Univ, Grad Sch Med, Dept Adv Res Treatment Strategies Resp Dis, Chiba, Japan; [Hiwasa, Takaki] Chiba Univ, Grad Sch Med, Dept Biochem & Genet, Chiba, Japan; [Hiwasa, Takaki] Chiba Univ, Grad Sch Med, Dept Neurol Surg, Chiba, Japan; [Tanabe, Nobuhiro; Sanada, Takayuki Jujo; Shigeta, Ayako] Chiba Univ, Grad Sch Med, Dept Adv Med Pulm Hypertens, Chiba, Japan; [Takizawa, Hirotaka] Kashiwado Mem Fdn, Port Sq Kashiwado Clin, Chiba, Japan; [Kashiwado, Koichi] Kashiwado Hosp, Dept Neurol, Kashiwado Mem Fdn, Chiba, Japan	Chiba University; Chiba University; Chiba University; Chiba University; Chiba University	Naito, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Japan.; Naito, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Adv Res Treatment Strategies Resp Dis, Chiba, Japan.	akira-n.390@chiba-u.jp	Jujo, Takayuki/Q-7627-2018	Jujo, Takayuki/0000-0001-5725-1810	Teijin Pharma, Ltd. (Tokyo, Japan); Ono Pharmaceutical, Ltd. (Osaka, Japan); endowed department of Actelion Pharmaceuticals Japan (Tokyo, Japan); Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan [H26 Intractable diseases-General-076]; Japan Agency for Medical Research and Development (AMED) [15ek0109127h0001]; Ministry of Education, Culture, Sports, Science and Technology of Japan [25461148]	Teijin Pharma, Ltd. (Tokyo, Japan); Ono Pharmaceutical, Ltd. (Osaka, Japan); endowed department of Actelion Pharmaceuticals Japan (Tokyo, Japan); Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Akira Naito is a member of the Joint Collaborative Department with Teijin Pharma, Ltd. (Tokyo, Japan) and Ono Pharmaceutical, Ltd. (Osaka, Japan). Nobuhiro Tanabe, Takayuki Jujo Sanada, and Ayako Shigeta are members of the endowed department of Actelion Pharmaceuticals Japan (Tokyo, Japan). These companies provided support in the form of salaries for authors [AN, NT, TJS, AS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. Research grants from the Respiratory Failure Research Group (H26 Intractable diseases-General-076) from the Ministry of Health, Labour and Welfare, Japan to KT. A grant to the Pulmonary Hypertension Research Group (15ek0109127h0001) from the Japan Agency for Medical Research and Development (AMED) to KT. A research grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25461148) to NT.	Aldred MA, 2010, AM J RESP CRIT CARE, V182, P1153, DOI 10.1164/rccm.201003-0491OC; Altmann J, 2016, EXPERT REV HEMATOL, V9, P69, DOI 10.1586/17474086.2016.1112264; Broderick R, 2016, NAT CELL BIOL, V18, P271, DOI 10.1038/ncb3303; Chen J, 1998, J CEREBR BLOOD F MET, V18, P646, DOI 10.1097/00004647-199806000-00007; Federici C, 2015, AM J RESP CRIT CARE, V192, P219, DOI 10.1164/rccm.201411-2128OC; Fesmire J, 2010, REV BRAS REUMATOL, V50, P545, DOI 10.1590/S0482-50042010000500007; Goto K, 2015, J MOL BIOMARK DIAGN, V6, P2; Hasunuma Y, 1997, CLIN EXP IMMUNOL, V107, P569, DOI 10.1046/j.1365-2249.1997.d01-948.x; Hiwasa T, 2015, GRATIS J BIOMEDICAL, V1; Hiwasa T, 2017, SREUM SH3BP5 SPECIFI; Hiwasa Takaki, 2016, J Circ Biomark, V5, P8, DOI 10.5772/63218; Kobayashi K, 2001, J LIPID RES, V42, P697; Lang IM, 2013, EUR RESPIR J, V41, P462, DOI 10.1183/09031936.00049312; Matsumura T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195015; Matsumura T, 2017, J CLIN SLEEP MED, V13, P393, DOI 10.5664/jcsm.6488; Montecucco F, 2011, EUR HEART J, V32, P412, DOI 10.1093/eurheartj/ehq521; Mourao A, 2010, RNA, V16, P1205, DOI 10.1261/rna.2009910; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141; Ranchoux B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060990; Roux-Lombard P, 2013, CLIN REV ALLERG IMMU, V44, P84, DOI 10.1007/s12016-010-8233-z; Schulze WM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04142-7; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Yeager ME, 2001, CIRC RES, V88, pE2; Zhang X, 2017, J MOL BIOMARKERS DIA, V08; Zhang XK, 2010, CELL CYCLE, V9, P4437, DOI 10.4161/cc.9.22.13887	26	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211377	10.1371/journal.pone.0211377	http://dx.doi.org/10.1371/journal.pone.0211377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759165	Green Submitted, Green Published, gold			2022-12-26	WOS:000458761300041
J	Gomes, AL; Kinchesh, P; Gilchrist, S; Allen, PD; Lourenco, LM; Ryan, AJ; Smart, SC				Gomes, Ana L.; Kinchesh, Paul; Gilchrist, Stuart; Allen, Philip D.; Lourenco, Luiza Madia; Ryan, Anderson J.; Smart, Sean C.			Cardio-Respiratory synchronized bSSFP MRI for high throughput in vivo lung tumour quantification	PLOS ONE			English	Article							HYPERPOLARIZED HE-3; INVERSION-RECOVERY; GRADIENT-ECHO; MICE; OXYGEN; SUSCEPTIBILITY; SEGMENTATION; MODEL; RATS; UTE	The identification and measurement of tumours is a key requirement in the study of tumour development in mouse models of human cancer. Disease burden in autochthonous tumours, such as those arising in the lung, can be seen with non-invasive imaging, but cannot be accurately measured using standard tools such as callipers. Lung imaging is further complicated in the mouse due to instabilities arising from the rapid but cyclic cardio-respiratory motions, and the desire to use free-breathing animals. Female A/JOlaHsd mice were either injected (i.p.) with PBS 0.1ml/10g body weight (n = 6), or 10% urethane/PBS 0.1ml/10g body weight (n = 12) to induce autochthonous lung tumours. Cardio-respiratory synchronised bSSFP MRI, at 200 mu m isotropic resolution was performed at 8, 13 and 18 weeks post induction. Images from the same mouse at different time points were aligned using threshold-based segmented masks of the lungs (ITK-SNAP and MATLAB) and tumour volumes were determined via threshold-based segmentation (ITK-SNAP). Scan times were routinely below 10 minutes and tumours were readily identifiable. Image registration allowed serial measurement of tumour volumes as small as 0.056 mm(3). Repetitive imaging did not lead to mouse welfare issues. We have developed a motion desensitised scan that enables high sensitivity MRI to be performed with high throughput capability of greater than 4 mice/hour. Image segmentation and registration allows serial measurement of individual, small tumours. This allows fast and highly efficient volumetric lung tumour monitoring in cohorts of 30 mice per imaging time point. As a result, adaptive trial study designs can be achieved, optimizing experimental and welfare outcomes.	[Kinchesh, Paul; Gilchrist, Stuart; Allen, Philip D.; Lourenco, Luiza Madia; Ryan, Anderson J.; Smart, Sean C.] Univ Oxford, Canc Res UK, Oxford, England; [Kinchesh, Paul; Gilchrist, Stuart; Allen, Philip D.; Lourenco, Luiza Madia; Ryan, Anderson J.; Smart, Sean C.] Univ Oxford, Med Res Council Oxford Inst Radiat Oncol, Dept Oncol, Oxford, England; [Gomes, Ana L.] Francis Crick Inst, Haematopoiet Stem Cell Lab, London, England	Cancer Research UK; University of Oxford; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; Francis Crick Institute	Gomes, AL (corresponding author), Francis Crick Inst, Haematopoiet Stem Cell Lab, London, England.	ana.gomes@crick.ac.uk	RYAN, Anderson/ACG-0319-2022; Ryan, Anderson J/O-7701-2015; Lourenco, Luiza Helena Madia/D-2460-2019	RYAN, Anderson/0000-0001-6241-7969; Ryan, Anderson J/0000-0001-6241-7969; Lourenco, Luiza Helena Madia/0000-0002-1107-5038; Gomes, Ana L/0000-0002-4796-6537	Cancer Research UK [C5255/A12678, C2522/A10339]; Medical Research Council Unit Grant for Oxford Institute for Radiation Oncology; MRC [MC_UU_00001/6, MC_PC_12006] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council Unit Grant for Oxford Institute for Radiation Oncology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported financially by Cancer Research UK (C5255/A12678, C2522/A10339 to SCS), and Medical Research Council Unit Grant for Oxford Institute for Radiation Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JW, 1986, CANCER RES, V46, P4911; Bankson JA, 2008, J MAGN RESON IMAGING, V27, P57, DOI 10.1002/jmri.21221; Beckmann N, 2001, NMR BIOMED, V14, P297, DOI 10.1002/nbm.706; Bishop J, 2006, MAGN RESON MED, V55, P472, DOI 10.1002/mrm.20794; Cancer Research UK, 2014, CANC STAT TYP; Driehuys B, 2012, RADIOLOGY, V262, P279, DOI 10.1148/radiol.11102172; Fain SB, 2007, J MAGN RESON IMAGING, V25, P910, DOI 10.1002/jmri.20876; FESTING MFW, 1994, GENET RES, V64, P99, DOI 10.1017/S0016672300032705; Gibiino F, 2015, MAGN RESON MATER PHY, V28, P207, DOI 10.1007/s10334-014-0459-y; Hemberger KRF, 2015, MAGN RESON MATER PHY, V28, P217, DOI 10.1007/s10334-014-0462-3; Hensley H, 2007, CANCER BIOL THER, V6, P1717, DOI 10.4161/cbt.6.11.4830; Hori Y, 2008, CANCER SCI, V99, P1774, DOI 10.1111/j.1349-7006.2008.00889.x; Jakob PM, 2001, J MAGN RESON IMAGING, V14, P795, DOI 10.1002/jmri.10024; Kellar A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/621324; Kersemans V, 2015, MAGN RESON IMAGING, V33, P847, DOI 10.1016/j.mri.2015.03.011; Kinchesh P, 2016, 24 ANN M INT SOC MAG; Kroon D.-J., 2011, SEGMENTATION MANDIBU; Krupnick AS, 2012, NAT PROTOC, V7, P128, DOI 10.1038/nprot.2011.424; Ma WJ, 2015, J MAGN RESON IMAGING, V41, P1465, DOI 10.1002/jmri.24680; Mai VM, 1999, MAGNET RESON MED, V41, P866, DOI 10.1002/(SICI)1522-2594(199905)41:5<866::AID-MRM2>3.0.CO;2-D; MALKINSON AM, 1989, TOXICOLOGY, V54, P241, DOI 10.1016/0300-483X(89)90062-0; Olson JD, 2012, RADIAT RES, V178, P321, DOI 10.1667/RR2800.1; Scheffler K, 2003, MAGN RESON MED, V49, P395, DOI 10.1002/mrm.10351; Tibiletti M, 2017, MAGN RESON MED, V78, P739, DOI 10.1002/mrm.26463; Togao O, 2011, J MAGN RESON IMAGING, V34, P539, DOI 10.1002/jmri.22645; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094945; Wang W, 2011, MAGN RESON MED, V65, P620, DOI 10.1002/mrm.22737; Wild JM, 2011, NMR BIOMED, V24, P130, DOI 10.1002/nbm.1565; Wilding LA, 2017, J AM ASSOC LAB ANIM, V56, P148; Xiang QS, 2014, MAGN RESON MED, V71, P927, DOI 10.1002/mrm.25098; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8; Zurek M, 2014, MAGN RESON MED, V71, P2180, DOI 10.1002/mrm.24876	33	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212172	10.1371/journal.pone.0212172	http://dx.doi.org/10.1371/journal.pone.0212172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753240	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600051
J	Jordan, RA; Egizi, A				Jordan, Robert A.; Egizi, Andrea			The growing importance of lone star ticks in a Lyme disease endemic county: Passive tick surveillance in Monmouth County, NJ, 2006-2016	PLOS ONE			English	Article							AMBLYOMMA-AMERICANUM ACARI; IXODES-SCAPULARIS ACARI; BORRELIA-BURGDORFERI; EHRLICHIA-CHAFFEENSIS; INCREASING INCIDENCE; PARASITIZING HUMANS; FOCAL DISTRIBUTION; BORNE PATHOGENS; IXODIDAE TICKS; UNITED-STATES	As human cases of tick-borne disease continue to increase, there is a heightened imperative to collect data on human-tick encounters to inform disease prevention. Passive tick surveillance programs that encourage members of the public to submit ticks they have encountered can provide a relatively low-cost means of collecting such data. We report the results of 11 years of tick submissions (2006-2016) collected in Monmouth County, New Jersey, an Atlantic coastal county long endemic for Lyme disease. A total of 8,608 ticks acquired in 22 U.S. states were submitted, 89.7% of which were acquired in Monmouth County, from 52 of the County's 53 municipalities. Seasonal submission rates reflected known phenology of common human-biting ticks, but annual submissions of both Amblyomma americanum and Dermacentor variabilis increased significantly over time while numbers of Ixodes scapularis remained static. By 2016, A. americanum had expanded northward in the county and now accounted for nearly half (48.1%) of submissions, far out-pacing encounters with I. scapularis (28.2% of submissions). Across all tick species and stages the greatest number of ticks were removed from children (ages 0-9, 40.8%) and older adults (ages 50+, 23.8%) and these age groups were also more likely to submit partially or fully engorged ticks, suggesting increased risk of tick-borne disease transmission to these vulnerable age groups. Significantly more people (43.2%) reported acquiring ticks at their place of residence than in a park or natural area (17.9%). This pattern was more pronounced for residents over 60 years of age (72.7% acquired at home). Education that stresses frequent tick checks should target older age groups engaged in activity around the home. Our results strongly suggest that encounter rates with ticks other than I. scapularis are substantial and increasing and that their role in causing human illness should be carefully investigated.	[Jordan, Robert A.; Egizi, Andrea] Monmouth Cty Mosquito Control Div, Tick Borne Dis Program, Tinton Falls, NJ 07724 USA; [Jordan, Robert A.; Egizi, Andrea] Rutgers State Univ, Ctr Vector Biol, Dept Entomol, New Brunswick, NJ 08854 USA	Rutgers State University New Brunswick	Jordan, RA (corresponding author), Monmouth Cty Mosquito Control Div, Tick Borne Dis Program, Tinton Falls, NJ 07724 USA.; Jordan, RA (corresponding author), Rutgers State Univ, Ctr Vector Biol, Dept Entomol, New Brunswick, NJ 08854 USA.	robert.jordan@co.monmouth.nj.us	Egizi, Andrea/AAV-1689-2020	Egizi, Andrea/0000-0002-4604-045X	Monmouth County Board of Chosen Freeholders	Monmouth County Board of Chosen Freeholders	We thank Martin Chomsky, Terry L. Schulze, and Daniel Markowski, for initiating the Monmouth County Tick-borne Disease Program and establishing a laboratory at Rutgers University, Center for Vector Biology. We are indebted to Sean P. Healy and Vivien E. Roegner for many years of diligent data collection and to Mosquito Control office staff for assisting residents with their submissions. Lyme disease case data were provided by the New Jersey Department of Health, Communicable Disease Service, with special thanks to Lindsay Lowe, Kim Cervantes, and Shereen Semple. We appreciate the support this project and the Tick-borne Disease Program has received from the Monmouth County Board of Chosen Freeholders. And importantly, we thank the residents of Monmouth County for submitting their ticks to our program.	Armstrong PM, 2001, B WORLD HEALTH ORGAN, V79, P916; Blanton L, 2008, SO MED J; BOWEN GS, 1984, AM J EPIDEMIOL, V120, P387; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; CLIFFORD CM, 1978, J MED ENTOMOL, V15, P57, DOI 10.1093/jmedent/15.1.57; Connally NP, 2006, J VECTOR ECOL, V31, P364, DOI 10.3376/1081-1710(2006)31[364:APEFAP]2.0.CO;2; Cromley EK, 1998, AM J EPIDEMIOL, V147, P472, DOI 10.1093/oxfordjournals.aje.a009473; Dahlgren FS, 2016, AM J TROP MED HYG, V94, P35, DOI 10.4269/ajtmh.15-0580; Dister SW, 1997, AM J TROP MED HYG, V57, P687, DOI 10.4269/ajtmh.1997.57.687; Dumler JS, 2007, CLIN INFECT DIS, V45, pS45, DOI 10.1086/518146; Egizi A, 2018, TICKS TICK-BORNE DIS, V9, P418, DOI 10.1016/j.ttbdis.2017.12.009; Egizi A, 2017, EMERG INFECT DIS, V23, P939, DOI 10.3201/eid2306.160528; Eisen L, 2018, TICKS TICK-BORNE DIS, V9, P535, DOI 10.1016/j.ttbdis.2018.01.002; Eisen L, 2016, J MED ENTOMOL, V53, P1063, DOI 10.1093/jme/tjw103; Eisen L, 2016, J MED ENTOMOL, V53, P1050, DOI 10.1093/jme/tjw092; EISEN R. J., 2017, ILAR J, V23, P1; Eisen RJ, 2012, J MED ENTOMOL, V49, P11, DOI 10.1603/ME11138; Eremeeva ME, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00055; Falco RC, 1999, AM J EPIDEMIOL, V149, P771, DOI 10.1093/oxfordjournals.aje.a009886; FALCO RC, 1988, AM J EPIDEMIOL, V128, P1146; Feder HM, 2011, CLIN INFECT DIS, V53, pE142, DOI 10.1093/cid/cir553; Felz MW, 1999, J MED ENTOMOL, V36, P361, DOI 10.1093/jmedent/36.3.361; Hahn MB, 2018, TICKS TICK-BORNE DIS, V9, P340, DOI 10.1016/j.ttbdis.2017.11.010; Heitman KN, 2016, AM J TROP MED HYG, V94, P52, DOI 10.4269/ajtmh.15-0540; Johnson JL, 2004, VECTOR-BORNE ZOONOT, V4, P137, DOI 10.1089/1530366041210710; Kannangara DW, 2018, VECTOR-BORNE ZOONOT, V18, P641, DOI 10.1089/vbz.2018.2278; KEIRANS JE, 1989, J MED ENTOMOL, V26, P435, DOI 10.1093/jmedent/26.5.435; Keirans JE, 1996, J MED ENTOMOL, V33, P297, DOI 10.1093/jmedent/33.3.297; Liang WC, 1999, AM J PREV MED, V17, P8, DOI 10.1016/S0749-3797(99)00040-9; Mather TN, 1996, AM J EPIDEMIOL, V144, P1066, DOI 10.1093/oxfordjournals.aje.a008879; Mead P, 2018, TICKS TICK-BORNE DIS, V9, P319, DOI 10.1016/j.ttbdis.2017.11.006; Mixson TR, 2004, J MED ENTOMOL, V41, P1104, DOI 10.1603/0022-2585-41.6.1104; Monmouth County Division of Planning, 2017, AGING POPULATION STU; Nelder MP, 2019, TICKS TICK-BORNE DIS, V10, P146, DOI 10.1016/j.ttbdis.2018.10.001; Nelder MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105358; NJDOH, 2017, NEW JERS REP DIS STA; Ogden NH, 2006, J MED ENTOMOL, V43, P600, DOI 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2; Oliver JD, 2017, J MED ENTOMOL, V54, P1727, DOI 10.1093/jme/tjx121; Pepin KM, 2012, AM J TROP MED HYG, V86, P1062, DOI 10.4269/ajtmh.2012.11-0630; Rainey T, 2018, J MED ENTOMOL, V55, P757, DOI 10.1093/jme/tjy006; Rand PW, 2007, J MED ENTOMOL, V44, P1118, DOI 10.1603/0022-2585(2007)44[1118:PSIMAA]2.0.CO;2; Ripoche M, 2018, J MED ENTOMOL, V55, P1016, DOI 10.1093/jme/tjy030; Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1; Rossi Carlo, 2015, MSMR, V22, P2; Savage HM, 2016, J MED ENTOMOL, V53, P607, DOI 10.1093/jme/tjw028; Schulze TL, 2006, J MED ENTOMOL, V43, P1269, DOI 10.1603/0022-2585(2006)43[1269:RAAPOS]2.0.CO;2; Schulze TL, 2013, J MED ENTOMOL, V50, P379, DOI 10.1603/ME12088; Schulze TL, 2011, J AM MOSQUITO CONTR, V27, P236, DOI 10.2987/11-6111.1; Schulze TL, 2005, J MED ENTOMOL, V42, P450, DOI 10.1603/0022-2585(2005)042[0450:REFAPO]2.0.CO;2; Schulze TL, 1996, J MED ENTOMOL, V33, P963, DOI 10.1093/jmedent/33.6.963; Schulze TL, 2005, J MED ENTOMOL, V42, P285, DOI 10.1603/0022-2585(2005)042[0285:IOMAMH]2.0.CO;2; Schulze TL, 2002, ENVIRON ENTOMOL, V31, P1085, DOI 10.1603/0046-225X-31.6.1085; Schwartz AM, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6622a1; Sokol R.R., 1995, BIOMETRY; Sonenshine DE, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030478; Stafford KC, 1998, J CLIN MICROBIOL, V36, P1240, DOI 10.1128/JCM.36.5.1240-1244.1998; Stafford KC, 2018, J MED ENTOMOL, V55, P1561, DOI 10.1093/jme/tjy115; Stromdahl EY, 2012, ZOONOSES PUBLIC HLTH, V59, P48, DOI 10.1111/j.1863-2378.2012.01475.x; Stromdahl EY, 2001, J MED ENTOMOL, V38, P67, DOI 10.1603/0022-2585-38.1.67; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; U.S. Census Bureau, 2020, AM COMMUNITY SURVEY; Xu G, 2016, VECTOR-BORNE ZOONOT, V16, P520, DOI 10.1089/vbz.2015.1912	63	37	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211778	10.1371/journal.pone.0211778	http://dx.doi.org/10.1371/journal.pone.0211778			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753233	Green Published, gold, Green Submitted			2022-12-26	WOS:000458395600023
J	Masson, T; Fabre, ML; Ferrelli, ML; Pidre, ML; Romanowski, V				Masson, Tomas; Laura Fabre, Maria; Leticia Ferrelli, Maria; Luis Pidre, Matias; Romanowski, Victor			Protein composition of the occlusion bodies of Epinotia aporema granulovirus	PLOS ONE			English	Article							BUDDED VIRUS PRODUCTION; PROTEOMIC ANALYSIS; SEQUENCE-ANALYSIS; BV PRODUCTION; CORE GENE; NUCLEOPOLYHEDROVIRUS	Within family Baculoviridae, members of the Betabaculovirus genus are employed as bio-control agents against lepidopteran pests, either alone or in combination with selected members of the Alphabaculovirus genus. Epinotia aporema granulovirus (EpapGV) is a fast killing betabaculovirus that infects the bean shoot borer (E. aporema) and is a promising bio-pesticide. Because occlusion bodies (OBs) play a key role in baculovirus horizontal transmission, we investigated the composition of EpapGV OBs. Using mass spectrometry-based proteomics we could identify 56 proteins that are included in the OBs during the final stages of larval infection. Our data provides experimental validation of several annotated hypothetical coding sequences. Proteogenomic mapping against genomic sequence detected a previously unannotated ac 110-like core gene and a putative translation fusion product of ORFs epap48 and epap49. Comparative studies of the proteomes available for the family Baculoviridae highlight the conservation of core gene products as parts of the occluded virion. Two proteins specific for betabaculoviruses (Epap48 and Epap95) are incorporated into OBs. Moreover, quantification based on emPAI values showed that Epap95 is one of the most abundant components of EpapGV OBs.	[Masson, Tomas; Laura Fabre, Maria; Leticia Ferrelli, Maria; Luis Pidre, Matias; Romanowski, Victor] Univ Nacl La Plata, IBBM, UNLP CONICET, Fac Ciencias Exactas, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Romanowski, V (corresponding author), Univ Nacl La Plata, IBBM, UNLP CONICET, Fac Ciencias Exactas, La Plata, Buenos Aires, Argentina.	victor@biol.unlp.edu.ar		Ferrelli, Maria Leticia/0000-0001-9086-4563; Masson, Tomas/0000-0002-2634-6283; Pidre, Matias/0000-0002-8606-021X; Romanowski, Victor/0000-0001-6378-7929; Fabre, Maria Laura/0000-0003-1875-4196	Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) [PICT 2014-1827]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2014-1827]; Universidad Nacional de La Plata (UNLP) [11/X854]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, FONCyT)	Fondo para la Investigacion Cientifica y Tecnologica (FONCyT)(FONCyT); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Universidad Nacional de La Plata (UNLP)(National University of La Plata); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, FONCyT)(ANPCyTFONCyT)	This work was supported by Fondo para la Investigacion Cientifica y Tecnologica (FONCyT), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), PICT 2014-1827, Dr. Victor Romanowski; Universidad Nacional de La Plata (UNLP) 11/X854, Dr. Victor Romanowski. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Silvia Margarita Moreno and Dr. Maria Pia Valacco, from the Centro de Estudios Quimicos y Biologicos por Espectrometria de Masas (CEQUIBIEM-CONICET-FCEN-UBA), for their help with sample preparation protocols, data acquisition and subsequent analysis. This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, FONCyT) and Universidad Nacional de La Plata (UNLP) to Victor Romanowski.	Alfonso V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046146; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bezier A, 2017, J GEN VIROL, V98, P284, DOI 10.1099/jgv.0.000661; Biswas S, 2018, J VIROL, V92, DOI 10.1128/JVI.01713-17; Boogaard B, 2018, INSECTS, V9, DOI 10.3390/insects9030084; Braconi CT, 2014, J GEN VIROL, V95, P980, DOI 10.1099/vir.0.061127-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braunagel SC, 2003, P NATL ACAD SCI USA, V100, P9797, DOI 10.1073/pnas.1733972100; Brito Anderson Fernandes de, 2015, Genome Biol Evol, V8, P94, DOI 10.1093/gbe/evv231; Chen L, 2012, ARCH VIROL, V157, P617, DOI 10.1007/s00705-011-1211-9; Doellinger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141527; Dong F, 2016, VIRUS RES, V221, P47, DOI 10.1016/j.virusres.2016.05.005; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Escasa SR, 2006, J GEN VIROL, V87, P1917, DOI 10.1099/vir.0.81792-0; Greco TM, 2014, ANNU REV VIROL, V1, P581, DOI 10.1146/annurev-virology-031413-085527; Haase S, 2015, VIRUSES-BASEL, V7, P2230, DOI 10.3390/v7052230; Harrison RL, 2008, VIRUS GENES, V36, P565, DOI 10.1007/s11262-008-0218-0; Harrison RL, 2018, J GEN VIROL, V99, P1185, DOI 10.1099/jgv.0.001107; Hou DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153365; Hou DH, 2013, J VIROL, V87, P829, DOI 10.1128/JVI.02329-12; Ince IA, 2010, VIROLOGY, V405, P253, DOI 10.1016/j.virol.2010.05.038; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Javed MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02115-16; Kang M, 2014, J VIROL, V88, P12541, DOI 10.1128/JVI.02031-14; Leroy B, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020050; Ferrelli ML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-548; McCarthy CB, 2008, VIROLOGY, V375, P277, DOI 10.1016/j.virol.2008.01.039; McCarthy CB, 2008, VIROLOGY, V372, P325, DOI 10.1016/j.virol.2007.10.019; Moldovan N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26955-8; Nesvizhskii AI, 2014, NAT METHODS, V11, P1114, DOI [10.1038/NMETH.3144, 10.1038/nmeth.3144]; Passarelli AL, 2011, VIROLOGY, V411, P383, DOI 10.1016/j.virol.2011.01.009; Perera O, 2007, J VIROL, V81, P4585, DOI 10.1128/JVI.02391-06; Sanchez NE, 2008, ENCY ENTOMOLOGY, P2587, DOI [10.1007/978-1-4020-6359-6_2186, DOI 10.1007/978-1-4020-6359-6_2186]; Sciocco-Cap A, 2001, APPL ENVIRON MICROB, V67, P3702, DOI 10.1128/AEM.67.8.3702-3706.2001; Shi AQ, 2018, J VIROL, V92, DOI 10.1128/JVI.01509-17; Tan YP, 2009, J GEN VIROL, V90, P359, DOI 10.1099/vir.0.005934-0; Tao XY, 2013, J VIROL, V87, P8441, DOI 10.1128/JVI.01290-13; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; Vidick S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083842; Wang XF, 2011, J PROTEOME RES, V10, P2817, DOI 10.1021/pr2000804; Wu WB, 2010, J VIROL, V84, P12351, DOI 10.1128/JVI.01598-10; Xu F, 2011, VIRUS RES, V158, P1, DOI 10.1016/j.virusres.2011.02.014; Yuan MJ, 2008, VIROLOGY, V379, P87, DOI 10.1016/j.virol.2008.06.015; Yuan MJ, 2011, J VIROL, V85, P11664, DOI 10.1128/JVI.05275-11; Zhang XX, 2015, J GEN VIROL, V96, P2394, DOI 10.1099/vir.0.000146; Zhu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086450	46	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0207735	10.1371/journal.pone.0207735	http://dx.doi.org/10.1371/journal.pone.0207735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753194	Green Published, gold, Green Submitted			2022-12-26	WOS:000458395600003
J	Mezzadra, R; de Bruijn, M; Jae, LT; Gomez-Eerland, R; Duursma, A; Scheeren, FA; Brummelkamp, TR; Schumacher, TN				Mezzadra, Riccardo; de Bruijn, Marjolein; Jae, Lucas T.; Gomez-Eerland, Raquel; Duursma, Anja; Scheeren, Ferenc A.; Brummelkamp, Thijn R.; Schumacher, Ton N.			SLFN11 can sensitize tumor cells towards IFN-gamma-mediated T cell killing	PLOS ONE			English	Article							INTERFERON-GAMMA; PD-1 BLOCKADE; RESISTANCE; IDENTIFICATION; MECHANISMS; THERAPY; GENES	Experimental and clinical observations have highlighted the role of cytotoxic T cells in human tumor control. However, the parameters that control tumor cell sensitivity to T cell attack remain incompletely understood. To identify modulators of tumor cell sensitivity to T cell effector mechanisms, we performed a whole genome haploid screen in HAP1 cells. Selection of tumor cells by exposure to tumor-specific T cells identified components of the interferon-gamma (IFN-gamma) receptor (IFNGR) signaling pathway, and tumor cell killing by cytotoxic T cells was shown to be in large part mediated by the pro-apoptotic effects of IFN-gamma. Notably, we identified schlafen 11 (SLFN11), a known modulator of DNA damage toxicity, as a regulator of tumor cell sensitivity to T cell-secreted IFN-gamma. SLFN11 does not influence IFNGR signaling, but couples IFNGR signaling to the induction of the DNA damage response (DDR) in a context dependent fashion. In line with this role of SLFN11, loss of SLFN11 can reduce IFN-gamma mediated toxicity. Collectively, our data indicate that SLFN11 can couple IFN-gamma exposure of tumor cells to DDR and cellular apoptosis. Future work should reveal the mechanistic basis for the link between IFNGR signaling and DNA damage response, and identify tumor cell types in which SLFN11 contributes to the anti-tumor activity of T cells.	[Mezzadra, Riccardo; de Bruijn, Marjolein; Gomez-Eerland, Raquel; Scheeren, Ferenc A.; Schumacher, Ton N.] Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Jae, Lucas T.; Brummelkamp, Thijn R.] Netherlands Canc Inst, Oncode Inst, Div Biochem, Amsterdam, Netherlands; [Duursma, Anja] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Brummelkamp, Thijn R.] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Brummelkamp, Thijn R.] Cancergenomics nl, Amsterdam, Netherlands; [Jae, Lucas T.] Ludwig Maximilians Univ Munchen, Gene Ctr, Munich, Germany; [Jae, Lucas T.] Ludwig Maximilians Univ Munchen, Dept Biochem, Munich, Germany; [Scheeren, Ferenc A.] Leiden Univ, Dept Med Oncol, Med Ctr, Leiden, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Munich; University of Munich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schumacher, TN (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands.	t.schumacher@nki.nl	Jae, Lucas/AAY-3438-2021; Jae, Lucas/AAH-5342-2020; Schumacher, Ton/Y-2432-2019	Jae, Lucas/0000-0002-3531-1760; Schumacher, Ton/0000-0003-0517-8804; Mezzadra, Riccardo/0000-0002-7737-8461	European Research Council [AdG SENSIT]; KWF Kankerbestrijding grant [NKI-2014-7474]; ERC AdG SENSIT; KWF [NKI-2014-7474]	European Research Council(European Research Council (ERC)European Commission); KWF Kankerbestrijding grant(KWF Kankerbestrijding); ERC AdG SENSIT; KWF	This work was supported by European Research Council AdG SENSIT to TNS and by KWF Kankerbestrijding grant NKI-2014-7474 to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Chong Sun and Meike Logtenberg for valuable discussions and the NKI genomic core facility for RNA sequencing experiments. This work was supported by ERC AdG SENSIT to T.N.S. and by KWF grant NKI-2014-7474 to A.D.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Brockmann M, 2017, NATURE, V546, P307, DOI 10.1038/nature22376; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Duncan LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039651; Fruh K, 1999, CURR OPIN IMMUNOL, V11, P76, DOI 10.1016/S0952-7915(99)80014-4; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Hinrichs CS, 2014, IMMUNOL REV, V257, P56, DOI 10.1111/imr.12132; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jorritsma A, 2007, BLOOD, V110, P3564, DOI 10.1182/blood-2007-02-075010; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; Kearney CJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3451; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133; Mezzadra R, 2017, NATURE, V549, P106, DOI 10.1038/nature23669; Mu YH, 2016, EMBO REP, V17, P94, DOI 10.15252/embr.201540964; Murai J, 2018, MOL CELL, V69, P371, DOI 10.1016/j.molcel.2018.01.012; Murai J, 2016, ONCOTARGET, V7, P76534, DOI 10.18632/oncotarget.12266; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Sanderson NSR, 2012, P NATL ACAD SCI USA, V109, P7835, DOI 10.1073/pnas.1116058109; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shin DS, 2017, CANCER DISCOV, V7, P188, DOI 10.1158/2159-8290.CD-16-1223; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; Xiao Q, 2018, NAT MED, V24, P262, DOI 10.1038/nm.4496; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zoppoli G, 2012, P NATL ACAD SCI USA, V109, P15030, DOI 10.1073/pnas.1205943109	29	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212053	10.1371/journal.pone.0212053	http://dx.doi.org/10.1371/journal.pone.0212053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753225	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600041
J	Shan, XY; Otsuka, S; Yakura, T; Naito, M; Nakano, T; Kawakami, Y				Shan, Xiyao; Otsuka, Shun; Yakura, Tomiko; Naito, Munekazu; Nakano, Takashi; Kawakami, Yasuo			Morphological and mechanical properties of the human triceps surae aponeuroses taken from elderly cadavers: Implications for muscle-tendon interactions	PLOS ONE			English	Article							GASTROCNEMIUS APONEUROSIS; TENSILE PROPERTIES; HUMAN SOLEUS; STRAIN; DISPLACEMENT; HYSTERESIS; THICKNESS; STIFFNESS; BEHAVIOR; COMPLEX	The human triceps surae (two gastrocnemii and soleus) has aponeuroses in the proximal and distal aspects, the latter of which insert into the calcaneus by sharing the common Achilles tendon. These tendinous tissues are known to have elasticity and upon muscle contraction the aponeurosis is stretched both longitudinally (along the muscle's line of action) and transversely. Higher aponeurosis transverse deformability has been documented, but there is a paucity of information on the morphology and mechanical properties of human aponeurosis. This study aimed to identify morphological and mechanical characteristics of the human triceps surae aponeuroses. Twenty-five triceps surae muscle-tendon units were procured from 13 human donors (formalin fixed, 6 males, 7 females) aged 67-91 years. Specimens of aponeuroses were excised from the eight regions (posterior and anterior regions of the gastrocnemius medialis and lateralis, medial and lateral parts of soleus; proximal, middle, and distal sites each, 2-4 cm x 2-4 cm). Aponeurosis thickness was measured using a digital caliper. Uniaxial tensile tests were implemented to determine the mechanical properties of specimens loaded longitudinally (along the muscle's line of action) and transversely. The aponeurosis thickness showed significant differences between muscles and sites, while Young's modulus showed direction-dependent (longitudinal vs. transverse) differences within sites. Results show different morphology and mechanical properties of aponeuroses between synergist muscles. The reason for site-dependent differences in stiffness is due to a reduced aponeurosis thickness rather than a reduction in the material property. The anisotropic elastic feature (differences between longitudinal and transverse directions) of the aponeuroses was more pronounced than previous in vivo findings, suggesting inherent material design of the aponeurosis that matches three-dimensional contractile behavior of muscle fibers.	[Shan, Xiyao; Otsuka, Shun; Kawakami, Yasuo] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Shan, Xiyao; Otsuka, Shun; Yakura, Tomiko; Naito, Munekazu; Nakano, Takashi; Kawakami, Yasuo] Aichi Med Univ, Dept Anat, Nagakute, Aichi, Japan	Waseda University; Aichi Medical University	Kawakami, Y (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.; Kawakami, Y (corresponding author), Aichi Med Univ, Dept Anat, Nagakute, Aichi, Japan.	ykawa@waseda.jp	Kawakami, Yasuo/AFM-0651-2022; Kawakami, Yasuo/AAH-3075-2022; Shan, Xiyao/AAX-6091-2020	Kawakami, Yasuo/0000-0003-0588-4039; Kawakami, Yasuo/0000-0003-0588-4039; Shan, Xiyao/0000-0002-0987-2310; YAKURA, TOMIKO/0000-0002-2605-8396	Japan Society for The Promotion of Science (JSPS) KAKENHI [16H01870]	Japan Society for The Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for The Promotion of Science (JSPS) KAKENHI Grant Number 16H01870 (Grant-in-aid for Scientific Research (A)).	Arampatzis A, 2007, J BIOMECH, V40, P1946, DOI 10.1016/j.jbiomech.2006.09.005; Azizi E, 2009, J PHYSIOL-LONDON, V587, P4309, DOI 10.1113/jphysiol.2009.173690; Azizi E, 2009, INTEGR COMP BIOL, V49, P51, DOI 10.1093/icb/icp006; Bojsen-Moller J, 2004, J APPL PHYSIOL, V97, P1908, DOI 10.1152/japplphysiol.00084.2004; Dixon JB, 2009, CURR REV MUSCULOSKE, V2, P74, DOI 10.1007/s12178-009-9045-8; Farris DJ, 2011, J BIOMECH, V44, P822, DOI 10.1016/j.jbiomech.2010.12.015; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Finni T, 2003, J APPL PHYSIOL, V95, P829, DOI 10.1152/japplphysiol.00775.2002; Finni T, 2013, J APPL PHYSIOL, V114, P515, DOI 10.1152/japplphysiol.01005.2012; Foure A, 2012, PHYSIOL MEAS, V33, pN1, DOI 10.1088/0967-3334/33/1/N1; Foure A, 2010, J APPL PHYSIOL, V109, P849, DOI 10.1152/japplphysiol.01150.2009; Fukunaga T, 2002, EXERC SPORT SCI REV, V30, P106, DOI 10.1097/00003677-200207000-00003; Hayashi S, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000196; Herzog JA, 2012, BIOPHYS J, V102, p360A, DOI 10.1016/j.bpj.2011.11.1967; Hof AL, 2002, ACTA PHYSIOL SCAND, V174, P17, DOI 10.1046/j.1365-201x.2002.00917.x; Huijing PA, 1999, J BIOMECH, V32, P329, DOI 10.1016/S0021-9290(98)00186-9; Hwang SW, 2012, J ANAT, V221, P69, DOI 10.1111/j.1469-7580.2012.01510.x; Iwanuma S, 2011, J APPL PHYSIOL, V110, P1615, DOI 10.1152/japplphysiol.00776.2010; Kawakami Y., 2012, J PHYS FITNESS SPORT, V1, P287; Kostyukov AI, 1995, ALPHA AND GAMMA MOTOR SYSTEMS, P115; Kubo K, 2002, J APPL PHYSIOL, V92, P595, DOI 10.1152/japplphysiol.00658.2001; Kumar P, 2011, INDIAN J PLAST SURG, V44, P478, DOI 10.4103/0970-0358.90828; Lake SP, 2010, J BIOMECH, V43, P727, DOI 10.1016/j.jbiomech.2009.10.017; Ninh LN, 2018, J VET MED SCI, V80, P606, DOI 10.1292/jvms.17-0480; Lewis G, 1997, J Foot Ankle Surg, V36, P435; Lynch HA, 2003, J BIOMECH ENG-T ASME, V125, P726, DOI 10.1115/1.1614819; Maganaris CN, 2000, J BIOMECH, V33, P1723, DOI 10.1016/S0021-9290(00)00130-5; Maganaris CN, 2002, J BIOMECH, V35, P1019, DOI 10.1016/S0021-9290(02)00047-7; Maganaris CN, 2001, J ANAT, V199, P449, DOI 10.1046/j.1469-7580.2001.19940449.x; Magnusson SP, 2008, J PHYSIOL-LONDON, V586, P71, DOI 10.1113/jphysiol.2007.139105; Magnusson SP, 2003, ACTA PHYSIOL SCAND, V177, P185, DOI 10.1046/j.1365-201X.2003.01048.x; Magnusson SP, 2001, J PHYSIOL-LONDON, V531, P277, DOI 10.1111/j.1469-7793.2001.0277j.x; Marieswaran M, 2018, ACTA BIOENG BIOMECH, V20, P31, DOI 10.5277/ABB-01134-2018-03; Miller KS, 2012, J BIOMECH, V45, P2061, DOI 10.1016/j.jbiomech.2012.06.006; Mogi Y, 2013, JPN J PHYS FIT SPORT, V62, P303; Morrow DA, 2010, J MECH BEHAV BIOMED, V3, P124, DOI 10.1016/j.jmbbm.2009.03.004; Muramatsu T, 2001, J APPL PHYSIOL, V90, P1671, DOI 10.1152/jappl.2001.90.5.1671; Narici MV, 2005, SCAND J MED SCI SPOR, V15, P392, DOI 10.1111/j.1600-0838.2005.00458.x; Oda T, 2015, ADV BIOMED ENG, V4, P12, DOI 10.14326/abe.4.12; Onambele GL, 2006, J APPL PHYSIOL, V100, P2048, DOI 10.1152/japplphysiol.01442.2005; Otsuka S, 2018, J BIOMECH, V77, P69, DOI 10.1016/j.jbiomech.2018.06.018; Raiteri BJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2260; Raiteri BJ, 2018, EUR J SPORT SCI, V18, P1128, DOI 10.1080/17461391.2018.1472299; Roberts TJ, 2011, J EXP BIOL, V214, P353, DOI 10.1242/jeb.038588; SCOTT SH, 1995, J MORPHOL, V224, P73, DOI 10.1002/jmor.1052240109; Slane LC, 2017, EUR RADIOL, V27, P474, DOI 10.1007/s00330-016-4409-0; Zhang GJ, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034254	47	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211485	10.1371/journal.pone.0211485	http://dx.doi.org/10.1371/journal.pone.0211485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735517	gold, Green Published, Green Submitted			2022-12-26	WOS:000458181200021
J	Ammer-Herrmenau, C; Kulkarni, U; Andreas, N; Ungelenk, M; Ravens, S; Hubner, C; Kather, A; Kurth, I; Bauer, M; Kamradt, T				Ammer-Herrmenau, Christoph; Kulkarni, Upasana; Andreas, Nico; Ungelenk, Martin; Ravens, Sarina; Huebner, Christian; Kather, Angela; Kurth, Ingo; Bauer, Michael; Kamradt, Thomas			Sepsis induces long-lasting impairments in CD4(+) T-cell responses despite rapid numerical recovery of T-lymphocyte populations	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; POLYMICROBIAL SEPSIS; CECAL LIGATION; HOMEOSTATIC PROLIFERATION; THYMIC EMIGRANTS; SEPTIC SHOCK; 2-HIT MODEL; NAIVE; SUSCEPTIBILITY; INDUCTION	Massive apoptosis of lymphocytes is a hallmark of sepsis. The resulting immunosuppression is associated with secondary infections, which are often lethal. Moreover, sepsis-survivors are burdened with increased morbidity and mortality for several years after the sepsis episode. The duration and clinical consequences of sepsis induced-immunosuppression are currently unknown. We have used the mouse model of peritoneal contamination and infection (PCI) to investigate the quantitative and qualitative recovery of T lymphocytes for 3.5 months after sepsis with or without IL-7 treatment. Thymic output and the numbers of naive and effector/memory CD4(+) and CD8(+) lymphocytes quickly recovered after sepsis. IL-7 treatment resulted in an accelerated recovery of CD8(+) lymphocytes. Next generation sequencing revealed no significant narrowing of the T cell receptor repertoire 3.5 months after sepsis. In contrast, detailed functional analyses of T helper (Th)-cell responses towards a fungal antigen revealed a significant loss of Th cells. Whereas cytokine production was not impaired at the single cell level, the absolute number of Th cells specific for the fungal antigen was reduced. Our data indicate a clinically relevant loss of pathogen-specific T cell clones after sepsis. Given the small number of naive T lymphocytes specific for a given antigen, this decrement of T cell clones remains undetected even by sensitive methods such as deep sequencing. Taken together, our data are compatible with long lasting impairments in CD4(+) T-cell responses after sepsis despite rapid recovery of T lymphocyte populations.	[Ammer-Herrmenau, Christoph; Kulkarni, Upasana; Andreas, Nico; Kather, Angela; Kamradt, Thomas] Jena Univ Hosp, Inst Immunol, Jena, Germany; [Ungelenk, Martin; Huebner, Christian; Kurth, Ingo] Jena Univ Hosp, Inst Human Genet, Jena, Germany; [Ravens, Sarina] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Kurth, Ingo] Rhein Westfal TH Aachen, Med Fac, Inst Human Genet, Aachen, Germany; [Bauer, Michael] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany; [Bauer, Michael] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Kulkarni, Upasana] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Hannover Medical School; RWTH Aachen University; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Michigan System; University of Michigan	Kamradt, T (corresponding author), Jena Univ Hosp, Inst Immunol, Jena, Germany.	thomas.kamradt@med.uni-jena.de	Andreas, Nico/AAQ-8256-2021; Ammer-Herrmenau, Christoph/GPK-8096-2022	Ravens, Sarina/0000-0002-3265-6341; Kurth, Ingo/0000-0002-5642-8378; Bauer, Michael/0000-0002-1521-3514; Kamradt, Thomas/0000-0001-8443-5893; Kather, Angela/0000-0001-7652-698X; Andreas, Nico/0000-0002-4591-7037	German Ministry of Education and Science (BMBF; Center for Sepsis Control and Care); Studienstiftung des deutschen Volkes	German Ministry of Education and Science (BMBF; Center for Sepsis Control and Care)(Federal Ministry of Education & Research (BMBF)); Studienstiftung des deutschen Volkes	This work was supported by grants from the German Ministry of Education and Science (BMBF; Center for Sepsis Control and Care to M.B. and T.K.). C.H. is supported by the Studienstiftung des deutschen Volkes.	Adrie C, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0242-0; AYALA A, 1995, SHOCK, V3, P259, DOI 10.1097/00024382-199504000-00003; Bauer M, 2016, EBIOMEDICINE, V6, P114, DOI 10.1016/j.ebiom.2016.03.006; Benjamim CF, 2003, AM J PATHOL, V163, P2605, DOI 10.1016/S0002-9440(10)63615-2; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Cabrera-Perez J, 2015, J IMMUNOL, V194, P1609, DOI 10.4049/jimmunol.1401711; Condotta SA, 2015, J IMMUNOL, V195, P116, DOI 10.4049/jimmunol.1402473; Davis CG, 2011, BIOCHEM BIOPH RES CO, V414, P37, DOI 10.1016/j.bbrc.2011.09.017; Delano MJ, 2016, IMMUNOL REV, V274, P330, DOI 10.1111/imr.12499; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Donnelly JP, 2015, CRIT CARE MED, V43, P1916, DOI 10.1097/CCM.0000000000001147; Duong S, 2014, J IMMUNOL, V192, P3618, DOI 10.4049/jimmunol.1303460; Fink PJ, 2013, ANNU REV IMMUNOL, V31, P31, DOI 10.1146/annurev-immunol-032712-100010; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Francois B, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98960; Gonnert FA, 2011, J SURG RES, V170, pE123, DOI 10.1016/j.jss.2011.05.019; GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302; Gurung P, 2011, J IMMUNOL, V187, P2148, DOI 10.4049/jimmunol.1101180; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2002, J IMMUNOL, V168, P2493, DOI 10.4049/jimmunol.168.5.2493; Izraelson M, 2017, IMMUNOLOGY; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Kim HK, 2016, EUR J IMMUNOL, V46, P1669, DOI 10.1002/eji.201546214; Kulkarni U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192304; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lyn-Kew K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011145; Mackall CL, 1996, J IMMUNOL, V156, P4609; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Markwart R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115094; Martin CE, 2013, BLOOD, V121, P4484, DOI 10.1182/blood-2012-08-449215; Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096; Muenzer JT, 2006, SHOCK, V26, P565, DOI 10.1097/01.shk.0000235130.82363.ed; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Pastille E, 2011, J IMMUNOL, V186, P977, DOI 10.4049/jimmunol.1001147; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Roquilly A, 2017, IMMUNITY, V47, P135, DOI 10.1016/j.immuni.2017.06.021; Scharf DH, 2010, J AM CHEM SOC, V132, P10136, DOI 10.1021/ja103262m; Scicluna BP, 2017, LANCET RESP MED, V5, P816, DOI 10.1016/S2213-2600(17)30294-1; Shindo Y, 2017, J LEUKOCYTE BIOL, V101, P543, DOI 10.1189/jlb.4A1215-581R; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Toti P, 2004, AM J CLIN PATHOL, V122, P765, DOI 10.1309/RV6E9BMC9954A2WU; Unsinger J, 2012, J INFECT DIS, V206, P606, DOI 10.1093/infdis/jis383; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Unsinger J, 2009, J LEUKOCYTE BIOL, V85, P382, DOI 10.1189/jlb.0808491; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; van Vught LA, 2017, AM J RESP CRIT CARE, V196, P458, DOI [10.1164/rccm.201606-1225OC, 10.1164/rccm.201606-1225oc]; van Vught LA, 2016, JAMA-J AM MED ASSOC, V315, P1469, DOI 10.1001/jama.2016.2691; Venet F, 2013, CRIT CARE MED, V41, P111, DOI 10.1097/CCM.0b013e3182657948; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Walton AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098819; Wang JW, 2011, CURR OPIN IMMUNOL, V23, P532, DOI 10.1016/j.coi.2011.05.004; WANG SD, 1994, J IMMUNOL, V152, P5014; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Yende S, 2016, CRIT CARE MED, V44, P1461, DOI 10.1097/CCM.0000000000001658; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zhang Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10059	62	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211716	10.1371/journal.pone.0211716	http://dx.doi.org/10.1371/journal.pone.0211716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730978	Green Published, Green Submitted, gold			2022-12-26	WOS:000458026000053
J	Mayoral, AP; Ibarz, E; Gracia, L; Mateo, J; Herrera, A				Mayoral, Ana P.; Ibarz, Elena; Gracia, Luis; Mateo, Jesus; Herrera, Antonio			The use of Barthel index for the assessment of the functional recovery after osteoporotic hip fracture: One year follow-up	PLOS ONE			English	Article							QUALITY-OF-LIFE; ELDERLY-PATIENTS; MORTALITY; MOBILITY; REHABILITATION; COMPLICATIONS; DETERIORATION; EPIDEMIOLOGY; PERFORMANCE; MANAGEMENT	The Barthel index evolution was analyzed in a sample of older people with osteoporotic hip fracture in order to verify the influence of comorbidities and cognitive impairment on the physical recovery of those patients, during the first year following the fracture. A prospective observational study was carried out between October 1, 2012 and March 31, 2013. A sample of 247 individuals was initially selected. After a primary revision, 39 participants were excluded (clearly not meeting inclusion criteria, lack of data, or not agree to participate in the study), and finally a total of 208 participants were included in the analysis, 166 women, with an average age of 84.59 years, and 42 men, with an average age of 82.05. 54.80% of all cases were older than 85 years. The mean Barthel index value prior to fracture was 76.63, decreasing to 64.91 at one-year follow-up. Only 22.12% of patients achieved a full recovery for activities of daily living. A statistical analysis was performed by comparing Barthel index recovery depending on the values of Charlson and Pfeiffer indexes, respectively. The mean differences in Barthel index drop between the one-year follow-up and the hospital admission values were found statistical significant (p<0.01). These findings indicate that Charlson and Pfeiffer indexes clearly influence the Barthel index recovery. Low values of Charlson and Pfeiffer indexes resulted in better Barthel index recovery. In conclusion, the Barthel index is a good tool to evaluate the physical recovery after osteoporotic hip fracture.	[Mayoral, Ana P.] Univ Zaragoza, Hlth Sci Sch, Zaragoza, Spain; [Ibarz, Elena; Gracia, Luis] Univ Zaragoza, Dept Mech Engn, Zaragoza, Spain; [Ibarz, Elena; Gracia, Luis; Herrera, Antonio] Aragon Inst Engn Res, Zaragoza, Spain; [Mateo, Jesus] Miguel Servet Univ Hosp, Dept Orthopaed Surg & Traumatol, Zaragoza, Spain; [Mateo, Jesus; Herrera, Antonio] Univ Zaragoza, Dept Surg, Zaragoza, Spain; [Mateo, Jesus; Herrera, Antonio] Aragon Hlth Sci Inst, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; Miguel Servet University Hospital; University of Zaragoza	Herrera, A (corresponding author), Aragon Inst Engn Res, Zaragoza, Spain.; Herrera, A (corresponding author), Univ Zaragoza, Dept Surg, Zaragoza, Spain.; Herrera, A (corresponding author), Aragon Hlth Sci Inst, Zaragoza, Spain.	antonio.herrera@unizar.es	Herrera, Antonio/E-5532-2011; Ibarz, Elena/ABF-7630-2020; Mateo, Jesús J./AAA-9385-2019	Herrera, Antonio/0000-0001-7877-4733; Mateo, Jesús J./0000-0002-8289-791X				Adunsky A, 2011, J AM MED DIR ASSOC, V12, P439, DOI 10.1016/j.jamda.2010.09.003; Angleman SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133789; Ariza-Vega P, 2017, AM J PHYS MED REHAB, V96, P109, DOI 10.1097/PHM.0000000000000550; Auais MA, 2012, PHYS THER, V92, P1437, DOI 10.2522/ptj.20110274; Azagra R, 2014, OSTEOPOROSIS INT, V25, P1267, DOI 10.1007/s00198-013-2586-0; Beaupre LA, 2005, J GEN INTERN MED, V20, P1019, DOI 10.1111/j.1525-1497.2005.00219.x; Bellelli G, 2012, OSTEOPOROSIS INT, V23, P2189, DOI 10.1007/s00198-011-1849-x; Boonen S, 2004, OSTEOPOROSIS INT, V15, P87, DOI 10.1007/s00198-003-1515-z; Bower ES, 2016, AM J GERIAT PSYCHIAT, V24, P1228, DOI 10.1016/j.jagp.2016.08.006; Bryant DM, 2009, J ORTHOP TRAUMA, V23, P434, DOI 10.1097/BOT.0b013e318162aaf9; Buecking B, 2014, OSTEOPOROSIS INT, V25, P475, DOI 10.1007/s00198-013-2415-5; Centers for Disease Control and Prevention, 2016, IMP FACTS FALLS; Cenzer IS, 2016, J AM GERIATR SOC, V64, P1863, DOI 10.1111/jgs.14237; Cooper C., 1997, AM J MED S2A, V103, P12, DOI DOI 10.1016/S0002-9343(97)90022-X; Di Monaco M, 2012, AM J PHYS MED REHAB, V91, P309, DOI 10.1097/PHM.0b013e3182466162; Ekegren CL, 2016, INJURY, V47, P2182, DOI 10.1016/j.injury.2016.05.033; Frihagen F, 2008, INJURY, V39, P1147, DOI 10.1016/j.injury.2008.03.027; Griffin XL, 2015, BONE JOINT J, V97B, P372, DOI 10.1302/0301-620X.97B3.35738; Handoll HHG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000168.pub3; Herrera A, 2006, INT ORTHOP, V30, P11, DOI 10.1007/s00264-005-0026-2; Ho HH, 2010, OSTEOPOROSIS INT, V21, pS573, DOI 10.1007/s00198-010-1416-x; Ho V, 2000, HEALTH SERV RES, V34, P1499; Ishidou Y, 2017, GERIATR GERONTOL INT, V17, P391, DOI 10.1111/ggi.12718; Kammerlander C, 2011, ARCH ORTHOP TRAUM SU, V131, P1435, DOI 10.1007/s00402-011-1313-6; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; Khan SK, 2009, INJURY, V40, P692, DOI 10.1016/j.injury.2009.01.010; Landi F, 2017, OSTEOPOROSIS INT, V28, P1569, DOI 10.1007/s00198-017-3929-z; Lau TW, 2017, OSTEOPOROSIS INT, V28, P791, DOI 10.1007/s00198-016-3845-7; Lee D, 2014, ANN REHABIL MED-ARM, V38, P827, DOI 10.5535/arm.2014.38.6.827; Mariconda M, 2016, J ORTHOP TRAUMA, V30, P71, DOI 10.1097/BOT.0000000000000448; Martin-Martin LM, 2015, J AGING HEALTH, V27, P827, DOI 10.1177/0898264315569451; Miralles R, 2006, INSTRUMENTOS ESCALAS; Mundi S, 2014, ACTA ORTHOP, V85, P54, DOI 10.3109/17453674.2013.878831; Padron-Monedero A, 2017, OSTEOPOROSIS INT, V28, P1559, DOI 10.1007/s00198-017-3926-2; Pedersen TJ, 2016, ACTA ORTHOP, V87, P374, DOI 10.1080/17453674.2016.1197534; Pioli G, 2016, OSTEOPOROSIS INT, V27, P2009, DOI 10.1007/s00198-016-3485-y; Caeiro JR, 2017, CALCIFIED TISSUE INT, V100, P29, DOI 10.1007/s00223-016-0193-8; Randell AG, 2000, OSTEOPOROSIS INT, V11, P460, DOI 10.1007/s001980070115; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Rodriguez-Fernandez P, 2011, CLIN ORTHOP RELAT R, V469, P3218, DOI 10.1007/s11999-010-1756-z; Seitz DP, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-9; Serra J A, 2002, An Med Interna, V19, P389; Soderqvist A, 2006, J BONE JOINT SURG AM, V88A, P2115, DOI 10.2106/JBJS.E.01409; STONE SP, 1994, J ROY COLL PHYS LOND, V28, P419; Tang VL, 2017, J GEN INTERN MED, V32, P153, DOI 10.1007/s11606-016-3848-2; Vergara I, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-124; Vochteloo AJH, 2013, GERIATR GERONTOL INT, V13, P334, DOI 10.1111/j.1447-0594.2012.00904.x; Wade D T, 1988, Int Disabil Stud, V10, P64; Wagner P, 2012, GERIATR ORTHOP SURG, V3, P55, DOI 10.1177/2151458512450708; WHO, 2007, WHO GLOB REP FALLP	51	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0212000	10.1371/journal.pone.0212000	http://dx.doi.org/10.1371/journal.pone.0212000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730973	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000087
J	Chen, C; Bai, LP; Cao, FQ; Wang, SN; He, HW; Song, MC; Chen, HL; Liu, Y; Guo, J; Si, Q; Pan, YD; Zhu, RZ; Chuang, TH; Xiang, R; Luo, YP				Chen, Chong; Bai, Lipeng; Cao, Fengqi; Wang, Shengnan; He, Huiwen; Song, Mingcheng; Chen, Huilin; Liu, Yan; Guo, Jian; Si, Qin; Pan, Yundi; Zhu, Ruizhe; Chuang, Tsung-Hsien; Xiang, Rong; Luo, Yunping			Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis	ONCOGENE			English	Article							EXTRACELLULAR PH; MELANOMA-CELLS; MYC; HETEROGENEITY; MITOCHONDRIAL; EXPRESSION; GROWTH; REPRESSION	The altered metabolism and acidic microenvironment plays an important role in promoting tumor malignant characteristics. A small population of cancer stem cells (CSCs) were considered as a therapy target to reserve tumor relapse, resistance, and metastasis. However, the molecular mechanism that regulates CSCs metabolism remains poorly understood. In this study, we demonstrate a fundamental role of stemness gene LIN28B in maintaining CSCs glycolysis metabolism. Using LIN28B-expressing cancer cell lines, we found that the rate of extracellular acidification, glucose uptake, and lactate secretion are all suppressed by LIN28B knockdown in vitro and in vivo. Importantly, metabolic analyses reveal that CSCs have enhanced aerobic glycolysis metabolic characteristics and the glycolytic product lactate further promotes cancer associated stemness properties. LIN28B silencing suppresses MYC expression that further increases miR-34a-5p level. Furthermore, the glycolysis metabolism of human breast cancer cell line MDA-MB-231 is suppressed by either MYC siRNA or miR-34a-5p mimic Clinically, high MYC and low miR-34a-5p level are correlated with high LIN28B expression and poor prognosis in human breast cancer patients. Notably, blocking LIN28B/MYC/miR-34a-5p signaling pathway by LIN28B-specific inhibitor causes dramatic inhibition of tumor growth and metastasis in immunodeficient orthotopic mouse models of human breast cancer cell MDA-MB-231. Taken together, our findings offer a preclinical investigation of targeting LIN28B to suppress CSCs glycolysis metabolism and tumor progression that may improve the therapeutic benefit for cancer patients.	[Chen, Chong; Bai, Lipeng; Cao, Fengqi; Wang, Shengnan; He, Huiwen; Song, Mingcheng; Chen, Huilin; Liu, Yan; Guo, Jian; Si, Qin; Pan, Yundi; Zhu, Ruizhe; Luo, Yunping] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; [Chen, Chong; Bai, Lipeng; Cao, Fengqi; Wang, Shengnan; He, Huiwen; Song, Mingcheng; Chen, Huilin; Liu, Yan; Guo, Jian; Si, Qin; Pan, Yundi; Zhu, Ruizhe; Luo, Yunping] Peking Union Med Coll, Sch Basic Med, Beijing 100005, Peoples R China; [Chen, Chong; Bai, Lipeng; Cao, Fengqi; Wang, Shengnan; He, Huiwen; Song, Mingcheng; Chen, Huilin; Liu, Yan; Guo, Jian; Si, Qin; Pan, Yundi; Zhu, Ruizhe; Luo, Yunping] Chinese Acad Med Sci, Inst Basic Med Sci, Collaborat Innovat Ctr Biotherapy, Beijing 100005, Peoples R China; [Bai, Lipeng] Jiangxi Canc Hosp, Dept Clin Lab, Nanchang 330029, Jiangxi, Peoples R China; [Chuang, Tsung-Hsien] Natl Hlth Res Inst, Immunol Res Ctr, Miaoli, Taiwan; [Xiang, Rong] Nankai Univ, Dept Immunol, Tianjin 300071, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; National Health Research Institutes - Taiwan; Nankai University	Luo, YP (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China.; Luo, YP (corresponding author), Peking Union Med Coll, Sch Basic Med, Beijing 100005, Peoples R China.; Luo, YP (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Collaborat Innovat Ctr Biotherapy, Beijing 100005, Peoples R China.	ypluo@ibms.pumc.edu.cn	Zhu, Ruizhe/HGF-1928-2022; Chuang, Tsung-Hsien/F-9679-2010		973 Program of China [2013CB967202]; Fundamental Research Funds for the Central Universities [33320140173]; National Natural Science Foundation of China [91029734, 81071711, 81502562]	973 Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the 973 Program of China (2013CB967202, Yunping Luo); the National Natural Science Foundation of China (91029734 and 81071711, Yunping Luo), the National Natural Science Foundation of China (81502562, Chong Chen); and the Fundamental Research Funds for the Central Universities (33320140173, Chong Chen). We thank Zhigang Wang (Department of Bioengineering, Chinese Academy of Medical Sciences) for the bioinformatics analysis in this study and Cameron R. Mckay (Department of Immunology, Nankai University) for critically reading and polishing this manuscript.	ALBRIGHT JD, 1981, J MED CHEM, V24, P592, DOI 10.1021/jm00137a020; American Type Culture Collection, 2007, ATCC TECHN B, V8; Bu PC, 2013, CELL STEM CELL, V12, P602, DOI 10.1016/j.stem.2013.03.002; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen C, 2015, CANCER RES, V75, P1725, DOI 10.1158/0008-5472.CAN-14-2111; Ciavardelli D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.285; Corbet C, 2016, CELL METAB, V24, P311, DOI 10.1016/j.cmet.2016.07.003; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Feng C, 2012, CELL CYCLE, V11, P2486, DOI 10.4161/cc.20893; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088893; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Kleppe M, 2014, NAT MED, V20, P342, DOI 10.1038/nm.3522; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee KM, 2017, CELL METAB, V26, P633, DOI 10.1016/j.cmet.2017.09.009; Levi BP, 2009, BLOOD, V113, P1670, DOI 10.1182/blood-2008-05-156752; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Ma XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6212; Mayr F, 2013, INT J MOL SCI, V14, P16532, DOI 10.3390/ijms140816532; Moellering RE, 2008, CLIN EXP METASTAS, V25, P411, DOI 10.1007/s10585-008-9145-7; Nguyen LH, 2014, CANCER CELL, V26, P248, DOI 10.1016/j.ccr.2014.06.018; Park EY, 2014, CANCER RES, V74, P7573, DOI 10.1158/0008-5472.CAN-14-1140; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Roos M, 2016, ACS CHEM BIOL, V11, P2773, DOI 10.1021/acschembio.6b00232; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Silva AS, 2009, CANCER RES, V69, P2677, DOI 10.1158/0008-5472.CAN-08-2394; Spinelli JB, 2017, SCIENCE, V358, P941, DOI 10.1126/science.aam9305; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Valton J, 2014, METHODS, V69, P151, DOI 10.1016/j.ymeth.2014.06.013; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wang Y, 2011, ONCOGENE, V30, P1470, DOI 10.1038/onc.2010.531; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu LW, 2015, ELIFE, V4, DOI 10.7554/eLife.09431; Xiao ZG, 2014, CANCER RES, V74, P6236, DOI 10.1158/0008-5472.CAN-14-0855; Ye XQ, 2011, INT J CANCER, V129, P820, DOI 10.1002/ijc.25944; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhang SY, 2014, CANCER RES, V74, P5311, DOI 10.1158/0008-5472.CAN-14-0529; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	53	41	43	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2019	38	23					4527	4539		10.1038/s41388-019-0735-4	http://dx.doi.org/10.1038/s41388-019-0735-4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB4KM	30742065				2022-12-26	WOS:000470240300007
J	Wang, YC; Hirata, T; Maeda, Y; Murakami, Y; Fujita, M; Kinoshita, T				Wang, Yicheng; Hirata, Tetsuya; Maeda, Yusuke; Murakami, Yoshiko; Fujita, Morihisa; Kinoshita, Taroh			Free, unlinked glycosylphosphatidylinositols on mammalian cell surfaces revisited	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylphosphatidylinositol (GPI anchor); glycolipid; galactose; membrane lipid; glycosylation; post-translational modification (PTM); fatty acid remodeling; galactose; glycan biology; GPI transamidase; N-acetylgalactosamine	GPI-ANCHORED PROTEINS; MOLECULAR-WEIGHT ANTIGEN; TOXOPLASMA-GONDII; YEAST; HYPERPHOSPHATASIA; EXPRESSION; MUTATIONS; TRANSPORT; ER; MEMBRANE	Glycosylphosphatidylinositols (GPIs) are linked to many cell-surface proteins, anchor these proteins in the membrane, and are well characterized. However, GPIs that exist in the free form on the mammalian cell surface remain largely unexplored. To investigate free GPIs in cultured cell lines and mouse tissues, here we used the T5-4E10 mAb (T5 mAb), which recognizes unlinked GPIs having an N-acetylgalactosamine (GalNAc) side chain linked to the first mannose at the nonreducing terminus. We detected free GPIs bearing the GalNAc side chain on the surface of Neuro2a and CHO, but not of HEK293, K562, and C2C12 cells. Furthermore, free GPIs were present in mouse pons, medulla oblongata, spinal cord, testis, epididymis, and kidney. Using a panel of Chinese hamster ovary cells defective in both GPI-transamidase and GPI remodeling pathway, we demonstrate that free GPIs follow the same structural remodeling pathway during passage from the endoplasmic reticulum to the plasma membrane as do protein-linked GPI. Specifically, free GPIs underwent post-GPI attachment to protein 1 (PGAP1)-mediated inositol deacylation, PGAP5-mediated removal of the ethanolamine phosphate from the second mannose, and PGAP3- and PGAP2-mediated fatty acid remodeling. Moreover, T5 mAb recognized free GPIs even if the inositol-linked acyl chain or ethanolamine-phosphate side chain linked to the second mannose is not removed. In contrast, addition of a fourth mannose by phosphatidylinositol glycan anchor biosynthesis class Z (PIGZ) inhibited T5 mAb-mediated detection of free GPIs. Our results indicate that free GPIs are normal components of the plasma membrane in some tissues and further characterize free GPIs in mammalian cells.	[Wang, Yicheng; Hirata, Tetsuya; Maeda, Yusuke; Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Wang, Yicheng; Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, World Premier Int WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Fujita, Morihisa] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi 214122, Jiangsu, Peoples R China	Osaka University; Osaka University; Jiangnan University	Kinoshita, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	tkinoshi@biken.osaka-u.ac.jp	Fujita, Morihisa/AAM-4142-2020; Wang, Yicheng/AAJ-3439-2021; Wang, Yicheng/AAM-1923-2020; Kinoshita, Taroh/C-7353-2009	Wang, Yicheng/0000-0001-7789-1938; 	MEXT Japan Society for the Promotion of Science (JSPS) [JP16H04753]	MEXT Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants-in aid Grant Number JP16H04753 from MEXT Japan Society for the Promotion of Science (JSPS) (to T. K). The authors declare that they have no conflicts of interest with the contents of this article.	Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Ashida H, 2005, MOL BIOL CELL, V16, P1439, DOI 10.1091/mbc.E04-09-0802; BALDWIN MA, 1990, ANAL BIOCHEM, V191, P174, DOI 10.1016/0003-2697(90)90405-X; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Baumann NA, 2000, J BIOL CHEM, V275, P7378, DOI 10.1074/jbc.275.10.7378; Chiyonobu T, 2014, J MED GENET, V51, P203, DOI 10.1136/jmedgenet-2013-102156; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ferguson M. A. J., 2017, GLYCOSYLPHOSPHATIDYL; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Gas-Pascual E, 2019, J BIOL CHEM, V294, P1104, DOI 10.1074/jbc.RA118.006072; Gotze S, 2014, ANGEW CHEM INT EDIT, V53, P13701, DOI 10.1002/anie.201406706; Hill A, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.28; Hirata T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02799-0; Hirata T, 2015, MOL BIOL CELL, V26, P3071, DOI 10.1091/mbc.E14-11-1568; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Hong YJ, 2003, MOL BIOL CELL, V14, P1780, DOI 10.1091/mbc.E02-12-0794; Kawamoto M, 2018, BMJ CASE REP, V2018; Kinoshita T, 2016, J LIPID RES, V57, P6, DOI 10.1194/jlr.R063313; Krawitz PM, 2013, BLOOD, V122, P1312, DOI 10.1182/blood-2013-01-481499; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; Seong J, 2013, J LIPID RES, V54, P1077, DOI 10.1194/jlr.M034421; SHARMA SD, 1983, J IMMUNOL, V131, P977; Singh N, 1996, J BIOL CHEM, V271, P12879, DOI 10.1074/jbc.271.22.12879; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; Striepen B, 1997, J MOL BIOL, V266, P797, DOI 10.1006/jmbi.1996.0806; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; Taron BW, 2004, J BIOL CHEM, V279, P36083, DOI 10.1074/jbc.M405081200; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; TOMAVO S, 1994, PARASITOLOGY, V108, P139, DOI 10.1017/S0031182000068220; VANTHOF W, 1995, J BIOL CHEM, V270, P24150; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Wu CL, 2016, NUCLEIC ACIDS RES, V44, pD313, DOI 10.1093/nar/gkv1104; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	40	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5038	5049		10.1074/jbc.RA119.007472	http://dx.doi.org/10.1074/jbc.RA119.007472			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30728244	Green Published, hybrid			2022-12-26	WOS:000463985600026
J	Vrbik, I; Van Nest, SJ; Meksiarun, P; Loeppky, J; Brolo, A; Lum, JJ; Jirasek, A				Vrbik, Irene; Van Nest, Samantha J.; Meksiarun, Phiranuphon; Loeppky, Jason; Brolo, Alexandre; Lum, Julian J.; Jirasek, Andrew			Haralick texture feature analysis for quantifying radiation response heterogeneity in murine models observed using Raman spectroscopic mapping	PLOS ONE			English	Article							EUKARYOTIC CELLS	Tumour heterogeneity plays a large role in the response of tumour tissues to radiation therapy. Inherent biological, physical, and even dose deposition heterogeneity all play a role in the resultant observed response. We here implement the use of Haralick textural analysis to quantify the observed glycogen production response, as observed via Raman spectroscopic mapping, of tumours irradiated within a murine model. While an array of over 20 Haralick features have been proposed, we here concentrate on five of the most prominent features: homogeneity, local homogeneity, contrast, entropy, and correlation. We show that these Haralick features can be used to quantify the inherent heterogeneity of the Raman spectroscopic maps of tumour response to radiation. Furthermore, our results indicate that Haralick-calculated textural features show a statistically significant dose dependent variation in response heterogeneity, specifically, in glycogen production in tumours irradiated with clinically relevant doses of ionizing radiation. These results indicate that Haralick textural analysis provides a quantitative methodology for understanding the response of murine tumours to radiation therapy. Future work in this area can, for example, utilize the Haralick textural features for understanding the heterogeneity of radiation response as measured by biopsied patient tumour samples, which remains the standard of patient tumour investigation.	[Vrbik, Irene; Loeppky, Jason] Univ British Columbia, Dept Stat, Okanagan Campus, Kelowna, BC, Canada; [Van Nest, Samantha J.] Univ Victoria, Dept Phys & Astron, Victoria, BC, Canada; [Meksiarun, Phiranuphon; Jirasek, Andrew] Univ British Columbia, Dept Phys, Okanagan Campus, Kelowna, BC, Canada; [Brolo, Alexandre] Univ Victoria, Dept Chem, Victoria, BC, Canada; [Lum, Julian J.] BC Canc, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada; [Lum, Julian J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	University of British Columbia; University of Victoria; University of British Columbia; University of Victoria; University of Victoria	Jirasek, A (corresponding author), Univ British Columbia, Dept Phys, Okanagan Campus, Kelowna, BC, Canada.	andrew.jirasek@ubc.ca		Van Nest, Samantha/0000-0002-1156-5811	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institute for Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The funding partners for this study are The Natural Sciences and Engineering Research Council of Canada (NSERC) and The Canadian Institute for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albregtsen Fritz, 2008, IMAGE PROCESSING LAB, V5; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Arvis V., 2004, Image Analysis & Stereology, V23, P63, DOI 10.5566/ias.v23.p63-72; Asselin MC, 2012, EUR J CANCER, V48, P447, DOI 10.1016/j.ejca.2011.12.025; Barooah, 2013, INT J ADV RES ELECT, V2, P4206; Begg AC, 2009, INT J RADIAT BIOL, V85, P825, DOI 10.3109/09553000903184366; Chaddad A., 2011, Proceedings of the 2011 First International Conference on Informatics and Computational Intelligence (ICI 2011), P55, DOI 10.1109/ICI.2011.20; CONNERS RW, 1980, IEEE T PATTERN ANAL, V2, P204, DOI 10.1109/TPAMI.1980.4767008; Eilers P.H.C., 2005, BASELINE CORRECTION, V1, P5; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Haralock R. M., 1991, COMPUTER ROBOT VISIO; Harder SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21006; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kishore B, 2014, INT J COMPUTER APPL, V6; Kumar RM., 2014, INT J COMPUTER SCI I, V5, P7668; Liland K.H., 2015, BASELINE BASELINE CO; Makowski AJ, 2015, SPIE BIOS INT SOC OP; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Matthews Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135356; O'Connor JP, 2014, CLIN CANC RES; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Randen T, 1999, IEEE T PATTERN ANAL, V21, P291, DOI 10.1109/34.761261; Rosch P, 2006, BIOPOLYMERS, V82, P312, DOI 10.1002/bip.20449; Schie IW, 2016, ANALYST, V141, P6387, DOI 10.1039/c6an01018k; Talari ACS, 2015, APPL SPECTROSC REV, V50, P46, DOI 10.1080/05704928.2014.923902; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Van Nest SJ, 2018, RADIAT RES, V189, P497, DOI 10.1667/RR15003.1; Young T.Y, 1994, HDB PATTERN RECOGNIT, V2; Zayed Nourhan, 2015, INT J BIOMEDICAL IMA, V2015, P12	30	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212225	10.1371/journal.pone.0212225	http://dx.doi.org/10.1371/journal.pone.0212225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768630	Green Published, gold, Green Submitted			2022-12-26	WOS:000458766300023
J	Moore, PJ; Lyons, TJ; Gallacher, J; Weiner, MW; Aisen, P; Petersen, R; Jack, CR; Jagust, W; Trojanowki, JQ; Toga, AW; Beckett, L; Green, RC; Saykin, AJ; Morris, J; Shaw, LM; Khachaturian, Z; Sorensen, G; Carrillo, M; Kuller, L; Raichle, M; Paul, S; Davies, P; Fillit, H; Hefti, F; Holtzman, D; Mesulam, MM; Potter, W; Snyder, P; Montine, T; Jimenez, G; Donohue, M; Gessert, D; Harless, K; Salazar, J; Cabrera, Y; Walter, S; Hergesheimer, L; Harvey, D; Donohue, M; Bernstein, M; Fox, N; Thompson, P; Schuff, N; Decarli, C; Borowski, B; Gunter, J; Senjem, M; Vemuri, P; Jones, D; Kantarci, K; Ward, C; Koeppe, RA; Foster, N; Reiman, EM; Chen, K; Mathis, C; Cairns, NJ; Franklin, E; Taylor-Reinwald, L; Lee, V; Korecka, M; Figurski, M; Crawford, K; Neu, S; Foroud, TM; Potkin, S; Shen, L; Faber, K; Kim, S; Nho, K; Thal, L; Buckholtz, N; Albert, M; Frank, R; Hsiao, J; Quinn, J; Silbert, LC; Lind, B; Kaye, JA; Carter, R; Dolen, S; Schneider, LS; Pawluczyk, S; Becerra, M; Teodoro, L; Spann, BM; Brewer, J; Vanderswag, H; Fleisher, A; Ziolkowski, J; Heidebrink, JL; Lord, JL; Mason, SS; Albers, CS; Knopman, D; Johnson, K; Villanueva-Meyer, J; Pavlik, V; Pacini, N; Lamb, A; Kass, JS; Doody, RS; Shibley, V; Chowdhury, M; Rountree, S; Dang, M; Stern, Y; Honig, LS; Bell, KL; Yeh, R; Ances, B; Winkfield, D; Carroll, M; Oliver, A; Creech, ML; Mintun, MA; Schneider, S; Marson, D; Geldmacher, D; Love, MN; Griffith, R; Clark, D; Brockington, J; Grossman, H; Mitsis, E; Shah, RC; Lamar, M; Samuels, P; Duara, R; Greig-Custo, MT; Rodriguez, R; Onyike, C; D'Agostino, D; Kielb, S; Sadowski, M; Sheikh, MO; Singleton-Garvin, J; Ulysse, A; Gaikwad, M; Doraiswamy, PM; Petrella, JR; James, O; Borges-Neto, S; Wong, TZ; Coleman, E; Karlawish, JH; Wolk, DA; Vaishnavi, S; Clark, CM; Arnold, SE; Smith, CD; Jicha, G; Hardy, P; El Khouli, R; Oates, E; Conrad, G; Lopez, OL; Oakley, M; Simpson, DM; Porsteinsson, AP; Martin, K; Kowalksi, N; Keltz, M; Goldstein, BS; Makino, KM; Ismail, MS; Brand, C; Thai, G; Pierce, A; Yanez, B; Sosa, E; Witbracht, M; Womack, K; Mathews, D; Quiceno, M; Levey, AI; Lah, JJ; Cellar, JS; Burns, JM; Swerdlow, RH; Brooks, WM; Woo, E; Silverman, DHS; Teng, E; Kremen, S; Apostolova, L; Tingus, K; Lu, PH; Bartzokis, G; Graff-Radford, NR; Parfitt, F; Poki-Walker, K; Farlow, MR; Hake, AM; Matthews, BR; Brosch, JR; Herring, S; van Dyck, CH; Carson, RE; Varma, P; Chertkow, H; Bergman, H; Hosein, C; Black, S; Stefanovic, B; Heyn, C; Hsiung, GYR; Mudge, B; Sossi, V; Feldman, H; Assaly, M; Finger, E; Pasternack, S; Pavlosky, W; Rachinsky, I; Drost, D; Kertesz, A; Bernick, C; Munic, D; Mesulam, MM; Rogalski, E; Lipowski, K; Weintraub, S; Bonakdarpour, B; Kerwin, D; Wu, CK; Johnson, N; Sadowsky, C; Villena, T; Turner, RS; Johnson, K; Reynolds, B; Sperling, RA; Johnson, KA; Marshall, GA; Yesavage, J; Taylor, JL; Chao, S; Lane, B; Rosen, A; Tinklenberg, J; Zamrini, E; Belden, CM; Sirrel, SA; Kowall, N; Killiany, R; Budson, AE; Norbash, A; Johnson, PL; Obisesan, TO; Oyonumo, NE; Allard, J; Ogunlana, O; Lerner, A; Ogrocki, P; Tatsuoka, C; Fatica, P; Fletcher, E; Maillard, P; Olichney, J; Carmichael, O; Kittur, S; Borrie, M; Lee, TY; Bartha, R; Johnson, S; Asthana, S; Carlsson, CM; Tariot, P; Burke, A; Hetelle, J; DeMarco, K; Trncic, N; Reeder, S; Bates, V; Capote, H; Rainka, M; Scharre, DW; Kataki, M; Tarawneh, R; Zimmerman, EA; Celmins, D; Hart, D; Pearlson, GD; Blank, K; Anderson, K; Flashman, LA; Seltzer, M; Hynes, ML; Santulli, RB; Sink, KM; Yang, M; Mintz, A; Ott, BR; Tremont, G; Daiello, LA; Bodge, C; Salloway, S; Malloy, P; Correia, S; Lee, A; Rosen, HJ; Miller, BL; Perry, D; Mintzer, J; Spicer, K; Bachman, D; Pasternak, S; Rogers, J; Pomara, N; Hernando, R; Sarrael, A; Miller, DD; Smith, KE; Koleva, H; Nam, KW; Shim, H; Schultz, SK; Relkin, N; Chiang, G; Lin, M; Ravdin, L; Smith, A; Leach, C; Raj, BA; Fargher, K; Neylan, T; Grafman, J; Hayes, J; Finley, S; Householder, E; Friedl, K; Fleischman, D; Arfanakis, K; Varon, D; Martin, KS; Preda, A; Nguyen, D; Massoglia, D; Brawman-Mintzer, O; Martinez, W; Landau, S; Rosen, H; Behan, K; Sabbagh, MN; Jacobson, SA; Wolday, S; Fruehling, JJ; Harding, S; Peskind, ER; Petrie, EC; Li, G; Furst, AJ; Mackin, S; Raman, R; Drake, E; Donohue, M; Shaffer, E; Nelson, C; David,; Butters, M; Zmuda, M; Reyes, D; Nudelman, KN; Au, YH; Scherer, K; Catalinotto, D; Stark, S; Ong, E; Fernandez, D				Moore, P. J.; Lyons, T. J.; Gallacher, J.; Weiner, Michael W.; Aisen, Paul; Petersen, Ronald; Jack, Clifford R., Jr.; Jagust, William; Trojanowki, John Q.; Toga, Arthur W.; Beckett, Laurel; Green, Robert C.; Saykin, Andrew J.; Morris, John; Shaw, Leslie M.; Khachaturian, Zaven; Sorensen, Greg; Carrillo, Maria; Kuller, Lew; Raichle, Marc; Paul, Steven; Davies, Peter; Fillit, Howard; Hefti, Franz; Holtzman, David; Mesulam, M. Marcel; Potter, William; Snyder, Peter; Montine, Tom; Jimenez, Gustavo; Donohue, Michael; Gessert, Devon; Harless, Kelly; Salazar, Jennifer; Cabrera, Yuliana; Walter, Sarah; Hergesheimer, Lindsey; Harvey, Danielle; Donohue, Michael; Bernstein, Matthew; Fox, Nick; Thompson, Paul; Schuff, Norbert; DeCArli, Charles; Borowski, Bret; Gunter, Jeff; Senjem, Matt; Vemuri, Prashanthi; Jones, David; Kantarci, Kejal; Ward, Chad; Koeppe, Robert A.; Foster, Norm; Reiman, Eric M.; Chen, Kewei; Mathis, Chet; Cairns, Nigel J.; Franklin, Erin; Taylor-Reinwald, Lisa; Lee, Virginia; Korecka, Magdalena; Figurski, Michal; Crawford, Karen; Neu, Scott; Foroud, Tatiana M.; Potkin, Steven; Shen, Li; Faber, Kelley; Kim, Sungeun; Nho, Kwangsik; Thal, Lean; Buckholtz, Neil; Albert, Marilyn; Frank, Richard; Hsiao, John; Quinn, Joseph; Silbert, Lisa C.; Lind, Betty; Kaye, Jeffrey A.; Carter, Raina; Dolen, Sara; Schneider, Lon S.; Pawluczyk, Sonia; Becerra, Mauricio; Teodoro, Liberty; Spann, Bryan M.; Brewer, James; Vanderswag, Helen; Fleisher, Adam; Ziolkowski, Jaimie; Heidebrink, Judith L.; Lord, Joanne L.; Mason, Sara S.; Albers, Colleen S.; Knopman, David; Johnson, Kris; Villanueva-Meyer, Javier; Pavlik, Valory; Pacini, Nathaniel; Lamb, Ashley; Kass, Joseph S.; Doody, Rachelle S.; Shibley, Victoria; Chowdhury, Munir; Rountree, Susan; Dang, Mimi; Stern, Yaakov; Honig, Lawrence S.; Bell, Karen L.; Yeh, Randy; Ances, Beau; Winkfield, David; Carroll, Maria; Oliver, Angela; Creech, Mary L.; Mintun, Mark A.; Schneider, Stacy; Marson, Daniel; Geldmacher, David; Love, Marissa Natelson; Griffith, Randall; Clark, David; Brockington, John; Grossman, Hillel; Mitsis, Effie; Shah, Raj C.; Lamar, Melissa; Samuels, Patricia; Duara, Ranjan; Greig-Custo, Maria T.; Rodriguez, Rosemarie; Onyike, Chiadi; D'Agostino, Daniel, II; Kielb, Stephanie; Sadowski, Martin; Sheikh, Mohammed O.; Singleton-Garvin, Jamika; Ulysse, Anaztasia; Gaikwad, Mrunalini; Doraiswamy, P. Murali; Petrella, Jeffrey R.; James, Olga; Borges-Neto, Salvador; Wong, Terence Z.; Coleman, Edward; Karlawish, Jason H.; Wolk, David A.; Vaishnavi, Sanjeev; Clark, Christopher M.; Arnold, Steven E.; Smith, Charles D.; Jicha, Greg; Hardy, Peter; El Khouli, Riham; Oates, Elizabeth; Conrad, Gary; Lopez, Oscar L.; Oakley, MaryAnn; Simpson, Donna M.; Porsteinsson, Anton P.; Martin, Kim; Kowalksi, Nancy; Keltz, Melanie; Goldstein, Bonnie S.; Makino, Kelly M.; Ismail, M. Saleem; Brand, Connie; Thai, Gaby; Pierce, Aimee; Yanez, Beatriz; Sosa, Elizabeth; Witbracht, Megan; Womack, Kyle; Mathews, Dana; Quiceno, Mary; Levey, Allan I.; Lah, James J.; Cellar, Janet S.; Burns, Jeffrey M.; Swerdlow, Russell H.; Brooks, William M.; Woo, Ellen; Silverman, Daniel H. S.; Teng, Edmond; Kremen, Sarah; Apostolova, Liana; Tingus, Kathleen; Lu, Po H.; Bartzokis, George; Graff-Radford, Neill R.; Parfitt, Francine; Poki-Walker, Kim; Farlow, Martin R.; Hake, Ann Marie; Matthews, Brandy R.; Brosch, Jared R.; Herring, Scott; van Dyck, Christopher H.; Carson, Richard E.; Varma, Pradeep; Chertkow, Howard; Bergman, Howard; Hosein, Chris; Black, Sandra; Stefanovic, Bojana; Heyn, Chris (Chinthaka); Hsiung, Ging-Yuek Robin; Mudge, Benita; Sossi, Vesna; Feldman, Howard; Assaly, Michele; Finger, Elizabeth; Pasternack, Stephen; Pavlosky, William; Rachinsky, Irina; Drost, Dick; Kertesz, Andrew; Bernick, Charles; Munic, Donna; Mesulam, Marek-Marsel; Rogalski, Emily; Lipowski, Kristine; Weintraub, Sandra; Bonakdarpour, Borna; Kerwin, Diana; Wu, Chuang-Kuo; Johnson, Nancy; Sadowsky, Carl; Villena, Teresa; Turner, Raymond Scott; Johnson, Kathleen; Reynolds, Brigid; Sperling, Reisa A.; Johnson, Keith A.; Marshall, Gad A.; Yesavage, Jerome; Taylor, Joy L.; Chao, Steven; Lane, Barton; Rosen, Allyson; Tinklenberg, Jared; Zamrini, Edward; Belden, Christine M.; Sirrel, Sherye A.; Kowall, Neil; Killiany, Ronald; Budson, Andrew E.; Norbash, Alexander; Johnson, Patricia Lynn; Obisesan, Thomas O.; Oyonumo, Ntekim E.; Allard, Joanne; Ogunlana, Olu; Lerner, Alan; Ogrocki, Paula; Tatsuoka, Curtis; Fatica, Parianne; Fletcher, Evan; Maillard, Pauline; Olichney, John; Carmichael, Owen; Kittur, Smita; Borrie, Michael; Lee, T-Y; Bartha, Rob; Johnson, Sterling; Asthana, Sanjay; Carlsson, Cynthia M.; Tariot, Pierre; Burke, Anna; Hetelle, Joel; DeMarco, Kathryn; Trncic, Nadira; Reeder, Stephanie; Bates, Vernice; Capote, Horacio; Rainka, Michelle; Scharre, Douglas W.; Kataki, Maria; Tarawneh, Rawan; Zimmerman, Earl A.; Celmins, Dzintra; Hart, David; Pearlson, Godfrey D.; Blank, Karen; Anderson, Karen; Flashman, Laura A.; Seltzer, Marc; Hynes, Mary L.; Santulli, Robert B.; Sink, Kaycee M.; Yang, Mia; Mintz, Akiva; Ott, Brian R.; Tremont, Geoffrey; Daiello, Lori A.; Bodge, Courtney; Salloway, Stephen; Malloy, Paul; Correia, Stephen; Lee, Athena; Rosen, Howard J.; Miller, Bruce L.; Perry, David; Mintzer, Jacobo; Spicer, Kenneth; Bachman, David; Pasternak, Stephen; Rogers, John; Pomara, Nunzio; Hernando, Raymundo; Sarrael, Antero; Miller, Delwyn D.; Smith, Karen Ekstam; Koleva, Hristina; Nam, Ki Won; Shim, Hyungsub; Schultz, Susan K.; Relkin, Norman; Chiang, Gloria; Lin, Michael; Ravdin, Lisa; Smith, Amanda; Leach, Christi; Raj, Balebail Ashok; Fargher, Kristin; Neylan, Thomas; Grafman, Jordan; Hayes, Jacqueline; Finley, Shannon; Householder, Erin; Friedl, Karl; Fleischman, Debra; Arfanakis, Konstantinos; Varon, Daniel; Martin, Kimberly S.; Preda, Adrian; Nguyen, Dana; Massoglia, Dino; Brawman-Mintzer, Olga; Martinez, Walter; Landau, Susan; Rosen, Howard; Behan, Kelly; Sabbagh, Marwan N.; Jacobson, Sandra A.; Wolday, Saba; Fruehling, J. Jay; Harding, Sandra; Peskind, Elaine R.; Petrie, Eric C.; Li, Gail; Furst, Ansgar J.; Mackin, Scott; Raman, Rema; Drake, Erin; Donohue, Mike; Shaffer, Elizabeth; Nelson, Craig; Bickford, David; Butters, Meryl; Zmuda, Michelle; Reyes, Denise; Nudelman, Kelly N.; Au, Yiu Ho; Scherer, Kelly; Catalinotto, Daniel; Stark, Samuel; Ong, Elise; Fernandez, Dariella		Alzheimers Dis Neuroimaging Init	Random forest prediction of Alzheimer's disease using pairwise selection from time series data	PLOS ONE			English	Article							STRUCTURAL MRI; MCI; CLASSIFICATION; CONVERSION; DIAGNOSIS; DEMENTIA; CRITERIA; STRATEGY	Time-dependent data collected in studies of Alzheimer's disease usually has missing and irregularly sampled data points. For this reason time series methods which assume regular sampling cannot be applied directly to the data without a pre-processing step. In this paper we use a random forest to learn the relationship between pairs of data points at different time separations. The input vector is a summary of the time series history and it includes both demographic and non-time varying variables such as genetic data. To test the method we use data from the TADPOLE grand challenge, an initiative which aims to predict the evolution of subjects at risk of Alzheimer's disease using demographic, physical and cognitive input data. The task is to predict diagnosis, ADAS-13 score and normalised ventricles volume. While the competition proceeds, forecasting methods may be compared using a leaderboard dataset selected from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and with standard metrics for measuring accuracy. For diagnosis, we find an mAUC of 0.82, and a classification accuracy of 0.73 compared with a benchmark SVM predictor which gives mAUC = 0.62 and BCA = 0.52. The results show that the method is effective and comparable with other methods.	[Moore, P. J.; Lyons, T. J.] Univ Oxford, Math Inst, Oxford, England; [Gallacher, J.] Univ Oxford, Dept Psychiat, Oxford, England; [Weiner, Michael W.; Jagust, William; Rosen, Howard J.; Miller, Bruce L.; Perry, David; Neylan, Thomas; Hayes, Jacqueline; Finley, Shannon; Landau, Susan; Rosen, Howard; Mackin, Scott; Nelson, Craig; Bickford, David; Au, Yiu Ho; Scherer, Kelly; Catalinotto, Daniel; Stark, Samuel; Ong, Elise; Fernandez, Dariella] UC San Francisco, San Francisco, CA USA; [Aisen, Paul; Toga, Arthur W.; Jimenez, Gustavo; Donohue, Michael; Gessert, Devon; Harless, Kelly; Salazar, Jennifer; Cabrera, Yuliana; Walter, Sarah; Hergesheimer, Lindsey; Crawford, Karen; Neu, Scott; Schneider, Lon S.; Pawluczyk, Sonia; Becerra, Mauricio; Teodoro, Liberty; Spann, Bryan M.; Raman, Rema; Donohue, Mike; Shaffer, Elizabeth] Univ Southern Calif, Los Angeles, CA USA; [Petersen, Ronald; Jack, Clifford R., Jr.; Bernstein, Matthew; Borowski, Bret; Gunter, Jeff; Senjem, Matt; Vemuri, Prashanthi; Jones, David; Kantarci, Kejal; Ward, Chad; Mason, Sara S.; Albers, Colleen S.; Knopman, David; Johnson, Kris; Reyes, Denise] Mayo Clin, Rochester, MN USA; [Jagust, William; Landau, Susan] Univ Calif Berkeley, Berkeley, CA USA; [Trojanowki, John Q.; Shaw, Leslie M.; Karlawish, Jason H.; Wolk, David A.; Vaishnavi, Sanjeev; Clark, Christopher M.; Arnold, Steven E.] Univ Penn, Philadelphia, PA 19104 USA; [Beckett, Laurel; Harvey, Danielle; DeCArli, Charles] Univ Calif Davis, Davis, CA USA; [Green, Robert C.; Drake, Erin] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Saykin, Andrew J.; Foroud, Tatiana M.; Shen, Li; Faber, Kelley; Kim, Sungeun; Nho, Kwangsik; Farlow, Martin R.; Hake, Ann Marie; Matthews, Brandy R.; Brosch, Jared R.; Herring, Scott; Nudelman, Kelly N.] Indiana Univ, Bloomington, IN 47405 USA; [Morris, John; Raichle, Marc; Holtzman, David; Cairns, Nigel J.; Franklin, Erin; Taylor-Reinwald, Lisa; Ances, Beau; Winkfield, David; Carroll, Maria; Oliver, Angela; Creech, Mary L.; Mintun, Mark A.; Schneider, Stacy; Householder, Erin] Washington Univ St Louis, St Louis, MO USA; [Khachaturian, Zaven] Prevent Alzheimers Dis 2020, Rockville, MD USA; [Sorensen, Greg] Siemens, Munich, Germany; [Carrillo, Maria] Alzheimers Assoc, Chicago, IL USA; [Kuller, Lew; Mathis, Chet; Lopez, Oscar L.; Oakley, MaryAnn; Simpson, Donna M.; Butters, Meryl; Zmuda, Michelle] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Paul, Steven; Relkin, Norman; Chiang, Gloria; Ravdin, Lisa] Cornell Univ, Ithaca, NY 14853 USA; [Davies, Peter] Yeshiva Univ, Albert Einstein Coll Med, New York, NY 10033 USA; [Fillit, Howard] AD Drug Discovery Fdn, New York, NY USA; [Hefti, Franz] Acumen Pharmaceut, Livermore, CA USA; [Mesulam, M. Marcel] Northwestern Univ, Evanston, IL 60208 USA; [Potter, William] NIMH, Bethesda, MD 20892 USA; [Snyder, Peter] Brown Univ, Providence, RI 02912 USA; [Montine, Tom; Peskind, Elaine R.; Petrie, Eric C.; Li, Gail] Univ Washington, Seattle, WA 98195 USA; [Donohue, Michael; Thal, Lean; Brewer, James; Vanderswag, Helen; Fleisher, Adam] Univ Calif San Diego, San Diego, CA USA; [Fox, Nick] Univ London, London, England; [Thompson, Paul] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA; [Schuff, Norbert] UCSF MRI, San Francisco, CA USA; [Koeppe, Robert A.; Ziolkowski, Jaimie; Heidebrink, Judith L.; Lord, Joanne L.] Univ Michigan, Ann Arbor, MI 48109 USA; [Foster, Norm] Univ Utah, Salt Lake City, UT 84112 USA; [Reiman, Eric M.; Chen, Kewei] Banner Alzheimers Inst, Phoenix, AZ USA; [Trojanowki, John Q.; Shaw, Leslie M.; Lee, Virginia; Korecka, Magdalena; Figurski, Michal] UPenn Sch Med, Philadelphia, PA USA; [Potkin, Steven; Thai, Gaby; Pierce, Aimee; Yanez, Beatriz; Sosa, Elizabeth; Witbracht, Megan; Preda, Adrian; Nguyen, Dana] UC Irvine, Irvine, CA USA; [Buckholtz, Neil; Hsiao, John] NIA, Bethesda, MD 20892 USA; [Albert, Marilyn; Onyike, Chiadi; D'Agostino, Daniel, II; Kielb, Stephanie] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Frank, Richard] Richard Frank Consulting, New York, NY USA; [Quinn, Joseph; Silbert, Lisa C.; Lind, Betty; Kaye, Jeffrey A.; Carter, Raina; Dolen, Sara] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Villanueva-Meyer, Javier; Pavlik, Valory; Pacini, Nathaniel; Lamb, Ashley; Kass, Joseph S.; Doody, Rachelle S.; Shibley, Victoria; Chowdhury, Munir; Rountree, Susan; Dang, Mimi] Baylor Coll Med, Houston, TX 77030 USA; [Stern, Yaakov; Honig, Lawrence S.; Bell, Karen L.; Yeh, Randy] Columbia Univ, Med Ctr, New York, NY 10027 USA; [Marson, Daniel; Geldmacher, David; Love, Marissa Natelson; Griffith, Randall; Clark, David; Brockington, John] Univ Alabama Birmingham, Birmingham, AL USA; [Grossman, Hillel; Mitsis, Effie] Mt Sinai Sch Med, New York, NY USA; [Shah, Raj C.; Lamar, Melissa; Samuels, Patricia; Fleischman, Debra; Arfanakis, Konstantinos] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Duara, Ranjan; Greig-Custo, Maria T.; Rodriguez, Rosemarie; Varon, Daniel] Wien Ctr, New York, NY USA; [Sadowski, Martin; Sheikh, Mohammed O.; Singleton-Garvin, Jamika; Ulysse, Anaztasia; Gaikwad, Mrunalini] NYU, New York, NY 10003 USA; [Doraiswamy, P. Murali; Petrella, Jeffrey R.; James, Olga; Borges-Neto, Salvador; Wong, Terence Z.; Coleman, Edward] Duke Univ, Med Ctr, Durham, NC 27706 USA; [Smith, Charles D.; Jicha, Greg; Hardy, Peter; El Khouli, Riham; Oates, Elizabeth; Conrad, Gary] Univ Kentucky, Lexington, KY 40506 USA; [Porsteinsson, Anton P.; Martin, Kim; Kowalksi, Nancy; Keltz, Melanie; Goldstein, Bonnie S.; Makino, Kelly M.; Ismail, M. Saleem; Brand, Connie; Martin, Kimberly S.] Univ Rochester, Med Ctr, Rochester, NY 14627 USA; [Womack, Kyle; Mathews, Dana; Quiceno, Mary] Univ Texas Southwestern Med Sch, Houston, TX USA; [Levey, Allan I.; Lah, James J.; Cellar, Janet S.] Emory Univ, Atlanta, GA 30322 USA; [Burns, Jeffrey M.; Swerdlow, Russell H.; Brooks, William M.] Univ Kansas, Med Ctr, Lawrence, KS 66045 USA; [Woo, Ellen; Silverman, Daniel H. S.; Teng, Edmond; Kremen, Sarah; Apostolova, Liana; Tingus, Kathleen; Lu, Po H.; Bartzokis, George] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Graff-Radford, Neill R.; Parfitt, Francine; Poki-Walker, Kim] Mayo Clin, Jacksonville, FL 32224 USA; [van Dyck, Christopher H.; Carson, Richard E.; Varma, Pradeep] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Chertkow, Howard; Bergman, Howard; Hosein, Chris] McGill Univ, Montreal Jewish Gen Hosp, Montreal, PQ, Canada; [Black, Sandra; Stefanovic, Bojana; Heyn, Chris (Chinthaka)] Sunnybrook Hlth Sci, Toronto, ON, Canada; [Hsiung, Ging-Yuek Robin; Mudge, Benita; Sossi, Vesna; Feldman, Howard; Assaly, Michele] UBC Clin AD & Related Disorders, Vancouver, BC, Canada; [Finger, Elizabeth; Pasternack, Stephen; Pavlosky, William; Rachinsky, Irina; Drost, Dick; Kertesz, Andrew] Cognit Neurol St Josephs, London, ON, Canada; [Bernick, Charles; Munic, Donna] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Cleveland, OH 44106 USA; [Mesulam, Marek-Marsel; Rogalski, Emily; Lipowski, Kristine; Weintraub, Sandra; Bonakdarpour, Borna; Kerwin, Diana; Wu, Chuang-Kuo; Johnson, Nancy] Northwestern Univ, Evanston, IL 60208 USA; [Sadowsky, Carl; Villena, Teresa; Martinez, Walter] Premiere Res Inst Palm Beach Neurol, W Palm Beach, FL USA; [Turner, Raymond Scott; Johnson, Kathleen; Reynolds, Brigid; Behan, Kelly] Georgetown Univ, Med Ctr, Washington, DC 20057 USA; [Sperling, Reisa A.; Johnson, Keith A.; Marshall, Gad A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Yesavage, Jerome; Taylor, Joy L.; Chao, Steven; Lane, Barton; Rosen, Allyson; Tinklenberg, Jared; Furst, Ansgar J.] Stanford Univ, Stanford, CA 94305 USA; [Zamrini, Edward; Belden, Christine M.; Sirrel, Sherye A.; Sabbagh, Marwan N.; Jacobson, Sandra A.] Banner Sun Hlth Res Inst, Sun City, AZ USA; [Kowall, Neil; Killiany, Ronald; Budson, Andrew E.; Norbash, Alexander; Johnson, Patricia Lynn] Boston Univ, Boston, MA 02215 USA; [Obisesan, Thomas O.; Oyonumo, Ntekim E.; Allard, Joanne; Ogunlana, Olu; Wolday, Saba] Howard Univ, Washington, DC 20059 USA; [Lerner, Alan; Ogrocki, Paula; Tatsuoka, Curtis; Fatica, Parianne] Case Western Reserve Univ, Cleveland, OH 44106 USA; [DeCArli, Charles; Fletcher, Evan; Maillard, Pauline; Olichney, John; Carmichael, Owen] Univ Calif Davis, Sacramento, CA 95817 USA; [Kittur, Smita] Neurol Care CNY, Liverpool, NY USA; [Borrie, Michael; Lee, T-Y; Bartha, Rob] Parkwood Inst, London, ON, Canada; [Johnson, Sterling; Asthana, Sanjay; Carlsson, Cynthia M.; Fruehling, J. Jay; Harding, Sandra] Univ Wisconsin, Madison, WI 53706 USA; [Fleisher, Adam; Tariot, Pierre; Burke, Anna; Hetelle, Joel; DeMarco, Kathryn; Trncic, Nadira; Reeder, Stephanie] Banner Alzheimers Inst, Phoenix, AZ USA; [Bates, Vernice; Capote, Horacio; Rainka, Michelle] Dent Neurol Inst, Amherst, NY USA; [Scharre, Douglas W.; Kataki, Maria; Tarawneh, Rawan] Ohio State Univ, Columbus, OH 43210 USA; [Zimmerman, Earl A.; Celmins, Dzintra; Hart, David] Albany Med Coll, Albany, NY 12208 USA; [Pearlson, Godfrey D.; Blank, Karen; Anderson, Karen] Hartford Hosp, Olin Neuropsychiat Res Ctr, Hartford, CT 06115 USA; [Flashman, Laura A.; Seltzer, Marc; Hynes, Mary L.; Santulli, Robert B.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Sink, Kaycee M.; Yang, Mia; Mintz, Akiva] Wake Forest Univ Hlth Sci, Winston Salem, NC USA; [Ott, Brian R.; Tremont, Geoffrey; Daiello, Lori A.] Rhode Isl Hosp, Providence, RI 02903 USA; [Bodge, Courtney; Salloway, Stephen; Malloy, Paul; Correia, Stephen; Lee, Athena] Butler Hosp, Providence, RI 02906 USA; [Mintzer, Jacobo; Spicer, Kenneth; Bachman, David; Massoglia, Dino; Brawman-Mintzer, Olga] Med Univ South Carolina, Columbia, SC USA; [Finger, Elizabeth; Rachinsky, Irina; Drost, Dick; Kertesz, Andrew; Pasternak, Stephen; Rogers, John] St Josephs Hlth Care, Toronto, ON, Canada; [Pomara, Nunzio; Hernando, Raymundo; Sarrael, Antero] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; [Miller, Delwyn D.; Smith, Karen Ekstam; Koleva, Hristina; Nam, Ki Won; Shim, Hyungsub; Schultz, Susan K.] Univ Iowa, Coll Med, Iowa City, IA 52242 USA; [Relkin, Norman; Chiang, Gloria; Lin, Michael; Ravdin, Lisa] Cornell Univ, Ithaca, NY 14853 USA; [Smith, Amanda; Leach, Christi; Raj, Balebail Ashok; Fargher, Kristin] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Tampa, FL USA; [Trojanowki, John Q.; Shaw, Leslie M.; Lee, Virginia; Korecka, Magdalena; Figurski, Michal] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Rehabil Inst Chicago, Evanston, IL 60208 USA; [Friedl, Karl] US Dept Def, Arlington, VA USA	University of Oxford; University of Oxford; University of California System; University of California San Francisco; University of Southern California; Mayo Clinic; University of California System; University of California Berkeley; University of Pennsylvania; University of California System; University of California Davis; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Indiana University System; Indiana University Bloomington; Washington University (WUSTL); Siemens AG; Siemens Germany; Alzheimer's Association; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cornell University; Yeshiva University; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Brown University; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of London; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; Banner Research; Banner Health; Banner Alzheimer's Institute; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Oregon Health & Science University; Baylor College of Medicine; Columbia University; University of Alabama System; University of Alabama Birmingham; Icahn School of Medicine at Mount Sinai; Rush University; New York University; Duke University; University of Kentucky; University of Rochester; Emory University; University of Kansas; University of Kansas Medical Center; University of California System; University of California Los Angeles; Mayo Clinic; Yale University; McGill University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of British Columbia; Cleveland Clinic Foundation; Northwestern University; Georgetown University; Harvard University; Brigham & Women's Hospital; Stanford University; Banner Research; Banner Health; Banner Sun Health Research Institute; Boston University; Howard University; Case Western Reserve University; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; Banner Research; Banner Health; Banner Alzheimer's Institute; University System of Ohio; Ohio State University; Albany Medical College; Hartford Hospital; Dartmouth College; Wake Forest University; Wake Forest University School of Medicine; Lifespan Health Rhode Island; Rhode Island Hospital; Butler Hospital Rhode Island; Medical University of South Carolina; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Nathan Kline Institute for Psychiatric Research; University of Iowa; Cornell University; State University System of Florida; University of South Florida; University of Pennsylvania; Pennsylvania Medicine; Northwestern University; Feinberg School of Medicine; Shirley Ryan AbilityLab; United States Department of Defense	Moore, PJ (corresponding author), Univ Oxford, Math Inst, Oxford, England.	moorep@maths.ox.ac.uk; Michael.Weiner@ucsf.edu	Snyder, Peter J./W-2609-2019; Butters, Meryl/AAR-2863-2021; Jimenez-Maggiora, Gustavo A/V-6341-2019; Jack, Clifford R/F-2508-2010; Lyons, Terry/AAG-6890-2020; Jagust, William/ABE-6426-2020; Killiany, Ronald/Y-7251-2019; Thompson, Paul M/C-4194-2018; Kass, Joseph/AAM-7392-2020; Levey, Allan/F-2104-2011; Paul, Steve/ABE-5400-2020; Nudelman, Kelly/AFM-1022-2022; Shah, Raj/AAS-2210-2021; Cairns, Nigel/AAB-9713-2020; Vaishnavi, Sanjeev/AGU-9275-2022; DeCarli, Charles/B-5541-2009; Preda, Adrian/K-8889-2013	Jimenez-Maggiora, Gustavo A/0000-0001-9745-5121; Jack, Clifford R/0000-0001-7916-622X; Killiany, Ronald/0000-0003-4740-2181; Thompson, Paul M/0000-0002-4720-8867; Levey, Allan/0000-0002-3153-502X; Shah, Raj/0000-0001-9706-9730; Cairns, Nigel/0000-0001-9858-3344; Vaishnavi, Sanjeev/0000-0002-6288-250X; Preda, Adrian/0000-0003-3373-2438; Moore, Paul/0000-0001-6171-4072; Gallacher, John/0000-0002-2394-5299	UK Medical Research Council (MRC) Dementias Platform; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; Bio-Clinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research AMP; Development, LLC; Johnson AMP; Johnson Pharmaceutical Research AMP; Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; EPSRC [EP/S026347/1] Funding Source: UKRI; MRC [MR/L023784/1, MR/L023784/2] Funding Source: UKRI	UK Medical Research Council (MRC) Dementias Platform; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; Bio-Clinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research AMP; Development, LLC; Johnson AMP; Johnson Pharmaceutical Research AMP; Development LLC.; Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PM and JG received funding from the UK Medical Research Council (MRC) Dementias Platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. The ADNI principal investigator is Michael W. Weiner, MD. (Michael.Weiner@ucsf.edu). A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; Bio-Clinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Arbabshirani MR, 2017, NEUROIMAGE, V145, P137, DOI 10.1016/j.neuroimage.2016.02.079; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bron EE, 2015, NEUROIMAGE, V111, P562, DOI 10.1016/j.neuroimage.2015.01.048; Burns A, ALZHEIMERS DIS, DOI [10.1136/bmj.b158, DOI 10.1136/BMJ.B158]; Dimitriadis SI, 2018, J NEUROSCI METH, V302, P14, DOI 10.1016/j.jneumeth.2017.12.010; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Falahati F, 2014, J ALZHEIMERS DIS, V41, P685, DOI 10.3233/JAD-131928; Ganz M, 2015, NEUROIMAGE, V122, P131, DOI 10.1016/j.neuroimage.2015.08.006; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Lebedev AV, 2014, NEUROIMAGE-CLIN, V6, P115, DOI 10.1016/j.nicl.2014.08.023; Li H, 2014, CURR EYE RES, V9, P1, DOI DOI 10.1109/JSTARS.2014.2348173; Marinescu RV, 2018, ARXIV E PRINTS; Moradi E, 2015, NEUROIMAGE, V104, P398, DOI 10.1016/j.neuroimage.2014.10.002; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; Prestia A, 2015, ALZHEIMERS DEMENT, V11, P1191, DOI 10.1016/j.jalz.2014.12.001; Rasmussen C., 2006, GAUSSIAN PROCESSES M, V1; Rathore S, 2017, NEUROIMAGE, V155, P530, DOI 10.1016/j.neuroimage.2017.03.057; Sarica A, 2018, EDITORIAL SPECIAL IS; Sarica A, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00329; Seo EH, 2017, PSYCHIAT INVEST, V14, P205, DOI 10.4306/pi.2017.14.2.205; Sorensen L, 2014, P MICCAI WORKSH CHAL, P111; Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A; Weiner MW, 2017, ALZHEIMERS DEMENT, V13, P561, DOI 10.1016/j.jalz.2016.10.006	24	40	40	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0211558	10.1371/journal.pone.0211558	http://dx.doi.org/10.1371/journal.pone.0211558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763336	Green Published, gold			2022-12-26	WOS:000458763900015
J	Scholz, SM; Damm, O; Elkenkamp, S; Marcus, U; Greiner, W; Schmidt, AJ				Scholz, Stefan Michael; Damm, Oliver; Elkenkamp, Svenja; Marcus, Ulrich; Greiner, Wolfgang; Schmidt, Axel Jeremias			Population size and self-reported characteristics and sexual preferences of men-who-have-sex-with-men (MSM) in Germany based on social network data	PLOS ONE			English	Article							RISK-TAKING	Background In the absence of detailed information about the population size and behaviour data of men-who-have-sex-with-men (MSM), the estimation of prevalence rates of sexually transmitted infections (STIs) and the design of public health interventions become difficult. The aim of the present study is to estimate the lower boundary of age-specific population sizes and retrieve self-reported information from this population. Methods We used publicly accessible data from a large online dating and social network website for MSM in Germany to retrieve data on the age and regional distribution of profiles. The profiles were also stratified by their information on the preferred position during anal intercourse, safer sex, and sexual identity. Results A total of 464,873 user profiles correspond to an average 15.2 profiles per 1,000 male inhabitants in Germany, varying between 7.6 and 45.6 across federal states. Although the information on the absolute numbers for different age groups is limited by the search engine, age-specific relative frequencies were found to increase from 12.9 in the age group of 18 to 20 year olds to 24.6 profiles per 1,000 male inhabitants in the 28 to 30 year olds. The data shows age-specific trends for safer sex with an increasing easiness of reporting "never" engaging in safer sex or stating that safer sex "needs discussion" with increasing age. Around one third of profile owners stated to be versatile with respect to the preferred position in anal intercourse. All other options ("only bottom", "more bottom", "only top", "more top") were preferred equally likely by roughly 10% of profile owners, respectively. Conclusions Online social network or dating sites can provide some information about specific populations in the absence of other data sources. The presented results are the first to report age-specific rates of MSM per 1,000 male inhabitants in Germany and may be useful to estimate age-specific prevalence or incidence rates as well as to inform health promotion activities and modelling studies for MSM in Germany.	[Scholz, Stefan Michael; Damm, Oliver; Elkenkamp, Svenja; Greiner, Wolfgang] Bielefeld Univ, Dept Hlth Econ & Hlth Management, Sch Publ Hlth, Bielefeld, Germany; [Scholz, Stefan Michael] Leibniz Univ Hannover, CHERH, Hannover, Germany; [Marcus, Ulrich] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Schmidt, Axel Jeremias] London Sch Hyg & Trop Med, Sigma Res, London, England	University of Bielefeld; Leibniz University Hannover; Robert Koch Institute; University of London; London School of Hygiene & Tropical Medicine	Scholz, SM (corresponding author), Bielefeld Univ, Dept Hlth Econ & Hlth Management, Sch Publ Hlth, Bielefeld, Germany.; Scholz, SM (corresponding author), Leibniz Univ Hannover, CHERH, Hannover, Germany.	stefan.scholz@uni-bielefeld.de	Scholz, Stefan/W-9109-2019; Marcus, Ulrich/AAF-3085-2020	Scholz, Stefan/0000-0002-8421-8829; Marcus, Ulrich/0000-0002-3143-2717; Schmidt, Axel J./0000-0002-6910-4399	German Research Foundation (DFG); Open Access Publication Fund of Bielefeld University	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of Bielefeld University	We acknowledge the financial support of the German Research Foundation (DFG) and the Open Access Publication Fund of Bielefeld University for the article processing charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh M., 2017, ARXIV170400119; [Anonymous], SOCIAL COGNITIVE AFF; Bavinton BR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-917; Berg RC, 2009, ARCH SEX BEHAV, V38, P754, DOI 10.1007/s10508-008-9462-6; Bochow M, 2011, SCHWULE MANNER HIV A; Centers for Disease Control and Prevention, 2016, SEX TRANSM DIS SURV; Clements- Nolle K, 2014, NEVADA J PUBLIC HLTH, V11, P113; Cunningham S, 2010, SEX TRANSM INFECT, V86, P100, DOI 10.1136/sti.2010.044875; Drewes J., 2016, SCHWULE MANNER HIV A; Egger PH, 2015, EUR J HEALTH ECON, V16, P941, DOI 10.1007/s10198-014-0640-2; European Centre for Disease Prevention and Control, 2015, SEX TRANSM INF EUR 2; Gray RT, 2011, SEX TRANSM DIS, V38, P1151, DOI 10.1097/OLQ.0b013e318238b85d; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Grulich AE, 2015, CROI C RETR OPP INF; Hampton MC, 2013, AIDS BEHAV, V17, P931, DOI 10.1007/s10461-012-0139-8; Hancock JT, 2007, CHI P ONL REPR SELF; Holmes Dave, 2005, Nurs Inq, V12, P10, DOI 10.1111/j.1440-1800.2005.00252.x; Klausner JD, 2000, JAMA-J AM MED ASSOC, V284, P447, DOI 10.1001/jama.284.4.447; Kocabey E., 2017, P 11 INT AAAI C WEB; Landovitz RJ, 2013, J URBAN HEALTH, V90, P729, DOI 10.1007/s11524-012-9766-7; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Leblanc NM, 2017, J ADV NURS, V73, P1583, DOI 10.1111/jan.13228; Marcus U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-180; Rice E, 2012, J AIDS CLIN RES, VS4; Rodger A, 2014, CROI C RETR OPP INF; Russell M. A., 2014, MINING SOCIAL WEB; Statistisches Bundesamt, 2016, BEV ERW BEV GRUNDL Z, P2016; Su JY, 2015, AUST NZ J PUBL HEAL, V39, P293, DOI 10.1111/1753-6405.12342; The EMIS Network, 2013, EMIS 2010 EUR MEN WH; Weatherburn P, 2013, SEX RES SOC POLICY, V10, P243, DOI 10.1007/s13178-013-0119-4	31	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212175	10.1371/journal.pone.0212175	http://dx.doi.org/10.1371/journal.pone.0212175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5JX	30763362	Green Published, gold, Green Submitted			2022-12-26	WOS:000458763900047
J	Koutentakis, K; Hoyos, J; Rosales-Statkus, ME; Guerras, JM; Pulido, J; de la Fuente, L; Belza, MJ				Koutentakis, Konstantinos; Hoyos, Juan; Rosales-Statkus, Maria-Elena; Guerras, Juan-Miguel; Pulido, Jose; de la Fuente, Luis; Belza, Maria-Jose			HIV self-testing in Spain: A valuable testing option for men-who-have-sex-with-men who have never tested for HIV	PLOS ONE			English	Article							PREVENTION; HOME; MSM	Background We assessed the capacity of HIV self-testing to promote testing among untested men who have sex with men (MSM) and determined the most benefited subpopulations. Methods An online questionnaire was disseminated on several gay websites in Spain from September 2012 to April 2013. We used Poisson regression to estimate factors associated with the intention to use self-testing if already available. Among those who reported intention of use, we assessed several aspects related to the testing and linkage to care process by type of barrier reported: low perceived risk (LR), structural barriers (SB) and fear of testing positive (FTP). Results Of 2589 never-tested MSM, 83% would have used self-testing if already available. Intention of use was associated with age >= 30 (adj.PR, 95%CI: 1.05, 1.01-1.10), having had protected (adj.PR, 95%CI: 1.15, 1.02-1.30) or unprotected (adj.PR, 95%CI: 1.21, 1.07-1.37) anal intercourse and reporting FTP (adj.PR, 95%CI: 1.12, 1.05-1.20) or SB to access HIV testing (adj.PR, 95%CI: 1.23, 1.19-1.28). Among those who reported intention of using a self-testi, 78.3% declared it their preferred option (83.8% in the SB group; p<0.001), and 56.8% would always use this testing option (60.9% among the SB group; p = 0.001). In the case of obtaining a positive self-test, 69.3% would seek confirmatory testing, 15.3% would self-test again before taking any decision and 13.0% reported not being sure of what they would do. Conclusion HIV self-testing in Spain has the potential of becoming a highly used testing methodology for untested MSM and could represent the gateway to testing especially among older, at risk MSM who report SB or FTP as main barriers to testing.	[Koutentakis, Konstantinos; Rosales-Statkus, Maria-Elena; Guerras, Juan-Miguel; de la Fuente, Luis] Carlos III Hlth Inst, Natl Ctr Epidemiol, Madrid, Spain; [Hoyos, Juan; Rosales-Statkus, Maria-Elena; de la Fuente, Luis; Belza, Maria-Jose] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain; [Hoyos, Juan; Pulido, Jose] Madrid Complutense Univ, Dept Publ & Motherchild Hlth, Fac Med, Madrid, Spain; [Pulido, Jose] Carlos III Hlth Inst, Natl Sch Hlth, Dept Hlth Programs, Madrid, Spain; [Belza, Maria-Jose] Carlos III Hlth Inst, Natl Sch Hlth, Dept Epidemiol & Biostat, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Complutense University of Madrid	Hoyos, J (corresponding author), Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain.; Hoyos, J (corresponding author), Madrid Complutense Univ, Dept Publ & Motherchild Hlth, Fac Med, Madrid, Spain.	jhoyos@externos.isciii.es	Moreira, Juan Miguel Guerras/ABA-3367-2021	Moreira, Juan Miguel Guerras/0000-0001-6708-3291; Pulido, Jose/0000-0001-8487-7384	Ministerio de Sanidad, Servicios Sociales e igualdad [MSSSI EC11-279]; Ayuda Juan de la Cierva-Incorporacion [IJCI-2015-23261]	Ministerio de Sanidad, Servicios Sociales e igualdad; Ayuda Juan de la Cierva-Incorporacion	This study was funded by the Ministerio de Sanidad, Servicios Sociales e igualdad (https://www.msssi.gob.es/) (MSSSI EC11-279). Work by JP was also partially supported by "Ayuda Juan de la Cierva-Incorporacion" (Grant number IJCI-2015-23261).	Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Carvalho C, 2013, HIV MED, V14, P15, DOI 10.1111/hiv.12058; Centro Nacional de Epidemiologia. Vigilancia Epidemiologica del VIH/SIDA en Sistema de informacion sobre Nuevos Diagnosticos de VIH y Registro Nacional de SIDA, VIG EP VIH SIDA ESP; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; den Dees C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009480; Diez M, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.47.20971; Rosales-Statkus ME, 2015, AIDS BEHAV, V19, P472, DOI 10.1007/s10461-014-0975-9; European Centre for Disease Prevention and Control, HIV AIDS SURV EUR 20; European Centre for Disease Prevention and Control, HIV TEST INCR UPT EF; European Centre for Disease Prevention and Control, HIV STI PREV MEN WHO; Fernandez-Davila P, 2013, HIV MED, V14, P44, DOI 10.1111/hiv.12060; Flowers P, 2017, HIV MED, V18, P245, DOI 10.1111/hiv.12420; Frith L, 2007, LANCET, V369, P243, DOI 10.1016/S0140-6736(07)60113-5; Greacen T, 2013, AIDS CARE, V25, P49, DOI 10.1080/09540121.2012.687823; Katz D, 2012, C RETR OPP INF CROI; Koutentakis K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3204-9; Lee J, 2009, ANN ACAD MED SINGAP, V38, P714; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mayer K, 2014, AIDS 2014 20 INT AID; Nash SG, 2017, HIV TESTING ENGLAND; Prati G, 2014, INT J STD AIDS, V25, P496, DOI 10.1177/0956462413515193; Spielberg F, 2004, LANCET INFECT DIS, V4, P640, DOI 10.1016/S1473-3099(04)01150-8; The EMIS Network, EMIS 2010 EUR MEN WH; Walensky RP, 2006, ANN INTERN MED, V145, P459, DOI 10.7326/0003-4819-145-6-200609190-00010; WHO, GUID PROV IN HIV TES; Witzel TC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011372; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302	27	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0210637	10.1371/journal.pone.0210637	http://dx.doi.org/10.1371/journal.pone.0210637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759090	Green Published, gold			2022-12-26	WOS:000458761300018
J	Basanta, MD; Rebollar, EA; Parra-Olea, G				Delia Basanta, M.; Rebollar, Eria A.; Parra-Olea, Gabriela			Potential risk of Batrachochytrium salamandrivorans in Mexico	PLOS ONE			English	Article							CHYTRID FUNGUS; CHIROPTEROTRITON CAUDATA; EMERGING DISEASE; CHYTRIDIOMYCOSIS; PATHOGEN; DYNAMICS; PLETHODONTIDAE; DENDROBATIDIS; BIODIVERSITY; EXTIRPATION	The recent decline in populations of European salamanders caused by the chytrid fungus Batrachochytrium salamandrivorans (Bsal) has generated worldwide concern, as it is a major threat to amphibians. Evaluation of the areas most suitable for the establishment of Bsal combined with analysis of the distribution of salamander species could be used to generate and implement biosecurity measures and protect biodiversity at sites with high salamander diversity. In this study, we identified the areas most suitable for the establishment of Bsal in Mexico. Mexico has the second-highest salamander species diversity in the world; thus, we identified areas moderately to highly suitable for the establishment of Bsal with high salamander diversity as potential hotspots for surveillance. Central and Southern Mexico were identified as high-risk zones, with 13 hotspots where 30% of Mexican salamander species occur, including range-restricted species and endangered species. We propose that these hotspots should be thoroughly monitored for the presence of Bsal to prevent the spread of the pathogen if it is introduced to the country.	[Delia Basanta, M.; Parra-Olea, Gabriela] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, AP, Tercer Circuito Exterior S-N,Ciudad Univ, Mexico City, DF, Mexico; [Delia Basanta, M.] Unidad Posgrad, Posgrad Ciencias Biol, Edificio A,1 Piso,Circuito Posgrad,Ciudad Univ, Mexico City, DF, Mexico; [Rebollar, Eria A.] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Parra-Olea, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, AP, Tercer Circuito Exterior S-N,Ciudad Univ, Mexico City, DF, Mexico.	gparra@ib.unam.mx	Rebollar, Eria/B-2044-2015; Rebollar Caudillo, Eria/HFZ-8793-2022	Basanta, M. Delia/0000-0002-1633-0691; Parra-Olea, Gabriela/0000-0002-0175-925X; Rebollar, Eria/0000-0001-8827-023X	Programa de Posgrado en Ciencias Biologicas, UNAM; CONACyT [CVU/Becario: 509293/288791]; DGAPA-UNAM; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT-UNAM) [IN203617]	Programa de Posgrado en Ciencias Biologicas, UNAM; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT-UNAM)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	MDB was supported with a scholarship by Programa de Posgrado en Ciencias Biologicas, UNAM and CONACyT (CVU/Becario: 509293/288791). GPO was supported by DGAPA-UNAM and CONACyT while on sabbatical at the University of Otago, New Zealand. This research was supported by grants from the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT-UNAM) IN203617 to GPO.	AmphibiaWeb, 2018, AMPH WEB INF AMPH BI; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Castillo AG, 2018, PEERJ, V6, DOI 10.7717/peerj.4907; Catenazzi A, 2011, CONSERV BIOL, V25, P382, DOI 10.1111/j.1523-1739.2010.01604.x; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Cunningham AA, 2015, VET REC, V176, P468, DOI 10.1136/vr.h2264; DARDA DM, 1994, HERPETOLOGICA, V50, P164; ESRI, ARCGIS ARCM 10 2; Feldmeier S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165682; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garcia-Castillo M. G., 2018, AMPHIB REPTILE CONSE, V12, P37; Garcia-Castillo MG, 2017, ZOOTAXA, V4363, P489, DOI 10.11646/zootaxa.4363.4.2; Gonzalez BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078894; Gray MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005251; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Katz TS, 2018, BIOL INVASIONS, V20, P2107, DOI 10.1007/s10530-018-1690-7; Knapp RA, 2016, P NATL ACAD SCI USA, V113, P11889, DOI 10.1073/pnas.1600983113; Laking AE, 2017, SCI REP-UK, V7, DOI 10.1038/srep44443; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2004, BIOL CONSERV, V119, P555, DOI 10.1016/j.biocon.2004.01.017; Lopez-Velazquez A., 2018, QUITRIDIOMICOSIS MEX, V5, P35; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Mendoza-Almeralla C, 2015, REV MEX BIODIVERS, V86, P238, DOI 10.7550/rmb.42588; Meza-Parral Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121652; Munoz ALA, 2010, RIQUEZA DIVERSIDAD E; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Nakamura M., 2011, ECOLOGICAL NICHES GE, V56; Ochoa-Ochoa LM, 2017, ECOSISTEMAS, V26, P27, DOI 10.7818/ECOS.2017.26-2.04; Ochoa-Ochoa LM, 2011, BIOL CONSERV, V144, P2710, DOI 10.1016/j.biocon.2011.07.032; Ochoa-Ochoa LM., 2006, AREAS DIVERSIDAD END; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parra-Olea G, 2003, CAN J ZOOL, V81, P2048, DOI 10.1139/Z03-155; Parra-Olea G, 2014, REV MEX BIODIVERS, V85, pS460, DOI 10.7550/rmb.32027; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Richgels KLD, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150616; Roedder Dennis, 2009, Diversity, V1, P52; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Rovito SM, 2009, P NATL ACAD SCI USA, V106, P3231, DOI 10.1073/pnas.0813051106; Sabino-Pinto J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30240-z; Shrestha UB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106405; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Smith GR, 2017, HERPETOLOGICAL B, V139, P13; Spitzen-van der Sluijs A, 2016, EMERG INFECT DIS, V22, P1286, DOI 10.3201/eid2207.160109; Stebbins RC., 1997, NATURAL HIST AMPHIBI; Stegen G, 2017, NATURE, V544, P353, DOI 10.1038/nature22059; Nguyen TT, 2017, AMPHIBIA-REPTILIA, V38, P554, DOI 10.1163/15685381-00003125; Team RC, 2015, R A LANGUAGE AND ENV; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Voyles J, 2018, SCIENCE, V359, P1517, DOI 10.1126/science.aao4806; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake David B., 1992, Tulane Studies in Zoology and Botany Supplementary Publication, V1, P303; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Yap TA, 2015, SCIENCE, V349, P481, DOI 10.1126/science.aab1052; Yuan ZY, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12436	57	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211960	10.1371/journal.pone.0211960	http://dx.doi.org/10.1371/journal.pone.0211960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753218	Green Published, Green Submitted, gold			2022-12-26	WOS:000458395600034
J	Garcia-Sempere, A; Hurtado, I; Bejarano-Quisoboni, D; Rodriguez-Bernal, C; Santa-Ana, Y; Peiro, S; Sanfelix-Gimeno, G				Garcia-Sempere, Anibal; Hurtado, Isabel; Bejarano-Quisoboni, Daniel; Rodriguez-Bernal, Clara; Santa-Ana, Yared; Peiro, Salvador; Sanfelix-Gimeno, Gabriel			Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based, real-world study	PLOS ONE			English	Article							PRIMARY-HEALTH-CARE; ANTITHROMBOTIC THERAPY; INCEPTION-COHORT; PREVENT STROKE; WARFARIN; METAANALYSIS; OUTCOMES; PREVALENCE; MANAGEMENT; INTENSITY	Background Worldwide, there is growing evidence that quality of international normalized ratio (INR) control in atrial fibrillation patients treated with Vitamin K Antagonists (VKA) is suboptimal. However, sex disparities in population-based real-world settings have been scarcely studied, as well as patterns of switching to second-line Non-VKA oral anticoagulants (NOAC). We aimed to assess the quality of INR control in atrial fibrillation patients treated with VKA in the region of Valencia, Spain, for the whole population and differencing by sex, and to identify factors associated with poor control. We also quantified switching to Non-VKA oral anticoagulants (NOAC) and we identified factors associated to switching. Methods This is a cross-sectional, population-based study. Information was obtained through linking different regional electronic databases. Outcome measures were Time in Therapeutic Range (TTR) and percentage of INR determinations in range (PINRR) in 2015, and percentage of switching to NOAC in 2016, for the whole population and stratified by sex. Results We included 22,629 patients, 50.4% were women. Mean TTR was 62.3% for women and 63.7% for men, and PINNR was 58.3% for women and 60.1% for men (p<0.001). Considering the TTR<65% threshold, 53% of women and 49.3% of men had poor anticoagulation control (p<0.001). Women, long-term users antiplatelet users, and patients with comorbidities, visits to Emergency Department and use of alcohol were more likely to present poor INR control. 5.4% of poorly controlled patients during 2015 switched to a NOAC throughout 2016, with no sex differences. Conclusion The quality of INR control of all AF patients treated with VKA in 2015 in our Southern European region was suboptimal, and women were at a higher risk of poor INR control. This reflects sex disparities in care, and programs for improving the quality of oral anticoagulation should incorporate the gender perspective. Clinical inertia may be lying behind the observed low rates of switching in patient with poor INR control.	[Garcia-Sempere, Anibal; Hurtado, Isabel; Bejarano-Quisoboni, Daniel; Rodriguez-Bernal, Clara; Santa-Ana, Yared; Peiro, Salvador; Sanfelix-Gimeno, Gabriel] Fdn Biomed Res Valencia FISABIO, Hlth Serv Res Unit, Valencia, Spain		Garcia-Sempere, A (corresponding author), Fdn Biomed Res Valencia FISABIO, Hlth Serv Res Unit, Valencia, Spain.	Garcia_ani@gva.es	Rodriguez-Bernal, Clara/ABF-9659-2021; Sanfélix-Gimeno, Gabriel/E-9140-2012; Peiro, Salvador/H-5778-2017; Hurtado, Isabel/I-3395-2017; GARCIA-SEMPERE, ANIBAL/AAA-9137-2019; García-Sempere, Aníbal/ABA-7989-2021	Rodriguez-Bernal, Clara/0000-0003-2617-8635; Sanfélix-Gimeno, Gabriel/0000-0001-7098-4576; Peiro, Salvador/0000-0002-3902-569X; Hurtado, Isabel/0000-0002-8475-8112; García-Sempere, Aníbal/0000-0002-4313-3976; Santa-Ana-Tellez, Yared/0000-0003-3086-446X	Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica (FISABIO) from the Valencia Ministry of Health; Daiichi-Sankyo	Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica (FISABIO) from the Valencia Ministry of Health; Daiichi-Sankyo(Daiichi Sankyo Company Limited)	This work was partially supported by a Collaboration Agreement between the Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica (FISABIO) from the Valencia Ministry of Health and Daiichi-Sankyo, a non-conditioned research grant to conduct independent real-world research in chronic healthcare and pharmacoepidemiology. There was no additional external funding received for this study. The institutions funding the study did not play any role in the study design, collection, analysis, or interpretation of data, in the writing of the manuscript, or in the decision to submit it for publication. The authors' work was independent of the funding agencies.	Abohelaika S, 2016, BRIT J CLIN PHARMACO, V82, P1076, DOI 10.1111/bcp.13046; Rodriguez JCA, 2017, MED CLIN-BARCELONA, V148, P571, DOI 10.1016/j.medcli.2017.02.007; Roca RA, 2015, MED CLIN-BARCELONA, V145, P192, DOI 10.1016/j.medcli.2014.09.023; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Sanchez MA, 2015, REV ESP CARDIOL, V68, P761, DOI 10.1016/j.rec.2014.11.019; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Apostolakis S, 2013, CHEST, V144, P1555, DOI 10.1378/chest.13-0054; Baker WL, 2009, J MANAGE CARE PHARM, V15, P244, DOI 10.18553/jmcp.2009.15.3.244; Barrios V, 2017, REV CLIN ESP, V217, P193, DOI 10.1016/j.rce.2016.12.011; Barrios V, 2015, REV ESP CARDIOL, V68, P769, DOI 10.1016/j.rec.2015.04.017; BJERKELUND CJ, 1969, AM J CARDIOL, V23, P208, DOI 10.1016/0002-9149(69)90068-X; Bjorck F, 2016, JAMA CARDIOL, V1, P172, DOI 10.1001/jamacardio.2016.0199; Blackshear JL, 1996, LANCET, V348, P633; Boned-Ombuena A, 2017, ATEN PRIM, V49, P534, DOI 10.1016/j.aprim.2016.11.015; Cinza-Sanjurjo S, 2015, REV ESP CARDIOL, V68, P753, DOI 10.1016/j.rec.2014.04.018; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Cotte FE, 2014, CLIN THER, V36, P1160, DOI 10.1016/j.clinthera.2014.07.016; Esteve-Pastor MA, 2018, FANTASIIA REGISTRY E, V20, P1435; Fernandez Lopez P, 2016, ESTUDIO ECOPAVIK SEM, V42, P530, DOI DOI 10.1016/J.SEMERG.2015.12.006; Garcia-Sempere A, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00576; Haas S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164076; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Heidbuchel H, 2017, EUR HEART J, V38, P2137, DOI 10.1093/eurheartj/ehw058; Heneghan C, 2006, LANCET, V367, P404, DOI 10.1016/S0140-6736(06)68139-7; HIRSH J, 1989, CHEST, V95, pS5, DOI 10.1378/chest.95.2.5S; Hirsh J, 1989, CHEST, V96, P962; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Johnson ES, 2013, PHARMACOEPIDEM DR S, V22, P1, DOI 10.1002/pds.3334; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lehto M, 2017, PHARMACOEPIDEM DR S, V26, P657, DOI 10.1002/pds.4194; Lip GYH, 2014, EXPERT REV CARDIOVAS, V12, P403, DOI 10.1586/14779072.2014.896196; Mani H, 2014, DRUG DES DEV THER, V8, P789, DOI 10.2147/DDDT.S45644; Mearns ES, 2014, THROMB J, V12, DOI 10.1186/1477-9560-12-14; Melamed OC, 2011, AM J MANAG CARE, V17, P232; Mueller S, 2014, EUR J INTERN MED, V25, P247, DOI 10.1016/j.ejim.2013.12.013; Nilsson H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113627; Oake N, 2008, CAN MED ASSOC J, V179, P235, DOI 10.1503/cmaj.080171; Palareti G, 1997, THROMB HAEMOSTASIS, V78, P1438; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Roldan I, 2016, REV ESP CARDIOL, V69, P551, DOI 10.1016/j.rec.2016.03.009; Segal JB, 2000, J GEN INTERN MED, V15, P56, DOI 10.1046/j.1525-1497.2000.04329.x; Singer DE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000067; Steinberg BA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2116; Sullivan RM, 2012, AM J CARDIOL, V110, P1799, DOI 10.1016/j.amjcard.2012.08.014; van Walraven C, 2006, CHEST, V129, P1155, DOI 10.1378/chest.129.5.1155; Vinereanu D, 2015, EUR HEART J, V36, P3268, DOI 10.1093/eurheartj/ehv447; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561	48	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211681	10.1371/journal.pone.0211681	http://dx.doi.org/10.1371/journal.pone.0211681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753227	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600019
J	Choung, S; Kim, JM; Joung, KH; Lee, ES; Kim, HJ; Ku, BJ				Choung, Sorim; Kim, Ji Min; Joung, Kyong Hye; Lee, Eaum Seok; Kim, Hyun Jin; Ku, Bon Jeong			Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice	PLOS ONE			English	Article							FOLLOW-UP; NAFLD; MECHANISMS; STEATOSIS; SREBPS; CANCER	Non-alcoholic fatty liver disease (NAFLD) is one of the main causes of chronic liver disease. NAFLD begins with excessive lipid accumulation in the liver and progresses to nonalcoholic steatohepatitis (NASH) and cirrhosis. NAFLD is closely linked to dysregulated hepatic lipid metabolism. Although recent studies have reported that epidermal growth factor receptor (EGFR) signaling regulates lipid metabolism, the roles of EGFR and EGFR inhibitors as modulators of lipid metabolism are largely unknown. Here, we investigated whether inhibiting EGFR using the EGFR tyrosine kinase inhibitor (TKI) PD153035 improves NAFLD. Our results demonstrate that EGFR was activated in liver tissues from high fat diet (HFD)induced NAFLD mice. Inhibiting EGFR using PD153035 significantly reduced phosphatidylinositol-3-kinase/protein kinase B signaling and sterol responsive elementary binding protein 1 and 2 expression, which prevented HFD-induced hepatic steatosis and hypercholesterolemia by reducing de novo lipogenesis and cholesterol synthesis and enhancing fatty acid oxidation. Additionally, inhibiting EGFR improved HFD-induced glucose intolerance. In conclusion, these results indicate that EGFR plays an important role in NAFLD and is a potential therapeutic target.	[Choung, Sorim; Ku, Bon Jeong] Chungnam Natl Univ, Dept Med Sci, Coll Med, Daejeon, South Korea; [Kim, Ji Min; Joung, Kyong Hye; Lee, Eaum Seok; Kim, Hyun Jin; Ku, Bon Jeong] Chungnam Natl Univ, Dept Internal Med, Coll Med, Sch Med, Daejeon, South Korea	Chungnam National University; Chungnam National University	Ku, BJ (corresponding author), Chungnam Natl Univ, Dept Med Sci, Coll Med, Daejeon, South Korea.; Ku, BJ (corresponding author), Chungnam Natl Univ, Dept Internal Med, Coll Med, Sch Med, Daejeon, South Korea.	bonjeong@cnu.ac.kr		Ku, Bon Jeong/0000-0002-3414-8949; Kim, Hyun Jin/0000-0002-6760-4963	National Research Foundation of Korea (NRF) - Korean Government [NRF-2016R1D1A1A09916900]	National Research Foundation of Korea (NRF) - Korean Government	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (NRF-2016R1D1A1A09916900) to BJK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Bian Y, 2015, BIOCHEM BIOPH RES CO, V463, P612, DOI 10.1016/j.bbrc.2015.05.108; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fountas A, 2015, TRENDS ENDOCRIN MET, V26, P643, DOI 10.1016/j.tem.2015.09.003; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang LH, 2015, ACTA PHARM SIN B, V5, P390, DOI 10.1016/j.apsb.2015.07.001; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Ku BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042915; Makinoshima H, 2014, J BIOL CHEM, V289, P20813, DOI 10.1074/jbc.M114.575464; Malaguarnera M, 2009, J MOL MED, V87, P679, DOI 10.1007/s00109-009-0464-1; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Milic S, 2014, WORLD J GASTROENTERO, V20, P9330, DOI 10.3748/wjg.v20.i28.9330; Mukai E, 2014, DIABETES RES CLIN PR, V106, P303, DOI 10.1016/j.diabres.2014.08.023; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Reid AE, 2001, GASTROENTEROLOGY, V121, P710, DOI 10.1053/gast.2001.27126; Ru Peng, 2013, Cancers (Basel), V5, P1469, DOI 10.3390/cancers5041469; Serfaty L, 2008, DIABETES METAB, V34, P634, DOI 10.1016/S1262-3636(08)74597-X; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Yamauchi Y, 2011, CANCER RES, V71, P4989, DOI 10.1158/0008-5472.CAN-10-4108; Yewale C, 2013, BIOMATERIALS, V34, P8690, DOI 10.1016/j.biomaterials.2013.07.100; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	29	19	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0210828	10.1371/journal.pone.0210828	http://dx.doi.org/10.1371/journal.pone.0210828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735525	Green Published, Green Submitted, gold			2022-12-26	WOS:000458181200016
J	Olaya-Abril, A; Luque-Almagro, VM; Perez, MD; Lopez, CM; Amil, F; Cabello, P; Saez, LP; Moreno-Vivian, C; Roldan, MD				Olaya-Abril, Alfonso; Manuel Luque-Almagro, Victor; Dolores Perez, Maria; Maria Lopez, Cristina; Amil, Francisco; Cabello, Purificacion; Paloma Saez, Lara; Moreno-Vivian, Conrado; Dolores Roldan, Maria			Putative small RNAs controlling detoxification of industrial cyanide-containing wastewaters by Pseudomonas pseudoalcaligenes CECT5344	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; E-WASTE; BACTERIA; BIODEGRADATION; DESTRUCTION; DEGRADATION; NITROGEN; IMPACT	The alkaliphilic bacterium Pseudomonas pseudoalcaligenes CECT5344 uses free cyanide and several metal-cyanide complexes as the sole nitrogen source and tolerates high concentrations of metals like copper, zinc and iron, which are present in the jewelry wastewaters. To understand deeply the regulatory mechanisms involved in the transcriptional regulation of cyanide-containing wastewaters detoxification by P. pseudoalcaligenes CECT5344, RNA-Seq has been performed from cells cultured with a cyanide-containing jewelry wastewater, sodium cyanide or ammonium chloride as the sole nitrogen source. Small RNAs (sRNAs) that may have potential regulatory functions under cyanotrophic conditions were identified. In total 20 sRNAs were identified to be differentially expressed when compared the jewelry residue versus ammonium as nitrogen source, 16 of which could be amplified successfully by RT-PCR. As predicted targets of these 16 sRNAs were several components of the nit1C gene cluster encoding the nitrilase NitC essential for cyanide assimilation, the cioAB gene cluster that codes for the cyanide-insensitive cytochrome bd-type terminal oxidase, the medium length-polyhydroxyalkanoates (ml-PHAs) gene cluster, and gene clusters related with a global nitrogen limitation response like those coding for glutamine synthase and urease. Other targets were non-clustered genes (or their products) involved in metal resistance and iron acquisition, such as metal extrusion systems and the ferric uptake regulatory (Fur) protein, and a GntR-like regulatory family member probably involved in the regulation of the cyanide assimilation process in the strain CECT5344. Induction of genes targeted by sRNAs in the jewelry residue was demonstrated by qRT-PCR.	[Olaya-Abril, Alfonso; Manuel Luque-Almagro, Victor; Dolores Perez, Maria; Maria Lopez, Cristina; Paloma Saez, Lara; Moreno-Vivian, Conrado; Dolores Roldan, Maria] Univ Cordoba, Dept Bioquim & Biol Mol, Edificio Severo Ochoa,Campus Rabanales, Cordoba, Spain; [Amil, Francisco] SCAI, Unidad Prote, Campus Rabanales, Cordoba, Spain; [Cabello, Purificacion] Univ Cordoba, Dept Bot Ecol & Fisiol Vegetal, Edificio Celestino Mutis,Campus Rabanales, Cordoba, Spain	Universidad de Cordoba; Universidad de Cordoba; Universidad de Cordoba	Roldan, MD (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Edificio Severo Ochoa,Campus Rabanales, Cordoba, Spain.	bb2rorum@uco.es	Cabello, Purificación/K-2805-2014; Luque-Almagro, Victor M./A-3516-2011; Abril, Alfonso Olaya/L-9176-2014; Roldan, Maria Dolores/K-4370-2014	Abril, Alfonso Olaya/0000-0002-8961-1099; Roldan, Maria Dolores/0000-0001-7173-8641; Amil-Ruiz, Francisco/0000-0002-3470-0860; Lopez, Cristina Maria/0000-0001-8980-3106	Ministerio de Economia y Competitividad, FEDER-UE [BIO2015-64311-R]	Ministerio de Economia y Competitividad, FEDER-UE	This work was exclusively funded by Grant BIO2015-64311-R (Ministerio de Economia y Competitividad, FEDER-UE. Website: http://www.ciencia.gob.es/).The authors MDR and CMV were awarded with this Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcil A, 2003, BIOTECHNOL LETT, V25, P445, DOI 10.1023/A:1022608213814; Akcil A, 2003, MINER ENG, V16, P643, DOI 10.1016/S0892-6875(03)00101-8; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASMUS E, 1953, FRESEN Z ANAL CHEM, V138, P414, DOI 10.1007/BF00461093; Baxter J, 2006, ANTON LEEUW INT J G, V90, P1, DOI 10.1007/s10482-006-9057-y; Becerra G, 2011, BIOCHEM SOC T, V39, P1854, DOI 10.1042/BST20110706; Cabello P, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny032; Dash RR, 2009, J HAZARD MATER, V163, P1, DOI 10.1016/j.jhazmat.2008.06.051; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; DUBEY SK, 1995, WORLD J MICROB BIOT, V11, P257, DOI 10.1007/BF00367095; Dutta T, 2018, GENE, V656, P60, DOI 10.1016/j.gene.2018.02.068; Ebbs S, 2004, CURR OPIN BIOTECH, V15, P231, DOI 10.1016/j.copbio.2004.03.006; Estepa J, 2012, ENV MICROBIOL REP, V4, P326, DOI 10.1111/j.1758-2229.2012.00337.x; Gaimster H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01806; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Gleadow RM, 2014, ANNU REV PLANT BIOL, V65, P155, DOI 10.1146/annurev-arplant-050213-040027; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Gupta N, 2010, J HAZARD MATER, V176, P1, DOI 10.1016/j.jhazmat.2009.11.038; Holmqvist E, 2017, BIOCHEM SOC T, V45, P1203, DOI 10.1042/BST20160363; Ibanez MI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172908; Johnson DB, 2014, CURR OPIN BIOTECH, V30, P24, DOI 10.1016/j.copbio.2014.04.008; Kery MB, 2014, NUCLEIC ACIDS RES, V42, pW124, DOI 10.1093/nar/gku317; Khoo JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S13; Li L, 2013, NUCLEIC ACIDS RES, V41, pD233, DOI 10.1093/nar/gks1264; Luque-Almagro VM, 2015, J BIOTECHNOL, V214, P171, DOI 10.1016/j.jbiotec.2015.09.032; Luque-Almagro VM, 2018, APPL MICROBIOL BIOT, V102, P1067, DOI 10.1007/s00253-017-8678-6; Luque-Almagro VM, 2016, CURR OPIN BIOTECH, V38, P9, DOI 10.1016/j.copbio.2015.12.004; Luque-Almagro VM, 2013, ENVIRON MICROBIOL, V15, P253, DOI 10.1111/j.1462-2920.2012.02875.x; Luque-Almagro VM, 2005, BIOCHEM SOC T, V33, P168, DOI 10.1042/BST0330168; Cobos IM, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0267-8; MCCLURE R, 2013, NUCLEIC ACIDS RES, V41, pNIL41, DOI DOI 10.1093/nar/gkt444; MORRISON GR, 1971, ANAL BIOCHEM, V43, P527, DOI 10.1016/0003-2697(71)90283-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Natarajan G, 2015, CHEMOSPHERE, V136, P232, DOI 10.1016/j.chemosphere.2015.05.046; Natarajan G, 2014, BIORESOURCE TECHNOL, V152, P80, DOI 10.1016/j.biortech.2013.10.108; Nitzan M, 2017, ANNU REV BIOPHYS, V46, P131, DOI 10.1146/annurev-biophys-070816-034058; Oliva G, 2015, FEMS MICROBIOL REV, V39, P331, DOI 10.1093/femsre/fuv022; Papenfort K, 2015, P NATL ACAD SCI USA, V112, pE4772, DOI 10.1073/pnas.1507825112; Patil YB, 2000, PROCESS BIOCHEM, V35, P1139, DOI 10.1016/S0032-9592(00)00150-3; Paya G, 2018, GENES-BASEL, V9, DOI 10.3390/genes9020083; Quesada A, 2007, APPL ENVIRON MICROB, V73, P5118, DOI 10.1128/AEM.00503-07; Raza K., 2012, AM J BIOMED ENG, V2, P206, DOI DOI 10.5923/j.ajbe.20120205.03; Reese M.G., 2000, THESIS; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryall B, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-108; Sambrook J., 2001, MOL CLONING LAB MANU; Smits THM, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00616-15; Solovjev V, 2011, METAGENOMICITAPP, P61; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; van Iterson M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-450; Wibberg D, 2016, J BIOTECHNOL, V232, P61, DOI 10.1016/j.jbiotec.2016.04.008; Wibberg D, 2014, J BIOTECHNOL, V175, P67, DOI 10.1016/j.jbiotec.2014.02.004; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0212032	10.1371/journal.pone.0212032	http://dx.doi.org/10.1371/journal.pone.0212032			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735537	gold, Green Submitted, Green Published			2022-12-26	WOS:000458181200054
J	Sawyer, WS; Wang, L; Uehara, T; Tamrakar, P; Prathapam, R; Mostafavi, M; Metzger, LE; Feng, B; Rath, CMB				Sawyer, William S.; Wang, Lisha; Uehara, Tsuyoshi; Tamrakar, Pramila; Prathapam, Ramadevi; Mostafavi, Mina; Metzger, Louis E.; Feng, Brian; Rath, Christopher M. Baxter			Targeted lipopolysaccharide biosynthetic intermediate analysis with normal-phase liquid chromatography mass spectrometry	PLOS ONE			English	Article							ESCHERICHIA-COLI; HETEROGENEITY; INHIBITORS; BARRIER	Lipopolysacharride (LPS) forms the outer leaflet of the outer membrane in Gram-negative bacteria and contributes to the permeability barrier and immune response. In this study, we established a method for monitoring the LPS biosynthetic intermediates of the Raetz pathway (lpxA-lpxK) in Escherichia coli. Metabolites from compound-treated cells and genetically-perturbed cells were extracted from whole cells and concentrated by mixed-mode weak anion exchange (WAX) solid-phase extraction (SPE) prior to analysis by normal phase (NP) LC-MS/MS. Data was normalized to cell density and an internal standard prior to comparison against untreated cells in order to determine fold accumulation and depletion for affected metabolites. Using this LC-MS/MS method, we were able to reliably monitor changes in levels of the LPS intermediates in response to compound-treatment and genetic modification. In addition, we found that deletion of periplasmic CDP-diacylglycerol pyropho-sphatase dramatically increased levels of the UDP-containing LPS intermediates, suggesting the enzymatic breakdown during sample preparation. This assay allows for probing a key essential pathway in Gram-negative bacteria in an effort to discover antibacterial agents that inhibit enzymes in the LPS biosynthetic pathway.	[Sawyer, William S.; Wang, Lisha; Uehara, Tsuyoshi; Tamrakar, Pramila; Prathapam, Ramadevi; Mostafavi, Mina; Metzger, Louis E.; Feng, Brian; Rath, Christopher M. Baxter] Novartis Inst Biomed Res, Infect Dis, Emeryville, CA 94608 USA; [Sawyer, William S.] Genentech Inc, San Francisco, CA USA; [Tamrakar, Pramila] BioMarin Pharmaceut, San Rafael, CA USA; [Metzger, Louis E.] Tierra Biosci, San Francisco, CA USA; [Rath, Christopher M. Baxter] AbSci, Vancouver, WA 98660 USA	Novartis; Roche Holding; Genentech; BioMarin Pharmaceutical Inc.	Rath, CMB (corresponding author), Novartis Inst Biomed Res, Infect Dis, Emeryville, CA 94608 USA.; Rath, CMB (corresponding author), AbSci, Vancouver, WA 98660 USA.	crath@abscibio.com		Uehara, Tsuyoshi/0000-0001-6994-4286; Sawyer, William/0000-0002-7593-1972; Baxter Rath, Christopher/0000-0002-3513-1209	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	All funding for this project was supplied by the Novartis Institutes for Biomedical Research. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Current employers listed, such as Genentech, Tierra Biosciences, and AbSci were not involved with the research in any way, and are listed for purposes of identifying and contacting the authors only.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Babinski KJ, 2002, J BIOL CHEM, V277, P25937, DOI 10.1074/jbc.M204067200; Babinski KJ, 2002, J BIOL CHEM, V277, P25947, DOI 10.1074/jbc.M204068200; Bainbridge BW, 2008, J BACTERIOL, V190, P4549, DOI 10.1128/JB.00234-08; Bodewits K, 2010, ANTIMICROB AGENTS CH, V54, P3531, DOI 10.1128/AAC.01600-09; Bojkovic J, 2016, J BACTERIOL, V198, P731, DOI 10.1128/JB.00639-15; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Clements JM, 2002, ANTIMICROB AGENTS CH, V46, P1793, DOI 10.1128/AAC.46.6.1793-1799.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dovala D, 2016, P NATL ACAD SCI USA, V113, pE6064, DOI 10.1073/pnas.1610746113; Emiola A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121216; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Iwanaga S, 2007, P JPN ACAD B-PHYS, V83, P110, DOI 10.2183/pjab.83.110; Jenkins RJ., THESIS; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; KOMURO T, 1988, J CHROMATOGR, V450, P381, DOI 10.1016/S0021-9673(01)83593-7; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Langsdorf EF, 2010, J BIOMOL SCREEN, V15, P52, DOI 10.1177/1087057109355319; Li CJ, 2011, P NATL ACAD SCI USA, V108, P11387, DOI 10.1073/pnas.1108840108; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Madsen JA, 2011, ANAL CHEM, V83, P5107, DOI 10.1021/ac103271w; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; O'Shea R, 2008, J MED CHEM, V51, P2871, DOI 10.1021/jm700967e; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; RADIKA K, 1988, J BIOL CHEM, V263, P14859; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Richie DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160918; ROCK CO, 1982, J BIOL CHEM, V257, P10759; Stanton TB, 2013, TRENDS MICROBIOL, V21, P111, DOI 10.1016/j.tim.2012.11.002; Tan L, 2002, J CLIN MICROBIOL, V40, P4372, DOI 10.1128/JCM.40.11.4372-4374.2002; VUORIO R, 1992, ANTIMICROB AGENTS CH, V36, P826, DOI 10.1128/AAC.36.4.826	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211803	10.1371/journal.pone.0211803	http://dx.doi.org/10.1371/journal.pone.0211803			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735516	Green Published, Green Submitted, gold			2022-12-26	WOS:000458181200029
J	Garcia-Llamas, P; Rangel, TF; Calvo, L; Suarez-Seoane, S				Garcia-Llamas, Paula; Rangel, Thiago Fernando; Calvo, Leonor; Suarez-Seoane, Susana			Linking species functional traits of terrestrial vertebrates and environmental filters: A case study in temperate mountain systems	PLOS ONE			English	Article							HABITAT SELECTION; PLANT DIVERSITY; RICHNESS; BIODIVERSITY; PATTERNS; BIRD; RESPONSES; MODELS; AREAS; SPAIN	Knowledge on the relationships between species functional traits and environmental filters is key to understanding the mechanisms underlying the current patterns of biodiversity loss from a multi-taxa perspective. The aim of this study was to identify the main environmental factors driving the functional structure of a terrestrial vertebrate community (mammals, breeding birds, reptiles and amphibians) in a temperate mountain system (the Cantabrian Mountains; NW Spain). Based on the Spanish Inventory of Terrestrial Vertebrate Species, we selected three functional traits (feeding guild, habitat use type and daily activity) and defined, for each trait, a set of functional groups considering vertebrate species with common functional characteristics. The community functional structure was evaluated by means of two functional indexes indicative of functional redundancy (species richness within each functional group) and functional diversity. Ordinary least squares regression and conditional autoregressive models were applied to determine the response of community functional structure to environmental filters (climate, topography, land cover, physiological state of vegetation, landscape heterogeneity and human influence). The results revealed that both functional redundancy and diversity of terrestrial vertebrates were non-randomly distributed across space; rather, they were driven by environmental filters. Climate, topography and human influence were the best predictors of community functional structure. The influence of land cover, physiological state of vegetation and landscape heterogeneity varied among functional groups. The results of this study are useful to identify the general assembly rules of species functional traits and to illustrate the importance of environmental filters in determining functional structure of terrestrial vertebrate communities in mountain systems.	[Garcia-Llamas, Paula; Calvo, Leonor; Suarez-Seoane, Susana] Univ Leon, Fac Biol & Environm Sci, Biodivers & Environm Management Dept, Leon, Spain; [Rangel, Thiago Fernando] Univ Fed Goias, Inst Biol Sci, Ecol Dept, Goiania, Go, Brazil	Universidad de Leon; Universidade Federal de Goias	Garcia-Llamas, P (corresponding author), Univ Leon, Fac Biol & Environm Sci, Biodivers & Environm Management Dept, Leon, Spain.	pgarcl@unileon.es	CALVO, Leonor/K-9942-2014; Rangel, Thiago F/H-8708-2012; Suárez-Seoane, Susana/D-8246-2015	CALVO, Leonor/0000-0003-3710-0817; Rangel, Thiago F/0000-0002-2001-7382; Suárez-Seoane, Susana/0000-0001-7656-4214	Ministry of Education of Spain [FPU12/05194]	Ministry of Education of Spain(Spanish Government)	Garcia-Llamas was supported by a predoctoral fellowship from the Ministry of Education of Spain, reference number FPU12/05194.	Aiello-Lammens ME, 2016, ECOGRAPHY, V40, P1; Alonso JC, 2012, BEHAV ECOL, V23, P491, DOI 10.1093/beheco/arr215; Alves J, 2014, MAMM BIOL, V79, P338, DOI 10.1016/j.mambio.2014.05.007; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Aubin I, 2013, BIODIVERS CONSERV, V22, P2957, DOI 10.1007/s10531-013-0565-6; Barbaro L, 2009, ECOGRAPHY, V32, P321, DOI 10.1111/j.1600-0587.2008.05546.x; Belmaker J, 2012, J BIOGEOGR, V39, P193, DOI 10.1111/j.1365-2699.2011.02591.x; Blaum N, 2011, BIODIVERS CONSERV, V20, P2333, DOI 10.1007/s10531-011-9995-1; Bruno D, 2016, J APPL ECOL, V53, P846, DOI 10.1111/1365-2664.12619; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cazorla B, 2015, 4 C IB EC; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chapin III F.S., 2007, TERRESTRIAL ECOSYSTE, P81, DOI DOI 10.1007/978-3-540-32730-1_7; Chillo V, 2012, J ARID ENVIRON, V87, P95, DOI 10.1016/j.jaridenv.2012.06.016; Concepcion ED, 2016, ECOGRAPHY, V40, P1; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; COUGHENOUR MB, 1991, J RANGE MANAGE, V44, P530, DOI 10.2307/4003033; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; DIAZ M, 1992, ECOGRAPHY, V15, P77, DOI 10.1111/j.1600-0587.1992.tb00011.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Diaz S, 2013, ECOL EVOL, V3, P2958, DOI 10.1002/ece3.601; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Duflot R, 2014, ACTA OECOL, V56, P19, DOI 10.1016/j.actao.2014.01.004; Ortiz-Yusty CE, 2013, CALDASIA, V35, P65; EL-KEBLAWY A., 2014, J BIODIVERS ENDANGER, V2, P1, DOI DOI 10.4172/2332-2543.1000120; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; Ernst R, 2006, BIOL CONSERV, V133, P143, DOI 10.1016/j.biocon.2006.05.028; Ferretti F, 2011, BEHAV ECOL SOCIOBIOL, V65, P875, DOI 10.1007/s00265-010-1088-8; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Garcia-Llamas P, 2016, INT J APPL EARTH OBS, V50, P95, DOI 10.1016/j.jag.2016.03.010; Gomez-Ortiz Y, 2017, COMMUNITY ECOL, V18, P121, DOI 10.1556/168.2017.18.2.1; Gravel D, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0268; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Guareschi S, 2015, BIOL CONSERV, V187, P134, DOI 10.1016/j.biocon.2015.04.018; Hanspach Jan, 2015, Ecosystem Health and Sustainability, V1, P32, DOI 10.1890/EHS15-0027.1; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; Hulme Philip E., 2002, P132; Kaptue Tchuente AT, 2011, REMOTE SENS ENVIRON, V115, P452, DOI 10.1016/j.rse.2010.09.015; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Lautenschlager S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26495; Lee MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170540; Lorenzo M, 2012, ATLAS AVES INVIERNO; Maiorano L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074989; Marchand P, 2014, BIOL CONSERV, V177, P1, DOI 10.1016/j.biocon.2014.05.022; Marone L, 1997, REV CHIL HIST NAT, V70, P73; Martinelli Gustavo, 2007, Braz. J. Bot., V30, P587, DOI 10.1590/S0100-84042007000400005; Martui R., 2003, ATLAS AVES REPRODUCT; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; Mbaka JG, 2015, ACTA OECOL, V69, P65, DOI 10.1016/j.actao.2015.09.002; McDonald Lyman L., 2005, P465; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Menger J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171540; Ninyerola M, 2005, ATLAS CLIMATICO DIGI; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Nunes CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157442; Osborne PE, 2007, ECOGRAPHY, V30, P819, DOI 10.1111/j.2007.0906-7590.05233.x; Palomo L.J., 2007, ATLAS LIBRO ROJO MAM; Pescador DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118876; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pia MV, 2013, J ARID ENVIRON, V91, P31, DOI 10.1016/j.jaridenv.2012.11.004; Pita R, 2009, AGR ECOSYST ENVIRON, V132, P57, DOI 10.1016/j.agee.2009.02.008; Pleguezuelos J.M., 2002, ATLAS LIBRO ROJO ANF; Podani J, 2006, OIKOS, V115, P179, DOI 10.1111/j.2006.0030-1299.15048.x; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rivas-Martinez S., 2004, BIOCLIMATIC BIOGEOGR; Rivas-Matinez S, 2015, WORLDWIDE BIOCLIMATI; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scherer C, 2016, ECOL MODEL, V326, P75, DOI 10.1016/j.ecolmodel.2015.07.005; Schmid B, 2003, FUNCTIONAL CONSEQUEN, P120; Seto KC, 2004, INT J REMOTE SENS, V25, P4309, DOI 10.1080/0143116042000192358; Suarez-Seoane S, 2014, ECOGRAPHY, V37, P279, DOI 10.1111/j.1600-0587.2013.00077.x; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; Tognelli MF, 2004, ECOGRAPHY, V27, P427, DOI 10.1111/j.0906-7590.2004.03732.x; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Ullisch D., 2012, FUNDAMENTAL RES GROW; Virgos E, 1998, CAN J ZOOL, V76, P1294, DOI 10.1139/cjz-76-7-1294; Wall MM, 2004, J STAT PLAN INFER, V121, P311, DOI 10.1016/S0378-3758(03)00111-3; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	87	8	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211760	10.1371/journal.pone.0211760	http://dx.doi.org/10.1371/journal.pone.0211760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730962	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000056
J	Ledien, J; Souv, K; Leang, R; Huy, R; Cousien, A; Peas, M; Froehlich, Y; Duboz, R; Ong, S; Duong, V; Buchy, P; Dussart, P; Tarantola, A				Ledien, Julia; Souv, Kimsan; Leang, Rithea; Huy, Rekol; Cousien, Anthony; Peas, Muslim; Froehlich, Yves; Duboz, Raphael; Ong, Sivuth; Duong, Veasna; Buchy, Philippe; Dussart, Philippe; Tarantola, Arnaud			An algorithm applied to national surveillance data for the early detection of major dengue outbreaks in Cambodia	PLOS ONE			English	Article							BURDEN	Dengue is a national priority disease in Cambodia. The Cambodian National Dengue Surveillance System is based on passive surveillance of dengue-like inpatients reported by public hospitals and on a sentinel, pediatric hospital-based active surveillance system. This system works well to assess trends but the sensitivity of the early warning and time-lag to usefully inform hospitals can be improved. During The ECOnomic development, ECOsystem MOdifications, and emerging infectious diseases Risk Evaluation (ECOMORE) project's knowledge translation platforms, Cambodian hospital staff requested an early warning tool to prepare for major outbreaks. Our objective was therefore to find adapted tools to improve the early warning system and preparedness. Dengue data was provided by the National Dengue Control Program (NDCP) and are routinely obtained through passive surveillance. The data were analyzed at the provincial level for eight Cambodian provinces during 2008-2015. The R surveillance package was used for the analysis. We evaluated the effectiveness of Bayesian algorithms to detect outbreaks using count data series, comparing the current count to an expected distribution obtained from observations of past years. The analyses bore on 78,759 patients with dengue-like syndromes. The algorithm maximizing sensitivity and specificity for the detection of major dengue outbreaks was selected in each province. The overall sensitivity and specificity were 73% and 97%, respectively, for the detection of significant outbreaks during 2008-2015. Depending on the province, sensitivity and specificity ranged from 50% to 100% and 75% to 100%, respectively. The final algorithm meets clinicians' and decisionmakers' needs, is cost-free and is easy to implement at the provincial level.	[Ledien, Julia; Souv, Kimsan; Cousien, Anthony; Peas, Muslim; Froehlich, Yves; Duboz, Raphael; Tarantola, Arnaud] Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia; [Souv, Kimsan; Leang, Rithea; Huy, Rekol] CNM, Phnom Penh, Cambodia; [Cousien, Anthony] Inst Pasteur, Math Modelling Infect Dis Lab, Paris, France; [Duboz, Raphael] INRA, CIRAD, ASTRE, UMR, Montpellier, France; [Ong, Sivuth; Duong, Veasna; Dussart, Philippe] Inst Pasteur Cambodge, Virol Unit, Phnom Penh, Cambodia; [Buchy, Philippe] GlaxoSmithKline, Vaccines R&D, Singapore, Singapore; [Tarantola, Arnaud] Inst Pasteur Nouvelle Caledonie, Epidemiol Unit, Noumea, New Caledonia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; National Center Parasitology, Entomology & Malaria Control; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CIRAD; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; GlaxoSmithKline	Ledien, J (corresponding author), Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia.	ledien-julia@hotmail.fr	Tarantola, Arnaud/D-2149-2015; Duong, Veasna/I-9684-2014; Dussart, Philippe/P-4152-2014	Tarantola, Arnaud/0000-0002-6946-7958; Duboz, Raphael/0000-0002-2853-6195; Duong, Veasna/0000-0003-0353-1678; Dussart, Philippe/0000-0002-1931-3037; Ledien, Julia/0000-0002-6116-8371	Agence francaise de Developpement (AFD)	Agence francaise de Developpement (AFD)	The ECOMORE project was funded by the Agence francaise de Developpement (AFD) https://www.afd.fr/. The funder provided support in the form of salaries for authors JL, KS, AC, MP, YF, SO, VD, PD and AT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. One of the authors is employed by a commercial company (GlaxoSmithKline) but was previously working at Pasteur institute where he managed the laboratory-confirmation of dengue cases. These data are used in our paper and all the persons who have collected and handle these data were invited to be a co-author. The commercial company had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Arima Y, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/wpsar.2014.5.4.002, 10.5365/WPSAR.2014.5.4.002]; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2015, EPIDEMICS-NETH, V11, P92, DOI 10.1016/j.epidem.2015.03.002; Buckeridge DL, 2005, J BIOMED INFORM, V38, P99, DOI 10.1016/j.jbi.2004.11.007; Cambodian Ministry of Health, 2010, STAND OP PROC NAT DE; Chen CC, 2013, J INFECTION, V67, P65, DOI 10.1016/j.jinf.2013.03.012; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Hohle M, 2007, COMPUTATION STAT, V22, P571, DOI 10.1007/s00180-007-0074-8; Huy R, 2010, B WORLD HEALTH ORGAN, V88, P650, DOI 10.2471/BLT.09.073908; Kalayanarooj S, 2017, J INFECT DIS, V215, pS79, DOI 10.1093/infdis/jiw609; Mohsin MFM, 2014, APPL SOFT COMPUT, V24, P612, DOI 10.1016/j.asoc.2014.08.030; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Riebler A, 2004, THESIS; Robertson C, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-16; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; STROUP DF, 1989, STAT MED, V8, P323, DOI 10.1002/sim.4780080312; Teurlai M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001957; Vong S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000903; WHO, INT DIS SURV RESP	22	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0212003	10.1371/journal.pone.0212003	http://dx.doi.org/10.1371/journal.pone.0212003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730979	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000458026000088
J	Yang, J; Guo, YQ; Lu, CJ; Zhang, RH; Wang, YY; Luo, L; Zhang, YL; Chu, CH; Wang, KJ; Obbad, S; Yan, WB; Li, X				Yang, Jian; Guo, Yuqi; Lu, Cuijie; Zhang, Ruohan; Wang, Yaoyu; Luo, Liang; Zhang, Yanli; Chu, Catherine H.; Wang, Katherine J.; Obbad, Sabrine; Yan, Wenbo; Li, Xin			Inhibition of Karyopherin beta 1 suppresses prostate cancer growth	ONCOGENE			English	Article							NF-KAPPA-B; TUMOR-CELL SURVIVAL; IMPORTIN BETA-1; NUCLEAR IMPORT; C-MYC; MESENCHYMAL TRANSITION; TRANSPORT RECEPTOR; METFORMIN TARGETS; POOR-PROGNOSIS; PROTEIN	Prostate cancer (PCa) initiation and progression requires activation of numerous oncogenic signaling pathways. Nuclear-cytoplasmic transport of oncogenic factors is mediated by Karyopherin proteins during cell transformation. However, the role of nuclear transporter proteins in PCa progression has not been well defined. Here, we report that the KPNB1, a key member of Karyopherin beta subunits, is highly expressed in advanced prostate cancers. Further study showed that targeting KPNB1 suppressed the proliferation of prostate cancer cells. The knockdown of KPNB1 reduced nuclear translocation of c-Myc, the expression of downstream cell cycle modulators, and phosphorylation of regulator of chromatin condensation 1 (RCC1), a key protein for spindle assembly during mitosis. Meanwhile, CHIP assay demonstrated the binding of c-Myc to KPNB1 promoter region, which indicated a positive feedback regulation of KPNB1 expression mediated by the c-Myc. In addition, NF-kappa B subunit p50 translocation to nuclei was blocked by KPNB1 inhibition, which led to an increase in apoptosis and a decrease in tumor sphere formation of PCa cells. Furthermore, subcutaneous xenograft tumor models with a stable knockdown of KPNB1 in C42B PCa cells validated that the inhibition of KPNB1 could suppress the growth of prostate tumor in vivo. Moreover, the intravenously administration of importazole, a specific inhibitor for KPNB1, effectively reduced PCa tumor size and weight in mice inoculated with PC3 PCa cells. In summary, our data established the functional link between KPNB1 and PCa prone c-Myc, NF-kB, and cell cycle modulators. More importantly, inhibition of KPNB1 could be a new therapeutic target for PCa treatment.	[Yang, Jian; Guo, Yuqi; Lu, Cuijie; Zhang, Ruohan; Wang, Yaoyu; Luo, Liang; Zhang, Yanli; Chu, Catherine H.; Wang, Katherine J.; Obbad, Sabrine; Yan, Wenbo; Li, Xin] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Li, Xin] NYU, Langone Med Ctr, Dept Urol, New York, NY 10016 USA; [Li, Xin] NYU, Langone Med Ctr, Perlmutter Canc Inst, New York, NY 10016 USA	New York University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Li, X (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA.; Li, X (corresponding author), NYU, Langone Med Ctr, Dept Urol, New York, NY 10016 USA.; Li, X (corresponding author), NYU, Langone Med Ctr, Perlmutter Canc Inst, New York, NY 10016 USA.	xl15@nyu.edu	yan, wenbo/GXV-2795-2022	Li, Xin/0000-0002-7414-5734	NYU CSCB Pilot Study Award; National Institutes of Health [R01CA180277, R01DE025992, R01DE027074]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025992, R01DE027074] Funding Source: NIH RePORTER	NYU CSCB Pilot Study Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was partly supported by NYU CSCB Pilot Study Award to JY, National Institutes of Health grants R01CA180277, R01DE025992 and R01DE027074 to XL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/476357; Akinyeke T, 2013, CARCINOGENESIS, V34, P2823, DOI 10.1093/carcin/bgt307; Alshareeda AT, 2015, BRIT J CANCER, V112, P1929, DOI 10.1038/bjc.2015.165; Altan B, 2013, CARCINOGENESIS, V34, P2314, DOI 10.1093/carcin/bgt214; Angus L, 2014, CARCINOGENESIS, V35, P1121, DOI 10.1093/carcin/bgt491; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Cai YX, 2016, DIGEST DIS SCI, V61, P747, DOI 10.1007/s10620-015-3948-6; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Elgogary A, 2016, P NATL ACAD SCI USA, V113, pE5328, DOI 10.1073/pnas.1611406113; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Gagne B, 2017, TRAFFIC, V18, P362, DOI 10.1111/tra.12480; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Ha S, 2018, CHEMBIOCHEM, V19, P131, DOI 10.1002/cbic.201700489; Hadjebi O, 2008, BBA-MOL CELL RES, V1783, P1467, DOI 10.1016/j.bbamcr.2008.03.015; He XL, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0422-1; Hood FE, 2007, J CELL SCI, V120, P3436, DOI 10.1242/jcs.009092; Huang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.256; Huang L, 2018, J CANCER, V9, P157, DOI 10.7150/jca.20879; Hutchins JRA, 2004, CURR BIOL, V14, P1099, DOI 10.1016/j.cub.2004.05.021; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Koch HB, 2007, CELL CYCLE, V6, P205, DOI 10.4161/cc.6.2.3742; Kodama M, 2017, P NATL ACAD SCI USA, V114, pE7301, DOI 10.1073/pnas.1705441114; Koh Cheryl M, 2010, Genes Cancer, V1, P617, DOI 10.1177/1947601910379132; Kuusisto HV, 2015, BBA-MOL CELL RES, V1853, P1870, DOI 10.1016/j.bbamcr.2015.05.002; Laurila E, 2014, EXP CELL RES, V322, P159, DOI 10.1016/j.yexcr.2013.11.014; Liang PZ, 2013, TRAFFIC, V14, P1132, DOI 10.1111/tra.12097; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lu T, 2016, BIOCHEM BIOPH RES CO, V478, P1189, DOI 10.1016/j.bbrc.2016.08.093; Lundberg L, 2013, ANTIVIR RES, V100, P662, DOI 10.1016/j.antiviral.2013.10.004; Mahipal A, 2016, PHARMACOL THERAPEUT, V164, P135, DOI 10.1016/j.pharmthera.2016.03.020; Martens-de Kemp SR, 2013, CLIN CANCER RES, V19, P1994, DOI 10.1158/1078-0432.CCR-12-2539; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Qin ZH, 1999, J NEUROSCI, V19, P4023; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shen SH, 2017, ONCOTARGET, V8, P41432, DOI 10.18632/oncotarget.18186; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; Stelma T, 2016, IUBMB LIFE, V68, P268, DOI 10.1002/iub.1484; THALMANN GN, 1994, CANCER RES, V54, P2577; van der Watt PJ, 2016, MOL CANCER THER, V15, P560, DOI 10.1158/1535-7163.MCT-15-0052; van der Watt PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027723; Vuorinen EM, 2017, BBA-MOL BASIS DIS, V1863, P211, DOI 10.1016/j.bbadis.2016.09.015; Wang HJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13072; Wang J, 2016, ONCOL REP, V36, P441, DOI 10.3892/or.2016.4830; Wang SX, 2015, J PHYSIOL BIOCHEM, V71, P763, DOI 10.1007/s13105-015-0440-x; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Winkler J, 2014, HEPATOLOGY, V60, P884, DOI 10.1002/hep.27207; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Yan WQ, 2015, CELL SIGNAL, V27, P851, DOI 10.1016/j.cellsig.2015.01.013; Yang J, 2017, ONCOGENE, V36, P2868, DOI 10.1038/onc.2016.440; Yang L, 2015, ASIA PAC J OPER RES, V32, DOI 10.1142/S0217595915400084; Zhang PY, 2014, J PATHOL, V232, P308, DOI 10.1002/path.4294	54	24	26	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2019	38	24					4700	4714		10.1038/s41388-019-0745-2	http://dx.doi.org/10.1038/s41388-019-0745-2			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IC7ND	30742095	Green Accepted			2022-12-26	WOS:000471160500004
J	Block, I; Muller, C; Sdogati, D; Pedersen, H; List, M; Jaskot, AM; Syse, SD; Hansen, PL; Schmidt, S; Christiansen, H; Casella, C; Olsen, SB; Blomstrom, MM; Riedel, A; Thomassen, M; Kruse, TA; Hansen, SWK; Kioschis, P; Mollenhauer, J				Block, Ines; Mueller, Carolin; Sdogati, Daniel; Pedersen, Henriette; List, Markus; Jaskot, Aleksandra M.; Syse, Silje Damkjaer; Hansen, Pernille Lund; Schmidt, Steffen; Christiansen, Helle; Casella, Cinzia; Olsen, Sidsel Bering; Blomstrom, Monica M.; Riedel, Angela; Thomassen, Mads; Kruse, Torben A.; Hansen, Soren W. Karlskov; Kioschis, Petra; Mollenhauer, Jan			CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3	ONCOGENE			English	Article							UNFOLDED PROTEIN RESPONSE; SOMATIC MUTATIONS; PROPERDIN BINDS; LARGE-SCALE; INHIBITION; EXPRESSION; PROLIFERATION; DEFICIENCY; LANDSCAPE; MORTALITY	Breast cancer is a heterogeneous genetic disease driven by the accumulation of individual mutations per tumor. Whole-genome sequencing approaches have identified numerous genes with recurrent mutations in primary tumors. Although mutations in well characterized tumor suppressors and oncogenes are overrepresented in these sets, the majority of the genetically altered genes have so far unknown roles in breast cancer progression. To improve the basic understanding of the complex disease breast cancer and to potentially identify novel drug targets or regulators of known cancer-driving pathways, we analyzed 86 wild-type genes and 94 mutated variants for their effect on cell growth using a serially constructed panel of MCF7 cell lines. We demonstrate in subsequent experiments that the metal cation transporter CNNM4 regulates growth by induction of apoptosis and identified a tumor suppressive role of complement factor properdin (CFP) in vitro and in vivo. CFP appears to induce the intracellular upregulation of the pro-apoptotic transcription factor DDIT3 which is associated with endoplasmic reticulum-stress response.	[Block, Ines; Mueller, Carolin; Sdogati, Daniel; Pedersen, Henriette; List, Markus; Jaskot, Aleksandra M.; Syse, Silje Damkjaer; Hansen, Pernille Lund; Schmidt, Steffen; Christiansen, Helle; Casella, Cinzia; Olsen, Sidsel Bering; Blomstrom, Monica M.; Riedel, Angela; Mollenhauer, Jan] Univ Southern Denmark, Inst Mol Med, Lundbeckfonden Ctr Excellence NanoCAN, Odense, Denmark; [Block, Ines; Mueller, Carolin; Sdogati, Daniel; Pedersen, Henriette; List, Markus; Jaskot, Aleksandra M.; Syse, Silje Damkjaer; Hansen, Pernille Lund; Schmidt, Steffen; Christiansen, Helle; Casella, Cinzia; Olsen, Sidsel Bering; Blomstrom, Monica M.; Riedel, Angela; Mollenhauer, Jan] Univ Southern Denmark, Inst Mol Med, Mol Oncol, Odense, Denmark; [Block, Ines; Thomassen, Mads; Kruse, Torben A.] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark; [Hansen, Pernille Lund; Olsen, Sidsel Bering; Hansen, Soren W. Karlskov] Univ Southern Denmark, Dept Canc & Inflammat Res, Odense, Denmark; [Thomassen, Mads; Kruse, Torben A.] Univ Southern Denmark, Dept Human Genet, Odense, Denmark; [Kioschis, Petra] Mannheim Univ Appl Sci, Dept Biotechnol, Mannheim, Germany; [Block, Ines] Martin Luther Univ Halle Wittenberg, Inst Physiol Chem, Halle, Saale, Germany; [Mueller, Carolin] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Pedersen, Henriette; Blomstrom, Monica M.] Danish Canc Soc Res Ctr, Brain Tumor Biol Grp, Copenhagen, Denmark; [List, Markus] Tech Univ Munich, TUM Sch Life Sci, Chair Expt Bioinformat, Big Data BioMed Grp, D-85354 Freising Weihenstephan, Germany; [Riedel, Angela] HI STEM gGmbH, Heidelberg Inst Stem Cell Technol & Expt Med, Heidelberg, Germany; [Riedel, Angela] German Canc Res Ctr, Cell Biol & Tumor Biol Program, Heidelberg, Germany	Lundbeckfonden; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Martin Luther University Halle Wittenberg; University of Southern Denmark; Danish Cancer Society; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ)	Block, I (corresponding author), Univ Southern Denmark, Inst Mol Med, Lundbeckfonden Ctr Excellence NanoCAN, Odense, Denmark.; Block, I (corresponding author), Univ Southern Denmark, Inst Mol Med, Mol Oncol, Odense, Denmark.; Block, I (corresponding author), Odense Univ Hosp, Dept Clin Genet, Odense, Denmark.; Block, I (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Physiol Chem, Halle, Saale, Germany.	Ines.Block@uk-halle.de	Block, Ines/Q-5507-2016; Riedel, Angela/ABC-7207-2020; Hansen, Pernille Lund/F-3919-2016; Pedersen, Henriette/S-6231-2017	Block, Ines/0000-0003-1964-6031; Hansen, Soren/0000-0002-8186-4630; Bering Olsen, Sidsel/0000-0001-8465-6629; Hansen, Pernille Lund/0000-0001-8284-4917; Pedersen, Henriette/0000-0002-6872-0405; List, Markus/0000-0002-0941-4168	Lundbeck Foundation (Grant NanoCAN); Rektorspuljen SDU2020 Program [DAWN-2020]; Region Syddanmarks Ph.D.- and Forskningspulje; Fonden Til Laegevidenskabens Fremme; MIO project of the OUH Frontlinjepuljen; Aase og Ejnar Danielsens Fond; Torben og Alice Frimodts Fond; Kong Christian den Tiendes Fond; Brodrene Hartmanns Fond; Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning; Grosserer A. V. Lykfeldt og Hustrus Legat; Familien Hede Nielsens Fond; Oda og Hans Svenningsens Fond; Lippmann Fonden; Gangsted Fonden; Kraeftens Bekaempelse; INTERREG 4A-program Syddanmark-Schleswig-K.E.R.N.; European Regional Development Fund	Lundbeck Foundation (Grant NanoCAN); Rektorspuljen SDU2020 Program; Region Syddanmarks Ph.D.- and Forskningspulje; Fonden Til Laegevidenskabens Fremme; MIO project of the OUH Frontlinjepuljen; Aase og Ejnar Danielsens Fond; Torben og Alice Frimodts Fond; Kong Christian den Tiendes Fond; Brodrene Hartmanns Fond; Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning; Grosserer A. V. Lykfeldt og Hustrus Legat; Familien Hede Nielsens Fond; Oda og Hans Svenningsens Fond; Lippmann Fonden; Gangsted Fonden; Kraeftens Bekaempelse; INTERREG 4A-program Syddanmark-Schleswig-K.E.R.N.; European Regional Development Fund(European Commission)	The work was supported by the Lundbeck Foundation (Grant NanoCAN), and the Rektorspuljen SDU2020 Program (Grant: DAWN-2020); Region Syddanmarks Ph.D.- and Forskningspulje; Fonden Til Laegevidenskabens Fremme; MIO project of the OUH Frontlinjepuljen; Aase og Ejnar Danielsens Fond; Torben og Alice Frimodts Fond, Kong Christian den Tiendes Fond, Brodrene Hartmanns Fond, Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning, Grosserer A. V. Lykfeldt og Hustrus Legat, Familien Hede Nielsens Fond, Oda og Hans Svenningsens Fond, Lippmann Fonden and Gangsted Fonden. The work was further support by scholarships granted by Kraeftens Bekaempelse and was co-financed by the INTERREG 4A-program Syddanmark-Schleswig-K.E.R.N. with funds from The European Regional Development Fund. The funding sources had no role in study design, collection of data and analysis, nor in the decision to publish, or preparation of the article.	Al-Rayahi IAM, 2017, IMMUN INFLAMM DIS, V5, P68, DOI 10.1002/iid3.142; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Bathum L, 2006, MOL IMMUNOL, V43, P473, DOI 10.1016/j.molimm.2005.02.017; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Chittenden TW, 2008, GENOMICS, V91, P508, DOI 10.1016/j.ygeno.2008.03.002; End C, 2009, EUR J IMMUNOL, V39, P833, DOI 10.1002/eji.200838689; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fijen CAP, 1999, MOL IMMUNOL, V36, P863, DOI 10.1016/S0161-5890(99)00107-8; Flamant L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-391; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Funato Y, 2014, J CLIN INVEST, V124, P5398, DOI 10.1172/JCI76614; Gulerez I, 2016, EMBO REP, V17, P1890, DOI 10.15252/embr.201643393; Guo DH, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-15; Guo J, 2015, ONCOL REP, V33, P3124, DOI 10.3892/or.2015.3902; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; Kostantin E, 2016, J BIOL CHEM, V291, P10716, DOI 10.1074/jbc.M115.705863; Kretowski R, 2016, MOL CELL BIOCHEM, V417, P35, DOI 10.1007/s11010-016-2711-4; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Laurberg T, 2017, ACTA ONCOL, V56, P59, DOI 10.1080/0284186X.2016.1246803; List M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04278; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; McDonald ER, 2017, CELL, V170, P577, DOI 10.1016/j.cell.2017.07.005; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mollenhauer J, 2000, CANCER RES, V60, P1704; Muller H, 2008, CLIN EXP IMMUNOL, V151, P123, DOI 10.1111/j.1365-2249.2007.03528.x; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Orlandi R, 2002, CANCER RES, V62, P567; Park SH, 2012, J BIOL CHEM, V287, P19841, DOI 10.1074/jbc.M111.330639; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; PILLEMER L, 1954, SCIENCE, V120, P279, DOI 10.1126/science.120.3112.279; Pio R, 2013, SEMIN IMMUNOL, V25, P54, DOI 10.1016/j.smim.2013.04.001; Pluquet O, 2015, AM J PHYSIOL-CELL PH, V308, pC415, DOI 10.1152/ajpcell.00334.2014; Schlesinger M, 1996, LEUKEMIA, V10, P1509; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vivian J, 2017, NAT BIOTECHNOL, V35, P314, DOI 10.1038/nbt.3772; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wittig-Blaich S, 2017, ONCOTARGET, V8, P23760, DOI 10.18632/oncotarget.15863; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983; Zhu J, 2012, CANCER SCI, V103, P2092, DOI 10.1111/cas.12020	52	8	8	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2019	38	23					4560	4573		10.1038/s41388-019-0739-0	http://dx.doi.org/10.1038/s41388-019-0739-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB4KM	30755730				2022-12-26	WOS:000470240300009
J	Levy, M; Elkoshi, N; Barber-Zucker, S; Hoch, E; Zarivach, R; Hershfinkel, M; Sekler, I				Levy, Moshe; Elkoshi, Nadav; Barber-Zucker, Shiran; Hoch, Eitan; Zarivach, Raz; Hershfinkel, Michal; Sekler, Israel			Zinc transporter 10 (ZnT10)-dependent extrusion of cellular Mn2+ is driven by an active Ca2+-coupled exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zinc; anion transport; calcium transport; membrane transport; manganese; hypermanganesemia; manganese extrusion; solute carrier family 30 member 10 (SLC30A10); zinc transport; zinc transporter (ZnT); ion transport; Ca2+ coupled exchange; active transport; cation diffusion facilitator	ALZHEIMERS-DISEASE; INTRACELLULAR TRAFFICKING; MANGANESE; MUTATIONS; SLC30A10; PARKINSONISM; MECHANISM; ALIGNMENT; PROTEINS; CALCIUM	Manganese (Mn2+) is extruded from the cell by the zinc transporter 10 (ZnT10). Loss of ZnT10 expression caused by autosomal mutations in the ZnT10 gene leads to hypermanganesemia in multiple organs. Here, combining fluorescent monitoring of cation influx in HEK293-T cells expressing human ZnT10 with molecular modeling of ZnT10 cation selectivity, we show that ZnT10 is exploiting the transmembrane Ca2+ inward gradient for active cellular exchange of Mn2+. In analyzing ZnT10 activity we used the ability of Fura-2 to spectrally distinguish between Mn2+ and Ca2+ fluxes. We found that (a) application of Mn2+-containing Ca2+-free solution to ZnT10-expressing cells triggers an influx of Mn2+, (b) reintroduction of Ca2+ leads to cellular Mn2+ extrusion against an inward Mn2+ gradient, and (c) the cellular transport of Mn2+ by ZnT10 is coupled to a reciprocal movement of Ca2+. Remarkably, replacing a single asparagine residue in ZnT10 (Asp-43) with threonine (ZnT10 N43T) converted the Mn2+/Ca2+ exchange to an uncoupled channel mode, permeable to both Ca2+ and Mn2+. The findings in our study identify the first ion transporter that uses the Ca2+ gradient for active counter-ion exchange. They highlight a remarkable versatility in metal selectivity and mode of transport controlled by the tetrahedral metal transport site of ZnT proteins.	[Levy, Moshe; Elkoshi, Nadav; Hershfinkel, Michal; Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, IL-8410501 Beer Sheva, Israel; [Hoch, Eitan] Broad Inst & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Hoch, Eitan] Broad Inst & Harvard, Metab Program, Cambridge, MA 02142 USA; [Barber-Zucker, Shiran; Zarivach, Raz] Ben Gurion Univ Negev, Dept Life Sci, IL-8410501 Beer Sheva, Israel; [Barber-Zucker, Shiran; Zarivach, Raz] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-8410501 Beer Sheva, Israel; [Barber-Zucker, Shiran; Zarivach, Raz] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-8410501 Beer Sheva, Israel	Ben Gurion University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Ben Gurion University; Ben Gurion University; Ben Gurion University	Sekler, I (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, IL-8410501 Beer Sheva, Israel.	Sekler@bgu.ac.il	ZARIVACH, RAZ/F-1671-2012	ZARIVACH, RAZ/0000-0001-6543-0296; Sekler, Israel/0000-0002-7550-1550; Hershfinkel, Michal/0000-0003-1652-1989	Israel Science Foundation [ISF 1429/17 ISF-China 1210/14, DIP SE2372/1-1, ISF 891/14]; Israel Ministry of Science, Technology and Space, Israel Science Foundation [167/16]; European Molecular Biology Organization; CMST COST Action [CM1306]	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Science, Technology and Space, Israel Science Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); CMST COST Action	This work was supported by Israel Science Foundation Grants ISF 1429/17 ISF-China 1210/14 and DIP SE2372/1-1 (to I. S.) and ISF 891/14 (to M. H.) and by the Israel Ministry of Science, Technology and Space, Israel Science Foundation Grant 167/16) (to R. Z. and S. B. -Z.). This work is also supported by the European Molecular Biology Organization and CMST COST Action CM1306. The authors declare that they have no conflicts of interest with the contents of this article.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Barber-Zucker S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16777-5; Barcena HS, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1250-x; Basurto-Islas G, 2013, J BIOL CHEM, V288, P17495, DOI 10.1074/jbc.M112.446070; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Boron WF., 2005, MED PHYSL CELLULAR M, V2nd; Bosomworth HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065475; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; BURCH RE, 1975, CLIN CHEM, V21, P501; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; Fernandes J, 2017, TOXICOL SCI, V155, P213, DOI 10.1093/toxsci/kfw196; FONTERIZ RI, 1991, FEBS LETT, V283, P89, DOI 10.1016/0014-5793(91)80560-P; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hare DJ, 2016, METALLOMICS, V8, P628, DOI 10.1039/c6mt00019c; Hoch E, 2012, P NATL ACAD SCI USA, V109, P7202, DOI 10.1073/pnas.1200362109; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kwakye Gunnar F, 2011, Curr Protoc Toxicol, VChapter 12, DOI 10.1002/0471140856.tx1218s48; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Lyubartseva G, 2010, BRAIN PATHOL, V20, P343, DOI 10.1111/j.1750-3639.2009.00283.x; MARKESBERY WR, 1984, NEUROTOXICOLOGY, V5, P49; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Martinez-Finley EJ, 2013, FREE RADICAL BIO MED, V62, P65, DOI 10.1016/j.freeradbiomed.2013.01.032; Matias Madeleine G, 2010, BMC Res Notes, V3, P158, DOI 10.1186/1756-0500-3-158; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Ohana E, 2004, J BIOL CHEM, V279, P4278, DOI 10.1074/jbc.M309229200; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Patrushev N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033211; Pirchl M, 2009, NEUROPSYCHIATRIE, V23, P187; Quadri M, 2015, MOVEMENT DISORD, V30, P996, DOI 10.1002/mds.26202; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Roth JA, 2006, BIOL RES, V39, P45, DOI 10.4067/S0716-97602006000100006; Ruffin VA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00043; Rutter GA, 2015, DIABETOLOGIA, V58, P31, DOI 10.1007/s00125-014-3405-7; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sekler I, 2007, MOL MED, V13, P337, DOI 10.2119/2007-00037.Sekler; SIMONS TJB, 1988, NEUROSURG REV, V11, P119, DOI 10.1007/BF01794675; Smith MR, 2017, BIOCHEM BIOPH RES CO, V482, P388, DOI 10.1016/j.bbrc.2016.10.126; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tong YW, 2014, J ALZHEIMERS DIS, V42, P865, DOI 10.3233/JAD-140534; Ward ML, 2003, J PHYSIOL-LONDON, V546, P537, DOI 10.1113/jphysiol.2002.029132; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935	48	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5879	5889		10.1074/jbc.RA118.006816	http://dx.doi.org/10.1074/jbc.RA118.006816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30755481	hybrid, Green Published			2022-12-26	WOS:000465077500019
J	Serio, RN; Laursen, KB; Urvalek, AM; Gross, SS; Gudas, LJ				Serio, Ryan N.; Laursen, Kristian B.; Urvalek, Alison M.; Gross, Steven S.; Gudas, Lorraine J.			Ethanol promotes differentiation of embryonic stem cells through retinoic acid receptor-gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						stem cells; differentiation; alcohol; retinol; retinoic acid; alcohol-associated birth defects; RAR; Rdh10; Stra6; teratogen; ethanol	VITAMIN-A; POTENTIAL MECHANISM; NUCLEAR RECEPTORS; GENE-EXPRESSION; RAR-GAMMA; F9 CELLS; METABOLISM; 4-OXORETINOL; DISRUPTION; ACTIVATION	Ethanol (EtOH) is a teratogen, but its teratogenic mechanisms are not fully understood. The alcohol form of vitamin A (retinol/ROL) can be oxidized to all-trans-retinoic acid (RA), which plays a critical role in stem cell differentiation and development. Using an embryonic stem cell (ESC) model to analyze EtOH's effects on differentiation, we show here that EtOH and acetaldehyde, but not acetate, increase differentiation-associated mRNA levels, and that EtOH decreases pluripotency-related mRNAs. Using reporter assays, ChIP assays, and retinoic acid receptor- (RAR) knockout ESC lines generated by CRISPR/Cas9 and homologous recombination, we demonstrate that EtOH signals via RAR binding to RA response elements (RAREs) in differentiation-associated gene promoters or enhancers. We also report that EtOH-mediated increases in homeobox A1 (Hoxa1) and cytochrome P450 family 26 subfamily A member 1 (Cyp26a1) transcripts, direct RA target genes, require the expression of the RA-synthesizing enzyme, aldehyde dehydrogenase 1 family member A2 (Aldh1a2), suggesting that EtOH-mediated induction of Hoxa1 and Cyp26a1 requires ROL from the serum. As shown with CRISPR/Cas9 knockout lines, the retinol dehydrogenase gene Rdh10 and a functional RARE in the ROL transporter stimulated by retinoic acid 6 (Stra6) gene are required for EtOH induction of Hoxa1 and Cyp26a1. We conclude that EtOH stimulates stem cell differentiation by increasing the influx and metabolism of ROL for downstream RAR-dependent transcription. In stem cells, EtOH may shift cell fate decisions to alter developmental outcomes by increasing endogenous ROL/RA signaling via increased Stra6 expression and ROL oxidation.	[Serio, Ryan N.; Gross, Steven S.; Gudas, Lorraine J.] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Laursen, Kristian B.; Urvalek, Alison M.; Gross, Steven S.; Gudas, Lorraine J.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University	Gudas, LJ (corresponding author), 1300 York Ave, New York, NY 10065 USA.	ljgudas@med.cornell.edu			National Institutes of Health [F31-AA024024, T32-CA062948, R01-AA018332, R21-AA021484]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD067244] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA024024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the National Institutes of Health Grants F31-AA024024 (to R. N. S.) and T32-CA062948, R01-AA018332, and R21-AA021484 (to L. J. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achkar CC, 1996, P NATL ACAD SCI USA, V93, P4879, DOI 10.1073/pnas.93.10.4879; Al Tanoury Z, 2014, J CELL SCI, V127, P2095, DOI 10.1242/jcs.145979; Arzumanyan A, 2009, ALCOHOL CLIN EXP RES, V33, P2172, DOI 10.1111/j.1530-0277.2009.01057.x; Belyaeva OV, 2017, J BIOL CHEM, V292, P5884, DOI 10.1074/jbc.M117.776914; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; BOYLAN JF, 1993, P NATL ACAD SCI USA, V90, P9601, DOI 10.1073/pnas.90.20.9601; Chen AC, 1996, J BIOL CHEM, V271, P14971, DOI 10.1074/jbc.271.25.14971; Chen Y, 2016, SCIENCE, V353, DOI 10.1126/science.aad8266; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Collins MD, 1999, ANNU REV PHARMACOL, V39, P399, DOI 10.1146/annurev.pharmtox.39.1.399; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Deltour L, 1996, FASEB J, V10, P1050, DOI 10.1096/fasebj.10.9.8801166; Delva L, 1999, MOL CELL BIOL, V19, P7158; Diani-Moore S, 2014, DRUG METAB DISPOS, V42, P294, DOI 10.1124/dmd.113.055368; Fernandez CC, 2009, J CELL BIOCHEM, V106, P427, DOI 10.1002/jcb.22023; Feuerborn A, 2015, TRENDS GENET, V31, P483, DOI 10.1016/j.tig.2015.07.001; Gao W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112698; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Gudas L J, 1986, Prog Clin Biol Res, V226, P181; Gudas LJ, 2013, SEMIN CELL DEV BIOL, V24, P701, DOI 10.1016/j.semcdb.2013.08.002; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kashyap V, 2013, J CELL SCI, V126, P999, DOI 10.1242/jcs.119701; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kim YK, 2015, HEPATOL SURG NUTR, V4, P268, DOI 10.3978/j.issn.2304-3881.2015.01.06; Lane MA, 1999, P NATL ACAD SCI USA, V96, P13524, DOI 10.1073/pnas.96.23.13524; Langston AW, 1997, J BIOL CHEM, V272, P2167, DOI 10.1074/jbc.272.4.2167; Langton S, 2008, DEV BIOL, V315, P331, DOI 10.1016/j.ydbio.2007.12.021; LAROSA GJ, 1988, P NATL ACAD SCI USA, V85, P329, DOI 10.1073/pnas.85.2.329; Laursen KB, 2018, J BIOL CHEM, V293, P11891, DOI 10.1074/jbc.RA118.001951; Laursen KB, 2015, J BIOL CHEM, V290, P4356, DOI 10.1074/jbc.M114.613968; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Lopez-Lazaro M, 2016, ORAL ONCOL, V62, P149, DOI 10.1016/j.oraloncology.2016.10.001; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Marrs JA, 2010, ALCOHOL, V44, P707, DOI 10.1016/j.alcohol.2009.03.004; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Molotkov A, 2002, J BIOL CHEM, V277, P22553, DOI 10.1074/jbc.M201603200; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; Sanchez-Alvarez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063794; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Shabtai Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18719-7; Simandi Z, 2016, MOL CELL, V63, P647, DOI 10.1016/j.molcel.2016.06.039; Smith SM, 2014, BIRTH DEFECTS RES C, V102, P210, DOI 10.1002/bdrc.21078; Stowell AR, 1998, J FORENSIC SCI, V43, P14, DOI 10.1520/JFS16083J; Suh MJ, 2006, ANAL CHEM, V78, P5719, DOI 10.1021/ac060492j; SULIK KK, 1988, DEVELOPMENT, V103, P213; TALBOT NC, 1993, MOL REPROD DEV, V36, P139, DOI 10.1002/mrd.1080360204; TANEJA R, 1995, P NATL ACAD SCI USA, V92, P7854, DOI 10.1073/pnas.92.17.7854; Taneja R, 1996, P NATL ACAD SCI USA, V93, P6197, DOI 10.1073/pnas.93.12.6197; Urvalek AM, 2014, J BIOL CHEM, V289, P19519, DOI 10.1074/jbc.M114.556555; Veazey KJ, 2013, ALCOHOL CLIN EXP RES, V37, P1111, DOI 10.1111/acer.12080; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; Wongsiriroj N, 2014, J LIPID RES, V55, P104, DOI 10.1194/jlr.M043844; Yelin R, 2005, DEV BIOL, V279, P193, DOI 10.1016/j.ydbio.2004.12.014; Yelin R, 2007, DIFFERENTIATION, V75, P393, DOI 10.1111/j.1432-0436.2006.00147.x; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zachman RD, 1998, ALCOHOL CLIN EXP RES, V22, P1544, DOI 10.1097/00000374-199810000-00026; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164	60	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5536	5548		10.1074/jbc.RA118.007153	http://dx.doi.org/10.1074/jbc.RA118.007153			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30737277	Green Published, hybrid			2022-12-26	WOS:000464517500024
J	Abdulazeez, S; Sultana, S; Almandil, NB; Almohazey, D; Bency, J; Borgio, JF				Abdulazeez, Sayed; Sultana, Shaheen; Almandil, Noor B.; Almohazey, Dana; Bency, Jesvin; Borgio, J. Francis			The rs61742690 (S783N) single nucleotide polymorphism is a suitable target for disrupting BCL11A-mediated foetal-to-adult globin switching	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SWISS-MODEL; WEB SERVER; PREDICTION; GENE; MUTATIONS; INTERFACES; REPOSITORY; SEQUENCE; BCL11A	Background B-cell lymphoma/leukaemia 11A (BCL11A) is a C2H2-type zinc-finger transcription factor protein that is a critical modulator of haemoglobin switching and suppresses the production of foetal haemoglobin. Variation in the BCL11A gene ameliorates the severity of sickle cell disease (SCD) and beta-thalassemia (beta-that). The BCL11A gene is located on chromosome 2p16.1 and encodes an 835-amino acid protein. Method Using state-of-the-art in silico tools, this study examined the most pathogenic non-synonymous single nucleotide polymorphisms (nsSNPs) that disrupt the BCL11A protein and mediate foetal-to-adult globin switching. A total of 11,463 SNPs were retrieved from the Single Nucleotide Polymorphism database (dbSNP). These included 799 in the 5' untranslated region (UTR), 486 in the 3' UTR, and 266 non-synonymous, 189 coding synonymous, six nonsense, and six stop-gained SNPs. Results and discussion In silico tools (SIFT, SNAP, PolyPhen-2, PANTHER, I-Mutant, PROVEAN, SNPs&GO, mCSM, and PhD-SNP) predicted the five most-deleterious nsSNPs: rs61742690, rs62142605, rs17028351, rs115666026, and rs74987258. Molecular dynamic simulation and homology modelling of the mutated proteins (S783N, D643N, G451S, K670R, and M313L) of the most deleterious nsSNPs revealed their functional and structural impact. nsSNP rs61742690 was predicted to be the most deleterious, as supported by eight of the nine in silico tools. Conclusions Complete failure in the protein protein interactions with functional partners (KLF1 and others) and significant changes (+/- 100% variation) in the interface energy revealed that rs61742690 (S783N) in the zinc-finger domain is a suitable target for disrupting BCL11A-mediated foetal-to-adult globin switching.	[Abdulazeez, Sayed; Borgio, J. Francis] Imam Abdulrahman Bin Faisal Univ, Dept Genet Res, IRMC, Dammam, Saudi Arabia; [Sultana, Shaheen] Interserve Learning & Employment, Al Khobar, Saudi Arabia; [Almandil, Noor B.] Imam Abdulrahman Bin Faisal Univ, IRMC, Dept Clin Pharm Res, Dammam, Saudi Arabia; [Almohazey, Dana] Imam Abdulrahman Bin Faisal Univ, IRMC, Dept Stem Cell Res, Dammam, Saudi Arabia; [Bency, Jesvin] Malankara Catholic Coll, Dept Biotechnol, Kaliakkavilai, Tamil Nadu, India	Imam Abdulrahman Bin Faisal University; Imam Abdulrahman Bin Faisal University; Imam Abdulrahman Bin Faisal University	Borgio, JF (corresponding author), Imam Abdulrahman Bin Faisal Univ, Dept Genet Res, IRMC, Dammam, Saudi Arabia.	fbalexander@iau.edu.sa	Borgio, J Francis/P-5586-2014; Sayed, Abdulazeez/I-6770-2019; Almohazey, Dana/D-8048-2017; Almandil, Noor B/A-3533-2015	Borgio, J Francis/0000-0001-7199-1540; Sayed, Abdulazeez/0000-0002-9763-9446; Almohazey, Dana/0000-0003-0963-5136; Almandil, Noor B/0000-0002-7049-3563				AbdulAzeez S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147702; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Baspinar A, 2014, NUCLEIC ACIDS RES, V42, pW285, DOI 10.1093/nar/gku397; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Borgio JF, 2016, AM J TRANSL RES, V8, P4224; Brunham LR, 2005, PLOS GENET, V1, P739, DOI 10.1371/journal.pgen.0010083; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Gromiha MM, 2004, PROTEINS, V55, P316, DOI 10.1002/prot.20052; Guerler A, 2013, J CHEM INF MODEL, V53, P717, DOI 10.1021/ci300579r; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hecht M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S1; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kuznetsov IB, 2008, PROTEINS, V72, P74, DOI 10.1002/prot.21899; Kuzu G, 2012, CURR OPIN STRUC BIOL, V22, P367, DOI 10.1016/j.sbi.2012.04.004; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Lu L, 2002, PROTEINS, V49, P350, DOI 10.1002/prot.10222; Mosca R, 2013, NAT METHODS, V10, P47, DOI [10.1038/NMETH.2289, 10.1038/nmeth.2289]; Mukherjee S, 2011, STRUCTURE, V19, P955, DOI 10.1016/j.str.2011.04.006; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh PK, 2016, GENE, V576, P141, DOI 10.1016/j.gene.2015.09.084; Singh RK, 2017, COMPUT BIOL CHEM, V67, P122, DOI 10.1016/j.compbiolchem.2016.12.009; Tiwari Abhishek, 2007, In Silico Biology, V7, P651; Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367; Tyagi M, 2012, EMBO REP, V13, P266, DOI 10.1038/embor.2011.261; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212492	10.1371/journal.pone.0212492	http://dx.doi.org/10.1371/journal.pone.0212492			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768627	gold, Green Published, Green Submitted			2022-12-26	WOS:000458766300042
J	Agga, GE; Cook, KL; Netthisinghe, AMP; Gilfillen, RA; Woosley, PB; Sistani, KR				Agga, Getahun E.; Cook, Kimberly L.; Netthisinghe, Annesly M. P.; Gilfillen, Rebecca A.; Woosley, Paul B.; Sistani, Karamat R.			Persistence of antibiotic resistance genes in beef cattle backgrounding environment over two years after cessation of operation	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; TETRACYCLINE RESISTANCE; COPPER SUPPLEMENTATION; ESCHERICHIA-COLI; SOIL NUTRIENTS; BACTERIA; CHLORTETRACYCLINE; PCR; QUANTIFICATION; POPULATIONS	Confined animal feeding operations can facilitate the spread of genes associated with antibiotic resistance. It is not known how cattle removal from beef cattle backgrounding operation affects the persistence of antibiotic resistance genes (ARGs) in the environment. We investigated the effect of cessation of beef cattle backgrounding operation on the persistence and distribution of ARGs in the beef cattle backgrounding environment. The study was conducted at a pasture-feedlot type beef cattle backgrounding operation which consisted of feeding and grazing areas that were separated by a fence with an access gate. Backgrounding occurred for seven years before cattle were removed from the facility. Soil samples (n = 78) from 26 georeferenced locations were collected at the baseline before cattle were removed, and then one year and two years after cattle were removed. Metagenomic DNA was extracted from the soil samples and total bacterial population (16S rRNA), total Enterococcus species and class 1 integrons (intl1), and erythromycin (ermB and ermF), sulfonamide (sul1 and sul2) and tetracycline (tetO, tetW and tetQ) resistance genes were quantified. Concentrations of total bacteria, Enterococcus spp., class 1 integrons, and ARGs were higher in the feeding area and its immediate vicinity (around the fence and the gate) followed by a gradient decline along the grazing area. Although the concentrations of total bacteria, Enterococcus spp., class 1 integrons and ARGs in the feeding area significantly decreased two years after cattle removal, their concentrations were still higher than that observed in the grazing area. Higher concentrations over two years in the feeding area when compared to the grazing area suggest a lasting effect of confined beef cattle production system on the persistence of bacteria and ARGs in the soil.	[Agga, Getahun E.; Cook, Kimberly L.; Sistani, Karamat R.] ARS, Food Anim Environm Syst Res Unit, USDA, Bowling Green, KY 42101 USA; [Netthisinghe, Annesly M. P.; Gilfillen, Rebecca A.; Woosley, Paul B.] Western Kentucky Univ, Dept Agr, Bowling Green, KY 42101 USA; [Cook, Kimberly L.] ARS, Nutr Food Safety & Qual, Off Natl Programs, USDA, Beltsville, MD USA	United States Department of Agriculture (USDA); Western Kentucky University; United States Department of Agriculture (USDA)	Agga, GE (corresponding author), ARS, Food Anim Environm Syst Res Unit, USDA, Bowling Green, KY 42101 USA.	Getahun.Agga@usda.gov	Netthisinghe, Annesly/AAE-9224-2020	Agga, Getahun/0000-0002-9903-5283; Cook, Kimberly/0000-0001-7604-0306	United States Department of Agriculture [6445-12630-003-00D, 5040-12630-006-00-D]; Agricultural Research Service, USDA CRIS projects [6445-12630-003-00D, 5040-12630-006-00-D]	United States Department of Agriculture(United States Department of Agriculture (USDA)); Agricultural Research Service, USDA CRIS projects	This research was funded by the United States Department of Agriculture (#6445-12630-003-00D to KRS and KLC, and #5040-12630-006-00-D to KRS and GEA). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the Agricultural Research Service, USDA CRIS projects (#6445-12630-003-00D and #5040-12630-006-00-D). We thank Rohan Parekh, Jason Simmons, and Stacy Antle for technical support. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. USDA is an equal opportunity provider and employer.	Agga GE, 2014, PREV VET MED, V114, P231, DOI 10.1016/j.prevetmed.2014.02.010; Agga GE, 2016, APPL ENVIRON MICROB, V82, P7197, DOI 10.1128/AEM.01928-16; Agga GE, 2016, MICROB DRUG RESIST, V22, P598, DOI 10.1089/mdr.2015.0259; Agga GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132586; Agga GE, 2015, PREV VET MED, V119, P179, DOI 10.1016/j.prevetmed.2015.02.008; Aminov RI, 2001, APPL ENVIRON MICROB, V67, P22, DOI 10.1128/AEM.67.1.22-32.2001; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Bass L, 1999, ANTIMICROB AGENTS CH, V43, P2925, DOI 10.1128/AAC.43.12.2925; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Cameron A, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0127-3; Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06; Cook KL, 2014, J ENVIRON QUAL, V43, P1546, DOI 10.2134/jeq2013.10.0432; FDA, 2003, 152 FDA CTR VET MED; FDA, 2013, 213 FDA US DEP HLTH; FDA, 2017, 2016 SUMM REP ANT SO; FDA, 2012, 209 GFI; Frahm E, 2003, J MICROBIOL METH, V52, P123, DOI 10.1016/S0167-7012(02)00150-1; Franklin AM, 2016, J ENVIRON QUAL, V45, P377, DOI 10.2134/jeq2016.01.0023; Gillings MR, 2015, ISME J, V9, P1269, DOI 10.1038/ismej.2014.226; Harms G, 2003, ENVIRON SCI TECHNOL, V37, P343, DOI 10.1021/es0257164; Koike S, 2007, APPL ENVIRON MICROB, V73, P4813, DOI 10.1128/AEM.00665-07; Liu JX, 2016, ENVIRON MICROBIOL, V18, P557, DOI 10.1111/1462-2920.13097; Luby E, 2016, J ENVIRON QUAL, V45, P441, DOI 10.2134/jeq2015.07.0367; Miller E, 2018, FOODBORNE PATHOG DIS, V15, P689, DOI 10.1089/fpd.2018.2475; Netthisinghe AMP, 2015, J ENVIRON QUAL, V44, P1892, DOI 10.2134/jeq2014.11.0483; Netthisinghe AMP, 2013, J ENVIRON QUAL, V42, P532, DOI 10.2134/jeq2012.0203; Peel DS, 2003, VET CLIN N AM-FOOD A, V19, P365, DOI 10.1016/S0749-0720(03)00032-X; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Roberts MC, 2016, J ENVIRON QUAL, V45, P576, DOI 10.2134/jeq2015.04.0207; Roberts MC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00040; Robinson TP, 2016, LANCET, V387, pE1, DOI 10.1016/S0140-6736(15)00730-8; Stalder T, 2014, ISME J, V8, P768, DOI 10.1038/ismej.2013.189; Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P1947, DOI 10.1021/es902893f; Thomson DU, 2006, VET CLIN N AM-FOOD A, V22, P373, DOI 10.1016/j.cvfa.2006.03.010; Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111; USDA, FEEDLOT 2011 4; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Vikram A, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.01682-17, 10.1128/aem.01682-17]; Williams-Nguyen J, 2016, J ENVIRON QUAL, V45, P394, DOI 10.2134/jeq2015.07.0336; World Health Organization, CRIT IMP ANT HUM MED	42	24	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212510	10.1371/journal.pone.0212510	http://dx.doi.org/10.1371/journal.pone.0212510			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768641	gold, Green Submitted, Green Published			2022-12-26	WOS:000458766300046
J	Karlsson, A; Jauhiainen, A; Gulati, R; Eklund, M; Gronberg, H; Etzioni, R; Clements, M				Karlsson, Andreas; Jauhiainen, Alexandra; Gulati, Roman; Eklund, Martin; Gronberg, Henrik; Etzioni, Ruth; Clements, Mark			A natural history model for planning prostate cancer testing: Calibration and validation using Swedish registry data	PLOS ONE			English	Article							UNITED-STATES; POPULATION; MORTALITY; SWEDEN; IMPACT; ERSPC	Recent prostate cancer screening trials have given conflicting results and it is unclear how to reduce prostate cancer mortality while minimising overdiagnosis and overtreatment. Prostate cancer testing is a partially observable process, and planning for testing requires either extrapolation from randomised controlled trials or, more flexibly, modelling of the cancer natural history. An existing US prostate cancer natural history model (Gulati et al, Biostatistics 2010;11:707-719) did not model for differences in survival between Gleason 6 and 7 cancers and predicted too few Gleason 7 cancers for contemporary Sweden. We re-implemented and re-calibrated the US model to Sweden. We extended the model to more finely describe the disease states, their time to biopsy-detectable cancer and prostate cancer survival. We first calibrated the model to the incidence rate ratio observed in the European Randomised Study of Screening for Prostate Cancer (ERSPC) together with age-specific cancer staging observed in the Stockholm PSA (prostate-specific antigen) and Biopsy Register; we then calibrated age-specific survival by disease states under contemporary testing and treatment using the Swedish National Prostate Cancer Register. After calibration, we were able to closely match observed prostate cancer incidence trends in Sweden. Assuming that patients detected at an earlier stage by screening receive a commensurate survival improvement, we find that the calibrated model replicates the observed mortality reduction in a simulation of ERSPC. Using the resulting model, we predicted incidence and mortality following the introduction of regular testing. Compared with a model of the current testing pattern, organised 8 yearly testing for men aged 55-69 years was predicted to reduce prostate cancer incidence by 14% and increase prostate cancer mortality by 2%. The model is open source and suitable for planning for effective prostate cancer screening into the future.	[Karlsson, Andreas; Eklund, Martin; Gronberg, Henrik; Clements, Mark] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Jauhiainen, Alexandra] AstraZeneca, Gothenburg, Sweden; [Gulati, Roman; Etzioni, Ruth] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Gronberg, Henrik] Karolinska Univ Solna, Dept Urol, Stockholm, Sweden; [Etzioni, Ruth] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Etzioni, Ruth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Karolinska Institutet; AstraZeneca; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Karlsson, A (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	andreas.a.karlsson@ki.se	Gulati, Roman/AAE-4298-2019	Gulati, Roman/0000-0002-7592-6567	Swedish Research Council [2018-02526, 2015-03292, 2017-00800]; Cancerfonden [CAN 2018/539, CAN 2015/649, CAN 2015/1190, CAN 2018/750, CAN 2018/741]; Swedish eScience Research Centre; NordForsk; Prostatacancerforbundet; National Cancer Institute [U01 CA199338, R50 CA221836]; NATIONAL CANCER INSTITUTE [U01CA199338, R50CA221836] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society); Swedish eScience Research Centre; NordForsk; Prostatacancerforbundet; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was received from the Swedish Research Council (MC: 2018-02526, ME: 2015-03292, 2017-00800, HG: 2017-00800), Cancerfonden (MC: CAN 2018/539, ME: CAN 2015/649, CAN 2015/1190, CAN 2018/741, HG: CAN 2018/750), the Swedish eScience Research Centre (MC), NordForsk (MC), Prostatacancerforbundet (MC) and National Cancer Institute (RG, RE: U01 CA199338; RG: R50 CA221836). Author AJ is a full time employee and shareholder of AstraZeneca. AstraZeneca provided support in the form of salary for author AJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; Creighton P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-734; de Koning HJ, 2018, CANCER-AM CANCER SOC, V124, P1197, DOI 10.1002/cncr.31178; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Etzioni R, 2008, MED DECIS MAKING, V28, P323, DOI 10.1177/0272989X07312719; Gulati R, 2014, CANCER-AM CANCER SOC, V120, P3519, DOI 10.1002/cncr.28932; Gulati R, 2013, ANN INTERN MED, V158, P145, DOI 10.7326/0003-4819-158-3-201302050-00003; Gulati R, 2012, CANCER CAUSE CONTROL, V23, P827, DOI 10.1007/s10552-012-9951-8; Gulati R, 2010, BIOSTATISTICS, V11, P707, DOI 10.1093/biostatistics/kxq036; Hagel E, 2009, SCAND J UROL NEPHROL, P1; Heijnsdijk EAM, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju366; Karlsson A, 2016, P IEEE INT C E-SCI, P323, DOI 10.1109/eScience.2016.7870915; Koitsalu M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200409; Krahn M, 2008, JAMA-J AM MED ASSOC, V300, P436, DOI 10.1001/jama.300.4.436; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Mariotto AB, 2007, CANCER-AM CANCER SOC, V109, P1877, DOI 10.1002/cncr.22607; Martin RM, 2018, JAMA-J AM MED ASSOC, V319, P883, DOI 10.1001/jama.2018.0154; Nordstrom T, 2013, EUR UROL, V63, P419, DOI 10.1016/j.eururo.2012.10.001; Pataky R, 2014, INT J CANCER, V135, P939, DOI 10.1002/ijc.28732; Roth JA, 2016, JAMA ONCOL, V2, P890, DOI 10.1001/jamaoncol.2015.6275; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Tsodikov A, 2017, ANN INTERN MED, V167, P449, DOI 10.7326/M16-2586; Van Hemelrijck M, 2013, INT J EPIDEMIOL, V42, P956, DOI 10.1093/ije/dys068; Wever EM, 2010, JNCI-J NATL CANCER I, V102, P352, DOI 10.1093/jnci/djp533; Wilt TJ, 2017, NEW ENGL J MED, V377, P132, DOI 10.1056/NEJMoa1615869	30	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0211918	10.1371/journal.pone.0211918	http://dx.doi.org/10.1371/journal.pone.0211918			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763406	gold, Green Published, Green Submitted			2022-12-26	WOS:000458763900031
J	Randall, MC; Carling, GT; Dastrup, DB; Miller, T; Nelson, ST; Rey, KA; Hansen, NC; Bickmore, BR; Aanderud, ZT				Randall, Matthew C.; Carling, Gregory T.; Dastrup, Dylan B.; Miller, Theron; Nelson, Stephen T.; Rey, Kevin A.; Hansen, Neil C.; Bickmore, Barry R.; Aanderud, Zachary T.			Sediment potentially controls in-lake phosphorus cycling and harmful cyanobacteria in shallow, eutrophic Utah Lake	PLOS ONE			English	Article							PHOSPHATE ADSORPTION; RELEASE; WATER; MANAGEMENT; RETENTION; NITROGEN; BLOOMS	Lakes worldwide are impacted by eutrophication and harmful algal or cyanobacteria blooms (HABs) due to excessive nutrients, including legacy P released from sediments in shallow lakes. Utah Lake (northern Utah, USA) is a shallow lake with urban development primarily on the east side of the watershed, providing an opportunity to evaluate HABs in relation to a gradient of legacy sediment P. In this study, we investigated sediment composition and P concentrations in sediment, pore water, and the water column in relation to blooms of harmful cyanobacteria species. Sediments on the east side of the lake had P concentrations up to 1710 mg/kg, corresponding to elevated P concentrations in pore water (up to 10.8 mg/L) and overlying water column (up to 1.7 mg/L). Sediment P concentrations were positively correlated with Fe2O3, CaO, and organic matter abundance, and inversely correlated with SiO2, demonstrating the importance of sediment composition for P sorption and mineral precipitation. Although the sediment contained <3% Fe2O3 by weight, approximately half of the sediment P was associated with redox-sensitive Fe oxide/hydroxide minerals that could be released to the water column under reducing conditions. Cyanobacteria cell counts indicate that blooms of Aphanizomenon flos-aquae and Dolichospermum flosaquae species tend to occur on the east side of Utah Lake, corresponding to areas with elevated P concentrations in the sediment, pore water, and water column. Our findings suggest that shallow lake eutrophication may be a function of P in legacy sediments that contribute to observed HABs in specific locations of shallow lakes.	[Randall, Matthew C.; Carling, Gregory T.; Nelson, Stephen T.; Rey, Kevin A.; Bickmore, Barry R.] Brigham Young Univ, Dept Geol Sci, Provo, UT 84602 USA; [Dastrup, Dylan B.; Hansen, Neil C.; Aanderud, Zachary T.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Miller, Theron] Wasatch Front Water Qual Council, Salt Lake City, UT USA	Brigham Young University; Brigham Young University	Carling, GT (corresponding author), Brigham Young Univ, Dept Geol Sci, Provo, UT 84602 USA.	greg.carling@byu.edu		Carling, Gregory/0000-0001-5820-125X	Wasatch Front Water Quality Council	Wasatch Front Water Quality Council	G.T. Carling received a grant from the Wasatch Front Water Quality Council for the work. Funder's web page: http://wfwqc.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hmeidan HY, 2018, HYDROLOGY-BASEL, V5, DOI 10.3390/hydrology5010008; Andersson A, 2015, ESTUAR COAST SHELF S, V164, P161, DOI 10.1016/j.ecss.2015.07.013; Beversdorf LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056103; Bostrom B, 1985, PHOSPHORUS FRESHWATE; CH2MHILL, 2010, STAT NUTR REM COST I; Copetti D, 2016, WATER RES, V97, P162, DOI 10.1016/j.watres.2015.11.056; Descy JP, 2016, ECOL INFORM, V34, P129, DOI 10.1016/j.ecoinf.2016.05.003; Diaz J, 2008, SCIENCE, V320, P652, DOI 10.1126/science.1151751; Ding SM, 2015, WATER RES, V74, P100, DOI 10.1016/j.watres.2015.02.008; Egemose S, 2009, HYDROBIOLOGIA, V636, P203, DOI 10.1007/s10750-009-9949-8; Gomez E, 1999, WATER RES, V33, P2437, DOI 10.1016/S0043-1354(98)00468-0; Gulati RD, 2007, DEV HYDROBIOLOGY, V196; Hadas O, 1999, LIMNOLOGICAL ECOPHYS, P1439; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hogsett M.C., 2015, DISSERTATION; Hupfer M, 2009, LIMNOL OCEANOGR-METH, V7, P399, DOI 10.4319/lom.2009.7.399; Huser BJ, 2016, WATER RES, V97, P122, DOI 10.1016/j.watres.2015.06.051; Huser BJ, 2016, HYDROBIOLOGIA, V763, P23, DOI 10.1007/s10750-015-2356-4; ISTVANOVICS V, 1989, WATER RES, V23, P1357, DOI 10.1016/0043-1354(89)90074-2; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Lai DYF, 2008, MAR POLLUT BULL, V57, P349, DOI 10.1016/j.marpolbul.2008.01.038; Lurling M, 2016, WATER RES, V97, P1, DOI 10.1016/j.watres.2016.03.035; Macharia AN, 2012, RECONSTRUCTING PALEO; Moore PA, 1998, J ENVIRON QUAL, V27, P1428, DOI 10.2134/jeq1998.00472425002700060020x; Mortimer CH, 1942, J ECOL, V30, P147, DOI 10.2307/2256691; Nowlin WH, 2005, FRESHWATER BIOL, V50, P301, DOI 10.1111/j.1365-2427.2004.01316.x; Ogdahl ME, 2014, JOVE-J VIS EXP, DOI 10.3791/51617; Olsen JM, 2018, HYDROLOGY-BASEL, V5, DOI 10.3390/hydrology5030045; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; PSENNER R, 1984, Archiv fuer Hydrobiologie Supplement, V70, P111; PSOMAS, 2007, UT LAK TMDL POLL LOA; Qin B., 2007, DEV HYDROBIOLOGY, V194; RICHARDSON CJ, 1985, SCIENCE, V228, P1424, DOI 10.1126/science.228.4706.1424; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Sharpley A, 2013, J ENVIRON QUAL, V42, P1308, DOI 10.2134/jeq2013.03.0098; Sondergaard M, 2001, ScientificWorldJournal, V1, P427; SONDERGAARD M, 1992, HYDROBIOLOGIA, V228, P91, DOI 10.1007/BF00006480; Sondergaard M, 2013, HYDROBIOLOGIA, V710, P95, DOI 10.1007/s10750-012-1091-3; Song H, 2017, APPL MICROBIOL BIOT, V101, P1685, DOI 10.1007/s00253-016-7968-8; Steinman AD, 2015, LAKE RESERV MANAGE, V31, P115, DOI 10.1080/10402381.2015.1014582; ThomasArrigo LK, 2018, ENVIRON SCI TECHNOL, V52, P12316, DOI 10.1021/acs.est.8b03206; Welch E.B., 1995, LAKE RESERV MANAGE, V11, P273, DOI DOI 10.1080/07438149509354208; Wood SA, 2017, HYDROBIOLOGIA, V785, P71, DOI 10.1007/s10750-016-2904-6	43	25	27	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212238	10.1371/journal.pone.0212238	http://dx.doi.org/10.1371/journal.pone.0212238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763352	Green Submitted, Green Published, gold			2022-12-26	WOS:000458763900052
J	Hale, LP; Rajam, G; Carlone, GM; Jiang, C; Owzar, K; Dugan, G; Caudell, D; Chao, N; Cline, JM; Register, TC; Sempowski, GD				Hale, Laura P.; Rajam, Gowrisankar; Carlone, George M.; Jiang, Chen; Owzar, Kouros; Dugan, Greg; Caudell, David; Chao, Nelson; Cline, J. Mark; Register, Thomas C.; Sempowski, Gregory D.			Late effects of total body irradiation on hematopoietic recovery and immune function in rhesus macaques	PLOS ONE			English	Article							ACUTE-RADIATION-SYNDROME; LYMPHOID ORGANS; THYMIC FUNCTION; ANTIBODIES; PROTEIN; AGE; EXPOSURE; SUBSETS; MODELS; BLOOD	While exposure to radiation can be lifesaving in certain settings, it can also potentially result in long-lasting adverse effects, particularly to hematopoietic and immune cells. This study investigated hematopoietic recovery and immune function in rhesus macaques Cross-sectionally (at a single time point) 2 to 5 years after exposure to a single large dose (6.5 to 8.4 Gray) of total body radiation (TBI) derived from linear accelerator-derived photons (2 MeV, 80 cGy/minute) or Cobalt 60-derived gamma irradiation (60 cGy/min). Hematopoietic recovery was assessed through measurement of complete blood counts, lymphocyte subpopulation analysis, and thymus function assessment. Capacity to mount specific antibody responses against rabies, Streptococcus pneumoniae, and tetanus antigens was determined 2 years after TBI. Irradiated macaques showed increased white blood cells, decreased platelets, and decreased frequencies of peripheral blood T cells. Effects of prior radiation on production and export of new T cells by the thymus was dependent on age at the time of analysis, with evidence of interaction with radiation dose for CD8+ T cells. Irradiated and control animals mounted similar mean antibody responses to proteins from tetanus and rabies and to 10 of 11 serotype-specific pneumococcal polysaccharides. However, irradiated animals uniformly failed to make antibodies against polysaccharides from serotype 5 pneumococci, in contrast to the robust responses of non-irradiated controls. Trends toward decreased serum levels of anti-tetanus IgM and slower peak antibody responses to rabies were also observed. Taken together, these data show that dose-related changes in peripheral blood cells and immune responses to both novel and recall antigens can be detected 2 to 5 years after exposure to whole body radiation. Longer term follow-up data on this cohort and independent validation will be helpful to determine whether these changes persist or whether additional changes become evident with increasing time since radiation, particularly as animals begin to develop aging-related changes in immune function.	[Hale, Laura P.; Sempowski, Gregory D.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Hale, Laura P.; Sempowski, Gregory D.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Rajam, Gowrisankar; Carlone, George M.] Ctr Dis Control & Prevent CDC, Immunobiol Lab, Atlanta, GA USA; [Jiang, Chen; Owzar, Kouros] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA; [Owzar, Kouros] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Dugan, Greg; Caudell, David; Cline, J. Mark; Register, Thomas C.] Wake Forest Sch Med, Dept Pathol, Comparat Med Sect, Winston Salem, NC USA; [Chao, Nelson; Sempowski, Gregory D.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Duke University; Duke University; Centers for Disease Control & Prevention - USA; Duke University; Duke University; Wake Forest University; Duke University	Hale, LP (corresponding author), Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA.; Hale, LP (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA.	laura.hale@duke.edu		Sempowski, Gregory/0000-0003-0391-6594; Register, Thomas/0000-0002-4078-0166	National Institutes of Health/National Institute of Allergy and Infectious Diseases [U19 A167798]; Department of Defense/Congressionally Directed Medical Research Program [W81XWH-15-1-0574]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG049638] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Defense/Congressionally Directed Medical Research Program(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases U19 A167798 (NC) and by the Department of Defense/Congressionally Directed Medical Research Program grant W81XWH-15-1-0574 (JMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autissier P, 2010, J IMMUNOL METHODS, V360, P119, DOI 10.1016/j.jim.2010.06.017; Chen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011056; Chinn IK, 2012, SEMIN IMMUNOL, V24, P309, DOI 10.1016/j.smim.2012.04.005; Citrin DE, 2017, NEW ENGL J MED, V377, P1065, DOI 10.1056/NEJMra1608986; Council N.R., 2011, GUIDE CARE USE LAB A, V8th ed., P246, DOI [10.17226/12910, DOI 10.17226/12910]; DeBo RJ, 2015, INT J RADIAT BIOL, V91, P510, DOI 10.3109/09553002.2015.1028597; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Dudakov JA, 2011, BEST PRACT RES CL HA, V24, P467, DOI 10.1016/j.beha.2011.05.003; Farese AM, 2012, HEALTH PHYS, V103, P367, DOI 10.1097/HP.0b013e31825f75a7; Fisher R., 1970, STAT METHODS RES WOR; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; Fulop T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00271; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; GRAY BM, 1979, J IMMUNOL METHODS, V28, P187, DOI 10.1016/0022-1759(79)90340-5; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Hakoda M, 2006, RADIAT RES, V166, P360, DOI 10.1667/RR3589.1; Hayashi T, 2018, IMPACT EARLY LIFE EX; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Ito R, 2017, RADIAT RES, V187, P589, DOI 10.1667/RR4554.1; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Kajimura J, 2018, RADIAT RES, V189, P84, DOI 10.1667/RR4854; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kong FK, 1998, IMMUNITY, V8, P97, DOI 10.1016/S1074-7613(00)80462-8; Lal G, 2005, J IMMUNOL METHODS, V296, P135, DOI 10.1016/j.jim.2004.11.006; Lepletier A, 2015, GERONTOLOGY, V61, P504, DOI 10.1159/000375160; Lumniczky K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00517; Lynch Heather E, 2013, Methods Mol Biol, V979, P147, DOI 10.1007/978-1-62703-290-2_12; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; MacVittie TJ, 2015, HEALTH PHYS, V109, P342, DOI 10.1097/HP.0000000000000352; MacVittie TJ, 2012, HEALTH PHYS, V103, P411, DOI 10.1097/HP.0b013e31826525f0; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Messaoudi I, 2011, ANTIOXID REDOX SIGN, V14, P261, DOI 10.1089/ars.2010.3241; Murasko D M, 1990, Annu Rev Gerontol Geriatr, V10, P71; Pickering JW, 2002, AM J CLIN PATHOL, V117, P589; R Core Team, 2018, R LANG ENV STAT COMP; Sambhara S, 2009, CURR TOP MICROBIOL, V333, P413, DOI 10.1007/978-3-540-92165-3_20; Singh VK, 2017, INT J RADIAT BIOL, V93, P851, DOI 10.1080/09553002.2017.1332438; Sopper S, 1997, CYTOMETRY, V29, P351; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; Terpstra T, 1952, INDAGATIONES MATHEMA, V14, P327; Uckun FM, 1997, CLIN CANCER RES, V3, P325; Vialle S, CARBOHYDRATE RES, V340, P91; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Xiao SY, 2017, J IMMUNOL, V199, P2701, DOI 10.4049/jimmunol.1600934; Yu JZ, 2015, RADIAT RES, V184, P46, DOI 10.1667/RR13918.1	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0210663	10.1371/journal.pone.0210663	http://dx.doi.org/10.1371/journal.pone.0210663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759098	gold, Green Published, Green Submitted			2022-12-26	WOS:000458761300019
J	Hassan, AS; Bibby, DF; Mwaringa, SM; Agutu, CA; Ndirangu, KK; Sanders, EJ; Cane, PA; Mbisa, JL; Berkley, JA				Hassan, Amin S.; Bibby, David F.; Mwaringa, Shalton M.; Agutu, Clara A.; Ndirangu, Kennedy K.; Sanders, Eduard J.; Cane, Patricia A.; Mbisa, Jean L.; Berkley, James A.			Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal Kenya	PLOS ONE			English	Article							OLIGONUCLEOTIDE LIGATION ASSAY; ANTIRETROVIRAL-NAIVE ADULTS; TYPE-1; MUTATIONS; NEVIRAPINE; THERAPY; FAILURE; SURVEILLANCE; ADHERENCE; MULTIPLE	Background The epidemiology of HIV-1 drug resistance (HIVDR) determined by Sanger capillary sequencing, has been widely studied. However, much less is known about HIVDR detected using next generation sequencing (NGS) methods. We aimed to determine the presence, persistence and effect of pre-treatment HIVDR variants detected using NGS in HIV-1 infected antiretroviral treatment (ART) naive participants from rural Coastal Kenya. Methods In a retrospective longitudinal study, samples from HIV-1 infected participants collected prior [n = 2 time-points] and after [n = 1 time-point] ART initiation were considered. An ultra deep amplicon-based NGS assay, calling for nucleotide variants at >2.0% frequency of viral population, was used. Suspected virologic failure (sVF) was defined as a one-off HIV-1 viral load of >1000 copies/ml whilst on ART. Results Of the 50 eligible participants, 12 (24.0% [95% CI: 13.1-38.2]) had at least one detectable pre-treatment HIVDR variant against Protease Inhibitors (PIs, n = 6 [12%]), Nucleoside Reverse Transcriptase Inhibitors (NRTIs, n = 4 [8.0%]) and Non-NRTIs (n = 3 [6.0%]). Overall, 15 pre-treatment resistance variants were detected (frequency, range: 2.3-92.0%). A positive correlation was observed between mutation frequency and absolute load for NRTI and/or NNRTI variants (r = 0.761 [p = 0.028]), but not for PI variants (r = -0.117 [p = 0.803]). Participants with pre-treatment NRTI and/or NNRTI resistance had increased odds of sVF (OR = 6.0; 95% CI = 1.0-36.9; p = 0.054). Conclusions Using NGS, pre-treatment resistance variants were common, though observed PI variants were unlikely transmitted, but rather probably generated de novo. Even when detected from a low frequency, pre-treatment NRTI and/or NNRTI resistance variants may adversely affect treatment outcomes.	[Hassan, Amin S.; Mwaringa, Shalton M.; Agutu, Clara A.; Sanders, Eduard J.; Berkley, James A.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Bibby, David F.; Cane, Patricia A.; Mbisa, Jean L.] Publ Hlth England, Virus Reference Dept, London, England; [Ndirangu, Kennedy K.] Kilifi Cty Hosp, Kilifi, Kenya; [Sanders, Eduard J.; Berkley, James A.] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England	Public Health England; University of Oxford	Hassan, AS (corresponding author), KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.	ahassan@kemri-wellcome.org		Bibby, David/0000-0002-8458-9662; Berkley, James/0000-0002-1236-849X; Hassan, Amin S./0000-0001-5296-4264; Mbisa, Jean/0000-0002-0348-9679	Wellcome Trust [WT089351MA, WT083579MA, 107752/Z/15/Z]; Ministry of Health through the Kilifi County government; International AIDS Vaccine Initiative (IAVI); Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [DEL-15-006]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); UK government	Wellcome Trust(Wellcome TrustEuropean Commission); Ministry of Health through the Kilifi County government; International AIDS Vaccine Initiative (IAVI); Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); UK government	ASH and JAB were funded by Wellcome Trust fellowships (WT089351MA and WT083579MA respectively). SMM and CM were employees of the KEMRI/Wellcome Trust Research Programme. KKN was an employee at the Kilifi County Hospital, which receives support from Ministry of Health through the Kilifi County government. EJS was supported by the International AIDS Vaccine Initiative (IAVI). DFB, PAC and JLM were employed by Public Health England. ASH was also supported by the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative (grant #DEL-15-006). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (grant #107752/Z/15/Z) and the UK government. The employers and funding bodies played no part in the design, collection, analysis and interpretation of data and manuscript preparation.	[Anonymous], 2012, WHO GLOBAL STRATEGY; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Barbour JD, 2004, AIDS, V18, P1683, DOI 10.1097/01.aids.0000131391.91468.ff; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Boender T. S., 2015, CLIN INFECT DIS; Boltz VF, 2011, P NATL ACAD SCI USA, V108, P9202, DOI 10.1073/pnas.1105688108; Buckton AJ, 2011, ANTIVIR THER, V16, P9, DOI 10.3851/IMP1687; Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; Cane P, 2011, METHODS MOL BIOL, V665, P123, DOI 10.1007/978-1-60761-817-1_8; Castro H, 2013, J INFECT DIS, V208, P1459, DOI 10.1093/infdis/jit345; Chung MH, 2014, JAIDS-J ACQ IMM DEF, V67, P246, DOI 10.1097/QAI.0000000000000312; Cunningham E., 2015, ENHANCED SURVE UNPUB; Cunningham E, 2017, J ANTIMICROB CHEMOTH, V72, P227, DOI 10.1093/jac/dkw404; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Gill CJ, 2005, AIDS, V19, P1243, DOI 10.1097/01.aids.0000180094.04652.3b; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamers RL, 2012, LANCET INFECT DIS, V12, P307, DOI 10.1016/S1473-3099(11)70255-9; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Hassan AS, 2013, AIDS RES HUM RETROV, V29, P129, DOI [10.1089/aid.2012.0167, 10.1089/AID.2012.0167]; Hauser A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020357; Hue S, 2012, AIDS RES HUM RETROV, V28, P220, DOI 10.1089/aid.2011.0048; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; (Kenya National AIDS and STI Control Programme (NASCOP), 2011, GUIDELINES ANTIRETRO, V4th; Lalonde MS, 2007, J CLIN MICROBIOL, V45, P2604, DOI 10.1128/JCM.00431-07; Li JZ, 2013, CLIN INFECT DIS, V56, P1667, DOI 10.1093/cid/cit125; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lockman S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001236; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Pham QD, 2014, AIDS, V28, P2751, DOI 10.1097/QAD.0000000000000494; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Vandenhende MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086771; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; World Health Organization, 2015, GUID START ANT THER; Zou XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098740	44	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0210559	10.1371/journal.pone.0210559	http://dx.doi.org/10.1371/journal.pone.0210559			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759103	gold, Green Published, Green Submitted			2022-12-26	WOS:000458761300017
J	Xu, YW; Pilla, SJ; Alexander, GC; Murimi, IB				Xu, Yunwen; Pilla, Scott J.; Alexander, G. Caleb; Murimi, Irene B.			Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study	PLOS ONE			English	Article							TYPE-2; SECRETAGOGUES; METFORMIN	Background Clinical guidelines recommend that metformin be continued after insulin is initiated among patients with type 2 diabetes, yet little is known regarding how often metformin or other non-insulin diabetes medications are continued in this setting. Methods We conducted a retrospective cohort study to characterize rates and use patterns of six classes of non-insulin diabetes medications: biguanides (metformin), sulfonylureas, thiazolidinediones (TZDs), glucagon-like peptide 1 receptor agonists (GLP1 receptor agonists), dipeptidyl peptidase 4 inhibitors (DPP4 inhibitors), and sodium-glucose co-transporter inhibitors (SGLT2 inhibitors), among patients with type 2 diabetes initiating insulin. We used the 2010-2015 MarketScan Commercial Claims and Encounters data examining 72,971 patients with type 2 diabetes aged 18-65 years old who initiated insulin and had filled a prescription for a non-insulin diabetes medication in the 90 days prior to insulin initiation. Our primary outcome was the proportion of patients refilling the various non-insulin diabetes medications during the first 90 days after insulin initiation. We also used time-to-event analysis to characterize the time to discontinuation of specific medication classes. Results Metformin was the most common non-insulin medication used prior to insulin initiation (N = 53,017, 72.7%), followed by sulfonylureas (N = 25,439, 34.9%) and DPP4 inhibitors (N = 8,540, 11.7%). More than four out of five patients (N = 65,902, 84.7%) refilled prescriptions for any non-insulin diabetes medications within 90 days after insulin initiation. Within that period, metformin remained the most common medication with the highest continuation rate of 84.6%, followed by SGLT2 inhibitors (81.9%) and TZDs (79.3%). Sulfonylureas were the least likely medications to be continued (73.6% continuation) though they remained the second most common medication class used after insulin initiation. The median time to discontinuation varied by therapeutic class from the longest time to discontinuation of 26.4 months among metformin users to the shortest (3.0 months) among SGLT2 inhibitor users. Conclusion While metformin was commonly continued among commercially insured adults starting insulin, rates of continuation of other non-insulin diabetes medications were also high. Further studies are needed to determine the comparative effectiveness and safety of continuing insulin secretagogues and newer diabetes medications after insulin initiation.	[Xu, Yunwen; Alexander, G. Caleb; Murimi, Irene B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Xu, Yunwen; Alexander, G. Caleb; Murimi, Irene B.] Johns Hopkins Univ, Ctr Drug Safety & Effectiveness, Baltimore, MD 21218 USA; [Pilla, Scott J.; Alexander, G. Caleb] Johns Hopkins Med, Div Gen Internal Med, Dept Med, Baltimore, MD USA; [Murimi, Irene B.] Massachusetts Coll Pharm & Hlth Sci Univ, Program Pharmaceut Econ & Policy, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Murimi, IB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.; Murimi, IB (corresponding author), Johns Hopkins Univ, Ctr Drug Safety & Effectiveness, Baltimore, MD 21218 USA.; Murimi, IB (corresponding author), Massachusetts Coll Pharm & Hlth Sci Univ, Program Pharmaceut Econ & Policy, Boston, MA 02115 USA.	irene.murimi@mcphs.edu						Al Khaja KAJ, 2001, ANN PHARMACOTHER, V35, P1350; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS73, DOI 10.2337/dc18-S008; Bergenstal RM, 2013, DIABETES CARE, V36, pE107, DOI 10.2337/dc13-0295; Centers for Disease Control and Prevention, 2017, NAT DIAB STAT REP; Evans JL, 2000, ENDOTEXT S DARTMOUTH; Hayes RP, 2008, INT J CLIN PRACT, V62, P860, DOI 10.1111/j.1742-1241.2008.01742.x; Hemmingsen B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1771; Jayathissa S, 2017, NEW ZEAL MED J, V130, P49; Lazarus B, 2018, JAMA INTERN MED, V178, P903, DOI 10.1001/jamainternmed.2018.0292; Maruthur NM, 2016, ANN INTERN MED, V164, P740, DOI 10.7326/M15-2650; Moon SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175334; Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes, 2018, DIABETES CARE S1, V41, pS73, DOI [10.2337/dc18-S008, DOI 10.2337/DC18-S008]; Pilla SJ, 2018, DIABETES RES CLIN PR, V139, P221, DOI 10.1016/j.diabres.2018.02.032; Raskin P, 2008, DIABETES-METAB RES, V24, P3, DOI 10.1002/dmrr.783; Schlender L, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0574-5; Shah AD, 2016, ENDOCR PRACT, V22, P502, DOI 10.4158/EP151123.CO; Swinnen SG, 2010, DIABETES OBES METAB, V12, P923, DOI 10.1111/j.1463-1326.2010.01258.x; Tseng YJ, 2017, DIABETES CARE, V40, P1500, DOI 10.2337/dc17-0213; Turner LW, 2014, DIABETES CARE, V37, P985, DOI 10.2337/dc13-2097; US Food and Drug Administration, 2016, FDA DRUG SAF COMM FD; Vos RC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006992.pub2; Yang WY, 2018, DIABETES CARE, V41, P917, DOI 10.2337/dci18-0007; Zhuo XH, 2015, DIABETES CARE, V38, P581, DOI 10.2337/dc14-1687	23	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211820	10.1371/journal.pone.0211820	http://dx.doi.org/10.1371/journal.pone.0211820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759121	Green Submitted, Green Published, gold			2022-12-26	WOS:000458761300060
J	Yasaka, M; Minematsu, K; Toyoda, K; Mori, E; Hirano, T; Hamasaki, T; Yamagami, H; Nagao, T; Yoshimura, S; Uchiyama, S; Yamaguchi, T; Okada, Y; Okuda, S; Kimura, K; Tanahashi, N; Terayama, Y; Hashimoto, Y; Hasegawa, Y; Houkin, K; Matsumoto, M; Kitagawa, K; Yasaka, M; Nagata, K; Nogawa, S; Kumon, Y; Kimura, T; Furukawa, Y; Sakamoto, T; Sakai, M; Kudo, K; Hirai, T; Kobayashi, S				Yasaka, Masahiro; Minematsu, Kazuo; Toyoda, Kazunori; Mori, Etsuro; Hirano, Teruyuki; Hamasaki, Toshimitsu; Yamagami, Hiroshi; Nagao, Takehiko; Yoshimura, Shinichi; Uchiyama, Shinichiro; Yamaguchi, Takenori; Okada, Yasushi; Okuda, Satoshi; Kimura, Kazumi; Tanahashi, Norio; Terayama, Yasuo; Hashimoto, Yoichiro; Hasegawa, Yasuhiro; Houkin, Kiyohiro; Matsumoto, Masayasu; Kitagawa, Kazuo; Yasaka, Masahiro; Nagata, Ken; Nogawa, Shigeru; Kumon, Yoshiaki; Kimura, Takeshi; Furukawa, Yutaka; Sakamoto, Tomohiro; Sakai, Makoto; Kudo, Kohsuke; Hirai, Toshinori; Kobayashi, Shotai		RELAXED Study Grp	Rivaroxaban administration after acute ischemic stroke: The RELAXED study	PLOS ONE			English	Article							NONVALVULAR ATRIAL-FIBRILLATION; INTRACRANIAL HEMORRHAGE; JAPANESE PATIENTS; ASIAN PATIENTS; RISK; THROMBOLYSIS; METAANALYSIS; ALTEPLASE; WARFARIN	The efficacy of early anticoagulation in acute stroke with nonvalvular atrial fibrillation (NVAF) remains unclear. We performed a study to evaluate the risk of recurrent ischemic stroke (IS) and major bleeding in acute IS patients with NVAF who started rivaroxaban. This observational study evaluated patients with NVAF and acute IS/transient ischemic attack (TIA) in the middle cerebral arterial territory who started rivaroxaban within 30 days after the index IS/TIA. The primary endpoints were recurrent IS and major bleeding within 90 days after the index IS/TIA. The relationship between the endpoints and the time to start rivaroxaban was evaluated by correlation analysis using cerebral infarct volume, determined by diffusion-weighted magnetic resonance images within 48 hours of onset of the index IS/TIA. Of 1309 patients analyzed, recurrent IS occurred in 30 (2.3%) and major bleeding in 11 (0.8%) patients. Among patients with known infarct size (N = 1207), those with small (<4.0 cm(3)), medium (>= 4.0 and <22.5 cm(3)), and large (>= 22.5 cm(3)) infarcts started rivaroxaban a median of 2.9, 2.9, and 5.8 days, respectively, after the index IS/TIA. Recurrent IS was significantly less frequent when starting rivaroxaban <= 14 days versus >= 15 days after IS (2.0% versus 6.8%, P=0.0034). Incidences of recurrent IS and major bleeding in whom rivaroxaban was started <3 days (N = 584) after IS were also low: 1.5% and 0.7%, respectively. Initiation of rivaroxaban administration in acute IS or TIA was associated with a low recurrence of IS (2.3%), and a low incidence of major bleeding events (0.8%) for 90 days after the index stroke. For the prevention of recurrent attacks in acute IS patients with NVAF, it is feasible to start the administration of rivaroxaban within 14 days of onset. Rivaroxaban started within 3 days of onset may be a feasible treatment option for patients with a small or medium-sized infarction.	[Yasaka, Masahiro; Okada, Yasushi] Natl Hosp Org Kyushu Med Ctr, Clin Res Inst, Dept Cerebrovasc Med & Neurol, Fukuoka, Fukuoka, Japan; [Minematsu, Kazuo; Toyoda, Kazunori; Hamasaki, Toshimitsu; Yamagami, Hiroshi; Yamaguchi, Takenori] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan; [Minematsu, Kazuo; Toyoda, Kazunori; Hamasaki, Toshimitsu; Yamagami, Hiroshi; Yamaguchi, Takenori] Natl Cerebral & Cardiovasc Ctr, Dept Data Sci, Suita, Osaka, Japan; [Mori, Etsuro; Yoshimura, Shinichi] Osaka Univ, United Grad Sch Child Dev, Dept Behav Neurol & Neuropsychiat, Suita, Osaka, Japan; [Hirano, Teruyuki] Kyorin Univ, Dept Stroke & Cerebrovasc Med, Tokyo, Japan; [Nagao, Takehiko] Tama Nagayama Hosp, Nippon Med Sch, Dept Neurol, Tokyo, Japan; [Yoshimura, Shinichi; Kobayashi, Shotai] Hyogo Coll Med, Dept Neurosurg, Nishinomiya, Hyogo, Japan; [Uchiyama, Shinichiro] Int Univ Hlth, Tokyo, Japan; [Uchiyama, Shinichiro] Sanno Hosp, Ctr Brain & Cerebral Vessels, Tokyo, Japan; [Uchiyama, Shinichiro] Sanno Med Ctr, Tokyo, Japan; [Okuda, Satoshi] Natl Hosp Org Nagoya Med Ctr, Dept Neurol, Nagoya, Aichi, Japan; [Kimura, Kazumi] Kawasaki Med Sch, Dept Stroke Med, Kurashiki, Okayama, Japan; [Tanahashi, Norio] Saitama Med Univ, Saitama Int Med Ctr, Dept Neurol & Cerebrovasc Med, Hidaka, Japan; [Terayama, Yasuo] Iwate Med Univ, Dept Internal Med, Div Neurol & Gerontol, Morioka, Iwate, Japan; [Hashimoto, Yoichiro] Kumamoto City Hosp, Dept Neurol, Kumamoto, Japan; [Hasegawa, Yasuhiro] St Marianna Univ, Sch Med, Dept Internal Med, Div Neurol, Kawasaki, Kanagawa, Japan; [Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Kitagawa, Kazuo] Tokyo Womens Med Univ, Dept Neurol, Tokyo, Japan; [Mori, Etsuro] Tohoku Univ, Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi, Japan; [Nagata, Ken] Yokohama Gen Hosp, Dept Neurol, Yokohama, Kanagawa, Japan; [Nogawa, Shigeru] Tokai Univ, Hachioji Hosp, Dept Neurol, Tokyo, Japan; [Kumon, Yoshiaki] Ehime Univ, Grad Sch Med, Dept Regenerat Community Med, Matsuyama, Ehime, Japan; [Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Furukawa, Yutaka] Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Med, Kobe, Hyogo, Japan; [Sakamoto, Tomohiro] Saiseikai Kumamoto Hosp, Cardiovasc Ctr, Div Cardiol, Kumamoto, Japan; [Hamasaki, Toshimitsu; Sakai, Makoto] Iwate Med Univ, Dept Radiol, Morioka, Iwate, Japan; [Kudo, Kohsuke] Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Sapporo, Hokkaido, Japan; [Hirai, Toshinori] Univ Miyazaki, Fac Med, Dept Radiol, Miyazaki, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Osaka University; Kyorin University; Nippon Medical School; Hyogo College of Medicine; Nagoya Medical Center; Kawasaki Medical School; Saitama Medical University; Iwate Medical University; Saint Marianna University; Hokkaido University; Hiroshima University; Tokyo Women's Medical University; Tohoku University; Tokai University; Ehime University; Kyoto University; Kobe City Medical Center General Hospital; Saiseikai Kumamoto Hospital; Iwate Medical University; Hokkaido University; University of Miyazaki	Yasaka, M (corresponding author), Natl Hosp Org Kyushu Med Ctr, Clin Res Inst, Dept Cerebrovasc Med & Neurol, Fukuoka, Fukuoka, Japan.	yasakamasahiro@gmail.com	Kudo, Kohsuke/AAK-9938-2021; Hamasaki, Toshimitsu/N-3851-2015	Kudo, Kohsuke/0000-0001-5351-9242; Hamasaki, Toshimitsu/0000-0002-4928-1160; HIRAI, TOSHINORI/0000-0003-1480-2197; Yasaka, Masahiro/0000-0002-1163-8355	Bayer Yakuhin Ltd. [017926]	Bayer Yakuhin Ltd.	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was planned by Japan Cardiovascular Research Foundation and funded by Bayer Yakuhin Ltd. (contract No.: 017926).	Arihiro S, 2016, INT J STROKE, V11, P565, DOI 10.1177/1747493016632239; Azoulay L, 2014, EUR HEART J, V35, P1881, DOI 10.1093/eurheartj/eht499; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hong KS, 2017, JAMA NEUROL, V74, P1206, DOI 10.1001/jamaneurol.2017.2161; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Komori M, 2014, CIRC J, V78, P1335, DOI 10.1253/circj.CJ-13-1534; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; Man-Son-Hing M, 2003, ARCH INTERN MED, V163, P1580, DOI 10.1001/archinte.163.13.1580; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Nakagawara J, 2010, STROKE, V41, P1984, DOI 10.1161/STROKEAHA.110.589606; Paciaroni M, 2007, STROKE, V38, P423, DOI 10.1161/01.STR.0000254600.92975.1f; Paciaroni M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007034; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Seiffge DJ, 2016, NEUROLOGY, V87, P1856, DOI 10.1212/WNL.0000000000003283; Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136; Tanigawa T, 2013, DRUG METAB PHARMACOK, V28, P59, DOI 10.2133/dmpk.DMPK-12-RG-034; Toyoda K, 2015, INT J STROKE, V10, P836, DOI 10.1111/ijs.12452; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Whiteley WN, 2013, LANCET NEUROL, V12, P539, DOI 10.1016/S1474-4422(13)70079-6; Yasaka M, 2016, J STROKE CEREBROVASC, V25, P1342, DOI 10.1016/j.jstrokecerebrovasdis.2016.01.035; Yasaka M, 2014, CIRC J, V78, P2367, DOI 10.1253/circj.CJ-14-0720; Yasaka M, 2014, STROKE, V45, P1608, DOI 10.1161/STROKEAHA.114.005339	23	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0212354	10.1371/journal.pone.0212354	http://dx.doi.org/10.1371/journal.pone.0212354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759158	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300085
J	Aleixo, ALQD; de Oliveira, RVC; Albuquerque, MC; Biancardi, AL; Curi, ALL; Benchimol, EI; Amendoeira, MRR				Quintella do Couto Aleixo, Ana Luisa; de Oliveira, Raquel Vasconcelos C.; Albuquerque, Maira Cavalcanti; Biancardi, Ana Luiza; Land Curi, Andre Luiz; Benchimol, Eliezer Israel; Reis Amendoeira, Maria Regina			Toxoplasmic retinochoroiditis: The influence of age, number of retinochoroidal lesions and genetic polymorphism for IFN-gamma+874 T/A as risk factors for recurrence in a survival analysis	PLOS ONE			English	Article							OCULAR TOXOPLASMOSIS; GLOBAL REASSESSMENT; MEMORIAL-LECTURE; RESISTANCE; PATTERNS; DISEASE; GAMMA; EYE	Purpose To analyze risk factors for recurrent toxoplasmic retinochoroiditis. Design Single center prospective case series. Population and Methods A total of 230 patients with toxoplasmic retinochoroiditis were prospectively followed to assess recurrences. All patients were treated with a specific drug regime for toxoplasmosis in each episode of active retinochoroiditis. Individuals with chronic diseases and pregnant women were excluded. Survival analysis by extended Cox regression model (Prentice-Williams-Peterson counting process model) was performed to evaluate the time between recurrences according to some potential risk factors: age, number of retinochoroidal lesions at initial evaluation, sex and interferon gamma +874 T/A gene polymorphism. Hazard Ratios (HR) and 95% confidence intervals (CI) were provided to interpret the risk effects. Results One hundred sixty-two recurrence episodes were observed in 104 (45.2%) patients during follow-up that lasted from 269 to 1976 days. Mean age at presentation was 32.8 years (Standard deviation = 11.38). The risk of recurrence during follow up was influenced by age (HR = 1.02, 95% CI = 1.01-1.04) and number of retinochoroidal lesions at the beginning of the study (HR = 1.60, 95% CI = 1.07-2.40). Heterozygosis for IFN-gamma gene polymorphism at position +874 T/A was also associated with recurrence (HR = 1.49, 95% CI = 1.04-2.14). Conclusion The risk of ocular toxoplasmosis recurrence after an active episode increased with age and was significantly higher in individuals with primary lesions, which suggests that individuals with this characteristic and the elderly could benefit from recurrence prophylactic strategies with antimicrobials. Results suggest an association between IFN-gamma gene polymorphism at position +874 T/A and recurrence.	[Quintella do Couto Aleixo, Ana Luisa; Land Curi, Andre Luiz; Benchimol, Eliezer Israel] Evandro Chagas Natl Inst Infect Dis FIOCRUZ, Infect Ophthalmol Lab, Rio De Janeiro, Brazil; [de Oliveira, Raquel Vasconcelos C.] Evandro Chagas Natl Inst Infect Dis FIOCRUZ, Rio De Janeiro, Brazil; [Albuquerque, Maira Cavalcanti; Reis Amendoeira, Maria Regina] Oswaldo Cruz Inst FIOCRUZ, Rio De Janeiro, Brazil; [Biancardi, Ana Luiza] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Aleixo, ALQD (corresponding author), Evandro Chagas Natl Inst Infect Dis FIOCRUZ, Infect Ophthalmol Lab, Rio De Janeiro, Brazil.	ana.quintella@ini.fiocruz.br	Aleixo, Ana Luisa Quintella do Couto/Y-3865-2019	Aleixo, Ana Luisa Quintella do Couto/0000-0002-8303-3793	Evandro Chagas National Institute of Infectology, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil	Evandro Chagas National Institute of Infectology, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil	The study was supported by the Evandro Chagas National Institute of Infectology, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch-Driessen LEH, 2002, OPHTHALMOLOGY, V109, P869, DOI 10.1016/S0161-6420(02)00990-9; Cordeiro CA, 2013, ACTA OPHTHALMOL, V91, pE311, DOI 10.1111/aos.12046; de Albuquerque MC, 2009, MEM I OSWALDO CRUZ, V104, P451, DOI 10.1590/S0074-02762009000300009; Felix JPF, 2014, AM J OPHTHALMOL, V157, P762, DOI 10.1016/j.ajo.2013.12.022; Fox BA, 2004, INT J PARASITOL, V34, P323, DOI 10.1016/j.ijpara.2003.12.001; FRIEDMAN.CT, 1969, ARCH OPHTHALMOL-CHIC, V81, P481; Garweg JG, 2008, BRIT J OPHTHALMOL, V92, P1253, DOI 10.1136/bjo.2007.123661; Gilbert RE, 1999, EPIDEMIOL INFECT, V123, P283, DOI 10.1017/S0950268899002800; GLASNER PD, 1992, AM J OPHTHALMOL, V114, P136, DOI 10.1016/S0002-9394(14)73976-5; HAY J, 1995, BMJ-BRIT MED J, V310, P1021, DOI 10.1136/bmj.310.6986.1021; Holland GN, 2008, AM J OPHTHALMOL, V145, P1007, DOI 10.1016/j.ajo.2008.01.023; Holland GN, 2009, MEM I OSWALDO CRUZ, V104, P351, DOI 10.1590/S0074-02762009000200031; Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032; Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040; HOLLAND GN, 1996, OCULAR INFECT IMMUNI, P1183; Jamieson SE, 2010, GENES IMMUN, V11, P374, DOI 10.1038/gene.2010.31; Neves Ede S, 2004, PARASITOLOGY, V34, P323; Neves ED, 2012, REV SOC BRAS MED TRO, V45, P757; OCONNOR GR, 1983, AM J OPHTHALMOL, V96, P577, DOI 10.1016/S0002-9394(14)73415-4; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; PRENTICE RL, 1981, BIOMETRIKA, V68, P373, DOI 10.1093/biomet/68.2.373; Aleixo ALQD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004685; Aleixo ALQD, 2009, REV SOC BRAS MED TRO, V42, P165, DOI 10.1590/S0037-86822009000200014; Reich M, 2015, RETINA-J RET VIT DIS, V35, P809, DOI 10.1097/IAE.0000000000000361; Silva GAV, 2014, CYTOKINE, V65, P130, DOI 10.1016/j.cyto.2013.12.002; Silveira C, 2002, AM J OPHTHALMOL, V134, P41, DOI 10.1016/S0002-9394(02)01527-1; Sullivan WJ, 2012, FEMS MICROBIOL REV, V36, P717, DOI 10.1111/j.1574-6976.2011.00305.x; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869	28	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211627	10.1371/journal.pone.0211627	http://dx.doi.org/10.1371/journal.pone.0211627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753197	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600014
J	Lillywhite, HB; Sheehy, CM; Sandfoss, MR; Crowe-Riddell, J; Grech, A				Lillywhite, Harvey B.; Sheehy, Coleman M., III; Sandfoss, Mark R.; Crowe-Riddell, Jenna; Grech, Alana			Drinking by sea snakes from oceanic freshwater lenses at first rainfall ending seasonal drought	PLOS ONE			English	Article							FILE SNAKE; DEHYDRATION; BEHAVIOR	Acquisition of fresh water (FW) is problematic for FW-dependent animals living in marine environments that are distant from sources of FW associated with land. Knowledge of how marine vertebrates respond to oceanic rainfall, and indeed the drinking responses of vertebrates generally following drought, is extremely scant. The Yellow-bellied Sea Snake (Hydrophis platurus) is the only pelagic species of squamate reptile and ranges across the Indo-Pacific oceans, having one of the largest geographic distributions of any vertebrate species. It requires FW and dehydrates at sea during periods of drought. Here we report drinking behaviors of sea snakes precisely at the transition from dry to wet season when rainfall first impacted the ocean following 6 months of seasonal drought. We show that the percentage of sea snakes that voluntarily drank FW in the laboratory when captured over eight successive days decreased from 80% to 13% before and after rainfall commenced, respectively. The percentage of snakes that drank immediately following capture exhibited a significant linear decline as the earliest rains of the wet season continued. Drinking by snakes indicates thirst related to dehydration, and thus thirsty snakes must have dehydrated during the previous six months of drought. Hence, the progressive decline in percentage of thirsty snakes indicates they were drinking from FW lenses associated with the first rainfall events of the wet season. These data reinforce the importance of accessing oceanic FW from precipitation, with implications for survival and distribution of pelagic populations that might be subjected to intensifying drought related to climate change.	[Lillywhite, Harvey B.; Sheehy, Coleman M., III; Sandfoss, Mark R.; Crowe-Riddell, Jenna] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Sheehy, Coleman M., III] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Grech, Alana] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Crowe-Riddell, Jenna] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; James Cook University; University of Adelaide	Lillywhite, HB (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	hblill@ufl.edu	Grech, Alana/U-7776-2019	Grech, Alana/0000-0003-4117-3779; Crowe-Riddell, Jenna Margaret/0000-0003-2794-2914	National Science Foundation [IOS-0926802]; University of Florida Seahorse Key Fellowship	National Science Foundation(National Science Foundation (NSF)); University of Florida Seahorse Key Fellowship	This research was supported by the National Science Foundation, grant # IOS-0926802 to HBL. JC-R was a Fulbright Postgraduate Scholar, and MS was supported in part by a University of Florida Seahorse Key Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet X, 2008, AUSTRAL ECOL, V33, P911, DOI 10.1111/j.1442-9993.2008.01917.x; Brischoux F, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0436; Brischoux F, 2012, ECOGRAPHY, V35, P994, DOI 10.1111/j.1600-0587.2012.07717.x; Brischoux F, 2011, MAR BIOL, V158, P2343, DOI 10.1007/s00227-011-1738-z; Climate Prediction Center National Centers for Environmental Prediction National Weather Service NOAA U.S. Department of Commerce, 2015, NOAA CPC MORPH TECHN, DOI 10.5065/D60R9MF6; DUNSON WA, 1976, J COMP PHYSIOL, V108, P303, DOI 10.1007/BF00691678; DUNSON WA, 1974, AM J PHYSIOL, V227, P430, DOI 10.1152/ajplegacy.1974.227.2.430; DUNSON WA, 1989, B MAR SCI, V44, P229; Heatwole H, 1999, SEA SNAKES; Hulme M, 1998, GEOPHYS RES LETT, V25, P3379, DOI 10.1029/98GL02562; Lillywhite HB, 2015, J ZOOL, V296, P261, DOI 10.1111/jzo.12239; Lillywhite HB, 2008, PHYSIOL BIOCHEM ZOOL, V81, P785, DOI 10.1086/588306; Lillywhite HB, 2008, BIOSCIENCE, V58, P947, DOI 10.1641/B581008; Lillywhite HB, 2018, BIOSCIENCE, V68, P15, DOI 10.1093/biosci/bix132; Lillywhite HB, 2015, J HERPETOL, V49, P184, DOI 10.1670/14-004; Lillywhite HB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0119; Lillywhite HB, 2014, PHYSIOL BIOCHEM ZOOL, V87, P46, DOI 10.1086/673375; Lillywhite HB, 2012, INTEGR COMP BIOL, V52, P227, DOI 10.1093/icb/ics039; Lillywhite HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028556; Lillywhite HB, 1996, ZOO BIOL, V15, P315; Neelin JD, 2006, P NATL ACAD SCI USA, V103, P6110, DOI 10.1073/pnas.0601798103; Randall DJ, 2002, ECKERT ANIMAL PHYSL, V5; Sheehy CM, 2012, INTEGR COMP BIOL, V52, P321, DOI 10.1093/icb/ics088; Zimmer C, 1998, WATERS EDGE MACROEVO	24	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0212099	10.1371/journal.pone.0212099	http://dx.doi.org/10.1371/journal.pone.0212099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730972	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000458026000097
J	Stefanski, AL; Martinez, N; Peterson, LK; Callahan, TJ; Treacy, E; Luck, M; Friend, SF; Hermesch, A; Maltepe, E; Phang, T; Dragone, LL; Winn, VD				Stefanski, Adrianne L.; Martinez, Nadine; Peterson, Lisa K.; Callahan, Tiffany J.; Treacy, Eric; Luck, Marisa; Friend, Samantha F.; Hermesch, Amy; Maltepe, Emin; Phang, Tzu; Dragone, Leonard L.; Winn, Virginia D.			Murine trophoblast-derived and pregnancy-associated exosome-enriched extracellular vesicle microRNAs: Implications for placenta driven effects on maternal physiology	PLOS ONE			English	Article							FAS LIGAND; IMMUNE PRIVILEGE; READ ALIGNMENT; 1ST TRIMESTER; EXPRESSION; HYPOXIA; CELLS; MOLECULES; REVEALS; PATHWAY	The role of extracellular vesicles (EVs), specifically exosomes, in intercellular communication likely plays a key role in placental orchestration of pregnancy and maternal immune sensing of the fetus. While murine models are powerful tools to study pregnancy and maternal-fetal immune interactions, in contrast to human placental exosomes, the content of murine placental and pregnancy exosomes remains largely understudied. Using a recently developed in vitro culture technique, murine trophoblast stem cells derived from B6 mice were differentiated into syncytial-like cells. EVs from the conditioned media, as well as from pregnant and non-pregnant sera, were enriched for exosomes. The RNA composition of these murine trophoblast-derived and pregnancy-associated exosome-enriched-EVs (ExoE-EVs) was determined using RNA-sequencing analysis and expression levels confirmed by qRT-PCR. Differentially abundant miRNAs were detected in syncytial differentiated ExoE-EVs, particularly from the X chromosome cluster (mmu-miR-322-3p, mmu-miR-322-5p, mmu-miR-503-5p, mmu-miR-542-3p, and mmu-miR-450a-5p). These were confirmed to be increased in pregnant mouse sera ExoE-EVs by qRT-PCR analysis. Interestingly, fifteen miRNAs were only present within the pregnancy-derived ExoE-EVs compared to non-pregnant controls. Mmu-miR-292-3p and mmu-miR-183-5p were noted to be some of the most abundant miRNAs in syncytial ExoE-EVs and were also present at higher levels in pregnant versus non-pregnant sera ExoE-EVs. The bioinformatics tool, MultiMir, was employed to query publicly available databases of predicted miRNA-target interactions. This analysis reveals that the X-chromosome miRNAs are predicted to target ubiquitin-mediated proteolysis and intracellular signaling pathways. Knowing the cargo of placental and pregnancy-specific ExoE-EVs as well as the predicted biological targets informs studies using murine models to examine not only maternal-fetal immune interactions but also the physiologic consequences of placental-maternal communication.	[Stefanski, Adrianne L.; Hermesch, Amy; Winn, Virginia D.] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO 80045 USA; [Stefanski, Adrianne L.] Univ Colorado, Sch Med, Dept Med, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Martinez, Nadine; Winn, Virginia D.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Peterson, Lisa K.; Treacy, Eric; Luck, Marisa; Friend, Samantha F.; Dragone, Leonard L.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Callahan, Tiffany J.] Univ Colorado, Sch Med, Computat Biosci Program, Aurora, CO USA; [Maltepe, Emin; Phang, Tzu] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Dragone, Leonard L.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Dragone, Leonard L.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco	Winn, VD (corresponding author), Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO 80045 USA.; Winn, VD (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	vwinn@stanford.edu	Callahan, Tiffany J/AAY-9170-2021	Callahan, Tiffany J/0000-0002-8169-9049; Treacy, Eileen/0000-0002-6226-1615; Winn, Virginia/0000-0003-1136-2907; Friend, Samantha/0000-0002-2936-5041	American College of Rheumatology Within our Research Grant; Colorado Clinical Translational Science Institution Co-pilot Award - National Institutes of Health/National Clinical and Translational Science Award [UL1 TR001082]; Colorado National Clinical and Translational Science Award [TL1 TR001081]; National Institutes of Health National Institute of Child Health and Human Development [R21 HD086253, T32 HD007186]; University of Colorado Department of Obstetrics and Gynecology Academic Enrichment Grant; American Recovery and Reinvestment Act Award from the National Center for Research Resources [1S10RR026780-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD086253, T32HD007186] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, TL1TR001081] Funding Source: NIH RePORTER	American College of Rheumatology Within our Research Grant; Colorado Clinical Translational Science Institution Co-pilot Award - National Institutes of Health/National Clinical and Translational Science Award; Colorado National Clinical and Translational Science Award; National Institutes of Health National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Colorado Department of Obstetrics and Gynecology Academic Enrichment Grant; American Recovery and Reinvestment Act Award from the National Center for Research Resources; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the American College of Rheumatology Within our Research Grant (LLD), Colorado Clinical Translational Science Institution Co-pilot Award supported by National Institutes of Health/National Clinical and Translational Science Award UL1 TR001082 (LLD), Colorado National Clinical and Translational Science Award TL1 TR001081 (ALS), National Institutes of Health National Institute of Child Health and Human Development T32 HD007186 (AH), National Institutes of Health National Institute of Child Health and Human Development R21 HD086253 (VDW and NM), University of Colorado Department of Obstetrics and Gynecology Academic Enrichment Grant (VDW). The project described was supported, in part, by American Recovery and Reinvestment Act Award Number 1S10RR026780-01 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [LLD, ALS, AH, VDW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abrahams VM, 2004, MOL HUM REPROD, V10, P55, DOI 10.1093/molehr/gah006; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; Aronesty E., 2011, EA UTILS COMMAND LIN; Atay S, 2011, AM J REPROD IMMUNOL, V65, P65, DOI 10.1111/j.1600-0897.2010.00880.x; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Choi HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056949; Dahl KDC, 2005, MOL CELL BIOL, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Frangsmyr L, 2005, MOL HUM REPROD, V11, P35, DOI 10.1093/molehr/gah129; Friend SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075200; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Hong CS, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.29289; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Jin HS, 2013, P NATL ACAD SCI USA, V110, P624, DOI 10.1073/pnas.1213819110; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawamura K, 2011, ENDOCRINOLOGY, V152, P1090, DOI 10.1210/en.2010-1124; Kawamura K, 2009, ENDOCRINOLOGY, V150, P3774, DOI 10.1210/en.2009-0213; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kshirsagar SK, 2012, PLACENTA, V33, P982, DOI 10.1016/j.placenta.2012.10.005; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Mincheva-Nilsson L, 2014, AM J REPROD IMMUNOL, V72, P440, DOI 10.1111/aji.12311; Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009; Mouillet JF, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110049; Patel J, 2010, PLACENTA, V31, P951, DOI 10.1016/j.placenta.2010.08.008; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ru YB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku631; Sakaram S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28168-5; Salomon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098667; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stenqvist AC, 2013, J IMMUNOL, V191, P5515, DOI 10.4049/jimmunol.1301885; Tannetta D, 2014, CELL MOL IMMUNOL, V11, P548, DOI 10.1038/cmi.2014.42; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; Wu H, 2010, P NATL ACAD SCI USA, V107, P18161, DOI 10.1073/pnas.1005595107	51	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0210675	10.1371/journal.pone.0210675	http://dx.doi.org/10.1371/journal.pone.0210675			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730971	Green Published, Green Submitted, gold			2022-12-26	WOS:000458026000009
J	Tan, XF; Zwiazek, JJ				Tan, Xiangfeng; Zwiazek, Janusz J.			Stable expression of aquaporins and hypoxia-responsive genes in adventitious roots are linked to maintaining hydraulic conductance in tobacco (Nicotiana tabacum) exposed to root hypoxia	PLOS ONE			English	Article							TAMARACK LARIX-LARICINA; SPRUCE PICEA-MARIANA; RADIAL OXYGEN LOSS; WATER TRANSPORT; WATERLOGGING TOLERANCE; STOMATAL CONDUCTANCE; ANOXIA TOLERANCE; ETHYLENE; SURVIVAL; PLANTS	Formation of adventitious roots in plants is a common response to hypoxia caused by flooding. In tobacco, after one week of root hypoxia treatment, plants produced twice as many adventitious roots as the aerated plants, but their maximum length was reduced. Hypoxia severely reduced net photosynthesis, transpiration rates, and photosynthetic light responses. Relative transcript abundance of the examined aquaporins in lateral roots was reduced by hypoxia, but in adventitious roots it remained unchanged. This apparent lack of an effect of root hypoxia on the aquaporin expression likely contributed to maintenance of high hydraulic conductance in adventitious roots. Lateral roots had lower porosity compared with adventitious roots and the expression of the ACS (1-aminocyclopropane-1-carboxylate synthase) gene was induced in hypoxic lateral roots, but not in adventitious roots, providing additional evidence that lateral roots were more affected by hypoxia compared with adventitious roots. ATP concentrations were markedly lower in both hypoxic lateral and adventitious roots compared with aerated roots, while the expression of fermentation-related genes, ADH1 (alcohol dehydrogenase 1) and PDC1 (pyruvate decarboxylase 1), was higher in lateral roots compared with adventitious roots. Since root porosity was greater in adventitious compared with lateral roots, the results suggest that the improved O-2 delivery and stable root aquaporin expression in adventitious roots were likely the key factors helping flooded tobacco plants maintain high rates of root hydraulic conductance and, consequently, shoot gas exchange.	[Tan, Xiangfeng; Zwiazek, Janusz J.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta	Zwiazek, JJ (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	jzwiazek@ualberta.ca	Tan, Xiangfeng/GPP-2458-2022; Zwiazek, Janusz/AAP-2543-2021	Tan, Xiangfeng/0000-0003-4671-0131; Zwiazek, Janusz/0000-0003-2784-5508	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery (NSERC.ca)	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery (NSERC.ca)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery (NSERC.ca) Grant to JJZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko T, 2012, PLANT CELL ENVIRON, V35, P1618, DOI 10.1111/j.1365-3040.2012.02513.x; Ahkami AH, 2009, NEW PHYTOL, V181, P613, DOI 10.1111/j.1469-8137.2008.02704.x; [Anonymous], 1972, MINERAL NUTR PLANTS; Araki H, 2006, FIELD CROP RES, V96, P98, DOI 10.1016/j.fcr.2005.05.007; Aroca R, 2005, PLANT PHYSIOL, V137, P341, DOI 10.1104/pp.104.051045; Ayi QL, 2016, ANN BOT-LONDON, V118, P675, DOI 10.1093/aob/mcw051; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Bellini C, 2014, ANNU REV PLANT BIOL, V65, P639, DOI 10.1146/annurev-arplant-050213-035645; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; BRADFORD KJ, 1980, PLANT PHYSIOL, V65, P322, DOI 10.1104/pp.65.2.322; Calvo-Polanco M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-99; Chang WWP, 2000, PLANT PHYSIOL, V122, P295, DOI 10.1104/pp.122.2.295; Choi WG, 2007, J BIOL CHEM, V282, P24209, DOI 10.1074/jbc.M700982200; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; De Simone O, 2003, PLANT PHYSIOL, V132, P206, DOI 10.1104/pp.102.014902; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; ELSE MA, 1995, PLANT PHYSIOL, V109, P1017, DOI 10.1104/pp.109.3.1017; Else MA, 2001, PHYSIOL PLANTARUM, V111, P46, DOI 10.1034/j.1399-3054.2001.1110107.x; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; Gibbs J, 2003, FUNCT PLANT BIOL, V30, P1, DOI [10.1071/PP98095_ER, 10.1071/PP98095]; Herzog M, 2016, PLANT CELL ENVIRON, V39, P1068, DOI 10.1111/pce.12676; Hirabayashi Y, 2013, NAT CLIM CHANGE, V3, P816, DOI [10.1038/nclimate1911, 10.1038/NCLIMATE1911]; HUNT PG, 1981, PLANT SOIL, V59, P427, DOI 10.1007/BF02184547; Islam MA, 2004, TREES-STRUCT FUNCT, V18, P35, DOI 10.1007/s00468-003-0276-9; Islam MA, 2003, TREE PHYSIOL, V23, P545, DOI 10.1093/treephys/23.8.545; Jackson MB, 1996, ANN BOT-LONDON, V77, P17, DOI 10.1006/anbo.1996.0003; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; JENSEN CR, 1969, AGRON J, V61, P474, DOI 10.2134/agronj1969.00021962006100030045x; Kamaluddin M, 2002, PLANT PHYSIOL, V128, P962, DOI 10.1104/pp.010791; Kozlowski TT, 1997, TREE PHYSL MONOGR, V1, P1, DOI [DOI 10.1093/TREEPHYS/17.7.490, 10.1093/treephys/17.7.490]; KRAMER PJ, 1954, PLANT PHYSIOL, V29, P241, DOI 10.1104/pp.29.3.241; Lee MO, 2007, J PLANT BIOL, V50, P496, DOI 10.1007/BF03030689; Lee SH, 2010, PLANT CELL ENVIRON, V33, P769, DOI 10.1111/j.1365-3040.2009.02103.x; Lee SC, 2011, NEW PHYTOL, V190, P457, DOI 10.1111/j.1469-8137.2010.03590.x; Liu FL, 2005, PLANT PHYSIOL, V137, P1115, DOI 10.1104/pp.104.055475; Liu J, 2014, PLANTA, V240, P553, DOI 10.1007/s00425-014-2106-2; Maurel C, 2015, PHYSIOL REV, V95, P1321, DOI 10.1152/physrev.00008.2015; McDonald MP, 2003, PLANT BIOLOGY, V5, P550, DOI 10.1055/s-2003-44790; Mekhedov SL, 1996, PLANT CELL PHYSIOL, V37, P531, DOI 10.1093/oxfordjournals.pcp.a028976; Mugnai S, 2011, PLANT CELL PHYSIOL, V52, P1107, DOI 10.1093/pcp/pcr061; Muries B, 2011, MOL BIOSYST, V7, P1322, DOI 10.1039/c0mb00285b; Mustroph A, 2010, PLANT PHYSIOL, V152, P1484, DOI 10.1104/pp.109.151845; Navarro-Rodenas A, 2015, PLANT CELL ENVIRON, V38, P2475, DOI 10.1111/pce.12552; Padakandla SR, 2016, ECOL INDIC, V70, P431, DOI 10.1016/j.ecolind.2016.06.008; Pagnussat GC, 2002, PLANT PHYSIOL, V129, P954, DOI 10.1104/pp.004036; Reeksting BJ, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0893-2; Rieu I, 2005, J EXP BOT, V56, P841, DOI 10.1093/jxb/eri078; Rodriguez-Gamir J, 2010, PHYSIOL PLANTARUM, V139, P159, DOI 10.1111/j.1399-3054.2010.01351.x; SACHS MM, 1980, CELL, V20, P761, DOI 10.1016/0092-8674(80)90322-0; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Skirycz A, 2010, PLANT PHYSIOL, V152, P226, DOI 10.1104/pp.109.148965; Steffens B, 2006, PLANTA, V223, P604, DOI 10.1007/s00425-005-0111-1; Tan XF, 2018, J PLANT PHYSIOL, V227, P20, DOI 10.1016/j.jplph.2018.05.003; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; TYREE MT, 1995, J EXP BOT, V46, P83, DOI 10.1093/jxb/46.1.83; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; van Dongen JT, 2015, ANNU REV PLANT BIOL, V66, P345, DOI 10.1146/annurev-arplant-043014-114813; VANDERSMAN AJM, 1991, FUNCT ECOL, V5, P304; Vidoz ML, 2010, PLANT J, V63, P551, DOI 10.1111/j.1365-313X.2010.04262.x; Voesenek LACJ, 2013, CURR OPIN PLANT BIOL, V16, P647, DOI 10.1016/j.pbi.2013.06.008; Voesenek LACJ, 2013, PLANT BIOLOGY, V15, P426, DOI 10.1111/plb.12014; Voesenek LACJ, 2015, NEW PHYTOL, V206, P57, DOI 10.1111/nph.13209; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Ye ZP, 2007, PHOTOSYNTHETICA, V45, P637, DOI 10.1007/s11099-007-0110-5; Yu Q, 1999, J PLANT PHYSIOL, V155, P431, DOI 10.1016/S0176-1617(99)80127-8; Zwiazek JJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40411	69	17	17	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0212059	10.1371/journal.pone.0212059	http://dx.doi.org/10.1371/journal.pone.0212059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730995	Green Published, Green Submitted, gold			2022-12-26	WOS:000458026000090
J	Zhu, SM; Tian, H; Niu, XD; Wang, J; Li, X; Jiang, N; Wen, SM; Chen, XR; Ren, SC; Xu, CL; Chang, CS; Flores-Morales, A; Shang, ZQ; Sun, YH; Niu, YJ				Zhu, Shimiao; Tian, Hao; Niu, Xiaodan; Wang, Jiang; Li, Xing; Jiang, Ning; Wen, Simeng; Chen, Xuanrong; Ren, Shancheng; Xu, Chuanliang; Chang, Chawnshang; Flores-Morales, Amilcar; Shang, Zhiqun; Sun, Yinghao; Niu, Yuanjie			Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer	ONCOGENE			English	Article							ANDROGEN-DEPRIVATION THERAPY; TUMOR-CELLS; INCREASED SURVIVAL; DIFFERENTIATION; ADENOCARCINOMA; PHENOTYPE; RESISTANCE; MECHANISM; BIOLOGY	Castration-resistant prostate cancer (CRPC) with neuroendocrine differentiation (NED) is a lethal disease for which effective therapies are urgently needed. The mechanism underlying development of CRPC with NED, however, remains largely uncharacterized. In this study, we explored and characterized the functional role of neurotensin (NTS) in cell line and animal models of CRPC with NED. NTS was acutely induced by androgen deprivation in animal models of prostate cancer (PCa) and activated downstream signaling leading to NED through activation of neurotensin receptor 1 (NTSR1) and neurotensin receptor 3 (NTSR3), but not neurotensin receptor 2 (NTSR2). Our findings also revealed the existence of a CK8(+)/CK14(+) subpopulation in the LNCaP cell line that expresses high levels of both NTSR1 and NTSR3, and displays an enhanced susceptibility to develop neuroendocrine-like phenotypes upon treatment with NTS. More importantly, NTSR1 pathway inhibition prevented the development of NED and castration resistance in vivo. We propose a novel role of NTS in the development of CRPC with NED, and a possible strategy to prevent the onset of NED by targeting the NTS signaling pathway.	[Zhu, Shimiao; Tian, Hao; Wang, Jiang; Li, Xing; Jiang, Ning; Wen, Simeng; Chen, Xuanrong; Shang, Zhiqun; Niu, Yuanjie] Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Dept Urol, Tianjin 300211, Peoples R China; [Niu, Xiaodan] Univ Minnesota, Minneapolis, MN 55455 USA; [Ren, Shancheng; Xu, Chuanliang; Sun, Yinghao] Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Chang, Chawnshang] Univ Rochester, Dept Pathol, Rochester, NY 14620 USA; [Flores-Morales, Amilcar] Univ Copenhagen, Dept Hlth Sci, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark	Tianjin Medical University; University of Minnesota System; University of Minnesota Twin Cities; Naval Medical University; University of Rochester; University of Copenhagen	Shang, ZQ; Niu, YJ (corresponding author), Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Dept Urol, Tianjin 300211, Peoples R China.; Sun, YH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai 200433, Peoples R China.	zhiqun_shang@tmu.edu.cn; sunyh@medmail.com.cn; niuyuanjie9317@163.com		Wen, Simeng/0000-0001-7989-7700	National Basic Research Program of China [2012CB518304]; National Natural Science Foundation of China [81802573, 81472682, 81772756]; Natural Science Foundation of Tianjin [17JCZDJC35300, 15JCZDJC35400, 15JCYBJC27200]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by National Basic Research Program of China (2012CB518304), National Natural Science Foundation of China (81802573, 81472682, and 81772756), and Natural Science Foundation of Tianjin (17JCZDJC35300, 15JCZDJC35400, and 15JCYBJC27200).	Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Azzouni F, 2012, UROL CLIN N AM, V39, P435, DOI 10.1016/j.ucl.2012.07.002; Beltran H, 2012, J CLIN ONCOL, V30, pE386, DOI 10.1200/JCO.2011.41.5166; Cindolo L, 2007, UROL INT, V79, P287, DOI 10.1159/000109711; Davies AH, 2018, NAT REV UROL, V15, P271, DOI 10.1038/nrurol.2018.22; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Delk NA, 2012, AUTOPHAGY, V8, P650, DOI 10.4161/auto.19226; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Friedlander TW, 2012, UROL CLIN N AM, V39, P453, DOI 10.1016/j.ucl.2012.07.003; Gingrich JR, 1997, CANCER RES, V57, P4687; Hashimoto K, 2015, LAB INVEST, V95, P283, DOI 10.1038/labinvest.2014.165; Huang JT, 2006, PROSTATE, V66, P1399, DOI 10.1002/pros.20434; Ito T, 2001, ONCOL REP, V8, P1221; Jiang N, 2015, ONCOGENE, V34, P2764, DOI 10.1038/onc.2014.206; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Lapuk AV, 2012, J PATHOL, V227, P286, DOI 10.1002/path.4047; Li P, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-55; Li YA, 2017, EUR UROL, V71, P68, DOI 10.1016/j.eururo.2016.04.028; Lorente D, 2015, NAT REV UROL, V12, P37, DOI 10.1038/nrurol.2014.345; Martin S, 2002, GASTROENTEROLOGY, V123, P1135, DOI 10.1053/gast.2002.36000; Niu Y, 2010, ONCOGENE, V29, P3593, DOI 10.1038/onc.2010.121; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Palapattu GS, 2009, PROSTATE, V69, P787, DOI 10.1002/pros.20928; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Sauer CG, 2006, PROSTATE, V66, P227, DOI 10.1002/pros.20338; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; SEHGAL I, 1994, P NATL ACAD SCI USA, V91, P4673, DOI 10.1073/pnas.91.11.4673; Sella A, 2000, EUR UROL, V38, P250, DOI 10.1159/000020289; Tyler-McMahon BM, 2000, REGUL PEPTIDES, V93, P125, DOI 10.1016/S0167-0115(00)00183-X; Valerie NCK, 2011, CANCER RES, V71, P6817, DOI 10.1158/0008-5472.CAN-11-1646; Vashchenko N, 2005, EUR UROL, V47, P147, DOI 10.1016/j.eururo.2004.09.007; Vincent JP, 1999, TRENDS PHARMACOL SCI, V20, P302, DOI 10.1016/S0165-6147(99)01357-7; Wu Zherui, 2012, Front Endocrinol (Lausanne), V3, P184, DOI 10.3389/fendo.2012.00184; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043; Zou M, 2017, CANCER DISCOV, V7, P736, DOI 10.1158/2159-8290.CD-16-1174	37	23	23	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2019	38	24					4875	4884		10.1038/s41388-019-0750-5	http://dx.doi.org/10.1038/s41388-019-0750-5			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IC7ND	30770901	hybrid, Green Published			2022-12-26	WOS:000471160500015
J	Maclean, KN; Jiang, H; Phinney, WN; Keating, AK; Hurt, KJ; Stabler, SP				Maclean, Kenneth N.; Jiang, Hua; Phinney, Whitney N.; Keating, Amy K.; Hurt, K. Joseph; Stabler, Sally P.			Taurine alleviates repression of betaine-homocysteine S-methyltransferase and significantly improves the efficacy of long-term betaine treatment in a mouse model of cystathionine -synthase-deficient homocystinuria	FASEB JOURNAL			English	Article						transsulfuration; coagulation; homocysteine; TNF-; glutathione	CYSTEINE METABOLISM; MICE; METHIONINE; EXPRESSION; THERAPY; HYPERHOMOCYSTEINEMIA; INDUCTION; OXIDATION; FIBROSIS; TISSUES	Classical cystathionine -synthase-deficient homocystinuria (HCU) is a life-threatening inborn error of sulfur metabolism. Treatment for pyridoxine-nonresponsive HCU involves lowering homocysteine (Hcy) with a methionine (Met)-restricted diet and betaine supplementation. Betaine treatment efficacy diminishes significantly over time due to impairment of betaine-Hcy S-methyltransferase (BHMT) function. Little is known regarding the regulation of BHMT in HCU. Using a betaine-responsive preclinical mouse model of HCU, we observed that this condition induces a 75% repression of BHMT mRNA, protein and enzyme activity, and significant depletion of hepatic betaine levels. BHMT repression was proportional to plasma Hcy levels but was not observed in mouse models of homocystinuria due to either methylenetetrahydrofolate reductase or Met synthase deficiency. Both Met supplementation and chemically induced glutathione depletion exacerbated hepatic BHMT repression in HCU mice but not wild-type (WT) controls. Conversely, cysteine treatment normalized hepatic BHMT expression in HCU mice but had no effect in WT control animals. Taurine treatment induced BHMT expression in HCU mice by 5-fold and restored maximal lowering of Hcy levels during long-term betaine treatment with a concomitant normalization of inflammatory cytokine expression and a significantly improved coagulative phenotype. Collectively, our findings indicate that adjuvantial taurine treatment has the potential to significantly improve clinical outcomes in HCU.Maclean, K. N., Jiang, H, Phinney, W. N., Keating, A. K., Hurt, K. J., Stabler, S. P. Taurine alleviates repression of betaine-homocysteine S-methyltransferase and significantly improves the efficacy of long-term betaine treatment in a mouse model of cystathionine -synthase-deficient homocystinuria.	[Maclean, Kenneth N.; Jiang, Hua; Keating, Amy K.] Univ Colorado, Sch Med, Dept Pediat, Mail Stop 8313,POB 6511, Aurora, CO 80045 USA; [Phinney, Whitney N.; Stabler, Sally P.] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Hurt, K. Joseph] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Maclean, KN (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Mail Stop 8313,POB 6511, Aurora, CO 80045 USA.	ken.maclean@ucdenver.edu	Hurt, K. Joseph/J-8266-2019	Hurt, K. Joseph/0000-0001-6906-350X	William R. Hummel Homocystinuria Research Fund	William R. Hummel Homocystinuria Research Fund	K.N.M. gratefully acknowledges financial support from the William R. Hummel Homocystinuria Research Fund and holds the Ehst-Hummel-Kaufmann Family Endowed Chair in Inherited Metabolic Disease. The authors declare no conflicts of interest.	ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; ARUOMA OI, 1988, BIOCHEM J, V256, P251, DOI 10.1042/bj2560251; ATLAS M, 1984, J MOL CELL CARDIOL, V16, P311, DOI 10.1016/S0022-2828(84)80602-1; Baric I, 2005, J INHERIT METAB DIS, V28, P885, DOI 10.1007/s10545-005-0192-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonhaus D W, 1983, Prog Clin Biol Res, V125, P195; Broze GJ, 2001, THROMB HAEMOSTASIS, V85, P747; CARSON NAJ, 1965, J PEDIATR-US, V66, P565, DOI 10.1016/S0022-3476(65)80121-4; Castro C, 2008, ARCH BIOCHEM BIOPHYS, V472, P26, DOI 10.1016/j.abb.2008.01.017; CHANDA R, 1970, Developmental Psychobiology, V3, P191, DOI 10.1002/dev.420030306; CRITCHLE.M, 1966, P ROY SOC MED, V59, P484, DOI 10.1177/003591576605900604; El Idrissi A, 2008, NEUROSCI LETT, V436, P19, DOI 10.1016/j.neulet.2008.02.070; Eyring KR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190916; Faverzani JL, 2017, CELL MOL NEUROBIOL, V37, P1477, DOI 10.1007/s10571-017-0478-0; FINKELSTEIN JD, 1982, BIOCHEM BIOPH RES CO, V108, P344, DOI 10.1016/0006-291X(82)91872-1; GAHL WA, 1988, J INHERIT METAB DIS, V11, P291, DOI 10.1007/BF01800372; GORDON RE, 1986, AM J PATHOL, V125, P585; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; Gupta S, 2014, FASEB J, V28, P781, DOI 10.1096/fj.13-240770; GUREVICH VS, 1980, B EXP BIOL MED+, V89, P436, DOI 10.1007/BF00830891; HAYES KC, 1989, AM J CLIN NUTR, V49, P1211, DOI 10.1093/ajcn/49.6.1211; Hogg N, 1999, FREE RADICAL BIO MED, V27, P28, DOI 10.1016/S0891-5849(99)00029-5; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Imbard A, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150094; Jiang H, 2015, BIOL OPEN, V4, P1154, DOI 10.1242/bio.013433; Jiang H, 2014, FASEB J, V28, P4044, DOI 10.1096/fj.14-253633; Jiang H, 2012, MOL GENET METAB, V107, P55, DOI 10.1016/j.ymgme.2012.04.025; Jones DP, 1998, CLIN CHIM ACTA, V275, P175, DOI 10.1016/S0009-8981(98)00089-8; Jurkowska H, 2016, AMINO ACIDS, V48, P665, DOI 10.1007/s00726-015-2108-9; Kang KW, 1999, NITRIC OXIDE-BIOL CH, V3, P265, DOI 10.1006/niox.1999.0233; Keating AK, 2011, MOL GENET METAB, V103, P330, DOI 10.1016/j.ymgme.2011.04.012; Knock E, 2008, J NUTR, V138, P653, DOI 10.1093/jn/138.4.653; Koc H, 2002, ANAL CHEM, V74, P4734, DOI 10.1021/ac025624x; KOMROWER GM, 1966, ARCH DIS CHILD, V41, P666, DOI 10.1136/adc.41.220.666; Lawson-Yuen A, 2006, MOL GENET METAB, V88, P201, DOI 10.1016/j.ymgme.2006.02.004; LEFAUCONNIER JM, 1976, BRAIN RES, V117, P105, DOI 10.1016/0006-8993(76)90559-X; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Maclean KN, 2018, FASEB J, V32, P1265, DOI 10.1096/fj.201700586R; Maclean KN, 2012, MOL GENET METAB, V105, P395, DOI 10.1016/j.ymgme.2011.11.190; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Maclean KN, 2002, HUM MUTAT, V19, P641, DOI 10.1002/humu.10089; MALCANGIO M, 1989, PSYCHOPHARMACOLOGY, V98, P316, DOI 10.1007/BF00451681; Maynard L. A., 1962, ANIMAL NUTRITION, P283; Miller CM, 2005, BIOCHEM J, V392, P443, DOI 10.1042/BJ20050356; Mudd SH, 2007, AM J CLIN NUTR, V85, P19, DOI 10.1093/ajcn/85.1.19; Mudd SH, 2012, MOL GENET METAB, V105, P228, DOI 10.1016/j.ymgme.2011.11.006; MUDD SH, 1985, AM J HUM GENET, V37, P1; Mudd SH, 2003, MOL GENET METAB, V79, P6, DOI 10.1016/S1096-7192(03)00066-0; Mulligan JD, 1998, J NUTR BIOCHEM, V9, P351, DOI 10.1016/S0955-2863(98)00025-4; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; MURPHY JV, 1985, J INHERIT METAB DIS, V8, P109, DOI 10.1007/BF01811482; Orendac M, 2003, J INHERIT METAB DIS, V26, P761, DOI 10.1023/B:BOLI.0000009963.88420.c2; Ou XP, 2007, BIOCHEM J, V401, P87, DOI 10.1042/BJ20061119; PERRY TL, 1968, LANCET, V2, P474; Pullin CH, 2002, J INHERIT METAB DIS, V25, P107, DOI 10.1023/A:1015672625913; Roman HB, 2013, ANTIOXID REDOX SIGN, V19, P1321, DOI 10.1089/ars.2012.5010; Sakamoto A, 2003, PEDIATR INT, V45, P333, DOI 10.1046/j.1442-200X.2003.01714.x; Soupart P., 1962, AMINO ACID POOLS, P220; Stabler SP, 2017, JIMD REP, V37, P55, DOI 10.1007/8904_2017_15; Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9; STURMAN JA, 1977, LIFE SCI, V21, P1, DOI 10.1016/0024-3205(77)90420-9; Suarez LM, 2014, NEUROPHARMACOLOGY, V79, P101, DOI 10.1016/j.neuropharm.2013.10.035; Swanson DA, 2001, MOL CELL BIOL, V21, P1058, DOI 10.1128/MCB.21.4.1058-1065.2001; van Gelder N M, 1985, Prog Clin Biol Res, V179, P149; WANG QJ, 1989, P SOC EXP BIOL MED, V190, P330; WILCKEN DEL, 1983, NEW ENGL J MED, V309, P448, DOI 10.1056/NEJM198308253090802; WRIGHT CE, 1986, ANNU REV BIOCHEM, V55, P427, DOI 10.1146/annurev.bi.55.070186.002235; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yokoi K, 2008, PEDIATR INT, V50, P694, DOI 10.1111/j.1442-200X.2008.02717.x	71	8	9	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6339	6353		10.1096/fj.201802069RR	http://dx.doi.org/10.1096/fj.201802069RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30768359				2022-12-26	WOS:000466932600042
J	Lessard, DV; Zinder, OJ; Hotta, T; Verhey, KJ; Ohi, R; Berger, CL				Lessard, Dominique V.; Zinder, Oraya J.; Hotta, Takashi; Verhey, Kristen J.; Ohi, Ryoma; Berger, Christopher L.			Polyglutamylation of tubulin's C-terminal tail controls pausing and motility of kinesin-3 family member KIF1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular motor; single-molecule biophysics; kinesin; post-translational modification (PTM); microtubule; cytoskeleton; K-loop; KIF1A; neuron; polyglutamylation	AXONAL-TRANSPORT; BETA-TUBULIN; CARGO TRANSPORT; ALPHA-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; FRONTOTEMPORAL DEMENTIA; PROTEIN KIF1A; MOTOR KIF1A; K-LOOP; TAU	The kinesin-3 family member KIF1A plays a critical role in site-specific neuronal cargo delivery during axonal transport. KIF1A cargo is mislocalized in many neurodegenerative diseases, indicating that KIF1A's highly efficient, superprocessive motility along axonal microtubules needs to be tightly regulated. One potential regulatory mechanism may be through posttranslational modifications (PTMs) of axonal microtubules. These PTMs often occur on the C-terminal tails of the microtubule tracks, act as molecular traffic signals helping to direct kinesin motor cargo delivery, and include C-terminal tail polyglutamylation important for KIF1A cargo transport. KIF1A initially interacts with microtubule C-terminal tails through its K-loop, a positively charged surface loop of the KIF1A motor domain. However, the role of the K-loop in KIF1A motility and response to perturbations in C-terminal tail polyglutamylation is underexplored. Using single-molecule imaging, we present evidence that KIF1A pauses on different microtubule lattice structures, linking multiple processive segments together and contributing to KIF1A's characteristic superprocessive run length. Furthermore, modifications of the KIF1A K-loop or tubulin C-terminal tail polyglutamylation reduced KIF1A pausing and overall run length. These results suggest a new mechanism to regulate KIF1A motility via pauses mediated by K-loop/polyglutamylated C-terminal tail interactions, providing further insight into KIF1A's role in axonal transport.	[Lessard, Dominique V.; Zinder, Oraya J.; Berger, Christopher L.] Univ Vermont, Dept Mol Physiol & Biophys, 122 HSRF,149 Beaumont Ave, Burlington, VT 05405 USA; [Hotta, Takashi; Verhey, Kristen J.; Ohi, Ryoma] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Vermont; University of Michigan System; University of Michigan	Berger, CL (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, 122 HSRF,149 Beaumont Ave, Burlington, VT 05405 USA.	cberger@uvm.edu		Berger, Christopher/0000-0001-8481-3479	NIGMS, National Institutes of Health [GM101066, GM070862, GM086610]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070862, R01GM086610, R01GM101066] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants GM101066 (to C.L.B.), GM070862 (to K.J.V), and GM086610 (to R.O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; AUDEBERT S, 1994, J CELL SCI, V107, P2313; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; Carabalona A, 2016, NAT NEUROSCI, V19, P253, DOI 10.1038/nn.4213; Castle MJ, 2014, MOL THER, V22, P554, DOI 10.1038/mt.2013.237; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Dantas TJ, 2016, CYTOSKELETON, V73, P566, DOI 10.1002/cm.21293; Ghosh-Roy A, 2012, DEV CELL, V23, P716, DOI 10.1016/j.devcel.2012.08.010; Ginsburg A, 2017, J PHYS CHEM B, V121, P8427, DOI 10.1021/acs.jpcb.7b01057; Goedert M, 2000, ANN NY ACAD SCI, V920, P74; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Gramlich MW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44290; Gumy LF, 2017, NEURON, V94, P347, DOI 10.1016/j.neuron.2017.03.046; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hoeprich GJ, 2017, TRAFFIC, V18, P304, DOI 10.1111/tra.12478; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; Hotta T, 2016, PLANT PHYSIOL, V170, P1189, DOI 10.1104/pp.15.01173; Hung COY, 2016, TRAFFIC, V17, P1155, DOI 10.1111/tra.12428; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Karasmanis EP, 2018, DEV CELL, V46, P204, DOI 10.1016/j.devcel.2018.06.013; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; Kondo M, 2012, NEURON, V73, P743, DOI 10.1016/j.neuron.2011.12.020; Kopeikina KJ, 2012, TRANSL NEUROSCI, V3, P223, DOI 10.2478/s13380-012-0032-y; Lacroix B, 2011, METHODS MOL BIOL, V777, P57, DOI 10.1007/978-1-61779-252-6_4; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Larcher JC, 1996, J BIOL CHEM, V271, P22117, DOI 10.1074/jbc.271.36.22117; Lee JR, 2015, HUM MUTAT, V36, P69, DOI 10.1002/humu.22709; Lee JR, 2003, J BIOL CHEM, V278, P2624, DOI 10.1074/jbc.M211152200; Lipka J, 2016, EMBO J, V35, P302, DOI 10.15252/embj.201592929; Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Magiera MM, 2018, CELL, V173, P1323, DOI 10.1016/j.cell.2018.05.018; McVicker DP, 2014, CYTOSKELETON, V71, P184, DOI 10.1002/cm.21163; McVicker DP, 2011, J BIOL CHEM, V286, P42873, DOI 10.1074/jbc.M111.292987; Monroy BY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03909-2; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Niwa S, 2016, CELL REP, V16, P2129, DOI 10.1016/j.celrep.2016.07.043; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Padzik A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00057; Regnard C, 1999, J CELL SCI, V112, P4281; Rodriguez-Martin T, 2016, NEUROBIOL DIS, V85, P1, DOI 10.1016/j.nbd.2015.10.007; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Schoch KM, 2016, NEURON, V90, P941, DOI 10.1016/j.neuron.2016.04.042; Siddiqui N, 2017, BIOCHEMISTRY-MOSCOW+, V82, P803, DOI 10.1134/S0006297917070057; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Soppina V, 2014, MOL BIOL CELL, V25, P2161, DOI 10.1091/mbc.E14-01-0696; Soppina V, 2014, P NATL ACAD SCI USA, V111, P5562, DOI 10.1073/pnas.1400759111; Stavoe AKH, 2016, DEV CELL, V38, P171, DOI 10.1016/j.devcel.2016.06.012; Stern JL, 2017, MOL BIOL CELL, V28, P1079, DOI 10.1091/mbc.E16-10-0728; Tanaka Y, 2016, NEURON, V90, P1215, DOI 10.1016/j.neuron.2016.05.002; Thompson AR, 2013, BIOPHYS J, V104, P2651, DOI 10.1016/j.bpj.2013.05.022; Trybus KM, 2013, CURR BIOL, V23, pR623, DOI 10.1016/j.cub.2013.06.005; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Widlund PO, 2012, MOL BIOL CELL, V23, P4393, DOI 10.1091/mbc.E12-06-0444; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhang R, 2018, P NATL ACAD SCI USA, V115, pE6191, DOI 10.1073/pnas.1802637115	71	23	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6353	6363		10.1074/jbc.RA118.005765	http://dx.doi.org/10.1074/jbc.RA118.005765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30770469	hybrid, Green Published			2022-12-26	WOS:000468402000013
J	Arends, RM; Nelwan, EJ; Soediro, R; van Crevel, R; Alisjahbana, B; Pohan, HT; von Borries, AKL; Schene, AH; van der Ven, AJAM; Schellekens, AFA				Arends, Rachel M.; Nelwan, Erni J.; Soediro, Ratna; van Crevel, Reinout; Alisjahbana, Bachti; Pohan, Herdiman T.; von Borries, A. Katinka L.; Schene, Aart H.; van der Ven, Andre J. A. M.; Schellekens, Arnt F. A.			Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis seroprevalence among female prisoners in Indonesia: A cross-sectional study	PLOS ONE			English	Article							GLOBAL BURDEN; HEPATITIS-C; DRUG-ABUSE; DISEASE; AGE; INHIBITION; PUNISHMENT; SYSTEMS; REWARD; MEN	HIV, hepatitis B and C, and syphilis share common transmission routes of which primarily unsafe sexual contact and injecting drug use are important. Impulsivity is a major factor contributing to this transmission risk behavior; however comprehensive studies within female, prison, and Asian populations are scarce. This cross-sectional study aims to delineate the contributions of different aspects of impulsivity to risk behavior, among female inmates living in a prison in Jakarta (N = 214). The relationships between various aspects of impulsivity, risk behaviors and seropositivity were tested using analyses of variance and logistic regression analyses. Motor impulsivity was related to alcohol use, reward-related impulsivity to drug use, and cognitive/goal-directed impulsivity to sexual risk behavior. Finally, goal directed impulsivity was also directly associated with seropositivity. Specific aspects of impulsivity are associated with different types of risk behavior in Indonesian female prisoners, which can be relevant for future studies on infection prevention strategies for such a population.	[Arends, Rachel M.; Schene, Aart H.; Schellekens, Arnt F. A.] Radboud Univ Nijmegen, Med Ctr, Div Res, Dept Psychiat, Nijmegen, Netherlands; [Nelwan, Erni J.; Pohan, Herdiman T.] Univ Indonesia, Div Trop & Infect Dis, Dept Internal Med, Depok, Java, Indonesia; [Soediro, Ratna] Pondok Bambu Prison, Jakarta, Java, Indonesia; [van Crevel, Reinout; van der Ven, Andre J. A. M.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Alisjahbana, Bachti] Univ Padjadjaran, Div Trop & Infect Dis, Dept Internal Med, Bandung, Java, Indonesia; [von Borries, A. Katinka L.] Landersverband Rheinland LVR Klin, Bedburg Hau, North Rhine Wes, Germany; [Schene, Aart H.; Schellekens, Arnt F. A.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Schellekens, Arnt F. A.] Nijmegen Inst Scientist Practitioners Addict, Nijmegen, Netherlands	Radboud University Nijmegen; University of Indonesia; Radboud University Nijmegen; Universitas Padjadjaran; Radboud University Nijmegen	Arends, RM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Div Res, Dept Psychiat, Nijmegen, Netherlands.	rachel.arends@radboudumc.nl	van Crevel, reinout/A-6636-2010; Schellekens, Arnt F.A./G-5611-2013	van Crevel, reinout/0000-0002-6233-6410; Schellekens, Arnt F.A./0000-0002-7715-5209				[Anonymous], 2017, UNAIDS DAT 2017; Belaunzaran-Zamudio PF, 2017, AIDS RES HUM RETROV, V33, P524, DOI [10.1089/AID.2016.0271, 10.1089/aid.2016.0271]; BOEKELOO BO, 1994, AM J PUBLIC HEALTH, V84, P754, DOI 10.2105/AJPH.84.5.754; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Connell CM, 2009, J STUD ALCOHOL DRUGS, V70, P943, DOI 10.15288/jsad.2009.70.943; Dantas-Duarte A, 2016, PSYCHIAT RES, V243, P75, DOI 10.1016/j.psychres.2016.04.114; Degenhardt L, 2016, LANCET INFECT DIS, V16, P1385, DOI 10.1016/S1473-3099(16)30325-5; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Dir AL, 2014, CLIN PSYCHOL REV, V34, P551, DOI 10.1016/j.cpr.2014.08.004; Duell N, 2018, J YOUTH ADOLESCENCE, V47, P1052, DOI 10.1007/s10964-017-0752-y; Giotakos O, 2003, EPIDEMIOL INFECT, V130, P497, DOI 10.1017/S0950268803008318; Hamilton KR, 2012, ALCOHOL CLIN EXP RES, V36, P434, DOI 10.1111/j.1530-0277.2011.01708.x; Johansen S.v. L, 2014, SENSATION SEEKING IM; Kojima N, 2018, CURR EPIDEMIOL REP, V5, P24, DOI 10.1007/s40471-018-0138-z; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Margolin A, 2007, J CLIN PSYCHOL, V63, P979, DOI 10.1002/jclp.20407; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Perry RI, 2013, DRUG ALCOHOL DEPEN, V133, P222, DOI 10.1016/j.drugalcdep.2013.04.032; Rubenstein LS, 2016, LANCET, V388, P1202, DOI 10.1016/S0140-6736(16)30663-8; Rubia K, 2011, BIOL PSYCHIAT, V69, pE69, DOI 10.1016/j.biopsych.2010.09.023; Semple SJ, 2006, J ADDICT DIS, V25, P105, DOI 10.1300/J069v25n04_10; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2020, GLOB HIV AIDS STAT F; UNAIDS, 2017, GLOB AIDS UPD 2017 E; UNAIDS, 2014, PRIS GAP REP; Wilson MJ, 2016, AM J DRUG ALCOHOL AB, V42, P231, DOI 10.3109/00952990.2015.1121269; WMA, 2008, DECLARATION HELSINKI; World Health Organisation, 2021, SEXUALLY TRANSMITTED; World Health Organization , 2014, PROC TRANSL AD INSTR; World Health Organization, 2016, REP GLOB SEX TRANSM; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002	35	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0207970	10.1371/journal.pone.0207970	http://dx.doi.org/10.1371/journal.pone.0207970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5KT	30768609	Green Published, Green Submitted, gold			2022-12-26	WOS:000458766300003
J	Liang, Y; Hiley, M; Kanosue, K				Liang, Ying; Hiley, Michael; Kanosue, Kazuyuki			The effect of contact sport expertise on postural control	PLOS ONE			English	Article							FEMALE COLLEGIATE SOCCER; VISUAL CONTRIBUTION; DYNAMIC BALANCE; BALLET DANCERS; BODY SWAY; PERFORMANCE; GYMNASTICS; RESPONSES; CONFIGURATION; COORDINATION	It has been demonstrated that expertise in sport influences standing balance ability. However, little is known concerning how physical contact in sport affects balance ability. The aim of this study was to examine whether differences between contact and limited-contact sport experiences results in differences in postural control. Twenty male collegiate athletes (10 soccer/contact, 10 baseball/limited contact) and ten male untrained students stood quietly on a force plate under various bipedal and unipedal conditions, with and without vision. Significant differences for sway area and COP speed were found between the soccer players and the other two groups for unipedal stances without vision. Soccer players were found to have superior postural control compared with participants involved in limited contact sport or no sport at all. Contact sports may lead to increased postural control through enhanced use of proprioceptive and vestibular information.	[Liang, Ying] Anhui Normal Univ, Dept Phys Educ, Wuhu, Peoples R China; [Hiley, Michael] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Kanosue, Kazuyuki] Waseda Univ, Fac Sports Sci, Tokorozawa, Saitama, Japan	Anhui Normal University; Loughborough University; Waseda University	Liang, Y (corresponding author), Anhui Normal Univ, Dept Phys Educ, Wuhu, Peoples R China.	chloe_liangying@163.com		Liang, Ying/0000-0001-8387-1191	Ministry of Education, Culture, Sports, Science and Technology of Japan under Global COE 'Sport Sciences for the Promotion of Active Life', Waseda University; Anhui Provincial Natural Science [1608085QH175]	Ministry of Education, Culture, Sports, Science and Technology of Japan under Global COE 'Sport Sciences for the Promotion of Active Life', Waseda University; Anhui Provincial Natural Science	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, under Grant-in-Aid from the Global COE 'Sport Sciences for the Promotion of Active Life', Waseda University; and Anhui Provincial Natural Science under Grant [number 1608085QH175]. No: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asseman FB, 2008, GAIT POSTURE, V27, P76, DOI 10.1016/j.gaitpost.2007.01.004; Asslander L, 2014, J NEUROPHYSIOL, V111, P1852, DOI 10.1152/jn.00669.2013; Bardy BG, 1999, J EXP PSYCHOL HUMAN, V25, P1284, DOI 10.1037/0096-1523.25.5.1284; Biec E, 2010, EUR J APPL PHYSIOL, V110, P703, DOI 10.1007/s00421-010-1551-2; Blenkinsop GM, 2016, HUM MOVEMENT SCI, V48, P112, DOI 10.1016/j.humov.2016.04.011; Bottaro A, 2005, HUM MOVEMENT SCI, V24, P588, DOI 10.1016/j.humov.2005.07.006; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Bressel E, 2007, J ATHL TRAINING, V42, P42; Bruyneel AV, 2010, NEUROSCI LETT, V485, P228, DOI 10.1016/j.neulet.2010.09.017; BURLEIGH AL, 1994, J NEUROPHYSIOL, V72, P2892, DOI 10.1152/jn.1994.72.6.2892; Casabona A, 2016, GAIT POSTURE, V46, P91, DOI 10.1016/j.gaitpost.2016.02.019; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davlin CD, 2004, PERCEPT MOTOR SKILL, V98, P1171, DOI 10.2466/PMS.98.4.1171-1176; Deveau J, 2014, CURR BIOL, V24, pR146, DOI 10.1016/j.cub.2014.01.004; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Feizolahi F, 2015, SCI J REHAB MED, V3, P89; Garcia C, 2011, NEUROSCI LETT, V492, P29, DOI 10.1016/j.neulet.2011.01.047; Gautier G, 2008, J MOTOR BEHAV, V40, P400, DOI 10.3200/JMBR.40.5.400-408; Gautier G, 2008, GAIT POSTURE, V28, P46, DOI 10.1016/j.gaitpost.2007.09.007; Gerbino PG, 2007, GAIT POSTURE, V26, P501, DOI 10.1016/j.gaitpost.2006.11.205; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Golomer E, 1999, NEUROSCI LETT, V267, P189, DOI 10.1016/S0304-3940(99)00356-0; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1987, PHYS THER, V67, P1881, DOI 10.1093/ptj/67.12.1881; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Hugel F, 1999, INT J SPORTS MED, V20, P86, DOI 10.1055/s-1999-970270; Ivanenko YP, 1999, EUR J NEUROSCI, V11, P647, DOI 10.1046/j.1460-9568.1999.00471.x; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; Kiefer AW, 2011, GAIT POSTURE, V34, P76, DOI 10.1016/j.gaitpost.2011.03.016; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; Marchetti P. H., 2012, ATHL TRAIN SPORT HEA, V4, P251; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; Matsuda S, 2010, PERCEPT MOTOR SKILL, V111, P167, DOI 10.2466/05.23.26.27.PMS.111.4.167-177; Mesure S, 1997, NEUROREPORT, V8, P3507, DOI 10.1097/00001756-199711100-00018; NASHNER L, 1978, BRAIN RES, V150, P403, DOI 10.1016/0006-8993(78)90291-3; Negahban H, 2013, GAIT POSTURE, V38, P226, DOI 10.1016/j.gaitpost.2012.11.016; Nolan L, 2004, GAIT POSTURE, V19, P11, DOI 10.1016/S0966-6362(03)00007-9; Paillard T, 2006, SCAND J MED SCI SPOR, V16, P345, DOI 10.1111/j.1600-0838.2005.00502.x; Paillard T, 2006, J ATHL TRAINING, V41, P172; Patti Antonino, 2018, J Phys Ther Sci, V30, P1052, DOI 10.1589/jpts.30.1052; Perrin P, 2002, GAIT POSTURE, V15, P187, DOI 10.1016/S0966-6362(01)00149-7; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-6; Schmit JM, 2005, EXP BRAIN RES, V163, P370, DOI 10.1007/s00221-004-2185-6; STOFFREGEN TA, 1988, PSYCHOL REV, V95, P3, DOI 10.1037/0033-295X.95.1.3; Thorpe JL, 2008, J STRENGTH COND RES, V22, P1429, DOI 10.1519/JSC.0b013e31818202db; Vuillerme N, 2004, BRAIN RES BULL, V63, P161, DOI 10.1016/j.brainresbull.2004.02.006; Vuillerme N, 2001, NEUROSCI LETT, V303, P83, DOI 10.1016/S0304-3940(01)01722-0; Washington RL, 2001, PEDIATRICS, V107, P1205; Williams DSB, 2016, J SPORT HEALTH SCI, V5, P70, DOI 10.1016/j.jshs.2016.01.010	50	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212334	10.1371/journal.pone.0212334	http://dx.doi.org/10.1371/journal.pone.0212334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5JX	30763383	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900069
J	Bennett, AB; Lovell, S				Bennett, Ashley B.; Lovell, Sarah			Landscape and local site variables differentially influence pollinators and pollination services in urban agricultural sites	PLOS ONE			English	Article							HYMENOPTERA APOIDEA ANTHOPHILA; BEES HYMENOPTERA; FORAGING RANGES; BODY-SIZE; LAND-USE; ABUNDANCE; RICHNESS; ASSEMBLAGES; DIVERSITY; COMMUNITY	Urbanization has detrimental effects on biodiversity and ecosystem functioning, as agricultural and semi-natural habitats are converted into landscapes dominated by built features. Urban agricultural sites are a growing component of urban landscapes and have potential to serve as a source of biodiversity conservation and ecosystem service provisioning in urban areas. In 19 urban agricultural sites, we investigated how surrounding land cover and local site variables supported bees and pollination services. We found the abundance of bees differentially responded to landscape and local scale variables depending on body size and nesting habit. Large-bodied bees, Bombus and Apis species, were positively associated with increasing amounts of impervious cover, while the abundance of small-bodied soil nesting Halictus species increased as the proportion of flower area, a local variable, increased. Bee richness declined with increasing levels of impervious cover, while bee community composition changed along a gradient of increasing impervious cover. Pollination services, measured at each site using sentinel cucumber plants, declined as hardscape, a local variable, increased. To improve bee conservation and pollination services in urban agricultural sites, our results suggest urban planning strategies should minimize impervious cover at large spatial scales while land managers should focus locally on incorporating floral resources, which increases food and nesting resources especially for smaller bee species. Local site design coupled with regional urban planning can advance the success of urban agriculture, while benefiting biodiversity by creating opportunities for pollinator conservation in urban landscapes.	[Bennett, Ashley B.; Lovell, Sarah] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Bennett, Ashley B.] EPRI, Knoxville, TN 37932 USA	University of Illinois System; University of Illinois Urbana-Champaign; Electric Power Research Institute (EPRI)	Bennett, AB (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.; Bennett, AB (corresponding author), EPRI, Knoxville, TN 37932 USA.	abennett@epri.com			USDA through Hatch Act funds; Mini-Grants Program of the North Central Region Integrated Pest Management Center	USDA through Hatch Act funds; Mini-Grants Program of the North Central Region Integrated Pest Management Center	Support for this project was provided by USDA through Hatch Act funds (project no. ILLU-802-383) and the Mini-Grants Program of the North Central Region Integrated Pest Management Center.	Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Aronson MFJ, 2017, FRONT ECOL ENVIRON, V15, P189, DOI 10.1002/fee.1480; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Benjamin FE, 2014, J APPL ECOL, V51, P440, DOI 10.1111/1365-2664.12198; Bennet DG, 2018, NEW ZEAL J ECOL, V42, P40, DOI 10.20417/nzjecol.42.1; Bennett AB, 2014, INSECT CONSERV DIVER, V7, P405, DOI 10.1111/icad.12062; Bennett AB, 2014, AGR ECOSYST ENVIRON, V193, P1, DOI 10.1016/j.agee.2014.04.016; Bennett AB, 2013, ECOL APPL, V23, P86, DOI 10.1890/11-2029.1; Bennett AB, 2012, LANDSCAPE URBAN PLAN, V104, P26, DOI 10.1016/j.landurbplan.2011.09.007; Burkman CE, 2014, BIOL CONTROL, V75, P58, DOI 10.1016/j.biocontrol.2014.02.015; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Cane JH, 2006, ECOL APPL, V16, P632, DOI 10.1890/1051-0761(2006)016[0632:CRWADB]2.0.CO;2; Cane JH, 2000, J KANSAS ENTOMOL SOC, V73, P225; Choate BA, 2018, J INSECT CONSERV, V22, P391, DOI 10.1007/s10841-018-0068-6; Clucas B, 2018, URBAN ECOSYST, V21, P635, DOI 10.1007/s11252-018-0748-8; Couvillon M, 2015, APIDOLOGIE, V46, P61, DOI 10.1007/s13592-014-0302-5; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; Egerer MH, 2017, ANN ENTOMOL SOC AM, V110, P97, DOI 10.1093/aesa/saw063; Fortel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104679; Foster G, 2017, URBAN ECOSYST, V20, P425, DOI 10.1007/s11252-016-0604-7; Gaston K. J., 2010, URBAN ECOLOGY; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Geslin B, 2016, ECOL EVOL, V6, P6599, DOI 10.1002/ece3.2374; Gibbs J, 2011, ZOOTAXA, P1; Gibbs J, 2010, ZOOTAXA, P1; Gingras D, 1999, J ECON ENTOMOL, V92, P435, DOI 10.1093/jee/92.2.435; Glaum P, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170156; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Harrison T, 2018, GLOBAL CHANGE BIOL, V24, P287, DOI 10.1111/gcb.13921; Hopfenmuller S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104439; Hoyle H, 2018, LANDSCAPE URBAN PLAN, V180, P103, DOI 10.1016/j.landurbplan.2018.08.017; Hunter MR, 2008, INSECT CONSERV DIVER, V1, P189, DOI 10.1111/j.1752-4598.2008.00024.x; Jha S, 2013, P NATL ACAD SCI USA, V110, P555, DOI 10.1073/pnas.1208682110; Jones EL, 2012, EUR J ENTOMOL, V109, P463, DOI 10.14411/eje.2012.060; Joshi NK, 2015, ANN ENTOMOL SOC AM, V108, P785, DOI 10.1093/aesa/sav057; Junker RR, 2010, J ANIM ECOL, V79, P818, DOI 10.1111/j.1365-2656.2010.01698.x; Kantsa A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03448-w; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Kong FH, 2010, LANDSCAPE URBAN PLAN, V95, P16, DOI 10.1016/j.landurbplan.2009.11.001; Kremen C, 2000, CONSERV BIOL, V14, P1226, DOI 10.1046/j.1523-1739.2000.00013.x; LaBERGE WALLACE E., 1956, UNIV KANSAS SCI BULL, V37, P911; Larson JL, 2014, J INSECT CONSERV, V18, P863, DOI 10.1007/s10841-014-9694-9; Larue AAC, 2016, J ANIM ECOL, V85, P396, DOI 10.1111/1365-2656.12441; Legendre P., 2012, NUMERICAL ECOLOGY; Lerman SB, 2016, ANN ENTOMOL SOC AM, V109, P713, DOI 10.1093/aesa/saw043; Lovell ST, 2013, LANDSCAPE ECOL, V28, P1447, DOI 10.1007/s10980-013-9912-y; Lowenstein DM, 2012, ENVIRON ENTOMOL, V41, P532, DOI 10.1603/EN11241; Lowenstein DM, 2015, OECOLOGIA, V179, P811, DOI 10.1007/s00442-015-3389-0; Matteson K.C., 2009, CITIES ENV, V2, P1, DOI [10.15365/cate.2152009, DOI 10.15365/CATE.2152009]; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; Melathopoulos AP, 2015, ECOL ECON, V109, P59, DOI 10.1016/j.ecolecon.2014.11.007; MITCHELL THEODORE B., 1960, N CAROLINA AGRIC EXPT STA TECH BULL, V141, P1; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Pardee GL, 2014, URBAN ECOSYST, V17, P641, DOI 10.1007/s11252-014-0349-0; Quistberg RD, 2016, ENVIRON ENTOMOL, V45, P592, DOI 10.1093/ee/nvw025; R Core Team, 2021, R LANGUAGE ENV STAT; Rader R, 2013, GLOBAL CHANGE BIOL, V19, P3103, DOI 10.1111/gcb.12264; Reverte S, 2016, ANN BOT-LONDON, V118, P249, DOI 10.1093/aob/mcw103; Rowe L, 2018, ENVIRON ENTOMOL, V47, P1128, DOI 10.1093/ee/nvy091; Shackelford G, 2013, BIOL REV, V88, P1002, DOI 10.1111/brv.12040; Simao MCM, 2018, J APPL ECOL, V55, P1759, DOI 10.1111/1365-2664.13085; Sivakoff FS, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10061926; Su ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119276; Threlfall CG, 2015, BIOL CONSERV, V187, P240, DOI 10.1016/j.biocon.2015.05.003; Tonietto R, 2011, LANDSCAPE URBAN PLAN, V103, P102, DOI 10.1016/j.landurbplan.2011.07.004; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; Watson JC, 2011, ENVIRON ENTOMOL, V40, P621, DOI 10.1603/EN10231; Winfree R, 2011, ANNU REV ECOL EVOL S, V42, P1, DOI 10.1146/annurev-ecolsys-102710-145042; Wolf Amy T., 2008, Great Lakes Entomologist, V41, P129; Wray JC, 2014, ECOL ENTOMOL, V39, P83, DOI 10.1111/een.12070; Wright IR, 2015, EUR J ENTOMOL, V112, P303, DOI 10.14411/eje.2015.028; Xie ZH, 2013, ENTOMOL SCI, V16, P170, DOI 10.1111/ens.12009; Zanette LRS, 2005, LANDSCAPE URBAN PLAN, V71, P105, DOI 10.1016/j.landurbplan.2004.02.003; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	80	40	41	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0212034	10.1371/journal.pone.0212034	http://dx.doi.org/10.1371/journal.pone.0212034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5IX	30759171	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300071
J	Lin, SW; Wang, SK; Lu, MC; Wang, CL; Koo, M				Lin, Shi-Wei; Wang, Sheng-Kai; Lu, Ming-Chi; Wang, Chun-Lung; Koo, Malcolm			Acute rhinosinusitis among pediatric patients with allergic rhinitis: A nationwide, population-based cohort study	PLOS ONE			English	Article							ACUTE BACTERIAL SINUSITIS; PREVALENCE; MANAGEMENT; CHILDREN; ASTHMA	Background While chronic rhinosinusitis is a common complication of allergic rhinitis, the link between acute rhinosinusitis and allergic rhinitis is unclear. The aim of this study was to evaluate the risk of incident acute rhinosinusitis among pediatric patients with allergic rhinitis, using a nationwide, population-based health claims research database. Methods Newly diagnosed allergic rhinitis patients aged 5-18 years were identified from the health claim records of the Longitudinal Health Insurance Database 2000 of Taiwan's National Health Insurance Research Database. A comparison cohort was assembled by randomly selecting patients from the same database with frequency matching by sex, age group, and index year. All patients were followed until a diagnosis of acute rhinosinusitis or the end of the follow-up period. Cox proportional hazards model was used to assess the association between allergic rhinitis and acute rhinosinusitis. Results Of the 43,588 pediatric patients included in this study, 55.4% were male and 43.9% were between the ages of 5.0-7.9 years. The risk of acute rhinosinusitis was significantly higher in pediatric patients with allergic rhinitis compared to those without the condition (adjusted hazard ratio = 3.03, 95% confidence interval = 2.89-3.18). Similar hazard ratios were observed between male and female pediatric patients. Conclusions This secondary cohort study using a nationwide, population-based health claim data of the Taiwan's NHIRD showed that allergic rhinitis was significantly associated with a higher risk of acute rhinosinusitis among pediatric patients.	[Lin, Shi-Wei; Wang, Sheng-Kai; Wang, Chun-Lung] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Pediat, Chiayi, Taiwan; [Lu, Ming-Chi] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lu, Ming-Chi; Wang, Chun-Lung] Tzu Chi Univ, Sch Med, Hualien, Hualien, Taiwan; [Koo, Malcolm] Tzu Chi Univ Sci & Technol, Grad Inst Long Term Care, Hualien, Hualien, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Tzu Chi University of Science & Technology; University of Toronto	Wang, CL (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Pediat, Chiayi, Taiwan.; Wang, CL (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Hualien, Taiwan.; Koo, M (corresponding author), Tzu Chi Univ Sci & Technol, Grad Inst Long Term Care, Hualien, Hualien, Taiwan.; Koo, M (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	M120673@tzuchi.com.tw; m.koo@utoronto.ca	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167				Ahmad N, 2008, OTOLARYNG CLIN N AM, V41, P267, DOI 10.1016/j.otc.2007.11.010; Alho OP, 2003, ALLERGY, V58, P767, DOI 10.1034/j.1398-9995.2003.00252.x; Anon Jack B, 2003, Paediatr Drugs, V5 Suppl 1, P25; Blair C, 2001, J ALLERGY CLIN IMMUN, V108, P424, DOI 10.1067/mai.2001.117793; DeMuri G, 2013, PEDIATR REV, V34, P429, DOI 10.1542/pir.34-10-429; Droma Y, 2007, CLIN EXP ALLERGY, V37, P1326, DOI 10.1111/j.1365-2222.2007.02781.x; Dykewicz MS, 2010, J ALLERGY CLIN IMMUN, V125, pS103, DOI 10.1016/j.jaci.2009.12.989; Fang A, 2015, PEDIATR EMERG CARE, V31, P789, DOI 10.1097/PEC.0000000000000599; Foden N, 2013, BRIT J GEN PRACT, V63, P611, DOI 10.3399/bjgp13X674620; Huang WH, 2006, LARYNGOSCOPE, V116, P288, DOI 10.1097/01.mlg.0000197316.36698.c4; Kirtsreesakul V, 2004, CURR OPIN ALLERGY CL, V4, P17, DOI 10.1097/01.all.0000113673.18759.c9; Kronemer KA, 1997, PEDIATR RADIOL, V27, P837; Leo G, 2018, J LARYNGOL OTOL, V132, P150, DOI 10.1017/S0022215118000038; Liao PF, 2009, PEDIATR NEONATOL, V50, P18, DOI 10.1016/S1875-9572(09)60025-5; Lin SW, 2012, INT J PEDIATR OTORHI, V76, P70, DOI 10.1016/j.ijporl.2011.10.002; Marom T, 2014, PEDIATR INFECT DIS J, V33, P803, DOI 10.1097/INF.0000000000000278; Marseglia GL, 2007, INT J IMMUNOPATH PH, V20, P97, DOI 10.1177/039463200702000111; National Health Insurance Administration, NATIONAL HEALTH INSU; NEWMAN LJ, 1994, JAMA-J AM MED ASSOC, V271, P363, DOI 10.1001/jama.271.5.363; Reid JR, 2004, PEDIATR RADIOL, V34, P933, DOI 10.1007/s00247-004-1252-2; Skoner DR, 2001, J ALLERGY CLIN IMMUN, V108, pS2, DOI 10.1067/mai.2001.115569; Wald ER, 2013, PEDIATRICS, V132, pE262, DOI 10.1542/peds.2013-1071; Wheatley LM, 2015, NEW ENGL J MED, V372, P456, DOI 10.1056/NEJMcp1412282; Worrall G, 2011, CAN FAM PHYSICIAN, V57, P565	24	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211547	10.1371/journal.pone.0211547	http://dx.doi.org/10.1371/journal.pone.0211547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753196	gold, Green Published, Green Submitted			2022-12-26	WOS:000458395600012
J	Sauvegrain, P; Chantry, AA; Chiesa-Dubruille, C; Keita, H; Goffinet, F; Deneux-Tharaux, C				Sauvegrain, Priscille; Chantry, Anne Alice; Chiesa-Dubruille, Coralie; Keita, Hawa; Goffinet, Francois; Deneux-Tharaux, Catherine			Monitoring quality of obstetric care from hospital discharge databases: A Delphi survey to propose a new set of indicators based on maternal health outcomes	PLOS ONE			English	Article							POSTPARTUM HEMORRHAGE; DELIVERY; VALIDITY; CODES	Objectives Most indicators proposed for assessing quality of care in obstetrics are process indicators and do not directly measure health effects, and cannot always be identified from routinely available databases. Our objective was to propose a set of indicators to assess the quality of hospital obstetric care from maternal morbidity outcomes identifiable in permanent hospital discharge databases. Methods Various maternal morbidity outcomes potentially reflecting quality of obstetric care were first selected from a systematic literature review. Then a three-round Delphi consensus survey was conducted online from 11/2016 through 02/2017 among a French panel of 37 expert obstetricians, anesthetists-critical-care specialists, midwives, quality-of-care researchers, and user representatives. For a given maternal outcome, several definitions could be proposed and the indicator (i.e. corresponding rate) could be applied to all women or restricted to specific subgroup(s). Results Of the 49 experts invited to participate, 37 agreed. The response rate was 92% in the second round and 97% in the third. Finally, a set of 13 indicators was selected to assess the quality of hospital obstetric care: rates of uterine rupture, postpartum hemorrhage, transfusion incident, severe perineal lacerations, episiotomy, cesarean, cesarean under general anesthesia, post-cesarean site infection, anesthesia-related complications, postpartum pulmonary embolism, maternal readmission and maternal mortality. Six were considered in specific subgroups, with, for example, the postpartum hemorrhage rate assessed among all women and also among women at low risk of PPH.	[Sauvegrain, Priscille; Chantry, Anne Alice; Chiesa-Dubruille, Coralie; Goffinet, Francois; Deneux-Tharaux, Catherine] Paris Descartes Univ, Sorbonne Paris Cite,DHU Risks Pregnancy, Perinatal & Pediat Epidemiol Res Team Epope, INSERM,UMR 1153,Ctr Epidemiol & Stat,Obstetr, Paris, France; [Sauvegrain, Priscille] AP HP Pitie Salpetriere, Dept Obstet & Gynecol, Paris, France; [Chantry, Anne Alice] Univ Paris 05, AP HP, DHU Risks Pregnancy, Sch Midw, Paris, France; [Keita, Hawa] AP HP Louis Mourier, Dept Anesthesia & Reanimat, DHU Risks Pregnancy, Colombes, France; [Keita, Hawa] Paris Diderot Univ, Sorbonne Paris Cite, Rech Clin Coordonne Ville Hop Methodol & Soc REME, Paris, France; [Goffinet, Francois] AP HP Cochin Port Royal, Dept Obstet & Gynecol, DHU Risks Pregnancy, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Sauvegrain, P (corresponding author), Paris Descartes Univ, Sorbonne Paris Cite,DHU Risks Pregnancy, Perinatal & Pediat Epidemiol Res Team Epope, INSERM,UMR 1153,Ctr Epidemiol & Stat,Obstetr, Paris, France.; Sauvegrain, P (corresponding author), AP HP Pitie Salpetriere, Dept Obstet & Gynecol, Paris, France.	priscille.sauvegrain@inserm.fr	Deneux-Tharaux, Catherine/R-1111-2016; chantry, anne/GRO-3006-2022	Sauvegrain, Priscille/0000-0003-1014-6655; haller, guy/0000-0001-7367-7029	French Directorate [1358]	French Directorate	The Momassi project received funding from the French Directorate-General for the organization of care as part of a research program on the performance of the System of specific care to indicators of the quality and safety of care (PREPS-IQ 2013 no1358). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailit JL, 2016, AM J OBSTET GYNECOL, V215, pB8, DOI 10.1016/j.ajog.2016.06.048; Bailit JL, 2013, AM J OBSTET GYNECOL, V208, P427, DOI [10.1016/j.ajog.2013.03.002, 10.1016/j.ajog.2013.07.019]; Boulkedid R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060663; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Bunch KJ, 2018, BJOG INT J OBSTET GY; Chantry AA, 2011, J CLIN EPIDEMIOL, V64, P1014, DOI 10.1016/j.jclinepi.2010.11.015; Deneux-Tharaux C, 2017, GYNECOL OBST FERT SE, V45, pS8, DOI 10.1016/j.gofs.2017.10.025; Driessen M, 2011, OBSTET GYNECOL, V117, P21, DOI 10.1097/AOG.0b013e318202c845; Fischer R.G., 1978, J ACAD LIBR, V4, P64; Freidson E., 1988, PROFESSION MED STUDY; Goff SL, 2012, PAEDIATR PERINAT EP, V26, P421, DOI 10.1111/j.1365-3016.2012.01303.x; Haller G, 2010, J GYNECOL OBST BIO R, V39, P371, DOI 10.1016/j.jgyn.2010.05.011; Janakiraman V, 2010, OBSTET GYNECOL, V116, P728, DOI 10.1097/AOG.0b013e3181ea4d4f; Kesmodel US, 2011, ACTA OBSTET GYN SCAN, V90, P295, DOI 10.1111/j.1600-0412.2011.01078.x; Kristensen S, 2009, INT J QUAL HEALTH C, V21, P169, DOI 10.1093/intqhc/mzp015; Kyser KL, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.010; Mann S, 2006, JT COMM J QUAL PATIE, V32, P497, DOI 10.1016/S1553-7250(06)32065-X; Sagot P, 2012, EUR J OBSTET GYN R B, V162, P160, DOI 10.1016/j.ejogrb.2012.02.021; Schaap T, 2019, BJOG-INT J OBSTET GY, V126, P394, DOI 10.1111/1471-0528.14833; Sibanda T, 2013, EUR J OBSTET GYN R B, V166, P23, DOI 10.1016/j.ejogrb.2012.09.018; Sigakis MJG, 2016, ANESTH ANALG, V123, P731, DOI 10.1213/ANE.0000000000001436; Wildman K, 2003, EUR J OBSTET GYN R B, V111, pS53, DOI 10.1016/j.ejogrb.2003.09.006; Woiski MD, 2015, ACTA OBSTET GYN SCAN, V94, P1118, DOI 10.1111/aogs.12718	23	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211955	10.1371/journal.pone.0211955	http://dx.doi.org/10.1371/journal.pone.0211955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753232	Green Published, gold, Green Submitted			2022-12-26	WOS:000458395600032
J	Scarpati, M; Qi, Y; Govind, S; Singh, S				Scarpati, Michael; Qi, Yan; Govind, Shubha; Singh, Shaneen			A combined computational strategy of sequence and structural analysis predicts the existence of a functional eicosanoid pathway in Drosophila melanogaster	PLOS ONE			English	Article							PROSTAGLANDIN E-2 SYNTHASE; HUMAN ALDOSE REDUCTASE; CRYSTAL-STRUCTURE; ARACHIDONIC-ACID; PROTEIN-STRUCTURE; WEB SERVER; LIPID MEDIATORS; ACTIVE-SITE; CYCLOOXYGENASE; IDENTIFICATION	This study reports on a putative eicosanoid biosynthesis pathway in Drosophila melanogaster and challenges the currently held view that mechanistic routes to synthesize eicosanoid or eicosanoid-like biolipids do not exist in insects, since to date, putative fly homologs of most mammalian enzymes have not been identified. Here we use systematic and comprehensive bioinformatics approaches to identify most of the mammalian eicosanoid synthesis enzymes. Sensitive sequence analysis techniques identified candidate Drosophila enzymes that share low global sequence identities with their human counterparts. Twenty Drosophila candidates were selected based upon (a) sequence identity with human enzymes of the cyclooxygenase and lipoxygenase branches, (b) similar domain architecture and structural conservation of the catalytic domain, and (c) presence of potentially equivalent functional residues. Evaluation of full-length structural models for these 20 top-scoring Drosophila candidates revealed a surprising degree of conservation in their overall folds and potential analogs for functional residues in all 20 enzymes. Although we were unable to identify any suitable candidate for lipoxygenase enzymes, we report structural homology models of three fly cyclooxygenases. Our findings predict that the D. melanogaster genome likely codes for one or more pathways for eicosanoid or eicosanoid-like biolipid synthesis. Our study suggests that classical and/or novel eicosanoids mediators must regulate biological functions in insects-predictions that can be tested with the power of Drosophila genetics. Such experimental analysis of eicosanoid biology in a simple model organism will have high relevance to human development and health.	[Scarpati, Michael; Qi, Yan; Singh, Shaneen] CUNY Brooklyn Coll, Brooklyn, NY 11210 USA; [Scarpati, Michael; Qi, Yan; Govind, Shubha; Singh, Shaneen] CUNY, Grad Ctr, PhD Program Biol, New York, NY 10031 USA; [Govind, Shubha; Singh, Shaneen] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10031 USA; [Govind, Shubha] CUNY City Coll, New York, NY 10031 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; City College of New York (CUNY)	Singh, S (corresponding author), CUNY Brooklyn Coll, Brooklyn, NY 11210 USA.; Singh, S (corresponding author), CUNY, Grad Ctr, PhD Program Biol, New York, NY 10031 USA.; Singh, S (corresponding author), CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10031 USA.	ssingh@brooklyn.cuny.edu		Singh, Shaneen/0000-0002-4003-5756; Govind, Shubha/0000-0002-6436-639X	PSC CUNY [61298-00 49]; NSF [0618233]; NASA [NNX15AB42G]	PSC CUNY; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	This work was supported in part by PSC CUNY 61298-00 49 and NSF 0618233 to SMS and NASA NNX15AB42G to SG.	Adrian TE, 2008, PPAR RES, V2008, DOI 10.1155/2008/827096; Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOHREN KM, 1994, BIOCHEMISTRY-US, V33, P2021, DOI 10.1021/bi00174a007; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Boyce JA, 2008, CURR MOL MED, V8, P335, DOI 10.2174/156652408785160989; Bresell A, 2005, FEBS J, V272, P1688, DOI 10.1111/j.1742-4658.2005.04596.x; Bresson E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00098; Bresson E, 2011, J CLIN ENDOCR METAB, V96, P210, DOI 10.1210/jc.2010-1589; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; BUNDY GL, 1985, ADV PROSTAG THROMB L, V14, P229; Capdevila JH, 2002, PROSTAG OTH LIPID M, V68-9, P325, DOI 10.1016/S0090-6980(02)00038-2; CASAS J, 1986, REV ESP FISIOL, V42, P507; Castonguay R, 2007, BIOCHEMISTRY-US, V46, P12253, DOI 10.1021/bi700956c; Chandrasekharan NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-241; Chiang CW, 2006, J MOL BIOL, V364, P266, DOI 10.1016/j.jmb.2006.09.039; Chuang SS, 2004, J BIOL CHEM, V279, P6305, DOI 10.1074/jbc.M311830200; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; El-Hawari Y, 2009, CHEM-BIOL INTERACT, V178, P234, DOI 10.1016/j.cbi.2008.11.004; ELKABBANI O, 1994, ACTA CRYSTALLOGR D, V50, P859, DOI 10.1107/S0907444994005275; Fang X, 1999, J LIPID RES, V40, P699; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Funk CD, 1996, BBA-LIPID LIPID MET, V1304, P65, DOI 10.1016/S0005-2760(96)00107-5; Garscha U, 2009, J BIOL CHEM, V284, P13755, DOI 10.1074/jbc.M808665200; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Guengerich FP, 2016, TRENDS PHARMACOL SCI, V37, P625, DOI 10.1016/j.tips.2016.05.006; Hansen J, 2013, APPL MICROBIOL BIOT, V97, P4737, DOI 10.1007/s00253-013-4887-9; HECKER M, 1987, EUR J BIOCHEM, V169, P113, DOI 10.1111/j.1432-1033.1987.tb13587.x; Horn T, 2015, PROG LIPID RES, V57, P13, DOI 10.1016/j.plipres.2014.11.001; Huang XQ, 2006, BIOORGAN MED CHEM, V14, P3553, DOI 10.1016/j.bmc.2006.01.010; Inoue T, 2003, NAT STRUCT BIOL, V10, P291, DOI 10.1038/nsb907; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jarving R, 2004, J BIOL CHEM, V279, P13624, DOI 10.1074/jbc.M313258200; Jegerschold C, 2008, P NATL ACAD SCI USA, V105, P11110, DOI 10.1073/pnas.0802894105; John B, 2003, NUCLEIC ACIDS RES, V31, P3982, DOI 10.1093/nar/gkg460; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kalgutkar AS, 2000, P NATL ACAD SCI USA, V97, P925, DOI 10.1073/pnas.97.2.925; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Khor BY, 2015, THEOR BIOL MED MODEL, V12, DOI 10.1186/s12976-015-0014-1; Kim Y, 2018, DEV COMP IMMUNOL, V83, P130, DOI 10.1016/j.dci.2017.12.005; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Nayeem A, 2006, PROTEIN SCI, V15, P808, DOI 10.1110/ps.051892906; Niesen FH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013719; Nitanai Y, 2002, J MOL BIOL, V321, P177, DOI 10.1016/S0022-2836(02)00632-0; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; PAGES M, 1986, PROSTAG OTH LIPID M, V32, P729, DOI 10.1016/0090-6980(86)90195-4; Park J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105717; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Peters-Golden M, 2003, PROSTAG LEUKOTR ESS, V69, P99, DOI 10.1016/S0952-3278(03)00070-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Pundir S, 2015, CURR PROTOC BIOINFOR, V50, P10; RAGAB A, 1987, INSECT BIOCHEM, V17, P863, DOI 10.1016/0020-1790(87)90021-7; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Reddanna P, 2003, ARCH BIOCHEM BIOPHYS, V413, P158, DOI 10.1016/S0003-9861(03)00080-8; Rocha PN, 2003, SPRINGER SEMIN IMMUN, V25, P215, DOI 10.1007/s00281-003-0132-4; Roche DB, 2014, METHODS MOL BIOL, V1137, P83, DOI 10.1007/978-1-4939-0366-5_7; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruiz F, 2004, ACTA CRYSTALLOGR D, V60, P1347, DOI 10.1107/S0907444904011370; Sanglas L, 2009, P NATL ACAD SCI USA, V106, P1743, DOI 10.1073/pnas.0812623106; Schneider C, 2000, J BIOL CHEM, V275, P4743, DOI 10.1074/jbc.275.7.4743; SCHNEIDER MR, 1994, CANCER METAST REV, V13, P349, DOI 10.1007/BF00666104; Schrodinger L.L.C., 2015, PYMOL MOL GRAPH SYST; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Shen LR, 2010, J LIPID RES, V51, P2985, DOI 10.1194/jlr.M008524; Shimamoto S, 2007, J BIOL CHEM, V282, P31373, DOI 10.1074/jbc.M700123200; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Sidhu RS, 2010, BIOCHEMISTRY-US, V49, P7069, DOI 10.1021/bi1003298; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Sjogren T, 2013, P NATL ACAD SCI USA, V110, P3806, DOI 10.1073/pnas.1218504110; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sobrado M, 2009, J NEUROSCI, V29, P3875, DOI 10.1523/JNEUROSCI.5529-08.2009; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stanley David, 2011, Front Endocrinol (Lausanne), V2, P105, DOI 10.3389/fendo.2011.00105; Sutherland M, 2001, BIOCHEM J, V353, P91, DOI 10.1042/bj3530091; Tan LL, 2016, LIPIDS, V51, P435, DOI 10.1007/s11745-016-4131-3; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Tholander F, 2008, CHEM BIOL, V15, P920, DOI 10.1016/j.chembiol.2008.07.018; Thunnissen MMGM, 2002, FASEB J, V16, P1648, DOI 10.1096/fj.01-1017fje; Thuresson ED, 2002, ADV EXP MED BIOL, V507, P67; Tootle TL, 2008, DEVELOPMENT, V135, P839, DOI 10.1242/dev.017590; Tosatto SCE, 2008, ANTIOXID REDOX SIGN, V10, P1515, DOI 10.1089/ars.2008.2055; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Valmsen K, 2004, EUR J BIOCHEM, V271, P3533, DOI 10.1111/j.0014-2956.2004.04289.x; Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang LH, 2002, PROSTAG OTH LIPID M, V68-9, P409, DOI 10.1016/S0090-6980(02)00045-X; Watanabe K, 2003, BIOCHEM BIOPH RES CO, V306, P577, DOI 10.1016/S0006-291X(03)01025-8; Watson M., 2014, IDENTIFICATION LIPID; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; West MB, 2013, J BIOL CHEM, V288, P31902, DOI 10.1074/jbc.M113.498139; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xiao GS, 1997, BIOCHEMISTRY-US, V36, P1836, DOI 10.1021/bi962476u; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yamada T, 2005, J MOL BIOL, V348, P1163, DOI 10.1016/j.jmb.2005.03.035; Yan RX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02619; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Yoshida Y, 2008, ANAL BIOCHEM, V379, P105, DOI 10.1016/j.ab.2008.04.028; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	121	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211897	10.1371/journal.pone.0211897	http://dx.doi.org/10.1371/journal.pone.0211897			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753230	Green Published, gold, Green Submitted			2022-12-26	WOS:000458395600029
J	Ye, Q; Zhang, CN; Wang, ZL; Feng, YY; Zhou, AG; Xie, SL; Xiang, Q; Song, EF; Zou, JX				Ye, Qiao; Zhang, Chaonan; Wang, Zhenlu; Feng, Yongyong; Zhou, Aiguo; Xie, Shaolin; Xiang, Qiong; Song, Enfeng; Zou, Jixing			Induction of oxidative stress, apoptosis and DNA damage by koumine in Tetrahymena thermophila	PLOS ONE			English	Article							CILIATED PROTOZOAN; CELL VIABILITY; RAT MODEL; METALLOTHIONEIN; RESPONSES; TOXICITY; GROWTH; PROLIFERATION; REPRODUCTION; RESISTANCE	Koumine is a component of the Chinese medicinal herb Gelsemium elegans and is toxic to vertebrates. We used the ciliate Tetrahymena thermophila as a model to evaluate the toxic effects of this indole alkaloid in eukaryotic microorganisms. Koumine inhibited T. thermophila growth and viability in a dose-dependent manner. Moreover, this drug produced oxidative stress in T. thermophila cells and expressions of antioxidant enzymes were significantly elevated at high koumine levels (p < 0.05). Koumine also caused significant levels of apoptosis (p < 0.05) and induced DNA damage in a dose-dependent manner. Mitophagic vacuoles were present in cells indicating induction of autophagy by this drug. Expression of ATG7, MTT2/4, CYP1 and HSP70 as well as the MAP kinase pathway gene MPK1 and MPK3 were significantly altered after exposed to koumine. This study represents a preliminary toxicological evaluation of koumine in the single celled eukaryote T. thermophila.	[Ye, Qiao; Zhang, Chaonan; Wang, Zhenlu; Feng, Yongyong; Zhou, Aiguo; Xie, Shaolin; Zou, Jixing] South China Agr Univ, Coll Marine Sci, Hlth Aquaculture Lab, Guangzhou, Guangdong, Peoples R China; [Ye, Qiao; Zhang, Chaonan; Wang, Zhenlu; Feng, Yongyong; Zhou, Aiguo; Xie, Shaolin; Zou, Jixing] South China Agr Univ, Coll Marine Sci, Joint Lab Guangdong Prov & Hong Kong Reg Marine B, Guangzhou, Guangdong, Peoples R China; [Xiang, Qiong; Song, Enfeng] Wuhan Univ, Dept Tradit Chinese Med, Renmin Hosp, Wuhan, Hubei, Peoples R China	South China Agricultural University; South China Agricultural University; Wuhan University	Zou, JX (corresponding author), South China Agr Univ, Coll Marine Sci, Hlth Aquaculture Lab, Guangzhou, Guangdong, Peoples R China.; Zou, JX (corresponding author), South China Agr Univ, Coll Marine Sci, Joint Lab Guangdong Prov & Hong Kong Reg Marine B, Guangzhou, Guangdong, Peoples R China.	zoujixing@scau.edu.cn	Zhou, Aiguo/AAN-2012-2020	Zhou, Aiguo/0000-0002-7209-1234	earmarked fund for China Agriculture Research System [CARS-45]	earmarked fund for China Agriculture Research System	This study was supported by the earmarked fund for China Agriculture Research System(CARS-45) to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal N, 2018, INDIAN J GASTROENTER, V37, P353, DOI 10.1007/s12664-018-0860-y; Barata C, 2005, COMP BIOCHEM PHYS C, V140, P175, DOI 10.1016/j.cca.2005.01.013; Belfield C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089936; Cai Jing, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P1851; Chang Y, 2011, SCI CHINA LIFE SCI, V54, P617, DOI 10.1007/s11427-011-4194-6; Chi De-biao, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P994; Diaz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000291; Dondero F, 2004, PROTIST, V155, P157, DOI 10.1078/143446104774199565; Duan YF, 2016, FISH SHELLFISH IMMUN, V58, P10, DOI 10.1016/j.fsi.2016.09.004; Dutt V, 2010, Pharmacogn Rev, V4, P185, DOI 10.4103/0973-7847.70916; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fang L, 2019, BIOMED PHARMACOTHER, V109, P2456, DOI 10.1016/j.biopha.2018.04.012; Feng LF, 2014, AQUAT TOXICOL, V149, P126, DOI 10.1016/j.aquatox.2014.02.004; Franco ME, 2018, COMP BIOCHEM PHYS C, V206, P32, DOI 10.1016/j.cbpc.2018.02.006; Gafter-Gvili A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068341; Gallego A, 2007, CHEMOSPHERE, V68, P647, DOI 10.1016/j.chemosphere.2007.02.031; Gao L, 2015, CHEMOSPHERE, V139, P434, DOI 10.1016/j.chemosphere.2015.07.059; Gao L, 2013, CHEMOSPHERE, V93, P2507, DOI 10.1016/j.chemosphere.2013.09.041; Gonzalez Y, 2014, ONCOTARGET, V5, P1526, DOI 10.18632/oncotarget.1715; Hussain T, 2014, MOL CELL BIOCHEM, V391, P127, DOI 10.1007/s11010-014-1995-5; Iqbal S, 2014, AM J PHYSIOL-CELL PH, V306, pC1176, DOI 10.1152/ajpcell.00017.2014; Kanki T, 2015, BBA-MOL CELL RES, V1853, P2756, DOI 10.1016/j.bbamcr.2015.01.005; Kogure N, 2008, CHEM PHARM BULL, V56, P870, DOI 10.1248/cpb.56.870; Lee E, 2004, TOXICOL SCI, V81, P121, DOI 10.1093/toxsci/kfh184; Li J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10562; Li W, 2015, FOOD CHEM TOXICOL, V80, P1, DOI 10.1016/j.fct.2015.01.015; Liang XM, 2013, CHEMOSPHERE, V90, P1281, DOI 10.1016/j.chemosphere.2012.09.087; Ling Q, 2014, BIOL PHARM BULL, V37, P858, DOI 10.1248/bpb.b13-00843; Liu M, 2013, PSYCHOPHARMACOLOGY, V225, P839, DOI 10.1007/s00213-012-2867-x; Liu M, 2011, BIOL PHARM BULL, V34, P1877, DOI 10.1248/bpb.34.1877; Liu XL, 2011, FISH SHELLFISH IMMUN, V30, P495, DOI 10.1016/j.fsi.2010.11.018; Luo YY, 2019, ENVIRON TOXICOL PHAR, V65, P73, DOI 10.1016/j.etap.2018.12.007; Lynn DH, 2012, METHOD CELL BIOL, V109, P11, DOI 10.1016/B978-0-12-385967-9.00002-5; Ma N, 2015, J BASIC MICROB, V55, P1002, DOI 10.1002/jobm.201400847; Ma WY, 2018, EBIOMEDICINE, V32, P182, DOI 10.1016/j.ebiom.2018.05.021; Maria VL, 2014, ENVIRON RES, V133, P164, DOI 10.1016/j.envres.2014.05.027; Metcalfe NB, 2013, TRENDS ECOL EVOL, V28, P347, DOI 10.1016/j.tree.2013.01.015; Padmini E, 2011, HYPERTENS PREGNANCY, V30, P133, DOI 10.3109/10641950902974252; Patel A, 2011, MOL BIOCHEM PARASIT, V176, P90, DOI 10.1016/j.molbiopara.2010.12.008; Perez-Salamo I, 2014, PLANT PHYSIOL, V165, P319, DOI 10.1104/pp.114.237891; Qiu HQ, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0050-1; Rujjanawate C, 2003, J ETHNOPHARMACOL, V89, P91, DOI 10.1016/S0378-8741(03)00267-8; Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002; Moyses CRS, 2015, REV BRAS PARASITOL V, V24, P283, DOI 10.1590/S1984-29612015054; Turkewitz AP, 2002, TRENDS GENET, V18, P35, DOI 10.1016/S0168-9525(01)02560-4; Van Tiem LA, 2011, TOXICOL APPL PHARM, V254, P280, DOI 10.1016/j.taap.2011.05.002; Varghese J, 2003, APOPTOSIS, V8, P363, DOI 10.1023/A:1024121017841; [王晓红 Wang Xiaohong], 2018, [测绘通报, Bulletin of Surveying and Mapping], P38; Xu Y, 2012, PHARMACOL BIOCHEM BE, V101, P504, DOI 10.1016/j.pbb.2012.02.009; Yan S, 2014, CELL MOL LIFE SCI, V71, P3951, DOI 10.1007/s00018-014-1666-4; Ye Q, 2018, PEERJ, V6, DOI 10.7717/peerj.6093; Yu ZY, 2019, ENVIRON POLLUT, V244, P398, DOI 10.1016/j.envpol.2018.10.033; Yurinskaya MM, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.336; Zhang XH, 2015, CELL BIOCHEM BIOPHYS, V72, P411, DOI 10.1007/s12013-014-0479-2; Zhang Z, 2012, FITOTERAPIA, V83, P704, DOI 10.1016/j.fitote.2012.02.007	56	7	10	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212231	10.1371/journal.pone.0212231	http://dx.doi.org/10.1371/journal.pone.0212231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753239	gold, Green Published, Green Submitted			2022-12-26	WOS:000458395600056
J	Garcia-Bustos, V; Sebastian, R; Izquierdo, M; Rios-Navarro, C; Bodi, V; Chorro, FJ; Ruiz-Sauri, A				Garcia-Bustos, Victor; Sebastian, Rafael; Izquierdo, Maite; Rios-Navarro, Cesar; Bodi, Vicente; Javier Chorro, Francisco; Ruiz-Sauri, Amparo			Changes in the spatial distribution of the Purkinje network after acute myocardial infarction in the pig	PLOS ONE			English	Article							VENTRICULAR-TACHYCARDIA; CONDUCTING SYSTEM; FIBERS; CELLS; ABLATION; ISCHEMIA; ULTRASTRUCTURE	Purkinje cells (PCs) are more resistant to ischemia than myocardial cells, and are suspected to participate in ventricular arrhythmias following myocardial infarction (MI). Histological studies afford little evidence on the behavior and adaptation of PCs in the different stages of MI, especially in the chronic stage, and no quantitative data have been reported to date beyond subjective qualitative depictions. The present study uses a porcine model to present the first quantitative analysis of the distal cardiac conduction system and the first reported change in the spatial distribution of PCs in three representative stages of MI: an acute model both with and without reperfusion; a subacute model one week after reperfusion; and a chronic model one month after reperfusion. Purkinje cells are able to survive after 90 minutes of ischemia and subsequent reperfusion to a greater extent than cardiomyocytes. A decrease is observed in the number of PCs, which suffer reversible subcellular alterations such as cytoplasm vacuolization, together with redistribution from the mesocardium-the main localization of PCs in the heart of ungulate species-towards the endocardium and perivascular epicardial areas. However, these changes mainly occur during the first week after ischemia and reperfusion, and are maintained in the chronic stages. This anatomical substrate can explain the effectiveness of endo-epicardial catheter ablation of monomorphic ventricular tachycardias in the chronic scar after infarction, and sets a basis for further electrophysiological and molecular studies, and future therapeutic strategies.	[Garcia-Bustos, Victor; Ruiz-Sauri, Amparo] Univ Valencia, Fac Med, Dept Pathol, Valencia, Spain; [Garcia-Bustos, Victor] Hosp Univ & Politecn La Fe, Dept Internal Med Unit, Valencia, Spain; [Sebastian, Rafael] Univ Valencia, Computat Multiscale Simulat Lab, Valencia, Spain; [Izquierdo, Maite; Rios-Navarro, Cesar; Bodi, Vicente; Javier Chorro, Francisco; Ruiz-Sauri, Amparo] INCLIVA Biomed Res Inst, Valencia, Spain; [Izquierdo, Maite; Bodi, Vicente; Javier Chorro, Francisco] Hosp Clin Univ Valencia, Dept Cardiol, Valencia, Spain; [Bodi, Vicente; Javier Chorro, Francisco] Carlos III Hlth Inst, CIBERCV, Madrid, Spain	University of Valencia; Hospital Universitari i Politecnic La Fe; University of Valencia; Hospital Clinic Universitari de Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Sebastian, R (corresponding author), Univ Valencia, Computat Multiscale Simulat Lab, Valencia, Spain.	rafael.sebastian@uv.es	Ríos-Navarro, Cesar/AAB-3875-2019; Chorro, Francisco J/AAB-6766-2020; Sebastian, Rafael/E-9386-2011; Garcia-Bustos, Victor/ABA-7652-2020	Ríos-Navarro, Cesar/0000-0002-6405-6279; Sebastian, Rafael/0000-0001-6746-5740; Garcia-Bustos, Victor/0000-0002-1785-258X	Programa VLC-BIOCLINIC Subprograma A [01-ESPUMA-JULIAN-RUIZ-2017-A]; Spanish Ministerio de Ciencia y Competitividad [TIN2014-59932-JIN]; 'Instituto de Salud Carlos III' [PI14/00271, PI17/01836, PIE15/00013, PI15/01408]	Programa VLC-BIOCLINIC Subprograma A; Spanish Ministerio de Ciencia y Competitividad(Spanish Government); 'Instituto de Salud Carlos III'(Instituto de Salud Carlos IIIEuropean Commission)	The authors report the following funding: ARS: Programa VLC-BIOCLINIC Subprograma A: Grant number: 01-ESPUMA-JULIAN-RUIZ-2017-A, Web: http://vlc-bioclinic.es; RS: Spanish Ministerio de Ciencia y Competitividad, Grant number: TIN2014-59932-JIN, Web: http://www.mineco.gob.es/portal/site/mineco/; VB: 'Instituto de Salud Carlos III', Grant numbers: PI14/00271, PI17/01836, PIE15/00013, Web: http://www.isciii.es/; FJC: 'Instituto de Salud Carlos III', Grant number: PI15/01408, Web: http://www.isciii.es/.	Arnar DO, 1997, CIRCULATION, V96, P2421; BAGDONAS AA, 1961, AM HEART J, V61, P206, DOI 10.1016/0002-8703(61)90577-4; Bansch D, 2003, CIRCULATION, V108, P3011, DOI 10.1161/01.CIR.0000103701.30662.5C; BELLA PD, 2013, CIRCULATION, V127, P1359, DOI DOI 10.1161/CIRCULATI0NAHA.112.000872; Bodi V, 2010, CARDIOVASC RES, V87, P601, DOI 10.1093/cvr/cvq091; Bogun F, 2006, J AM COLL CARDIOL, V48, P2500, DOI 10.1016/j.jacc.2006.07.062; Boyden PA, 2003, CARDIOVASC RES, V57, P681, DOI 10.1016/S0008-6363(02)00725-3; BOYDEN PA, 1989, CIRC RES, V65, P955, DOI 10.1161/01.RES.65.4.955; Davies F, 1930, J ANAT, V64, P129; Demir S, 2018, J ELECTROCARDIOL, V51, P409, DOI 10.1016/j.jelectrocard.2018.02.011; Dun W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106830; FRIEDMAN PL, 1975, CIRC RES, V36, P127, DOI 10.1161/01.RES.36.1.127; FRIEDMAN PL, 1973, CIRC RES, V33, P612, DOI 10.1161/01.RES.33.5.612; FRIEDMAN PL, 1973, CIRC RES, V33, P597, DOI 10.1161/01.RES.33.5.597; Gomez-Heras SG, 2015, HISTOL HISTOPATHOL, V30, P841, DOI 10.14670/HH-11-591; Garcia-Bustos V, 2017, J ANAT, V230, P664, DOI 10.1111/joa.12594; GREENSPAN K, 1963, AM J PHYSIOL, V204, P5, DOI 10.1152/ajplegacy.1963.204.1.5; Guo Y, 2017, ARCH CARDIOVASC DIS, V9, P167; Hervas A, 2016, J ANAT, V228, P47, DOI 10.1111/joa.12395; Izquierdo M, 2015, CIRC-ARRHYTHMIA ELEC, V8, P882, DOI 10.1161/CIRCEP.115.002827; Masuda K, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004224; Matsuyama TA, 2017, J HISTOCHEM CYTOCHEM, V65, P655, DOI 10.1369/0022155417730280; Moskowitz IPG, 2007, CELL, V129, P1365, DOI 10.1016/j.cell.2007.04.036; Mountantonakis Stavros E, 2015, HeartRhythm Case Rep, V1, P439, DOI 10.1016/j.hrcr.2015.06.004; MYERS WW, 1966, AM J PHYSIOL, V211, P739, DOI 10.1152/ajplegacy.1966.211.3.739; Rentschler S, 2012, CIRCULATION, V126, P1058, DOI 10.1161/CIRCULATIONAHA.112.103390; SHAROV VG, 1989, VIRCHOWS ARCH B, V57, P131, DOI 10.1007/BF02899074; Szumowski L, 2004, J AM COLL CARDIOL, V44, P1700, DOI 10.1016/j.jacc.2004.08.034; Tribulova N, 2002, ACTA HISTOCHEM, V104, P393, DOI 10.1078/0065-1281-00670; Tsai SY, 2015, STEM CELL REP, V4, P1089, DOI 10.1016/j.stemcr.2015.04.015; WIECHA J, 1993, EUR HEART J, V14, P9, DOI 10.1093/eurheartj/14.suppl_E.9	31	5	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0212096	10.1371/journal.pone.0212096	http://dx.doi.org/10.1371/journal.pone.0212096			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742681	Green Submitted, gold, Green Published			2022-12-26	WOS:000458393400048
J	Le, GM; Radcliffe, K; Lyles, C; Lyson, HC; Wallace, B; Sawaya, G; Pasick, R; Centola, D; Sarkar, U				Le, Gem M.; Radcliffe, Kate; Lyles, Courtney; Lyson, Helena C.; Wallace, Byron; Sawaya, George; Pasick, Rena; Centola, Damon; Sarkar, Urmimala			Perceptions of cervical cancer prevention on Twitter uncovered by different sampling strategies	PLOS ONE			English	Article							HEALTH; EPIDEMIOLOGY; FACEBOOK; TOOLS	Introduction Cervical cancer prevention is possible through use of the HPV vaccine and Pap tests, yet the vaccine remains underutilized. Methods We obtained publicly-available Twitter data from 2014 using three sampling strategies (top-ranked, simple random sample, and topic model) based on key words related to cervical cancer prevention. We conducted a content analysis of 100 tweets from each of the three samples and examined the extent to which the narratives and frequency of themes differed across samples. Results Advocacy-related tweets constituted the most prevalent theme to emerge across all three sample types, and were most frequently found in the top-ranked sample. A random sample detected the same themes as topic modeling, but the relative frequency of themes identified from topic modeling fell in-between top-ranked and random samples. Discussion Variations in themes uncovered by different sampling methods suggest it is useful to qualitatively assess the relative frequency of themes to better understand the breadth and depth of social media conversations about health. Conclusions Future studies using social media data should consider sampling methods to uncover a wider breadth of conversations about health on social media.	[Le, Gem M.; Radcliffe, Kate; Lyles, Courtney; Lyson, Helena C.; Sarkar, Urmimala] UCSF, Ctr Vulnerable Populat, Div Gen Internal Med, Dept Med, San Francisco, CA 94143 USA; [Wallace, Byron] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA; [Sawaya, George] UCSF, Dept Obstet & Gynecol, San Francisco, CA USA; [Pasick, Rena] UCSF, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Centola, Damon] Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; Northeastern University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Pennsylvania	Le, GM (corresponding author), UCSF, Ctr Vulnerable Populat, Div Gen Internal Med, Dept Med, San Francisco, CA 94143 USA.	gem.le@ucsf.edu		Radcliffe, Kate/0000-0001-7532-1675	National Cancer Institute [1R01CA178875-01A1]; NATIONAL CANCER INSTITUTE [R01CA178875] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute 1R01CA178875-01A1 (Sarkar & Centola), www.nih.gov.	Charmaz K, 2015, QUAL HEALTH RES, V25, P1610, DOI 10.1177/1049732315613982; Creswell JW KA, 2011, BEST PRACTICES MIXED; Dedoose, 2014, DED VERS 5 0 11 WEB; Du JC, 2017, STUD HEALTH TECHNOL, V245, P1218, DOI 10.3233/978-1-61499-830-3-1218; Du JC, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0469-6; Gallagher KM, 2012, ANN BEHAV MED, V43, P101, DOI 10.1007/s12160-011-9308-7; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Greenwood S, 2016, SOCIAL MEDIA UPDATE; Guetterman TC, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9702; Hamad EO, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5391; Hillemanns P, 2016, ONCOL RES TREAT, V39, P501, DOI 10.1159/000448385; Lenoir P, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8421; Massey PM, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6670; McLaughlin ML, 2016, HEALTH COMMUN, V31, P998, DOI 10.1080/10410236.2015.1027033; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Nyitray AG, 2014, CURR PROBL DERMATOL, V45, P75, DOI 10.1159/000358370; R Zaman T, 2010, PREDICTING INFORM SP; Rajani R, 2011, QJM-INT J MED, V104, P819, DOI 10.1093/qjmed/hcr078; Ramo DE, 2018, ADDICTION, V113, P1683, DOI 10.1111/add.14245; Ramo DE, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2217-0; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sasa  Petrovic, 2011, RT WIN PREDICTING ME; Suh B, 2010, 2010 IEEE 2 INT C SO, V2, P177, DOI [10.1109/SocialCom.2010.33, DOI 10.1109/SOCIALCOM.2010.33]; Teoh D, 2018, J LOW GENIT TRACT DI, V22, P8, DOI 10.1097/LGT.0000000000000363; Walker TY, 2017, MMWR-MORBID MORTAL W, V66, P874, DOI 10.15585/mmwr.mm6633a2	25	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211931	10.1371/journal.pone.0211931	http://dx.doi.org/10.1371/journal.pone.0211931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL0OI	30742683	Green Published, gold, Green Submitted			2022-12-26	WOS:000458393400033
J	Oreskovic, Z; Nechvatalova, K; Krejci, J; Kummer, V; Faldyna, M				Oreskovic, Zrinka; Nechvatalova, Katerina; Krejci, Josef; Kummer, Vladimir; Faldyna, Martin			Aspects of intradermal immunization with different adjuvants: The role of dendritic cells and Th1/Th2 response	PLOS ONE			English	Article							IMMUNE-RESPONSE; T-CELLS; PIGS; ACTIVATION; CHEMOKINES; VACCINATION; MECHANISMS; MATURATION; INFECTION; CXCL16	Intradermal (i.d.) application of vaccine is promising way how to induce specific immune response against particular pathogens. Adjuvants, substances added into vaccination dose with the aim to increase immunogenicity, play important role in activation of dendritic cells with subsequent activation of lymphocytes. They can, however, induce unwanted local reactions. The aim of the study was to determine the effect of i.d. administration of model antigen keyhole limped hemocyanine alone or with different adjuvants-aluminium hydroxide and oil-based adjuvants-on local histopathological reaction as well as dendritic cell activation at the site of administration and local cytokine and chemokine response. This was assessed at 4 and 24 hours after application. Selection of the adjuvants was based on the fact, that they differently enhance antibody or cell-mediated immunity. The results showed activation of dendritic cells and both Th1 and Th2 response stimulated by oil-based adjuvants. It was associated with higher expression of set of genes, incl. chemokine receptor CCR7 or Th1-associated chemokine CXCL10 and cytokine IFN gamma. Application of the antigen with aluminium hydroxide induced higher expression of Th2-associated IL4 or IL13. On the other hand, both complete and incomplete Freund's adjuvants provoked strong local reaction associated with influx of neutrophils. This was accompanied with high expression of proinflammatory IL1 or neutrophil chemoattractant CXCL8. Surprisingly, similarly strong local reaction was detected also after application of aluminium hydroxide-based adjuvant. The best balanced local reaction with sufficient activation of immune cells was detected after application of oil-based adjuvants Montanide and Emulsigen.	[Oreskovic, Zrinka; Nechvatalova, Katerina; Krejci, Josef; Kummer, Vladimir; Faldyna, Martin] Vet Res Inst, Dept Immunol, Brno, Czech Republic; [Oreskovic, Zrinka] Masaryk Univ, Fac Sci, Inst Expt Biol, Brno, Czech Republic	Czech Veterinary Research Institute; Masaryk University Brno	Faldyna, M (corresponding author), Vet Res Inst, Dept Immunol, Brno, Czech Republic.	faldyna@vri.cz			Ministry of Agriculture of the Czech Republic [QJ1510218, RO0518]; Ministry of Education, Youth and Sports of the Czech Republic [LO1218]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	The work was supported by the Ministry of Agriculture of the Czech Republic (QJ1510218 and RO0518) and the Ministry of Education, Youth and Sports of the Czech Republic (LO1218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade N, 2007, TOXICOL SCI, V99, P488, DOI 10.1093/toxsci/kfm178; Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9; Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114; Bashir MM, 2009, ARCH DERMATOL RES, V301, P87, DOI 10.1007/s00403-008-0893-7; Bautista EM, 2002, VET IMMUNOL IMMUNOP, V88, P131, DOI 10.1016/S0165-2427(02)00152-6; Bergmann-Leitner ES, 2014, VACCINES-BASEL, V2, P252, DOI 10.3390/vaccines2020252; Bernardy J, 2008, VACCINE, V26, P6368, DOI 10.1016/j.vaccine.2008.09.027; Buckwalter MR, 2009, CURR BIOL, V19, pR355, DOI 10.1016/j.cub.2009.03.012; Ciabattini A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00427; Clausen BE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00534; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Eble PL, 2009, VACCINE, V27, P1272, DOI 10.1016/j.vaccine.2008.12.011; Feldmeyer L, 2010, EUR J CELL BIOL, V89, P638, DOI 10.1016/j.ejcb.2010.04.008; Foti M, 1999, INT IMMUNOL, V11, P979, DOI 10.1093/intimm/11.6.979; Gerdts V, 2015, ILAR J, V56, P53, DOI 10.1093/ilar/ilv009; Glenn GM, 2006, CURR TOP MICROBIOL, V304, P247; Hjorto GM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00568; HogenEsch H, 2002, VACCINE, V20, pS34, DOI 10.1016/S0264-410X(02)00169-X; Jiao XD, 2010, VACCINE, V28, P1832, DOI 10.1016/j.vaccine.2009.11.083; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Krejci J, 2013, RES VET SCI, V94, P73, DOI 10.1016/j.rvsc.2012.07.021; Kunzi V, 2009, VACCINE, V27, P3561, DOI 10.1016/j.vaccine.2009.03.062; KUTSCH CL, 1993, J INVEST DERMATOL, V101, P79, DOI 10.1111/1523-1747.ep12360119; Lambert PH, 2008, VACCINE, V26, P3197, DOI 10.1016/j.vaccine.2008.03.095; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Latta M, 2007, IMMUNOLOGY, V121, P555, DOI 10.1111/j.1365-2567.2007.02603.x; Lebre MC, 2005, IMMUNOL CELL BIOL, V83, P525, DOI 10.1111/j.1440-1711.2005.01365.x; Leroux-Roels G, 2010, VACCINE, V28, pC25, DOI 10.1016/j.vaccine.2010.07.021; Marquet F, 2014, J IMMUNOL, V193, P5883, DOI 10.4049/jimmunol.1303150; McColl SR, 2002, IMMUNOL CELL BIOL, V80, P489, DOI 10.1046/j.1440-1711.2002.01113.x; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Ondrackova P, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-98; Oreskovic Z, 2017, RES VET SCI, V114, P41, DOI 10.1016/j.rvsc.2017.03.007; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Reid SD, 2000, CURR OPIN IMMUNOL, V12, P114, DOI 10.1016/S0952-7915(99)00059-X; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Richmond JM, 2014, COLD SPRING HARB PER, V4, P1; Rosato PC, 2017, CURR OPIN VIROL, V22, P44, DOI 10.1016/j.coviro.2016.11.011; Rothkotter HJ, 2009, DEV COMP IMMUNOL, V33, P267, DOI 10.1016/j.dci.2008.06.016; Steffen S, 2018, J INVEST DERMATOL, V138, P344, DOI 10.1016/j.jid.2017.08.041; Sticchi L, 2010, J Prev Med Hyg, V51, P7; Surnmerfield A, 2015, MOL IMMUNOL, V66, P14, DOI 10.1016/j.molimm.2014.10.023; van der Voort R, 2010, J LEUKOCYTE BIOL, V87, P1029, DOI 10.1189/jlb.0709482; Vestergaard C, 2004, EXP DERMATOL, V13, P265, DOI 10.1111/j.0906-6705.2004.00149.x; Volf J, 2012, VET MICROBIOL, V156, P127, DOI 10.1016/j.vetmic.2011.10.004; Wang JN, 2016, CYTOKINE, V81, P10, DOI 10.1016/j.cyto.2016.01.012	48	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211896	10.1371/journal.pone.0211896	http://dx.doi.org/10.1371/journal.pone.0211896			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742635	Green Published, Green Submitted, gold			2022-12-26	WOS:000458393400030
J	Strassburger, K; Kang, E; Teleman, AA				Strassburger, Katrin; Kang, Evangeline; Teleman, Aurelio A.			Drosophila ZDHHC8 palmitoylates scribble and Ras64B and controls growth and viability	PLOS ONE			English	Article							PROTEIN PALMITOYLATION; CELL POLARITY; TUMOR-GROWTH; MOUSE MODEL; EXPRESSION; ACYLTRANSFERASE; STABILITY; FLYBASE; DHHC3; RISK	Palmitoylation is an important posttranslational modification regulating diverse cellular functions. Consequently, aberrant palmitoylation can lead to diseases such as neuronal disorders or cancer. In humans there are roughly one hundred times more palmitoylated proteins than enzymes catalyzing palmitoylation (palmitoyltransferases). Therefore, it is an important challenge to establish the links between palmitoyltransferases and their targets. From publicly available data, we find that expression of human ZDHHC8 correlates significantly with cancer survival. To elucidate the organismal function of ZDHHC8, we study the Drosophila ortholog of hZDHHC8, CG34449/dZDHHC8. Knockdown of dZDHHC8 causes tissue over-growth while dZDHHC8 mutants are larval lethal. We provide a list of 159 palmitoylated proteins in Drosophila and present data suggesting that scribble and Ras64B are targets of dZDHHC8.	[Strassburger, Katrin; Kang, Evangeline; Teleman, Aurelio A.] German Canc Res Ctr, Heidelberg, Germany; [Strassburger, Katrin; Kang, Evangeline; Teleman, Aurelio A.] Heidelberg Univ, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Teleman, AA (corresponding author), German Canc Res Ctr, Heidelberg, Germany.; Teleman, AA (corresponding author), Heidelberg Univ, Heidelberg, Germany.	a.teleman@dkfz.de	Teleman, Aurelio A/E-6864-2013; Teleman, Aurelio/V-8470-2019	Teleman, Aurelio A/0000-0002-4237-9368; Teleman, Aurelio/0000-0002-4237-9368	Helmholtz Postdoc Programm	Helmholtz Postdoc Programm	This work was partially funded by Helmholtz Postdoc Programm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; Bannan Barbra A, 2008, Fly (Austin), V2, P198; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen BE, 2016, NAT CHEM BIOL, V12, P686, DOI 10.1038/nchembio.2119; De I, 2018, EUR J CELL BIOL, V97, P319, DOI 10.1016/j.ejcb.2018.03.005; Draper JM, 2009, MOL MEMBR BIOL, V26, P5, DOI 10.1080/09687680802683839; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; He M, 2014, J CELL BIOL, V206, P273, DOI 10.1083/jcb.201401016; Mansilla F, 2007, BRIT J CANCER, V96, P1896, DOI 10.1038/sj.bjc.6603818; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Mukai J, 2015, NEURON, V86, P680, DOI 10.1016/j.neuron.2015.04.003; Murphy J, 2016, J BIOL CHEM, V291, P23036, DOI 10.1074/jbc.M116.742767; Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113; Runkle KB, 2016, MOL CELL, V62, P385, DOI 10.1016/j.molcel.2016.04.003; Sanders SS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004405; Sharma C, 2017, CANCER RES, V77, P6880, DOI 10.1158/0008-5472.CAN-17-1536; Sharma C, 2012, CELL MOL LIFE SCI, V69, P2233, DOI 10.1007/s00018-012-0924-6; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sudo H, 2012, CANCER SCI, V103, P203, DOI 10.1111/j.1349-7006.2011.02126.x; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Thompson CA, 2017, AM J MED GENET B, V174, P295, DOI 10.1002/ajmg.b.32515; Tiebe M, 2015, DEV CELL, V33, P272, DOI 10.1016/j.devcel.2015.03.013; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wurtzel Jeremy G T, 2012, Small GTPases, V3, P139, DOI 10.4161/sgtp.21084; Yamamoto Y, 2007, ONCOLOGY-BASEL, V72, P132, DOI 10.1159/000111132; Yang CC, 2015, P NATL ACAD SCI USA, V112, P1785, DOI 10.1073/pnas.1420850112; Zhang J, 2008, MOL CELL PROTEOMICS, V7, P1378, DOI 10.1074/mcp.M800069-MCP200	37	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0198149	10.1371/journal.pone.0198149	http://dx.doi.org/10.1371/journal.pone.0198149			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735487	Green Published, Green Submitted, gold			2022-12-26	WOS:000458181200001
J	Volnitskiy, A; Shtam, T; Burdakov, V; Kovalev, R; Konev, A; Filatov, M				Volnitskiy, Andrey; Shtam, Tatiana; Burdakov, Vladimir; Kovalev, Roman; Konev, Alexander; Filatov, Michael			Abnormal activity of transcription factors gli in high-grade gliomas	PLOS ONE			English	Article							CELL SELF-RENEWAL; PROTEIN-KINASE-A; SONIC-HEDGEHOG; STEM-CELLS; SIGNALING PATHWAY; KRUPPEL FAMILY; SPLICE VARIANT; MESSENGER-RNA; GLIOBLASTOMA; EXPRESSION	Malignant transformation is associated with loss of cell differentiation, anaplasia. Transcription factors gli, required for embryonic development, may be involved in this process. We studied the activity of transcription factors gli in high-grade gliomas and their role in maintenance of stem cell state and glioma cell survival. 20 glioma cell lines and a sample of a normal adult brain tissue were used in the present study. We found the expression of gli target genes, including GLI1 and FOXM1, in all tested glioma cell lines, but not in the normal tissue. Interestingly, the expression of gli target genes in some glioma cell lines was observed together with a high level of their transcriptional repressor, Gli3R. Knockdown of GLI3 in one of these lines resulted in decrease of gli target gene expression. These data suggest that Gli3R does not prevent the gli target genes transcription, and gli3 acts in glioma cells more as an activator, than a repressor of transcription. We observed that gli regulated the expression of such genes, as SOX2 or OCT4 that maintain stem cell state, and TET1, involving in DNA demethylation. Treatment with GANT61 or siRNA against GLI1, GLI2, or GLI3 could result in complete glioma cell death, while cyclopamine had a weaker and line-specific effect on glioma cell survival. Thus, the gli transcription factors are abnormally active in high-grade gliomas, regulate expression of genes, maintaining the stem cell state, and contribute to glioma cell survival.	[Volnitskiy, Andrey; Shtam, Tatiana; Burdakov, Vladimir; Kovalev, Roman; Konev, Alexander; Filatov, Michael] Petersburg Nucl Phys Inst, Kurchatov Inst, Natl Res Ctr, Gatchina, Russia; [Shtam, Tatiana] NN Petrov Natl Med Res Ctr Oncol, Leningradskaya, St Petersburg, Pesochnyj, Russia	National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute	Volnitskiy, A; Filatov, M (corresponding author), Petersburg Nucl Phys Inst, Kurchatov Inst, Natl Res Ctr, Gatchina, Russia.	voln.a@yandex.ru; fil53ster@gmail.com	Burdakov, Vladimir S/C-4264-2014; Shtam, Tatyana A/B-1274-2014; Filatov, Michael/D-5004-2014	Burdakov, Vladimir S/0000-0001-6025-7367; Shtam, Tatyana A/0000-0003-0651-4785; Filatov, Michael/0000-0003-3908-3061	UMNIK program of Russian Foundation for Assistance to Small Innovative Enterprises (FASIE) [16907]; Russian Foundation for Basic Research [18-015-00289]	UMNIK program of Russian Foundation for Assistance to Small Innovative Enterprises (FASIE); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was performed with financial assistance of UMNIK program of Russian Foundation for Assistance to Small Innovative Enterprises (FASIE) to Andrey V Volnitskiy, contract 16907, "Development and optimization of the prognostic markers of malignant gliomas system based on real-time PCR" and the Russian Foundation for Basic Research (grant number 18-015-00289 to TAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiria SA, 2014, J NEURO-ONCOL, V119, P243, DOI 10.1007/s11060-014-1481-7; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Becher OJ, 2008, CANCER RES, V68, P2241, DOI 10.1158/0008-5472.CAN-07-6350; Braun S, 2012, CANCER BIOL THER, V13, P487, DOI 10.4161/cbt.19591; Carpenter RL, 2015, ONCOTARGET, V6, P22653, DOI 10.18632/oncotarget.4248; Chiang MF, 2015, EXP BIOL MED, V240, P392, DOI 10.1177/1535370214565989; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Ehtesham M, 2007, ONCOGENE, V26, P5752, DOI 10.1038/sj.onc.1210359; Gopinath S, 2013, CARCINOGENESIS, V34, P550, DOI 10.1093/carcin/bgs375; Hoang-Minh LB, 2016, ONCOTARGET, V7, P7029, DOI 10.18632/oncotarget.6854; Hsieh A, 2011, J CELL PHYSIOL, V226, P1118, DOI 10.1002/jcp.22433; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Jiang K, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002375; Katayama M, 2002, J NEURO-ONCOL, V59, P107, DOI 10.1023/A:1019660421216; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Li JL, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0463-3; Li QY, 2011, ANZ J SURG, V81, P440, DOI 10.1111/j.1445-2197.2010.05585.x; Lo HW, 2009, CANCER RES, V69, P6790, DOI 10.1158/0008-5472.CAN-09-0886; Malatesta M, 2013, CANCER RES, V73, P6323, DOI 10.1158/0008-5472.CAN-12-4660; Mazumdar T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075253; Naryzhny SN, 2009, ANAL BIOCHEM, V392, P90, DOI 10.1016/j.ab.2009.05.037; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; SALGALLER M, 1991, CANCER LETT, V57, P243, DOI 10.1016/0304-3835(91)90164-D; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Shahi MH, 2016, TUMOR BIOL, V37, P15107, DOI 10.1007/s13277-016-5365-7; Shahi MH, 2008, ONCOL REP, V19, P681; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Sheng T, 2006, J BIOL CHEM, V281, P9, DOI 10.1074/jbc.C500300200; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Takezaki T, 2011, CANCER SCI, V102, P1306, DOI 10.1111/j.1349-7006.2011.01943.x; Teh MT, 2002, CANCER RES, V62, P4773; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Uchida H, 2011, J NEURO-ONCOL, V104, P697, DOI 10.1007/s11060-011-0552-2; Ulasov IV, 2011, MOL MED, V17, P103, DOI 10.2119/molmed.2010.00062; Valadez JG, 2013, CANCER LETT, V328, P297, DOI 10.1016/j.canlet.2012.10.002; Volnitskiy AV, 2014, CELL TISSUE BIOL, V8, P368, DOI DOI 10.1134/S1990519X14050101; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang K, 2010, NEUROL RES, V32, P975, DOI 10.1179/016164110X12681290831360; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; XIAO HG, 1994, PEDIATR NEUROSURG, V20, P178, DOI 10.1159/000120783; Yan GN, 2014, J PATHOL, V234, P11, DOI 10.1002/path.4349; Yan GN, 2013, ONCOL LETT, V6, P1524, DOI 10.3892/ol.2013.1569; Yavan A, 2010, DEV CELL, V19, P54, DOI 10.1016/j.devcel.2010.06.007; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zeng HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015900; Zhan X, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-4; Zhu H, 2014, CANCER LETT, V343, P51, DOI 10.1016/j.canlet.2013.09.014	61	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211980	10.1371/journal.pone.0211980	http://dx.doi.org/10.1371/journal.pone.0211980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730955	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000084
J	Gashaye, KT; Tsegaye, AT; Shiferaw, G; Worku, AG; Abebe, SM				Gashaye, Kiros Terefe; Tsegaye, Adino Tesfahun; Shiferaw, Getachew; Worku, Abebaw Gebeyehu; Abebe, Solomon Mekonnen			Client satisfaction with existing labor and delivery care and associated factors among mothers who gave birth in university of Gondar teaching hospital; Northwest Ethiopia: Institution based cross-sectional study	PLOS ONE			English	Article							WOMENS SATISFACTION; CHILDBIRTH; EXPERIENCE; SERVICES; PAIN	Background There are many reasons for mothers not receiving modern obstetric care, being dissatisfied by health care deliveries is one of the major factors. There are limited studies about maternal satisfaction with labor and delivery care services in Ethiopia and particularly in the study area. Therefore, the aim of this study was to better understand client satisfaction on existing labor and delivery care service and associated factors among mothers who gave birth in the University of Gondar Teaching Hospital, Ethiopia. Methods This institution based cross-sectional study was conducted at the University of Gondar Referral Hospital. 593 mothers who gave birth between July and September 2016 were enrolled. Study participants were selected by systematic random sampling. A standardized, interviewer-administered questionnaire was used to collect data. Descriptive and summary statistics were performed. A linear regression model was fitted and variables having a P value of <= 0.05 in the multivariable model were considered statistically significant. Result Overall, 31.3% of mothers were satisfied by the existing labor and delivery care. Living in rural areas (-2.9%; 95% CI: -5.75,-0.12) and the presence of a co-morbidity (-3.2%; 95% CI:-5.70, -0.72) were the factor which have a negative influence on maternal satisfaction. On the other hand, travel time to reach to the hospital (hours) (0.79%; 95% CI: 0.07, 1.52), birth by episiotomy or assisted vaginal delivery (6.3%; 95%CI: 1.56, 11.04), and receiving cost-free maternal health services (6.66%; 95%CI: 3.31, 10.01) were the factors that had positive influence. Conclusion The level of satisfaction of laboring mothers with the labor and delivery care services was poor. Rural residency and chronic medical co-morbidity were negatively associated with level of satisfaction while travel time, mode of delivery, and payment free delivery service had a statistically significant positive influence on satisfaction.	[Gashaye, Kiros Terefe; Shiferaw, Getachew] Univ Gondar, Sch Med, Dept Obstet & Gynecol, Coll Med & Hlth Sci, Gondar, Ethiopia; [Tsegaye, Adino Tesfahun] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Worku, Abebaw Gebeyehu] Univ Gondar, Inst Publ Hlth, Dept Reprod Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Abebe, Solomon Mekonnen] Univ Gondar, Inst Publ Hlth, Dept Nutr, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar	Tsegaye, AT (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia.	atesfahun1@gmail.com		Worku, Abebaw Gebeyehu/0000-0002-1146-3399	University of Gondar	University of Gondar	We would like to thank the University of Gondar referral hospital's administrative bodies for their cooperation and permission to conduct the study. We are grateful to the University of Gondar for financial support as well as the data collectors who participated in this study for their commitment.	Amdemichael R, 2014, GYNECOLOGY OBSTET, V4, P1; Asefa A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0024-9; Bazant ES, 2009, INT J QUAL HEALTH C, V21, P79, DOI 10.1093/intqhc/mzn058; Behruzi R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-25; Bitew K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/460767; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Bowser D, 2010, EXPLORING EVIDENCE D; Bruggemann Odalea M, 2007, Reprod Health, V4, P5, DOI 10.1186/1742-4755-4-5; Bruggemann OM, 2007, REPROD HLTH, V4; Cengiz E., 2010, J NAVAL SCI ENG, V6, P76; Central Statistical Agency, 2014, ETH MIN DEM HLTH SUR; Changole J, 2010, MALAWI MED J, V22, P5; Cunningham F, 2014, WILLIAMS OBSTET, V24e; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; Declercq ER, 2014, J PERINAT EDUC, V23, P9, DOI 10.1891/1058-1243.23.1.9; Dewana Z, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0125-0; DOLIVEIRA AFPL, 2002, LANCET, V359, P1681; Dzomeku MV., 2011, INT J NURS MIDWIFERY, V3, P30, DOI DOI 10.5897/IJNM.9000029; Gil-Wey B, 2011, CAN J ANESTH, V58, P936, DOI 10.1007/s12630-011-9550-2; Goodman P, 2004, J ADV NURS, V46, P212, DOI 10.1111/j.1365-2648.2003.02981.x; Guest ML, 2009, RURAL REMOTE HEALTH, V9; Gungor I, 2007, WESTERN J NURS RES, V29, P213, DOI 10.1177/0193945906292538; Hodnett ED, 2002, AM J OBSTET GYNECOL, V186, pS160, DOI 10.1067/mob.2002.121141; Kigenyi O, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-162; Kumbani LC, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-30; Melese T, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.76.3189; Mohammad K., 2014, INT J NURS MIDWIFERY, V6, P32, DOI [10.5897/ijnm2014.0127, DOI 10.5897/IJNM2014.0127]; Nketiah-Amponsah E., 2009, GLOBAL J HLTH SCI, V1, P50, DOI [10.5539/gjhs.v1n2p50, DOI 10.5539/GJHS.V1N2P50]; Pewitt AT, 2008, J PERINAT EDUC, V17, P42, DOI 10.1624/105812408X329593; Pitchforth E, 2010, SOC SCI MED, V71, P1739, DOI 10.1016/j.socscimed.2010.08.001; Redshaw M., 2010, DELIVERED CARE NATL; Roro Meselech Assegid, 2014, BMC Res Notes, V7, P556, DOI 10.1186/1756-0500-7-556; Rosen HE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0728-4; Rudman A, 2007, WOMENS EVALUATION IN; Rudman A, 2007, WEMENS EVALUATION IN; Silal S.P., 2012, BMC HEALTH SERV RES, V12, P1; Sioma-Markowska U, 2015, NEUROENDOCRINOL LETT, V36, P447; Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735; Taghavi S., 2015, J ANAL RES CLIN MED, V3, P77; Tayelgn A, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-78; The White Ribbon Alliance for Safe Motherhood, 2013, ADV PROM RESP MAT CA; WHO, 2014, WORLD HLTH STAT; WHO (World Health Organization), 2015, STRAT END PREV MAT M; World Health Organization, 2015, PREVENTION ELIMINATI; World Health Organization, 2005, RESP MAT CAR UN RIGH; Yohannes B., 2013, INT J SCI TECHNOL RE, V2, P74	46	17	17	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210693	10.1371/journal.pone.0210693	http://dx.doi.org/10.1371/journal.pone.0210693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK4EL	30726297	gold, Green Published, Green Submitted			2022-12-26	WOS:000457874000024
J	Wang, WC; Yang, X; Dai, JL; Lu, Y; Zhang, J; Keller, ET				Wang, Wenchu; Yang, Xin; Dai, Jinlu; Lu, Yi; Zhang, Jian; Keller, Evan T.			Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; CELL-PROLIFERATION; FACTOR EGR-1; IN-VITRO; TUMOR; MICROENVIRONMENT; EXPRESSION; RECEPTOR; PROTEIN; DIFFERENTIATION	Bone is the most frequent site of prostate cancer (PCa) metastasis; however, little is known about the role of the most common cell in bone, the osteocyte (OCy), in cancer biology. In this study we explored the crosstalk between PCa cells and OCys to determine if it contributes to PCa progression. PCa cells induced OCys to promote PCa proliferation, migration and invasion. A chemokine screen revealed that PCa cell induced OCys to produce growth-derived factor 15 (GDF15). Knockdown of GDF15 in OCys demonstrated that PCa cells conferred the ability on OCys to promote PCa proliferation, migration and invasion through GDF15. Consistent with this finding was the observation that the GDF15 receptor, GFRAL, was expressed on multiple PCa cell lines. Transcription factor array screening of PCa cells exposed to OCys with or without knockdown of GDF15 revealed that GDF15 in OCys promoted early growth response 1 (EGR1) expression in the PCa cells. Knockdown of EGR1 expression in PCa cells revealed it was required for the OCy-derived GDF15-mediated induction of in vitro PCa cell proliferation, migration and invasion. Subcutaneous co-injection of PCa cells and OCys into mice revealed that OCys promoted tumor growth in vivo, which was diminished by knockdown of GDF15 in the OCys. Knockdown of GDF15 in the tibiae diminished growth of PCa cancer cells injected into the tibiae, which was accompanied by decreased tumor cell proliferation and EGR1 expression. These results shed light on a novel mechanism through which PCa cells educate OCys to promote progression of PCa bone metastasis. They also suggest that targeting of GDF15-based and EGR1-based signaling pathways should be further explored for their potential to diminish progression of PCa bone metastasis.	[Wang, Wenchu; Yang, Xin; Zhang, Jian] Guangxi Med Univ, Ctr Translat Med, Guangxi 530021, Peoples R China; [Wang, Wenchu; Yang, Xin; Dai, Jinlu; Keller, Evan T.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Wang, Wenchu; Yang, Xin; Zhang, Jian] Guangxi Med Univ, Sch Preclin Med, Guangxi, Peoples R China; [Wang, Wenchu; Yang, Xin; Zhang, Jian] Minist Educ, Key Lab Longev & Ageing Related Dis, Nanning, Peoples R China; [Lu, Yi; Zhang, Jian] Southern Univ Sci & Technol, Sch Med, Shenzhen, Guangdong, Peoples R China; [Keller, Evan T.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA	Guangxi Medical University; University of Michigan System; University of Michigan; Guangxi Medical University; Southern University of Science & Technology; University of Michigan System; University of Michigan	Keller, ET (corresponding author), Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA.; Keller, ET (corresponding author), Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.	etkeller@umich.edu	ZHANG, JIAN/Q-6334-2018; Keller, Evan T/M-1446-2016; Lu, Yi/J-6746-2018; Dai, Jin/GVT-2414-2022	Keller, Evan T/0000-0002-7592-7535; Lu, Yi/0000-0002-1060-6925; Dai, Jin/0000-0003-3063-746X	NIH [R01-CA190554, P01-CA093900]; NSFC [81130046, 81773146, JCYJ20170412154619484]; NATIONAL CANCER INSTITUTE [R01CA190554, P01CA093900] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R01-CA190554, NIH P01-CA093900, NSFC Key Project 81130046, NSFC 81773146 and JCYJ20170412154619484.	Adamson E, 2003, CANCER BIOL THER, V2, P617; Adamson ED, 2002, TUMOR BIOL, V23, P93, DOI 10.1159/000059711; Arora S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r166; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.onc.1206560; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Bruzzese F, 2014, CANCER RES, V74, P3408, DOI 10.1158/0008-5472.CAN-13-2259; Bultynck G, 2016, BBA-REV CANCER, V1866, P121, DOI 10.1016/j.bbcan.2016.07.003; Compton JT, 2014, J BONE JOINT SURG AM, V96A, P1659, DOI 10.2106/JBJS.M.01096; Cui YX, 2016, ANTICANCER RES, V36, P1193; Dai JL, 2014, CLIN CANCER RES, V20, P617, DOI 10.1158/1078-0432.CCR-13-0839; Dai JL, 2010, CANCER RES, V70, P5014, DOI 10.1158/0008-5472.CAN-10-0100; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Delgado-Calle J, 2016, CANCER RES, V76, P1089, DOI 10.1158/0008-5472.CAN-15-1703; Deng XY, 2014, CANCER TREAT REV, V40, P730, DOI 10.1016/j.ctrv.2014.04.003; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Florkowska M, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-8; Gartrell BA, 2015, EUR UROL, V68, P850, DOI 10.1016/j.eururo.2015.06.039; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Hall CL, 2006, CANCER METAST REV, V25, P551, DOI 10.1007/s10555-006-9022-2; Han MH, 2013, TOXICOL LETT, V220, P157, DOI 10.1016/j.toxlet.2013.04.020; Hayes VM, 2006, CANCER EPIDEM BIOMAR, V15, P1223, DOI 10.1158/1055-9965.EPI-06-0063; Hensel J, 2016, UROLOGY, V92, P6, DOI 10.1016/j.urology.2015.12.039; Hinoi E, 2012, J BONE MINER RES, V27, P938, DOI 10.1002/jbmr.1538; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Kalajzic I, 2013, BONE, V54, P296, DOI 10.1016/j.bone.2012.09.040; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Keller ET, 2001, CANCER METAST REV, V20, P333, DOI 10.1023/A:1015599831232; Korenchuk S, 2001, IN VIVO, V15, P163; KOUTSILIERIS M, 1993, ANTICANCER RES, V13, P443; Krishn SR, 2019, MATRIX BIOL, V77, P41, DOI 10.1016/j.matbio.2018.08.004; Languino LR, 2016, AM J TRANSL RES, V8, P2432; Li J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122249; Liu CT, 1996, CRIT REV ONCOGENESIS, V7, P101, DOI 10.1615/CritRevOncog.v7.i1-2.70; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Ma JJ, 2009, J BIOL CHEM, V284, P34600, DOI 10.1074/jbc.M109.016246; Ma Y, 2016, ONCOL REP, V35, P3068, DOI 10.3892/or.2016.4641; Miftakhova R, 2016, CANCER RES, V76, P2453, DOI 10.1158/0008-5472.CAN-15-2340; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Ortiz A, 2012, RECENT RESULTS CANC, V192, P225, DOI 10.1007/978-3-642-21892-7_11; Ozen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042717; Paralkar VM, 1998, J BIOL CHEM, V273, P13760, DOI 10.1074/jbc.273.22.13760; Parra E, 2013, ONCOL REP, V30, P911, DOI 10.3892/or.2013.2503; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Salah Z, 2007, CANCER RES, V67, P9835, DOI 10.1158/0008-5472.CAN-07-1886; Selander KS, 2007, CANCER EPIDEM BIOMAR, V16, P532, DOI 10.1158/1055-9965.EPI-06-0841; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sottnik JL, 2015, CANCER RES, V75, P2151, DOI 10.1158/0008-5472.CAN-14-2493; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Sun T, 2013, DIGEST DIS SCI, V58, P423, DOI 10.1007/s10620-012-2356-4; Tsai VWW, 2018, CELL METAB, V28, P353, DOI 10.1016/j.cmet.2018.07.018; Turner CJ, 2016, CURR OSTEOPOROS REP, V14, P170, DOI 10.1007/s11914-016-0323-2; Vanhara P, 2012, PROSTATE CANCER P D, V15, P320, DOI 10.1038/pcan.2012.6; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; Zhang M, 2017, MOL CANCER RES, V15, P457, DOI 10.1158/1541-7786.MCR-16-0392; Zhang W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167222; Zhou JZ, 2016, ONCOGENE, V35, P5597, DOI 10.1038/onc.2016.101	66	45	49	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2019	38	23					4540	4559		10.1038/s41388-019-0736-3	http://dx.doi.org/10.1038/s41388-019-0736-3			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB4KM	30755731	Green Accepted			2022-12-26	WOS:000470240300008
J	Zhang, L; Li, WL; Cao, L; Xu, JY; Qian, Y; Chen, HR; Zhang, YQ; Kang, W; Gou, HY; Wong, CC; Yu, J				Zhang, Li; Li, Weilin; Cao, Lei; Xu, Jiaying; Qian, Yun; Chen, Huarong; Zhang, Yanquan; Kang, Wei; Gou, Hongyan; Wong, Chi Chun; Yu, Jun			PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53	ONCOGENE			English	Article							FACTOR-BINDING PROTEIN-5; EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH; DIFFERENTIATION; TUMORIGENESIS; PROGRESSION; EXPRESSION; PBX1	Promoter methylation plays a vital role in tumorigenesis through transcriptional silencing of tumor suppressive genes. Using genome-wide methylation array, we first identified PBX/Knotted Homeobox 2 (PKNOX2) as a candidate tumor suppressor in gastric cancer. PKNOX2 mRNA expression is largely silenced in gastric cancer cell lines and primary gastric cancer via promoter methylation. Promoter methylation of PKNOX2 was associated with poor survival in gastric cancer patients. A series of in vitro and in vivo functional studies revealed that PKNOX2 functions as a tumor suppressor. Ectopic PKNOX2 expression inhibited cell proliferation in GC cell lines and suppressed growth of tumor xenografts in mice via induction of apoptosis and cell cycle arrest; and suppressed cell migration and invasion by blocking epithelial-to-mesenchymal transition. On the other hand, knockdown PKNOX2 in normal gastric epithelial cells triggered diverse malignant phenotypes. Mechanistically, PKNOX2 exerts its tumor suppressive effect by promoting the up-regulation of Insulin like Growth Factor Binding Protein 5 (IGFBP5) and TP53. PKNOX2 binds to the promoter regions of IGFBP5 and TP53 and transcriptionally activated their expression by chromatin immunoprecipitation (ChIP)-PCR assay. IGFBP5 knockdown partly abrogated tumor suppressive effect of PKNOX2, indicating that the function(s) of PKNOX2 are dependent on IGFBP5. IGFBP5 promoted PKNOX2-mediated up-regulation of p53. As a consequence, p53 transcription target genes were coordinately upregulated in PKNOX2-expressing GC cells, leading to tumor suppression. In summary, our results identified PKNOX2 as a tumor suppressor in gastric cancer by activation of IGFBP5 and p53 signaling pathways. PKNOX2 promoter hypermethylation might be a biomarker for the poor survival of gastric cancer patients.	[Zhang, Li; Li, Weilin; Cao, Lei; Xu, Jiaying; Chen, Huarong; Zhang, Yanquan; Gou, Hongyan; Wong, Chi Chun; Yu, Jun] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China; [Zhang, Li; Li, Weilin; Cao, Lei; Xu, Jiaying; Chen, Huarong; Zhang, Yanquan; Gou, Hongyan; Wong, Chi Chun; Yu, Jun] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, State Key Lab Digest Dis,Dept Med & Therapeut, Hong Kong, Peoples R China; [Li, Weilin] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Peoples R China; [Qian, Yun] Shenzhen Univ Hosp, Dept Gastroenterol, Shenzhen, Peoples R China; [Kang, Wei] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Shenzhen University; Chinese University of Hong Kong	Wong, CC; Yu, J (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China.; Wong, CC; Yu, J (corresponding author), Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, State Key Lab Digest Dis,Dept Med & Therapeut, Hong Kong, Peoples R China.	chichun.wong@cuhk.edu.hk; junyu@cuhk.edu.hk	Wong, Chi Chun/C-4636-2016; Chen, Huarong/ABZ-5810-2022; Zhang, Yanquan/D-5615-2017; Yu, Jun/D-8569-2015; chen, huarong/ABH-8561-2020; KANG, Wei/C-5451-2016; xu, jia/GSD-6347-2022; Li, Weilin/ABG-9032-2021	Zhang, Yanquan/0000-0003-3527-9972; Yu, Jun/0000-0001-5008-2153; chen, huarong/0000-0003-2192-1864; KANG, Wei/0000-0002-4651-677X; 	National Key R&D Program of China [2018YFC135000/2018YFC1315004]; RGC/GRF Hong Kong [14114615, 14101917, 14111216, 14106145, 14108718]; National Natural Science Foundation of China (NSFC) [81772501, 81502064]; HMRF Hong Kong [03140856]; Vice-Chancellor's Discretionary Fund CUHK; Shenzhen Virtual University Park Support Scheme; CUHK direct grant	National Key R&D Program of China; RGC/GRF Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); HMRF Hong Kong; Vice-Chancellor's Discretionary Fund CUHK; Shenzhen Virtual University Park Support Scheme; CUHK direct grant(Chinese University of Hong Kong)	This project was supported by research funds from National Key R&D Program of China (No. 2018YFC135000/2018YFC1315004), RGC/GRF Hong Kong (14114615, 14101917, 14111216, 14106145, and 14108718); National Natural Science Foundation of China (NSFC) (81772501 and 81502064); HMRF Hong Kong (03140856); Vice-Chancellor's Discretionary Fund CUHK; Shenzhen Virtual University Park Support Scheme to CUHK Shenzhen Research Institute; CUHK direct grant.	Adrien D, 2010, LANGENBECK ARCH SURG, V395, P261, DOI 10.1007/s00423-009-0465-0; Ahn BY, 2010, CANCER RES, V70, P3013, DOI 10.1158/0008-5472.CAN-09-3108; Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Banno K, 2012, INT J ONCOL, V41, P793, DOI 10.3892/ijo.2012.1528; Brendolan A, 2005, DEVELOPMENT, V132, P3113, DOI 10.1242/dev.01884; Butt AJ, 2003, J BIOL CHEM, V278, P29676, DOI 10.1074/jbc.M301965200; Capellini TD, 2006, DEVELOPMENT, V133, P2263, DOI 10.1242/dev.02395; Castro AC, 2007, J PATHOL, V211, P507, DOI DOI 10.1002/PATH.2138; Choi YJ, 2015, CARCINOGENESIS, V36, P553, DOI 10.1093/carcin/bgv022; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fernandez LC, 2008, CANCER LETT, V266, P144, DOI 10.1016/j.canlet.2008.02.042; Gullu G, 2012, CHIN J CANCER, V31, P266, DOI 10.5732/cjc.011.10405; Haller K, 2002, DEV DYNAM, V225, P358, DOI 10.1002/dvdy.10167; Hung PS, 2008, J PATHOL, V214, P368, DOI 10.1002/path.2280; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li WL, 2018, ONCOGENE, V37, P6383, DOI 10.1038/s41388-018-0402-1; Mao BJ, 2015, INT J ONCOL, V46, P459, DOI 10.3892/ijo.2014.2765; Natalwala A, 2008, WORLD J GASTROENTERO, V14, P3792, DOI 10.3748/wjg.14.3792; Pirini F, 2017, ONCOTARGET, V8, P38501, DOI 10.18632/oncotarget.16258; Qian Y, 2017, CANCER RES, V77, P1968, DOI 10.1158/0008-5472.CAN-16-1595; Qin P, 2004, J BIOL CHEM, V279, P16263, DOI 10.1074/jbc.M313938200; Saavedra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125834; Shah N, 2014, CLIN CANCER RES, V20, P4400, DOI 10.1158/1078-0432.CCR-13-1486; Shersher DD, 2011, ANN THORAC SURG, V92, P1805, DOI 10.1016/j.athoracsur.2011.06.058; Sureshbabu A, 2012, J CELL SCI, V125, P1693, DOI 10.1242/jcs.092882; Yamashita H, 2009, CANCER SCI, V100, P2028, DOI 10.1111/j.1349-7006.2009.01274.x; Zhang L, 2010, MOL BIOL REP, V37, P2579, DOI 10.1007/s11033-009-9777-y	30	22	22	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2019	38	23					4590	4604		10.1038/s41388-019-0743-4	http://dx.doi.org/10.1038/s41388-019-0743-4			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB4KM	30745575	Green Published, hybrid			2022-12-26	WOS:000470240300011
J	Vicen, M; Vitverova, B; Havelek, R; Blazickova, K; Machacek, M; Rathouska, J; Najmanova, I; Dolezelova, E; Prasnicka, A; Sternak, M; Bernabeu, C; Nachtigal, P				Vicen, Matej; Vitverova, Barbora; Havelek, Radim; Blazickova, Katerina; Machacek, Miloslav; Rathouska, Jana; Najmanova, Iveta; Dolezelova, Eva; Prasnicka, Alena; Sternak, Magdalena; Bernabeu, Carmelo; Nachtigal, Petr			Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro	FASEB JOURNAL			English	Article						hypercholesterolemia; oxysterols; endothelial cells; mice	DENSITY-LIPOPROTEIN RECEPTOR; SOLUBLE ENDOGLIN; APOLIPOPROTEIN-B; KAPPA-B; EXPRESSION; CELLS; RELEASE; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; TRANSCRIPTION	Our objective was to investigate the effect of cholesterol [hypercholesterolemia and 7-ketocholesterol (7K)] on endoglin (Eng) expression and regulation with respect to endothelial or vascular dysfunction in vivo and in vitro. In vivo experiments were performed in 2-mo-old atherosclerosis-prone apolipoprotein E-deficient/LDL receptor-deficient (ApoE(-/-)/LDLR-/-) female mice and their wild-type C57BL/6J littermates. In in vitro experiments, human aortic endothelial cells (HAECs) were treated with 7K. ApoE(-/-)/LDLR-/- mice developed hypercholesterolemia accompanied by increased circulating levels of P-selectin and Eng and a disruption of NO metabolism. Functional analysis of the aorta demonstrated impaired vascular reactivity, and Western blot analysis revealed down-regulation of membrane Eng/Smad2/3/eNOS signaling in ApoE(-/-)/LDLR-/- mice. 7K increased Eng expression via Kruppel-like factor 6 (KLF6), liver X nuclear receptor, and NF-B in HAECs. 7K-induced Eng expression was prevented by the treatment with 2-hydroxypropyl--cyclodextrin; 8-{[5-chloro-2-(4-methylpiperazin-1-yl) pyridine-4-carbonyl] amino}-1-(4-fluorophenyl)-4, 5-dihydrobenzo[g]indazole-3-carboxamide; or by KLF6 silencing. 7K induced increased adhesion and transmigration of monocytic human leukemia promonocytic cell line cells and was prevented by Eng silencing. We concluded that hypercholesterolemia altered Eng expression and signaling, followed by endothelial or vascular dysfunction before formation of atherosclerotic lesions in ApoE(-/-)/LDLR-/- mice. By contrast, 7K increased Eng expression and induced inflammation in HAECs, which was followed by an increased adhesion and transmigration of monocytes via endothelium, which was prevented by Eng inhibition. Thus, we propose a relevant role for Eng in endothelial or vascular dysfunction or inflammation when exposed to cholesterol.Vicen, M., Vitverova, B., Havelek, R., Blazickova, K., Machacek, M., Rathouska, J., Najmanova, I., Dolezelova, E., Prasnicka, A., Sternak, M., Bernabeu, C., Nachtigal, P. Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro.	[Vicen, Matej; Vitverova, Barbora; Blazickova, Katerina; Rathouska, Jana; Najmanova, Iveta; Dolezelova, Eva; Prasnicka, Alena; Nachtigal, Petr] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biol & Med Sci, Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic; [Machacek, Miloslav] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biochem Sci, Hradec Kralove, Czech Republic; [Havelek, Radim] Charles Univ Prague, Fac Med Hradec Kralove, Dept Med Biochem, Hradec Kralove, Czech Republic; [Sternak, Magdalena] JCET, Krakow, Poland; [Bernabeu, Carmelo] CSIC, Ctr Biol Res, Madrid, Spain; [Bernabeu, Carmelo] Biomed Res Networking Ctr Rare Dis CIBERER, Madrid, Spain	Charles University Prague; Charles University Prague; Charles University Prague; University Hospital Hradec Kralove; Jagiellonian University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Nachtigal, P (corresponding author), Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biol & Med Sci, Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic.	petr.nachtigal@faf.cuni.cz	Bernabeu, Carmelo/L-3226-2014; Havelek, Radim/S-5723-2016; Najmanová, Iveta/T-5295-2017; Vicen, Matej/S-8443-2017; Machacek, Miloslav/T-3378-2017; Vitverova, Barbora/T-4468-2017; Prašnická, Alena/A-8903-2017; Rathouska, Jana/Q-2796-2016	Bernabeu, Carmelo/0000-0002-1563-6162; Havelek, Radim/0000-0003-0528-1334; Najmanová, Iveta/0000-0002-8443-0512; Vicen, Matej/0000-0002-7568-6989; Machacek, Miloslav/0000-0001-7221-5914; Vitverova, Barbora/0000-0002-4446-2712; Prašnická, Alena/0000-0002-6671-0318; Rathouska, Jana/0000-0001-6363-9715	Project Efficiency and Safety Improvement of Current Drugs and Nutraceuticals: Advanced Methods-New Challenges (EFSA-CDN) - European Regional Development Fund (ERDF) [CZ.02.1.01/0.0/0.0/16_019/0000841]; Charles University Grant Agency [GAUK 1158413C, 1216217]; Specific University Research [SVV260414]; Czech Health Research Council [AZV CR 17-31754A]; Consejo Superior de Investigaciones Cientificas [201420E039]; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) [ISCIII-CB06/07/0038]; Fonds Europeen de Developpement Economique et Regional (FEDER) funds	Project Efficiency and Safety Improvement of Current Drugs and Nutraceuticals: Advanced Methods-New Challenges (EFSA-CDN) - European Regional Development Fund (ERDF); Charles University Grant Agency; Specific University Research; Czech Health Research Council; Consejo Superior de Investigaciones Cientificas; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Fonds Europeen de Developpement Economique et Regional (FEDER) funds	The authors thank Dr. Alena Mrkvicova and Milena Hajzlerova (both from the Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic) for assistance during PCR analysis, Dr. Veronika Skarkova (Department of Medical Biology and Genetics, Faculty of Medicine in Hradec Kralove, Charles University) for assistance during Elisa analysis and preparation of samples for Western blots, Drs. Soa ejkova (Institute of Clinical and Experimental Medicine, Prague, Czech Republic) and Feroz Ahmad (Department of Biomedical Sciences, University of Reading, Reading, United Kingdom) for help with the human acute monocytic leukemia cell line, Dr. Petra Hirova (Liver Pathobiology Laboratory, Mayo Clinic, Rochester, Minnesota) for information about immunocytochemistry, Dr. Hana Jansova (Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University) for help with preparation of substances for cell treatments, Dr. Vera Kralova (Department of Medical Biology and Genetics, Faculty of Medicine in Hradec Kralove, Charles University) for help with flow cytometry, and Pavlina Lukeova (Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University) for help during chamber slide preparation. This work was supported by Project Efficiency and Safety Improvement of Current Drugs and Nutraceuticals: Advanced Methods-New Challenges (EFSA-CDN; CZ.02.1.01/0.0/0.0/16_019/0000841) cofunded by the European Regional Development Fund (ERDF), grants of Charles University Grant Agency (GAUK 1158413C and 1216217), Specific University Research (SVV260414), and Czech Health Research Council (AZV CR 17-31754A). C.B. was supported by grants from Consejo Superior de Investigaciones Cientificas (201420E039) and Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER; ISCIII-CB06/07/0038). CIBERER is an initiative of the Instituto de Salud Carlos III (ISCIII) of Spain supported by Fonds Europeen de Developpement Economique et Regional (FEDER) funds. The authors declare no conflicts of interest.	Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001; Brown AJ, 2000, J LIPID RES, V41, P226; Brownfoot FC, 2014, PLACENTA, V35, P724, DOI 10.1016/j.placenta.2014.06.374; Carman CV, 2008, BLOOD, V112, P929, DOI 10.1182/blood-2008-05-153601; Chalubinski M, 2013, INFLAMM RES, V62, P1015, DOI 10.1007/s00011-013-0660-x; Coisne C, 2016, MOLECULES, V21, DOI 10.3390/molecules21121748; Coisne C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00185; Csanyi G, 2012, PROSTAG OTH LIPID M, V98, P107, DOI 10.1016/j.prostaglandins.2012.02.002; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; Deckert V, 1997, CIRCULATION, V95, P723, DOI 10.1161/01.CIR.95.3.723; Dopico AM, 2018, PFLUG ARCH EUR J PHY, V470, P1271, DOI 10.1007/s00424-018-2151-y; Friedman A, 2015, B MATH BIOL, V77, P758, DOI 10.1007/s11538-014-0010-3; Gallardo-Vara E, 2016, ANGIOGENESIS, V19, P155, DOI 10.1007/s10456-016-9495-8; Gojova A, 2003, BLOOD, V102, P4052, DOI 10.1182/blood-2003-05-1729; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Hayden JM, 2002, J LIPID RES, V43, P26; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Henry-Berger J, 2008, BIOL REPROD, V78, P968, DOI 10.1095/biolreprod.107.066498; ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431; Jawien J, 2007, EUR J PHARMACOL, V556, P129, DOI 10.1016/j.ejphar.2006.11.028; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Kaczara P, 2018, FEBS J, V285, P1346, DOI 10.1111/febs.14411; Kaitu'u-Lino TJ, 2012, AM J PATHOL, V180, P888, DOI 10.1016/j.ajpath.2011.11.014; Kij A, 2016, J PHARMACEUT BIOMED, V129, P148, DOI 10.1016/j.jpba.2016.06.050; Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeradbiomed.2005.08.025; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Mbalaviele G, 2009, J PHARMACOL EXP THER, V329, P14, DOI 10.1124/jpet.108.143800; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Mitra S, 2011, CARDIOVASC DRUG THER, V25, P419, DOI 10.1007/s10557-011-6341-5; Nachtigal P, 2012, ATHEROSCLEROSIS, V224, P4, DOI 10.1016/j.atherosclerosis.2012.03.001; Nemeckova I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119665; Olkkonen VM, 2012, BIOMOLECULES, V2, P76, DOI 10.3390/biom2010076; Ollauri-Ibanez C, 2017, EXPERT OPIN BIOL TH, V17, P1053, DOI 10.1080/14712598.2017.1346607; Przyborowski K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130908; Puig-Kroger A, 2001, BLOOD, V98, P2175, DOI 10.1182/blood.V98.7.2175; Rathouska J, 2015, ATHEROSCLEROSIS, V243, P383, DOI 10.1016/j.atherosclerosis.2015.10.003; Rossi E, 2018, CELL MOL LIFE SCI, V75, P1269, DOI 10.1007/s00018-017-2694-7; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Ruiz-Remolina L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188204; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Santibanez JF, 2007, J CELL PHYSIOL, V210, P456, DOI 10.1002/jcp.20878; SOMLYO AP, 1994, NATURE, V372, P812; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Strasky Z, 2011, CIRC J, V75, P1747, DOI 10.1253/circj.CJ-10-1285; Testa G, 2018, BIOCHIMIE, V153, P220, DOI 10.1016/j.biochi.2018.06.006; Toporsian M, 2005, CIRC RES, V96, P684, DOI 10.1161/01.res.0000159936.38601.22; Valbuena-Diez AC, 2012, CIRCULATION, V126, P2612, DOI 10.1161/CIRCULATIONAHA.112.101261; van Laake LW, 2006, CIRCULATION, V114, P2288, DOI 10.1161/CIRCULATIONAHA.106.639161; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Vaya J, 2001, FREE RADICAL RES, V34, P485, DOI 10.1080/10715760100300431; Vecerova L, 2012, J ATHEROSCLER THROMB, V19, P115, DOI 10.5551/jat.8185; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Vitverova B, 2018, ATHEROSCLEROSIS, V271, P15, DOI 10.1016/j.atherosclerosis.2018.02.008; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Yamagata K, 2013, MICROVASC RES, V88, P25, DOI 10.1016/j.mvr.2013.03.006; Yu Q, 2015, EUR J PHARMACOL, V748, P166, DOI 10.1016/j.ejphar.2014.08.037; Zemankova L, 2015, J PHYSIOL PHARMACOL, V66, P403; Zhang YP, 2014, EUR J PHARMACOL, V725, P10, DOI 10.1016/j.ejphar.2014.01.008; Zhang Y, 2014, J BIOL CHEM, V289, P12876, DOI 10.1074/jbc.M113.535831	61	16	16	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6099	6114		10.1096/fj.201802245R	http://dx.doi.org/10.1096/fj.201802245R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30753095	Bronze			2022-12-26	WOS:000466932600025
J	Liu, L; Zhou, Y; Qu, MB; Qiu, Y; Guo, XM; Zhang, YB; Liu, T; Yang, J; Yang, Q				Liu, Lin; Zhou, Yong; Qu, Mingbo; Qiu, Yu; Guo, Xingming; Zhang, Yuebin; Liu, Tian; Yang, Jun; Yang, Qing			Structural and biochemical insights into the catalytic mechanisms of two insect chitin deacetylases of the carbohydrate esterase 4 family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chitin; carbohydrate; carbohydrate-binding protein; protein structure; Bombyx mori; structural biology; carbohydrate esterase; chitin deacetylase; chitosan; deacetylation activity; SeMet single-wavelength anomalous diffraction	DE-N-ACETYLATION; OLIGOSACCHARIDE DEACETYLASE; PHYLOGENETIC ANALYSIS; DOMAIN ORGANIZATION; PROTEIN; CHITOSAN; BINDING; WALL; IDENTIFICATION; POLY-BETA-1,6-N-ACETYL-D-GLUCOSAMINE	Insect chitin deacetylases (CDAs) catalyze the removal of acetyl groups from chitin and modify this polymer during its synthesis and reorganization. CDAs are essential for insect survival and therefore represent promising targets for insecticide development. However, the structural and biochemical characteristics of insect CDAs have remained elusive. Here, we report the crystal structures of two insect CDAs from the silk moth Bombyx mori: BmCDA1, which may function in cuticle modification, and BmCDA8, which may act in modifying peritrophic membranes in the midgut. Both enzymes belong to the carbohydrate esterase 4 (CE4) family. Comparing their overall structures at 1.98-2.4 resolution with those from well-studied microbial CDAs, we found that two unique loop regions in BmCDA1 and BmCDA8 contribute to the distinct architecture of their substrate-binding clefts. These comparisons revealed that both BmCDA1 and BmCDA8 possess a much longer and wider substrate-binding cleft with a very open active site in the center than the microbial CDAs, including VcCDA from Vibrio cholerae and ArCE4A from Arthrobacter species AW19M34-1. Biochemical analyses indicated that BmCDA8 is an active enzyme that requires its substrates to occupy subsites 0, +1, and +2 for catalysis. In contrast, BmCDA1 also required accessory proteins for catalysis. To the best of our knowledge, our work is the first to unveil the structural and biochemical features of insect proteins belonging to the CE4 family.	[Liu, Lin; Zhou, Yong; Qu, Mingbo; Guo, Xingming; Liu, Tian; Yang, Jun; Yang, Qing] Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, Dalian 116024, Peoples R China; [Liu, Lin; Zhou, Yong; Qu, Mingbo; Guo, Xingming; Liu, Tian; Yang, Jun; Yang, Qing] Dalian Univ Technol, Sch Software, Dalian 116024, Peoples R China; [Qiu, Yu] Sanofi, Biol Res, Dept Prot Engn, Bridgewater, NJ 08807 USA; [Zhang, Yuebin] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Mol Modeling & Design, State Key Lab Mol React Dynam, Dalian 116024, Peoples R China; [Yang, Qing] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Dalian University of Technology; Dalian University of Technology; Sanofi-Aventis; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yang, Q (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, Dalian 116024, Peoples R China.; Yang, Q (corresponding author), Dalian Univ Technol, Sch Software, Dalian 116024, Peoples R China.; Yang, Q (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	qingyang@dlut.edu.cn	Liu, Tian/E-2481-2012; Yang, Qing/GZK-2526-2022; Qu, Mingbo/L-6231-2016	Liu, Tian/0000-0001-9768-5496; Yang, Qing/0000-0001-8623-7532; Qu, Mingbo/0000-0003-0397-1630; liu, lin/0000-0002-4248-7377	National Key RAMP;D Program of China [2017YFD0200501]; Program for National Natural Science Funds for Distinguished Young Scholar [31425021]; National Natural Science Foundation of China [31772193]	National Key RAMP;D Program of China; Program for National Natural Science Funds for Distinguished Young Scholar; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by the National Key R&D Program of China (2017YFD0200501), the Program for National Natural Science Funds for Distinguished Young Scholar (31425021), and the National Natural Science Foundation of China (31772193). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andres E, 2014, ANGEW CHEM INT EDIT, V53, P6882, DOI 10.1002/anie.201400220; Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; Arnaouteli S, 2015, J BIOL CHEM, V290, P13465, DOI 10.1074/jbc.M115.640029; Aruchami M., 1986, P263; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Blair DE, 2006, BIOCHEMISTRY-US, V45, P9416, DOI 10.1021/bi0606694; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Brosson D, 2005, FEMS MICROBIOL LETT, V247, P81, DOI 10.1016/j.femsle.2005.04.031; Chatterjee S, 2005, PROCESS BIOCHEM, V40, P395, DOI 10.1016/j.procbio.2004.01.025; Das S, 2006, MOL BIOCHEM PARASIT, V148, P86, DOI 10.1016/j.molbiopara.2006.03.002; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; El Gueddari NE, 2002, NEW PHYTOL, V156, P103, DOI 10.1046/j.1469-8137.2002.00487.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Giastas P, 2018, BIOCHEMISTRY-US, V57, P753, DOI 10.1021/acs.biochem.7b00919; Guo W, 2005, INSECT BIOCHEM MOLEC, V35, P1224, DOI 10.1016/j.ibmb.2005.06.003; Hekmat O, 2003, BIOCHEM J, V374, P369, DOI 10.1042/BJ20030204; Heustis RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040426; Hirano T, 2015, FEBS LETT, V589, P145, DOI 10.1016/j.febslet.2014.11.039; Jakubowska AK, 2010, J VIROL, V84, P2547, DOI 10.1128/JVI.01860-09; Kadokura K, 2007, BIOTECHNOL LETT, V29, P1209, DOI 10.1007/s10529-007-9386-6; KAFETZOPOULOS D, 1993, P NATL ACAD SCI USA, V90, P2564, DOI 10.1073/pnas.90.7.2564; Little DJ, 2015, J BIOL CHEM, V290, P22827, DOI 10.1074/jbc.M115.672469; Little DJ, 2014, J BIOL CHEM, V289, P35907, DOI 10.1074/jbc.M114.611400; Little DJ, 2014, P NATL ACAD SCI USA, V111, P11013, DOI 10.1073/pnas.1406388111; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Liu T, 2011, BIOCHEM J, V438, P467, DOI 10.1042/BJ20110390; Liu ZL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02043-1; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Muthukrishnan S., 2016, EXTRACELLULAR COMPOS, P31, DOI DOI 10.1007/978-3-319-40740-1; Oberbarnscheidt L, 2007, PROTEINS, V66, P250, DOI 10.1002/prot.21217; Petkau G, 2012, J BIOL CHEM, V287, P21396, DOI 10.1074/jbc.M112.359984; Qi-Sheng Wang, 2018, Nuclear Science and Techniques, V29, DOI 10.1007/s41365-018-0398-9; Qu M, 2017, INSECT MOL BIOL, V26, P432, DOI 10.1111/imb.12308; Qu MB, 2014, J PROTEOME RES, V13, P2931, DOI 10.1021/pr5000957; Shaik MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019207; Shao ZR, 2019, NEW PHYTOL, V221, P1890, DOI 10.1111/nph.15510; Stivala A, 2011, BIOINFORMATICS, V27, P3315, DOI 10.1093/bioinformatics/btr575; Taylor EJ, 2006, J BIOL CHEM, V281, P10968, DOI 10.1074/jbc.M513066200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tetreau G, 2015, INSECT BIOCHEM MOLEC, V62, P114, DOI 10.1016/j.ibmb.2015.01.006; Tokuyasu K, 2000, BIOCHEMISTRY-US, V39, P8837, DOI 10.1021/bi0005355; TSIGOS I, 1995, J BIOL CHEM, V270, P26286, DOI 10.1074/jbc.270.44.26286; Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1; Tuveng TR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187544; Urch JE, 2009, PROTEIN SCI, V18, P1197, DOI 10.1002/pro.128; Wang G, 2010, INFECT IMMUN, V78, P4660, DOI 10.1128/IAI.00307-10; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Xi Y, 2014, INSECT MOL BIOL, V23, P695, DOI 10.1111/imb.12113; Yu RR, 2019, INSECT MOL BIOL, V28, P301, DOI 10.1111/imb.12554; Yu RR, 2016, J BIOL CHEM, V291, P24352, DOI 10.1074/jbc.M116.720581; Zhao Y, 2010, MAR DRUGS, V8, P24, DOI 10.3390/md8010024; Zhong XW, 2014, INT J MOL SCI, V15, P1946, DOI 10.3390/ijms15021946; Zhou GY, 2010, AFR J MICROBIOL RES, V4, P2597	58	13	18	4	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5774	5783		10.1074/jbc.RA119.007597	http://dx.doi.org/10.1074/jbc.RA119.007597			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30755482	Green Published, hybrid			2022-12-26	WOS:000465077500004
J	Speciale, I; Duncan, GA; Unione, L; Agarkova, IV; Garozzo, D; Jimenez-Barbero, J; Lin, S; Lowary, TL; Molinaro, A; Noel, E; Laugieri, ME; Tonetti, MG; Van Etten, JL; De Castro, C				Speciale, Immacolata; Duncan, Garry A.; Unione, Luca; Agarkova, Irina V.; Garozzo, Domenico; Jimenez-Barbero, Jesus; Lin, Sicheng; Lowary, Todd L.; Molinaro, Antonio; Noel, Eric; Laugieri, Maria Elena; Tonetti, Michela G.; Van Etten, James L.; De Castro, Cristina			The N-glycan structures of the antigenic variants of chlorovirus PBCV-1 major capsid protein help to identify the virus-encoded glycosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA viruses; glycosyltransferase; bioinformatics; nuclear magnetic resonance (NMR); N-linked glycosylation; post-translational modification (PTM); capsid protein; molecular modeling; Paramecium bursaria chlorella virus 1 (PBCV-1)	CHLORELLA; GLYCOSYLATION; PATHWAY; BIOSYNTHESIS; FEATURES; REVEALS; GLUCOSE	The chlorovirus Paramecium bursaria chlorella virus 1 (PBCV-1) is a large dsDNA virus that infects the microalga Chlorella variabilis NC64A. Unlike most other viruses, PBCV-1 encodes most, if not all, of the machinery required to glycosylate its major capsid protein (MCP). The structures of the four N-linked glycans from the PBCV-1 MCP consist of nonasaccharides, and similar glycans are not found elsewhere in the three domains of life. Here, we identified the roles of three virus-encoded glycosyltransferases (GTs) that have four distinct GT activities in glycan synthesis. Two of the three GTs were previously annotated as GTs, but the third GT was identified in this study. We determined the GT functions by comparing the WT glycan structures from PBCV-1 with those from a set of PBCV-1 spontaneous GT gene mutants resulting in antigenic variants having truncated glycan structures. According to our working model, the virus gene a064r encodes a GT with three domains: domain 1 has a -l-rhamnosyltransferase activity, domain 2 has an -l-rhamnosyltransferase activity, and domain 3 is a methyltransferase that decorates two positions in the terminal -l-rhamnose (Rha) unit. The a075l gene encodes a -xylosyltransferase that attaches the distal d-xylose (Xyl) unit to the l-fucose (Fuc) that is part of the conserved N-glycan core region. Last, gene a071r encodes a GT that is involved in the attachment of a semiconserved element, -d-Rha, to the same l-Fuc in the core region. Our results uncover GT activities that assemble four of the nine residues of the PBCV-1 MCP N-glycans.	[Speciale, Immacolata; De Castro, Cristina] Univ Napoli Federico II, Dept Agr Sci, Via Univ 100, I-80055 Portici, NA, Italy; [Duncan, Garry A.] Nebraska Wesleyan Univ, Dept Biol, Lincoln, NE 68504 USA; [Unione, Luca; Jimenez-Barbero, Jesus] CIC BioGUNE, Chem Glycobiol Lab, Bizkaia Technol Pk,Bld 800, Derio 48170, Spain; [Agarkova, Irina V.; Noel, Eric; Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Agarkova, Irina V.; Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Garozzo, Domenico] CNR, Inst Polymers Composites & Biomat, Via P Gaifami 18, I-95126 Catania, Italy; [Jimenez-Barbero, Jesus] Basque Fdn Sci IKERBASQUE, Bilbao 48940, Spain; [Jimenez-Barbero, Jesus] Univ Basque Country, Dept Organ Chem 2, Fac Sci & Technol, UPV EHU, Leioa 48940, Spain; [Lin, Sicheng; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Gunning Lemieux Chem Ctr, Edmonton, AB T6G 2G2, Canada; [Lin, Sicheng; Lowary, Todd L.] Univ Alberta, Dept Chem, Gunning Lemieux Chem Ctr, Edmonton, AB T6G 2G2, Canada; [Molinaro, Antonio] Univ Napoli Federico II, Dept Chem Sci, I-80126 Naples, Italy; [Noel, Eric] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Laugieri, Maria Elena; Tonetti, Michela G.] Univ Genoa, Dept Expt Med, Viale Benedetto 15-1, I-16132 Genoa, Italy; [Laugieri, Maria Elena; Tonetti, Michela G.] Univ Genoa, Ctr Excellence Biomed Res, Viale Benedetto 15-1, I-16132 Genoa, Italy	University of Naples Federico II; CIC bioGUNE; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Polimeri, Compositi e Biomateriali (IPCB-CNR); Basque Foundation for Science; University of Basque Country; University of Alberta; University of Alberta; University of Naples Federico II; University of Nebraska System; University of Nebraska Lincoln; University of Genoa; University of Genoa	De Castro, C (corresponding author), Univ Napoli Federico II, Dept Agr Sci, Via Univ 100, I-80055 Portici, NA, Italy.; Van Etten, JL (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA.	jvanetten1@unl.edu; decastro@unina.it	Garozzo, Domenico/I-8839-2014; Tonetti, Michela/F-3039-2018; TONETTI, MICHELA/AAF-3404-2021; Lowary, Todd L/F-9608-2019; De Castro, Cristina/I-5899-2012; JIMENEZ-BARBERO, JESUS/D-4431-2014; Unione, Luca/O-6483-2017	Garozzo, Domenico/0000-0002-9087-9818; TONETTI, MICHELA/0000-0002-8829-7173; Lowary, Todd L/0000-0002-8331-8211; De Castro, Cristina/0000-0002-5147-1756; Noel, Eric/0000-0003-0839-5476; Speciale, Immacolata/0000-0003-4363-7450; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Unione, Luca/0000-0002-8724-8783	Mizutani Foundation Grant [180047]; National Institutes of Health IDeA Networks of Biomedical Research Excellence program; National Science Foundation [1736030]; MINECO, CSIC [CTQ2015-64597-C2-1P]; MINECO, Severo Ochoa Excellence Accreditation [SEV-2016-0644]	Mizutani Foundation Grant; National Institutes of Health IDeA Networks of Biomedical Research Excellence program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); MINECO, CSIC; MINECO, Severo Ochoa Excellence Accreditation	This work was supported by Mizutani Foundation Grant 180047 (to C. D. C.), the National Institutes of Health IDeA Networks of Biomedical Research Excellence program (to G. A. D.), and National Science Foundation Grant 1736030 (to J. V. E.). This work was also supported by MINECO, CSIC, Grant CTQ2015-64597-C2-1P and Severo Ochoa Excellence Accreditation SEV-2016-0644 (to CIC bioGUNE). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bagdonaite I, 2018, GLYCOBIOLOGY, V28, P443, DOI 10.1093/glycob/cwy021; BOCK K, 1983, ADV CARBOHYD CHEM BI, V41, P27, DOI 10.1016/S0065-2318(08)60055-4; Chothi MP, 2010, J VIROL, V84, P8829, DOI 10.1128/JVI.00770-10; Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6; De Castro C, 2018, P NATL ACAD SCI USA, V115, pE44, DOI 10.1073/pnas.1613432115; De Castro C, 2016, ANGEW CHEM INT EDIT, V55, P654, DOI 10.1002/anie.201509150; De Castro C, 2013, P NATL ACAD SCI USA, V110, P13956, DOI 10.1073/pnas.1313005110; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; DeAngelis PL, 1997, SCIENCE, V278, P1800, DOI 10.1126/science.278.5344.1800; DOMS RW, 1993, VIROLOGY, V193, P545, DOI 10.1006/viro.1993.1164; Dunigan DD, 2012, J VIROL, V86, P8821, DOI 10.1128/JVI.00907-12; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Gohlke H, 2002, ANGEW CHEM INT EDIT, V41, P2645; Graves MV, 2001, VIROLOGY, V285, P332, DOI 10.1006/viro.2001.0937; Hunter E., 2007, FIELDS VIROLOGY, P141; Jeanniard A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-158; Jeevarajah D, 2004, J BACTERIOL, V186, P6792, DOI 10.1128/JB.186.20.6792-6799.2004; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Landstein D, 1995, VIROLOGY, V214, P413, DOI 10.1006/viro.1995.0051; Markine-Goriaynoff N, 2004, J GEN VIROL, V85, P2741, DOI 10.1099/vir.0.80320-0; Mulakala C, 2013, J MOL GRAPH MODEL, V46, P41, DOI 10.1016/j.jmgm.2013.09.005; Neves RPP, 2013, J CHEM THEORY COMPUT, V9, P2718, DOI 10.1021/ct400055v; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; Olofsson S, 1998, SCAND J INFECT DIS, V30, P435, DOI 10.1080/00365549850161386; Piacente F, 2017, J BIOL CHEM, V292, P7385, DOI 10.1074/jbc.M117.783217; Piacente F, 2014, GLYCOBIOLOGY, V24, P51, DOI 10.1093/glycob/cwt089; Piacente F, 2012, J BIOL CHEM, V287, P3009, DOI 10.1074/jbc.M111.314559; Quispe CF, 2017, VIROLOGY, V500, P103, DOI 10.1016/j.virol.2016.10.013; Rommel AJ, 2016, BIOCHEM J, V473, P3451, DOI 10.1042/BCJ20160280; Speciale I, 2017, ANTON LEEUW INT J G, V110, P1391, DOI 10.1007/s10482-017-0861-3; Tonetti M, 2003, J BIOL CHEM, V278, P21559, DOI 10.1074/jbc.M301543200; Van Etten JL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040088; Van Etten JL, 2010, BBA-GEN SUBJECTS, V1800, P152, DOI 10.1016/j.bbagen.2009.07.024; VANETTEN JL, 1983, SCIENCE, V219, P994, DOI 10.1126/science.219.4587.994; VANETTEN JL, 1983, VIROLOGY, V126, P117, DOI 10.1016/0042-6822(83)90466-X; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; WANG IN, 1993, P NATL ACAD SCI USA, V90, P3840, DOI 10.1073/pnas.90.9.3840; Zhang Y, 2007, STRUCTURE, V15, P1031, DOI 10.1016/j.str.2007.07.006	39	12	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5688	5699		10.1074/jbc.RA118.007182	http://dx.doi.org/10.1074/jbc.RA118.007182			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30737276	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000464517500036
J	Basas, J; Palau, M; Gomis, X; Almirante, B; Gavalda, J				Basas, Jana; Palau, Marta; Gomis, Xavier; Almirante, Benito; Gavalda, Joan			Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicsan and Candida glabrata infections in an experimental model	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; ALBICANS BIOFILMS; DISEASES SOCIETY; RABBIT MODEL; 2009 UPDATE; CASPOFUNGIN; MICAFUNGIN; MANAGEMENT	Objective The aims of this study were as follows. First, we sought to compare the in vitro susceptibility of liposomal amphotericin B (LAmB) and anidulafungin on Candida albicans and Candida glabrata biofilms growing on silicone discs. Second, we sought to compare the activity of LAmB versus anidulafungin for the treatment of experimental catheter-related C. albicans and C. glabrata infections with the antifungal lock technique in a rabbit model. Methods Two C. albicans and two C. glabrata clinical strains were used. The minimum biofilm eradication concentration for 90% eradication (MBEC90) values were determined after 48h of treatment with LAmB and anidulafungin. Confocal microscopy was used to visualize the morphology and viability of yeasts growing in biofilms. Central venous catheters were inserted into New Zealand rabbits, which were inoculated of each strain of C. albicans and C. glabrata. Then, catheters were treated for 48h with saline or with antifungal lock technique using either LAmB (5mg/mL) or anidulafungin (3.33mg/mL). Results In vitro: anidulafungin showed greater activity than LAmB against C. albicans and C. glabrata strains. For C. albicans: MBEC90 of anidulafungin versus LAmB: CA176, 0.03 vs. 128 mg/L; CA180, 0.5 vs. 64 mg/L. For C. glabrata: MBEC90 of anidulafungin versus LAmB: CG171, 0.5 vs. 64 mg/L; CG334, 2 vs. 32 mg/L. In vivo: for C. albicans species, LAmB and anidulafungin achieved significant reductions relative to growth control of log(10) cfu recovered from the catheter tips (CA176: 3.6 +/- 0.3 log(10) CFU, p <= 0.0001; CA180: 3.8 +/- 0.1 log(10) CFU, p <= 0.01). For C. glabrata, anidulafungin lock therapy achieved significant reductions relative to the other treatments (CG171: 4.8 log(10) CFU, p <= 0.0001; CG334: 5.1 log(10) CFU, p <= 0.0001) Conclusions For the C. albicans strains, both LAmB and anidulafungin may be promising antifungal lock technique for long-term catheter-related infections; however, anidulafungin showed significantly higher activity than LAmB against the C. glabrata strains.	[Basas, Jana; Palau, Marta; Gomis, Xavier; Almirante, Benito; Gavalda, Joan] Hosp Valle De Hebron, Vall Hebron Res Inst VHIR, Infect Dis Dept, Antibiot Resistance Lab, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Gavalda, J (corresponding author), Hosp Valle De Hebron, Vall Hebron Res Inst VHIR, Infect Dis Dept, Antibiot Resistance Lab, Barcelona, Spain.	joan.gavalda@vhir.org		Almirante, Benito/0000-0002-1189-2361; Gavalda, Joan/0000-0002-9829-3141; Gomis Rodriguez, Javier/0000-0001-6258-3721; Palau Gauthier, Marta/0000-0002-4567-9868	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III [FIS PI070394]; European Development Regional Fund "A way to achieve Europe" ERDF; Spanish Network for Research in Infectious Diseases [REIPI RD12/0015]; Pfizer, Inc.	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Development Regional Fund "A way to achieve Europe" ERDF; Spanish Network for Research in Infectious Diseases; Pfizer, Inc.(Pfizer)	This study was supported by research grants from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (FIS PI070394) and was co-financed by the European Development Regional Fund "A way to achieve Europe" ERDF, the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015), and partially by Pfizer, Inc. The funder had no involvement in the design and conduct of the study; analysis, interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Basas J, 2016, J ANTIMICROB CHEMOTH, V71, P2895, DOI 10.1093/jac/dkw251; BENOIT JL, 1995, CLIN INFECT DIS, V21, P1286, DOI 10.1093/clinids/21.5.1286; Buckler BS, 2008, PEDIATR INFECT DIS J, V27, P762, DOI 10.1097/INF.0b013e318170b68b; Cateau E, 2008, J ANTIMICROB CHEMOTH, V62, P153, DOI 10.1093/jac/dkn160; Chandra J, 2005, CURR DRUG TARGETS, V6, P887, DOI 10.2174/138945005774912762; Chandra J, 2011, VIRULENCE, V2, P466, DOI 10.4161/viru.2.5.16341; Chandra J, 2008, NAT PROTOC, V3, P1909, DOI 10.1038/nprot.2008.192; EUCAST, 2016, BREAKP TABL INT MICS, P35; Imbert C, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010006; JOHNSON DC, 1994, PEDIATR INFECT DIS J, V13, P930, DOI 10.1097/00006454-199410000-00015; Kawai A, 2015, J INFECT CHEMOTHER, V21, P647, DOI 10.1016/j.jiac.2015.05.007; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Kucharikova S, 2010, ANTIMICROB AGENTS CH, V54, P4474, DOI 10.1128/AAC.00697-10; Lamoth F, 2018, J ANTIMICROB CHEMOTH, V73, pi4, DOI 10.1093/jac/dkx444; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Oncu S, 2011, J INFECT CHEMOTHER, V17, P634, DOI 10.1007/s10156-011-0224-3; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Puig-Asensio M, 2014, CLIN MICROBIOL INFEC, V20, pO245, DOI 10.1111/1469-0691.12380; Ramage G, 2013, ANTIMICROB AGENTS CH, V57, P2369, DOI 10.1128/AAC.02344-12; Rodriguez D, 2007, CLIN MICROBIOL INFEC, V13, P788, DOI 10.1111/j.1469-0691.2007.01758.x; Salma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077600; Schinabeck MK, 2004, ANTIMICROB AGENTS CH, V48, P1727, DOI 10.1128/AAC.48.5.1727-1732.2004; Shuford JA, 2006, J INFECT DIS, V194, P710, DOI 10.1086/506452; Viale P, 2001, CLIN INFECT DIS, V33, P1947, DOI 10.1086/323554; Walraven CJ, 2013, ANTIMICROB AGENTS CH, V57, P1, DOI 10.1128/AAC.01351-12	25	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212426	10.1371/journal.pone.0212426	http://dx.doi.org/10.1371/journal.pone.0212426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779771	Green Submitted, Green Published, gold			2022-12-26	WOS:000459062900054
J	Takada, H; Kurosaki, M; Nakanishi, H; Takahashi, Y; Itakura, J; Tsuchiya, K; Yasui, Y; Tamaki, N; Takaura, K; Komiyama, Y; Higuchi, M; Kubota, Y; Wang, WN; Okada, M; Shimizu, T; Watakabe, K; Enomoto, N; Izumi, N				Takada, Hitomi; Kurosaki, Masayuki; Nakanishi, Hiroyuki; Takahashi, Yuka; Itakura, Jun; Tsuchiya, Kaoru; Yasui, Yutaka; Tamaki, Nobuharu; Takaura, Kenta; Komiyama, Yasuyuki; Higuchi, Mayu; Kubota, Youhei; Wang, Wann; Okada, Mao; Shimizu, Takao; Watakabe, Keiya; Enomoto, Nobuyuki; Izumi, Namiki			Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; ESOPHAGEAL-VARICES; LIVER-BIOPSY; THROMBOCYTOPENIA; THROMBOPOIETIN; HEPATITIS	Background and aims The present study aimed to report our real-life experience of the TPO receptor agonist lusutrombopag for cirrhotic patients with low platelet counts. Methods We studied platelet counts in 1,760 cirrhotic patients undergoing invasive procedures at our hospital between January 2014 and December 2017. In addition, we studied 25 patients who were administered lusutrombopag before invasive procedures between June 2017 and January 2018. Effectiveness of lusutrombopag to raise platelet counts and to avoid transfusion and treatment-related adverse events were analyzed. Results In 1,760 cirrhotic patients without lusutrombopag prior to invasive procedures, proportion of patients whose platelet counts <50,000/mu L and needed platelet transfusions were 66% (n = 27/41) for radiofrequency ablation, 43% (n = 21/49) for transarterial chemoembolization, and 55% (n = 21/38) for endoscopic injection sclerotherapy / endoscopic variceal ligation, respectively. In 25 cirrhotic patients treated by lusutrombopag prior to the invasive procedures, platelet counts significantly increased compared with baseline (82,000 26,000 vs. 41,000 +/- 11,000/mu L) (p < 0.01). Out of 25 patients, only 4 patients (16%) needed platelet transfusion before the invasive procedures. The proportion of patients with low platelet count and who needed platelet transfusions was significantly low in patients treated with lusutrombopag compared to those not treated with lusutrombopag (16% (4/25) vs. 54% (69/128), p = 0.001). Platelet counts after lusutrombopag treatment and prior to invasive procedures were lower in patients with a baseline platelet count <= 30,000/mu L (n = 8) compared with those with a baseline platelet count >30,000/mu L (n = 17) (50,000 +/- 20,000 vs 86,000 +/- 26,000/mu L, p = 0.002). Patients with a baseline platelet count <= 30,000/mu L with spleen index (calculated by multiplying the transverse diameter by the vertical diameter measured by ultrasonography) >= 40 cm(2) (n = 3) had a lower response rate to lusutrombopag compared to those with spleen index <40 cm(2) (n = 5) (0% vs. 100%, p = 0.02). Hemorrhagic complication was not observed. Recurrence of portal thrombosis was observed and thrombolysis therapy was required in one patient who had prior history of thrombosis. Conclusions Lusutrombopag is an effective and safe drug for thrombocytopenia in cirrhotic patients, and can reduce the frequency of platelet transfusions.	[Takada, Hitomi; Kurosaki, Masayuki; Nakanishi, Hiroyuki; Takahashi, Yuka; Itakura, Jun; Tsuchiya, Kaoru; Yasui, Yutaka; Tamaki, Nobuharu; Takaura, Kenta; Komiyama, Yasuyuki; Higuchi, Mayu; Kubota, Youhei; Wang, Wann; Okada, Mao; Shimizu, Takao; Watakabe, Keiya; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Takada, Hitomi; Komiyama, Yasuyuki; Enomoto, Nobuyuki] Univ Yamanashi, Fac Med, Dept Internal Med 1, Kofu, Yamanashi, Japan	University of Yamanashi	Izumi, N (corresponding author), Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan.	izumi012@musashino.jrc.or.jp	Nakanishi, Hiroyuki/AAD-9324-2020	Nakanishi, Hiroyuki/0000-0003-3982-3314; Yasui, Yutaka/0000-0002-6117-4990; Tamaki, Nobuharu/0000-0003-4634-6616; Tsuchiya, Kaoru/0000-0003-0436-5915	Japan Agency of Medical Research and Development [15fk0210007h0002]	Japan Agency of Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by a grant from the Japan Agency of Medical Research and Development (grant number: 15fk0210007h0002, URL: http://www.amed.go.jp/en/). Additionally, NI received lecture fees from SHIONOGI & CO., LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2008, J HEPATOL, V48, P1000, DOI 10.1016/j.jhep.2008.03.009; BALLARD HS, 1989, ALCOHOL CLIN EXP RES, V13, P706, DOI 10.1111/j.1530-0277.1989.tb00408.x; Boyum JH, 2016, MAYO CLIN PROC, V91, P329, DOI 10.1016/j.mayocp.2015.11.015; Cantor SB, 2003, CANCER, V97, P3099, DOI 10.1002/cncr.11447; Giannini EG, 2010, CLIN GASTROENTEROL H, V8, P899, DOI 10.1016/j.cgh.2010.06.018; Giannini EG, 2006, ALIMENT PHARM THER, V23, P1055, DOI 10.1111/j.1365-2036.2006.02889.x; INABNET WB, 1995, AM SURGEON, V61, P603; Joshi N, 2017, TOXICOL APPL PHARM, V328, P54, DOI 10.1016/j.taap.2017.05.018; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim ES, 2016, DRUGS, V76, P155, DOI 10.1007/s40265-015-0525-4; Kuter DJ, 2009, BLOOD, V114, P3748, DOI 10.1182/blood-2009-05-224766; Lisman T, 2006, HEPATOLOGY, V44, P53, DOI 10.1002/hep.21231; Lisman T, 2012, NEW ENGL J MED, V367, P2055, DOI 10.1056/NEJMc1211471; Madhotra R, 2002, J CLIN GASTROENTEROL, V34, P81, DOI 10.1097/00004836-200201000-00016; MCVAY PA, 1990, AM J CLIN PATHOL, V94, P747, DOI 10.1093/ajcp/94.6.747; Nurden AT, 2009, LANCET, V373, P1562, DOI 10.1016/S0140-6736(09)60255-5; Okubo M, 2000, CLIN SCI, V99, P207, DOI 10.1042/CS20000023; Peck-Radosavljevic M, 1998, HEPATOLOGY, V28, P1424, DOI 10.1002/hep.510280535; Sakamaki A, 2017, CLIN J GASTROENTEROL, V10, P261, DOI 10.1007/s12328-017-0735-2; Schiffer CA, 2017, J CLIN ONCOL, V28; Terrault NA, 2014, J HEPATOL, V61, P1253, DOI 10.1016/j.jhep.2014.07.007; Thomopoulos KC, 2003, DIGEST LIVER DIS, V35, P473, DOI 10.1016/S1590-8658(03)00219-6; Vadhan-Raj S, 2003, J CLIN ONCOL, V21, P3158, DOI 10.1200/JCO.2003.08.003; Wang CS, 2004, CLIN INFECT DIS, V39, P790, DOI 10.1086/423384	24	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0211122	10.1371/journal.pone.0211122	http://dx.doi.org/10.1371/journal.pone.0211122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768601	Green Published, Green Submitted, gold			2022-12-26	WOS:000458766300005
J	Azuma, K; Tan, X; Asano, S; Shimizu, K; Ogawa, A; Inoue, T; Murata, H; Asaoka, R; Obata, R				Azuma, Keiko; Tan, Xue; Asano, Shotaro; Shimizu, Kimiko; Ogawa, Asako; Inoue, Tatsuya; Murata, Hiroshi; Asaoka, Ryo; Obata, Ryo			The association of choroidal structure and its response to anti-VEGF treatment with the short-time outcome in pachychoroid neovasculopathy	PLOS ONE			English	Article							EXTEND REGIMEN; MACULAR DEGENERATION; AFLIBERCEPT; NEOVASCULARIZATION; THERAPY; VASCULOPATHY; THICKNESS	Pachychoroid neovasculopathy (PNV) shares some anatomical features with other pachychoroid spectrum diseases, but little is known about the characteristics on the treatment with anti-vascular endothelial growth factor (VEGF). We investigated the effect of choroidal structure and responses to anti-VEGF on the prognosis of pachychoroid neovasculopathy (PNV) and other types of neovascular age-related macular degeneration (non-PNV). Twenty-one eyes with PNV and 34 eyes with non-PNV who had anti-VEGF treatment were retrospectively reviewed. Choroidal neovascularization (CNV) area at baseline was measured with fluorescein angiography (FAG). The luminal and stromal area in the choroid was measured by enhanced-depth-imaging (EDI) OCT at baseline and 1 month. The association between dry macula or LogMAR VA (visual acuity, VA) at 1 month and baseline values or changes in the luminal or stromal area at 1 month, baseline CNV area, or anti-VEGF drugs were analyzed in patients with or without PNV. In non-PNV, change of luminal area (coefficient = 7.0x10(-5), p = 0.0001), baseline CNV area (coefficient = 0.18, p = 0.033), and aflibercept vs. ranibizumab (coefficient = 0.29, p = 0.0048) were chosen as predictors for dry macula by the model selection. Similarly, in non-PNV, change of luminal area (coefficient = 6.1x10(-6), p = 0.033), baseline CNV area (coefficient = 0.034, p = 0.022), and aflibercept vs. ranibizumab (coefficient = 0.056, p = 0.0020) were chosen as predictors for greater VA improvement. In PNV, however, none of these factors was chosen as predictors for dry macula or VA improvement by the model selection. The result of the present study implied that structural response after anti-VEGF might be different between non-PNV and PNV in the treatment with anti-VEGF agents.	[Azuma, Keiko; Tan, Xue; Asano, Shotaro; Shimizu, Kimiko; Ogawa, Asako; Inoue, Tatsuya; Murata, Hiroshi; Asaoka, Ryo; Obata, Ryo] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Azuma, Keiko; Tan, Xue; Asano, Shotaro; Shimizu, Kimiko; Ogawa, Asako; Inoue, Tatsuya; Murata, Hiroshi; Asaoka, Ryo; Obata, Ryo] Univ Tokyo, Fac Med, Tokyo, Japan; [Tan, Xue] Tokyo Shinjuku Med Ctr, Dept Ophthalmol, Tokyo, Japan	University of Tokyo; University of Tokyo	Obata, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.; Obata, R (corresponding author), Univ Tokyo, Fac Med, Tokyo, Japan.	robata-tky@umin.ac.jp			JSPS KAKENHI [JP16K11260]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was done under JSPS KAKENHI grant number JP16K11260. The organization had no role in study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the article for publication.	Asano S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197042; Azuma K, 2016, RETINA-J RET VIT DIS, V36, P2158, DOI 10.1097/IAE.0000000000001047; Burnham KP, 2014, ECOLOGY, V95, P627, DOI 10.1890/13-1066.1; Cheung CMG, 2019, EYE, V33, P14, DOI 10.1038/s41433-018-0158-4; Cho HJ, 2013, AM J OPHTHALMOL, V156, P1192, DOI 10.1016/j.ajo.2013.07.001; Cicchetti D. V., 1994, GUIDELINES CRITERIA, P284; Fung AT, 2012, RETINA-J RET VIT DIS, V32, P1829, DOI 10.1097/IAE.0b013e3182680a66; Hata M, 2017, INVEST OPHTH VIS SCI, V58, P292, DOI 10.1167/iovs.16-20967; Kinoshita T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163104; KLEIN R, 1992, OPHTHALMOLOGY, V99, P1686; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; Koizumi H, 2016, OPHTHALMOLOGY, V123, P617, DOI 10.1016/j.ophtha.2015.10.039; Koizumi H, 2013, AM J OPHTHALMOL, V155, P305, DOI 10.1016/j.ajo.2012.07.018; Kuroda Y, 2016, AM J OPHTHALMOL, V169, P199, DOI 10.1016/j.ajo.2016.06.043; Lee JH, 2016, RETINA-J RET VIT DIS, V36, P889, DOI 10.1097/IAE.0000000000000809; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Matsumoto H, 2018, JPN J OPHTHALMOL, V62, P144, DOI 10.1007/s10384-018-0562-0; Miyake M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16204; Miyake M, 2014, INVEST OPHTH VIS SCI, V55, P3223, DOI 10.1167/iovs.14-14059; Nomura Y, 2015, JPN J OPHTHALMOL, V59, P261, DOI 10.1007/s10384-015-0387-z; Pang CE, 2015, RETINA-J RET VIT DIS, V35, P1, DOI 10.1097/IAE.0000000000000331; Shin MC, 2011, RETINA-J RET VIT DIS, V31, P1937, DOI 10.1097/IAE.0b013e31820a6a17; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Stewart MW, 2008, BRIT J OPHTHALMOL, V92, P667, DOI 10.1136/bjo.2007.134874; Terao N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28484-w; Tibshirani RJ, 2012, ANN STAT, V40, P1198, DOI 10.1214/12-AOS1003; Ting DSW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08276-4; Yamamoto A, 2017, OPHTHALMOLOGICA, V237, P139, DOI 10.1159/000458538; Yamazaki T, 2012, OPHTHALMOLOGY, V119, P1621, DOI 10.1016/j.ophtha.2012.02.022	29	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212055	10.1371/journal.pone.0212055	http://dx.doi.org/10.1371/journal.pone.0212055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763369	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900036
J	Begic, E; Hadzidedic, S; Kulaglic, A; Ramic-Brkic, B; Begic, Z; Causevic, M				Begic, Edin; Hadzidedic, Suncica; Kulaglic, Ajla; Ramic-Brkic, Belma; Begic, Zijo; Causevic, Mirsada			SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patients	PLOS ONE			English	Article							HEART-FAILURE; CARDIOVASCULAR-DISEASE; MULTIPLE IMPUTATION; ELDERLY-PATIENTS; NT-PROBNP; BNP; AGE; DYSFUNCTION; DIAGNOSIS; BIOMARKER	Alzheimer's disease represents the most common age-related neurodegenerative disorder and a leading cause of progressive cognitive impairment. Predicting cognitive decline is challenging but would be invaluable in an increasingly aging population which also experiences a rising cardiovascular risk. In order to examine whether plasma measurements of one of the established biomarkers of heart failure, brain natriuretic peptide (BNP), reflect a decline in cognitive function, associated with Alzheimer's disease neurodegeneration, BNP levels were analysed, by using a novel assay called a SOMAscan, in 1. cognitively healthy, control subjects; 2. subjects with mild cognitive impairment, and 3. subjects with Alzheimer's disease. The results of our study show that the levels of the BNP were significantly different between the three types of diagnoses (p < 0.05), whereby subjects with mild cognitive impairment had the lowest mean BNP value, and healthy subjects had the highest BNP value. Importantly, our results show that the levels of the BNP are influenced by the presence of at least one APOE4 allele in the healthy (p < 0.05) and in the Alzheimer's disease groups of subjects (p < 0.1). As the levels of the BNP appear to be independent of the APOE4 genotype in subjects with mild cognitive impairment, the results of our study support inclusion of measurements of plasma levels of the BNP in the list of the core Alzheimer's disease biomarkers for identification of the mild cognitive impairment group of patients. In addition, the results of our study warrant further investigations into molecular links between Alzheimer's disease-type cognitive decline and cardiovascular disorders.	[Begic, Edin; Causevic, Mirsada] Sarajevo Sch Sci & Technol, Sarajevo Med Sch, Dept Pharmacol, Sarajevo, Bosnia & Herceg; [Begic, Edin] Gen Hosp Prim Dr Abdulah Nakas, Dept Cardiol, Sarajevo, Bosnia & Herceg; [Hadzidedic, Suncica; Kulaglic, Ajla; Ramic-Brkic, Belma] Sarajevo Sch Sci & Technol, Comp Sci & Informat Syst Dept, Sarajevo, Bosnia & Herceg; [Begic, Zijo] Univ Clin Ctr, Dept Pediat Cardiol, Sarajevo, Bosnia & Herceg	University of Sarajevo; University of Sarajevo	Causevic, M (corresponding author), Sarajevo Sch Sci & Technol, Sarajevo Med Sch, Dept Pharmacol, Sarajevo, Bosnia & Herceg.	mirsada.causevic@ssst.edu.ba	Begic, Edin/AAN-1606-2020; Causevic, Mirsada/AAM-7423-2020; Kulaglic, Ajla/ABA-4120-2020; Ramic-Brkic, Belma/AHB-2625-2022	Begic, Edin/0000-0001-6842-262X; Causevic, Mirsada/0000-0002-6099-6415; Kulaglic, Ajla/0000-0003-3410-7079; Ramic-Brkic, Belma/0000-0002-8205-0137; Begic, Zijo/0000-0002-1863-5755	EFPIA companies; SMEs, InnoMed (Innovative Medicines in Europe); European Union of the Sixth Framework program [FP6-2004-LIFESCIHEALTH-5]	EFPIA companies; SMEs, InnoMed (Innovative Medicines in Europe); European Union of the Sixth Framework program	The authors received no funding for the work presented in this study. However, the authors used the AddNeuroMed data that have been obtained through a public-private partnership supported by EFPIA companies and SMEs as part of InnoMed (Innovative Medicines in Europe), an Integrated Project funded by the European Union of the Sixth Framework program priority FP6-2004-LIFESCIHEALTH-5, which was awarded to the clinical leads, who were responsible for data collection - Iwona Kloszewska (Lodz), Simon Lovestone (London), Patrizia Mecocci (Perugia), Hilkka Soininen (Kuopio), Magda Tsolaki (Thessaloniki), and Bruno Vellas (Toulouse), imaging leads - Andy Simmons (London), Lars-Olof Wahlund (Stockholm) and Christian Spenger (Zurich), and bioinformatics leads - Richard Dobson (London) and Stephen Newhouse (London). The authors have obtained authorised access to the AddNeuroMed data from the Sage Bionetworks Access and Compliance Team (https://www.synapse.org/#!Synapse: syn2790911/wiki/235389).	Abete P, 2014, AGEING RES REV, V18, P41, DOI 10.1016/j.arr.2014.07.003; Adelborg K, 2017, EUR J HEART FAIL, V19, P253, DOI 10.1002/ejhf.631; Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32, DOI 10.2174/1567205012666141218140953; Blennow K, 2017, NEUROL THER, V6, pS15, DOI 10.1007/s40120-017-0073-9; Brown JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106716; Cannon JA, 2017, J CARD FAIL, V23, P464, DOI 10.1016/j.cardfail.2017.04.007; Choi S, 2007, EMERG MED J, V24, P343, DOI 10.1136/emj.2006.041368; Daniels LB, 2011, AM J MED, V124, P670, DOI 10.1016/j.amjmed.2011.02.027; de Goeij MCM, 2013, NEPHROL DIAL TRANSPL, V28, P2415, DOI 10.1093/ndt/gft221; Doust J, 2006, AM FAM PHYSICIAN, V74, P1893; Edvinsson ML, 2014, J GERIATR CARDIOL, V11, P50, DOI 10.3969/j.issn.1671-5411.2014.01.004; Fillit H, 2008, AM J GERIATR PHARMAC, V6, P100, DOI 10.1016/j.amjopharm.2008.06.004; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gunstad J, 2006, AM J CARDIOL, V98, P538, DOI 10.1016/j.amjcard.2006.02.062; Hammerer-Lercher A, 2004, CLIN CHEM, V50, P1174, DOI 10.1373/clinchem.2003.028316; Heckman GA, 2007, CLIN INTERV AGING, V2, P209; Hill SA, 2014, HEART FAIL REV, V19, P421, DOI 10.1007/s10741-014-9447-6; Hoth KF, 2008, COGN BEHAV NEUROL, V21, P65, DOI 10.1097/WNN.0b013e3181799dc8; Hu WT, 2012, NEUROLOGY, V79, P897, DOI 10.1212/WNL.0b013e318266fa70; Huang MW, 2018, J HEALTHC ENG, V2018, DOI 10.1155/2018/1817479; Huang MW, 2016, EXPERT SYST, V33, P432, DOI 10.1111/exsy.12155; Itoh Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181349; Jefferson AL, 2015, CIRCULATION, V131, P1333, DOI 10.1161/CIRCULATIONAHA.114.012438; Keyzer JM, 2014, CLIN CHEM LAB MED, V52, P1341, DOI 10.1515/cclm-2013-0791; Kiddle SJ, 2014, J ALZHEIMERS DIS, V38, P515, DOI 10.3233/JAD-130380; Kondziella D, 2009, NEUROREPORT, V20, P825, DOI 10.1097/WNR.0b013e328326f82f; Kwak SK, 2017, KOREAN J ANESTHESIOL, V70, P407, DOI 10.4097/kjae.2017.70.4.407; Langa KM, 2014, JAMA-J AM MED ASSOC, V312, P2551, DOI 10.1001/jama.2014.13806; Latini R, 2002, CIRCULATION, V106, P2454, DOI 10.1161/01.CIR.0000036747.68104.AC; Lee KJ, 2010, AM J EPIDEMIOL, V171, P624, DOI 10.1093/aje/kwp425; Liu GY, 2014, NEUROBIOL AGING, V35, P786, DOI 10.1016/j.neurobiolaging.2013.10.084; Magnussen C, 2018, J INTERN MED, V283, P530, DOI 10.1111/joim.12756; Marksteiner J, 2014, EXP GERONTOL, V50, P114, DOI 10.1016/j.exger.2013.12.001; Mattsson N, 2018, ALZHEIMERS DEMENT, V14, P913, DOI 10.1016/j.jalz.2018.02.009; Mosing MA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002609; Nilsson K, 2012, DEMENT GER COGN D EX, V2, P10, DOI 10.1159/000334997; Nordlund A, 2015, J CARD FAIL, V21, P702, DOI 10.1016/j.cardfail.2015.04.006; Parab Reshma, 2005, Crit Pathw Cardiol, V4, P140, DOI 10.1097/01.hpc.0000174912.89563.ba; Picano E, 2014, INT J CARDIOL, V175, P21, DOI 10.1016/j.ijcard.2014.05.004; Ponikowski Piotr, 2016, Rev Esp Cardiol (Engl Ed), V69, P1167, DOI 10.1016/j.rec.2016.11.005; Potter LR, 2011, FEBS J, V278, P1808, DOI 10.1111/j.1742-4658.2011.08082.x; Raymond I, 2003, HEART, V89, P745, DOI 10.1136/heart.89.7.745; Reifman A, 2010, ENCY RES DESIGN, V3, P1636, DOI DOI 10.4135/9781412961288.N502; Riedel BC, 2016, J STEROID BIOCHEM, V160, P134, DOI 10.1016/j.jsbmb.2016.03.012; Sattlecker M, 2014, ALZHEIMERS DEMENT, V10, P724, DOI 10.1016/j.jalz.2013.09.016; Shi L, 2018, J ALZHEIMERS DIS, V62, P1181, DOI 10.3233/JAD-170531; Suemoto Claudia Kimie, 2009, Dement. neuropsychol., V3, P308, DOI 10.1590/S1980-57642009DN30400008; Tsutamoto T, 1997, AM HEART J, V134, P910, DOI 10.1016/S0002-8703(97)80014-2; Tsutamoto T, 2001, J AM COLL CARDIOL, V37, P1228, DOI 10.1016/S0735-1097(01)01116-0; Vuolteenaho O, 2005, ADV CLIN CHEM, V40, P1, DOI 10.1016/S0065-2423(05)40001-3; Yoshimura M, 2002, AM J MED, V112, P716, DOI 10.1016/S0002-9343(02)01121-X; Zheng TP, 2016, DIABETES CARE, V39, P1594, DOI 10.2337/dc16-0316	53	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212261	10.1371/journal.pone.0212261	http://dx.doi.org/10.1371/journal.pone.0212261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763368	gold, Green Published, Green Submitted			2022-12-26	WOS:000458763900053
J	Li, YZ; Tang, WM; Liu, GX				Li, Yuzhong; Tang, Wenming; Liu, Guixiong			Improved scheduling algorithm for signal processing in asynchronous distributed ultrasonic total-focusing-method system	PLOS ONE			English	Article							APERTURE; ARRAY	Compared to the conventional ultrasonic phased-array system, a large-element phased-array system employing the total focusing method (TFM) can yield improved image resolution and accuracy, providing more flexible scanning methods and image merging functionality. In order to meet various forms of ultrasonic multi-group scanning, an architecture for multi-group scan integration called the "asynchronous distributed ultrasonic TFM system" is proposed, and a novel scheduling algorithm called "the sum of start time and processing time adjacent (SSPA) algorithm" is presented. The architecture adds a focus and group scheduler (FGS) and signal processing scheduler (SPS) to the traditional ultrasonic phased array system and constructs a signal processing arbitration (SPA) with several signal processing modules (SPMs). The FGS provides the focus parameters, pixel memory range, and number of pixels in each group. The SPS controls the SPA for the ultrasonic scanning data obtained from the elements, with SPM-sharing output data; hence, the optimal priority order and SPM assignment are realized, enabling switching of reading operations among the first-in-first-out memories for signal processing and minimal time-slot waiting. The SSPA algorithm is used to solve the job-shop scheduling problem with start time, which considers the processing time and start time, in order to reduce the time slot after each scheduling using adjacent operations. Therefore, the architecture enhances the flexibility of the multi-group scan, and this algorithm decreases the makespan, achieving higher efficiency compared to conventional scheduling algorithms. The reliability and validity of the algorithm are substantiated after its implementation using FPGA technology. The SPM utilization rate and the real-time performance of the ultrasonic TFM are improved. Thus, the proposed algorithm and architecture have considerable potential application in multi-sensor systems.	[Li, Yuzhong; Tang, Wenming; Liu, Guixiong] South China Univ Technol, Sch Mech & Automot Engn, Guangzhou, Guangdong, Peoples R China; [Li, Yuzhong] Huizhou Econ & Polytech Coll, Sch Informat Engn, Huizhou, Peoples R China; [Tang, Wenming] Guangzhou Doppler Elect Technol Co Ltd, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Li, YZ (corresponding author), South China Univ Technol, Sch Mech & Automot Engn, Guangzhou, Guangdong, Peoples R China.; Li, YZ (corresponding author), Huizhou Econ & Polytech Coll, Sch Informat Engn, Huizhou, Peoples R China.	melyz@mail.scut.edu.cn			National Key Foundation for Exploring Scientific Instruments [2013YQ230575]; Guangzhou Science and Technology Plan Project [201509010008]; Guangzhou Doppler Electronic Technologies Co., Ltd.	National Key Foundation for Exploring Scientific Instruments; Guangzhou Science and Technology Plan Project; Guangzhou Doppler Electronic Technologies Co., Ltd.	This work was financially supported by the National Key Foundation for Exploring Scientific Instruments (2013YQ230575), and the Guangzhou Science and Technology Plan Project (201509010008). This fund was received by the study group and not any individual author. Additional financial support was received from Guangzhou Doppler Electronic Technologies Co., Ltd. (http://en.cndoppler.com/) in the form of salary to WT, who was employed by the company during the time of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ADAMS J, 1988, MANAGE SCI, V34, P391, DOI 10.1287/mnsc.34.3.391; [Anonymous], 2013, F249113 ASTM; BALAS E, 1969, OPER RES, V17, P941, DOI 10.1287/opre.17.6.941; Bank D, 2007, IEEE T ROBOT, V23, P370, DOI 10.1109/TRO.2007.895060; Caicedo D, 2012, P 20 EUR SIGN PROC C; Caicedo D, 2014, IEEE SENS J, V14, P234, DOI 10.1109/JSEN.2013.2282958; Caicedo D, 2012, IEEE SENS J, V12, P849, DOI 10.1109/JSEN.2011.2161667; Chronaki K, 2017, IEEE T PARALL DISTR, V28, P2074, DOI 10.1109/TPDS.2016.2633347; Fischetti M, 2017, EUR J OPER RES, V263, P258, DOI 10.1016/j.ejor.2017.04.057; Garey M.R., 1979, COMPUTERS INTRACTABI; Holmes C, 2005, NDT&E INT, V38, P701, DOI 10.1016/j.ndteint.2005.04.002; Hossain MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176214; Jackson JR, 1955, 43 LOS ANG U CAL MAN; Jensen JA, 2006, ULTRASONICS, V44, pE5, DOI 10.1016/j.ultras.2006.07.017; Jifei H J H, 1999, VEH EL C, DOI [10.1109/IVEC.1999.830645, DOI 10.1109/IVEC.1999.830645]; Jing Liu, 2017, Visualization in Engineering, V5, DOI 10.1186/s40327-017-0044-3; Kim H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163535; Li YB, 2008, IEEE T ULTRASON FERR, V55, P236, DOI 10.1109/TUFFC.2008.632; Lin SW, 2018, IEEE ACCESS, V6, P16464, DOI 10.1109/ACCESS.2018.2816959; Long J, 2017, IEEE SYST J, V11, P868, DOI 10.1109/JSYST.2015.2448355; MCNAB A, 1987, NDT INT, V20, P333, DOI 10.1016/0308-9126(87)90290-2; Njiki M, 2013, IEEE ANN INT CONF CY, P468, DOI 10.1109/CYBER.2013.6705491; Ou XY, 2017, IEEE ROBOT AUTOM LET, V2, P1848, DOI 10.1109/LRA.2017.2710259; PANWALKAR SS, 1977, OPER RES, V25, P45, DOI 10.1287/opre.25.1.45; Patil S, 2005, P INT C NEXT GEN COM, P96, DOI [10.1109/ngct.2015.7375090, DOI 10.1109/NGCT.2015.7375090]; Pinedo ML, 2016, SCHEDULING THEORY AL, DOI [10.1080/15458830.1996.11770714, DOI 10.1080/15458830.1996.11770714]; Priyantha N. B., 2000, MobiCom 2000. Proceedings of the Sixth Annual International Conference on Mobile Computing and Networking, P32, DOI 10.1145/345910.345917; Rodriguez-Flores L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190939; Ruobo Lin, 2015, International Journal of Engineering and Technology, V7, P249, DOI 10.7763/IJET.2015.V7.800; Smith W. E., 1956, NAV RES LOGIST Q, V3, P59, DOI DOI 10.1002/NAV.3800030106; Song JH, 2012, IEEE T BIO-MED ENG, V59, P435, DOI 10.1109/TBME.2011.2174057; Srinivasan S, 2013, IEEE SENS J, V13, P2517, DOI 10.1109/JSEN.2013.2254594; Suzuki A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194049; Takeshi Yamada, 1997, IEE CONTROL ENG SERI, V55, P134; Tang WM, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17102355; TAYLOR KJW, 1976, BRIT J RADIOL, V49, P519, DOI 10.1259/0007-1285-49-582-519; Wang C, 2017, INT J ACOUST VIB, V22, P536, DOI 10.20855/ijav.2017.22.4500; Wang SF, SYSTEM ENG THEORY PR, V23, P49, DOI [10.3321/j.issn:1000-6788.2003.01.009, DOI 10.3321/J.ISSN:1000-6788.2003.01.009]; Wu A, 2009, ICEMI 2009 P 9 INT C, DOI [10.1109/ICEMI.2009.5274785, DOI 10.1109/ICEMI.2009.5274785]; Wu S. Y. D., 1987, THESIS; Yaashuwanth C, 2009, INT J COMPUT SCI INF, V6, P61; Ying KC, 2018, COMPUT IND ENG, V121, P73, DOI 10.1016/j.cie.2018.05.030; Zhang F, 2012, MOBILE NETW APPL, V17, P582, DOI 10.1007/s11036-011-0311-9	43	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212285	10.1371/journal.pone.0212285	http://dx.doi.org/10.1371/journal.pone.0212285			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763380	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900061
J	Kalra, P; Brandl, J; Gaub, T; Niederalt, C; Lippert, J; Sahle, S; Kupfer, L; Kummer, U				Kalra, Priyata; Brandl, Julian; Gaub, Thomas; Niederalt, Christoph; Lippert, Joerg; Sahle, Sven; Kuepfer, Lars; Kummer, Ursula			Quantitative systems pharmacology of interferon alpha administration: A multi-scale approach	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; RECEPTOR-MEDIATED PHARMACOKINETICS; TISSUE DISTRIBUTION; RECOMBINANT HUMAN; IN-VIVO; CONSENSUS INTERFERON; VIRUS-INFECTION; LIVER-BIOPSY; CELL-TYPE; MODEL	The therapeutic effect of a drug is governed by its pharmacokinetics which determine the downstream pharmacodynamic response within the cellular network. A complete understanding of the drug-effect relationship therefore requires multi-scale models which integrate the properties of the different physiological scales. Computational modelling of these individual scales has been successfully established in the past. However, coupling of the scales remains challenging, although it will provide a unique possibility of mechanistic and holistic analyses of therapeutic outcomes for varied treatment scenarios. We present a methodology to combine whole-body physiologically-based pharmacokinetic (PBPK) models with mechanistic intracellular models of signal transduction in the liver for therapeutic proteins. To this end, we developed a whole-body distribution model of IFN-alpha in human and a detailed intracellular model of the JAK/STAT signalling cascade in hepatocytes and coupled them at the liver of the whole-body human model. This integrated model infers the time resolved concentration of IFN-alpha arriving at the liver after intravenous injection while simultaneously estimates the effect of this dose on the intracellular signalling behaviour in the liver. In our multi-scale physiologically-based pharmacokinetic/pharmacodynamic (PBPK/PD) model, receptor saturation is seen at low doses, thus giving mechanistic insights into the pharmacodynamic (PD) response. This model suggests a fourfold lower intracellular response after administration of a typical IFN-alpha dose to an individual as compared to the experimentally observed responses in in vitro setups. In conclusion, this work highlights clear differences between the observed in vitro and in vivo drug effects and provides important suggestions for future model-based study design.	[Kalra, Priyata; Brandl, Julian; Sahle, Sven; Kummer, Ursula] Heidelberg Univ, Dept Modelling Biol Proc, COS BioQuant, Neuenheimer Feld 267, Heidelberg, Germany; [Brandl, Julian] Tech Univ Denmark, Dept Syst Biol, Lyngby, Denmark; [Gaub, Thomas; Niederalt, Christoph; Lippert, Joerg; Kuepfer, Lars] Bayer Pharma, Clin Sci, Kaiser Wilhelm Allee 1, Leverkusen, Germany	Ruprecht Karls University Heidelberg; Technical University of Denmark; Bayer AG; Bayer Healthcare Pharmaceuticals	Kummer, U (corresponding author), Heidelberg Univ, Dept Modelling Biol Proc, COS BioQuant, Neuenheimer Feld 267, Heidelberg, Germany.	ursula.kummer@bioquant.uni-heidelberg.de	Kuepfer, Lars/AAD-5884-2022; Kuepfer, Lars/F-5795-2012	Kuepfer, Lars/0000-0002-8741-7786; Brandl, Julian/0000-0002-3479-8642	Bundesministerium fur Bildung and Forschung (ImmunoQuant); Bundesministerium fur Bildung and Forschung [LiSym 031L0039]	Bundesministerium fur Bildung and Forschung (ImmunoQuant)(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Bildung and Forschung(Federal Ministry of Education & Research (BMBF))	This research was supported by Bundesministerium fur Bildung and Forschung (ImmunoQuant to UK) and (LiSym 031L0039 to LK). Four of the authors (LK, TG, CN, JL) are employees of Bayer Pharma. However, the funder/company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; [Anonymous], 2014, GUT MICROBES, V5, P1, DOI 10.4161/jkst.25530; Apweiler R, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.290; Benson N, 2010, ANTIMICROB AGENTS CH, V54, P1179, DOI 10.1128/AAC.00551-09; BILLIAU A, 1981, ARCH VIROL, V68, P19, DOI 10.1007/BF01315163; BOHOSLAWEC O, 1986, J INTERFERON RES, V6, P207, DOI 10.1089/jir.1986.6.207; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; BORNEMANN LD, 1985, EUR J CLIN PHARMACOL, V28, P469, DOI 10.1007/BF00544369; Cai YM, 2012, REGUL PEPTIDES, V173, P74, DOI 10.1016/j.regpep.2011.09.008; Chatelut E, 1999, BRIT J CLIN PHARMACO, V47, P365, DOI 10.1046/j.1365-2125.1999.00912.x; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Cordes H, 2018, NPJ SYST BIOL APPL, V4, DOI 10.1038/s41540-018-0048-1; Daud AI, 2011, CANCER CHEMOTH PHARM, V67, P657, DOI 10.1007/s00280-010-1326-9; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Di Bisceglie AM, 1998, LANCET, V351, P351, DOI 10.1016/S0140-6736(97)07361-3; Eigenmann MJ, 2017, J PHYSIOL-LONDON, V595, P7311, DOI 10.1113/JP274819; Eissing T, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00004; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Friedman RM, 2008, CLIN USES INTERFERON; Gambin Anna, 2013, JAKSTAT, V2, pe24672, DOI 10.4161/jkst.24672; Gavutis M, 2006, BIOPHYS J, V90, P3345, DOI 10.1529/biophysj.105.072546; Gavutis M, 2005, BIOPHYS J, V88, P4289, DOI 10.1529/biophysj.104.055855; Goldstein B, 2004, NAT REV IMMUNOL, V4, P445, DOI 10.1038/nri1374; GREENBERG HB, 1976, NEW ENGL J MED, V295, P517, DOI 10.1056/NEJM197609022951001; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; HAWKINS MJ, 1984, J CLIN ONCOL, V2, P221, DOI 10.1200/JCO.1984.2.3.221; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; Heim MH, 2010, SIGNALING PATHWAYS IN LIVER DISEASES, SECOND EDITION, P189, DOI 10.1007/978-3-642-00150-5_12; Heintges T, 1998, DIGEST DIS SCI, V43, P1562, DOI 10.1023/A:1018827201670; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653; JOHNS TG, 1990, CANCER RES, V50, P4718; Kagan L, 2010, PHARM RES-DORDR, V27, P920, DOI 10.1007/s11095-010-0098-6; Krauss M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002750; Kuepfer L, 2016, CPT-PHARMACOMET SYST, V5, P516, DOI 10.1002/psp4.12134; Kuepfer L, 2018, MODEL BASED ASSAY DE; Kuepfer L, 2007, NAT BIOTECHNOL, V25, P1001, DOI 10.1038/nbt1330; Lamken P, 2004, J MOL BIOL, V341, P303, DOI 10.1016/j.jmb.2004.05.059; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Mager DE, 2003, J PHARMACOL EXP THER, V306, P262, DOI 10.1124/jpet.103.049502; Mager DE, 2002, PHARMACEUT RES, V19, P1537, DOI 10.1023/A:1020468902694; Maiwald T, 2010, COMBINING THEORETICA; Maiwald T, 2010, FEBS J, V277, P4741, DOI 10.1111/j.1742-4658.2010.07880.x; Max von Kleist, 2007, P FDN SYSTEMS BIOL E, V231; Meyer M, 2012, DRUG METAB DISPOS, V40, P892, DOI 10.1124/dmd.111.043174; Niederalt C, 2018, J PHARMACOKINET PHAR, V45, P235, DOI 10.1007/s10928-017-9559-4; Nieforth KA, 1996, CLIN PHARMACOL THER, V59, P636, DOI 10.1016/S0009-9236(96)90003-X; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; RADWANSKI E, 1987, J CLIN PHARMACOL, V27, P432, DOI 10.1002/j.1552-4604.1987.tb03044.x; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Reddy KR, 2004, DEV PHARMACOKINETICS; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Schlaak JF, 2002, J BIOL CHEM, V277, P49428, DOI 10.1074/jbc.M205571200; SHAH I, 1984, AM J HEMATOL, V17, P363, DOI 10.1002/ajh.2830170406; Sharma V, 2013, P 2013 SUMM COMP SIM; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Theil C, 2018, NPJ SBA; Thiel C, 2017, CPT-PHARMACOMET SYST, V6, P136, DOI 10.1002/psp4.12153; Thiel C, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005280; Thiel C, 2017, ARCH TOXICOL, V91, P865, DOI 10.1007/s00204-016-1723-x; Trifan A, 2012, WORLD J GASTROENTERO, V18, P5514, DOI 10.3748/wjg.v18.i39.5514; Vera J, 2011, PROG BIOPHYS MOL BIO, V106, P426, DOI 10.1016/j.pbiomolbio.2011.06.013; WILLS RJ, 1984, CLIN PHARMACOL THER, V35, P722, DOI 10.1038/clpt.1984.101; Witthoft T, 2008, BIOL-TARGETS THER, V2, P635; Wolber EM, 2002, J INTERF CYTOK RES, V22, P1185, DOI 10.1089/10799900260475704; Wu HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31349; Yamada S, 2003, FEBS LETT, V534, P190, DOI 10.1016/S0014-5793(02)03842-5	74	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0209587	10.1371/journal.pone.0209587	http://dx.doi.org/10.1371/journal.pone.0209587			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759154	Green Published, Green Submitted, gold			2022-12-26	WOS:000458761300009
J	Keller, EJ; Giafaglione, B; Chrisman, HB; Collins, JD; Vogelzang, RL				Keller, Eric J.; Giafaglione, Brad; Chrisman, Howard B.; Collins, Jeremy D.; Vogelzang, Robert L.			The growing pains of physician-administration relationships in an academic medical center and the effects on physician engagement	PLOS ONE			English	Article							IDENTITY; BURNOUT; IMPACT; DIVISIONS; BOARD	Background Physician engagement has become a key metric for healthcare leadership and is associated with better healthcare outcomes. However, engagement tends to be low and difficult to measure and improve. This study sought to efficiently characterize the professional cultural dynamics between physicians and administrators at an academic hospital and how those dynamics affect physician engagement. Materials and methods A qualitative mixed methods analysis was completed in 6 weeks, consisting of a preliminary analysis of the hospital system's history that was used to purposefully recruit 20 physicians across specialties and 20 healthcare administrators across management levels for semi-structured interviews and observation. Participation rates of 77% (20/26) and 83% (20/24) were achieved for physicians and administrators, respectively. Cohorts consisted of equal numbers of men and women with experience ranging from 1 to 35 years within the organization. Field notes and transcripts were systematically analyzed using an iterative inductive-deductive approach. Emergent themes were presented and discussed with approximately 400 physicians and administrators within the organization to assess validity and which results were most meaningful. Results & discussion This investigation indicated a professional cultural disconnect was undermining efforts to improve physician engagement. This disconnect was further complicated by a minority (10%) not believing an issue existed and conflicting connotations not readily perceived by participants who often offered similar solutions. Physicians and administrators felt these results accurately reflected their realities and used this information as a common language to plan targeted interventions to improve physician engagement. Limitations of the study included its cross-sectional nature with a modest sample size at a single institution. Conclusions A qualitative mixed methods analysis efficiently identified professional cultural barriers within an academic hospital to serve as an institution-specific guide to improving physician engagement.	[Keller, Eric J.] Northwestern Univ, Feinberg Sch Med, Ctr Bioeth & Med Humanities, Chicago, IL 60611 USA; [Keller, Eric J.; Chrisman, Howard B.; Collins, Jeremy D.; Vogelzang, Robert L.] HuNamics LLC, Palo Alto, CA 94301 USA; [Giafaglione, Brad; Vogelzang, Robert L.] Northwestern Med, Phys Engagement, Chicago, IL 60602 USA; [Chrisman, Howard B.; Collins, Jeremy D.; Vogelzang, Robert L.] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Vogelzang, RL (corresponding author), HuNamics LLC, Palo Alto, CA 94301 USA.; Vogelzang, RL (corresponding author), Northwestern Med, Phys Engagement, Chicago, IL 60602 USA.; Vogelzang, RL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA.	vogelzang@northwestern.edu		Keller, Eric/0000-0003-4327-483X; Vogelzang, Robert/0000-0002-5684-7943	Northwestern Medicine Physician Engagement Committee	Northwestern Medicine Physician Engagement Committee	Interview transcription fees were funded by the Northwestern Medicine Physician Engagement Committee to EJK. However, this committee did not perform the analysis and this funding is unlikely to have affected the results of this investigation.	Abdulsalam Y, 2018, J OPER MANAG, V57, P11, DOI 10.1016/j.jom.2018.01.001; [Anonymous], 2017, ONL REP; Berenson RA, 2007, HEALTH AFFAIR, V26, pW31, DOI 10.1377/hlthaff.26.1.w31; Burger J, 2014, GALLUP BUSINESS J; Charmaz K., 2006, CONSTRUCTING GROUNDE, Vxiii; Clandinin DJ, 2000, NARRATIVE INQUIRY EX, Vxxvi, DOI [10.1186/S12968-016-0274-X, DOI 10.1186/S12968-016-0274-X]; Finn R, 2008, HUM RELAT, V61, P103, DOI 10.1177/0018726707085947; Fiol CM, 2009, ACAD MANAGE REV, V34, P32, DOI 10.5465/AMR.2009.35713276; Fisher R, 1997, GETTING YES NEGOTIAT, Vxv; Ford-Eickhoff K, 2011, HEALTH CARE MANAGE R, V36, P145, DOI 10.1097/HMR.0b013e3182099f6e; Greenaway KH, 2015, PERS SOC PSYCHOL B, V41, P171, DOI 10.1177/0146167214559709; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Kaissi A, 2014, INT J HEALTH SERV, V44, P567, DOI 10.2190/HS.44.3.h; Keller EJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172865; Keller EJ, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0274-x; Kreindler SA, 2014, J HEALTH ORGAN MANAG, V28, P41, DOI 10.1108/JHOM-02-2013-0024; Kreindler SA, 2012, MILBANK Q, V90, P347, DOI 10.1111/j.1468-0009.2012.00666.x; Llewellyn-Thomas H. A., 2009, SHARED DECISION MAKI, P123; Menon S., 2013, INTERDISCIPLINARY PE; Petriglieri JL, 2011, ACAD MANAGE REV, V36, P641, DOI 10.5465/amr.2009.0087; Prins JT, 2010, MED EDUC, V44, P236, DOI 10.1111/j.1365-2923.2009.03590.x; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P432, DOI 10.1016/j.mayocp.2015.01.012; Spradley JP, 1979, ETHNOGRAPHIC INTERVI, Vvii; Spurgeon P, 2008, INT J CLIN LEADERSHI, V16; Stubblefield A., 2005, BAPTIST HLTH CARE JO, Vxiv; Swensen S, 2016, J HEALTHC MANAG, V61, P105, DOI 10.1097/00115514-201603000-00008; Veronesi G, 2013, SOC SCI MED, V77, P147, DOI 10.1016/j.socscimed.2012.11.019; von Knorring M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-271; Waldman JD, 2006, J HEALTHC MANAG, V51, P171; Weber D., 2005, POSITIVE DEVIANCE 1	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0212014	10.1371/journal.pone.0212014	http://dx.doi.org/10.1371/journal.pone.0212014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5IX	30759151	Green Published, Green Submitted, gold			2022-12-26	WOS:000458761300069
J	Lindeman, LC; Kamstra, JH; Ballangby, J; Hurem, S; Martin, LM; Brede, DA; Teien, HC; Oughton, DH; Salbu, B; Lyche, JL; Alestrom, P				Lindeman, Leif Christopher; Kamstra, Jorke Harmen; Ballangby, Jarle; Hurem, Selma; Martin Martin, Leonardo; Brede, Dag Anders; Teien, Hans Christian; Oughton, Deborah H.; Salbu, Brit; Lyche, Jan Ludvig; Alestrom, Peter			Gamma radiation induces locus specific changes to histone modification enrichment in zebrafish and Atlantic salmon	PLOS ONE			English	Article							DNA-DAMAGE; GENE-EXPRESSION; DANIO-RERIO; METHYLATION; GENOME; EXPOSURE; STATE; ACETYLATION; IRRADIATION; H3	Ionizing radiation is a recognized genotoxic agent, however, little is known about the role of the functional form of DNA in these processes. Post translational modifications on histone proteins control the organization of chromatin and hence control transcriptional responses that ultimately affect the phenotype. The purpose of this study was to investigate effects on chromatin caused by ionizing radiation in fish. Direct exposure of zebrafish (Danio rerio) embryos to gamma radiation (10.9 mGy/h for 3h) induced hyper-enrichment of H3K4me3 at the genes hnf4a, gmnn and vegfab. A similar relative hyper-enrichment was seen at the hnf4a loci of irradiated Atlantic salmon (Salmo salar) embryos (30 mGy/h for 10 days). At the selected genes in ovaries of adult zebrafish irradiated during gametogenesis (8.7 and 53 mGy/h for 27 days), a reduced enrichment of H3K4me3 was observed, which was correlated with reduced levels of histone H3 was observed. F1 embryos of the exposed parents showed hyper-methylation of H3K4me3, H3K9me3 and H3K27me3 on the same three loci, while these differences were almost negligible in F2 embryos. Our results from three selected loci suggest that ionizing radiation can affect chromatin structure and organization, and that these changes can be detected in F1 offspring, but not in subsequent generations.	[Lindeman, Leif Christopher; Kamstra, Jorke Harmen; Ballangby, Jarle; Hurem, Selma; Martin Martin, Leonardo; Brede, Dag Anders; Teien, Hans Christian; Oughton, Deborah H.; Salbu, Brit; Lyche, Jan Ludvig; Alestrom, Peter] Norwegian Univ Life Sci, Ctr Environm Radioact CERAD CoE, As, Norway; [Lindeman, Leif Christopher; Ballangby, Jarle; Brede, Dag Anders; Teien, Hans Christian; Oughton, Deborah H.; Salbu, Brit] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway; [Kamstra, Jorke Harmen; Hurem, Selma; Martin Martin, Leonardo; Lyche, Jan Ludvig; Alestrom, Peter] Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway; [Martin Martin, Leonardo] Univ Camaguey UC Ignacio Agramonte Loynaz, Fac Agropecuary Sci, Camaguey, Cuba	Norwegian University of Life Sciences; Norwegian University of Life Sciences; Norwegian University of Life Sciences	Lindeman, LC (corresponding author), Norwegian Univ Life Sci, Ctr Environm Radioact CERAD CoE, As, Norway.; Lindeman, LC (corresponding author), Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway.		Hurem, Selma/AAC-3141-2019	Ballangby, Jarle/0000-0003-1341-6884; Hurem, Selma/0000-0001-5379-3305; Kamstra, Jorke/0000-0001-7984-0229	Research Council of Norway (RCN) through its Centre of Excellence (CoE) Centre of Environmental Radiology, funding scheme [223268/F50]	Research Council of Norway (RCN) through its Centre of Excellence (CoE) Centre of Environmental Radiology, funding scheme(Research Council of Norway)	This work was supported by the Research Council of Norway (RCN) through its Centre of Excellence (CoE) Centre of Environmental Radiology, funding scheme (Project No. 223268/F50). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F.W., 1984, P1; Amundson SA, 2003, HEALTH PHYS, V85, P36, DOI 10.1097/00004032-200307000-00009; an A, 2013, METHODS, V62, P207, DOI [10.1016/j.ymeth.2013.04.011, DOI 10.1016/J.YMETH.2013.04.011]; [Anonymous], 2007, BIOCHEMISTRY-US, V46, P10745, DOI [10.1021/bi700475b, DOI 10.1021/BI700475B]; Becker JS, 2016, TRENDS GENET, V32, P29, DOI 10.1016/j.tig.2015.11.001; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bjerke H, 2014, DOSIMETRI FIGARO GAM, V2; Chellappa K, 2012, BIOMARK MED, V6, P297, DOI [10.2217/BMM.12.23, 10.2217/bmm.12.23]; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Chervona Y, 2012, METALLOMICS, V4, P619, DOI 10.1039/c2mt20033c; Choi VWY, 2015, CANCER LETT, V356, P91, DOI 10.1016/j.canlet.2013.10.020; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Eberle AB, 2018, METHODS MOL BIOL, V1689, P227, DOI 10.1007/978-1-4939-7380-4_18; Fritz A, 1996, GENETICS, V144, P1735; Gorodilov YN, 1996, ENVIRON BIOL FISH, V47, P109, DOI 10.1007/BF00005034; Hall J, 2017, MUTAT RES-REV MUTAT, V771, P59, DOI 10.1016/j.mrrev.2017.01.001; HOLM S, 1979, SCAND J STAT, V6, P65; Howe Caitlin G, 2016, Curr Environ Health Rep, V3, P225, DOI 10.1007/s40572-016-0104-1; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hurem S, 2018, ECOTOX ENVIRON SAFE, V154, P19, DOI 10.1016/j.ecoenv.2018.02.031; Hurem S, 2018, ENVIRON POLLUT, V234, P855, DOI 10.1016/j.envpol.2017.12.023; Hurem S, 2017, ENVIRON RES, V159, P564, DOI 10.1016/j.envres.2017.07.053; Hurem S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179259; Jaenisch R., 2003, NATURE GENETICS S, V33, P10, DOI DOI 10.1126/SCIENCE.1063127; Jarvis RB, 2003, MUTAT RES-GEN TOX EN, V541, P63, DOI 10.1016/S1383-5718(03)00182-7; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kallqvist TR, 2003, O21279 NORW I WAT RE, P34; Kamstra JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33817-w; Kamstra JH, 2015, ENVIRON SCI POLLUT R, V22, P16262, DOI 10.1007/s11356-014-3466-7; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Klosin A, 2017, SCIENCE, V356, P316, DOI 10.1126/science.aah6412; Kong EY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122108; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Lindbo-Hansen EL, 2017, INT J RAD BIOL UNPUB; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Maroschik B, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-15; Merrifield Matt, 2013, Frontiers in Genetics, V4, P40, DOI 10.3389/fgene.2013.00040; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakano T, 2017, FREE RADICAL BIO MED, V107, P136, DOI 10.1016/j.freeradbiomed.2016.11.041; O'Leary VB, 2015, CELL REP, V11, P474, DOI 10.1016/j.celrep.2015.03.043; Olcina MM, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140649; Schick S, 2015, J CELL SCI, V128, P4380, DOI 10.1242/jcs.173633; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Seiler DM, 2011, CHROMOSOME RES, V19, P883, DOI 10.1007/s10577-011-9244-1; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Wagner DE, 2018, SCIENCE, V360, P981, DOI 10.1126/science.aar4362; West CM, 2011, GENOME MED, V3, DOI 10.1186/gm268; Zhang TY, 2015, EMBO REP, V16, P1467, DOI 10.15252/embr.201540945	55	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0212123	10.1371/journal.pone.0212123	http://dx.doi.org/10.1371/journal.pone.0212123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759148	Green Submitted, Green Published, gold			2022-12-26	WOS:000458761300075
J	Poom, L; Lindskog, M; Winman, A; van den Berg, R				Poom, Leo; Lindskog, Marcus; Winman, Anders; van den Berg, Ronald			Grouping effects in numerosity perception under prolonged viewing conditions	PLOS ONE			English	Article							PERCEIVED NUMEROSITY; APPROXIMATE NUMBER; ITEM ARRANGEMENT; JUDGMENT; SYMMETRY	Humans can estimate numerosities such as the number sheep in a flock without deliberate counting. A number of biases have been identified in these estimates, which seem primarily rooted in the spatial organization of objects (grouping, symmetry, etc). Most previous studies on the number sense used static stimuli with extremely brief exposure times. However, outside the laboratory, visual scenes are often dynamic and freely viewed for prolonged durations (e.g., a flock of moving sheep). The purpose of the present study is to examine grouping-induced numerosity biases in stimuli that more closely mimic these conditions. To this end, we designed two experiments with limited-dot-lifetime displays (LDDs), in which each dot is visible for a brief period of time and replaced by a new dot elsewhere after its disappearance. The dynamic nature of LDDs prevents subjects from counting even when they are free-viewing a stimulus under prolonged presentation. Subjects estimated the number of dots in arrays that were presented either as a single group or were segregated into two groups by spatial clustering, dot size, dot color, or dot motion. Grouping by color and motion reduced perceived numerosity compared to viewing them as a single group. Moreover, the grouping effect sizes between these two features were correlated, which suggests that the effects may share a common, feature-invariant mechanism. Finally, we find that dot size and total stimulus area directly affect perceived numerosity, which makes it difficult to draw reliable conclusions about grouping effects induced by spatial clustering and dot size. Our results provide new insights into biases in numerosity estimation and they demonstrate that the use of LDDs is an effective method to study the human number sense under prolonged viewing.	[Poom, Leo; Lindskog, Marcus; Winman, Anders; van den Berg, Ronald] Uppsala Univ, Dept Psychol, Uppsala, Sweden	Uppsala University	Poom, L (corresponding author), Uppsala Univ, Dept Psychol, Uppsala, Sweden.	leo.poom@psyk.uu.se		Lindskog, Marcus/0000-0003-1326-6177; van den Berg, Ronald/0000-0001-7353-5960	Swedish Research Council (Vetenskapsradet) [2015-00371, 2013-01005]; Marie Sklodowska Curie Actions [INCA 600398]	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Marie Sklodowska Curie Actions	LP acknowledges support from the Swedish Research Council (Vetenskapsradet; reg. nr. 2013-01005). RB acknowledges support from the Swedish Research Council (Vetenskapsradet; reg.nr. 2015-00371) and Marie Sklodowska Curie Actions, Cofund (project INCA 600398). There was no additional external funding received for this study.; LP acknowledges support from the Swedish Research Council (Vetenskapsradet; reg. nr. 2013-01005). RB acknowledges support from the Swedish Research Council (Vetenskapsradet; reg.nr. 2015-00371) and Marie Sklodowska Curie Actions, Cofund (project INCA 600398).	ALLIK J, 1991, PERCEPT PSYCHOPHYS, V49, P303, DOI 10.3758/BF03205986; Anobile G, 2014, PSYCHOL SCI, V25, P265, DOI 10.1177/0956797613501520; Apthorp D, 2015, CURR BIOL, V25, pR267, DOI 10.1016/j.cub.2015.02.017; BEVAN W, 1963, AM J PSYCHOL, V76, P464, DOI 10.2307/1419789; Chen QX, 2014, ACTA PSYCHOL, V148, P163, DOI 10.1016/j.actpsy.2014.01.016; Dakin SC, 2011, P NATL ACAD SCI USA, V108, P19552, DOI 10.1073/pnas.1113195108; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Franconeri SL, 2009, COGNITION, V113, P1, DOI 10.1016/j.cognition.2009.07.002; FRITH CD, 1972, PERCEPT PSYCHOPHYS, V11, P409, DOI 10.3758/BF03206279; Gebuis T, 2012, J EXP PSYCHOL GEN, V141, P642, DOI 10.1037/a0026218; Gebuis T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025405; Gebuis T, 2010, NEUROPSYCHOLOGIA, V48, P394, DOI 10.1016/j.neuropsychologia.2009.09.027; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; GINSBURG N, 1976, PERCEPT MOTOR SKILL, V43, P663, DOI 10.2466/pms.1976.43.2.663; GINSBURG N, 1988, PERCEPT MOTOR SKILL, V67, P656, DOI 10.2466/pms.1988.67.2.656; GINSBURG N, 1978, AM J PSYCHOL, V91, P267, DOI 10.2307/1421536; GINSBURG N, 1991, PERCEPTION, V20, P681, DOI 10.1068/p200681; GINSBURG N, 1987, AM J PSYCHOL, V100, P193, DOI 10.2307/1422403; He LX, 2009, PSYCHON B REV, V16, P509, DOI 10.3758/PBR.16.3.509; HOWE E, 1987, ACTA PSYCHOL, V64, P3, DOI 10.1016/0001-6918(87)90058-8; Hurewitz F, 2006, P NATL ACAD SCI USA, V103, P19599, DOI 10.1073/pnas.0609485103; Im HY, 2016, VISION RES, V126, P291, DOI 10.1016/j.visres.2015.08.013; Jevons WS, 1871, NATURE; KRUEGER LE, 1972, PERCEPT PSYCHOPHYS, V11, P5, DOI 10.3758/BF03212674; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; MILLER AI, 1968, AM J PSYCHOL, V81, P83, DOI 10.2307/1420810; Nicholls MER, 1999, NEUROPSYCHOLOGIA, V37, P307, DOI 10.1016/S0028-3932(98)00074-8; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; PIAGET J, 1968, SCIENCE, V162, P976, DOI 10.1126/science.162.3857.976; Poom L, 2011, ATTEN PERCEPT PSYCHO, V73, P1833, DOI 10.3758/s13414-011-0132-8; Raphael S, 2016, VISION RES, V124, P15, DOI 10.1016/j.visres.2014.12.022; Razpurker-Apfeld I, 2007, PERCEPT PSYCHOPHYS, V69, P732, DOI 10.3758/BF03193775; Ross J, 2010, J VISION, V10, DOI 10.1167/10.2.10; SHEPARD RN, 1975, COGNITIVE PSYCHOL, V7, P82, DOI 10.1016/0010-0285(75)90006-7; Shuman M., 2006, J VISION, V6, P777, DOI [DOI 10.1167/6.6.777.[, 10.1167/6.6.777]; Soltesz F, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-13; TEGHTSOONIAN M, 1965, AM J PSYCHOL, V78, P392, DOI 10.2307/1420573; Tokita M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00431; Tokita M, 2010, ATTEN PERCEPT PSYCHO, V72, P1839, DOI 10.3758/APP.72.7.1839; van den Berg R, 2017, J EXP PSYCHOL HUMAN, V43, P1084, DOI 10.1037/xhp0000387; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]; Zhao JY, 2016, COGNITION, V146, P217, DOI 10.1016/j.cognition.2015.09.018; Zimmermann E, 2016, SCI REP-UK, V6, DOI 10.1038/srep32810	44	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0207502	10.1371/journal.pone.0207502	http://dx.doi.org/10.1371/journal.pone.0207502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5IX	30759086	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300006
J	Drayss, M; Claus, H; Hubert, K; Thiel, K; Berger, A; Sing, A; van der Linden, M; Vogel, U; Lam, TT				Drayss, Maria; Claus, Heike; Hubert, Kerstin; Thiel, Katrin; Berger, Anja; Sing, Andreas; van der Linden, Mark; Vogel, Ulrich; Thien-Tri Lam			Asymptomatic carriage of Neisseria meningitidis, Haemophilus influenzae, Streptococcus pneumoniae, Group A Streptococcus and Staphylococcus aureus among adults aged 65 years and older	PLOS ONE			English	Article							INVASIVE MENINGOCOCCAL DISEASE; RISK-FACTORS; NASOPHARYNGEAL CARRIAGE; PNEUMOCOCCAL CARRIAGE; NASAL COLONIZATION; NURSING-HOMES; EPIDEMIOLOGY; CARE; PREVALENCE; TRANSMISSION	Objective The aim of this study was to determine the prevalence of Neisseria meningitidis, Haemophilus influenzae, Streptococcus pneumoniae, group A Streptococcus (GAS), and Staphylococcus aureus in asymptomatic elderly people and to unravel risk factors leading to colonization. Methods A multi-centre cross-sectional study was conducted including 677 asymptomatic adults aged 65 years or more, living at home or in nursing homes. Study areas were Greater Aachen (North-Rhine-Westphalia) and Wuerzburg (Bavaria), both regions with medium to high population density. Nasal and oropharyngeal swabs as well as questionnaires were collected from October 2012 to May 2013. Statistical analysis included multiple logistic regression models. Results The carriage rate was 1.9% ([95% CI: 1.0-3.3%]; 13/677) for H. influenzae, 0.3% ([95% CI: 0-1.1%]; 2/677) for N. meningitidis and 0% ([95% CI: 0-0.5%]; 0/677) for S. pneumoniae and GAS. Staphylococcus aureus was harboured by 28.5% of the individuals ([95% CI: 25.1-32.1%]; 193/677) and 0.7% ([95% CI: 0.2-1.7%]; 5/677) were positive for methicillin-resistant S. aureus. Among elderly community-dwellers colonization with S. aureus was significantly associated with higher educational level (adjusted OR: 1.905 [95% CI: 1.248-2.908]; p = 0.003). Among nursing home residents colonization was associated with being married (adjusted OR: 3.367 [1.502-7.546]; p = 0.003). Conclusion The prevalence of N. meningitidis, H. influenzae, S. pneumoniae and GAS was low among older people in Germany. The S. aureus rate was expectedly high, while MRSA was found in less than 1% of the individuals.	[Drayss, Maria; Claus, Heike; Hubert, Kerstin; Thiel, Katrin; Vogel, Ulrich; Thien-Tri Lam] Univ Wurzburg, Inst Hyg & Microbiol, Natl Reference Ctr Meningococci & Haemophilus Inf, Wurzburg, Germany; [Berger, Anja; Sing, Andreas] Bavarian Hlth & Food Safety Author, Natl Consulting Lab Diphtheria, Oberschleissheim, Germany; [van der Linden, Mark] Univ Hosp RWTH, Natl Reference Ctr Streptococci, Inst Med Microbiol, Aachen, Germany	University of Wurzburg; Bavarian Health & Food Safety Authority; RWTH Aachen University; RWTH Aachen University Hospital	Lam, TT (corresponding author), Univ Wurzburg, Inst Hyg & Microbiol, Natl Reference Ctr Meningococci & Haemophilus Inf, Wurzburg, Germany.	ttlam@hygiene.uni-wuerzburg.de	van der Linden, Mark/B-9305-2009	van der Linden, Mark/0000-0002-6574-4313; Drayss, Maria/0000-0002-2723-9754; Lam, Thien-Tri/0000-0003-3001-0149	German Federal Ministry of Health via the Robert Koch Institute; National Reference Laboratories Network [FKZ 415]; German Research Foundation (DFG); University of Wuerzburg	German Federal Ministry of Health via the Robert Koch Institute; National Reference Laboratories Network; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	The study was supported by the German Federal Ministry of Health via the Robert Koch Institute and its National Reference Laboratories Network (FKZ 415). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2016, LANCET GLOB HEALTH, V4, pE989, DOI 10.1016/S2214-109X(16)30244-3; Almeida ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090974; Bewick V, 2004, CRIT CARE, V8, P46, DOI 10.1186/cc2428; Bosch AATM, 2016, VACCINE, V34, P531, DOI 10.1016/j.vaccine.2015.11.060; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Cummins A, 2012, J INFECTION, V64, P156, DOI 10.1016/j.jinf.2011.11.017; da Silveira M, 2018, ANN CLIN MICROB ANTI, V17, DOI 10.1186/s12941-018-0271-z; Ortiz-Romero MD, 2017, PEDIATR INFECT DIS J, V36, P919, DOI 10.1097/INF.0000000000001625; den Heijer CDJ, 2013, LANCET INFECT DIS, V13, P409, DOI 10.1016/S1473-3099(13)70036-7; Dworkin MS, 2007, CLIN INFECT DIS, V44, P810, DOI 10.1086/511861; Esposito S, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0057-0; Giufre M, 2017, CLIN MICROBIOL INFEC, V23, P961, DOI 10.1016/j.cmi.2017.04.006; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Gu FF, 2016, AM J INFECT CONTROL, V44, P805, DOI 10.1016/j.ajic.2016.01.032; Hart J, 2015, J DIABETES COMPLICAT, V29, P1092, DOI 10.1016/j.jdiacomp.2015.06.005; Hellenbrand W, 2013, J INFECTION, V66, P48, DOI 10.1016/j.jinf.2012.09.008; Holtfreter S, 2016, J CLIN MICROBIOL, V54, P2774, DOI 10.1128/JCM.00312-16; Imohl M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0787-1; Imohl M, 2010, FEMS IMMUNOL MED MIC, V58, P389, DOI 10.1111/j.1574-695X.2010.00652.x; Jomrich N, 2015, INFECT DIS-NOR, V47, P504, DOI 10.3109/00365548.2015.1007476; Koeck R., 2016, New Microbes and New Infections, V9, P24, DOI 10.1016/j.nmni.2015.11.004; Kwetkat A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190716; Lasseter G, 2010, EPIDEMIOL INFECT, V138, P686, DOI 10.1017/S0950268810000233; Marrie TJ, 2018, AM J MED, V131, DOI 10.1016/j.amjmed.2017.06.039; McKinnell JA, 2013, INFECT CONT HOSP EP, V34, P1077, DOI 10.1086/673157; Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003; Murphy CR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-269; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Nelson GE, 2016, CLIN INFECT DIS, V63, P478, DOI 10.1093/cid/ciw248; Nillius D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153030; Peters C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169425; Reynaga E, 2018, INFECT CONT HOSP EP, V39, P90, DOI 10.1017/ice.2017.244; Ridda I, 2010, VACCINE, V28, P3902, DOI 10.1016/j.vaccine.2010.03.073; RKI, 2018, EPID B, V34, P335, DOI DOI 10.17886/EPIBULL-2018-042.3; Robert Koch Institut, 2016, EPIDEMIOLOGISCHES B, DOI [10.17886/EpiBull-2016-064.2, DOI 10.17886/EPIBULL-2016-064.2]; Robert-Koch-Institut, 2013, INF JB 2012; Robert-Koch-Institut, 2017, INF JB MELD ERKR 201; Roberts J, 2009, J INFECTION, V58, P103, DOI 10.1016/j.jinf.2008.12.005; Roghmann MC, 2015, INFECT CONT HOSP EP, V36, P1050, DOI 10.1017/ice.2015.119; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Shaikh N, 2010, PEDIATRICS, V126, pE557, DOI 10.1542/peds.2009-2648; Soeters HM, 2018, CLIN INFECT DIS, V67, P881, DOI 10.1093/cid/ciy187; Statistisches Bundesamt (Destatis), 2018, STAT JB 2018; Statistisches Bundesamt (Destatis), 2015, STATISTISCHES JAHRBU; Sun JS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2802-1; Teutsch B, 2017, INFECTION, V45, P607, DOI 10.1007/s15010-017-1017-0; Trotter CL, 2003, EPIDEMIOL INFECT, V130, P201, DOI 10.1017/S0950268802008130; van Deursen AMM, 2016, VACCINE, V34, P4, DOI 10.1016/j.vaccine.2015.11.014; Van Eldere J, 2014, LANCET INFECT DIS, V14, P1281, DOI 10.1016/S1473-3099(14)70734-0; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Walter J, 2015, EUROSURVEILLANCE, V20, P21, DOI 10.2807/1560-7917.ES.2015.20.46.30067; Whittaker R, 2017, VACCINE, V35, P2034, DOI 10.1016/j.vaccine.2017.03.007; Whittaker R, 2017, EMERG INFECT DIS, V23, P396, DOI 10.3201/eid2303.161552	56	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0212052	10.1371/journal.pone.0212052	http://dx.doi.org/10.1371/journal.pone.0212052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735539	gold, Green Published, Green Submitted			2022-12-26	WOS:000458181200056
J	Zhang, QF; Li, HX; Dong, X; Tu, WJ				Zhang, Qinfen; Li, Hongxin; Dong, Xuan; Tu, Wenjuan			Short-term effects of single-dose chloral hydrate on neonatal auditory perception: An auditory event-related potential study	PLOS ONE			English	Article							RECOGNITION MEMORY; PRETERM INFANTS; DRUGS; NEUROTOXICITY	Objective To study the short-term effects of a single-dose chloral hydrate on neonatal auditory perception by measuring auditory event-related potentials (aERPs). Methods Thirty-nine full-term neonates, aged 2-28 days and weighing 2980-4350 g, were divided into two groups including a chloral hydrate group (CH group, n = 17) and a non-chloral hydrate control group (non-CH group, n = 22). The CH group was given single-dose chloral hydrate (30 mg/kg) orally before aERPs measurement. An auditory oddball paradigm was used to elicit aERPs. P2 and N2 components of the ERP were recorded from electrodes at the Fz and Cz locations, and the areas under their curves (P2 and N2 areas) were calculated for the comparison between two groups. Results Significant differences was found in the P2 area between the two groups at Fz and Cz (Fz:F (1,37) = 487.75, P < 0.05; Cz: F (1,37) = 1465.94, P < 0.05). Similarly, significant difference was also in the N2 area between the two groups at both locations (Fz: F(1,37) = 153.38, P < 0.05; Cz: F(1,37) = 798.42, P < 0.05). Conclusion A single-dose of chloral hydrate impacts neonatal auditory perception in the short-term. Long-term effects will also be studied in future.	[Zhang, Qinfen; Li, Hongxin; Dong, Xuan; Tu, Wenjuan] Changzhou Childrens Hosp, Changzhou, Jiangsu, Peoples R China		Dong, X; Tu, WJ (corresponding author), Changzhou Childrens Hosp, Changzhou, Jiangsu, Peoples R China.	dx6868@hotmail.com; tuwenjuan2008@163.com	ZHANG, QINFEN/GVT-5473-2022	ZHANG, QINFEN/0000-0001-7329-284X	Jiangsu Provincial Natural Science Foundation of China [BK20161194]	Jiangsu Provincial Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province)	This work was supported by Jiangsu Provincial Natural Science Foundation of China (grant number BK20161194 to Qinfen Zhang).	Allegaert K, 2005, EUR J PEDIATR, V164, P403, DOI 10.1007/s00431-005-1648-5; Avlonitou E, 2011, INT J PEDIATR OTORHI, V75, P760, DOI 10.1016/j.ijporl.2011.02.010; Chait M, 2010, NEUROPSYCHOLOGIA, V48, P3262, DOI 10.1016/j.neuropsychologia.2010.07.007; deReginer RA, 2000, J PEDIATR-US, V137, P777, DOI 10.1067/mpd.2000.109149; Durrmeyer X, 2010, PEDIATR RES, V67, P117, DOI 10.1203/PDR.0b013e3181c8eef3; Fellman V, 2016, SEMINARS FETAL NEONA, V11, P452; GARCIALARREA L, 1992, NEUROPSYCHOLOGIA, V30, P723, DOI 10.1016/0028-3932(92)90042-K; Guerra GG, 2011, PEDIATR ANESTH, V21, P932, DOI 10.1111/j.1460-9592.2011.03581.x; Hofacer RD, 2013, ANN NEUROL, V73, P695, DOI 10.1002/ana.23892; Krzisch M, 2013, ANESTHESIOLOGY, V118, P602, DOI 10.1097/ALN.0b013e3182815948; Kushnerenko EV, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00595; Laszlo Vutskits, 2014, PEDIAT SEDATION OUTS, V9, P553; Leipala JA, 2011, EARLY HUM DEV, V87, P89, DOI 10.1016/j.earlhumdev.2010.11.009; Lin YC, 2006, J FORMOS MED ASSOC, V105, P235, DOI 10.1016/S0929-6646(09)60311-9; Loepke AW, 2010, PEDIATR CRIT CARE ME, V11, P217, DOI 10.1097/PCC.0b013e3181b80383; Mai XQ, 2012, DEV NEUROPSYCHOL, V37, P400, DOI 10.1080/87565641.2011.650807; Patel Salil H, 2005, Int J Med Sci, V2, P147; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Roze JC, 2008, ARCH PEDIAT ADOL MED, V162, P728, DOI 10.1001/archpedi.162.8.728; Sing K, 1996, J TOXICOL-CLIN TOXIC, V34, P101, DOI 10.3109/15563659609020242; Stefan K., 2006, CLIN NEUROPHYSIOL, V117, P1746, DOI [10.1016/j.clinph.2006.05, DOI 10.1016/J.CLINPH.2006.05]; Stocks J, 1996, INFANT RESP FUNCTION; Stratmann G, 2011, ANESTH ANALG, V113, P1170, DOI 10.1213/ANE.0b013e318232066c; Suppiej A, 2010, EARLY HUM DEV, V86, P807, DOI 10.1016/j.earlhumdev.2010.09.002; Thoresen M, 1997, ELECTROEN CLIN NEURO, V102, P152, DOI 10.1016/S0921-884X(96)96509-1; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Yuen CL., 2017, INT J EPILEPSY, V4, P51	27	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0212195	10.1371/journal.pone.0212195	http://dx.doi.org/10.1371/journal.pone.0212195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735558	Green Published, gold, Green Submitted			2022-12-26	WOS:000458181200059
J	Plenge-Tellechea, LF; Hernandez-Ramos, AD; Munoz, JM; Barraza-Garza, G; Rico-Escobar, E; Melendez-Martinez, D				Fernando Plenge-Tellechea, Luis; Daniel Hernandez-Ramos, Angel; Manuel Munoz, Juan; Barraza-Garza, Guillermo; Rico-Escobar, Edna; Melendez-Martinez, David			Acanthocytosis and brain damage in area postrema and choroid plexus: Description of novel signs of Loxosceles apachea envenomation in rats	PLOS ONE			English	Article							SPIDER VENOMS; BROWN; IDENTIFICATION; TOXINS; RECEPTORS; CLONING	Loxocelism is a neglected medical problem that depends on its severity, can cause a cutaneous or viscero-cutaneous syndrome. This syndrome is characterized by hemostatic effects and necrosis, and the severity of the loxoscelism depends on the amount of venom injected, the zone of inoculation, and the species. In the Chihuahuan desert, the most abundant species is L. apachea. Its venom and biological effects are understudied, including neurological effects. Thus, our aim is to explore the effect of this regional species of medical interest in the United States-Mexico border community, using rat blood and central nervous system (CNS), particularly, two brain structures involved in brain homeostasis, Area postrema (AP) and Choroid plexus (PC). L. apachea specimens were collected and venom was obtained. Different venom concentrations (0, 0.178 and 0.87 mu g/g) were inoculated into Sprague-Dawley rats (intraperitoneal injection). Subsequently, blood was extracted and stained with Wright staining; coronal sections of AP were obtained and stained with Hematoxylin- Eosin (HE) staining and laminin. immunolabelling, the same was done with CP sections. Blood, AP and CP were observed under the microscope and abnormalities in erythrocytes and fluctuation in leukocyte types were described and quantified in blood. Capillaries were also quantified in AP and damage was described in CP. L. apachea venom produced a segmented neutrophil increment (neutrophilia), lymphocyte diminishment (leukopenia) and erythrocytes presented membrane abnormalities (acanthocytosis). Extravasated erythrocytes were observed in HE stained sections from both, AP and CP, which suggest that near to this section a hemorrhage is present; through immunohistofluorescence, a diminishment of laminin. was observed in AP endothelial cells and in CP ependymal cells when these structures were exposed to L. apachea venom. In conclusion, L. apachea venom produced leukopenia, netrophilia and acanthocytosis in rat peripheral blood, and also generated hemorrhages on AP and CP through degradation of laminin gamma.	[Fernando Plenge-Tellechea, Luis; Daniel Hernandez-Ramos, Angel; Manuel Munoz, Juan; Barraza-Garza, Guillermo; Rico-Escobar, Edna; Melendez-Martinez, David] Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Dept Ciencias Quim Biol, Lab Biol Mol & Bioquim, Ciudad Juarez, Chihuahua, Mexico	Universidad Autonoma de Ciudad Juarez	Plenge-Tellechea, LF (corresponding author), Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Dept Ciencias Quim Biol, Lab Biol Mol & Bioquim, Ciudad Juarez, Chihuahua, Mexico.	fplenge@uacj.mx	Meléndez-Mártinez, David L./AAI-9388-2020; PLenge, Luis/AAA-9458-2022; Barraza-Garza, Guillermo/AAF-7125-2020	Meléndez-Mártinez, David L./0000-0003-3643-2668; Plenge, Luis/0000-0002-1619-5004; Barraza-Garza, Guillermo/0000-0002-4149-9587	PIFI for the Academic Groups from Universidad Autonoma de Ciudad Juarez	PIFI for the Academic Groups from Universidad Autonoma de Ciudad Juarez	This study was funded by PIFI for the Academic Groups from Universidad Autonoma de Ciudad Juarez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T, 1992, LAB METHODS HISTOTEC, P55; Barbaro KC, 2005, TOXICON, V45, P489, DOI 10.1016/j.toxicon.2004.12.009; Bednaski AV, 2015, TOXICON, V98, P62, DOI 10.1016/j.toxicon.2015.02.008; Patino AC, 2013, TOXICON, V63, P32, DOI 10.1016/j.toxicon.2012.11.010; Carr JH., 2010, ATLAS HEMATOLOGIA CL; Chaim OM, 2011, TOXINS, V3, P309, DOI 10.3390/toxins3030309; Da Silveira RB, 2007, BIOCHEM J, V406, P355, DOI 10.1042/BJ20070363; da Silveira RB, 2002, TOXICON, V40, P815, DOI 10.1016/S0041-0101(02)00078-8; de Castro CS, 2004, TOXICON, V44, P273, DOI 10.1016/j.toxicon.2004.05.028; de Oliveira-Lima KC, 2016, TOXICON, V116, P35, DOI 10.1016/j.toxicon.2015.08.005; Furbee RB, 2006, CLIN LAB MED, V26, P211, DOI 10.1016/j.cll.2006.02.004; GERTSCH WJ, 1983, B AM MUS NAT HIST, V175, P265; Gremski LH, 2014, TOXICON, V83, P91, DOI 10.1016/j.toxicon.2014.02.023; Gremski LH, 2010, MOL BIOSYST, V6, P2403, DOI 10.1039/c004118a; Hurtado-Valenzuela JG, 2005, REV MEX PED, V72, P85; Lamour NF, 2005, MOL INTERV, V5, P358, DOI 10.1124/mi.5.6.8; Mantopoulos D, 2016, CUTAN OCUL TOXICOL, V35, P168, DOI 10.3109/15569527.2015.1027906; Maolood N, 2009, J CHEM NEUROANAT, V37, P182, DOI 10.1016/j.jchemneu.2008.12.007; Nowatzki J, 2010, TOXICON, V56, P535, DOI 10.1016/j.toxicon.2010.03.027; Pace LB, 2009, J VET EMERG CRIT CAR, V19, P329, DOI 10.1111/j.1476-4431.2009.00440.x; Paxinos W, 2005, RAT BRAIN STEREOTAXI; Perez AV, 2007, TOXICON, V49, P1063, DOI 10.1016/j.toxicon.2006.12.011; Ramos Rodriguez Hector Gabriel, 2008, Advances in Environmental Biology, V2, P9; Rivera IG, 2015, TOXINS, V7, P1457, DOI 10.3390/toxins7051457; Rodak B, 2004, HEMATOLOGIA FUNDAMEN; Sade YB, 2012, INT J BIOCHEM CELL B, V44, P170, DOI 10.1016/j.biocel.2011.10.013; Santos BF, 2000, FEBS LETT, V477, P199, DOI 10.1016/S0014-5793(00)01803-2; Schenone H, 2003, REV MED CHILE, V131, P437; Soape MP, 2014, SW RESP CRITICAL CAR, V2, P45; Swanson DL, 2006, CLIN DERMATOL, V24, P213, DOI 10.1016/j.clindermatol.2005.11.006; Tavares FL, 2004, HUM EXP TOXICOL, V23, P477, DOI 10.1191/0960327104ht475oa; Thanos CG, 2010, ADV EXP MED BIOL, V670, P80; Trevisan-Silva D, 2013, TOXICON, V76, P11, DOI 10.1016/j.toxicon.2013.08.065; Trevisan-Silva D, 2010, BIOCHIMIE, V92, P21, DOI 10.1016/j.biochi.2009.10.003; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; VANDEURS B, 1976, J ULTRA MOL STRUCT R, V55, P400, DOI 10.1016/S0022-5320(76)80096-2; Veiga SS, 2001, BRAZ J MED BIOL RES, V34, P843, DOI 10.1590/S0100-879X2001000700002; Vuitika L, 2016, BBA-MOL CELL BIOL L, V1861, P970, DOI 10.1016/j.bbalip.2016.05.009; Wijesinghe DS, 2007, METHOD ENZYMOL, V434, P265, DOI 10.1016/S0076-6879(07)34015-9; Willis CL, 2007, NEUROSCIENCE, V150, P498, DOI 10.1016/j.neuroscience.2007.09.023; Zanetti VC, 2002, BLOOD COAGUL FIBRIN, V13, P135, DOI 10.1097/00001721-200203000-00009	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211689	10.1371/journal.pone.0211689	http://dx.doi.org/10.1371/journal.pone.0211689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730934	Green Published, Green Submitted, gold			2022-12-26	WOS:000458026000044
J	Kain, V; Van Der Pol, W; Mariappan, N; Ahmad, A; Eipers, P; Gibson, DL; Gladine, C; Vigor, C; Durand, T; Morrow, C; Halade, GV				Kain, Vasundhara; Van Der Pol, William; Mariappan, Nithya; Ahmad, Aftab; Eipers, Peter; Gibson, Deanna L.; Gladine, Cecile; Vigor, Claire; Durand, Thierry; Morrow, Casey; Halade, Ganesh, V			Obesogenic diet in aging mice disrupts gut microbe composition and alters neutrophil:lymphocyte ratio, leading to inflamed milieu in acute heart failure	FASEB JOURNAL			English	Article						inflammation; leukocytes; myocardial infarction; resolution of inflammation; nonresolving inflammation	FATTY-ACIDS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; OBESITY; INFLAMMATION; SUPPLEMENTATION; PHYTOPROSTANES; DYSREGULATION; ISOPROSTANES; DYSBIOSIS	Calorie-dense obesogenic diet (OBD) is a prime risk factor for cardiovascular disease in aging. However, increasing age coupled with changes in the diet can affect the interaction of intestinal microbiota influencing the immune system, which can lead to chronic inflammation. How age and calorie-enriched OBD interact with microbial flora and impact leukocyte profiling is currently under investigated. Here, we tested the interorgan hypothesis to determine whether OBD in young and aging mice alters the gut microbe composition and the splenic leukocyte profile in acute heart failure (HF). Young (2-mo-old) and aging (18-mo-old) mice were supplemented with standard diet (STD, approximate to 4% safflower oil diet) and OBD (10% safflower oil) for 2 mo and then subjected to coronary artery ligation to induce myocardial infarction. Fecal samples were collected pre- and post-diet intervention, and the microbial flora were analyzed using 16S variable region 4 rRNA gene DNA sequencing and Quantitative Insights Into Microbial Ecology informatics. The STD and OBD in aging mice resulted in an expansion of the genus Allobaculum in the fecal microbiota. However, we found a pathologic change in the neutrophil:lymphocyte ratio in aging mice in comparison with their young counterparts. Thus, calorie-enriched OBD dysregulated splenic leukocytes by decreasing immune-responsive F4/80(+) and CD169(+) macrophages in aging mice. OBD programmed neutrophil swarming with an increase in isoprostanoid levels, with dysregulation of lipoxygenases, cytokines, and metabolite-sensing receptor expression. In summary, calorie-dense OBD in aging mice disrupted the composition of the gut microbiome, which correlates with the development of integrative and system-wide nonresolving inflammation in acute HF.Kain, V., Van Der Pol, W., Mariappan, N., Ahmad, A., Eipers, P., Gibson, D. L., Gladine, C., Vigor, C., Durand, T., Morrow, C., Halade, G. V. Obesogenic diet in aging mice disrupts gut microbe composition and alters neutrophil:lymphocyte ratio, leading to inflamed milieu in acute heart failure.	[Kain, Vasundhara; Halade, Ganesh, V] Univ Alabama Birmingham, Div Cardiovasc Dis, Dept Med, 310A Zeigler Res Bldg,703 19th St South, Birmingham, AL 35294 USA; [Van Der Pol, William] Univ Alabama Birmingham, Biomed Informat, Ctr Clin & Translat Sci, Birmingham, AL 35294 USA; [Mariappan, Nithya; Ahmad, Aftab] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL 35294 USA; [Eipers, Peter; Morrow, Casey] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Gibson, Deanna L.] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada; [Gladine, Cecile] Univ Clermont Ferrand, UNH, INRA, Ctr Rech Nutr Humaine CRNH Auvergne, Clermont Ferrand, France; [Vigor, Claire; Durand, Thierry] Univ Montpellier, Unite Mixte Rech UMR 247, IBMM, CNRS,ENSCM, Montpellier, France	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of British Columbia; University of British Columbia Okanagan; INRAE; Centre National de la Recherche Scientifique (CNRS); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Halade, GV (corresponding author), Univ Alabama Birmingham, Div Cardiovasc Dis, Dept Med, 310A Zeigler Res Bldg,703 19th St South, Birmingham, AL 35294 USA.	ganeshhalade@uabmc.edu	Ahmad, Aftab/ABC-2734-2020; Gibson, Deanna L/CAF-4166-2022; Kain, Vasundhara/AAL-7371-2021	Ahmad, Aftab/0000-0003-0686-0987; Gibson, Deanna L/0000-0003-0052-7550; VIGOR, Claire/0000-0002-1569-0425	U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health (NCCIH) [AT006704, HL132989]; University of Alabama at Birmingham (UAB) Pittman Scholar Award; American Heart Association postdoctoral fellowship [POST31000008]; Microbiome Resource, Comprehensive Cancer Center [P30AR050948]; Center for Clinical Translational Science [UL1TR001417]; University-Wide Institutional Core; Heflin Center for Genomic Sciences; Microbiome Center at the University of Alabama at Birmingham; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001417, UL1TR003096] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132989] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health (NCCIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham (UAB) Pittman Scholar Award; American Heart Association postdoctoral fellowship(American Heart Association); Microbiome Resource, Comprehensive Cancer Center; Center for Clinical Translational Science; University-Wide Institutional Core; Heflin Center for Genomic Sciences; Microbiome Center at the University of Alabama at Birmingham; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge support from U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health (NCCIH) (formerly known as NCCAM) Grants AT006704 and HL132989, a University of Alabama at Birmingham (UAB) Pittman Scholar Award (to G.V.H.), and an American Heart Association postdoctoral fellowship (POST31000008 to V.K.). The authors also acknowledge the support of the Microbiome Resource, Comprehensive Cancer Center (P30AR050948), Center for Clinical Translational Science (UL1TR001417), University-Wide Institutional Core, Heflin Center for Genomic Sciences, and Microbiome Center at the University of Alabama at Birmingham. The authors declare no conflicts of interest.	Ander Bradley P, 2003, Exp Clin Cardiol, V8, P164; Arora T, 2012, BRIT J NUTR, V108, P1382, DOI 10.1017/S0007114511006957; Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Bauer J, 2014, BRIT J PHARMACOL, V171, P3115, DOI 10.1111/bph.12677; Beam J, 2015, J BIOL CHEM, V290, P23371, DOI 10.1074/jbc.M115.682195; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang DH, 2015, ANTON LEEUW INT J G, V108, P1309, DOI 10.1007/s10482-015-0583-3; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; DeGruttola AK, 2016, INFLAMM BOWEL DIS, V22, P1137, DOI 10.1097/MIB.0000000000000750; Galano JM, 2017, PROG LIPID RES, V68, P83, DOI 10.1016/j.plipres.2017.09.004; Ghosh S, 2013, BRIT J NUTR, V110, P515, DOI 10.1017/S0007114512005326; Gill HS, 2001, AM J CLIN NUTR, V74, P833; Gill HS, 2001, J CLIN IMMUNOL, V21, P264, DOI 10.1023/A:1010979225018; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Gupta P, 2016, CELL REP, V16, P1749, DOI 10.1016/j.celrep.2016.07.010; Halade GV, 2018, J LEUKOCYTE BIOL, V104, P1173, DOI 10.1002/JLB.3A0618-223R; Halade GV, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1818; Halade GV, 2018, AM J PHYSIOL-HEART C, V314, pH255, DOI 10.1152/ajpheart.00528.2017; Halade GV, 2017, COMPR PHYSIOL, V7, P1463, DOI 10.1002/cphy.c170011; Halade GV, 2016, AGING-US, V8, P2611, DOI 10.18632/aging.101077; Haley PJ, 2003, TOXICOLOGY, V188, P49, DOI 10.1016/S0300-483X(03)00043-X; Haumer M, 2005, J VASC SURG, V41, P610, DOI 10.1016/j.jvs.2005.01.013; Jadapalli JK, 2018, AM J PHYSIOL-HEART C, V315, pH1091, DOI 10.1152/ajpheart.00290.2018; Kain V, 2018, J MOL CELL CARDIOL, V118, P70, DOI 10.1016/j.yjmcc.2018.03.004; Kain V, 2018, AM J PHYSIOL-HEART C, V314, pH160, DOI 10.1152/ajpheart.00297.2017; Kain V, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0444-7; Kalupahana NS, 2011, ADV NUTR, V2, P304, DOI 10.3945/an.111.000505; Kitai Takeshi, 2016, Curr Heart Fail Rep, V13, P103, DOI 10.1007/s11897-016-0285-9; Kumar Ranjit, 2014, Curr Protoc Hum Genet, V82, DOI 10.1002/0471142905.hg1808s82; Leung KS, 2014, CHEM PHYS LIPIDS, V180, P53, DOI 10.1016/j.chemphyslip.2014.02.004; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lopez EF, 2015, AM J PHYSIOL-HEART C, V308, pH269, DOI 10.1152/ajpheart.00604.2014; Ludwig DS, 2018, SCIENCE, V362, P764, DOI 10.1126/science.aau2096; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; MEHTA J, 1989, CIRCULATION, V79, P549, DOI 10.1161/01.CIR.79.3.549; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469; Ormerod KL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0181-2; Perez OA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah5520; Ponnappan S, 2011, ANTIOXID REDOX SIGN, V14, P1551, DOI 10.1089/ars.2010.3228; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Sacks FM, 2017, CIRCULATION, V136, pE1, DOI 10.1161/CIR.0000000000000510; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vigen Rebecca, 2012, Curr Heart Fail Rep, V9, P369, DOI 10.1007/s11897-012-0114-8; Willett WC, 2007, J CARDIOVASC MED, V8, pS42, DOI 10.2459/01.JCM.0000289275.72556.13; Wong CK, 2015, J NUTR BIOCHEM, V26, P319, DOI 10.1016/j.jnutbio.2014.11.004; Yonny ME, 2016, J AGR FOOD CHEM, V64, P8296, DOI 10.1021/acs.jafc.6b03011	55	28	29	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6456	6469		10.1096/fj.201802477R	http://dx.doi.org/10.1096/fj.201802477R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30768364	Green Published, Green Submitted			2022-12-26	WOS:000466932600051
J	Lee, BJ; Jun, HO; Kim, JH; Kim, JH				Lee, Byung Joo; Jun, Hyoung Oh; Kim, Jin Hyoung; Kim, Jeong Hun			Astrocytic cystine/glutamate antiporter is a key regulator of erythropoietin expression in the ischemic retina	FASEB JOURNAL			English	Article						ischemic optic neuropathy; ischemic retinopathy; system xc(-)	GLUTAMATE NEUROTOXICITY; SYSTEM X(C)(-); BRAIN; NEUROPROTECTION; CONTRIBUTES; HIF-1-ALPHA; TOXICITY; RELEASE; HIF-1	Ischemic retinopathies and optic neuropathies are important causes of vision loss. The neuroprotective effect of erythropoietin (EPO) in ischemic neuronal injury and the expression of EPO and its receptor in retinal tissue have been well documented. However, the exact regulatory mechanism of EPO expression in retinal ischemia still remains to be elucidated. In this study, we investigated the role of cystine/glutamate antiporter (system xc(-)) in the regulation of astrocytic EPO expression by using both in vitro and in vivo models. Under hypoxia, the expression of astrocytic system xc(-) is up-regulated both in vitro and in vivo. Inhibition of system xc(-) resulted in depletion of intracellular glutathione (GSH) and decrement of GSH disulfide ratios in human brain astrocytes (HBAs). In HBAs, hypoxia-induced stabilization of hypoxia-inducible factor (Hif)-2 is nearly completely abolished by inhibition of system xc(-). Hypoxia-induced up-regulation of astrocytic EPO expression is suppressed by both pharmacological inhibition and siRNA-mediated knockdown of system xc(-). In contrast, basal EPO expression under normoxia is not affected by system xc(-) modulation. In summary, under hypoxia, increased system xc(-) acts as the major source of intracellular GSH, which helps in stabilizing Hif-2 and subsequent up-regulation of EPO in astrocytes.Lee, B. J., Jun, H. O., Kim, J. H., Kim, J. H. Astrocytic cystine/glutamate antiporter is a key regulator of erythropoietin expression in the ischemic retina.	[Lee, Byung Joo; Jun, Hyoung Oh; Kim, Jin Hyoung; Kim, Jeong Hun] Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul, South Korea; [Lee, Byung Joo; Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Ophthalmol, 101 Daehak Ro, Seoul 03080, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, 101 Daehak Ro, Seoul 03080, South Korea.	steph25@snu.ac.kr		Kim, Jeong Hun/0000-0003-2957-1766	Bio and Medical Technology Development Program of the National Research Foundation of Korea (NRF) - Korean Ministry of Science, Information and Communications Technology and Future Planning (MSIP) [NRF-2015M3A9E6028949]; Korea Research Institute of Standards and Science [KRISS-2018-GP2018-0018]; Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) - MSIP [2018M3D1A1058826]; National Research Foundation of Korea; Ministry of Education, Science, and Technology [2015M3A7B6027946]	Bio and Medical Technology Development Program of the National Research Foundation of Korea (NRF) - Korean Ministry of Science, Information and Communications Technology and Future Planning (MSIP)(National Research Foundation of Korea); Korea Research Institute of Standards and Science; Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) - MSIP(National Research Foundation of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Bio and Medical Technology Development Program of the National Research Foundation of Korea (NRF), funded by the Korean Ministry of Science, Information and Communications Technology and Future Planning (MSIP) (NRF-2015M3A9E6028949 to J.H.K.); the Development of Platform Technology for Innovative Medical Measurements Program from the Korea Research Institute of Standards and Science (KRISS-2018-GP2018-0018 to J.H.K.); the Creative Materials Discovery Program through the National Research Foundation of Korea (NRF), funded by the MSIP (2018M3D1A1058826 to J.H.K.); and a research grant from the National Research Foundation of Korea and the Ministry of Education, Science, and Technology (2015M3A7B6027946 to J.H.K.). The authors declare no conflict of interests.	Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Chen H, 2008, FEBS LETT, V582, P3899, DOI 10.1016/j.febslet.2008.10.031; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Diaz Z, 2005, J NEUROCHEM, V93, P392, DOI 10.1111/j.1471-4159.2005.03038.x; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Goss JR, 1998, EXP NEUROL, V149, P301, DOI 10.1006/exnr.1997.6712; Gu LM, 2014, INVEST OPHTH VIS SCI, V55, P8208, DOI 10.1167/iovs.14-14435; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hsieh CH, 2017, J PATHOL, V241, P337, DOI 10.1002/path.4838; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kim JH, 2006, J BIOCHEM MOL BIOL, V39, P339; Komnig D, 2018, J NEUROCHEM, V145, P258, DOI 10.1111/jnc.14296; Lewerenz J, 2012, AMINO ACIDS, V42, P171, DOI 10.1007/s00726-011-0862-x; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; Nikinmaa M, 2004, J CELL SCI, V117, P3201, DOI 10.1242/jcs.01192; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750; REGAN RF, 1991, NEUROSCIENCE, V43, P585, DOI 10.1016/0306-4522(91)90317-H; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Soria FN, 2014, J CLIN INVEST, V124, P3645, DOI 10.1172/JCI71886; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Watanabe Y, 2016, P NATL ACAD SCI USA, V113, P6011, DOI 10.1073/pnas.1524198113; Yamasaki M, 2005, BRAIN RES, V1050, P15, DOI 10.1016/j.brainres.2005.05.037; Yoo SJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.381	30	9	10	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6045	6054		10.1096/fj.201802144R	http://dx.doi.org/10.1096/fj.201802144R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30742774				2022-12-26	WOS:000466932600021
J	Absalom, NL; Ahring, PK; Liao, VW; Balle, T; Jiang, T; Anderson, LL; Arnold, JC; McGregor, IS; Bowen, MT; Chebib, M				Absalom, Nathan L.; Ahring, Philip K.; Liao, Vivian W.; Balle, Thomas; Jiang, Tian; Anderson, Lyndsey L.; Arnold, Jonathon C.; McGregor, Iain S.; Bowen, Michael T.; Chebib, Mary			Functional genomics of epilepsy-associated mutations in the GABA(A) receptor subunits reveal that one mutation impairs function and two are catastrophic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GABA receptor; epilepsy; channel activation; neurotransmitter; cryo-electron microscopy; brain disorder; concatemer; heterozygous; missense; synaptic transmission; neurotransmission	GABRA1; GAMMA-2-SUBUNIT; ACTIVATION; ALPHA-1	A number of epilepsy-causing mutations have recently been identified in the genes of the 1, 3, and 2 subunits comprising the -aminobutyric acid type A (GABA(A)) receptor. These mutations are typically dominant, and in certain cases, such as the 1 and 3 subunits, they may lead to a mix of receptors at the cell surface that contain no mutant subunits, a single mutated subunit, or two mutated subunits. To determine the effects of mutations in a single subunit or in two subunits on receptor activation, we created a concatenated protein assembly that links all five subunits of the 132 receptor and expresses them in the correct orientation. We created nine separate receptor variants with a single-mutant subunit and four receptors containing two subunits of the 2(R323Q), 3(D120N), 3(T157M), 3(Y302C), and 3(S254F) epilepsy-causing mutations. We found that the singly mutated 2(R323Q) subunit impairs GABA activation of the receptor by reducing GABA potency. A single 3(D120N), 3(T157M), or 3(Y302C) mutation also substantially impaired receptor activation, and two copies of these mutants within a receptor were catastrophic. Of note, an effect of the 3(S254F) mutation on GABA potency depended on the location of this mutant subunit within the receptor, possibly because of the membrane environment surrounding the transmembrane region of the receptor. Our results highlight that precise functional genomic analyses of GABA(A) receptor mutations using concatenated constructs can identify receptors with an intermediate phenotype that contribute to epileptic phenotypes and that are potential drug targets for precision medicine approaches.	[Absalom, Nathan L.; Ahring, Philip K.; Liao, Vivian W.; Balle, Thomas; Jiang, Tian; Anderson, Lyndsey L.; Arnold, Jonathon C.; McGregor, Iain S.; Bowen, Michael T.; Chebib, Mary] Univ Sydney, Brain & Mind Ctr, 94 Mallett St, Camperdown, NSW 2050, Australia; [Anderson, Lyndsey L.; Arnold, Jonathon C.; McGregor, Iain S.; Bowen, Michael T.] Univ Sydney, Lambert Initiat Cannabinoid Therapeut, 94 Mallett St, Camperdown, NSW 2050, Australia; [Absalom, Nathan L.; Ahring, Philip K.; Liao, Vivian W.; Balle, Thomas; Jiang, Tian; Chebib, Mary] Univ Sydney, Sch Pharm, Fac Med & Hlth, Camperdown, NSW 2006, Australia; [Anderson, Lyndsey L.; Arnold, Jonathon C.] Univ Sydney, Discipline Pharmacol, Fac Med & Hlth, Camperdown, NSW 2006, Australia; [McGregor, Iain S.; Bowen, Michael T.] Univ Sydney, Sch Psychol, Fac Sci, Camperdown, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Chebib, M (corresponding author), Univ Sydney, Brain & Mind Ctr, 94 Mallett St, Camperdown, NSW 2050, Australia.	mary.collins@sydney.edu.au	Arnold, Jonathon C/ACF-5231-2022; Liao, Vivian/AAD-9818-2022	Liao, Vivian/0000-0001-8608-0563; mcgregor, iain/0000-0002-9307-7159; Jiang, Tian/0000-0002-0379-6345; Arnold, Jonathon/0000-0002-0159-9997; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Balle, Thomas/0000-0002-0233-8350	Lambert Initiative; National Health and Medical Research Council [APP1124567, APP1081733]	Lambert Initiative; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Lambert Initiative and by National Health and Medical Research Council Grants APP1124567 and APP1081733. The authors declare that they have no conflicts of interest with the contents of this article.	Absalom NL, 2004, EXP PHYSIOL, V89, P145, DOI 10.1113/expphysiol.2003.026815; Ahring PK, 2016, PHARMACOL RES, V111, P563, DOI 10.1016/j.phrs.2016.05.014; Ahring PK, 2018, J GEN PHYSIOL, V150, P453, DOI 10.1085/jgp.201711846; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Boillot M, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000035; Bouzat C, 2012, J PHYSIOL-PARIS, V106, P23, DOI 10.1016/j.jphysparis.2011.09.012; Chua HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141359; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Gallagher MJ, 2004, J NEUROSCI, V24, P5570, DOI 10.1523/JNEUROSCI.1301-04.2004; Gontika Maria P, 2017, Child Neurol Open, V4, p2329048X17706794, DOI 10.1177/2329048X17706794; Greenfield LJ, 2002, NEUROPHARMACOLOGY, V42, P502, DOI 10.1016/S0028-3908(01)00196-4; Hammer H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120239; Has ATC, 2016, SCI REP-UK, V6, DOI 10.1038/srep28674; Hernandez CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162883; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Howard MA, 2017, ANNU REV NEUROSCI, V40, P149, DOI 10.1146/annurev-neuro-072116-031250; Janve VS, 2016, ANN NEUROL, V79, P806, DOI 10.1002/ana.24631; Johannesen K, 2016, NEUROLOGY, V87, P1140, DOI 10.1212/WNL.0000000000003087; Kang JQ, 2015, NAT NEUROSCI, V18, P988, DOI 10.1038/nn.4024; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Khazipov R, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022764; Kodera H, 2016, EPILEPSIA, V57, P566, DOI 10.1111/epi.13344; Lachance-Touchette P, 2011, EUR J NEUROSCI, V34, P237, DOI 10.1111/j.1460-9568.2011.07767.x; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Laverty D, 2019, NATURE, V565, P516, DOI 10.1038/s41586-018-0833-4; Liu J, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0392-5; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Moller RS, 2016, MOL SYNDROMOL, V7, P210, DOI 10.1159/000448369; Olsen RW, 2018, NEUROPHARMACOLOGY, V136, P10, DOI 10.1016/j.neuropharm.2018.01.036; Papandreou A, 2016, DEV MED CHILD NEUROL, V58, P416, DOI 10.1111/dmcn.12976; Phulera S, 2018, ELIFE, V7, DOI 10.7554/eLife.39383; Purohit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3984; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; Shen DD, 2017, BRAIN, V140, P49, DOI 10.1093/brain/aww272; Shin DJ, 2018, MOL PHARMACOL, V93, P178, DOI 10.1124/mol.117.110403; Sigel E, 2006, BIOCHEM SOC T, V34, P868, DOI 10.1042/BST0340868; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Sigel E, 2009, BIOCHEM SOC T, V37, P1338, DOI 10.1042/BST0371338; Stosser MB, 2018, GENET MED, V20, P403, DOI 10.1038/gim.2017.114; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; WOOD J D, 1975, Progress in Neurobiology (Oxford), V5, P77, DOI 10.1016/0301-0082(75)90008-8	47	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6157	6171		10.1074/jbc.RA118.005697	http://dx.doi.org/10.1074/jbc.RA118.005697			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30728247	Green Published, hybrid			2022-12-26	WOS:000465077500043
J	Gong, SP; Chen, YN; Meng, FL; Zhang, YD; Wu, H; Li, CY; Zhang, GP				Gong, Shipeng; Chen, Yongning; Meng, Fanliang; Zhang, Yadi; Wu, Huan; Li, Chanyuan; Zhang, Guangping			RCC2, a regulator of the RalA signaling pathway, is identified as a novel therapeutic target in cisplatin-resistant ovarian cancer	FASEB JOURNAL			English	Article						DDP; bioinformatics analysis; RalBP1; proliferation and apoptosis	RAS; GTPASES; TRANSFORMATION; INHIBITION; EXPRESSION; CELLS; APOPTOSIS; SURVIVAL; LUNG	Currently, cisplatin (DDP) is the first-line chemotherapeutic agent used for treatment of ovarian cancer, but gradually acquired drug resistance minimizes its therapeutic outcomes. We aimed to identify crucial genes associated with DDP resistance in ovarian cancer and uncover potential mechanisms. Two sets of gene expression data were downloaded from Gene Expression Omnibus, and bioinformatics analysis was conducted. In our study, the differentially expressed genes between DDP-sensitive and DDP-resistant ovarian cancer were screened in GSE15709 and GSE51373 database, and chromosome condensation 2 regulator (RCC2) and nucleoporin 160 were identified as 2 genes that significantly up-regulated in DDP-resistant ovarian cancer cell lines compared with DDP-sensitive cell lines. Moreover, RCC2, Ral small GTPase (RalA), and Ral binding protein-1 (RalBP1) expression was found to be significantly higher in DDP-resistant ovarian cancer tissues than in DDP-sensitive tissues. RCC2 plays a positive role in cell proliferation, apoptosis, and migration in DDP-resistant ovarian cancer cell lines in vitro and in vivo. Furthermore, RCC2 could interact with RalA, thus promoting its downstream effector RalBP1. RalA knockdown could reverse the effects of RCC2 overexpression on DDP-resistant ovarian cancer cell proliferation, apoptosis, and migration. Similarly, RalA overexpression could alleviate the effects of RCC2 knockdown in DDP-resistant ovarian cancer cells. Taken together, RCC2 may function as an oncogene, regulating the RalA signaling pathway, and intervention of RCC2 expression might be a promising therapeutic strategy for DDP-resistant ovarian cancer.	[Gong, Shipeng; Chen, Yongning; Meng, Fanliang; Zhang, Yadi; Li, Chanyuan] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China; [Wu, Huan] Chongqing Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Chongqing, Peoples R China; [Zhang, Guangping] Peoples Hosp Huadu Dist, Dept Gynecol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Chongqing Medical University	Gong, SP (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China.	gsp2103@163.com	Zhang, Guang-Ping/T-2664-2019; Zhang, Guang-Ping/C-8300-2011	Zhang, Guang-Ping/0000-0002-1620-0221; Zhang, Guang-Ping/0000-0002-1620-0221	Guangdong Science and Technology Department [2016A020215115]; National Natural Science Foundation of China [81402127]; Science and Technology Bureau of Huadu District [HD15CXY006]; Tianhe District [201604KW010]	Guangdong Science and Technology Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Bureau of Huadu District; Tianhe District	This work was supported by grants from the Guangdong Science and Technology Department (2016A020215115, to S.G.), the National Natural Science Foundation of China (81402127, to S.G.), and the Science and Technology Bureau of Huadu District (HD15CXY006, to S.G.) and Tianhe District (201604KW010, to S.G.). The authors declare no conflicts of interest.	Ali AA, 2017, NANOMED-NANOTECHNOL, V13, P921, DOI 10.1016/j.nano.2016.11.019; ANDREASSEN PR, 1991, J CELL SCI, V99, P523; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bruun J, 2015, CLIN CANCER RES, V21, P3759, DOI 10.1158/1078-0432.CCR-14-3294; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Dennis G, 2003, GENOME BIOL, V4; Drake KJ, 2007, INT J ONCOL, V30, P139; Ezzeldin M, 2014, MOL ONCOL, V8, P1043, DOI 10.1016/j.molonc.2014.03.020; Feng X, 2017, ONCOTARGETS THER, V10, P5899, DOI 10.2147/OTT.S145833; Foster T, 2009, GYNECOL ONCOL, V115, P290, DOI 10.1016/j.ygyno.2009.07.026; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Fujii K, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201800015; Gu CM, 2016, ONCOTARGET, V7, P20561, DOI 10.18632/oncotarget.7987; Gupta AK, 2001, METHOD ENZYMOL, V333, P284; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Kashatus DF, 2013, EXP CELL RES, V319, P2337, DOI 10.1016/j.yexcr.2013.06.020; Kidd AR, 2010, INT J RADIAT ONCOL, V78, P205, DOI 10.1016/j.ijrobp.2010.03.023; Kim IA, 2004, CANCER METAST REV, V23, P227, DOI 10.1023/B:CANC.0000031763.95152.09; Kirschner K, 2010, ANTICANCER RES, V30, P3223; Knizhnik A V, 2011, Mol Biol (Mosk), V45, P307; Li Y, 2018, GENE, V663, P9, DOI 10.1016/j.gene.2018.04.033; Male H, 2012, LUNG CANCER, V77, P252, DOI 10.1016/j.lungcan.2012.03.007; Martin Timothy D, 2012, Small GTPases, V3, P126, DOI 10.4161/sgtp.19571; Matchett KB, 2014, ADV EXP MED BIOL, V773, P323, DOI 10.1007/978-1-4899-8032-8_15; Materon EM, 2014, BIOSENS BIOELECTRON, V58, P232, DOI 10.1016/j.bios.2014.02.070; Matsuo M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-15; McCrudden CM, 2017, MOL THER-NUCL ACIDS, V6, P249, DOI 10.1016/j.omtn.2016.12.010; McKenna WG, 2003, ONCOGENE, V22, P5866, DOI 10.1038/sj.onc.1206699; Mollinari C, 2003, DEV CELL, V5, P295, DOI 10.1016/S1534-5807(03)00205-3; Musella A, 2015, ANN SURG ONCOL, V22, P4211, DOI 10.1245/s10434-015-4523-2; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Nguyen-Ba G, 1999, ONCOL REP, V6, P925; Pang B, 2017, CLIN CANCER RES, V23, P5598, DOI 10.1158/1078-0432.CCR-16-2909; Papini D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8678; Qin XY, 2017, CELL BIOL INT, V41, P1110, DOI 10.1002/cbin.10819; Shimozono N, 2015, CANCER RES, V75, P4458, DOI 10.1158/0008-5472.CAN-15-0418; Singhal SS, 2007, CANCER RES, V67, P4382, DOI 10.1158/0008-5472.CAN-06-4124; Sun Y, 2016, CANCER BIOTHER RADIO, V31, P246, DOI 10.1089/cbr.2016.2034; Wang HX, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0130-x; Wei W, 2017, ANN ONCOL, V28, P16, DOI 10.1093/annonc/mdx447; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Wu N, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3908-y; Xu ZZ, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0840-y	45	15	16	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5350	5365		10.1096/fj.201801529RR	http://dx.doi.org/10.1096/fj.201801529RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30768358	Bronze			2022-12-26	WOS:000462888500058
J	Ito, H; Uragami, N; Miyazaki, T; Yokoyama, N; Inoue, H				Ito, Hiroaki; Uragami, Naoyuki; Miyazaki, Tomokazu; Yokoyama, Noboru; Inoue, Haruhiro			Raman spectroscopic evaluation of human serum using metal plate and 785-and 1064-nm excitation lasers	PLOS ONE			English	Article							SCATTERING	In this study, we utilized a stainless steel (SUS304) plate for measuring the Raman scattering spectra of body fluid samples. Using this stainless steel plate, we recorded the Raman scattering spectra of 99.5% ethanol and human serum samples by performing irradiation with 785- and 1064-nm lasers. Raman scattering spectra with intensities equal to or greater than those reported previously were obtained. In addition, the Raman scattering spectra acquired using the 1064-nm laser were less influenced by autofluorescence than those obtained via use of the shorter-wavelength laser. Moreover, the shapes of the spectra did not show any dependence on integration time, and denaturation of the samples was minimal. Our method, based on 1064-nm laser and the stainless steel plate, provides performance equal to or better than the methods reported thus far for the measurement of Raman scattering spectra from liquid samples. This method can be employed to rapidly evaluate the components of serum in liquid form without using surface-enhanced Raman scattering.	[Ito, Hiroaki; Uragami, Naoyuki; Yokoyama, Noboru; Inoue, Haruhiro] Showa Univ, Ctr Digest Dis, Koto Toyosu Hosp, Koto Ku, Tokyo, Japan; [Miyazaki, Tomokazu] JSR Corp, Res Planning Dept, Minato Ku, Tokyo, Japan	Showa University; JSR Corporation	Ito, H (corresponding author), Showa Univ, Ctr Digest Dis, Koto Toyosu Hosp, Koto Ku, Tokyo, Japan.	h.ito@med.showa-u.ac.jp		Ito, Hiroaki/0000-0002-0761-0632	Japan Society for the Promotion of Science (JSPS) (KAKENHI) [JP17K09022]	Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Hiroaki Ito received a grant from the Japan Society for the Promotion of Science (JSPS) (KAKENHI Grants-in-Aid for Scientific Research (C), Number JP17K09022). JSR Corporation did not provide research funding for this study. JSR Corporation lent the micro-Raman spectrometer to the researchers for the measurements. Both JSPS and JSR Corporation played no role in the study design; collection, analysis, or interpretation of the data; writing of the manuscript; or decision to submit the manuscript for publication.	Ando M, 2011, APPL SPECTROSC, V65, P488, DOI 10.1366/10-06196; Bailey GF, 1980, PDA J PHARM SCI TECH, V34, P127; Baker MJ, 2016, CHEM SOC REV, V45, P1803, DOI 10.1039/c5cs00585j; Barman I, 2012, ANAL CHEM, V84, P2474, DOI 10.1021/ac203266a; Deng Y, 2015, FOOD CHEM, V171, P168, DOI 10.1016/j.foodchem.2014.09.002; Dolenko TA, 2015, J PHYS CHEM A, V119, P10806, DOI 10.1021/acs.jpca.5b06678; Ito H, 2015, SCI REP-UK, V5, DOI 10.1038/srep10455; Ito H, 2014, NANOMED-NANOTECHNOL, V10, P599, DOI 10.1016/j.nano.2013.09.006; Lewis AT, 2017, J RAMAN SPECTROSC, V48, P119, DOI 10.1002/jrs.4980; McGuire MF, 2008, STAINLESS STEELS DES, P73; Mehta K, 2018, ANALYST, V143, P1916, DOI 10.1039/c8an00224j; Patra PP, 2013, J PHYS CHEM LETT, V4, P1167, DOI 10.1021/jz400496n; Reddy N. M., 2012, INT J INNOV TECHNOL, V2, P23; Romanenko AV, 2018, APPL SPECTROSC, V72, P847, DOI 10.1177/0003702817752487; SHEPHERD IW, 1972, APPL OPTICS, V11, P1924, DOI 10.1364/AO.11.001924; Shimoyama M, 2003, ANALYST, V128, P950, DOI 10.1039/b301239e; Sonnenberg A, 2014, CLIN CHEM, V60, P500, DOI 10.1373/clinchem.2013.214874; WANG DS, 1980, APPL OPTICS, V19, P2256, DOI 10.1364/AO.19.002256; Yutani K, 1985, Adv Biophys, V20, P13	19	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0211986	10.1371/journal.pone.0211986	http://dx.doi.org/10.1371/journal.pone.0211986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768643	Green Published, Green Submitted, gold			2022-12-26	WOS:000458766300019
J	Kim, T; Kim, HY				Kim, Taewook; Kim, Ha Young			Forecasting stock prices with a feature fusion LSTM-CNN model using different representations of the same data	PLOS ONE			English	Article							TECHNICAL ANALYSIS; NEURAL-NETWORKS; RETURNS; PREDICTION; VOLATILITY; SYSTEM; VOLUME	Forecasting stock prices plays an important role in setting a trading strategy or determining the appropriate timing for buying or selling a stock. We propose a model, called the feature fusion long short-term memory-convolutional neural network (LSTM-CNN) model, that combines features learned from different representations of the same data, namely, stock time series and stock chart images, to predict stock prices. The proposed model is composed of LSTM and a CNN, which are utilized for extracting temporal features and image features. We measure the performance of the proposed model relative to those of single models (CNN and LSTM) using SPDR S&P 500 ETF data. Our feature fusion LSTM-CNN model outperforms the single models in predicting stock prices. In addition, we discover that a candlestick chart is the most appropriate stock chart image to use to forecast stock prices. Thus, this study shows that prediction error can be efficiently reduced by using a combination of temporal and image features from the same data rather than using these features separately.	[Kim, Taewook; Kim, Ha Young] Ajou Univ, Dept Financial Engn, Suwon, South Korea; [Kim, Ha Young] Ajou Univ, Dept Data Sci, Suwon, South Korea	Ajou University; Ajou University	Kim, HY (corresponding author), Ajou Univ, Dept Financial Engn, Suwon, South Korea.; Kim, HY (corresponding author), Ajou Univ, Dept Data Sci, Suwon, South Korea.	hayoungkim@ajou.ac.kr	Kim, Taewook/GSD-3143-2022	Kim, Ha Young/0000-0001-5853-7589; Kim, taewook/0000-0002-3261-9073	Technology Advancement Research Program - Korean Ministry of Land, Infrastructure and Transport [17CTAP-C129782-01]	Technology Advancement Research Program - Korean Ministry of Land, Infrastructure and Transport	Financial support for this research was supported by a grant (17CTAP-C129782-01) from the Technology Advancement Research Program funded by the Korean Ministry of Land, Infrastructure and Transport (https//www.kaia.re.kr).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebiyi AA, 2014, UKSIM INT CONF COMP, P106, DOI 10.1109/UKSim.2014.67; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Ba JL, P IEEE INT C COMP VI; Bao W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180944; BLUME L, 1994, J FINANC, V49, P153, DOI 10.2307/2329139; Brooks C, 1998, J FORECASTING, V17, P59, DOI 10.1002/(SICI)1099-131X(199801)17:1<59::AID-FOR676>3.3.CO;2-8; Brown DP, 1989, REV FINANC STUD, V2, P527, DOI 10.1093/rfs/2.4.527; Caruana R, 1997, MACH LEARN, V28, P41, DOI 10.1023/A:1007379606734; Chen J, 2001, J FINANC ECON, V61, P345, DOI 10.1016/S0304-405X(01)00066-6; Chen JF, 2016, INT C CLOUD COMP BIG, P87, DOI [10.1109/CCBD.2016.027, 10.1109/CCBD.2016.51]; Chen K, 2015, PROCEEDINGS 2015 IEEE INTERNATIONAL CONFERENCE ON BIG DATA, P2823, DOI 10.1109/BigData.2015.7364089; Cowles A, 1933, ECONOMETRICA, V1, P309, DOI 10.2307/1907042; Donahue J, 2017, IEEE T PATTERN ANAL, V39, P677, DOI 10.1109/TPAMI.2016.2599174; FAMA EF, 1992, J FINANC, V47, P427, DOI 10.2307/2329112; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; FRENCH KR, 1987, J FINANC ECON, V19, P3, DOI 10.1016/0304-405X(87)90026-2; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Guo ZV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101397; Guresen E, 2011, EXPERT SYST APPL, V38, P10389, DOI 10.1016/j.eswa.2011.02.068; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hu G, 2017, DEEP STOCK REPRESENT; Izumi Y, 2006, P 2006 IEEE C EV COM, P8531; Jeantheau T, 2004, FINANC STOCH, V8, P111, DOI 10.1007/s00780-003-0103-6; KEIM DB, 1986, J FINANC ECON, V17, P357, DOI 10.1016/0304-405X(86)90070-X; Kim KJ, 2000, EXPERT SYST APPL, V19, P125, DOI 10.1016/S0957-4174(00)00027-0; Kimoto T., 1990, IJCNN International Joint Conference on Neural Networks (Cat. No.90CH2879-5), P1, DOI 10.1109/IJCNN.1990.137535; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lee KH, 1999, EXPERT SYST APPL, V16, P357, DOI 10.1016/S0957-4174(99)00011-1; LI H, 1995, GRAPH MODEL IM PROC, V57, P235, DOI 10.1006/gmip.1995.1022; Li ZZ, 2018, IEEE T PATTERN ANAL, V40, P2935, DOI 10.1109/TPAMI.2017.2773081; Ma L, 2015, IEEE I CONF COMP VIS, P2623, DOI 10.1109/ICCV.2015.301; MEESE RA, 1983, J INT ECON, V14, P3, DOI 10.1016/0022-1996(83)90017-X; Murphy J. J., 1999, TECHNICAL ANAL FINAN; Neely C, 1997, J FINANC QUANT ANAL, V43; Nelson DMQ, 2017, IEEE IJCNN, P1419, DOI 10.1109/IJCNN.2017.7966019; Siripurapu A., 2014, STANFORD U DEP COMPU, P1; Snoek C. G. M., 2005, 13th Annual ACM International Conference on Multimedia, P399, DOI 10.1145/1101149.1101236; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Svalina I, 2013, EXPERT SYST APPL, V40, P6055, DOI 10.1016/j.eswa.2013.05.029; Szegedy C, P IEEE COMP SOC C CO; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Targ S, 2016, ARXIV PREPRINT ARXIV; TAYLOR MP, 1992, J INT MONEY FINANC, V11, P304, DOI 10.1016/0261-5606(92)90048-3; Tsang PM, 2007, ENG APPL ARTIF INTEL, V20, P453, DOI 10.1016/j.engappai.2006.10.002; Varadharajan P, 2011, J CONT MANAG RES, V5, P12; Wang JZ, 2011, EXPERT SYST APPL, V38, P14346, DOI 10.1016/j.eswa.2011.04.222; Wang J, 2016, PROC CVPR IEEE, P2285, DOI 10.1109/CVPR.2016.251; Wu Z, 2016, WIDER DEEPER REVISIT, DOI [10.1162/neco.1997.9.8.1735%5Cnfile:///Files/F0/F0267A41-D807-4137-A5AC-8D9A84E9E12C.pdf%5Cnpapers3://publication/doi/10.1162/neco.1997.9.8.1735%5Cnfile:///Files/B1/B10E2649-D486-4D93-B71B-80023681156B.pdf, DOI 10.1162/NECO.1997.9.8.1735%5CNFILE:///FILES/F0/F0267A41-D807-4137-A5AC-8D9A84E9E12C.PDF%5CNPAPERS3://PUBLICATION/DOI/10.1162/NECO.1997.9.8.1735%5CNFILE:///FILES/B1/B10E2649-D486-4D93-B71B-80023681156B]; Zhang YD, 2009, EXPERT SYST APPL, V36, P8849, DOI 10.1016/j.eswa.2008.11.028	49	103	106	28	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212320	10.1371/journal.pone.0212320	http://dx.doi.org/10.1371/journal.pone.0212320			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5KT	30768647	Green Published, Green Submitted, gold			2022-12-26	WOS:000458766300029
J	Lee, S; Salapa, HE; Levin, MC				Lee, Sangmin; Salapa, Hannah E.; Levin, Michael C.			Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitis	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; NEURODEGENERATION; INFLAMMATION; PLASMA	Antibodies, including antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1, have been shown to contribute to the pathogenesis of multiple sclerosis, thus it is important to assess their biological activity using animal models of disease. Near-infrared optical imaging of fluorescently labeled antibodies and matrix metalloproteinase activity were measured and quantified in an animal model of multiple sclerosis, experimental autoimmune encephalomyelitis. We successfully labeled, imaged and quantified the fluorescence signal of antibodies that localized to the central nervous system of mice with experimental autoimmune encephalomyelitis. Fluorescently labeled anti-heterogeneous nuclear ribonucleoprotein A1 antibodies persisted in the central nervous system of mice with experimental autoimmune encephalomyelitis, colocalized with matrix metalloproteinase activity, correlated with clinical disease and shifted rostrally within the spinal cord, consistent with experimental autoimmune encephalomyelitis being an ascending paralysis. The fluorescent antibody signal also colocalized with matrix metalloproteinase activity in brain. Previous imaging studies in experimental autoimmune encephalomyelitis analyzed inflammatory markers such as cellular immune responses, dendritic cell activity, blood brain barrier integrity and myelination, but none assessed fluorescently labeled antibodies within the central nervous system. This data suggests a strong association between autoantibody localization and disease. This system can be used to detect other antibodies that might contribute to the pathogenesis of auto immune diseases of the central nervous system including multiple sclerosis.	[Lee, Sangmin; Levin, Michael C.] Univ Tennessee, Hlth Sci Ctr, Dept Neurol, Memphis, TN 38163 USA; [Salapa, Hannah E.; Levin, Michael C.] Univ Saskatchewan, Off Saskatchewan Multiple Sclerosis Clin Res Chai, Saskatoon, SK, Canada; [Salapa, Hannah E.; Levin, Michael C.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada; [Levin, Michael C.] Univ Saskatchewan, Neurol Div, Dept Med, Saskatoon, SK, Canada; [Levin, Michael C.] Vet Affairs Med Ctr, Res Serv, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Levin, MC (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Neurol, Memphis, TN 38163 USA.; Levin, MC (corresponding author), Univ Saskatchewan, Off Saskatchewan Multiple Sclerosis Clin Res Chai, Saskatoon, SK, Canada.; Levin, MC (corresponding author), Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada.; Levin, MC (corresponding author), Univ Saskatchewan, Neurol Div, Dept Med, Saskatoon, SK, Canada.; Levin, MC (corresponding author), Vet Affairs Med Ctr, Res Serv, Memphis, TN 38104 USA.	michael.levin@usask.ca		Levin, Michael/0000-0002-3880-9193	 [I01 BX001996]		This work was supported by grant #I01 BX001996, Veterans Affairs, https://www.va.gov, to MCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antel J, 2012, ACTA NEUROPATHOL, V123, P627, DOI 10.1007/s00401-012-0953-0; Ayzenberg I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118550; Berger C, 2007, J IMMUNOL METHODS, V323, P65, DOI 10.1016/j.jim.2007.02.009; Carbajal K. S., 2015, J IMMUNOLOGY; Cho H, 2016, ARTIF ORGANS, V40, P1009, DOI 10.1111/aor.12685; Douglas Joshua N, 2016, J Clin Cell Immunol, V7, P402; Douglas JN, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0647-y; Eaton VL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-138; Fraussen J, 2014, AUTOIMMUN REV, V13, P1126, DOI 10.1016/j.autrev.2014.07.002; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Gelfand JM, 2017, NEUROTHERAPEUTICS, V14, P835, DOI 10.1007/s13311-017-0557-4; Hannocks MJ, 2017, MATRIX BIOL; Kandagaddala LD, 2012, EXP TOXICOL PATHOL, V64, P109, DOI 10.1016/j.etp.2010.07.002; Keegan M, 2005, LANCET, V366, P579, DOI 10.1016/S0140-6736(05)67102-4; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Lee S, 2011, J NEUROIMMUNOL, V235, P56, DOI 10.1016/j.jneuroim.2011.02.007; Levin M. C, 2013, J CLIN CELL IMMUNOL, V4; Luo J, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-6; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Sagar D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-245; Salapa HE, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7060069; Schmitz K, 2017, JOVE-J VIS EXP, DOI 10.3791/55321; Wang CN, 2011, J NEUROSCI, V31, P2382, DOI 10.1523/JNEUROSCI.2698-10.2011	23	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212357	10.1371/journal.pone.0212357	http://dx.doi.org/10.1371/journal.pone.0212357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768649	Green Published, gold, Green Submitted			2022-12-26	WOS:000458766300034
J	Skinner, S; Diaw, M; Mbaye, MN; Joly, P; Renoux, C; Masson, C; Cuerq, C; Lopez, P; Ndour, M; Diedhiou, D; Sow, D; Diop, S; Samb, A; Pialoux, V; Connes, P				Skinner, Sarah; Diaw, Mor; Mbaye, Maimouna Ndour; Joly, Philippe; Renoux, Celine; Masson, Celine; Cuerq, Charlotte; Lopez, Philomene; Ndour, Malick; Diedhiou, Demba; Sow, Djiby; Diop, Saliou; Samb, Abdoulaye; Pialoux, Vincent; Connes, Philippe			Evaluation of agreement between hemoglobin A1c, fasting glucose, and fructosamine in Senegalese individuals with and without sickle-cell trait	PLOS ONE			English	Article							ALTERNATIVE MARKERS; A(1C); DIAGNOSIS; HBA(1C); HBA1C; RISK; VARIABILITY; VALUES; GENDER; GOALS	Fasting glucose (FG) and glycated hemoglobin A1c (HbA1c) perform sub-optimally in people of African origin, especially in individuals with sickle-cell trait (SCT). The purpose of this study was to compare the relationships between HbA1c, FG, and fructosamine in individuals from Senegal with and without SCT. HbA1c, FG, and fructosamine were measured in 203 adults from Senegal (100 control: 45 with type 2 diabetes (T2D); 103 SCT: 51 with T2D). Significant, positive correlations were observed between HbA1c and FG, fructosamine and FG, and fructosamine and HbA1c in both groups. The limits of agreement were inappropriately large in both groups for the Bland-Altman plots of HbA1c and FG (control: -95.97 to 83.97%; SCT: -115.9 to 91.52%), fructosamine and FG (control: -100.6 to 99.89%; SCT: -105.6 to 100.6%), and fructosamine and HbA1c (control: -52.03 to 38.98%; SCT: -88.04 to 71.41%). In both groups, the greatest proportion of subjects were considered above the clinical cut-point for hyperglycemia when fructosamine was used as the criterion (control: 33%; SCT: 44.6%), and the lowest percentage of subjects were classified as over the clinical cut-point when HbA1c was used as the criterion (control: 21%; SCT: 27.7%). Substantial disparities between HbA1c, FG, and fructosamine were observed in both groups, and these differences were exaggerated in the SCT group. Therefore, these three biomarkers should not be considered to be interchangeable measures of glycemic control. These biomarkers should be used thoughtfully, and special care should be taken when using them in individuals with SCT.	[Skinner, Sarah; Joly, Philippe; Renoux, Celine; Pialoux, Vincent; Connes, Philippe] Univ Lyon 1, Claude Bernard Univ Lyon 1, Interuniv Lab Biol Motor Funct EA7424, Vasc Biol & Red Blood Cell Team, Villeurbanne, France; [Skinner, Sarah; Joly, Philippe; Renoux, Celine; Pialoux, Vincent; Connes, Philippe] Lab Excellence GR Ex, Paris, France; [Diaw, Mor; Samb, Abdoulaye] UCAD, FMPO, Lab Physiol & Funct Explorat, Dakar, Senegal; [Mbaye, Maimouna Ndour; Masson, Celine; Diedhiou, Demba; Sow, Djiby] Abass Ndao Hosp Ctr, Med Clin 2, Dakar, Senegal; [Joly, Philippe; Renoux, Celine] Biol Ctr East, Lab Biochem Erythrocyte Pathol, Bron, France; [Cuerq, Charlotte] Biol Ctr South, Lab Biol Res Nutr & Diabet, Pierre Benite, France; [Lopez, Philomene; Ndour, Malick] Cheikh Univ Anta Diop Dakar, Univ Med Pharm & Odontol, Lab Pharmaceut Biochem, Dakar, Senegal; [Diop, Saliou] UCAD, FMPO, Lab Hematoummunol, Dakar, Senegal; [Pialoux, Vincent; Connes, Philippe] Inst Univ France, Paris, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar; Institut Universitaire de France	Connes, P (corresponding author), Univ Lyon 1, Claude Bernard Univ Lyon 1, Interuniv Lab Biol Motor Funct EA7424, Vasc Biol & Red Blood Cell Team, Villeurbanne, France.; Connes, P (corresponding author), Lab Excellence GR Ex, Paris, France.; Connes, P (corresponding author), Inst Univ France, Paris, France.	pconnes@yahoo.fr	Connes, Philippe/J-7835-2019; RENOUX, Céline/AAL-3556-2020; Carmen, Team1/Y-7382-2019	Connes, Philippe/0000-0002-9232-0268; Carmen, Team1/0000-0003-4234-1746; Lab, Carmen/0000-0002-5935-3236; RENOUX, Celine/0000-0002-7263-805X				American Diabetes Association, 2018, Diabetes Care, V41, pS13, DOI 10.2337/dc18-S002; Bae JC, 2014, J DIABETES INVEST, V5, P60, DOI 10.1111/jdi.12123; Bergenstal RM, 2017, ANN INTERN MED, V167, P95, DOI 10.7326/M16-2596; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cohen RM, 2003, DIABETES CARE, V26, P163, DOI 10.2337/diacare.26.1.163; Danese Elisa, 2015, J Diabetes Sci Technol, V9, P169, DOI 10.1177/1932296814567227; Diaw M, 2015, DIABETES CARE, V38, P2120, DOI 10.2337/dc15-0699; Guo FJ, 2014, METAB SYNDR RELAT D, V12, P258, DOI 10.1089/met.2013.0128; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Juraschek SP, 2012, CLIN CHEM, V58, P1648, DOI 10.1373/clinchem.2012.188367; Juraschek SP, 2012, DIABETES CARE, V35, P2265, DOI 10.2337/dc12-0787; Lacy ME, 2017, JAMA-J AM MED ASSOC, V317, P507, DOI 10.1001/jama.2016.21035; Little RR, 2011, CLIN CHEM, V57, P205, DOI 10.1373/clinchem.2010.148841; Macdonald DR, 2008, ANN CLIN BIOCHEM, V45, P421, DOI 10.1258/acb.2008.007259; Malmstrom H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111463; Naik RP, 2017, J AM SOC NEPHROL, V28, P2180, DOI 10.1681/ASN.2016101086; Naik RP, 2015, HEMATOL-AM SOC HEMAT, P160, DOI 10.1182/asheducation-2015.1.160; Narbonne H, 2001, DIABETES METAB, V27, P598; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nayak AU, 2011, DIABETES CARE, V34, P1712, DOI 10.2337/dc10-1767; NGSP, 2016, HBA1C ASS INT NAT HE; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Parrinello CM, 2016, DIABETES CARE, V39, P589, DOI 10.2337/dc15-1360; Parrinello CM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0548-3; Selvin E, 2017, ANN INTERN MED, V167, P131, DOI 10.7326/M17-1231; Selvin E, 2014, LANCET DIABETES ENDO, V2, P279, DOI 10.1016/S2213-8587(13)70199-2; Skinner S, 2018, LANCET DIABETES ENDO; Sumner AE, 2016, DIABETES CARE, V39, P271, DOI 10.2337/dc15-1699; Sumner AE, 2015, DIABETES CARE, V38, P213, DOI 10.2337/dc14-1179; Utumatwishima JN, 2018, NAT REV ENDOCRINOL, V14, P45, DOI 10.1038/nrendo.2017.127; World Health Organization, 2010, SICKL CELL DIS STRAT; Xu AP, 2016, J CLIN LAB ANAL, V30, P1078, DOI 10.1002/jcla.21983	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212552	10.1371/journal.pone.0212552	http://dx.doi.org/10.1371/journal.pone.0212552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768636	Green Published, Green Submitted, gold			2022-12-26	WOS:000458766300047
J	Hue-Beauvais, C; Aujean, E; Miranda, G; Ralliard-Rousseau, D; Valentino, S; Brun, N; Ladebese, S; Pechoux, C; Chavatte-Palmer, P; Charlier, M				Hue-Beauvais, Cathy; Aujean, Etienne; Miranda, Guy; Ralliard-Rousseau, Delphine; Valentino, Sarah; Brun, Nicolas; Ladebese, Stessy; Pechoux, Christine; Chavatte-Palmer, Pascale; Charlier, Madia			Impact of exposure to diesel exhaust during pregnancy on mammary gland development and milk composition in the rabbit	PLOS ONE			English	Article							AIR-POLLUTION; GENE-EXPRESSION; PERINATAL EXPOSURE; LACTATION; LEPTIN; GROWTH; MODEL; DIET; PARTICLES; GESTATION	Exposure to fine-particulate air pollution is a major global health concern because it is associated with reduced birth weight and an increased risk of cardiovascular disease. Here we have investigated the potential for exposure to diesel exhaust during pregnancy to influence mammary gland development and milk composition. Female rabbits were therefore exposed by nose-only inhalation to either diluted diesel exhaust fumes (1 mg/m(3)) or clean air for 2h/day, 5 days/week, from the 3rd to the 27th days of pregnancy. On Day 28 of pregnancy, mammary glands were collected from twelve females (six controls and six diesel-exposed) and assessed for morphological and functional alterations. Milk samples were collected from eighteen dams (nine controls and nine diesel-exposed) during early (days 2 to 4) and established (days 13 to 16) lactation to verify the composition of fatty acids and major proteins and leptin levels. The mammary alveolar lumina contained numerous fat globules, and stearoyl CoA reductase expression was higher in mammary epithelia from diesel exhaust-exposed rabbits, which together suggested increased mammary lipid biosynthesis. Gas chromatography analysis of the composition of milk fatty acids revealed a sharp rise in the total fatty acid content, mainly due to monounsaturated fatty acids. Liquid chromatography-mass spectrometry analysis of milk samples enabled identification and quantification of the main rabbit milk proteins and their main phosphorylated isoforms, and revealed important changes to individual casein and whey protein contents and to their most phosphorylated isoforms during early lactation. Taken together, these findings suggest that repeated daily exposure to diesel exhaust fumes during pregnancy at urban pollution levels can influence lipid metabolism in the mammary gland and the lipid and protein composition of milk. As milk may contribute to metabolic programming, such alterations affecting milk composition should be taken into account from a public health perspective.	[Hue-Beauvais, Cathy; Aujean, Etienne; Miranda, Guy; Brun, Nicolas; Ladebese, Stessy; Pechoux, Christine; Charlier, Madia] Univ Paris Saclay, AgroParisTech, INRA, UMR GABI, Jouy En Josas, France; [Ralliard-Rousseau, Delphine; Valentino, Sarah; Chavatte-Palmer, Pascale] Univ Paris Saclay, INRA, ENVA, UMR BDR, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Charlier, M (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, UMR GABI, Jouy En Josas, France.	madia.charlier@inra.fr	Chavatte-Palmer, Pascale/K-7349-2012	Chavatte-Palmer, Pascale/0000-0002-4581-6092; Charlier, Madia/0000-0001-5107-5836	ERC program e-DOHAD; Agence Nationale de la Recherche (ANR, France) project EPPAP	ERC program e-DOHAD; Agence Nationale de la Recherche (ANR, France) project EPPAP(French National Research Agency (ANR))	The ERC program e-DOHAD and the Agence Nationale de la Recherche (ANR, France) project EPPAP (PI: Dr. Pascale Chavatte-Palmer) funded the animal experiments. EPPAP also covered the costs of mammary gland analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano GA, 2015, MOL CELL ENDOCRINOL, V411, P258, DOI 10.1016/j.mce.2015.05.007; Aoki N, 1999, BBA-GEN SUBJECTS, V1427, P298, DOI 10.1016/S0304-4165(99)00029-X; Attig L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064616; Baheiraei Azam, 2014, Acta Med Iran, V52, P280; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Bartha T, 2005, DOMEST ANIM ENDOCRIN, V29, P193, DOI 10.1016/j.domaniend.2005.03.010; Bolton JL, 2014, BRAIN BEHAV IMMUN, V37, P30, DOI 10.1016/j.bbi.2013.10.029; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Bonnet M, 2002, REPROD NUTR DEV, V42, P399, DOI 10.1051/rnd:2002034; Bouret SG, 2010, BRAIN RES, V1350, P2, DOI 10.1016/j.brainres.2010.04.011; Burgaz S, 2002, CHEMOSPHERE, V47, P57, DOI 10.1016/S0045-6535(01)00185-0; Chang ET, 2018, AM J EPIDEMIOL, V187, P399, DOI [10.1093/aje/kwy038, 10.1093/aje/kwx352]; Chen MJ, 2017, PART FIBRE TOXICOL, V14, DOI 10.1186/s12989-017-0183-7; Courter LA, 2007, MUTAT RES-FUND MOL M, V625, P72, DOI 10.1016/j.mrfmmm.2007.05.005; Dadvand P, 2013, ENVIRON HEALTH PERSP, V121, P367, DOI 10.1289/ehp.1205575; DENAMUR R, 1963, CR HEBD ACAD SCI, V256, P4748; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Ellsworth L, 2018, REPRODUCTION, V156, pR23, DOI 10.1530/REP-17-0780; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Fleisch AF, 2015, EPIDEMIOLOGY, V26, P43, DOI 10.1097/EDE.0000000000000203; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freney EJ, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-8; Frutos V, 2015, GYNECOL ENDOCRINOL, V31, P7, DOI 10.3109/09513590.2014.958992; Gorr MW, 2014, AM J PHYSIOL-HEART C, V307, pH1353, DOI 10.1152/ajpheart.00526.2014; Grandjean P, 2015, ENDOCRINOLOGY, V156, P3408, DOI 10.1210/EN.2015-1350; Graur D, 1996, NATURE, V379, P333, DOI 10.1038/379333a0; Gregory DJ, 2017, AM J PHYSIOL-LUNG C, V313, pL395, DOI 10.1152/ajplung.00035.2017; Heindel JJ, 2017, REPROD TOXICOL, V68, P3, DOI 10.1016/j.reprotox.2016.10.001; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hennighausen L, 1997, MOL BIOL REP, V24, P169, DOI 10.1023/A:1006851531360; Howlin J, 2006, J MAMMARY GLAND BIOL, V11, P283, DOI 10.1007/s10911-006-9024-2; Hu X, 2002, J NATL CANCER I, V94, P1704, DOI 10.1093/jnci/94.22.1704; Hue-Beauvais C, 2017, J ANIM SCI, V95, P761, DOI 10.2527/jas.2016.0847; Hue-Beauvais C, 2015, J ANIM SCI, V93, P1641, DOI 10.2527/jas.2014-8139; Hue-Beauvais C, 2011, DEV DYNAM, V240, P347, DOI 10.1002/dvdy.22536; Jerrett M, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-49; Kass L, 2012, REPROD TOXICOL, V33, P390, DOI 10.1016/j.reprotox.2012.02.002; Koch E, 2013, PHYSIOL GENOMICS, V45, P645, DOI 10.1152/physiolgenomics.00020.2013; Kowalska M, 2017, ENVIRON SCI POLLUT R, V24, P24223, DOI 10.1007/s11356-017-9995-0; Lactoferrin Telang S., 2018, NUTRIENTS, V10, DOI [10.3390/nu10091228, DOI 10.3390/NU10091228]; Lew BJ, 2009, TOXICOL SCI, V111, P151, DOI 10.1093/toxsci/kfp125; Li CM, 2013, J REPROD DEVELOP, V59, P145, DOI 10.1262/jrd.2012-145; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu R, 2018, EBIOMEDICINE, V36, P29, DOI 10.1016/j.ebiom.2018.09.020; Maertens L, 2006, WORLD RABBIT SCI, V14, P205; Martin P, 2012, ADV DAIRY CHEM PROTE; Morale SE, 2005, EARLY HUM DEV, V81, P197, DOI 10.1016/j.earlhumdev.2004.09.008; MORRISON WR, 1964, J LIPID RES, V5, P600; Neville MC, 2012, J MAMMARY GLAND BIOL, V17, P167, DOI 10.1007/s10911-012-9261-5; Pedersen M, 2013, LANCET RESP MED, V1, P695, DOI 10.1016/S2213-2600(13)70192-9; Reynolds CM, 2015, NUTRIENTS, V7, P8090, DOI 10.3390/nu7095384; Rousseau D, 2003, AM J PHYSIOL-HEART C, V285, pH1294, DOI 10.1152/ajpheart.00651.2002; Saad HE, 2011, REPROD TOXICOL, V32, P15, DOI 10.1016/j.reprotox.2011.03.001; Samet J M, 2000, Res Rep Health Eff Inst, V94, P5; Shorten PR, 2004, J DAIRY RES, V71, P385, DOI 10.1017/S0022029904000354; Solomon GM, 2002, ENVIRON HEALTH PERSP, V110, pA339, DOI 10.1289/ehp.021100339; STRONG CR, 1972, BIOCHEM J, V128, P1303, DOI 10.1042/bj1281303; Topala Tamara, 2014, Clujul Med, V87, P215, DOI 10.15386/cjmed-357; United States Environmental Protection Agency, 2002, HLTH ASS DOC DIES EN; Vahidinia A, 2019, BIOL TRACE ELEM RES, V187, P32, DOI 10.1007/s12011-018-1355-5; Valentino SA, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0151-7; van Esterik JCJ, 2014, TOXICOLOGY, V321, P40, DOI 10.1016/j.tox.2014.04.001; Veras MM, 2009, ENVIRON RES, V109, P536, DOI 10.1016/j.envres.2009.03.006; Weldy CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088582; Wu XY, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/856521	65	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212132	10.1371/journal.pone.0212132	http://dx.doi.org/10.1371/journal.pone.0212132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763367	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900046
J	Sereia, AL; de Oliveira, MT; Baranoski, A; Marques, LLM; Ribeiro, FM; Isolani, RG; de Medeiros, DC; Chierrito, D; Lazarin-Bidoia, D; Zielinski, AAF; Novello, CR; Nakamura, CV; Mantovani, MS; de Mello, JCP				Sereia, Ana Luiza; de Oliveira, Marcelo Tempesta; Baranoski, Adrivanio; Medeiros Marques, Leila Larisa; Ribeiro, Fabianne Martins; Isolani, Raquel Garcia; de Medeiros, Daniela Cristina; Chierrito, Danielly; Lazarin-Bidoia, Danielle; Ferreira Zielinski, Acacio Antonio; Novello, Claudio Roberto; Nakamura, Celso Vataru; Mantovani, Mario Sergio; Palazzo de Mello, Joao Carlos			In vitro evaluation of the protective effects of plant extracts against amyloid-beta peptide-induced toxicity in human neuroblastoma SH-SY5Y cells	PLOS ONE			English	Article							PHENYLPROPANOID-SUBSTITUTED FLAVAN-3-OLS; TRICHILIA-CATIGUA; ALZHEIMERS-DISEASE; SEMIPURIFIED EXTRACT; STRYPHNODENDRON-ADSTRINGENS; NATURAL-PRODUCTS; STEM BARK; EXPRESSION; TANNINS; DEATH	Alzheimer's disease (AD) is the most common form of dementia and has no cure. Therapeutic strategies focusing on the reduction of oxidative stress, modulation of amyloid-beta (A beta) toxicity and inhibition of tau protein hyperphosphorylation are warranted to avoid the development and progression of AD. The aim of this study was to screen the crude extracts (CEs) and ethyl-acetate fractions (EAFs) of Guazuma ulmifolia, Limonium brasiliense, Paullinia cupana, Poincianella pluviosa, Stryphnodendron adstringens and Trichilia catigua using preliminary in vitro bioassays (acetylcholinesterase inhibition, antioxidant activity and total polyphenol content) to select extracts/fractions and assess their protective effects against A beta(25-35) toxicity in SH-SY5Y cells. The effect of the EAF of S. adstringens on mitochondrial membrane potential, lipid peroxidation, superoxide production and mRNA expression of 10 genes related to AD was also evaluated and the electropherogram fingerprints of EAFs were established by capillary electrophoresis. Chemometric tools were used to correlate the in vitro activities of the samples with their potential to be evaluated against AD and to divide extracts/fractions into four clusters. Pretreatment with the EAFs grouped in cluster 1 (S. adstringens, P. pluviosa and L. brasiliense) protected SH-SY5Y cells from A beta(25-35)-induced toxicity. The EAF of S. adstringens at 15.62 mu g/mL was able completely to inhibit the mitochondrial depolarization (69%), superoxide production (49%) and A beta(25-35)-induced lipid peroxidation (35%). With respect to mRNA expression, the EAF of S. adstringens also prevented the MAPT mRNA overexpression (expression ratio of 2.387x) induced by A beta(25-35), which may be related to tau protein hyperphosphorylation. This is the first time that the neuroprotective effects of these fractions have been demonstrated and that the electropherogram fingerprints for the EAFs of G. ulmifolia, L. brasiliense, P. cupana, P. pluviosa and S. adstringens have been established. The study expands knowledge of the in vitro protective effects and quality control of the evaluated fractions.	[Sereia, Ana Luiza; de Oliveira, Marcelo Tempesta; Medeiros Marques, Leila Larisa; Ribeiro, Fabianne Martins; Isolani, Raquel Garcia; de Medeiros, Daniela Cristina; Chierrito, Danielly; Lazarin-Bidoia, Danielle; Nakamura, Celso Vataru; Palazzo de Mello, Joao Carlos] Univ Estadual Maringa, Dept Pharm, Programa Posgrad Ciencias Farmaceut, Maringa, Parana, Brazil; [Baranoski, Adrivanio; Mantovani, Mario Sergio] Univ Estadual Londrina, Dept Gen Biol, Programa Posgrad Genet & Biol Mol, Londrina, Parana, Brazil; [Ferreira Zielinski, Acacio Antonio] Univ Fed Santa Catarina, Dept Chem Engn & Food Engn, Florianopolis, SC, Brazil; [Novello, Claudio Roberto] Univ Tecnol Fed Parana, Acad Dept Chem & Biol, Francisco Beltrao, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Londrina; Universidade Federal de Santa Catarina (UFSC); Universidade Tecnologica Federal do Parana	de Mello, JCP (corresponding author), Univ Estadual Maringa, Dept Pharm, Programa Posgrad Ciencias Farmaceut, Maringa, Parana, Brazil.	mello@uem.br	Zielinski, Acácio AF/N-4432-2013; Mello, Joao Carlos Palazzo de/B-9418-2013; Mantovani, Mário Sérgio/AAE-3456-2020; Bidoia, Danielle Lazarin/AAQ-2024-2020; de Oliveira, Marcelo Tempesta/N-1459-2013; Nakamura, Celso Vataru/AAA-5620-2019	Zielinski, Acácio AF/0000-0002-6184-9628; Mello, Joao Carlos Palazzo de/0000-0002-7532-3395; Mantovani, Mário Sérgio/0000-0001-5268-6508; de Oliveira, Marcelo Tempesta/0000-0002-1514-351X; Baranoski, Adrivanio/0000-0001-8808-9262	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP); Complexo de Centrais de Apoio a Pesquisa (COMCAP/UEM); Fundacao Araucaria; Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica (INCT_if)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Complexo de Centrais de Apoio a Pesquisa (COMCAP/UEM); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica (INCT_if)	The authors are grateful to Brazilian agencies Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - www.capes.gov.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - www.cnpq.br), Financiadora de Estudos e Projetos (FINEP - www.finep.gov.br), Complexo de Centrais de Apoio a Pesquisa (COMCAP/UEM -www.comcap.uem.br), Fundacao Araucaria (www.fappr.pr.gov.br), and Instituto Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica (INCT_if - http://inct.cnpq.br/web/inct-if) for their financial support and fellowships awarded to A. L. Sereia, M. T. de Oliveira, A. Baranoski, F. M. Ribeiro, R. G. Isolani, D. C. Medeiros, and D. Chierrito. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MN, 2013, SAUDI PHARM J, V21, P143, DOI 10.1016/j.jsps.2012.05.002; Ali SK, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-121; [Anonymous], 2010, FARMACOPEIA BRASILEI, V2, P671; Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001; Bernardo J, 2018, J ETHNOPHARMACOL, V211, P247, DOI 10.1016/j.jep.2017.09.039; Blainski A, 2017, REV BRAS FARMACOGN, V27, P162, DOI 10.1016/j.bjp.2016.08.009; Blainski A, 2017, J ETHNOPHARMACOL, V198, P313, DOI 10.1016/j.jep.2017.01.013; Blainski A, 2013, MOLECULES, V18, P6852, DOI 10.3390/molecules18066852; Boasquivis PF, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9241308; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Bueno FG, 2014, FITOTERAPIA, V99, P252, DOI 10.1016/j.fitote.2014.10.007; Caleare AD, 2017, FITOTERAPIA, V118, P87, DOI 10.1016/j.fitote.2017.03.002; Calixto JT, 2016, SAUDI J BIOL SCI, V23, P434, DOI 10.1016/j.sjbs.2015.10.009; Campanini MZ, 2014, AAPS PHARMSCITECH, V15, P86, DOI 10.1208/s12249-013-0049-8; Castillo WO, 2016, NEUROTOXICOLOGY, V57, P291, DOI 10.1016/j.neuro.2016.10.013; Chen TF, 2013, FOOD CHEM TOXICOL, V62, P538, DOI 10.1016/j.fct.2013.09.015; Chen Y, 2010, ELECTROPHORESIS, V31, P1493, DOI 10.1002/elps.200900592; Costa MA, 2010, REGUL TOXICOL PHARM, V58, P330, DOI 10.1016/j.yrtph.2010.07.006; de Mello JCP, 1999, PHYTOCHEMISTRY, V51, P1105, DOI 10.1016/S0031-9422(98)00715-8; deMello JP, 1996, PHYTOCHEMISTRY, V42, P857, DOI 10.1016/0031-9422(95)00953-1; deMello JP, 1996, PHYTOCHEMISTRY, V41, P807, DOI 10.1016/0031-9422(95)00686-9; Dey A, 2017, BIOTECHNOL ADV, V35, P178, DOI 10.1016/j.biotechadv.2016.12.005; dos Santos EL, 2018, FREE RADICAL BIO MED, V128, pS66, DOI 10.1016/j.freeradbiomed.2018.10.136; Zielinski AAF, 2014, FOOD RES INT, V60, P246, DOI 10.1016/j.foodres.2013.09.010; Fujihara K, 2017, BIOORGAN MED CHEM, V25, P3377, DOI 10.1016/j.bmc.2017.04.023; Godinho J, 2018, BEHAV BRAIN RES, V337, P173, DOI 10.1016/j.bbr.2017.08.050; Hashimoto M, 2011, J NUTR BIOCHEM, V22, P22, DOI 10.1016/j.jnutbio.2009.11.005; Hwang YJ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-310; Ishida K, 2006, J ANTIMICROB CHEMOTH, V58, P942, DOI 10.1093/jac/dkl377; Klein T, 2013, REV BRAS FARMACOGN, V23, P186, DOI 10.1590/S0102-695X2012005000147; Klein T, 2012, TALANTA, V88, P502, DOI 10.1016/j.talanta.2011.11.023; Lattanzio F, 2016, EXP TOXICOL PATHOL, V68, P271, DOI 10.1016/j.etp.2016.02.001; Lazarin-Bidoia D, 2013, FREE RADICAL BIO MED, V60, P17, DOI 10.1016/j.freeradbiomed.2013.01.008; Lee C, 2011, FOOD CHEM TOXICOL, V49, P1261, DOI 10.1016/j.fct.2011.03.005; Longhini R, 2013, J SEP SCI, V36, P1247, DOI 10.1002/jssc.201200911; Lopes GC, 2009, J BRAZIL CHEM SOC, V20, P1103, DOI 10.1590/S0103-50532009000600016; Lopes GC, 2008, BIOCHEM SYST ECOL, V36, P925, DOI 10.1016/j.bse.2008.10.004; Torma PDMR, 2017, FOOD CHEM, V222, P94, DOI 10.1016/j.foodchem.2016.12.006; Marquele FD, 2005, J PHARMACEUT BIOMED, V39, P455, DOI 10.1016/j.jpba.2005.04.004; Marques LLM, 2016, FOOD CHEM, V212, P703, DOI 10.1016/j.foodchem.2016.06.028; Montenegro JMF, 2017, PHYSIOL BEHAV, V173, P42, DOI 10.1016/j.physbeh.2017.01.034; Morais SM, 2017, S AFR J BOT, V110, P251, DOI 10.1016/j.sajb.2016.08.003; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Okimoto Y, 2000, FEBS LETT, V474, P137, DOI 10.1016/S0014-5793(00)01587-8; Omar SH, 2017, J NUTR BIOCHEM, V47, P1, DOI 10.1016/j.jnutbio.2017.02.016; Park SY, 2010, ARCH PHARM RES, V33, P1589, DOI 10.1007/s12272-010-1010-y; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Prince M., 2016, WORLD ALZHEIMER REPO; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Resende FO, 2011, J BRAZIL CHEM SOC, V22, P2087, DOI 10.1590/S0103-50532011001100010; Rhee IK, 2001, J CHROMATOGR A, V915, P217, DOI 10.1016/S0021-9673(01)00624-0; Rodrigues MJ, 2019, S AFR J BOT, V120, P87, DOI 10.1016/j.sajb.2017.12.003; Ruchel JB, 2017, PHYSIOL BEHAV, V168, P11, DOI 10.1016/j.physbeh.2016.10.003; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Seidl C, 2010, Z NATURFORSCH C, V65, P440; Sereia AL, 2017, PHYTOCHEM ANALYSIS, V28, P144, DOI 10.1002/pca.2653; Shakir Taner, 2013, Am J Neurodegener Dis, V2, P70; Shukla AK, 2012, EUR J MED CHEM, V54, P49, DOI 10.1016/j.ejmech.2012.04.034; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sun WJ, 2009, NEUROSCI LETT, V450, P340, DOI 10.1016/j.neulet.2008.11.067; Wang HQ, 2010, BRAIN RES, V1360, P159, DOI 10.1016/j.brainres.2010.08.100; Yu HM, 2014, NEUROCHEM INT, V75, P89, DOI 10.1016/j.neuint.2014.06.001; Zeng KW, 2010, NEUROPHARMACOLOGY, V59, P542, DOI 10.1016/j.neuropharm.2010.07.020; Zhang L, 2010, NEUROCHEM INT, V57, P547, DOI 10.1016/j.neuint.2010.06.021	66	12	12	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212089	10.1371/journal.pone.0212089	http://dx.doi.org/10.1371/journal.pone.0212089			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763379	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900040
J	Ishikawa, K; Kohno, R; Hasegawa, E; Nakao, S; Yoshida, S; Sonoda, KH				Ishikawa, Keijiro; Kohno, Ri-ichiro; Hasegawa, Eiichi; Nakao, Shintaro; Yoshida, Shigeo; Sonoda, Koh-Hei			Preoperative estimation of distance between retinal break and limbus with wide-field fundus imaging: Potential clinical utility for conventional scleral buckling	PLOS ONE			English	Article							ANGLE VIEWING SYSTEM; DETACHMENT	Objective Accurate scleral marking of retinal breaks is essential for successful scleral buckling. This study aimed to investigate the use of wide-field fundus images obtained with an Optos for preoperative estimation of the distance from the limbus to the retinal breaks. Methods and analysis This is a retrospective review of 29 eyes from 26 patients with rhegmatogenous retinal detachment who received scleral buckling with anatomically successful repair. They underwent wide-field fundus photography with Optos California. In the pre- and postoperative fundus images, we measured distances from the macula to the retinal tears (T-M), to the center of the vortex veins (V-M), to the optic disc (D-M), and to the posterior edge of the scleral buckle (B-M). Results (BM-V-M) / D-M was significantly correlated with the distance from the limbus to the posterior edge of the scleral buckle that had been determined intraoperatively. (r = 0.705; p<0.001) We applied a regression line derived from this correlation with the value of (T-M-V-M) / D-M in order to calculate estimated distances between retinal breaks and the limbus. The calculated distances were all within the range of distances from the limbus to the anterior and posterior edges of the scleral buckles. Conclusion Preoperative analysis of Optos images may be useful for estimating the distance from the limbus to retinal breaks, which might aid scleral marking during scleral buckling surgery.	[Ishikawa, Keijiro; Kohno, Ri-ichiro; Hasegawa, Eiichi; Nakao, Shintaro; Sonoda, Koh-Hei] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Fukuoka, Japan; [Yoshida, Shigeo] Kurume Univ, Dept Ophthalmol, Sch Med, Kurume, Fukuoka, Japan	Kyushu University; Kurume University	Ishikawa, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Fukuoka, Japan.	keijishi@med.kyushu-u.ac.jp		Ishikawa, Keijiro/0000-0002-4590-4471				Aras C, 2012, OPHTHALMOLOGICA, V227, P107, DOI 10.1159/000333101; BONNET M, 1986, J FR OPHTALMOL, V9, P615; Chen SDM, 2004, AM J OPHTHALMOL, V137, P1159, DOI 10.1016/j.ajo.2004.01.028; Flores-Moreno I, 2013, AM J OPHTHALMOL, V155, P314, DOI 10.1016/j.ajo.2012.07.015; Gogia V, 2014, INDIAN J OPHTHALMOL, V62, P893, DOI 10.4103/0301-4738.141068; Haug SJ, 2016, RETINA-J RET VIT DIS, V36, P203, DOI 10.1097/IAE.0000000000000820; Imai H, 2015, CLIN OPHTHALMOL, V9, P2103, DOI 10.2147/OPTH.S91339; Kita M, 2013, CLIN OPHTHALMOL, V7, P587, DOI 10.2147/OPTH.S42923; Kornberg DL, 2016, SEMIN OPHTHALMOL, V31, P505, DOI 10.3109/08820538.2014.981551; Li XJ, 2016, INT J OPHTHALMOL-CHI, V9, P1310, DOI 10.18240/ijo.2016.09.13; LIM MC, 1995, OPHTHALMOLOGY, V102, P942, DOI 10.1016/S0161-6420(95)30930-X; Nagiel A, 2016, RETINA-J RET VIT DIS, V36, P660, DOI 10.1097/IAE.0000000000000937; Nagpal M, 2013, ASIA-PAC J OPHTHALMO, V2, P165, DOI 10.1097/APO.0b013e3182929b75; Nam KY, 2013, RETINA-J RET VIT DIS, V33, P880, DOI 10.1097/IAE.0b013e31827e2602; Narayanan R, 2016, RETINA-J RET VIT DIS, V36, P830, DOI 10.1097/IAE.0000000000000792; Nicholson L, 2016, OSLI RETINA, V47, P644, DOI 10.3928/23258160-20160707-06; Oishi A, 2014, INVEST OPHTH VIS SCI, V55, P2424, DOI 10.1167/iovs.13-13738; Prokopich CL., 2007, CLIN PROCEDURES PRIM, DOI [10.1016/B978-0-7506-8896-3.50010-9, DOI 10.1016/B978-0-7506-8896-3.50010-9]; Seider Michael I, 2016, J Ophthalmic Vis Res, V11, P304, DOI 10.4103/2008-322X.188402; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P829, DOI 10.1097/IAE.0b013e31820c841e; Tomita Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13256; Yokoyama T, 2015, CLIN OPHTHALMOL, V9, P169, DOI 10.2147/OPTH.S75648	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212284	10.1371/journal.pone.0212284	http://dx.doi.org/10.1371/journal.pone.0212284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753247	Green Submitted, gold, Green Published			2022-12-26	WOS:000458395600058
J	Tgavalekos, K; Pham, T; Krishnamurthy, N; Sassaroli, A; Fantini, S				Tgavalekos, Kristen; Thao Pham; Krishnamurthy, Nishanth; Sassaroli, Angelo; Fantini, Sergio			Frequency-resolved analysis of coherent oscillations of local cerebral blood volume, measured with near-infrared spectroscopy, and systemic arterial pressure in healthy human subjects	PLOS ONE			English	Article							TISSUE OXYHEMOGLOBIN CONCENTRATIONS; CEREBROVASCULAR REACTIVITY; INTRACRANIAL-PRESSURE; DYNAMIC-MODEL; AUTOREGULATION; FLOW; HEMODYNAMICS; BRAIN; OXYGENATION; TIME	We report a study on twenty-two healthy human subjects of the dynamic relationship between cerebral hemoglobin concentration ([HbT]), measured with near-infrared spectroscopy (NIRS) in the prefrontal cortex, and systemic arterial blood pressure (ABP), measured with finger plethysmography. [HbT] is a measure of local cerebral blood volume (CBV). We induced hemodynamic oscillations at discrete frequencies in the range 0.04-0.20 Hz with cyclic inflation and deflation of pneumatic cuffs wrapped around the subject's thighs. We modeled the transfer function of ABP and [HbT] in terms of effective arterial (K-(a)) and venous (K-(v)) compliances, and a cerebral autoregulation time constant (tau((AR))). The mean values (+/- standard errors) of these parameters across the twenty-two subjects were K-(a) = 0.01 +/- 0.01 mu M/mmHg, K-(v) = 0.09 +/- 0.05 mu M/mmHg, and tau((AR)) = 2.2 +/- 1.3 s. Spatially resolved measurements in a subset of eight subjects reveal a spatial variability of these parameters that may exceed the inter-subject variability at a set location. This study sheds some light onto the role that ABP and cerebral blood flow (CBF) play in the dynamics of [HbT] measured with NIRS, and paves the way for new non-invasive optical studies of cerebral blood flow and cerebral autoregulation.	[Tgavalekos, Kristen; Thao Pham; Krishnamurthy, Nishanth; Sassaroli, Angelo; Fantini, Sergio] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Tufts University	Fantini, S (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	Sergio.Fantini@tufts.edu			National Institutes of Health [R01-NS095334, R21-EB020347]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB020347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health, Grants No. R01-NS095334 to SF and R21-EB020347 to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Addison P.S., 2015, IEEE REV BIOMED ENG, V8, P78, DOI DOI 10.1109/RBME.2015.2436978; Baker WB, 2017, J CEREB BLOOD FLOW M; Barrett MJP, 2012, NEUROIMAGE, V62, P482, DOI 10.1016/j.neuroimage.2012.05.005; BAUMBACH GL, 1985, ANN BIOMED ENG, V13, P303, DOI 10.1007/BF02584248; Bruns A, 2004, J NEUROSCI METH, V137, P321, DOI 10.1016/j.jneumeth.2004.03.002; Budohoski KP, 2012, BRIT J ANAESTH, V108, P89, DOI 10.1093/bja/aer324; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Caicedo A, 2011, PEDIATR RES, V69, P548, DOI 10.1203/PDR.0b013e3182176d85; Carrera E, 2011, J NEUROTRAUM, V28, P889, DOI 10.1089/neu.2010.1377; Claassen JAHR, 2016, J CEREBR BLOOD F MET, V36, P665, DOI 10.1177/0271678X15626425; Cui RF, 2014, MICROVASC RES, V93, P14, DOI 10.1016/j.mvr.2014.02.008; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Diedler J, 2011, ANESTH ANALG, V113, P849, DOI 10.1213/ANE.0b013e3182285dc0; Donnelly J, 2016, CRIT CARE, V18, P1; Efron B, 1993, INTRO BOOTSTRAP, P105; FANTINI S, 1994, APPL OPTICS, V33, P5204, DOI 10.1364/AO.33.005204; Fantini S, 2014, NEUROIMAGE, V85, P202, DOI 10.1016/j.neuroimage.2013.03.065; Figueroa CA, 2014, PROC IUTAM, V10, P382, DOI 10.1016/j.piutam.2014.01.033; Fraser CD, 2013, J APPL PHYSIOL, V115, P52, DOI 10.1152/japplphysiol.00068.2013; Gao YJ, 2015, BEHAV BRAIN RES, V278, P330, DOI 10.1016/j.bbr.2014.10.019; Gilmore MM, 2011, J PERINATOL, V31, P722, DOI 10.1038/jp.2011.17; GOBEL U, 1989, J CEREBR BLOOD F MET, V9, P491, DOI 10.1038/jcbfm.1989.72; Govindan RB, 2014, FRONT HUM NEUROSCI, V17, P67008; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hu XA, 2006, MED ENG PHYS, V28, P304, DOI 10.1016/j.medengphy.2005.07.006; Hueber DM, 1999, P SOC PHOTO-OPT INS, V3597, P618, DOI 10.1117/12.356784; Ito H, 2005, J CEREBR BLOOD F MET, V25, P852, DOI 10.1038/sj.jcbfm.9600076; Ito H, 2001, ANN NUCL MED, V15, P111, DOI 10.1007/BF02988600; Kainerstorfer JM, 2014, ACAD RADIOL, V21, P185, DOI 10.1016/j.acra.2013.10.012; Kainerstorfer JM, 2015, J CEREB BLOOD FLOW M, P1; Kasprowicz M, 2012, ULTRASOUND MED BIOL, V38, P1129, DOI 10.1016/j.ultrasmedbio.2012.02.014; Khaksari K, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.12.121615; Kim T, 2011, J CEREBR BLOOD F MET, V31, P1211, DOI 10.1038/jcbfm.2010.226; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Lee S-P, MAGN RESON MED; Li ZY, 2011, MICROVASC RES, V82, P304, DOI 10.1016/j.mvr.2011.08.004; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; Nabeel PM, 2017, PHYSIOL MEAS, V38, P2122, DOI 10.1088/1361-6579/aa9550; Nitzan M, 2002, PHYSIOL MEAS, V23, P85, DOI 10.1088/0967-3334/23/1/308; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Onaizah O, 2017, MED ENG PHYS, V49, P121, DOI 10.1016/j.medengphy.2017.08.009; Orini M, 2012, IEEE T BIO-MED ENG, V59, P663, DOI 10.1109/TBME.2011.2171959; PAPADEMETRIOU MD, 2012, J BIOMED OPT, V17, DOI DOI 10.1016/J.NICL.2016.01.020; Payne SJ, 2011, BIOMED OPT EXPRESS, V2, P966, DOI 10.1364/BOE.2.000979; Payne SJ, 2009, ANN BIOMED ENG, V37, P2288, DOI 10.1007/s10439-009-9763-5; Pierro ML, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.2.026005; Pierro ML, 2012, NEUROIMAGE, V63, P1571, DOI 10.1016/j.neuroimage.2012.07.015; Quick CM, 1998, AM J PHYSIOL-HEART C, V274, pH1393, DOI 10.1152/ajpheart.1998.274.4.H1393; Quick CM, 2000, ANN BIOMED ENG, V28, P291, DOI 10.1114/1.268; Reinhard M, 2006, J NEUROL SCI, V250, P103, DOI 10.1016/j.jns.2006.07.011; Reinhard M, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.9.097005; Rivera-Lara L, 2017, ANESTHESIOLOGY, V126, P1187, DOI 10.1097/ALN.0000000000001625; ROVAINEN CM, 1993, J CEREBR BLOOD F MET, V13, P359, DOI 10.1038/jcbfm.1993.49; Rowley AB, 2007, PHYSIOL MEAS, V28, P161, DOI 10.1088/0967-3334/28/2/005; Sassaroli A, 2018, J INNOV OPT HEAL SCI, V11, DOI 10.1142/S1793545818500360; Soul JS, 2007, PEDIATR RES, V61, P467, DOI 10.1203/pdr.0b013e31803237f6; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Steiner LA, 2009, NEUROCRIT CARE, V10, P122, DOI 10.1007/s12028-008-9140-5; Tgavalekos KT, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.10.101410; Tian FH, 2016, NEUROIMAGE-CLIN, V11, P124, DOI 10.1016/j.nicl.2016.01.020; Tsuji M, 2000, PEDIATRICS, V106, P625, DOI 10.1542/peds.106.4.625; VILLRINGER A, 1994, CIRC RES, V75, P55, DOI 10.1161/01.RES.75.1.55; Wang J.J., 2003, AM J PHYSIOL-HEART C, V284, pH1358; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wong FY, 2008, PEDIATRICS, V121, pE604, DOI 10.1542/peds.2007-1487; Wong FY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043165; Zhang R, 2009, J PHYSIOL-LONDON, V587, P2567, DOI 10.1113/jphysiol.2008.168302; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320	71	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211710	10.1371/journal.pone.0211710	http://dx.doi.org/10.1371/journal.pone.0211710			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753203	Green Published, gold, Green Submitted			2022-12-26	WOS:000458395600020
J	Zulkefli, NN; Masdar, MS; Isahak, WNRW; Jahim, JM; Rejab, SAM; Lye, CC				Zulkefli, Nurul Noramelya; Masdar, Mohd Shahbudin; Isahak, Wan Nor Roslam Wan; Jahim, Jamaliah Md; Rejab, Syahril Anuar Md; Lye, Chew Chien			Removal of hydrogen sulfide from a biogas mimic by using impregnated activated carbon adsorbent	PLOS ONE			English	Article							CELL ANODE DEGRADATION; TRACE COMPOUNDS; CHEMICAL REGENERATION; ADSORPTION; FUEL; PERFORMANCE; ENERGY; SOFC; CO2; ENHANCEMENT	Adsorption technology has led to the development of promising techniques to purify biogas, i.e., biomethane or biohydrogen. Such techniques mainly depend on the adsorbent ability and operating parameters. This research focused on adsorption technology for upgrading biogas technique by developing a novel adsorbent. The commercial coconut shell activated carbon (CAC) and two types of gases (H2S/N-2 and H2S/N-2/CO2) were used. CAC was modified by copper sulfate (CuSO4), zinc acetate (ZnAc2), potassium hydroxide (KOH), potassium iodide (KI), and sodium carbonate (Na2CO3) on their surface to increase the selectivity of H2S removal. Commercial H2S adsorbents were soaked in 7 wt.% of impregnated solution for 30 min before drying at 120 degrees C for 24 h. The synthesized adsorbent's physical and chemical properties, including surface morphology, porosity, and structures, were characterized by SEM-EDX, FTIR, XRD, TGA, and BET analyses. For real applications, the modified adsorbents were used in a real-time 0.85 L single-column adsorber unit. The operating parameters for the H2S adsorption in the adsorber unit varied in L/D ratio (0.5-2.5) and feed flow rate (1.5-5.5 L/min) where, also equivalent with a gas hourly space velocity, GHSV (212.4-780.0 hour(-1)) used. The performances of H2S adsorption were then compared with those of the best adsorbent that can be used for further investigation. Characterization results revealed that the impregnated solution homogeneously covered the adsorbent surface, morphology, and properties (i.e., crystallinity and surface area). BET analysis further shows that the modified adsorbents surface area decreased by up to 96%. Hence, ZnAc2-CAC clarify as the best adsorption capacity ranging within 1.3-1.7 mg H2S/g, whereby the studied extended to adsorption-desorption cycle.	[Zulkefli, Nurul Noramelya; Masdar, Mohd Shahbudin; Isahak, Wan Nor Roslam Wan; Jahim, Jamaliah Md] Univ Kebangsaan Malaysia, Res Ctr Sustainable Proc Technol CESPRO, Fac Engn & Built Environm, Ukm Bangi, Selangor, Malaysia; [Masdar, Mohd Shahbudin; Isahak, Wan Nor Roslam Wan; Jahim, Jamaliah Md] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Program Chem Engn, Ukm Bangi, Selangor, Malaysia; [Masdar, Mohd Shahbudin; Jahim, Jamaliah Md] Univ Kebangsaan Malaysia, Fuel Cell Inst, Ukm Bangi, Selangor, Malaysia; [Rejab, Syahril Anuar Md; Lye, Chew Chien] Sime Darby Res Sdn Bhd, Jalan Pulau Carey, Pulau Carey, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Masdar, MS (corresponding author), Univ Kebangsaan Malaysia, Res Ctr Sustainable Proc Technol CESPRO, Fac Engn & Built Environm, Ukm Bangi, Selangor, Malaysia.; Masdar, MS (corresponding author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Program Chem Engn, Ukm Bangi, Selangor, Malaysia.; Masdar, MS (corresponding author), Univ Kebangsaan Malaysia, Fuel Cell Inst, Ukm Bangi, Selangor, Malaysia.	shahbud@ukm.edu.my	Masdar, Mohd Shahbudin/M-2008-2016; ZULKEFLI, NURUL NORAMELYA/CAJ-3890-2022; Chew, Chien Lye/AAY-8193-2021; Masdar, Mohd Shahbudin/AAA-7572-2019; Isahak, Wan Nor Roslam Wan/C-6454-2015	Masdar, Mohd Shahbudin/0000-0001-5714-7415; ZULKEFLI, NURUL NORAMELYA/0000-0002-8145-6098; Masdar, Mohd Shahbudin/0000-0001-5714-7415; Isahak, Wan Nor Roslam Wan/0000-0002-1051-3120; Chew, Chien Lye/0000-0002-0165-1222	Universiti Kebangsaan Malaysia [DIP-2017-020, DIP-2017-020 UKM]; Sime Darby Research Sdn Bhd [KK-2014-043]; Sime Darby Research (SDR) Research Project [KK-2014-013]; Sime Darby Research Sdn. Bhd.	Universiti Kebangsaan Malaysia; Sime Darby Research Sdn Bhd; Sime Darby Research (SDR) Research Project; Sime Darby Research Sdn. Bhd.	Initials of the authors who received each award: M.S. Masdar. Grant numbers awarded to each author: DIP-2017-020 from Universiti Kebangsaan Malaysia and KK-2014-043 from Sime Darby Research Sdn Bhd. The full name of each funder: Universiti Kebangsaan Malaysia and Sime Darby Research Sdn Bhd. URL of each funder website Universiti Kebangsaan Malaysia http://www.ukm.my/portal/ms/.Sime Darby Research Sdn Bhd http://www.simedarbyplantation.com/our-businesses/researchdevelopment/overview.Did the sponsors or funders play any role Yes. Universiti Kebangsaan Malaysia: Analysis services Syahril Anuar Md Rejab and Chew Chien Lye are employed by Sime Darby Research Sdn. Bhd. Sime Darby Research Sdn. Bhd. provided support in the form of salaries for authors SAMR and CCL, and played a role in data collection and analysis. The contents/finding data of this paper have been checked through the Sime Darby Research Intellectual Properties Committee. As a result, this paper obtained a permission to publish in any related public journal. The specific roles of these authors are articulated in the 'author contributions' section.; This study was partially supported by the Universiti Kebangsaan Malaysia under code DIP-2017-020 UKM and Sime Darby Research (SDR) Research Project under code KK-2014-013.	Barelli L, 2017, INT J HYDROGEN ENERG, V42, P10341, DOI 10.1016/j.ijhydene.2017.02.021; Barelli L, 2015, FUEL PROCESS TECHNOL, V140, P21, DOI 10.1016/j.fuproc.2015.08.012; Caglayan BS, 2013, J HAZARD MATER, V252, P19, DOI 10.1016/j.jhazmat.2013.02.028; Cavalli A, 2018, APPL ENERG, V231, P1, DOI 10.1016/j.apenergy.2018.09.060; Chambers AK, 2002, GAS UTILIZATION SEWA; Choo HS, 2013, J ENG SCI TECHNOL, V8, P741; Conway BE, 2002, J POWER SOURCES, V105, P169, DOI 10.1016/S0378-7753(01)00936-3; Cui H, 2009, CATAL TODAY, V139, P274, DOI 10.1016/j.cattod.2008.03.024; Devil R. S, 2015, J ENV NANOTECHNOL, V4, P19; Dewil R, 2006, ENERG CONVERS MANAGE, V47, P1711, DOI 10.1016/j.enconman.2005.10.016; Farzad S, 2007, J NAT GAS CHEM, V16, P22, DOI 10.1016/S1003-9953(07)60021-8; Feng WG, 2005, ENVIRON SCI TECHNOL, V39, P9744, DOI 10.1021/es0507158; Gulagi A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180611; Gurses A, 2016, ACTA PHYS POL A, V129, P849, DOI 10.12693/APhysPolA.129.849; Halim MYA, 2014, MATERIALS, V7, P7737, DOI 10.3390/ma7127737; Isik-Gulsac I, 2016, BRAZ J CHEM ENG, V33, P1021, DOI 10.1590/0104-6632.20160334s20150164; Kupecki J, 2018, APPL ENERG, V230, P1573, DOI 10.1016/j.apenergy.2018.09.092; Lanzini A, 2017, PROG ENERG COMBUST, V61, P150, DOI 10.1016/j.pecs.2017.04.002; Liu M, 2013, APPL ENERG, V108, P149, DOI 10.1016/j.apenergy.2013.03.020; Madi H, 2016, J POWER SOURCES, V326, P349, DOI 10.1016/j.jpowsour.2016.07.003; Madi H, 2015, J POWER SOURCES, V279, P460, DOI 10.1016/j.jpowsour.2015.01.053; Mescia D, 2011, INT J HYDROGEN ENERG, V36, P7884, DOI 10.1016/j.ijhydene.2011.01.057; Miltner M, 2017, J CLEANER PRODUCTION; Mt Yusuf N. Y, 2018, INT J HYDROGEN ENERG; Mulbry W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185738; Nahm SW, 2012, CHEM ENG J, V210, P500, DOI 10.1016/j.cej.2012.09.023; Narbaitz RM, 2012, CHEM ENG J, V197, P414, DOI 10.1016/j.cej.2012.05.049; Natalie H., 2012, THESIS; Nurul N.Z., 2016, INT J APPL ENG RES, V11, P10060; Okman I, 2014, APPL SURF SCI, V293, P138, DOI 10.1016/j.apsusc.2013.12.117; Papadias DD, 2012, ENERGY, V44, P257, DOI 10.1016/j.energy.2012.06.031; Papurello D, 2019, SEP PURIF TECHNOL, V210, P80, DOI 10.1016/j.seppur.2018.07.081; Papurello D, 2018, RENEW ENERG, V125, P344, DOI 10.1016/j.renene.2018.02.122; Papurello D, 2018, WASTE MANAGE, V72, P306, DOI 10.1016/j.wasman.2017.11.030; Papurello D, 2017, APPL ENERG, V208, P637, DOI 10.1016/j.apenergy.2017.09.090; Papurello D, 2016, ENRGY PROCED, V101, P424, DOI 10.1016/j.egypro.2016.11.054; Phooratsamee W., 2014, American Journal of Environmental Sciences, V10, P431, DOI 10.3844/ajessp.2014.431.445; Pokorna D, 2015, BIOTECHNOL ADV, V33, P1246, DOI 10.1016/j.biotechadv.2015.02.007; Rasi S, 2007, ENERGY, V32, P1375, DOI 10.1016/j.energy.2006.10.018; Rasi S, 2011, ENERG CONVERS MANAGE, V52, P3369, DOI 10.1016/j.enconman.2011.07.005; Ryckebosch E, 2011, BIOMASS BIOENERG, V35, P1633, DOI 10.1016/j.biombioe.2011.02.033; Sabio E, 2004, CARBON, V42, P2285, DOI 10.1016/j.carbon.2004.05.007; Salvador F, 2015, MICROPOR MESOPOR MAT, V202, P259, DOI 10.1016/j.micromeso.2014.02.045; Salvador F, 2015, MICROPOR MESOPOR MAT, V202, P277, DOI 10.1016/j.micromeso.2014.08.019; Samanta A, 2012, IND ENG CHEM RES, V51, P1438, DOI 10.1021/ie200686q; Shah I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122603; Sidek MZ, 2019, MATER RES EXPRESS, V6, DOI 10.1088/2053-1591/aae6bf; Sitthikhankaew R, 2014, SEP SCI TECHNOL, V49, P354, DOI 10.1080/01496395.2013.841240; Sitthikhankaew R, 2011, ENRGY PROCED, V9, DOI 10.1016/j.egypro.2011.09.003; Soraya H, 2015, J TAIWAN I CHEM, P1; Srenscek-Nazzal J, 2016, ACTA PHYS POL, P129; Sun K, 2009, IRAN J CHEM CHEM ENG, V28, P79; Tan IAW, 2008, COLLOID SURFACE A, V318, P88, DOI 10.1016/j.colsurfa.2007.12.018; Tangjuank S, 2009, INT J PHYS SCI, V4, P412; Toledo-Cervantes A, 2017, ALGAL RES, V25, P237, DOI 10.1016/j.algal.2017.05.006; Vinodhini V, 2010, DESALINATION, V264, P9, DOI 10.1016/j.desal.2010.06.073; Vivekanand G, 2007, CANADIAN J CHEM ENG, V85; Xu H, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/238287; Zhang L, 2013, ASIAN J CHEM, V25, P2355, DOI 10.14233/ajchem.2013.13552; Zulkefli NN, 2017, IOP CONF SER-MAT SCI, V206, DOI 10.1088/1757-899X/206/1/012069	61	28	30	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211713	10.1371/journal.pone.0211713	http://dx.doi.org/10.1371/journal.pone.0211713			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753209	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600021
J	Avolio, AW; Gaspari, R; Teofili, L; Bianco, G; Spinazzola, G; Soave, PM; Paiano, G; Francesconi, AG; Arcangeli, A; Nicolotti, N; Antonelli, M				Avolio, Alfonso Wolfango; Gaspari, Rita; Teofili, Luciana; Bianco, Giuseppe; Spinazzola, Giorgia; Soave, Paolo Maurizio; Paiano, Gianfranco; Francesconi, Alessandra Gioia; Arcangeli, Andrea; Nicolotti, Nicola; Antonelli, Massimo			Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis	PLOS ONE			English	Article							PULMONARY COMPLICATIONS; MECHANICAL VENTILATION; PROLONGED VENTILATION; DONOR; RECIPIENT; SCORE; END; MODEL; MELD; ALLOCATION	Background Postoperative respiratory failure (PRF, namely mechanical ventilation >48 hours) significantly affects morbidity and mortality in liver transplantation (LTx). Previous studies analyzed only one or two categories of PRF risk factors (preoperative, intraoperative or postoperative ones). The aims of this study were to identify PRF predictors, to assess the length of stay (LoS) in ICU and the 90-day survival according to the PRF in LTx patients. Methods Two classification approaches were used: systematic classification (recipient-related preoperative factors; intraoperative factors; logistic factors; donor factors; postoperative ICU factors; postoperative surgical factors) and patient/organ classification (patient-related general factors; native-liver factors; new-liver factors; kidney factors; heart factors; brain factors; lung factors). Two hundred adult non-acute patients were included. Missing analysis was performed. The competitive role of each factor was assessed. Results PRF occurred in 36.0% of cases. Among 28 significant PRF predictors at univariate analysis, 6 were excluded because of collinearity, 22 were investigated by ROC curves and by logistic regression analysis. Recipient age (OR = 1.05; p = 0.010), female sex (OR = 2.75; p = 0.018), Model for End-Stage Liver Disease (MELD, OR = 1.09; p<0.001), restrictive lung pattern (OR = 2.49; p = 0.027), intraoperative veno-venous bypass (VVBP, OR = 3.03; p = 0.008), pre-extubation PaCO2 (OR = 1.11; p = 0.003) and Model for Early Allograft Function (MEAF, OR = 1.37; p<0.001) resulted independent PRF risk factors. As compared to patients without PRF, the PRF-group had longer LoS (10 days IQR 7-18 versus 5 days IQR 4-7, respectively; p<0.001) and lower day-90 survival (86.0% versus 97.6% respectively, p<0.001). Conclusion In conclusion, MELD, restrictive lung pattern, surgical complexity as captured by VVBP, pre-extubation PaCO2 and MEAF are the main predictors of PRF in non-acute LTx patients.	[Avolio, Alfonso Wolfango; Bianco, Giuseppe] Fdn Policlin Univ A Gemelli IRCCS, Dept Surg Transplantat Serv, Rome, Italy; [Avolio, Alfonso Wolfango; Gaspari, Rita; Teofili, Luciana; Arcangeli, Andrea; Antonelli, Massimo] Univ Cattolica Sacro Cuore, Rome, Italy; [Gaspari, Rita; Spinazzola, Giorgia; Soave, Paolo Maurizio; Paiano, Gianfranco; Francesconi, Alessandra Gioia; Arcangeli, Andrea; Antonelli, Massimo] Fdn Policlin Univ A Gemelli IRCCS, Dept Anaesthesiol & Intens Care Med, Rome, Italy; [Teofili, Luciana] Fdn Policlin Univ A Gemelli IRCCS, Inst Hematol, Rome, Italy; [Nicolotti, Nicola] Fdn Policlin Univ A Gemelli IRCCS, Inst Hyg & Epidemiol, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Avolio, AW (corresponding author), Fdn Policlin Univ A Gemelli IRCCS, Dept Surg Transplantat Serv, Rome, Italy.; Avolio, AW (corresponding author), Univ Cattolica Sacro Cuore, Rome, Italy.	alfonso.avolio@unicatt.it	Gaspari, Rita/Q-5421-2019; Bianco, Giuseppe/Y-8865-2019; Nicolotti, Nicola/P-9895-2019; Bianco, Giuseppe/C-1707-2019; spinazzola, giorgia gs/K-3571-2018; Nicolotti, Nicola/K-1846-2018	Bianco, Giuseppe/0000-0001-7451-4002; Nicolotti, Nicola/0000-0002-3096-6397; Bianco, Giuseppe/0000-0001-7451-4002; spinazzola, giorgia gs/0000-0001-8055-5142; Nicolotti, Nicola/0000-0002-3096-6397; teofili, luciana/0000-0002-7214-1561; Soave, paolo maurizio/0000-0002-0645-5722; Avolio, Alfonso/0000-0003-2491-7625; GASPARI, Rita/0000-0003-0141-3686				Agopian VG, 2018, JAMA SURG, V153, P436, DOI 10.1001/jamasurg.2017.5040; Allison, 2001, LOGISTIC REGRESSION; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Antonelli M, 2000, JAMA-J AM MED ASSOC, V283, P235, DOI 10.1001/jama.283.2.235; Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; Avolio AW, 2006, TRANSPL P, V38, P1059, DOI 10.1016/j.transproceed.2006.03.008; Avolio AW, 2013, AM J TRANSPLANT, V13, P522, DOI 10.1111/ajt.12031; Avolio AW, 2011, AM J TRANSPLANT, V11, P2724, DOI 10.1111/j.1600-6143.2011.03732.x; Avolio AW, 2012, TRANSPL INT, V25, P294, DOI 10.1111/j.1432-2277.2011.01423.x; Avolio AW, 2011, DIGEST LIVER DIS, V43, P921, DOI 10.1016/j.dld.2011.05.016; Avolio AW, 2006, TRANSPLANT P, V38, P1066, DOI 10.1016/j.transproceed.2006.03.009; Avolio AW, 1999, TRANSPLANT P, V31, P434, DOI 10.1016/S0041-1345(98)01694-7; Avolio AW, 2000, TRANSPLANT P, V32, P131, DOI 10.1016/S0041-1345(99)00910-0; Barone M, 2017, DIGEST LIVER DIS, V49, P957, DOI 10.1016/j.dld.2017.07.004; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Bozbas SS, 2008, EXP CLIN TRANSPLANT, V6, P264; Cameron AM, 2006, ANN SURG, V243, P748, DOI 10.1097/01.sla.0000219669.84192.b3; Canet J, 2010, ANESTHESIOLOGY, V113, P1338, DOI 10.1097/ALN.0b013e3181fc6e0a; Cholongitas E, 2007, AM J TRANSPLANT, V7, P685, DOI 10.1111/j.1600-6143.2007.01666.x; Cillo U, 2015, AM J TRANSPLANT, V15, P2552, DOI 10.1111/ajt.13408; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Cleland Stuart, 2016, World J Transplant, V6, P291, DOI 10.5500/wjt.v6.i2.291; Cucchetti A, 2006, J AM COLL SURGEONS, V203, P670, DOI 10.1016/j.jamcollsurg.2006.06.018; Dutkowski P, 2011, ANN SURG, V254, P745, DOI 10.1097/SLA.0b013e3182365081; Faenza S, TRANSPLANT P, V38, P1131; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Gajic O, 2004, CRIT CARE MED, V32, P1817, DOI 10.1097/01.CCM.0000133019.52531.30; Garutti I, 2015, ANESTH ANALG, V121, P736, DOI 10.1213/ANE.0000000000000875; Glanemann M, 2001, ACTA ANAESTH SCAND, V45, P333, DOI 10.1034/j.1399-6576.2001.045003333.x; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Huang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022689; Jacob M, 2005, LIVER TRANSPLANT, V11, P814, DOI 10.1002/lt.20456; Kleine M, 2013, LIVER TRANSPLANT, V19, P862, DOI 10.1002/lt.23673; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Levesque E, 2012, TRANSPLANTATION, V94, P532, DOI 10.1097/TP.0b013e31825c1d41; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MCALISTER VC, 1993, TRANSPLANTATION, V55, P826, DOI 10.1097/00007890-199304000-00027; Pareja E, 2015, LIVER TRANSPLANT, V21, P38, DOI 10.1002/lt.23990; Park MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136230; Pedersen MR, 2016, J TRANSPLANT, V2016, DOI 10.1155/2016/6787854; Roch A, 2005, CHEST, V127, P224, DOI 10.1378/chest.127.1.224; Rodriguez-Roisin R, 2004, EUR RESPIR J, V24, P861, DOI 10.1183/09031936.04.00010904; Sinclair M, 2016, ALIMENT PHARM THER, V43, P765, DOI 10.1111/apt.13549; Slankamenac K, 2014, ANN SURG, V260, P757, DOI 10.1097/SLA.0000000000000948; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; SVENSSON LG, 1991, J VASC SURG, V14, P271; Wang A, 2016, TRANSPL P, V48, P120, DOI 10.1016/j.transproceed.2016.01.004; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Yuan H, 2014, AM J SURG, V208, P582, DOI 10.1016/j.amjsurg.2014.06.004; Yun BC, 2009, HEPATOLOGY, V49, P1610, DOI 10.1002/hep.22846; Zimmerman JE, 1996, HEPATOLOGY, V23, P1393, DOI 10.1002/hep.510230615	52	12	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211678	10.1371/journal.pone.0211678	http://dx.doi.org/10.1371/journal.pone.0211678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742650	Green Submitted, Green Published, gold			2022-12-26	WOS:000458393400017
J	Bourouis, M; Mondin, M; Dussert, A; Leopold, P				Bourouis, Marc; Mondin, Magali; Dussert, Aurore; Leopold, Pierre			Control of basal autophagy rate by vacuolar peduncle	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE; NEURONAL SURVIVAL; CELL-GROWTH; DROSOPHILA; MEMBRANE; ENDOCYTOSIS; COMPLEX; COORDINATION; HUNTINGTIN; PROTEINS	Basal autophagy is as a compressive catabolic mechanism engaged in the breakdown of damaged macromolecules and organelles leading to the recycling of elementary nutrients. Thought essential to cellular refreshing, little is known about the origin of a constitutional rate of basal autophagy. Here, we found that loss of Drosophila vacuolar peduncle (vap), a presumed GAP enzyme, is associated with enhanced basal autophagy rate and physiological alterations resulting in a wasteful cell energy balance, a hallmark of overactive autophagy. By contrast, starvation-induced autophagy was disrupted in vap mutant conditions, leading to a block of maturation into autolysosomes. This phenotype stem for exacerbated biogenesis of PI(3)P-dependent endomembranes, including autophagosome membranes and ectopic fusions of vesicles. These findings shed new light on the neurodegenerative phenotype found associated to mutant vap adult brains in a former study. A partner of Vap, Sprint (Spri), acting as an endocytic GEF for Rab5, had the converse effect of leading to a reduction in PI(3)P-dependent endomembrane formation in mutants. Spri was conditional to normal basal autophagy and instrumental to the starvation-sensitivity phenotype specific of vap. Rab5 activity itself was essential for PI(3)P and for pre-autophagosome structures formation. We propose that Vap/Spri complexes promote a cell surface-derived flow of endocytic Rab5-containing vesicles, the traffic of which is crucial for the implementation of a basal autophagy rate.	[Bourouis, Marc; Mondin, Magali] Univ Cote dAzur, CNRS, Inst Biol Valrose, Nice, France; [Dussert, Aurore; Leopold, Pierre] Univ Cote dAzur, INSERM, Inst Biol Valrose, Nice, France; [Leopold, Pierre] Inst Curie, Ctr Rech, Genet & Dev Biol Unit, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Bourouis, M (corresponding author), Univ Cote dAzur, CNRS, Inst Biol Valrose, Nice, France.	bourouis@unice.fr		Mondin, Magali/0000-0001-5802-007X	CNRS; INSERM; European Research Council [268813]; Labex Signalife program [ANR-11-LABX-0028-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Research Council(European Research Council (ERC)European Commission); Labex Signalife program	This work was supported by the CNRS: http://www.cnrs.fr, INSERM: https://www.inserm.fr (salary to A.D.), the European Research Council: https://erc.europa.eu/funding-and-grants/managing-project/open-access (Advanced grant no. 268813 to P.L.), the Labex Signalife program: http://www.agence-nationale-recherche.fr and http://signalife.unice.fr (grant ANR-11-LABX-0028-01 to P.L.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Balaji K, 2012, J CELL SCI; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Botella JA, 2003, MOL BIOL CELL, V14, P241, DOI 10.1091/mbc.E02-05-0297; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Cebollero E, 2012, AUTOPHAGY, V8, P1868, DOI 10.4161/auto.22162; Cebollero E, 2012, CURR BIOL, V22, P1545, DOI 10.1016/j.cub.2012.06.029; Chang YY, 2010, FEBS LETT, V584, P1342, DOI 10.1016/j.febslet.2010.01.006; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875; Denton D, 2012, CELL DEATH DIFFER, V19, P1299, DOI 10.1038/cdd.2012.43; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Feldmann P, 1999, MOL CELL BIOL, V19, P1928; Finsterer J, 2014, EUR J MED GENET, V57, P103, DOI 10.1016/j.ejmg.2014.01.002; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Gutierrez E, SPECIALISED HEPATOCY; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hegedus K, 2016, MOL BIOL CELL, V27, P3132, DOI 10.1091/mbc.E16-03-0205; Holland P, 2015, NAT CELL BIOL, V17, P1094, DOI 10.1038/ncb3224; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Jean S, 2014, J CELL SCI, V127, P923, DOI 10.1242/jcs.093773; Jean S, 2012, NAT REV MOL CELL BIO, V13, P463, DOI 10.1038/nrm3379; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Lamb CA, 2013, BIOESSAYS, V35, P34, DOI 10.1002/bies.201200130; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Mauvezin C, 2014, METHODS, V68, P134, DOI 10.1016/j.ymeth.2014.03.014; McPhee CK, 2009, BBA-MOL CELL RES, V1793, P1452, DOI 10.1016/j.bbamcr.2009.02.009; Melani M, 2017, MOL BIOL CELL; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Mi N, 2015, NAT CELL BIOL, V17, P1112, DOI 10.1038/ncb3215; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Musiwaro P, 2013, AUTOPHAGY, V9, P1407, DOI 10.4161/auto.25455; Nandi N, 2014, J CELL BIOL, V207, P253, DOI 10.1083/jcb.201404028; Nefeld TP, 2007, AUTOPHAGY, V3, P477; Neufeld TP, 2008, AUTOPHAGY, V4, P557, DOI 10.4161/auto.5782; Neufeld TP, 2012, J CELL SCI, V125, P2359, DOI 10.1242/jcs.103333; Otomo A, 2011, FEBS LETT, V585, P730, DOI 10.1016/j.febslet.2011.01.045; Pircs K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044214; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Reggiori F, 2012, INT J CELL BIOL; Rowshanravan B, 2014, J CELL SCI, V127, P2849, DOI 10.1242/jcs.139329; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Ryoo HD, 2010, CURR OPIN CELL BIOL, V22, P889, DOI 10.1016/j.ceb.2010.08.022; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Schink KO, 2013, BIOESSAYS, V35, P900, DOI 10.1002/bies.201300064; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Tiebe M, 2015, DEV CELL, V33, P272, DOI 10.1016/j.devcel.2015.03.013; Tooze SA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018358; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Tooze SA, 2008, CURR OPIN NEUROBIOL, V18, P504, DOI 10.1016/j.conb.2008.09.015; van der Bliek AM, 2005, NAT CELL BIOL, V7, P548, DOI 10.1038/ncb0605-548; Velichkova M, 2010, J CELL BIOL, V190, P407, DOI 10.1083/jcb.200911020; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	79	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0209759	10.1371/journal.pone.0209759	http://dx.doi.org/10.1371/journal.pone.0209759			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735514	Green Submitted, Green Published, gold			2022-12-26	WOS:000458181200010
J	Mosher, V; Swain, M; Pang, J; Kaplan, G; Sharkey, K; MacQueen, G; Goodyear, BG				Mosher, Victoria; Swain, Mark; Pang, Jack; Kaplan, Gilaad; Sharkey, Keith; MacQueen, Glenda; Goodyear, Bradley Gordon			Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions	PLOS ONE			English	Article							QUALITY-OF-LIFE; URSODEOXYCHOLIC ACID; MULTIPLE-SCLEROSIS; CONTROLLED-TRIAL; CIRRHOSIS; FATIGUE; IRON; IMPACT; VALIDATION; DISEASE	Background Many patients with primary biliary cholangitis (PBC) experience non-hepatic symptoms that are possibly linked to altered interoception, the sense of the body's internal state. We used magnetic resonance imaging (MRI) to determine if PBC patients exhibit structural and functional changes of the thalamus and insula, brain regions that process signals related to interoception. Methods Fifteen PBC patients with mild disease and 17 controls underwent 3 Tesla T-1-weighted MRI, resting-state functional MRI, and quantitative susceptibility mapping (QSM), to measure thalamic and insular volume, neuronal activity and iron deposition, respectively. Group differences were assessed using analysis of covariance, and stepwise linear regression was used to determine the predictive power of clinical indicators of disease. Results PBC patients exhibited reduced thalamic volume (p < 0.01), and ursodeoxycholic acid (UDCA) non-responders exhibited lower left thalamus activity (p = 0.05). PBC patients also exhibited reduced anterior insula activity (p = 0.012), and liver stiffness positively correlated with MRI indicators of anterior insula iron deposition (p < 0.02). Conclusions PBC affects structure and function of brain regions critically important to interoception. Moreover, these brain changes occur in patients with early, milder disease and thus may potentially be reversible.	[Mosher, Victoria; Swain, Mark; Pang, Jack; Kaplan, Gilaad] Univ Calgary, Dept Med, Calgary, AB, Canada; [Mosher, Victoria; Goodyear, Bradley Gordon] Univ Calgary, Seaman Family MR Res Ctr, Calgary, AB, Canada; [Swain, Mark; Sharkey, Keith] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Swain, Mark] Univ Calgary, Calgary Div Gastroenterol & Hepatol, Liver Unit, Calgary, AB, Canada; [Pang, Jack; Sharkey, Keith; MacQueen, Glenda; Goodyear, Bradley Gordon] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Sharkey, Keith] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [MacQueen, Glenda; Goodyear, Bradley Gordon] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [MacQueen, Glenda] Univ Calgary, Mathison Ctr Mental Hlth Res & Educ, Calgary, AB, Canada; [Goodyear, Bradley Gordon] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Goodyear, Bradley Gordon] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Goodyear, BG (corresponding author), Univ Calgary, Seaman Family MR Res Ctr, Calgary, AB, Canada.; Goodyear, BG (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.; Goodyear, BG (corresponding author), Univ Calgary, Dept Psychiat, Calgary, AB, Canada.; Goodyear, BG (corresponding author), Univ Calgary, Dept Radiol, Calgary, AB, Canada.; Goodyear, BG (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.	goodyear@ucalgary.ca	Kaplan, Gil/AAH-2335-2021	Kaplan, Gil/0000-0003-2719-0556; Sharkey, Keith/0000-0001-9560-1711	Cal Wenzel Family Foundation Chair in Hepatology; Canadian Institutes of Health Research Team Grant: Health Challenges in Chronic Inflammation Initiative	Cal Wenzel Family Foundation Chair in Hepatology; Canadian Institutes of Health Research Team Grant: Health Challenges in Chronic Inflammation Initiative	This work was supported by the Cal Wenzel Family Foundation Chair in Hepatology (MGS) and Canadian Institutes of Health Research Team Grant: Health Challenges in Chronic Inflammation Initiative (MGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery JA, 2014, BIOL PSYCHIAT, V76, P258, DOI 10.1016/j.biopsych.2013.11.027; Bjornsson E, 2010, LIVER INT, V30, P251, DOI 10.1111/j.1478-3231.2009.02160.x; Blackburn P, 2007, LIVER INT, V27, P654, DOI 10.1111/j.1478-3231.2007.01500.x; Carbone M, 2013, J HEPATOL, V59, P490, DOI 10.1016/j.jhep.2013.04.017; Cauch-Dudek K, 1998, GUT, V43, P705, DOI 10.1136/gut.43.5.705; Corpechot C, 2012, HEPATOLOGY, V56, P198, DOI 10.1002/hep.25599; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; D'Mello C, 2014, BRAIN BEHAV IMMUN, V35, P9, DOI 10.1016/j.bbi.2013.10.009; DRAYER B, 1987, AM J ROENTGENOL, V149, P357, DOI 10.2214/ajr.149.2.357; Hagemeier J, 2012, AM J NEURORADIOL, V33, P1596, DOI 10.3174/ajnr.A3030; Harrison NA, 2009, BIOL PSYCHIAT, V66, P415, DOI 10.1016/j.biopsych.2009.03.007; HEATHCOTE EJ, 1994, HEPATOLOGY, V19, P1149, DOI 10.1002/hep.1840190512; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; Huet PM, 2000, AM J GASTROENTEROL, V95, P760; Jacoby A, 2005, GUT, V54, P1622, DOI 10.1136/gut.2005.065862; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jones DE, 2010, J HEPATOL, V53, P911, DOI 10.1016/j.jhep.2010.05.026; Jones DEJ, 2006, GUT, V55, P536, DOI 10.1136/gut.2005.080317; Kiviniemi V, 2000, MAGN RESON MED, V44, P373, DOI 10.1002/1522-2594(200009)44:3<373::AID-MRM5>3.0.CO;2-P; Lammers WJ, 2015, GASTROENTEROLOGY, V149, P1804, DOI 10.1053/j.gastro.2015.07.061; Langkammer C, 2012, NEUROIMAGE, V62, P1593, DOI 10.1016/j.neuroimage.2012.05.049; LINDOR KD, 1994, GASTROENTEROLOGY, V106, P1284, DOI 10.1016/0016-5085(94)90021-3; Liu YO, 2011, J NEUROL SCI, V304, P127, DOI 10.1016/j.jns.2011.01.023; Mehta V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057573; Mells GF, 2013, HEPATOLOGY, V58, P273, DOI 10.1002/hep.26365; Mosher VAL, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.34; Newton JL, 2006, J HEPATOL, V44, P776, DOI 10.1016/j.jhep.2005.12.012; Newton JL, 2008, HEPATOLOGY, V48, P541, DOI 10.1002/hep.22371; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Patriat R, 2013, NEUROIMAGE, V78, P463, DOI 10.1016/j.neuroimage.2013.04.013; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; Poupon R, 2010, J HEPATOL, V52, P745, DOI 10.1016/j.jhep.2009.11.027; POUPON RE, 1991, NEW ENGL J MED, V324, P1548, DOI 10.1056/NEJM199105303242204; Qian ZM, 1998, BRAIN RES REV, V27, P257, DOI 10.1016/S0165-0173(98)00012-5; van Rensburg SJ, 2004, METAB BRAIN DIS, V19, P97, DOI 10.1023/B:MEBR.0000027421.33085.8b; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhou FQ, 2014, CLIN IMAG, V38, P605, DOI 10.1016/j.clinimag.2014.05.006	42	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211906	10.1371/journal.pone.0211906	http://dx.doi.org/10.1371/journal.pone.0211906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735529	Green Submitted, Green Published, gold			2022-12-26	WOS:000458181200040
J	Gao, XT; Gao, SY; Guan, Y; Huang, L; Huang, JL; Lin, L; Liu, Y; Zhao, H; Huang, BJ; Yuan, TY; Liu, Y; Liang, DD; Zhang, YY; Ma, XE; Li, L; Li, J; Zhou, DZ; Shi, D; Xu, L; Chen, YH				Gao, Xueting; Gao, Siyun; Guan, Yi; Huang, Lin; Huang, Jiale; Lin, Li; Liu, Yuan; Zhao, Hong; Huang, Bijun; Yuan, Tianyou; Liu, Yi; Liang, Dandan; Zhang, Yangyang; Ma, Xiue; Li, Li; Li, Jun; Zhou, Daizhan; Shi, Dan; Xu, Liang; Chen, Yi-Han			Toll-like receptor 3 controls QT interval on the electrocardiogram by targeting the degradation of Kv4.2/4.3 channels in the endoplasmic reticulum	FASEB JOURNAL			English	Article						cardiac repolarization; transient outward potassium channel; degradation; ER retention	CURRENT I-TO; QUALITY-CONTROL; HEART-FAILURE; RECOGNITION; ACTIVATION; TLR3; REPOLARIZATION; STIMULATION; CONTRIBUTES; HOMEOSTASIS	TLRs have been proven to be essential mediators for the early innate immune response. Overactivation of TLR-mediated immune signaling promotes deterioration of cardiovascular diseases; however, the role of TLRs in the heart under physiologic conditions remains neglected. Here, we show that Tlr3 deficiency induced the endoplasmic reticulum (ER) retention of Kv4.2/4.3 proteins and consequent degradation via the ubiquitin-proteasome pathway. Knockout of Tlr3 resulted in a prolonged QT interval (the space between the start of the Q wave and the end of the T wave) in mice with no significant signs of inflammation and tissue abnormality in cardiac muscles. Prolongation of action potential duration resulted from the depression of transient outward potassium channel (I-to) currents in Tlr3-deficient ventricular myocytes mirrored the change in QT interval. Mechanistically, we found that Tlr3 was exclusively localized in the ER of cardiomyocytes where it interacted with Kv4.2/4.3 subunits of I-to channel. Thus, our data indicated that TLR3 directly regulates I-to channel protein dynamics to maintain cardiac repolarization, which may implicate a new molecular surveillance system for cardiac electrophysiological homeostasis.Gao, X., Gao, S., Guan, Y., Huang, L., Huang, J., Lin, L., Liu, Y., Zhao, H., Huang, B., Yuan, T., Liu, Y., Liang, D., Zhang, Y., Ma, X., Li, L., Li, J., Zhou, D., Shi, D., Xu, L., Chen, Y.-H. Toll-like receptor 3 controls QT interval on the electrocardiogram by targeting the degradation of Kv4.2/4.3 channels in the endoplasmic reticulum.	[Gao, Xueting; Gao, Siyun; Guan, Yi; Huang, Lin; Huang, Jiale; Lin, Li; Liu, Yuan; Huang, Bijun; Yuan, Tianyou; Liu, Yi; Liang, Dandan; Zhang, Yangyang; Ma, Xiue; Li, Li; Li, Jun; Zhou, Daizhan; Shi, Dan; Xu, Liang; Chen, Yi-Han] East Hosp, Heart Hlth Ctr, Shanghai, Peoples R China; [Gao, Siyun; Guan, Yi; Huang, Jiale; Lin, Li; Yuan, Tianyou; Liu, Yi; Liang, Dandan; Zhang, Yangyang; Ma, Xiue; Li, Jun; Zhou, Daizhan; Shi, Dan; Xu, Liang; Chen, Yi-Han] Minist Educ China, Key Lab Arrhythmias, East Hosp, Shanghai, Peoples R China; [Zhao, Hong] Tongji Hosp, Dept Pediat, Shanghai, Peoples R China; [Li, Jun; Chen, Yi-Han] Tongji Univ, Dept Pathol & Pathophysiol, Sch Med, Shanghai, Peoples R China; [Gao, Xueting; Gao, Siyun; Guan, Yi; Huang, Lin; Huang, Jiale; Lin, Li; Liu, Yuan; Huang, Bijun; Liang, Dandan; Zhang, Yangyang; Ma, Xiue; Li, Li; Li, Jun; Zhou, Daizhan; Shi, Dan; Xu, Liang; Chen, Yi-Han] Tongji Univ, Inst Med Genet, Shanghai, Peoples R China	Ministry of Education, China; Tongji University; Tongji University	Xu, L (corresponding author), Tongji Univ, East Hosp, Key Lab Arrhythmias, Minist Educ China,Sch Med, Jimo Rd 150, Shanghai 200120, Peoples R China.; Chen, YH (corresponding author), Tongji Univ, East Hosp, Heart Hlth Ctr, Sch Med, Jimo Rd 150, Shanghai 200120, Peoples R China.	xuliang_east@126.com; yihanchen@tongji.edu.cn	zhang, yangyang/GZG-7467-2022; Chen, Yi/HIR-2608-2022	Li, Li/0000-0003-0524-7515	Key Program of National Natural Science Foundation of China [81530017]; National Innovative Research Groups Program of the National Natural Science Foundation of China [81521061]; National Natural Science Foundation of China [81770397, 81670360, 81500252, 81770267, 81670295]; Outstanding Young Talent Training Program of Shanghai Municipal Commission of Health and Family Planning [2017YQ045]; Fundamental Research Funds for the Central Universities; National Key Research and Development Program [2018YFC1312504]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Innovative Research Groups Program of the National Natural Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Talent Training Program of Shanghai Municipal Commission of Health and Family Planning; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Key Research and Development Program	This work was funded by the Key Program of National Natural Science Foundation of China (81530017 to Y.-H.C.), the National Innovative Research Groups Program of the National Natural Science Foundation of China (81521061 to Y.-H.C.), the General Program of the National Natural Science Foundation of China (81770397 to Y.-H.C.; 81670360 to J.L.; 81500252 and 81770267 to D.L.; 81670295 to L.L.), the Outstanding Young Talent Training Program of Shanghai Municipal Commission of Health and Family Planning (2017YQ045 to D.L.), the Fundamental Research Funds for the Central Universities to Y.-H.C. and D.L., and the National Key Research and Development Program (2018YFC1312504 to L.X.). The authors declare no conflicts of interest.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Chen C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000683; Cole JE, 2011, P NATL ACAD SCI USA, V108, P2372, DOI 10.1073/pnas.1018515108; Esmail S, 2016, J CELL BIOCHEM, V117, P2757, DOI 10.1002/jcb.25574; Farkas D, 2019, AM J RESP CRIT CARE, V199, P199, DOI 10.1164/rccm.201707-1370OC; Figarella-Branger D, 2003, MUSCLE NERVE, V28, P659, DOI 10.1002/mus.10462; Foeger NC, 2013, J PHYSIOL-LONDON, V591, P4149, DOI 10.1113/jphysiol.2013.255836; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Gao M, 2012, CRIT CARE MED, V40, P2390, DOI 10.1097/CCM.0b013e3182535aeb; Gao T, 2018, J CELL MOL MED, V22, P395, DOI 10.1111/jcmm.13328; Garantziotis S, 2008, ANNU REV MED, V59, P343, DOI 10.1146/annurev.med.59.061206.112455; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Gorbea C, 2010, J BIOL CHEM, V285, P23206, DOI 10.1074/jbc.M109.047464; Guo WN, 1999, J PHYSIOL-LONDON, V521, P587, DOI 10.1111/j.1469-7793.1999.00587.x; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hodgkinson CP, 2018, STEM CELLS, V36, P1198, DOI 10.1002/stem.2833; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Li J, 2015, CIRC RES, V116, P1655, DOI 10.1161/CIRCRESAHA.116.306287; Lim KH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011247; Liu L, 2015, J CELL MOL MED, V19, P2728, DOI 10.1111/jcmm.12659; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Monnerat-Cahli G, 2014, J MOL CELL CARDIOL, V76, P116, DOI 10.1016/j.yjmcc.2014.08.012; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Panama BK, 2016, J BIOL CHEM, V291, P4156, DOI 10.1074/jbc.M115.694984; Panama BK, 2011, CIRC RES, V108, P537, DOI 10.1161/CIRCRESAHA.110.229112; Ramnath D, 2017, SEMIN CELL DEV BIOL, V61, P22, DOI 10.1016/j.semcdb.2016.08.014; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Roth GM, 2014, JOVE-J VIS EXP, DOI 10.3791/51109; Saito T, 2009, CIRC RES, V105, P343, DOI 10.1161/CIRCRESAHA.108.190041; Schmitt N, 2014, PHYSIOL REV, V94, P609, DOI 10.1152/physrev.00022.2013; Schroder M, 2005, TRENDS IMMUNOL, V26, P462, DOI 10.1016/j.it.2005.07.002; Tian J, 2013, CARDIOVASC RES, V98, P391, DOI 10.1093/cvr/cvt047; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Wang XH, 2018, CELL DEATH DIFFER, V25, P966, DOI 10.1038/s41418-017-0036-9; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Xu L, 2015, J MOL CELL BIOL, V7, P476, DOI 10.1093/jmcb/mjv054; Yang X, 2006, AM J PHYSIOL-HEART C, V291, pH2334, DOI 10.1152/ajpheart.00252.2006; Yin Q, 2015, ANNU REV IMMUNOL, V33, P393, DOI 10.1146/annurev-immunol-032414-112258	50	3	3	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6197	6208		10.1096/fj.201801464R	http://dx.doi.org/10.1096/fj.201801464R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30758987	Bronze			2022-12-26	WOS:000466932600032
J	Tuladhar, R; Yarravarapu, N; Ma, YY; Zhang, CW; Herbert, J; Kim, J; Chen, C; Lum, L				Tuladhar, Rubina; Yarravarapu, Nageswari; Ma, Yuyong; Zhang, Chengwei; Herbert, Jeremiah; Kim, James; Chen, Chuo; Lum, Lawrence			Stereoselective fatty acylation is essential for the release of lipidated WNT proteins from the acyltransferase Porcupine (PORCN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Wnt pathway; signal transduction; fatty acid; Wnt signaling; acyltransferase; posttranslational modification (PTM); fatty acylation; membrane-bound O-acyltransferase (MBOAT); palmitoleation; Porcupine (PORCN); Wntless (WLS)	BOUND O-ACYLTRANSFERASES; SECRETION; INHIBITION; PALMITOYLATION; IDENTIFICATION; RECOGNITION; WNTLESS; CANCER; TISSUE	The maintenance of adult animal tissues depends upon highly conserved intercellular signaling molecules that include the secreted WNT proteins. Although it is generally accepted that lipidation of WNTs by the acyltransferase Porcupine (PORCN) and their subsequent recognition by the Wntless (WLS) protein is essential for their cellular secretion, the molecular understanding of this process remains limited. Using structurally diverse fatty acyl donor analogs and mouse embryonic fibroblasts expressing PORCN protein from different metazoan phyla, we demonstrate here that PORCN active-site features, which are conserved across the animal kingdom, enforce cis-9 fatty acylation of WNTs. Aberrant acylation of a WNT with an exogenously supplied trans-9 fatty acid induced the accumulation of WNT-PORCN complexes, suggesting that the fatty acyl species is critical for the extrication of lipidated WNTs from PORCN. Our findings reveal a previously unrecognized fatty acyl-selective checkpoint in the manufacturing of a lipoprotein that forms a basis for WNT signaling sensitivity to trans fats and to PORCN inhibitors in clinical development.	[Tuladhar, Rubina; Yarravarapu, Nageswari; Herbert, Jeremiah; Lum, Lawrence] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Ma, Yuyong; Zhang, Chengwei; Chen, Chuo] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kim, James] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kim, James] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lum, L (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.; Chen, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.; Kim, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.; Kim, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.	james.kim@utsouthwestern.edu; chuo.chen@utsouthwestern.edu; lawrence.lum@utsouthwestern.edu	Yarravarapu, Nageswari/AAY-7197-2021	Chen, Chuo/0000-0002-3118-4901; Yarravarapu, Nageswari/0000-0002-1975-0077	Welch Foundation [I-1665]; Cancer Prevention and Research Institute of Texas Grant [RP130212]; NCI, National Institutes of Health [1R01 CA168761]; American Cancer Society [RSG-16-090-01-TBG]; NATIONAL CANCER INSTITUTE [R01CA168761] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas Grant; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Welch Foundation Grant I-1665 (to L. L.); Cancer Prevention and Research Institute of Texas Grant RP130212 (to L. L. and C. C.); NCI, National Institutes of Health Grant 1R01 CA168761 (to J. K.); and American Cancer Society Grant RSG-16-090-01-TBG (to J. K). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrami L, 2008, P NATL ACAD SCI USA, V105, P5384, DOI 10.1073/pnas.0710389105; Asciolla JJ, 2017, J BIOL CHEM, V292, P13507, DOI 10.1074/jbc.C117.800136; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep19665; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Dodge ME, 2012, J BIOL CHEM, V287, P23246, DOI 10.1074/jbc.M112.372029; Duraiswamy AJ, 2015, J MED CHEM, V58, P5889, DOI 10.1021/acs.jmedchem.5b00507; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Glaeser K, 2018, EMBO J, V37, DOI 10.15252/embj.201797311; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Holstein TW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007922; Janda CY, 2015, BIOCHEM SOC T, V43, P211, DOI 10.1042/BST20140249; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kulak O, 2013, JOVE-J VIS EXP, DOI 10.3791/50369; Lee CJ, 2019, J BIOL CHEM, V294, P231, DOI 10.1074/jbc.RA118.005746; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Ma D, 2018, NATURE, V562, P286, DOI 10.1038/s41586-018-0568-2; Madan B, 2016, ONCOGENE, V35, P2197, DOI 10.1038/onc.2015.280; Miranda M, 2014, FEBS LETT, V588, P4815, DOI 10.1016/j.febslet.2014.11.016; Nile AH, 2017, P NATL ACAD SCI USA, V114, P4147, DOI 10.1073/pnas.1618293114; Nile AH, 2016, NAT CHEM BIOL, V12, P60, DOI [10.1038/NCHEMBIO.2005, 10.1038/nchembio.2005]; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tuladhar R, 2015, BIOCHEM SOC T, V43, P235, DOI 10.1042/BST20140282; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017	40	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6273	6282		10.1074/jbc.RA118.007268	http://dx.doi.org/10.1074/jbc.RA118.007268			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30737280	Green Published, hybrid			2022-12-26	WOS:000468402000006
J	Zahid, FM; Ramzan, S; Faisal, S; Hussain, I				Zahid, Faisal Maqbool; Ramzan, Shakeela; Faisal, Shahla; Hussain, Ijaz			Gender based survival prediction models for heart failure patients: A case study in Pakistan	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SYSTOLIC FUNCTION; RISK-FACTORS; REGRESSION; SELECTION; ETIOLOGY; ANEMIA	Objectives The objective of this study was to build and assess the performance of survival prediction models using the gender-specific informative risk factors for patients with left ventricular systolic dysfunction. Methods A lasso approach was used to decide the informative predictors for building semi-parametric proportional hazards Cox model. Separate models were built for all patients [N = 299], male patients [N-male = 194 (64.88%)], and female patients [N-female = 105 (35.12%)], to observe the risk factors associated with the individual's risk of death. The likelihood-ratio test was used to test the goodness of fit of the selected model, and the C-index was used to assess the predictive performance of the selected model(s) with respect to the overall model with all observed risk factors. Results The survival prediction model for females is notably different from that for males. For males, smoking, diabetes, and anaemia, whereas for females, ejection fraction, sodium, and platelets count are non-informative with zero regression coefficients. The goodness of fit of the selected models with respect to the general model with all observed risk factors is tested using the likelihood-ratio test. The results are in favor of the selected models with p-values 0.51,0.61, and 0.70 for all patients, male patients, and female patients, respectively. The same values of C-index for the full model and the selected models for overall data, for males, and for females (0.72, 0.73, and 0.77 for overall data, male data, and female data, respectively) indicate that the selected models are as good as the corresponding overall models regarding their predictive performance. Conclusion There is a substantial difference in the survival prediction models for heart failure (HF) of male and female patients in this study. More studies are needed in Pakistan for confirming this striking male-female difference regarding the potential risk factors to predict survival with heart failure.	[Zahid, Faisal Maqbool; Faisal, Shahla] Govt Coll Univ, Dept Stat, Faisalabad, Pakistan; [Ramzan, Shakeela] Faisalabad Med Univ, Allied Hosp, Faisalabad, Pakistan; [Hussain, Ijaz] Quaid I Azam Univ, Dept Stat, Islamabad, Pakistan	Government College University Faisalabad; Quaid I Azam University	Faisal, S (corresponding author), Govt Coll Univ, Dept Stat, Faisalabad, Pakistan.	shahla_ramzan@yahoo.com	Hussain, Ijaz/AAN-5885-2020	Hussain, Ijaz/0000-0002-1586-1503; /0000-0002-6303-5986				Adams KF, 1999, CIRCULATION, V99, P1816, DOI 10.1161/01.CIR.99.14.1816; Adams KF, 1996, J AM COLL CARDIOL, V28, P1781, DOI 10.1016/S0735-1097(96)00380-4; Ahmad T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181001; Ahmadi A, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016019; Assiri Abdullah S, 2011, Heart Views, V12, P18, DOI 10.4103/1995-705X.81555; Azad N, 2011, J GERIATR CARDIOL, V8, P15, DOI 10.3724/SP.J.1263.2011.00015; Aziz KU, 2012, PAKISTAN HEART J, V41; Barolia R, 2017, J PAK MED ASSOC, V67, P1723; Bella JN, 2006, AM J CARDIOL, V98, P834, DOI 10.1016/j.amjcard.2006.03.069; Brandsaeter B, 2011, INT J CARDIOL, V146, P354, DOI 10.1016/j.ijcard.2009.07.014; Chin MH, 1998, MED CARE, V36, P1033, DOI 10.1097/00005650-199807000-00010; Cox D R, 2018, ANAL SURVIVAL DATA, DOI DOI 10.1201/9781315137438; Kajimoto K, 2017, AM J CARDIOL, V120, P435, DOI 10.1016/j.amjcard.2017.04.043; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keteepe-Arachi T, 2017, EUR CARDIOL REV, V12, P10, DOI 10.15420/ecr.2016:32:1; Kim J, 2012, COMMUN STAT-SIMUL C, V41, P1593, DOI 10.1080/03610918.2011.611311; Ma SG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-60; Martinez-Selles M, 2012, EUR J HEART FAIL, V14, P473, DOI 10.1093/eurjhf/hfs026; McClellan WM, 2002, J AM SOC NEPHROL, V13, P1928, DOI 10.1097/01.ASN.0000018409.45834.FA; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; Mehta PA, 2006, HEART, V92, P14, DOI 10.1136/hrt.2005.070342; Parashar S, 2009, AM J CARDIOL, V103, P1120, DOI 10.1016/j.amjcard.2008.12.043; Razzolini R, 2015, ITAL J GENDER SPECIF, V1, P15, DOI DOI 10.1723/2012.21914; Regitz-Zagrosek V, 2010, CIRC J, V74, P1265, DOI 10.1253/circj.CJ-10-0196; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Samuel RS, 1999, WOMEN HEALTH ISS, V9, P219, DOI 10.1016/S1049-3867(99)00008-0; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Utazirubanda JC, 2018, ARXIV180208622; WHO, 2017, CARD DIS KEY FACTS; WHO, 2014, CARDIOVASCULAR DIS; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890	32	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0210602	10.1371/journal.pone.0210602	http://dx.doi.org/10.1371/journal.pone.0210602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779736	Green Published, Green Submitted, gold			2022-12-26	WOS:000459062900008
J	Kaprio, T; Rasila, T; Hagstrom, J; Mustonen, H; Lankila, P; Haglund, C; Andersson, LC				Kaprio, Tuomas; Rasila, Tiina; Hagstrom, Jaana; Mustonen, Harri; Lankila, Petri; Haglund, Caj; Andersson, Leif C.			Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer	PLOS ONE			English	Article							EXPRESSION; CELLS; METASTASIS; RAB27A; GENE	Ornithine decarboxylase (ODC) is the rate-limiting enzyme of polyamine synthesis. The two ODC antizyme inhibitors (AZIN1) and (AZIN2) are regulators of the catalytic activity of ODC. While AZIN1 is a regulator of cell proliferation, AZIN2 is involved in intracellular vesicle transport and secretion. There are no previous reports on the impact of AZIN2 expression in human cancer. We applied immunohistochemistry with antibodies to human AZIN2 on tissue micro- arrays of colorectal cancers (CRC) from 840 patients with a median follow-up of 5.1 years (range 0-25.8). The 5-year disease-specific survival rate was 58.9% (95% CI 55.0-62.8%). High AZIN2 expression was associated with mucinous histology (p = 0.002) and location in the right hemicolon (p = 0.021). We found no association with age, gender, stage, or histological tumor grade. High tumor expression of AZIN2 predicted an unfavorable prognosis (p<0.0001, log-rank test), compared to low AZIN2 expression. Cox multivariable analysis identified AZIN2 as an independent factor of an unfavorable prognosis in CRC. The strongest AZIN2 expression was seen in invasive tumor cells having morphological features of epithelial-mesenchymal transition (EMT). Induction of EMT in HT-29 CRC cells lead to upregulated expression of endogenous AZIN2. Given that AZIN2 is a regulator of vesicle transport and secretion, we overexpressed human AZIN2 cDNA in T84 CRC cells, and found strongly enhanced accumulation of CD63-positive exosomes in the culture medium. These findings indicate that AZIN2 expression is a signature of EMT-associated secretory phenotype that is linked to an adverse prognosis in CRC.	[Kaprio, Tuomas; Mustonen, Harri; Haglund, Caj] Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland; [Kaprio, Tuomas; Hagstrom, Jaana; Haglund, Caj] Univ Helsinki, Translat Canc Biol, Res Programs Unit, Helsinki, Finland; [Kaprio, Tuomas] Lahti Cent Hosp, Dept Surg, Lahti, Finland; [Rasila, Tiina; Hagstrom, Jaana; Lankila, Petri; Andersson, Leif C.] Univ Helsinki, Haartman Inst, Dept Pathol, Helsinki, Finland; [Rasila, Tiina; Hagstrom, Jaana; Lankila, Petri; Andersson, Leif C.] HUSLAB, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Kaprio, T (corresponding author), Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland.; Kaprio, T (corresponding author), Univ Helsinki, Translat Canc Biol, Res Programs Unit, Helsinki, Finland.; Kaprio, T (corresponding author), Lahti Cent Hosp, Dept Surg, Lahti, Finland.	tuomas.kaprio@helsinki.fi	Kaprio, Tuomas/AAD-8042-2020; Hagström, Jaana/G-1468-2018	Kaprio, Tuomas/0000-0002-0377-9975; Hagström, Jaana/0000-0001-6079-7881; Mustonen, Harri Kalevi/0000-0001-5632-6796	Finska Lakaresallskapet; Sigrid Juselius Foundation; Finnish Cancer Foundation; Magnus Ehrnrooth Foundation; Liv och Halsa Foundation	Finska Lakaresallskapet; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Foundation; Magnus Ehrnrooth Foundation; Liv och Halsa Foundation	This study was supported by grants from Finska Lakaresallskapet (http://www.fls.fi) (CH), the Sigrid Juselius Foundation (hilps://sigridjuselius.fi) (CH), the Finnish Cancer Foundation (www.syopasaatio.fi) (TK, CH), the Magnus Ehrnrooth Foundation (https://www.magnusehrnroothinsaatio.fi/) (TR, PL, LCA) and the Liv och Halsa Foundation (http://www.livochhalsa.fi) (CH, LCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442; Auvinen M, 1997, CANCER RES, V57, P3016; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Dong WW, 2015, DISCOV MED, V20, P357; FUJITA K, 1982, BIOCHEM J, V204, P647, DOI 10.1042/bj2040647; Ho JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039469; Hoffmann K, 2008, BRIT J HAEMATOL, V140, P656, DOI 10.1111/j.1365-2141.2008.06981.x; Kanerva K, 2008, BIOCHEM J, V409, P187, DOI 10.1042/BJ20071004; Kanerva K, 2010, EXP CELL RES, V316, P1896, DOI 10.1016/j.yexcr.2010.02.021; Kanerva K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006858; Kim KJ, 2016, J PATHOL TRANSL MED, V50, P459, DOI 10.4132/jptm.2016.10.02; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Makitie LT, 2009, HISTOCHEM CELL BIOL, V132, P633, DOI 10.1007/s00418-009-0636-7; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Naito Y, 2017, CELL MOL LIFE SCI, V74, P697, DOI 10.1007/s00018-016-2346-3; O'Connor ES, 2011, J CLIN ONCOL, V29, P3381, DOI 10.1200/JCO.2010.34.3426; Olsen RR, 2011, MOL CANCER RES, V9, P1285, DOI 10.1158/1541-7786.MCR-11-0178; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pitkanen LT, 2001, BIOCHEM BIOPH RES CO, V287, P1051, DOI 10.1006/bbrc.2001.5703; Qiu SQ, 2017, CANCER SCI, V108, P163, DOI 10.1111/cas.13122; Rasila T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151175; Reka AK, 2014, CARCINOGENESIS, V35, P1292, DOI 10.1093/carcin/bgu041; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silva J, 2012, GENE CHROMOSOME CANC, V51, P409, DOI 10.1002/gcc.21926; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wang JS, 2008, MOL CANCER RES, V6, P372, DOI 10.1158/1541-7786.MCR-07-0162; Wang QQ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0372-2; Zhu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.59	31	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0211564	10.1371/journal.pone.0211564	http://dx.doi.org/10.1371/journal.pone.0211564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768610	gold, Green Published, Green Submitted			2022-12-26	WOS:000458766300009
J	Tousley, A; Iuliano, M; Weisman, E; Sapp, E; Richardson, H; Vodicka, P; Alexander, J; Aronin, N; DiFiglia, M; Kegel-Gleason, KB				Tousley, Adelaide; Iuliano, Maria; Weisman, Elizabeth; Sapp, Ellen; Richardson, Heather; Vodicka, Petr; Alexander, Jonathan; Aronin, Neil; DiFiglia, Marian; Kegel-Gleason, Kimberly B.			Huntingtin associates with the actin cytoskeleton and alpha-actinin isoforms to influence stimulus dependent morphology changes	PLOS ONE			English	Article							INTERFERENCE-REFLECTION; MUTANT HUNTINGTIN; TARGETED DISRUPTION; EMBRYONIC LETHALITY; LACKING HUNTINGTIN; ARP2/3 COMPLEX; CROSS-LINKING; WILD-TYPE; PROTEIN; CELL	One response of cells to growth factor stimulus involves changes in morphology driven by the actin cytoskeleton and actin associated proteins which regulate functions such as cell adhesion, motility and in neurons, synaptic plasticity. Previous studies suggest that Hunting-tin may be involved in regulating morphology however, there has been limited evidence linking endogenous Huntingtin localization or function with cytoplasmic actin in cells. We found that depletion of Huntingtin in human fibroblasts reduced adhesion and altered morphology and these phenotypes were made worse with growth factor stimulation, whereas the presence of the Huntington's Disease mutation inhibited growth factor induced changes in morphology and increased numbers of vinculin-positive focal adhesions. Huntingtin immunoreactivity localized to actin stress fibers, vinculin-positive adhesion contacts and membrane ruffles in fibroblasts. Interactome data from others has shown that Huntingtin can associate with alpha-actinin isoforms which bind actin filaments. Mapping studies using a cDNA encoding alpha-actinin-2 showed that it interacts within Huntingtin as 399-969. Double-label immunofluorescence showed Huntingtin and alpha-actinin-1 co-localized to stress fibers, membrane ruffles and lamellar protrusions in fibroblasts. Proximity ligation assays confirmed a close molecular interaction between Huntingtin and alpha-actinin-1 in human fibroblasts and neurons. Huntingtin silencing with siRNA in fibroblasts blocked the recruitment of alpha-actinin-1 to membrane foci. These studies support the idea that Huntingtin is involved in regulating adhesion and actin dependent functions including those involving alpha-actinin.	[Tousley, Adelaide; Iuliano, Maria; Weisman, Elizabeth; Sapp, Ellen; Richardson, Heather; Vodicka, Petr; Alexander, Jonathan; DiFiglia, Marian; Kegel-Gleason, Kimberly B.] Massachusetts Gen Hosp, Dept Neurol, Lab Cellular Neurobiol, Charlestown, MA 02129 USA; [Aronin, Neil] Univ Massachusetts, Med Sch, Dept Med & Cell Biol, Worcester, MA USA	Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester	Kegel-Gleason, KB (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Lab Cellular Neurobiol, Charlestown, MA 02129 USA.	kegel@helix.mgh.harvard.edu	Vodicka, Petr/C-3845-2009; Vodicka, Petr/AAF-3442-2019; Iuliano, Maria/AGZ-1132-2022	Vodicka, Petr/0000-0002-6605-9158; Vodicka, Petr/0000-0002-6605-9158; Iuliano, Maria/0000-0003-4072-3724	CHDI, Inc.; Dake Family Fund	CHDI, Inc.; Dake Family Fund	This work was supported by contracts from CHDI, Inc. to KKG and MD and the Dake Family Fund to MD.	ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4; ABERCROMBIE M, 1975, EXP CELL RES, V92, P57, DOI 10.1016/0014-4827(75)90636-9; Angeli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009053; Caron NS, 2013, P NATL ACAD SCI USA, V110, P14610, DOI 10.1073/pnas.1301342110; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Culver BP, 2012, J BIOL CHEM, V287, P21599, DOI 10.1074/jbc.M112.359307; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; DEPASQUALE JA, 1987, J CELL BIOL, V105, P2803, DOI 10.1083/jcb.105.6.2803; DeRooij KE, 1996, HUM MOL GENET, V5, P1093, DOI 10.1093/hmg/5.8.1093; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Dragatsis I, 1998, DEVELOPMENT, V125, P1529; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; GEIGER B, 1985, J CELL BIOL, V101, P1523, DOI 10.1083/jcb.101.4.1523; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Greenwood JA, 2000, J CELL BIOL, V150, P627, DOI 10.1083/jcb.150.3.627; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hall DD, 2013, NEURON, V78, P483, DOI 10.1016/j.neuron.2013.02.032; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; HEATH JP, 1978, J CELL SCI, V29, P197; Hodges JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101770; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; IZZARD CS, 1976, J CELL SCI, V21, P129; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kegel KB, 2009, J NEUROCHEM, V110, P1585, DOI 10.1111/j.1471-4159.2009.06255.x; Kim M, 1999, NEUROSCIENCE, V89, P1159, DOI 10.1016/S0306-4522(98)00400-X; Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063; Kwan W, 2012, J CLIN INVEST, V122, P4737, DOI 10.1172/JCI64484; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; LAZARIDES E, 1976, J CELL BIOL, V68, P202, DOI 10.1083/jcb.68.2.202; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McKinstry SU, 2014, J NEUROSCI, V34, P9455, DOI 10.1523/JNEUROSCI.4699-13.2014; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; Miller JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003042; Munsie L, 2011, HUM MOL GENET, V20, P1937, DOI 10.1093/hmg/ddr075; Murphy ACH, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0029-7; Myre MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002052; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; NOBES CD, 1995, J CELL SCI, V108, P225; O'Kusky JR, 1999, BRAIN RES, V818, P468, DOI 10.1016/S0006-8993(98)01312-2; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Reiner A, 2001, J NEUROSCI, V21, P7608, DOI 10.1523/JNEUROSCI.21-19-07608.2001; Ritch JJ, 2012, MOL CELL NEUROSCI, V50, P70, DOI 10.1016/j.mcn.2012.03.011; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Song C, 2002, J BIOL CHEM, V277, P6703, DOI 10.1074/jbc.M110338200; Sousa CM, 2013, EMBO MOL MED, V5, P309, DOI 10.1002/emmm.201201546; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Thion MS, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv208; Tourette C, 2014, J BIOL CHEM, V289, P6709, DOI 10.1074/jbc.M113.523696; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Valencia A, 2013, J HUNTINGTONS DIS, V2, P459, DOI 10.3233/JHD-130080; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Vijayvargia R, 2016, ELIFE, V5, DOI 10.7554/eLife.11184; Wang N, 2014, NAT MED, V20, P540, DOI 10.1038/nm.3514; Wang Y, 2011, MOL BIOL CELL, V22, P2270, DOI 10.1091/mbc.E10-11-0926; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zamir E, 1999, J CELL SCI, V112, P1655; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	74	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212337	10.1371/journal.pone.0212337	http://dx.doi.org/10.1371/journal.pone.0212337			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768638	gold, Green Submitted, Green Published			2022-12-26	WOS:000458766300032
J	Hata, H; Uemura, Y; Ouchi, K; Matsuba, H				Hata, Hiroki; Uemura, Yohsuke; Ouchi, Kaito; Matsuba, Hideki			Hybridization between an endangered freshwater fish and an introduced congeneric species and consequent genetic introgression	PLOS ONE			English	Article							MALE ROSE BITTERLINGS; REPRODUCTIVE ECOLOGY; MICROSATELLITE LOCI; SPECIATION REVERSAL; TANAKIA-LIMBATA; TELEOSTEI; HYBRIDS; ACHEILOGNATHINAE; COMPETITION; CYPRINIDAE	Artificial transplantation of organisms and consequent invasive hybridization can lead to the extinction of native species. In Matsuyama, Japan, a native bitterling fish, Tanakia lanceolata, is known to form hybrids with another bitterling species, T. limbata, which was recently introduced from western Kyushu, Japan. These bitterlings spawn in the gills of two freshwater unionid species, Pronodularia japanensis and Nodularia douglasiae nipponensis, which have rapidly declined on the Matsuyama Plain in the past 30 years. To gauge the effect of invasive hybridization, we determined the genetic introgression between T. lanceolata and T. limbata and analyzed the morphology of these species and their hybrids to infer their niche overlap. We collected adult individuals of Tanakia spp. and genotyped them based on six microsatellite loci and mitochondrial cytochrome b sequences. We analyzed their meristic characters and body shapes by geometric morphometrics. We found that 10.9% of all individuals collected were hybrids. Whereas T. lanceolata were more densely distributed downstream and T. limbata were distributed upstream, their hybrids were widely distributed, covering the entire range of native T. lanceolata. The body height and anal fin length of T. limbata were greater than those of T. lanceolata, but their hybrids were highly morphologically variable, covering both parental morphs, and were widely distributed in the habitats of both parental species. Hybridization has occurred in both directions, but introduced T. limbata females and native T. lanceolata males are more likely to have crossed. This study shows that invasive hybridization with the introduced T. limbata is a potential threat to the native population of T. lanceolata via genetic introgression and replacement of its niche in streams.	[Hata, Hiroki; Ouchi, Kaito; Matsuba, Hideki] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime, Japan; [Uemura, Yohsuke] Ehime Univ, Fac Sci, Dept Biol, Matsuyama, Ehime, Japan	Ehime University; Ehime University	Hata, H (corresponding author), Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime, Japan.	hata@sci.ehime-u.ac.jp	Uemura, Yohsuke/F-8412-2019	Uemura, Yohsuke/0000-0002-7703-9857	Environmental Research and Technology Development Fund from Ministry of the Environment, Japan [4RFd-1201]; JSPS KAKENHI [17K07568, 15H02420]	Environmental Research and Technology Development Fund from Ministry of the Environment, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Environmental Research and Technology Development Fund from Ministry of the Environment, Japan (4RFd-1201, http://www.env.go.jp/policy/kenkyu/suishin/english/gaiyou/index.html), JSPS KAKENHI (17K07568 and 15H02420, https://www.jsps.go.jp/).	Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; ALLENDORF F W, 1988, Conservation Biology, V2, P170, DOI 10.1111/j.1523-1739.1988.tb00168.x; Anderson EC, 2002, GENETICS, V160, P1217; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Cheng PL, 2014, ZOOL SCI, V31, P300, DOI 10.2108/zs130069; Coyne J.A., 2004, SPECIATION; Dawson DA, 2003, MOL ECOL NOTES, V3, P199, DOI 10.1046/j.1471-8286.2003.00395.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ehime Prefecture, 2014, FRESHW FISH RED DAT, P107; Fukuhara S., 2014, INTRO FRESHWATER FIS, P66; Fukuhara Shuichi, 1998, Memoirs of Osaka Kyoiku University Series III Natural Science and Applied Science, V47, P27; Gilles A, 2001, MOL PHYLOGENET EVOL, V19, P22, DOI 10.1006/mpev.2000.0916; Haag WR, 2012, NORTH AMERICAN FRESHWATER MUSSELS: NATURAL HISTORY, ECOLOGY, AND CONSERVATION, P1, DOI 10.1017/CBO9781139048217; Hashiguchi Y, 2006, ZOOL SCI, V23, P309, DOI 10.2108/zsj.23.309; Hosoya K., 2013, FISHES JAPAN PICTORI, P310; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Irisarri I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05479-9; Kagawa K, 2018, ECOL LETT, V21, P264, DOI 10.1111/ele.12891; Kanoh Y, 1996, ETHOLOGY, V102, P883; Kanoh Y, 2000, ENVIRON BIOL FISH, V57, P143, DOI 10.1023/A:1004585405848; Kawamura K, 2001, ZOOL SCI, V18, P1027, DOI 10.2108/zsj.18.1027; Kawamura K, 2000, J HERED, V91, P464, DOI 10.1093/jhered/91.6.464; Kitamura JI, 2007, ENVIRON BIOL FISH, V78, P37, DOI 10.1007/s10641-006-9076-6; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kondo T., 2008, MONOGRAPH UNIONOIDA; Konishi M, 2003, J FISH BIOL, V63, P213, DOI 10.1046/j.1095-8649.2003.00146.x; Kuwahara Akihiro, 2017, Hozen Seitaigaku Kenkyu, V22, P91; Leavy TR, 2009, N AM J FISH MANAGE, V29, P72, DOI 10.1577/M07-040.1; Mabuchi K, 2008, MOL ECOL, V17, P796, DOI 10.1111/j.1365-294X.2007.03626.x; Matsuba Hideki, 2014, Japanese Journal of Ichthyology, V61, P89; Matsushima O., INTRO FRESHWATER FIS; McKelvey KS, 2016, ECOL EVOL, V6, P688, DOI 10.1002/ece3.1887; Mills SC, 2003, BEHAV ECOL SOCIOBIOL, V54, P98, DOI 10.1007/s00265-003-0616-1; Mukai T, 2013, DOMESTIC ALIEN FISHE; NAGATA Y, 1988, JPN J ICHTHYOL, V35, P320, DOI 10.1007/BF02938430; Nagata Y., 1985, NATURAL SCI APPL SCI, V34, P9; Nakamnra M., 1955, Bulletin of the Biogeographical Society of Japan, P333; Negishi Junjiro N., 2008, Japanese Journal of Ecology (Otsu), V58, P37; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Onikura N, 2006, J JPN SOC WATER ENV, V29, P837; Onikura N, 2016, ICHTHYOL RES, V63, P347, DOI 10.1007/s10228-015-0504-5; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2018, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reichard M, 2004, BEHAV ECOL SOCIOBIOL, V56, P34, DOI 10.1007/s00265-004-0760-2; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rohlf FJ, 2016, TPSDIG2 VERSION 2 32; ROSENTHAL A, 1993, NUCLEIC ACIDS RES, V21, P173, DOI 10.1093/nar/21.1.173; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Shirai Y, 2009, MOL ECOL RESOUR, V9, P1031, DOI 10.1111/j.1755-0998.2009.02566.x; Smith C, 2002, BEHAV ECOL SOCIOBIOL, V51, P433, DOI 10.1007/s00265-002-0468-0; Smith C, 2004, J ZOOL, V262, P107, DOI 10.1017/S0952836903004497; Stelkens RB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-283; Suzuki N, 1986, B COLL AGR VET MED N, V43, P151; Taborsky M., 2004, ADV STUD BEHAV, V23, P1; Toscano BJ, 2010, BIOL J LINN SOC, V99, P768, DOI 10.1111/j.1095-8312.2010.01383.x; Uemura Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203423; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; van Dongen WFD, 2012, J ORNITHOL, V153, P585, DOI 10.1007/s10336-011-0755-5; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Watanabe K, 2016, CHALLENGES FRESHWATE; WIEPKEMA P. R., 1961, ARCH NEERLAND ZOOL, V14, P103	65	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212452	10.1371/journal.pone.0212452	http://dx.doi.org/10.1371/journal.pone.0212452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763376	Green Submitted, Green Published, gold			2022-12-26	WOS:000458763900082
J	Nishikiori, T; Hayashi, S; Watanabe, M; Yasutaka, T				Nishikiori, Tatsuhiro; Hayashi, Seiji; Watanabe, Mirai; Yasutaka, Tetsuo			Impact of clearcutting on radiocesium export from a Japanese forested catchment following the Fukushima nuclear accident	PLOS ONE			English	Article							SUSPENDED SEDIMENT; DISSOLVED RADIOCESIUM; VERTICAL-DISTRIBUTION; SOIL-EROSION; LAND USES; CS-137; RADIONUCLIDES; ECOSYSTEMS; HILLSLOPES; LITTERFALL	Changes in Cs-137 export over time following clearcutting were investigated in a Japanese forested catchment affected by the Fukushima nuclear accident. A total of 13% of the catchment area was clear-cut 2 years after the accident. Annual suspended solids (SS) export at the catchment outlet increased 1.4 to 2.0 times after clearcutting; however, Cs-137 export increased slightly (up to 1.1 times), corresponding to 0.21% to 0.30% of the Cs-137 inventory in the catchment. The smaller change in Cs-137 export than in SS export was due to a rapid decrease in the activity concentration following clearcutting. This decrease was likely caused by both natural attenuation and SS derived from sources with a low activity concentration in the clear-cut area. Monitoring of the sediment transport from hillslopes in small-scale experimental plots showed that the Cs-137 yield in the skid trail was 3.6 to 21 times greater than those in clear-cut and unlogged forest floors. This significant Cs-137 transport was due to greater soil erosion (by up to two orders of magnitude) along the skid trail, despite the lower activity concentration than those in the other plots. This indicates that while skid trails were involved in the rapid decrease of the activity concentration of SS, they were a potential source of the increased export of Cs-137 and SS. Net Cs-137 export increased by clearcutting (the export excluding the decrease accompanied by natural attenuation) was estimated to account for only 0.092% of the inventory in the catchment for 2.5 years. These results imply that the impact of clearcutting on Cs-137 export was temporary in this catchment.	[Nishikiori, Tatsuhiro; Watanabe, Mirai] Natl Inst Environm Studies, Ctr Reg Environm Res, Tsukuba, Ibaraki, Japan; [Nishikiori, Tatsuhiro] Fukushima Prefectural Ctr Environm Creat, Fukasa Ku, Fukushima, Japan; [Hayashi, Seiji] Natl Inst Environm Studies, Fukushima Branch, Fukasa Ku, Fukushima, Japan; [Yasutaka, Tetsuo] Natl Inst Adv Ind Sci & Technol, Higashi Ku, Tsukuba, Ibaraki, Japan	National Institute for Environmental Studies - Japan; National Institute of Advanced Industrial Science & Technology (AIST)	Hayashi, S (corresponding author), Natl Inst Environm Studies, Fukushima Branch, Fukasa Ku, Fukushima, Japan.	shayashi@nies.go.jp		Yasutaka, Tetsuo/0000-0001-6000-663X	Ministry of the Environment, Government of Japan	Ministry of the Environment, Government of Japan(Ministry of the Environment, Japan)	This work received support from the Ministry of the Environment, Government of Japan to SH, https://www.env.go.jp/en/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Baird E.J., 2012, WATERSHED MANAGEMENT, V15, P1; Bathurst JC, 2014, WATER RESOUR RES, V50, P8383, DOI 10.1002/2014WR015711; BROWN GW, 1971, WATER RESOUR RES, V7, P1189, DOI 10.1029/WR007i005p01189; Buesseler K, 2017, ANNU REV MAR SCI, V9, P173, DOI 10.1146/annurev-marine-010816-060733; Buttle JM, 2011, ECOL STUD-ANAL SYNTH, V216, P659, DOI 10.1007/978-94-007-1363-5_33; Croke JC, 2006, ENVIRON REV, V14, P59, DOI 10.1139/A05-016; Eisenbies MH, 2007, FOREST ECOL MANAG, V242, P77, DOI 10.1016/j.foreco.2007.01.051; Eklof K, 2016, AMBIO, V45, pS163, DOI 10.1007/s13280-015-0752-7; Endo I, 2015, J ENVIRON RADIOACTIV, V149, P176, DOI 10.1016/j.jenvrad.2015.07.027; Evrard O, 2015, J ENVIRON RADIOACTIV, V148, P92, DOI 10.1016/j.jenvrad.2015.06.018; Feller MC, 2005, J AM WATER RESOUR AS, V41, P785, DOI 10.1111/j.1752-1688.2005.tb04464.x; Forest Soil Division, 1976, B GOV FOR EXP STA, V280, P1; Fu BH, 2010, ENVIRON MODELL SOFTW, V25, P1, DOI 10.1016/j.envsoft.2009.07.013; Fujii K, 2014, SOIL SCI PLANT NUTR, V60, P751, DOI 10.1080/00380768.2014.926781; Grant G.E., 1991, IAHS-AISH P, V203, P31; GUILLITTE O, 1994, SCI TOTAL ENVIRON, V157, P207, DOI 10.1016/0048-9697(94)90581-9; Heisterkamp S., 2016, COMPUTER SOFTWARE, V3, P1, DOI DOI 10.1016/J.CR0PR0.2007.08.015; IAEA, 2006, ENV CONS CHERM ACC T; Ito S, 2018, J FOR RES, V23, P28, DOI [10.1080/13416979.2017.1418162, DOI 10.1080/13416979.2017.1418162]; IUSS Working Group WRB, 2007, WORLD REF BAS SOIL R, V103; Iwagami S, 2017, J ENVIRON RADIOACTIV, V166, P466, DOI 10.1016/j.jenvrad.2016.07.025; Japan Meteorological Agency, 2018, DAT DOC; Kajimoto T., 2015, Journal of the Japanese Forest Society, V97, P33, DOI 10.4005/jjfs.97.33; Kato H, 2017, J ENVIRON RADIOACTIV, V166, P449, DOI 10.1016/j.jenvrad.2015.04.016; Kato H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052928; Koarashi J, 2012, SCI TOTAL ENVIRON, V431, P392, DOI 10.1016/j.scitotenv.2012.05.041; Koizumi A, 2013, ENVIRON SCI TECHNOL, V47, P9612, DOI 10.1021/es401422g; Komatsu M, J ENV RADIOACT; Komatsu M, 2016, J ENVIRON RADIOACTIV, V161, P2, DOI 10.1016/j.jenvrad.2015.09.016; Lewis J, 2001, WATER SCI APPL, V2, P85; MAFF (Ministry of Agriculture Forestry and Fisheries), 2011, REP RES 2010 WORLD C; MAFF (Ministry of Agriculture Forestry and Fisheries), 2014, ANN REP FOR FOR JAP; MEXT (Ministry of Education Education Culture Sports Science and Technology), 2012, AIRB MON DISTR SURV; MOE (Ministry of the Environment Government of Japan), 2017, ENV REM; Morino Y, 2013, ENVIRON SCI TECHNOL, V47, P2314, DOI 10.1021/es304620x; Niizato T, 2016, J ENVIRON RADIOACTIV, V161, P11, DOI 10.1016/j.jenvrad.2016.04.017; Nishikiori T., 2015, Journal of the Japanese Forest Society, V97, P63, DOI 10.4005/jjfs.97.63; Nishikiori T, 2019, SCI TOTAL ENVIRON, V659, P783, DOI 10.1016/j.scitotenv.2018.12.359; Nishikiori T, 2017, J ENVIRON RADIOACTIV, V177, P58, DOI 10.1016/j.jenvrad.2017.06.005; Nishikiori T, 2015, SCI TOTAL ENVIRON, V502, P611, DOI 10.1016/j.scitotenv.2014.09.063; Onda Y, 2011, SOIL CONSERVATION ME, P61; Schuller P, 2013, J ENVIRON RADIOACTIV, V124, P147, DOI 10.1016/j.jenvrad.2013.05.002; Seutloali KE, 2015, EARTH SCI RES J, V19, P73, DOI 10.15446/esrj.v19n1.43841; Strebl F, 1999, SCI TOTAL ENVIRON, V226, P75, DOI 10.1016/S0048-9697(98)90051-1; Takahashi J, 2015, J ENVIRON RADIOACTIV, V139, P351, DOI 10.1016/j.jenvrad.2014.07.004; Teramage MT, 2014, SCI TOTAL ENVIRON, V490, P435, DOI 10.1016/j.scitotenv.2014.05.034; Tsuji H, 2016, J GEOPHYS RES-BIOGEO, V121, P2588, DOI 10.1002/2016JG003428; Tsuji H, 2015, J RADIOANAL NUCL CH, V303, P1803, DOI 10.1007/s10967-014-3800-z; Tsuji H, 2014, J RADIOANAL NUCL CH, V299, P139, DOI 10.1007/s10967-013-2735-0; van Dijk AIJM, 2002, J HYDROL, V261, P1, DOI 10.1016/S0022-1694(02)00020-3; Vinichuk MM, 2003, J ENVIRON RADIOACTIV, V64, P27, DOI 10.1016/S0265-931X(02)00056-5; Wallbrink PJ, 2002, CATENA, V47, P179, DOI 10.1016/S0341-8162(01)00185-0; Wallbrink PJ, 1996, EROSION SEDIMENT YIE; Walling DE, 2000, SCI TOTAL ENVIRON, V251, P205, DOI 10.1016/S0048-9697(00)00384-3; Wischmeier W.H., 1978, PREDICTING RAINFALL; Yoshimura K, 2015, J ENVIRON RADIOACTIV, V139, P362, DOI 10.1016/j.jenvrad.2014.07.019	57	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212348	10.1371/journal.pone.0212348	http://dx.doi.org/10.1371/journal.pone.0212348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763401	Green Submitted, Green Published, gold			2022-12-26	WOS:000458763900072
J	Pearlman, A; Rahman, MT; Upadhyay, K; Loke, J; Ostrer, H				Pearlman, Alexander; Rahman, Mohammed Tanjimur; Upadhyay, Kinnari; Loke, Johnny; Ostrer, Harry			Ectopic Otoconin 90 expression in triple negative breast cancer cell lines is associated with metastasis functions	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; HMGA2; SURVIVAL; AMPLIFICATION; TRASTUZUMAB; THERAPY; TRIB3	Triple negative breast cancer (TNBC) is an aggressive tumor with propensity to metastasize and poor treatment options. Improving treatment options would be impactful; thus, finding a tumor-specific cell surface protein with metastasis promoting functions that could be knocked out was the goal of this study. The Otoconin 90 gene (OC90), frequently amplified in tumors on chromosome 8q24.22, was identified as a potential therapeutic candidate. Normally OC90 is expressed in the cochlea with no known function in other normal tissues. In silico analysis of The Cancer Genome Atlas (TCGA) multi-tumor RNAseq cohorts revealed that OC90 is expressed in many tumor types at high prevalence and genomic amplification is associated with the elevated mRNA expression. In vitro assays in TNBC cell lines revealed OC90 expression with control over cell viability, apoptosis and invasion. RNA-seq analysis of OC90-siRNA knockdown and OC90-overexpression in BT20, BT549, HCC38 cell lines identified co-expressed transcripts, HMGA2, POLE2 and TRIB3. Altered expression of HMGA2, POLE2 and TRIB3 was predictive of survival among members of the Metabric breast cancer cohort. Thus, OC90 represents a potential therapeutic target whose knockdown could improve the treatment of TNBC.	[Pearlman, Alexander; Rahman, Mohammed Tanjimur; Upadhyay, Kinnari; Loke, Johnny; Ostrer, Harry] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Ostrer, H (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	harry.ostrer@einstein.yu.edu		Upadhyay, Kinnari/0000-0002-9251-3457; Rahman, Mohammed/0000-0002-9790-0069				Abe O, 2005, LANCET, V366, P2087; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; Dong ST, 2016, ONCOL REP, V36, P2339, DOI 10.3892/or.2016.5017; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hartmann E, 2008, J CLIN ONCOL, V26, P4966, DOI 10.1200/JCO.2007.12.0410; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Miyoshi N, 2009, BRIT J CANCER, V101, P1664, DOI 10.1038/sj.bjc.6605361; Montemurro F, 2006, NEW ENGL J MED, V354, P2186; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Pearlman Alexander, 2018, Genes Cancer, V9, P66, DOI 10.18632/genesandcancer.165; Piscuoglio S, 2012, HISTOPATHOLOGY, V60, P397, DOI 10.1111/j.1365-2559.2011.04121.x; Rahman MT, 2012, BRIT J CANCER, V107, P300, DOI 10.1038/bjc.2012.246; Rahman MT, 2012, ANTICANCER RES, V32, P3091; Rahman MT, 2012, CANCER-AM CANCER SOC, V118, P2846, DOI 10.1002/cncr.26598; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sun M, 2014, ONCOGENE, V33, P3528, DOI 10.1038/onc.2013.328; Vivian J, 2017, NAT BIOTECHNOL, V35, P314, DOI 10.1038/nbt.3772; Wang XC, 2011, CLIN CANCER RES, V17, P2570, DOI 10.1158/1078-0432.CCR-10-2542; Xi YN, 2014, ASIAN PAC J TROP MED, V7, P289, DOI 10.1016/S1995-7645(14)60040-7; Zekri Abdel-Rahman N, 2015, Asian Pac J Cancer Prev, V16, P3543	26	7	7	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0211737	10.1371/journal.pone.0211737	http://dx.doi.org/10.1371/journal.pone.0211737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763339	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900023
J	Neumann, JR; Dash-Wagh, S; Jack, A; Rak, A; Jungling, K; Hamad, MIK; Pape, HC; Kreutz, MR; Puskarjov, M; Wahle, P				Neumann, Janine R.; Dash-Wagh, Suvarna; Jack, Alexander; Raek, Andrea; Juengling, Kay; Hamad, Mohammad I. K.; Pape, Hans-Christian; Kreutz, Michael R.; Puskarjov, Martin; Wahle, Petra			The primate-specific peptide Y-P30 regulates morphological maturation of neocortical dendritic spines	PLOS ONE			English	Article							SURVIVAL-PROMOTING PEPTIDE; HEPARAN-SULFATE PROTEOGLYCAN; TYROSINE PHOSPHORYLATION; PTP-SIGMA; SYNAPTIC-TRANSMISSION; MESSENGER-RNA; EXPRESSION; PROTEIN; TRKC; BINDING	The 30-amino acid peptide Y-P30 corresponds to the N-terminus of the primate-specific, sweat gland-derived dermcidin prepropeptide. Previous work has revealed that Y-P30 enhances the interaction of pleiotrophin and syndecans-2/3, and thus represents a natural ligand to study this signaling pathway. In immature neurons, Y-P30 activates the c-Src and p42/44 ERK kinase pathway, increases the amount of F-actin in axonal growth cones, and promotes neuronal survival, cell migration and axonal elongation. The action of Y-P30 on axonal growth requires syndecan-3 and heparan sulfate side chains. Whether Y-P30 has the potential to influence dendrites and dendritic protrusions has not been explored. The latter is suggested by the observations that syndecan-2 expression increases during postnatal development, that syndecan-2 becomes enriched in dendritic spines, and that overexpression of syndecan-2 in immature neurons results in a premature morphological maturation of dendritic spines. Here, analysing rat cortical pyramidal and non-pyramidal neurons in organotypic cultures, we show that Y-P30 does not alter the development of the dendritic arborization patterns. However, Y-P30 treatment decreases the density of apical, but not basal dendritic protrusions at the expense of the filopodia. Analysis of spine morphology revealed an unchanged mushroom/stubby-to-thin spine ratio and a shortening of the longest decile of dendritic protrusions. Whole-cell recordings from cortical principal neurons in dissociated cultures grown in the presence of Y-P30 demonstrated a decrease in the frequency of glutamatergic mEPSCs. Despite these differences in protrusion morphology and synaptic transmission, the latter likely attributable to presynaptic effects, calcium event rate and amplitude recorded in pyramidal neurons in organotypic cultures were not altered by Y-P30 treatment. Together, our data suggest that Y-P30 has the capacity to decelerate spinogenesis and to promote morphological, but not synaptic, maturation of dendritic protrusions.	[Neumann, Janine R.; Dash-Wagh, Suvarna; Jack, Alexander; Raek, Andrea; Hamad, Mohammad I. K.; Wahle, Petra] Ruhr Univ Bochum, Fak Biol & Biotechnol, AG Entwicklungsneurobiol, Bochum, Germany; [Juengling, Kay; Pape, Hans-Christian] Westfalische Wilhelms Univ Munster, Inst Physiol 1, Munster, Germany; [Kreutz, Michael R.] Leibniz Inst Neurobiol, Neuroplastizitat, Magdeburg, Germany; [Kreutz, Michael R.] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Leibniz Grp Dendrit Organelles & Synapt Funct, Hamburg, Germany; [Puskarjov, Martin] Univ Helsinki, Fac Biol & Environm Sci, Mol & Integrat Biosci, Helsinki, Finland	Ruhr University Bochum; University of Munster; Leibniz Institut fur Neurobiologie (LIN); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Helsinki	Wahle, P (corresponding author), Ruhr Univ Bochum, Fak Biol & Biotechnol, AG Entwicklungsneurobiol, Bochum, Germany.	petra.wahle@rub.de	Jack, Alexander/GRE-6283-2022	Puskarjov, Martin/0000-0001-7201-2615; Wahle, Petra/0000-0002-8710-0375	Deutsche Forschungsgemeinschaft [736]; Bundesministerium fur Bildung und Forswchung (Forderschwerpunkt Neurotraumatologie); Emil Aaltonen Foundation; Stammzellnetzwerk NRW [AZ 224 - 400 010 04]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forswchung (Forderschwerpunkt Neurotraumatologie); Emil Aaltonen Foundation; Stammzellnetzwerk NRW	This work was supported by Deutsche Forschungsgemeinschaft Graduate Program 736 (stipends to SDW, J RN, MIKH and KJ), Bundesministerium fur Bildung und Forswchung (Forderschwerpunkt Neurotraumatologie, Teilprojekt All to HCP and PW), Emil Aaltonen Foundation (to MP) and Stammzellnetzwerk NRW (AZ 224 - 400 010 04 to PW).	Ai H, 2013, NEUROSCI BULL, V29, P614, DOI 10.1007/s12264-013-1337-8; Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Ammendrup-Johnsen I, 2015, J NEUROSCI, V35, P12425, DOI 10.1523/JNEUROSCI.1330-15.2015; Berry KP, 2017, NEURON, V96, P43, DOI 10.1016/j.neuron.2017.08.008; Chow BDW, 2016, J HUM LACT, V32, P168, DOI 10.1177/0890334415592402; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; Coles CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6209; Condomitti G, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00014; Cunningham TJ, 1998, J NEUROSCI, V18, P7047; Cunningham TJ, 2000, EXP NEUROL, V163, P457, DOI 10.1006/exnr.2000.7390; Dash-Wagh S, 2011, MOL CELL NEUROSCI, V48, P195, DOI 10.1016/j.mcn.2011.07.005; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Engelhardt M, 2018, EXP NEUROL, V302, P169, DOI 10.1016/j.expneurol.2017.12.011; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Ethell IM, 2000, J CELL BIOL, V151, P53, DOI 10.1083/jcb.151.1.53; Gorba T, 1999, EUR J NEUROSCI, V11, P1179, DOI 10.1046/j.1460-9568.1999.00551.x; Hamad MIK, 2011, DEVELOPMENT, V138, P4301, DOI 10.1242/dev.071076; Han KA, 2016, J NEUROSCI, V36, P4816, DOI 10.1523/JNEUROSCI.4024-15.2016; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Hu HT, 2014, DEV NEUROBIOL, V74, P1011, DOI 10.1002/dneu.22181; Huang TN, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00406; Huang TN, 2010, J NEUROCHEM, V112, P1562, DOI 10.1111/j.1471-4159.2010.06569.x; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Ivenshitz M, 2010, J NEUROPHYSIOL, V104, P1052, DOI 10.1152/jn.00914.2009; Jack A, 2019, MOL NEUROBIOL, V56, P4960, DOI 10.1007/s12035-018-1414-0; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; Knox R, 2014, STROKE, V45, P3040, DOI 10.1161/STROKEAHA.114.006170; Landgraf P, 2004, FASEB J, V18, P225, DOI 10.1096/fj.04-1789fje; Landgraf P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085924; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Lessmann V, 1998, GEN PHARMACOL-VASC S, V31, P667; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Macharadze T, 2011, NEUROREPORT, V22, P544, DOI 10.1097/WNR.0b013e328348b512; Mikhaylova Marina, 2014, BMC Res Notes, V7, P400, DOI 10.1186/1756-0500-7-400; Naito Y, 2017, NEUROSCI RES, V116, P10, DOI 10.1016/j.neures.2016.09.009; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nakazawa T, 2006, EMBO J, V25, P2867, DOI 10.1038/sj.emboj.7601156; Neumann JR, 2015, BRAIN STRUCT FUNCT, V220, P1935, DOI 10.1007/s00429-014-0764-2; Patz S, 2006, EUR J NEUROSCI, V24, P2453, DOI 10.1111/j.1460-9568.2006.05126.x; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rieg S, 2006, J INVEST DERMATOL, V126, P354, DOI 10.1038/sj.jid.5700041; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schittek B, 2012, J INNATE IMMUN, V4, P349, DOI 10.1159/000336844; Schneeberg J, 2009, EUR J PHARMACOL, V616, P81, DOI 10.1016/j.ejphar.2009.05.029; Takahashi H, 2013, TRENDS NEUROSCI, V36, P522, DOI 10.1016/j.tins.2013.06.002; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Uvarov P, 2006, J NEUROSCI, V26, P13463, DOI 10.1523/JNEUROSCI.4731-06.2006; Wang TF, 2004, J NEUROCHEM, V91, P1483, DOI 10.1111/j.1471-4159.2004.02845.x; Xu XH, 2010, TOXICOL APPL PHARM, V249, P188, DOI 10.1016/j.taap.2010.09.007	60	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211151	10.1371/journal.pone.0211151	http://dx.doi.org/10.1371/journal.pone.0211151			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759095	Green Published, Green Submitted, gold			2022-12-26	WOS:000458761300031
J	Wilhelm, JF; Bain, DJ; Green, MB; Bush, KF; McDowell, WH				Wilhelm, Jessica F.; Bain, Daniel J.; Green, Mark B.; Bush, Kathleen F.; McDowell, William H.			Trace metals in Northern New England streams: Evaluating the role of road salt across broad spatial scales with synoptic snapshots	PLOS ONE			English	Article							DEICING SALTS; NEW-HAMPSHIRE; CATION POOLS; HEAVY-METALS; GROUNDWATER; WATER; MOBILIZATION; CONTAMINATION; CATCHMENTS; SODIUM	Mobilization of trace metals from soils to surface waters can impact both human and ecosystem health. This study resamples a water sample archive to explore the spatial pattern of streamwater total concentrations of arsenic, cadmium, copper, lead, and zinc and their associations with biogeochemical controls in northern New England. Road deicing appears to result in elevated trace metal concentrations, as trace metal concentrations are strongly related to sodium concentrations and are most elevated when the sodium: chloride ratio is near 1.0 (similar to halite). Our results are consistent with previous laboratory and field studies that indicate cation exchange as a metal mobilization mechanism when road salt is applied to soils containing metals. This study also documents associations among sodium, chloride, dissolved organic carbon, iron, and metal concentrations, suggesting cation exchange mechanisms related to road deicing are not the only mechanisms that increase trace metal concentrations in surface waters. In addition to cation exchange, this study considers dissolved organic carbon complexation and oxidation-reduction conditions affecting metal mobility from soils in a salt-rich environment. These observations demonstrate that road deicing has the potential to increase streamwater trace metal concentrations across broad spatial scales and increase risks to human and ecosystem health.	[Wilhelm, Jessica F.; Green, Mark B.; Bush, Kathleen F.] Plymouth State Univ, Ctr Environm, Plymouth, NH 03264 USA; [Bain, Daniel J.] Univ Pittsburgh, Dept Geol & Environm Sci, Pittsburgh, PA USA; [Green, Mark B.] US Forest Serv, Northern Res Stn, Durham, NH USA; [Bush, Kathleen F.] New Hampshire Dept Hlth & Human Serv, Concord, NH 03301 USA; [McDowell, William H.] Univ New Hampshire, Nat Resources & Environm, Durham, NH 03824 USA	University System Of New Hampshire; Plymouth State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Agriculture (USDA); United States Forest Service; University System Of New Hampshire; University of New Hampshire	Wilhelm, JF (corresponding author), Plymouth State Univ, Ctr Environm, Plymouth, NH 03264 USA.	wilhelmjf1@gmail.com	McDowell, William H/E-9767-2010; Bain, Daniel J/G-3055-2013	McDowell, William H/0000-0002-8739-9047; Bain, Daniel/0000-0003-1979-7016	National Science Foundation; Plymouth State University Center for the Environment; University of Pittsburgh Department of Geology and Environmental Science; New Hampshire Established Program to Stimulate Competitive Research [NSF EPS-1101245]; U.S. Forest Service	National Science Foundation(National Science Foundation (NSF)); Plymouth State University Center for the Environment; University of Pittsburgh Department of Geology and Environmental Science; New Hampshire Established Program to Stimulate Competitive Research; U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	Support for this study was provided by the National Science Foundation, Plymouth State University Center for the Environment, University of Pittsburgh Department of Geology and Environmental Science, New Hampshire Established Program to Stimulate Competitive Research (NSF EPS-1101245), and the U.S. Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMRHEIN C, 1992, ENVIRON SCI TECHNOL, V26, P703, DOI 10.1021/es00028a006; AMRHEIN C, 1990, J ENVIRON QUAL, V19, P765, DOI 10.2134/jeq1990.00472425001900040022x; Backstrom M, 2004, WATER RES, V38, P720, DOI 10.1016/j.watres.2003.11.006; Boudette EL, 1985, 85202 US GEOL SURV; CHAO TT, 1972, SOIL SCI SOC AM PRO, V36, P764, DOI 10.2136/sssaj1972.03615995003600050024x; Corsi SR, 2015, SCI TOTAL ENVIRON, V508, P488, DOI 10.1016/j.scitotenv.2014.12.012; Corsi SR, 2010, ENVIRON SCI TECHNOL, V44, P7376, DOI 10.1021/es101333u; Cunningham Mary Ann, 2008, Urban Ecosystems, V11, P17, DOI 10.1007/s11252-007-0031-x; Daley ML, 2009, J N AM BENTHOL SOC, V28, P929, DOI 10.1899/09-052.1; Findlay SEG, 2011, ANN NY ACAD SCI, V1223, P58, DOI 10.1111/j.1749-6632.2010.05942.x; Fram M.S., 1999, DOC COMPOSITION MAY, V2, P99; Hanes RE, 1976, EFFECTS DEICING SALT; Inserillo EA, 2017, HYDROL PROCESS, V31, P1074, DOI 10.1002/hyp.11091; Jackson RB, 2005, P NATL ACAD SCI USA, V102, P14487, DOI 10.1073/pnas.0507389102; Kaushal SS, 2015, WATER-SUI, V7, P4063, DOI 10.3390/w7084063; Kelly VR, 2008, ENVIRON SCI TECHNOL, V42, P410, DOI 10.1021/es071391l; Lofgren S, 2001, WATER AIR SOIL POLL, V130, P863, DOI 10.1023/A:1013895215558; Lovely DR, 1991, ENV SCI TECHNOL STAT, V25; Lovett GM, 2005, BIOGEOCHEMISTRY, V72, P191, DOI 10.1007/s10533-004-0357-x; Mason CF, 1999, J ENVIRON QUAL, V28, P82, DOI 10.2134/jeq1999.00472425002800010009x; Neal C, 2000, HYDROL EARTH SYST SC, V4, P295, DOI 10.5194/hess-4-295-2000; Norrstrom AC, 2001, WATER AIR SOIL POLL, V127, P281, DOI 10.1023/A:1005221314856; Ostendorf DW, 2009, HYDROL RES, V40, P520, DOI 10.2166/nh.2009.062; Peryea FJ, 1997, WATER AIR SOIL POLL, V93, P243, DOI 10.1023/A:1022196704677; Peters SC, 1999, ENVIRON SCI TECHNOL, V33, P1328, DOI 10.1021/es980999e; Peters SC, 2003, APPL GEOCHEM, V18, P1773, DOI 10.1016/S0883-2927(03)00109-4; Rossi RJ, 2017, HYDROL PROCESS, V31, P177, DOI 10.1002/hyp.10989; SHANLEY JB, 1994, J ENVIRON QUAL, V23, P977, DOI 10.2134/jeq1994.00472425002300050019x; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Stets EG, 2018, SCI TOTAL ENVIRON, V613, P1498, DOI 10.1016/j.scitotenv.2017.07.119; Talukder MRR, 2016, ARCH ENVIRON OCCUP H, P1; Team RC, 2014, R LANG ENV STAT COMP; US EPA O, 2015, NAT REC WAT QUAL CRI; Williams DD, 2000, WATER RES, V34, P127, DOI 10.1016/S0043-1354(99)00129-3; Zehetner F, 2009, WATER AIR SOIL POLL, V198, P125, DOI 10.1007/s11270-008-9831-8; Ziegler BA, 2015, ENVIRON SCI TECHNOL, V49, P13179, DOI 10.1021/acs.est.5b02341; Zuidema S, 2018, J ENVIRON QUAL, V47, P839, DOI 10.2134/jeq2017.11.0418	37	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0212011	10.1371/journal.pone.0212011	http://dx.doi.org/10.1371/journal.pone.0212011			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759149	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300068
J	Stanco, D; Caprara, C; Ciardelli, G; Mariotta, L; Gola, M; Minonzio, G; Soldati, G				Stanco, Deborah; Caprara, Christian; Ciardelli, Gianluca; Mariotta, Luca; Gola, Mauro; Minonzio, Greta; Soldati, Gianni			Tenogenic differentiation protocol in xenogenic-free media enhances tendon-related marker expression in ASCs	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; STEM-CELLS; ADIPOSE-TISSUE; TGF-BETA; IN-VIVO; INTERNATIONAL-SOCIETY; GROWTH-FACTOR; BOVINE SERUM; REPAIR; INJURY	Adipose-derived stem cells (ASCs) are multipotent and immune-privileged mesenchymal cells, making them ideal candidates for therapeutic purposes to manage tendon disorders. Providing safe and regulated cell therapy products to patients requires adherence to good manufacturing practices. To this aim we investigated the in vitro tenogenic differentiation potential of ASCs using a chemically defined serum-free medium (SF) or a xenogenic-free human pooled platelet lysate medium (hPL) suitable for cell therapy and both supplemented with CTGF, TGF beta-3, BMP-12 and ascorbic acid (AA) soluble factors. Human ASCs were isolated from 4 healthy donors and they were inducted to differentiate until 14 days in both hPL and SF tenogenic media (hPL-TENO and SF-TENO). Cell viability and immunophenotype profile were analysed to evaluate mesenchymal stem cell (MSC) characteristics in both xenogenic-free media. Moreover, the expression of stemness and tendon-related markers upon cell differentiation by RT-PCR, protein staining and cytofluorimetric analysis were also performed. Our results showed the two xenogenic-free media well support cell viability of ASCs and maintain their MSC nature as demonstrated by their typical immunophenototype profile and by the expression of NANOG, OCT4 and Ki67 genes. Moreover, both hPL-TENO and SF-TENO expressed significant high levels of the tendon-related genes SCX, COL1A1, COL3A1, COMP, MMP3 and MMP13 already at early time points in comparison to the respective controls. Significant up-regulations in scleraxis, collagen and tenomodulin proteins were also demonstrated at in both differentiated SF and hPL ASCs. In conclusion, we demonstrated firstly the feasibility of both serum and xenogenic-free media tested to culture ASCs moving forward the GMP-compliant approaches for clinical scale expansion of human MSCs needed for therapeutical application of stem cells. Moreover, a combination of CTGF, BMP-12, TGF beta 3 and AA factors strongly and rapidly induce human ASCs to differentiate into tenocyte-like cells.	[Stanco, Deborah; Caprara, Christian; Mariotta, Luca; Gola, Mauro; Minonzio, Greta; Soldati, Gianni] Swiss Stem Cell Fdn, Gentilino, Switzerland; [Stanco, Deborah; Ciardelli, Gianluca] Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy	Polytechnic University of Turin	Soldati, G (corresponding author), Swiss Stem Cell Fdn, Gentilino, Switzerland.	gianni.soldati@gmail.com	Ciardelli, Gianluca/ABC-2531-2020; Stanco, Deborah/AAV-6387-2021	Ciardelli, Gianluca/0000-0003-0199-1427; STANCO, DEBORAH/0000-0001-6973-1555; Soldati, Gianni/0000-0001-6309-9456	Swiss Stem Cell Foundation	Swiss Stem Cell Foundation	The study was funded by Swiss Stem Cell Foundation.	Abat F, 2018, J Exp Orthop, V5, P38, DOI 10.1186/s40634-018-0145-5; [Anonymous], 2015, REGEN MED, V10, P729, DOI [10.2217/RME.14.92, DOI 10.2217/RME.14.92]; Bagnaninchi PO, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.030643; Barco R., 2014, REV ESPANOLA CIRUGIA, V59, P3, DOI DOI 10.1016/J.REC0T.2014.07.008; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Brini AT, 2017, SCI REP, V7; Chen CH, 2008, J HAND SURG-AM, V33A, P1834, DOI 10.1016/j.jhsa.2008.07.003; Chen HS, 2015, CELL TRANSPLANT, V24, P509, DOI 10.3727/096368915X686968; Dai R, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6737345; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ferraro GA, 2013, J CELL BIOCHEM, V114, P1039, DOI 10.1002/jcb.24443; Forslund C, 2003, J ORTHOPAED RES, V21, P617, DOI 10.1016/S0736-0266(03)00010-X; Giannasi C, 2018, INT J PERIODONT REST, V38, P127, DOI 10.11607/prd.3304; Goncalves AI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083734; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; Isaac C, 2012, J SHOULDER ELB SURG, V21, P181, DOI 10.1016/j.jse.2011.10.004; Jiang YK, 2017, J TISSUE ENG REGEN M, V11, P2525, DOI 10.1002/term.2150; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Kishore V, 2012, BIOMATERIALS, V33, P2137, DOI 10.1016/j.biomaterials.2011.11.066; Klein MB, 2002, J HAND SURG-AM, V27A, P615, DOI 10.1053/jhsu.2002.34004; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Lee CH, 2015, J CLIN INVEST, V120, P3340, DOI [10.1016/S0736-0266(03)00010-X, DOI 10.1016/S0736-0266(03)00010-X]; Lin DS, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.510; Lindroos B, 2009, CYTOTHERAPY, V11, P958, DOI 10.3109/14653240903233081; Liu JP, 2015, CELL PHYSIOL BIOCHEM, V35, P1831, DOI 10.1159/000373994; Lou JR, 2001, J ORTHOPAED RES, V19, P1199, DOI 10.1016/S0736-0266(01)00042-0; Lui PPY, 2016, CYTOTHERAPY, V18, P99, DOI 10.1016/j.jcyt.2015.10.005; Mackensen A, 2000, CANCER IMMUNOL IMMUN, V49, P152, DOI 10.1007/s002620050614; Minonzio G, 2014, CRYOBIOLOGY, V69, P211, DOI 10.1016/j.cryobiol.2014.07.005; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niemeyer P, 2008, CYTOTHERAPY, V10, P784, DOI 10.1080/14653240802419302; Park BS, 2010, BIOMED RES-TOKYO, V31, P27, DOI 10.2220/biomedres.31.27; Patrikoski M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt175; Pirrone C., 2017, J STEM CELL RES MED, V2, P1, DOI [10.15761/JSCRM.10001232017, DOI 10.15761/JSCRM.10001232017]; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Ragni E, 2013, J CELL MOL MED, V17, P168, DOI 10.1111/j.1582-4934.2012.01660.x; Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448; Schallmoser K, 2009, J VIS EXP; Schneider PRA, 2011, J ORTHOP RES, V29, P1351, DOI 10.1002/jor.21400; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Shen HM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057055, 10.1371/journal.pone.0057746]; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Sodersten F, 2013, CONNECT TISSUE RES, V54, P62, DOI 10.3109/03008207.2012.734879; Spina A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00354; Stellavato A, 2017, CELL PHYSIOL BIOCHEM, V44, P1078, DOI 10.1159/000485414; SWEAT F, 1964, ARCH PATHOL, V78, P69; Uysal CA, 2012, J PLAST RECONSTR AES, V65, P1712, DOI 10.1016/j.bjps.2012.06.011; Mora MV, 2014, INJURY, V45, pS22, DOI 10.1016/S0020-1383(14)70006-3; Vieira MHC, 2014, GENET MOL RES, V13, P10434, DOI 10.4238/2014.December.12.5; Vuornos K, 2016, TISSUE ENG PT A, V22, P513, DOI 10.1089/ten.tea.2015.0276; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; Yang G, 2013, BIRTH DEFECTS RES C, V99, P203, DOI 10.1002/bdrc.21041	57	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212192	10.1371/journal.pone.0212192	http://dx.doi.org/10.1371/journal.pone.0212192			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753235	gold, Green Published, Green Submitted			2022-12-26	WOS:000458395600052
J	Tian, Y; Mendes, J; Pedgaonkar, A; Ibrahim, M; Jensen, L; Schroeder, JD; Wilson, B; DiBella, EVR; Adluru, G				Tian, Ye; Mendes, Jason; Pedgaonkar, Apoorva; Ibrahim, Mark; Jensen, Leif; Schroeder, Joyce D.; Wilson, Brent; DiBella, Edward V. R.; Adluru, Ganesh			Feasibility of multiple-view myocardial perfusion MRI using radial simultaneous multi-slice acquisitions	PLOS ONE			English	Article							LONG-AXIS; RECONSTRUCTION; 1ST-PASS; REGULARIZATION; SEGMENTATION; HEART	Purpose Dynamic contrast enhanced MRI of the heart typically acquires 2-4 short-axis (SA) slices to detect and characterize coronary artery disease. This acquisition scheme is limited by incomplete coverage of the left ventricle. We studied the feasibility of using radial simultaneous multi-slice (SMS) technique to achieve SA, 2-chamber and/or 4-chamber long-axis (2CH LA and/or 4CH LA) coverage with and without electrocardiography (ECG) gating using a motion-robust reconstruction framework. Methods 12 subjects were scanned at rest and/or stress, free breathing, with or without ECG gating. Multiple sets of radial SMS k-space were acquired within each cardiac cycle, and each SMS set sampled 3 parallel slices that were either SA, 2CH LA, or 4CH LA slices. The radial data was interpolated onto Cartesian space using an SMS GRAPPA operator gridding method. Self-gating and respiratory states binning of the data were done. The binning information as well as a pixel tracking spatiotemporal constrained reconstruction method were applied to obtain motion-robust image reconstructions. Reconstructions with and without the pixel tracking method were compared for signal-to-noise ratio and contrast-to-noise ratio. Results Full coverage of the heart (at least 3 SA and 3 LA slices) during the first pass of contrast at every heartbeat was achieved by using the radial SMS acquisition. The proposed pixel tracking reconstruction improves the average SNR and CNR by 21% and 30% respectively, and reduces temporal blurring for both gated and ungated acquisitions. Conclusion Acquiring simultaneous multi-slice SA, 2CH LA and/or 4CH LA myocardial perfusion images in every heartbeat is feasible in both gated and ungated acquisitions. This can add confidence when detecting and characterizing coronary artery disease by revealing ischemia in different views, and by providing apical coverage that is improved relative to SA slices alone. The proposed pixel tracking framework improves the reconstruction while adding little computational cost.	[Tian, Ye; Mendes, Jason; Pedgaonkar, Apoorva; Jensen, Leif; Schroeder, Joyce D.; DiBella, Edward V. R.; Adluru, Ganesh] Univ Utah, Dept Radiol & Imaging Sci, UCAIR, Salt Lake City, UT 84112 USA; [Tian, Ye] Univ Utah, Dept Phys & Astron, Salt Lake City, UT USA; [Ibrahim, Mark; Wilson, Brent] Univ Utah, Div Cardiol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Adluru, G (corresponding author), Univ Utah, Dept Radiol & Imaging Sci, UCAIR, Salt Lake City, UT 84112 USA.	ganesh.adluru@utah.edu	Tian, Ye/AAD-5068-2021	Tian, Ye/0000-0002-8559-4404; DiBella, Edward/0000-0001-9196-3731	National Institutes of Health [R01HL138082]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL135328, R01HL138082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Institutes of Health grant R01HL138082. G.A. is the principal investigator of this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adluru G, 2012, J CARDIOVASC MAGN S1, V14, pP242, DOI DOI 10.1186/1532-429X-14-S1-P242; Adluru G, 2013, SPIE OPTICAL ENG APP; Adluru G, 2017, P 25 ANN M ISMRM HON; Adluru G, 2006, J MAGN RESON IMAGING, V24, P1062, DOI 10.1002/jmri.20756; Adluru G, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/341684; Adluru G, 2009, J MAGN RESON IMAGING, V29, P466, DOI 10.1002/jmri.21585; Asif MS, 2013, MAGN RESON MED, V70, P800, DOI 10.1002/mrm.24524; Baron CA, 2018, MAGN RESON MED, V79, P2685, DOI 10.1002/mrm.26928; Benkert T, 2018, MAGN RESON MED, V80, P286, DOI 10.1002/mrm.27030; Cerqueira MD, 2002, INT J CARDIOVAS IMAG, V18, P539; Chen LY, 2012, MED PHYS, V39, P5204, DOI 10.1118/1.4738965; Chow K, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0187-0; Christensen GE, 1996, IEEE T IMAGE PROCESS, V5, P1435, DOI 10.1109/83.536892; DiBella E, 2018, P 26 ANN M ISMRM PAR; Ebrahimi M, 2015, STAT ATLASES COMPUTA; Elkington AG, 2004, J CARDIOVASC MAGN R, V6, P811, DOI 10.1081/JCMR-200036129; Fair MJ, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0162-9; Feng L, 2018, MAGN RESON MED, V80, P77, DOI 10.1002/mrm.27002; Feng L, 2014, MAGN RESON MED, V72, P707, DOI 10.1002/mrm.24980; Fessler JA, 2005, IEEE T SIGNAL PROCES, V53, P3393, DOI 10.1109/TSP.2005.853152; Harrison A, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-26; Likhite D, 2016, J MAGN RESON IMAGING, V43, P1369, DOI 10.1002/jmri.25107; Ma H, 2019, ACAD RADIOL, V26, P519, DOI 10.1016/j.acra.2018.05.008; Mickevicius NJ, 2017, MAGN RESON MED, V78, P1700, DOI 10.1002/mrm.26555; Mohsin YQ, 2017, MAGN RESON MED, V77, P1238, DOI 10.1002/mrm.26215; Odille F, 2018, MAGN RESON MED, V79, P2665, DOI 10.1002/mrm.26923; Seiberlich N, 2008, MAGN RESON MED, V59, P930, DOI 10.1002/mrm.21565; Sharif B, 2018, INT J CARDIOVAS IMAG, V34, P661, DOI 10.1007/s10554-017-1265-1; Sharif B, 2015, MAGN RESON MED, V74, P1661, DOI 10.1002/mrm.25752; Tian Y, 2017, MED PHYS, V44, P4025, DOI 10.1002/mp.12357; Todd N, 2009, MAGN RESON MED, V62, P406, DOI 10.1002/mrm.22012; Wajer F, 2011, ISMRM 9 SCI M EXH GL; Wang HN, 2016, MAGN RESON IMAGING, V34, P1329, DOI 10.1016/j.mri.2016.07.015; Wang Y, 2005, J MAGN RESON IMAGING, V22, P53, DOI 10.1002/jmri.20351; Yutzy SR, 2011, MAGN RESON MED, V65, P1630, DOI 10.1002/mrm.22752; Zhou RX, 2018, J CARDIOVASC MAGN R, V20, DOI 10.1186/s12968-018-0427-1	36	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211738	10.1371/journal.pone.0211738	http://dx.doi.org/10.1371/journal.pone.0211738			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742641	Green Published, Green Submitted, gold			2022-12-26	WOS:000458393400022
J	Filimonow, K; Saiz, N; Suwinska, A; Wyszomirski, T; Grabarek, JB; Ferretti, E; Piliszek, A; Plusa, B; Maleszewski, M				Filimonow, Katarzyna; Saiz, Nestor; Suwinska, Aneta; Wyszomirski, Tomasz; Grabarek, Joanna B.; Ferretti, Elisabetta; Piliszek, Anna; Plusa, Berenika; Maleszewski, Marek			No evidence of involvement of E-cadherin in cell fate specification or the segregation of Epi and PrE in mouse blastocysts	PLOS ONE			English	Article							PARIETAL ENDODERM CELLS; EMBRYONIC STEM-CELLS; PRIMITIVE ENDODERM; REICHERTS MEMBRANE; VISCERAL ENDODERM; EPITHELIAL DIFFERENTIATION; LINEAGE ALLOCATION; DOWN-REGULATION; EXPRESSION; INNER	During preimplantation mouse development stages, emerging pluripotent epiblast (Epi) and extraembryonic primitive endoderm (PrE) cells are first distributed in the blastocyst in a "salt-and-pepper" manner before they segregate into separate layers. As a result of segregation, PrE cells become localised on the surface of the inner cell mass (ICM), and the Epi is enclosed by the PrE on one side and by the trophectoderm on the other. During later development, a subpopulation of PrE cells migrates away from the ICM and forms the parietal endoderm (PE), while cells remaining in contact with the Epi form the visceral endoderm (VE). Here, we asked: what are the mechanisms mediating Epi and PrE cell segregation and the subsequent VE vs PE specification? Differences in cell adhesion have been proposed; however, we demonstrate that the levels of plasma membrane- bound E-cadherin (CDH1, cadherin 1) in Epi and PrE cells only differ after the segregation of these lineages within the ICM. Moreover, manipulating E-cadherin levels did not affect lineage specification or segregation, thus failing to confirm its role during these processes. Rather, we report changes in E-cadherin localisation during later PrE-to-PE transition which are accompanied by the presence of Vimentin and Twist, supporting the hypothesis that an epithelial-to-mes-enchymal transition process occurs in the mouse peri-implantation blastocyst.	[Filimonow, Katarzyna; Suwinska, Aneta; Maleszewski, Marek] Univ Warsaw, Dept Embryol, Fac Biol, Warsaw, Poland; [Filimonow, Katarzyna; Saiz, Nestor; Grabarek, Joanna B.; Plusa, Berenika] Univ Manchester, Div Dev Biol & Med, Oxford Rd, Manchester, Lancs, England; [Filimonow, Katarzyna; Piliszek, Anna] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Expt Embryol, Postepu 36a, Jastrzebiec, Poland; [Wyszomirski, Tomasz] Univ Warsaw, Fac Biol, Biol & Chem Res Ctr, Warsaw, Poland; [Ferretti, Elisabetta] Univ Copenhagen, Danish Stem Cell Ctr DanStem, Copenhagen N, Denmark; [Saiz, Nestor] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Grabarek, Joanna B.] Univ Manchester, Canc Res UK Manchester Inst, Wilmslow Rd, Manchester, Lancs, England	University of Warsaw; University of Manchester; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; University of Warsaw; University of Copenhagen; Memorial Sloan Kettering Cancer Center; Cancer Research UK; University of Manchester	Maleszewski, M (corresponding author), Univ Warsaw, Dept Embryol, Fac Biol, Warsaw, Poland.; Plusa, B (corresponding author), Univ Manchester, Div Dev Biol & Med, Oxford Rd, Manchester, Lancs, England.	berenika.plusa@manchester.ac.uk; maleszewski@biol.uw.edu.pl	Wyszomirski, Tomasz/V-8605-2018; Ferretti, Elisabetta/ABD-7257-2021; Grabarek, Joanna/AAH-4253-2020	Wyszomirski, Tomasz/0000-0001-8385-2919; Filimonow, Katarzyna/0000-0002-3924-6011; Maleszewski, Marek/0000-0002-6699-0452; Suwinska, Aneta/0000-0001-8366-2197; Saiz, Nestor/0000-0003-0637-791X	National Science Center (Poland) [OPUS 2013/09/B/NZ3/02404]; Short Term FEBS Fellowship; Travelling Grant Company of Biologists; Obra Social la Caixa; University of Manchester; Novo Nordisk Foundation Section for Basic Stem Cell Research; Manchester Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC) [BP R107861]; EU European Regional Development Fund under the Innovative Economy Operational Program, 2007-2013; BBSRC [BB/G012393/1] Funding Source: UKRI	National Science Center (Poland); Short Term FEBS Fellowship; Travelling Grant Company of Biologists; Obra Social la Caixa(La Caixa Foundation); University of Manchester; Novo Nordisk Foundation Section for Basic Stem Cell Research; Manchester Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU European Regional Development Fund under the Innovative Economy Operational Program, 2007-2013; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	K.Filimonow, A.Suwinska and M.Maleszewski at University of Warsaw were supported by the grant OPUS 2013/09/B/NZ3/02404 from the National Science Center (Poland). K. Filimonow work at University of Manchester was supported by Short Term FEBS Fellowship and Travelling Grant Company of Biologists. N. Saiz was funded by Obra Social la Caixa and The University of Manchester. E.Ferretti was supported by Novo Nordisk Foundation Section for Basic Stem Cell Research. Work in B.Plusa's lab was funded by a Manchester Fellowship and by the Biotechnology and Biological Sciences Research Council (BBSRC) [BP R107861]. Part of the work done by T.Wyszomirski was carried out at the Biological and Chemical Research Centre, University of Warsaw, established within a project co-financed by the EU European Regional Development Fund under the Innovative Economy Operational Program, 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Artus J, 2011, DEV BIOL, V350, P393, DOI 10.1016/j.ydbio.2010.12.007; Balakier H, 2013, FERTIL STERIL, V99, P518, DOI 10.1016/j.fertnstert.2012.09.020; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; COLLINS JE, 1995, TRENDS BIOCHEM SCI, V20, P307, DOI 10.1016/S0968-0004(00)89057-X; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Dard N, 2001, DEV BIOL, V233, P161, DOI 10.1006/dbio.2001.0192; Descalzo SM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.49; DICKSON AD, 1979, J ANAT, V129, P571; Dunlap SM, 2012, CANCER PREV RES, V5, P930, DOI 10.1158/1940-6207.CAPR-12-0034; ENDERS AC, 1978, ANAT REC, V190, P65, DOI 10.1002/ar.1091900107; Faunes F, 2013, DEVELOPMENT, V140, P1171, DOI 10.1242/dev.085654; Feng X, 2017, ONCOTARGET, V8, P33365, DOI 10.18632/oncotarget.16497; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; FULTON BP, 1978, NATURE, V273, P149, DOI 10.1038/273149a0; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; Gerbe F, 2008, DEV BIOL, V313, P594, DOI 10.1016/j.ydbio.2007.10.048; Godde NJ, 2010, J MAMMARY GLAND BIOL, V15, P149, DOI 10.1007/s10911-010-9180-2; Grabarek Joanna B, 2012, Methods Mol Biol, V916, P275, DOI 10.1007/978-1-61779-980-8_21; Grabarek JB, 2012, DEVELOPMENT, V139, P129, DOI 10.1242/dev.067702; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hawkins K, 2012, STEM CELLS, V30, P1842, DOI 10.1002/stem.1148; HOGAN BLM, 1980, DEV BIOL, V80, P289, DOI 10.1016/0012-1606(80)90405-4; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Krupa M, 2014, DEV BIOL, V385, P136, DOI 10.1016/j.ydbio.2013.09.008; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kurimoto K, 2010, CURR OPIN GENET DEV, V20, P470, DOI 10.1016/j.gde.2010.06.003; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; LANE EB, 1983, NATURE, V303, P701, DOI 10.1038/303701a0; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Le Bin GC, 2014, DEVELOPMENT, V141, P1001, DOI 10.1242/dev.096875; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; LEHTONEN E, 1983, EMBO J, V2, P1023, DOI 10.1002/j.1460-2075.1983.tb01540.x; LEHTONEN E, 1983, DEV BIOL, V100, P158, DOI 10.1016/0012-1606(83)90206-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch CC, 2010, J ONCOL, V2010, DOI 10.1155/2010/530745; Maitre JL, 2016, NATURE, V536, P344, DOI 10.1038/nature18958; Maitre JL, 2015, NAT CELL BIOL, V17, P849, DOI 10.1038/ncb3185; Maurer ME, 2005, J CELL SCI, V118, P5345, DOI 10.1242/jcs.02650; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Moore R, 2014, MOL CELL BIOL, V34, P560, DOI 10.1128/MCB.00937-13; Moore R, 2009, GENESIS, V47, P579, DOI 10.1002/dvg.20536; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; Oda H, 2011, J CELL BIOL, V193, P1137, DOI 10.1083/jcb.201008173; Paca A, 2012, DEV BIOL, V361, P90, DOI 10.1016/j.ydbio.2011.10.013; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Rossant J, 2003, PHILOS T ROY SOC B, V358, P1341, DOI 10.1098/rstb.2003.1329; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Saiz N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13463; Saiz N, 2013, DEVELOPMENT, V140, P4311, DOI 10.1242/dev.093922; Saiz N, 2013, REPRODUCTION, V145, pR65, DOI 10.1530/REP-12-0381; SALAMAT M, 1995, ANAT EMBRYOL, V192, P275; Sasaki H, 2015, SEMIN CELL DEV BIOL, V47-48, P80, DOI 10.1016/j.semcdb.2015.05.003; Schrode N, 2000, GENES N Y N, V51, P219; Sobotta J., 1911, Archiv fuer Mikroskopische Anatomie Bonn, V78, DOI 10.1007/BF02978986; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Stephenson RO, 2010, DEVELOPMENT, V137, P3383, DOI 10.1242/dev.050195; Suwinska A, 2008, DEV BIOL, V322, P133, DOI 10.1016/j.ydbio.2008.07.019; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veltmaat JM, 2000, INT J DEV BIOL, V44, P297; Verheijen MHG, 1999, INT J DEV BIOL, V43, P711; Vinot S, 2005, DEV BIOL, V282, P307, DOI 10.1016/j.ydbio.2005.03.001; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang Z, 2007, BIOCHEM BIOPH RES CO, V358, P925, DOI 10.1016/j.bbrc.2007.05.023; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yuki K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04568; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang Y, 2018, INT J ONCOL; ZIOMEK CA, 1980, CELL, V21, P935, DOI 10.1016/0092-8674(80)90457-2	85	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0212109	10.1371/journal.pone.0212109	http://dx.doi.org/10.1371/journal.pone.0212109			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735538	gold, Green Submitted, Green Published			2022-12-26	WOS:000458181200057
J	Li, M; Furlong, JL; Yorio, PL; Portnoff, L				Li, Min; Furlong, Jennifer L.; Yorio, Patrick L.; Portnoff, Lee			A new approach to measure the resistance of fabric to liquid and viral penetration	PLOS ONE			English	Article							R PACKAGE; FLUIDS; BLOOD	Protective clothing manufacturers routinely test their products for resistance to liquid and viral penetration. Several of the test methods specified by the American Society for Testing and Materials (ASTM) and the International Organization for Standardization (ISO) for penetration testing produce binary results (i.e. pass or fail), deliver imprecise pressure regulation, and do not record the location at which penetration events occur. Instead, our approach measures a continuous variable (time of penetration) during a slow and continuous increase of hydrostatic pressure and retains the location of penetration events. Using a fluorescent dye to enhance visual detection, we evaluate temporal and spatial patterns of penetration events. We then compare the time of liquid penetration with the time of penetration of two bacteriophages (Phi-X174 and MS2). For the fabric tested, the mean viral penetration occurred 0.29 minutes earlier than liquid penetration when solved by logistic regression. The breakthrough time of MS2 was not different from the Phi-X174 bacteriophage. The time of liquid penetration was a latent indicator of the time of viral penetration.	[Li, Min] Calif Univ Penn, Dept Chem & Phys, California, PA USA; [Furlong, Jennifer L.; Yorio, Patrick L.; Portnoff, Lee] NIOSH, Natl Personal Protect Technol Lab Pittsburgh, Pittsburgh, PA 15222 USA	Pennsylvania State System of Higher Education (PASSHE); California University of Pennsylvania; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Portnoff, L (corresponding author), NIOSH, Natl Personal Protect Technol Lab Pittsburgh, Pittsburgh, PA 15222 USA.	LPortnoff@cdc.gov		Portnoff, Lee/0000-0002-3768-9361				AAMI Protective Barriers Committee, 2012, PB702012 ANSIAAMI; [Anonymous], 1992, ES2292 ASTM; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2017, TM422017 AATCC; [Anonymous], 2017, TM1272017 AATCC; [Anonymous], 1992, ES2192 ASTM; ASTM International, 2017, F1670F1670M17A ASTM; ASTM International, 2013, F1671F1671M13 ASTM I; ASTM International, 2017, F90317 ASTM INT; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Beck W, 1983, AORN J, V38, P384, DOI 10.1016/S0001-2092(07)65942-0; BELKIN NL, 1994, AM J INFECT CONTROL, V22, P172, DOI 10.1016/0196-6553(94)90006-X; Benaglia T, 2009, J STAT SOFTW, V32, P1; International Organization for Standardization, 2004, 166042004 ISO; International Organization for Standardization (ISO), 2004, 166032004 ISO; Jaques PA, 2016, J OCCUP ENVIRON HYG, V13, P881, DOI 10.1080/15459624.2016.1186279; Portnoff L, 2019, J TEST EVAL, V47, P1635, DOI 10.1520/JTE20170285; Shimasaki N, 2016, BIOCONTROL SCI, V21, P141, DOI 10.4265/bio.21.141; Tarantola A, 2006, AM J INFECT CONTROL, V34, P367, DOI 10.1016/j.ajic.2004.11.011; 1991, FED REG, V56, P64004	20	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211827	10.1371/journal.pone.0211827	http://dx.doi.org/10.1371/journal.pone.0211827			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735524	Green Published, gold, Green Submitted			2022-12-26	WOS:000458181200034
J	Kulaga, K; Budka, M				Kulaga, Kinga; Budka, Michal			Bird species detection by an observer and an autonomous sound recorder in two different environments: Forest and farmland	PLOS ONE			English	Article							POINT COUNTS; ACOUSTIC RECORDINGS; MEASUREMENT ERROR; COMMUNITY; ABUNDANCE; DISTANCE; POPULATIONS; CORNCRAKE; LONG	Birds are commonly used as bio-indicators of the quality of environments and the changes to them. Therefore, ecologists put a lot of effort into the monitoring of their population trends. One of the methods used for bird population monitoring is autonomous sound recording. Current studies provide inconsistent results when the number of detected species by autonomous sound recorders was compared with that delivered by an observer. In our study, observers counted birds using a point-count method at 64 random points in forest and farmland. At the same points, autonomous sound recorders recorded the soundscape four separate times (including counting by observer period) and the species present in the recordings were later identified by observers in the lab. We compared the number of species detected by simultaneous observations and recordings, as well as the number of species detected by recorders during four different surveys. Additionally, we calculated the Sorensen index to compare the species composition during different surveys at the same point. We found that observers detected more species than autonomous sound recorders. However, differences in the number of detected species were habitat dependent-observers detected more species than recorders in farmland, but not in the forest. When the time for recording was doubled, recorders were more effective than observers during a single survey. The average Sorensen index between the four repeated surveys performed by autonomous sound recorders ranged from 0.58 to 0.67, however we did not find significant differences in the number of species detected during different surveys conducted at the same point. Our study showed that 10-minutes sampling from the same point gives various species composition estimates but not species richness estimates between different surveys. Therefore, even when recorders detect less species than observers during the simultaneous surveys, increasing the survey duration of recorders may alter this difference. The use of autonomous sound recording for monitoring bird populations should be promoted, especially in forest habitats, as this technique is easier to standardise, eliminates many errors observed in the traditional point-count approach, enables conducting survey during adverse field conditions and delivers more reliable results for the majority of the species.	[Kulaga, Kinga; Budka, Michal] Adam Mickiewicz Univ, Dept Behav Ecol, Poznan, Poland	Adam Mickiewicz University	Budka, M (corresponding author), Adam Mickiewicz Univ, Dept Behav Ecol, Poznan, Poland.	m.budka@amu.edu.pl	Budka, Michał/R-5812-2019	Budka, Michał/0000-0002-1244-013X; Kulaga, Kinga/0000-0003-1958-4379	Ministry of Science and Higher Education [IP2014 005073]; National Science Centre [20156/17/B/NZ8/02347]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre(National Science Centre, Poland)	In the study the authors used equipment funded by Ministry of Science and Higher Education (grant Iuventus Plus no IP2014 005073) and National Science Centre (grant Opus no 20156/17/B/NZ8/02347).	ADRETHAUSBERGER M, 1984, IBIS, V126, P372, DOI 10.1111/j.1474-919X.1984.tb00258.x; Alexander JD, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1799; Alldredge MW, 2007, J WILDLIFE MANAGE, V71, P2759, DOI 10.2193/2006-161; Alldredge MW, 2006, AUK, V123, P1172, DOI 10.1642/0004-8038(2006)123[1172:EDPFMP]2.0.CO;2; Alquezar RD, 2015, WILSON J ORNITHOL, V127, P712, DOI 10.1676/14-104.1; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; BOWMAKER JK, 1978, VISION RES, V18, P1125, DOI 10.1016/0042-6989(78)90095-0; Buckland S.T., 2001, pi; Budka M, 2015, BIRD STUDY, V62, P153, DOI 10.1080/00063657.2015.1011078; Budka M, 2013, AGR ECOSYST ENVIRON, V171, P33, DOI 10.1016/j.agee.2013.03.007; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Celis-Murillo A, 2012, J FIELD ORNITHOL, V83, P166, DOI 10.1111/j.1557-9263.2012.00366.x; Celis-Murillo A, 2009, J FIELD ORNITHOL, V80, P64, DOI 10.1111/j.1557-9263.2009.00206.x; Darras K, 2018, J APPL ECOL, V55, P2575, DOI 10.1111/1365-2664.13229; Darras K, 2018, METHODS ECOL EVOL, V9, P1928, DOI 10.1111/2041-210X.13031; DEJONG MJ, 1985, J FIELD ORNITHOL, V56, P213; Diefenbach DR, 2003, AUK, V120, P1168, DOI 10.1642/0004-8038(2003)120[1168:VIGBCR]2.0.CO;2; Digby A, 2013, METHODS ECOL EVOL, V4, P675, DOI 10.1111/2041-210X.12060; Ehnes M, 2018, J ECOACOUSTICS, V2; Freemark Kathryn, 1995, U S Forest Service General Technical Report PSW, V149, P69; FULLER RJ, 1978, BRIT BIRDS, V71, P235; FULLER RJ, 1984, BIRD STUDY, V31, P195, DOI 10.1080/00063658409476841; Gibb R, 2019, METHODS ECOL EVOL, V10, P169, DOI 10.1111/2041-210X.13101; Goldsmith F.B., 2012, MONITORING CONSERVAT, V3; Gwinner E., 1973, Journal Reprod Fert, V19, P51; Harris JBC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077902; Holmes SB, 2014, WILDLIFE SOC B, V38, P591, DOI 10.1002/wsb.421; Howe Robert W., 1995, U S Forest Service General Technical Report PSW, V149, P83; Hutto RL, 2009, J FIELD ORNITHOL, V80, P387, DOI 10.1111/j.1557-9263.2009.00245.x; Jayakumar R, 2013, EXPERT OPIN ENV BIOL, V2, P3; Klingbeil BT, 2015, PEERJ, V3, DOI 10.7717/peerj.973; La VT, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1294; Leach EC, 2016, EMU, V116, P305, DOI 10.1071/MU15097; Marques TA, 2004, BIOMETRICS, V60, P757, DOI 10.1111/j.0006-341X.2004.00226.x; Moller AP, 2014, BEHAV ECOL, V25, P960, DOI 10.1093/beheco/aru073; O'Connell TJ, 2000, ECOL APPL, V10, P1706, DOI 10.2307/2641233; Ovaskainen O, 2018, ECOL LETT, V21, P1244, DOI 10.1111/ele.13092; Pacifici K, 2008, AUK, V125, P600, DOI 10.1525/auk.2008.07078; PARKER TA, 1991, AUK, V108, P443; PILASTRO A, 1993, ARCH ENVIRON CON TOX, V24, P355, DOI 10.1007/BF01128733; Pimm S, 2006, P NATL ACAD SCI USA, V103, P10941, DOI 10.1073/pnas.0604181103; R Development Core Team, 2016, R LANG ENV STAT COMP; Ralph CJ, 1993, HDB FIELD METHODS MO; Ralph CJ, 1995, MONITORING BIRD POPU, P187; Reif J, 2008, BIODIVERS CONSERV, V17, P3307, DOI 10.1007/s10531-008-9430-4; Reif J, 2006, J BIOGEOGR, V33, P1959, DOI 10.1111/j.1365-2699.2006.01547.x; Rek P, 2013, BEHAV PROCESS, V99, P121, DOI 10.1016/j.beproc.2013.07.009; Riede K, 1998, J INSECT CONSERV, V2, P217, DOI 10.1023/A:1009695813606; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Schieck J, 1997, CONDOR, V99, P179, DOI 10.2307/1370236; Scott J. M., 1981, STUD AVIAN BIOL, V6, P334; Sedlacek O, 2015, OSTRICH, V86, P213, DOI 10.2989/00306525.2015.1049669; Shonfield J, 2017, AVIAN CONSERV ECOL, V12, DOI 10.5751/ACE-00974-120114; Siegel RB, 2001, J FIELD ORNITHOL, V72, P228, DOI 10.1648/0273-8570-72.2.228; Simons TR, 2007, AUK, V124, P986, DOI 10.1642/0004-8038(2007)124[986:EAOTAD]2.0.CO;2; STEIN RC, 1968, AUK, V85, P229, DOI 10.2307/4083583; Stephan B, 1999, NEUE BREHM BUCHEREI, P95; Stephens PA, 2016, SCIENCE, V352, P84, DOI 10.1126/science.aac4858; Stowell D, 2019, METHODS ECOL EVOL, V10, P368, DOI 10.1111/2041-210X.13103; Sutherland W. J., 2004, BIRD ECOLOGY CONSERV; Tomialojc L, 2004, ACTA ORNITHOL, V39, P67, DOI 10.3161/068.039.0101; Tomialojc L., 1980, Notatki Ornitologiczne, V21, P33; Tomialojc L, 2010, ORNIS POLONICA, V51, P285; Venier LA, 2012, WILDLIFE SOC B, V36, P30, DOI 10.1002/wsb.88; Wesolowski T, 2006, ACTA ORNITHOL, V41, P55, DOI 10.3161/068.041.0112; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wimmer J, 2013, ECOL APPL, V23, P1419, DOI 10.1890/12-2088.1; Zwart MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102770	68	16	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211970	10.1371/journal.pone.0211970	http://dx.doi.org/10.1371/journal.pone.0211970			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730984	Green Published, Green Submitted, gold			2022-12-26	WOS:000458026000080
J	Moon, S; Ryoo, HW; Ahn, JY; Park, JB; Lee, DE; Kim, JH; Jin, SC; Lee, KW				Moon, Sungbae; Ryoo, Hyun Wook; Ahn, Jae Yun; Park, Jung Bae; Lee, Dong Eun; Kim, Jung Ho; Jin, Sang-chan; Lee, Kyung Woo			A 5-year change of knowledge and willingness by sampled respondents to perform bystander cardiopulmonary resuscitation in a metropolitan city	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; CPR; SURVIVAL; SKILLS; ASSOCIATION; RETENTION; BARRIERS; STUDENTS; FACILITATORS; LAYPERSONS	Background Nationwide and regional interventions can help improve bystander cardiopulmonary resuscitation (CPR) awareness, knowledge, and the willingness. Periodic community investigation will help monitor the effect. This study aimed to compare the experience of CPR education, CPR knowledge, and CPR willingness, during a 5-year interval. Methods This is a pre and post study. Two surveys were done in February 2012 and December 2016. National and regional intervention including legislation promoting public involvement, standardizing CPR education programs, training CPR instructors, and installing supporting organizations were done at the period. In both surveys, respondents were selected via quota sampling in Daegu Metropolitan City and answered the survey through face-to-face interview. Respondents' general demographic characteristics, CPR educational experience, CPR knowledge and CPR willingness were questioned. Results Total of 2141 respondents (1000 in 2012, 1141 in 2016) were selected. The percentage of respondents who received CPR education itself and recent education were higher after intervention compared to before intervention (36.2% vs. 55.1%, 16.9% vs. 30.1%, respectively). Correct knowledge of performing CPR seems to be improved overall (1.6% vs. 11.7%, odd ratio 14.28, 95% confidence interval 5.68-35.94). However, less respondents were willing to perform CPR on strangers (54.5% vs 35.0%). Conclusion Nationwide and regional interventions to promote bystander CPR and CPR education were associated with increased CPR education experience and improved correct CPR knowledge in performing bystander CPR. Willingness to perform bystander CPR on family did not increase significantly and CPR willingness to strangers was decreased. Additional legal and technological measures should be implemented to promote bystander CPR.	[Moon, Sungbae; Ryoo, Hyun Wook; Ahn, Jae Yun; Park, Jung Bae; Lee, Dong Eun] Kyungpook Natl Univ, Sch Med, Dept Emergency Med, Daegu, South Korea; [Kim, Jung Ho] Yeungnam Univ, Coll Med, Dept Emergency Med, Daegu, South Korea; [Jin, Sang-chan] Keimyung Univ, Sch Med, Dept Emergency Med, Daegu, South Korea; [Lee, Kyung Woo] Daegu Catholic Univ, Med Ctr, Dept Emergency Med, Daegu, South Korea	Kyungpook National University; Yeungnam University; Keimyung University; Catholic University of Daegu	Ryoo, HW (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Emergency Med, Daegu, South Korea.	ryoo@knu.ac.kr	Ahn, Jae Yun/N-2652-2017; Moon, Sungbae/F-4010-2015	Ahn, Jae Yun/0000-0002-1050-8575; Lee, Dong Eun/0000-0002-2057-5261; Ryoo, Hyun Wook/0000-0002-1361-9887; Moon, Sungbae/0000-0001-6928-8573; Kim, Jungho/0000-0002-3215-4640	Daegu Metropolitan City [20161221-0057]	Daegu Metropolitan City	This study was supported by the Daegu Metropolitan City [grant number 20161221-0057] to HWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yeonsin Kim, Mi Kyeong Kim, Heung Jun Kim, and Public Health Division of Daegu Metropolitan City Hall for their continued support.	119 Rescue and EMS Bureau, 2011, BAS PROP 119 RESC EM; Ahn MO, 2017, 2016 EMERGENCY MED S; Bouland AJ, 2017, PREHOSP EMERG CARE, V21, P662, DOI 10.1080/10903127.2017.1308605; Bray JE, 2017, EMERG MED AUSTRALAS, V29, P158, DOI 10.1111/1742-6723.12720; Brinkrolf P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178938; Brown LE, 2017, J AM COLL CARDIOL, V70, P2688, DOI 10.1016/j.jacc.2017.09.1101; Bull S, 2013, LANCET, V382, P27; Caputo ML, 2017, RESUSCITATION, V114, P73, DOI 10.1016/j.resuscitation.2017.03.003; Cartledge S, 2017, RESUSCITATION, V118, pe51; Center for Disease Prevention, 2017, STAND CARD ED LAYP; Chronic Disease Control Research Center for Disease Prevention, 2017, 2006 2016 SUDD CARD; Daya MR, 2015, RESUSCITATION, V91, P108, DOI 10.1016/j.resuscitation.2015.02.003; Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838; Eisenburg M, 2018, ACTING ON THE CALL; Geri G, 2017, RESUSCITATION, V115, P129, DOI 10.1016/j.resuscitation.2017.04.016; Fernandes JMG, 2014, ARQ BRAS CARDIOL, V102, P593, DOI 10.5935/abc.20140071; Hansen CM, 2015, JAMA-J AM MED ASSOC, V314, P255, DOI 10.1001/jama.2015.7938; Hernandez-Padilla JM, 2015, RESUSCITATION, V93, P27, DOI 10.1016/j.resuscitation.2015.05.008; Huang Q, 2016, J EMERG MED, V51, P712, DOI 10.1016/j.jemermed.2016.02.033; Hyun Il Seo M.D., 2017, [Journal of The Korean Society of Emergency Medicine, 대한응급의학회지], V28, P287; Iserbyt P, 2014, ACTA ANAESTH BELG, V65, P23; KCDC, 2012, SURV CURR SIT CARD R; Kim YJ, 2017, CLIN EXP EMERG MED, V4, P88, DOI 10.15441/ceem.16.175; Kitamura T, 2012, CIRCULATION, V126, P2834, DOI 10.1161/CIRCULATIONAHA.112.109496; Lee MJ, 2013, RESUSCITATION, V84, P889, DOI 10.1016/j.resuscitation.2013.01.009; Meaney PA, 2013, CIRCULATION, V128, P417, DOI 10.1161/CIR.0b013e31829d8654; Miller MG, 2015, JSMAHS, V2, P1; Muise J, 2018, HLTH ED J, P1; Na YH, 2011, J KOREAN SOC EMERG M, V22, P656; National Geography Information Institute, 2017, HUM GEOGR NAT ATL KO; Nielsen AM, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-39; Oliver E, 2014, EMERG MED J, V31, P518, DOI 10.1136/emermed-2012-202191; Porzer M, 2017, BIOMED PAP, V161, P348, DOI 10.5507/bp.2017.054; Rajan S, 2016, CIRCULATION, V134, P2095, DOI 10.1161/CIRCULATIONAHA.116.024400; Rescue and EMS Bureau, 2016, EMS ACT STAT 1 HALF; Ringh M, 2015, NEW ENGL J MED, V372, P2316, DOI 10.1056/NEJMoa1406038; Sasson C, 2013, CIRC-CARDIOVASC QUAL, V6, P550, DOI 10.1161/CIRCOUTCOMES.111.000097; Shams A, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005091; Sipsma K, 2011, RESUSCITATION, V82, P564, DOI 10.1016/j.resuscitation.2010.12.007; Son JW, 2017, CLIN EXP EMERG MED, V4, P80, DOI 10.15441/ceem.16.160; Statistics Korea, 2014, POP HOUS HOUS UN POP; Urban J, 2013, RESUSCITATION, V84, P1574, DOI 10.1016/j.resuscitation.2013.04.014; Vaillancourt C, 2007, ACAD EMERG MED, V14, P877, DOI 10.1197/j.aem.2007.06.021; Vaillancourt C, 2013, RESUSCITATION, V84, P1747, DOI 10.1016/j.resuscitation.2013.08.001; Wander PL, 2014, RESUSCITATION, V85, P1594, DOI 10.1016/j.resuscitation.2014.08.026; Yeung J, 2017, RESUSCITATION, V120, P138, DOI 10.1016/j.resuscitation.2017.08.010; 박세진, 2017, [Journal of The Korean Society of Emergency Medicine, 대한응급의학회지], V28, P620; Zhang S, 2015, EUROPACE, V17, P1720, DOI 10.1093/europace/euv103	48	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211804	10.1371/journal.pone.0211804	http://dx.doi.org/10.1371/journal.pone.0211804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730932	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000059
J	Weineck, F; Messner, M; Hauke, G; Pollatos, O				Weineck, Felicitas; Messner, Matthias; Hauke, Gernot; Pollatos, Olga			Improving interoceptive ability through the practice of power posing: A pilot study	PLOS ONE			English	Article							MEDIATES BODILY SENSIBILITY; HEARTBEAT EVOKED-POTENTIALS; INDIVIDUAL-DIFFERENCES; SUBMISSIVE BEHAVIOR; BODY PERCEPTION; AWARENESS; ANXIETY; EMOTION; SENSITIVITY; ACCURACY	Interoception refers to the detection and perception of signals from the inner body. Deficits in this domain have been linked to psychopathologies, prompting the search for strategies to improve this ability. Preliminary studies have shown that interoception could be enhanced through the manipulation of subjective feelings of power. We tested the effects of adopting powerful postures on different facets of interoception. Firstly, we measured the impact of a single power posing session on interoceptive ability in 41 healthy females. Then, the same participants were randomly assigned to two conditions (daily power posing practice vs. no practice). After one week the conditions alternated. Interoceptive accuracy, measured by the heartbeat tracking task, interoceptive sensibility, measured by the Body Perception Questionnaire (BPQ) and confidence ratings, as well as subjective feelings of power were assessed at baseline, after a single power posing session and after one week of training. A single power posing session significantly increased individuals' interoceptive accuracy. Also, power posing reduced individuals' scores on the BPQ after one week of daily practice and increased subjective feelings of power after one session and one week of daily practice. These findings suggest that adopting powerful postures has the potential to increase interoceptive accuracy, as well as subjective feelings of power, and to reduce interoceptive sensibility, measured by questionnaire.	[Weineck, Felicitas; Messner, Matthias; Hauke, Gernot; Pollatos, Olga] Ulm Univ, Dept Clin & Hlth Psychol, Ulm, Germany; [Hauke, Gernot] ERA, Munich, Germany	Ulm University	Weineck, F (corresponding author), Ulm Univ, Dept Clin & Hlth Psychol, Ulm, Germany.	felicitas.weineck@uni-ulm.de			Landesgraduiertenfordergesetz (LGFG) / Ulm University	Landesgraduiertenfordergesetz (LGFG) / Ulm University	The research was funded by a PhD scholarship awarded to Felicitas Weineck according to the Landesgraduiertenfordergesetz (LGFG) / Ulm University.	Ainley V, 2013, CONSCIOUS COGN, V22, P1231, DOI 10.1016/j.concog.2013.08.004; Ainley V, 2012, PSYCHOPHYSIOLOGY, V49, P1672, DOI 10.1111/j.1469-8986.2012.01468.x; Anderson C, 2012, J PERS, V80, P313, DOI 10.1111/j.1467-6494.2011.00734.x; Arnette SL, 2012, INT J BUSINESS SOCIA, V3; Badoud D, 2017, NEUROSCI BIOBEHAV R, V77, P237, DOI 10.1016/j.neubiorev.2017.03.017; Baranauskas M, 2017, PHYSIOL BEHAV, V180, P1, DOI 10.1016/j.physbeh.2017.07.032; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; Belletier C, 2018, ANN N Y ACAD SCI; Berner LA, 2018, PSYCHOL MED, V48, P142, DOI 10.1017/S0033291717001635; Blais AR, 2005, PERS INDIV DIFFER, V38, P1701, DOI 10.1016/j.paid.2004.11.004; Bogels SM, 2004, CLIN PSYCHOL REV, V24, P827, DOI 10.1016/j.cpr.2004.06.005; Bombari D, 2017, EMOTION, V17, P55, DOI 10.1037/emo0000207; Bornemann B, 2017, PSYCHOPHYSIOLOGY, V54, P469, DOI 10.1111/psyp.12790; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brener J, 1995, PSYCHOPHYSIOLOGY; Brinol P, 2007, J PERS SOC PSYCHOL, V93, P1040, DOI 10.1037/0022-3514.93.6.1040; Brinol P, 2009, EUR J SOC PSYCHOL, V39, P1053, DOI 10.1002/ejsp.607; Bulbena-Cabre A, 2017, ANSIEDAD ESTRES, V23, P99, DOI 10.1016/j.anyes.2017.07.002; Cai W, 2017, SOCIAL PSYCHOL; Carney DR, 2015, PSYCHOL SCI, V26, P657, DOI 10.1177/0956797614566855; Carney DR, 2010, PSYCHOL SCI, V21, P1363, DOI 10.1177/0956797610383437; Carney DR, 2005, J NONVERBAL BEHAV, V29, P105, DOI 10.1007/s10919-005-2743-z; Christensen JF, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13008; Cohen P, 1999, MULTIVAR BEHAV RES, V34, P315, DOI 10.1207/S15327906MBR3403_2; Connan F, 2007, INT J EAT DISORDER, V40, P733, DOI 10.1002/eat.20427; Conty L, 2010, COGNITION, V115, P133, DOI 10.1016/j.cognition.2009.12.005; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Cui HR, 2016, HUM BRAIN MAPP, V37, P1459, DOI 10.1002/hbm.23113; DALY JA, 1989, PERS INDIV DIFFER, V10, P903, DOI 10.1016/0191-8869(89)90025-1; Damasio A.R., 2000, FEELING WHAT HAPPENS; Desmedt O, 2018, BIOL PSYCHOL, V138, P185, DOI 10.1016/j.biopsycho.2018.09.004; Domschke K, 2010, CLIN PSYCHOL REV, V30, P1, DOI 10.1016/j.cpr.2009.08.008; Dunn BD, 2010, PSYCHOL SCI, V21, P1835, DOI 10.1177/0956797610389191; Duquette P, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00135; Eccles JA, 2015, NEUROPSYCHOLOGIA, V77, P90, DOI 10.1016/j.neuropsychologia.2015.08.006; EHLERS A, 1995, BEHAV RES THER, V33, P69, DOI 10.1016/0005-7967(94)E0002-Z; Ewing DL, 2017, BIOL PSYCHOL, V127, P163, DOI 10.1016/j.biopsycho.2017.05.011; Farb N, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01898; Fast NJ, 2012, ORGAN BEHAV HUM DEC, V117, P249, DOI 10.1016/j.obhdp.2011.11.009; Filson J, 2010, J INTERPERS VIOLENCE, V25, P400, DOI 10.1177/0886260509334401; Fischer D, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00452; Fischer D, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00199; Fischer J, 2011, J EXP SOC PSYCHOL, V47, P1146, DOI 10.1016/j.jesp.2011.06.008; FISKE ST, 1993, AM PSYCHOL, V48, P621, DOI 10.1037/0003-066X.48.6.621; Fiske ST., 1996, EUR REV SOC PSYCHOL, V7, P31, DOI DOI 10.1080/14792779443000094; Forkmann T, 2016, INT J PSYCHOPHYSIOL, V109, P71, DOI 10.1016/j.ijpsycho.2016.09.019; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Fustos J, 2013, SOC COGN AFFECT NEUR, V8, P911, DOI 10.1093/scan/nss089; Furman DJ, 2013, J AFFECT DISORDERS, V151, P780, DOI 10.1016/j.jad.2013.06.044; Galinsky AD, 2006, PSYCHOL SCI, V17, P1068, DOI 10.1111/j.1467-9280.2006.01824.x; Garfinkel SN, 2016, BIOL PSYCHOL, V114, P117, DOI 10.1016/j.biopsycho.2015.12.003; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Garfinkel SN, 2013, SOC COGN AFFECT NEUR, V8, P231, DOI 10.1093/scan/nss140; Gordon AM, 2017, J PERS SOC PSYCHOL, V113, P310, DOI 10.1037/pspp0000120; Guinote A, 2007, EUR REV SOC PSYCHOL, V18, P256, DOI 10.1080/10463280701692813; Guinote A, 2010, SOC COGNITION, V28, P110, DOI 10.1521/soco.2010.28.1.110; Hackford J, 2019, J BEHAV THER EXP PSY, V62, P80, DOI 10.1016/j.jbtep.2018.09.004; Hall JA, 2005, PSYCHOL BULL, V131, P898, DOI 10.1037/0033-2909.131.6.898; Herbert BM, 2007, PSYCHOPHYSIOLOGY, V44, P194, DOI 10.1111/j.1469-8986.2007.00493.x; Herbert BM, 2012, BIOL PSYCHOL, V89, P71, DOI 10.1016/j.biopsycho.2011.09.004; Homma I, 2008, EXP PHYSIOL, V93, P1011, DOI 10.1113/expphysiol.2008.042424; Huang L, 2011, PSYCHOL SCI, V22, P95, DOI 10.1177/0956797610391912; Kehr HM, 2004, PERS SOC PSYCHOL B, V30, P315, DOI 10.1177/0146167203256967; Keltner D, 2003, PSYCHOL REV, V110, P265, DOI 10.1037/0033-295X.110.2.265; Kever A, 2015, PERS INDIV DIFFER, V87, P20, DOI 10.1016/j.paid.2015.07.014; Khalsa SS, 2008, PSYCHOPHYSIOLOGY, V45, P671, DOI 10.1111/j.1469-8986.2008.00666.x; Kingsley M, 2005, INT J SPORTS MED, V26, P39, DOI 10.1055/s-2004-817878; Kunstman JW, 2016, J BEHAV THER EXP PSY, V50, P178, DOI 10.1016/j.jbtep.2015.08.003; Lowe B., 2001, GESUNDHEITSFRAGEBOGE; Maister L, 2017, ELIFE, V6, DOI 10.7554/eLife.25318; Maister Lara, 2017, Psychol Conscious (Wash D C), V4, P248, DOI 10.1037/cns0000110; MCCLELLAND DC, 1989, PSYCHOL REV, V96, P690, DOI 10.1037/0033-295X.96.4.690; Meessen J, 2016, J PSYCHOPHYSIOL, V30, P76, DOI 10.1027/0269-8803/a000157; Mehling W, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0013; Mehling WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048230; Melloni M, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-47; Moeini-Jazani M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01322; Murphy J, 2018, PSYCHON B REV, V25, P1193, DOI 10.3758/s13423-017-1339-z; Nair S, 2015, HEALTH PSYCHOL, V34, P632, DOI 10.1037/hea0000146; Nielsen L, 2006, EMOTION, V6, P392, DOI 10.1037/1528-3542.6.3.392; Pallier G, 2002, J GEN PSYCHOL, V129, P257, DOI 10.1080/00221300209602099; Parkin L, 2014, MINDFULNESS, V5, P298, DOI 10.1007/s12671-012-0181-7; Pfeifer G, 2017, BIOL PSYCHOL, V126, P19, DOI 10.1016/j.biopsycho.2017.04.001; Pitesa M, 2013, ACAD MANAGE J, V56, P635, DOI 10.5465/amj.2011.0891; Pollatos Olga, 2008, Eat Behav, V9, P381, DOI 10.1016/j.eatbeh.2008.02.001; Pollatos O, 2007, J ANXIETY DISORD, V21, P931, DOI 10.1016/j.janxdis.2006.12.004; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V65, P167, DOI 10.1016/j.ijpsycho.2007.03.005; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V63, P117, DOI 10.1016/j.ijpsycho.2006.09.003; Pollatos O, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00484; Pollatos O, 2016, PSYCHIAT RES, V240, P328, DOI 10.1016/j.psychres.2016.04.072; Pollatos O, 2009, DEPRESS ANXIETY, V26, P167, DOI 10.1002/da.20504; Porges SW., 1993, BODY PERCEPT QUEST L, V15, P2009; Rawolle M, 2016, PERS INDIV DIFFER, V89, P65, DOI 10.1016/j.paid.2015.09.030; Rawolle M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00923; Ring C, 2015, BIOL PSYCHOL, V104, P193, DOI 10.1016/j.biopsycho.2014.12.010; Santangelo G, 2018, PARKINSONISM RELAT D; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Scheepers D, 2012, J EXP SOC PSYCHOL, V48, P371, DOI 10.1016/j.jesp.2011.06.014; Schirmer-Mokwa KL, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00349; Schmid PC, 2013, EUR J SOC PSYCHOL, V43, P201, DOI 10.1002/ejsp.1937; Schwartz CE, 1997, PSYCHOSOM MED, V59, P362, DOI 10.1097/00006842-199707000-00005; Seth AK, 2013, TRENDS COGN SCI, V17, P565, DOI 10.1016/j.tics.2013.09.007; Shah P, 2016, CORTEX, V81, P215, DOI 10.1016/j.cortex.2016.03.021; Smith PK, 2008, SOC COGNITION, V26, P1, DOI 10.1521/soco.2008.26.1.1; Sokolowski K, 2000, J PERS ASSESS, V74, P126, DOI 10.1207/S15327752JPA740109; SPIELBERGER CD, 1970, STAI MANUAL STAIT TR; Stoeckart PF, 2017, PSYCHOL RES-PSYCH FO, V81, P560, DOI 10.1007/s00426-016-0768-z; Strigo IA, 2013, INT J EAT DISORDER, V46, P23, DOI 10.1002/eat.22045; Terasawa Y, 2013, SOC COGN AFFECT NEUR, V8, P259, DOI 10.1093/scan/nss108; Terhaar J, 2012, CLIN NEUROPHYSIOL, V123, P1950, DOI 10.1016/j.clinph.2012.02.086; Troop NA, 2003, PSYCHOL PSYCHOTHER-T, V76, P237, DOI 10.1348/147608303322362479; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Werner NS, 2009, PSYCHOPHYSIOLOGY, V46, P1123, DOI 10.1111/j.1469-8986.2009.00855.x; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905; Williams DeWayne P, 2017, Clin Physiol Funct Imaging, V37, P776, DOI 10.1111/cpf.12321; Young HA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186312; Zaki J, 2012, NEUROIMAGE, V62, P493, DOI 10.1016/j.neuroimage.2012.05.012; Zamariola G, 2018, BIOL PSYCHOL, V137, P12, DOI 10.1016/j.biopsycho.2018.06.006; Zamariola G, 2017, BODY IMAGE, V20, P130, DOI 10.1016/j.bodyim.2017.01.005	119	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211453	10.1371/journal.pone.0211453	http://dx.doi.org/10.1371/journal.pone.0211453			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5RX	30730938	gold, Green Published, Green Submitted			2022-12-26	WOS:000458026000024
J	Andersson, C; Krogager, ML; Skals, RK; Appel, EVR; Have, CT; Grarup, N; Pedersen, O; Jeppesen, JL; Pedersen, OD; Dominguez, H; Dixen, U; Engstrom, T; Tonder, N; Roden, DM; Stender, S; Gislason, GH; Enghusen-Poulsen, H; Hansen, T; Kober, L; Torp-Pedersen, C; Weeke, PE				Andersson, Charlotte; Krogager, Maria Lukacs; Skals, Regitze Kuhr; Appel, Emil Vincent Rosenbaum; Have, Christian Theil; Grarup, Niels; Pedersen, Oluf; Jeppesen, Jorgen L.; Pedersen, Ole Dyg; Dominguez, Helena; Dixen, Ulrik; Engstrom, Thomas; Tonder, Niels; Roden, Dan M.; Stender, Steen; Gislason, Gunnar H.; Enghusen-Poulsen, Henrik; Hansen, Torben; Kober, Lars; Torp-Pedersen, Christian; Weeke, Peter E.			Association of genetic variants previously implicated in coronary artery disease with age at onset of coronary artery disease requiring revascularizations	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; HEART-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; RISK-FACTORS; YOUNG; SCORE	Background The relation between burden of risk factors, familial coronary artery disease (CAD), and known genetic variants underlying CAD and low-density lipoprotein cholesterol (LDL-C) levels is not well-explored in clinical samples. We aimed to investigate the association of these measures with age at onset of CAD requiring revascularizations in a clinical sample of patients undergoing first-time coronary angiography. Methods 1599 individuals (mean age 64 years [min-max 29-96 years], 28% women) were genotyped (from blood drawn as part of usual clinical care) in the Copenhagen area (2010-2014). The burden of common genetic variants was measured as aggregated genetic risk scores (GRS) of single nucleotide polymorphisms (SNPs) discovered in genome-wide association studies. Results Self-reported familial CAD (prevalent in 41% of the sample) was associated with -3.2 years (95% confidence interval -4.5, -2.2, p<0.0001) earlier need of revascularization in sex-adjusted models. Patients with and without familial CAD had similar mean values of CADGRS (unweighted scores 68.4 vs. 68.0, p = 0.10, weighted scores 67.7 vs. 67.5, p = 0.49) and LDL-C-GRS (unweighted scores 58.5 vs. 58.3, p = 0.34, weighted scores 63.3 vs. 61.1, p = 0.41). The correlation between the CAD-GRS and LDL-C-GRS was low (r = 0.14, p<0.001). In multivariable adjusted regression models, each 1 standard deviation higher values of LDL-C-GRS and CAD-GRS were associated with -0.70 years (95% confidence interval -1.25, -0.14, p = 0.014) and -0.51 years (-1.07, 0.04, p = 0.07) earlier need for revascularization, respectively. Conclusions Young individuals presenting with CAD requiring surgical interventions had a higher genetic burden of SNPs relating to LDL-C and CAD (although the latter was statistically non-significant), compared with older individuals. However, the absolute difference was modest, suggesting that genetic screening can currently not be used as an effective prediction tool of when in life a person will develop CAD. Whether undiscovered genetic variants can still explain a "missing heritability" in early-onset CAD warrants more research.	[Andersson, Charlotte; Gislason, Gunnar H.] Herlev & Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Krogager, Maria Lukacs; Skals, Regitze Kuhr; Torp-Pedersen, Christian] Aalborg Univ Hosp, Unit Epidemiol & Biostat, Aalborg, Denmark; [Krogager, Maria Lukacs] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Appel, Emil Vincent Rosenbaum; Have, Christian Theil; Grarup, Niels; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark; [Jeppesen, Jorgen L.] Amager & Hvidovre Hosp Glostrup, Sect Cardiol, Dept Internal Med, Glostrup, Denmark; [Pedersen, Ole Dyg] Roskilde Hosp, Dept Cardiol, Roskilde, Denmark; [Dominguez, Helena; Weeke, Peter E.] Bispebjerg & Frederiksberg Hosp, Dept Cardiol, Bispebjerg, Denmark; [Dominguez, Helena] Univ Copenhagen, Dept Biomed, Copenhagen, Denmark; [Dixen, Ulrik] Amager & Hvidovre Hosp Hvidovre, Dept Cardiol, Hvidovre, Denmark; [Engstrom, Thomas; Kober, Lars] Rigshosp, Copenhagen Univ Hosp, Dept Cardiol, Copenhagen, Denmark; [Tonder, Niels] Hillerod Hosp, Dept Cardiol Nephrol & Endocrinol, Hillerod, Denmark; [Roden, Dan M.; Weeke, Peter E.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Roden, Dan M.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Roden, Dan M.] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA; [Stender, Steen] Copenhagen Univ Hosp, Dept Clin Biochem, Gentofte, Denmark; [Gislason, Gunnar H.] Danish Heart Fdn, Copenhagen, Denmark; [Gislason, Gunnar H.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Enghusen-Poulsen, Henrik] Univ Copenhagen, Rigshosp, Lab Clin Pharmacol, Copenhagen, Denmark; [Enghusen-Poulsen, Henrik] Univ Copenhagen, Bispebjerg & Frederiksberg Hosp, Dept Clin Pharmacol, Copenhagen, Denmark; [Enghusen-Poulsen, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Hansen, Torben] Steno Diabet Ctr, Gentofte, Denmark; [Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Hlth Sci & Technol, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Copenhagen; University of Southern Denmark; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Steno Diabetes Center; Aalborg University; Aalborg University Hospital	Andersson, C (corresponding author), Herlev & Gentofte Hosp, Dept Cardiol, Hellerup, Denmark.	ca@heart.dk	Pedersen, Oluf/AAG-8015-2020; Roden, Dan/ABD-5412-2021; DOMINGUEZ, Helena/ABC-1905-2021; Pedersen, Oluf/Z-1731-2019; Gislason, Gunnar/B-7561-2009; Grarup, Niels/K-2807-2015	DOMINGUEZ, Helena/0000-0002-7089-2636; Pedersen, Oluf/0000-0002-3321-3972; Gislason, Gunnar/0000-0002-0548-402X; Grarup, Niels/0000-0001-5526-1070; Krogager, Maria/0000-0001-9285-6903; Kober, Lars/0000-0002-6635-1466; stender, steen/0000-0003-1037-1158; Hansen, Torben/0000-0001-8748-3831; Have, Christian Theil/0000-0002-8634-4781	Novo Nordisk Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson C, 2018, CIRCULATION, V137, P1290, DOI 10.1161/CIRCULATIONAHA.117.032491; de Ferranti SD, 2016, CIRCULATION, V133, P1067, DOI 10.1161/CIRCULATIONAHA.115.018791; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Doughty M, 2002, AM HEART J, V143, P56, DOI 10.1067/mhj.2002.120300; Hasselbalch AL, 2008, J NUTR, V138, P2406, DOI 10.3945/jn.108.087668; Helgadottir A, 2016, NAT GENET, V48, P634, DOI 10.1038/ng.3561; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Krarup NT, 2015, ATHEROSCLEROSIS, V240, P305, DOI 10.1016/j.atherosclerosis.2015.03.022; Lightfoot JT, 2011, J NUTR, V141, P526, DOI 10.3945/jn.110.127290; Loukola Anu, 2014, Curr Addict Rep, V1, P75; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Micha R, 2017, JAMA-J AM MED ASSOC, V317, P912, DOI 10.1001/jama.2017.0947; Murabito JM, 2005, JAMA-J AM MED ASSOC, V294, P3117, DOI 10.1001/jama.294.24.3117; Natarajan P, 2017, CIRCULATION, V135, P2091, DOI 10.1161/CIRCULATIONAHA.116.024436; Navas-Nacher EL, 2001, ANN INTERN MED, V134, P433, DOI 10.7326/0003-4819-134-6-200103200-00007; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nielsen M, 2013, EUR HEART J, V34, P1198, DOI 10.1093/eurheartj/ehs475; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Otaki Y, 2013, AM J CARDIOL, V111, P1081, DOI 10.1016/j.amjcard.2012.12.042; Parikh NI, 2007, CIRCULATION, V116, P1473, DOI 10.1161/CIRCULATIONAHA.107.705202; Saw J, 2014, CAN J CARDIOL, V30, P814, DOI 10.1016/j.cjca.2014.01.011; SELLERS TA, 1991, GENET EPIDEMIOL, V8, P105, DOI 10.1002/gepi.1370080204; Tada H, 2016, EUR HEART J, V37, P561, DOI 10.1093/eurheartj/ehv462; Thanassoulis G, 2012, CIRC-CARDIOVASC GENE, V5, P113, DOI 10.1161/CIRCGENETICS.111.961342; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Waziri H, 2016, INT J CARDIOL, V203, P697, DOI 10.1016/j.ijcard.2015.09.012; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211690	10.1371/journal.pone.0211690	http://dx.doi.org/10.1371/journal.pone.0211690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726294	Green Published, gold, Green Submitted			2022-12-26	WOS:000457874000073
J	Lodberg, A; van der Eerden, BCJ; Boers-Sijmons, B; Thomsen, JS; Bruel, A; van Leeuwen, JPTM; Eijken, M				Lodberg, Andreas; van der Eerden, Bram C. J.; Boers-Sijmons, Bianca; Thomsen, Jesper Skovhus; Bruel, Annemarie; van Leeuwen, Johannes P. T. M.; Eijken, Marco			A follistatin-based molecule increases muscle and bone mass without affecting the red blood cell count in mice	FASEB JOURNAL			English	Article						IASP; therapeutic; erythropoiesis; muscle anabolic; osteoporosis	ACTIVIN-A; PARATHYROID-HORMONE; ERYTHROID-DIFFERENTIATION; ANDROGEN DEPRIVATION; POSTMENOPAUSAL WOMEN; MINERAL DENSITY; II RECEPTORS; MOUSE MODEL; MYOSTATIN; PROTEIN	Inhibitors of the activin receptor signaling pathway (IASPs) have become candidate therapeutics for sarcopenia and bone remodeling disorders because of their ability to increase muscle and bone mass. However, IASPs utilizing activin type IIA and IIB receptors are also potent stimulators of erythropoiesis, a feature that may restrict their usage to anemic patients because of increased risk of venous thromboembolism. Based on the endogenous TGF- superfamily antagonist follistatin (FST), a molecule in the IASP class, FSTHBS-mFc, was generated and tested in both ovariectomized and naive BALB/c and C57BL/6 mice. In ovariectomized mice, FSTHBS-mFc therapy dose-dependently increased cancellous bone mass up to 42% and improved bone microstructural indices. For the highest dosage of FSTHBS-mFc (30 mg/kg, 2 times/wk), the increase in cancellous bone mass was similar to that observed with parathyroid hormone therapy (1-34, 80 mu g/kg, 5 times/wk). Musculus quadriceps femoris mass dose-dependently increased up to 21% in ovariectomized mice. In both ovariectomized and naive mice, FSTHBS-mFc therapy did not influence red blood cell count or hematocrit or hemoglobin levels. If the results are reproduced, a human FSTHBS-mFc version could be applicable in patients with musculoskeletal conditions irrespective of hematocrit status.Lodberg, A., van der Eerden, B. C. J., Boers-Sijmons, B., Thomsen, J. S., Bruel, A., van Leeuwen, J. P. T. M., Eijken, M. A follistatin-based molecule increases muscle and bone mass without affecting the red blood cell count in mice.	[Lodberg, Andreas] Aarhus Univ Hosp, Dept Pulm Med, Aarhus, Denmark; [Lodberg, Andreas; Thomsen, Jesper Skovhus; Bruel, Annemarie] Aarhus Univ Hosp, Dept Biomed, Aarhus, Denmark; [Eijken, Marco] Aarhus Univ Hosp, Dept Renal Med, Aarhus, Denmark; [Eijken, Marco] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark; [van der Eerden, Bram C. J.; Boers-Sijmons, Bianca; van Leeuwen, Johannes P. T. M.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Erasmus University Rotterdam; Erasmus MC	Lodberg, A (corresponding author), Aarhus Univ, Dept Biomed, Wilhelm Meyers Alle 3, DK-8000 Aarhus C, Denmark.	andreaslodberg@gmail.com	Lodberg, Andreas/ABB-2541-2021; van der Eerden, Bram CJ/I-7496-2012; Bruel, Annemarie/AAT-2310-2020; van Leeuwen, Johannes/D-5015-2014	Lodberg, Andreas/0000-0001-9261-8753; van der Eerden, Bram CJ/0000-0003-4403-6497; Thomsen, Jesper Skovhus/0000-0001-9386-6679; Eijken, Marco/0000-0002-9043-3971; van Leeuwen, Johannes/0000-0002-2282-4006; Bruel, Annemarie/0000-0003-4833-0888				Attie KM, 2014, AM J HEMATOL, V89, P766, DOI 10.1002/ajh.23732; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; Bhattacharya I, 2018, CLIN PHARM DRUG DEV, V7, P484, DOI 10.1002/cpdd.386; Bialek P, 2014, BONE, V60, P162, DOI 10.1016/j.bone.2013.12.002; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Braekkan SK, 2010, HAEMATOL-HEMATOL J, V95, P270, DOI 10.3324/haematol.2009.008417; Burton LA, 2010, CLIN INTERV AGING, V5, P217; Carrancio S, 2014, BRIT J HAEMATOL, V165, P870, DOI 10.1111/bjh.12838; Cash JN, 2009, EMBO J, V28, P2662, DOI 10.1038/emboj.2009.205; Chiu CS, 2013, J GERONTOL A-BIOL, V68, P1181, DOI 10.1093/gerona/glt030; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Datta-Mannan A, 2013, J PHARMACOL EXP THER, V344, P616, DOI 10.1124/jpet.112.201491; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Dussiot M, 2014, NAT MED, V20, P398, DOI 10.1038/nm.3468; Eijken M, 2007, FASEB J, V21, P2949, DOI 10.1096/fj.07-8080com; Fajardo RJ, 2010, BONE, V46, P64, DOI 10.1016/j.bone.2009.09.018; Fuller K, 2000, BIOCHEM BIOPH RES CO, V268, P2, DOI 10.1006/bbrc.2000.2075; Gaddy-Kurten D, 2002, ENDOCRINOLOGY, V143, P74, DOI 10.1210/en.143.1.74; Goh BC, 2017, J BIOL CHEM, V292, P13809, DOI 10.1074/jbc.M117.782128; Hammers DW, 2017, EMBO MOL MED, V9, P531, DOI 10.15252/emmm.201607231; Hirotani H, 2002, CALCIFIED TISSUE INT, V70, P330, DOI 10.1007/s00223-001-2037-3; Ikenoue T, 1999, J CELL BIOCHEM, V75, P206, DOI 10.1002/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.3.CO;2-K; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; Koncarevic A, 2010, ENDOCRINOLOGY, V151, P4289, DOI 10.1210/en.2010-0134; Lach-Trifilieff E, 2014, MOL CELL BIOL, V34, P606, DOI 10.1128/MCB.01307-13; Latres E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15153; Latres E, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0060-8; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee YS, 2013, P NATL ACAD SCI USA, V110, pE3713, DOI 10.1073/pnas.1309907110; Liu LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136968; Liu WQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12794; Lodberg A, 2018, BONE, V110, P326, DOI 10.1016/j.bone.2018.02.026; Lodberg Andreas, 2015, Bone Rep, V2, P59, DOI 10.1016/j.bonr.2015.04.001; Lotinun S, 2010, BONE, V46, P1082, DOI 10.1016/j.bone.2010.01.370; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-24; Miller PD, 2016, JAMA-J AM MED ASSOC, V316, P722, DOI 10.1001/jama.2016.11136; Morvan F, 2017, P NATL ACAD SCI USA, V114, P12448, DOI 10.1073/pnas.1707925114; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Padhi D, 2014, J CLIN ENDOCR METAB, V99, pE1967, DOI 10.1210/jc.2014-1271; Pearsall RS, 2008, P NATL ACAD SCI USA, V105, P7082, DOI 10.1073/pnas.0711263105; Pistilli EE, 2011, AM J PATHOL, V178, P1287, DOI 10.1016/j.ajpath.2010.11.071; Platzbecker U, 2017, LANCET ONCOL, V18, P1338, DOI 10.1016/S1470-2045(17)30615-0; Polkey MI, 2019, AM J RESP CRIT CARE, V199, P313, DOI 10.1164/rccm.201802-0286OC; Poole KES, 2005, CURR OPIN PHARMACOL, V5, P612, DOI 10.1016/j.coph.2005.07.004; Rooks D, 2017, J AM GERIATR SOC, V65, P1988, DOI 10.1111/jgs.14927; Rooks DS, 2017, J CACHEXIA SARCOPENI, V8, P727, DOI 10.1002/jcsm.12205; Ruckle J, 2009, J BONE MINER RES, V24, P744, DOI 10.1359/JBMR.081208; SAKAI R, 1993, BIOCHEM BIOPH RES CO, V195, P39, DOI 10.1006/bbrc.1993.2006; Shen C, 2018, J PHARMACOL EXP THER, V366, P291, DOI 10.1124/jpet.118.248195; SHIMONAKA M, 1991, ENDOCRINOLOGY, V128, P3313, DOI 10.1210/endo-128-6-3313; SHIOZAKI M, 1992, P NATL ACAD SCI USA, V89, P1553, DOI 10.1073/pnas.89.5.1553; Sidis Y, 2005, ENDOCRINOLOGY, V146, P130, DOI 10.1210/en.2004-1041; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Thomsen JS, 2012, CALCIFIED TISSUE INT, V90, P294, DOI 10.1007/s00223-012-9576-7; Trendelenburg AU, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-3; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Vallet S, 2010, P NATL ACAD SCI USA, V107, P5124, DOI 10.1073/pnas.0911929107; Vegger JB, 2014, BONE, V66, P287, DOI 10.1016/j.bone.2014.06.020; Virchow R. L. K., 1910, THROMBOSE EMBOLIE 18, V7; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2; Westbroek I, 2007, J CELL BIOCHEM, V101, P360, DOI 10.1002/jcb.21177; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Woodhouse L, 2016, J FRALITY AGING, V5, P62, DOI 10.14283/jfa.2016.81; Yaden BC, 2014, J PHARMACOL EXP THER, V349, P355, DOI 10.1124/jpet.113.211169; Yamawaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078076; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2; Zhu YX, 2016, BIOANALYSIS, V8, P193, DOI 10.4155/bio.15.238	82	10	11	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6001	6010		10.1096/fj.201801969RR	http://dx.doi.org/10.1096/fj.201801969RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30759349	Bronze			2022-12-26	WOS:000466932600017
J	Kitab, B; Satoh, M; Ohmori, Y; Munakata, T; Sudoh, M; Kohara, M; Tsukiyama-Kohara, K				Kitab, Bouchra; Satoh, Masaaki; Ohmori, Yusuke; Munakata, Tsubasa; Sudoh, Masayuki; Kohara, Michinori; Tsukiyama-Kohara, Kyoko			Ribonucleotide reductase M2 promotes RNA replication of hepatitis C virus by protecting NS5B protein from hPLIC1-dependent proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatitis C virus (HCV); RNA polymerase; RNA virus; RNA synthesis; ribonucleotide reductase; host factor; hPLIC1; M2 subunit of ribonucleotide reductase; NS5B; viral replication; plus-stranded RNA virus; viral polymerase; liver cancer	CELL-CYCLE; DNA-DAMAGE; EXPRESSION; RRM2; QUANTIFICATION; UBIQUITINATION; PATHWAY; TARGET	Hepatitis C virus (HCV) establishes a chronic infection that can lead to cirrhosis and hepatocellular carcinoma. The HCV life cycle is closely associated with host factors that promote or restrict viral replication, the characterization of which could help to identify potential therapeutic targets. To this end, here we performed a genome-wide microarray analysis and identified ribonucleotide reductase M2 (RRM2) as a cellular factor essential for HCV replication. We found that RRM2 is up-regulated in response to HCV infection in quiescent hepatocytes from humanized chimeric mouse livers. To elucidate the molecular basis of RRM2 expression in HCV-infected cells, we used HCV-infected hepatocytes from chimeric mice and hepatoma cells infected with the HCV strain JFH1. Both models exhibited increased RRM2 mRNA and protein expression levels. Moreover, siRNA-mediated silencing of RRM2 suppressed HCV replication and infection. Of note, RRM2 and RNA polymerase nonstructural protein 5B (NS5B) partially co-localized in cells and co-immunoprecipitated, suggesting that they might interact. RRM2 knockdown reduced NS5B expression, which depended on the protein degradation pathway, as NS5B RNA levels did not decrease and NS5B protein stability correlated with RRM2 protein levels. We also found that RRM2 silencing decreased levels of hPLIC1 (human homolog 1 of protein linking integrin-associated protein and cytoskeleton), a ubiquitin-like protein that interacts with NS5B and promotes its degradation. This finding suggests that there is a dynamic interplay between RRM2 and the NS5B-hPLIC1 complex that has an important function in HCV replication. Together, these results identify a role of host RRM2 in viral RNA replication.	[Kitab, Bouchra; Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Transboundary Anim Dis Ctr, Kagoshima 8908580, Japan; [Kitab, Bouchra; Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Lab Anim Hyg, Kagoshima 8908580, Japan; [Satoh, Masaaki] Natl Inst Infect Dis, Virol 1, Shinjuku Ku, Tokyo 1628640, Japan; [Ohmori, Yusuke; Sudoh, Masayuki] Chugai Pharmaceut Co Ltd, Res Div, Kamakura, Kanagawa 2478530, Japan; [Munakata, Tsubasa; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 1568506, Japan	Kagoshima University; Kagoshima University; National Institute of Infectious Diseases (NIID); Chugai Pharmaceutical Co., Ltd.; Roche Holding; Tokyo Metropolitan Institute of Medical Science	Tsukiyama-Kohara, K (corresponding author), Kagoshima Univ, Transboundary Anim Dis Ctr, Kagoshima 8908580, Japan.; Tsukiyama-Kohara, K (corresponding author), Kagoshima Univ, Joint Fac Vet Med, Lab Anim Hyg, Kagoshima 8908580, Japan.; Kohara, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 1568506, Japan.	kohara-mc@igakuken.or.jp; kkohara@vet.kagoshima-u.ac.jp			Japan Agency for Medical Research and Development [16fk0210108s0201]; Japan Science and Technology Agency; Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Agency for Medical Research and Development Grants 16fk0210108s0201 and 16fk0210108s0201 (to M. K. and K. T.-K.) and by grants from the Japan Science and Technology Agency; the Ministry of Health, Labour, and Welfare of Japan; and the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation. The authors declare that they have no conflicts of interest with the contents of this article.	Anacker DC, 2016, VIROLOGY, V499, P383, DOI 10.1016/j.virol.2016.09.028; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Chung RT, 2014, NEW ENGL J MED, V370, P1576, DOI 10.1056/NEJMp1400986; Dai L, 2015, BLOOD, V126, P2821, DOI 10.1182/blood-2015-07-658823; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gao L, 2003, J VIROL, V77, P4149, DOI 10.1128/JVI.77.7.4149-4159.2003; Grolmusz VK, 2016, AM J CANCER RES, V6, P2041; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kyono K, 2002, BIOCHEM BIOPH RES CO, V292, P659, DOI 10.1006/bbrc.2002.6702; Lee B, 2014, GUT LIVER, V8, P662, DOI 10.5009/gnl13392; Liu X, 2016, BIOCHEM PHARMACOL, V103, P118, DOI 10.1016/j.bcp.2016.01.003; Liu XY, 2013, CLIN SCI, V124, P567, DOI 10.1042/CS20120240; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 2013, CURR TOP MICROBIOL, V369, P167, DOI 10.1007/978-3-642-27340-7_7; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Munakata T, 2005, P NATL ACAD SCI USA, V102, P18159, DOI 10.1073/pnas.0505605102; Nishimura T, 2009, J BIOL CHEM, V284, P36442, DOI 10.1074/jbc.M109.043232; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Ricardo-Lax I, 2015, J HEPATOL, V63, P789, DOI 10.1016/j.jhep.2015.05.017; Saito M, 2012, J MED VIROL, V84, P733, DOI 10.1002/jmv.23250; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Salem NE, 2013, MICROBIOL IMMUNOL, V57, P179, DOI 10.1111/1348-0421.12025; Satoh M, 2011, J INFECT DIS, V204, P1172, DOI 10.1093/infdis/jir501; Scholle F, 2004, J VIROL, V78, P1513, DOI 10.1128/JVI.78.3.1513-1524.2004; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Tsukiyama-Kohara K, 2004, J BIOL CHEM, V279, P14531, DOI 10.1074/jbc.M312822200; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang N, 2014, BRIT J CANCER, V110, P1034, DOI 10.1038/bjc.2013.817; Watanabe T, 2006, GENE THER, V13, P883, DOI 10.1038/sj.gt.3302734; Wilson PM, 2011, NUCLEIC ACIDS RES, V39, pE112, DOI 10.1093/nar/gkr350	33	12	12	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5759	5773		10.1074/jbc.RA118.004397	http://dx.doi.org/10.1074/jbc.RA118.004397			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30755480	Green Published, hybrid			2022-12-26	WOS:000465077500003
J	Maeda, TK; Sugiura, D; Okazaki, IM; Maruhashi, T; Okazaki, T				Maeda, Takeo K.; Sugiura, Daisuke; Okazaki, Il-mi; Maruhashi, Takumi; Okazaki, Taku			Atypical motifs in the cytoplasmic region of the inhibitory immune co-receptor LAG-3 inhibit T cell activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; T cell; T cell receptor (TCR); inhibition mechanism; immunotherapy; monoclonal antibody; cytokine induction; co-receptor; immune checkpoint; LAG-3	CUTTING EDGE; PROTEIN; CD223; MECHANISM; BLOCKADE; KINASE; LIGAND; PD-1; CD4	T cell activation is tightly regulated by both stimulatory and inhibitory co-receptors and has been a focus in the development of interventions for managing cancer or autoimmune diseases. Targeting the inhibitory co-receptors programmed cell death 1 (PD-1) and cytotoxic T lymphocyte-associated protein 4 (CTLA-4) has successfully eradicated tumors but induced immune-related adverse events in humans and mice. The beneficial and adverse effects of targeting these co-receptors highlight their importance in cancer immunity and also autoimmunity. Although the therapeutic potencies of other inhibitory co-receptors are under extensive investigation, their inhibitory mechanisms and their functional differences are not well understood. Here we analyzed the inhibitory mechanisms of lymphocyte activation gene-3 (LAG-3), another inhibitory co-receptor, by using an in vitro T cell activation system and a high-affinity anti-LAG-3 antibody that strongly interferes with the binding of LAG-3 to its ligand. We found that the expression level of LAG-3 strongly correlates with the inhibitory function of LAG-3, suggesting that LAG-3 functions as a rheostat rather than as a breaker of T cell activation. By evaluating the inhibitory capacities of various LAG-3 variants relative to their expression levels, we found that LAG-3 transduces two independent inhibitory signals through an FXXL motif in the membrane-proximal region and the C-terminal EX repeat. These motifs have not been reported previously for inhibitory co-receptors, suggesting that LAG-3 inhibits T cell activation through a nonredundant inhibitory mechanisms along with the other inhibitory co-receptors. Our findings provide a rationale for combinatorial targeting of LAG-3 and the other inhibitory co-receptors to improve cancer immunotherapy.	[Maeda, Takeo K.; Sugiura, Daisuke; Okazaki, Il-mi; Maruhashi, Takumi; Okazaki, Taku] Tokushima Univ, Div Immune Regulat, Inst Adv Med Sci, 3-18-15 Kuramoto, Tokushima 7708503, Japan	Tokushima University	Okazaki, T (corresponding author), Tokushima Univ, Div Immune Regulat, Inst Adv Med Sci, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	tokazaki@genome.tokushima-u.ac.jp		Okazaki, Il-mi/0000-0001-8644-0100; Sugiura, Daisuke/0000-0002-3865-3889; Maruhashi, Takumi/0000-0003-2944-1611; Okazaki, Taku/0000-0003-4790-1925	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency; Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development [JP18am0301007]; Japan Society for the Promotion of Science [JP18H05417]	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development JP18am0301007 (to T. O.), and Grant-in-Aid by the Japan Society for the Promotion of Science JP18H05417 (to T. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews LP, 2017, IMMUNOL REV, V276, P80, DOI 10.1111/imr.12519; Bae J, 2014, J IMMUNOL, V193, P3101, DOI 10.4049/jimmunol.1401025; BAIXERAS E, 1992, J EXP MED, V176, P327, DOI 10.1084/jem.176.2.327; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Camisaschi C, 2010, J IMMUNOL, V184, P6545, DOI 10.4049/jimmunol.0903879; Chiara F, 2004, J BIOL CHEM, V279, P19732, DOI 10.1074/jbc.M314070200; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; HUARD B, 1995, EUR J IMMUNOL, V25, P2718, DOI 10.1002/eji.1830250949; Iouzalen N, 2001, EUR J IMMUNOL, V31, P2885, DOI 10.1002/1521-4141(2001010)31:10<2885::AID-IMMU2885>3.0.CO;2-2; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Marion S, 2007, J BIOL CHEM, V282, P18937, DOI 10.1074/jbc.M700090200; Maruhashi T, 2018, NAT IMMUNOL, V19, P1415, DOI 10.1038/s41590-018-0217-9; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Terskikh AV, 1997, P NATL ACAD SCI USA, V94, P1663, DOI 10.1073/pnas.94.5.1663; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Wang J, 2019, CELL, V176, P334, DOI 10.1016/j.cell.2018.11.010; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2003, EUR J IMMUNOL, V33, P970, DOI 10.1002/eji.200323382; Workman CJ, 2002, EUR J IMMUNOL, V32, P2255, DOI 10.1002/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392	31	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6017	6026		10.1074/jbc.RA119.007455	http://dx.doi.org/10.1074/jbc.RA119.007455			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30760527	hybrid, Green Published			2022-12-26	WOS:000465077500032
J	Yamamoto, M; Du, QL; Song, JP; Wang, HY; Watanabe, A; Tanaka, Y; Kawaguchi, Y; Inoue, J; Matsuda, Z				Yamamoto, Mizuki; Du, Qingling; Song, Jiping; Wang, Hongyun; Watanabe, Aya; Tanaka, Yuetsu; Kawaguchi, Yasushi; Inoue, Jun-ichiro; Matsuda, Zene			Cell-cell and virus-cell fusion assay-based analyses of alanine insertion mutants in the distal 9 portion of the JRFL gp41 subunit from HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); membrane fusion; viral protein; virology; virus entry; envelope protein; gp41; NanoLuc; syncytia formation; Vpr	MEMBRANE-FUSION; SCANNING MUTAGENESIS; HEPTAD REPEAT; COILED COILS; PROTEIN; GLYCOPROTEIN; AGGREGATION; REPORTER; REGIONS; EPITOPE	Membrane fusion is the first essential step in HIV-1 replication. The gp41 subunit of HIV-1 envelope protein (Env), a class I fusion protein, achieves membrane fusion by forming a structure called a six-helix bundle composed of N- and C-terminal heptad repeats. We have recently shown that the distal portion of the 9 helix in the C-terminal heptad repeat of X4-tropic HXB2 Env plays a critical role in the late-stage membrane fusion and viral infection. Here, we used R5-tropic JRFL Env and constructed six alanine insertion mutants, 641+A to 646+A, in the further distal portion of 9 where several glutamine residues are conserved (the number corresponds to the position of the inserted alanine in JRFL Env). 644+A showed the most severe defect in syncytia formation. Decreased fusion pore formation activity, revealed by a dual split protein assay, was observed in all mutants except 641+A. Sequence analysis and substitution of inserted 644A with Gln revealed that the glutamine residue at position 644 that forms complex hydrogen-bond networks with other polar residues on the surface of the six-helix bundle is critical for cell-cell fusion. We also developed a split NanoLuc (R) (Nluc) reporter-based assay specific to the virus-cell membrane fusion step to analyze several of the mutants. Interestingly syncytia-competent mutants failed to display Nluc activities. In addition to defective fusion activity, a reduction of Env incorporation into virions may further contribute to differences in cell-cell and virus-cell fusions.	[Yamamoto, Mizuki; Watanabe, Aya; Kawaguchi, Yasushi; Inoue, Jun-ichiro; Matsuda, Zene] Univ Tokyo, Res Ctr Asian Infect Dis, Inst Med Sci, 4-6-1 Minato Ku, Tokyo 1088639, Japan; [Yamamoto, Mizuki; Watanabe, Aya; Inoue, Jun-ichiro] Univ Tokyo, Div Cellular & Mol Biol, Inst Med Sci, 4-6-1 Minato Ku, Tokyo 1088639, Japan; [Kawaguchi, Yasushi] Univ Tokyo, Div Mol Virol, Inst Med Sci, Dept Microbiol & Immunol, Tokyo 1088639, Japan; [Du, Qingling; Song, Jiping; Wang, Hongyun; Matsuda, Zene] Chinese Acad Sci, Lab Struct Virol & Immunol, Inst Biophys, Beijing 100864, Peoples R China; [Tanaka, Yuetsu] Univ Ryukyus, Dept Immunol, Grad Sch Med, Nishihara, Okinawa, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of the Ryukyus	Matsuda, Z (corresponding author), Univ Tokyo, Res Ctr Asian Infect Dis, Inst Med Sci, 4-6-1 Minato Ku, Tokyo 1088639, Japan.; Inoue, J (corresponding author), Univ Tokyo, Div Cellular & Mol Biol, Inst Med Sci, 4-6-1 Minato Ku, Tokyo 1088639, Japan.	jun-i@ims.u-tokyo.ac.jp; zmatsuda@ims.u-tokyo.ac.jp	Yamamoto, Mizuki/AAW-1688-2020	Yamamoto, Mizuki/0000-0003-3731-1702; Kawaguchi, Yasushi/0000-0001-8232-6925	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development [JP18fm0108006]; Program of Japan Initiative for Global Research Network on Infectious Diseases from the Japan Agency for Medical Research and Development [JP18fm0108006]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [16H06575]; Japan Society for the Promotion of Science [18K15235]	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Program of Japan Initiative for Global Research Network on Infectious Diseases from the Japan Agency for Medical Research and Development; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Research Program on Emerging and Re-emerging Infectious Diseases and the Program of Japan Initiative for Global Research Network on Infectious Diseases from the Japan Agency for Medical Research and Development under Grant JP18fm0108006; Grantin-Aid 16H06575 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to J. I.); and Grant-in-Aid 18K15235 from Japan Society for the Promotion of Science (to M. Y.). This work was also supported by funds from the Japan Society for the Promotion of Science Coreto-Core Program, A: Advanced Research Networks (to J. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Brown JH, 1996, PROTEINS, V26, P134; BUTINI L, 1994, EUR J IMMUNOL, V24, P2191, DOI 10.1002/eji.1830240939; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; Diaz-Aguilar B, 2013, BIOCHEMISTRY-US, V52, P3552, DOI 10.1021/bi400201h; Dixon A. S. V., 2017, U. S. patent, Patent No. [9,797,889 B2, 9797889]; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; GRUBER MF, 1991, AIDS RES HUM RETROV, V7, P45, DOI 10.1089/aid.1991.7.45; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; HEINZ DW, 1993, NATURE, V361, P561, DOI 10.1038/361561a0; Ishikawa H, 2012, PROTEIN ENG DES SEL, V25, P813, DOI 10.1093/protein/gzs051; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; Johnson LM, 2011, J AM CHEM SOC, V133, P10038, DOI 10.1021/ja203358t; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kondo N, 2015, J BIOL CHEM, V290, P6558, DOI 10.1074/jbc.M114.623181; Liu DH, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0410-9; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Matsuda Z., 2011, CURR PROTOC CELL BIO, V50, DOI [10.1002/0471143030.cb2609s50, DOI 10.1002/0471143030.CB2609S50]; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Nakane S, 2015, METHODS MOL BIOL, P229, DOI 10.1007/978-1-4939-2703-6_17; Nakane S, 2015, J BIOL CHEM, V290, P15279, DOI 10.1074/jbc.M114.628610; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Schwinn MK, 2018, ACS CHEM BIOL, V13, P467, DOI 10.1021/acschembio.7b00549; Sen J, 2010, BIOCHEMISTRY-US, V49, P5057, DOI 10.1021/bi1005267; Suntoke TR, 2005, J BIOL CHEM, V280, P19852, DOI 10.1074/jbc.M502196200; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Vetter IR, 1996, PROTEIN SCI, V5, P2399, DOI 10.1002/pro.5560051203; Wang HB, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113880, 10.1371/journal.pone.0089155, 10.1371/journal.pone.0091730]; Wang JQ, 2009, J VIROL METHODS, V161, P216, DOI 10.1016/j.jviromet.2009.06.017; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Yi HA, 2015, BIOCHEMISTRY-US, V54, P1681, DOI 10.1021/bi501171r; YUAN X, 1990, AIDS RES HUM RETROV, V6, P1265, DOI 10.1089/aid.1990.6.1265	42	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5677	5687		10.1074/jbc.RA118.004579	http://dx.doi.org/10.1074/jbc.RA118.004579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30737278	Green Published, hybrid			2022-12-26	WOS:000464517500035
J	Hei, ZF; Wu, SQ; Liu, ZZ; Wang, J; Fang, PF				Hei, Zhoufei; Wu, Siqi; Liu, Zaizhou; Wang, Jing; Fang, Pengfei			Retractile lysyl-tRNA synthetase-AIMP2 assembly in the human multi-aminoacyl-tRNA synthetase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; protein complex; crystal structure; molecular biology; translation; aminoacyl-tRNA syntheses complex-interacting multifunctional protein 2 (AIMP2); cardiomyopathy; lysyl-tRNA synthetase (LysRS); multi-aminoacyl-tRNA syntheses complex (MSC)	ACTIVATING POLYPEPTIDE-II; P43 COMPONENT; TRANSLATION; PHOSPHORYLATION; CYTOKINE; TRIGGER	Multi-aminoacyl-tRNA synthetase complex (MSC) is the second largest machinery for protein synthesis in human cells and also regulates multiple nontranslational functions through its components. Previous studies have shown that the MSC can respond to external signals by releasing its components to function outside it. The internal assembly is fundamental to MSC regulation. Here, using crystal structural analyses (at 1.88 resolution) along with molecular modeling, gel-filtration chromatography, and co-immunoprecipitation, we report that human lysyl-tRNA synthetase (LysRS) forms a tighter assembly with the scaffold protein aminoacyl-tRNA synthetase complex-interacting multifunctional protein 2 (AIMP2) than previously observed. We found that two AIMP2 N-terminal peptides form an antiparallel scaffold and hold two LysRS dimers through four binding motifs and additional interactions. Of note, the four catalytic subunits of LysRS in the tightly assembled complex were all accessible for tRNA recognition. We further noted that two recently reported human disease-associated mutations conflict with this tighter assembly, cause LysRS release from the MSC, and inactivate the enzyme. These findings reveal a previously unknown dimension of MSC subcomplex assembly and suggest that the retractility of this complex may be critical for its physiological functions.	[Hei, Zhoufei; Wu, Siqi; Liu, Zaizhou; Wang, Jing; Fang, Pengfei] Univ Chinese Acad Sci, Chinese Acad Sci, State Key Lab Bioorgan & Nat Prod Chem, Ctr Excellence Mol Synth,Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; University of Chinese Academy of Sciences, CAS	Fang, PF (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.	fangpengfei@sioc.ac.cn	Fang, Pengfei/O-3696-2015	Fang, Pengfei/0000-0002-3448-5494; Wang, Jing/0000-0002-7566-1212; Hei, Zhoufei/0000-0002-1350-3729	National Natural Science Foundation of China [21778064, 21778067]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB20000000]; 1000-Talent Young Investigator Award; 100-Talent Program of the Chinese Academy of Sciences; State Key Laboratory of Bioorganic and Natural Products Chemistry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); 1000-Talent Young Investigator Award; 100-Talent Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Bioorganic and Natural Products Chemistry(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grant 21778064, Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB20000000, and a 1000-Talent Young Investigator Award (to P.F.); and by the 100-Talent Program of the Chinese Academy of Sciences, National Natural Science Foundation of China Grant 21778067, and funds from the State Key Laboratory of Bioorganic and Natural Products Chemistry (to J. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arif A, 2012, MOL CELL BIOL, V32, P5046, DOI 10.1128/MCB.01168-12; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Cho HY, 2015, J BIOL CHEM, V290, P29313, DOI 10.1074/jbc.M115.690867; CIRAKOGLU B, 1985, FEBS LETT, V183, P185; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; Duchon AA, 2017, J VIROL, V91, DOI 10.1128/JVI.01240-17; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang PF, 2011, P NATL ACAD SCI USA, V108, P8239, DOI 10.1073/pnas.1100224108; Fu YY, 2014, P NATL ACAD SCI USA, V111, P15084, DOI 10.1073/pnas.1408836111; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Havrylenko S, 2015, INT J MOL SCI, V16, P6571, DOI 10.3390/ijms16036571; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; KAO J, 1992, J BIOL CHEM, V267, P20239; Kim DG, 2016, CANCER RES, V76, P3422, DOI 10.1158/0008-5472.CAN-15-3255; Kim DG, 2014, NAT CHEM BIOL, V10, P29, DOI [10.1038/nchembio.1381, 10.1038/NCHEMBIO.1381]; Kim DG, 2012, FASEB J, V26, P4142, DOI 10.1096/fj.12-207639; Kleiman L, 2010, FEBS LETT, V584, P359, DOI 10.1016/j.febslet.2009.11.038; Kwon NH, 2011, P NATL ACAD SCI USA, V108, P19635, DOI 10.1073/pnas.1103922108; Lee EY, 2016, NAT IMMUNOL, V17, P1252, DOI 10.1038/ni.3542; Lee MS, 2016, J MICROBIOL BIOTECHN, V26, P432, DOI 10.4014/jmb.1511.11056; Liu S, 2016, RNA, V22, P1828, DOI 10.1261/rna.058081.116; Motzik A, 2013, TRENDS MOL MED, V19, P726, DOI 10.1016/j.molmed.2013.07.011; Murray JC, 2004, J LEUKOCYTE BIOL, V75, P772, DOI 10.1189/jlb.1003487; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Park SG, 2002, J BIOL CHEM, V277, P45243, DOI 10.1074/jbc.M207934200; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Remion A, 2016, FEBS OPEN BIO, V6, P696, DOI 10.1002/2211-5463.12074; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Schwarz MA, 1999, J EXP MED, V190, P341, DOI 10.1084/jem.190.3.341; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shalak V, 2007, J BIOL CHEM, V282, P10935, DOI 10.1074/jbc.M611737200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verrigni D, 2017, CLIN GENET, V91, P918, DOI 10.1111/cge.12931; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019	40	12	12	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4775	4783		10.1074/jbc.RA118.006356	http://dx.doi.org/10.1074/jbc.RA118.006356			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30733335	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000463985600004
J	Rahman, NA; Abu Hanifah, S; Mobarak, NN; Su'ait, MS; Ahmad, A; Shyuan, LK; Khoon, LT				Rahman, Noriah Abdul; Abu Hanifah, Sharina; Mobarak, Nadhratun Naiim; Su'ait, Mohd Sukor; Ahmad, Azizan; Shyuan, Loh Kee; Khoon, Lee Tian			Synthesis and characterizations of o-nitrochitosan based biopolymer electrolyte for electrochemical devices	PLOS ONE			English	Article							MOLECULAR-STRUCTURE; CONTROLLED-RELEASE; CHITOSAN; CONDUCTIVITY; MICROGELS; CHITIN; SALT	For the past decade, much attention was focused on polysaccharide natural resources for various purposes. Throughout the works, several efforts were reported to prepare new function of chitosan by chemical modifications for renewable energy, such as fuel cell application. This paper focuses on synthesis of the chitosan derivative, namely, O-nitrochitosan which was synthesized at various compositions of sodium hydroxide and reacted with nitric acid fume. Its potential as biopolymer electrolytes was studied. The substitution of nitro group was analyzed by using Attenuated Total Reflectance Fourier Transform Infra-Red (ATR-FTIR) analysis, Nuclear Magnetic Resonance (NMR) and Elemental Analysis (CHNS). The structure was characterized by X-ray Diffraction (XRD) and its thermal properties were examined by using differential scanning calorimetry (DSC) and thermal gravimetric analysis (TGA). Whereas, the ionic conductivity of the samples was analyzed by electro-chemical impedance spectroscopy (EIS). From the IR spectrum results, the nitro group peaks of O-nitrochitosan, positioned at 1646 and 1355 cm(-1), were clearly seen for all pH media. At pH 6, O-nitrochitosan exhibited the highest degree of substitution at 0.74 when analyzed by CHNS analysis and NMR further proved that C-6 of glucosamine ring was shifted to the higher field. However, the thermal stability and glass transition temperatures were decreased with acidic condition. The highest ionic conductivity of O-nitrochitosan was obtained at similar to 10(-6) cm(-1). Overall, the electrochemical property of new O-nitrochitosan showed a good improvement as compared to chitosan and other chitosan derivatives. Hence, O-nitrochitosan is a promising biopolymer electrolyte and has the potential to be applied in electrochemical devices.	[Rahman, Noriah Abdul; Abu Hanifah, Sharina; Mobarak, Nadhratun Naiim; Ahmad, Azizan] Univ Kebangsaan Malaysia, Fac Sci & Technol, Bangi, Selangor Darul, Malaysia; [Abu Hanifah, Sharina; Mobarak, Nadhratun Naiim; Su'ait, Mohd Sukor; Ahmad, Azizan] Univ Kebangsaan Malaysia, Polymer Res Ctr PORCE, Fac Sci & Technol, Bangi, Selangor Darul, Malaysia; [Su'ait, Mohd Sukor] Univ Kebangsaan Malaysia, SERI, Bangi, Selangor Darul, Malaysia; [Shyuan, Loh Kee; Khoon, Lee Tian] Univ Kebangsaan Malaysia, FCI, Bangi, Selangor Darul, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Abu Hanifah, S (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Bangi, Selangor Darul, Malaysia.; Abu Hanifah, S (corresponding author), Univ Kebangsaan Malaysia, Polymer Res Ctr PORCE, Fac Sci & Technol, Bangi, Selangor Darul, Malaysia.; Khoon, LT (corresponding author), Univ Kebangsaan Malaysia, FCI, Bangi, Selangor Darul, Malaysia.	sharina@ukm.edu.my; edison_tiankhoon@hotmail.com	Loh, Kee Shyuan/B-3648-2016; mobarak, nadhratun naiim/AAT-8391-2021; KHOON, LEE TIAN/AAI-8042-2020; Su'ait, Mohd Sukor/A-5426-2011	Loh, Kee Shyuan/0000-0002-2555-7521; mobarak, nadhratun naiim/0000-0002-0636-3473; KHOON, LEE TIAN/0000-0002-9490-4451; Su'ait, Mohd Sukor/0000-0001-9257-0657	Fundamental research grant scheme UKM [FRGS/1/2016/TK07/UKM/02/2]; Modal Insan UKM [MI-2018-002]	Fundamental research grant scheme UKM; Modal Insan UKM	This work was supported by Fundamental research grant scheme UKM FRGS/1/2016/TK07/UKM/02/2, http://research.ukm.my/kpt/frgs/, to Dr. Sharina Abu Hanifah, and Modal Insan UKM, MI-2018-002, http://appsmu.ukm.my/smip/login, to Dr. Lee Tian Khoon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2015, CARBOHYD POLYM, V132, P164, DOI 10.1016/j.carbpol.2015.06.034; An NT, 2009, CARBOHYD POLYM, V75, P489, DOI 10.1016/j.carbpol.2008.08.017; Aziz NA, 2012, J NON-CRYST SOLIDS, V358, P1581, DOI 10.1016/j.jnoncrysol.2012.04.019; Cardoso J, 2015, J PHYS CHEM BIOPHYS, V10; Chen LY, 2002, J APPL POLYM SCI, V83, P1233, DOI 10.1002/app.2290; Chen LY, 2003, CARBOHYD RES, V338, P333, DOI 10.1016/S0008-6215(02)00462-7; de Abreu FR, 2009, CARBOHYD POLYM, V75, P214, DOI 10.1016/j.carbpol.2008.06.009; de Alvarenga ES, BIOTECHNOLOGY BIOPOL; de Britto D, 2007, CARBOHYD POLYM, V69, P305, DOI 10.1016/j.carbpol.2006.10.007; Jaafar NK, 2011, MATER RES INNOV, V15, P202, DOI 10.1179/143307511X13031890749136; Jayakumar R, 2008, INT J BIOL MACROMOL, V42, P335, DOI 10.1016/j.ijbiomac.2007.12.011; Jayakumar R, 2010, PROG MATER SCI, V55, P675, DOI 10.1016/j.pmatsci.2010.03.001; Jha PK, 2013, COATINGS, V3, P140, DOI 10.3390/coatings3030140; Kittur FS, 2002, CARBOHYD POLYM, V49, P185, DOI 10.1016/S0144-8617(01)00320-4; Kurek M, 2012, POLYM DEGRAD STABIL, V97, P1232, DOI 10.1016/j.polymdegradstab.2012.05.039; Liew CW, 2012, ECS J SOLID STATE SC, P1; Liew JWY, 2018, ENERGIES, V11, DOI 10.3390/en11071910; Ma GP, 2008, CARBOHYD POLYM, V74, P121, DOI 10.1016/j.carbpol.2008.01.028; Majid SR, 2005, PHYSICA B, V355, P78, DOI 10.1016/j.physb.2004.10.025; Mobarak Nadhratun Naiim, 2015, Advanced Materials Research, V1107, P168, DOI 10.4028/www.scientific.net/AMR.1107.168; Mobarak NN, 2013, ELECTROCHIM ACTA, V92, P161, DOI 10.1016/j.electacta.2012.12.126; Mobarak NN, 2012, SOLID STATE IONICS, V224, P51, DOI 10.1016/j.ssi.2012.07.010; Mobarak NN, 2013, AIP CONF PROC, V1571, P843, DOI 10.1063/1.4858760; Pires NR, 2013, CARBOHYD POLYM, V91, P92, DOI 10.1016/j.carbpol.2012.08.011; Quijada-Garrido I, 2007, CARBOHYD POLYM, V68, P173, DOI 10.1016/j.carbpol.2006.07.025; Rahman NA, 2015, SAINS MALAYS, V44, P995, DOI 10.17576/jsm-2015-4407-11; Rao KSVK, 2006, CARBOHYD POLYM, V66, P333, DOI 10.1016/j.carbpol.2006.03.025; Samanta HS, 2014, CARBOHYD POLYM, V106, P109, DOI 10.1016/j.carbpol.2014.01.097; Suyatma NE, 2005, J AGR FOOD CHEM, V53, P3950, DOI 10.1021/jf048790+; Tsai HS, 2010, J APPL POLYM SCI, V116, P1686, DOI 10.1002/app.31689; Vaghari H., 2013, SUSTAIN CHEM PROCESS, P1, DOI [10.1186/2043-7129-1-16, DOI 10.1186/2043-7129-1-16]; Wan Y, 2003, POLYMER, V44, P1057, DOI 10.1016/S0032-3861(02)00881-9; Wang WL, 2015, CARBOHYD POLYM, V127, P11, DOI 10.1016/j.carbpol.2015.03.040; Yusuf SNF, 2016, RSC ADV, V6, P27714, DOI 10.1039/c6ra04188d	34	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212066	10.1371/journal.pone.0212066	http://dx.doi.org/10.1371/journal.pone.0212066			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768616	Green Published, gold, Green Submitted			2022-12-26	WOS:000458766300020
J	Dieter, BP; Meek, RL; Anderberg, RJ; Cooney, SK; Bergin, JL; Zhang, HY; Nair, V; Kretzler, M; Brosius, FC; Tuttle, KR				Dieter, Brad P.; Meek, Rick L.; Anderberg, Robert J.; Cooney, Sheryl K.; Bergin, Jen L.; Zhang, Hongyu; Nair, Viji; Kretzler, Matthias; Brosius, Frank C.; Tuttle, Katherine R.			Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease	PLOS ONE			English	Article							INDUCTION; PROTEIN; A3; INFLAMMATION; NEPHROPATHY; RECRUITMENT; EXPRESSION; GENE	Background Serum amyloid A (SAA), a potent inflammatory mediator, and Janus kinase 2 (JAK2), an intracellular signaling kinase, are increased by diabetes. The aims were to elucidate: 1) a JAK2-mediated pathway for increased SAA in the kidneys of diabetic mice; 2) a JAK2-SAA pathway for inflammation in podocytes. Methods Akita diabetic mice (129S6) with podocyte JAK2 overexpression and angiotensin II infusion (4 weeks) were given a JAK1,2 inhibitor (LY03103801, 3 mg/kg/day orally for the last two weeks). Kidneys were immunostained for SAA isoform 3 (SAA3). SAA3 knockout and control mouse podocytes were exposed to advanced glycation end products (AGE) or exogenous SAA with JAK2 inhibition (Tyrphostin AG 490, 50 mu M). JAK2 activity (phosphorylation, Western blot, 1 hour) and mRNA for SAA3 and associated inflammatory genes (Cxcl5, Ccl2, and Ccl5) were measured by RT-PCR (20 hours). Results SAA3 protein was present throughout the diabetic kidney, and podocyte JAK2 overexpression increased tubulointerstitial SAA3 compared to wild type diabetic controls, 43% versus 14% (p = 0.007); JAK1,2 inhibition attenuated the increase in SAA3 to 15% (p = 0.003). Urine albumin-to-creatinine ratio (r = 0.49, p = 0.03), mesangial index (r = 0.64, p = 0.001), and glomerulosclerosis score (r = 0.51, p = 0.02) were associated with SAA3 immunostaining scores across mouse groups. Exposing podocytes to AGE or exogenous SAA increased JAK2 activity within one hour and mRNA for associated inflammatory genes after 20 hours. JAK2 inhibition reduced SAA3 mRNA expression in podocytes exposed to AGE or SAA. SAA3 knockout podocytes had > 85% lower AGE-induced inflammatory genes. Conclusion JAK1,2 inhibition reduced SAA and histological features of DKD in podocyte JAK2-overexpressing mice. In podocytes exposed to a diabetes-like condition, JAK2 inhibition reduced expression of SAA, while SAA knockout blocked expression of associated proinflammatory mediators. SAA may promote JAK2-dependent inflammation in the diabetic kidney.	[Dieter, Brad P.; Meek, Rick L.; Anderberg, Robert J.; Cooney, Sheryl K.; Bergin, Jen L.; Tuttle, Katherine R.] Providence Hlth Care, Providence Med Res Ctr, Spokane, WA 99220 USA; [Zhang, Hongyu; Nair, Viji; Kretzler, Matthias; Brosius, Frank C.] Univ Michigan, Internal Med, Ann Arbor, MI 48109 USA; [Nair, Viji; Brosius, Frank C.] Univ Michigan, Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Tuttle, Katherine R.] Univ Washington, Inst Translat Hlth Sci, Kidney Res Inst, Div Nephrol, Seattle, WA 98195 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle	Dieter, BP (corresponding author), Providence Hlth Care, Providence Med Res Ctr, Spokane, WA 99220 USA.	brad.dieter@providence.org		Tuttle, Katherine/0000-0002-2235-0103	National Institutes of Health [U01 DK60994, R24DK082841]; Juvenile Diabetes Research Foundation International [2-SRA-201-257-Q-R]; Michigan O'Brien Translational Kidney Core Center [P30 DK081943]; Michigan Diabetes Research Center [P30 DK020572]; A.A. Taubman Medical Research Institute at the University of Michigan; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Michigan O'Brien Translational Kidney Core Center; Michigan Diabetes Research Center; A.A. Taubman Medical Research Institute at the University of Michigan; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Sources of support for this work include grants from National Institutes of Health (U01 DK60994, R24DK082841) and Juvenile Diabetes Research Foundation International (2-SRA-201-257-Q-R), and research support from the Michigan O'Brien Translational Kidney Core Center (P30 DK081943), the Michigan Diabetes Research Center (P30 DK020572), and the A.A. Taubman Medical Research Institute at the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg RJ, 2015, LAB INVEST, V95, P250, DOI 10.1038/labinvest.2014.163; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Berthier CC, 2009, DIABETES, V58, P469, DOI 10.2337/db08-1328; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; den Hartigh LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108564; Dieter BP, 2016, J DIABETES COMPLICAT; Hagihara K, 2004, BIOCHEM BIOPH RES CO, V314, P363, DOI 10.1016/j.bbrc.2003.12.096; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hodgin JB, 2013, DIABETES, V62, P299, DOI 10.2337/db11-1667; HOFFMAN JS, 1982, J BIOL CHEM, V257, P518; Meek RL, 2013, NEPHROL DIAL TRANSPL, V28, P1711, DOI 10.1093/ndt/gfs579; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Migita K, 2014, CLIN EXP IMMUNOL, V175, P208, DOI 10.1111/cei.12234; Migita K, 2011, J RHEUMATOL, V38, P2309, DOI 10.3899/jrheum.101362; Mullan RH, 2006, ARTHRITIS RHEUM-US, V54, P105, DOI 10.1002/art.21518; Saulnier PJ, 2017, AM J NEPHROL, V46, P276, DOI 10.1159/000481269; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Thaler R, 2015, FASEB J, V29, P1344, DOI 10.1096/fj.14-265512; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuttle KR, 2005, J AM SOC NEPHROL, V16, P1537, DOI 10.1681/ASN.2005040393; Tuttle KR, 2018, NEPHROL DIAL TRANSPL, P1; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Zhang H, 2017, KIDNEY INT; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	26	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0211555	10.1371/journal.pone.0211555	http://dx.doi.org/10.1371/journal.pone.0211555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763329	gold, Green Published, Green Submitted			2022-12-26	WOS:000458763900014
J	Lai, YT; Cheng, KC; Lai, CN; Lai, YJ				Lai, Yen-Tso; Cheng, Kuan-Chen; Lai, Chia-Nuan; Lai, Ying-Jang			Isolation and identification of aroma producing strain with esterification capacity from yellow water	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE YEAST; ETHYL-ACETATE PRODUCTION; LACTIC-ACID BACTERIUM; ALCOHOL ACETYLTRANSFERASE; KLUYVEROMYCES-MARXIANUS; ETHANOL-PRODUCTION; FERMENTATION; WINE; OPTIMIZATION; TEMPERATURE	Kaoliang is a refreshing fragranced type of Chinese spirits with slight apple fragrance that comes from ethyl acetate (EA). Special aromas are produced by esterification microorganisms, which affect the taste and quality of the wine. In this study, new yeast strains were isolated from yellow water, a by-product during fermentation process. Meanwhile, the optimal culture condition was determined for its growth and EA production. Three new strains, Kazachstaniaexigua, Candida humilis and Saccharomyces cerevisiae were identified from yellow water. Among these strains, S. cerevisiae S5 was the new and dominant strain. Results from response surface methodology showed that S. cerevisiae S5 produced 161.88 ppm of EA, in the medium with 4.91% yeast extract, 9.82% peptone, and 20.91% glucose after 96 hours of cultivation at 27.53 degrees C. GC analysis showed that aroma compounds, such as EA, isoamyl acetate and 2-phenylethanol increased from the sample of optimal condition when compared to the one from initial fermentation condition.	[Lai, Yen-Tso; Cheng, Kuan-Chen] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Cheng, Kuan-Chen; Lai, Chia-Nuan] Natl Taiwan Univ, Grad Inst Food Sci Technol, Taipei, Taiwan; [Cheng, Kuan-Chen] China Med Univ, Dept Med Res, China Med Univ Hosp, Taichung, Taiwan; [Lai, Ying-Jang] Natl Quemoy Univ, Dept Food Sci, Kinmen, Taiwan	National Taiwan University; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lai, YJ (corresponding author), Natl Quemoy Univ, Dept Food Sci, Kinmen, Taiwan.	d91641006@ntu.edu.tw		Ying Jang, Lai/0000-0003-1827-2250				Alonso-del-Real J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00150; An KJ, 2018, LWT-FOOD SCI TECHNOL, V87, P537, DOI 10.1016/j.lwt.2017.09.032; Barnett J. A., 1983, YEASTS CHARACTERISTI; BOX GEP, 1951, J R STAT SOC B, V13, P1, DOI 10.1111/j.2517-6161.1951.tb00067.x; Brandt MJ, 2004, EUR FOOD RES TECHNOL, V218, P333, DOI 10.1007/s00217-003-0867-0; Callejon RM, 2010, ANAL CHIM ACTA, V660, P68, DOI 10.1016/j.aca.2009.09.040; Chang YC, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8112060; Chen R., 2018, OPTIMIZATION FINGER; Cheng KC, 2013, BIORESOURCE TECHNOL, V128, P44, DOI 10.1016/j.biortech.2012.09.085; Christiaens JF, 2014, CELL REP, V9, P425, DOI 10.1016/j.celrep.2014.09.009; de la Roza C, 2003, PROCESS BIOCHEM, V38, P1451, DOI 10.1016/S0032-9592(03)00026-8; Pereira GVD, 2014, INT J FOOD MICROBIOL, V188, P60, DOI 10.1016/j.ijfoodmicro.2014.07.008; Leite AMD, 2013, BRAZ J MICROBIOL, V44, P341, DOI 10.1590/S1517-83822013000200001; de Souza CJA, 2012, BIORESOURCE TECHNOL, V109, P63, DOI 10.1016/j.biortech.2012.01.024; de Souza RB, 2016, METALLOMICS, V8, P1193, DOI 10.1039/c6mt00157b; Detroy RW, 2018, BIOCONVERSION AGR BI, P19; Di Cagno R, 2014, APPL ENVIRON MICROB, V80, P3161, DOI 10.1128/AEM.00309-14; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Etienne-Mesmin L, 2011, APPL ENVIRON MICROB, V77, P1127, DOI 10.1128/AEM.02130-10; Fadel M, 2013, Biotechnol Res Int, V2013, P253286, DOI 10.1155/2013/253286; Fan GS, 2018, J AM SOC BREW CHEM, V76, P117, DOI 10.1080/03610470.2017.1396849; Costa GHG, 2018, SUGAR TECH, V20, P371, DOI 10.1007/s12355-018-0603-5; Hai J, 2016, FOOD SCI, V23; Hsieh SC, 2016, APPL MICROBIOL BIOT, V100, P2629, DOI 10.1007/s00253-015-7149-1; Hsu KD, 2017, J FOOD DRUG ANAL, V25, P804, DOI 10.1016/j.jfda.2016.12.006; Kim D. W., 2007, Korean Journal of Poultry Science, V34, P137; Kruis AJ, 2017, METAB ENG, V41, P92, DOI 10.1016/j.ymben.2017.03.004; Kuo CP, 2008, PRODUCTION KAOLIANG; Li LY, 2007, LIQUOR MAKING SCI TE, V2; [廖永红 Liao Yonghong], 2012, [食品科学, Food Science], V33, P181; Lilly M, 2000, APPL ENVIRON MICROB, V66, P744, DOI 10.1128/AEM.66.2.744-753.2000; Liti G, 2015, ELIFE, V4, DOI 10.7554/eLife.05835; Liu Y., 2009, LIQUOR MAKING SCI TE, V12; Loser C, 2015, APPL MICROBIOL BIOT, V99, P1131, DOI 10.1007/s00253-014-6098-4; Loser C, 2014, APPL MICROBIOL BIOT, V98, P5397, DOI 10.1007/s00253-014-5765-9; Loser C, 2013, J BIOTECHNOL, V163, P17, DOI 10.1016/j.jbiotec.2012.10.009; Matias-Guiu P, 2018, FOOD CHEM, V245, P1087, DOI 10.1016/j.foodchem.2017.11.062; Minervini F, 2012, APPL ENVIRON MICROB, V78, P1251, DOI 10.1128/AEM.07721-11; Nielsen J, 2008, FEMS YEAST RES, V8, P122, DOI 10.1111/j.1567-1364.2007.00302.x; Parapouli M, 2010, PROCESS BIOCHEM, V45, P1094, DOI 10.1016/j.procbio.2010.03.028; Park CB, 2003, FEMS MICROBIOL LETT, V221, P187, DOI 10.1016/S0378-1097(03)00213-1; Peng Q, 2015, FOOD CHEM, V178, P301, DOI 10.1016/j.foodchem.2015.01.023; Plata C, 2003, FOOD MICROBIOL, V20, P217, DOI 10.1016/S0740-0020(02)00101-6; RAPP A, 1992, DEV FOOD SCI, V28, P485, DOI DOI 10.1016/B978-0-444-88558-6.50025-8; Mateos JAR, 2006, ENZYME MICROB TECH, V40, P151, DOI 10.1016/j.enzmictec.2005.10.048; Rezaei MN, 2015, CEREAL CHEM, V92, P588, DOI 10.1094/CCHEM-04-15-0061-R; Sevda S. B., 2011, Journal of Food Processing and Technology, V2, P118; Sutani A, 2015, FISHERIES SCI, V81, P929, DOI 10.1007/s12562-015-0912-5; Tchango Tchango J, 2000, CAHIERS ETUDES RECHE; Vadde KK, 2006, IEEE T MOBILE COMPUT, V5, P627, DOI 10.1109/TMC.2006.82; Verstrepen KJ, 2004, YEAST, V21, P367, DOI 10.1002/yea.1100; WOLFE AD, 1965, BIOCHIM BIOPHYS ACTA, V95, P146, DOI 10.1016/0005-2787(65)90219-4; Xiao ZB, 2016, FLAVOUR FRAG J, V31, P217, DOI 10.1002/ffj.3304; Yang G, 2011, CHINA BREW, V12; Yu W., 2012, CHINA BREW, V31, P87; Yue GJ, 2012, BIOMASS BIOENERG, V39, P48, DOI 10.1016/j.biombioe.2010.08.041; 김은정, 2007, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V36, P366	57	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0211356	10.1371/journal.pone.0211356	http://dx.doi.org/10.1371/journal.pone.0211356			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763353	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900012
J	Towler, A; Kemp, RI; Burton, AM; Dunn, JD; Wayne, T; Moreton, R; White, D				Towler, Alice; Kemp, Richard I.; Burton, A. Mike; Dunn, James D.; Wayne, Tanya; Moreton, Reuben; White, David			Do professional facial image comparison training courses work?	PLOS ONE			English	Article							FACE; IDENTITIES; EXPERTISE; STRATEGY	Facial image comparison practitioners compare images of unfamiliar faces and decide whether or not they show the same person. Given the importance of these decisions for national security and criminal investigations, practitioners attend training courses to improve their face identification ability. However, these courses have not been empirically validated so it is unknown if they improve accuracy. Here, we review the content of eleven professional training courses offered to staff at national security, police, intelligence, passport issuance, immigration and border control agencies around the world. All reviewed courses include basic training in facial anatomy and prescribe facial feature (or 'morphological') comparison. Next, we evaluate the effectiveness of four representative courses by comparing face identification accuracy before and after training in novices (n = 152) and practitioners (n = 236). We find very strong evidence that short (1-hour and half-day) professional training courses do not improve identification accuracy, despite 93% of trainees believing their performance had improved. We find some evidence of improvement in a 3-day training course designed to introduce trainees to the unique feature-by-feature comparison strategy used by facial examiners in forensic settings. However, observed improvements are small, inconsistent across tests, and training did not produce the qualitative changes associated with examiners' expertise. Future research should test the benefits of longer examination-focussed training courses and incorporate longitudinal approaches to track improvements caused by mentoring and deliberate practice. In the absence of evidence that training is effective, we advise agencies to explore alternative evidence-based strategies for improving the accuracy of face identification decisions.	[Towler, Alice; Kemp, Richard I.; Dunn, James D.; Wayne, Tanya; White, David] Univ New South Wales, Sydney, NSW, Australia; [Burton, A. Mike] Univ York, York, N Yorkshire, England; [Moreton, Reuben] Metropolitan Police Serv, London, England; [Moreton, Reuben] Open Univ, Milton Keynes, Bucks, England	University of New South Wales Sydney; University of York - UK; Open University - UK	Towler, A (corresponding author), Univ New South Wales, Sydney, NSW, Australia.	a.towler@unsw.edu.au	White, David/AAS-9824-2021; Burton, Mike/A-9491-2008	Burton, Mike/0000-0002-2035-2084; Dunn, James/0000-0002-6964-909X; Kemp, Richard/0000-0003-2819-265X; Towler, Alice/0000-0003-4092-8703; White, David/0000-0002-6366-2699; Moreton, Reuben/0000-0001-6369-6031	Australian Postgraduate Award; Australian Research Council [LP110100448, LP130100702, LP160101523]; Department of Foreign Affairs and Trade; Australian Passport Office; European Research Council [323262]	Australian Postgraduate Award(Australian Government); Australian Research Council(Australian Research Council); Department of Foreign Affairs and Trade; Australian Passport Office; European Research Council(European Research Council (ERC)European Commission)	This research was supported by an Australian Postgraduate Award (education.gov.au/research-training-program) to AT, Australian Research Council Linkage grants to RK and DW (LP110100448; LP130100702; LP160101523) in partnership with the Department of Foreign Affairs and Trade, Australian Passport Office (arc.gov.au/linkage-projects), and a European Research Council grant to MB (n.323262; erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, FOR SCI CRIM COURTS; Balsdon T, 2018, COGNITIVE RES PRINCI, V3, P1; Bell S, 2018, P NATL ACAD SCI USA, V115, P4541, DOI 10.1073/pnas.1712161115; Bindemann M, 2014, COGENT PSYCHOL, V1, DOI 10.1080/23311908.2014.986903; Bindemann M, 2012, J EXP PSYCHOL-APPL, V18, P277, DOI 10.1037/a0029635; Bobak A., 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0148148; Bobak AK, 2019, Q J EXP PSYCHOL, V72, P872, DOI 10.1177/1747021818776145; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; Bruce V, 2001, J EXP PSYCHOL-APPL, V7, P207, DOI 10.1037/1076-898X.7.3.207; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Dowsett AJ, 2015, BRIT J PSYCHOL, V106, P433, DOI 10.1111/bjop.12103; Edmond G., 2017, AUSTR J FORENSIC SCI, V57, P144, DOI [10.1016/j.scijus.2016.11.005, DOI 10.1016/J.SCIJUS.2016.11.005EDM0ND]; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Facial Identification Scientific Working Group, 2011, GUID REC FAC COMP TR; Jeckeln G, 2018, BRIT J PSYCHOL, V109, P724, DOI 10.1111/bjop.12291; Kemp R, 1997, APPL COGNITIVE PSYCH, V11, P211; McKone E, 2011, COGN NEUROPSYCHOL, V28, P109, DOI 10.1080/02643294.2011.616880; Megreya A.M., 2017, FACE PROCESSING SYST, P173; National Research Council, 2009, STRENGTHENING FORENS; Norell K, 2015, J FORENSIC SCI, V60, P331, DOI 10.1111/1556-4029.12660; O'Toole AJ, 2012, ACM T APPL PERCEPT, V9, DOI 10.1145/2355598.2355599; Palermo R, 2017, Q J EXP PSYCHOL, V70, P218, DOI 10.1080/17470218.2016.1161058; Papesh MH, 2018, COGNITIVE RES PRINCI, V3, P1, DOI [10.1080/17470218.2016.1161058, DOI 10.1080/17470218.2016.1161058]; Phillips PJ, 2012, IMAGE VISION COMPUT, V30, P177, DOI 10.1016/j.imavis.2012.01.004; Phillips PJ, 2018, P NATL ACAD SCI USA, DOI [10.1111/1556-4029.12660, DOI 10.1111/1556-4029.12660]; Prince J, 2012, EXAMINE EMERGING POL; Ritchie KL, 2015, COGNITION, V141, P161, DOI 10.1016/j.cognition.2015.05.002; Searston RA, 2017, J APPL RES MEM COGN, V6, P442, DOI 10.1016/j.jarmac.2017.08.006; Spaun NA, 2009, LECT NOTES COMPUT SC, V5558, P161, DOI 10.1007/978-3-642-01793-3_17; Towler A., 2017, FACE PROCESSING SYST; Towler A, 2018, J APPL RES MEM COGN, V7, P199, DOI 10.1016/j.jarmac.2018.03.010; Towler A, 2017, J EXP PSYCHOL-APPL, V23, P47, DOI 10.1037/xap0000108; Towler A, 2014, PERCEPTION, V43, P214, DOI 10.1068/p7676; White D, 2015, P ROY SOC B-BIOL SCI, V282, P73, DOI 10.1098/rspb.2015.1292; White D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139827; White D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103510; White D, 2014, PSYCHON B REV, V21, P100, DOI 10.3758/s13423-013-0475-3; White D, 2013, APPL COGNITIVE PSYCH, V27, P769, DOI 10.1002/acp.2971; Wirth BE, 2017, J EXP PSYCHOL-APPL, V23, P138, DOI 10.1037/xap0000114; WOODHEAD MM, 1979, ERGONOMICS, V22, P333, DOI 10.1080/00140137908924617	41	37	37	11	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211037	10.1371/journal.pone.0211037	http://dx.doi.org/10.1371/journal.pone.0211037			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5IX	30759105	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000458761300027
J	Bressano, M; Massa, AN; Arias, RS; de Blas, F; Oddino, C; Faustinelli, PC; Soave, S; Soave, JH; Perez, MA; Sobolev, VS; Lamb, MC; Balzarini, M; Buteler, MI; Seijo, JG				Bressano, Marina; Massa, Alicia N.; Arias, Renee S.; de Blas, Francisco; Oddino, Claudio; Faustinelli, Paola C.; Soave, Sara; Soave, Juan H.; Perez, Maria A.; Sobolev, Victor S.; Lamb, Marshall C.; Balzarini, Monica; Buteler, Mario I.; Guillermo Seijo, J.			Introgression of peanut smut resistance from landraces to elite peanut cultivars (Arachis hypogaea L.)	PLOS ONE			English	Article							LINKAGE MAP; IDENTIFICATION; DURANENSIS; IPAENSIS; CROSSES; MARKER; GENOME; GENES	Smut disease caused by the fungal pathogen Thecaphora frezii Carranza & Lindquist is threatening the peanut production in Argentina. Fungicides commonly used in the peanut crop have shown little or no effect controlling the disease, making it a priority to obtain peanut varieties resistant to smut. In this study, recombinant inbred lines (RILs) were developed from three crosses between three susceptible peanut elite cultivars (Arachis hypogaea L. subsp. hypogaea) and two resistant landraces (Arachis hypogaea L. subsp. fastigiata Waldron). Parents and RILs were evaluated under high inoculum pressure (12000 teliospores g(-1) of soil) over three years. Disease resistance parameters showed a broad range of variation with incidence mean values ranging from 1.0 to 35.0% and disease severity index ranging from 0.01 to 0.30. Average heritability (h(2)) estimates of 0.61 to 0.73 indicated that resistance in the RILs was heritable, with several lines (4 to 7 from each cross) showing a high degree of resistance and stability over three years. Evidence of genetic transfer between genetically distinguishable germplasm (introgression in a broad sense) was further supported by simple-sequence repeats (SSRs) and Insertion/Deletion (InDel) marker genotyping. This is the first report of smut genetic resistance identified in peanut landraces and its introgression into elite peanut cultivars.	[Bressano, Marina; Perez, Maria A.; Balzarini, Monica] Univ Nacl Cordoba, Fac Ciencias Agr, Cordoba, Argentina; [Massa, Alicia N.; Arias, Renee S.; Faustinelli, Paola C.; Sobolev, Victor S.; Lamb, Marshall C.] USDA ARS, Natl Peanut Res Lab, Dawson, GA 31742 USA; [de Blas, Francisco] UNC, CONICET, Inst Multidisciplinario Biol Vegetal IMBIV, Cordoba, Argentina; [Oddino, Claudio; Soave, Sara; Soave, Juan H.; Buteler, Mario I.] Gen Cabrera, Criadero El Carmen, Cordoba, Argentina; [Guillermo Seijo, J.] UNNE, CONICET, Inst Bot Nordeste IBONE, Corrientes, Argentina; [Guillermo Seijo, J.] Univ Nacl Nordeste, Fac Ciencias Exactas & Nat, Corrientes, Argentina	National University of Cordoba; United States Department of Agriculture (USDA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bressano, M (corresponding author), Univ Nacl Cordoba, Fac Ciencias Agr, Cordoba, Argentina.; Arias, RS (corresponding author), USDA ARS, Natl Peanut Res Lab, Dawson, GA 31742 USA.	marinabressano@gmail.com; Renee.Arias@ars.usda.gov	Seijo, Jose Guillermo/AAH-6527-2020	Seijo, Jose Guillermo/0000-0001-8699-2044; Balzarini, Monica/0000-0002-4858-4637; de Blas, Francisco/0000-0003-4500-3072; Bressano, Marina/0000-0001-9155-7290	USDA-ARS [6604-21000-004-00D, 6044-42000-011-00D]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project is part of a Material Transfer Research Agreement between USDA-ARS and Criadelo El Carmen. The latter performed the phenotyping studies; whereas the genetic analysis and writing of the manuscript was done by USDA_ARS scientists supported in part by USDA-ARS research projects: 6604-21000-004-00D and 6044-42000-011-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonina IG, 2004, PLANT BREEDING, V123, P220, DOI 10.1111/j.1439-0523.2004.00932.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arias RS, 2011, PLANT PATHOL, V60, P709, DOI 10.1111/j.1365-3059.2010.02421.x; Arias RS, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1355-9; BCCBA, AN MET 2014; BCCBA, AN MET 2015; BCCBA, AN MET 2017; BCCBA, AN MET 2016; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Branch WD, 2018, PLANT HLTH PROG, V19, P201, DOI 10.1094/PHP-04-18-0018-RS; Burow MD, 2001, GENETICS, V159, P823; Cazzola N, 2012, 27 JORN NAC MAN COL; Chenault KD, 2009, EUPHYTICA, V166, P357, DOI 10.1007/s10681-008-9816-0; Chopra R, 2016, G3-GENES GENOM GENET, V6, P3825, DOI 10.1534/g3.115.026898; Clevenger JP, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00564; Conforto C, 2013, EUR J PLANT PATHOL, V137, P663, DOI 10.1007/s10658-013-0296-2; Culbreath AK, 2012, PLANT HLTH PROG, DOI [10.1094/PHP-2012-0227-03-RS, DOI 10.1094/PHP-2012-0227-03-RS]; de Paula AF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175940; Dutra WF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198776; Falconer D. S., 1996, INTRO QUANTITATIVE G; Favero AP, 2015, GENET MOL RES, V14, P16694, DOI 10.4238/2015.December.11.17; Favero AP, 2015, GENET MOL BIOL, V38, P353, DOI 10.1590/S1415-475738320140376; Ferguson ME, 2004, THEOR APPL GENET, V108, P1064, DOI 10.1007/s00122-003-1535-2; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Guo DL, 2008, BIOCHEM GENET, V46, P323, DOI 10.1007/s10528-008-9143-0; Gupta SK, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0343-0; Janila P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00023; Jelihovschi E.G., 2014, TEMA (São Carlos), V15, P3, DOI 10.5540/tema.2014.015.01.0003; Krapovickas A, 2009, BONPLANDIA CORRIENTE, V18, p95 , DOI DOI 10.30972/bon.1821339; Leal-Bertioli SCM, 2018, AM J BOT, V105, P1053, DOI 10.1002/ajb2.1112; Leal-Bertioli SCM, 2015, G3-GENES GENOM GENET, V5, P1403, DOI 10.1534/g3.115.018796; Leal-Bertioli SCM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-112; Liu LF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00988; Mallikarjuna N, 2004, PLANT BREEDING, V123, P573, DOI 10.1111/j.1439-0523.2004.01036.x; Marinelli A., 2008, Agriscientia, V25, P1; Rago AM, 2017, PLANT DIS, V101, P400, DOI 10.1094/PDIS-09-16-1248-FE; McKinney HH, 1923, J AGRIC RES, V26, P0195; Moretzsohn Marcio de Carvalho, 2004, BMC Plant Biology, V4, P11, DOI 10.1186/1471-2229-4-11; Moretzsohn MC, 2005, THEOR APPL GENET, V111, P1060, DOI 10.1007/s00122-005-0028-x; Oddino C, 2010, 25 JORN NAC MAN COL; Paredes JA, 2016, 31 JORN NAC MAN COL; Paredes JA, 2015, 15 JORN FIT ARG U NA; Paredes JA, 2015, 30 JORN NAC MAN COL; Proite K, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-7; R Core Team, 2013, R LANG ENV STAT COMP; Rohlf FJ, 2008, NTSYSPC NUMERICAL TA; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Seijo JG, 2004, AM J BOT, V91, P1294, DOI 10.3732/ajb.91.9.1294; Simpson C. E., 2001, Peanut Science, V28, P114, DOI 10.3146/i0095-3679-28-2-12; SUBRAHMANYAM P, 1980, Peanut Science, V7, P10, DOI 10.3146/i0095-3679-7-1-3; Wei T, 2017, R PACKAGE CORRPLOT V; WYNNE JC, 1991, ANNU REV PHYTOPATHOL, V29, P279, DOI 10.1146/annurev.py.29.090191.001431	53	6	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211920	10.1371/journal.pone.0211920	http://dx.doi.org/10.1371/journal.pone.0211920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735547	Green Published, gold			2022-12-26	WOS:000458181200043
J	Brandon, JA; Kraemer, M; Vandra, J; Halder, S; Ubele, M; Morris, AJ; Smyth, SS				Brandon, J. Anthony; Kraemer, Maria; Vandra, Julia; Halder, Suchismita; Ubele, Margo; Morris, Andrew J.; Smyth, Susan S.			Adipose-derived autotaxin regulates inflammation and steatosis associated with diet-induced obesity	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID; INSULIN-RESISTANCE; ADIPOCYTE DIFFERENTIATION; LPA RECEPTORS; EXPRESSION; CONTRIBUTES; BINDING	Autotaxin (ATX) is a secreted enzyme that generates the bioactive lipid lysophosphatidic acid (LPA). We generated mice with global inducible post-natal inactivation or adipose-specific loss of the Enpp2 gene encoding ATX. The animals are phenotypically unremarkable and exhibit differences in adipocyte size and adipose tissue expression of inflammatory genes after high fat feeding without gross differences in fat distribution or body mass. Surprisingly, both models of Enpp2- deficiency exhibited marked protection from high fat diet-induced hepatic steatosis. This phenotype was not associated with differences in dietary fat absorption but may be accounted for by differences in hepatic expression of genes involved in de novo synthesis of triglycerides. These findings suggest that pharmacological inhibition of ATX might be protective against hepatic steatosis.	[Brandon, J. Anthony; Kraemer, Maria; Vandra, Julia; Halder, Suchismita; Ubele, Margo; Morris, Andrew J.; Smyth, Susan S.] Univ Kentucky, Gill Heart & Vasc Inst, Div Cardiovasc Med, Lexington, KY 40506 USA; [Morris, Andrew J.; Smyth, Susan S.] Dept Vet Affairs Med Ctr, Lexington, KY 40511 USA	University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Smyth, SS (corresponding author), Univ Kentucky, Gill Heart & Vasc Inst, Div Cardiovasc Med, Lexington, KY 40506 USA.; Smyth, SS (corresponding author), Dept Vet Affairs Med Ctr, Lexington, KY 40511 USA.	SusanSmyth@uky.edu		Kraemer, Maria/0000-0002-1806-5641	VA merit Award from the United States (U.S.) Department of Veterans Affairs [BX002769, CX001550]; Heart Lung and Blood Institute of the National Institutes of Health [R01HL120507]; IDeA award from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103527]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	VA merit Award from the United States (U.S.) Department of Veterans Affairs(US Department of Veterans Affairs); Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); IDeA award from the National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is the result of work supported in part with resources and the use of facilities at the Lexington VA Medical Center, supported in part by VA merit Award #BX002769 (SSS) and CX001550 (AJM) from the United States (U.S.) Department of Veterans Affairs. This project was supported by a grant from the Heart Lung and Blood Institute R01HL120507 (SSS) and by an IDeA award from the National Institute of General Medical Sciences P20GM103527 (SSS) of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; Baader M, 2018, BRIT J PHARMACOL, V175, P693, DOI 10.1111/bph.14118; Bain G, 2017, J PHARMACOL EXP THER, V360, P1, DOI 10.1124/jpet.116.237156; Benesch MGK, 2015, FASEB J, V29, P3990, DOI 10.1096/fj.15-274480; Benesch MGK, 2015, J LIPID RES, V56, P1134, DOI 10.1194/jlr.M057661; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; Fayyaz S, 2017, CELL PHYSIOL BIOCHEM, V43, P445, DOI 10.1159/000480470; Federico L, 2012, MOL ENDOCRINOL, V26, P786, DOI 10.1210/me.2011-1229; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Holcapek M, 2018, ANAL CHEM, V90, P4249, DOI 10.1021/acs.analchem.7b05395; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Leblanc R, 2014, BLOOD, V124, P3141, DOI 10.1182/blood-2014-04-568683; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Nakagawa H, 2011, CLIN CHIM ACTA, V412, P1201, DOI 10.1016/j.cca.2011.03.014; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Nishimura S, 2014, DIABETES, V63, P4154, DOI 10.2337/db13-1694; Nochi H, 2008, J IMMUNOL, V181, P5111, DOI 10.4049/jimmunol.181.7.5111; Ogden CL, 2014, JAMA-J AM MED ASSOC, V312, P189, DOI [10.1001/jama.2014.6228, 10.1001/jama.2014.6219]; Oikonomou N, 2012, AM J RESP CELL MOL, V47, P566, DOI 10.1165/rcmb.2012-0004OC; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Rai V, 2012, J EXP MED, V209, P2339, DOI 10.1084/jem.20120873; Rancoule C, 2012, J PHYSIOL BIOCHEM, V68, P635, DOI 10.1007/s13105-012-0181-z; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Simon MF, 2005, J BIOL CHEM, V280, P14656, DOI 10.1074/jbc.M412585200; Simons B, 2012, METABOLITES, V2, P195, DOI 10.3390/metabo2010195; Sun SH, 2017, J LIPID RES, V58, P2102, DOI [10.1194/jlr.M075655, 10.1194/jlr.m075655]; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tigyi G, 2001, PROSTAG OTH LIPID M, V64, P47, DOI 10.1016/S0090-6980(01)00107-1; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; Wu T, 2014, FASEB J, V28, P861, DOI 10.1096/fj.13-232868; Yang F, 2018, WORLD J GASTROENTERO, V24, P4132, DOI 10.3748/wjg.v24.i36.4132; Yukiura H, 2011, J BIOL CHEM, V286, P43972, DOI 10.1074/jbc.M111.301093	42	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0208099	10.1371/journal.pone.0208099	http://dx.doi.org/10.1371/journal.pone.0208099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730895	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000004
J	Garnier, F; Couchoud, C; Landais, P; Moranne, O				Garnier, Fanny; Couchoud, Cecile; Landais, Paul; Moranne, Olivier			Increased incidence of acute kidney injury requiring dialysis in metropolitan France	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; UNITED-STATES; REPLACEMENT THERAPY; SEVERE SEPSIS; OUTCOMES; EPIDEMIOLOGY; MORTALITY; TRENDS; AKI	Background Acute kidney injury requiring dialysis (AKI-D) is associated with high mortality. Information about its epidemiology is nonetheless sparse in some countries. The objective of this study was to assess its epidemiology and prognosis in metropolitan France. Methods Using the French hospital discharge database, the study focused on adults hospitalized in metropolitan France between 2009 and 2014 and diagnosed with AKI-D according to the codes of the French common classification of medical procedures. Crude and standardized incidence rates (SIR) by gender and age were calculated. We explored the changes in patients' characteristics, modalities of renal replacement therapy (RRT), in-hospital care, and mortality, along with their determinants. Trends over time in the SIR for AKI-D, its principal diagnoses, and comorbidities were analyzed with joinpoint models. Results Between 2009 and 2014, the AKI-D SIR increased from 475 (95% CI, 468 to 482) to 512 per million population (95% CI, 505 to 519). AKI-D was twice as high in men as women. Median age was 68 years. Over the study period, the AKI-D SIR steadily increased in all age groups, particularly in the elderly. The most common comorbidities were cardio-cerebrovascular diseases (64.8%), pulmonary disease (42.2%), CKD (33.8%), and diabetes (26.0%); all of these except CKD increased significantly over time. In 2009, heart failure (17.2%), sepsis (17.0%), AKI (13.0%), digestive diseases (10.7%), and shock (6.6%) were the most frequent principal diagnoses, with a significant increase in heart failure and digestive diseases. The proportion of patients with at least one ICU stay and continuous RRT increased from 80.3% to 83.9% and from 56.9% to 61.8% (p<0.001), respectively. In-hospital mortality was high but stable (47%) and higher in patients with an ICU stay. Conclusions This is the first exhaustive study in metropolitan France of the SIR for AKI-D. It shows this SIR has increased significantly over 6 years, together with ICU care and continuous RRT. In-hospital mortality is high but stable.	[Garnier, Fanny; Moranne, Olivier] Nimes Univ Hosp, Nephrol Dialysis Apheresis Unit, Nimes, France; [Garnier, Fanny; Landais, Paul; Moranne, Olivier] Univ Montpellier, Lab Biostat Epidemiol Clin Res & Hlth Econ, UPRES EA2415, Montpellier, France; [Couchoud, Cecile] Biomed Agcy, REIN Registry, La Plaine St Denis, France	Universite de Montpellier; CHU de Nimes; Universite de Montpellier	Moranne, O (corresponding author), Nimes Univ Hosp, Nephrol Dialysis Apheresis Unit, Nimes, France.; Moranne, O (corresponding author), Univ Montpellier, Lab Biostat Epidemiol Clin Res & Hlth Econ, UPRES EA2415, Montpellier, France.	Olivier.moranne@chu-nimes.fr	moranne, olivier/AAA-3056-2019	moranne, olivier/0000-0002-3127-1415	French national society of nephrology dialys transplantation	French national society of nephrology dialys transplantation	The project benefits from a grant from French national society of nephrology dialys transplantation to FG, but funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshinnia F, 2009, RENAL FAILURE, V31, P647, DOI 10.3109/08860220903151401; Agence Technique de l'Information Sur l'Hospitalisation, 2015, MAN GHM VERS DEF 11G; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1203, DOI 10.1093/ndt/gfm744; Brown JR, 2016, AM J NEPHROL, V43, P261, DOI 10.1159/000445846; Carlson N, 2016, PLOS ONE, V11; Cole L, 2001, INTENS CARE MED, V27, P978, DOI 10.1007/s001340100963; Oliveira MAD, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0564-z; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Gaudry S, 2016, NEW ENGL J MED, V375, P122, DOI 10.1056/NEJMoa1603017; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Hsu RK, 2016, CLIN J AM SOC NEPHRO, V11, P14, DOI 10.2215/CJN.04520415; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Kashani K, 2017, KIDNEY INT, V92, P721, DOI 10.1016/j.kint.2017.03.020; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kolhe NV, 2015, KIDNEY INT, V88, P1161, DOI 10.1038/ki.2015.234; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Landais P, 2014, HEALTH INFORM SER, P191, DOI 10.1007/978-2-8178-0478-1_9; Lassale M, 2014, 2014 ESRD INCIDENCE; Lauridsen MD, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1170-8; Lenihan CR, 2013, ANN THORAC SURG, V95, P20, DOI 10.1016/j.athoracsur.2012.05.131; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mavrakanas TA, 2017, CLIN J AM SOC NEPHRO, V12, P1624, DOI 10.2215/CJN.04020417; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Rauf Anis Abdul, 2008, J Intensive Care Med, V23, P195, DOI 10.1177/0885066608315743; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Ronco C, 2004, BLOOD PURIFICAT, V22, P164, DOI 10.1159/000074937; Sakhuja A, 2015, AM J RESP CRIT CARE, V192, P951, DOI 10.1164/rccm.201502-0329OC; Servillo G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/108951; Siew ED, 2015, KIDNEY INT, V87, P46, DOI 10.1038/ki.2014.293; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; The Kidney Improving Global Outcomes (KDIGO) Working Group, 2012, KIDNEY INT S2, P193; Toft P, 2000, Ugeskr Laeger, V162, P2868; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Wald R, 2015, AM J KIDNEY DIS, V65, P870, DOI 10.1053/j.ajkd.2014.10.017; Wonnacott A, 2014, CLIN J AM SOC NEPHRO, V9, P1007, DOI 10.2215/CJN.07920713; Zarbock A, 2016, JAMA-J AM MED ASSOC, V315, P2190, DOI 10.1001/jama.2016.5828	47	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211541	10.1371/journal.pone.0211541	http://dx.doi.org/10.1371/journal.pone.0211541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730975	Green Published, Green Submitted, gold			2022-12-26	WOS:000458026000034
J	Liang, MF; Xie, XQ; Pan, J; Jin, GW; Yu, C; Wei, ZY				Liang, Mingfu; Xie, Xingqiao; Pan, Jian; Jin, Gaowei; Yu, Cong; Wei, Zhiyi			Structural basis of the target-binding mode of the G protein-coupled receptor kinase-interacting protein in the regulation of focal adhesion dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						focal adhesion; crystal structure; structure-function; protein-protein interaction; protein complex; structural biology; cell migration; GTPase activating protein (GAP); complex structure; paxillin (PXN); PTPRF-interacting protein alpha 2 (PPFIA2); single alpha-helix	PAXILLIN LD MOTIFS; GTPASE-ACTIVATING PROTEINS; EXTRACELLULAR-MATRIX; GIT1; FAMILY; DOMAIN; RECOGNITION; PIX; VINCULIN; COMPLEX	Focal adhesions (FAs) are specialized sites where intracellular cytoskeleton elements connect to the extracellular matrix and thereby control cell motility. FA assembly depends on various scaffold proteins, including the G protein-coupled receptor kinase-interacting protein 1 (GIT1), paxillin, and liprin-. Although liprin- and paxillin are known to competitively interact with GIT1, the molecular basis governing these interactions remains elusive. To uncover the underlying mechanisms of how GIT1 is involved in FA assembly by alternatively binding to liprin- and paxillin, here we solved the crystal structures of GIT1 in complex with liprin- and paxillin at 1.8 and 2.6 resolutions, respectively. These structures revealed that the paxillin-binding domain (PBD) of GIT1 employs distinct binding modes to recognize a single -helix of liprin- and the LD4 motif of paxillin. Structure-based design of protein variants produced two binding-deficient GIT1 variants; specifically, these variants lost the ability to interact with liprin- only or with both liprin- and paxillin. Expressing the GIT1 variants in COS7 cells, we discovered that the two PBD-meditated interactions play different roles in either recruiting GIT1 to FA or facilitating FA assembly. Additionally, we demonstrate that, unlike for the known binding mode of the FAT domain to LD motifs, the PBD of GIT1 uses different surface patches to achieve high selectivity in LD motif recognition. In summary, our results have uncovered the mechanisms by which GIT1's PBD recognizes cognate paxillin and liprin- structures, information we anticipate will be useful for future investigations of GIT1-protein interactions in cells.	[Liang, Mingfu; Xie, Xingqiao; Pan, Jian; Jin, Gaowei; Yu, Cong; Wei, Zhiyi] Southern Univ Sci & Technol, Dept Biol, Shenzhen 518055, Peoples R China; [Xie, Xingqiao] Southern Univ Sci & Technol, Acad Adv Interdisciplinary Studies, Shenzhen 518055, Peoples R China; [Yu, Cong] Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen 518055, Peoples R China; [Yu, Cong] Shenzhen Key Lab Cell Microenvironm, Shenzhen 518055, Peoples R China; [Wei, Zhiyi] SUSTech, Neural & Cognit Sci Res Ctr, Shenzhen, Peoples R China	Southern University of Science & Technology; Southern University of Science & Technology; Southern University of Science & Technology	Yu, C; Wei, ZY (corresponding author), Southern Univ Sci & Technol, Dept Biol, Shenzhen 518055, Peoples R China.; Yu, C (corresponding author), Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen 518055, Peoples R China.; Yu, C (corresponding author), Shenzhen Key Lab Cell Microenvironm, Shenzhen 518055, Peoples R China.; Wei, ZY (corresponding author), SUSTech, Neural & Cognit Sci Res Ctr, Shenzhen, Peoples R China.	yuc@sustc.edu.cn; weizy@sustc.edu.cn	Wei, Zhiyi/N-9995-2019; Wei, Zhiyi/C-4315-2014; , 余聪/AAK-9457-2020	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; 	National Natural Science Foundation of China [31770791, 31570741, 31870757]; Natural Science Foundation of Guangdong Province [2016A030312016]; Science and Technology Planning Project of Guangdong Province [2017B030301018]; Shenzhen Science and Technology Innovation Commission [JCYJ20160229153100269, JCYJ20160301112450474, ZDSYS20140509142721429]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Shenzhen Science and Technology Innovation Commission	This work was supported by National Natural Science Foundation of China Grants 31770791 and 31570741 (to Z. W.) and 31870757 (to C. Y.); Natural Science Foundation of Guangdong Province Grant 2016A030312016; Science and Technology Planning Project of Guangdong Province Grant 2017B030301018; and Shenzhen Science and Technology Innovation Commission Grants JCYJ20160229153100269 (to Z. W.), JCYJ20160301112450474 (to X. X.), and ZDSYS20140509142721429 (to C. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam T, 2014, BIOCHEM J, V460, P317, DOI 10.1042/BJ20140298; Asperti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020757; Asperti C, 2010, EXP CELL RES, V316, P915, DOI 10.1016/j.yexcr.2010.01.017; Asperti C, 2009, J CELL SCI, V122, P3225, DOI 10.1242/jcs.054155; Astro V, 2016, SCI REP-UK, V6, DOI 10.1038/srep33653; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Burridge K, 2017, FEBS J, V284, P3355, DOI 10.1111/febs.14195; Cernohorska M, 2016, BBA-MOL CELL RES, V1863, P1282, DOI 10.1016/j.bbamcr.2016.03.016; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eva R, 2014, CURR OPIN NEUROBIOL, V27, P179, DOI 10.1016/j.conb.2014.03.018; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Garron ML, 2008, J MOL BIOL, V375, P1320, DOI 10.1016/j.jmb.2007.11.040; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Haase K, 2014, PROG MOL BIOL TRANSL, V126, P103, DOI 10.1016/B978-0-12-394624-9.00005-1; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Hong ST, 2015, EXP NEUROBIOL, V24, P8, DOI 10.5607/en.2015.24.1.8; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Kanteti R, 2016, ONCOTARGET, V7, P31586, DOI 10.18632/oncotarget.8040; Ko J, 2003, J NEUROSCI, V23, P1667; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; Lulo J, 2009, BIOCHEM BIOPH RES CO, V383, P347, DOI 10.1016/j.bbrc.2009.04.011; Manabe R, 2002, J CELL SCI, V115, P1497; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nishiya N, 2002, J BIOCHEM, V132, P279, DOI 10.1093/oxfordjournals.jbchem.a003222; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Stiegler AL, 2012, J BIOL CHEM, V287, P32566, DOI 10.1074/jbc.M112.367342; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Totaro A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093199; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Vanarotti MS, 2016, BIOCHEMISTRY-US, V55, P1332, DOI 10.1021/acs.biochem.5b01274; Vanarotti MS, 2014, J MOL BIOL, V426, P3985, DOI 10.1016/j.jmb.2014.08.014; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Vitali Teresa, 2019, Small GTPases, V10, P280, DOI 10.1080/21541248.2017.1299271; Webb DJ, 2007, J BIOL CHEM, V282, P6929, DOI 10.1074/jbc.M610981200; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Wong MY, 2018, P NATL ACAD SCI USA, V115, P2234, DOI 10.1073/pnas.1719012115; Yoo Sungsoo M, 2020, Small GTPases, V11, P77, DOI 10.1080/21541248.2017.1362496; Zhang ZWM, 2008, J BIOL CHEM, V283, P18685, DOI 10.1074/jbc.M801274200; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zhou W, 2016, J CELL SCI, V129, P1963, DOI 10.1242/jcs.179465; Zurner M, 2009, GENOMICS, V93, P243, DOI 10.1016/j.ygeno.2008.10.007	54	6	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5827	5839		10.1074/jbc.RA118.006915	http://dx.doi.org/10.1074/jbc.RA118.006915			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30737283	Green Published, hybrid			2022-12-26	WOS:000465077500015
J	Ross, LC; Speed, JDM; Oien, DI; Grygoruk, M; Hassel, K; Lyngstad, A; Moen, A				Ross, Louise C.; Speed, James D. M.; Oien, Dag-Inge; Grygoruk, Mateusz; Hassel, Kristian; Lyngstad, Anders; Moen, Asbjorn			Can mowing restore boreal rich-fen vegetation in the face of climate change?	PLOS ONE			English	Article							SPECIES RICHNESS; SHORT-TERM; MANAGEMENT; PATTERNS; MEADOWS; WATER	Low-frequency mowing has been proposed to be an effective strategy for the restoration and management of boreal fens after abandonment of traditional haymaking. This study investigates how mowing affects long-term vegetation change in both oceanic and continental boreal rich-fen vegetation. This will allow evaluation of the effectiveness of mowing as a management and restoration tool in this ecosystem in the face of climate change. At two nature reserves in Central Norway (Tagdalen, 63 degrees 03' N, 9 degrees 05 E, oceanic climate and Solendet, 62 degrees 40' N, 11 degrees 50' E, continental climate), we used permanent plot data from the two sites to compare plant species composition from the late 1960s to the early 1980s with that recorded in 2012-2015 in abandoned and mown fens. Changes in species composition and frequency were analysed by multivariate and univariate methods in relation to environmental variables and modelled climate and groundwater data. Mowing resulted in a decline in shrub and Molinia caerulea cover at the continental and oceanic sites respectively, and the total cover of specialist fen species had increased to a significantly greater extent in the mown plots than the unmown at the continental site. However, mowing did not have an effect on the cover of specialist bryophyte species, and some specialist species declined regardless of mowing treatment. Temperature sums had increased at both sites, but precipitation had not changed significantly. Mowing was shown to be the most important determinant of plant community composition at both sites, with local environmental conditions being of secondary importance. In conclusion, the abandonment of traditional management practices results in the loss of characteristic fen species. In order to encourage the restoration of typical rich-fen vegetation, particularly in oceanic areas, additional management measures, such as more intensive mowing, may be required.	[Ross, Louise C.; Speed, James D. M.; Oien, Dag-Inge; Hassel, Kristian; Lyngstad, Anders; Moen, Asbjorn] Norwegian Univ Sci & Technol, NTNU Univ Museum, Dept Nat Hist, Trondheim, Norway; [Ross, Louise C.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Grygoruk, Mateusz] Warsaw Univ Life Sci SGGW, Dept Hydraul Engn, Warsaw, Poland	Norwegian University of Science & Technology (NTNU); University of Aberdeen; Warsaw University of Life Sciences	Ross, LC (corresponding author), Norwegian Univ Sci & Technol, NTNU Univ Museum, Dept Nat Hist, Trondheim, Norway.; Ross, LC (corresponding author), Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland.	louise.ross@abdn.ac.uk	Speed, James D. M./C-1099-2009; Hassel, Kristian/AAD-7241-2022	Speed, James D. M./0000-0002-0633-5595; Hassel, Kristian/0000-0002-1906-8166	Polish-Norwegian Research Programme [Pol-Nor/199522/86/2013]	Polish-Norwegian Research Programme	This study was part of the project "Mires and climate: towards enhancing functional resilience of fen peatlands" funded by the Polish-Norwegian Research Programme (project number Pol-Nor/199522/86/2013) awarded to Professor Alojzy Z. Nowak-vice-rector for Research and Liaison at the University of Warsaw https://www.forskningsradet.no/en/Funding/EEA_Poland/1253980306792. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2004, GLOBAL CHANGE BIOL, V10, P1599, DOI 10.1111/j.1365-2486.2004.00815.x; Aune Egil Ingvar, 1996, Norwegian Journal of Agricultural Sciences, V10, P125; Austrheim G, 2007, ECOSCIENCE, V14, P178, DOI 10.2980/1195-6860(2007)14[178:IBSRGA]2.0.CO;2; Benot ML, 2014, ECOSYSTEMS, V17, P458, DOI 10.1007/s10021-013-9734-4; Bergamini A, 2009, PERSPECT PLANT ECOL, V11, P65, DOI 10.1016/j.ppees.2008.10.001; Bernhardt-Romermann M, 2001, J APPL ECOL, V48, P1088; Billeter R, 2007, BOT HELV, V117, P1, DOI 10.1007/s00035-007-0743-9; Birch KS, 2015, RESPONSES RICH FEN A; Britton AJ, 2017, APPL VEG SCI, V20, P194, DOI 10.1111/avsc.12260; Bucharova A, 2012, BIOL CONSERV, V145, P39, DOI 10.1016/j.biocon.2011.09.016; Collins SL, 1998, SCIENCE, V280, P745, DOI 10.1126/science.280.5364.745; Crawford RMM, 2000, NEW PHYTOL, V147, P257, DOI 10.1046/j.1469-8137.2000.00705.x; Elven R., 2005, NORSK FLORA; Essl F, 2012, BIODIVERS CONSERV, V21, P655, DOI 10.1007/s10531-011-0206-x; Fernandez-Pascual E, 2015, FOLIA GEOBOT, V50, P293, DOI 10.1007/s12224-015-9223-y; FRISVOLL AA, 1995, NINA TEMAHEFTE, V4, P1; Green TGA, 1995, ECOPHYSIOLOGY PHOTOS; Grootjans AP, 2005, BASIC APPL ECOL, V6, P185, DOI 10.1016/j.baae.2005.01.008; Grygoruk M, 2014, ECOL ENG, V73, P598, DOI 10.1016/j.ecoleng.2014.09.041; Grytnes JA, 2014, GLOBAL ECOL BIOGEOGR, V23, P876, DOI 10.1111/geb.12170; Gusewell S, 1998, J VEG SCI, V9, P861, DOI 10.2307/3237051; Hajkova P, 2003, PRESLIA, V75, P271; Hajkova P, 2009, J APPL ECOL, V46, P417, DOI 10.1111/j.1365-2664.2009.01608.x; Harbaugh A.W., 2005, MODFLOW 2005 US GEOL, P6, DOI [10.3133/tm6A16, DOI 10.3133/TM6A16]; Henriksen S, 2015, 2015 NORWEGIAN RED L; Jimenez-Alfaro B, 2014, APPL VEG SCI, V17, P367, DOI 10.1111/avsc.12065; Kolos A, 2013, ECOL ENG, V55, P23, DOI 10.1016/j.ecoleng.2013.02.008; LAAKSONEN K, 1979, FENNIA, V157, P171; Lindgaard A., 2011, NORWEGIAN RED LIST E; Lundberg A, 2017, ERDKUNDE, V71, P127, DOI 10.3112/erdkunde.2017.02.03; Lyngstad A, 2017, WETLANDS, V37, P1, DOI 10.1007/s13157-016-0794-z; Maalouf JP, 2012, J APPL ECOL, V49, P795, DOI 10.1111/j.1365-2664.2012.02151.x; Malmer N., 1962, OPERA BOT, V7, P1; Menichino NM, 2016, ECOL ENG, V86, P210, DOI 10.1016/j.ecoleng.2015.09.073; Middleton BA, 2006, APPL VEG SCI, V9, P307, DOI 10.1658/1402-2001(2006)9[307:BMOFAF]2.0.CO;2; Moen A., 1999, Norsk Geografisk Tidsskrift, V53, P93, DOI 10.1080/00291959950136812; Moen A, 1990, GUNNERIA, V63, P1; Moen A., 2017, MIRES PEATLANDS EURO; Moen A, 2015, FOLIA GEOBOT, V50, P25, DOI 10.1007/s12224-015-9204-1; Moen A, 2012, NORD J BOT, V30, P226, DOI 10.1111/j.1756-1051.2011.01253.x; Pakarinen P., 1984, SAMPLING METHODS TAX; Pedrotti E, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00202.1; Peintinger M, 2006, PLANT ECOL, V185, P1, DOI 10.1007/s11258-005-9079-y; Peterka T, 2017, APPL VEG SCI, V20, P124, DOI 10.1111/avsc.12271; QUINN GP, 2002, EXPT DESIGN STAT ANA; Ross LC, 2012, J VEG SCI, V23, P755, DOI 10.1111/j.1654-1103.2012.01390.x; ROWELL TA, 1988, J ECOL, V76, P73, DOI 10.2307/2260455; Sjors H., 1948, ACTA PHYTOGEOGR SUEC, V21, P1; Sletvold N, 2013, GLOBAL CHANGE BIOL, V19, P2729, DOI 10.1111/gcb.12167; Sletvold N, 2010, BIOL CONSERV, V143, P747, DOI 10.1016/j.biocon.2009.12.017; Stammel B, 2003, APPL VEG SCI, V6, P245, DOI 10.1111/j.1654-109X.2003.tb00585.x; Stechova T, 2007, BIOL CONSERV, V135, P443, DOI 10.1016/j.biocon.2006.10.021; Sutherland WJ, 2002, NATURE, V418, P834, DOI 10.1038/418834a; Thebault A, 2014, J ECOL, V102, P896, DOI 10.1111/1365-2745.12236; Tveito OE, 2005, METEOROL APPL, V12, P57, DOI 10.1017/S1350482705001490	55	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211272	10.1371/journal.pone.0211272	http://dx.doi.org/10.1371/journal.pone.0211272			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779747	Green Submitted, Green Published, gold			2022-12-26	WOS:000459062900013
J	Ibal, JC; Pham, HQ; Park, CE; Shin, JH				Ibal, Jerald Conrad; Huy Quang Pham; Park, Chang Eon; Shin, Jae-Ho			Information about variations in multiple copies of bacterial 16S rRNA genes may aid in species identification	PLOS ONE			English	Article							OPERON COPY NUMBER; INTRAGENOMIC HETEROGENEITY; PCR COAMPLIFICATION; CHIMERIC MOLECULES; BACILLUS-CEREUS; DNA; DIVERSITY; SEQUENCE; CONSEQUENCE; POLYMERASE	Variable region analysis of 16S rRNA gene sequences is the most common tool in bacterial taxonomic studies. Although used for distinguishing bacterial species, its use remains limited due to the presence of variable copy numbers with sequence variation in the genomes. In this study, 16S rRNA gene sequences, obtained from completely assembled whole genome and Sanger electrophoresis sequencing of cloned PCR products from Serratia fonticola GS2, were compared. Sanger sequencing produced a combination of sequences from multiple copies of 16S rRNA genes. To determine whether the variant copies of 16S rRNA genes affected Sanger sequencing, two ratios (5:5 and 8:2) with different concentrations of cloned 16S rRNA genes were used; it was observed that the greater the number of copies with similar sequences the higher its chance of amplification. Effect of multiple copies for taxonomic classification of 16S rRNA gene sequences was investigated using the strain GS2 as a model. 16S rRNA copies with the maximum variation had 99.42% minimum pair wise similarity and this did not have an effect on species identification. Thus, PCR products from genomes containing variable 16S rRNA gene copies can provide sufficient information for species identification except from species which have high similarity of sequences in their 16S rRNA gene copies like the case of Bacillus thuringiensis and Bacillus cereus. In silico analysis of 1,616 bacterial genomes from long-read sequencing was also done. The average minimum pairwise similarity for each phylum was reported with their average genome size and average "unique copies" of 16S rRNA genes and we found that the phyla Proteobacteria and Firmicutes showed the highest amount of variation in their copies of their 16S rRNA genes. Overall, our results shed light on how the variations in the multiple copies of the 16S rRNA genes of bacteria can aid in appropriate species identification.	[Ibal, Jerald Conrad; Huy Quang Pham; Park, Chang Eon; Shin, Jae-Ho] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea	Kyungpook National University	Shin, JH (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	jhshin@knu.ac.kr	Park, Chang Eon/ACL-1997-2022	Park, Chang Eon/0000-0001-7379-2422	Strategic Initiative for Microbiomes in Agriculture and Food - Ministry of Agriculture, Food and Rural Affairs [918010-4]	Strategic Initiative for Microbiomes in Agriculture and Food - Ministry of Agriculture, Food and Rural Affairs	This work was supported by: JS, Grant number: 918010-4, Funder: The Strategic Initiative for Microbiomes in Agriculture and Food funded by Ministry of Agriculture, Food and Rural Affairs.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Carneiro MO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-375; Carr IM, 2009, BIOINFORMATICS, V25, P3244, DOI 10.1093/bioinformatics/btp583; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Chen LH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088886, 10.1371/journal.pone.0101544, 10.1371/journal.pone.0099645]; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; CLAYTON RA, 1995, INT J SYST BACTERIOL, V45, P595, DOI 10.1099/00207713-45-3-595; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; Engene N, 2011, FOTTEA, V11, P17, DOI 10.5507/fot.2011.003; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Gupta PK, 2008, TRENDS BIOTECHNOL, V26, P602, DOI 10.1016/j.tibtech.2008.07.003; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jung BK, 2017, J BIOTECHNOL, V241, P158, DOI 10.1016/j.jbiotec.2016.12.002; Kampfer P, 2015, INT J SYST EVOL MICR, V65, P1406, DOI 10.1099/ijs.0.000112; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mechergui A, 2014, APMIS, V122, P437, DOI 10.1111/apm.12164; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Nemergut DR, 2016, ISME J, V10, P1147, DOI 10.1038/ismej.2015.191; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Reischl U, 1998, J CLIN MICROBIOL, V36, P1761, DOI 10.1128/JCM.36.6.1761-1764.1998; Ren ZM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/697279; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Roller BRK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.160, 10.1038/nmicrobiol.2016.160]; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wagner J, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0891-4; Wang GCY, 1996, MICROBIOL-SGM, V142, P1107, DOI 10.1099/13500872-142-5-1107; Wang GCY, 1997, APPL ENVIRON MICROB, V63, P4645, DOI 10.1128/AEM.63.12.4645-4650.1997; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990	35	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212090	10.1371/journal.pone.0212090	http://dx.doi.org/10.1371/journal.pone.0212090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768621	Green Submitted, Green Published, gold			2022-12-26	WOS:000458766300021
J	Lexchin, J				Lexchin, Joel			Association between commercial funding of Canadian patient groups and their views about funding of medicines: An observational study	PLOS ONE			English	Article								Background Patient groups represent the interest of their members when it comes to drug funding. Many patient groups receive grants from pharmaceutical companies that make products being considered for funding. This research examines whether there is an association between the positions that Canadian groups take about the products and conflicts of interest with the companies. Methods The Common Drug Review (CDR) and panCanadian Oncology Drug Review (pCODR) make recommendations to Canadian provincial and federal drug plans about funding particular drug-indications. Both utilize input from patient groups in making their recommendations. Patient group submissions are available from both organizations and these submissions contain statements about conflicts of interest. Views of the patient groups, with and without a conflict with the company making the drug under consideration and without any conflicts at all, were assessed and then compared with the recommendations from CDR and pCODR. Results There was a total of 222 reports for drug-indications. There were 372 submissions from 93 different patient groups. Groups declared a total of 1896 conflicts with drug companies in 324 (87.1%) individual submissions. There were 268 submissions where groups declared a conflict with the company making the product or said they had no conflict. Irrespective of whether there was a conflict, the views of patient groups about the drug-indications under consideration were the same. There was no statistically significant difference between views of patient groups and the recommendations from CDR and/or pCODR. Conclusions The large majority of patient groups making submissions about funding of particular drug-indications had conflicts with the companies making the products and their views about the products were almost always positive. This association between funding and views needs to be further investigated to determine if a true cause and effect exists.	[Lexchin, Joel] York Univ, Sch Hlth Policy & Management, Toronto, ON, Canada; [Lexchin, Joel] Univ Hlth Network, Emergency Dept, Toronto, ON, Canada; [Lexchin, Joel] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada	York University - Canada; University of Toronto; University Health Network Toronto; University of Toronto	Lexchin, J (corresponding author), York Univ, Sch Hlth Policy & Management, Toronto, ON, Canada.; Lexchin, J (corresponding author), Univ Hlth Network, Emergency Dept, Toronto, ON, Canada.; Lexchin, J (corresponding author), Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.	jlexchin@yorku.ca						[Anonymous], 2014, CADTH COMM DRUG REV CADTH COMM DRUG REV; [Anonymous], 2016, PCODR EXP REV COMM T; Batt S, 2017, HLTH ADVOCACY INC PH; Berglas Sarah, 2016, Res Involv Engagem, V2, P21, DOI 10.1186/s40900-016-0036-9; Burton Bob, 2005, BMJ, V331, P1359, DOI 10.1136/bmj.331.7529.1359-b; CADTH, 2014, SUBS ENTR BIOL EM TR; CADTH(Canadian Agency forDrugs and Technologies in Health), 2017, INTR NEW PAT INP TEM; Claypool R., 2016, PATIENTS GROUPS BIG; Facey K, 2017, PATIENT INVOLV HEAL, P67; Goomansingh C., 2014, GLOBAL NEWS; Government of Ontario, 2018, HLTH SECT PAYM TRANS; Hughes David, 2013, Healthc Policy, V9, P52; Keizer B, 2010, PILOT STUDY POSITION; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McCoy MS, 2017, NEW ENGL J MED, V376, P880, DOI 10.1056/NEJMsr1610625; Perehudoff SK, 2011, PATIENT CONSUMER VOI; Rose SL, 2017, JAMA INTERN MED, V177, P344, DOI 10.1001/jamainternmed.2016.8443; Rubenstein S., 2007, WALL STREET J; Weeks C., 2016, GLOBE MAIL	19	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212399	10.1371/journal.pone.0212399	http://dx.doi.org/10.1371/journal.pone.0212399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768629	Green Published, gold, Green Submitted			2022-12-26	WOS:000458766300036
J	Mori, GB; Schietti, J; Poorter, L; Piedade, MTF				Mori, Gisele Biem; Schietti, Juliana; Poorter, Lourens; Fernandez Piedade, Maria Teresa			Trait divergence and habitat specialization in tropical floodplain forests trees	PLOS ONE			English	Article							WOOD SPECIFIC-GRAVITY; LEAF TRAITS; SPECIES DISTRIBUTIONS; VARZEA FORESTS; PLANT TRAITS; TRADE-OFFS; COMMUNITY; DIVERSITY; CLASSIFICATION; VEGETATION	Habitat heterogeneity of tropical forests is thought to lead to specialization in plants and contribute to the high diversity of tree species in Amazonia. One prediction of habitat specialization is that species specialized for resource-rich habitats will have traits associated with high resource acquisition and fast growth while species specialized for resource-poor habitats will have traits associated with high resource conservation and persistence but slow growth. We tested this idea for seven genera and for twelve families from nutrient-rich white-water floodplain forest (varzea) and nutrient-poor black-water (igapo) floodplain forest. We measured 11 traits that are important for the carbon and nutrient balance of the trees, and compared trait variation between habitat types (white-and black-water forests), and the effect of habitat and genus/family on trait divergence. Functional traits of congeneric species differed between habitat types, where white-water forest species invested in resource acquisition and productive tissues, whereas black-water forest species invested in resource conservation and persistent tissues. Habitat specialization is leading to the differentiation of floodplain tree species of white-water and black-water forests, thus contributing to a high diversity of plant species in floodplain forests.	[Mori, Gisele Biem; Schietti, Juliana; Fernandez Piedade, Maria Teresa] INPA, Manaus, Amazonas, Brazil; [Mori, Gisele Biem; Poorter, Lourens] WUR, Forest Ecol & Forest Management Grp, Wageningen, Netherlands	Institute Nacional de Pesquisas da Amazonia; Wageningen University & Research	Mori, GB (corresponding author), INPA, Manaus, Amazonas, Brazil.; Mori, GB (corresponding author), WUR, Forest Ecol & Forest Management Grp, Wageningen, Netherlands.	giselebiem@gmail.com	Schietti, Juliana/AAV-7451-2020; Piedade, Maria Teresa/C-5372-2013; Poorter, Lourens/AAL-1709-2021; Schietti, Juliana/B-8226-2015	Schietti, Juliana/0000-0002-1687-4373; Piedade, Maria Teresa/0000-0002-7320-0498; Schietti, Juliana/0000-0002-1687-4373; Biem Mori, Gisele/0000-0002-6825-9508	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) [140069/2015-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PDSE/CAPES, Brazil) [88881.134479/2016-01]; CNPq/FAPEAMFundacao de Amparo a Pesquisa do Amazonas [441590/2016-0]; Institute Nacional de Ciencia e tecnologia Centro de Estudos das Adaptacoes da Biota Aguatica da Amazonia INCT-ADAPTA II CNPq [465540/2014-7]; CNPq, Brazil [140069/2015-1]; PDSE/CAPES, Brazil [88881.134479/2016-01]; CNPq/FAPEAM [441590/2016-0]; INCT-ADAPTA II, CNPq [465540/2014-7]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PDSE/CAPES, Brazil); CNPq/FAPEAMFundacao de Amparo a Pesquisa do Amazonas; Institute Nacional de Ciencia e tecnologia Centro de Estudos das Adaptacoes da Biota Aguatica da Amazonia INCT-ADAPTA II CNPq; CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PDSE/CAPES, Brazil; CNPq/FAPEAM; INCT-ADAPTA II, CNPq	Gisele Biem Mod was supported by a research grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil, 140069/2015-1) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PDSE/CAPES, Brazil. 88881.134479/2016-01). The research was supported by CNPq/FAPEAMFundacao de Amparo a Pesquisa do Amazonas, 441590/2016-0 and by Institute Nacional de Ciencia e tecnologia Centro de Estudos das Adaptacoes da Biota Aguatica da Amazonia INCT-ADAPTA II CNPq (465540/2014-7).; Financial support was provided by CNPq, Brazil (140069/2015-1), PDSE/CAPES, Brazil (88881.134479/2016-01), CNPq/FAPEAM (441590/2016-0) and by INCT-ADAPTA II, CNPq (465540/2014-7). We are grateful for the people of Jaraua, Mamiraua, and Abacate, Uatuma, for their hospitality and assistance during field work.	[Anonymous], 2018, R LANG ENV STAT COMP, DOI DOI 10.18637/JSS.V028.I05; Baraloto C, 2005, ECOLOGY, V86, P2461, DOI 10.1890/04-1956; Burnham K. P., 2002, ECOLOGICAL MODELLING, V172, DOI [10.1016/j.ecolmodel.2003.11.004, DOI 10.1016/J.ECOLMODEL.2003.11.004]; Burns JH, 2012, P NATL ACAD SCI USA, V109, P3599, DOI 10.1073/pnas.1116085108; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Condit R, 2012, BETA DIVERSITY TROPI, V666, DOI [10.1126/science.1066854, DOI 10.1126/SCIENCE.1066854]; Cosme LHM, 2017, NEW PHYTOL, V215, P113, DOI 10.1111/nph.14508; de Oliveira AA, 2014, J PLANT ECOL, V7, P134, DOI 10.1093/jpe/rtt073; de Souza FC, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1587; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Donovan LA, 2014, J ECOL, V102, P302, DOI 10.1111/1365-2745.12193; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Fine PVA, 2005, EVOLUTION, V59, P1464; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Fortunel C, 2009, ECOLOGY, V90, P598, DOI 10.1890/08-0418.1; GRIME JP, 1974, NATURE, V250, P26, DOI 10.1038/250026a0; Hietz P, 2017, NEW PHYTOL, V213, P170, DOI 10.1111/nph.14123; Hoffmann WA, 2005, FUNCT ECOL, V19, P932, DOI 10.1111/j.1365-2435.2005.01045.x; Instituto de Conservacao e Desenvolvimento Sustentavel do Amazonas I, 2009, SER TECN PLAN GEST R, V1-2, P150; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Junk WJ, 2011, WETLANDS, V31, P623, DOI 10.1007/s13157-011-0190-7; Karin Furch, 2000, CENTRAL AMAZON FLOOD, P109; Karin Furch, CENTRAL AMAZON FLOOD; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Lamarre GPA, 2012, ECOLOGY, V93, pS195, DOI 10.1890/11-0397.1; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Leandro R, 2019, FOREST ECOL MANAG, V432, P365; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Oliveira RS, 2019, NEW PHYTOL, V221, P1457, DOI 10.1111/nph.15463; Opio C, 2000, FOREST ECOL MANAG, V137, P245, DOI 10.1016/S0378-1127(99)00312-6; Paoli GD, 2006, J TROP ECOL, V22, P397, DOI 10.1017/S0266467406003208; Parolin P., 1998, Ecotropica, V4, P25; Parolin Pia, 2000, Acta Amazonica, V30, P441; Parolin Pia, 2012, Pesquisas Botanica, P7; Parolin P, 2010, AOB PLANTS, DOI 10.1093/aobpla/plq003; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Poorter L, 2006, ECOLOGY, V87, P1289, DOI 10.1890/0012-9658(2006)87[1289:AOMTST]2.0.CO;2; PRANCE GT, 1979, BRITTONIA, V31, P26, DOI 10.2307/2806669; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Rozendaal DMA, 2006, FUNCT ECOL, V20, P207, DOI 10.1111/j.1365-2435.2006.01105.x; Savage JA, 2012, ECOLOGY, V93, pS138, DOI 10.1890/11-0406.1; Schongart J, 2002, J TROP ECOL, V18, P581, DOI 10.1017/S0266467402002389; Sioli H, 1956, ERDKUNDE, V89109; Svenning JC, 1999, J ECOL, V87, P55, DOI 10.1046/j.1365-2745.1999.00329.x; Swenson NG, 2008, AM J BOT, V95, P516, DOI 10.3732/ajb.95.4.516; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Valladares F, 2000, ECOLOGY, V81, P1925, DOI 10.1890/0012-9658(2000)081[1925:PPRTLO]2.0.CO;2; Waldhoff D, 2010, AMAZONIAN FLOODPLAIN, P180; Wittmann F, 2002, J TROP ECOL, V18, P805, DOI 10.1017/S0266467402002523; Wittmann F, 2006, J BIOGEOGR, V33, P1334, DOI 10.1111/j.1365-2699.2006.01495.x; Wonn Hagan T., 2001, Western Journal of Applied Forestry, V16, P87; WORBES M, 1992, J VEG SCI, V3, P553, DOI 10.2307/3235812; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zuur Alain F., 2009, P1	62	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212232	10.1371/journal.pone.0212232	http://dx.doi.org/10.1371/journal.pone.0212232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768631	Green Submitted, Green Published, gold			2022-12-26	WOS:000458766300024
J	Gorscak, E; O'Connor, PM				Gorscak, Eric; O'Connor, Patrick M.			A new African Titanosaurian Sauropod Dinosaur from the middle Cretaceous Galula Formation (Mtuka Member), Rukwa Rift Basin, Southwestern Tanzania	PLOS ONE			English	Article							RAPETOSAURUS-KRAUSEI SAUROPODA; RED SANDSTONE GROUP; KEM KEM BEDS; NEUQUENSAURUS-AUSTRALIS; BASAL TITANOSAUR; BAURU GROUP; SP-NOV.; PATAGONIA; EVOLUTION; OSTEOLOGY	The African terrestrial fossil record has been limited in its contribution to our understanding of both regional and global Cretaceous paleobiogeography, an interval of significant geologic and macroevolutionary change. A common component in Cretaceous African faunas, titanosaurian sauropods diversified into one of the most specious groups of dinosaurs worldwide. Here we describe the new titanosaurian Mnyamawamtuka moyowamkia gen. et sp. nov. from the Mtuka Member of the Galula Formation in southwest Tanzania. The new specimen preserves teeth, elements from all regions of the postcranial axial skeleton, parts of both appendicular girdles, and portions of both limbs including a complete metatarsus. Unique traits of M. moyowamkia include the lack of an interpostzygapophyseal lamina in posterior dorsal vertebrae, pronounced posterolateral expansion of middle caudal centra, and an unusually small sternal plate. Phylogenetic analyses consistently place M. moyowamkia as either a close relative to lithostrotian titanosaurians (e.g., parsimony, uncalibrated Bayesian analyses) or as a lithostrotian and sister taxon to Malawisaurus dixeyi from the nearby Aptian? Dinosaur Beds of Malawi (e.g., tip-dating Bayesian analyses). M. moyowamkia shares a few features with M. dixeyi, including semi-spatulate teeth and a median lamina between the neural canal and interpostzygapophyseal lamina in anterior dorsal vertebrae. Both comparative morphology and phylogenetic analyses support Mnyamawamtuka as a distinct and distant relative to Rukwatitan bisepultus and Shingopana songwensis from the younger Namba Member of the Galula Formation with these results largely congruent with newly constrained ages for the Mtuka Member (Aptian-Cenomanian) and Namba Member (Campanian). Coupled with recent discoveries from the Dahkla Oasis, Egypt (e.g., Mansourasaurus shahinae) and other parts of continental Afro-Arabia, the Tanzania titanosaurians refine perspectives on the development of African terrestrial faunas throughout the Cretaceous a critical step in understanding non-marine paleobiogeographic patterns of Africa that have remained elusive until the past few years.	[Gorscak, Eric] Midwestern Univ, Dept Anat, Downers Grove, IL 60515 USA; [Gorscak, Eric] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA; [Gorscak, Eric] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Gorscak, Eric; O'Connor, Patrick M.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Gorscak, Eric; O'Connor, Patrick M.] Ohio Univ, Ohio Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA	Midwestern University; Field Museum of Natural History (Chicago); University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Gorscak, E (corresponding author), Midwestern Univ, Dept Anat, Downers Grove, IL 60515 USA.; Gorscak, E (corresponding author), Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA.; Gorscak, E (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.; Gorscak, E (corresponding author), Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA.; Gorscak, E (corresponding author), Ohio Univ, Ohio Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA.	eric.gorscak@gmail.com	OConnor, Patrick M/I-9383-2012	OConnor, Patrick M/0000-0002-6762-3806; Gorscak, Eric/0000-0002-4019-8301	U.S. National Science Foundation [NSF EAR_0617561, EAR_085421, EAR_1349825]; National Geographic Society; Ohio University Heritage College of Osteopathic Medicine; Ohio University Office of Research and Sponsored Programs; Ohio University African Studies Program; Ohio University Student Enhancement Award; Ohio University Original Work Grant; Jurassic Foundation; Paleontological Society	U.S. National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Ohio University Heritage College of Osteopathic Medicine; Ohio University Office of Research and Sponsored Programs; Ohio University African Studies Program; Ohio University Student Enhancement Award; Ohio University Original Work Grant; Jurassic Foundation; Paleontological Society	This research was supported by the U.S. National Science Foundation (NSF EAR_0617561, EAR_085421, EAR_1349825; P.M.O.), the National Geographic Society (Committee for Research and Exploration Grant) (P.M.O.), the Ohio University Heritage College of Osteopathic Medicine, Ohio University Office of Research and Sponsored Programs (P.M.O.), Ohio University African Studies Program, Ohio University Student Enhancement Award and Original Work Grant (E.G.), the Jurassic Foundation (E. G.), and the Paleontological Society (E.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armin Kellner Alexander Wilhelm, 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P529; Averianov Alexander, 2017, Biological Communications, V62, P6, DOI 10.21638/11701/spbu03.2017.102; Bandeira KLN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163373; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Bonaparte J. F., 2000, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V256, P25; Bonaparte JF, 2006, CRETACEOUS RES, V27, P364, DOI 10.1016/j.cretres.2005.07.004; Bonaparte Jose F., 1993, Ameghiniana, V30, P271; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Calvo JO, 2003, REV GEOL CHILE, V30, P333; Calvo JO, 2007, AN ACAD BRAS CIENC, V79, P529, DOI 10.1590/S0001-37652007000300013; Calvo Jorge O., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P485; Canudo JI, 2008, J VERTEBR PALEONTOL, V28, P712, DOI 10.1671/0272-4634(2008)28[712:ANSTSG]2.0.CO;2; Carballido JL, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1219; Carballido JL, 2014, J SYST PALAEONTOL, V12, P335, DOI 10.1080/14772019.2013.764935; Carballido JL, 2011, J VERTEBR PALEONTOL, V31, P93, DOI 10.1080/02724634.2011.539651; Carvalho ID, 2017, J S AM EARTH SCI, V75, P74, DOI 10.1016/j.jsames.2017.01.010; Cerda IA, 2012, PALAEONTOL Z, V86, P441, DOI 10.1007/s12542-012-0140-6; COLIN JP, 1990, CR ACAD SCI II, V311, P1025; Coria RA, 2013, ZOOTAXA, V3683, P357, DOI 10.11646/zootaxa.3683.4.2; Csiki Z, 2010, NEUES JAHRB GEOL P-A, V258, P297, DOI 10.1127/0077-7749/2010/0098; Curry Rogers KA, SAUROPODS EVOLUTION; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; D'Emic MD, 2011, J VERTEBR PALEONTOL, V31, P1072, DOI 10.1080/02724634.2011.595856; D'Emic MD, 2011, ACTA PALAEONTOL POL, V56, P61, DOI 10.4202/app.2009.0149; Dal Sasso C, 2016, CRETACEOUS RES, V64, P88, DOI 10.1016/j.cretres.2016.03.008; Day JJ, 2002, SCIENCE, V296, P1659, DOI 10.1126/science.1070167; De Almeida Campos Diogenes, 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P565; Diaz VD, 2016, CRETACEOUS RES, V68, P49, DOI 10.1016/j.cretres.2016.08.001; Diez Diaz V, 2013, PALAEONTOL ELECTRON, V16, p19A; Ezcurra MD, 2012, SYST BIOL, V61, P553, DOI 10.1093/sysbio/syr115; Fanti F., 2012, EARTH LIFE GLOBAL BI, P883; Gallina PA, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.924957; Gallina PA, 2011, AN ACAD BRAS CIENC, V83, P235, DOI 10.1590/S0001-37652011005000001; GILMORE C, 1946, US GEOLOGICAL SURV C, P1; Goloboff P, 2008, CLADISTICS, V24, P91; Gomani E. M., 2005, PALAEONTOL ELECTRON, V8, P27; Gomani Elizabeth M., 1999, National Science Museum Monographs, V15, P235; Riga BJG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19165; Gonzalez Riga BJ, 2018, ZOOL J LINN SOC-LOND; Gorscak E, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1343250; Gorscak E, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.1047; Gorscak E, 2014, J VERTEBR PALEONTOL, V34, P1133, DOI 10.1080/02724634.2014.845568; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Ibrahim Nizar, 2016, Bulletin of the New Mexico Museum of Natural History and Science, P149; JACOBS LL, 1993, PALAEONTOLOGY, V36, P523; Jacobs Louis L., 1996, Memoirs of the Queensland Museum, V39, P595; Jain SL, 1997, J VERTEBR PALEONTOL, V17, P114, DOI 10.1080/02724634.1997.10010958; Juarez Valieri R.D., 2011, PALEONTOLOGIA DINOSA, V8332, P143; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kellner A. W. A, 2006, GEOLOGIA, V74, P1; Kellner Alexander W.A., 1999, National Science Museum Monographs, V15, P111; Lacovara Kenneth J, 2014, Sci Rep, V4, P6196, DOI 10.1038/srep06196; Lamanna Matthew C., 2014, Bulletin of Gunma Museum of Natural History, V18, P1; Le Loeuff J, 2005, LIFE O PAST, P115; Lee MSY, 2015, CURR BIOL, V25, pR922, DOI 10.1016/j.cub.2015.07.009; Lee MSY, 2014, SYST BIOL, V63, P442, DOI 10.1093/sysbio/syt110; LELOEUFF J, 1995, CR ACAD SCI II A, V321, P693; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Longrich NR, 2017, CRETACEOUS RES, V76, P40, DOI 10.1016/j.cretres.2017.03.021; Mannion PD, 2013, CRETACEOUS RES, V45, P49, DOI 10.1016/j.cretres.2013.07.007; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Mannion PD, 2012, J VERTEBR PALEONTOL, V32, P614, DOI 10.1080/02724634.2012.660898; Mannion PD, 2011, ZOOL J LINN SOC-LOND, V163, P155, DOI 10.1111/j.1096-3642.2011.00699.x; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; Martinez RD, 2004, J VERTEBR PALEONTOL, V24, P107, DOI 10.1671/9.1; Martinez-Aranguren R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088394; Mateus O, 2011, AN ACAD BRAS CIENC, V83, P221, DOI 10.1590/S0001-37652011000100012; Matzke NJ, 2015, BEASTMASTER AUTOMATE; Muller J, 2006, SYSTEMATIC BIOL, V55, P503, DOI 10.1080/10635150600755396; O'Connor PM, 2010, NATURE, V466, P748, DOI 10.1038/nature09061; O'Connor PM, 2006, J AFR EARTH SCI, V44, P277, DOI 10.1016/j.jafrearsci.2005.11.022; O'Reilly JE, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0081; Otero A, 2008, AMEGHINIANA, V45, P333; Otero A, 2010, ACTA PALAEONTOL POL, V55, P399, DOI 10.4202/app.2009.0099; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Poropat SF, 2015, GONDWANA RES, V27, P995, DOI 10.1016/j.gr.2014.03.014; Poropat SF, 2015, PAP PALAEONTOL, V1, P59, DOI 10.1002/spp2.1004; Powell J.E., 1992, DINOSAURIOS ENTORNO, P165; Rauhut OWM, 2005, NATURE, V435, P670, DOI 10.1038/nature03623; Remes K, 2007, PALAEONTOLOGY, V50, P653, DOI 10.1111/j.1475-4983.2007.00652.x; Riga BJG, 2005, AMEGHINIANA, V42, P535; Roberts EM, 2010, J AFR EARTH SCI, V57, P179, DOI 10.1016/j.jafrearsci.2009.09.002; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rogers KC, 2004, J VERTEBR PALEONTOL, V24, P121, DOI 10.1671/A1109-10; Rogers KC, 2009, J VERTEBR PALEONTOL, V29, P1046, DOI 10.1671/039.029.0432; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Salgado L, 2015, HIST BIOL, V27, P525, DOI 10.1080/08912963.2014.894038; SALGADO L, 1991, Ameghiniana, V28, P333; Salgado L, 2008, PALAEONTOLOGY, V51, P881, DOI 10.1111/j.1475-4983.2008.00781.x; Salgado L, 2010, J VERTEBR PALEONTOL, V30, P1760, DOI 10.1080/02724634.2010.520783; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Sallam HM, 2018, NAT ECOL EVOL, V2, P445, DOI 10.1038/s41559-017-0455-5; Santucci Rodrigo M., 2011, Zootaxa, V3085, P1; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Sertich JJW, 2014, J VERTEBR PALEONTOL, V34, P576, DOI 10.1080/02724634.2013.819808; Smith JB, 2001, SCIENCE, V292, P1704, DOI 10.1126/science.1060561; Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Upchurch P, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P104; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Whitlock JA, 2011, PALAEOGEOGR PALAEOCL, V309, P333, DOI 10.1016/j.palaeo.2011.07.001; Whitlock JA, 2011, ZOOL J LINN SOC-LOND, V161, P872, DOI 10.1111/j.1096-3642.2010.00665.x; Widlansky SJ, 2018, J AFR EARTH SCI, V139, P403, DOI 10.1016/j.jafrearsci.2017.11.029; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Wilson JA, 2016, ZOOL J LINN SOC-LOND, V178, P611, DOI 10.1111/zoj.12420; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663	115	26	26	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211412	10.1371/journal.pone.0211412	http://dx.doi.org/10.1371/journal.pone.0211412			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759122	Green Published, gold			2022-12-26	WOS:000458761300044
J	Hansen, JF; Christiansen, KM; Staugaard, B; Moessner, BK; Lillevang, S; Krag, A; Christensen, PB				Hansen, Janne Fuglsang; Christiansen, Karen Molgaard; Staugaard, Benjamin; Moessner, Belinda Klemmensen; Lillevang, Soren; Krag, Aleksander; Christensen, Peer Brehm			Combining liver stiffness with hyaluronic acid provides superior prognostic performance in chronic hepatitis C	PLOS ONE			English	Article							CHRONIC VIRAL-HEPATITIS; TRANSIENT ELASTOGRAPHY; NONINVASIVE TESTS; FIBROSIS PROGRESSION; DIAGNOSTIC-ACCURACY; LEVELS PREDICT; CIRRHOSIS; RISK; SURVIVAL; OUTCOMES	Background Non-invasive methods are the first choice for liver fibrosis evaluation in chronic liver diseases, but few studies investigate the ability of combined methods to predict outcomes. Methods 591 chronic hepatitis C patients with baseline liver stiffness (LSM) by FibroScan and hyaluronic acid measurements were identified retrospectively. The patients were grouped by baseline LSM: < 10kPa, 10-16.9kPa, and 17-75kPa. Primary outcomes were all-cause mortality and liver-related mortality, analyzed using cox regression and competing risk regression models, respectively. Results Median follow-up was 46.1 months. Prevalence of cirrhosis at baseline was 107/591 (18.1%). Median LSM was 6.8kPa (IQR 5.3-11.6) and divided into groups, 404/591 (68.4%) had a LSM < 10kPa, 100/591 (16.9%) had a LSM between 10-16.9kPa and 87/591 (14.7%) had a LSM between 17-75kPa. There were 69 deaths, 27 from liver-related disease. 26 patients developed cirrhosis and 30 developed complications of cirrhosis. The mortality rate in the 17-75kPa group was 9.7/100 person-years, compared to 2.2/100 person-years and 1.1/100 person-years in the 10-16.9kPa and <10kPa groups (p<0.005). Liver-related mortality increased 10-fold for each group (p<0.005). Cirrhotic complications occurred almost exclusively in the 17-75kPa group, with an incidence of 10.3/100 person-years, compared to 1.8/100 person-years and 0.2/100 person-years in the 10-16.9kPa and <10kPa groups (p<0.005). Median hyaluronic acid in the 17-75kPa group was approximately 200ng/mL. Patients with a LSM 17-75kPa had significantly higher risks of death, liver-related death, and complications to cirrhosis if their hyaluronic acid measurement was more than or equal to 200ng/mL at baseline, with hazard ratios of 3.25 (95% CI 1.48-7.25), 7.7 (95% CI 2.32-28), and 3.2 (95% CI 1.35-7.39), respectively. Conclusions The combination of LSM and circulating hyaluronic acid measurements significantly improved prognostic ability, relative to LSM alone. Combined static and dynamic markers of liver fibrosis could provide superior risk prediction.	[Hansen, Janne Fuglsang; Christiansen, Karen Molgaard; Staugaard, Benjamin; Moessner, Belinda Klemmensen; Christensen, Peer Brehm] Odense Univ Hosp, Dept Infect Dis, Odense, Denmark; [Hansen, Janne Fuglsang; Krag, Aleksander; Christensen, Peer Brehm] Univ Southern Denmark, Fac Hlth Sci, Dept Clin Res, Odense, Denmark; [Lillevang, Soren] Odense Univ Hosp, Dept Clin Immunol, Odense, Denmark; [Krag, Aleksander] Odense Univ Hosp, Dept Gastroenterol & Hepatol, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Hansen, JF (corresponding author), Odense Univ Hosp, Dept Infect Dis, Odense, Denmark.; Hansen, JF (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Dept Clin Res, Odense, Denmark.	janne.fuglsang.hansen@rsyd.dk	Krag, Aleksander/ABH-9649-2020; Lillevang, Søren Thue/W-2430-2019	Krag, Aleksander/0000-0002-9598-4932; Lillevang, Søren Thue/0000-0002-5470-7867; Christensen, Peer Brehm/0000-0003-1394-058X; Hansen, Janne Fuglsang/0000-0002-8039-0699	Region of Southern Denmark; Danish National Advanced Technology Foundation	Region of Southern Denmark; Danish National Advanced Technology Foundation	This study was investigator-initiated. JFH's salary was supported by the Region of Southern Denmark (https://www.regionsyddanmark.dk/wm228983) and the Danish National Advanced Technology Foundation (https://www.teknologiudvikling.dk) (no grant numbers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arain SA, 2011, SAUDI MED J, V32, P1241; Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2015, DIGEST DIS, V33, P498, DOI 10.1159/000374097; Castera L, 2010, J HEPATOL, V52, P191, DOI 10.1016/j.jhep.2009.11.008; Cepeda JA, 2017, CLIN INFECT DIS; Christiansen KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111912; Danish Health Authority, HLTH LIF STYL; de Ledinghen V, 2013, ALIMENT PHARM THER, V37, P979, DOI 10.1111/apt.12307; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; EASL, EASL REC TREATM HEP; Fraquelli M, 2011, J HEPATOL, V54, P621, DOI 10.1016/j.jhep.2010.07.017; Gonzalez FA, 2015, HIV MED, V16, P211, DOI 10.1111/hiv.12197; Guechot J, 1996, CLIN CHEM, V42, P558; Guechot J, 2000, J HEPATOL, V32, P447, DOI 10.1016/S0168-8278(00)80396-7; Halfon Philippe, 2005, Comp Hepatol, V4, P6, DOI 10.1186/1476-5926-4-6; Kaneda H, 2006, J GASTROEN HEPATOL, V21, P1459, DOI 10.1111/j.1440-1746.2006.04447.x; Kang W, 2014, WORLD J GASTROENTERO, V20, P2613, DOI 10.3748/wjg.v20.i10.2613; Klibansky DA, 2012, J VIRAL HEPATITIS, V19, pE184, DOI 10.1111/j.1365-2893.2011.01493.x; Kopke-Aguiar LA, 2002, ACTA TROP, V84, P117, DOI 10.1016/S0001-706X(02)00136-5; Lau DTY, 1998, HEPATOLOGY, V28, P1121, DOI 10.1002/hep.510280430; Macias J, 2013, AIDS, V27, P2541, DOI 10.1097/QAD.0b013e32836381f3; Merchante N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1291-3; Mueller S, 2015, LIVER INT, V35, P2514, DOI 10.1111/liv.12904; Neuman MG, 2016, CLIN BIOCHEM, V49, P302, DOI 10.1016/j.clinbiochem.2015.07.019; Nunes D, 2010, AM J GASTROENTEROL, V105, P1346, DOI 10.1038/ajg.2009.746; Pang JXQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095776; Perez-Latorre L, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw212; PERUCCI CA, 1991, AM J PUBLIC HEALTH, V81, P1307, DOI 10.2105/AJPH.81.10.1307; Peters L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064283; Peters L, 2011, ANTIVIR THER, V16, P667, DOI 10.3851/IMP1815; Poynard T, 2014, J HEPATOL, V60, P706, DOI 10.1016/j.jhep.2013.11.016; Resino S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-244; Scrucca L, 2010, BONE MARROW TRANSPL, V45, P1388, DOI 10.1038/bmt.2009.359; Vergniol J, 2014, HEPATOLOGY, V60, P65, DOI 10.1002/hep.27069; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Vispo E, 2009, ANTIVIR THER, V14, P187; Wong GLH, 2014, CLIN MOL HEPATOL, V20, P228, DOI 10.3350/cmh.2014.20.3.228	38	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0212036	10.1371/journal.pone.0212036	http://dx.doi.org/10.1371/journal.pone.0212036			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742668	Green Published, gold, Green Submitted			2022-12-26	WOS:000458393400038
J	Navodani, T; Gartland, D; Brown, SJ; Riggs, E; Yelland, J				Navodani, Tharanga; Gartland, Deirdre; Brown, Stephanie J.; Riggs, Elisha; Yelland, Jane			Common maternal health problems among Australian-born and migrant women: A prospective cohort study	PLOS ONE			English	Article							POSTNATAL DEPRESSION; IMMIGRANT WOMEN; CARE; EXPERIENCES; SERVICES; QUESTIONNAIRE; INCONTINENCE; SEVERITY; SYMPTOMS; BIRTH	Background Migrant women of non-English speaking background make up an increasing proportion of women giving birth in high income countries, such as Australia, Canada and the United Kingdom. The aim of this study was to assess the prevalence of common physical and psychosocial health problems during pregnancy and up to 18 months postpartum among migrant women of non-English speaking background compared to Australian-born women. Methods Prospective pregnancy cohort study of 1507 nulliparous women. Women completed self-administered questionnaires or telephone interviews in early and late pregnancy and at 3, 6, 9, 12 and 18 months postpartum. Standardised instruments were used to assess incontinence, depressive symptoms and intimate partner violence. Findings Migrant women of non-English speaking background (n = 243) and Australian-born mothers (n = 1115) reported a similar pattern of physical health problems during pregnancy and postpartum. The most common physical health problems were: exhaustion, back pain, constipation and urinary incontinence. Around one in six Australian-born women (16.9%) and more than one in four migrant women (22.5%) experienced intimate partner abuse in the first 12 months postpartum. Compared to Australian-born women, migrant women were more likely to report depressive symptoms at 12 and 18 months postpartum. Conclusion Physical and mental health problems are common among women of non-English speaking background and Australian-born women, and frequently persist up to 18 months postpartum. Migrant women experience a higher burden of postpartum depressive symptoms and intimate partner violence, and may face additional challenges accessing appropriate care and support.	[Navodani, Tharanga; Gartland, Deirdre; Brown, Stephanie J.; Riggs, Elisha; Yelland, Jane] Murdoch Childrens Res Inst, Intergenerat Hlth Grp, Parkville, Vic, Australia; [Navodani, Tharanga] Minist Hlth, Colombo, Sri Lanka; [Gartland, Deirdre; Brown, Stephanie J.] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Brown, Stephanie J.; Riggs, Elisha; Yelland, Jane] Univ Melbourne, Dept Gen Practice, Parkville, Vic, Australia; [Brown, Stephanie J.; Riggs, Elisha; Yelland, Jane] Univ Melbourne, Primary Hlth Care Acad Ctr, Parkville, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Melbourne	Yelland, J (corresponding author), Murdoch Childrens Res Inst, Intergenerat Hlth Grp, Parkville, Vic, Australia.; Yelland, J (corresponding author), Univ Melbourne, Dept Gen Practice, Parkville, Vic, Australia.; Yelland, J (corresponding author), Univ Melbourne, Primary Hlth Care Acad Ctr, Parkville, Vic, Australia.	jane.yelland@mcri.edu.au	Gartland, Deirdre/K-4266-2019; Brown, Stephanie/AAE-1662-2019; Riggs, Elisha/K-4267-2019	Gartland, Deirdre/0000-0001-6749-8147; Riggs, Elisha/0000-0003-0799-7467; Yelland, Jane/0000-0003-0377-5824; Brown, Stephanie/0000-0001-9812-0067	National Health and Medical Research Council (NHMRC) [199222, 433006, 491205]; Victorian Government's Operational Infrastructure Support Program; ARC Future Fellowship; NHMRC Career Development Fellowship; NHMRC Senior Research Fellowship; NHMRC Career Development Award	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; ARC Future Fellowship(Australian Research Council); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the National Health and Medical Research Council (NHMRC www.nhmrc.gov.au) grants #199222, #433006 and #491205, and supported by the Victorian Government's Operational Infrastructure Support Program. Stephanie Brown held a NHMRC Career Development Award (2008-2011), an ARC Future Fellowship (2012-2015) and currently holds a NHMRC Senior Research Fellowship (2016-2020). Jane Yelland is supported by a NHMRC Career Development Fellowship (2014-2017).	Almeida L, 2013, MATERN CHILD HLTH J, V17, P1346, DOI 10.1007/s10995-012-1149-x; Australian Institute Health and Welfare, 2017, PERINATAL STATISTICS, V33; Australian Institute of Health and Welfare, 2018, AUSTRALIAS MOTHERS B; Bandyopadhyay M, 2010, AUST NZ J PUBL HEAL, V34, P412, DOI 10.1111/j.1753-6405.2010.00575.x; Brown S, 1998, BRIT J OBSTET GYNAEC, V105, P156, DOI 10.1111/j.1471-0528.1998.tb10045.x; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Department of Premier and Cabinet, 2013, VICT DIV POP 2011 CE; Eastwood JG, 2011, AUST NZ J PSYCHIAT, V45, P1040, DOI 10.3109/00048674.2011.619160; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Gunthorpe W, 2000, NEUROUROL URODYNAM, V19, P595, DOI 10.1002/1520-6777(2000)19:5<595::AID-NAU6>3.0.CO;2-Q; Hanley J, 2001, BRIT MED J, V322, P1096, DOI 10.1136/bmj.322.7294.1096; Hegarty Kelsey, 2005, Violence Vict, V20, P529, DOI 10.1891/vivi.2005.20.5.529; Hegarty KL, 2013, J INTERPERS VIOLENCE, V28, P273, DOI 10.1177/0886260512454722; Henderson S, 2011, AUST J PRIM HEALTH, V17, P195, DOI 10.1071/PY10065; Hynie Michaela, 2011, Can J Nurs Res, V43, P26; Khanlou N, 2017, J PREGNANCY, V2017, DOI 10.1155/2017/8783294; Lansakara N, 2010, MATERN CHILD HLTH J, V14, P807, DOI 10.1007/s10995-009-0514-x; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Phillimore J, 2016, SOC SCI MED, V148, P152, DOI 10.1016/j.socscimed.2015.11.030; Riggs E, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0145-3; Shafiei T, 2015, MIDWIFERY, V31, P671, DOI 10.1016/j.midw.2015.03.011; Small R, 2003, ETHNIC HEALTH, V8, P189, DOI 10.1080/1355785032000136416; Small R, 1999, AUST NZ J PUBL HEAL, V23, P385, DOI 10.1111/j.1467-842X.1999.tb01279.x; Small R, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-152; Small R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088457; Stewart DE, 2008, CAN J PSYCHIAT, V53, P121, DOI 10.1177/070674370805300208; TALLEY NJ, 1995, AUST NZ J MED, V25, P302, DOI 10.1111/j.1445-5994.1995.tb01894.x; Yelland J, 2015, MIDWIFERY, V31, P664, DOI 10.1016/j.midw.2015.03.001; Yelland J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-771	29	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211685	10.1371/journal.pone.0211685	http://dx.doi.org/10.1371/journal.pone.0211685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL0OI	30742634	Green Published, gold			2022-12-26	WOS:000458393400018
J	Keel, I; Schurch, R; Weiss, J; Zwahlen, M; Immer, FF; Bechir, M; Delalay, C; Delalay, C; Eckhart, F; Endermann, S; Fassler, E; Feiner, AS; Gasche, Y; Ghanfili, E; Lenherr, R; Moretti, D; Nebiker, M; Pfluger, M; Pilon, N; Re-Genscheit, S; Sauter, T; Sprachta, J; Tisljar, K				Keel, Isabelle; Schurch, Roger; Weiss, Julius; Zwahlen, Marcel; Immer, Franz F.; Bechir, Markus; Delalay, Corinne; Eckert, Philippe; Eckhart, Friedemann; Endermann, Susann; Fassler, Edith; Feiner, Adam-Scott; Gasche, Yvan; Ghanfili, Eva; Lenherr, Renato; Moretti, Diane; Nebiker, Mathias; Pfluger, Marc; Pilon, Nathalie; Re-Genscheit, Stefan; Sauter, Thomas; Sprachta, Jan; Tisljar, Kai		Com Natl Don d'Organes CNDO	Is there an association between consent rates in Swiss hospitals and critical care staffs' attitudes towards organ donation, their knowledge and confidence in the donation process?	PLOS ONE			English	Article							DONOR; DECISION; NEEDS; NONDONOR	This study investigated the critical care staff's attitude, knowledge and involvement with donation, skills and confidence with donation-related tasks and their association with consent rates at the hospital level. In 2015, we conducted a cross-sectional survey among critical care staff of hospitals involved in organ donation using an anonymous online questionnaire with a response rate of 56.4% (n = 2799). The hospital level consent rate was obtained from the Swiss Monitoring of Potential Donors database (2013-2015). For each hospital, we calculated a mean score for each predictor of interest of the Hospital Attitude Survey and investigated the association with hospital consent rates with generalized linear mixed-effect models. In univariable analysis, one score point increase in doctors' confidence resulted in a 66% (95% CI: 45%-80%) reduction in the odds to consent, and one score point increase in nurses' attitudes resulted in a 223% (95% CI: 84%-472%) increase in the odds to consent. After simultaneously adjusting for all major predictors found in the crude models, only levels of education of medical and nursing staff remained as significant predictors for hospital consent rates. In Switzerland, efforts are needed to increase consent rates for organ donation and should concentrate on continuous support as well as specific training of the hospital staff involved in the donation process.	[Keel, Isabelle; Weiss, Julius; Immer, Franz F.; Com Natl Don d'Organes CNDO] Swiss Natl Fdn Organ Donat & Transplantat, Bern, Switzerland; [Schurch, Roger] Univ Bern, CTU Bern, Dept Clin Res, Bern, Switzerland; [Schurch, Roger; Zwahlen, Marcel] Univ Bern, ISPM, Bern, Switzerland; [Bechir, Markus] Zentrum Innere Med ZIM Aarau, Aarau, Switzerland; [Delalay, Corinne; Gasche, Yvan; Moretti, Diane] Hop Univ Geneve, Geneva, Switzerland; [Eckert, Philippe; Feiner, Adam-Scott; Pilon, Nathalie] CHU Vaudois, Lausanne, Switzerland; [Eckhart, Friedemann] Kantonsspital Luzern, Luzern, Switzerland; [Endermann, Susann; Fassler, Edith] Kantonsspital St Gallen, St Gallen, Switzerland; [Ghanfili, Eva] Osped Reg Lugano Civico, Lugano, Switzerland; [Lenherr, Renato; Re-Genscheit, Stefan] Univ Spital Zurich, Zurich, Switzerland; [Nebiker, Mathias; Pfluger, Marc] Inselspital Bern, Bern, Switzerland; [Sauter, Thomas] Lindenhofspital Bern, Bern, Switzerland; [Sprachta, Jan; Tisljar, Kai] Univ Spital Basel, Basel, Switzerland	University of Bern; University of Bern; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Lucerne Cantonal Hospital; University of Zurich; University Zurich Hospital; University of Basel	Immer, FF (corresponding author), Swiss Natl Fdn Organ Donat & Transplantat, Bern, Switzerland.	franz.immer@swisstransplant.org	Zwahlen, Marcel/AFF-8559-2022	Zwahlen, Marcel/0000-0002-6772-6346				[Anonymous], 2007, 810211 SR; [Anonymous], 2020, GLOBAL ORGAN SHORTAG; Babaie Mohadese, 2015, Glob J Health Sci, V7, P129, DOI 10.5539/gjhs.v7n6p129; Balthasar A, 2009, AUSWERTUNGEN AUSGEWA; Bogh L, 2005, TRANSPL P, V37, P3256, DOI 10.1016/j.transproceed.2005.09.063; Czerwinski J, 2016, TRANSPL P, V48, P2429, DOI 10.1016/j.transproceed.2015.12.144; DuBois James M, 2006, Prog Transplant, V16, P65; Hulme W, 2016, ANAESTHESIA, V71, P1053, DOI 10.1111/anae.13535; Irving MJ, 2014, TRANSPL INT, V27, P617, DOI 10.1111/tri.12307; Irving MJ, 2012, NEPHROL DIAL TRANSPL, V27, P2526, DOI 10.1093/ndt/gfr683; Jacoby L, 2010, AM J CRIT CARE, V19, pE52, DOI 10.4037/ajcc2010396; Jacoby LH, 2005, DIMENS CRIT CARE NUR, V24, P183, DOI 10.1097/00003465-200507000-00009; Kosieradzki M, 2014, J TRANSPLANT, V2014, DOI 10.1155/2014/296912; Not I, 2016, SCHWEIZERISCHE ARZTE, V97, P52; Pelleriaux B, 2008, PROG TRANSPLANT, V18, P173; Zambudio AR, 2009, PROG TRANSPLANT, V19, P371; Rithalia Amber, 2009, BMJ, V338, pa3162, DOI 10.1136/bmj.a3162; Rodrigue JR, 2006, AM J TRANSPLANT, V6, P190, DOI 10.1111/j.1600-6143.2005.01130.x; Roels L, 2010, TRANSPL INT, V23, P842, DOI 10.1111/j.1432-2277.2010.01065.x; Schulz PJ, 2006, PATIENT EDUC COUNS, V64, P294, DOI 10.1016/j.pec.2006.03.009; Siminoff LA, 2002, J TRAUMA, V53, P754, DOI 10.1097/00005373-200210000-00023; Simpkin AL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b991; Smudla A, 2012, ANN TRANSPL, V17, P93; Swisstransplant, SWISSPOD REP; Swisstransplant Comite National de Don d'Organes, INF MAT FACHP; Swisstransplant. Jahresbericht, 2014, ANN REPORT; Walchli-Bhend S, 2011, ORGANS TISSUES CELLS, V14, P25; Webb G, 2015, TRANSPLANTATION, V99, P1396, DOI 10.1097/TP.0000000000000504; Weiss J, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14401; Weiss J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106845; Weiss JH, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14045	31	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211614	10.1371/journal.pone.0211614	http://dx.doi.org/10.1371/journal.pone.0211614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735508	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000458181200023
J	Lund, TB; Kondrup, SV; Sandoe, P				Lund, Thomas Boker; Kondrup, Sara Vincentzen; Sandoe, Peter			A multidimensional measure of animal ethics orientation - Developed and applied to a representative sample of the Danish public	PLOS ONE			English	Article							MEAT; WELFARE; ATTITUDES; MODEL; WILLINGNESS; VEGETARIANS; BEHAVIOR; VALUES; FOOD	We present a questionnaire-based measure of four animal ethics orientations. The orientations, which were developed in light of existing empirical studies of attitudes to animal use and ethical theory, are: animal rights, anthropocentrism, lay utilitarianism, and animal protection. The two latter orientations can be viewed as variants of animal welfarism. Three studies were conducted in Denmark in order to identify the hypothesised orientations, evaluate their concurrent validity, and report their prevalence and relevance in animal-related opinion formation and behaviour. Explorative factor analysis (Study 1) and confirmative factor analysis (Study 2) successfully identified the four orientations. Study 2 revealed good measurement invariance, as there was none or very modest differential item functioning across age, gender, living area, and contrasting population segments. Evaluation of concurrent validity in Study 2 found that the orientations are associated with different kinds of behaviour and opinion when the human use of animals is involved in the hypothesised directions. In Study 3, a representative population study, the animal protection orientation proved to be most prevalent in the Danish population, and as in study 2 the four orientations were associated with different behaviours and opinions. Remarkably, the animal protection orientation does not lead to increased animal welfare-friendly meat consumption, the main reason for this being non-concern about the current welfare status of farm animals. We argue that the developed measure covers a wide range of diversity in animal ethics orientations that is likely to exist in a modern society such as Denmark and can be used in future studies to track changes in the orientations and to understand and test hypotheses about the sources and justifications of people's animal-related opinions and behaviours.	[Lund, Thomas Boker; Kondrup, Sara Vincentzen; Sandoe, Peter] Univ Copenhagen, Dept Food & Resource Econ, Frederiksberg C, Denmark; [Sandoe, Peter] Univ Copenhagen, Dept Vet & Anim Sci, Frederiksberg C, Denmark	University of Copenhagen; University of Copenhagen	Lund, TB (corresponding author), Univ Copenhagen, Dept Food & Resource Econ, Frederiksberg C, Denmark.	tblu@ifro.ku.dk	Kondrup, Sara Vincentzen/O-5749-2015; Lund, Thomas/E-4584-2015; Sandoe, Peter/E-8758-2015	Kondrup, Sara Vincentzen/0000-0003-2285-6187; Lund, Thomas/0000-0001-5282-1562; Sandoe, Peter/0000-0003-0397-3273	Ministry of Environment and Food of Denmark	Ministry of Environment and Food of Denmark	The Ministry of Environment and Food of Denmark funded data collection and salary for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C.J., 2007, FEMINIST CARE TRADIT, P21; [Anonymous], 2014, EARTH PERSPECTIVES; Bastian B, 2012, PERS SOC PSYCHOL B, V38, P247, DOI 10.1177/0146167211424291; Blokhuis H. J., 2008, TRENDS FOOD SCI TECH, V19, P79, DOI DOI 10.1016/J.TIFS.2008.09.007; Boogaard BK, 2006, LIVEST SCI, V104, P13, DOI 10.1016/j.livsci.2006.02.010; Bratanova B, 2011, APPETITE, V57, P193, DOI 10.1016/j.appet.2011.04.020; Breen R, 2013, SOCIOL METHOD RES, V42, P164, DOI 10.1177/0049124113494572; Byrd E, 2017, ANIMALS, V7, DOI 10.3390/ani7110083; Clark B, 2017, FOOD POLICY, V68, P112, DOI 10.1016/j.foodpol.2017.01.006; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Council of Europe, 1976, 087 ETS COUNC EUR; Davidov E, 2014, ANNU REV SOCIOL, V40, P55, DOI 10.1146/annurev-soc-071913-043137; Eaves R, 2011, ENCY MEASUREMENT STA, P201; European Commission, 2015, NON TRADITIONAL REF, DOI [10.2875/884639, DOI 10.2875/884639]; Francione G., 2010, ANIMAL RIGHTS DEBATE; Francione GL, 2010, LAW CULT HUMANIT, V6, P24, DOI 10.1177/1743872109348989; Fraser A., 2006, PUBLIC ATTITUDES PES; Fruh K, 2017, J AGR ENVIRON ETHIC, V30, P55, DOI 10.1007/s10806-017-9653-z; Gaard Greta Claire, 2011, 5 FORM, V23, P26, DOI DOI 10.1353/FF.2011.0017; Gamborg C, 2017, J OUTDOOR REC TOUR, V17, P20, DOI 10.1016/j.jort.2016.12.002; Garner R, 2017, CONTEMP POLIT THEORY, V16, P459, DOI 10.1057/s41296-016-0072-0; Garner Robert, 2005, ANIMAL ETHICS; Graca J, 2014, J AGR ENVIRON ETHIC, V27, P749, DOI 10.1007/s10806-014-9488-9; Graham JM, 2006, EDUC PSYCHOL MEAS, V66, P930, DOI 10.1177/0013164406288165; Hagelin J, 2003, PUBLIC UNDERST SCI, V12, P67, DOI 10.1177/0963662503012001247; Hair J, 2007, MULTIVAR DATA ANAL, P89; Herzog Jr H. A., 1991, ANTHROZO, V4, p184?191, DOI [10.2752/089279391787057170, DOI 10.2752/089279391787057170]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jodoin MG, 2010, APPL MEAS EDUC, V14, P329; Kendall HA, 2006, RURAL SOCIOL, V71, P399, DOI 10.1526/003601106778070617; Kline RB, 2005, PRINCIPLES PRACTICE; Knight S, 2004, ANTHROZOOS, V17, P43, DOI 10.2752/089279304786991945; Kohler U, 2011, STATA J, V11, P420, DOI 10.1177/1536867X1101100306; Kunst JR, 2016, APPETITE, V105, P758, DOI 10.1016/j.appet.2016.07.009; Lindeberg S, 2012, AM J HUM BIOL, V24, P110, DOI 10.1002/ajhb.22218; Loughnan S, 2014, CURR DIR PSYCHOL SCI, V23, P104, DOI 10.1177/0963721414525781; Lund TB, 2016, ANTHROZOOS, V29, P89, DOI 10.1080/08927936.2015.1083192; Lund TB, 2012, ANTHROZOOS, V25, P475, DOI 10.2752/175303712X13479798785896; Lundmark F, 2014, J AGR ENVIRON ETHIC, V27, P991, DOI 10.1007/s10806-014-9512-0; MCKELVEY RD, 1975, J MATH SOCIOL, V4, P103, DOI 10.1080/0022250X.1975.9989847; Palmer Clare, 2018, P3, DOI 10.1079/9781786390202.0003; Piazza J, 2015, APPETITE, V91, P114, DOI 10.1016/j.appet.2015.04.011; Reimers V, 2016, J FASH MARK MANAG, V20, P383, DOI 10.1108/JFMM-12-2015-0097; Rhemtulla M, 2012, PSYCHOL METHODS, V17, P354, DOI 10.1037/a0029315; Rothgerber H, 2015, APPETITE, V87, P251, DOI 10.1016/j.appet.2014.12.206; Shani A., 2008, International Journal of Contemporary Hospitality Management, V20, P679, DOI 10.1108/09596110810892236; Sheppard R, 1991, 210 LINC U AGR EC RE; Van der Werff E, 2014, ENVIRON BEHAV, V46, P626, DOI 10.1177/0013916512475209; Webb DJ, 2008, J BUS RES, V61, P91, DOI 10.1016/j.jbusres.2007.05.007; Wuensch KL, 2002, ANTHROZOOS, V15, P139, DOI 10.2752/089279302786992621; Yunes MC, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7100075; Zumbo BD, 1999, HDB THEORY METHODS D	52	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211656	10.1371/journal.pone.0211656	http://dx.doi.org/10.1371/journal.pone.0211656			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5RX	30731000	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000041
J	Schmidt-Braekling, T; Sieber, D; Gosheger, G; Theil, JC; Moellenbeck, B; Andreou, D; Dieckmann, R				Schmidt-Braekling, Tom; Sieber, Dorothee; Gosheger, Georg; Theil, Jan C.; Moellenbeck, Burkhard; Andreou, Dimosthenis; Dieckmann, Ralf			Dislocation rates with combinations of anti-protrusio cages and dual mobility cups in revision cases: Are we safe?	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; SCHNEIDER ANTIPROTRUSIO CAGE; ACETABULAR REVISION; FOLLOW-UP; RECONSTRUCTION; INSTABILITY; SURGERY; RINGS; RISK	Background Due to the increasing numbers of revision total hip arthroplasty (THA) procedures being carried out, the frequency of major acetabular defects is also rising. A combination of an anti-protrusio cage and a dual mobility cup has been used in our department since 2007 in order to reduce the dislocation rate associated with complex defects. Although both implants have an important place in endoprosthetics, there are as yet limited data on the dislocation and complication rates with this combination. Methods This retrospective study included all patients in whom a Burch-Schneider cage and a dual mobility cup were implanted in our department between 2007 and 2014 and who had a minimum follow-up period of 24 months. Results The study included 79 patients with a mean follow-up period of 5.3 years. The implant survival rate was 85% at 65 months. Postoperative dislocation occurred in two cases (2.1%), with the first dislocation taking place within the first 3 weeks in both of these patients. Conclusions The present study shows a promising dislocation rate with a combination of an anti-protrusio cage and a dual mobility cup. Particularly in the medium-term follow-up, no further dislocations occurred in the study. A maximum cup inclination of 45 degrees in revision cases was associated with a lower dislocation rate in this group of patients.	[Schmidt-Braekling, Tom; Sieber, Dorothee; Gosheger, Georg; Theil, Jan C.; Moellenbeck, Burkhard; Andreou, Dimosthenis; Dieckmann, Ralf] Univ Munster, Dept Orthopaed & Tumor Orthopaed, Munster, Germany	University of Munster	Schmidt-Braekling, T (corresponding author), Univ Munster, Dept Orthopaed & Tumor Orthopaed, Munster, Germany.	Tom.Schmidt-Braekling@ukmuenster.de						Berstock JR, 2014, BONE JOINT RES, V3, P175, DOI 10.1302/2046-3758.36.2000239; BOUSQUET G, 1986, REV CHIR ORTHOP, V72, P70; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P570, DOI 10.2106/JBJS.D.02121; Carroll FA, 2008, J BONE JOINT SURG BR, V90B, P574, DOI 10.1302/0301-620X.90B5.19789; Carter AH, 2011, J ARTHROPLASTY, V26, P46, DOI 10.1016/j.arth.2011.03.021; Chalmers BP, 2018, CLIN ORTHOP RELAT R, V476, P305, DOI 10.1007/s11999.0000000000000026; Civinini R, 2012, CLIN ORTHOP RELAT R, V470, P3542, DOI 10.1007/s11999-012-2428-y; DANTONIO JA, 1989, CLIN ORTHOP RELAT R, P126; Gill TJ, 1998, J BONE JOINT SURG BR, V80B, P946, DOI 10.1302/0301-620X.80B6.8658; Guyen O, 2007, CLIN ORTHOP RELAT R, P202, DOI 10.1097/01.blo.0000238796.59596.1f; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Jo S, 2015, J ARTHROPLASTY, V30, P1177, DOI 10.1016/j.arth.2015.02.001; KAVANAGH BF, 1987, J BONE JOINT SURG AM, V69A, P1144, DOI 10.2106/00004623-198769080-00006; Kurtz SM, 2007, J BONE JOINT SURG AM, V89A, P144, DOI 10.2106/JBJS.G.00587; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217, DOI 10.2106/00004623-197860020-00014; MORREY BF, 1992, ORTHOP CLIN N AM, V23, P237; Patel PD, 2007, J ARTHROPLASTY, V22, P86, DOI 10.1016/j.arth.2006.12.111; Perka C, 2001, J ARTHROPLASTY, V16, P568, DOI 10.1054/arth.2001.23919; PETERS CL, 1995, J ARTHROPLASTY, V10, P307, DOI 10.1016/S0883-5403(05)80179-2; Pieringer H, 2006, J ARTHROPLASTY, V21, P489, DOI 10.1016/j.arth.2005.02.016; Pulido L, 2011, INT ORTHOP, V35, P289, DOI 10.1007/s00264-010-1198-y; Regis D, 2012, J ARTHROPLASTY, V27, P1057, DOI 10.1016/j.arth.2011.11.019; Salassa T, 2014, CLIN ORTHOP RELAT R, V472, P962, DOI 10.1007/s11999-013-3344-5; Sanchez-Sotelo J, 2009, CLIN ORTHOP RELAT R, V467, P219, DOI 10.1007/s11999-008-0480-4; Schlegel UJ, 2008, ORTHOPADE, V37, P904, DOI 10.1007/s00132-008-1314-5; Schneider L, 2011, Orthop Traumatol Surg Res, V97, P807, DOI 10.1016/j.otsr.2011.09.010; Symeonides PP, 2009, J ARTHROPLASTY, V24, P168, DOI 10.1016/j.arth.2007.10.009; Udomkiat P, 2001, J ARTHROPLASTY, V16, P961, DOI 10.1054/arth.2001.27669; Wachtl SW, 2000, J ARTHROPLASTY, V15, P959, DOI 10.1054/arth.2000.17942; Wetters NG, 2013, CLIN ORTHOP RELAT R, V471, P410, DOI 10.1007/s11999-012-2561-7; Winter E, 2001, J BONE JOINT SURG AM, V83A, P862, DOI 10.2106/00004623-200106000-00007; WOO RYG, 1982, J BONE JOINT SURG AM, V64, P1295, DOI 10.2106/00004623-198264090-00004	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0212072	10.1371/journal.pone.0212072	http://dx.doi.org/10.1371/journal.pone.0212072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730966	Green Submitted, gold, Green Published			2022-12-26	WOS:000458026000093
J	Sciuto, KJ; Deng, SW; Moreno, A; Zaitsev, AV				Sciuto, Katie J.; Deng, Steven W.; Moreno, Alonso; Zaitsev, Alexey V.			Chronology of critical events in neonatal rat ventricular myocytes occurring during reperfusion after simulated ischemia	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; GAP-JUNCTIONAL HEMICHANNELS; CARDIOMYOCYTE DEATH; CARDIAC ISCHEMIA; CELL-DEATH; PORE; CONNEXIN-43; HEART; MECHANISMS; CALCIUM	While an ischemic insult poses a lethal danger to myocardial cells, a significant proportion of cardiac myocytes remain viable throughout the ischemic episode and die, paradoxically, only after the blood flow is reinstated. Despite decades of research, the actual chronology of critical events leading to cardiomyocyte death during the reperfusion phase remains poorly understood. Arguably, identification of the pivotal event in this setting is necessary to design effective strategies aimed at salvaging the myocardium after an ischemic attack. Here we used neonatal rat ventricular myocytes (NRVMs) subjected to 20-30 min of simulated ischemia followed by 1 hour of "reperfusion". Using different combinations of spectrally-compatible fluorescent indicators, we analyzed the relative timing of the following events: (1) abnormal increase in cytoplasmic [Ca2+] (T-CaCy); (2) abnormal increase in mitochondrial [Ca2+] (T-CaMi); (3) loss of mitochondrial inner membrane potential (Delta Psi(m)) indicating mitochondrial permeability transitions (T-MPT); (4) sacrolemmal permeabilization (SP) to the normally impermeable small fluorophore TO-PRO3 (T-SP). In additional experiments we also analyzed the timing of abnormal uptake of Zn2+ into the cytoplasm (T-ZnCy) relative to T-CaCy and T-SP. We focused on those NRVMs which survived anoxia, as evidenced by at least 50% recovery of Delta Psi(m) and the absence of detectable SP. In these cells, we found a consistent sequence of critical events in the order, from first to last, of T-CaCy, T-CaMi, T-MPT, T-SP. After detecting T-CaCy and T-CaMi, abrupt switches between 1.1 mM and nominally zero [Ca2+] in the perfusate quickly propagated to the cytoplasmic and mitochondrial [Ca2+]. Depletion of the sarcoplasmic reticulum with ryanodine (5 mu M)/thapsigargin (1 mu M) accelerated all events without changing their order. In the presence of ZnCl2 (10-30 mu M) in the perfusate we found a consistent timing sequence T-CaCy < T-Zn <= T-SP. In some cells ZnCl2 interfered with Ca2+ uptake, causing "steps" or "gaps" in the [Ca2+](Cy) curve, a phenomenon never observed in the absence of ZnCl2. Together, these findings suggest an evolving permeabilization of NRVM's sarcolemma during reoxygenation, in which the expansion of the pore size determines the timing of critical events, including T-MPT.	[Sciuto, Katie J.; Moreno, Alonso; Zaitsev, Alexey V.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; [Sciuto, Katie J.; Deng, Steven W.; Zaitsev, Alexey V.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Moreno, Alonso] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Moreno, Alonso] Leonhardts Launchpads Utah LLC, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Zaitsev, AV (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA.; Zaitsev, AV (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.	Alexey.Zaitsev@utah.edu		Zaitsev, Artem/0000-0002-2314-0482	Research Grant from Nora Eccles Treadwell Foundation; United States National Science Foundation Graduate Research Fellowship [1256065]; University of Utah Undergraduate Research Opportunities Program Grant	Research Grant from Nora Eccles Treadwell Foundation; United States National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); University of Utah Undergraduate Research Opportunities Program Grant	This work was supported by a Research Grant from Nora Eccles Treadwell Foundation (no web site; no grant ID) to A.V.Z.; by a United States National Science Foundation Graduate Research Fellowship Grant #1256065 to K.J.S., and by a University of Utah Undergraduate Research Opportunities Program Grant (https://our.utah.edu/urop/; no grant ID) to S.W.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrienko T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167300; Andrienko TN, 2009, J MOL CELL CARDIOL, V46, P1027, DOI 10.1016/j.yjmcc.2009.03.015; Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Barria I, 2018, AM J TROP MED HYG, V98, P105, DOI 10.4269/ajtmh.17-0293; Bell RM, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0558-1; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; Bers DM, 2001, EXCITATION CONTRACTI; BEYER EC, 1989, J CELL BIOL, V108, P595, DOI 10.1083/jcb.108.2.595; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Choi BR, 2000, J PHYSIOL-LONDON, V529, P171, DOI 10.1111/j.1469-7793.2000.00171.x; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; CROMPTON M, 1988, EUR J BIOCHEM, V178, P489, DOI 10.1111/j.1432-1033.1988.tb14475.x; Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; Davidson SM, 2012, CARDIOVASC RES, V93, P445, DOI 10.1093/cvr/cvr349; Dedkova EN, 2016, BIOCHEM SOC T, V44, P25, DOI 10.1042/BST20150218; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Garcia-Dorado D, 2012, CARDIOVASC RES, V94, P168, DOI 10.1093/cvr/cvs116; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Halestrap AP, 2015, J MOL CELL CARDIOL, V78, P129, DOI 10.1016/j.yjmcc.2014.08.018; Henry V.K., 1994, CRC HDB THERMOPHYSIC; John S, 2003, ACTA PHYSIOL SCAND, V179, P23, DOI 10.1046/j.1365-201X.2003.01197.x; Kanaporis G, 2011, AM J PHYSIOL-CELL PH, V300, pC600, DOI 10.1152/ajpcell.00316.2010; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; LAU AF, 1991, J MOL CELL CARDIOL, V23, P659, DOI 10.1016/0022-2828(91)90975-R; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Matsumoto-Ida M, 2006, CIRCULATION, V114, P1497, DOI 10.1161/CIRCULATIONAHA.106.628834; MORENO AP, 1992, BIOPHYS J, V62, P51, DOI 10.1016/S0006-3495(92)81775-7; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; NAZARETH W, 1991, J MOL CELL CARDIOL, V23, P1351, DOI 10.1016/0022-2828(91)90181-K; Ohana E, 2004, J BIOL CHEM, V279, P4278, DOI 10.1074/jbc.M309229200; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Piper HM, 1999, ANN THORAC SURG, V68, P1913, DOI 10.1016/S0003-4975(99)01025-5; RETAMAL MA, 2014, FRONT PHYSIOL, V5, P88212; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Ruiz-Meana M, 2007, BASIC RES CARDIOL, V102, P542, DOI 10.1007/s00395-007-0675-y; Ruiz-Meana M, 2009, AM J PHYSIOL-HEART C, V297, pH1281, DOI 10.1152/ajpheart.00435.2009; Sandilos JK, 2012, J PHYSIOL-LONDON, V590, P6257, DOI 10.1113/jphysiol.2012.240911; Schulz R, 2015, PHARMACOL THERAPEUT, V153, P90, DOI 10.1016/j.pharmthera.2015.06.005; Sciuto KJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200301; Smith K.C, 2011, UNIFIED MODEL ELECTR; Stoner JD, 2007, AM J PHYSIOL-HEART C, V292, pH109, DOI 10.1152/ajpheart.00925.2006; Su Z, 1999, J MOL CELL CARDIOL, V31, P1125, DOI 10.1006/jmcc.1999.0949; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; Tuncay E, 2011, CARDIOVASC RES, V89, P634, DOI 10.1093/cvr/cvq352; Wang N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0309-x; Wu JH, 2014, BIOCHEM J, V464, P13, DOI 10.1042/BJ20140931; Wu MY, 2018, CELL PHYSIOL BIOCHEM, V46, P1650, DOI 10.1159/000489241; Yi T, 2013, AM J PHYSIOL-HEART C, V305, pH706, DOI 10.1152/ajpheart.00025.2013; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0212076	10.1371/journal.pone.0212076	http://dx.doi.org/10.1371/journal.pone.0212076			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730997	Green Submitted, gold, Green Published			2022-12-26	WOS:000458026000094
J	Wood, HN; Venken, T; Willems, H; Jacobs, A; Reis, AJ; da Silva, PEA; Homolka, S; Niemann, S; Rohde, KH; Hooyberghs, J				Wood, Hillary N.; Venken, Tom; Willems, Hanny; Jacobs, An; Reis, Ana Julia; Almeida da Silva, Pedro Eduardo; Homolka, Susanne; Niemann, Stefan; Rohde, Kyle H.; Hooyberghs, Jef			Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RIFAMPIN RESISTANCE; RAPID DETECTION; DIAGNOSIS; HETERORESISTANCE; FLUOROQUINOLONE; EVOLUTION	In Mycobacterium tuberculosis (Mtb) the detection of single nucleotide polymorphisms (SNPs) is of high importance both for diagnostics, since drug resistance is primarily caused by the acquisition of SNPs in multiple drug targets, and for epidemiological studies in which strain typing is performed by SNP identification. To provide the necessary coverage of clinically relevant resistance profiles and strain types, nucleic acid-based measurement techniques must be able to detect a large number of potential SNPs. Since the Mtb problem is pressing in many resource-poor countries, requiring low-cost point-of-care biosensors, this is a non-trivial technological challenge. This paper presents a proof-of-concept in which we chose simple DNA-DNA hybridization as a sensing principle since this can be transferred to existing low-cost hardware platforms, and we pushed the multiplex boundaries of it. With a custom designed probe set and a physicochemical-driven data analysis it was possible to simultaneously detect the presence of SNPs associated with first- and second-line drug resistance and Mtb strain typing. We have demonstrated its use for the identification of drug resistance and strain type from a panel of phylogenetically diverse clinical strains. Furthermore, reliable detection of the presence of a minority population (<5%) of drug-resistant Mtb was possible.	[Wood, Hillary N.; Rohde, Kyle H.] Univ Cent Florida, Coll Med, Div Immun & Pathogenesis, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Venken, Tom; Willems, Hanny; Jacobs, An; Hooyberghs, Jef] VITO, Flemish Inst Technol Res, Mol, Belgium; [Reis, Ana Julia; Almeida da Silva, Pedro Eduardo] Univ Fed Rio Grande FURG, Fac Med, Lab TB, Rio Grande So Sul, RS, Brazil; [Homolka, Susanne; Niemann, Stefan] Res Ctr Borstel, Mol & Expt Mycobacteriol, Borstel, Germany; [Homolka, Susanne; Niemann, Stefan] German Ctr Infect Res, Borstel, Germany; [Hooyberghs, Jef] Hasselt Univ, Theoret Phys, Diepenbeek, Belgium; [Wood, Hillary N.] MRIGlobal, Palm Bay, FL USA; [Venken, Tom] VIB Ctr Canc Biol, Leuven, Belgium; [Venken, Tom] Katholieke Univ Leuven, Dept Human Genet, Lab Translat Genet, Leuven, Belgium	State University System of Florida; University of Central Florida; VITO; Universidade Federal do Rio Grande; Forschungszentrum Borstel; German Center for Infection Research; Hasselt University; Flanders Institute for Biotechnology (VIB); KU Leuven	Rohde, KH (corresponding author), Univ Cent Florida, Coll Med, Div Immun & Pathogenesis, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	kyle.rohde@ucf.edu	Niemann, Stefan/C-9327-2011	Venken, Tom/0000-0003-0773-1810; Willems, Hanny/0000-0001-9848-1997; almeida da silva, pedro/0000-0003-1666-1295; Reis, AlessanRSS/0000-0001-8486-7469; Rohde, Kyle/0000-0001-9838-3238; Niemann, Stefan/0000-0002-6604-0684	UCF; FWO [K226314N]	UCF; FWO(FWO)	The authors would like to acknowledge funding for this project provided by startup funds from UCF to KHR. Jef Hooyberghs acknowledges funding of a travel grant by FWO (K226314N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Ahmad N, 2016, BRAZ J INFECT DIS, V20, P41, DOI 10.1016/j.bjid.2015.09.011; Avalos E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120470; Bobadilla-del-Valle M, 2001, EMERG INFECT DIS, V7, P1010, DOI 10.3201/eid0706.010615; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chakravorty S, 2017, MBIO, V8, DOI [10.1128/mBio.00812-17, 10.1128/mbio.00812-17]; Cho SN, 2007, TUBERCULOSIS, V87, pS14, DOI 10.1016/j.tube.2007.05.001; Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Dookie N, 2018, J ANTIMICROB CHEMOTH, V73, P1138, DOI 10.1093/jac/dkx506; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; DUNLAP NE, 1995, AM J RESP CRIT CARE, V152, P1702, DOI 10.1164/ajrccm.152.5.7582316; El-Hajj HH, 2001, J CLIN MICROBIOL, V39, P4131, DOI 10.1128/JCM.39.11.4131-4137.2001; Feuerriegel S, 2014, J ANTIMICROB CHEMOTH, V69, P1205, DOI 10.1093/jac/dkt535; Folkvardsen DB, 2013, J CLIN MICROBIOL, V51, P4220, DOI 10.1128/JCM.01602-13; Hadiwikarta WW, 2015, BIOSENS BIOELECTRON, V64, P411, DOI 10.1016/j.bios.2014.09.043; Hadiwikarta WW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks475; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Hooyberghs J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.012901; Hooyberghs J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp109; Hooyberghs J, 2010, BIOSENS BIOELECTRON, V26, P1692, DOI 10.1016/j.bios.2010.07.039; Laurenzo D, 2011, ACTA TROP, V119, P5, DOI 10.1016/j.actatropica.2011.04.008; Linger Y, 2014, J CLIN MICROBIOL, V52, P2100, DOI 10.1128/JCM.00238-14; Makinen J, 2006, J CLIN MICROBIOL, V44, P350, DOI 10.1128/JCM.44.2.350-352.2006; Mathys V, 2014, INT J TUBERC LUNG D, V18, P1255, DOI 10.5588/ijtld.14.0297; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; Stucki D, 2016, J CLIN MICROBIOL, V54, P1862, DOI 10.1128/JCM.00126-16; Tang PJ, 2017, EXP THER MED, V13, P2332, DOI 10.3892/etm.2017.4250; Tolani MP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-9; van Grinsven B, 2011, LAB CHIP, V11, P1656, DOI 10.1039/c1lc20027e; VANSOOLINGEN D, 1994, METHOD ENZYMOL, V235, P196; Willems H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177384; World Health Organization, 2015, GLOBAL TUBERCULOSIS; Zagorodko O, 2014, ANAL CHEM, V86, P11211, DOI 10.1021/ac502705n; Zhang DF, 2016, ANTIMICROB AGENTS CH, V60, P6600, DOI 10.1128/AAC.00664-16; Zhang XB, 2012, J CLIN MICROBIOL, V50, P1471, DOI 10.1128/JCM.05793-11	40	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0212064	10.1371/journal.pone.0212064	http://dx.doi.org/10.1371/journal.pone.0212064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730960	Green Submitted, gold, Green Published			2022-12-26	WOS:000458026000091
J	Ye, C; Xu, DY; Qin, YB; Wang, LH; Wang, RP; Li, WC; Kuai, ZX; Zhu, YM				Ye, Chen; Xu, Daoyun; Qin, Yongbin; Wang, Lihui; Wang, Rongpin; Li, Wuchao; Kuai, Zixiang; Zhu, Yuemin			Estimation of intravoxel incoherent motion parameters using low b-values	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; FITTING ALGORITHMS; PERFUSION; LIVER; ACQUISITION; CIRRHOSIS	Intravoxel incoherent motion (IVIM) imaging is a magnetic resonance imaging (MRI) technique widely used in clinical applications for various organs. However, IVIM imaging at low b-values is a persistent problem. This paper aims to investigate in a systematic and detailed manner how the number of low b-values influences the estimation of IVIM parameters. To this end, diffusion-weighted (DW) data with different low b-values were simulated to get insight into the distributions of subsequent IVIM parameters. Then, in vivo DW data with different numbers of low b-values and different number of excitations (NEX) were acquired. Finally, least-squares (LSQ) and Bayesian shrinkage prior (BSP) fitting methods were implemented to estimate IVIM parameters. The influence of the number of low b-values on IVIM parameters was analyzed in terms of relative error (RE) and structural similarity (SSIM). The results showed that the influence of the number of low b-values on IVIM parameters is variable. LSQ is more dependent on the number of low b-values than BSP, but the latter is more sensitive to noise.	[Ye, Chen; Xu, Daoyun; Qin, Yongbin; Wang, Lihui] Guizhou Univ, Key Lab Intelligent Med Image Anal & Precise Diag, Sch Comp Sci & Technol, Guiyang, Guizhou, Peoples R China; [Wang, Rongpin; Li, Wuchao] Guizhou Prov Peoples Hosp, Dept Radiol, Guiyang, Guizhou, Peoples R China; [Kuai, Zixiang] Harbin Med Univ, Canc Hosp, Harbin, Heilongjiang, Peoples R China; [Zhu, Yuemin] Univ Lyon, INSA Lyon, CNRS, INSERM,CREATIS UMR 5220,U1206, Lyon, France	Guizhou University; Harbin Medical University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Xu, DY (corresponding author), Guizhou Univ, Key Lab Intelligent Med Image Anal & Precise Diag, Sch Comp Sci & Technol, Guiyang, Guizhou, Peoples R China.	dyxu@gzu.edu.cn	Zhu, Yuemin/K-7292-2014	Zhu, Yuemin/0000-0001-6814-1449; Ye, Chen/0000-0002-4209-2383	National Nature Science Foundations of China [61762019, 61661010, 81701654]; Funds for Talents of Guizhou University [2013-33]; Nature Science Foundation of Guizhou province [20152044, [2016]1096]; Program PHC-Cai Yuanpei [41400TC]	National Nature Science Foundations of China(National Natural Science Foundation of China (NSFC)); Funds for Talents of Guizhou University; Nature Science Foundation of Guizhou province; Program PHC-Cai Yuanpei	This work was funded in part by the National Nature Science Foundations of China (Grant No. 61762019, 61661010, 81701654), the Funds for Talents of Guizhou University (No. 2013-33), the Nature Science Foundation of Guizhou province (Qiankehe J No.20152044, [2016]1096), and the Program PHC-Cai Yuanpei 2018 (No 41400TC).	Andreou A, 2013, EUR RADIOL, V23, P428, DOI 10.1007/s00330-012-2604-1; Bennett KM, 2003, MAGNET RESON MED, V50, P727, DOI 10.1002/mrm.10581; Bretthorst GL, 2005, CONCEPT MAGN RESON A, V27A, P55, DOI 10.1002/cmr.a.20043; Cameron D, 2015, ECHO PLANAR IMAGING; Cho GY, 2015, MAGN RESON MED, V74, P1077, DOI 10.1002/mrm.25484; Cohen AD, 2015, MAGN RESON MED, V73, P306, DOI 10.1002/mrm.25109; Dyvorne HA, 2013, RADIOLOGY, V266, P920, DOI 10.1148/radiol.12120686; Federau C, 2014, J MAGN RESON IMAGING, V39, P624, DOI 10.1002/jmri.24195; Freiman M, 2013, MED IMAGE ANAL, V17, P325, DOI 10.1016/j.media.2012.12.001; Fusco R, 2017, MAGN RESON MATER PHY, V30, P113, DOI 10.1007/s10334-016-0591-y; Gustafsson O, 2018, MAGN RESON MED, V79, P1674, DOI 10.1002/mrm.26783; Hiepe P, 2013, P INT SOC MAG RESON, P3491; Hiepe P., 2013, ISMRM, V44, P2577; Holland SK, 1989, MAGN RESON IMAGING, V7, P339; Ichikawa S, 2013, MAGN RESON IMAGING, V31, P414, DOI 10.1016/j.mri.2012.08.004; Iima M, 2018, ACTA RADIOL OPEN, V7, DOI 10.1177/2058460117751565; Iima M, 2016, RADIOLOGY, V278, P13, DOI 10.1148/radiol.2015150244; Jain A. K., 1989, FUNDAMENTALS DIGITAL; Kuai ZX, 2016, MAGN RESON MED, V76, P1594, DOI 10.1002/mrm.26064; Le Bihan D., 2018, WHAT CAN WE SEE IVIM, P1, DOI [10.1016/j.neuroimage.2017.12.062, DOI 10.1016/J.NEUROIMAGE.2017.12.062]; Le Bihan D, 2008, RADIOLOGY, V249, P748, DOI 10.1148/radiol.2493081301; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1989, MAGNET RESON MED, V10, P324; Lemke A, 2009, INVEST RADIOL, V44, P769, DOI 10.1097/RLI.0b013e3181b62271; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Merisaari H, 2017, MAGN RESON MED, V77, P1249, DOI 10.1002/mrm.26169; NEIL JJ, 1993, MAGNET RESON MED, V29, P642, DOI 10.1002/mrm.1910290510; Nguyen A, 2017, MAGN RESON IMAGING, V35, P91, DOI 10.1016/j.mri.2016.08.005; Orton MR, 2014, MAGN RESON MED, V71, P411, DOI 10.1002/mrm.24649; Park HJ, 2017, J MAGN RESON IMAGING, V45, P1637, DOI 10.1002/jmri.25535; Patel J, 2017, DIAGNOSIS CIRRHOSIS, V31, P589, DOI [10.1002/jmri.22081.Diagnosis, DOI 10.1002/JMRI.22081.DIAGNOSIS]; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Rydhog AS, 2017, NEUROIMAGE, V156, P423, DOI 10.1016/j.neuroimage.2017.04.023; Sijbers J, 1996, MAGN RESON IMAGING, V14, P1157, DOI 10.1016/S0730-725X(96)00219-6; van Baalen S, 2017, J MAGN RESON IMAGING, V46, P228, DOI 10.1002/jmri.25519; van der Bel R, 2017, EUR J RADIOL, V91, P168, DOI 10.1016/j.ejrad.2017.03.008; While PT, 2017, MAGN RESON MED, V78, P2373, DOI 10.1002/mrm.26598	38	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211911	10.1371/journal.pone.0211911	http://dx.doi.org/10.1371/journal.pone.0211911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726298	Green Submitted, Green Published, gold			2022-12-26	WOS:000457874000087
J	Nachmany, I; Bogoch, Y; Sivan, A; Amar, O; Bondar, E; Zohar, N; Yakubovsky, O; Fainaru, O; Klausner, JM; Pencovich, N				Nachmany, Ido; Bogoch, Yoel; Sivan, Ayelet; Amar, Omer; Bondar, Ekaterina; Zohar, Nitzan; Yakubovsky, Oran; Fainaru, Ofer; Klausner, Joseph M.; Pencovich, Niv			CD11b(+)Ly6G(+) myeloid-derived suppressor cells promote liver regeneration in a murine model of major hepatectomy	FASEB JOURNAL			English	Article						liver resection; immature myeloid cells; angiogenesis; immune suppression	ANGIOGENESIS; RECRUITMENT; EXPRESSION; PLATELETS; CANCER	Liver regeneration depends on sequential activation of pathways and cells involving the remaining organ in recovery of mass. Proliferation of parenchyma is dependent on angiogenesis. Understanding liver regeneration-associated neovascularization may be useful for development of clinical interventions. Myeloid-derived suppressor cells (MDSCs) promote tumor angiogenesis and play a role in developmental processes that necessitate rapid vascularization. We therefore hypothesized that the MDSCs could play a role in liver regeneration. Following partial hepatectomy, MDSCs were enriched within regenerating livers, and their depletion led to increased liver injury and postoperative mortality, reduced liver weights, decreased hepatic vascularization, reduced hepatocyte hypertrophy and proliferation, and aberrant liver function. Gene expression profiling of regenerating liver-derived MDSCs demonstrated a large-scale transcriptional response involving key pathways related to angiogenesis. Functionally, enhanced reactive oxygen species production and angiogenic capacities of regenerating liver-derived MDSCs were confirmed. A comparative analysis revealed that the transcriptional response of MDSCs during liver regeneration resembled that of peripheral blood MDSCs during progression of abdominal tumors, suggesting a common MDSC gene expression profile promoting angiogenesis. In summary, our study shows that MDSCs contribute to early stages of liver regeneration possibly by exerting proangiogenic functions using a unique transcriptional program.Nachmany, I., Bogoch, Y., Sivan, A., Amar, O., Bondar, E., Zohar, N., Yakubovsky, O., Fainaru, O., Klausner, J. M., Pencovich, N. CD11b(+)Ly6G(+) myeloid-derived suppressor cells promote liver regeneration in a murine model of major hepatectomy.	[Nachmany, Ido; Bogoch, Yoel; Sivan, Ayelet; Amar, Omer; Bondar, Ekaterina; Zohar, Nitzan; Yakubovsky, Oran; Klausner, Joseph M.; Pencovich, Niv] Tel Aviv Univ, Sackler Sch Med, Tel Aviv Sourasky Med Ctr,Dept Surg B,Surg Div, Hepatopancreato Biliary HPB Canc Res,Lab Mol Gene, Tel Aviv, Israel; [Fainaru, Ofer] Rambam Med Ctr, Dept Obstet & Gynecol, In Vitro Fertilizat IVF Unit, Haifa, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology	Pencovich, N (corresponding author), Tel Aviv Sourasky Med Ctr, 6 Weizmarm St, IL-6423906 Tel Aviv, Israel.	Nivp@tlvmc.gov.il			Alexander Grass Foundation; "Reut" Foundation	Alexander Grass Foundation; "Reut" Foundation	This study was partially funded by the Alexander Grass Foundation and the "Reut" Foundation. The funders had no part in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the article for publication. The authors declare no conflicts of interest.	Beury DW, 2016, J IMMUNOL, V196, P3470, DOI 10.4049/jimmunol.1501785; Castellaneta A, 2006, HEPATOLOGY, V43, P807, DOI 10.1002/hep.21098; Cekic C, 2014, CANCER RES, V74, P7250, DOI 10.1158/0008-5472.CAN-13-3583; Chauhan A, 2016, HEPATOLOGY, V64, P1774, DOI 10.1002/hep.28526; Chung PY, 2003, LIVER TRANSPLANT, V9, P248, DOI 10.1053/jlts.2003.50053; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Das SK, 2007, LIFE SCI, V81, P1555, DOI 10.1016/j.lfs.2007.09.027; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Drixler TA, 2002, ANN SURG, V236, P703, DOI 10.1097/00000658-200212000-00002; Fainaru O, 2013, FERTIL STERIL, V99, P910, DOI 10.1016/j.fertnstert.2012.11.018; Fainaru O, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.060; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Harun N, 2007, J SURG RES, V138, P284, DOI 10.1016/j.jss.2006.06.024; Janakiram M, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1026534; Kaur S, 2013, HEPATOL INT, V7, P959, DOI 10.1007/s12072-013-9483-7; Kim JA, 2010, BLOOD, V116, P1623, DOI 10.1182/blood-2009-08-237040; Kron P, 2016, HEPATOLOGY, V64, P2198, DOI 10.1002/hep.28809; Kwon YJ, 2015, CLIN MOL HEPATOL, V21, P7, DOI 10.3350/cmh.2015.21.1.7; Li N, 2017, ONCOTARGET, V8, P3628, DOI 10.18632/oncotarget.12275; Lisman T, 2016, BLOOD, V128, P625, DOI 10.1182/blood-2016-04-692665; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Mei-Dan E, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.025; Meirow Y, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00523; Melgar-Lesmes P, 2015, J HEPATOL, V63, P917, DOI 10.1016/j.jhep.2015.05.011; Meyer J, 2015, J HEPATOL, V63, P1263, DOI 10.1016/j.jhep.2015.07.002; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Momiyama M, 2012, J SURG RES, V178, P280, DOI 10.1016/j.jss.2012.03.020; Motz GT, 2011, NAT REV IMMUNOL, V11, P702, DOI 10.1038/nri3064; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nosbaum A, 2016, J IMMUNOL, V196, P2010, DOI 10.4049/jimmunol.1502139; Ostrand-Rosenberg S, 2018, J IMMUNOL, V200, P422, DOI 10.4049/jimmunol.1701019; Pencovich N, 2013, GENES IMMUN, V14, P90, DOI 10.1038/gene.2012.59; Poschke I, 2012, CLIN IMMUNOL, V144, P250, DOI 10.1016/j.clim.2012.06.003; Shi JH, 2014, WORLD J GASTROENTERO, V20, P16167, DOI 10.3748/wjg.v20.i43.16167; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Siriwardena AK, 2014, NAT REV CLIN ONCOL, V11, P446, DOI 10.1038/nrclinonc.2014.90; Solito S, 2014, ANN NY ACAD SCI, V1319, P47, DOI 10.1111/nyas.12469; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Uda Y, 2013, SURGERY, V153, P70, DOI 10.1016/j.surg.2012.06.021; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Zaslavsky A, 2010, MOL CANCER RES, V8, P1198, DOI 10.1158/1541-7786.MCR-10-0047	48	5	5	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5967	5978		10.1096/fj.201801733R	http://dx.doi.org/10.1096/fj.201801733R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30730772	Bronze			2022-12-26	WOS:000466932600014
J	Ponzini, E; De Palma, A; Cerboni, L; Natalello, A; Rossi, R; Moons, R; Konijnenberg, A; Narkiewicz, J; Legname, G; Sobott, F; Mauri, P; Santambrogio, C; Grandori, R				Ponzini, Erika; De Palma, Antonella; Cerboni, Lucilla; Natalello, Antonino; Rossi, Rossana; Moons, Rani; Konijnenberg, Albert; Narkiewicz, Joanna; Legname, Giuseppe; Sobott, Frank; Mauri, PierLuigi; Santambrogio, Carlo; Grandori, Rita			Methionine oxidation in -synuclein inhibits its propensity for ordered secondary structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein (-synuclein); dopamine; amyloid; mass spectrometry (MS); circular dichroism (CD); Fourier transform IR (FTIR); neurodegenerative disease; epigallocatechin-3-gallate; ion mobility (IM); methionine oxidation	ALPHA-SYNUCLEIN; INFRARED-SPECTROSCOPY; DOPAMINE; INSIGHTS; AGGREGATION; MECHANISMS; SULFOXIDE; REGULATOR; OLIGOMERS; TOXICITY	alpha-Synuclein (AS) is an intrinsically disordered protein highly expressed in dopaminergic neurons. Its amyloid aggregates are the major component of Lewy bodies, a hallmark of Parkinson's disease (PD). AS is particularly exposed to oxidation of its methionine residues, both in vivo and in vitro. Oxidative stress has been implicated in PD and oxidized -synuclein has been shown to assemble into soluble, toxic oligomers, rather than amyloid fibrils. However, the structural effects of methionine oxidation are still poorly understood. In this work, oxidized AS was obtained by prolonged incubations with dopamine (DA) or epigallocatechin-3-gallate (EGCG), two inhibitors of AS aggregation, indicating that EGCG promotes the same final oxidation product as DA. The conformational transitions of the oxidized and non-oxidized protein were monitored by complementary biophysical techniques, including MS, ion mobility (IM), CD, and FTIR spectroscopy assays. Although the two variants displayed very similar structures under conditions that stabilize highly disordered or highly ordered states, differences emerged in the intermediate points of transitions induced by organic solvents, such as trifluoroethanol (TFE) and methanol (MeOH), indicating a lower propensity of the oxidized protein for forming either - or -type secondary structures. Furthermore, oxidized AS displayed restricted secondary-structure transitions in response to dehydration and slightly amplified tertiary-structure transitions induced by ligand binding. This difference in susceptibility to induced folding could explain the loss of fibrillation potential observed for oxidized AS. Finally, site-specific oxidation kinetics point out a minor delay in Met-127 modification, likely due to the effects of AS intrinsic structure.	[Ponzini, Erika; Cerboni, Lucilla; Natalello, Antonino; Santambrogio, Carlo; Grandori, Rita] Univ Milano Bicocca, Dept Biotechnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy; [De Palma, Antonella; Rossi, Rossana; Mauri, PierLuigi] Natl Res Council Italy, Inst Biomed Technol, I-20090 Milan, Italy; [Moons, Rani; Konijnenberg, Albert; Sobott, Frank] Univ Antwerp, Biomol & Analyt Mass Spectrometry, Groenenborgerlaan 171, B-2020 Antwerp, Belgium; [Narkiewicz, Joanna; Legname, Giuseppe] SISSA, Dept Neurosci, I-34136 Trieste, Italy; [Narkiewicz, Joanna; Legname, Giuseppe] ELETTRA Sincrotrone Trieste SCpA, I-34136 Trieste, Italy; [Sobott, Frank] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Sobott, Frank] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Antwerp; International School for Advanced Studies (SISSA); Elettra Sincrotrone Trieste; University of Leeds; University of Leeds	Santambrogio, C; Grandori, R (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.	carlo.santambrogio@unimib.it; rita.grandori@unimib.it	Ponzini, Erika/X-9593-2019; Rossi, Rossana/H-9229-2018; De Palma, Antonella/K-8451-2016; Mauri, Pietro Luigi/AAC-3095-2019; Legname, Giuseppe/C-1723-2012; Santambrogio, Carlo/W-6070-2019; Natalello, Antonino/B-9659-2012	Ponzini, Erika/0000-0002-3103-740X; Rossi, Rossana/0000-0002-0313-7083; De Palma, Antonella/0000-0001-5937-8604; Mauri, Pietro Luigi/0000-0003-4364-0393; Legname, Giuseppe/0000-0003-0716-4393; Santambrogio, Carlo/0000-0003-3986-6971; Natalello, Antonino/0000-0002-1489-272X	Fondazione Regionale per la Ricerca Biomedica (FRRB-Regione Lombardia); University of MilanoBicocca (FAR -Fondo di Ateneo per la Ricerca); EU COST Action [BM1403]	Fondazione Regionale per la Ricerca Biomedica (FRRB-Regione Lombardia); University of MilanoBicocca (FAR -Fondo di Ateneo per la Ricerca); EU COST Action(European Cooperation in Science and Technology (COST))	This work was supported by the Fondazione Regionale per la Ricerca Biomedica (FRRB-Regione Lombardia), a grant from the University of MilanoBicocca (FAR -Fondo di Ateneo per la Ricerca), and the EU COST Action BM1403. The authors declare that they have no conflicts of interest with the contents of this article.	Ami Diletta, 2012, Methods Mol Biol, V895, P85, DOI 10.1007/978-1-61779-927-3_7; Ami D, 2012, BIOPHYS J, V102, P1676, DOI 10.1016/j.bpj.2012.02.045; Arakawa H, 2004, BIOL PHARM BULL, V27, P277, DOI 10.1248/bpb.27.277; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bengoa-Vergniory N, 2017, ACTA NEUROPATHOL, V134, P819, DOI 10.1007/s00401-017-1755-1; Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009; Binolfi A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10251; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Carmo-Goncalves P, 2014, AMYLOID, V21, P163, DOI 10.3109/13506129.2014.912208; Coskuner O, 2013, ACS CHEM NEUROSCI, V4, P1549, DOI 10.1021/cn4001389; De Franceschi G, 2017, J BIOL CHEM, V292, P6927, DOI 10.1074/jbc.M116.765149; Devika PT, 2008, PHARMACOL RES, V57, P351, DOI 10.1016/j.phrs.2008.03.008; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Hansel A, 2005, BBA-PROTEINS PROTEOM, V1703, P239, DOI 10.1016/j.bbapap.2004.09.010; Herrera FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003394; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; Kjaergaard M, 2010, PROTEIN SCI, V19, P1555, DOI 10.1002/pro.435; Konijnenberg A, 2016, ANAL CHEM, V88, P8468, DOI 10.1021/acs.analchem.6b00731; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latawiec D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009234; Lautenschlager J, 2017, TRENDS CELL BIOL, V27, P468, DOI 10.1016/j.tcb.2017.02.002; Legge FS, 2009, J PHYS CHEM B, V113, P14006, DOI 10.1021/jp903842u; Leong SL, 2009, NEUROCHEM RES, V34, P1838, DOI 10.1007/s11064-009-9986-8; Leong SL, 2009, FREE RADICAL BIO MED, V46, P1328, DOI 10.1016/j.freeradbiomed.2009.02.009; Maltsev AS, 2013, J AM CHEM SOC, V135, P2943, DOI 10.1021/ja312415q; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Nakaso K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055068; Natalello A, 2015, METHODS MOL BIOL, V1258, P347, DOI 10.1007/978-1-4939-2205-5_20; Natalello A, 2011, PROTEINS, V79, P611, DOI 10.1002/prot.22909; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Pivato M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050027; Rekas A, 2010, EUR BIOPHYS J BIOPHY, V39, P1407, DOI 10.1007/s00249-010-0595-x; Rodriguez AR, 2013, BIOMACROMOLECULES, V14, P3610, DOI 10.1021/bm400971p; Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007; Schildknecht S, 2013, J NEUROCHEM, V125, P491, DOI 10.1111/jnc.12226; Celej MS, 2012, BIOCHEM J, V443, P719, DOI 10.1042/BJ20111924; Spillantini MG, 2018, CELL TISSUE RES, V373, P137, DOI 10.1007/s00441-017-2706-9; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; Vitali M, 2018, BBA-GEN SUBJECTS, V1862, P1556, DOI 10.1016/j.bbagen.2018.03.026; Zhou WB, 2010, BBA-MOL BASIS DIS, V1802, P322, DOI 10.1016/j.bbadis.2009.12.004	43	19	20	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5657	5665		10.1074/jbc.RA118.001907	http://dx.doi.org/10.1074/jbc.RA118.001907			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30755483	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000464517500033
J	Vangelisti, A; Mascagni, F; Giordani, T; Sbrana, C; Turrini, A; Cavallini, A; Giovannetti, M; Natali, L				Vangelisti, Alberto; Mascagni, Flavia; Giordani, Tommaso; Sbrana, Cristiana; Turrini, Alessandra; Cavallini, Andrea; Giovannetti, Manuela; Natali, Lucia			Arbuscular mycorrhizal fungi induce the expression of specific retrotransposons in roots of sunflower (Helianthus annuus L.)	PLOS ONE			English	Article							TOBACCO TNT1 RETROTRANSPOSON; TRANSPOSABLE ELEMENTS; EPIGENETIC REGULATION; REPETITIVE COMPONENT; LTR-RETROTRANSPOSONS; PLANT DOMESTICATION; PROVIDES INSIGHTS; GENE-EXPRESSION; COPY-NUMBER; GENOME SIZE	Retrotransposon expression during arbuscular mycorrhizal (AM) fungal colonisation of sunflower roots (Helianthus annuus) was analysed using Illumina RNA-Seq, in order to verify whether mycorrhizal symbiosis can activate retrotransposable elements. Illumina cDNA libraries were produced from RNAs isolated from the roots of sunflower plants at 4 and 16 days after inoculation with the AM fungus Rhizoglomus irregulare and from their respective control plants. Illumina reads were mapped to a library of reverse transcriptase-encoding sequences, putatively belonging to long terminal repeat retrotransposons of Gypsy and Copia superfamilies. Forty-six different reverse transcriptase sequences were transcribed, although at a low rate, in mycorrhizal or control roots and only four were significantly overexpressed at day 16, compared with control roots. Almost all expressed or over-expressed sequences belonged to low-copy elements, mostly, of the Copia superfamily. A meta-analysis, using publicly available Illumina cDNA libraries obtained from sunflower plants treated with different hormones and chemicals, mimicking stimuli produced by abiotic and biotic stresses, was also conducted. Such analyses indicated that the four reverse transcriptase sequences over-expressed in mycorrhizal roots were explicitly induced only by AM symbiosis, showing the specificity of AM stimuli compared to that of other fungal/plant interactions.	[Vangelisti, Alberto; Mascagni, Flavia; Giordani, Tommaso; Turrini, Alessandra; Cavallini, Andrea; Giovannetti, Manuela; Natali, Lucia] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy; [Sbrana, Cristiana] UOS Pisa, Inst Agr Biol & Biotechnol, CNR, Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR)	Natali, L (corresponding author), Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.	lucia.natali@unipi.it	SBRANA, CRISTIANA/AAQ-4983-2020; Giordani, Tommaso/AAC-7352-2021; Cavallini, Andrea/AAF-1812-2020; Turrini, Alessandra/AHC-4708-2022	Sbrana, Cristiana/0000-0002-8058-8566; Mascagni, Flavia/0000-0001-9747-8040	University of Pisa, Italy (Plantomics)	University of Pisa, Italy (Plantomics)	This research is supported by a project of University of Pisa, Italy (Plantomics) to LN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anca IA, 2014, J PLANT PHYSIOL, V171, P1533, DOI 10.1016/j.jplph.2014.07.003; Araim G, 2009, J AGR FOOD CHEM, V57, P2255, DOI 10.1021/jf803173x; Avio L, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01089; Badouin H, 2017, NATURE, V546, P148, DOI 10.1038/nature22380; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Barghini E, 2015, MAR GENOM, V24, P397, DOI 10.1016/j.margen.2015.10.002; Battini F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04959-0; Beguiristain T, 2001, PLANT PHYSIOL, V127, P212, DOI 10.1104/pp.127.1.212; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brechenmacher L, 2004, MYCORRHIZA, V14, P253, DOI 10.1007/s00572-003-0263-4; Buti M, 2009, GENOME, V52, P904, DOI [10.1139/G09-064, 10.1139/g09-064]; Buti M, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy010; Cameron DD, 2013, TRENDS PLANT SCI, V18, P539, DOI 10.1016/j.tplants.2013.06.004; Chen ECH, 2018, NEW PHYTOL, V220, P1161, DOI 10.1111/nph.14989; De Coninck B, 2015, TRENDS PLANT SCI, V20, P91, DOI 10.1016/j.tplants.2014.09.007; Fiorilli V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00636; Fiorilli V, 2009, NEW PHYTOL, V184, P975, DOI 10.1111/j.1469-8137.2009.03031.x; Gallou A, 2012, FUNCT INTEGR GENOMIC, V12, P183, DOI 10.1007/s10142-011-0241-4; Gaude N, 2012, PLANT SIGNAL BEHAV, V7, P461, DOI 10.4161/psb.19650; Gianinazzi S, 2010, MYCORRHIZA, V20, P519, DOI 10.1007/s00572-010-0333-3; Giordani T, 2014, CURR PLANT BIOL, V1, P45, DOI 10.1016/j.cpb.2014.05.001; Giordani T, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1036-5; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Gorinsek B, 2004, MOL BIOL EVOL, V21, P781, DOI 10.1093/molbev/msh057; Grandbastien M, 2005, CYTOGENET GENOME RES, V110, P229, DOI 10.1159/000084957; Grandbastien MA, 1997, GENETICA, V100, P241, DOI 10.1023/A:1018302216927; Grunwald U, 2004, PLANT MOL BIOL, V55, P553, DOI 10.1007/s11103-004-1303-y; Handa Y, 2015, PLANT CELL PHYSIOL, V56, P1490, DOI 10.1093/pcp/pcv071; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hogekamp C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-306; Hogekamp C, 2011, PLANT PHYSIOL, V157, P2023, DOI 10.1104/pp.111.186635; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Kawakami T, 2011, GENOME BIOL EVOL, V3, P156, DOI 10.1093/gbe/evr005; Kazazian HH, 2000, SCIENCE, V289, P1152, DOI 10.1126/science.289.5482.1152; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Leff JW, 2017, NEW PHYTOL, V214, P412, DOI 10.1111/nph.14323; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lohse S, 2005, PLANT PHYSIOL, V139, P329, DOI 10.1104/pp.105.061457; Mascagni F, 2018, GENES-BASEL, V9, DOI 10.3390/genes9090433; Mascagni F, 2017, GENE, V634, P5, DOI 10.1016/j.gene.2017.08.014; Mascagni F, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4050-6; Mascagni F, 2015, GENOME BIOL EVOL, V7, P3368, DOI 10.1093/gbe/evv230; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Melayah D, 2001, PLANT J, V28, P159, DOI 10.1046/j.1365-313X.2001.01141.x; Mhiri C, 1999, MOL PLANT MICROBE IN, V12, P592, DOI 10.1094/MPMI.1999.12.7.592; Mhiri C, 1997, PLANT MOL BIOL, V33, P257, DOI 10.1023/A:1005727132202; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Natali L, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0937-z; Natali L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-686; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Pepe Alessandra, 2017, Mycorrhiza, V27, P659, DOI 10.1007/s00572-017-0779-7; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; POUTEAU S, 1994, PLANT J, V5, P535, DOI 10.1046/j.1365-313X.1994.5040535.x; Ropars J, 2015, NEW PHYTOL, V208, P638, DOI 10.1111/nph.13448; Savary R, 2018, ISME J, V12, P17, DOI 10.1038/ismej.2017.153; Schaarschmidt S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r62; Shu B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00408; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; SMITH SE, 1990, AUST J PLANT PHYSIOL, V17, P177, DOI 10.1071/PP9900177; Staton SE, 2012, PLANT J, V72, P142, DOI 10.1111/j.1365-313X.2012.05072.x; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Turrini A, 2016, BIOL FERT SOILS, V52, P643, DOI 10.1007/s00374-016-1106-8; Usai G, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1181-5; Vangelisti A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18445-0; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; von Sternberg R, 2005, CYTOGENET GENOME RES, V110, P108, DOI 10.1159/000084942; Vukich M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-150; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wright DA, 2002, GENOME RES, V12, P122, DOI 10.1101/gr.196001; Yamazaki M, 2001, MOL GENET GENOMICS, V265, P336, DOI 10.1007/s004380000421	78	12	12	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212371	10.1371/journal.pone.0212371	http://dx.doi.org/10.1371/journal.pone.0212371			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779767	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900051
J	Anton, AG; Garza, V; Justribo, JH; Traba, J				Garcia Anton, Alexander; Garza, Vicente; Hernandez Justribo, Jorge; Traba, Juan			Factors affecting Dupont's lark distribution and range regression in Spain	PLOS ONE			English	Article							CHERSOPHILUS-DUPONTI; FRAGMENTED POPULATIONS; EXTINCTION RISK; HABITAT; SIZE; PERFORMANCE; THRESHOLDS; PREDICTION; SELECTION; DYNAMICS	In this work, we analyse factors explaining the distribution and range regression of Dupont's lark in Spain, the only European country in which this threatened alaudid is present. Dupont's lark is an extremely elusive and scarce species, distributed across a reduced and strongly fragmented range, showing a metapopulational structure with unknown dispersive and connective mechanisms. We used maximum entropy modelling (Maxent) on nearly 15,000 Dupont's lark observations (1985-2015) to assess the probability of presence at a 1 km resolution across its European range. Moreover, we tested the probability of extinction by comparing pre- and post-2000 observations by means of a GLM over a subset of cells with presence-absence data. We obtained strong model fitting (AUC = 0.919), in which species occurrence was explained by low values of plant productivity (NDVI), climate (high temperature range and medium annual precipitation), land use (increasing with sclerophyllous scrubland), flat topography and human disturbance (associated with low human population density). The species also tolerates dry farming, but not other farm types or forest cover. The probability map identified two main regions known as the species' core areas: the steppes of the Iberian System and the Ebro Valley. The North Plateau is characterised by a dispersed structure of small and very fragmented patches of suitable habitat, while a succession of discontinuous probability patches form an Eastern Corridor connecting the central core areas to the southernmost populations. Finally, the model identified small and isolated patches of high probability of presence along the eastern coastline. The species tends to occur in the best available areas but, at the same time, the model revealed a large area of suitable but unoccupied habitat. Our results correct the previous estimation of occupation area from 1,480 to 1,010.78 km(2), a reduction of 26.22%. The current distribution of Dupont's lark is almost completely covered by Important Bird Areas (IBAs), highlighting their importance for bird conservation, but only 44.89% is included in Natura 2000 Special Protection Areas (SPAs). A comparison of pre- and post-2000 periods revealed a range contraction of 44%. Probability of extinction increased with higher temperature range and lower annual precipitation, and with decreases in population density, which suggests that this species is extremely vulnerable to both climate change and rural abandonment, due to its dependence on traditional grazing. These results suggest the need for a re-evaluation of the conservation status of Dupont's lark in Spain. They urge the preservation of not only current extant populations, but also the unoccupied suitable areas that could be critical for metapopulation structure, and the development of policies addressing the preservation of traditional grazing.	[Garcia Anton, Alexander; Garza, Vicente; Traba, Juan] Univ Autonoma Madrid, Dept Ecol, TEG UAM, Madrid, Spain; [Garza, Vicente] C Via Limite, Madrid, Spain; [Hernandez Justribo, Jorge] INECO, Madrid, Spain	Autonomous University of Madrid	Traba, J (corresponding author), Univ Autonoma Madrid, Dept Ecol, TEG UAM, Madrid, Spain.	juan.traba@uam.es		Garcia Anton, Alexander/0000-0002-3854-4850	Spanish Ministry of Environment; Dupont's Lark Monitoring Program in Medinaceli Region - Fundacion Patrimonio Natural de Castilla y Leon; Comunidad de Madrid [S2013/MAE-2719]; Fundacion Biodiversidad, of the Ministry of Agriculture, Food and Environment; European Commission [LIFE15-NAT-ES-000802]; BBVA Foundation	Spanish Ministry of Environment(Spanish Government); Dupont's Lark Monitoring Program in Medinaceli Region - Fundacion Patrimonio Natural de Castilla y Leon; Comunidad de Madrid(Comunidad de Madrid); Fundacion Biodiversidad, of the Ministry of Agriculture, Food and Environment; European Commission(European CommissionEuropean Commission Joint Research Centre); BBVA Foundation(BBVA Foundation)	Data used in this paper come from different projects, in particular the II National Census (2004-2006), granted by the Spanish Ministry of Environment; and the Dupont's Lark Monitoring Program in Medinaceli Region, funded by Fundacion Patrimonio Natural de Castilla y Leon. This is a contribution to the Excellence Network Remedinal 3CM (S2013/MAE-2719), supported by Comunidad de Madrid, and to the projects "Criteria for the management and conservation of the Spanish population of Dupont's Lark, supported by Fundacion Biodiversidad, of the Ministry of Agriculture, Food and Environment; LIFE Ricoti (LIFE15-NAT-ES-000802), supported by the European Commission; and BBVA-Dron Ricoti, funded by the BBVA Foundation. INECO provided support in the form of salary for author JHZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; We wish to acknowledge Francisco Quico Suarez, who led the Dupont's lark research group until his early death in 2010. Many people collected data in the field; we especially wish to thank: A. Agirre, R. Aymi, M. Calero, E. Carriles, J. T. Garcia, I. Hervas, E. G. de la Morena, J. J. Mate and J. Vinuela, and other contributors. Data used in this paper come from different projects, in particular the II National Census (2004-2006), granted by the Spanish Ministry of Environment; and the Dupont's Lark Monitoring Program in Medinaceli Region, funded by FundaciOn Patrimonio Natural de Castilla y Leon. This is a contribution to the Excellence Network Remedinal 3CM (52013/MAE-2719), supported by Comunidad de Madrid, and to the projects "Criteria for the management and conservation of the Spanish population of Dupont's Lark, supported by FundaciOn Biodiversidad, of the Ministry of Agriculture, Food and Environment; LIFE Ricoti (LIFE15-NAT-ES-000802), supported by the European Commission; and BBVA-Dron Ricoti, funded by the BBVA Foundation.	BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cramp S, 1980, BIRDS W PALEARTIC; De Juana E, 2017, HDB BIRDS WORLD ALIV; Delgado MP, 2011, ARDEOLA, V58, P223, DOI 10.13157/arla.58.2.2011.223; Dillon MO, 1990, ELSEVIER OCEANOGRAPH; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Estrada A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149810; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gao XJ, 2008, GLOBAL PLANET CHANGE, V62, P195, DOI 10.1016/j.gloplacha.2008.02.002; Garcia JT, 2008, ORYX, V42, P592, DOI 10.1017/S0030605308000653; Garcia JT, 2008, MOL PHYLOGENET EVOL, V46, P237, DOI 10.1016/j.ympev.2007.06.022; Garza V, 2005, ARDEOLA, V52, P133; Garza V., 1990, Ardeola, V37, P3; Garza V, 2006, ECOLOGIA, V20, P85; Garza V., 2004, LIBRO ROJO AVES ESPA, P309; Garza V, 2010, ALONDRA RICOTI CHERS, P141; Garza V, 2016, QUERCUS, V359, P24; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gomez JM, 2019, J CHILD SEX ABUS, V28, P318, DOI 10.1080/10538712.2018.1539425; Gomez-Catasus J, PEER J; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Inigo A., 2008, ACTION PLAN DUPONTS; Jaksic FM, 1999, WILSON BULL, V111, P527; Koening A., 1888, J ORNITHOL, V183, P9; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Martin-Vivaldi M., 1999, Zoologica Baetica, V10, P185; Mendez M, 2014, EVOL APPL, V7, P506, DOI 10.1111/eva.12154; Mendez M, 2011, BIOL CONSERV, V144, P2615, DOI 10.1016/j.biocon.2011.07.011; Nogues-Bravo D, 2006, ARDEOLA, V53, P55; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Garcia JO, 2010, DAIMON, P29; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Perez-Granados C, 2018, ARDEA, V106, P139, DOI 10.5253/arde.v106i2.a6; Perez-Granados C, 2014, QUERCUS, V337, P18; Perez-Granados C, 2013, ARDEOLA, V60, P143, DOI 10.13157/arla.60.1.2012.143; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Seoane J, 2006, BIOL CONSERV, V128, P241, DOI 10.1016/j.biocon.2005.09.032; Suarez F, 1983, B ESTACION CENTRAL E, P67; Suarez F., 2010, ALONDRA RICOTI CHERS; Suarez F, 2006, BIRD CONSERV INT, V16, P317, DOI 10.1017/S0959270906000505; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Talabante C, 2015, 1 WORKSH NAC AL RIC; Tella JL, 2005, ORYX, V39, P90, DOI 10.1017/S0030605305000165; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Vogeli M, 2011, BIOL LETTERS, V7, P954, DOI 10.1098/rsbl.2011.0241; Xue JR, 2017, J SENSORS, V2017, DOI 10.1155/2017/1353691; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	61	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0211549	10.1371/journal.pone.0211549	http://dx.doi.org/10.1371/journal.pone.0211549			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768612	gold, Green Submitted, Green Published			2022-12-26	WOS:000458766300008
J	Morseth, MS; Aakre, I; Barikmo, I; Dahl, L; Henjum, S				Morseth, Marianne S.; Aakre, Inger; Barikmo, Ingrid; Dahl, Lisbeth; Henjum, Sigrun			High iodine content in local animal milk and risk of exceeding EFSA upper intake level for iodine among Saharawi women	PLOS ONE			English	Article							DRINKING-WATER ACCESS; THYROID-DYSFUNCTION; REFUGEE CAMPS; CHILDREN; GOITER; EXCESS; INTELLIGENCE; PREVALENCE; TINDOUF; VOLUME	Excessive iodine intake is a major public health problem in the Saharawi refugee camps in Algeria, where animal milk is an important source of iodine. The purpose of this study was to assess the association between iodine concentrations in locally produced animal milk and in animal drinking water and further to assess the risk of exceeding European Food Safety Authority (EFSA) tolerable upper intake level for iodine (600 mu g/d) among Saharawi women. In 2009 and 2010, 202 milk samples from goats and sheep and 52 milk samples from camel were collected. Iodine in milk was determined by Inductively Coupled Plasma-Mass Spectrometry (ICP-MS). In addition, iodine in 56 water samples from the general water system and 54 water samples from wells, was determined by modified Sandell-Kolthoff reaction. Animal milk is generally consumed mixed with water. The median (min, max) iodine intake from goat/sheep milk mixed with water in camps with high iodine content in human drinking water was 284 (57, 2889) mu g/d and 19% of participants exceeded EFSA upper intake level for iodine. The median (min, max) iodine intake from camel milk mixed with water in all camps was 2100 (210, 11100) and 47% of participants exceeded the EFSA upper intake level. The median (min, max) iodine content in goat/sheep milk from camps with moderate and high iodine content in water was 507 (101, 4791) mu g/L and 1612 (487, 9323) mu g/L, respectively (p < 0.001). The iodine content in goat/sheep milk was positively associated with iodine content in animal drinking water (regression coefficient, B 5.71, 95% CI 4.03, 7.39). In conclusion, consumption of camel milk and living in camps with high water iodine content increased the risk of exceeding the EFSA upper intake level for iodine. We suggest that purified water for both human and animal consumption should be provided.	[Morseth, Marianne S.; Aakre, Inger; Barikmo, Ingrid; Henjum, Sigrun] OsloMet Oslo Metropolitan Univ, Fac Hlth Sci, Dept Nursing & Hlth Promot, Oslo, Norway; [Dahl, Lisbeth] IMR, Bergen, Norway	Oslo Metropolitan University (OsloMet); Institute of Marine Research - Norway	Morseth, MS (corresponding author), OsloMet Oslo Metropolitan Univ, Fac Hlth Sci, Dept Nursing & Hlth Promot, Oslo, Norway.	mmorseth@oslomet.no		Morseth, Marianne/0000-0001-5681-1433; Henjum, Sigrun/0000-0002-0671-2688	Norwegian Church Aid; Food and Agriculture Organization of the United Nations	Norwegian Church Aid; Food and Agriculture Organization of the United Nations	I.B received funding from Norwegian Church Aid (https://www.kirkensnodhjelp.no/en/) and the Food and Agriculture Organization of the United Nations (http://www.fao.org/home/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakre I., 2017, THESIS; Aakre I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187241; Aakre I, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070398; Aakre I, 2015, J TRACE ELEM MED BIO, V31, P279, DOI 10.1016/j.jtemb.2014.09.009; Ashworth DJ, COMPREHENSIVE HDB IO; Barikmo I, 2010, ENV IMPLICATION IODI; Barlowska J, 2011, COMPR REV FOOD SCI F, V10, P291, DOI 10.1111/j.1541-4337.2011.00163.x; Bornstein S., 1990, RANGIFER, V3, P231; Bougma K, 2013, NUTRIENTS, V5, P1384, DOI 10.3390/nu5041384; Burgi H, 2010, BEST PRACT RES CL EN, V24, P107, DOI 10.1016/j.beem.2009.08.010; Centers for Disease Control and Prevention, EQUIP ENS QUAL UR IO; Chen W, 2017, AM J CLIN NUTR, V105, P228, DOI 10.3945/ajcn.116.139725; Cui SL, 2017, BIOMED ENVIRON SCI, V30, P88, DOI 10.3967/bes2017.012; Dahl L, 2003, BRIT J NUTR, V90, P679, DOI 10.1079/BJN2003921; European Commission, 2002, OP SCI COMM FOOD TOL; Fecher PA, 1998, J ANAL ATOM SPECTROM, V13, P977, DOI 10.1039/a801671b; Gao TS, 2004, CHINESE MED J-PEKING, V117, P1518; Henjum S, 2012, PUBLIC HEALTH NUTR, V15, P1512, DOI 10.1017/S1368980011002886; Iodine Global Network, 2017, GLOB SCOR IOD NUTR 2; IOM, 2001, DIET REF INT VIT A V; Katagiri R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173722; Laurberg P, 2009, COMPREHENSIVE HANDBOOK OF IODINE: NUTRITIONAL, BIOCHEMICAL, PATHOLOGICAL AND THERAPEUTIC ASPECTS, P449, DOI 10.1016/B978-0-12-374135-6.00047-9; Leung AM, 2014, NAT REV ENDOCRINOL, V10, P136, DOI 10.1038/nrendo.2013.251; LI M, 1987, LANCET, V2, P257; Liu HL, 2009, J PUBLIC HEALTH-UK, V31, P32, DOI 10.1093/pubmed/fdn097; Luo YQ, 2014, INT J MOL SCI, V15, P12895, DOI 10.3390/ijms150712895; National Research Council, 2006, NUTR REQ SMALL RUM S; Ohashi T, 2000, CLIN CHEM, V46, P529; Pichel N, 2018, J TRACE ELEM MED BIO, V48, P57, DOI 10.1016/j.jtemb.2018.03.006; Pichel N, 2017, J TRACE ELEM MED BIO, V42, P32, DOI 10.1016/j.jtemb.2017.03.011; Qian Ming, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P246; Ren Sisi, 2014, Wei Sheng Yan Jiu, V43, P133; Sandell E. B., 1937, MICROCHIM ACTA, V1, P9, DOI [10.1007/BF01476194, DOI 10.1007/BF01476194]; Semba RD, 2001, NUTR REV, V59, P269; Sullivan KM, 2000, URINARY IODINE ASSES; Troan G, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.29829; UNHCR; WFP, 2012, JOINT NEEDS ASS SAH; UNHCR; WFP, 2012, NUTR SURV SAH REF CA; van der Reijden OL, 2017, BEST PRACT RES CL EN, V31, P385, DOI 10.1016/j.beem.2017.10.004; Vivar M, 2016, SCI TOTAL ENVIRON, V550, P534, DOI 10.1016/j.scitotenv.2016.01.113; Volpato G, 2014, PASTORALISM, V4, DOI 10.1186/s13570-014-0007-4; WHO, 2011, GUID DRINK WAT QUAL; Yagil R, 1994, SCI CAMELS MILK PROD; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P840, DOI 10.1093/ajcn/81.4.840; Zimmermann MB, 2015, THYROID RES, V8, DOI 10.1186/s13044-015-0020-8; Zimmermann MB, 2011, SEMIN CELL DEV BIOL, V22, P645, DOI 10.1016/j.semcdb.2011.07.009	46	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212465	10.1371/journal.pone.0212465	http://dx.doi.org/10.1371/journal.pone.0212465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768637	Green Published, gold, Green Submitted			2022-12-26	WOS:000458766300041
J	Andrie, RP; Beiert, T; Knappe, V; Linhart, M; Stockigt, F; Klein, AM; Ghanem, A; Lubkemeier, I; Roll, W; Nickenig, G; Fleischmann, BK; Schrickel, JW				Andrie, Rene P.; Beiert, Thomas; Knappe, Vincent; Linhart, Markus; Stoeckigt, Florian; Klein, Alexandra M.; Ghanem, Alexander; Luebkemeier, Indra; Roell, Wilhelm; Nickenig, Georg; Fleischmann, Bernd K.; Schrickel, Jan W.			Treatment with mononuclear cell populations improves post-infarction cardiac function but does not reduce arrhythmia susceptibility	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; STEM-CELLS; TRANSPLANTATION; CARDIOMYOCYTES; TRANSDIFFERENTIATE; TRANSFUSION; EXPRESSION; THERAPY	Background Clinical and experimental data give evidence that transplantation of stem and progenitor cells in myocardial infarction could be beneficial, although the underlying mechanism has remained elusive. Ventricular tachyarrhythmia is the most frequent and potentially lethal complication of myocardial infarction, but the impact of mono nuclear cells on the incidence of ventricular arrhythmia is still not clear. Objective We aimed to characterize the influence of splenic mononuclear cell populations on ventricular arrhythmia after myocardial infarction. Methods We assessed electrical vulnerability in vivo in mice with left ventricular cryoinfarction 14 days after injury and intramyocardial injection of specific subpopulations of mononuclear cells (MNCs) (CD11b-positive cells, Sca-1-positive cells, early endothelial progenitor cells (eEPCs)). As positive control group we used embryonic cardiomyocytes (eCMs). Epicardial mapping was performed for analysing conduction velocities in the border zone. Left ventricular function was quantified by echocardiography and left heart catheterization. Results In vivo pacing protocols induced ventricular tachycardia (VT) in 30% of non-infarcted mice. In contrast, monomorphic or polymorphic VT could be evoked in 94% of infarcted and vehicle-injected mice (p<0.01). Only transplantation of eCMs prevented post-infarction VT and improved conduction velocities in the border zone in accordance to increased expression of connexin 43. Cryoinfarction resulted in a broad aggravation of left ventricular function. All transplanted cell types augmented left ventricular function to a similar extent. Conclusions Transplantation of different MNC populations after myocardial infarction improves left ventricular function similar to effects of eCMs. Prevention of inducible ventricular arrhythmia is only seen after transplantation of eCMs.	[Andrie, Rene P.; Beiert, Thomas; Knappe, Vincent; Linhart, Markus; Stoeckigt, Florian; Nickenig, Georg; Schrickel, Jan W.] Univ Bonn, Dept Cardiol, Bonn, Germany; [Klein, Alexandra M.; Fleischmann, Bernd K.] Univ Bonn, Inst Physiol 1, Life & Brain Ctr, Bonn, Germany; [Ghanem, Alexander] Asklepios Hosp Hamburg, Dept Cardiol, Hamburg, Germany; [Luebkemeier, Indra] Univ Bonn, LIMES Inst, Mol Genet, Bonn, Germany; [Roell, Wilhelm] Univ Bonn, Dept Cardiovasc Surg, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn	Andrie, RP (corresponding author), Univ Bonn, Dept Cardiol, Bonn, Germany.	Rene.Andrie@ukbonn.de		Roell, Wilhelm/0000-0002-2213-5024	Bonfor program (Medical faculty, University of Bonn); German Heart Foundation	Bonfor program (Medical faculty, University of Bonn); German Heart Foundation	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. RPA was supported by Bonfor program (Medical faculty, University of Bonn) and German Heart Foundation.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Beiert T, 2018, INT J CARDIOL, V250, P21, DOI 10.1016/j.ijcard.2017.09.017; Bocchi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017750; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Delewi R, 2014, EUR HEART J, V35, P989, DOI 10.1093/eurheartj/eht372; Dimmeler S, 2008, ARTERIOSCL THROM VAS, V28, P208, DOI 10.1161/ATVBAHA.107.155317; Duerr GD, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/961298; Ghanem A, 2011, CELL TRANSPLANT, V20, P1621, DOI 10.3727/096368910X564049; Kawamoto A, 2001, CIRCULATION, V103, P634; Kuhlmann MT, 2006, J EXP MED, V203, P87, DOI 10.1084/jem.20051151; Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Liao SY, 2010, HEART RHYTHM, V7, P1852, DOI 10.1016/j.hrthm.2010.09.006; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507; Roell W, 2002, CIRCULATION, V105, P2435, DOI 10.1161/01.CIR.0000016063.66513.BB; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Schuh A, 2008, BASIC RES CARDIOL, V103, P69, DOI 10.1007/s00395-007-0685-9; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Shiba Y, 2016, NATURE, V538, P388, DOI 10.1038/nature19815; Shiba Y, 2014, J CARDIOVASC PHARM T, V19, P368, DOI 10.1177/1074248413520344; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Sun J, 2009, AM J PHYSIOL-HEART C, V296, pH43, DOI 10.1152/ajpheart.00613.2008; Tian YK, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0583-0; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; Wassmann S, 2006, CIRC RES, V99, pE74, DOI 10.1161/01.RES.0000246095.90247.d4; Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74	34	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0208301	10.1371/journal.pone.0208301	http://dx.doi.org/10.1371/journal.pone.0208301			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763348	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900002
J	Khattar, ZA; Lanois, A; Hadchity, L; Gaudriault, S; Givaudan, A				Khattar, Ziad Abi; Lanois, Anne; Hadchity, Linda; Gaudriault, Sophie; Givaudan, Alain			Spatiotemporal expression of the putative MdtABC efflux pump of Phtotorhabdus luminescens occurs in a protease-dependent manner during insect infection	PLOS ONE			English	Article							BACTERIUM PHOTORHABDUS-LUMINESCENS; 2-COMPONENT REGULATORY SYSTEM; LOCUSTA-MIGRATORIA ORTHOPTERA; MULTIDRUG-RESISTANCE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; ERWINIA-CHRYSANTHEMI; MOLECULAR-CLONING; VIRULENCE	Photorhabdus luminescens is an enterobacterium establishing a mutualistic symbiosis with nematodes, that also kills insects after septicaemia and connective tissue colonization. The role of the bacterial mdtABC genes encoding a putative multidrug efflux system from the resistance/nodulation/cell division family was investigated. We showed that a mdtA mutant and the wild type had similar levels of resistance to antibiotics, antimicrobial peptides, metals, detergents and bile salts. The mdtA mutant was also as pathogenic as the wild-type following intrahaemocoel injection in Locusta migratoria, but had a slightly attenuated phenotype in Spodoptera littoralis. A transcriptional fusion of the mdtA promoter (P-mdtA) and the green fluorescent protein (gfp) encoding gene was induced by copper in bacteria cultured in vitro. The P-mdtA-gfp fusion was strongly induced within bacterial aggregates in the haematopoietic organ during late stages of infection in L. migratoria, whereas it was only weakly expressed in insect plasma throughout infection. A medium supplemented with haematopoietic organ extracts induced the P-mdtA-gfp fusion ex vivo, suggesting that site-specific mdtABC expression resulted from insect signals from the haematopoietic organ. Finally, we showed that protease inhibitors abolished ex vivo activity of the P-mdtA-gfp fusion in the presence of haematopoietic organ extracts, suggesting that proteolysis by-products play a key role in upregulating the putative MdtABC efflux pump during insect infection with P. luminescens.	[Khattar, Ziad Abi; Hadchity, Linda] Lebanese Univ, Lab Georesources Geosciences & Environm, Microbiol Team, Fac Sci 2, Fanar, Lebanon; [Lanois, Anne; Gaudriault, Sophie; Givaudan, Alain] INRA, UMR Divers Genomes & Interact Microorganismes Ins, Montpellier, France; [Lanois, Anne; Gaudriault, Sophie; Givaudan, Alain] Univ Montpellier, UMR Divers Genomes & Interact Microorganismes Ins, Montpellier, France	Lebanese University; INRAE; Universite de Montpellier; Universite de Montpellier	Khattar, ZA (corresponding author), Lebanese Univ, Lab Georesources Geosciences & Environm, Microbiol Team, Fac Sci 2, Fanar, Lebanon.	ziad.abikhattar@ul.edu.lb	, Gaudriault/AAK-9152-2021	, Gaudriault/0000-0003-2789-4959; Abi Khattar, Ziad/0000-0003-4386-7467	University of Montpellier [0836]; National Council for Scientific Research - Lebanon (CNRS-L) [02-05-2016]	University of Montpellier; National Council for Scientific Research - Lebanon (CNRS-L)	ZAK was funded by a grant PR No. 0836 from the University of Montpellier (https://www.umontpellier.fr/university-of-montpellier) and a grant research project Ref. 02-05-2016 from the National Council for Scientific Research - Lebanon (CNRS-L) (http://www.cnrs.edu.lb/english/home).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Alvarez-Ortega C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00007; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; ASHHURST DE, 1980, EUR J BIOCHEM, V103, P75, DOI 10.1111/j.1432-1033.1980.tb04290.x; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Barabote RD, 2003, J BACTERIOL, V185, P5772, DOI 10.1128/JB.185.19.5772-5778.2003; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005; Bina XR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006804; Bina XR, 2008, INFECT IMMUN, V76, P3595, DOI 10.1128/IAI.01620-07; Bina XR, 2008, FEMS MICROBIOL LETT, V279, P226, DOI 10.1111/j.1574-6968.2007.01033.x; Blanco P, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4010014; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Boemare Noel, 2002, P35, DOI 10.1079/9780851995670.0035; Brillard J, 2002, J BACTERIOL, V184, P3871, DOI 10.1128/JB.184.14.3871-3878.2002; Brugirard-Ricaud K, 2005, CELL MICROBIOL, V7, P363, DOI 10.1111/j.1462-5822.2004.00466.x; Cabral CM, 2004, APPL ENVIRON MICROB, V70, P3831, DOI 10.1128/AEM.70.7.3831-3838.2004; Chiang SL, 1999, ANNU REV MICROBIOL, V53, P129, DOI 10.1146/annurev.micro.53.1.129; Daborn PJ, 2001, J BACTERIOL, V183, P5834, DOI 10.1128/JB.183.20.5834-5839.2001; Derzelle S, 2004, J BACTERIOL, V186, P1270, DOI 10.1128/JB.186.5.1270-1279.2004; Du DJ, 2018, NAT REV MICROBIOL, V16, P523, DOI 10.1038/s41579-018-0048-6; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Duvic B, 2012, J INSECT PHYSIOL, V58, P881, DOI 10.1016/j.jinsphys.2012.04.001; Eleftherianos I, 2006, INSECT BIOCHEM MOLEC, V36, P517, DOI 10.1016/j.ibmb.2006.04.001; Enright MR, 2005, J INVERTEBR PATHOL, V88, P40, DOI 10.1016/j.jip.2004.10.002; Enright MR, 2004, MICROB ECOL, V48, P414, DOI 10.1007/s00248-003-0166-0; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Ffrench-Constant R, 2003, FEMS MICROBIOL REV, V26, P433, DOI 10.1111/j.1574-6976.2003.tb00625.x; Fischer-Le Saux M, 1999, INT J SYST BACTERIOL, V49, P1645, DOI 10.1099/00207713-49-4-1645; GOTOH N, 1995, ANTIMICROB AGENTS CH, V39, P2567, DOI 10.1128/AAC.39.11.2567; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Groisman EA, 2016, ANNU REV MICROBIOL, V70, P103, DOI 10.1146/annurev-micro-102215-095331; Hirakata Y, 2002, J EXP MED, V196, P109, DOI 10.1084/jem.20020005; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; HOFFMANN D, 1974, J INVERTEBR PATHOL, V24, P238, DOI 10.1016/0022-2011(74)90017-2; HOFFMANN JA, 1969, J INSECT PHYSIOL, V15, P1375, DOI 10.1016/0022-1910(69)90198-X; James F., 2009, DEFENSIVE MUTUALISM; Joshi T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-222; Jubelin G, 2011, ENVIRON MICROBIOL, V13, P1271, DOI 10.1111/j.1462-2920.2011.02427.x; KAWABATA T, 1995, P NATL ACAD SCI USA, V92, P7774, DOI 10.1073/pnas.92.17.7774; Kovach ME, 1995, 4 NEW DERIVATIVES BR; Kwun MJ, 2014, ANTIMICROB AGENTS CH, V58, P6306, DOI 10.1128/AAC.03668-14; Lacroix FJC, 1996, FEMS MICROBIOL LETT, V135, P161, DOI 10.1016/0378-1097(95)00443-2; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; LI JX, 1995, APPL ENVIRON MICROB, V61, P4329, DOI 10.1128/AEM.61.12.4329-4333.1995; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; MA D, 1993, J BACTERIOL, V175, P6299, DOI 10.1128/JB.175.19.6299-6313.1993; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Marokhazi J, 2004, APPL ENVIRON MICROB, V70, P7311, DOI 10.1128/AEM.70.12.7311-7320.2004; Marokhazi J, 2004, BIOCHEM J, V379, P633, DOI 10.1042/BJ20031116; Marokhazi J, 2007, FEBS J, V274, P1946, DOI 10.1111/j.1742-4658.2007.05739.x; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Mouammine A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43670; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Nielsen-LeRoux C, 2012, CURR OPIN MICROBIOL, V15, P220, DOI 10.1016/j.mib.2012.04.006; Nikaido H, 1998, J BACTERIOL, V180, P4686, DOI 10.1128/JB.180.17.4686-4692.1998; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Nishino K, 2005, J BACTERIOL, V187, P1763, DOI 10.1128/JB.187.5.1763-1772.2005; Nishino K, 2007, J BACTERIOL, V189, P9066, DOI 10.1128/JB.01045-07; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Pages JM, 2005, TRENDS MOL MED, V11, P382, DOI 10.1016/j.molmed.2005.06.006; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; Perez A, 2012, ANTIMICROB AGENTS CH, V56, P2084, DOI 10.1128/AAC.05509-11; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Pletzer D, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-185; Ravirala RS, 2007, MOL PLANT MICROBE IN, V20, P313, DOI 10.1094/MPMI-20-3-0313; Rediers H, 2005, MICROBIOL MOL BIOL R, V69, P217, DOI 10.1128/MMBR.69.2.217-261.2005; Schumacher A, 2006, J ANTIMICROB CHEMOTH, V57, P344, DOI 10.1093/jac/dki446; Schwartzman JA, 2016, TRENDS MICROBIOL, V24, P414, DOI 10.1016/j.tim.2016.02.012; Shi DS, 2017, J AGR FOOD CHEM, V65, P60, DOI 10.1021/acs.jafc.6b04303; Silva CP, 2002, CELL MICROBIOL, V4, P329, DOI 10.1046/j.1462-5822.2002.00194.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Tobias NJ, 2017, ENVIRON MICROBIOL, V19, P119, DOI 10.1111/1462-2920.13502; Wang D, 2013, METALLOMICS, V5, P372, DOI 10.1039/c3mt20217h; Wang Lixia, 2001, Weishengwu Xuebao, V41, P753; Wang S., 2012, BACTERIAL 2 COMPONEN; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Wollenberg AC, 2016, APPL ENVIRON MICROB, V82, P5824, DOI 10.1128/AEM.01211-16	82	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212077	10.1371/journal.pone.0212077	http://dx.doi.org/10.1371/journal.pone.0212077			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763358	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900039
J	Klose, J; Trefz, S; Wagner, T; Steffen, L; Charrier, AP; Radhakrishnan, P; Volz, C; Schmidt, T; Ulrich, A; Dieter, SM; Ball, C; Glimm, H; Schneider, M				Klose, Johannes; Trefz, Stefan; Wagner, Tobias; Steffen, Luca; Charrier, Arsalie Preissendorfer; Radhakrishnan, Praveen; Volz, Claudia; Schmidt, Thomas; Ulrich, Alexis; Dieter, Sebastian M.; Ball, Claudia; Glimm, Hanno; Schneider, Martin			Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model	PLOS ONE			English	Article							STEM-CELLS; INITIATING CELLS; GROWTH; APOPTOSIS; ANTICANCER; AUTOPHAGY; PEROXISOMES; METABOLISM	Objectives Salinomycin is a polyether antibiotic with selective activity against human cancer stem cells. The impact of salinomycin on patient-derived primary human colorectal cancer cells has not been investigated so far. Thus, here we aimed to investigate the activity of salinomycin against tumor initiating cells isolated from patients with colorectal cancer. Methods Primary tumor-initiating cells (TIC) isolated from human patients with colorectal liver metastases or from human primary colon carcinoma were exposed to salinomycin and compared to treatment with 5-FU and oxaliplatin. TICs were injected subcutaneously into NOD/SCID mice to induce a patient-derived mouse xenograft model of colorectal cancer. Animals were treated either with salinomycin, FOLFOX regimen, or salinomycin and FOLFOX. Human colorectal cancer cells were used to delineate an underlying molecular mechanism of salinomycin in this tumor entity. Results Applying TICs isolated from human patients with colorectal liver metastases or from human primary colon carcinoma, we demonstrated that salinomycin exerts increased antiproliferative activity compared to 5-fluorouracil and oxaliplatin treatment. Consistently, salinomycin alone or in combination with FOLFOX exerts superior antitumor activity compared to FOLFOX therapy in a patient-derived mouse xenograft model of colorectal cancer. Salinomycin induces apoptosis of human colorectal cancer cells, accompanied by accumulation of dysfunctional mitochondria and reactive oxygen species. These effects are associated with expressional down-regulation of superoxide dismutase-1 (SOD1) in response to salinomycin treatment. Conclusion Collectively, the results of this pre-clinical study indicate that salinomycin alone or in combination with 5-fluorouracil and oxaliplatin exerts increased antitumoral activity compared to common chemotherapy.	[Klose, Johannes; Trefz, Stefan; Wagner, Tobias; Steffen, Luca; Charrier, Arsalie Preissendorfer; Radhakrishnan, Praveen; Volz, Claudia; Schmidt, Thomas; Ulrich, Alexis; Schneider, Martin] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Dieter, Sebastian M.; Glimm, Hanno] Natl Ctr Tumor Dis NCT Heidelberg, Translat Funct Canc Genom, Heidelberg, Germany; [Dieter, Sebastian M.; Glimm, Hanno] German Canc Res Ctr, Heidelberg, Germany; [Ball, Claudia; Glimm, Hanno] Natl Ctr Tumor Dis NCT Dresden, Dept Translat Med Oncol, Dresden, Germany; [Ball, Claudia; Glimm, Hanno] German Canc Res Ctr, Dresden, Germany; [Glimm, Hanno] Tech Univ Dresden, Univ Hosp Carl Gustav Carus Dresden, Ctr Personalized Oncol, Dresden, Germany; [Glimm, Hanno] German Consortium Translat Canc Res DKTK Dresden, Dresden, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Technische Universitat Dresden; Carl Gustav Carus University Hospital	Klose, J (corresponding author), Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany.	Johannes.Klose@med.uni-heidelberg.de	Schmidt, Thomas/Y-8431-2019	Schmidt, Thomas/0000-0002-7166-3675; Dieter, Sebastian/0000-0003-1324-7638; Ball, Claudia/0000-0002-1749-3791	DFG [KL-2843/2-1]; Deutsche Krebshilfe (German Cancer Aid); Colon-Resist-Net	DFG(German Research Foundation (DFG)); Deutsche Krebshilfe (German Cancer Aid)(Deutsche Krebshilfe); Colon-Resist-Net	This work was supported by DFG grant KL-2843/2-1 to Johannes Klose and by Deutsche Krebshilfe (German Cancer Aid) and Colon-Resist-Net to Claudia Ball and Hanno Glimm. The funder had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Antonenkov VD, 2010, ANTIOXID REDOX SIGN, V13, P525, DOI 10.1089/ars.2009.2996; Antoszczak M, 2015, ANTI-CANCER AGENT ME, V15, P575, DOI 10.2174/1871520615666150101130209; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Borgstrom B, 2016, CHEMISTRY; Borgstrom B, 2013, CHEM COMMUN, V49, P9944, DOI 10.1039/c3cc45983g; Brown KM, 2018, J SURG RES, V227, P158, DOI 10.1016/j.jss.2018.02.018; Brown KM, 2016, ONCOTARGET, V7, P66212, DOI 10.18632/oncotarget.11184; Chen X, 2014, INT J MOL MED, V34, P35, DOI 10.3892/ijmm.2014.1752; Chung SS, 2017, ANTICANCER RES, V37, P445, DOI 10.21873/anticanres.11336; DANFORTH HD, 1977, POULTRY SCI, V56, P926, DOI 10.3382/ps.0560926; de Aberasturi AL, 2016, CANCER LETT, V370, P165, DOI 10.1016/j.canlet.2015.10.012; Melo FDE, 2017, NATURE, V543, P676, DOI 10.1038/nature21713; Dewangan J, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695035; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Dong TT, 2011, ANN SURG ONCOL, V18, P1797, DOI 10.1245/s10434-011-1561-2; Dubash TD, 2016, CANCER LETT, V371, P326, DOI 10.1016/j.canlet.2015.11.037; Fan CW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.337; Fanali C, 2014, WORLD J GASTROENTERO, V20, P923, DOI 10.3748/wjg.v20.i4.923; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Giessler KM, 2017, J EXP MED, V214, P2073, DOI 10.1084/jem.20162017; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Huang XL, 2018, ACS CENTRAL SCI, V4, P760, DOI 10.1021/acscentsci.8b00257; Huang XL, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2142-3; Huczynski A, 2015, EUR J MED CHEM, V93, P33, DOI 10.1016/j.ejmech.2015.01.045; Jiang J, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0680-z; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Klonisch T, 2008, TRENDS MOL MED, V14, P450, DOI 10.1016/j.molmed.2008.08.003; Klose J, 2017, BIOCHEM BIOPH RES CO, V1151, DOI [10.1016/j.biopha.2017.02.110, DOI 10.1016/J.BIOPHA.2017.02.110]; Klose J, 2018, ONCOTARGET, V9, P3619, DOI 10.18632/oncotarget.23339; Klose J, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2879-8; Klose J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095970; Li T, 2016, ONCOTARGET, V7, P26580, DOI 10.18632/oncotarget.8555; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Markowska A, 2018, ADV CLIN EXP MED, V27, P1017, DOI 10.17219/acem/73999; MIYAZAKI Y, 1974, J ANTIBIOT, V27, P814, DOI 10.7164/antibiotics.27.814; Naujokat C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/950658; PLUMLEE KH, 1995, J VET DIAGN INVEST, V7, P419, DOI 10.1177/104063879500700327; Radhakrishnan P, 2016, CANCER RES, V76, P2219, DOI 10.1158/0008-5472.CAN-15-1474; Rai G, 2017, BIOMED PHARMACOTHER, V89, P1142, DOI 10.1016/j.biopha.2017.02.110; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Schenk M, 2015, CANCER LETT, V358, P161, DOI 10.1016/j.canlet.2014.12.037; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Seol HS, 2014, CANCER LETT, V345, P56, DOI 10.1016/j.canlet.2013.11.010; Shimokawa M, 2017, NATURE, V545, P187, DOI 10.1038/nature22081; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Story Phillipa, 2004, N Z Med J, V117, pU799; Tang QL, 2011, CANCER LETT, V311, P113, DOI 10.1016/j.canlet.2011.07.016; Mai TT, 2017, NAT CHEM, V9, P1025, DOI [10.1038/NCHEM.2778, 10.1038/nchem.2778]; Verdoodt B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044132; Vlachogiannis G, 2018, SCIENCE, V359, P920, DOI 10.1126/science.aao2774; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097414; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Yu SN, 2017, ONCOL REP, V37, P3321, DOI 10.3892/or.2017.5615; Zhang C, 2015, ONCOL REP, V34, P2469, DOI 10.3892/or.2015.4253; Zhang XF, 2016, INT J NANOMED, V11, P3655, DOI 10.2147/IJN.S111279; Zhou J, 2013, TOXICOL LETT, V222, P139, DOI 10.1016/j.toxlet.2013.07.022; Zou ZZ, 2017, ONCOTARGET, V8, P22414, DOI 10.18632/oncotarget.5628	60	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0211916	10.1371/journal.pone.0211916	http://dx.doi.org/10.1371/journal.pone.0211916			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763370	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900030
J	Raknes, G; Smabrekke, L				Raknes, Guttorm; Smabrekke, Lars			Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study	PLOS ONE			English	Article							LDN	In recent years, low dose naltrexone (LDN) has been used as an off-label therapy for several chronic diseases. Results from small laboratory and clinical studies indicate some beneficial effects of LDN in autoimmune diseases, but clinical research on LDN in rheumatic disease is limited. Using a pharmacoepidemiological approach, we wanted to test the hypothesis that starting LDN leads to reduced dispensing of medicines used in the treatment of rheumatic disease. We performed a controlled before-after study based on the Norwegian Prescription Database (NorPD) to compare prescriptions to patients one year before and one year after starting LDN in 2013. The identified patients (n = 360) were stratified into three groups based on LDN exposure. Outcomes were differences in dispensing of medicines used in rheumatic disease. In persistent LDN users, there was a 13% relative reduction in cumulative defined daily doses (DDD) of all medicines examined corresponding to -73.3 DDD per patient (95% CI -120,2 to -26.4, p = 0.003), and 23% reduction of analgesics (-21.6 DDD (95% CI -35.5 to -7.6, p<0.009)). There was no significant DDD change in patients with lower LDN exposure. Persistent LDN users had significantly reduced DDDs of NSAID and opioids, and a lower proportion of users of DMARDs (-6.7 percentage points, 95% CI -12.3 to-1.0, p = 0.028), TNF-alpha antagonists and opioids. There was a decrease in the number of NSAID users among patients with the least LDN exposure. Important limitations are that prescription data are proxies for clinical effects and that a control group unexposed to LDN is lacking. The results support the hypothesis that persistent use of LDN reduces the need for medication used in the treatment of rheumatic and seropositive arthritis. Randomised clinical trials on LDN in rheumatic disease are warranted.	[Raknes, Guttorm] Univ Hosp North Norway, Reg Med Informat & Pharmacovigilance Ctr RELIS, Tromso, Norway; [Raknes, Guttorm] Raknes Res, Ulset, Norway; [Smabrekke, Lars] UiT, Fac Hlth Sci, Dept Pharm, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Raknes, G (corresponding author), Univ Hosp North Norway, Reg Med Informat & Pharmacovigilance Ctr RELIS, Tromso, Norway.; Raknes, G (corresponding author), Raknes Res, Ulset, Norway.	guttorm.raknes@relis.no		Raknes, Guttorm/0000-0002-3376-6761				Altman DG, 1991, PRACTICAL STAT MED R, V1, P234; Boyden SD, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0581-0; Bridgman Alanna C, 2018, JAAD Case Rep, V4, P827, DOI 10.1016/j.jdcr.2018.06.001; Cree BAC, 2010, ANN NEUROL, V68, P145, DOI 10.1002/ana.22006; Furu K., 2008, Norsk Epidemiologi, V18, P129; Li ZJ, 2018, INT IMMUNOPHARMACOL, V61, P178, DOI 10.1016/j.intimp.2018.05.020; McLaughlin PJ, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0093-0; Polus S, 2017, J CLIN EPIDEMIOL, V91, P56, DOI 10.1016/j.jclinepi.2017.07.008; Rahn KA, 2011, BRAIN RES, V1381, P243, DOI 10.1016/j.brainres.2011.01.036; Raknes G, 2018, J CROHNS COLITIS, V12, P677, DOI 10.1093/ecco-jcc/jjy008; Raknes G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187423; Raknes G, 2017, PHARMACOEPIDEM DR S, V26, P685, DOI 10.1002/pds.4201; Raknes G, 2017, PHARMACOEPIDEM DR S, V26, P136, DOI 10.1002/pds.4110; Shiller AD, 2017, HEALING CHRONIC PAIN; Skard K., 2013, UNKNOWN MED LDN GIVE; Smith JP, 2011, DIGEST DIS SCI, V56, P2088, DOI 10.1007/s10620-011-1653-7; World Organization of Family Doctors (WONCA), 1998, INT CLASS COMM WICC; Younger J, 2013, ARTHRITIS RHEUM-US, V65, P529, DOI 10.1002/art.37734; Younger J, 2009, PAIN MED, V10, P663, DOI 10.1111/j.1526-4637.2009.00613.x	19	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212460	10.1371/journal.pone.0212460	http://dx.doi.org/10.1371/journal.pone.0212460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763385	gold, Green Published, Green Submitted			2022-12-26	WOS:000458763900083
J	Andrzejewski, KA; Polcyn, MJ; Winkler, DA; Chindebvu, EG; Jacobs, LL				Andrzejewski, Kate A.; Polcyn, Michael J.; Winkler, Dale A.; Chindebvu, Elizabeth Gomani; Jacobs, Louis L.			The braincase of Malawisaurus dixeyi (Sauropoda: Titanosauria): A 3D reconstruction of the brain endocast and inner ear	PLOS ONE			English	Article							DINOSAURS; PATAGONIA; NEUQUEN; HEAD	A braincase of the Cretaceous titanosaurian sauropod Malawisaurus dixeyi, complete except for the olfactory region, was CT scanned and a 3D rendering of the endocast and inner ear was generated. Cranial nerves appear in the same configuration as in other sauropods, including derived features that appear to characterize titanosaurians, specifically, an abducens nerve canal that passes lateral to the pituitary fossa rather than entering it. Furthermore, the hypoglossal nerve exits the skull via a single foramen, consistent with most titanosaurians, while other saurischians, including the basal titanosauriform, Giraffatitan, contain multiple rootlets. The size of the vestibular labyrinth is smaller than in Giraffatitan, but larger than in most derived titanosaurians. Similar to the condition found in Giraffatitan, the anterior semicircular canal is larger than the posterior semicircular canal. This contrasts with more derived titanosaurians that contain similarly sized anterior and posterior semicircular canals, congruent with the interpretation of Malawisaurus as a basal titanosaurian. Measurements of the humerus of Malawisaurus provide a body mass estimate of 4.7 metric tons. Comparison of body mass to radius of the semicircular canals of the vestibular labyrinth reveals that Malawisaurus fits the allometric relationship found in previous studies of extant mammals and Giraffatitan brancai. As in Giraffatitan, the anterior semicircular canal is significantly larger than is predicted by the allometric relationship suggesting greater sensitivity and slower movement of the head in the sagittal plane.	[Andrzejewski, Kate A.; Polcyn, Michael J.; Winkler, Dale A.; Jacobs, Louis L.] Southern Methodist Univ, Roy M Huffington Dept Earth Sci, Dallas, TX 75275 USA; [Chindebvu, Elizabeth Gomani] Minist Civ Educ Culture & Community Dev, Lilongwe, Malawi	Southern Methodist University	Andrzejewski, KA (corresponding author), Southern Methodist Univ, Roy M Huffington Dept Earth Sci, Dallas, TX 75275 USA.	kruoff@mail.smu.edu		Jacobs, Louis/0000-0002-7735-3678; Andrzejewski, Kate/0000-0002-9761-7079	National Geographic Society [2882-84, 3578-87, 4114-89, 4329-90, 4676-91]; Institute for the Study of Earth and Man (ISEM) at Southern Methodist University	National Geographic Society(National Geographic Society); Institute for the Study of Earth and Man (ISEM) at Southern Methodist University	Funded by 1. LLJ Grants: 2882-84; 3578-87; 4114-89; 4329-90; 4676-91. National Geographic Society. https://www.nationalgeographic.org/. 2. MJP. Institute for the Study of Earth and Man (ISEM) at Southern Methodist University. https://www.smu.edu/Dedman/Academics/InstitutesCenters/ISEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlin JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079585; Calvo Jorge O., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P485; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Carabajal AP, 2012, ANAT REC, V295, P2141, DOI 10.1002/ar.22572; Clarke AH, 2005, J VESTIBUL RES-EQUIL, V15, P65; Colin J. K., 1990, SCI PARIS SERIE II, V331, P1025; EBY GN, 1995, J AFR EARTH SCI, V20, P275, DOI 10.1016/0899-5362(95)00054-W; Filippi LS, 2008, AMEGHINIANA, V45, P575; Fraas E, 1908, PALAEONTOGRAPHICA, V55, P105; Frey R., ANATOMICAL IMAGING N; Gomani EM, 2005, PALAEONTOL ELECTRON, V8; HAUGHTON S. H., 1928, TRANS ROY SOC SOUTH AJRICA, V16, P67; Hopson J.A., 1979, P39; JACOBS LL, 1993, PALAEONTOLOGY, V36, P523; Janensch W, 1935, PALAEONTOGRAPHICA S, V7, P145; Knoll F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054991; Knoll F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030060; Le Loeuff Jean, 2012, Journal of Stratigraphy, V36, P486; Malinzak M, 2011, AM J PHYS ANTHROPOL, P144; Malinzak MD, 2012, P NATL ACAD SCI USA, V109, P17914, DOI 10.1073/pnas.1206139109; Martinez RDF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151661; Pentelkov VG, 1979, DOKL AKAD NAUK SSSR, V235, P92; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Spoor F, 2002, NATURE, V417, P163, DOI 10.1038/417163a; SPOOR F, 1995, J ANAT, V186, P271; Sternfield R., 1911, SITZUNGSBERICHTE GES, P398; Sues H-D, 2015, J VERTEBR PALEONTOL, V35, P1; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Wild R., 1991, STUTTGARTER BEITRA B, V173, P1; Wilson J. A., 2009, Contributions from the Museum of Paleontology University of Michigan, V32, P17; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6	31	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211423	10.1371/journal.pone.0211423	http://dx.doi.org/10.1371/journal.pone.0211423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759166	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300047
J	van Westrhenen, N; Fritz, E; Vermeer, A; Boelen, P; Kleber, R				van Westrhenen, Nadine; Fritz, Elzette; Vermeer, Adri; Boelen, Paul; Kleber, Rolf			Creative arts in psychotherapy for traumatized children in South Africa: An evaluation study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; THERAPY PROGRAM; SUBSTANCE-ABUSE; SEXUAL-ABUSE; HEALTH-CARE; SYMPTOMS; GROWTH; ADOLESCENTS; DEPRESSION; ANXIETY	Aim To evaluate the feasibility and effect of a 10-session creative arts in psychotherapy group programme on posttraumatic stress symptoms, behavioural problems, and posttraumatic growth, in children who experienced a traumatic event. Design A multicentre non-randomized controlled trial with a treatment and a control condition conducted in South Africa (4 sites). Methods 125 children aged 7 to 13 years were assigned either to the treatment condition receiving creative arts in psychotherapy or a control condition with a low-level supportive programme without treatment. Attrition rates were 63.4% and in total 47 children completed the programme and questionnaires assessing posttraumatic stress, posttraumatic growth and behaviour problems both at baseline and follow-up; 23 in the treatment group and 24 in the control group. Adjusted mean differences were analysed using ANCOVA with bootstrapping. Results Results showed that both hyperarousal symptoms (d = 0.61) and avoidance symptoms (d = 0.41) decreased more in the treatment group compared to the control group. There was no significant effect of the intervention found for reported levels of behavioural problems and posttraumatic growth. Conclusion In spite of severe challenges implementing and executing this pioneering study in underprivileged areas of South Africa, support was found for creative arts in psychotherapy reducing hyperarousal and avoidance symptoms, but not for other symptoms. Valuable lessons were learned on feasibility of implementing this intervention in a developing context.	[van Westrhenen, Nadine; Boelen, Paul; Kleber, Rolf] Univ Utrecht, Dept Clin Psychol, Utrecht, Netherlands; [van Westrhenen, Nadine] Vrije Univ Amsterdam, Athena Inst, Amsterdam, Netherlands; [Fritz, Elzette] Univ Johannesburg, Dept Educ Psychol, Johannesburg, South Africa; [Vermeer, Adri] Univ Utrecht, Dept Educ & Pedag, Utrecht, Netherlands; [Boelen, Paul; Kleber, Rolf] Arq Psychotrauma Expert Grp, Diemen, Netherlands	Utrecht University; Vrije Universiteit Amsterdam; University of Johannesburg; Utrecht University; Arq Psychotrauma Expert Group	van Westrhenen, N (corresponding author), Univ Utrecht, Dept Clin Psychol, Utrecht, Netherlands.; van Westrhenen, N (corresponding author), Vrije Univ Amsterdam, Athena Inst, Amsterdam, Netherlands.	nadinevanwestrhenen@live.nl	Goldwasser, Dr Norman/F-6854-2019	Goldwasser, Dr Norman/0000-0002-8051-8330				Achenbach T. M., 2007, MULTICULTURAL SUPPLE; Achenbach T.M., 1991, MANUAL CHILD BEHAV C, DOI DOI 10.1023/A; Alisic E, 2008, J CLIN PSYCHIAT, V69, P1455, DOI 10.4088/JCP.v69n0913; Amaya-Jackson L., 1995, CHILD PTSD CHECKLIST; Bensimon M, 2008, ART PSYCHOTHER, V35, P34, DOI 10.1016/j.aip.2007.09.002; Boeije H, 2013, J MIX METHOD RES, V7, P347, DOI 10.1177/1558689813482756; Boyes ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046905; Bracken P, 2012, BRIT J PSYCHIAT, V201, P430, DOI 10.1192/bjp.bp.112.109447; Bruwer B, 2011, PSYCHIAT SERV, V62, P774, DOI 10.1176/ps.62.7.pss6207_0774; Calhoun L., 2014, HDB POSTTRAUMATIC GR; Campbell J., 2008, HERO 1000 FACES; Campbell-Hall V, 2010, TRANSCULT PSYCHIATRY, V47, P610, DOI 10.1177/1363461510383459; Cassidy S, 2014, ART PSYCHOTHER, V41, P353, DOI 10.1016/j.aip.2014.07.003; Clay Rebecca, 2009, Clin Child Psychol Psychiatry, V14, P411, DOI 10.1177/1359104509104049; Coholic D., 2009, TRAUMATOLOGY, V15, P64, DOI [10.1177/1534765609341590, DOI 10.1177/1534765609341590]; Dirik G, 2008, J CLIN PSYCHOL MED S, V15, P193, DOI 10.1007/s10880-008-9115-x; Eaton LG, 2007, ARTS PSYCHOTHERAPY, P34; Ehring T, 2014, CLIN PSYCHOL REV, V34, P645, DOI 10.1016/j.cpr.2014.10.004; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fincham DS, 2009, COMPR PSYCHIAT, V50, P193, DOI 10.1016/j.comppsych.2008.09.001; Gillies Donna, 2013, Evid Based Child Health, V8, P1004, DOI 10.1002/ebch.1916; Gladding ST, 2003, HANDBOOK OF ART THERAPY, P243; Halprin A., 2015, MOVING LIFE 5 DECADE; Heide FJ, 2016, EUROPEAN J PSYCHOTRA, V7, P28687, DOI DOI 10.3402/ejpt.v7.28687; Herman J., 1992, TRAUMA RECOVERY; Ho RTH, 2015, ART PSYCHOTHER, V46, P9, DOI 10.1016/j.aip.2015.09.004; Hogan S., 2009, INT J ART THERAPY, V14, P29, DOI [DOI 10.1080/17454830903006331, https://doi.org/10.1080/17454830903006331]; Jewkes RK, 2010, CHILD ABUSE NEGLECT, V34, P833, DOI 10.1016/j.chiabu.2010.05.002; Jiang J, 2016, ART PSYCHOTHER, V48, P62, DOI 10.1016/j.aip.2016.02.002; Kaminer D, 2013, PEACE CONFL, V19, P112, DOI 10.1037/a0032487; Kehle-Forbes SM, 2013, PSYCHOL TRAUMA-US, V5, P317, DOI 10.1037/a0030040; Killian B, 2016, SEXUAL ABUSE YOUNG C; Kilmer RP, 2009, J TRAUMA STRESS, V22, P248, DOI 10.1002/jts.20410; King G, 2004, CHILD ABUSE NEGLECT, V28, P683, DOI 10.1016/j.chiabu.2003.12.003; Kozlowska K., 2001, CLIN CHILD PSYCHOL P, V6, P49, DOI DOI 10.1177/1359104501006001006; Lev-Wiesel Rachel, 2007, Clin Child Psychol Psychiatry, V12, P65, DOI 10.1177/1359104507071056; Levine P.A., 2010, UNSPOKEN VOICE BODY; Lowe SR, 2013, J CONSULT CLIN PSYCH, V81, P877, DOI 10.1037/a0033252; Lyshak-Stelzer F, 2007, ART THER, V24, P163, DOI 10.1080/07421656.2007.10129474; Madu SN, 2001, ARCH SEX BEHAV, V30, P311, DOI 10.1023/A:1002704331364; Malchiodi C.A., 2015, CREATIVE INTERVENTIO, V2nd Ed; Malchiodi CA, 2013, EXPRESSIVE THERAPIES, DOI [10.1177/1359104507071056, DOI 10.1177/1359104507071056]; McNiff Shaun, 2004, ART HEALS CREATIVITY; Mudlaff, 2000, TERRIBLE THING HAPPE; Nickerson A, 2011, CLIN PSYCHOL REV, V31, P399, DOI 10.1016/j.cpr.2010.10.004; Pretorius G, 2010, S AFR J PSYCHOL, V40, P63, DOI 10.1177/008124631004000107; Quinlan R, 2016, ART PSYCHOTHER, V47, P72, DOI 10.1016/j.aip.2015.09.006; Saraceno B, 2007, LANCET, P370; Schnurr PP, 2007, JAMA-J AM MED ASSOC, P297; Schouten KA, 2015, TRAUMA VIOLENCE ABUS, V16, P220, DOI 10.1177/1524838014555032; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Seedat S, 2004, BRIT J PSYCHIAT, V184, P169, DOI 10.1192/bjp.184.2.169; Seedat S, 2009, SAMJ S AFR MED J, V99, P346; Silverman WK, 2008, J CLIN CHILD ADOLESC, V37, P156, DOI 10.1080/15374410701818293; Stuckey HL, 2010, AM J PUBLIC HEALTH, V100, P254, DOI 10.2105/AJPH.2008.156497; Suliman S, 2009, COMPR PSYCHIAT, V50, P121, DOI 10.1016/j.comppsych.2008.06.006; Tol WA, 2011, LANCET, P378; Tol WA, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-56; Tran US, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0979-2; Ugurlu N, 2016, VULNERABLE CHILD YOU, V11, P89, DOI 10.1080/17450128.2016.1181288; Van Westrhenen N, 2018, KNOWLEDGE MANAGEMENT; van Westrhenen N, 2017, ART PSYCHOTHER, V54, P128, DOI 10.1016/j.aip.2017.04.013; van Westrhenen N, 2014, ART PSYCHOTHER, V41, P527, DOI 10.1016/j.aip.2014.10.004; Yalom ID., 2008, THEORY PRACTICE GROU, V5	64	10	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0210857	10.1371/journal.pone.0210857	http://dx.doi.org/10.1371/journal.pone.0210857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5IX	30759101	Green Submitted, Green Published, gold			2022-12-26	WOS:000458761300020
J	Vigalondo, B; Patino, J; Draper, I; Mazimpaka, V; Shevock, JR; Losada-Lima, A; Gonzalez-Mancebo, JM; Garilleti, R; Lara, F				Vigalondo, Beatriz; Patino, Jairo; Draper, Isabel; Mazimpaka, Vicente; Shevock, James R.; Losada-Lima, Ana; Gonzalez-Mancebo, Juana M.; Garilleti, Ricardo; Lara, Francisco			The long journey of Orthotrichum shevockii (Orthotrichaceae, Bryopsida): From California to Macaronesia	PLOS ONE			English	Article							FOUNDER-EVENT SPECIATION; INTEGRATIVE TAXONOMY; DISTANCE DISPERSAL; PHYLOGENETIC ANALYSIS; ISLAND BIOGEOGRAPHY; CRYPTIC SPECIATION; UNIVERSAL PRIMERS; OCEANIC ISLANDS; JET-STREAM; GENUS	Biogeography, systematics and taxonomy are complementary scientific disciplines. To understand a species' origin, migration routes, distribution and evolutionary history, it is first necessary to establish its taxonomic boundaries. Here, we use an integrative approach that takes advantage of complementary disciplines to resolve an intriguing scientific question. Populations of an unknown moss found in the Canary Islands (Tenerife Island) resembled two different Californian endemic species: Orthotrichum shevockii and O. kellmanii. To determine whether this moss belongs to either of these species and, if so, to explain its presence on this distant oceanic island, we combined the evaluation of morphological qualitative characters, statistical morphometric analyses of quantitative traits, and molecular phylogenetic inferences. Our results suggest that the two Californian mosses are conspecific, and that the Canarian populations belong to this putative species, with only one taxon thus involved. Orthotrichum shevockii (the priority name) is therefore recognized as a morphologically variable species that exhibits a transcontinental disjunction between western North America and the Canary Islands. Within its distribution range, the area of occupancy is limited, a notable feature among bryophytes at the intraspecific level. To explain this disjunction, divergence time and ancestral area estimation analyses are carried out and further support the hypothesis of a long-distance dispersal event from California to Tenerife Island.	[Vigalondo, Beatriz; Draper, Isabel; Mazimpaka, Vicente; Lara, Francisco] Univ Autonoma Madrid, Fac Ciencias, Dept Biol Bot, Madrid, Spain; [Patino, Jairo; Losada-Lima, Ana; Gonzalez-Mancebo, Juana M.] Univ La Laguna, Dept Bot Ecol & Fisiol Vegetal, San Cristobal la Laguna, Santa Cruz De T, Spain; [Patino, Jairo] CSIC, IPNA, Isl Ecol & Evolut Res Grp, San Cristobal la Laguna, Tenerife, Spain; [Patino, Jairo] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Shevock, James R.] Calif Acad Sci, Dept Bot, San Francisco, CA 94118 USA; [Garilleti, Ricardo] Univ Valencia, Fac Farm, Dept Bot & Geol, Valencia, Spain	Autonomous University of Madrid; Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); University of California System; University of California Berkeley; California Academy of Sciences; University of Valencia	Vigalondo, B (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Dept Biol Bot, Madrid, Spain.	beavigal@gmail.com	Garilleti, Ricardo/A-2862-2014; Patiño, Jairo/J-9595-2014; Lara Garcia, Francisco/I-3003-2014	Garilleti, Ricardo/0000-0002-5977-2908; Patiño, Jairo/0000-0001-5532-166X; Gonzalez-Mancebo, Juana Maria/0000-0002-3840-9501; Vigalondo, Beatriz/0000-0003-1425-4661; Lara Garcia, Francisco/0000-0002-1665-5277	Spanish Ministry of Education and Science [CGL2007-61389/BOS]; Spanish Ministry of Science and Innovation [CGL2011-28857/BOS]; Spanish Ministry of Economy and Competitiveness [CGL2013-43246-P, IJCI-2014-19691, RYC-2016-20506]; Spanish Ministry of Economy, Industry and Competitiveness [CGL2016-80772-P]; H2020 Marie Sktodowska-Curie Actions grant [747238]; Parque Nacional del Teide; Ministry of Economy and Competitiveness [BES-2012-051976]	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Economy, Industry and Competitiveness(Spanish Government); H2020 Marie Sktodowska-Curie Actions grant; Parque Nacional del Teide; Ministry of Economy and Competitiveness	This research was funded by the Spanish Ministry of Education and Science (CGL2007-61389/BOS) to F.L., the Spanish Ministry of Science and Innovation (CGL2011-28857/BOS) to V.M., the Spanish Ministry of Economy and Competitiveness (CGL2013-43246-P) to R.G., and the Spanish Ministry of Economy, Industry and Competitiveness (CGL2016-80772-P) to I.D. and the Spanish Ministry of Economy and Competitiveness (grants IJCI-2014-19691 and RYC-2016-20506) to J.P. J.P. also received the H2020 Marie Sktodowska-Curie Actions grant 747238. J.M.G-M and A.L-L. are grateful for funding from Parque Nacional del Teide. B.V. benefited from the support of the Ministry of Economy and Competitiveness through grant BES-2012-051976 of the Formacion de Personal Investigador (FPI) programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsos IG, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv036; [Anonymous], 2021, LANG ENV STAT COMP; Baldwin BG, 2010, ANN BOT-LONDON, V105, P849, DOI 10.1093/aob/mcq052; Caparros R, 2016, BOT J LINN SOC, V180, P427, DOI 10.1111/boj.12397; Carine MA, 2004, AM J BOT, V91, P1070, DOI 10.3732/ajb.91.7.1070; Carter BE, 2017, MOL PHYLOGENET EVOL, V107, P16, DOI 10.1016/j.ympev.2016.10.002; Chiang TY, 1998, BOT BULL ACAD SINICA, V39, P245; Christenhusz MJM, 2013, BOT J LINN SOC, V171, P277, DOI 10.1111/j.1095-8339.2012.01301.x; Cowie RH, 2006, J BIOGEOGR, V33, P193, DOI 10.1111/j.1365-2699.2005.01383.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; Devos N, 2009, EVOLUTION, V63, P779, DOI 10.1111/j.1558-5646.2008.00567.x; Draper I, 2015, BOT J LINN SOC, V177, P418, DOI 10.1111/boj.12250; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fernandez-Palacios JM, 2011, TERRESTRIAL ARTHROPO; Feuerer T, 2007, BIODIVERS CONSERV, V16, P85, DOI 10.1007/s10531-006-9142-6; FIEDOROW P, 1998, PLANT CYTOGENETICS, P244; Frahm JP, 2008, BIODIVERS CONSERV, V17, P277, DOI 10.1007/s10531-007-9251-x; Garilleti R, 2002, NOVA HEDWIGIA, V75, P207, DOI 10.1127/0029-5035/2002/0075-0207; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Gonzalez-Mancebo JM, 2008, CRYPTOGAMIE BRYOL, V29, P315; Hedenas L, 2014, TAXON, V63, P249, DOI 10.12705/632.16; Heinrichs J, 2006, PLANT SYST EVOL, V258, P227, DOI 10.1007/s00606-006-0411-3; Heinrichs J, 2015, TAXON, V64, P216, DOI 10.12705/642.5; Heinrichs J, 2009, J SYST EVOL, V47, P497, DOI 10.1111/j.1759-6831.2009.00028.x; Hutsemekers V, 2012, MOL PHYLOGENET EVOL, V62, P748, DOI 10.1016/j.ympev.2011.11.014; Hutsemekersa V, 2011, P NATL ACAD SCI USA, V108, P18989, DOI 10.1073/pnas.1109119108; Kadereit JW, 2012, TAXON, V61, P3, DOI 10.1002/tax.611001; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; KRISHNAMURTI TN, 1961, J METEOROL, V18, P172, DOI 10.1175/1520-0469(1961)018<0172:TSJSOW>2.0.CO;2; Kuang XY, 2014, THEOR APPL CLIMATOL, V117, P103, DOI 10.1007/s00704-013-0994-x; Laenen B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6134; Laenen B, 2011, J BIOGEOGR, V38, P631, DOI 10.1111/j.1365-2699.2010.02440.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lara F, 2014, FLORA BRIOFITICA IBE, P50; Lara F, 2016, CRYPTOGAMIE BRYOL, V37, P361, DOI 10.7872/cryb/v37.iss4.2016.361; Lara F, 2009, CRYPTOGAMIE BRYOL, V30, P129; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lewinsky J., 1993, BRYOBROTHERA, V2, P1; Lewinsky-Haapasaari J, 1998, BRYOLOGIST, V101, P435; Lewis LR, 2014, J BIOGEOGR, V41, P2385, DOI 10.1111/jbi.12385; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; Matzke N.J, 2013, FRONTIERS BIOGEOGRAP, V5; Matzke NJ, 2014, SYST BIOL, V63, P951, DOI 10.1093/sysbio/syu056; McDaniel SF, 2003, EVOLUTION, V57, P205; Medina NG., 2011, BIOGEOGRAPHY MICROSC, P209, DOI [10.1017/CBO9780511974878.012, DOI 10.1017/CBO9780511974878.012]; Medina R, 2013, TAXON, V62, P1133, DOI 10.12705/626.15; Medina R, 2012, TAXON, V61, P1180, DOI 10.1002/tax.616002; Muller DK, 2012, APPL BIOINFORMATICS, V4, P65, DOI [10.2165/00822942, DOI 10.2165/00822942]; Muller J., 2006, PHYDE PHYLOGENETIC D; Munoz J, 2004, SCIENCE, V304, P1144, DOI 10.1126/science.1095210; NADOT S, 1994, PLANT SYST EVOL, V191, P27, DOI 10.1007/BF00985340; Norris DH, 2004, BRYOLOGIST, V107, P209, DOI 10.1639/0007-2745(2004)107[0209:OKBOAR]2.0.CO;2; Otto R, 2016, J BIOGEOGR, V43, P911, DOI 10.1111/jbi.12684; Patino J, 2017, MOL PHYLOGENET EVOL, V106, P73, DOI 10.1016/j.ympev.2016.09.020; Patino J, 2015, J BIOGEOGR, V42, P2122, DOI 10.1111/jbi.12583; Patino J, 2015, SYST BIOL, V64, P579, DOI 10.1093/sysbio/syv013; Patino J, 2013, J ECOL, V101, P1245, DOI 10.1111/1365-2745.12136; Patino J, 2013, J BIOGEOGR, V40, P857, DOI 10.1111/jbi.12051; Rambaut A., 2014, TRACER V1 6; RAVEN PH, 1974, ANN MO BOT GARD, V61, P539, DOI 10.2307/2395021; Ree RH, 2018, J BIOGEOGR, V45, P741, DOI 10.1111/jbi.13173; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Renner MAM, 2013, PHYTOKEYS, V27, P1, DOI 10.3897/phytokeys.27.5523; Renner S, 2004, INT J PLANT SCI, V165, pS23, DOI 10.1086/383334; Ronquist F., 2011, MRBAYES VERSION 3 2; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ros RM, 2013, CRYPTOGAMIE BRYOL, V34, P99, DOI 10.7872/cryb.v34.iss2.2013.99; Sanmartin I, 2008, J BIOGEOGR, V35, P428, DOI 10.1111/j.1365-2699.2008.01885.x; Scheben A, 2016, J BIOGEOGR, V43, P1739, DOI 10.1111/jbi.12779; Shaw AJ, 2003, AM J BOT, V90, P540, DOI 10.3732/ajb.90.4.540; Shaw AJ, 2001, J BIOGEOGR, V28, P253; Sim-Sim M, 2017, SYST BIODIVERS, V15, P451, DOI 10.1080/14772000.2016.1271059; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; SouzaChies TT, 1997, PLANT SYST EVOL, V204, P109, DOI 10.1007/BF00982535; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stenoien HK, 2011, EVOLUTION, V65, P1181, DOI 10.1111/j.1558-5646.2010.01191.x; Szovenyi P, 2008, MOL ECOL, V17, P5364, DOI 10.1111/j.1365-294X.2008.04003.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; van Zanten B. O., 1988, NOVA HEDWIGIA S, V90, P41; Vanderpoorten A, 2007, AM J BOT, V94, P625, DOI 10.3732/ajb.94.4.625; Vanderpoorten A, 2009, INTRODUCTION TO BRYOPHYTES, P1, DOI 10.1017/CBO9780511626838; Vanderpoorten A., 2011, The biology of island floras, P338; Vanderpoorten A, 2008, J BIOGEOGR, V35, P654, DOI 10.1111/j.1365-2699.2007.01802.x; Vanderpoorten A, 2015, PHYTOTAXA, V210, P60, DOI 10.11646/phytotaxa.210.1.6; Vargas P, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv073; Vargas P, 2014, BOT J LINN SOC, V174, P349, DOI 10.1111/boj.12142; Vigalondo B, 2016, BOT J LINN SOC, V180, P30, DOI 10.1111/boj.12360; Villarreal JC, 2014, MOL PHYLOGENET EVOL, V78, P25, DOI 10.1016/j.ympev.2014.04.014; Vitt D. H., 1973, REVISION GENUS ORTHO; Werner O, 2003, SYST BOT, V28, P483; Wilkinson DM, 2012, J BIOGEOGR, V39, P89, DOI 10.1111/j.1365-2699.2011.02569.x; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085	97	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211017	10.1371/journal.pone.0211017	http://dx.doi.org/10.1371/journal.pone.0211017			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759110	Green Submitted, Green Published, gold			2022-12-26	WOS:000458761300025
J	Xu, Y; Gissberg, O; Pabon-Martinez, YV; Wengel, J; Lundin, KE; Smith, CIE; Zain, R; Nilsson, L; Villa, A				Xu, You; Gissberg, Olof; Pabon-Martinez, Y. Vladimir; Wengel, Jesper; Lundin, Karin E.; Smith, C. I. Edvard; Zain, Rula; Nilsson, Lennart; Villa, Alessandra			The ability of locked nucleic acid oligonucleotides to pre-structure the double helix: A molecular simulation and binding study	PLOS ONE			English	Article							BETA-D-LNA; FORCE-FIELD; DNA; DYNAMICS; DESIGN; RNA; THERMODYNAMICS; CHARMM	Locked nucleic acid (LNA) oligonucleotides bind DNA target sequences forming Watson-Crick and Hoogsteen base pairs, and are therefore of interest for medical applications. To be biologically active, such an oligonucleotide has to efficiently bind the target sequence. Here we used molecular dynamics simulations and electrophoresis mobility shift assays to elucidate the relation between helical structure and affinity for LNA-containing oligonucleotides. In particular, we have studied how LNA substitutions in the polypyrimidine strand of a duplex (thus forming a hetero duplex, i.e. a duplex with a DNA polypurine strand and an LNA/DNA polypyrimidine strand) enhance triplex formation. Based on seven polypyrimidine single strand oligonucleotides, having LNAs in different positions and quantities, we show that alternating LNA with one or more non-modified DNA nucleotides pre-organizes the hetero duplex toward a triple-helical-like conformation. This in turn promotes triplex formation, while consecutive LNAs distort the duplex structure disfavoring triplex formation. The results support the hypothesis that a pre-organization in the hetero duplex structure enhances the binding of triplex forming oligonucleotides. Our findings may serve as a criterion in the design of new tools for efficient oligonucleotide hybridization.	[Xu, You; Nilsson, Lennart; Villa, Alessandra] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Gissberg, Olof; Pabon-Martinez, Y. Vladimir; Lundin, Karin E.; Smith, C. I. Edvard; Zain, Rula] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Wengel, Jesper] Univ Southern Denmark, Dept Phys Chem & Pharm, Biomol Nanoscale Engn Ctr, Odense M, Denmark; [Zain, Rula] Karolinska Univ Hosp, Dept Clin Genet, Ctr Rare Dis, Stockholm, Sweden; [Xu, You] Westlake Univ, Sch Life Sci, Hangzhou, Zhejiang, Peoples R China; [Pabon-Martinez, Y. Vladimir] Univ Autonoma Bucaramanga, Bucaramanga, Colombia	Karolinska Institutet; Karolinska Institutet; University of Southern Denmark; Karolinska Institutet; Karolinska University Hospital; Westlake University	Villa, A (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	alessandra.villa@ki.se	Villa, Alessandra/A-1554-2010; Nilsson, Lennart/B-7208-2009	Villa, Alessandra/0000-0002-9573-0326; Nilsson, Lennart/0000-0002-5067-6397; Wengel, Jesper/0000-0001-9835-1009; Lundin, Karin/0000-0002-1489-3028; SMITH, C. I. Edvard/0000-0003-1907-3392	Swedish Research Council [2017-02131, 2015-04992]; Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) [02007/24122010]; Swelife Vinnova [180164]; Hjarnfonden; Neuroforbundet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Swelife Vinnova(Vinnova); Hjarnfonden; Neuroforbundet	L.N., A.V., and Y.X. were supported by Swedish Research Council (2015-04992) www.vr.se; Y. V. P. M was supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) (Ph.D. grant resolucion 02007/24122010); C. I. E. S. was supported by Swedish Research Council (2017-02131) www.vr.se; R. Z. was supported by Swelife Vinnova (180164) www.vinnova.se; and O.G. was supported by Hjarnfonden (n.a.) www.hjarnfonden.se and Neuroforbundet (n.a.) http://www.neuroforbundet.se/.All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chandrasekaran R, 2000, J BIOMOL STRUCT DYN, V17, P1011, DOI 10.1080/07391102.2000.10506589; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Escude C, 1998, P NATL ACAD SCI USA, V95, P3591, DOI 10.1073/pnas.95.7.3591; Esguerra M, 2014, NUCLEIC ACIDS RES, V42, P11329, DOI 10.1093/nar/gku848; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Friedrichs MS, 2009, J COMPUT CHEM, V30, P864, DOI 10.1002/jcc.21209; Hart K, 2012, J CHEM THEORY COMPUT, V8, P348, DOI 10.1021/ct200723y; Hartono YD, 2018, J CHEM INF MODEL, V58, P773, DOI 10.1021/acs.jcim.7b00741; Ivanova A, 2007, J PHYS CHEM A, V111, P9307, DOI 10.1021/jp073198j; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lundin KE, 2015, HUM GENE THER, V26, P475, DOI 10.1089/hum.2015.070; LUNDIN KE, 2013, ADV GENET, P47, DOI DOI 10.1016/B978-0-12-407676-1.00002-0; Obika S, 2001, BIOORGAN MED CHEM, V9, P1001, DOI 10.1016/S0968-0896(00)00325-4; Obika S, 1997, TETRAHEDRON LETT, V38, P8735, DOI 10.1016/S0040-4039(97)10322-7; Pabon-Martinez YV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09147-8; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Smith CIE, 2019, ANN REV PHARM TOXICO, V59, P25; Suresh G, 2014, J PHYS CHEM B, V118, P5853, DOI 10.1021/jp5014779; Suresh G, 2013, J PHYS CHEM B, V117, P5556, DOI 10.1021/jp4016068; Torigoe H, 2001, J BIOL CHEM, V276, P2354, DOI 10.1074/jbc.M007783200; Wengel J, 2003, LETT PEPT SCI, V10, P237, DOI 10.1007/BF02484561; Xu Y, 2016, J COMPUT CHEM, V37, P896, DOI 10.1002/jcc.24307; Yildirim I, 2014, J PHYS CHEM B, V118, P14177, DOI 10.1021/jp506703g; Zain R, 1999, CHEM BIOL, V6, P771, DOI 10.1016/S1074-5521(99)80124-0; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358	29	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211651	10.1371/journal.pone.0211651	http://dx.doi.org/10.1371/journal.pone.0211651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753192	Green Published, Green Submitted, gold			2022-12-26	WOS:000458395600016
J	Benomar, L; Moutaoufik, MT; Elferjani, R; Isabel, N; DesRochers, A; El Guellab, A; Khlifa, R; Hassania, LAI				Benomar, Lahcen; Moutaoufik, Mohamed Taha; Elferjani, Raed; Isabel, Nathalie; DesRochers, Annie; El Guellab, Ahmed; Khlifa, Rim; Idrissi Hassania, Lala Amina			Thermal acclimation of photosynthetic activity and RuBisCO content in two hybrid poplar clones	PLOS ONE			English	Article							TEMPERATURE RESPONSE; MESOPHYLL CONDUCTANCE; CO2 ASSIMILATION; LEAF NITROGEN; ELECTRON-TRANSPORT; BIOCHEMICAL-MODEL; PLANT RESPIRATION; ACTIVATION STATE; SPINACH LEAVES; TREE	The mechanistic bases of thermal acclimation of net photosynthetic rate (A(n)) are still difficult to discern, and the data sets available are scarce, particularly for hybrid poplar. In the present study, we examined the contribution of a number of biochemical and biophysical traits on thermal acclimation of A(n) for two hybrid poplar clones. We grew cuttings of Populus max-imowiczii x Populus nigra (MxN) and Populus maxi-mowiczii x Populus balsamifera (MxB) clones under two day/night temperature of 23 degrees C/18 degrees C and 33 degrees C/27 degrees C and under low and high soil nitrogen level. After ten weeks, we measured leaf RuBisCO (RAR) and RuBisCO activase (RARCA) amounts and the temperature response of A(n), dark respiration (R-d), stomatal conductance, (g(s)), apparent maximum carboxylation rate of CO2 (V-cmax) and apparent photosynthetic electron transport rate (J). Results showed that a 10 degrees C increase in growth temperature resulted in a shift in thermal optimum (T-opt) of An of 6.2 +/- 1.6 degrees C and 8.0 +/- 1.2 degrees C for clone MxB and MxN respectively, and an increased An and gs at the growth temperature for clone MxB but not MxN. RuBisCO amount was increased by N level but was insensitive to growth temperature while RARCA amount and the ratio of its short to long isoform was stimulated by the warm condition for clone MxN and at low N for clone MxB. The activation energy of apparent V-cmax and apparent J decreased under the warm condition for clone MxB and remained unchanged for clone MxN. Our study demonstrated the involvement of both RARCA, the activation energy of apparent V-cmax and stomatal conductance in thermal acclimation of A(n).	[Benomar, Lahcen; El Guellab, Ahmed] Univ Laval, Fac Foresterie Geog & Geomat, Quebec City, PQ, Canada; [Moutaoufik, Mohamed Taha] Univ Regina, Dept Biochem, Regina, SK, Canada; [Elferjani, Raed] Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada; [Isabel, Nathalie] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ, Canada; [DesRochers, Annie] Univ Quebec Abitibi Temiscamingue, Amos, PQ, Canada; [Khlifa, Rim] Univ Quebec Montreal, Dept Sci Biol, Montreal, PQ, Canada; [Idrissi Hassania, Lala Amina] Univ Ibn Zohr Agadir, Lab Biotechnol Vegetales, Fac Sci, Agadir, Morocco	Laval University; University of Regina; Agriculture & Agri Food Canada; Natural Resources Canada; Canadian Forest Service; University of Quebec; University Quebec Abitibi-Temiscamingue; University of Quebec; University of Quebec Montreal; Ibn Zohr University of Agadir	Benomar, L (corresponding author), Univ Laval, Fac Foresterie Geog & Geomat, Quebec City, PQ, Canada.	lahcen.benomar.1@gmail.com	Desrochers, Annie/B-8431-2015; Khlifa, Rim/AAC-6290-2019; Hassani, Lalla Mina Idrissi/AAT-5966-2021; benomar, lahcen/Q-3080-2019	Desrochers, Annie/0000-0002-4653-4062; Khlifa, Rim/0000-0003-3645-7558; Hassani, Lalla Mina Idrissi/0000-0001-9522-0695; Elferjani, Raed/0000-0003-0577-3769; benomar, lahcen/0000-0001-9301-5655; Moutaoufik, Mohamed Taha/0000-0002-2013-1601	Genomics RD Initiative; NSERC	Genomics RD Initiative; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by Genomics R&D Initiative (http://grdi-irdg.collaboration.gc.ca/eng/) grants to NI (Natural Resources Canada) and NSERC discovery Grant (http://www.nserc-crsng.gc.ca/ResearchPortal-PortailDeRecherche/Instructions-Instructions/DG-SD_eng.asp) to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspinwall MJ, 2017, TREE PHYSIOL, V37, P1095, DOI 10.1093/treephys/tpx047; Atkin OK, 2005, ADV PHOTO RESPIRAT, V18, P95; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Battaglia M, 1996, TREE PHYSIOL, V16, P81; Benomar L, 2018, ANN BOT-LONDON, V121, P443, DOI 10.1093/aob/mcx174; Bernacchi CJ, 2001, PLANT CELL ENVIRON, V24, P253, DOI 10.1111/j.1365-3040.2001.00668.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell C, 2007, NEW PHYTOL, V176, P375, DOI 10.1111/j.1469-8137.2007.02183.x; Cen YP, 2005, PLANT PHYSIOL, V139, P979, DOI 10.1104/pp.105.066233; Centritto M, 2011, TREE PHYSIOL, V31, P275, DOI 10.1093/treephys/tpq112; Crafts-Brandner SJ, 2000, P NATL ACAD SCI USA, V97, P13430, DOI 10.1073/pnas.230451497; Crous KY, 2018, GLOBAL CHANGE BIOL, V24, P4626, DOI 10.1111/gcb.14330; DesRochers A, 2003, CAN J FOREST RES, V33, P552, DOI [10.1139/x02-191, 10.1139/X02-191]; Dillaway DN, 2011, TREE PHYSIOL, V31, P1114, DOI 10.1093/treephys/tpr097; Dillaway DN, 2010, PLANT CELL ENVIRON, V33, P888, DOI 10.1111/j.1365-3040.2010.02114.x; Dubois JJB, 2007, NEW PHYTOL, V176, P402, DOI 10.1111/j.1469-8137.2007.02182.x; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FIELD C, 1983, OECOLOGIA, V56, P341, DOI 10.1007/BF00379710; Fisichelli NA, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00115.1; Flexas J, 2013, J EXP BOT, V64, P3965, DOI 10.1093/jxb/ert319; Gunderson CA, 2010, GLOBAL CHANGE BIOL, V16, P2272, DOI 10.1111/j.1365-2486.2009.02090.x; Hikosaka K, 2006, J EXP BOT, V57, P291, DOI 10.1093/jxb/erj049; Hikosaka K, 1999, PLANT CELL ENVIRON, V22, P841, DOI 10.1046/j.1365-3040.1999.00442.x; Hozain MI, 2010, TREE PHYSIOL, V30, P32, DOI 10.1093/treephys/tpp091; Kattge J, 2007, PLANT CELL ENVIRON, V30, P1176, DOI 10.1111/j.1365-3040.2007.01690.x; Kruse JR, 2017, TREES-STRUCT FUNCT, V31, P623, DOI 10.1007/s00468-016-1496-0; Kumarathunge DP, 2019, NEW PHYTOL, V222, P768, DOI 10.1111/nph.15668; Laitinen RAE, 2019, J EXP BOT, V70, P739, DOI 10.1093/jxb/ery404; Law RD, 2001, PLANTA, V214, P117, DOI 10.1007/s004250100592; Lloyd J, 2008, PHILOS T R SOC B, V363, P1811, DOI 10.1098/rstb.2007.0032; Medlyn BE, 2002, PLANT CELL ENVIRON, V25, P1167, DOI 10.1046/j.1365-3040.2002.00891.x; Miao ZW, 2009, PLANT CELL ENVIRON, V32, P109, DOI 10.1111/j.1365-3040.2008.01900.x; Ow LF, 2008, NEW PHYTOL, V178, P123, DOI 10.1111/j.1469-8137.2007.02357.x; Perdomo JA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00490; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Prins A, 2008, J EXP BOT, V59, P1935, DOI 10.1093/jxb/ern086; Qiu CP, 2017, PLANT CELL ENVIRON, V40, P1940, DOI 10.1111/pce.12997; Rasband WS, 2012, ASCL; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Reich PB, 2016, NATURE, V531, P633, DOI 10.1038/nature17142; Ristic Z, 2009, J EXP BOT, V60, P4003, DOI 10.1093/jxb/erp241; Sage RF, 2008, J EXP BOT, V59, P1581, DOI 10.1093/jxb/ern053; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Salvucci ME, 2004, PLANT PHYSIOL, V134, P1460, DOI 10.1104/pp.103.038323; Scafaro AP, 2017, GLOBAL CHANGE BIOL, V23, P2783, DOI 10.1111/gcb.13566; Silim SN, 2010, PHOTOSYNTH RES, V104, P19, DOI 10.1007/s11120-010-9527-y; Slot M, 2017, J EXP BOT, V68, P2275, DOI 10.1093/jxb/erx071; Theroux-Rancourt G, 2014, J EXP BOT, V65, P741, DOI 10.1093/jxb/ert436; Tjoelker MG, 1999, PLANT CELL ENVIRON, V22, P767, DOI 10.1046/j.1365-3040.1999.00435.x; Turnbull MH, 2002, PLANT CELL ENVIRON, V25, P1729, DOI 10.1046/j.1365-3040.2002.00947.x; von Caemmerer S, 2015, PLANT CELL ENVIRON, V38, P629, DOI 10.1111/pce.12449; Wang D, 2010, PHYSIOL PLANTARUM, V139, P55, DOI 10.1111/j.1399-3054.2009.01344.x; Warren CR, 2008, TREE PHYSIOL, V28, P11, DOI 10.1093/treephys/28.1.11; Way DA, 2014, PHOTOSYNTH RES, V119, P89, DOI 10.1007/s11120-013-9873-7; Weston DJ, 2007, AM J BOT, V94, P926, DOI 10.3732/ajb.94.6.926; Yamori W, 2008, PLANT CELL PHYSIOL, V49, P583, DOI 10.1093/pcp/pcn030; Yamori W, 2006, PLANT CELL ENVIRON, V29, P1659, DOI 10.1111/j.1365-3040.2006.01550.x; Yamori W, 2014, PHOTOSYNTH RES, V119, P101, DOI 10.1007/s11120-013-9874-6; Yamori W, 2011, PLANT CELL ENVIRON, V34, P764, DOI 10.1111/j.1365-3040.2011.02280.x; Yamori W, 2009, PLANT PHYSIOL, V151, P2073, DOI 10.1104/pp.109.146514; Yamori W, 2009, PLANT CELL PHYSIOL, V50, P203, DOI 10.1093/pcp/pcn189	62	11	12	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0206021	10.1371/journal.pone.0206021	http://dx.doi.org/10.1371/journal.pone.0206021			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742644	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000458393400002
J	Kim, H; Hong, I; Jung, WS				Kim, Hyunuk; Hong, Inho; Jung, Woo-Sung			Measuring national capability over big science's multidisciplinarity: A case study of nuclear fusion research	PLOS ONE			English	Article							RESEARCH COLLABORATION; RESEARCH INFRASTRUCTURES; PATTERNS; SYSTEMS; CHINA; INNOVATION; DYNAMICS; IMPACT	In the era of big science, countries allocate big research and development budgets to large scientific facilities that boost collaboration and research capability. A nuclear fusion device called the "tokamak" is a source of great interest for many countries because it ideally generates sustainable energy expected to solve the energy crisis in the future. Here, to explore the scientific effects of tokamaks, we map a country's research capability in nuclear fusion research with normalized revealed comparative advantage on five topical clusters-material, plasma, device, diagnostics, and simulation-detected through a dynamic topic model. Our approach captures not only the growth of China, India, and the Republic of Korea but also the decline of Canada, Japan, Sweden, and the Netherlands. Time points of their rise and fall are related to tokamak operation, highlighting the importance of large facilities in big science. The gravity model points out that two countries collaborate less in device, diagnostics, and plasma research if they have comparative advantages in different topics. This relation is a unique feature of nuclear fusion compared to other science fields. Our results can be used and extended when building national policies for big science.	[Kim, Hyunuk; Jung, Woo-Sung] Pohang Univ Sci & Technol, Dept Ind & Management Engn, Pohang, South Korea; [Kim, Hyunuk] Northwestern Univ, Kellogg Sch Management, Evanston, IL 60201 USA; [Kim, Hyunuk] Northwestern Inst Complex Syst, Evanston, IL USA; [Hong, Inho; Jung, Woo-Sung] Pohang Univ Sci & Technol, Dept Phys, Pohang, South Korea; [Jung, Woo-Sung] Asia Pacific Ctr Theoret Phys, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Northwestern University; Pohang University of Science & Technology (POSTECH); Asia Pacific Center for Theoretical Physics	Jung, WS (corresponding author), Pohang Univ Sci & Technol, Dept Ind & Management Engn, Pohang, South Korea.; Jung, WS (corresponding author), Pohang Univ Sci & Technol, Dept Phys, Pohang, South Korea.; Jung, WS (corresponding author), Asia Pacific Ctr Theoret Phys, Pohang, South Korea.	wsjung@postech.ac.kr	Jung, Woo-Sung/B-1251-2008; Hong, Inho/ABI-6931-2020	Jung, Woo-Sung/0000-0001-9590-3859; Hong, Inho/0000-0002-8069-6110; Kim, Hyunuk/0000-0002-4863-4729	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1B03932590]; NRF (National Research Foundation of Korea) - Korean Government [NRF-2017H1A2A1044205]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; NRF (National Research Foundation of Korea) - Korean Government	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1B03932590). H.K. acknowledges NRF (National Research Foundation of Korea) Grant funded by the Korean Government (NRF-2017H1A2A1044205-Global Ph.D. Fellowship Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta M, 2011, SCIENTOMETRICS, V87, P63, DOI 10.1007/s11192-010-0305-6; [Anonymous], 2011, SCI DIPLOMACY ANTARC; Autio E, 2004, RES POLICY, V33, P107, DOI 10.1016/S0048-7333(03)00105-7; Aymar R, 2002, PLASMA PHYS CONTR F, V44, P519, DOI 10.1088/0741-3335/44/5/304; BALASSA B, 1965, MANCH SCH ECON SOC, V33, P99, DOI 10.1111/j.1467-9957.1965.tb00050.x; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blei DM, 2006, INT C MACH LEARN ICM, V148, P113, DOI [10.1145/1143844.1143859, DOI 10.1145/1143844.1143859]; Borner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039464; Braams C. M., 2002, NUCL FUSION HALF CEN; Brumfiel G, 2003, NATURE, V425, P887, DOI 10.1038/425887b; CAPSHEW JH, 1992, OSIRIS, V7, P3, DOI 10.1086/368703; Castelnovo P, 2018, RES POLICY, V47, P1853, DOI 10.1016/j.respol.2018.06.018; Chen FF, 2011, INDISPENSABLE TRUTH: HOW FUSION POWER CAN SAVE THE PLANET, P1, DOI 10.1007/978-1-4419-7820-2; Chen G, 2015, SCIENTOMETRICS, V103, P707, DOI 10.1007/s11192-015-1545-2; Choi W, 2017, FUSION ENG DES, V124, P1263, DOI 10.1016/j.fusengdes.2017.02.063; CHUBIN DE, 1987, KNOWLEDGE, V9, P254, DOI 10.1177/0164025987009002006; Clery D, 2013, A PIECE OF THE SUN; Eddington A.S., 1926, INTERNAL CONSTITUTIO; Endres D. M., 2003, IEEE T INFORM THEORY; Etzkowitz H, 2000, RES POLICY, V29, P109, DOI 10.1016/S0048-7333(99)00055-4; Feller I, 1997, ECON DEV Q, V11, P283, DOI 10.1177/089124249701100401; FOGG G. E, 1992, HIST ANTARCTIC SCI; Fortin JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065263; FREEMAN C, 1995, CAMBRIDGE J ECON, V19, P5; Gerow A, 2018, P NATL ACAD SCI USA, V115, P3308, DOI 10.1073/pnas.1719792115; Gerrish S.M., 2010, P 27 INT C MACH LEAR, P375; Grandoni D, 2015, HUFFINGTON POST; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Guevara MR, 2016, SCIENTOMETRICS, V109, P1695, DOI 10.1007/s11192-016-2125-9; Hallonsten O, 2016, RES EVALUAT, V25, P486, DOI 10.1093/reseval/rvw019; Hallonsten O, 2013, SCIENTOMETRICS, V96, P497, DOI 10.1007/s11192-012-0945-9; Hameri A. -P., 1997, J TECHNOLOGY TRANSFE, V22, P27, DOI DOI 10.1007/BF02509160; Heidler R, 2015, SCIENTOMETRICS, V104, P295, DOI 10.1007/s11192-015-1577-7; Heinze T, 2008, RES POLICY, V37, P888, DOI 10.1016/j.respol.2008.01.009; Hoekman J, 2010, RES POLICY, V39, P662, DOI 10.1016/j.respol.2010.01.012; Horlings E, 2012, SOC FOOTPRINT BIG SC; Ikeda K, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/1/014002; Kikuchi M, 2010, ENERGIES, V3, P1741, DOI 10.3390/en3111741; Kim H, 2016, IND ENG MANAG SYST, V15, P92, DOI 10.7232/iems.2016.15.1.092; Laredo P., 2001, RES INNOVATION POLIC; LAWSON JD, 1957, P PHYS SOC LOND B, V70, P6, DOI 10.1088/0370-1301/70/1/303; Li N, 2017, SCIENTOMETRICS, V111, P493, DOI 10.1007/s11192-017-2259-4; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Oh W, 2005, J MANAGE INFORM SYST, V22, P265, DOI 10.2753/MIS0742-1222220309; Park HW, 2016, SCIENTOMETRICS, V109, P1017, DOI 10.1007/s11192-016-1978-2; Perianes-Rodriguez A, 2016, J INFORMETR, V10, P1178, DOI 10.1016/j.joi.2016.10.006; Pond R, 2007, PAP REG SCI, V86, P423, DOI 10.1111/j.1435-5957.2007.00126.x; Qiao LL, 2016, TECHNOL FORECAST SOC, V112, P102, DOI 10.1016/j.techfore.2016.07.029; REBUT PH, 1985, NUCL FUSION, V25, P1011, DOI 10.1088/0029-5515/25/9/003; Resnik DB, 2006, EPISTEME-J INDIV SOC, V2, P135, DOI 10.3366/epi.2005.2.3.135; Robinson, 2008, SOCIAL GEOGRAPHY, V3, P23, DOI [DOI 10.5194/SG-3-23-2008, 10.5194/sg-3-23-2008]; Sinha A, 2015, WWW'15 COMPANION: PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P243, DOI 10.1145/2740908.2742839; Smirnov VP, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/1/014003; Sonnenwald DH, 2007, ANNU REV INFORM SCI, V41, P643, DOI 10.1002/aris.2007.1440410121; Wang Q, 2016, J INFORMETR, V10, P347, DOI 10.1016/j.joi.2016.02.003; WEINBERG AM, 1961, SCIENCE, V134, P161, DOI 10.1126/science.134.3473.161; Wesson J., 2011, TOKAMAKS, V149; Wiedemann H., 2015, PARTICLE ACCELERATOR, DOI 10.1007/978-3-319-18317-6; Wylie R, 2006, DEFENCE PEACE ECON, V17, P257, DOI 10.1080/10242690600645233; Xin H, 2006, SCIENCE, V311, P1548, DOI 10.1126/science.311.5767.1548; Yu R, 2009, ANN REGIONAL SCI, V43, P267, DOI 10.1007/s00168-008-0213-3; Zhang C, 2017, SCIENTOMETRICS, V113, P1129, DOI 10.1007/s11192-017-2513-9	62	1	1	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211963	10.1371/journal.pone.0211963	http://dx.doi.org/10.1371/journal.pone.0211963			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK7PK	30735548	gold, Green Published, Green Submitted			2022-12-26	WOS:000458181200051
J	Aguilera-Montilla, N; Bailon, E; Uceda-Castro, R; Ugarte-Berzal, E; Santos, A; Gutierrez-Gonzalez, A; Perez-Sanchez, C; Van den Steen, PE; Opdenakker, G; Garcia-Marco, JA; Garcia-Pardo, A				Aguilera-Montilla, Noemi; Bailon, Elvira; Uceda-Castro, Rebeca; Ugarte-Berzal, Estefania; Santos, Andrea; Gutierrez-Gonzalez, Alejandra; Perez-Sanchez, Cristina; Van den Steen, Philippe E.; Opdenakker, Ghislain; Garcia-Marco, Jose A.; Garcia-Pardo, Angeles			MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest	ONCOGENE			English	Article							ALPHA-4-BETA-1 INTEGRIN; GELATINASE-B; MATRIX-METALLOPROTEINASE-9; SP1; PATHOGENESIS; INHIBITION; HEMOPEXIN; INVASION; PATHWAYS; SURVIVAL	We previously showed that MMP-9 contributes to CLL pathology by regulating cell survival and migration and that, when present at high levels, MMP-9 induces cell arrest. To further explore the latter function, we studied whether MMP-9 influences the gene-expression profile in CLL. Microarray analyses rendered 131 differentially expressed genes in MEC-1 cells stably transfected with MMP-9 (MMP-9-cells) versus cells transfected with empty vector (Mock-cells). Ten out of twelve selected genes were also differentially expressed in MEC-1 cells expressing the catalytically inactive MMP-9MutE mutant (MMP-9MutE-cells). Incubation of primary CLL cells with MMP-9 or MMP-9MutE also regulated gene and protein expression, including CD99, CD226, CD52, and CD274. Because CD99 is involved in leukocyte transendothelial migration, we selected CD99 for functional and mechanistic studies. The link between MMP-9 and CD99 was reinforced with MMP-9 gene silencing studies, which resulted in CD99 upregulation. CD99 gene silencing significantly reduced CLL cell adhesion, chemotaxis and transendothelial migration, while CD99 overexpression increased cell migration. Mechanistic analyses indicated that MMP-9 downregulated CD99 via binding to alpha 4 beta 1 integrin and subsequent inactivation of the Sp1 transcription factor. This MMP-9-induced mechanism is active in CLL lymphoid tissues, since CD99 expression and Sp1 phosphorylation was lower in bone marrow-derived CLL cells than in their peripheral blood counterparts. Our study establishes a new gene regulatory function for MMP-9 in CLL. It also identifies CD99 as an MMP-9 target and a novel contributor to CLL cell adhesion, migration and arrest. CD99 thus constitutes a new therapeutic target in CLL, complementary to MMP-9.	[Aguilera-Montilla, Noemi; Bailon, Elvira; Uceda-Castro, Rebeca; Santos, Andrea; Gutierrez-Gonzalez, Alejandra; Perez-Sanchez, Cristina; Garcia-Pardo, Angeles] CSIC, Ctr Invest Biol, Dept Mol Biomed, Madrid, Spain; [Ugarte-Berzal, Estefania; Van den Steen, Philippe E.; Opdenakker, Ghislain] Univ Leuven, KU Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Leuven, Belgium; [Garcia-Marco, Jose A.] Hosp Univ Puerta Hierro, Dept Hematol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); KU Leuven; Hospital Puerta de Hierro-Majadahonda	Garcia-Pardo, A (corresponding author), CSIC, Ctr Invest Biol, Dept Mol Biomed, Madrid, Spain.	agarciapardo@cib.csic.es	Gutiérrez, Alejandra/ABH-7404-2020; Opdenakker, Ghislain/V-8562-2019; Opdenakker, Ghislain/Q-3130-2017; Van den Steen, Philippe E/K-5132-2012	Gutiérrez, Alejandra/0000-0002-2858-2730; Opdenakker, Ghislain/0000-0003-1714-2294; Opdenakker, Ghislain/0000-0003-1714-2294; Van den Steen, Philippe E/0000-0002-7334-9145	Red Tematica de Investigacion Cooperativa en Cancer Grant from the Ministry of Economy and Competitivity (Spain) [RD12/0036/0061]; Comunidad de Madrid/European Union [S2010/BMD-2314]; Concerted Research Actions (KU Leuven C1 Grant) [C16/17/010]; Research Foundation of Flanders (FWO-Vlaanderen); Ministry of Economy and Competitivity (Spain) [SAF2015-69180R]	Red Tematica de Investigacion Cooperativa en Cancer Grant from the Ministry of Economy and Competitivity (Spain); Comunidad de Madrid/European Union; Concerted Research Actions (KU Leuven C1 Grant); Research Foundation of Flanders (FWO-Vlaanderen)(FWO); Ministry of Economy and Competitivity (Spain)	This work was supported by Grant SAF2015-69180R and Red Tematica de Investigacion Cooperativa en Cancer Grant RD12/0036/0061 from the Ministry of Economy and Competitivity (Spain) (to AGP); S2010/BMD-2314 (to AGP) from the Comunidad de Madrid/European Union; and by the Concerted Research Actions (KU Leuven C1 Grant C16/17/010) and the Research Foundation of Flanders (FWO-Vlaanderen, to EUB, PEVdS, and GO).	Alberti I, 2002, FASEB J, V16, P1946, DOI 10.1096/fj.02-0049fje; Amigo-Jimenez I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099993; Bailon E, 2018, BIOCHEM BIOPH RES CO, V495, P124, DOI 10.1016/j.bbrc.2017.10.129; Bailon E, 2014, J LEUKOCYTE BIOL, V96, P185, DOI 10.1189/jlb.3HI0913-521R; Bauvois B, 2002, LEUKEMIA, V16, P791, DOI 10.1038/sj.leu.2402472; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Bernard G, 2000, EUR J IMMUNOL, V30, P3061, DOI 10.1002/1521-4141(200010)30:10<3061::AID-IMMU3061>3.0.CO;2-M; Brachtl G, 2014, ANN HEMATOL, V93, P361, DOI 10.1007/s00277-013-1967-y; Coustan-Smith E, 2011, BLOOD, V117, P6267, DOI 10.1182/blood-2010-12-324004; Creighton Chad, 2003, In Silico Biology, V3, P301; Dal Bo M, 2016, LEUKEMIA, V30, P2011, DOI 10.1038/leu.2016.88; Davids MS, 2012, OPEN J HEMATOL, V3, pi, DOI DOI 10.13055/OJHMT_3_S1_03; Forconi F, 2015, BLOOD, V126, P573, DOI 10.1182/blood-2015-03-567388; Ganghammer S, 2016, HAEMATOLOGICA, V101, pE99, DOI 10.3324/haematol.2015.133470; Garc~ia-Pardo A, 2015, METALLOPROTEINASES M, V2015, P19, DOI DOI 10.2147/MNM.S63629; Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012; Goswami D, 2017, BLOOD, V129, P1811, DOI 10.1182/blood-2016-08-733394; Hahn JH, 1997, J IMMUNOL, V159, P2250; Hallek M, 2017, AM J HEMATOL, V92, P946, DOI 10.1002/ajh.24826; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Imbert AM, 2006, BLOOD, V108, P2578, DOI 10.1182/blood-2005-12-010827; Kamiguti AS, 2004, BRIT J HAEMATOL, V125, P128, DOI 10.1111/j.1365-2141.2004.04877.x; Lee IS, 2001, BLOOD, V97, P3596, DOI 10.1182/blood.V97.11.3596; Lee JH, 2007, CLIN CANCER RES, V13, P2584, DOI 10.1158/1078-0432.CCR-06-1785; Manara MC, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030159; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; McClanahan F, 2015, BLOOD, V126, P203, DOI 10.1182/blood-2015-01-622936; Mittal AK, 2014, MOL MED, V20, P290, DOI 10.2119/molmed.2012.00303; Muller WA, 2016, IMMUNOL REV, V273, P61, DOI 10.1111/imr.12443; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Parry HM, 2016, ONCOTARGET, V7, P68513, DOI 10.18632/oncotarget.12097; Pasello M, 2018, J CELL COMMUN SIGNAL, V12, P55, DOI 10.1007/s12079-017-0445-z; Pettitt AR, 2012, J CLIN ONCOL, V30, P1647, DOI 10.1200/JCO.2011.35.9695; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Redondo-Munoz J, 2008, BLOOD, V111, P383, DOI 10.1182/blood-2007-08-107300; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Scotlandi K, 2007, ONCOGENE, V26, P6604, DOI 10.1038/sj.onc.1210481; Seol Ho Jun, 2012, Genes Cancer, V3, P535, DOI 10.1177/1947601912473603; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; ten Hacken E, 2016, BBA-MOL CELL RES, V1863, P401, DOI 10.1016/j.bbamcr.2015.07.009; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764; Zucchini C, 2014, ONCOGENE, V33, P1912, DOI 10.1038/onc.2013.152	49	6	6	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2019	38	23					4605	4619		10.1038/s41388-019-0744-3	http://dx.doi.org/10.1038/s41388-019-0744-3			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB4KM	30760844	Green Submitted			2022-12-26	WOS:000470240300012
J	Tedja, R; Roberts, CM; Alvero, AB; Cardenas, C; Yang-Hartwich, Y; Spadinger, S; Pitruzzello, M; Yin, G; Glackin, CA; Mor, G				Tedja, Roslyn; Roberts, Cai M.; Alvero, Ayesha B.; Cardenas, Carlos; Yang-Hartwich, Yang; Spadinger, Sydney; Pitruzzello, Mary; Yin, Gang; Glackin, Carlotta A.; Mor, Gil			Protein kinase C alpha-mediated phosphorylation of Twist1 at Ser-144 prevents Twist1 ubiquitination and stabilizes it	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; ovarian cancer; ubiquitylation (ubiquitination); epithelial-mesenchymal transition (EMT); post-transcriptional regulation; embryonic development; NetphosK3; 1; PKCalpha; Twist1	NF-KAPPA-B; TRANSCRIPTION FACTOR; PKC-ALPHA; BREAST; EXPRESSION; DEGRADATION; ACTIVATION; MUTATIONS; BETA; DIFFERENTIATION	Twist1 is a basic helix-loop-helix transcription factor that plays a key role in embryonic development, and its expression is down-regulated in adult cells. However, Twist1 is highly expressed during cancer development, conferring a proliferative, migratory, and invasive phenotype to malignant cells. Twist1 expression can be regulated post-translationally by phosphorylation or ubiquitination events. We report in this study a previously unknown and relevant Twist1 phosphorylation site that controls its stability. To identify candidate phosphorylation sites in Twist1, we first conducted an in silico analysis of the Twist1 protein, which yielded several potential sites. Because most of these sites were predicted to be phosphorylated by protein kinase C (PKC), we overexpressed PKC alpha in several cell lines and found that it phosphorylates Twist1 on Ser-144. Using a combination of immunoblotting, immunoprecipitation, protein overexpression, and CRISPR/Cas9-mediated PKC alpha knockout experiments, we observed that PKC alpha-mediated Twist1 phosphorylation at Ser-144 inhibits Twist1 ubiquitination and consequently stabilizes it. These results provide evidence for a direct association between PKC alpha and Twist1 and yield critical insights into the PKC alpha/Twist1 signaling axis that governs cancer aggressiveness.	[Tedja, Roslyn; Roberts, Cai M.; Alvero, Ayesha B.; Cardenas, Carlos; Yang-Hartwich, Yang; Spadinger, Sydney; Pitruzzello, Mary; Mor, Gil] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06511 USA; [Yin, Gang] Cent S Univ, Xiangya Hosp, Sch Basic Med Sci, Dept Pathol, Changsha 410083, Hunan, Peoples R China; [Glackin, Carlotta A.] City Hope Natl Med Ctr, Dept Stem Cell & Dev Biol, Duarte, CA 91010 USA	Yale University; Central South University; City of Hope	Mor, G (corresponding author), Yale Univ, 333 Cedar St,LSOG312, New Haven, CT 06511 USA.	gil.mor@yale.edu		Alvero, Ayesha/0000-0002-6593-3595	NCI, National Institutes of Health [RO1CA199004]; Sands Family Foundation; Discovery to Cure Program; Debra Levine Endowment; NATIONAL CANCER INSTITUTE [R01CA199004] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sands Family Foundation; Discovery to Cure Program; Debra Levine Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI, National Institutes of Health Grant RO1CA199004 (to G. M., A. B. A., and R. T.) and funds from the Sands Family Foundation (to G. M. and A. B. A.), the Discovery to Cure Program (to G. M.), and the Debra Levine Endowment (to G. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abera MB, 2015, MOL PHARMACOL, V87, P832, DOI 10.1124/mol.115.097725; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Asanoma K, 2015, MOL CELL BIOL, V35, P4096, DOI 10.1128/MCB.00678-15; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chen Y, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-104; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Chow JYC, 2008, AM J PHYSIOL-GASTR L, V294, pG899, DOI 10.1152/ajpgi.00411.2007; Craveiro V, 2013, CANCER MED-US, V2, P751, DOI 10.1002/cam4.115; Croset M, 2014, J BONE MINER RES, V29, P1886, DOI 10.1002/jbmr.2215; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; El Ghouzzi V, 2000, HUM MOL GENET, V9, P813, DOI 10.1093/hmg/9.5.813; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Gajula RP, 2015, NEOPLASIA, V17, P16, DOI 10.1016/j.neo.2014.10.009; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Gitelman I, 1997, DEV BIOL, V189, P205, DOI 10.1006/dbio.1997.8614; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Howe LR, 2003, CANCER RES, V63, P1906; Johnson D, 1998, AM J HUM GENET, V63, P1282, DOI 10.1086/302122; Kamsteeg M, 2003, ONCOGENE, V22, P2611, DOI 10.1038/sj.onc.1206422; Kasinathan NK, 2018, J FUNCT FOODS, V41, P240, DOI 10.1016/j.jff.2017.12.048; Lahn M, 2004, ONCOLOGY-BASEL, V67, P1, DOI 10.1159/000080279; Lee MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029758; Lin YW, 2017, ONCOTARGET, V8, P75127, DOI 10.18632/oncotarget.20561; Maia AM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-184; Mandil R, 2001, CANCER RES, V61, P4612; Matsuo N, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-240; Nuti SV, 2014, ONCOTARGET, V5, P7260, DOI 10.18632/oncotarget.2428; O'Rourke MP, 2002, INT J DEV BIOL, V46, P401; Rose CSP, 1997, TRENDS GENET, V13, P384, DOI 10.1016/S0168-9525(97)01296-1; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shiota M, 2017, ENDOCR-RELAT CANCER, V24, P171, DOI 10.1530/ERC-16-0384; Shiota M, 2014, CLIN CANCER RES, V20, P951, DOI 10.1158/1078-0432.CCR-13-1809; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Sun XG, 1999, CELL GROWTH DIFFER, V10, P343; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Vichalkovski A, 2010, ONCOGENE, V29, P3554, DOI 10.1038/onc.2010.115; Wang N, 2015, ONCOTARGET, V6, P20977, DOI 10.18632/oncotarget.4007; WAYS DK, 1995, J CLIN INVEST, V95, P1906, DOI 10.1172/JCI117872; Xu Y, 2017, ONCOGENE, V36, P1157, DOI 10.1038/onc.2016.286; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yin G, 2013, ONCOGENE, V32, P39, DOI 10.1038/onc.2012.33; Zhong JT, 2013, DISCOV MED, V15, P7	47	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5082	5093		10.1074/jbc.RA118.005921	http://dx.doi.org/10.1074/jbc.RA118.005921			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30733340	Green Published, hybrid			2022-12-26	WOS:000463985600030
J	Holz, GG; Chepurny, OG; Leech, CA				Holz, George G.; Chepurny, Oleg G.; Leech, Colin A.			"A-kinase" regulator runs amok to provide a paradigm shift in cAMP signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The activity of the archetypal protein kinase A (PKA) is typically thought of in regards to the catalytic subunit, which is inhibited by the regulatory subunits in the absence of cAMP. However, it is now reported that one of the regulatory subunit isoforms (PKA-RI alpha) takes on a function of its own upon binding to cAMP, acting independently of this canonical cAMP signaling mechanism. PKA-RI alpha instead binds to and stimulates the catalytic activity of a guanine nucleotide exchange factor (P-REX1) that itself promotes Rac1 GTPase activation. This newly discovered function of PKA-RI alpha adds an additional layer of complexity to our understanding of cAMP signal transduction.	[Holz, George G.; Chepurny, Oleg G.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Holz, George G.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Leech, Colin A.] SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Holz, GG (corresponding author), SUNY Upstate Med Univ, IHP 4310 505 Irving Ave, Syracuse, NY 13210 USA.	holzg@upstate.edu	Holz, George G/A-3386-2012	Holz, George/0000-0002-1781-3580	National Institutes of Health [R01-DK069575]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01-DK069575 (to G. G. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chavez-Vargas L, 2016, J BIOL CHEM, V291, P6182, DOI 10.1074/jbc.M115.712216; Adame-Garcia SR, 2019, J BIOL CHEM, V294, P2232, DOI 10.1074/jbc.RA118.006691; Welch Heidi C E, 2015, Small GTPases, V6, P49, DOI 10.4161/21541248.2014.973770	3	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2247	2248		10.1074/jbc.H119.007622	http://dx.doi.org/10.1074/jbc.H119.007622			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30765510	Green Published, hybrid			2022-12-26	WOS:000458895400003
J	Ring, SC; Purfield, DC; Good, M; Breslin, P; Ryan, E; Blom, A; Evans, RD; Doherty, ML; Bradley, DG; Berry, DP				Ring, S. C.; Purfield, D. C.; Good, M.; Breslin, P.; Ryan, E.; Blom, A.; Evans, R. D.; Doherty, M. L.; Bradley, D. G.; Berry, D. P.			Variance components for bovine tuberculosis infection and multi-breed genome-wide association analysis using imputed whole genome sequence data	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; CATTLE; DAIRY; SUSCEPTIBILITY; GENETICS; TRAITS; RESISTANCE; PARATUBERCULOSIS; HAPLOTYPE; BADGERS	Bovine tuberculosis (bTB) is an infectious disease of cattle generally caused by Mycobacterium bovis, a bacterium that can elicit disease humans. Since the 1950s, the objective of the national bTB eradication program in Republic of Ireland was the biological extinction of bTB; that purpose has yet to be achieved. Objectives of the present study were to develop the statistical methodology and variance components to undertake routine genetic evaluations for resistance to bTB; also of interest was the detection of regions of the bovine genome putatively associated with bTB infection in dairy and beef breeds. The novelty of the present study, in terms of research on bTB infection, was the use of beef breeds in the genome-wide association and the utilization of imputed whole genome sequence data. Phenotypic bTB data on 781,270 animals together with imputed whole genome sequence data on 7,346 of these animals' sires were available. Linear mixed models were used to quantify variance components for bTB and EBVs were validated. Within-breed and multi-breed genome-wide associations were undertaken using a single-SNP regression approach. The estimated genetic standard deviation (0.09), heritability (0.12), and repeatability (0.30) substantiate that genetic selection help to eradicate bTB. The multi-breed genome-wide association analysis identified 38 SNPs and 64 QTL regions associated with bTB infection; two QTL regions (both on BTA23) identified in the multi-breed analysis overlapped with the within-breed analyses of Charolais, Limousin, and Holstein-Friesian. Results from the association analysis, coupled with previous studies, suggest bTB is controlled by an infinitely large number of loci, each having a small effect. The methodology and results from the present study will be used to develop national genetic evaluations for bTB in the Republic of Ireland. In addition, results can also be used to help uncover the biological architecture underlying resistance to bTB infection in cattle.	[Ring, S. C.; Purfield, D. C.; Berry, D. P.] TEAGASC, Anim & Grassland Res & Innovat Ctr, Moorepk, Fermoy, Cork, Ireland; [Ring, S. C.; Doherty, M. L.] Univ Coll Dublin, Sch Vet Med, Dublin 4, Ireland; [Good, M.; Breslin, P.; Ryan, E.] Dept Agr Food & Marine, Dublin 2, Ireland; [Blom, A.; Evans, R. D.] Irish Cattle Breeding Federat, Highfield House, Bandon, Cork, Ireland; [Bradley, D. G.] Univ Dublin, Smurfit Inst Genet, Trinity Coll, Dublin, Ireland	Teagasc; University College Dublin; Trinity College Dublin	Berry, DP (corresponding author), TEAGASC, Anim & Grassland Res & Innovat Ctr, Moorepk, Fermoy, Cork, Ireland.	donagh.berry@teagasc.ie	Berry, Donagh/J-7616-2012	Berry, Donagh/0000-0003-4349-1447; Good, Margaret/0000-0002-4720-2940; Purfield, Deirdre/0000-0001-5343-9226; Ring, Siobhan/0000-0001-7495-4286	Irish Department of Agriculture, Food and the Marine STIMULUS research grant HealthyGenes; Science Foundation Ireland [14/IA/2576, 16/RC/3835]; Department of Agriculture Food and the Marine; Department of Agriculture, Food and Marine on behalf of the Government of Ireland [16/RC/3835]; Science Foundation Ireland	Irish Department of Agriculture, Food and the Marine STIMULUS research grant HealthyGenes; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Department of Agriculture Food and the Marine; Department of Agriculture, Food and Marine on behalf of the Government of Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	Funding from the Irish Department of Agriculture, Food and the Marine STIMULUS research grant HealthyGenes is greatly appreciated as is the funding from the Science Foundation Ireland principal investigator award grant (14/IA/2576) and Department of Agriculture Food and the Marine and Science Foundation Ireland grant 16/RC/3835 (VistaMilk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This publication has emanated from research supported in part by a research grant from Science Foundation Ireland and the Department of Agriculture, Food and Marine on behalf of the Government of Ireland under the Grant 16/RC/3835 (VistaMilk) as well as funding from the Irish Department of Agriculture, Food and the Marine STIMULUS research grant HealthyGenes and funding from the Science Foundation Ireland principal investigator award grant (14/IA/2576). We gratefully acknowledge the 1000 Bull Genomes Consortium for providing accessibility to whole-genome sequence data which was used in this study.	Alpay F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111704; Banos G, 2017, J DAIRY SCI, V100, P1272, DOI 10.3168/jds.2016-11897; Barthel R, 2000, AM J VET RES, V61, P1140, DOI 10.2460/ajvr.2000.61.1140; Beissinger TM, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0105-9; Bermingham ML, 2014, HEREDITY, V112, P543, DOI 10.1038/hdy.2013.137; Bermingham ML, 2010, J DAIRY SCI, V93, P5413, DOI 10.3168/jds.2009-2925; Bermingham ML, 2009, J DAIRY SCI, V92, P3447, DOI 10.3168/jds.2008-1848; Berry DP, 2014, ANIMAL, V8, P105, DOI 10.1017/S1751731114000743; Berry DP, 2013, IRISH J AGR FOOD RES, V52, P1; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Brotherstone S, 2010, J DAIRY SCI, V93, P1234, DOI 10.3168/jds.2009-2609; Burdon RD, 2008, SILVAE GENET, V57, P179, DOI 10.1515/sg-2008-0027; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; DAFM, 2018, IR BOV TB ER PROGR 2; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Gilmour AR, 2009, ASREML USER GUIDE RE; Good M., 2006, IRISH VET J, V59, P3; Kadarmideen HN, 2011, ANIM GENET, V42, P656, DOI 10.1111/j.1365-2052.2011.02203.x; Karin Meyer, 2007, Journal of Zhejiang University-Science B, V8, P815, DOI 10.1631/jzus.2007.B0815; Kirkpatrick BW, 2011, ANIM GENET, V42, P149, DOI 10.1111/j.1365-2052.2010.02097.x; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; M?ntysaari E.A., 2010, INTERBULL B, V42, P21; Medina E, 1998, IMMUNOLOGY, V93, P270, DOI 10.1046/j.1365-2567.1998.00419.x; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Meyer K, 2012, GENETICS, V190, P275, DOI 10.1534/genetics.111.134841; Mullen EM, 2013, APPL ANIM BEHAV SCI, V144, P130, DOI 10.1016/j.applanim.2013.01.013; Mullen EM, 2015, APPL ANIM BEHAV SCI, V171, P170, DOI 10.1016/j.applanim.2015.08.021; Murphy D, 2010, RES VET SCI, V88, P1, DOI 10.1016/j.rvsc.2009.05.020; O Mairtin D, 1998, PREV VET MED, V34, P47, DOI 10.1016/S0167-5877(97)00067-6; O'Mahony DT, 2015, VET J, V203, P126, DOI 10.1016/j.tvjl.2014.10.011; O'Mahony DT, 2014, VET J, V202, P628, DOI 10.1016/j.tvjl.2014.10.016; Philipsson J, 2003, LIVEST PROD SCI, V83, P99, DOI 10.1016/S0301-6226(03)00047-2; Phillips Clive J. C., 2002, Animal Health Research Reviews, V3, P3, DOI 10.1079/AHRR200236; Raphaka K, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0493-7; Richardson IW, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0197-x; Richardson IW, 2014, GENET SEL EVOL, V46, DOI 10.1186/s12711-014-0077-1; Ring SC, 2018, J DAIRY SCI, V101, P6190, DOI 10.3168/jds.2018-14481; Sallam AM, 2017, J DAIRY RES, V84, P61, DOI 10.1017/S0022029916000807; Sargolzaei M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-478; Smith LA, 2009, BEHAV ECOL, V20, P426, DOI 10.1093/beheco/arn143; Stranden I, 1999, J DAIRY SCI, V82, P2779, DOI 10.3168/jds.S0022-0302(99)75535-9; Trimble WS, 2007, CELL, V130, P12, DOI 10.1016/j.cell.2007.06.039; Tsairidou S, 2018, ANIM GENET, V49, P103, DOI 10.1111/age.12637; van den Berg I, 2016, J DAIRY SCI, V99, P8932, DOI 10.3168/jds.2016-11073; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2003, J DAIRY SCI, V86, P1036, DOI 10.3168/jds.S0022-0302(03)73687-X; Woolhouse MEJ, 2005, BIOL LETTERS, V1, P350, DOI 10.1098/rsbl.2005.0331; Zare Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088380	53	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212067	10.1371/journal.pone.0212067	http://dx.doi.org/10.1371/journal.pone.0212067			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763354	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900037
J	Sufyan, M; Abd Rahim, N; Tan, C; Muhammad, MA; Raihan, SRS				Sufyan, Muhammad; Abd Rahim, Nasrudin; Tan, ChiaKwang; Muhammad, Munir Azam; Raihan, Siti Rohani Sheikh			Optimal sizing and energy scheduling of isolated microgrid considering the battery lifetime degradation	PLOS ONE			English	Article							STORAGE SYSTEM; OPTIMIZATION; ELECTRICITY; GENERATION; MANAGEMENT; OPERATION; WIND; COST; CUSTOMERS; ALGORITHM	The incessantly growing demand for electricity in today's world claims an efficient and reliable system of energy supply. Distributed energy resources such as diesel generators, wind energy and solar energy can be combined within a microgrid to provide energy to the consumers in a sustainable manner. In order to ensure more reliable and economical energy supply, battery storage system is integrated within the microgrid. In this article, operating cost of isolated microgrid is reduced by economic scheduling considering the optimal size of the battery. However, deep discharge shortens the lifetime of battery operation. Therefore, the real time battery operation cost is modeled considering the depth of discharge at each time interval. Moreover, the proposed economic scheduling with battery sizing is optimized using firefly algorithm (FA). The efficacy of FA is compared with other metaheuristic techniques in terms of performance measurement indices, which are cost of electricity and loss of power supply probability. The results show that the proposed technique reduces the cost of microgrid and attain optimal size of the battery.	[Sufyan, Muhammad; Abd Rahim, Nasrudin; Tan, ChiaKwang; Raihan, Siti Rohani Sheikh] Univ Malaya, Higher Inst Ctr Excellence HICoE, UM Power Energy Dedicated Adv Ctr UMPEDAC Wisma R, Kuala Lumpur, Malaysia; [Sufyan, Muhammad; Muhammad, Munir Azam] Iqra Univ, Main Campus, Karachi, Pakistan; [Muhammad, Munir Azam] Univ Malaya, Dept Elect Engn, Kuala Lumpur, Malaysia	Universiti Malaya; Iqra University; Universiti Malaya	Abd Rahim, N (corresponding author), Univ Malaya, Higher Inst Ctr Excellence HICoE, UM Power Energy Dedicated Adv Ctr UMPEDAC Wisma R, Kuala Lumpur, Malaysia.	nasrudin@um.edu.my	Raihan, Siti Rohani Sheikh/B-5210-2010; RAHIM, NASRUDIN ABD/B-9204-2010; muhammad, munir azam/P-8543-2019	Raihan, Siti Rohani Sheikh/0000-0001-7258-2212; RAHIM, NASRUDIN ABD/0000-0002-1834-1984; Muhammad, Munir Azam/0000-0001-7356-1923; Sufyan, Muhammad/0000-0001-7029-2262	Ministry of Higher Education through FRGS [FP052-2017A]; UM Power Energy Dedicated Advanced Centre (UMPEDAC); Higher Institution Centre of Excellence (HICoE) Program Research Grant, UMPEDAC - 2018 (MOHE HICOE - UMPEDAC);  [RU007-2018]	Ministry of Higher Education through FRGS; UM Power Energy Dedicated Advanced Centre (UMPEDAC); Higher Institution Centre of Excellence (HICoE) Program Research Grant, UMPEDAC - 2018 (MOHE HICOE - UMPEDAC); 	The authors would like to acknowledge the support by the Ministry of Higher Education through FRGS (FP052-2017A). The authors thank the technical and financial assistance of UM Power Energy Dedicated Advanced Centre (UMPEDAC), the Higher Institution Centre of Excellence (HICoE) Program Research Grant, UMPEDAC - 2018 (MOHE HICOE - UMPEDAC) and RU007-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghamohammadi MR, 2014, INT J ELEC POWER, V54, P325, DOI 10.1016/j.ijepes.2013.07.005; Alsaidan I., 2017, IEEE T POWER SYSTEMS, P1; Bahramirad S, 2012, IEEE T SMART GRID, V3, P2056, DOI 10.1109/TSG.2012.2217991; Borhanazad H, 2014, RENEW ENERG, V71, P295, DOI 10.1016/j.renene.2014.05.006; Carpinelli G, 2016, ELECTR POW SYST RES, V141, P73, DOI 10.1016/j.epsr.2016.07.013; Carta JA, 2011, ENERGY, V36, P2671, DOI 10.1016/j.energy.2011.02.008; Castronuovo ED, 2004, IEEE T POWER SYST, V19, P1599, DOI 10.1109/TPWRS.2004.831707; Chen SX, 2012, IEEE T SMART GRID, V3, P142, DOI 10.1109/TSG.2011.2160745; Eyer J., 2010, SANDIA NAT LAB, V20, P5; Fossati JP, 2015, RENEW ENERG, V77, P539, DOI 10.1016/j.renene.2014.12.039; Han S, 2014, APPL ENERG, V113, P1100, DOI 10.1016/j.apenergy.2013.08.062; Honghai Kuang, 2011, 2011 International Conference on Electrical and Control Engineering, P170; Ismail MS, 2013, ENERG CONVERS MANAGE, V69, P163, DOI 10.1016/j.enconman.2013.02.005; Jamshidi M., 2018, SUSTAINABLE CITIES S; Ju C., 2016, 2016 INT C PROBABILI, P1, DOI DOI 10.1109/POWERCON.2016.7754011; Kerdphol T., 2014, P IEEE PES INN SMART, P1, DOI DOI 10.1109/ISGTEUROPE.2014.7028895; Khorramdel H, 2016, IEEE T IND INFORM, V12, P834, DOI 10.1109/TII.2015.2509424; Li Y, 2018, APPL ENERG, V232, P54, DOI 10.1016/j.apenergy.2018.09.211; Li Y, 2019, IEEE T IND ELECTRON, V66, P1565, DOI 10.1109/TIE.2018.2840498; Li ZW, 2016, IET GENER TRANSM DIS, V10, P3622, DOI 10.1049/iet-gtd.2016.0418; Mbungu NT, 2018, SUSTAIN CITIES SOC, V41, P392, DOI 10.1016/j.scs.2018.05.049; Mehmood KK, 2017, IET RENEW POWER GEN, V11, P1305, DOI 10.1049/iet-rpg.2016.0938; Modiri-Delshad M, 2016, ENERGY, V116, P637, DOI 10.1016/j.energy.2016.09.140; Nguyen TA, 2015, IEEE T SUSTAIN ENERG, V6, P729, DOI 10.1109/TSTE.2015.2404780; Nojavan S, 2018, SOL ENERGY, V171, P580, DOI 10.1016/j.solener.2018.07.004; Nojavan S, 2017, ENERGY, V139, P89, DOI 10.1016/j.energy.2017.07.148; Nojavan S, 2017, INT J ELEC POWER, V93, P156, DOI 10.1016/j.ijepes.2017.05.023; Qiang Fu, 2013, IEEE Electrification Magazine, V1, P21, DOI 10.1109/MELE.2013.2294736; Robert FC, 2018, SUSTAIN CITIES SOC, V40, P735, DOI 10.1016/j.scs.2018.04.008; Rokni SGM, 2018, SUSTAIN CITIES SOC, V37, P222, DOI 10.1016/j.scs.2017.11.016; Sharma S, 2016, IET GENER TRANSM DIS, V10, P625, DOI 10.1049/iet-gtd.2015.0429; Sukumar S, 2017, ENERGY, V118, P1322, DOI 10.1016/j.energy.2016.11.018; Torreglosa JP, 2014, IEEE T IND INFORM, V10, P276, DOI 10.1109/TII.2013.2245140; Yang X., 2008, NATURE INSPIRED META, V2nd; Zhou CK, 2011, IEEE T ENERGY CONVER, V26, P1041, DOI 10.1109/TEC.2011.2159977	35	48	48	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0211642	10.1371/journal.pone.0211642	http://dx.doi.org/10.1371/journal.pone.0211642			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763331	Green Submitted, Green Published, gold			2022-12-26	WOS:000458763900019
J	Witberg, G; Plakht, Y; Bental, T; Feldman, BS; Leventer-Roberts, M; Levi, A; Gabay, H; Balicer, R; Gerber, Y; Kornowski, R				Witberg, Guy; Plakht, Ygal; Bental, Tamir; Feldman, Becca S.; Leventer-Roberts, Maya; Levi, Amos; Gabay, Hagit; Balicer, Ran; Gerber, Yariv; Kornowski, Ran			Development of a risk score for predicting the benefit versus harm of extending dual antiplatelet therapy beyond 6 months following percutaneous coronary intervention for stable coronary artery disease	PLOS ONE			English	Article							GUIDELINE FOCUSED UPDATE; DRUG-ELUTING STENTS; DAPT SCORE; DURATION; IMPLANTATION; OUTCOMES; EVENTS; VALIDATION; EFFICACY; TRIAL	Background Decisions on dual antiplatelet therapy (DAPT) duration should balance the opposing risks of ischaemia and bleeding. Our aim was to develop a risk score to identify stable coronary artery disease (SCAD) patients undergoing PCI who would benefit or suffer from extending DAPT beyond 6 months. Methods Retrospective analysis of a cohort of patients who completed 6 months of DAPT following PCI. Predictors of ischaemic and bleeding events for the 6-12 month period post-PCI were identified and a risk score was developed to estimate the likelihood of benefiting from extending DAPT beyond 6 months. Incidence of mortality, ischaemic and bleeding events for patients treated with DAPT for 6 vs. 6-12 months, was compared, stratified by strata of the risk score. Results The study included 2,699 patients. Over 6 months' follow up, there were 78 (2.9%) ischaemic and 43 (1.6%) bleeding events. Four variables (heart failure, left ventricular ejection fraction <= 30%, left main or three vessel CAD, status post (s/p) PCI and s/p stroke) predicted ischemic events, two variables (age>75, haemoglobin <10 g/dL) predicted bleeding. In the lower stratum of the risk score, 6-12 months of treatment with DAPT resulted in increased bleeding (p = 0.045) with no decrease in ischaemic events. In the upper stratum, 6-12 months DAPT was associated with reduced ischaemic events (p = 0.029), with no increase in bleeding. Conclusion In a population of SCAD patients who completed 6 months of DAPT, a risk score for subsequent ischaemic and bleeding events identified patients likely to benefit from continuing or stopping DAPT.	[Witberg, Guy; Bental, Tamir; Levi, Amos; Kornowski, Ran] Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel; [Witberg, Guy; Bental, Tamir; Levi, Amos; Kornowski, Ran] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Witberg, Guy; Gerber, Yariv] Tel Aviv Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel; [Plakht, Ygal; Feldman, Becca S.; Leventer-Roberts, Maya; Gabay, Hagit; Balicer, Ran] Clalit Hlth Serv, Clalit Res Inst, Chief Phys Off, Tel Aviv, Israel; [Plakht, Ygal; Balicer, Ran] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Leventer-Roberts, Maya] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Clalit Health Services; Ben Gurion University; Icahn School of Medicine at Mount Sinai	Witberg, G (corresponding author), Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel.; Witberg, G (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Witberg, G (corresponding author), Tel Aviv Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel.	vitberguy@gmail.com	Gerber, Yariv/AAU-8222-2021	Plakht, Ygal/0000-0003-0898-9776				Baber U, 2016, JACC-CARDIOVASC INTE, V9, P1349, DOI 10.1016/j.jcin.2016.04.009; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Bental T, 2010, CATHETER CARDIO INTE, V76, P374, DOI 10.1002/ccd.22507; Binder RK, 2015, EUR HEART J, V36, P1207, DOI 10.1093/eurheartj/ehv103; Bittl JA, 2016, J AM COLL CARDIOL, V68, P1116, DOI 10.1016/j.jacc.2016.03.512; Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Hannan EL, 2012, CIRCULATION, V125, P1870, DOI 10.1161/CIRCULATIONAHA.111.071811; Harada Y., 2017, THROMB HAEMOST, V117; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Leibowitz M, 2016, JAMA INTERN MED, V176, P1105, DOI 10.1001/jamainternmed.2016.2751; Lenzen MJ, 2005, EUR HEART J, V26, P1169, DOI 10.1093/eurheartj/ehi238; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Piccolo R, 2017, ANN INTERN MED, V167, P17, DOI 10.7326/M16-2389; Schulz-Schupke S, 2015, EUR HEART J, V36, P1252, DOI 10.1093/eurheartj/ehu523; Singer SR, 2012, AM J MANAG CARE, V18; Steg PG, 2007, ARCH INTERN MED, V167, P68, DOI 10.1001/archinte.167.1.68; Valgimigli M, 2017, EUR HEART J, V74, DOI [10.4244/EIJV11I1A11, DOI 10.4244/EIJV11I1A11]; Valgimigli M, 2015, EUROINTERVENTION, V11, P68, DOI 10.4244/EIJV11I1A11; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Wong YTA, 2017, J AM COLL CARDIOL, V69, P34357; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775; Yoshikawa Y, 2017, EUR HEART J, V38, P611; Yoshikawa Y, 2018, CIRCULATION, V137, P551, DOI 10.1161/CIRCULATIONAHA.117.028924	25	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0209661	10.1371/journal.pone.0209661	http://dx.doi.org/10.1371/journal.pone.0209661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763340	gold, Green Published, Green Submitted			2022-12-26	WOS:000458763900003
J	Hohmann, T; Feese, K; Ghadban, C; Dehghani, F; Grabiec, U				Hohmann, Tim; Feese, Kerstin; Ghadban, Chalid; Dehghani, Faramarz; Grabiec, Urszula			On the influence of cannabinoids on cell morphology and motility of glioblastoma cells	PLOS ONE			English	Article							PROSTATE-CANCER; MUTANT P53; GLIOMA INVASION; DOWN-REGULATION; MIGRATION; KINASE; ACTIVATION; GROWTH; CB1; ADHESION	The mechanisms behind the anti-tumoral effects of cannabinoids by impacting the migratory activity of tumor cells are only partially understood. Previous studies demonstrated that cannabinoids altered the organization of the actin cytoskeleton in various cell types. As actin is one of the main contributors to cell motility and is postulated to be linked to tumor invasion, we tested the following hypothesizes: 1) Can cannabinoids alter cell motility in a cannabinoid receptor dependent manner? 2) Are these alterations associated with reorganizations in the actin cytoskeleton? 3) If so, what are the underlying molecular mechanisms? Three different glioblastoma cell lines were treated with specific cannabinoid receptor 1 and 2 agonists and antagonists. Afterwards, we measured changes in cell motility using live cell imaging and alterations of the actin structure in fixed cells. Additionally, the protein amount of phosphorylated p44/42 mitogen-activated protein kinase (MAPK), focal adhesion kinases (FAK) and phosphorylated FAK (pFAK) over time were measured. Cannabinoids induced changes in cell motility, morphology and actin organization in a receptor and cell line dependent manner. No significant changes were observed in the analyzed signaling molecules. Cannabinoids can principally induce changes in the actin cytoskeleton and motility of glioblastoma cell lines. Additionally, single cell motility of glioblastoma is independent of their morphology. Furthermore, the observed effects seem to be independent of p44/42 MAPK and pFAK pathways.	[Hohmann, Tim; Feese, Kerstin; Ghadban, Chalid; Dehghani, Faramarz; Grabiec, Urszula] Martin Luther Univ Halle Wittenberg, Inst Anat & Cell Biol, Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Dehghani, F (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Anat & Cell Biol, Halle, Saale, Germany.	faramarz.dehghani@medizin.uni-halle.de	Hohmann, Urszula/ABB-7323-2020	Grabiec, Urszula/0000-0001-8376-4767	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	T.H. was supported by the funding programme Open Access Publishing by the German Research Foundation (DFG).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Aguado T, 2007, J BIOL CHEM, V282, P6854, DOI 10.1074/jbc.M608900200; Amarouch A., 2005, CANC RADIOTHERAPIE, V9, P196, DOI DOI 10.1016/J.CANRAD.2005.05.001; Anavi-Goffer S, 2012, J BIOL CHEM, V287, P91, DOI 10.1074/jbc.M111.296020; Bagher AM, 2016, MOL PHARMACOL, V89, P652, DOI 10.1124/mol.116.103465; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Bettiga A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42157; Blazquez C, 2003, FASEB J, V17, P529, DOI 10.1096/fj.02-0795fje; Blazquez C, 2006, FASEB J, V20, P2633, DOI 10.1096/fj.06-6638fje; BURGER PC, 1989, CANCER-AM CANCER SOC, V63, P2014, DOI 10.1002/1097-0142(19890515)63:10<2014::AID-CNCR2820631025>3.0.CO;2-L; Busquets-Garcia A, 2018, NEUROPSYCHOPHARMACOL, V43, P4, DOI 10.1038/npp.2017.206; CABRAL GA, 1987, ARCH TOXICOL, V60, P438, DOI 10.1007/BF00302387; Contassot E, 2004, J NEUROPATH EXP NEUR, V63, P956, DOI 10.1093/jnen/63.9.956; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; Dalton GD, 2013, CELL SIGNAL, V25, P1665, DOI 10.1016/j.cellsig.2013.03.020; Davis FG, 1999, CANCER, V85, P485, DOI 10.1002/(SICI)1097-0142(19990115)85:2<485::AID-CNCR29>3.3.CO;2-C; Downer EJ, 2007, EUR J PHARMACOL, V564, P57, DOI 10.1016/j.ejphar.2007.02.025; Ellert-Miklaszewska A, 2005, CELL SIGNAL, V17, P25, DOI 10.1016/j.cellsig.2004.05.011; Elobeid A, 2000, J NEUROSCI RES, V60, P245, DOI 10.1002/(SICI)1097-4547(20000415)60:2<245::AID-JNR14>3.0.CO;2-1; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Fang KangLing, 2011, EURASIP J EMBEDDED S, V2011, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1038/0NC.2011.256; Feng R, 2015, MOL CARCINOG; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Galanti G, 2008, ACTA ONCOL, V47, P1062, DOI 10.1080/02841860701678787; Galve-Roperh I, 2002, MOL PHARMACOL, V62, P1385, DOI 10.1124/mol.62.6.1385; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Gardner B, 2003, FASEB J, V17, P2157, DOI 10.1096/fj.03-0254fje; Golembieski WA, 2008, GLIA, V56, P1061, DOI 10.1002/glia.20679; Grimaldi C, 2006, EXP CELL RES, V312, P363, DOI 10.1016/j.yexcr.2005.10.024; Gurley SN, 2010, SYNTHESIS NOVEL CANN; Gurley SN, 2012, J NEURO-ONCOL, V110, P163, DOI 10.1007/s11060-012-0958-5; Guzman M, 2006, BRIT J CANCER, V95, P197, DOI 10.1038/sj.bjc.6603236; Haggstrom J, 2014, PROSTATE, V74, P1107, DOI 10.1002/pros.22827; Heppner FL, 1998, GLIA, V22, P180, DOI 10.1002/(SICI)1098-1136(199802)22:2<180::AID-GLIA9>3.0.CO;2-B; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Hohmann T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18092001; Hohmann T, 2017, CELL ADHES MIGR, V11, P54, DOI 10.1080/19336918.2016.1183867; Iannotti FA, 2016, PROG LIPID RES, V62, P107, DOI 10.1016/j.plipres.2016.02.002; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Kiessling TR, 2013, EUR BIOPHYS J BIOPHY, V42, P383, DOI 10.1007/s00249-013-0888-y; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lim DA, 2007, NEURO-ONCOLOGY, V9, P424, DOI 10.1215/15228517-2007-023; De Jesus ML, 2010, NEUROCHEM INT, V56, P829, DOI 10.1016/j.neuint.2010.03.007; Massi P, 2006, CELL MOL LIFE SCI, V63, P2057, DOI 10.1007/s00018-006-6156-x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McDougall JJ, 2008, BRIT J PHARMACOL, V153, P358, DOI 10.1038/sj.bjp.0707565; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moreno E, 2014, J BIOL CHEM, V289, P21960, DOI 10.1074/jbc.M114.561761; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nabissi M, 2015, INT J CANCER, V137, P1855, DOI 10.1002/ijc.29573; Nithipatikom K, 2004, CANCER RES, V64, P8826, DOI 10.1158/0008-5472.CAN-04-3136; Nithipatikom K, 2012, ENDOCRINOLOGY, V153, P29, DOI 10.1210/en.2011-1144; Oka S, 2004, J LEUKOCYTE BIOL, V76, P1002, DOI 10.1189/jlb.0404252; Panopoulos A, 2011, MOL BIOL CELL, V22, P2212, DOI 10.1091/mbc.E10-10-0849; Pertwee RG, 1997, PHARM THER, V74; Pisanti S, 2013, TRENDS PHARMACOL SCI, V34, P273, DOI 10.1016/j.tips.2013.03.003; Preet A, 2008, ONCOGENE, V27, P339, DOI 10.1038/sj.onc.1210641; Ramaekers BLT, 2011, CANCER TREAT REV, V37, P185, DOI 10.1016/j.ctrv.2010.08.004; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Sauer L, 2010, ONCOGENE, V29, P2628, DOI 10.1038/onc.2010.24; Scherer HJ, 1940, BRAIN, V63, P1, DOI 10.1093/brain/63.1.1; Singh NS, 2016, PHARMACOL RES, V111, P757, DOI 10.1016/j.phrs.2016.07.013; Solinas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076918; TAHIR SK, 1992, BIOCHEM CELL BIOL, V70, P1159, DOI 10.1139/o92-162; TAHIR SK, 1991, PHARMACOL BIOCHEM BE, V40, P617, DOI 10.1016/0091-3057(91)90372-9; Vaccani A, 2005, BRIT J PHARMACOL, V144, P1032, DOI 10.1038/sj.bjp.0706134; Velez-Pardo C, 2006, Med Chem, V2, P471, DOI 10.2174/157340606778250171; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; WALKER MD, 1978, J NEUROSURG, V49, P333, DOI 10.3171/jns.1978.49.3.0333; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; Walsh SK, 2015, PHARM RES PERSPECT, V3, P1; Wang W., 2013, CELL DEATH DIS, V4, pe574; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Weichsel J, 2010, CYTOM PART A, V77A, P52, DOI 10.1002/cyto.a.20818; Wilson RG, 1996, CELL BIOL INT, V20, P147, DOI 10.1006/cbir.1996.0019; Wu XY, 2012, J NEUROCHEM, V120, P842, DOI 10.1111/j.1471-4159.2011.07625.x; Yamada KM, 2001, J CELL SCI, V114, P2375	84	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212037	10.1371/journal.pone.0212037	http://dx.doi.org/10.1371/journal.pone.0212037			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753211	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600039
J	Kim, SM; Reinke, RF				Kim, Suk-Man; Reinke, Russell F.			A novel resistance gene for bacterial blight in rice, Xa43(t) identified by GWAS, confirmed by QTL mapping using a bi-parental population	PLOS ONE			English	Article							ORYZAE PV. ORYZAE; XANTHOMONAS-ORYZAE; DISEASE RESISTANCE; CONFERRING RESISTANCE; RECESSIVE GENE; INHERITANCE; PREDICTION; CULTIVARS; STRAINS; LINE	Bacterial blight (BB) caused by the Xanthomonas oryzae pv. oryzae (Xoo) pathogen is a significant disease in most rice cultivation areas. The disease is estimated to cause annual rice production losses of 20-30 percent throughout rice-growing countries in Asia. The discovery and deployment of durable resistance genes for BB is an effective and sustainable means of mitigating production losses. In this study QTL analysis and fine mapping were performed using an F-2 and a BC2F2 population derived from a cross with a new R-donor having broad spectrum resistance to Korean BB races. The QTL qBB11 was identified by composite interval mapping and explained 31.25% of the phenotypic variation (R-2) with LOD values of 43.44 harboring two SNP markers. The single major R-gene was designated Xa43 (t). Through dissection of the target region we were able to narrow the region to within 27.83-27.95 Mbp, a physical interval of about 119-kb designated by the two flanking markers IBb27os11_14 and S_BB11.ssr_9. Of nine ORFs in the target region two ORFs revealed significantly different expression levels of the candidate genes. From these results we developed a marker specific to this R-gene, which will have utility for future BB resistance breeding and/or R-gene pyramiding using marker assisted selection. Further characterization of the R-gene would be helpful to enhance understanding of mechanisms of BB resistance in rice.	[Kim, Suk-Man; Reinke, Russell F.] Int Rice Res Inst, Strateg Innovat Platform, Los Banos, Philippines; [Kim, Suk-Man] Rural Dev Adm, Natl Inst Crop Sci, IRRI Korea Off, Iseo Myeon, Jeollabuk Do, South Korea	CGIAR; International Rice Research Institute (IRRI); Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science	Reinke, RF (corresponding author), Int Rice Res Inst, Strateg Innovat Platform, Los Banos, Philippines.	r.reinke@irri.org		Kim, Suk-Man/0000-0002-6701-4824	Agenda Program of RDA [PJ013807-04]; Temperate Rice Research Consortium Working group 2; Global Rice Science Partnership of IRRI	Agenda Program of RDA; Temperate Rice Research Consortium Working group 2; Global Rice Science Partnership of IRRI	SMK received support from the Agenda Program of RDA PJ013807-04, the Temperate Rice Research Consortium Working group 2, and the Global Rice Science Partnership of IRRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandillo N, 2013, RICE, V6, DOI 10.1186/1939-8433-6-11; Busungu C, 2016, BREEDING SCI, V66, P636, DOI 10.1270/jsbbs.16062; Chen S, 2008, MOL BREEDING, V22, P433, DOI 10.1007/s11032-008-9187-1; Chen S, 2011, THEOR APPL GENET, V122, P1331, DOI 10.1007/s00122-011-1534-7; Chu ZH, 2006, THEOR APPL GENET, V112, P455, DOI 10.1007/s00122-005-0145-6; Gonzalez C, 2007, MOL PLANT MICROBE IN, V20, P534, DOI 10.1094/MPMI-20-5-0534; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Hur YJ, 2016, THEOR APPL GENET, V129, P1861, DOI 10.1007/s00122-016-2744-9; Hutin M, 2015, PLANT J, V84, P694, DOI 10.1111/tpj.13042; Ise K, 2002, EUPHYTICA, V127, P185, DOI 10.1023/A:1020286412751; Iyer-Pascuzzi AS, 2007, MOL PLANT MICROBE IN, V20, P731, DOI 10.1094/MPMI-20-7-0731; Jiang GH, 2006, MOL GENET GENOMICS, V275, P354, DOI 10.1007/s00438-005-0091-7; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Kim SM, 2015, THEOR APPL GENET, V128, P1933, DOI 10.1007/s00122-015-2557-2; Korinsak S, 2009, MAEJO INT J SCI TECH, V3, P235; Lee KS, 2003, PHYTOPATHOLOGY, V93, P147, DOI 10.1094/PHYTO.2003.93.2.147; Li HJ, 2012, MOL PLANT, V5, P281, DOI 10.1093/mp/ssr079; Liang LQ, 2017, PLANT BREEDING, V136, P603, DOI 10.1111/pbr.12493; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu JL, 2010, MOL PLANT PATHOL, V11, P419, DOI [10.1111/J.1364-3703.2009.00607.X, 10.1111/j.1364-3703.2009.00607.x]; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; MEW TW, 1992, PLANT DIS, V76, P1029, DOI 10.1094/PD-76-1029; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; RDA, 2012, MAN STAND EV METH AG; Saha S, 2015, J PURE APPL MICROBIO, V9, P725; Shen YJ, 2004, PLANT PHYSIOL, V135, P1198, DOI 10.1104/pp.103.038463; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Srinivasan B, 2005, CURR SCI INDIA, V88, P1229; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Tian DS, 2014, PLANT CELL, V26, P497, DOI 10.1105/tpc.113.119255; Verdier V, 2012, J BIOTECHNOL, V159, P320, DOI 10.1016/j.jbiotec.2011.09.020; Vikal Y., 2017, ADV INT RICE RES, DOI [10.5772/67361, DOI 10.5772/67361]; Yokotani N, 2013, J EXP BOT, V64, P5085, DOI 10.1093/jxb/ert298; Zhang F, 2015, PLANT PATHOL, V64, P568, DOI 10.1111/ppa.12283; Zhang J, 2006, PLANT BREEDING, V125, P600, DOI 10.1111/j.1439-0523.2006.01281.x	36	42	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211775	10.1371/journal.pone.0211775	http://dx.doi.org/10.1371/journal.pone.0211775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753229	gold, Green Published, Green Submitted			2022-12-26	WOS:000458395600022
J	Bath, NM; Ding, X; Wilson, NA; Verhoven, BM; Boldt, BA; Sukhwal, A; Reese, SR; Panzer, SE; Djamali, A; Redfield, RR				Bath, Natalie M.; Ding, Xiang; Wilson, Nancy A.; Verhoven, Bret M.; Boldt, Brittney A.; Sukhwal, Adarsh; Reese, Shannon R.; Panzer, Sarah E.; Djamali, Arjang; Redfield, Robert R., III			Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model	PLOS ONE			English	Article							ANTIBODY-MEDIATED REJECTION; B-CELLS; DEPLETION; BAFF; INFLAMMATION; LYMPHOCYTE; AUTOIMMUNE; RECIPIENTS; IMMUNITY; DISEASE	Alloantibody represents a significant barrier in kidney transplant through the sensitization of patients prior to transplant through antibody mediated rejection (ABMR). APRIL BLyS are critical survival factors for mature B lymphocytes plasma cells, the primary source of alloantibody. We examined the effect of APRIL/BLyS blockade via TACI-Ig (Transmembrane activator calcium modulator cyclophilin lig interactor-Immunoglobulin) in a preclinical rodent model as treatment for both desensitization ABMR. Lewis rats were sensitized with Brown Norway (BN) blood for 21 days. Following sensitization, animals were then sacrificed or romized into kidney transplant (G4, sensitized transplant control); desensitization with TACI-Ig followed by kidney transplant (G5, sensitized + pre-transplant TACI-Ig); kidney transplant with post-transplant TACI-Ig for 21 days (G6, sensitized + post-transplant TACI-Ig); desensitization with TACI-Ig followed by kidney transplant post-transplant TACI-Ig for 21 days (G7, sensitized + pre- post-transplant TACI-Ig). Animals were sacrificed on day 21 post-transplant tissues were analyzed using flow cytometry, IHC, ELISPOT, RTPCR. Sensitized animals treated with APRIL/BLyS blockade demonstrated a significant decrease in marginal zone non-switched B lymphocyte populations (p<0.01). Antibody secreting cells were also significantly reduced in the sensitized APRIL/BLyS blockade treated group. Post-transplant APRIL/BLyS blockade treated animals were found to have significantly less C4d deposition less ABMR as defined by Banff classification when compared to groups receiving APRIL/BLyS blockade before transplant or both before after transplant (p<0.0001). The finding of worse ABMR in groups receiving APRIL/BLyS blockade before both before after transplant may indicate that B lymphocyte depletion in this setting also resulted in regulatory lymphocyte depletion resulting in a worse rejection. Data presented here demonstrates that the targeting of APRIL BLyS can significantly deplete mature B lymphocytes, antibody secreting cells, effectively decrease ABMR when given post-transplant in a sensitized animal model.	[Bath, Natalie M.; Ding, Xiang; Verhoven, Bret M.; Redfield, Robert R., III] Univ Wisconsin Madison, Dept Surg, Div Transplant, Madison, WI 53706 USA; [Wilson, Nancy A.; Boldt, Brittney A.; Sukhwal, Adarsh; Reese, Shannon R.; Panzer, Sarah E.; Djamali, Arjang] Univ Wisconsin Madison, Dept Med, Div Nephrol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Redfield, RR (corresponding author), Univ Wisconsin Madison, Dept Surg, Div Transplant, Madison, WI 53706 USA.	redfield@surgery.wisc.edu	Redfield, Robert/GNP-1154-2022	Wilson, Nancy/0000-0002-9472-6026	KL2 grant [KL2TR002374, UL1TR002373]; UW Transplant Research Training Grant from the NIH/NCATS [T32 AI125231]; American College of Surgeons; Faculty Development Grant from the American Society of Transplant Surgeons Foundation; UW CCC Flow Cytometry Shared instrumentation core, the Shared Instrumentation grant [1S00OD018202-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002373, KL2TR002374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI125231] Funding Source: NIH RePORTER	KL2 grant; UW Transplant Research Training Grant from the NIH/NCATS; American College of Surgeons; Faculty Development Grant from the American Society of Transplant Surgeons Foundation; UW CCC Flow Cytometry Shared instrumentation core, the Shared Instrumentation grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	TACI-Ig was kindly provided by EMD Serono Research and Development Institute under an MTA. This study was supported by KL2 grant KL2TR002374, grant UL1TR002373 to UW ICTR, and UW Transplant Research Training Grant (T32 AI125231) from NIH/NCATS. Dr. Redfield's research was also supported in part by a fellowship from the American College of Surgeons, and a Faculty Development Grant from the American Society of Transplant Surgeons Foundation. The UW CCC Flow Cytometry Shared instrumentation core, including the Shared Instrumentation grant 1S00OD018202-01 Special BD LSR Fortessa, made possible the purchase and use of the BD LSR Fortessa. The funders had no role in study design, data collection and analysis, or decision to publish.	Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; BALDWIN WM, 1995, TRANSPLANTATION, V59, P797, DOI 10.1097/00007890-199503270-00001; Clatworthy MR, 2011, AM J TRANSPLANT, V11, P1359, DOI 10.1111/j.1600-6143.2011.03554.x; Clatworthy MR, 2009, NEW ENGL J MED, V360, P2683, DOI 10.1056/NEJMc0808481; Dall'Era M, 2007, ARTHRITIS RHEUM, V56, P4142, DOI 10.1002/art.23047; Darr UM, 1998, ORGANTRANSPLANTATION, P73; Dass S, 2007, ARTHRITIS RHEUM, V56, P2715, DOI 10.1002/art.22811; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Dillon SR, 2006, NAT REV DRUG DISCOV, V5, P235, DOI 10.1038/nrd1982; Djamali A, 2009, AM J TRANSPLANT, V9, P74, DOI 10.1111/j.1600-6143.2008.02463.x; Fillatreau S, 2015, CURR OPIN PHARMACOL, V23, P1, DOI 10.1016/j.coph.2015.04.006; Goetz M, 2007, INFLAMM BOWEL DIS, V13, P1365, DOI 10.1002/ibd.20215; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Hart A, 2018, AM J TRANSPLANT, V18, P18, DOI 10.1111/ajt.14557; Haselmayer P, 2017, EUR J IMMUNOL, V47, P1075, DOI 10.1002/eji.201746934; Hidalgo LG, 2009, AM J TRANSPLANT, V9, P2532, DOI 10.1111/j.1600-6143.2009.02800.x; Hong S, 2018, IMMUNITY, V49, P695, DOI 10.1016/j.immuni.2018.08.012; Huang G, 2014, AM J TRANSPLANT, V14, P1061, DOI 10.1111/ajt.12674; Jordan SC, 2014, CURR OPIN ORGAN TRAN, V19, P591, DOI 10.1097/MOT.0000000000000128; Kalled Susan L., 2005, V8, P206; Kirk AD, 2010, NAT REV NEPHROL, V6, P584, DOI 10.1038/nrneph.2010.111; Kwun J, 2015, AM J TRANSPLANT, V15, P815, DOI 10.1111/ajt.13045; Lateef A, 2010, CURR OPIN RHEUMATOL, V22, P504, DOI 10.1097/BOR.0b013e32833b475e; Loupy A, 2012, NAT REV NEPHROL, V8, P348, DOI 10.1038/nrneph.2012.81; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Montgomery RA, 2011, NEW ENGL J MED, V365, P318, DOI 10.1056/NEJMoa1012376; Newell KA, 2010, J CLIN INVEST, V120, P1836, DOI 10.1172/JCI39933; Parsons RF, 2010, TRANSPLANT REV-ORLAN, V24, P207, DOI 10.1016/j.trre.2010.05.004; Reese SR, 2015, TRANSPLANTATION, V99, P1785, DOI 10.1097/TP.0000000000000736; Rodriguez-Pinto D, 2005, CELL IMMUNOL, V238, P67, DOI 10.1016/j.cellimm.2006.02.005; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Scholz JL, 2008, P NATL ACAD SCI USA, V105, P15517, DOI 10.1073/pnas.0807841105; Scornik JC, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-217; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Vidyasagar A, 2008, AM J PHYSIOL-RENAL, V295, pF707, DOI 10.1152/ajprenal.90240.2008; Wortel CM, 2017, TRANSPL IMMUNOL, V41, P1, DOI 10.1016/j.trim.2017.02.004	39	9	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211865	10.1371/journal.pone.0211865	http://dx.doi.org/10.1371/journal.pone.0211865			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735519	Green Published, Green Submitted, gold			2022-12-26	WOS:000458181200035
J	Contreras-Jodar, A; Nayan, NH; Hamzaoui, S; Caja, G; Salama, AAK				Contreras-Jodar, Alexandra; Nayan, Nazri Hj.; Hamzaoui, Soufiane; Caja, Gerardo; Salama, Ahmed A. K.			Heat stress modifies the lactational performances and the urinary metabolomic profile related to gastrointestinal microbiota of dairy goats	PLOS ONE			English	Article							PROLACTIN; PLASMA; TEMPERATURE; AUTOPHAGY; HEALTH; ACIDS; BIOMARKERS; PARAMETERS; NUTRITION; MECHANISM	The aim of the study is to identify the candidate biomarkers of heat stress (HS) in the urine of lactating dairy goats through the application of proton Nuclear Magnetic Resonance (H-1 NMR)-based metabolomic analysis. Dairy does (n = 16) in mid-lactation were submitted to thermal neutral (TN; indoors; 15 to 20 degrees C; 40 to 45% humidity) or HS (climatic chamber; 37 degrees C day, 30 degrees C night; 40% humidity) conditions according to a crossover design (2 periods of 21 days). Thermophysiological traits and lactational performances were recorded and milk composition analyzed during each period. Urine samples were collected at day 15 of each period for H-1 NMR spectroscopy analysis. Principal component analysis (PCA) and partial least square-discriminant analysis (PLS-DA) assessment with cross validation were used to identify the goat urinary metabolome from the Human Metabolome Data Base. HS increased rectal temperature (1.2 degrees C), respiratory rate (3.5-fold) and water intake (74%), but decreased feed intake (35%) and body weight (5%) of the lactating does. No differences were detected in milk yield, but HS decreased the milk contents of fat (9%), protein (16%) and lactose (5%). Metabolomics allowed separating TN and HS urinary clusters by PLS-DA. Most discriminating metabolites were hippurate and other phenylalanine (Phe) derivative compounds, which increased in HS vs. TN does. The greater excretion of these gut-derived toxic compounds indicated that HS induced a harmful gastrointestinal microbiota over-growth, which should have sequestered aromatic amino acids for their metabolism and decreased the synthesis of neurotransmitters and thyroid hormones, with a negative impact on milk yield and composition. In conclusion, HS markedly changed the thermophysiological traits and lactational performances of dairy goats, which were translated into their urinary metabolomic profile through the presence of gut-derived toxic compounds. Hippurate and other Phe-derivative compounds are suggested as urinary biomarkers to detect heat-stressed dairy animals in practice.	[Contreras-Jodar, Alexandra; Hamzaoui, Soufiane; Caja, Gerardo; Salama, Ahmed A. K.] Univ Autonoma Barcelona, Dept Anim & Food Sci, Grp Res Ruminants G2R, Barcelona, Spain; [Nayan, Nazri Hj.] Univ Putra Malaysia, Dept Anim Sci, Fac Agr, Serdang, Selangor, Malaysia; [Hamzaoui, Soufiane] Univ Bouira, Dept Agron Sci, Bouira, Algeria	Autonomous University of Barcelona; Universiti Putra Malaysia; Universite Mohand Akli Ouelhadj Bouira	Caja, G; Salama, AAK (corresponding author), Univ Autonoma Barcelona, Dept Anim & Food Sci, Grp Res Ruminants G2R, Barcelona, Spain.	gerardo.caja@uab.es; ahmed.salama@sdstate.edu	Caja, Gerardo/AAH-2838-2020; Salama, Ahmed/O-1367-2013; Contreras-Jodar, Alexandra/AAQ-1615-2021	Caja, Gerardo/0000-0001-8606-3587; Salama, Ahmed/0000-0003-2065-9702; Contreras-Jodar, Alexandra/0000-0003-0565-2887; Nayan, Nazri/0000-0001-5399-4115	Ministry of Economy and Finance of Spain [AGL2013-44061-R, RTA205-00035-C03-02, ES-2012-052602]	Ministry of Economy and Finance of Spain	This study was part of 2 research projects funded by the Ministry of Economy and Finance of Spain (Project AGL2013-44061-R, to AAKS and GC, and Project RTA205-00035-C03-02, to GC) and it was also supported by a research scholarship to ACJ from the same funding source (Reference ES-2012-052602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamer M, 2011, ASIAN J ANIM VET ADV, V6, P1153, DOI 10.3923/ajava.2011.1153.1169; AOAC (Association of Official Analytical Chemists), 2003, OFF METH AN ASS OFF, DOI [10.2174/2213235X11301010092, DOI 10.2174/2213235X11301010092]; Baumgard LH, 2013, ANNU REV ANIM BIOSCI, V1, P311, DOI 10.1146/annurev-animal-031412-103644; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernabucci U, 2010, ANIMAL, V4, P1167, DOI 10.1017/S175173111000090X; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Castro-Costa A, 2015, J DAIRY SCI, V98, P4646, DOI 10.3168/jds.2014-8819; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; CLARKSON PM, 1993, NUTR NEEDS HOT ENV A; COLLIER RJ, 1982, J DAIRY SCI, V65, P2213, DOI 10.3168/jds.S0022-0302(82)82484-3; Colthorpe KL, 1998, J NEUROENDOCRINOL, V10, P503; Contreras-Jodar A, 2018, J DAIRY RES, V85, P423, DOI [10.1017/S0022029918000705, 10.1017/s0022029918000705]; Das R, 2016, VET WORLD, V9, P260, DOI 10.14202/vetworld.2016.260-268; Dokladny K, 2015, AUTOPHAGY, V11, P200, DOI 10.1080/15548627.2015.1009776; Dou S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188469; Dzurik R, 2001, KIDNEY INT, V59, pS278; Fan CY, 2018, ASIAN AUSTRAL J ANIM, V31, P1244, DOI 10.5713/ajas.17.0576; Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014; Gao ST, 2017, J DAIRY SCI, V100, P5040, DOI 10.3168/jds.2016-11913; Hamzaoui S, 2013, J DAIRY SCI, V96, P6355, DOI 10.3168/jds.2013-6665; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; Hooper HB, 2018, INT J BIOMETEOROL, V62, P2257, DOI 10.1007/s00484-018-1630-3; Hurley W. L., 2010, LACTATION BIOL WEBSI; Ippolito Danielle L., 2014, BMC Physiology, V14, P14, DOI 10.1186/s12899-014-0014-0; Ji P, 2018, J ETHNOPHARMACOL, V211, P101, DOI 10.1016/j.jep.2017.09.028; Kahl S, 2015, DOMEST ANIM ENDOCRIN, V52, P43, DOI 10.1016/j.domaniend.2015.02.001; Karlsson PC, 2005, J NUTR, V135, P2343; Klionsky DJ, 2013, J INNATE IMMUN, V5, P427, DOI 10.1159/000351979; KREGEL KC, 1988, J APPL PHYSIOL, V64, P2582, DOI 10.1152/jappl.1988.64.6.2582; Lambert GP, 2009, J ANIM SCI, V87, pE101, DOI 10.2527/jas.2008-1339; Lees HJ, 2013, J PROTEOME RES, V12, P1527, DOI 10.1021/pr300900b; Macfarlane GT, 1997, SCAND J GASTROENTERO, V32, P3, DOI 10.1080/00365521.1997.11720708; MARTIN AK, 1982, BRIT J NUTR, V47, P139, DOI 10.1079/BJN19820019; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; NRC, 1971, GUID ENV RES AN; Pallister T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13722-4; Patton RA, 2015, J DAIRY SCI, V98, P4707, DOI 10.3168/jds.2014-9000; Pearce SC, 2013, J ANIM SCI, V91, P5183, DOI 10.2527/jas.2013-6759; Pechlivanis A, 2010, J PROTEOME RES, V9, P6405, DOI 10.1021/pr100684t; R Core Team, 2013, R LANG ENV STAT COMP; Ramezani A, 2014, J AM SOC NEPHROL, V25, P657, DOI 10.1681/ASN.2013080905; Rhoads ML, 2009, J DAIRY SCI, V92, P1986, DOI 10.3168/jds.2008-1641; Ronchi B, 2001, LIVEST PROD SCI, V68, P231, DOI 10.1016/S0301-6226(00)00232-3; Salama AAK, 2014, SMALL RUMINANT RES, V121, P73, DOI 10.1016/j.smallrumres.2013.11.021; SERGENT D, 1985, REPROD NUTR DEV, V25, P629, DOI 10.1051/rnd:19850504; Shwartz G, 2009, J DAIRY SCI, V92, P935, DOI 10.3168/jds.2008-1496; Tian H, 2016, SCI REP-UK, V6, DOI 10.1038/srep24208; Tian H, 2015, J PROTEOMICS, V125, P17, DOI 10.1016/j.jprot.2015.04.014; TUCKER HA, 1991, P SOC EXP BIOL MED, V197, P74; Tytell M, 2001, Expert Opin Ther Targets, V5, P267, DOI 10.1517/14728222.5.2.267; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wheelock JB, 2010, J DAIRY SCI, V93, P644, DOI 10.3168/jds.2009-2295; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yamamoto H, 2009, CHEMOMETR INTELL LAB, V98, P136, DOI 10.1016/j.chemolab.2009.05.006	57	25	26	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0202457	10.1371/journal.pone.0202457	http://dx.doi.org/10.1371/journal.pone.0202457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735497	Green Published, Green Submitted, gold			2022-12-26	WOS:000458181200004
J	Zungu, NP; Mabaso, ML; Kumalo, F; Sigida, S; Mlangeni, L; Wabiri, N; Chasela, C				Zungu, Nompumelelo Precious; Mabaso, Musawenkosi Lionel; Kumalo, Faith; Sigida, Salome; Mlangeni, Lungelo; Wabiri, Njeri; Chasela, Charles			Prevalence of non-communicable diseases (NCDs) and associated factors among HIV positive educators: Findings from the 2015/6 survey of Health of Educators in Public Schools in South Africa	PLOS ONE			English	Article								Introduction In many sub-Saharan African countries, confronting the dual epidemic of HIV and NCDs is a public health priority especially in high HIV burden countries such as South Africa. Evidence shows that poor health as a consequence of NCDs and HIV among the workforce increases absenteeism and leads to decrease in productivity. However, the prevalence of these co-occurring chronic conditions and associated factors is unknown in the educator workforce. Improved understanding has implications for their management and wellbeing of educators. This paper reports the prevalence of selected NCDs and associated factors among HIV positive educators in South Africa using the 2015/6 survey of Educators in Public Schools in South Africa. Methods This was a second-generation surveillance undertaken among educators in selected public schools in all nine provinces in South Africa. A multi-stage stratified cluster design with probability proportional to size sampling was used to draw a random sample of schools. Factors associated with presence of NCDs were determined using a multivariate backward stepwise logistic regression analysis. Results A total of 1 365 schools were sampled within which 21 495 (85.5%) educators were interviewed. Out of 2691, HIV Positive educators that responded to the questions on NCDs, 36.9% reported having NCDs. The most commonly reported NCDs were high blood pressure (17.4%), and stomach ulcers (13.5%). The increased odds of reporting the presence of NCDs was significantly associated with being female than male [aOR = 1.5: 95% CI (1.1-1.9), p<0.002], age 45 to 54 years [aOR = 1.8: 95% CI (1.4-2.2), p = p<0.001], and age 55 years and older than those 18 to 24 years [aOR = 2.7: 95% CI (1.8-3.9), p<0.001). The decreased odds of reporting the presence of NCDs was significantly associated with not being absent from school for health reasons [aOR = 0.7: 95% CI (0.6-0.9), p = 0.003]. Conclusion NCDs care and active screening should be an integral part of HIV programmes including interventions such as prevention, treatment, care and support amongst public school educators in SA. The education department will need to invest in health promotion intervention programmes to prevent and mitigate the negative impact of NCDs and HIV on the sector.	[Zungu, Nompumelelo Precious; Mabaso, Musawenkosi Lionel; Sigida, Salome; Mlangeni, Lungelo; Wabiri, Njeri] Human Sci Res Council, Pretoria, South Africa; [Zungu, Nompumelelo Precious] Univ Pretoria, Dept Psychol, Pretoria, South Africa; [Kumalo, Faith] Dept Basic Educ, Pretoria, South Africa; [Chasela, Charles] Right Care, EQUIP Programme, Johannesburg, South Africa; [Chasela, Charles] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Dept Epidemiol & Biostat, Johannesburg, South Africa	Human Sciences Research Council-South Africa; University of Pretoria; University of Witwatersrand	Zungu, NP (corresponding author), Human Sci Res Council, Pretoria, South Africa.; Zungu, NP (corresponding author), Univ Pretoria, Dept Psychol, Pretoria, South Africa.	mzungu@hsrc.ac.za		Zungu, Nompumelelo/0000-0003-1275-2317	Global Fund to Fight AIDS, Tuberculosis and Malaria through Networking HIV and AIDS Community of Southern Africa (NACOSA); Human Sciences Research Council (HSRC)	Global Fund to Fight AIDS, Tuberculosis and Malaria through Networking HIV and AIDS Community of Southern Africa (NACOSA); Human Sciences Research Council (HSRC)	This work received support from The Global Fund to Fight AIDS, Tuberculosis and Malaria through Networking HIV and AIDS Community of Southern Africa (NACOSA) on behalf of The South African National AIDS Council (SANAC) and Department of Basic Education (DBE), and the Human Sciences Research Council (HSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, CLOS GAP GEN HLTH EQ; Chhoun P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187591; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Guariguata L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131737; Hofman Karen, 2014, SAMJ, S. Afr. med. j., V104, P01; Kolbe-Alexander T, 2014, J OCCUP ENVIRON MED, V56, P1094, DOI 10.1097/JOM.0000000000000236; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Minicuci N, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.21292; Narayan KMV, 2014, JAIDS-J ACQ IMM DEF, V67, pS2, DOI 10.1097/QAI.0000000000000267; Negin Joel, 2012, AIDS, V26 Suppl 1, pS55; Oni T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0750-1; Phaswana-Mafuya N, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20680; Ruchi Sogarwal, 2015, Journal of AIDS and Clinical Research, V6, P472; Shisana O, 2005, HLTH OUR ED FOCUS HI; Simbayi L., 2019, S AFRICAN NATL HIV P; Smit M, 2018, AIDS, V32, P773, DOI [10.1097/QAD.0000000000001754, 10.1097/qad.0000000000001754]; The Joint United Nations Programme on HIV/AIDS (UNAIDS) New York, 2011, CHRON CAR HIV NONC D; van Heerden A, 2017, J INT AIDS SOC, V20, DOI 10.1002/jia2.25012; Wandera SO, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25686; Zuma K, 2016, HLTH ED PUBLIC SCH S	20	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0209756	10.1371/journal.pone.0209756	http://dx.doi.org/10.1371/journal.pone.0209756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735504	Green Submitted, Green Published, gold			2022-12-26	WOS:000458181200009
J	Koziej, M; Polak, J; Wnuk, J; Trybus, M; Walocha, J; Chrapusta, A; Brzegowy, P; Mizia, E; Popiela, T; Holda, M				Koziej, Mateusz; Polak, Jakub; Wnuk, Jakub; Trybus, Marek; Walocha, Jerzy; Chrapusta, Anna; Brzegowy, Pawel; Mizia, Ewa; Popiela, Tadeusz; Holda, Mateusz			The transverse facial artery anatomy: Implications for plastic surgery procedures	PLOS ONE			English	Article							TOPOGRAPHICAL ANATOMY; FACE; MIDFACE	Background The transverse facial artery (TFA) perfuses the lateral face. Knowledge of topographical anatomy of the lateral face is crucial for safe procedural performance in aesthetic and plastic surgery, especially the face lift flap and face transplant. The aim of the present study was to assess detailed TFA morphometrical features. Patients and methods One-hundred computed tomography head angiographies were analyzed. TFA numbers and origins were recorded bilaterally (200 cases). TFA diameters and lengths in addition to their positions in relation to neighboring vessels and the zygomatic arches were measured. Results TFA was present in 96% of cases (192/ 200, left = 97, right = 95). A single TFA was present in 95.3% and double TFAs were present in 4.7% of cases. In 91.7%, the TFA originated from the superficial temporal artery, and in 3.1%, it originated from the external carotid artery. One left TFA originated from the maxillary artery. The TFA was significantly longer on the right than on the left side (56.626.0 versus 47.322.2 mm; p = 0.03). The TFA mean diameter was 1.00.4 mm (range: 0.4-2.2 mm) with no difference between face sides. TFA length correlated with its diameter (r = 0.46, p <0.05). The TFA always originated below the zygomatic arch, and it should be found in the 8.8 mm wide area beginning 17.0mm below the lower border of the zygomatic arch. Conclusions The TFA has a significant role in lateral face vascularization, and absence of this vessel is very uncommon.	[Koziej, Mateusz; Walocha, Jerzy; Mizia, Ewa; Holda, Mateusz] Jagiellonian Univ, Med Coll, Dept Anat, Krakow, Poland; [Koziej, Mateusz; Chrapusta, Anna] Malopolska Ctr Burns & Plast Surg, Krakow, Poland; [Koziej, Mateusz; Chrapusta, Anna] Ludwik Rydygier Hosp, Krakow, Poland; [Polak, Jakub; Wnuk, Jakub; Brzegowy, Pawel; Popiela, Tadeusz] Jagiellonian Univ, Med Coll, Dept Radiol, Krakow, Poland; [Trybus, Marek] Jagiellonian Univ, Med Coll, Dept Gen Surg 2, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Trybus, M (corresponding author), Jagiellonian Univ, Med Coll, Dept Gen Surg 2, Krakow, Poland.	m_trybus@interia.pl	Trybus, Marek/AAI-8705-2020; Walocha, Jerzy/AAS-9174-2020; Walocha, Jerzy/ABB-9607-2021; Hołda, Mateusz K/U-3199-2017; Hołda, Mateusz K./H-4705-2019	Hołda, Mateusz K/0000-0001-5754-594X; Hołda, Mateusz K./0000-0001-5754-594X; Polak, Jakub/0000-0001-9805-8267; Wnuk, Jakub/0000-0002-7915-6563	Jagiellonian University Medical College	Jagiellonian University Medical College	This work was supported by Jagiellonian University Medical College. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacar R, 2004, MORPHOLOGIE, V88, P191, DOI [10.1016/S1286-0115(04)98148-9, DOI 10.1016/S1286-0115(04)98148-9]; Baccarani A, 2006, ANN PLAS SURG, V57, P483, DOI 10.1097/01.sap.0000227486.28556.3e; Banks ND, 2009, PLAST RECONSTR SURG, V123, P1677, DOI 10.1097/PRS.0b013e3181a3f3ae; Bratu T, 2010, CLIN ANAT, V23, P460, DOI 10.1002/ca.20988; Cormack GC., 1986, ARTERIAL ANATOMY SKI; Eid N, 2011, CLIN ANAT, V24, P953, DOI 10.1002/ca.21126; Houseman ND, 2000, PLAST RECONSTR SURG, V105, P2287, DOI 10.1097/00006534-200006000-00001; Iida E, 2008, J COMPUT ASSIST TOMO, V32, P397, DOI 10.1097/RCT.0b013e3181151331; Lee JY, 2014, ANN PLAS SURG, V73, P321, DOI 10.1097/SAP.0b013e31827cd8d9; Levesque A, 2014, FACIAL PLAST SURG, V30, P373, DOI 10.1055/s-0034-1383558; Moyer Jeffrey S, 2005, Facial Plast Surg Clin North Am, V13, P469, DOI 10.1016/j.fsc.2005.04.005; Renshaw A, 2007, ANN PLAS SURG, V59, P82, DOI 10.1097/01.sap.0000252066.03494.53; Sakellariou A, 2014, ORAL MAXIL SURG CLIN, V26, P389, DOI 10.1016/j.coms.2014.05.007; Schaverien MV, 2009, PLAST RECONSTR SURG, V123, P1581, DOI 10.1097/PRS.0b013e3181a20544; Standring S, 2015, GRAYS ANATOMY ANATOM, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Tubbs R Shane, 2005, Folia Morphol (Warsz), V64, P226; Wei F, 2009, FLAPS RECONSTRUCTIVE; Yang HJ, 2010, CLIN ANAT, V23, P733, DOI 10.1002/ca.20999; Yang HJ, 2010, CLIN ANAT, V23, P168, DOI 10.1002/ca.20880; Zhao WR, 2019, AESTHET SURG J, V39, P1109, DOI 10.1093/asj/sjy228	20	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211974	10.1371/journal.pone.0211974	http://dx.doi.org/10.1371/journal.pone.0211974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730953	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000082
J	Spielmeyer, A; Schetelig, MF; Etang, J				Spielmeyer, Astrid; Schetelig, Marc F.; Etang, Josiane			High-throughput analysis of insecticides on malaria vectors using liquid chromatography tandem mass spectrometry	PLOS ONE			English	Article							GAS-CHROMATOGRAPHY; SCREENING SYSTEM; WATER-LOSS; PESTICIDES; MORTALITY; FOOD; QUECHERS; FORMATE	Background Different setups and protocols have been developed for investigating insecticide effects on Anopheles (An.) mosquitoes, vectors of malaria. However, chemical uptake resulting from their tarsal contact with insecticide-treated material has seldom been investigated. To address the challenges encountered in the interpretation of bioassay data, a high through-put method for chemical analysis on malaria vectors was developed and validated for five selected insecticides including alpha-cypermethrin (aCYP), deltamethrin (DM), etofenprox (EPX), permethrin (PM), pirimiphos-methyl (PPM). Methods The method includes a single chemical extraction step via an ultrasound probe on mosquito samples and analysis via liquid chromatography coupled to high-resolution tandem mass spectrometry (UHPLC-MS/MS). The protocol was established for two malaria vector species, Anopheles gambiae senso stricto (s.s.) and An. stephensi, both males and females. Recovery rates ranged from 70 to 100% without any influence of sex or species. The method was efficiently applied to female An. gambiae s.s. of the KISUMU1 reference strain, after susceptibility tests using the World Health Organization's standard protocol. Results Susceptibility tests revealed 13.4-18.4 minutes knockdown times for 50% mosquitoes during exposure to EPX and pyrethroids. The mortality rates 24 hours post-exposure to insecticides were mostly 99-100%, except in two PM and three PPM assays suggesting possible or confirmed resistance to these insecticides. The mean insecticide uptake in dead mosquitoes ranged from 23 pg (aCYP) to 1812 pg (EPX) per specimen. However, the mean uptake in survivors to PM and PPM was reduced by at least 25%, suggesting that acute doses were not achieved in these specimens during bioassays. Conclusions The developed and validated UHPLC-MS/MS method could be used to address some limitations of bioassays or to assess the penetration of insecticides in mosquito matrix with reference to cuticle thickness and other insecticide resistance mechanisms.	[Spielmeyer, Astrid] Justus Liebig Univ Giessen, Inst Food Chem & Food Biotechnol, Giessen, Germany; [Schetelig, Marc F.; Etang, Josiane] Justus Liebig Univ Giessen, Inst Insect Biotechnol, Giessen, Germany; [Etang, Josiane] IRY, Org Coordinat Lutte Endemies Afrique Cent OCEAC, Yaounde, Cameroon; [Etang, Josiane] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon	Justus Liebig University Giessen; Justus Liebig University Giessen	Schetelig, MF; Etang, J (corresponding author), Justus Liebig Univ Giessen, Inst Insect Biotechnol, Giessen, Germany.; Etang, J (corresponding author), IRY, Org Coordinat Lutte Endemies Afrique Cent OCEAC, Yaounde, Cameroon.; Etang, J (corresponding author), Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon.	Marc.schetelig@agrar.uni-giessen.de; josyet2@gmail.com	Schetelig, Marc F./AAD-2332-2019	Schetelig, Marc F./0000-0002-9217-394X	Alexander von Humboldt-Stiftung [3.4 - CMR - 1164160]; LOEWE Center for Insect Biotechnology & Bioresources of the Hessian State Ministry for Higher Education, Research and the Arts; Deutsche Forschungsgemeinschaft (DFG) [INST 162/490-1 FUGG]; State of Hesse [INST 162/490-1 FUGG]	Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation); LOEWE Center for Insect Biotechnology & Bioresources of the Hessian State Ministry for Higher Education, Research and the Arts; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); State of Hesse	This work was funded by the Alexander von Humboldt-Stiftung (grant number 3.4 - CMR - 1164160) in the framework of the Georg Forster Research Fellowship (HERMES) for Experienced Researchers (to JE). Funding was also provided by the LOEWE Center for Insect Biotechnology & Bioresources of the Hessian State Ministry for Higher Education, Research and the Arts (MFS). The authors are grateful to the Deutsche Forschungsgemeinschaft (DFG) and the State of Hesse for funding the TripleTOF mass spectrometer (INST 162/490-1 FUGG, Institute of Food Chemistry, Prof. Hamscher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder L, 2006, MASS SPECTROM REV, V25, P838, DOI 10.1002/mas.20091; Gonzalez-Curbelo MA, 2014, J CHROMATOGR A, V1358, P75, DOI 10.1016/j.chroma.2014.06.104; [Anonymous], 2016, WORLD HLTH ORG TECHN, DOI [10.1021/jp052915b, DOI 10.1021/JP052915B]; [Anonymous], 2005, GUIDELINES LAB FIELD; BERMEJO J, 1986, J CHROMATOGR, V351, P425, DOI 10.1016/S0021-9673(01)83520-2; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159; Chemat F, 2017, ULTRASON SONOCHEM, V34, P540, DOI 10.1016/j.ultsonch.2016.06.035; Dadzie S, 2017, J ENTOMOL ZOOL STUD, V5, P701; Deletre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082103; DETHIER VG, 1960, J ECON ENTOMOL, V53, P134, DOI 10.1093/jee/53.1.134; DIN Deutsches Institut fur Normung e. V, 3840251 DIN; European Commission Directorate-General for Health and Food Safety, 2017, OFF J EUR UNION; Finney D.J., 1971, PROBIT ANAL; GEROLT P, 1976, PESTIC SCI, V7, P604, DOI 10.1002/ps.2780070612; Glunt KD, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-350; Grieco JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000716; Grieco JP, 2005, J AM MOSQUITO CONTR, V21, P404, DOI 10.2987/8756-971X(2006)21[404:ANHSST]2.0.CO;2; He ZY, 2015, FOOD CHEM, V169, P372, DOI 10.1016/j.foodchem.2014.07.102; Jenkins DW, 2013, TROP MED INT HEALTH, V18, P2, DOI 10.1111/tmi.12011; Juo CG, 2014, RAPID COMMUN MASS SP, V28, P1813, DOI 10.1002/rcm.6962; KILLEEN GF, 2013, PARASITE VECTOR, V6, P88212; Kulma K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058322; Masia A, 2016, ANAL CHIM ACTA, V936, P40, DOI 10.1016/j.aca.2016.07.023; Mbare O, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-94; Oliver SV, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-390; Ouattara JPN, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-77; Pesticide Properties DataBase (PPDB), NON TRADITIONAL REF; Prato G D. R, 1997, NON TRADITIONAL REF; Rek JC, 2018, LANCET PLANET HEALTH, V2, pE83, DOI 10.1016/S2542-5196(18)30010-X; Rinkevich FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139841; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; SEELEY TD, 1994, BEHAV ECOL SOCIOBIOL, V34, P51, DOI 10.1007/BF00175458; SMITH A, 1969, B ENTOMOL RES, V59, P457, DOI 10.1017/S0007485300003424; Thanispong K, 2010, J MED ENTOMOL, V47, P833, DOI 10.1603/ME09246; Viana M, 2016, P NATL ACAD SCI USA, V113, P8975, DOI 10.1073/pnas.1603431113; Wanjala CL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1194-6; White GB, 2007, INSECT REPELLENTS PR; WHO, 2013, NON TRADITIONAL REF; WHO, 2006, GUIDELINES TESTING M; WHO, 2015, GLOB TECHN STRAT MAL; World Health Organization, 2011, GUIDELINES FOR MONIT; World Health Organization, 2017, DEPRESSION; Zheng HY, 2013, PESTIC BIOCHEM PHYS, V107, P153, DOI 10.1016/j.pestbp.2012.12.004	44	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211064	10.1371/journal.pone.0211064	http://dx.doi.org/10.1371/journal.pone.0211064			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730918	Green Published, Green Submitted, gold			2022-12-26	WOS:000458026000013
J	Campanella, F; Auster, PJ; Taylor, JC; Munoz, RC				Campanella, Fabio; Auster, Peter J.; Taylor, J. Christopher; Munoz, Roldan C.			Dynamics of predator-prey habitat use and behavioral interactions over diel periods at sub-tropical reefs	PLOS ONE			English	Article							FISH; RISK; THRESHOLDS; ECOSYSTEMS; MORPHOLOGY; LANDSCAPE; VIGILANCE; SELECTION; FEATURES; GEORGIA	The dynamics of fish communities at tropical and sub-tropical rocky reefs are influenced in many cases by predation activity and predator-prey interactions. These processes usually follow specific diel patterns in reef areas with higher rates of these interactions occurring during the crepuscular periods. However, other factors such as habitat complexity and species-specific behavior may alter these patterns, increasing variability in species interactions. A better understanding of the dynamics of these patterns and processes would allow us to manage and monitor fish communities in these productive and vulnerable areas more efficiently. We investigated behavioral changes of predators and prey fish in sub-tropical "livebottom" (sandstone) reefs at Gray's Reef National Marine Sanctuary (GRNMS), located 20 nautical miles off the coast of Georgia, USA, using fisheries acoustic methods in association with visual census and direct observation using SCUBA. Changes in co-location and habitat preferences of predators and prey over time throughout the diel cycle were investigated using species distribution models (MAXENT) based on habitat predictors and by means of spatial statistics. The results indicate that predator and prey distribution patterns changed considerably throughout the day. Prey and predator species exhibited complex spatial dynamics and behavior over diel periods, with prey modifying patterns of habitat use and spatial distribution, likely as a response of their interactions with predators. Crepuscular periods were confirmed to be the most active phases in terms of predator-prey interactions and consequently the most variable. The combination of tools and approaches used in this study provided valuable sources of information that support the inferences of predation risk-driven habitat selection of prey in this sub-tropical reef system.	[Campanella, Fabio] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Auster, Peter J.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Auster, Peter J.] Myst Aquarium, Mystic, CT USA; [Taylor, J. Christopher] NOAA, Natl Ctr Coastal Ocean Sci, Beaufort Lab, Beaufort, NC USA; [Munoz, Roldan C.] NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort Lab, Beaufort, NC USA	Centre for Environment Fisheries & Aquaculture Science; University of Connecticut; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA	Campanella, F (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England.	fabio.campanella@cefas.co.uk	Auster, Peter/ABI-3568-2020	Campanella, Fabio/0000-0002-4705-1791				Almany GR, 2004, OECOLOGIA, V141, P105, DOI 10.1007/s00442-004-1617-0; Auster PJ, 2013, B MAR SCI, V89, P377, DOI 10.5343/bms.2011.1123; Auster PJ, 2009, NEOTROP ICHTHYOL, V7, P109, DOI 10.1590/S1679-62252009000100014; Barley SC, 2017, MAR ECOL PROG SER, V565, P163, DOI 10.3354/meps11981; Bosiger YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111723; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Campanella F, 2016, FISH RES, V181, P63, DOI 10.1016/j.fishres.2016.03.027; Catano LB, 2016, J ANIM ECOL, V85, P146, DOI 10.1111/1365-2656.12440; Connell SD, 1996, MAR BIOL, V126, P347, DOI 10.1007/BF00347459; Costa B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085555; Danilowicz BS, 1999, MAR BIOL, V133, P337, DOI 10.1007/s002270050472; Davenport JM, 2013, ECOL EVOL, V3, P3063, DOI 10.1002/ece3.691; Di Iorio D., 2017, CLIMATE DATA SINERR, DOI [10.6073/pasta/f39f09f78f76e069005424e528bf2360, DOI 10.6073/PASTA/F39F09F78F76E069005424E528BF2360]; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Foote K.G., 1987, ICES COOPERATIVE RES, V144, P1, DOI DOI 10.1121/1.396131; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Gastauer S, 2017, ACOUST AUST, V45, P363, DOI 10.1007/s40857-017-0100-0; Gorini L, 2012, MAMMAL REV, V42, P55, DOI 10.1111/j.1365-2907.2011.00189.x; Hammerschlag N, 2010, MAR ECOL PROG SER, V414, P223, DOI 10.3354/meps08731; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2009, J ANIM ECOL, V78, P556, DOI 10.1111/j.1365-2656.2008.01512.x; Helfman G.S., 1993, BEHAV TELEOST FISHES, P479, DOI DOI 10.1007/978-94-011-1578-0; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; Hixon Mark A., 2015, P41; Hixon MA, 2011, B MAR SCI, V87, P727, DOI 10.5343/bms.2010.1055; Hobson E.S., 1968, FISH WILDLIFE SERV R, V73, P1; HOBSON ES, 1972, FISH BULL NATL OC AT, V70, P715; Kendall MS, 2009, B MAR SCI, V84, P265; Kendall MS, 2005, J COASTAL RES, V21, P1154, DOI 10.2112/03-0101R.1; Kendall MS, 2007, 50 NOAA NOS NCCOS; Koslow JA, 2009, ICES J MAR SCI, V66, P966, DOI 10.1093/icesjms/fsp082; Lannin R, 2011, MAR ECOL PROG SER, V442, P59, DOI 10.3354/meps09393; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; LIMA SL, 1995, ANIM BEHAV, V49, P11, DOI 10.1016/0003-3472(95)80149-9; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Liu CR, 2016, ECOL EVOL, V6, P337, DOI 10.1002/ece3.1878; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; LOVE RH, 1977, J ACOUST SOC AM, V62, P1397, DOI 10.1121/1.381672; Madin EMP, 2016, GLOBAL CHANGE BIOL, V22, P44, DOI 10.1111/gcb.13083; Madin EMP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00014; Marasco RJ, 2007, CAN J FISH AQUAT SCI, V64, P928, DOI 10.1139/F07-062; McFarland W., 1975, LIGHT ECOLOGICAL FAC, P249; MILINSKI M, 1978, NATURE, V275, P642, DOI 10.1038/275642a0; Milinski Manfred, 1993, Fish and Fisheries Series, V7, P285; Mourier J, 2016, CURR BIOL, V26, P2011, DOI 10.1016/j.cub.2016.05.058; Munoz RC, 5 YEAR REV SCI RES G; PANKHURST NW, 1989, ENVIRON BIOL FISH, V26, P201, DOI 10.1007/BF00004816; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pittman SJ, 2009, J COASTAL RES, V25, P27, DOI [10.2112/SI53-004.1, 10.2112/S153-004.1]; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; Rose KA, 2010, MAR COAST FISH, V2, P115, DOI 10.1577/C09-059.1; Ruttenberg BI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021062; Simmonds J., 2005, FISHERIES ACOUSTICS; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stallings CD, 2012, B MAR SCI, V88, P317, DOI 10.5343/bms.2012.1004; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Travis J, 2014, P NATL ACAD SCI USA, V111, P581, DOI 10.1073/pnas.1305853111; Walsh SM, 2012, J FISH BIOL, V80, P519, DOI 10.1111/j.1095-8649.2011.03209.x; Webster MS, 2002, OECOLOGIA, V131, P52, DOI 10.1007/s00442-001-0860-x; WERNER EE, 1988, ECOLOGY, V69, P1352, DOI 10.2307/1941633; Woillez M, 2009, AQUAT LIVING RESOUR, V22, P155, DOI 10.1051/alr/2009017; Yahel R, 2005, LIMNOL OCEANOGR, V50, P930, DOI 10.4319/lo.2005.50.3.0930	67	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211886	10.1371/journal.pone.0211886	http://dx.doi.org/10.1371/journal.pone.0211886			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726295	Green Published, Green Submitted, gold			2022-12-26	WOS:000457874000085
J	Torres-Hernandez, A; Wang, W; Nikiforov, Y; Tejada, K; Torres, L; Kalabin, A; Wu, Y; Ul Haq, MI; Khan, MY; Zhao, Z; Su, WY; Camargo, J; Hundeyin, M; Diskin, B; Adam, S; Rossi, JAK; Kurz, E; Aykut, B; Shadaloey, SAA; Leinwand, J; Miller, G				Torres-Hernandez, Alejandro; Wang, Wei; Nikiforov, Yuri; Tejada, Karla; Torres, Luisana; Kalabin, Aleksandr; Wu, Yue; Ul Haq, Muhammad Israr; Khan, Mohammed Y.; Zhao, Zhen; Su, Wenyu; Camargo, Jimmy; Hundeyin, Mautin; Diskin, Brian; Adam, Salma; Rossi, Juan A. Kochen; Kurz, Emma; Aykut, Berk; Shadaloey, Sorin A. A.; Leinwand, Joshua; Miller, George			Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis	ONCOGENE			English	Article							HEPATIC STELLATE CELLS; TYROSINE KINASE; RECEPTOR 4; INFLAMMATION; INHIBITION; INJURY; NK	Liver fibrosis and fibrosis-associated hepatocarcinogenesis are driven by chronic inflammation and are leading causes of morbidity and death worldwide. SYK signaling regulates critical processes in innate and adaptive immunity, as well as parenchymal cells. We discovered high SYK expression in the parenchymal hepatocyte, hepatic stellate cell (HSC), and the inflammatory compartments in the fibrotic liver. We postulated that targeting SYK would mitigate hepatic fibrosis and oncogenic progression. We found that inhibition of SYK with the selective small molecule inhibitors Piceatannol and PRT062607 markedly protected against toxin-induced hepatic fibrosis, associated hepatocellular injury and intra-hepatic inflammation, and hepatocarcinogenesis. SYK inhibition resulted in increased intra-tumoral expression of the p16 and p53 but decreased expression of Bcl-xL and SMAD4. Further, hepatic expression of genes regulating angiogenesis, apoptosis, cell cycle regulation, and cellular senescence were affected by targeting SYK. We found that SYK inhibition mitigated both HSC trans-differentiation and acquisition of an inflammatory phenotype in T cells, B cells, and myeloid cells. However, in vivo experiments employing selective targeted deletion of SYK indicated that only SYK deletion in the myeloid compartment was sufficient to confer protection against fibrogenic progression. Targeting SYK promoted myeloid cell differentiation into hepato-protective TNF alpha(low) CD206(hi) phenotype downregulating mTOR, IL-8 signaling and oxidative phosphorylation. Collectively, these data suggest that SYK is an attractive target for experimental therapeutics in treating hepatic fibrosis and oncogenesis.	[Torres-Hernandez, Alejandro; Wang, Wei; Nikiforov, Yuri; Tejada, Karla; Torres, Luisana; Kalabin, Aleksandr; Wu, Yue; Ul Haq, Muhammad Israr; Khan, Mohammed Y.; Zhao, Zhen; Su, Wenyu; Camargo, Jimmy; Hundeyin, Mautin; Diskin, Brian; Adam, Salma; Rossi, Juan A. Kochen; Kurz, Emma; Aykut, Berk; Shadaloey, Sorin A. A.; Leinwand, Joshua; Miller, George] NYU, Sch Med, Dept Surg, SA Localio Lab, 450 East 29th St, New York, NY 10016 USA; [Miller, George] NYU, Sch Med, Dept Cell Biol, 450 East 29th St, New York, NY 10016 USA	New York University; New York University	Miller, G (corresponding author), NYU, Sch Med, Dept Surg, SA Localio Lab, 450 East 29th St, New York, NY 10016 USA.; Miller, G (corresponding author), NYU, Sch Med, Dept Cell Biol, 450 East 29th St, New York, NY 10016 USA.	george.miller@nyumc.org	Hundeyin, Mautin/AAU-6792-2020	Kalabin, Aleksandr/0000-0003-4133-6267	Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center [P30CA016087]; NYU Cancer Institute Center Support Grant [NIH/NCI 5 P30CA16087]; NCI [CA168611, CA155649, CA193111]; Society of University Surgeons-Ethicon Resident Research Award; American Liver Foundation-Thomas F. Nealon, III Postdoctoral Research Fellowship Honoring Zachery Rue; American Liver Foundation Postdoctoral Research Fellowship; NYU Physician-Scientist Training Program; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER	Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center; NYU Cancer Institute Center Support Grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Society of University Surgeons-Ethicon Resident Research Award; American Liver Foundation-Thomas F. Nealon, III Postdoctoral Research Fellowship Honoring Zachery Rue; American Liver Foundation Postdoctoral Research Fellowship; NYU Physician-Scientist Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the NYU Langone Health Genome Technology Center (GTC) for expert library preparation and sequencing; the GTC is partially supported by the Cancer Center Support Grant P30CA016087 at the Laura and Isaac Perlmutter Cancer Center. We thank the NYU Langone Health Experimental Pathology Research Laboratory, which is partially funded by NYU Cancer Institute Center Support Grant NIH/NCI 5 P30CA16087, for expert tissue processing and equipment support. This work was supported by NCI CA168611 (GM), CA155649 (GM), CA193111 (ATH, BD), Society of University Surgeons-Ethicon Resident Research Award (ATH), American Liver Foundation-Thomas F. Nealon, III Postdoctoral Research Fellowship Honoring Zachery Rue (ATH), American Liver Foundation Postdoctoral Research Fellowship (WW), NYU Physician-Scientist Training Program (ATH).	Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1; Coffey G, 2017, J CLIN PHARMACOL, V57, P194, DOI 10.1002/jcph.794; Cornall RJ, 2000, P NATL ACAD SCI USA, V97, P1713, DOI 10.1073/pnas.97.4.1713; Daley D, 2017, J EXP MED, V214, P1711, DOI 10.1084/jem.20161707; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; de Rosamel L, 2017, EXPERT OPIN EMERG DR, V22, P175, DOI 10.1080/14728214.2017.1336538; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Guo JS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-21; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Inarrairaegui M, 2018, CLIN CANCER RES, V24, P1518, DOI 10.1158/1078-0432.CCR-17-0289; Kant R, 2014, J MED MICROBIOL, V63, P293, DOI 10.1099/jmm.0.064220-0; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Kurniawan DW, 2018, J CONTROL RELEASE, V288, P227, DOI 10.1016/j.jconrel.2018.09.004; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marcus A, 2014, ADV IMMUNOL, V122, P91, DOI 10.1016/B978-0-12-800267-4.00003-1; Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025; Miller YI, 2012, BRIT J PHARMACOL, V167, P990, DOI 10.1111/j.1476-5381.2012.02097.x; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008; Novobrantseva TI, 2005, J CLIN INVEST, V115, P3072, DOI 10.1172/JCI24798; O'Neill LAJ, 2016, CELL REP, V17, P625, DOI 10.1016/j.celrep.2016.09.085; Ochi A, 2012, J EXP MED, V209, P1671, DOI 10.1084/jem.20111706; Poynard T, 2003, J HEPATOL, V38, P257, DOI 10.1016/S0168-8278(02)00413-0; Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353; Qu C, 2018, HEPATOLOGY, V68, P1125, DOI 10.1002/hep.29881; Seifert L, 2015, CELL REP, V13, P1909, DOI 10.1016/j.celrep.2015.10.058; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Thapa M, 2015, HEPATOLOGY, V61, P2067, DOI 10.1002/hep.27761; Uehara T., 2014, CURR PROTOC PHARM, V66, P11; Wang W, 2017, HEPATOLOGY, V66, P108, DOI 10.1002/hep.29129; Weiskirchen Ralf, 2014, Hepatobiliary Surg Nutr, V3, P344, DOI 10.3978/j.issn.2304-3881.2014.11.03; Wick G, 2010, TRENDS IMMUNOL, V31, P110, DOI 10.1016/j.it.2009.12.001; Yang J, 2015, J HEPATOCELL CARCINO, V2, P11, DOI 10.2147/JHC.S44515; Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138; Zambirinis CP, 2015, J EXP MED, V212, P2077, DOI 10.1084/jem.20142162; Zhou Z, 2018, CELL MOL GASTROENTER, V5, P399, DOI 10.1016/j.jcmgh.2018.01.003	41	15	16	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2019	38	23					4512	4526		10.1038/s41388-019-0734-5	http://dx.doi.org/10.1038/s41388-019-0734-5			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB4KM	30742098				2022-12-26	WOS:000470240300006
J	Peng, W; Tong, C; Li, L; Huang, CY; Ran, YX; Chen, XH; Bai, YX; Liu, YM; Zhao, JL; Tan, B; Luo, XF; Wang, H; Wen, L; Zhang, C; Zhang, H; Ding, YB; Qi, HB; Baker, PN				Peng, Wei; Tong, Chao; Li, Lei; Huang, Chengyu; Ran, Yuxin; Chen, Xuehai; Bai, Yuxiang; Liu, Yamin; Zhao, Jianlin; Tan, Bin; Luo, Xiaofang; Wang, Hao; Wen, Li; Zhang, Chen; Zhang, Hua; Ding, Yubin; Qi, Hongbo; Baker, Philip N.			Trophoblastic proliferation and invasion regulated by ACTN4 is impaired in early onset preeclampsia	FASEB JOURNAL			English	Article						migration; AKT; podosome; placenta	ALPHA-ACTININ; BINDING-PROTEINS; SCREEN REVEALS; BETA-CATENIN; ALPHA-ACTININ-4; ACTIVATION; MOTILITY; COMPLEX; DIFFERENTIATION; CYTOSKELETON	Successful pregnancy requires normal placentation, which largely depends on the tight regulation of proliferation, invasion, and migration of trophoblast cells. Abnormal functioning of trophoblast cells may cause failure of uterine spiral artery remodeling, which may be related to pregnancy-related disorders, such as preeclampsia. Here, we reported that an actin-binding protein, -actinin (ACTN)4, was dysregulated in placentas from early onset preeclampsia. Moreover, knockdown of ACTN4 markedly inhibited trophoblast cell proliferation by reducing AKT membrane translocation. Furthermore, E-cadherin regulated ACTN4 and -catenin colocalization on trophoblast cell podosomes, and ACTN4 down-regulation suppressed the E-cadherin-induced cell invasion increase via depolymerizing actin filaments. Moreover, loss of ACTN4 recapitulated a number of the features of human preeclampsia. Therefore, our data indicate that ACNT4 plays a role in trophoblast function and is required for normal placental development.Peng, W., Tong, C., Li, L., Huang, C., Ran, Y., Chen, X., Bai, Y., Liu, Y., Zhao, J., Tan, B., Luo, X., Wang, H., Wen, L., Zhang, C., Zhang, H., Ding, Y., Qi, H., Baker, P. N. Trophoblastic proliferation and invasion regulated by ACTN4 is impaired in early onset preeclampsia.	[Peng, Wei; Tong, Chao; Li, Lei; Ran, Yuxin; Chen, Xuehai; Bai, Yuxiang; Liu, Yamin; Zhao, Jianlin; Tan, Bin; Luo, Xiaofang; Wang, Hao; Wen, Li; Zhang, Chen; Zhang, Hua; Qi, Hongbo] Chongqing Med Univ, Dept Obstet, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China; [Peng, Wei; Tong, Chao; Li, Lei; Ran, Yuxin; Chen, Xuehai; Bai, Yuxiang; Liu, Yamin; Zhao, Jianlin; Tan, Bin; Luo, Xiaofang; Wang, Hao; Wen, Li; Zhang, Chen; Zhang, Hua; Qi, Hongbo; Baker, Philip N.] Chongqing Med Univ, State Key Lab Maternal & Fetal Med Chongqing Muni, Chongqing, Peoples R China; [Peng, Wei; Tong, Chao; Li, Lei; Ran, Yuxin; Chen, Xuehai; Bai, Yuxiang; Liu, Yamin; Zhao, Jianlin; Tan, Bin; Luo, Xiaofang; Wang, Hao; Wen, Li; Zhang, Chen; Zhang, Hua; Qi, Hongbo; Baker, Philip N.] Chongqing Med Univ, Int Collaborat Lab Reprod & Dev, Chinese Minist Educ, Chongqing, Peoples R China; [Huang, Chengyu; Ding, Yubin] Chongqing Med Univ, Sch Publ Hlth & Management, Lab Reprod Biol, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China; [Li, Lei] Shandong Univ, Shandong Prov Hosp, Dept Obstet & Gynecol, Jinan, Shandong, Peoples R China; [Baker, Philip N.] Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Leicester	Qi, HB (corresponding author), Chongqing Med Univ, Dept Obstet, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China.; Ding, YB (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Lab Reprod Biol, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.	dingyb@gmail.com; qihongbock@163.com	Qi, Hongbo/AAJ-5536-2020; Tong, Chao/AAM-2225-2020	Tong, Chao/0000-0003-0828-2674; Ding, Yubin/0000-0002-7870-9445	National Key Research and Development Program of Reproductive Health and Major Birth Defects Control and Prevention [2018YFC1004103, 2016YFC1000407]; National Natural Science Foundation of China [81520108013, 81771613, 81671488, 81871189, 81801482, 81601305, 81601304]; Chongqing Municipal Education Commission [CXTDX201601014]; Science and Technology Commission of Chongqing [cstc2017jcyjBX0045]; Chongqing Entrepreneurship and Innovation Supporting Program [cx2017104]; 111 Plan of the Ministry of Education of the People's Republic of China; State Administration of Foreign Experts Affairs of China	National Key Research and Development Program of Reproductive Health and Major Birth Defects Control and Prevention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Municipal Education Commission; Science and Technology Commission of Chongqing; Chongqing Entrepreneurship and Innovation Supporting Program; 111 Plan of the Ministry of Education of the People's Republic of China; State Administration of Foreign Experts Affairs of China	The authors thank Xue and Junwei Gu (both from the School of Public Health and Management, Chongqing Medical University) for technical assistance of animal study and primary cytotrophoblast isolation. This work was supported by the National Key Research and Development Program of Reproductive Health and Major Birth Defects Control and Prevention (2018YFC1004103, 2016YFC1000407), the National Natural Science Foundation of China (81520108013, 81771613, 81671488, 81871189, 81801482, 81601305, 81601304), Chongqing Municipal Education Commission (CXTDX201601014), Science and Technology Commission of Chongqing (cstc2017jcyjBX0045), and Chongqing Entrepreneurship and Innovation Supporting Program for Returned Overseas Students (cx2017104). The authors also appreciate the support from the 111 Plan of the Ministry of Education of the People's Republic of China and the State Administration of Foreign Experts Affairs of China.	An HT, 2016, ONCOGENE, V35, P5893, DOI 10.1038/onc.2016.117; Araki N, 2000, J CELL SCI, V113, P3329; Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Beards F, 2017, THERANOSTICS, V7, P2940, DOI 10.7150/thno.18845; Berania I, 2017, INT J CANCER, V141, P2318, DOI 10.1002/ijc.30915; Berkane N, 2017, ENDOCR REV, V38, P123, DOI 10.1210/er.2016-1065; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Bridger PS, 2008, BIOL REPROD, V79, P274, DOI 10.1095/biolreprod.108.067637; Burke SD, 2016, J CLIN INVEST, V126, P2561, DOI 10.1172/JCI83918; Burton GJ, 2014, PLACENTA, V35, P289, DOI 10.1016/j.placenta.2014.02.007; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Collin GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037925; Corso J, 2016, P NATL ACAD SCI USA, V113, P5688, DOI 10.1073/pnas.1601053113; Cureton N, 2017, THERANOSTICS, V7, P3715, DOI 10.7150/thno.19678; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Edlund M, 2001, CELL MOTIL CYTOSKEL, V48, P190, DOI 10.1002/1097-0169(200103)48:3<190::AID-CM1008>3.0.CO;2-C; Fayyad AM, 2005, EARLY HUM DEV, V81, P865, DOI 10.1016/j.earlhumdev.2005.09.005; Fu L, 2017, P NATL ACAD SCI USA, V114, pE4631, DOI 10.1073/pnas.1703178114; Hamill KJ, 2013, FASEB J, V27, P546, DOI 10.1096/fj.12-217406; Hara T, 2007, MOL CELL PROTEOMICS, V6, P479, DOI 10.1074/mcp.M600129-MCP200; Hayashida Y, 2005, CANCER RES, V65, P8836, DOI 10.1158/0008-5472.CAN-05-0718; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; James JL, 2010, J PATHOL, V221, P363, DOI 10.1002/path.2719; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Karumanchi SA, 2006, METH MOLEC MED, V122, P393; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kong SB, 2018, GENESIS, V56, DOI 10.1002/dvg.23101; Kumeta M, 2010, J CELL SCI, V123, P1020, DOI 10.1242/jcs.059568; Liao Q, 2017, BRIT J CANCER, V117, P563, DOI 10.1038/bjc.2017.193; Magdolen U, 2004, BIOL CHEM, V385, P801, DOI 10.1515/BC.2004.105; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Murphy DJ, 2000, HYPERTENS PREGNANCY, V19, P221, DOI 10.1081/PRG-100100138; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Patel A, 2012, EUR J CELL BIOL, V91, P171, DOI 10.1016/j.ejcb.2011.11.006; Plaks V, 2013, P NATL ACAD SCI USA, V110, P11109, DOI 10.1073/pnas.1309561110; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Shao HS, 2010, J BIOL CHEM, V285, P2591, DOI 10.1074/jbc.M109.035790; Shibukawa Y, 2010, MOL BIOL CELL, V21, P3973, DOI 10.1091/mbc.E10-03-0261; Silva-Ayala D, 2013, P NATL ACAD SCI USA, V110, P10270, DOI 10.1073/pnas.1304932110; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Sun Y, 2016, MOL BIOL CELL, V27, P75, DOI 10.1091/mbc.E15-05-0319; Thomas DG, 2017, SEMIN CELL DEV BIOL, V71, P68, DOI 10.1016/j.semcdb.2017.05.024; Tobita T, 2017, PLACENTA, V59, pS37, DOI 10.1016/j.placenta.2017.09.012; Wang N, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0635-9; Wang Q, 2018, J CERAM SCI TECHNOL, V9, P1, DOI 10.4416/JCST2017-00044; Yung HW, 2014, J PATHOL, V234, P262, DOI 10.1002/path.4394; Zhang BZ, 2018, THERANOSTICS, V8, P2765, DOI 10.7150/thno.22904; Zhang YY, 2018, ONCOGENE, V37, P4033, DOI 10.1038/s41388-018-0260-x; Zhou CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029236	57	9	9	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6327	6338		10.1096/fj.201802058RR	http://dx.doi.org/10.1096/fj.201802058RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30776251	Green Submitted, Bronze			2022-12-26	WOS:000466932600041
J	Zhang, M; Hu, C; Moses, N; Haakenson, J; Xiang, SY; Quan, D; Fang, B; Yang, Z; Bai, WL; Bepler, G; Li, GM; Zhang, XM				Zhang, Mu; Hu, Chen; Moses, Niko; Haakenson, Joshua; Xiang, Shengyan; Quan, Daniel; Fang, Bin; Yang, Zhe; Bai, Wenlong; Bepler, Gerold; Li, Guo-Min; Zhang, Xiaohong Mary			HDAC6 regulates DNA damage response via deacetylating MLH1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone deacetylase 6 (HDAC6); DNA damage response; DNA mismatch repair; drug resistance; acetylation; acetylation; DNA damage response; DNA repair; HDAC6; MLH1	MISMATCH-REPAIR; HISTONE DEACETYLASES; HYPERMETHYLATION; EXPRESSION; MUTATIONS; CELLS	MutL homolog 1 (MLH1) is a key DNA mismatch repair protein, which plays an important role in maintenance of genomic stability and the DNA damage response. Here, we report that MLH1 is a novel substrate of histone deacetylase 6 (HDAC6). HDAC6 interacts with and deacetylates MLH1 both in vitro and in vivo. Interestingly, deacetylation of MLH1 blocks the assembly of the MutS-MutL complex. Moreover, we have identified four novel acetylation sites in MLH1 by MS analysis. The deacetylation mimetic mutant, but not the WT and the acetylation mimetic mutant, of MLH1 confers resistance to 6-thioguanine. Overall, our findings suggest that the MutS-MutL complex serves as a sensor for DNA damage response and that HDAC6 disrupts the MutS-MutL complex by deacetylation of MLH1, leading to the tolerance of DNA damage.	[Zhang, Mu; Hu, Chen; Bepler, Gerold; Zhang, Xiaohong Mary] Wayne State Univ, Sch Med, Dept Oncol, Karmanos Canc Inst,Mol Therapeut Program, Detroit, MI 48201 USA; [Moses, Niko] Wayne State Univ, Sch Med, Dept Oncol, Karmanos Canc Inst,Canc Biol Grad Program, Detroit, MI 48201 USA; [Haakenson, Joshua; Xiang, Shengyan; Bai, Wenlong] Univ S Florida, Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Quan, Daniel] Wayne State Univ, Sch Med, Detroit, MI 48201 USA; [Fang, Bin] H Lee Moffitt Canc Ctr & Res Inst, Prote Core, Tampa, FL 33612 USA; [Yang, Zhe] Wayne State Univ, Sch Med, Dept Microbiol Immunol & Biochem, Detroit, MI 48201 USA; [Li, Guo-Min] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; State University System of Florida; University of South Florida; Wayne State University; H Lee Moffitt Cancer Center & Research Institute; Wayne State University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, XM (corresponding author), Karmanos Canc Inst, 4100 John R St, Detroit, MI 48201 USA.	zhangx@karmanos.org	Bai, Wenlong/A-8977-2013; XIANG, SHENGYAN/C-3176-2013	Bai, Wenlong/0000-0002-9536-0556; XIANG, SHENGYAN/0000-0002-6940-3559; Quan, Daniel/0000-0003-1752-0080	National Institutes of Health [R01CA164147]; Karmanos Cancer Institute startup funds; Wayne State University; NATIONAL CANCER INSTITUTE [T32CA009531, R01CA164147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karmanos Cancer Institute startup funds; Wayne State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant R01CA164147 and by Karmanos Cancer Institute startup funds (to X. M. Z.) and Graduate Research Assistantship from Wayne State University (to X. M. Z. and N. M). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aebi S, 1996, CANCER RES, V56, P3087; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Fink D, 1998, CLIN CANCER RES, V4, P1; Gong JG, 1999, NATURE, V399, P806; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Han Y, 2016, ONCOTARGETS THER, V9, P5081, DOI 10.2147/OTT.S106345; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Larrea AA, 2010, CELL, V141, DOI 10.1016/j.cell.2010.05.002; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Papadopoulos N, 1997, HUM MUTAT, V10, P89, DOI 10.1002/(SICI)1098-1004(1997)10:2<89::AID-HUMU1>3.3.CO;2-K; Plotz G, 2003, NUCLEIC ACIDS RES, V31, P3217, DOI 10.1093/nar/gkg420; Trojan J, 2002, GASTROENTEROLOGY, V122, P211, DOI 10.1053/gast.2002.30296; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Verdel A, 1999, J BIOL CHEM, V274, P2440, DOI 10.1074/jbc.274.4.2440; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033160; Yanamadala S, 2003, MOL CANCER RES, V1, P747; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028	25	17	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5813	5826		10.1074/jbc.RA118.006374	http://dx.doi.org/10.1074/jbc.RA118.006374			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30770470	hybrid, Green Published			2022-12-26	WOS:000465077500014
J	de Taeye, SW; Go, EP; Sliepen, K; de la Pena, AT; Badal, K; Medina-Ramirez, M; Lee, WH; Desaire, H; Wilson, IA; Moore, JP; Ward, AB; Sanders, RW				de Taeye, Steven W.; Go, Eden P.; Sliepen, Kwinten; de la Pena, Alba Torrents; Badal, Kimberly; Medina-Ramirez, Max; Lee, Wen-Hsin; Desaire, Heather; Wilson, Ian A.; Moore, John P.; Ward, Andrew B.; Sanders, Rogier W.			Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); glycoprotein structure; structure-function; protein design; antibody; vaccine development; HIV-1 envelope glycoprotein trimer	CRYO-EM STRUCTURE; GLYCOSYLATION SITES; DISULFIDE BONDS; GLYCOPROTEIN COMPLEX; CYSTEINE RESIDUES; CRYSTAL-STRUCTURE; V1/V2 DOMAIN; GP120; POTENT; APEX	A successful HIV-1 vaccine will likely need to elicit broadly neutralizing antibodies (bNAbs) that target the envelope glycoprotein (Env) spike on the virus. Native-like recombinant Env trimers of the SOSIP design now serve as a platform for achieving this challenging goal. However, SOSIP trimers usually do not bind efficiently to the inferred germline precursors of bNAbs (gl-bNAbs). We hypothesized that the inherent flexibilities of the V1 and V2 variable loops in the Env trimer contribute to the poor recognition of gl-bNAb epitopes at the trimer apex that extensively involve V2 residues. To reduce local V2 flexibility and improve the binding of V2-dependent bNAbs and gl-bNAbs, we designed BG505 SOSIP.664 trimer variants containing newly created disulfide bonds intended to stabilize the V2 loop in an optimally antigenic configuration. The first variant, I184C/E190C, contained a new disulfide bond within the V2 loop, whereas the second variant, E153C/R178C, had a new disulfide bond that cross-linked V2 and V1. The resulting engineered native-like trimer variants were both more reactive with and were neutralized by V2 bNAbs and gl-bNAbs, a finding that may be valuable in the design of germline targeting and boosting trimer immunogens to create an antigenic conformation optimal for HIV vaccine development.	[de Taeye, Steven W.; Sliepen, Kwinten; de la Pena, Alba Torrents; Badal, Kimberly; Medina-Ramirez, Max; Sanders, Rogier W.] Univ Amsterdam, Amsterdam UMC, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Go, Eden P.; Desaire, Heather] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; [Lee, Wen-Hsin; Wilson, Ian A.; Ward, Andrew B.] IAVI Neutralizing Antibody Ctr, Scripps CHAVI ID, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Lee, Wen-Hsin; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA; [Moore, John P.; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	University of Amsterdam; University of Kansas; International AIDS Vaccine Initiative; Scripps Research Institute; Cornell University	Sanders, RW (corresponding author), Univ Amsterdam, Dept Med Microbiol, Amsterdam UMC, Ctr Infect & Immun Amsterdam, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl	Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Lee, Wen-Hsin/0000-0001-9445-6671	National Institutes of Health HIVRAD Grant [P01 AI110657]; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery [OPP1132237]; AIDSfonds Netherlands [2016019]; Netherlands Organization for Scientific Research [91818627]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI110657, UM1AI100663] Funding Source: NIH RePORTER	National Institutes of Health HIVRAD Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery; AIDSfonds Netherlands; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health HIVRAD Grant P01 AI110657, by Grant OPP1132237 from the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery, and by AIDSfonds Netherlands Grant 2016019. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of Vici Grant 91818627 from the Netherlands Organization for Scientific Research.	Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bohl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069406; Bonsignori M, 2017, IMMUNOL REV, V275, P145, DOI [10.1111/imr.12509, 10.]; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Bontjer I, 2010, J BIOL CHEM, V285, P36456, DOI 10.1074/jbc.M110.156588; Bontjer I, 2009, J VIROL, V83, P368, DOI 10.1128/JVI.01404-08; Cale EM, 2017, IMMUNITY, V46, P777, DOI 10.1016/j.immuni.2017.04.011; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; de la Pena AT, 2017, CELL REP, V20, P1805, DOI 10.1016/j.celrep.2017.07.077; de Taeye SW, 2016, TRENDS IMMUNOL, V37, P221, DOI 10.1016/j.it.2016.01.007; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Derdeyn CA, 2014, CURR OPIN HIV AIDS, V9, P210, DOI 10.1097/COH.0000000000000057; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Go EP, 2016, J VIROL, V90, P2884, DOI 10.1128/JVI.01953-15; Go EP, 2014, J PROTEOME RES, V13, P4012, DOI 10.1021/pr5003643; Go EP, 2011, J PROTEOME RES, V10, P578, DOI 10.1021/pr100764a; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; Hu GQ, 2011, J VIROL, V85, P2741, DOI 10.1128/JVI.01612-10; Jobes DV, 2006, AIDS RES HUM RETROV, V22, P1014, DOI 10.1089/aid.2006.22.1014; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Landais E, 2017, IMMUNITY, V47, P990, DOI 10.1016/j.immuni.2017.11.002; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mason RD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005537; Mathys L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101181; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Medina-Ramirez M, 2017, J EXP MED, V214, P2573, DOI 10.1084/jem.20161160; MOORE JP, 1994, J VIROL, V68, P6836, DOI 10.1128/JVI.68.11.6836-6847.1994; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Plotkin S, 2014, P NATL ACAD SCI USA, V111, P12283, DOI 10.1073/pnas.1400472111; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Rantalainen K, 2018, CELL REP, V23, P3249, DOI 10.1016/j.celrep.2018.05.046; Ringe R, 2012, VIROLOGY, V426, P34, DOI 10.1016/j.virol.2012.01.011; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Saha P, 2012, BIOCHEMISTRY-US, V51, P1836, DOI 10.1021/bi300003v; Sanders RW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-10; Sanders RW, 2008, MOL BIOL CELL, V19, P4707, DOI 10.1091/mbc.E08-07-0670; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Scharf L, 2015, CELL, V162, P1379, DOI 10.1016/j.cell.2015.08.035; Shen GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141233; Sliepen K, 2015, VIROLOGY, V486, P116, DOI 10.1016/j.virol.2015.08.002; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Stamatatos L, 1998, J VIROL, V72, P7840, DOI 10.1128/JVI.72.10.7840-7845.1998; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Thenin S, 2012, J GEN VIROL, V93, P1495, DOI 10.1099/vir.0.042614-0; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; van Anken E, 2008, MOL BIOL CELL, V19, P4298, DOI 10.1091/mbc.E07-12-1282; van den Kerkhof TLGM, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0279-4; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; Voss JE, 2017, CELL REP, V21, P222, DOI 10.1016/j.celrep.2017.09.024; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang WK, 1996, AIDS RES HUM RETROV, V12, P1195, DOI 10.1089/aid.1996.12.1195; WANG WK, 1995, AIDS RES HUM RETROV, V11, P185, DOI 10.1089/aid.1995.11.185; Watkins JD, 2011, J VIROL, V85, P12811, DOI 10.1128/JVI.05994-11; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; WILLEY RL, 1993, J VIROL, V67, P3639, DOI 10.1128/JVI.67.6.3639-3643.1993; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	86	13	14	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5616	5631		10.1074/jbc.RA118.005396	http://dx.doi.org/10.1074/jbc.RA118.005396			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30728245	Green Published, hybrid			2022-12-26	WOS:000464517500030
J	Huseby, CJ; Bundschuh, R; Kuret, J				Huseby, Carol J.; Bundschuh, Ralf; Kuret, Jeff			The role of annealing and fragmentation in human tau aggregation dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer's disease; tau protein (tau); aggregation; kinetics; mathematical modeling; neurodegeneration; amyloid; tauopathy; protein misfolding	PAIRED HELICAL FILAMENTS; TO-TAIL POLYMERIZATION; SECONDARY NUCLEATION; SENSITIVITY-ANALYSIS; ALZHEIMERS-DISEASE; PROTEIN-TAU; ACTIN; LENGTH; MECHANISM; ASSOCIATION	Alzheimer's disease pathogenesis is associated with the conversion of monomeric tau protein into filamentous aggregates. Because both toxicity and prion-like spread of pathogenic tau depend in part on aggregate size, the processes that underlie filament formation and size distribution are of special importance. Here, using a combination of biophysical and computational approaches, we investigated the fibrillation dynamics of the human tau isoform 2N4R. We found that tau filaments engage in a previously uncharacterized secondary process involving end-to-end annealing and that rationalization of empirical aggregation data composed of total protomer concentrations and fibril length distributions requires inclusion of this process along with filament fragmentation. We noted that annealing of 2N4R tau filaments is robust, with an intrinsic association rate constant of a magnitude similar to that mediating monomer addition and consistent with diffusion-mediated protein-protein interactions in the absence of long-range attractive forces. In contrast, secondary nucleation on the surface of tau filaments did not detectably contribute to tau aggregation dynamics. These results indicate that tau filament ends engage in a range of homotypic interactions involving monomers, oligomers, and filaments. They further indicate that, in the case of tau protein, fibril annealing and fragmentation along with primary nucleation and elongation are the major processes controlling filament size distribution.	[Huseby, Carol J.; Bundschuh, Ralf; Kuret, Jeff] Ohio State Univ, Interdisciplinary Biophys Grad Program, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Kuret, Jeff] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kuret, J (corresponding author), Ohio State Univ, Coll Med, 1060 Carmack Rd, Columbus, OH 43210 USA.	kuret.3@osu.edu	; Bundschuh, Ralf/B-9623-2008	Huseby, Carol/0000-0002-9558-5560; Bundschuh, Ralf/0000-0002-6699-8614	National Institutes of Health [AG054018]; NATIONAL INSTITUTE ON AGING [T32AG044402] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant AG054018 (to J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrianantoandro E, 2001, J MOL BIOL, V312, P721, DOI 10.1006/jmbi.2001.5005; Ball D. W., 2014, PHYS CHEM, P696; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Bridges AA, 2014, P NATL ACAD SCI USA, V111, P2146, DOI 10.1073/pnas.1314138111; Carlson SW, 2007, BIOCHEMISTRY-US, V46, P8838, DOI 10.1021/bi700403a; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chin AF, 2016, BIOPHYS J, V110, P362, DOI 10.1016/j.bpj.2015.12.013; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Chirita CN, 2004, BIOCHEMISTRY-US, V43, P1704, DOI 10.1021/bi036034b; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608918; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Crystal AS, 2003, J NEUROCHEM, V86, P1359, DOI 10.1046/j.1471-4159.2003.01949.x; Doi M., 1986, THEORY POLYM DYNAMIC, P24; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; FERRONE FA, 1985, J MOL BIOL, V183, P611, DOI 10.1016/0022-2836(85)90175-5; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GomezIsla T, 1996, J NEUROSCI, V16, P4491; GRAY EG, 1987, NEUROPATH APPL NEURO, V13, P91, DOI 10.1111/j.1365-2990.1987.tb00174.x; HAGESTEDT T, 1989, J CELL BIOL, V109, P1643, DOI 10.1083/jcb.109.4.1643; HILL TL, 1981, BIOPHYS J, V33, P353, DOI 10.1016/S0006-3495(81)84900-4; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P4803, DOI 10.1073/pnas.77.8.4803; HILL TL, 1983, BIOPHYS J, V44, P285, DOI 10.1016/S0006-3495(83)84301-X; Huseby CJ, 2016, METHODS MOL BIOL, V1345, P101, DOI 10.1007/978-1-4939-2978-8_7; Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Kundel F, 2018, ACS CHEM NEUROSCI, V9, P1276, DOI 10.1021/acschemneuro.8b00094; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Meyer V, 2016, J BIOL CHEM, V291, P12271, DOI 10.1074/jbc.M116.715557; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; MURPHY DB, 1988, J CELL BIOL, V106, P1947, DOI 10.1083/jcb.106.6.1947; Nanavaty N, 2017, METHODS MOL BIOL, V1523, P101, DOI 10.1007/978-1-4939-6598-4_6; Pastor MT, 2008, J MOL BIOL, V375, P695, DOI 10.1016/j.jmb.2007.08.012; Pavlova A, 2016, P NATL ACAD SCI USA, V113, pE127, DOI 10.1073/pnas.1504415113; Ramachandran G, 2012, J MOL BIOL, V421, P296, DOI 10.1016/j.jmb.2012.01.007; Ramachandran G, 2011, J BIOL CHEM, V286, P38948, DOI 10.1074/jbc.M111.271874; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; ROTHWELL SW, 1986, J CELL BIOL, V102, P619, DOI 10.1083/jcb.102.2.619; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A, 2012, CHEM REV, V112, pPR1, DOI 10.1021/cr200301u; Schafer KN, 2013, J BIOL CHEM, V288, P32599, DOI 10.1074/jbc.M113.503474; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; SEGEL LA, 1989, SIAM REV, V31, P446, DOI 10.1137/1031091; Sept D, 1999, BIOPHYS J, V77, P2911, DOI 10.1016/S0006-3495(99)77124-9; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tornquist M, 2018, CHEM COMMUN, V54, P8667, DOI 10.1039/c8cc02204f; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; WEGNER A, 1982, BIOCHEMISTRY-US, V21, P1909, DOI 10.1021/bi00537a032; WEGNER A, 1975, BIOPHYS CHEM, V3, P215, DOI 10.1016/0301-4622(75)80013-5; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Xue WF, 2013, BIOPHYS J, V105, P2811, DOI 10.1016/j.bpj.2013.10.034; Yin HS, 2006, FEBS LETT, V580, P211, DOI 10.1016/j.febslet.2005.11.077; Zampieri M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000420; Zhao DH, 2003, ORG BIOMOL CHEM, V1, P3471, DOI 10.1039/b308788c; Zhong Q, 2012, J BIOL CHEM, V287, P20711, DOI 10.1074/jbc.M112.364067	71	8	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4728	4737		10.1074/jbc.RA118.006943	http://dx.doi.org/10.1074/jbc.RA118.006943			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30745358	Green Published, hybrid			2022-12-26	WOS:000463985600001
J	Dessalegn, NG; Hailemichael, RG; Shewa-amare, A; Sawleshwarkar, S; Lodebo, B; Amberbir, A; Hillman, RJ				Dessalegn, Noah G.; Hailemichael, Rahel G.; Shewa-amare, Aster; Sawleshwarkar, Shailendra; Lodebo, Bereket; Amberbir, Alemayehu; Hillman, Richard J.			HIV Disclosure: HIV-positive status disclosure to sexual partners among individuals receiving HIV care in Addis Ababa, Ethiopia	PLOS ONE			English	Article							SEROSTATUS DISCLOSURE; SELF-DISCLOSURE; ADHERENCE; REASONS; DEPRESSION; PREDICTORS; INFECTION; HIV/AIDS; OUTCOMES; THERAPY	Introduction Disclosure of HIV status to sexual partners can help HIV prevention efforts and enable HIV positive people to receive social support, as well as increasing access and adherence to treatment. This study was conducted to determine the rate, processes, outcomes, and correlates of HIV status disclosure to sexual partners among HIV positive individuals. Method A cross-sectional study was conducted between September and November 2015 at two HIV outpatient clinics in Addis Ababa, Ethiopia. Data were collected using an interviewer administered semi-structured questionnaire. Logistic analysis was used to determine the independent correlates of serostatus disclosure. Results Of 742 participants, (371 men and 371 women), 727 (98%) were on antiretroviral therapy and 676 (91.1%) had at least one sexual partner since their HIV diagnosis, of whom 558 (82.5%) had disclosed their HIV status to their most recent sexual partner. Of those who reported having disclosed their status to their most recent sexual partner, 82 (14.7%) had at least one unprotected sexual encounter with the partner, after HIV diagnosis but prior to disclosure. The most commonly reported initial outcome of disclosure was gaining emotional and/or financial support. Some (11.3%) also reported that their disclosure immediately initiated their partner for HIV testing. Negative outcomes to disclosure, such as stigma and discrimination, were more common among females (26.2%) compared to males (12.7%). In the multiple regression analysis, disclosure was associated with greater condom use, greater social support, knowing the partner's HIV status, having a good relationship with the partner, and cohabiting with the partner. Conclusion HIV disclosure was common amongst participants, although sometimes delayed, with possible consequences for onward transmission. Fear of negative outcomes, such as verbal abuse and physical violence, were major barriers to disclosure. Efforts to support disclosure have the potential to contribute to HIV control and prevention by encouraging safer sexual practice, initiating partners for HIV testing, and enhancing support for people living with HIV.	[Dessalegn, Noah G.; Sawleshwarkar, Shailendra] Univ Sydney, Westmead Clin Sch, Fac Med & Hlth, Sydney, NSW, Australia; [Hailemichael, Rahel G.] Myungsung Med Coll, Addis Ababa, Ethiopia; [Shewa-amare, Aster] Zewditu Mem Hosp, Addis Ababa, Ethiopia; [Lodebo, Bereket] Wellstar Atlanta Med Ctr, Atlanta, GA USA; [Amberbir, Alemayehu] Dignitas Int, Med & Res Dept, Zomba, Malawi; [Hillman, Richard J.] Sydney Med Sch, Western Sydney Sexual Hlth Ctr, Western Sydney Local Hlth Dist, Parramatta, NSW, Australia; [Hillman, Richard J.] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW, Australia; [Dessalegn, Noah G.] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	University of Sydney; WellStar Atlanta Medical Center; University of Sydney; St Vincents Hospital Sydney; Emory University	Dessalegn, NG (corresponding author), Univ Sydney, Westmead Clin Sch, Fac Med & Hlth, Sydney, NSW, Australia.; Dessalegn, NG (corresponding author), Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	noah.gmd@gmail.com	Sawleshwarkar, Shailendra/AAB-3628-2020; Amberbir, Alemayehu/HGC-2647-2022; Hillman, Richard/AAM-1177-2020	Sawleshwarkar, Shailendra/0000-0002-9399-0490; Hillman, Richard/0000-0002-1859-0761	Australian Department of Foreign Affairs and Trade (DFAT); Western Sydney Sexual Health Clinic [AAS1416503]	Australian Department of Foreign Affairs and Trade (DFAT)(Australian Government); Western Sydney Sexual Health Clinic	This study was partly funded by Australian Department of Foreign Affairs and Trade (DFAT) [https://dfat.gov.au/pages/default.aspx] and Western Sydney Sexual Health Clinic [http://sydney.edu. au/medicine/wsshc/about/index.php]. Grant was received by Dr N.G. Dessalegn; Grant number: AAS1416503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-746; Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; [Anonymous], 2011, NETWORK NETWORKS HIV; Bachanas P, 2013, AIDS PATIENT CARE ST, V27, P425, DOI 10.1089/apc.2012.0388; Blaney NT, 2004, AIDS PATIENT CARE ST, V18, P405, DOI 10.1089/1087291041518201; Chandra PS, 2003, AIDS CARE, V15, P207, DOI 10.1080/0954012031000068353; (CSA) CSA, 2016, EM OBST NEWB CAR NEE; CSA ICF, 2012, ETH DEM HLTH SURV 20; Dalgard O., 2009, SOCIAL SUPPORT; De Rosa CJ, 1998, HEALTH PSYCHOL, V17, P224, DOI 10.1037/0278-6133.17.3.224; Deribe K, 2010, J SOCIAL ASPECTS HIV, V7, P31; Deribe K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-81; Dessie Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-422; Erku TA, 2012, PAN AFR MED J, V13, P87; Federal Democratic Republic of Ethiopia-Ministry of Health, 2010, HAR REG HLTH SECT DE; Federal HIV/AIDS Prevention and Control Office (FHAPCO), 2007, GUID HIV COUNS TEST, P4; Galletly CL, 2006, AIDS BEHAV, V10, P451, DOI 10.1007/s10461-006-9117-3; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; Gielen A C, 2000, Matern Child Health J, V4, P111, DOI 10.1023/A:1009522321240; Gonzalez JS, 2004, HEALTH PSYCHOL, V23, P413, DOI 10.1037/0278-6133.23.4.413; Harries AD, 2004, TB HIV CLIN MANUAL; Huba GJ, 1996, MOD 75 DISCL QUEST; Kalichman SC, 2003, J BEHAV MED, V26, P315, DOI 10.1023/A:1024252926930; Kassaye K. D., 2005, Ethiopian Journal of Health Development, V19, P126; Kesler MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193269; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; Loha E, 2012, AM J TROP MED HYG, V87, P450, DOI 10.4269/ajtmh.2012.12-0155; Maman S, 2003, GENDER DIMENSIONS HI; Miller AN, 2007, AIDS BEHAV, V11, P687, DOI 10.1007/s10461-006-9198-z; MOH Ethiopia/HAPCO, 2006, AIDS ETH; MOH Ethiopia/HAPCO, 2014, COUNTR PROGR REP HIV; Niccolai LM, 1999, SEX TRANSM DIS, V26, P281, DOI 10.1097/00007435-199905000-00008; Nosikov A, 2003, BIOMEDICAL HLTH RES, V57, P204; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pinkerton SD, 2007, AIDS BEHAV, V11, P698, DOI 10.1007/s10461-006-9187-2; Sauka M, 2000, AIDS CARE, V12, P737, DOI 10.1080/09540120020014282; Schonnesson LN, 2006, AIDS CARE, V18, P406, DOI 10.1080/09540120500456631a; Seid Mohammed, 2012, Afr J Reprod Health, V16, P97; Sendo EG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-765; Serovich JM, 2003, AIDS EDUC PREV, V15, P70, DOI 10.1521/aeap.15.1.70.23846; Simoni J. M., 2000, AIDS BEHAV, V4, P147, DOI [10.1023/A:1009508406855, DOI 10.1023/A:1009508406855]; Simoni JM, 2005, POSITIVE PREVENTION, P65; Ssali SN, 2010, AIDS PATIENT CARE ST, V24, P675, DOI 10.1089/apc.2010.0062; Starace F, 2006, HEALTH PSYCHOL, V25, P153, DOI 10.1037/0278-6133.25.2.153; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Tadios Yonas, 2006, Ethiop Med J, V44, P237; U. S. Department of Health & Human Services, GLOB HIV AIDS; UNAIDS, 2017, COUNTR FACTSH ETH; UNAIDS, 2018, UNAIDSJC2929E; UNAIDS, 2015, GLOBAL REPORT UNAIDS; Vu L, 2012, AIDS BEHAV, V16, P132, DOI 10.1007/s10461-010-9873-y; Yonah G, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-5; Zea MC, 2005, AIDS BEHAV, V9, P15, DOI 10.1007/s10461-005-1678-z	54	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0211967	10.1371/journal.pone.0211967	http://dx.doi.org/10.1371/journal.pone.0211967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5KT	30768642	Green Submitted, Green Published, gold			2022-12-26	WOS:000458766300017
J	Fernandez, E; Gorchs, G; Serrano, L				Fernandez, Enric; Gorchs, Gil; Serrano, Lydia			Use of consumer-grade cameras to assess wheat N status and grain yield	PLOS ONE			English	Article							LEAF PIGMENT CONTENT; CHLOROPHYLL CONTENT; WINTER-WHEAT; SPECTRAL REFLECTANCE; UNMANNED AIRCRAFT; NITROGEN STATUS; AREA INDEX; REMOTE; CROP; VEGETATION	Wheat Grain Yield (GY) and quality are particularly susceptible to nitrogen (N) fertilizer management. However, in rain-fed Mediterranean environments, crop N requirements might be variable due to the effects of water availability on crop growth. Therefore, in-season crop N status assessment is needed in order to apply N fertilizer in a cost-effective way while reducing environmental impacts. Remote sensing techniques might be useful at assessing in-season crop N status. In this study, we evaluated the capacity of vegetation indices formulated using blue (B), green (G), red (R) and near-infrared (NIR) bands obtained with a consumer grade camera to assess wheat N status. Chlorophyll Content Index (CCI) and fractional intercepted PAR (fIPAR) were measured at three phenological stages and GY and biomass were determined at harvest. Indices formulated using RG bands and the normalized difference vegetation index (NDVI) were significantly correlated with both CCI and fIPAR at the different phenological stage (0.71 < r < 0.81, P < 0.01). Moreover, indices formulated using RG bands were capable at differentiating unfertilized and fertilized plots. In addition, RGB indices and NDVI were found to be related to both crop biomass and GY at harvest, particularly when data were obtained at initial grain filling stage (r > 0.80, P < 0.01). Finally, RGB indices and NDVI obtained with a consumer-grade camera showed comparable capacity at assessing chlorophyll content and predicting both crop biomass and GY at harvest than those obtained with a spectroradiometer. This study highlights the potential of standard and modified consumer-grade cameras at assessing canopy traits related to crop N status and GY in wheat under Mediterranean conditions.	[Fernandez, Enric] Ctr Tecnol Telecomunicac Catalunya, Geomat Div, Barcelona, Spain; [Gorchs, Gil; Serrano, Lydia] Univ Politecn Cataluna, Dept Engn Agroalimentaria & Biotecnol, Barcelona, Spain	Centre Tecnologic Telecomunicacions Catalunya (CTTC); Universitat Politecnica de Catalunya	Serrano, L (corresponding author), Univ Politecn Cataluna, Dept Engn Agroalimentaria & Biotecnol, Barcelona, Spain.	lydia.serrano@upc.edu	Serrano, Lydia/K-6731-2013; Gorchs, Gil/L-4156-2014	Serrano, Lydia/0000-0003-3776-3370; Gorchs, Gil/0000-0002-2073-2597				Araus JL, 2004, ANN APPL BIOL, V144, P259, DOI 10.1111/j.1744-7348.2004.tb00342.x; Arregui LM, 2006, EUR J AGRON, V24, P140, DOI 10.1016/j.eja.2005.05.005; Atzberger C, 2013, REMOTE SENS-BASEL, V5, P949, DOI 10.3390/rs5020949; Bareth G, 2016, INT ARCH PHOTOGRAMM, V41, P837, DOI 10.5194/isprsarchives-XLI-B8-837-2016; Basso B, 2016, PRECIS AGRIC, V17, P168, DOI 10.1007/s11119-015-9414-9; Basso B, 2010, EUR J AGRON, V33, P132, DOI 10.1016/j.eja.2010.04.004; Borghi B, 1997, EUR J AGRON, V6, P145, DOI 10.1016/S1161-0301(96)02040-0; CAMPBELL CA, 1993, AGRON J, V85, P107, DOI 10.2134/agronj1993.00021962008500010021x; Casadesus J, 2014, J INTEGR PLANT BIOL, V56, P7, DOI 10.1111/jipb.12117; Debaeke P, 2006, J PLANT NUTR, V29, P75, DOI 10.1080/01904160500416471; Du MM, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9030289; FERNANDEZ S, 1994, INT J REMOTE SENS, V15, P1867, DOI 10.1080/01431169408954213; FILELLA I, 1995, CROP SCI, V35, P1400, DOI 10.2135/cropsci1995.0011183X003500050023x; FOWLER DB, 1990, AGRON J, V82, P655, DOI 10.2134/agronj1990.00021962008200040002x; Gabriel JL, 2017, BIOSYST ENG, V160, P124, DOI 10.1016/j.biosystemseng.2017.06.003; Abeledo LG, 2008, EUR J AGRON, V28, P541, DOI 10.1016/j.eja.2007.12.001; Gamon JA, 1999, NEW PHYTOL, V143, P105, DOI 10.1046/j.1469-8137.1999.00424.x; Garrido-Lestache E, 2005, EUR J AGRON, V23, P265, DOI 10.1016/j.eja.2004.12.001; GITELSON A, 1994, J PLANT PHYSIOL, V143, P286, DOI 10.1016/S0176-1617(11)81633-0; Gitelson AA, 1996, REMOTE SENS ENVIRON, V58, P289, DOI 10.1016/S0034-4257(96)00072-7; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Haboudane D, 2002, REMOTE SENS ENVIRON, V81, P416, DOI 10.1016/S0034-4257(02)00018-4; Hatfield JL, 2008, AGRON J, V100, pS117, DOI 10.2134/agronj2006.0370c; HORLER DNH, 1983, INT J REMOTE SENS, V4, P273, DOI 10.1080/01431168308948546; Hunt E. Raymond Jr, 2005, Precision Agriculture, V6, P359, DOI 10.1007/s11119-005-2324-5; Hunt ER, 2014, IEEE J-STARS, V7, P4566, DOI 10.1109/JSTARS.2014.2317876; Hunt ER, 2013, INT J APPL EARTH OBS, V21, P103, DOI 10.1016/j.jag.2012.07.020; Hunt ER, 2010, REMOTE SENS-BASEL, V2, P290, DOI 10.3390/rs2010290; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; JUSTES E, 1994, ANN BOT-LONDON, V74, P397, DOI 10.1006/anbo.1994.1133; Kyratzis AC, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01114; Lelong CCD, 2008, SENSORS-BASEL, V8, P3557, DOI 10.3390/s8053557; Lemaire G, 2008, EUR J AGRON, V28, P614, DOI 10.1016/j.eja.2008.01.005; Li Y, 2010, FIELD CROP RES, V118, P221, DOI 10.1016/j.fcr.2010.05.011; Liebisch F, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0048-8; Lopez-Bellido L, 1998, FIELD CROP RES, V57, P265, DOI 10.1016/S0378-4290(97)00137-8; Lussem U, 2017, INT ARCH PHOTOGRAMM, V42-2, P229, DOI 10.5194/isprs-archives-XLII-2-W6-229-2017; Milton EJ, 2002, INT J REMOTE SENS, V23, P1001, DOI 10.1080/01431160110104746; Passioura JB, 2002, FUNCT PLANT BIOL, V29, P537, DOI 10.1071/FP02020; Putra BTW, 2018, PRECIS AGRIC, V19, P238, DOI 10.1007/s11119-017-9513-x; Quemada M, 2014, REMOTE SENS-BASEL, V6, P2940, DOI 10.3390/rs6042940; Richardson AD, 2002, NEW PHYTOL, V153, P185, DOI 10.1046/j.0028-646X.2001.00289.x; Rodrigues FA, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10060930; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Schirrmann M, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8090706; Serrano L, 2000, CROP SCI, V40, P723, DOI 10.2135/cropsci2000.403723x; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; STEVEN MD, 1990, EAST SCH AG, P209; TUCKER CJ, 1981, REMOTE SENS ENVIRON, V11, P171, DOI 10.1016/0034-4257(81)90018-3; Vergara-Diaz O, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00666; Wezel A, 2014, AGRON SUSTAIN DEV, V34, P1, DOI 10.1007/s13593-013-0180-7; Wright D.L., 2004, GISCI REMOTE SENS, V41, P287, DOI 10.2747/1548-1603.41.4.287; YODER BJ, 1995, REMOTE SENS ENVIRON, V53, P199, DOI 10.1016/0034-4257(95)00135-N; Yousfi S, 2016, AGR WATER MANAGE, V164, P137, DOI 10.1016/j.agwat.2015.09.016; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang J, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030257	56	9	9	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0211889	10.1371/journal.pone.0211889	http://dx.doi.org/10.1371/journal.pone.0211889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768611	Green Submitted, Green Published, gold			2022-12-26	WOS:000458766300013
J	Su, JM; Cui, LF; Yang, WH; Shi, HJ; Jin, C; Shu, R; Li, HF; Zeng, XF; Wu, SL; Gao, X				Su, Jinmei; Cui, Liufu; Yang, Wenhao; Shi, Huijing; Jin, Cheng; Shu, Rong; Li, Hongfen; Zeng, Xiaofeng; Wu, Shouling; Gao, Xiang			Baseline high-sensitivity C-reactive protein predicts the risk of incident ankylosing spondylitis: Results of a community-based prospective study	PLOS ONE			English	Article							MULTICENTER; ETANERCEPT; PROGRESSION; PREVENTION; SMOKING; DAMAGE	Background A hospitalized-based cohort study suggested that elevated C-reactive protein (CRP) levels are associated with radiographic sacroiliitis progression in ankylosing spondylitis (AS) patients. However, data from community-based populations are limited. Objective We sought to determine the association between elevated CRP levels and AS diagnosis in a prospective community-based study of 129,681 Chinese adults over a follow-up period of 8 years. Methods We measured the plasma CRP concentration at baseline and every 2 years thereafter with the high-sensitivity (hs)-CRP test. Incident AS cases were confirmed on the basis of modified New York diagnostic criteria after review of medical records. We used Cox proportional hazard models to calculate hazard ratios (HRs) and 95% confidence intervals (95% Cls) for AS on the basis of hs-CRP concentrations, adjusting for age, sex, education, income, cigarette smoking, alcohol intake, physical activity, body mass index, blood-pressure status, blood glucose status, total cholesterol, history of cardiovascular disease, and use of antihypertensives, lipid-lowering agents, and aspirin. Results During 1,033,609 person-years (average 7.97 +/- 1.36 years per person) of follow-up, we identified 55 incident AS cases. Baseline hs-CRP was positively associated with the risk of future AS. Compared with hs-CRP < 1 mg/L, the HR was 1.28 (95% CI 0.54-3.08) for hs-CRP of 1.00-2.99 mg/L, 4.71 (95% CI 2.26-9.81) for hs-CRP of 3.00-9.99 mg/L, and 19.8 (95% CI 9.6-40.9) for hs-CRP >= 10.00 mg/L (P-trend < 0.001) after adjustment for potential confounders. We found similar results after excluding AS cases that occurred in the first 2 years of follow-up, and using the cumulative average hs-CRP concentration as a predictor. Conclusion This is the first study in a community-based cohort to demonstrate that CRP plasma concentrations predict the risk of future AS, thus providing a test that is easy to routinely perform in the clinic to assess for AS risk.	[Su, Jinmei; Zeng, Xiaofeng] Chinese Acad Med Sci, Dept Rheumatol, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing, Peoples R China; [Cui, Liufu; Yang, Wenhao; Shi, Huijing; Shu, Rong] Kailuan Gen Hosp, Dept Rheumatol, Tangshan, Peoples R China; [Jin, Cheng; Wu, Shouling] Kailuan Gen Hosp, Dept Cardiol, Tangshan, Peoples R China; [Jin, Cheng; Gao, Xiang] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Li, Hongfen] Kailuan Gen Hosp, Dept Cent Lab, Tangshan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zeng, XF (corresponding author), Chinese Acad Med Sci, Dept Rheumatol, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing, Peoples R China.; Wu, SL (corresponding author), Kailuan Gen Hosp, Dept Cardiol, Tangshan, Peoples R China.	zengxfpumc@163.com; drwusl@163.com	Zeng, Xiao/ABG-5938-2021; Yang, wenhao/GXG-5965-2022	, Xiang/0000-0003-2617-6509				American Diabetes Association, 2005, Diabetes Care, V28 Suppl 1, pS1; Braun J, 2002, LANCET, V359, P1187, DOI 10.1016/S0140-6736(02)08215-6; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Costello ME, 2015, ARTHRITIS RHEUMATOL, V67, P686, DOI 10.1002/art.38967; Davis JC, 2003, ARTHRITIS RHEUM, V48, P3230, DOI 10.1002/art.11325; Davis JC, 2005, ARTHRIT RHEUM-ARTHR, V53, P494, DOI 10.1002/art.21330; Dijkmans B, 2005, ARTHRITIS RHEUM-US, V52, pS634; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; FRANCOIS RJ, 1995, ANN RHEUM DIS, V54, P615, DOI 10.1136/ard.54.8.615; Huang S, 2017, AM J CLIN NUTR, V105, P905, DOI 10.3945/ajcn.116.144832; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Poddubnyy D, 2011, ANN RHEUM DIS, V70, P1369, DOI 10.1136/ard.2010.145995; Sieper J, 2002, ANN RHEUM DIS, V61, P8; Song IH, 2008, ARTHRITIS RHEUM-US, V58, P929, DOI 10.1002/art.23275; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P2136, DOI 10.1002/art.21913; van Tubergen A, 2012, ANN RHEUM DIS, V71, P518, DOI 10.1136/annrheumdis-2011-200411; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Villaverde-Garcia V, 2017, SEMIN ARTHRITIS RHEU, V46, P569, DOI 10.1016/j.semarthrit.2016.11.004; Wang L, 2015, INT J EPIDEMIOL, V44, P689, DOI 10.1093/ije/dyv079; Wu ZJ, 2017, CLIN CHEM, V63, P663, DOI 10.1373/clinchem.2016.260828; Zhang Q, 2013, STROKE, V44, P2451, DOI 10.1161/STROKEAHA.113.678839	23	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0211946	10.1371/journal.pone.0211946	http://dx.doi.org/10.1371/journal.pone.0211946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768617	Green Published, Green Submitted, gold			2022-12-26	WOS:000458766300016
J	Herzen, J; Karampinos, DC; Foehr, P; Birnbacher, L; Viermetz, M; Burgkart, R; Baum, T; Lohoefer, F; Wildgruber, M; Schilling, F; Willner, M; Marschner, M; Noel, PB; Rummeny, EJ; Pfeiffer, F; Jungmann, PM				Herzen, Julia; Karampinos, Dimitrios C.; Foehr, Peter; Birnbacher, Lorenz; Viermetz, Manuel; Burgkart, Rainer; Baum, Thomas; Lohoefer, Fabian; Wildgruber, Moritz; Schilling, Franz; Willner, Marian; Marschner, Mathias; Noel, Peter B.; Rummeny, Ernst J.; Pfeiffer, Franz; Jungmann, Pia M.			3D grating-based X-ray phase-contrast computed tomography for high-resolution quantitative assessment of cartilage: An experimental feasibility study with 3T MRI, 7T MRI and biomechanical correlation	PLOS ONE			English	Article							T-2 RELAXATION-TIME; ARTICULAR-CARTILAGE; KNEE OSTEOARTHRITIS; SPATIAL VARIATION; T2; PREDICTION; ALGORITHM; T-1-RHO	Objective Aim of this study was, to demonstrate the feasibility of high-resolution grating-based X-ray phase-contrast computed tomography (PCCT) for quantitative assessment of cartilage. Materials and methods In an experimental setup, 12 osteochondral samples were harvested from n = 6 bovine knees (n = 2 each). From each knee, one cartilage sample was degraded using 2.5% Trypsin. In addition to PCCT and biomechanical cartilage stiffness measurements, 3T and 7T MRI was performed including MSME SE T2 and ME GE T2* mapping sequences for relaxationtime measurements. Paired t-tests and receiver operating characteristics (ROC) curves were used for statistical analyses. Results PCCT provided high-resolution images for improved morphological cartilage evaluation as compared to 3T and 7T MRI. Quantitative analyses revealed significant differences between the superficial and the deep cartilage layer for T2 mapping as well as for PCCT (P<0.05). No significant difference was detected for PCCT between healthy and degraded samples (P>0.05). MRI and stiffness measurements showed significant differences between healthy and degraded osteochondral samples. Accuracy in the prediction of cartilage degradation was excellent for MRI and biomechanical analyses. Conclusion In conclusion, high-resolution grating-based X-ray PCCT cartilage imaging is feasible. In addition to MRI and biomechanical analyses it provides complementary, water content independent, information for improved morphological and quantitative characterization of articular cartilage ultrastructure.	[Herzen, Julia; Birnbacher, Lorenz; Viermetz, Manuel; Willner, Marian; Marschner, Mathias; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, Chair Biomed Phys, Garching, Germany; [Herzen, Julia; Birnbacher, Lorenz; Viermetz, Manuel; Willner, Marian; Marschner, Mathias; Pfeiffer, Franz] Tech Univ Munich, Sch BioEngn, Garching, Germany; [Karampinos, Dimitrios C.; Lohoefer, Fabian; Wildgruber, Moritz; Willner, Marian; Noel, Peter B.; Rummeny, Ernst J.; Pfeiffer, Franz; Jungmann, Pia M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, Munich, Germany; [Foehr, Peter; Burgkart, Rainer] Tech Univ Munich, Klinikum Rechts Isar, Dept Orthopaed & Sportsorthopaed, Munich, Germany; [Baum, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Neuroradiol, Munich, Germany; [Wildgruber, Moritz] Univ Klinikum Muenster, Dept Clin Radiol, Translat Res Imaging Ctr, Munster, Germany; [Schilling, Franz] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, Munich, Germany; [Pfeiffer, Franz] Tech Univ Munich, Inst Adv Study, Garching, Germany; [Jungmann, Pia M.] Univ Hosp Freiburg, Dept Radiol, Freiburg, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munster; Technical University of Munich; University of Munich; Technical University of Munich; University of Freiburg	Jungmann, PM (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, Munich, Germany.; Jungmann, PM (corresponding author), Univ Hosp Freiburg, Dept Radiol, Freiburg, Germany.	pia.jungmann@tum.de	Schilling, Franz/ABF-4848-2021; Baum, Thomas/M-6522-2014; Karampinos, Dimitrios C/A-5994-2011	Schilling, Franz/0000-0001-5239-4628; Baum, Thomas/0000-0002-4574-5212; Karampinos, Dimitrios C/0000-0003-4922-3662; Foehr, Peter/0000-0003-1042-546X; Jungmann, Pia/0000-0003-2198-3678; Noel, Peter/0000-0002-9671-6171; Pfeiffer, Franz/0000-0001-6665-4363	German Research Foundation (DFG); Technische Universitaet Muenchen; Deutsche Forschungsgemeinschaft [DFG WI 3686/4-1]; Commission for Clinical Research, Technische Universitaet Muenchen (TUM), TUM School of Medicine, Munich, Germany [8762152]; Bundesministerium fur Bildung und Forschung [BMBF 0315577C]; B. Braun-Stiftung [BBST-D-17-00070R1]; Arthrex GmbH (Munich, Germany); European Research Council (ERC, H2020) [AdG 695045]; DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP); DFG Gottfried Wilhelm Leibniz program; TUM Institute for Advanced Study - German Excellence Initiative; Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT); Philips	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitaet Muenchen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Commission for Clinical Research, Technische Universitaet Muenchen (TUM), TUM School of Medicine, Munich, Germany; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); B. Braun-Stiftung; Arthrex GmbH (Munich, Germany); European Research Council (ERC, H2020)(European Research Council (ERC)); DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); TUM Institute for Advanced Study - German Excellence Initiative; Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT); Philips	This work was supported by the German Research Foundation (DFG) and the Technische Universitaet Muenchen within the funding programme Open Access Publishing to JH and PMJ. This work was supported by grants of the Deutsche Forschungsgemeinschaft (DFG WI 3686/4-1) to M. Wildgruber, by the Commission for Clinical Research, Technische Universitaet Muenchen (TUM), TUM School of Medicine, Munich, Germany (Project 8762152) to PMJ, by the Bundesministerium fur Bildung und Forschung (BMBF 0315577C) to JH/FP, by B. Braun-Stiftung (BBST-D-17-00070R1) to PMJ and by Arthrex GmbH (Munich, Germany) to PMJ. We further acknowledge financial support through the European Research Council (ERC, H2020, AdG 695045), the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP), the DFG Gottfried Wilhelm Leibniz program and the support of the TUM Institute for Advanced Study, funded by the German Excellence Initiative to JH/FP. This work was carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT) to JH/FP. Dimitrios C. Karampinos and Peter B. Noel are receiving grant support from Philips. The grant support from Philips was not for this specific study. The study we performed was entirely independent of the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum T, 2013, OSTEOARTHR CARTILAGE, V21, P1474, DOI 10.1016/j.joca.2013.07.012; Birnbacher L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24022; Borthakur A, 2006, NMR BIOMED, V19, P781, DOI 10.1002/nbm.1102; Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc; Buettner O, 2013, FOOT ANKLE INT, V34, P1025, DOI 10.1177/1071100713477636; Burstein D, 2009, RADIOL CLIN N AM, V47, P675, DOI 10.1016/j.rcl.2009.04.003; Chabior M, 2011, MED PHYS, V38, P1189, DOI 10.1118/1.3553408; Crema MD, 2011, RADIOGRAPHICS, V31, P37, DOI 10.1148/rg.311105084; Dardzinski BJ, 1997, RADIOLOGY, V205, P546, DOI 10.1148/radiology.205.2.9356643; Deng X, 2007, MAGN RESON IMAGING, V25, P168, DOI 10.1016/j.mri.2006.10.015; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; Eggl E, 2015, RADIOLOGY, V275, P553, DOI 10.1148/radiol.14141317; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Fohr P, 2012, ORTHOPADE, V41, P820, DOI 10.1007/s00132-012-1953-4; Hahn D, 2015, SCI REP-UK, V5, DOI 10.1038/srep10452; Herzen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083369; Herzen J, 2009, OPT EXPRESS, V17, P10010, DOI 10.1364/OE.17.010010; Hirvasniemi J, 2013, OSTEOARTHR CARTILAGE, V21, P434, DOI 10.1016/j.joca.2012.12.009; Horn F, 2017, PHYS MED BIOL, V62, P6729, DOI 10.1088/1361-6560/aa7721; Jungmann PM, 2013, ARTHRIT CARE RES, V65, P1942, DOI 10.1002/acr.22093; Jungmann PM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/840170; Jungmann PM, 2014, SKELETAL RADIOL, V43, P271, DOI 10.1007/s00256-013-1783-4; Jungmann PM, 2013, J MAGN RESON IMAGING, V38, P1415, DOI 10.1002/jmri.24137; Juras V, 2009, J MAGN RESON, V197, P40, DOI 10.1016/j.jmr.2008.11.019; JURVELIN JS, 1995, J BIOMECH, V28, P231, DOI 10.1016/0021-9290(94)00060-H; Lammentausta E, 2006, J ORTHOP RES, V24, P366, DOI 10.1002/jor.20041; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Liebl H, 2015, ANN RHEUM DIS, V74, P1353, DOI 10.1136/annrheumdis-2013-204157; Maier CF, 2003, J MAGN RESON IMAGING, V17, P358, DOI 10.1002/jmri.10263; Marenzana M, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/24/8173; Momose A, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0023; Momose A, 2009, OPT EXPRESS, V17, P12540, DOI 10.1364/OE.17.012540; MOW VC, 1989, J BIOMECH, V22, P853, DOI 10.1016/0021-9290(89)90069-9; Nagashima M, 2014, ANAT SCI INT, V89, P95, DOI 10.1007/s12565-013-0204-z; Nieminen MT, 2004, J BIOMECH, V37, P321, DOI 10.1016/S0021-9290(03)00291-4; Nissi MJ, 2015, J ORTHOPAEDIC RES OF; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Pfeiffer F, 2013, Z MED PHYS, V23, P176, DOI 10.1016/j.zemedi.2013.02.002; Rautiainen J, 2014, MAGNETIC RESONANCE M; Schulz G, 2010, J R SOC INTERFACE, V7, P1665, DOI 10.1098/rsif.2010.0281; Smith HE, 2001, J MAGN RESON IMAGING, V14, P50, DOI 10.1002/jmri.1150; Stutman D, 2011, PHYS MED BIOL, V56, P5697, DOI 10.1088/0031-9155/56/17/015; Swann A C, 1989, Proc Inst Mech Eng H, V203, P143, DOI 10.1243/PIME_PROC_1989_203_026_01; Tanaka J, 2013, Z MED PHYS, V23, P222, DOI 10.1016/j.zemedi.2012.11.004; Theologis AA, 2012, KNEE, V19, P652, DOI 10.1016/j.knee.2011.09.004; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Welsch GH, 2011, EUR RADIOL, V21, P1136, DOI 10.1007/s00330-010-2029-7; Willner M, 2014, PHYS MED BIOL, V59, P1557, DOI 10.1088/0031-9155/59/7/1557; Willner M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151889; Willner M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137016	52	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212106	10.1371/journal.pone.0212106	http://dx.doi.org/10.1371/journal.pone.0212106			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763375	Green Submitted, Green Published, gold			2022-12-26	WOS:000458763900043
J	Laumer, IB; Auersperg, AMI; Bugnyar, T; Call, J				Laumer, Isabelle B.; Auersperg, Alice M. I.; Bugnyar, Thomas; Call, Josep			Orangutans (Pongo abelii) make flexible decisions relative to reward quality and tool functionality in a multi-dimensional tool-use task	PLOS ONE			English	Article							CHIMPANZEE PAN-TROGLODYTES; SELF-CONTROL; APES; EXCHANGE	Making economic decisions in a natural foraging situation that involves the use of tools may require an animal to consider more levels of relational complexity than merely deciding between an immediate and a delayed food option. We used the same method previously used with Goffin's cockatoos to investigate the orangutans' flexibility for making the most profitable decisions when confronted with five different settings that included one or two different apparatuses, two different tools and two food items (one more preferred than the other). We found that orangutans made profitable decisions relative to reward quality, when the task required the subjects to select a tool over an immediately accessible food reward. Furthermore, most subjects were sensitive to work-effort when the immediate and the delayed option (directly accessible by using a tool) led to the same outcome. Most subjects continued to make profitable decisions that required taking into account the tool functionality. In a final multidimensional task design in which subjects had to simultaneously focus on two apparatuses, two reward qualities and two different tools, the orangutans chose the functional tool to access the high quality reward.	[Laumer, Isabelle B.; Bugnyar, Thomas] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Auersperg, Alice M. I.] Univ Vienna, Med Univ Vienna, Univ Vet Med, Messerli Res Inst, Vienna, Austria; [Call, Josep] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Call, Josep] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; University of St Andrews; Max Planck Society	Laumer, IB (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	isabelle.laumer@univie.ac.at		Auersperg, Alice/0000-0001-7405-9791; Laumer, Isabelle/0000-0002-1597-0072; Call Balaguer, Josep/0000-0002-8597-8336	University of St Andrews; Max Planck Institute for Evolutionary Anthropology; University of Vienna; FWF [J 3404-B19, P 29084];  [Y366-617]	University of St Andrews; Max Planck Institute for Evolutionary Anthropology(Max Planck Society); University of Vienna; FWF(Austrian Science Fund (FWF)); 	This work was supported by the University of St Andrews and the Max Planck Institute for Evolutionary Anthropology. Isabelle Laumer was supported by a uni:docs fellowship of the University of Vienna, Alice Auersperg was supported by by FWF grants J 3404-B19 and P 29084, and Thomas Bugnyar by Y366-617.	Ancrenaz M., 2007, ORANGUTAN AERIAL SUR, P1; Auersperg AMI, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1092; Beran MJ, 2002, J GEN PSYCHOL, V129, P49, DOI 10.1080/00221300209602032; Dufour V, 2007, J COMP PSYCHOL, V121, P145, DOI 10.1037/0735-7036.121.2.145; Dufour V, 2012, BIOL LETTERS, V8, P201, DOI 10.1098/rsbl.2011.0726; Dunbar RIM, 2002, INT J PRIMATOL, V23, P785, DOI 10.1023/A:1015576915296; Evans TA, 2006, J COMP PSYCHOL, V120, P163, DOI 10.1037/0735-7036.120.2.163; GALDIKAS BMF, 1989, SCIENCE, V243, P152, DOI 10.1126/science.2911726; Hillemann F, 2014, ANIM BEHAV, V90, P1, DOI 10.1016/j.anbehav.2014.01.007; Laumer IB, 2016, SCI REP-UK, V6, DOI 10.1038/srep28380; Leonardi RJ, 2012, ANIM COGN, V15, P107, DOI 10.1007/s10071-011-0437-y; Manrique HM, 2011, ANIM COGN, V14, P775, DOI 10.1007/s10071-011-0410-9; Manrique HM, 2010, J EXP PSYCHOL ANIM B, V36, P409, DOI 10.1037/a0019296; Martin-Ordas G, 2008, ANIM COGN, V11, P423, DOI 10.1007/s10071-007-0132-1; Martin-Ordas G, 2014, MEMORY, V22, P129, DOI 10.1080/09658211.2013.806553; Martin-Ordas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052074; Martin-Ordas G, 2012, ANIM COGN, V15, P1007, DOI 10.1007/s10071-012-0504-z; Meulman EJM, 2013, TOOL USE IN ANIMALS: COGNITION AND ECOLOGY, P176; Morrogh-Bernard Helen C., 2009, P119; Mulcahy NJ, 2006, ANIM COGN, V9, P193, DOI 10.1007/s10071-006-0019-6; Mulcahy NJ, 2005, J COMP PSYCHOL, V119, P23, DOI 10.1037/0735-7036.119.1.23; Nakamichi M, 2004, BEHAV PROCESS, V65, P87, DOI 10.1016/j.beproc.2003.07.002; O'Hara M, 2019, BEHAVIOUR, V156, P661, DOI 10.1163/1568539X-00003523; Osvath M, 2008, ANIM COGN, V11, P661, DOI 10.1007/s10071-008-0157-0; Pele M, 2010, ANIM COGN, V13, P263, DOI 10.1007/s10071-009-0264-6; Rosati AG, 2007, CURR BIOL, V17, P1663, DOI 10.1016/j.cub.2007.08.033; Shumaker RW, 2011, ANIMAL TOOL BEHAV US, P1; Siegel S., 1988, NONPARAMETRIC STAT B, DOI [10.1177/014662168901300212, DOI 10.1177/014662168901300212]; van Schaik CP, 2005, CAM S BIO EVOL ANTHR, V44, P23, DOI 10.1017/CBO9780511542343.003; vanSchaik CP, 1996, NATURWISSENSCHAFTEN, V83, P186, DOI 10.1007/s001140050271; Visalberghi E, 2009, CURR BIOL, V19, P213, DOI 10.1016/j.cub.2008.11.064; Volter CJ, 2014, J EXP PSYCHOL-ANIM L, V40, P287, DOI 10.1037/xan0000025; Walkup KR, 2010, J COMP PSYCHOL, V124, P351, DOI 10.1037/a0019566; Westergaard GC, 2004, ANIM COGN, V7, P19, DOI 10.1007/s10071-003-0181-z	34	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211031	10.1371/journal.pone.0211031	http://dx.doi.org/10.1371/journal.pone.0211031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5IX	30759087	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300026
J	Yoon, K; Kim, N; Park, Y; Kim, BK; Park, JH; Shin, CM; Lee, DH; Surh, YJ				Yoon, Kichul; Kim, Nayoung; Park, Youngmi; Kim, Bo Kyung; Park, Ji Hyun; Shin, Cheol Min; Lee, Dong Ho; Surh, Young-Joon			Correlation between macrophage migration inhibitory factor and autophagy in Helicobacter pylori-associated gastric carcinogenesis	PLOS ONE			English	Article							CANCER CELLS; POTENTIAL ROLE; EXPRESSION; INFLAMMATION; ERADICATION; PROTEIN; ATG5; PROLIFERATION; PATHOGENESIS; ACTIVATION	The role of macrophage migration inhibitory factor (MIF) and autophagy in gastric cancer is not clear. We determined H. pylori infection status of the subjects and investigated the expression of MIF and autophagy markers (Atg5, LC3A and LC3B) in human gastric tissue at baseline. Then H. pylori eradication was done for H. pylori positive patients and MIF and Atg5 levels were investigated on each follow-up for both H. pylori-eradicated and H. pylori negative patients. Baseline tissue mRNA expression of MIF, Atg5, LC3A and LC3B was measured by real-time PCR in 453 patients (control 165, gastric dysplasia 82, and gastric cancer 206). Three hundred three patients (66.9%) had H. pylori infection at the time of enrollment. Only within H. pylori-positive group, MIF level was significantly elevated in patients with cancer than in control or dysplasia groups (P<0.05). LC3A and LC3B levels also showed significant differences within H. pylori-positive subgroups. H. pylori-positive dysplasia subgroup showed significantly lower (LC3A) (P<0.05) and higher (LC3B) mRNA levels (P<0.05) than in other subgroups. On follow-up, within H. pylori-eradicated group, Atg5 expression increased sequentially from control to dysplasia and cancer subgroups. Multiple linear regression showed autophagy markers (LC3A, LC3B, and Atg5) directly predicted MIF level (adjusted R-2 = 0.492, P<0.001). Serial follow-up showed longitudinal increase in Atg5 level in general, with constantly higher levels in H. pylori-eradicated group than in -negative group. Intestinal metaplasia (IM) group initially showed higher Atg5 expression than the IM-negative group. However, it was reversed between the groups eventually because of the lower rate of increase in IM group. These results suggest a role of MIF and autophagy markers and their interaction in H. pylori-associated gastric carcinogenesis.	[Yoon, Kichul; Kim, Nayoung; Shin, Cheol Min; Lee, Dong Ho] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; [Kim, Nayoung; Kim, Bo Kyung; Park, Ji Hyun; Lee, Dong Ho] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nayoung; Kim, Bo Kyung; Park, Ji Hyun; Lee, Dong Ho] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Park, Youngmi] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Seongnam, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, N (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.; Kim, N (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, N (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	nayoungkim49@empas.com		Kim, Nayoung/0000-0002-9397-0406; Shin, Cheol Min/0000-0003-2265-9845	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2011-0030001]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	Nayoung Kim - This work was supported by the National Research Foundation of Korea (NRF, http://www.nrf.re.kr/eng/main) grant for the Global Core Research Center (GCRC) funded by the Korean government (MSIP) (No. 2011-0030001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CH, 2011, PATHOL RES PRACT, V207, P433, DOI 10.1016/j.prp.2011.05.002; Beswick EJ, 2008, INFECT IMMUN, V76, P3233, DOI 10.1128/IAI.01534-07; Beswick EJ, 2006, WORLD J GASTROENTERO, V12, P5599, DOI 10.3748/wjg.v12.i35.5599; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Chaabane W, 2013, ARCH IMMUNOL THER EX, V61, P43, DOI 10.1007/s00005-012-0205-y; Chen N, 2011, CANCER BIOL THER, V11, P157, DOI 10.4161/cbt.11.2.14622; Choi YJ, 2015, CARCINOGENESIS, V36, P553, DOI 10.1093/carcin/bgv022; Chuang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037613; Codogno P, 2006, NAT CELL BIOL, V8, P1045, DOI 10.1038/ncb1006-1045; Conroy H, 2010, QJM-INT J MED, V103, P831, DOI 10.1093/qjmed/hcq148; Conteduca V, 2013, INT J ONCOL, V42, P5, DOI 10.3892/ijo.2012.1701; Dinis-Ribeiro M, 2012, VIRCHOWS ARCH, V460, P19, DOI 10.1007/s00428-011-1177-8; Handa O, 2007, BIOCHEM PHARMACOL, V73, P1697, DOI 10.1016/j.bcp.2006.10.022; He XX, 2006, GUT, V55, P797, DOI 10.1136/gut.2005.078113; Hsu HS, 2012, LUNG CANCER, V75, P167, DOI 10.1016/j.lungcan.2011.07.001; Huang XR, 2001, GASTROENTEROLOGY, V121, P619, DOI 10.1053/gast.2001.27205; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Kebapcilar L, 2010, CLINICS, V65, P799, DOI 10.1590/S1807-59322010000800010; Kim SE, 2013, J NEUROGASTROENTEROL, V19, P233, DOI 10.5056/jnm.2013.19.2.233; Koukourakis MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137675; Lebiedz P, 2006, HELICOBACTER, V11, P258, DOI 10.1111/j.1523-5378.2006.00411.x; Li GQ, 2009, WORLD J GASTROENTERO, V15, P5541, DOI 10.3748/wjg.15.5541; Li HX, 2012, CYTOKINE, V60, P346, DOI 10.1016/j.cyto.2012.07.015; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Liu H, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005864; Liu JL, 2014, BRIT J CANCER, V111, P944, DOI 10.1038/bjc.2014.355; Nabizadeh Marvast Majid, 2011, J Gastrointest Cancer, V42, P5, DOI 10.1007/s12029-010-9215-3; Rao S, 2014, AUTOPHAGY, V10, P529, DOI 10.4161/auto.27643; Ren Y, 2003, INT J CANCER, V107, P22, DOI 10.1002/ijc.11287; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimwell NJ, 2012, BRIT J CANCER, V107, P1595, DOI 10.1038/bjc.2012.405; Shin CM, 2016, DIGEST DIS SCI, V61, P1051, DOI 10.1007/s10620-016-4048-y; Shin Cheol Min, 2010, J Clin Gastroenterol, V44, pe34, DOI 10.1097/MCG.0b013e3181a159c4; Shin CM, 2009, HELICOBACTER, V14, P512, DOI 10.1111/j.1523-5378.2009.00726.x; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Stathas T, 2013, EUR REV MED PHARMACO, V17, P1455; Steeves MA, 2010, CURR OPIN CELL BIOL, V22, P218, DOI 10.1016/j.ceb.2009.12.013; Tahara E, 2003, IARC SCI PUBL, P327; Tsugawa H, 2012, CELL HOST MICROBE, V12, P764, DOI 10.1016/j.chom.2012.10.014; White ES, 2001, J IMMUNOL, V166, P7549, DOI 10.4049/jimmunol.166.12.7549; Wu MY, 2012, CELL RES, V22, P1003, DOI 10.1038/cr.2012.44; Xia HHX, 2005, WORLD J GASTROENTERO, V11, P1946; Xia HHX, 2009, CANCER-AM CANCER SOC, V115, P5441, DOI 10.1002/cncr.24609; Xu X, 2013, CARDIOVASC RES; Xu XD, 2008, CANCER LETT, V261, P147, DOI 10.1016/j.canlet.2007.11.028; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yoon K, 2016, HELICOBACTER PYLORI, P269; Yoon K, 2017, GUT LIVER, V11, P209, DOI 10.5009/gnl16224; Yoon K, 2015, J GASTROEN HEPATOL, V30, P490, DOI 10.1111/jgh.12839; Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028; Zhou WH, 2012, AUTOPHAGY, V8, P389, DOI 10.4161/auto.18641	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211736	10.1371/journal.pone.0211736	http://dx.doi.org/10.1371/journal.pone.0211736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742638	Green Published, gold, Green Submitted			2022-12-26	WOS:000458393400021
J	Martinez, L; Milanic, M; Malaina, I; Alvarez, C; Perez, MB; de la Fuente, IM				Martinez, Luis; Milanic, Martin; Malaina, Iker; Alvarez, Carmen; Perez, Martin-Blas; de la Fuente, Ildefonso M.			Weighted lambda superstrings applied to vaccine design	PLOS ONE			English	Article							T-CELL EPITOPES; PROTEIN-STRUCTURE; IMMUNOGENICITY; PREDICTION; ALGORITHM; CD4(+)	We generalize the notion of lambda-superstrings, presented in a previous paper, to the notion of weighted lambda-superstrings. This generalization entails an important improvement in the applications to vaccine designs, as it allows epitopes to be weighted by their immunogenicities. Motivated by these potential applications of constructing short weighted lambda-superstrings to vaccine design, we approach this problem in two ways. First, we formalize the problem as a combinatorial optimization problem (in fact, as two polynomially equivalent problems) and develop an integer programming (IP) formulation for solving it optimally. Second, we describe a model that also takes into account good pairwise alignments of the obtained superstring with the input strings, and present a genetic algorithm that solves the problem approximately. We apply both algorithms to a set of 169 strings corresponding to the Nef protein taken from patiens infected with HIV-1. In the IP-based algorithm, we take the epitopes and the estimation of the immunogenicities from databases of experimental epitopes. In the genetic algorithm we take as candidate epitopes all 9-mers present in the 169 strings and estimate their immunogenicities using a public bioinformatics tool. Finally, we used several bioinformatic tools to evaluate the properties of the candidates generated by our method, which indicated that we can score high immunogenic lambda-superstrings that at the same time present similar conformations to the Nef virus proteins.	[Martinez, Luis; Malaina, Iker; Perez, Martin-Blas; de la Fuente, Ildefonso M.] Univ Basque Country, UPV EHU, Dept Math, Bilbao, Spain; [Martinez, Luis; Malaina, Iker] Biocruces Bizkaia Hlth Res Inst, Baracaldo, Spain; [Martinez, Luis] BCAM, Bilbao, Spain; [Milanic, Martin] Univ Primorska, UP IAM & UP FAMNIT, Koper, Slovenia; [Alvarez, Carmen] IDIVAL Valdecilla Biomed Res Inst, Santander, Spain; [de la Fuente, Ildefonso M.] CEBAS CSIC Inst, Dept Nutr, Murcia, Spain	University of Basque Country; Basque Center for Applied Mathematics (BCAM); University of Primorska; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS)	Martinez, L (corresponding author), Univ Basque Country, UPV EHU, Dept Math, Bilbao, Spain.; Martinez, L (corresponding author), Biocruces Bizkaia Hlth Res Inst, Baracaldo, Spain.; Martinez, L (corresponding author), BCAM, Bilbao, Spain.	luis.martinez@ehu.eus	Martínez, Luis/G-6266-2012; Malaina, Iker/AAQ-1997-2020; Alvarez-Dominguez, Carmen/J-4675-2014; Milanic, Martin/L-1877-2016; Perez-Pinillla, Martin-Blas/K-9042-2017	Martínez, Luis/0000-0002-6297-1449; Malaina, Iker/0000-0002-1305-6623; Alvarez-Dominguez, Carmen/0000-0002-4585-6959; Milanic, Martin/0000-0002-8222-8097; De la Fuente, Ildefonso/0000-0001-6548-7583; Perez-Pinillla, Martin-Blas/0000-0002-3461-9990	Basque Government [IT753-13, IT974-16]; UPV/EHU [US18/21]; Slovenian Research Agency [I0-0035, P1-0285, N1-0032, J1-7051, J1-9110]; Basque Center of Applied Mathematics [US18/21]	Basque Government(Basque Government); UPV/EHU; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Basque Center of Applied Mathematics	This research was supported in part by the Basque Government, grants IT753-13 and IT974-16 and by the UPV/EHU and Basque Center of Applied Mathematics, grant US18/21. This research was also in part by the Slovenian Research Agency (I0-0035, research program P1-0285, and research projects N1-0032, J1-7051, and J1-9110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon N, 2006, ACM T ALGORITHMS, V2, P153, DOI 10.1145/1150334.1150336; Alvarez-Dominguez C, 2008, TRAFFIC, V9, P325, DOI 10.1111/j.1600-0854.2007.00683.x; Bergmann-Leitner ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071610; Bryson CJ, 2010, BIODRUGS, V24, P1, DOI 10.2165/11318560-000000000-00000; Calderon-Gonzalez R, 2015, J IMMUNOL METHODS, V424, P111, DOI 10.1016/j.jim.2015.05.009; Calderon-Gonzalez R, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00022; Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266; de Boer RJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00983-17; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Diaz R, 2001, P 3 INT S AD SYST EV, P37; Dinur I, 2014, STOC'14: PROCEEDINGS OF THE 46TH ANNUAL 2014 ACM SYMPOSIUM ON THEORY OF COMPUTING, P624, DOI 10.1145/2591796.2591884; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; El-Manzalawy Yasser, 2008, Comput Syst Bioinformatics Conf, V7, P121, DOI 10.1142/9781848162648_0011; Geginat G, 2001, J IMMUNOL, V166, P1877, DOI 10.4049/jimmunol.166.3.1877; Gusfield D., 1997, ALGORITHMS STRINGS T; Haupt R.L., 2004, PRACTICAL GENETIC AL, VSecond, DOI DOI 10.1002/0471671746; Hemmer B, 2000, INT IMMUNOL, V12, P375, DOI 10.1093/intimm/12.3.375; HUANG YX, 1995, J VIROL, V69, P93, DOI 10.1128/JVI.69.1.93-100.1995; IEDB, T CELL CLASS I PMHC; Kavanagh DG, 2006, BLOOD, V107, P1963, DOI 10.1182/blood-2005-04-1513; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Khan JM, 2012, IMMUNOME RES, V8, P1; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Manzourolajdad A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163688; Martinez L, 2015, J MATH BIOL, V70, P1327, DOI 10.1007/s00285-014-0797-4; MICHAEL NL, 1995, J VIROL, V69, P6758, DOI 10.1128/JVI.69.11.6758-6769.1995; MILLER CE, 1960, J ACM, V7, P326, DOI 10.1145/321043.321046; Moreau V, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-71; Nickle DC, 2007, PLOS COMPUT BIOL, V3, P754, DOI 10.1371/journal.pcbi.0030075; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; O'Neill E, 2006, J VIROL, V80, P1311, DOI 10.1128/JVI.80.3.1311-1320.2006; Pataki G, 2003, SIAM REV, V45, P116, DOI 10.1137/S00361445023685; Paul S, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/467852; Ponomarenko JV, 2009, STRUCTURAL BIOINFORM, V2, P849; Rasmussen M, 2016, J IMMUNOL; Rehermann B, 2005, J EXP MED, V201, P667, DOI 10.1084/jem.20050220; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schrijver A., 1998, THEORY LINEAR INTEGE; SETTE A, 1994, J IMMUNOL, V153, P5586; Sharma D, 2009, INDIAN J MED RES, V129, P637; Sharon J, 2014, IMMUNOLOGY, V142, P1, DOI 10.1111/imm.12213; Shmelkov E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089987; Singh P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026629; Skoberne M, 2002, J IMMUNOL, V168, P1854, DOI 10.4049/jimmunol.168.4.1854; Tong JC, 2007, BRIEF BIOINFORM, V8, P96, DOI 10.1093/bib/bbl038; Tung CW, 2007, BIOINFORMATICS, V23, P942, DOI 10.1093/bioinformatics/btm061; van Baalen CA, 2005, J INFECT DIS, V192, P1183, DOI 10.1086/444546; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang H-W, 2011, BIOMED RES INT, V2011; Wang SS, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005336; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	55	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211714	10.1371/journal.pone.0211714	http://dx.doi.org/10.1371/journal.pone.0211714			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735507	gold, Green Submitted, Green Published			2022-12-26	WOS:000458181200024
J	Seguret, A; Collignon, B; Cazenille, L; Chemtob, Y; Halloy, J				Seguret, Axel; Collignon, Bertrand; Cazenille, Leo; Chemtob, Yohann; Halloy, Jose			Loose social organisation of AB strain zebrafish groups in a two-patch environment	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; GROUP-SIZE; DANIO-RERIO; SHOALING BEHAVIOR; ANIMAL GROUPS; LEADERSHIP; FISH; MOVEMENTS; HABITAT; CHOICE	We study the collective behaviour of zebrafish shoals of different numbers of individuals (1, 2, 3, 5, 7, 10 and 20 AB zebrafish Danio rerio) in a constraint environment composed of two identical square rooms connected by a corridor. This simple set-up is similar to a natural patchy environment. We track the positions and the identities of the fish and compute the metrics at the group and at the individual levels. First, we show that the number of fish affects the behaviour of each individual in a group, the cohesion of the groups, the preferential interactions and the transition dynamics between the two rooms. Second, during collective departures, we show that the rankings of exit correspond to the topological organisations of the fish prior to their collective departure. This spatial organisation appears in the group a few seconds before a collective departure. These results provide new evidences on the spatial organisation of the groups and the effect of the number of fish on individual and collective behaviours in a patchy environment.	[Seguret, Axel; Collignon, Bertrand; Cazenille, Leo; Chemtob, Yohann; Halloy, Jose] Univ Paris Diderot, Sorbonne Paris Cite, LIED, UMR 8236, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel	Seguret, A; Halloy, J (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, LIED, UMR 8236, F-75013 Paris, France.	axel.seguret@univ-paris-diderot.fr; jose.halloy@univ-paris-diderot.fr		Halloy, Jose/0000-0003-1555-2484	European Union Information and Communication Technologies project ASSISIbf [FP7-ICT-FET-601074]	European Union Information and Communication Technologies project ASSISIbf	This work was supported by European Union Information and Communication Technologies project ASSISIbf, FP7-ICT-FET-601074 to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; Arunachalam M, 2013, ZEBRAFISH, V10, P1, DOI 10.1089/zeb.2012.0803; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Becco C, 2006, PHYSICA A, V367, P487, DOI 10.1016/j.physa.2005.11.041; Bourjade M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126344; Bourjade M, 2009, ETHOLOGY, V115, P321, DOI 10.1111/j.1439-0310.2009.01614.x; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Briard L, 2015, ETHOLOGY, V121, P888, DOI 10.1111/eth.12402; BYRNE RW, 1990, AM J PRIMATOL, V20, P313, DOI 10.1002/ajp.1350200409; Collignon B, 2017, ARXIV170103611; Collignon B, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150473; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Croft DP, 2003, OIKOS, V100, P429, DOI 10.1034/j.1600-0706.2003.12023.x; Dahlbom SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023565; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Dlugos CA, 2003, PHARMACOL BIOCHEM BE, V74, P471, DOI 10.1016/S0091-3057(02)01026-2; Engeszer RE, 2007, ANIM BEHAV, V74, P1269, DOI 10.1016/j.anbehav.2007.01.032; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; Frommen JG, 2009, BEHAV ECOL SOCIOBIOL, V63, P1141, DOI 10.1007/s00265-009-0767-9; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Hemelrijk CK, 2012, INTERFACE FOCUS, V2, P726, DOI 10.1098/rsfs.2012.0025; Herbert-Read JE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2564; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Hoare DJ, 2000, J FISH BIOL, V57, P1351, DOI 10.1006/jfbi.2000.1446; Hoare DJ, 2004, ANIM BEHAV, V67, P155, DOI 10.1016/j.anbehav.2003.04.004; Jeanson R, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00121; Jolles JW, 2017, CURR BIOL, V27, P2862, DOI 10.1016/j.cub.2017.08.004; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; King AJ, 2011, ANIM BEHAV, V82, P1337, DOI 10.1016/j.anbehav.2011.09.017; Kistler C, 2011, APPL ANIM BEHAV SCI, V135, P318, DOI 10.1016/j.applanim.2011.10.014; Krause J, 2002, LIVING GROUPS; Leblond C, 2006, BEHAVIOUR, V143, P1263, DOI 10.1163/156853906778691603; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; McClure MM, 2006, J FISH BIOL, V69, P553, DOI 10.1111/j.1095-8649.2006.01125.x; Miller N, 2007, BEHAV BRAIN RES, V184, P157, DOI 10.1016/j.bbr.2007.07.007; Miller N, 2013, P NATL ACAD SCI USA, V110, P5263, DOI 10.1073/pnas.1217513110; Miller NY, 2011, REV NEUROSCIENCE, V22, P17, DOI 10.1515/RNS.2011.004; Nakayama S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036606; Nakayama S, 2011, J ANIM ECOL, V80, P1299, DOI 10.1111/j.1365-2656.2011.01859.x; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; Oliveira RF, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00131; Parichy DM, 2015, ELIFE, V4, DOI 10.7554/eLife.05635; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; PETTERSSON LB, 1993, OECOLOGIA, V95, P353, DOI 10.1007/BF00320988; Pillot MH, 2010, BEHAV PROCESS, V83, P235, DOI 10.1016/j.beproc.2009.11.006; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; Radakov D. V., 1973, SCH ECOLOGY FISH; Rieucau G, 2010, BEHAV ECOL, V21, P684, DOI 10.1093/beheco/arq039; Rosenthal SB, 2015, P NATL ACAD SCI USA, V112, P4690, DOI 10.1073/pnas.1420068112; Seguret A., 2016, ROYAL SOC OPEN SCI, V23, pR709; Shelton DS, 2015, J COMP PSYCHOL, V129, P72, DOI 10.1037/a0038382; Sison M, 2010, BEHAV BRAIN RES, V207, P99, DOI 10.1016/j.bbr.2009.09.043; Spence R, 2006, J FISH BIOL, V69, P1435, DOI 10.1111/j.1095-8649.2006.01206.x; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Strandburg-Peshkin A, 2013, CURR BIOL, V23, pR709, DOI 10.1016/j.cub.2013.07.059; Sueur C, 2011, P ROY SOC B-BIOL SCI, V278, P1697, DOI 10.1098/rspb.2010.2084; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; Sueur C, 2008, INT J PRIMATOL, V29, P1085, DOI 10.1007/s10764-008-9262-9; Sueur C, 2011, OIKOS, V120, P1608, DOI 10.1111/j.1600-0706.2011.19685.x; Suriyampola PS, 2016, ZEBRAFISH, V13, P1, DOI 10.1089/zeb.2015.1159; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; Ward AJW, 2013, AM NAT, V181, P748, DOI 10.1086/670242; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501	69	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0206193	10.1371/journal.pone.0206193	http://dx.doi.org/10.1371/journal.pone.0206193			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK7PK	30735505	Green Published, Green Submitted, gold			2022-12-26	WOS:000458181200006
J	Gonzalez, SL; Ghermandi, L				Gonzalez, Sofia L.; Ghermandi, Luciana			Dwarf shrub facilitates seedling recruitment and plant diversity in semiarid grasslands	PLOS ONE			English	Article							NURSE PLANTS; HYDRAULIC LIFT; SOIL; DYNAMICS; PATAGONIA; GROWTH; ESTABLISHMENT; RESTORATION; COMPETITION; GRASSES	The facilitation mechanism maintains ecosystem richness by increasing seedling recruitment. Overgrazed grasslands of northwestern Patagonia are invaded by shrubs that could promote the seedling recruitment of forage species. We investigated the role of Acaena splendens shrubs on the maintenance of diversity and its usefulness as a nurse shrub in the recruitment of Festuca pallescens, a grass of high forage value present with a low cover in degraded grasslands. To test the performance of A. splendens as a nurse plant in non-degraded grassland, we recorded the species richness four years inside of A. splendens senescent shrubs and in gaps among dominant tussock grasses. Species were grouped in four functional groups: annual and biannual herbs and grasses, perennial herbs, perennial grasses and shrubs. To test the usefulness of A. splendens in the restoration of degraded grassland, we monitored the seedling emergence and survival of F. pallescens inside A. splendens and in gaps. We related seedling survival to meteorological and microenvironmental conditions. Species richness was higher in Acaena nurse plants than in gaps. The frequency of functional groups, with exception of annual and biannual herbs and grasses, were higher in Acaena than in gaps. Seedling emergence and survival of F. pallescens were higher in Acaena, but the seedlings died in summer in both microsites. Mean maximum temperature was higher and mean minimum humidity lower in gaps than in Acaena during spring. However, the spring-summer season in which we monitored F. pallescens survival, was exceptionally dry and hot, affecting the survival of F. pallescens seedlings. Our results show that A. splendens act as a nurse species increasing the richness in the non-degraded grassland and facilitating the seedling recruitment of an important forage species in the degraded grassland. Nevertheless, the facilitation mechanism will fail in drought conditions, indicating that this restoration tool is limited by climate.	[Gonzalez, Sofia L.; Ghermandi, Luciana] Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Gonzalez, SL (corresponding author), Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina.	sofia903@gmail.com	Gonzalez, Sofía/AAL-1321-2020		Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2015-0375]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica, PICT 2015-0375 (http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anchorena J, 2002, PLANT ECOL, V158, P97, DOI 10.1023/A:1014768822737; Ares J., 1990, MANAGED GRASSLANDS, P149; Armas C, 2005, J ECOL, V93, P978, DOI 10.1111/j.1365-2745.2005.01033.x; Bertiller MB, 1996, J ARID ENVIRON, V32, P161, DOI 10.1006/jare.1996.0014; Borza JK, 2007, WEED TECHNOL, V21, P518, DOI 10.1614/WT-06-110; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Butterfield BJ, 2009, J ECOL, V97, P1192, DOI 10.1111/j.1365-2745.2009.01569.x; CALDWELL MM, 1990, ISRAEL J BOT, V39, P395; Callaway R., 2008, POSITIVE INTERACTION; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Castro J, 2002, RESTOR ECOL, V10, P297, DOI 10.1046/j.1526-100X.2002.01022.x; Cavieres LA, 2010, POSITIVE PLANT INTERACTIONS AND COMMUNITY DYNAMICS, P39, DOI 10.1201/9781439824955-c3; Correa M.N, 1984, FLORA PATAGONICA 4; Defosse GE, 1997, J VEG SCI, V8, P677, DOI 10.2307/3237372; Egerova J, 2003, WETLANDS, V23, P250, DOI 10.1672/4-20; Flerchinger GN, 2004, ENCY SOILS ENV, V2; Flores J, 2003, J VEG SCI, V14, P911, DOI 10.1111/j.1654-1103.2003.tb02225.x; FOWLER NL, 1988, ECOLOGY, V69, P947, DOI 10.2307/1941250; FRANCO AC, 1989, J ECOL, V77, P870, DOI 10.2307/2260991; Franzese J, 2012, PLANT ECOL, V213, P471, DOI 10.1007/s11258-011-9995-y; Franzese J, 2009, J VEG SCI, V20, P251, DOI 10.1111/j.1654-1103.2009.05733.x; Gaitan J., 2004, CARACTERISTICAS DIST; Ghermandi L, 2013, J ARID ENVIRON, V97, P9, DOI 10.1016/j.jaridenv.2013.05.005; Ghermandi L, 2009, ECOSCIENCE, V16, P408, DOI 10.2980/16-3-3264; Godagnone R, 2009, INVENTARIO INTEGRADO; Gonzalez SL, 2010, ADV ENVIRON RES-SER, V2, P243; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Harper J. L, 1977, POPULATION BIOL PLAN; HARPER JL, 1961, EVOLUTION, V15, P209, DOI 10.2307/2406081; Holmgren M, 2001, ECOSYSTEMS, V4, P151, DOI 10.1007/s100210000065; Kitzberger T, 2000, ECOLOGY, V81, P1914, DOI 10.1890/0012-9658(2000)081[1914:EOCVOF]2.0.CO;2; Kowaljow E, 2007, SOIL BIOL BIOCHEM, V39, P1580, DOI 10.1016/j.soilbio.2007.01.008; Koyama A, 2013, J VEG SCI, V24, P473, DOI 10.1111/j.1654-1103.2012.01474.x; Larson JE, 2015, J APPL ECOL, V52, P199, DOI 10.1111/1365-2664.12350; LEON R J C, 1985, Phytocoenologia, V13, P181, DOI 10.1127/phyto/13/1985/181; Lopez DR, 2017, ACTA OECOL, V79, P70, DOI 10.1016/j.actao.2017.01.003; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Maestre FT, 2001, ECOL APPL, V11, P1641, DOI 10.1890/1051-0761(2001)011[1641:PFUFBG]2.0.CO;2; Marticorena A, 2006, ANN MO BOT GARD, V93, P412, DOI 10.3417/0026-6493(2007)93[412:RDGARE]2.0.CO;2; Mazzarino MJ, 1998, PLANT SOIL, V202, P125, DOI 10.1023/A:1004389011473; McPhail DC, 2016, AUST J BOT, V64, P111, DOI 10.1071/BT15182; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; NIERING WA, 1963, SCIENCE, V142, P15, DOI 10.1126/science.142.3588.15; Nittman JJ, 2009, REHABILITACION DESIE; O'Brien MJ, 2017, ECOL EVOL, V7, P2441, DOI 10.1002/ece3.2875; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Paruelo J, 1993, SECUENCIAS DETERIORO; Pilgrim DH, 1988, HYDROL SCI, V33, P4, DOI DOI 10.1080/02626668809491261; Pugnaire FI, 2004, J VEG SCI, V15, P85, DOI 10.1111/j.1654-1103.2004.tb02240.x; Reynolds JF, 2002, GEOGR REV, V93, P413; RICHARDS JH, 1987, OECOLOGIA, V73, P486, DOI 10.1007/BF00379405; Rossi BE, 2003, J VEG SCI, V14, P543, DOI 10.1658/1100-9233(2003)014[0543:EOPFOS]2.0.CO;2; Lopez DR, 2013, ECOL INDIC, V24, P1, DOI 10.1016/j.ecolind.2012.05.014; Soliveres S, 2015, J ECOL, V103, P1183, DOI 10.1111/1365-2745.12447; Soliveres S, 2011, PERSPECT PLANT ECOL, V13, P247, DOI 10.1016/j.ppees.2011.06.001; Soriano A., 1983, TEMPERATE DESERTS SE, P440; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Velasco V, 2013, GUA RECONOCIMIENTO E; WATT AS, 1947, NEW PHYTOL, V46, P97, DOI 10.1111/j.1469-8137.1947.tb05073.x; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492; Xu J, 2010, PLANT BIOLOGY, V12, P780, DOI 10.1111/j.1438-8677.2009.00271.x; Zhang GF, 2018, OIKOS, V127, P381, DOI 10.1111/oik.04630	65	11	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0212058	10.1371/journal.pone.0212058	http://dx.doi.org/10.1371/journal.pone.0212058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730964	gold, Green Published, Green Submitted			2022-12-26	WOS:000458026000089
J	Suzuki, S; Hoshi, S; Sekizawa, A; Sagara, Y; Tanaka, M; Kinoshita, K; Kitamura, T				Suzuki, Shunji; Hoshi, Shin-ichi; Sekizawa, Akihiko; Sagara, Yoko; Tanaka, Masanobu; Kinoshita, Katsuyuki; Kitamura, Tadaichi			Current status of Neisseria gonorrhoeae cervicitis in pregnant women in Japan	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; OPHTHALMIA-NEONATORUM; INFECTION; CHLAMYDIA; OUTCOMES; TESTS	We evaluated the current prevalence of gonococcal cervicitis among pregnant women in institutes that either do or do not routinely screen for gonococcal infection in Japan. We requested 2,330 obstetrical facilities to provide information on Neisseria gonorrhoeae cervicitis in pregnant women. A total of 1,876 (80.5%) of them responded. The universal screening test for gonococcal cervicitis, involving nucleic acid amplification for all pregnant women, was performed in 281 institutes (13.9% of institutes across Japan). The total rate of pregnant women with gonococcal cervicitis was 1.3% in the institutes performing the screening test during pregnancy, while it was only 0.2% (p < 0.01) in those not performing it. This suggests that 84% of infected women may have been missed in the institutes that do not routinely perform the screening test for gonococcal cervicitis. It may be time to examine the cost-effectiveness of providing gonococcal screening for all pregnant women in Japan.	[Suzuki, Shunji] Japanese Red Cross Katsushika Matern Hosp, Dept Obstet & Gynecol, Tokyo, Japan; [Suzuki, Shunji; Hoshi, Shin-ichi; Sekizawa, Akihiko; Sagara, Yoko; Tanaka, Masanobu; Kinoshita, Katsuyuki] Japan Assoc Obstetricians & Gynecologists, Tokyo, Japan; [Kitamura, Tadaichi] Japanese Fdn Sexual Hlth Med, Tokyo, Japan		Suzuki, S (corresponding author), Japanese Red Cross Katsushika Matern Hosp, Dept Obstet & Gynecol, Tokyo, Japan.; Suzuki, S (corresponding author), Japan Assoc Obstetricians & Gynecologists, Tokyo, Japan.	czg83542@mopera.ne.jp						Centers for Disease Control and Prevention, 2015, 2015 SEX TRANSM DIS; Conejero C, 2013, REV CHIL INFECTOL, V30, P489, DOI 10.4067/S0716-10182013000500004; Deguchi T, 2010, J UROLOGY, V184, P851, DOI 10.1016/j.juro.2010.04.078; Dona V, 2017, EXPERT REV MOL DIAGN, V17, P845, DOI 10.1080/14737159.2017.1360137; Heumann CL, 2017, SEX TRANSM DIS, V44, P266, DOI [10.1097/OLQ.0000000000000592, 10.1097/olq.0000000000000592]; Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists, 2018, GUID OFF GYN JAP 201; Kanoh Yuhsaku, 2002, Rinsho Byori, VSuppl 123, P57; Liu B, 2013, SEX TRANSM INFECT, V89, P672, DOI 10.1136/sextrans-2013-051118; MAXWELL GL, 1992, AM J OBSTET GYNECOL, V166, P945, DOI 10.1016/0002-9378(92)91369-L; Priority Health, 2018, 2018 PREVENTIVE HEAL; ROTHENBERG R, 1979, SEX TRANSM DIS, V6, P187, DOI 10.1097/00007435-197904000-00027; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P106, DOI 10.1111/j.1467-842X.2003.tb00797.x; Suzuki S, 2017, J MATERN-FETAL NEO M, V30, P2881, DOI 10.1080/14767058.2016.1266477; Suzuki S, 2016, JPN J INFECT DIS, V69, P347, DOI 10.7883/yoken.JJID.2015.561; Suzuki S, 2016, JPN J INFECT DIS, V69, P158, DOI 10.7883/yoken.JJID.2015.495; The Ministry of Health Labour and Welfare, 2018, REP NUMB SEX TRANSM; THOMPSON TR, 1974, JAMA-J AM MED ASSOC, V228, P186, DOI 10.1001/jama.228.2.186; Unemo M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1029-2; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Wangu Z, 2017, PEDIATR CLIN N AM, V64, P389, DOI 10.1016/j.pcl.2016.11.008; Woods Charles R, 2005, Semin Pediatr Infect Dis, V16, P258, DOI 10.1053/j.spid.2005.06.006	21	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211595	10.1371/journal.pone.0211595	http://dx.doi.org/10.1371/journal.pone.0211595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730922	gold, Green Published, Green Submitted			2022-12-26	WOS:000458026000036
J	Takehara, S; Zeredo, JL; Kumei, Y; Kagiyama, K; Fukasawa, K; Oshiro, A; Ueno, M; Kojimahara, N; Minakuchi, S; Kawaguchi, Y				Takehara, Sachiko; Zeredo, Jorge L.; Kumei, Yasuhiro; Kagiyama, Kensuke; Fukasawa, Kazumasa; Oshiro, Akiko; Ueno, Masayuki; Kojimahara, Noriko; Minakuchi, Shunsuke; Kawaguchi, Yoko			Characterization of oral microbiota in marmosets: Feasibility of using the marmoset as a human oral disease model	PLOS ONE			English	Article							DIVERSITY; UPDATE; CARIES	With rapid aging of the world's population, the demand for research, for a better understanding of aging and aging-related disorders, is increasing. Ideally, such research should be conducted on human subjects. However, due to ethical considerations, animals such as rodents and monkeys are used as alternatives. Among these alternative models, non-human primates are preferred because of their similarities with humans. The small South American common marmoset (Callithrix jacchus) may offer several advantages over other non-human primates in terms of its smaller size, shorter life-span, and dental anatomy identical to humans. The purpose of this study was to determine the viability of using the marmoset as a human oral disease model. We collected saliva samples from eight marmosets and eight human subjects. Prokaryotic DNA was extracted from the saliva samples, and 16S bacterial rRNA gene sequencing was performed on each of the samples. Our results indicated that the types of oral microbiomes detected among human and marmoset samples were nearly indistinguishable. In contrast, the oral microbiomes of our human and marmoset subjects were distinctly different from those reported for rats and dogs, which are currently popular research animals. The oral microbiomes of marmosets showed greater diversity than those of humans. However, the oral microbiota of marmosets exhibited less variation than those of humans, which may be attributed to the fact that the marmoset subjects were kept in a controlled environment with identical lifestyles. The characteristics of its oral microbiota, combined with other technical advantages, suggest that the marmoset may provide the best animal model thus far for the study of oral health. This study characterized the oral microbes of the marmoset, thereby providing information to support future application of the marmoset as a model for age-related oral disease.	[Takehara, Sachiko; Kojimahara, Noriko] Tokyo Womens Med Univ, Dept Publ Hlth, Tokyo, Japan; [Takehara, Sachiko; Oshiro, Akiko; Ueno, Masayuki; Kawaguchi, Yoko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Promot, Tokyo, Japan; [Zeredo, Jorge L.] Univ Brasilia, Grad Program Hlth Sci & Technol, Brasilia, DF, Brazil; [Kumei, Yasuhiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Biochem, Tokyo, Japan; [Kagiyama, Kensuke; Fukasawa, Kazumasa] Clea Japan Inc, Gifu, Japan; [Ueno, Masayuki] Saitama Prefectural Univ, Dept Hlth Sci, Saitama, Japan; [Minakuchi, Shunsuke] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Gerodontol & Oral Rehabil, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Medical & Dental University (TMDU); Universidade de Brasilia; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Takehara, S (corresponding author), Tokyo Womens Med Univ, Dept Publ Hlth, Tokyo, Japan.; Takehara, S (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Promot, Tokyo, Japan.	takehara.ohp@gmail.com			JSPS KAKENHI Grant [JP16K15852, JP16K11851]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant to Y. K. (JP16K15852) and S. T. (JP16K11851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Commercial affiliation of KF and KK did not play a role in the study.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Casteleyn C, 2012, LAB ANIM-UK, V46, P152, DOI 10.1258/la.2012.011167; Castelo-Branco C, 2014, GYNECOL ENDOCRINOL, V30, P16, DOI 10.3109/09513590.2013.852531; Chen ZG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33950-6; Colombo APV, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2017.1403843; Docktor MJ, 2012, INFLAMM BOWEL DIS, V18, P935, DOI 10.1002/ibd.21874; Ebersole JL, 2018, J CLIN PERIODONTOL, V45, P680, DOI 10.1111/jcpe.12881; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Ge XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065520; Hajishengallis G, 2010, MOL ORAL MICROBIOL, V25, P25, DOI 10.1111/j.2041-1014.2009.00562.x; Han Y W, 2014, Adv Dent Res, V26, P47, DOI 10.1177/0022034514528334; Hyde ER, 2014, FREE RADICAL BIO MED, V77, P249, DOI 10.1016/j.freeradbiomed.2014.09.017; Isaiah A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184899; Li HP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30397-7; Ling ZX, 2015, SCI REP-UK, V5, DOI 10.1038/srep17098; Lopez R, 2017, J CLIN PERIODONTOL, V44, pS145, DOI 10.1111/jcpe.12683; MacDougall M, 2016, J NEUROPHYSIOL, V116, P1286, DOI 10.1152/jn.00197.2016; Mattison JA, 2017, EXP GERONTOL, V94, P41, DOI 10.1016/j.exger.2016.12.005; Miller CT, 2016, NEURON, V90, P219, DOI 10.1016/j.neuron.2016.03.018; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Nishijima K, 2012, BIOGERONTOLOGY, V13, P439, DOI 10.1007/s10522-012-9388-1; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Preshaw PM, 2017, J CLIN PERIODONTOL, V44, pS153, DOI 10.1111/jcpe.12675; Ross Corinna N, 2012, J Aging Res, V2012, P567143, DOI 10.1155/2012/567143; Salmon AB, 2016, PATHOBIOL AGING AGE, V6, DOI 10.3402/pba.v6.32758; Scannapieco FA, 2016, PERIODONTOL 2000, V72, P153, DOI 10.1111/prd.12129; Takeshita T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06990; Tardif SD, 2011, ILAR J, V52, P54, DOI 10.1093/ilar.52.1.54; Teixeira FB, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00327; Wang JF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01843; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089269; Yamamoto T, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001262; Yamanaka W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042806; Zapata HJ, 2015, J AM GERIATR SOC, V63, P776, DOI 10.1111/jgs.13310; Zhao HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11779-9	36	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0207560	10.1371/journal.pone.0207560	http://dx.doi.org/10.1371/journal.pone.0207560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730898	Green Submitted, gold, Green Published			2022-12-26	WOS:000458026000003
J	Venkadakrishnan, VB; DePriest, AD; Kumari, S; Senapati, D; Ben-Salem, S; Su, YX; Mudduluru, G; Hu, Q; Cortes, E; Pop, E; Mohler, JL; Azabdaftari, G; Attwood, K; Shah, RB; Jamieson, C; Dehm, SM; Magi-Galluzzi, C; Klein, E; Sharifi, N; Liu, S; Heemers, HV				Venkadakrishnan, Varadha Balaji; DePriest, Adam D.; Kumari, Sangeeta; Senapati, Dhirodatta; Ben-Salem, Salma; Su, Yixue; Mudduluru, Giridhar; Hu, Qiang; Cortes, Eduardo; Pop, Elena; Mohler, James L.; Azabdaftari, Gissou; Attwood, Kristopher; Shah, Rajal B.; Jamieson, Christina; Dehm, Scott M.; Magi-Galluzzi, Cristina; Klein, Eric; Sharifi, Nima; Liu, Song; Heemers, Hannelore V.			Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy	ONCOGENE			English	Article							LESTAURTINIB CEP701; RECEPTOR; INHIBITOR; PHOSPHORYLATION; INDUCTION; RESISTANT; CEP-701; TRIAL; IDENTIFICATION; PROLIFERATION	Sustained reliance on androgen receptor (AR) after failure of AR-targeting androgen deprivation therapy (ADT) prevents effective treatment of castration-recurrent (CR) prostate cancer (CaP). Interfering with the molecular machinery by which AR drives CaP progression may be an alternative therapeutic strategy but its feasibility remains to be tested. Here, we explore targeting the mechanism by which AR, via RhoA, conveys androgen-responsiveness to serum response factor (SRF), which controls aggressive CaP behavior and is maintained in CR-CaP. Following a siRNA screen and candidate gene approach, RNA-Seq studies confirmed that the RhoA effector Protein Kinase N1 (PKN1) transduces androgen-responsiveness to SRF. Androgen treatment induced SRF-PKN1 interaction, and PKN1 knockdown or overexpression severely impaired or stimulated, respectively, androgen regulation of SRF target genes. PKN1 overexpression occurred during clinical CR-CaP progression, and hastened CaP growth and shortened CR-CaP survival in orthotopic CaP xenografts. PKN1's effects on SRF relied on its kinase domain. The multikinase inhibitor lestaurtinib inhibited PKN1 action and preferentially affected androgen regulation of SRF over direct AR target genes. In a CR-CaP patient-derived xenograft, expression of SRF target genes was maintained while AR target gene expression declined and proliferative gene expression increased. PKN1 inhibition decreased viability of CaP cells before and after ADT. In patient-derived CaP explants, lestaurtinib increased AR target gene expression but did not significantly alter SRF target gene or proliferative gene expression. These results provide proof-of-principle for selective forms of ADT that preferentially target different fractions of AR's transcriptional output to inhibit CaP growth.	[Venkadakrishnan, Varadha Balaji; Kumari, Sangeeta; Senapati, Dhirodatta; Ben-Salem, Salma; Su, Yixue; Mudduluru, Giridhar; Sharifi, Nima; Heemers, Hannelore V.] Cleveland Clin, Dept Canc Biol, Cleveland, OH 44106 USA; [Venkadakrishnan, Varadha Balaji] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [DePriest, Adam D.] Roswell Pk Comprehens Canc Ctr, Dept Canc Genet, Buffalo, NY USA; [Hu, Qiang; Cortes, Eduardo; Attwood, Kristopher; Liu, Song] Roswell Pk Comprehens Canc Ctr, Dept Biostat & Bioinformat, Buffalo, NY USA; [Pop, Elena; Mohler, James L.; Azabdaftari, Gissou] Roswell Pk Comprehens Canc Ctr, Dept Urol, Buffalo, NY USA; [Azabdaftari, Gissou] Roswell Pk Comprehens Canc Ctr, Dept Pathol & Lab Med, Buffalo, NY USA; [Shah, Rajal B.; Magi-Galluzzi, Cristina] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44106 USA; [Jamieson, Christina] Univ Calif San Diego, Dept Urol, La Jolla, CA 92093 USA; [Dehm, Scott M.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Dehm, Scott M.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Dehm, Scott M.] Univ Minnesota, Dept Urol, Minneapolis, MN USA; [Klein, Eric; Sharifi, Nima; Heemers, Hannelore V.] Cleveland Clin, Dept Urol, Cleveland, OH 44106 USA; [Sharifi, Nima; Heemers, Hannelore V.] Cleveland Clin, Dept Hematol Med Oncol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Heemers, HV (corresponding author), Cleveland Clin, Dept Canc Biol, Cleveland, OH 44106 USA.; Heemers, HV (corresponding author), Cleveland Clin, Dept Urol, Cleveland, OH 44106 USA.; Heemers, HV (corresponding author), Cleveland Clin, Dept Hematol Med Oncol, Cleveland, OH 44106 USA.	heemerh@ccf.org	Magi-Galluzzi, Cristina/AAW-6484-2020; Ben-Salem, Salma/E-1702-2016; Kumari, Sangeeta/AAB-7154-2022; Cortes, Eduardo/AAW-8005-2021	Ben-Salem, Salma/0000-0001-5023-6781; Kumari, Sangeeta/0000-0002-0692-0452; Klein, Eric A/0000-0002-1783-0698	DOD PCRP award [W81XWH-16-1-0404]; NIH NCI [CA166440, CA174777, CA077739, CA232979, CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA174777, R01CA166440, U24CA232979] Funding Source: NIH RePORTER	DOD PCRP award; NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by DOD PCRP award W81XWH-16-1-0404 (HVH), NIH NCI grants CA166440 (HVH), CA174777 (SMD), CA077739 (JLM), CA232979 (SL) and CA016056 (JLM and SL).	Attard G, 2018, J CLIN ONCOL, V36, P2639, DOI 10.1200/JCO.2018.77.9827; Centenera MM, 2013, NAT REV UROL, V10, P483, DOI 10.1038/nrurol.2013.126; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; Collins C, 2007, CANCER BIOL THER, V6, P1360; Dai C, 2017, COLD SPRING HARB PER, V7; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; George DJ, 1999, CANCER RES, V59, P2395; Godebu E, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0275-1; Gualdrini F, 2016, MOL CELL, V64, P1048, DOI 10.1016/j.molcel.2016.10.016; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heemers HV, 2007, CANCER RES, V67, P10592, DOI 10.1158/0008-5472.CAN-07-1917; Heemers HV, 2013, CURR DRUG TARGETS, V14, P481; Heemers HV, 2011, CANCER RES, V71, P1978, DOI 10.1158/0008-5472.CAN-10-2512; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; Itkonen HM, 2017, ONCOTARGET, V8, P38264, DOI 10.18632/oncotarget.16123; Iyer R, 2010, CLIN CANCER RES, V16, P1478, DOI 10.1158/1078-0432.CCR-09-1531; Jilg CA, 2014, ONCOTARGET, V5, P12646, DOI 10.18632/oncotarget.2653; Kajimoto K, 2011, AM J PHYSIOL-HEART C, V300, pH191, DOI 10.1152/ajpheart.00232.2010; Karantanos T, 2015, EUR UROL, V67, P470, DOI 10.1016/j.eururo.2014.09.049; Kim JY, 2014, MOL CELL, V54, P613, DOI 10.1016/j.molcel.2014.03.043; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Kohler J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034973; Kumari S, 2017, ENDOCR-RELAT CANCER, V24, pR275, DOI 10.1530/ERC-17-0121; Labbe DP, 2017, CLIN CANCER RES, V23, P7072, DOI 10.1158/1078-0432.CCR-17-0413; Li JN, 2017, ELIFE, V6, DOI 10.7554/eLife.20183; Li ZF, 2016, NATURE, V533, P547, DOI 10.1038/nature17954; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu S, 2017, ELIFE, V6, DOI 10.7554/eLife.28482.001; Luo J, 2018, EUR UROL, V73, P715, DOI 10.1016/j.eururo.2017.11.038; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Marshall JL, 2005, INVEST NEW DRUG, V23, P31, DOI 10.1023/B:DRUG.0000047103.64335.b0; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Mills IG, 2014, NAT REV CANCER, V14, P187, DOI 10.1038/nrc3678; Mitchell SH, 2000, MOL CELL ENDOCRINOL, V168, P89, DOI 10.1016/S0303-7207(00)00319-1; Miyamoto DT, 2018, CANCER DISCOV, V8, P288, DOI 10.1158/2159-8290.CD-16-1406; Miyamoto DT, 2015, SCIENCE, V349, P1351, DOI 10.1126/science.aab0917; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Nyquist MD, 2013, P NATL ACAD SCI USA, V110, P17492, DOI 10.1073/pnas.1308587110; O'Hurley G, 2014, PROSTATE, V74, P306, DOI 10.1002/pros.22752; O'Sullivan AG, 2017, BBA-MOL BASIS DIS, V1863, P838, DOI 10.1016/j.bbadis.2017.01.011; Olmos D, 2012, LANCET ONCOL, V13, P1114, DOI 10.1016/S1470-2045(12)70372-8; Prencipe M, 2015, PROSTATE, V75, P1704, DOI 10.1002/pros.23051; Prencipe M, 2013, PROSTATE, V73, P743, DOI 10.1002/pros.22618; Ravindranathan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2912; Scher HI, 2016, J CLIN ONCOL, V34, P1402, DOI 10.1200/JCO.2015.64.2702; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Schmidt LJ, 2012, MOL ENDOCRINOL, V26, P716, DOI 10.1210/me.2011-1130; Shabbir M, 2010, EXPERT OPIN INV DRUG, V19, P427, DOI 10.1517/13543781003598862; Shibata H, 1999, MOL BRAIN RES, V74, P126, DOI 10.1016/S0169-328X(99)00273-9; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Takanaga H, 1998, EXP CELL RES, V241, P363, DOI 10.1006/excr.1998.4060; Taniguchi T, 2001, J BIOL CHEM, V276, P10025, DOI 10.1074/jbc.M007427200; Treisman R, 1998, COLD SPRING HARB SYM, V63, P643, DOI 10.1101/sqb.1998.63.643; Viswanathan SR, 2018, CELL, V174, P433, DOI 10.1016/j.cell.2018.05.036; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Weeraratna AT, 2001, CLIN CANCER RES, V7, P2237; Yamoah K, 2015, J CLIN ONCOL, V33, P2789, DOI 10.1200/JCO.2014.59.8912; Yu WD, 2011, CLIN CANCER RES, V17, P4355, DOI 10.1158/1078-0432.CCR-10-2858	63	6	6	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2019	38	23					4496	4511		10.1038/s41388-019-0732-7	http://dx.doi.org/10.1038/s41388-019-0732-7			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB4KM	30742064	Green Accepted			2022-12-26	WOS:000470240300005
J	Glantschnig, C; Koenen, M; Gil-Lozano, M; Karbiener, M; Pickrahn, I; Williams-Dautovich, J; Patel, R; Cummins, CL; Giroud, M; Hartleben, G; Vogl, E; Bluher, M; Tuckermann, J; Uhlenhaut, H; Herzig, S; Scheideler, M				Glantschnig, Christina; Koenen, Mascha; Gil-Lozano, Manuel; Karbiener, Michael; Pickrahn, Ines; Williams-Dautovich, Jasmine; Patel, Rucha; Cummins, Carolyn L.; Giroud, Maude; Hartleben, Gotz; Vogl, Elena; Blueher, Matthias; Tuckermann, Jan; Uhlenhaut, Henriette; Herzig, Stephan; Scheideler, Marcel			A miR-29a-driven negative feedback loop regulates peripheral glucocorticoid receptor signaling	FASEB JOURNAL			English	Article						adipogenesis; adipose tissue; miRNA; arthritis; metabolism	ADIPOCYTE DIFFERENTIATION; RHEUMATOID-ARTHRITIS; PPAR-GAMMA; CORTICOSTEROID RESISTANCE; MOLECULAR-MECHANISMS; ADIPOGENESIS; EXPRESSION; CHROMATIN; HORMONES; PROMOTES	The glucocorticoid receptor (GR) represents the crucial molecular mediator of key endocrine, glucocorticoid hormone-dependent regulatory circuits, including control of glucose, protein, and lipid homeostasis. Consequently, aberrant glucocorticoid signaling is linked to severe metabolic disorders, including insulin resistance, obesity, and hyperglycemia, all of which also appear upon chronic glucocorticoid therapy for the treatment of inflammatory conditions. Of note, long-term glucocorticoid exposure under these therapeutic conditions typically induces glucocorticoid resistance, requiring higher doses and consequently triggering more severe metabolic phenotypes. However, the molecular basis of acquired glucocorticoid resistance remains unknown. In a screen of differential microRNA expression during glucocorticoid-dependent adipogenic differentiation of human multipotent adipose stem cells, we identified microRNA 29a (miR-29a) as one of the most down-regulated transcripts. Overexpression of miR-29a impaired adipogenesis. We found that miR-29a represses GR in human adipogenesis by directly targeting its mRNA, and downstream analyses revealed that GR mediates most of miR-29a's anti-adipogenic effects. Conversely, miR-29a expression depends on GR activation, creating a novel miR-29-driven feedback loop. miR-29a and GR expression were inversely correlated both in murine adipose tissue and in adipose tissue samples obtained from human patients. In the latter, miR-29a levels were additionally strongly negatively correlated with body mass index and adipocyte size. Importantly, inhibition of miR-29 in mice partially rescued the down-regulation of GR during dexamethasone treatment. We discovered that, in addition to modulating GR function under physiologic conditions, pharmacologic glucocorticoid application in inflammatory disease also induced miR-29a expression, correlating with reduced GR levels. This effect was abolished in mice with impaired GR function. In summary, we uncovered a novel GR-miR-29a negative feedback loop conserved between mice and humans, in health and disease. For the first time, we elucidate a microRNA-related mechanism that might contribute to GR dysregulation and resistance in peripheral tissues.Glantschnig, C., Koenen, M., Gil-Lozano, M., Karbiener, M., Pickrahn, I., Williams-Dautovich, J., Patel, R., Cummins, C. L., Giroud, M., Hartleben, G., Vogl, E., Bluher, M., Tuckermann, J., Uhlenhaut, H., Herzig, S., Scheideler, M. A miR-29a-driven negative feedback loop regulates peripheral glucocorticoid receptor signaling.	[Glantschnig, Christina; Gil-Lozano, Manuel; Giroud, Maude; Hartleben, Gotz; Vogl, Elena; Herzig, Stephan; Scheideler, Marcel] Helmholtz Ctr Munich, IDC, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany; [Uhlenhaut, Henriette] Helmholtz Ctr Munich, Res Grp Mol Endocrinol, Neuherberg, Germany; [Glantschnig, Christina; Gil-Lozano, Manuel; Giroud, Maude; Hartleben, Gotz; Vogl, Elena; Herzig, Stephan; Scheideler, Marcel] Heidelberg Univ Hosp, Joint Heidelberg IDC, Inner Med 1, Heidelberg, Germany; [Glantschnig, Christina; Gil-Lozano, Manuel; Giroud, Maude; Hartleben, Gotz; Vogl, Elena; Herzig, Stephan; Scheideler, Marcel] German Ctr Diabet Res DZD, Neuherberg, Germany; [Koenen, Mascha; Tuckermann, Jan] Ulm Univ, Inst Comparat Mol Endocrinol, Ulm, Germany; [Karbiener, Michael] Univ Hosp, Med Univ Graz, Dept Otorhinolaryngol, Div Phoniatr Speech & Swallowing, Graz, Austria; [Pickrahn, Ines] Univ Salzburg, Dept Legal Med, Salzburg, Austria; [Williams-Dautovich, Jasmine; Patel, Rucha; Cummins, Carolyn L.] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Blueher, Matthias] Med Res Ctr, Clin Endocrinol & Nephrol, Leipzig, Germany; [Herzig, Stephan] Tech Univ Munich, Sch Med, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; Ulm University; Medical University of Graz; Salzburg University; University of Toronto; Technical University of Munich	Herzig, S; Scheideler, M (corresponding author), Helmholtz Ctr Munich, IDC, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany.	stephan.herzig@helmholtz-muenchen.de; marcel.scheideler@helmholtz-muenchen.de	Uhlenhaut, Henriette/AAP-5400-2020; Koenen, Mascha/GWZ-9700-2022; Uhlenhaut, Henriette/AFR-1141-2022; Scheideler, Marcel/B-3087-2015	Cummins, Carolyn/0000-0001-7603-6577; Uhlenhaut, Henriette/0000-0002-4220-4779; Koenen, Mascha/0000-0002-1024-4506; Scheideler, Marcel/0000-0003-4650-7387	European Seventh Framework Programme (FP7) Project DIABAT [Health-F2-2011-27873]; Austrian Science Fund (FWF) [P25729-B19]; Austrian Academy of Sciences Fellowship [OAW-DOC 24325]; Collaborative Research Centre/Transregio (CRC/TRR) 205 "The Adrenal"; European Union Research and Innovation Funding Program (FP7) Brainage; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft (Grants Priority Program Immunobone) [1468/Tu 220/6-1, 1468/Tu 220//6-2]; Deutsche Forschungsgemeinschaft (Collaborative Research Centre) [1149/C02/INST 40/492-1, DFG-ANR/TU 220/13-1, 314061271]	European Seventh Framework Programme (FP7) Project DIABAT; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Academy of Sciences Fellowship(Austrian Science Fund (FWF)); Collaborative Research Centre/Transregio (CRC/TRR) 205 "The Adrenal"; European Union Research and Innovation Funding Program (FP7) Brainage; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft (Grants Priority Program Immunobone)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Collaborative Research Centre)(German Research Foundation (DFG))	The authors thank Christian Dani and Ez-Zoubir Amri (Institut de Biologie Valrose, Universite Nice Sophia Antipolis, France) for providing human multipotent adipose stem cells, Lara Shahidian (Institute of Functional Epigenetics, Helmholtz Center Munich, Germany) for technical help, Frits Mattijssen (previously at Institute for Diabetes and Cancer, Helmholtz Center Munich, Germany) for feedback on the manuscript, and Chloe Szwer for language editing. The authors also thank Quirin Reinold (Institute for Diabetes and Cancer, Helmholtz Center Munich, Germany) for highly competent technical assistance and Peter Weber (Institute for Diabetes and Cancer, and Research Unit of Radiation Cytogenetics, Helmholtz Center Munich, Germany) and David Rugamer (previously at Department of Statistics, Ludwig-Maximiians-Universitat Munich, Germany) for advice on statistical analysis. This work was supported by the European Seventh Framework Programme (FP7) Project DIABAT (Health-F2-2011-27873 to M.S. and S.H.), the Austrian Science Fund (FWF; P25729-B19 to M.S.), an Austrian Academy of Sciences Fellowship (OAW-DOC 24325 to C.G.), the Collaborative Research Centre/Transregio (CRC/TRR) 205 "The Adrenal" (to H.U. and S.H.), the Deutsche Forschungsgemeinschaft (Grants Priority Program Immunobone 468/Tu 220/6-1 and /6-2, Collaborative Research Centre 1149/C02/INST 40/492-1, DFG-ANR/TU 220/13-1, and Project Number 314061271), and the European Union Research and Innovation Funding Program (FP7) Brainage. M.G.L. and M.G. were partially funded by postdoctoral fellowships of the Alexander von Humboldt Foundation. The authors declare no conflicts of interest.	Adcock IM, 2012, CURR OPIN PHARMACOL, V12, P246, DOI 10.1016/j.coph.2012.02.006; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; [Anonymous], MOL CELL BIOL, V16, P202, DOI [DOI 10.1128/MCB.00260-16, 10.1128/MCB.16.1.202, DOI 10.1128/MCB.16.1.202]; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barnes Peter J, 2009, Lancet, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Baschant U, 2013, MOL CELL ENDOCRINOL, V380, P108, DOI 10.1016/j.mce.2013.06.009; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chikanza IC, 2004, RHEUMATOLOGY, V43, P1337, DOI 10.1093/rheumatology/keh333; Christensen AD, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00213; Clayton SA, 2018, J BIOL CHEM, V293, P1865, DOI 10.1074/jbc.R117.000366; COHEN A, 1960, JAMA-J AM MED ASSOC, V174, P831, DOI 10.1001/jama.1960.03030070009002; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; de Guia RM, 2015, EMBO J, V34, P344, DOI 10.15252/embj.201490464; de Guia RM, 2014, HORM MOL BIOL CLIN I, V19, P117, DOI 10.1515/hmbci-2014-0021; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engin A, 2017, ADV EXP MED BIOL, V960, P221, DOI 10.1007/978-3-319-48382-5_9; Farrell RJ, 2003, J ENDOCRINOL, V178, P339, DOI 10.1677/joe.0.1780339; Gomes PR, 2014, AM J PHYSIOL-ENDOC M, V306, pE109, DOI 10.1152/ajpendo.00364.2013; Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; Gu CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep38491; Hartmann K, 2016, PHYSIOL REV, V96, P409, DOI 10.1152/physrev.00011.2015; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Hubner S, 2015, BIOL CHEM, V396, P1223, DOI 10.1515/hsz-2015-0106; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Karbiener M, 2014, STEM CELLS, V32, P1578, DOI 10.1002/stem.1603; Karbiener M, 2011, RNA BIOL, V8, P850, DOI 10.4161/rna.8.5.16153; Kilroy G, 2016, J BIOL CHEM, V291, P27289, DOI 10.1074/jbc.M116.744672; Kilroy G, 2012, ENDOCRINOLOGY, V153, P1206, DOI 10.1210/en.2011-1725; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Koenen M, 2018, ANN RHEUM DIS, V77, P1610, DOI 10.1136/annrheumdis-2017-212762; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kroot EJA, 2006, ANN NY ACAD SCI, V1069, P300, DOI 10.1196/annals.1351.028; Ledderose C, 2012, CRIT CARE MED, V40, P2745, DOI 10.1097/CCM.0b013e31825b8ebc; Lee MJ, 2014, BBA-MOL BASIS DIS, V1842, P473, DOI 10.1016/j.bbadis.2013.05.029; Lian WS, 2017, J MOL MED, V95, P1327, DOI 10.1007/s00109-017-1583-8; Lowin T, 2009, ARTHRITIS RHEUM-US, V60, P3623, DOI 10.1002/art.24985; Mattijssen F, 2014, J BIOL CHEM, V289, P19279, DOI 10.1074/jbc.M114.570044; Meerson A, 2013, DIABETOLOGIA, V56, P1971, DOI 10.1007/s00125-013-2950-9; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Monach Paul A, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1522s81; Motulsky HJ., GRAPHPAD STAT GUIDE; Movahedi M, 2016, EUR J EPIDEMIOL, V31, P1045, DOI 10.1007/s10654-016-0167-1; Mudhasani R, 2011, J CELL PHYSIOL, V226, P1399, DOI 10.1002/jcp.22475; Mudhasani R, 2010, J CELL BIOCHEM, V110, P812, DOI 10.1002/jcb.22625; Mueller KM, 2017, DIABETES, V66, P272, DOI 10.2337/db16-0381; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pek SLT, 2016, MOL CELL ENDOCRINOL, V427, P112, DOI 10.1016/j.mce.2016.03.010; Pisani Didier F, 2011, Front Endocrinol (Lausanne), V2, P87, DOI 10.3389/fendo.2011.00087; Raff H, 2015, J PHYSIOL-LONDON, V593, P493, DOI 10.1113/jphysiol.2014.282871; Ramamoorthy S, 2013, MOL CELL BIOL, V33, P1711, DOI 10.1128/MCB.01151-12; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Roh HC, 2018, CELL METAB, V27, P1121, DOI 10.1016/j.cmet.2018.03.005; Ronchetti S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00170; Rose AJ, 2013, MOL CELL ENDOCRINOL, V380, P65, DOI 10.1016/j.mce.2013.03.007; Rose S, 2013, ANN RHEUM DIS, V72, P89, DOI 10.1136/annrheumdis-2012-201431; Ru Peng, 2017, RNA Dis, V4, DOI 10.14800/rd.1525; Ru P, 2016, CELL REP, V16, P1527, DOI 10.1016/j.celrep.2016.07.017; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Smith KM, 2012, J IMMUNOL, V189, P1567, DOI 10.4049/jimmunol.1103171; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; van Nieuwenhuijze A, 2017, CELL MOL LIFE SCI, V74, P2095, DOI 10.1007/s00018-017-2456-6; Vreugdenhil E, 2009, ENDOCRINOLOGY, V150, P2220, DOI 10.1210/en.2008-1335; Wang FS, 2013, ARTHRITIS RHEUM-US, V65, P1530, DOI 10.1002/art.37948; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wang SS, 2017, PROG NEURO-PSYCHOPH, V79, P417, DOI 10.1016/j.pnpbp.2017.07.024; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Zhang RH, 2014, J MOL ENDOCRINOL, V52, P235, DOI 10.1530/JME-13-0273; Zhang XM, 2016, OBESITY, V24, P1097, DOI 10.1002/oby.21467; Zhu YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170636	86	23	24	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5924	5941		10.1096/fj.201801385RR	http://dx.doi.org/10.1096/fj.201801385RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30742779	Bronze			2022-12-26	WOS:000466932600011
J	He, Y; Yu, LJ; Liu, JY; Li, YQ; Wu, YH; Huang, ZF; Wu, D; Wang, H; Wu, ZH; Qiu, GX				He, Yu; Yu, Lingjia; Liu, Jieying; Li, Yaqian; Wu, Yuanhao; Huang, Zhenfei; Wu, Di; Wang, Hai; Wu, Zhihong; Qiu, Guixing			Enhanced osteogenic differentiation of human bone-derived mesenchymal stem cells in 3-dimensional printed porous titanium scaffolds by static magnetic field through up-regulating Smad4	FASEB JOURNAL			English	Article						osteogenesis; bone defect; proteomics	PROLIFERATION RATE; TGF-BETA; REGENERATION; VIABILITY; MT	The reconstruction of large bone defects remains a significant challenge for orthopedists. Three-dimensional-printed (3DP) scaffold is considered a promising repair material. Static magnetic field (SMF) treatment is an effective and noninvasive therapeutic method to improve bone regeneration. However, the osteogenic effect of SMF on human bone-derived mesenchymal stem cells (hBMSCs) in 3DP scaffolds, as well as its potential mechanism, are unclear. In this study, the osteogenic effect of SMF on hBMSCs in a 3DP scaffold was investigated in vitro and in vivo. In addition, the potential mechanism for promoting osteogenesis was investigated by proteomic analysis. The results showed that SMF promoted osteogenic differentiation of hBMSCs in vitro. A total of 185 differential proteins were identified under SMF conditions by proteomic analysis. The osteogenic effect might be associated with bone morphogenetic protein-Smad1/5/8-signaling pathway and increased transport of phosphorylated Smad1/5/8 and phosphorylated Smad2/3 to the nucleus by up-regulating Smad4 under SMF conditions. The in vivo experiment showed that bone regeneration and osseointegration was enhanced by SMF in the rat model of bone defect. In conclusion, moderate SMF was a safe and effective method for enhancing osteogenesis in 3DP scaffolds in vitro and in vivo.He, Y., Yu, L., Liu, J., Li, Y., Wu, Y., Huang, Z., Wu, D., Wang, H., Wu, Z., Qiu, G. Enhanced osteogenic differentiation of human bone-derived mesenchymal stem cells in 3-dimensional printed porous titanium scaffolds by static magnetic field through up-regulating Smad4.	[He, Yu; Yu, Lingjia; Huang, Zhenfei; Wu, Di; Wang, Hai; Qiu, Guixing] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Orthopaed Surg, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China; [Liu, Jieying; Li, Yaqian; Wu, Yuanhao; Wu, Zhihong] Peking Union Med Coll, Peking Union Med Coll Hosp, Cent Lab, Beijing, Peoples R China; [Liu, Jieying; Li, Yaqian; Wu, Yuanhao; Wu, Zhihong] Chinese Acad Med Sci, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China; [Wu, Zhihong] Beijing Key Lab Genet Res Bone & Joint Dis, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Wang, H (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Orthopaed Surg, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China.; Wang, H (corresponding author), Chinese Acad Med Sci, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China.; Wu, ZH (corresponding author), Beijing Key Lab Genet Res Bone & Joint Dis, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China.	wanghai907@hotmail.com; wuzh3000@126.com	wu, zhi/GXH-3041-2022; Wu, Yuanhao/ABM-9242-2022; Liu, Jieying/ADZ-7556-2022; LI, YAQIAN/GQH-2240-2022		Fundamental Research Funds for Central Public Welfare Research Institutes, Chinese Academy of Medical Sciences [2016ZX310177-7]; National High-Tech Research and Development Program of China (863 Program) [2015AA020316, 2015AA033601]; Youth Foundation of Peking Union Medical College Hospital [PUMCH-2016-2.4]; Science and Technology Innovation Project of Medicine and Health, Chinese Academy of Medical Sciences [2017-I2M-2-001]	Fundamental Research Funds for Central Public Welfare Research Institutes, Chinese Academy of Medical Sciences; National High-Tech Research and Development Program of China (863 Program); Youth Foundation of Peking Union Medical College Hospital; Science and Technology Innovation Project of Medicine and Health, Chinese Academy of Medical Sciences	The authors thank Drs. Jingjing Tian and Lin Kang (Peking Union Medical College and Chinese Academy of Medical Sciences) for their help on the experiment. The authors also thank Dr. Sarah Dodds (Liwen Bianji, Edanz Editing, Beijing, China) for editing the English text of a draft of this manuscript. This work was supported by the Fundamental Research Funds for Central Public Welfare Research Institutes, Chinese Academy of Medical Sciences (2016ZX310177-7), the National High-Tech Research and Development Program of China (863 Program, 2015AA020316, 2015AA033601), Youth Foundation of Peking Union Medical College Hospital (PUMCH-2016-2.4), and Science and Technology Innovation Project of Medicine and Health, Chinese Academy of Medical Sciences (2017-I2M-2-001). The authors declare no conflicts of interest.	Arvidson K, 2011, J CELL MOL MED, V15, P718, DOI 10.1111/j.1582-4934.2010.01224.x; Aydin N, 2011, INT ORTHOP, V35, P135, DOI 10.1007/s00264-009-0932-9; Ba XL, 2011, BIOMATERIALS, V32, P7831, DOI 10.1016/j.biomaterials.2011.06.053; Beier JP, 2010, J TISSUE ENG REGEN M, V4, P216, DOI 10.1002/term.229; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chiu KH, 2007, ANN BIOMED ENG, V35, P1932, DOI 10.1007/s10439-007-9370-2; Costantino Cosimo, 2007, Acta Biomed, V78, P198; Hsu SH, 2010, CYTOTECHNOLOGY, V62, P143, DOI 10.1007/s10616-010-9271-3; Huang HM, 2006, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000203464.35561.be; Jouni FJ, 2013, IN VITRO CELL DEV-AN, V49, P212, DOI 10.1007/s11626-013-9580-x; Kim EC, 2015, BIOELECTROMAGNETICS, V36, P267, DOI 10.1002/bem.21903; Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814; Lewallen EA, 2016, GENE, V581, P95, DOI 10.1016/j.gene.2016.01.015; Li Y, 2012, ANN BIOMED ENG, V40, P2611, DOI 10.1007/s10439-012-0602-8; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Liu H, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/4/045012; Mehra A, 2002, BIOCHEM CELL BIOL, V80, P605, DOI 10.1139/O02-161; Moon YJ, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.75; Nune KC, 2016, J BIOMED MATER RES A, V104, P517, DOI 10.1002/jbm.a.35592; Puricelli Edela, 2009, Head Face Med, V5, P1, DOI 10.1186/1746-160X-5-1; Xiu P, 2016, ACS APPL MATER INTER, V8, P17964, DOI 10.1021/acsami.6b05893; Xu NF, 2016, SPINE, V41, pE50, DOI 10.1097/BRS.0000000000001179; Xu SZ, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/620984; Yamaguchi-Sekino S, 2011, MAGN RESON MED SCI, V10, P1, DOI 10.2463/mrms.10.1; Yamamoto Y, 2003, J DENT RES, V82, P962, DOI 10.1177/154405910308201205; Yan QC, 1998, MED ENG PHYS, V20, P397, DOI 10.1016/S1350-4533(98)00051-4; Yavari SA, 2014, BIOMATERIALS, V35, P6172, DOI 10.1016/j.biomaterials.2014.04.054; Yin B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040575; Zafari J, 2015, ELECTROMAGN BIOL MED, V34, P216, DOI 10.3109/15368378.2015.1076452; Zhang H, 2018, BONE, V107, P36, DOI 10.1016/j.bone.2017.10.024; Zhang JY, 2014, APPL ENERG, V114, P146, DOI 10.1016/j.apenergy.2013.09.057	32	28	30	7	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6069	6081		10.1096/fj.201802195R	http://dx.doi.org/10.1096/fj.201802195R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30763124	Bronze			2022-12-26	WOS:000466932600023
J	Soni, S; O'Dea, KP; Tan, YY; Cho, K; Abe, E; Romano, R; Cui, J; Ma, DQ; Sarathchandra, P; Wilson, MR; Takata, M				Soni, Sanooj; O'Dea, Kieran P.; Tan, Ying Ying; Cho, Kahori; Abe, Eiko; Romano, Rosalba; Cui, Jiang; Ma, Daqing; Sarathchandra, Padmini; Wilson, Michael R.; Takata, Masao			ATP redirects cytokine trafficking and promotes novel membrane TNF signaling via microvesicles	FASEB JOURNAL			English	Article						extracellular vesicles; protein signalling; cellular communication; danger signals	NECROSIS-FACTOR-ALPHA; ACUTE LUNG INJURY; ACID SPHINGOMYELINASE; ALVEOLAR MACROPHAGES; RELEASE; ACTIVATION; CELLS; RECEPTORS; INTERLEUKIN-1-BETA; STIMULATION	Cellular stress or injury induces release of endogenous danger signals such as ATP, which plays a central role in activating immune cells. ATP is essential for the release of nonclassically secreted cytokines such as IL-1 but, paradoxically, has been reported to inhibit the release of classically secreted cytokines such as TNF. Here, we reveal that ATP does switch off soluble TNF (17 kDa) release from LPS-treated macrophages, but rather than inhibiting the entire TNF secretion, ATP packages membrane TNF (26 kDa) within microvesicles (MVs). Secretion of membrane TNF within MVs bypasses the conventional endoplasmic reticulum- and Golgi transport-dependent pathway and is mediated by acid sphingomyelinase. These membrane TNF-carrying MVs are biologically more potent than soluble TNF in vivo, producing significant lung inflammation in mice. Thus, ATP critically alters TNF trafficking and secretion from macrophages, inducing novel unconventional membrane TNF signaling via MVs without direct cell-to-cell contact. These data have crucial implications for this key cytokine, particularly when therapeutically targeting TNF in acute inflammatory diseases.Soni, S., O'Dea, K. P., Tan, Y. Y., Cho, K., Abe, E., Romano, R., Cui, J., Ma, D., Sarathchandra, P., Wilson, M. R., Takata, M. ATP redirects cytokine trafficking and promotes novel membrane TNF signaling via microvesicles.	[Soni, Sanooj; O'Dea, Kieran P.; Tan, Ying Ying; Cho, Kahori; Abe, Eiko; Romano, Rosalba; Cui, Jiang; Ma, Daqing; Wilson, Michael R.; Takata, Masao] Imperial Coll London, Chelsea & Westminster Hosp, Fac Med, Sect Anaesthet Pain Med & Intens Care, 369 Fulham Rd, London SW10 9NH, England; [Sarathchandra, Padmini] Imperial Coll London, Natl Heart & Lung Inst, Harefield Hosp, Heart Sci Ctr, Harefield, Middx, England	Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital	Takata, M (corresponding author), Imperial Coll London, Chelsea & Westminster Hosp, Fac Med, Sect Anaesthet Pain Med & Intens Care, 369 Fulham Rd, London SW10 9NH, England.	m.takata@imperial.ac.uk	Ma, Daqing/GLT-2735-2022	Ma, Daqing/0000-0003-1235-0537; Tan, Ying Ying/0000-0002-7452-606X; Soni, Sanooj/0000-0001-8126-8313	Medical Research Council; Chelsea and Westminster Health Charity; British Journal of Anaesthesia [P54008]; MRC [MR/M018164/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chelsea and Westminster Health Charity; British Journal of Anaesthesia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council and British Journal of Anaesthesia (P54008) and the Chelsea and Westminster Health Charity. The authors declare no conflicts of interest.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Barbera-Cremades M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00862; Beckmann N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00331; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Boucsein C, 2003, EUR J NEUROSCI, V17, P2267, DOI 10.1046/j.1460-9568.2003.02663.x; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chiaruttini G, 2016, CELL REP, V14, P2624, DOI 10.1016/j.celrep.2016.02.055; Cohen HB, 2013, BLOOD, V122, P1935, DOI 10.1182/blood-2013-04-496216; CORTI A, 1992, BIOCHEM J, V284, P905, DOI 10.1042/bj2840905; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Dorr AD, 2011, J APPL PHYSIOL, V111, P177, DOI 10.1152/japplphysiol.00007.2011; Drago F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00910; Dubois-Colas N, 2014, J INFECT DIS, V210, P824, DOI 10.1093/infdis/jiu135; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Engele M, 2002, J IMMUNOL, V168, P1328, DOI 10.4049/jimmunol.168.3.1328; Fehrenbach H, 2003, EUR RESPIR J, V21, P421, DOI 10.1183/09031936.03.00083002; Giuliani AL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00123; Gulinelli S, 2012, EUR J IMMUNOL, V42, P3334, DOI 10.1002/eji.201142268; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Jiang H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-69; Kawamura H, 2012, IMMUNOLOGY, V136, P448, DOI 10.1111/j.1365-2567.2012.03601.x; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; Lacy P, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00190; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Laliberte RE, 1999, J BIOL CHEM, V274, P36944, DOI 10.1074/jbc.274.52.36944; Levin C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01214; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Manzanero S, 2012, METHODS MOL BIOL, V844, P177, DOI 10.1007/978-1-61779-527-5_12; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Miguel RDV, 2012, J IMMUNOL METHODS, V384, P191, DOI 10.1016/j.jim.2012.07.018; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Nalos M, 2008, INTENS CARE MED, V34, P1891, DOI 10.1007/s00134-008-1156-y; O'Dea KP, 2005, AM J RESP CRIT CARE, V172, P1119, DOI 10.1164/rccm.200504-605OC; Patel BV, 2013, J IMMUNOL, V190, P4274, DOI 10.4049/jimmunol.1202437; Patel BV, 2012, EUR RESPIR J, V39, P1162, DOI 10.1183/09031936.00093911; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perry DM, 2014, J BIOL CHEM, V289, P22401, DOI 10.1074/jbc.M114.589648; Pizzirani C, 2007, BLOOD, V109, P3856, DOI 10.1182/blood-2005-06-031377; Qiu P, 2013, CRIT CARE MED, V41, P2419, DOI 10.1097/CCM.0b013e3182982add; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Salome RG, 2000, J APPL PHYSIOL, V88, P10, DOI 10.1152/jappl.2000.88.1.10; Scott AJ, 2011, J BIOL CHEM, V286, P35466, DOI 10.1074/jbc.M111.277434; Shah D, 2014, AM J PHYSIOL-LUNG C, V306, pL152, DOI 10.1152/ajplung.00229.2013; Shurety W, 2001, LAB INVEST, V81, P107, DOI 10.1038/labinvest.3780216; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Soni S, 2016, THORAX, V71, P1020, DOI 10.1136/thoraxjnl-2015-208032; Thomas LM, 2010, J IMMUNOL, V185, P3740, DOI 10.4049/jimmunol.1001231; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Wilson MR, 2005, AM J PHYSIOL-LUNG C, V288, pL599, DOI 10.1152/ajplung.00304.2004; Woods SJ, 2015, AM J PHYSIOL-LUNG C, V308, pL912, DOI 10.1152/ajplung.00048.2015; Xuan W, 2016, SCI REP-UK, V6, DOI 10.1038/srep26277; Zhang HG, 2006, J IMMUNOL, V176, P7385, DOI 10.4049/jimmunol.176.12.7385; Zhao H, 2013, AM J TRANSPLANT, V13, P2006, DOI 10.1111/ajt.12293	61	24	24	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6442	6455		10.1096/fj.201802386R	http://dx.doi.org/10.1096/fj.201802386R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30776316	Green Published, hybrid			2022-12-26	WOS:000466932600050
J	Komatsubara, AT; Goto, Y; Kondo, Y; Matsuda, M; Aoki, K				Komatsubara, Akira T.; Goto, Yuhei; Kondo, Yohei; Matsuda, Michiyuki; Aoki, Kazuhiro			Single-cell quantification of the concentrations and dissociation constants of endogenous proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence correlation spectroscopy (FCS); protein-protein interaction; extracellular signal-regulated kinase (ERK); RSK; nuclear translocation; dissociation constant; fluorescence cross-correlation spectroscopy (FCCS); live-cell analysis; single-cell analysis	MAP KINASE CASCADE; ERK; DYNAMICS; REPAIR; GENE; PHOSPHORYLATION; HETEROGENEITY; INHIBITION; EFFICIENCY; PATHWAYS	Kinetic simulation is a useful approach for elucidating complex cell-signaling systems. The numerical simulations required for kinetic modeling in live cells critically require parameters such as protein concentrations and dissociation constants (K-d). However, only a limited number of parameters have been measured experimentally in living cells. Here we describe an approach for quantifying the concentration and K-d of endogenous proteins at the single-cell level with CRISPR/Cas9-mediated knock-in and fluorescence cross-correlation spectroscopy. First, the mEGFP gene was knocked in at the end of the mitogen-activated protein kinase 1 (MAPK1) gene, encoding extracellular signal-regulated kinase 2 (ERK2), through homology-directed repair or microhomology-mediated end joining. Next, the HaloTag gene was knocked in at the end of the ribosomal S6 kinase 2 (RSK2) gene. We then used fluorescence correlation spectroscopy to measure the protein concentrations of endogenous ERK2-mEGFP and RSK2-HaloTag fusion constructs in living cells, revealing substantial heterogeneities. Moreover, fluorescence cross-correlation spectroscopy analyses revealed temporal changes in the apparent K-d values of the binding between ERK2-mEGFP and RSK2-HaloTag in response to epidermal growth factor stimulation. Our approach presented here provides a robust and efficient method for quantifying endogenous protein concentrations and dissociation constants in living cells.	[Komatsubara, Akira T.; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto 6068501, Japan; [Komatsubara, Akira T.; Goto, Yuhei; Kondo, Yohei; Aoki, Kazuhiro] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Quantitat Biol, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan; [Goto, Yuhei; Kondo, Yohei; Aoki, Kazuhiro] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst, Quantitat Biol Res Grp, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan; [Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan; [Kondo, Yohei; Aoki, Kazuhiro] Kyoto Univ, Grad Sch Med, Imaging Platform Spatiotemporal Informat, Sakyo Ku, Kyoto 6068501, Japan; [Kondo, Yohei; Aoki, Kazuhiro] Grad Univ Adv Studies, SOKENDAI, Fac Life Sci, Dept Basic Biol, Okazaki, Aichi 4448787, Japan; [Komatsubara, Akira T.] RIKEN, Quantitat Biol Ctr, Lab Cell Polar Regulat, Suita, Osaka 5650874, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS); Kyoto University; Kyoto University; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); RIKEN	Aoki, K (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Exploratory Res Ctr Life & Living Syst, Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	k-aoki@nibb.ac.jp	Goto, Yuhei/AAX-5076-2021; Aoki, Kazuhiro/I-5483-2019	Goto, Yuhei/0000-0002-5597-158X; Aoki, Kazuhiro/0000-0001-7263-1555; Kondo, Yohei/0000-0002-2801-4522; Matsuda, Michiyuki/0000-0002-5876-9969	Spectrography and Bioimaging Facility; Functional Genomics Facility; NIBB Core Research Facilities; Platform for Dynamic Approaches to Living Systems from the Ministry of Education, Culture, Sports, and Science, Japan; JST, CREST Grant [JPMJCR1654]; MEXT/JSPS KAKENHI Grant [15H05949]; JSPS KAKENHI [16H01425, 16H01447, 16KT0069, 18H04754, 18H02444]; Hori Sciences and Arts Foundation; Nakajima Foundation	Spectrography and Bioimaging Facility; Functional Genomics Facility; NIBB Core Research Facilities; Platform for Dynamic Approaches to Living Systems from the Ministry of Education, Culture, Sports, and Science, Japan; JST, CREST Grant; MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hori Sciences and Arts Foundation; Nakajima Foundation	This work was supported by the Spectrography and Bioimaging Facility and Functional Genomics Facility, NIBB Core Research Facilities. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Platform for Dynamic Approaches to Living Systems from the Ministry of Education, Culture, Sports, and Science, Japan; by JST, CREST Grant JPMJCR1654; and by MEXT/JSPS KAKENHI Grant 15H05949 "Resonance Bio."; Supported by the Platform for Dynamic Approaches to Living Systems from the Ministry of Education, Culture, Sports, and Science, Japan; by JST, CREST Grant JPMJCR1654; by JSPS KAKENHI Grants 16H01425 "Resonance Bio," 16H01447, 16KT0069, 18H04754 "Resonance Bio," and 18H02444; and by funds from the Hori Sciences and Arts Foundation and the Nakajima Foundation.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Aoki K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01541; Aokia K, 2011, P NATL ACAD SCI USA, V108, P12675, DOI 10.1073/pnas.1104030108; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Burkhard KA, 2011, J BIOL CHEM, V286, P2477, DOI 10.1074/jbc.M110.177899; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Gaudet S, 2016, TRENDS BIOTECHNOL, V34, P458, DOI 10.1016/j.tibtech.2016.02.009; Kholodenko B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002961; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kinjo Masataka, 2011, Cold Spring Harb Protoc, V2011, P1262, DOI 10.1101/pdb.prot065938; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Ling QH, 2012, SCIENCE, V338, P655, DOI 10.1126/science.1225053; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Macville M, 1999, CANCER RES, V59, P141; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Miura H, 2018, CELL REP, V24, P2658, DOI 10.1016/j.celrep.2018.08.020; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Nakatake Y, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-64; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Ries J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113009; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Sadaie W, 2014, MOL CELL BIOL, V34, P3272, DOI 10.1128/MCB.00087-14; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; SCHWARTZ F, 1991, P NATL ACAD SCI USA, V88, P10416, DOI 10.1073/pnas.88.23.10416; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; Shi XK, 2009, BIOPHYS J, V97, P678, DOI 10.1016/j.bpj.2009.05.006; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Stewart-Ornstein J, 2016, CELL REP, V14, P1800, DOI 10.1016/j.celrep.2016.01.045; Sudhaharan T, 2009, J BIOL CHEM, V284, P13602, DOI 10.1074/jbc.M900894200; Vaidyanathan H, 2007, P NATL ACAD SCI USA, V104, P19837, DOI 10.1073/pnas.0704514104; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	44	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6062	6072		10.1074/jbc.RA119.007685	http://dx.doi.org/10.1074/jbc.RA119.007685			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30739083	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000465077500036
J	Saelices, L; Nguyen, BA; Chung, K; Wang, YF; Ortega, A; Lee, JH; Coelho, T; Bijzet, J; Benson, MD; Eisenberg, DS				Saelices, Lorena; Nguyen, Binh A.; Chung, Kevin; Wang, Yifei; Ortega, Alfredo; Lee, Ji H.; Coelho, Teresa; Bijzet, Johan; Benson, Merrill D.; Eisenberg, David S.			A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; protein aggregation; inhibition mechanism; aging; drug discovery; peptides; amyloidosis; inhibition; peptide; seeding; transthyretin	TAFAMIDIS; POLYNEUROPATHY; PROTEIN; AGGREGATION; DIFLUNISAL; DEPOSITS; SAFETY; POTENT	The tetrameric protein transthyretin is a transporter of retinol and thyroxine in blood, cerebrospinal fluid, and the eye, and is secreted by the liver, choroid plexus, and retinal epithelium, respectively. Systemic amyloid deposition of aggregated transthyretin causes hereditary and sporadic amyloidoses. A common treatment of patients with hereditary transthyretin amyloidosis is liver transplantation. However, this procedure, which replaces the patient's variant transthyretin with the WT protein, can fail to stop subsequent cardiac deposition, ultimately requiring heart transplantation. We recently showed that preformed amyloid fibrils present in the heart at the time of surgery can template or seed further amyloid aggregation of native transthyretin. Here we assess possible interventions to halt this seeding, using biochemical and EM assays. We found that chemical or mutational stabilization of the transthyretin tetramer does not hinder amyloid seeding. In contrast, binding of the peptide inhibitor TabFH2 to ex vivo fibrils efficiently inhibits amyloid seeding by impeding self-association of the amyloid-driving strands F and H in a tissue-independent manner. Our findings point to inhibition of amyloid seeding by peptide inhibitors as a potential therapeutic approach.	[Saelices, Lorena; Nguyen, Binh A.; Chung, Kevin; Wang, Yifei; Ortega, Alfredo; Lee, Ji H.; Eisenberg, David S.] Univ Calif Los Angeles, Inst Mol Biol, Dept Biol Chem, Howard Hughes Med Inst,UCLA DOE Inst, Box 951570, Los Angeles, CA 90095 USA; [Saelices, Lorena; Nguyen, Binh A.; Chung, Kevin; Wang, Yifei; Ortega, Alfredo; Lee, Ji H.; Eisenberg, David S.] Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, Howard Hughes Med Inst,UCLA DOE Inst, Box 951570, Los Angeles, CA 90095 USA; [Coelho, Teresa] Ctr Hosp Porto, Hosp Santo Antonio, Dept Neurophysiol, P-4099001 Porto, Portugal; [Coelho, Teresa] Ctr Hosp Porto, Hosp Santo Antonio, Corino de Andrade Unit, P-4099001 Porto, Portugal; [Bijzet, Johan] Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9713 GZ Groningen, Netherlands; [Benson, Merrill D.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of Groningen; Indiana University System; Indiana University Bloomington	Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Biol Chem, Howard Hughes Med Inst,UCLA DOE Inst, Box 951570, Los Angeles, CA 90095 USA.; Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, Howard Hughes Med Inst,UCLA DOE Inst, Box 951570, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu		Eisenberg, David/0000-0003-2432-5419; Saelices Gomez, Lorena/0000-0002-1904-2150	Amyloidosis Foundation [20160759, 20170827]; National Institutes of Health [R01-AG048120]; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON AGING [R01AG048120] Funding Source: NIH RePORTER	Amyloidosis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Amyloidosis Foundation Grant 20160759 and 20170827, National Institutes of Health Grant R01-AG048120, and The Howard Hughes Medical Institute. The authors and UCLA have filed an international patent application for the TTR inhibitors (number PCT/US17/40103). D. S. E. is an advisor and equity holder of ADRx, Inc. L. S. is a consultant of ADRx, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamski-Werner SL, 2004, J MED CHEM, V47, P355, DOI 10.1021/jm030347n; Benson MD, 2013, MUSCLE NERVE, V47, P157, DOI 10.1002/mus.23521; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Castano Adam, 2012, Congest Heart Fail, V18, P315, DOI 10.1111/j.1751-7133.2012.00303.x; Coelho T., 1996, NEUROMUSCUL DISORD, V6, pS20, DOI 10.1016/0960-8966(96)88826-2; Coelho Teresa, 1993, Journal of Rheumatology, V20, P179; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; Cruz MW, 2016, AMYLOID, V23, P178, DOI 10.1080/13506129.2016.1207163; Cruz MW, 2015, NEUROL THER, V4, P61, DOI 10.1007/s40120-015-0031-3; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Fujita T, 2017, CARDIOLOGY, V137, P74, DOI 10.1159/000455089; Galant NJ, 2017, CLIN SCI, V131, P395, DOI 10.1042/CS20160413; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hazenberg BPC, 1999, ANN RHEUM DIS, V58, P96, DOI 10.1136/ard.58.2.96; Higaki JN, 2016, AMYLOID, V23, P86, DOI 10.3109/13506129.2016.1148025; Hosoi A, 2016, J BIOL CHEM, V291, P25096, DOI 10.1074/jbc.M116.738138; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Lozeron P, 2013, EUR J NEUROL, V20, P1539, DOI 10.1111/ene.12225; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Obici L, 2014, EXPERT OPIN INV DRUG, V23, P1239, DOI 10.1517/13543784.2014.922541; Pinney JH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000098; Plante-Bordeneuve V, 2017, J NEUROL, V264, P268, DOI 10.1007/s00415-016-8337-3; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Saelices L, 2018, NEUROBIOL DIS, V120, P118, DOI 10.1016/j.nbd.2018.09.007; Saelices L, 2018, P NATL ACAD SCI USA, V115, pE6741, DOI 10.1073/pnas.1805131115; Saelices L, 2015, J BIOL CHEM, V290, P28932, DOI 10.1074/jbc.M115.659912; Seidler PM, 2018, NAT CHEM, V10, P170, DOI [10.1038/nchem.2889, 10.1038/NCHEM.2889]; Sekijima Y, 2015, AMYLOID, V22, P79, DOI 10.3109/13506129.2014.997872; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Yazaki M, 2000, BIOCHEM BIOPH RES CO, V274, P702, DOI 10.1006/bbrc.2000.3203	34	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6130	6141		10.1074/jbc.RA118.005257	http://dx.doi.org/10.1074/jbc.RA118.005257			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30733338	Green Published, hybrid			2022-12-26	WOS:000465077500041
J	Miyawaki, A; Iizuka, Y; Sugino, H; Watanabe, Y				Miyawaki, Akimitsu; Iizuka, Yoshiko; Sugino, Hitomi; Watanabe, Yoshifumi			IL-11 prevents IFN-gamma-induced hepatocyte death through selective downregulation of IFN-gamma/STAT1 signaling and ROS scavenging	PLOS ONE			English	Article							CELL-CYCLE ARREST; INTERFERON-GAMMA; INTERLEUKIN-11; SOCS3; EXPRESSION; SUPPRESSOR; INHIBITOR; STAT3; MODEL; MODULATION	Aims Interferon-gamma (IFN-gamma) exhibits hepatotoxicity through signal transducer and activator of transcription 1 (STAT1) activation. On the contrary, interleukin-11 (IL-11) shows tissue-protective effects on various organs including the liver through STAT3 activation. Here, we found that IL-11 pretreatment protects hepatocytes from IFN-gamma-induced death and investigated the molecular mechanisms, particularly focusing on signal crosstalk. Methods and results Primary culture mouse hepatocytes were treated with IL-11 prior to IFN-gamma, and cell death was evaluated by lactate dehydrogenase release into media. As a result, IL-11 pretreatment effectively suppressed IFN-gamma-induced hepatocyte death. Since IFN-gamma-induced hepatocyte death requires STAT1 signaling, the activity of STAT1 was analyzed. IFN-gamma robustly activated STAT1 with its peak at 1 hr after stimulation, which was significantly attenuated by IL-1 pretreatment. Consistently, IL-11 pretreatment impeded mRNA increase of STAT1-ownstream molecules promoting cell death, i.e., IRF-1, caspase 1, bak, and bax. IL-11-mediated suppression of STAT1 signaling was presumably due to upregulation of the suppressor of cytokine signaling (SOCS) genes, which are well-known negative feedback regulators of the JAK/STAT pathway. Interestingly, however, IFN-gamma pretreatment failed to affect the following IL-11-induced STAT3 activation, although IFN-gamma also upregulated SOCSs. Finally, we demonstrated that IL-11 pretreatment mitigated oxidative stress through increasing expression of ROS scavengers. Conclusion IL-11 protects hepatocytes from IFN-gamma-induced death via STAT1 signal suppression and ROS scavenging. Further investigation into the mechanisms underlying selective negative feedback regulation of IFN-gamma/STAT1 signaling compared to IL-11/STAT3 signaling may shed new light on the molecular biology of hepatocytes.	[Miyawaki, Akimitsu; Iizuka, Yoshiko; Sugino, Hitomi; Watanabe, Yoshifumi] Musashino Univ, Dept Pharmaceut Sci, Tokyo, Japan		Watanabe, Y (corresponding author), Musashino Univ, Dept Pharmaceut Sci, Tokyo, Japan.	ywatanab@musashino-u.ac.jp			Musashino University	Musashino University	This study was financially supported by Musashino University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Banerjee K, 2016, INT J CANCER, V138, P2570, DOI 10.1002/ijc.29923; Bluyssen HAR, 2010, AM J PHYSIOL-CELL PH, V299, pC354, DOI 10.1152/ajpcell.00513.2009; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Ellis M, 2006, CLIN IMMUNOL, V120, P129, DOI 10.1016/j.clim.2006.03.003; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Iwamoto T, 2000, ONCOGENE, V19, P4795, DOI 10.1038/sj.onc.1203829; Kano A, 1999, BIOCHEM BIOPH RES CO, V257, P672, DOI 10.1006/bbrc.1999.0276; Kano A, 1997, J BIOCHEM-TOKYO, V121, P677; Kershaw NJ, 2013, NAT STRUCT MOL BIOL, V20, P469, DOI 10.1038/nsmb.2519; Lehtonen A, 1997, J IMMUNOL, V159, P794; Luo XY, 2013, AM J PHYSIOL-GASTR L, V305, pG891, DOI 10.1152/ajpgi.00193.2013; Magrangeas F, 2001, BIOCHEM J, V353, P223, DOI 10.1042/0264-6021:3530223; Miyawaki A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01426-8; MORITA M, 1995, HEPATOLOGY, V21, P1585, DOI 10.1016/0270-9139(95)90463-8; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nikfarjam M, 2004, J INVEST SURG, V17, P291, DOI 10.1080/08941930490502871; Nishina T, 2017, J BIOL CHEM, V292, P205, DOI 10.1074/jbc.M116.744755; Nishina T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002056; Obana M, 2012, AM J PHYSIOL-HEART C, V303, pH569, DOI 10.1152/ajpheart.00060.2012; Onnis B, 2013, J CLIN INVEST, V123, P1615, DOI 10.1172/JCI59623; Satoh JI, 2013, GENE REGUL SYST BIO, V7, P41, DOI 10.4137/GRSB.S11433; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Starr R, 2009, J IMMUNOL, V183, P4537, DOI 10.4049/jimmunol.0901010; Szabo G, 2015, NAT REV GASTRO HEPAT, V12, P387, DOI 10.1038/nrgastro.2015.94; Szczepanek K, 2012, MITOCHONDRION, V12, P180, DOI 10.1016/j.mito.2011.08.011; Tanaka M, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0025-2; Trepicchio WL, 1997, J IMMUNOL, V159, P5661; Trepicchio WL, 2001, TOXICOL PATHOL, V29, P242, DOI 10.1080/019262301317052521; Watanabe Y, 2003, J CELL BIOCHEM, V89, P244, DOI 10.1002/jcb.10501; Waxman AB, 1998, J CLIN INVEST, V101, P1970, DOI 10.1172/JCI1337; WHEELOCK EF, 1965, SCIENCE, V149, P310, DOI 10.1126/science.149.3681.310; Xu DH, 2016, CANCER LETT, V373, P156, DOI 10.1016/j.canlet.2016.01.004; Yang LL, 2014, DIGEST DIS SCI, V59, P1406, DOI 10.1007/s10620-013-3015-0; Yu JJ, 2016, CLIN RES HEPATOL GAS, V40, P562, DOI 10.1016/j.clinre.2015.11.009; Zhu MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140176	42	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211123	10.1371/journal.pone.0211123	http://dx.doi.org/10.1371/journal.pone.0211123			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779746	Green Submitted, gold, Green Published			2022-12-26	WOS:000459062900012
J	Cavenagh, A; Chatterjee, S; Davies, W				Cavenagh, Alice; Chatterjee, Sohini; Davies, William			Behavioural and psychiatric phenotypes in female carriers of genetic mutations associated with X-linked ichthyosis	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; STEROID SULFATASE DEFICIENCY; SCHIZOTYPAL PERSONALITY; MOUSE MODEL; ATTENTION; SPECTRUM; AUTISM; SCALE; ENDOPHENOTYPES; PREVALENCE	X-linked ichthyosis (XLI) is a rare X-linked dermatological condition arising from deficiency for the enzyme steroid sulfatase (STS). STS is normally expressed in the brain, and males with XLI exhibit personality differences from males in the general population, and are at increased risk of developmental and mood disorders. As the STS gene escapes X-inactivation, female carriers of XLI-associated genetic mutations have reduced STS expression/activity relative to non-carrier females, and could manifest similar behavioural phenotypes to males with XLI. Additionally, as STS activity normally increases in female tissues towards late pregnancy and into the puerperium, carrier females could theoretically present with increased rates of postpartum psychopathology. Using a worldwide online survey comprising custom-designed demographic questionnaires and multiple validated psychological questionnaires, we collected detailed self-reported information on non-postpartum and postpartum behaviour in confirmed adult (>16yrs) female carriers of genetic mutations associated with XLI (n = 94) for statistical comparison to demographically-matched previously-published normative data from female controls (seven independent studies, 98 <= n <= 2562), adult males with XLI (n = 58), and to newly-obtained online survey data from a general population sample of mothers from the United Kingdom and United States of America (n = 263). The pattern of results in carrier females relative to controls was remarkably similar to that previously observed in males with XLI, with evidence for increased rates of developmental and mood disorders, and elevated levels of inattention, impulsivity, autism-related traits and general psychological distress. Carrier females exhibited a significantly elevated rate of postpartum mental health conditions (notably mild depression) relative to controls which could not be accounted for by social factors. Our data confirm the psychological profile associated with XLI-associated mutations, and suggest that female carriers may be at increased risk of psychopathology, including in the postpartum period. These findings are relevant to families affected by XLI, to clinicians involved in the care of these families, and to genetic counsellors.	[Cavenagh, Alice; Chatterjee, Sohini; Davies, William] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Sch Med, Cardiff, S Glam, Wales; [Cavenagh, Alice; Chatterjee, Sohini; Davies, William] Cardiff Univ, Div Psychol Med & Clin Neurosci, Sch Med, Cardiff, S Glam, Wales; [Davies, William] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales; [Davies, William] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University; Cardiff University	Davies, W (corresponding author), Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Sch Med, Cardiff, S Glam, Wales.; Davies, W (corresponding author), Cardiff Univ, Div Psychol Med & Clin Neurosci, Sch Med, Cardiff, S Glam, Wales.; Davies, W (corresponding author), Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales.; Davies, W (corresponding author), Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff, S Glam, Wales.	daviesw4@cardiff.ac.uk		Davies, William/0000-0002-7714-2440; Cavenagh, Alice/0000-0001-5726-7169	Medical Research Council (MRC) United Kingdom Centre Grant [MR/L010305/1]	Medical Research Council (MRC) United Kingdom Centre Grant	The work was supported by Medical Research Council (MRC) United Kingdom Centre Grant MR/L010305/1 (https://mrc.ukri.org/) and Cardiff University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badcock JC, 2006, PERS INDIV DIFFER, V40, P77, DOI 10.1016/j.paid.2005.06.015; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102251; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chatterjee S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164417; Chen HH, 2017, BIRTH-ISS PERINAT C, V44, P369, DOI 10.1111/birt.12295; Craig WY, 2010, PRENATAL DIAG, V30, P893, DOI 10.1002/pd.2588; Cuevas-Covarrubias SA, 1999, ACTA DERM-VENEREOL, V79, P143; Davies W, 2018, J MOL ENDOCRINOL; Davies W, 2007, BIOL PSYCHIAT, V61, P1351, DOI 10.1016/j.biopsych.2006.08.011; Davies W, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0532-x; Davies W, 2014, NEUROPSYCHOPHARMACOL, V39, P2622, DOI 10.1038/npp.2014.115; Davies W, 2012, TRENDS MOL MED, V18, P256, DOI 10.1016/j.molmed.2012.03.001; Davies W, 2009, BIOL PSYCHIAT, V66, P360, DOI 10.1016/j.biopsych.2009.01.001; Diociaiuti A, 2018, EXP DERMATOL; Edebol H, 2013, PSYCH J, V2, P48, DOI 10.1002/pchj.17; Fernandes NF, 2010, J AM ACAD DERMATOL, V62, P480, DOI 10.1016/j.jaad.2009.04.028; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Hand JL, 2015, J AM ACAD DERMATOL, V72, P617, DOI 10.1016/j.jaad.2014.12.020; Hong D S, 2012, Pediatr Endocrinol Rev, V9 Suppl 2, P710; Humby T, 2016, PSYCHONEUROENDOCRINO, V74, P363, DOI 10.1016/j.psyneuen.2016.09.019; Kent L, 2008, J MED GENET, V45, P519, DOI 10.1136/jmg.2008.057729; Kessler RC, 2010, PSYCHOL MED, V40, P225, DOI 10.1017/S0033291709990213; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Malik Amna, 2017, J Med Case Rep, V11, P267, DOI 10.1186/s13256-017-1420-2; Meltzer-Brody S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.22; Mendlowicz MV, 2000, J PSYCHIAT RES, V34, P221, DOI 10.1016/S0022-3956(00)00014-5; Milunsky J, 1999, CLIN GENET, V55, P455, DOI 10.1034/j.1399-0004.1999.550610.x; Muraca GM, 2014, J OBSTET GYNAECOL CA, V36, P803, DOI 10.1016/S1701-2163(15)30482-5; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PERUMAL AS, 1973, BRAIN RES, V59, P349, DOI 10.1016/0006-8993(73)90273-4; Rai D, 2018, JAMA PSYCHIAT, V75, P835, DOI 10.1001/jamapsychiatry.2018.1323; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Reyes Allyon A, 2012, IMPULSIVITY MEN WOME; Rodrigo-Nicolas B, 2018, BRIT J DERMATOL, V179, P933, DOI 10.1111/bjd.16826; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Slade T, 2011, AUST NZ J PSYCHIAT, V45, P308, DOI 10.3109/00048674.2010.543653; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Stergiakouli E, 2011, GENES BRAIN BEHAV, V10, P334, DOI 10.1111/j.1601-183X.2010.00672.x; Trent S, 2013, WORLD J TRANSLATIONA, V2, P1, DOI DOI 10.5528/WJTM.V2.I1.1); Trent S, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-21; Trent S, 2013, PSYCHONEUROENDOCRINO, V38, P1370, DOI 10.1016/j.psyneuen.2012.12.002; Trent S, 2012, NEUROPSYCHOPHARMACOL, V37, P1267, DOI 10.1038/npp.2011.314; Trent S, 2012, PSYCHONEUROENDOCRINO, V37, P221, DOI 10.1016/j.psyneuen.2011.06.006; Turner CA, 2018, BIOL PSYCHIAT, V84, P555, DOI 10.1016/j.biopsych.2018.04.013; Zinn AR, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-24	49	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212330	10.1371/journal.pone.0212330	http://dx.doi.org/10.1371/journal.pone.0212330			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5KT	30768640	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000458766300030
J	Basilissi, M; Tincati, C; Merlini, E; Ancona, G; Borghi, E; Borgo, F; Barassi, A; Monforte, AD; Marchetti, G				Basilissi, Matteo; Tincati, Camilla; Merlini, Esther; Ancona, Giuseppe; Borghi, Elisa; Borgo, Francesca; Barassi, Alessandra; Monforte, Antonella d'Arminio; Marchetti, Giulia			Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; T-CELLS; TH17 CELLS; ACTIVATION; RECOVERY; DISEASE; BARRIER; PATHOGENESIS; PERSISTENCE; DEPLETION	HIV infection causes the progressive depletion of CD4+ T-lymphocytes and profound modifications of T-cell homeostasis, which persist despite virologically-suppressive treatment and have been linked to a worse clinical outcome. Enduring alterations of the gastrointestinal tract may represent the underlying pathogenic mechanisms of these phenomena. Twenty-six HIV-infected subjects were assessed over a 12-month period following the introduction of antiretroviral therapy. 18 uninfected individuals were enrolled as controls. Parameters of peripheral T-cell homeostasis ( activation, maturation), gastrointestinal function (microbial translocation, gut inflammation, fecal microbiota composition) and mucosal immunity (CD4+CCR6+CD161+, CD4+CCR9+alpha 4 beta 7+, stem cell memory CD4+/CD8+ T-cells) were assessed. CD4+CCR6+CD161+ cells were depleted in HIV-infected untreated subjects and maintained significantly lower levels compared to controls, despite the introduction of effective antiviral treatment. The frequency of gut-homing CD4+CCR9+alpha 4 beta 7+ cells was also impaired in untreated infection and correlated with the HIV RNA load and CD4+HLADR+CD38+; during therapy, we observed a contraction of this pool in the peripheral blood and the loss of its correlation with antigenic exposure/immune activation. A partial correction of the balance between stem cell memory pools and T-cell homeostasis was registered following treatment. In HIV-infected subjects with moderate immune-suppression, antiretroviral therapy has a marginal impact on mucosal immune populations which feature distinctive kinetics in the periphery, possibly reflecting their diverse recruitment from the blood to the mucosa. The persistent defects in mucosal immunity may fuel peripheral T-cell abnormalities through diverse mechanisms, including the production of IL-17/IL-22, cellular permissiveness to infection and regulation of T-lymphocyte maturation.	[Basilissi, Matteo; Tincati, Camilla; Merlini, Esther; Ancona, Giuseppe; Monforte, Antonella d'Arminio; Marchetti, Giulia] Univ Milan, ASST Santi Paolo & Carlo, Clin Infect Dis, Dept Hlth Sci, Milan, Italy; [Borghi, Elisa; Borgo, Francesca] Univ Milan, Dept Hlth Sci, Microbiol Lab, Milan, Italy; [Barassi, Alessandra] Univ Milan, Dept Hlth Sci, Biochem Lab, ASST Santi Paolo & Carlo, Milan, Italy; [Basilissi, Matteo] Merck KGaA, Ist Ric Biomed Antoine Marxer RBM SpA, Colleretto Giacosa, TO, Italy; [Borgo, Francesca] IEO European Inst Oncol, Dept Expt Oncol, Milan, Italy	University of Milan; University of Milan; University of Milan; IRCCS European Institute of Oncology (IEO)	Tincati, C (corresponding author), Univ Milan, ASST Santi Paolo & Carlo, Clin Infect Dis, Dept Hlth Sci, Milan, Italy.	camilla.tincati@unimi.it	ANCONA, GIUSEPPE/AAC-6450-2022; Borghi, Elisa/I-8811-2012; BORGO, FRANCESCA CLAUDIA/AAM-7200-2020; TINCATI, CAMILLA/K-4501-2018	Borghi, Elisa/0000-0002-1893-0455; BORGO, FRANCESCA CLAUDIA/0000-0001-9685-1069; TINCATI, CAMILLA/0000-0002-3083-2962; barassi, alessandra/0000-0002-0404-8357	Italian Ministry of Health, Regione Lombardia [GR-2009-1592029]	Italian Ministry of Health, Regione Lombardia	The study was supported by the Italian Ministry of Health, Regione Lombardia, grant "Giovani Ricercatori" (number GR-2009-1592029; PI: GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Anthony KB, 2003, JAIDS-J ACQ IMM DEF, V33, P125, DOI 10.1097/00126334-200306010-00002; Bora A, 2014, J NEUROVIROL, V20, P457, DOI 10.1007/s13365-014-0263-5; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Briceno O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166496; Chung CY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004198; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; d'Ettorre G, 2011, CURR HIV RES, V9, P148, DOI 10.2174/157016211795945296; Dillon SM, 2016, AIDS, V30, P2737, DOI 10.1097/QAD.0000000000001289; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Girard A, 2016, JAIDS-J ACQ IMM DEF, V72, P259, DOI 10.1097/QAI.0000000000000943; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Greathead L, 2014, AIDS, V28, P1690, DOI 10.1097/QAD.0000000000000351; Gui JG, 2012, AGING DIS, V3, P280; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Islam FM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-234; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Kim CJ, 2013, J IMMUNOL, V191, P2164, DOI 10.4049/jimmunol.1300829; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; Kok A, 2015, MUCOSAL IMMUNOL, V8, P127, DOI 10.1038/mi.2014.50; Loiseau C, 2016, MUCOSAL IMMUNOL, V9, P1137, DOI 10.1038/mi.2016.7; Lugli E, 2013, J CLIN INVEST, V123, P594, DOI 10.1172/JCI66327; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; McGary CS, 2017, MUCOSAL IMMUNOL, V10, P1082, DOI 10.1038/mi.2016.116; Mudd JC, 2016, J INFECT DIS, V214, pS58, DOI 10.1093/infdis/jiw258; Nilsson J, 2007, AIDS, V21, P565, DOI 10.1097/QAD.0b013e3280117204; Page EE, 2014, JAIDS-J ACQ IMM DEF, V67, P227, DOI 10.1097/QAI.0000000000000294; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Ribeiro SP, 2014, J VIROL, V88, P13836, DOI 10.1128/JVI.01948-14; Salem M, 2013, JAIDS-J ACQ IMM DEF, V63, pE28, DOI 10.1097/QAI.0b013e3182893f96; Sivro A, 2008, INTEGRIN, DOI [10.1084/jem.20080397, DOI 10.1084/JEM.20080397]; Sokoya T, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/6825493; Somsouk M, 2015, AIDS, V29, P43, DOI 10.1097/QAD.0000000000000511; Tincati C, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0103-1; Tincati C, 2016, AIDS, V30, P991, DOI 10.1097/QAD.0000000000001015; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; Uzzan M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau4711; Vigano S, 2015, J VIROL, V89, P7829, DOI 10.1128/JVI.00789-15	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212075	10.1371/journal.pone.0212075	http://dx.doi.org/10.1371/journal.pone.0212075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763359	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900038
J	Daghestani, M; Purohit, R; Daghestani, M; Daghistani, M; Warsy, A				Daghestani, Maha; Purohit, Rituraj; Daghestani, Mazin; Daghistani, Mamoon; Warsy, Arjumand			Molecular dynamic (MD) studies on Gln233Arg (rs1137101) polymorphism of leptin receptor gene and associated variations in the anthropometric and metabolic profiles of Saudi women	PLOS ONE			English	Article							HUMAN OBESITY; RESISTANCE; VARIANTS; LEPR; LOCALIZATION; MECHANISMS; SIMULATION; MUTATIONS; STOMACH; DISEASE	The Gln233Arg (A>G; rs1137101) polymorphism of the leptin receptor gene (LEPR) has been investigated extensively and is reported to be associated with different metabolic states. In this investigation, we aimed to study the frequency of Gln233Arg genotypes and alleles in a group of Saudi women stratified by their body mass index (BMI), to correlate the LEPR genotypes with variations in anthropometric, lipid and hormonal parameters and to investigate conformational and structural variations in the mutant LEPR using molecular dynamic (MD) investigations. The study group included 122 Saudi women (normal weight = 60; obese = 62) attending the clinics for a routine checkup. Anthropometric data: height, weight, waist and hip circumference were recorded and fasting serum sample was used to estimate glucose, lipids, ghrelin, leptin and insulin. BMI, W/H ratio, and HOMA-IR values were calculated. Whole blood sample was used to extract DNA; exon 6 of the LEPR gene was amplified by PCR and sequencing was conducted on an ABI 3100 Avant Genetic Analyser. Molecular Dynamic Simulation studies were carried out using different softwares. The results showed the presence of all three genotypes of Gln233Arg in Saudi women, but the frequencies were significantly different when compared to reports from some populations. No differences were seen in the genotype and allele frequencies between the normal weight and obese women. Stratification by the genotypes showed significantly higher BMI, waist and hip circumference, leptin, insulin, fasting glucose and HOMA-IR and lower ghrelin levels in obese women carrying the GG genotype. Even in the normal weight group, individuals with GG genotype had higher BMI, waist and hip circumference and significantly lower ghrelin levels. The MD studies showed a significant effect of the Gln/Arg substitution on the conformation, flexibility, root-mean-square fluctuation (RMSF), radius of gyration (Rg) values, solvent-accessible surface area (SASA) and number of inter-and intra-molecular H-bonds. The results suggest that the structural changes brought about by the mutation, influence the signaling pathways by some unknown mechanism, which may be contributing to the abnormalities seen in the individuals carrying the G allele of rs1137101.	[Daghestani, Maha] King Saud Univ, Dept Zool, Cent Lab, Female Ctr Sci & Med Coll, Riyadh, Saudi Arabia; [Purohit, Rituraj] Inst Himalayan Bioresource Technol, CSIR, Div Biotechnol, Palampur, Himachal Prades, India; [Daghestani, Mazin] Umm Al Qura Univ, Dept Obstet & Gynecol, Mecca, Saudi Arabia; [Daghistani, Mamoon] King Abdul Aziz Med City, Dept Surg, Natl Guard Hlth Affairs, Jeddah, Saudi Arabia; [Warsy, Arjumand] King Saud Univ, Cent Lab, Female Ctr Sci & Med Coll, Riyadh, Saudi Arabia	King Saud University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Umm Al Qura University; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Jeddah; Ministry of National Guard - Health Affairs; King Saud University	Warsy, A (corresponding author), King Saud Univ, Cent Lab, Female Ctr Sci & Med Coll, Riyadh, Saudi Arabia.	aswarsy@gmail.com	Purohit, Rituraj/I-8856-2012; Purohit, Rituraj/AAF-6257-2021; Warsy, Arjumand/D-5274-2015	Purohit, Rituraj/0000-0002-2101-9398; Purohit, Rituraj/0000-0002-2101-9398; Warsy, Arjumand/0000-0001-6957-203X				Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196; Carpenter B, 2012, STRUCTURE, V20, P487, DOI 10.1016/j.str.2012.01.019; Cinti S, 2000, INT J OBESITY, V24, P789, DOI 10.1038/sj.ijo.0801228; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Dias NF, 2012, ARQ BRAS ENDOCRINOL, V56, P178, DOI 10.1590/S0004-27302012000300005; Dominguez-Reyes T, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0112-4; Duggal P, 2011, J CLIN INVEST, V121, P1191, DOI 10.1172/JCI45294; Rojano-Rodriguez ME, 2016, HEREDITAS, V153, P1, DOI 10.1186/s41065-016-0006-0; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Furusawa T, 2010, HUM GENET, V127, P287, DOI 10.1007/s00439-009-0768-9; Gu FY, 2012, BREAST CANCER RES TR, V131, P17, DOI 10.1007/s10549-011-1778-6; Guo X, 2011, MUCOSAL IMMUNOL, V4, P294, DOI 10.1038/mi.2010.76; Hoggard N, 1997, BIOCHEM BIOPH RES CO, V232, P383, DOI 10.1006/bbrc.1997.6245; Kimber W, 2008, ENDOCRINOLOGY, V149, P6043, DOI 10.1210/en.2008-0544; Kumar A, 2012, MUTAT RES-FUND MOL M, V738, P28, DOI 10.1016/j.mrfmmm.2012.08.005; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mackey-Lawrence NM, 2012, MUCOSAL IMMUNOL, V5, P472, DOI 10.1038/mi.2012.40; Madan R, 2014, INFECT IMMUN, V82, P341, DOI 10.1128/IAI.00972-13; Mahmoudi T, 2016, IRAN J CANCER PREV, V9, DOI 10.17795/ijcp-7013; Mancour LV, 2012, MOL CELL, V48, P655, DOI 10.1016/j.molcel.2012.09.003; Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014; Marie CS, INFECT IMMUN; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Ng ZY, 2014, PEDIATR INT, V56, P689, DOI 10.1111/ped.12336; Paracchini V, 2005, AM J EPIDEMIOL, V162, P101, DOI 10.1093/aje/kwi174; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Purohit R, 2014, J BIOMOL STRUCT DYN, V32, P1033, DOI 10.1080/07391102.2013.803264; Purohit R, 2011, J BIOMOL STRUCT DYN, V29, P137, DOI 10.1080/07391102.2011.10507379; Queiroz EM, 2015, BRAZ J MED BIOL RES, V48, P595, DOI 10.1590/1414-431X20154155; Rajendran V, 2012, AMINO ACIDS, V43, P603, DOI 10.1007/s00726-011-1108-7; Ramirez JP, 2011, CRIT CARE, V15, P1, DOI [10.1172/JCI45294, DOI 10.1172/JCI45294]; Saukko M, 2010, METAB SYNDR RELAT D, V8, P425, DOI 10.1089/met.2010.0004; Skibola CF, 2004, CANCER EPIDEM BIOMAR, V13, P779; Stratigopoulos G, 2009, OBESITY, V17, P126, DOI 10.1038/oby.2008.489; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Turner, 2005, XMGRACE VERSION 51 1; Verkerke H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094843; Wang BL, 2013, ASIA-PAC J PUBLIC HE, V25, p80S, DOI 10.1177/1010539513497218; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Winick JD, 1996, GENOMICS, V36, P221, DOI 10.1006/geno.1996.0455; Wu Jinghuan, 2016, Wei Sheng Yan Jiu, V45, P376; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Yang MM, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5412084; Yapijakis C, 2009, J CANCER RES CLIN, V135, P603, DOI 10.1007/s00432-008-0494-z; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6; Yiannakouris N, 2001, J CLIN ENDOCR METAB, V86, P4434, DOI 10.1210/jc.86.9.4434; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	53	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0211381	10.1371/journal.pone.0211381	http://dx.doi.org/10.1371/journal.pone.0211381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763324	Green Submitted, Green Published, gold			2022-12-26	WOS:000458763900013
J	Jacques, MF; Stockley, RC; Bostock, EI; Smith, J; DeGoede, CG; Morse, CI				Jacques, Matthew F.; Stockley, Rachel C.; Bostock, Emma I.; Smith, Jonathon; DeGoede, Christian G.; Morse, Christopher I.			Frequency of reported pain in adult males with muscular dystrophy	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY; GENERAL-POPULATION; NECK PAIN; DUCHENNE; PREVALENCE; CHILDREN; INDIVIDUALS; RELIABILITY; INTENSITY; PARALYSIS	Introduction The purpose of this study was to present and compare pain between adult males with Duchenne (DMD), Becker's (BMD), Limb-Girdle (LGMD) Facioscapulohumeral (FSHD) forms of Muscular Dystrophy (MD), and healthy controls (CTRL), using three different methods of assessment. Methods Pain was assessed using 1) a whole body visual analogue scale (VAS) of pain, 2) a generalised body map and 3) a localised body map. Results All types of MD reported more VAS pain than CTRL, with 97% of all MD participants reporting pain; however, no differences were reported between types of MD. The generalised body map approach identified more frequent pain in the shoulders of FSHD (93%) than other groups (13-43%), hips of DMD (87%) and LGMD (75%) than other groups (0-29%), and legs of all MD (64-78%) than CTRL (25%). The localised body map approach identified common areas of frequent pain across types of MD, posterior distal leg and distal back, as well as condition specific regions of frequent pain, for example posterior trapezius in FSHD, and anterior hip pain in DMD and LGMD. Conclusions Using a single pain value (VAS), increased pain was reported by adults with MD compared to CTRL, with no clear differences between different MD groups, suggesting pain is symptomatic of MD. The use of the generalised body map approach, and to an even greater extent the localised body map approach, identified specific areas of frequent pain relevant to each individual condition. These results indicate that whist the commonly used generalised approach can be used to identify broad anatomical regions, the localised approach provides a more comprehensive understanding of pain, reflective of clinical assessment, and should be utilised in future research.	[Jacques, Matthew F.; Bostock, Emma I.; Morse, Christopher I.] Manchester Metropolitan Univ, Fac Sci & Engn, Sch Healthcare Sci, Musculoskeletal Sci & Sports Med Res Ctr, Manchester, Lancs, England; [Stockley, Rachel C.] Univ Cent Lancashire, Sch Nursing, Preston, Lancs, England; [Smith, Jonathon] Neuromuscular Ctr, Winsford, Cheshire, England; [DeGoede, Christian G.] Royal Preston Hosp, Dept Paediat Neurol, Preston, Lancs, England	Manchester Metropolitan University; University of Central Lancashire; Royal Preston Hospital	Jacques, MF (corresponding author), Manchester Metropolitan Univ, Fac Sci & Engn, Sch Healthcare Sci, Musculoskeletal Sci & Sports Med Res Ctr, Manchester, Lancs, England.	matthew.jacques@stu.mmu.ac.uk	Stockley, Rachel/AAH-9346-2020; Morse, Christopher/AAE-7913-2022	Stockley, Rachel/0000-0003-4441-6860; Morse, Christopher/0000-0002-5261-2637; Jacques, Matthew/0000-0002-1058-1107; Bostock, Emma Louise/0000-0001-9340-8459				Abresch Richard T, 2002, Am J Hosp Palliat Care, V19, P39, DOI 10.1177/104990910201900109; ARCHIBALD K C, 1959, Arch Phys Med Rehabil, V40, P150; Ariens GAM, 2001, OCCUP ENVIRON MED, V58, P200, DOI 10.1136/oem.58.3.200; Bergsma A, 2017, NEUROMUSCULAR DISORD, V27, P1115, DOI 10.1016/j.nmd.2017.09.003; Biggar WD, 2006, PEDIATR REV, V27, P83, DOI 10.1542/pir.27-3-83; Bijur PE, 2001, ACAD EMERG MED, V8, P1153, DOI 10.1111/j.1553-2712.2001.tb01132.x; Binderup AT, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-234; Birnkrant DJ, 2018, LANCET NEUROL, V17, P347, DOI 10.1016/S1474-4422(18)30025-5; Blyth FM, 2001, PAIN, V89, P127, DOI 10.1016/S0304-3959(00)00355-9; BRATTBERG G, 1989, PAIN, V37, P215, DOI 10.1016/0304-3959(89)90133-4; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; BROOKE MH, 1981, MUSCLE NERVE, V4, P186, DOI 10.1002/mus.880040304; Bruce B, 2005, ARTHRITIS RES THER, V7, pR1263, DOI 10.1186/ar1825; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Bushby KMD, 1998, NEUROMUSCULAR DISORD, V8, P574, DOI 10.1016/S0960-8966(98)00088-1; Caneiro JP, 2010, MANUAL THER, V15, P54, DOI 10.1016/j.math.2009.06.002; CHAPMAN CR, 1985, PAIN, V22, P1, DOI 10.1016/0304-3959(85)90145-9; Connelly M, 2010, J PAIN SYMPTOM MANAG, V39, P579, DOI 10.1016/j.jpainsymman.2009.07.013; CROOK J, 1984, PAIN, V18, P299, DOI 10.1016/0304-3959(84)90824-8; Crossley KM, 2004, ARCH PHYS MED REHAB, V85, P815, DOI 10.1016/S0003-9993(03)00613-0; Douvillez B, 2005, PAIN OSTEOPENIA BODY, DOI [10.1016/j.annrmp.2005.03.011, DOI 10.1016/J.ANNRMP.2005.03.011]; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Engel JM, 2009, AM J HOSP PALLIAT ME, V26, P405, DOI 10.1177/1049909109346165; Gerwin RD, 2010, MUSCLE PAIN: DIAGNOSIS AND TREATMENT, P15, DOI 10.1007/978-3-642-05468-6_2; Giesecke T, 2004, ARTHRITIS RHEUM-US, V50, P613, DOI 10.1002/art.20063; GILBERT JR, 1993, AM J HUM GENET, V53, P401; GREGG JR, 1979, J BONE JOINT SURG AM, V61, P825, DOI 10.2106/00004623-197961060-00004; Hawker G. A., 2011, ARTHRITIS CARE RES, V63; Hoffman Amy J, 2005, Phys Med Rehabil Clin N Am, V16, P1099, DOI 10.1016/j.pmr.2005.08.015; Huml RA., 2015, MUSCULAR DYSTROPHY C; Hunt A, 2016, EUR J PAEDIATR NEURO, V20, P630, DOI 10.1016/j.ejpn.2016.03.002; Jaatun EAA, 2014, J PAIN SYMPTOM MANAG, V47, P45, DOI 10.1016/j.jpainsymman.2013.02.025; Jacques MF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169848; Jansen MJ, 2011, J PHYSIOTHER, V57, P11, DOI 10.1016/S1836-9553(11)70002-9; Jansen M, 2012, NEUROMUSCULAR DISORD, V22, P306, DOI 10.1016/j.nmd.2011.10.020; Jensen MP, 2008, ARCH PHYS MED REHAB, V89, P320, DOI 10.1016/j.apmr.2007.08.153; JOHNSON JTH, 1955, J BONE JOINT SURG AM, V37, P567, DOI 10.2106/00004623-195537030-00011; Lager C, 2015, EUR J PAEDIATR NEURO, V19, P537, DOI 10.1016/j.ejpn.2015.04.005; Lokken N, 2016, ANN NEUROLOGY; Lue YJ, 2009, KAOHSIUNG J MED SCI, V25, P325, DOI 10.1016/S1607-551X(09)70523-6; Mathur S, 2010, ARCH PHYS MED REHAB, V91, P1051, DOI 10.1016/j.apmr.2010.03.024; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Miro J, 2014, MUSCLE NERVE, V49, P900, DOI 10.1002/mus.24079; Moris G, 2017, MUSCLE NERVE; Morse CI, 2018, MUSCLE NERVE; Moulin DE, 1997, NEUROLOGY, V48, P328, DOI 10.1212/WNL.48.2.328; Nieto R, 2012, CLIN J PAIN, V28, P47, DOI 10.1097/AJP.0b013e31822019b1; Nourbakhsh MR, 2002, J ORTHOP SPORT PHYS, V32, P447, DOI 10.2519/jospt.2002.32.9.447; Padua L, 2009, MUSCLE NERVE, V40, P200, DOI 10.1002/mus.21308; Pangalila RF, 2015, ARCH PHYS MED REHAB, V96, P1242, DOI 10.1016/j.apmr.2015.02.012; PAPAGEORGIOU AC, 1995, SPINE, V20, P1889, DOI 10.1097/00007632-199509000-00009; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Reeves SL, 1996, EUR J CLIN NUTR, V50, P398; Ribeiro IL, 2016, MANUAL THER, V21, P134, DOI 10.1016/j.math.2015.07.002; Richardson M, 2009, DISABIL REHABIL-ASSI, V4, P181, DOI 10.1080/17483100802543114; SAEED MA, 1981, AM FAM PHYSICIAN, V24, P139; SAVEDRA MC, 1989, RES NURS HEALTH, V12, P307, DOI 10.1002/nur.4770120506; Simons DG, 1983, MYOFASCIAL PAIN SYND; Skalsky AJ, 2008, NEUROMUSCULAR DISORD, V18, P873, DOI 10.1016/j.nmd.2008.07.005; Stinson J, 2009, ARTHRITIS RHEUM, V60, pS577; Taimela S, 2000, SPINE, V25, P1021, DOI 10.1097/00007632-200004150-00018; Tawil R, 2008, NEUROTHERAPEUTICS, V5, P601, DOI 10.1016/j.nurt.2008.07.005; Tiffreau V, 2006, AM J PHYS MED REHAB, V85, P756, DOI 10.1097/01.phm.0000228518.26673.23; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; van der Kooi EL, 2007, J NEUROL, V254, P931, DOI 10.1007/s00415-006-0432-4; VIGNOS P J Jr, 1960, J Chronic Dis, V12, P273, DOI 10.1016/0021-9681(60)90105-3; von Baeyer CL, 2011, PAIN MANAG, V1, P61, DOI 10.2217/PMT.10.2; Zebracki K, 2008, DEV MED CHILD NEUROL, V50, P546, DOI 10.1111/j.1469-8749.2008.03005.x	68	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212437	10.1371/journal.pone.0212437	http://dx.doi.org/10.1371/journal.pone.0212437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763387	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000458763900080
J	Khosravi Shadmani, F; Farzadfar, F; Larijani, B; Mirzaei, M; Haghdoost, AA				Khosravi Shadmani, Fatemeh; Farzadfar, Farshad; Larijani, Bagher; Mirzaei, Moghadameh; Haghdoost, Ali Akbar			Trend and projection of mortality rate due to non-communicable diseases in Iran: A modeling study	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; GLOBAL BURDEN; INTERNATIONAL VARIATION; AIR-POLLUTION; UNITED-STATES; POPULATION; PREVALENCE; DEATH; BRAZIL; CHINA	Background Following the epidemiologic and demographic transition, non-communicable disease mortality is the leading cause of death in Iran. Projecting mortality trend can provide valuable tools for policy makers and planners. In this article, we have estimated the trend of non-communicable disease mortality during 2001-2015 and have projected it until 2030 at national and subnational levels in Iran. Methods The data employed was gathered from the Iranian death registration system and using the Spatio-temporal model, the trends of 4 major categories of non-communicable diseases (cancers, cardiovascular diseases, asthma and COPD, and diabetes) by 2030 were projected at the national and subnational levels. Results The results indicated that age standardized mortality rate for cancers, CVDs, and Asthma and COPD will continue to decrease in both sexes (cancers: from 81.8 in 2015 to 45.2 in 2030, CVDs: 307.3 to 173.0, and Asthma and COPD: from 52.1 to 46.6); however, in terms of diabetes, there is a steady trend in both sexes at national level (from 16.6 to 16.5). Age standardized mortality rates for cancers and CVDs, in males and females, were high in all provinces in 2001. The variation between the provinces is clearer in 2015, and it is expected to significantly decrease in all provinces by 2030. Conclusion Generally, the age standardized mortality rate from NCDs will decrease by 2030. Of course, given the experience of the past two decades in Iran, believing that the mortality rate will decrease may not be an easy notion to understand. However hard to believe, this decrease may be the result of better management of risk factors and early detection of patients due to more comprehensive care in all segments of society, as well as improved literacy and awareness across the country.	[Khosravi Shadmani, Fatemeh] Kerman Univ Med Sci, Inst Futures Studies Hlth, Modeling Hlth Res Ctr, Kerman, Iran; [Farzadfar, Farshad] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran; [Larijani, Bagher] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Mirzaei, Moghadameh] Kerman Univ Med Sci, Sch Publ Hlth, Dept Biostat & Epidemiol, Kerman, Iran; [Haghdoost, Ali Akbar] Kerman Univ Med Sci, Reg Knowledge Hub, Inst Futures Studies Hlth, Kerman, Iran; [Haghdoost, Ali Akbar] Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Inst Futures Studies Hlth, Kerman, Iran	Kerman University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization	Haghdoost, AA (corresponding author), Kerman Univ Med Sci, Reg Knowledge Hub, Inst Futures Studies Hlth, Kerman, Iran.; Haghdoost, AA (corresponding author), Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Inst Futures Studies Hlth, Kerman, Iran.	ahaghdoost@gmail.com	Shadmani, Fatemeh Khosravi/Y-9533-2019; Haghdoost, Ali Akbar/C-2823-2009; larijani, Bagher/ABE-3315-2020; mirzaei, moghaddameh/AAD-3175-2019	Shadmani, Fatemeh Khosravi/0000-0002-5172-7950; Haghdoost, Ali Akbar/0000-0003-4628-4849; larijani, Bagher/0000-0001-5386-7597; Farzadfar, Farshad/0000-0001-8288-4046; mirzaei, moghaddameh/0000-0001-7202-2821				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abildstrom SZ, 2003, HEART, V89, P507, DOI 10.1136/heart.89.5.507; Atash F, 2007, CITIES, V24, P399, DOI 10.1016/j.cities.2007.04.001; Barreto SM, 2007, REV PANAM SALUD PUBL, V22, P239, DOI 10.1590/S1020-49892007000900003; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Fang J, 2002, AM J MED, V113, P208, DOI 10.1016/S0002-9343(02)01172-5; Ishihara M, 2002, CIRC J, V66, P178, DOI 10.1253/circj.66.178; Jackson EA, 2002, AM HEART J, V144, P259, DOI 10.1067/mhj.2002.123837; Khosravi Shadmani F., 2018, NATL SUBNATIONAL LEV; Ko FWS, 2007, THORAX, V62, P780, DOI 10.1136/thx.2006.076166; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Lee SL, 2006, CLIN EXP ALLERGY, V36, P1138, DOI 10.1111/j.1365-2222.2006.02555.x; Li YC, 2013, B WORLD HEALTH ORGAN, V91, P650, DOI 10.2471/BLT.13.117549; MACCHIA ALEJANDRO, 2015, Rev. argent. cardiol., V83, P1; Makdisse Márcia Regina Pinho, 2002, Arq. Bras. Cardiol., V78, P369, DOI 10.1590/S0066-782X2002000400003; Malhao TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155996; Malta DC, 2017, SAO PAULO MED J, V135, P213, DOI 10.1590/1516-3180.2016.0330050117; Malta DC, 2014, EPIDEMIOL SERV SAUDE, V23, P599, DOI [10.5123/S1679-49742014000400002, 10.5123/S1679-49742014000400017, 10.5123/S1679-49742014000300002]; Mohammadi Y, 2014, ARCH IRAN MED, V17, P176, DOI 0141703/AIM.007; Oza S, 2011, PREV MED, V52, P428, DOI 10.1016/j.ypmed.2011.04.007; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Radisauskas Ricardas, 2003, Medicina (Kaunas), V39, P1208; Radkiewicz C, 2017, EUR J CANCER, V84, P130, DOI 10.1016/j.ejca.2017.07.013; Ribeiro ALP, 2016, CIRCULATION, V133, P422, DOI 10.1161/CIRCULATIONAHA.114.008727; Roche Madonna M, 2013, Diabetes Care, V36, P2582, DOI 10.2337/dc12-1272; Roth GA, 2015, CIRCULATION, V132, P1270, DOI 10.1161/CIRCULATIONAHA.115.016021; Santosa A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0313-8; Sheidaei A, 2017, ARCH IRAN MED, V20, P2, DOI 0172001/AIM.003; Shiels MS, 2017, LANCET, V389, P1043, DOI [10.1016/S0140-6736(17)30187-3, 10.1016/s0140-6736(17)30187-3]; United Nations, SUST DEV GOALS; Varmaghani M., 2018, CLIN RESPIR  J; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Zhai FY, 2009, NUTR REV, V67, pS56, DOI 10.1111/j.1753-4887.2009.00160.x; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6	38	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0211622	10.1371/journal.pone.0211622	http://dx.doi.org/10.1371/journal.pone.0211622			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763320	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900017
J	van den Akker, M; Vaes, B; Goderis, G; Van Pottelbergh, G; De Burghgraeve, T; Henrard, S				van den Akker, Marjan; Vaes, Bert; Goderis, Geert; Van Pottelbergh, Gijs; De Burghgraeve, Tine; Henrard, Severine			Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015	PLOS ONE			English	Article							OLDER-ADULTS; HEALTH-CARE	Objectives The aim of this paper was to describe the time trends in the prevalence of multimorbidity and polypharmacy in Flanders (Belgium) between 2000 and 2015, while controlling for age and sex. Methods Data were available from Intego, a Flemish-Belgian general practice-based morbidity registration network. The practice population between 2000 and 2015 was used as the denominator, representing a mean of 159,946 people per year. Age and gender-standardised prevalence rates were used for the trends of multimorbidity and polypharmacy in the total population and for subgroups. Joinpoint regression analyses were used to analyse the time trends and breaks in trends, for the entire population as well as for specific age and sex groups. Results Overall, in 2015, 22.7% of the population had multimorbidity, while the overall prevalence of polypharmacy was 20%. Throughout the study period the standardised prevalence rate of multimorbidity rose for both sexes and in all age groups. The largest relative increase in multimorbidity was observed in the younger age groups (up to the age of 50 years). The prevalence of polypharmacy showed a significant increase between 2000 and 2015 for all age groups except the youngest (0-25 years). Conclusion For all adult age groups multimorbidity and polypharmacy are frequent, dynamic over time and increasing. This asks for both epidemiological and interventional studies to improve the management of the resulting complex care.	[van den Akker, Marjan] Maastricht Univ, Sch Caphri, Dept Family Med, Maastricht, Netherlands; [van den Akker, Marjan; Vaes, Bert; Goderis, Geert; Van Pottelbergh, Gijs; De Burghgraeve, Tine; Henrard, Severine] Univ Leuven, KU Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Henrard, Severine] UCL, Louvain Drug Res Inst, Brussels, Belgium; [Henrard, Severine] UCL, Inst Hlth & Soc IRSS, Brussels, Belgium	Maastricht University; Maastricht University Medical Centre (MUMC); KU Leuven; Universite Catholique Louvain; Universite Catholique Louvain	van den Akker, M (corresponding author), Maastricht Univ, Sch Caphri, Dept Family Med, Maastricht, Netherlands.; van den Akker, M (corresponding author), Univ Leuven, KU Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium.	Marjan.vandenAkker@maastrichtuniversity.nl	Bert, Vaes/I-6850-2019; Henrard, Séverine/E-4816-2011	Bert, Vaes/0000-0001-5244-1930; Henrard, Séverine/0000-0002-0389-8093; Van Pottelbergh, gijs/0000-0002-4189-3517; van den Akker, Marjan/0000-0002-1022-8637; Goderis, Geert/0000-0001-5303-2290				Anderson E, 2016, CLIN TEACH, V13, P291, DOI 10.1111/tct.12485; Banerjee S, 2015, LANCET, V385, P587, DOI 10.1016/S0140-6736(14)61596-8; Barnett K, 2012, LANCET, V379; Bartholomeeusen S, 2005, FAM PRACT, V22, P442, DOI 10.1093/fampra/cmi054; Bleich SN, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150275; Charlesworth CJ, 2015, J GERONTOL A-BIOL, V70, P989, DOI 10.1093/gerona/glv013; Chi WC, 2017, ANN FAM MED, V15, P546, DOI 10.1370/afm.2106; Divo MJ, 2014, EUR RESPIR J, V44, P1055, DOI 10.1183/09031936.00059814; ElmstOhl S., 2013, HLTH AGING CLIN CARE, V5, P1, DOI DOI 10.4137/HACCE.S11173; Feng X, 2018, POPUL HEALTH MANAG, V21, P123, DOI 10.1089/pop.2017.0065; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Freid Virginia M, 2012, NCHS Data Brief, P1; Guthrie B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0322-7; Hays R, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2727-9; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Huiskes VJB, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-016-0577-x; Kim HJ, 2001, STAT MED, V20, P655, DOI 10.1002/sim.811; KNOTTNERUS JA, 1992, FAM PRACT, V9, P15, DOI 10.1093/fampra/9.1.15; Leppin AL, 2015, HEALTHCARE-BASEL, V3, P50, DOI 10.3390/healthcare3010050; Lewis Cliona, 2016, J Comorb, V6, P85, DOI 10.15256/joc.2016.6.87; Masnoon N, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0621-2; May C, 2009, BRIT MED J, V339, P485, DOI DOI 10.1177/1742395312463411; McPhail SM, 2016, RISK MANAG HEALTHC P, V9, P143, DOI 10.2147/RMHP.S97248; Meinow B, 2015, EUR J AGEING, V12, P285, DOI 10.1007/s10433-015-0351-2; Muth C, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0223-1; Nunes BP, 2016, ARCH GERONTOL GERIAT, V67, P130, DOI 10.1016/j.archger.2016.07.008; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Roland M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2510; Sinnott Carol, 2015, J Comorb, V5, P29, DOI 10.15256/joc.2015.5.51; Smith S., 2012, COCHRANE DATABASE SY; St Sauver JL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006413; Team RC, 2014, R LANG ENV STAT COMP; Truyers C, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-48; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; Vaes B, 2018, EUR J PUBLIC HEALTH, V28, P193, DOI 10.1093/eurpub/ckx106; van den Akker M, 2001, J CLIN EPIDEMIOL, V54, P675, DOI 10.1016/S0895-4356(00)00358-9; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van Oostrom SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160264; Xu XL, 2017, AGEING RES REV, V37, P53, DOI 10.1016/j.arr.2017.05.003	40	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212046	10.1371/journal.pone.0212046	http://dx.doi.org/10.1371/journal.pone.0212046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753214	Green Published, gold, Green Submitted			2022-12-26	WOS:000458395600040
J	Parodis, I; Ding, HH; Zickert, A; Cosson, G; Fathima, M; Gronwall, C; Mohan, C; Gunnarsson, I				Parodis, Ioannis; Ding, Huihua; Zickert, Agneta; Cosson, Guillaume; Fathima, Madiha; Gronwall, Caroline; Mohan, Chandra; Gunnarsson, Iva			Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; APOPTOTIC CELLS; DISEASE-ACTIVITY; KIDNEY BIOPSY; GAS6; CLASSIFICATION; ERYTHEMATOSUS; CLEARANCE; CYCLOPHOSPHAMIDE; STRATEGY	Axl is a receptor tyrosine kinase with important functions in immune regulation. We investigated serum levels of soluble (s)Axl in lupus nephritis (LN) in association with renal disease activity, tissue damage and treatment response. We surveyed 52 patients with International Society of Nephrology/Renal Pathology Society (ISN/RPS) class III/IV LN and 20 healthy controls. Renal biopsies were performed at the time of active LN and post-treatment. Patients were classified as clinical responders (CRs) or clinical non-responders based on the American College of Rheumatology (ACR) criteria. Improvement by >= 50% in renal activity index scores defined histological responders (HRs). sAxl levels were elevated in patients compared to controls (median: 18.9 ng/mL), both at baseline (median: 45.7; P<0.001) and post-treatment (median: 41.2 ng/mL; P<0.001). Baseline sAxl levels were higher in patients with class IV (median: 47.7 ng/mL) versus class III (median: 37.5 ng/mL) nephritis (P = 0.008), and showed moderate correlations with albuminuria (r = 0.30, P = 0.030) and creatinine (r = 0.35, P = 0.010). Baseline sAxl levels decreased in CRs (P = 0.002) and HRs (P<0.001), but not in non-responders; levels. 36.6 ng/mL yielded a >5 times higher probability of histology-based response (odds ratio, OR: 5.5; 95% confidence interval, CI: 1.2-25.1). High post-treatment sAxl levels were associated with worsening in chronicity index scores (P = 0.025); low levels predicted favourable renal outcome (creatinine <= 88.4 mu mol/L) 10 years after the baseline renal biopsy (area under the curve: 0.71; 95% CI: 0.54-0.89). In conclusion, sAxl may prove useful as a marker of renal activity, histological response to immunosuppression, and renal damage progression in LN. Persistently high sAxl levels after completion of treatment may be indicative of a need for treatment intensification.	[Parodis, Ioannis; Zickert, Agneta; Cosson, Guillaume; Fathima, Madiha; Gronwall, Caroline; Gunnarsson, Iva] Karolinska Inst, Div Rheumatol, Dept Med, Stockholm, Sweden; [Parodis, Ioannis; Zickert, Agneta; Cosson, Guillaume; Fathima, Madiha; Gronwall, Caroline; Gunnarsson, Iva] Karolinska Univ Hosp, Rheumatol, Stockholm, Sweden; [Ding, Huihua; Mohan, Chandra] Univ Houston, Dept Biomed Engn, Houston, TX USA; [Ding, Huihua] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Rheumatol, Shanghai, Peoples R China	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Houston System; University of Houston; Shanghai Jiao Tong University	Parodis, I (corresponding author), Karolinska Inst, Div Rheumatol, Dept Med, Stockholm, Sweden.; Parodis, I (corresponding author), Karolinska Univ Hosp, Rheumatol, Stockholm, Sweden.	ioannis.parodis@ki.se	Mohan, Chandra/GPX-8233-2022; Parodis, Ioannis/AAD-2693-2020	Parodis, Ioannis/0000-0002-4875-5395	Swedish Research Council; Swedish Rheumatism Association; Professor Nanna Svartz Foundation; King Gustaf V's 80-year Foundation; Ingegerd Johansson's Fund; Stockholm County Council; Karolinska Institutet Foundations; National Institutes of Health [R01 DK81872]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; Professor Nanna Svartz Foundation; King Gustaf V's 80-year Foundation; Ingegerd Johansson's Fund; Stockholm County Council(Stockholm County Council); Karolinska Institutet Foundations(Karolinska Institutet); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Swedish Research Council (IG); Swedish Rheumatism Association (IG); Professor Nanna Svartz Foundation (IP); King Gustaf V's 80-year Foundation (IG); Ingegerd Johansson's Fund (IG); Stockholm County Council (IP; IG); Karolinska Institutet Foundations (IP; IG) and the National Institutes of Health (R01 DK81872) (CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsuwaida A, 2012, NEPHROL DIAL TRANSPL, V27, P1472, DOI 10.1093/ndt/gfr517; Alsuwaida AO, 2014, MOD RHEUMATOL, V24, P453, DOI 10.3109/14397595.2013.844293; Alvarado AS, 2014, LUPUS, V23, P840, DOI 10.1177/0961203313518625; AUSTIN HA, 1983, AM J MED, V75, P382, DOI 10.1016/0002-9343(83)90338-8; BOUMPAS DT, 1992, LANCET, V340, P741, DOI 10.1016/0140-6736(92)92292-N; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Dall'Era M, 2015, ARTHRITIS RHEUMATOL, V67, P1305, DOI 10.1002/art.39026; Ekman C, 2010, J THROMB HAEMOST, V8, P838, DOI 10.1111/j.1538-7836.2010.03752.x; Ekman C, 2011, RHEUMATOLOGY, V50, P1064, DOI 10.1093/rheumatology/keq459; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fiebeler A, 2004, AM J KIDNEY DIS, V43, P286, DOI 10.1053/j.ajkd.2003.10.016; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gunnarsson I, 2007, ARTHRITIS RHEUM-US, V56, P1263, DOI 10.1002/art.22505; Houssiau FA, 2002, ARTHRITIS RHEUM-US, V46, P2121, DOI 10.1002/art.10461; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Levey AS, 2012, AM J KIDNEY DIS, V60, P683, DOI 10.1053/j.ajkd.2012.08.019; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Liang MH, 2006, ARTHRITIS RHEUM-US, V54, P421, DOI 10.1002/art.21625; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Malvar A, 2017, NEPHROL DIAL TRANSPL, V32, P1338, DOI 10.1093/ndt/gfv296; Melaragno MG, 1998, CIRC RES, V83, P697, DOI 10.1161/01.RES.83.7.697; Mok CC, 2016, ARTHRIT CARE RES, V68, P1303, DOI 10.1002/acr.22835; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nyman U, 2014, CLIN CHEM LAB MED, V52, P815, DOI 10.1515/cclm-2013-0741; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; Orme JJ, 2016, CLIN IMMUNOL, V169, P58, DOI 10.1016/j.clim.2016.05.011; Parodis I, 2017, SCAND J RHEUMATOL, V46, P263, DOI 10.1080/03009742.2016.1231339; Parodis I, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2014-000061; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Tamirou F, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2015-000123; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Ugolini-Lopes MR, 2017, LUPUS SCI MED, V4, DOI 10.1136/lupus-2017-000213; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wu TF, 2016, J PROTEOME RES, V15, P2102, DOI 10.1021/acs.jproteome.5b00905; Yanagita M, 2002, J CLIN INVEST, V110, P239, DOI 10.1172/JCI200214861; Yanagita M, 2001, AM J PATHOL, V158, P1423, DOI 10.1016/S0002-9440(10)64093-X; Zhen YX, 2018, J AUTOIMMUN, V93, P37, DOI 10.1016/j.jaut.2018.06.001; Zhu HJ, 2014, ADMIN SCI QUART, V59, P599, DOI 10.1177/0001839214545277; Zickert A, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000018; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	45	7	7	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0212068	10.1371/journal.pone.0212068	http://dx.doi.org/10.1371/journal.pone.0212068			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742665	Green Submitted, Green Published, gold			2022-12-26	WOS:000458393400045
J	Malfacini, D; Patt, J; Annala, S; Harpsoe, K; Eryilmaz, F; Reher, R; Crusemann, M; Hanke, W; Zhang, H; Tietze, D; Gloriam, DE; Brauner-Osborne, H; Stromgaard, K; Konig, GM; Inoue, A; Gomeza, J; Kostenis, E				Malfacini, Davide; Patt, Julian; Annala, Suvi; Harpsoe, Kasper; Eryilmaz, Funda; Reher, Raphael; Cruesemann, Max; Hanke, Wiebke; Zhang, Hang; Tietze, Daniel; Gloriam, David E.; Brauner-Osborne, Hans; Stromgaard, Kristian; Koenig, Gabriele M.; Inoue, Asuka; Gomeza, Jesus; Kostenis, Evi			Rational design of a heterotrimeric G protein subunit with artificial inhibitor sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; G protein-coupled receptor (GPCR); signal transduction; pharmacology; CRISPR; Cas; DMR; FR900359; label-free; YM-254890	CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVATION; RECEPTOR; G-ALPHA(Q); YM-254890; CYCLASE; TRANSDUCERS; MECHANISM; INSIGHTS	Transmembrane signals initiated by a range of extracellular stimuli converge on members of the Gq family of heterotrimeric G proteins, which relay these signals in target cells. Gq family G proteins comprise Gq, G11, G14, and G16, which upon activation mediate their cellular effects via inositol lipid-dependent and -independent signaling to control fundamental processes in mammalian physiology. To date, highly specific inhibition of Gq/11/14 signaling can be achieved only with FR900359 (FR) and YM-254890 (YM), two naturally occurring cyclic depsipeptides. To further development of FR or YM mimics for other G subunits, we here set out to rationally design G16 proteins with artificial FR/YM sensitivity by introducing an engineered depsipeptide-binding site. Thereby we permit control of G16 function through ligands that are inactive on the WT protein. Using CRISPR/Cas9-generated Gq/G11-null cells and loss- and gain-of-function mutagenesis along with label-free whole-cell biosensing, we determined the molecular coordinates for FR/YM inhibition of Gq and transplanted these to FR/YM-insensitive G16. Intriguingly, despite having close structural similarity, FR and YM yielded biologically distinct activities: it was more difficult to perturb Gq inhibition by FR and easier to install FR inhibition onto G16 than perturb or install inhibition with YM. A unique hydrophobic network utilized by FR accounted for these unexpected discrepancies. Our results suggest that non-Gq/11/14 proteins should be amenable to inhibition by FR scaffold-based inhibitors, provided that these inhibitors mimic the interaction of FR with G proteins harboring engineered FR-binding sites.	[Malfacini, Davide; Patt, Julian; Annala, Suvi; Eryilmaz, Funda; Gomeza, Jesus; Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Nussallee 6, D-53115 Bonn, Germany; [Reher, Raphael; Cruesemann, Max; Hanke, Wiebke; Koenig, Gabriele M.] Univ Bonn, Inst Pharmaceut Biol, Nussallee 6, D-53115 Bonn, Germany; [Harpsoe, Kasper; Zhang, Hang; Gloriam, David E.; Brauner-Osborne, Hans; Stromgaard, Kristian] Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Tietze, Daniel] Tech Univ Darmstadt, Eduard Zintl Inst Inorgan & Phys Chem, D-64287 Darmstadt, Germany; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Reher, Raphael] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biol & Biomed, La Jolla, CA 92093 USA; [Zhang, Hang] Zhengzhou Univ, Coinnovat Ctr Henan Prov New Drug R&D & Preclin S, Minist Educ, Key Lab Adv Drug Preparat Technol, 100 Kexue Ave, Zhengzhou 450001, Henan, Peoples R China; [Zhang, Hang] Zhengzhou Univ, Sch Pharmaceut Sci, 100 Kexue Ave, Zhengzhou 450001, Henan, Peoples R China	University of Bonn; University of Bonn; University of Copenhagen; Technical University of Darmstadt; Tohoku University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Zhengzhou University; Zhengzhou University	Kostenis, E (corresponding author), Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Nussallee 6, D-53115 Bonn, Germany.	kostenis@uni-bonn.de	Bräuner-Osborne, Hans/S-3298-2019; Harpsøe, Kasper/V-6870-2018; Gloriam, David E./A-1904-2011; Tietze, Daniel/D-4332-2012	Bräuner-Osborne, Hans/0000-0001-9495-7388; Harpsøe, Kasper/0000-0002-9326-9644; Gloriam, David E./0000-0002-4299-7561; Tietze, Daniel/0000-0002-9251-1902; Reher, Raphael/0000-0002-5858-1173; Crusemann, Max/0000-0001-6660-2715; Malfacini, Davide/0000-0003-4562-9550; Stromgaard, Kristian/0000-0003-2206-4737; Zhang, Hang/0000-0002-5479-3435	German Research Foundation (Deutsche Forschungsgemeinschaft) [FOR2372]; Lundbeck Foundation [1079971001]; Novo Nordisk Foundation [NNF17OC0031226]; Japan Agency for Medical Research and Development [PRIME JP17gm5910013, LEAP JP17gm0010004]; Deutsche Bund Umwelt (DBU)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Deutsche Bund Umwelt (DBU)	This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Grant FOR2372 (to E.K. and G. M. K.) and Lundbeck Foundation Grant 1079971001) and Novo Nordisk Foundation Grant NNF17OC0031226(to D.G.). Japan Agency for Medical Research and Development Grants PRIME JP17gm5910013 and LEAP JP17gm0010004 (to A. I.) partially supported this work. W.H. is greatful for a scholarship from the Deutsche Bund Umwelt (DBU) to support her doctoral studies. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a scholarship from the Deutsche Bund Umwelt (DBU).	Bolognini D, 2016, J BIOL CHEM, V291, P18915, DOI 10.1074/jbc.M116.736157; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bynagari YS, 2009, J BIOL CHEM, V284, P13413, DOI 10.1074/jbc.M808970200; Campbell AP, 2018, NAT REV DRUG DISCOV, V17, P789, DOI 10.1038/nrd.2018.135; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Crusemann M, 2018, ANGEW CHEM INT EDIT, V57, P836, DOI 10.1002/anie.201707996; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Gao Jianjiong, SCI SIGNAL, V6, DOI [10.1126/scisignal.2004088, DOI 10.1126/SCISIGNAL.2004088]; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goh FG, 2009, BRIT J PHARMACOL, V158, P1695, DOI 10.1111/j.1476-5381.2009.00415.x; Goricanec D, 2016, P NATL ACAD SCI USA, V113, pE3629, DOI 10.1073/pnas.1604125113; Gulati S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04432-0; Hamm HE, 1996, CURR OPIN CELL BIOL, V8, P189, DOI 10.1016/S0955-0674(96)80065-2; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Higa-Nakamine S, 2015, J BIOL CHEM, V290, P25974, DOI 10.1074/jbc.M115.681700; Hisaoka-Nakashima K, 2015, J BIOL CHEM, V290, P13678, DOI 10.1074/jbc.M114.622415; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Inamdar V, 2015, PLATELETS, V26, P771, DOI 10.3109/09537104.2014.998993; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Kaur H, 2015, ORG LETT, V17, P492, DOI 10.1021/ol503507g; KELLIS JT, 1988, NATURE, V333, P784, DOI 10.1038/333784a0; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Klepac K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10895; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li B, 2018, J BIOL CHEM, V293, P4752, DOI 10.1074/jbc.RA117.000163; Liao Y, 2016, J BIOL CHEM, V291, P7505, DOI 10.1074/jbc.M115.704122; Lokits AD, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1147-8; Lutz S, 2002, N-S ARCH PHARMACOL, V365, P50, DOI 10.1007/s00210-001-0500-3; Mahoney JP, 2016, CURR OPIN STRUC BIOL, V41, P247, DOI 10.1016/j.sbi.2016.11.005; Matthey M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2288; Maziarz M, 2018, J BIOL CHEM, V293, P19586, DOI 10.1074/jbc.RA118.005291; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Onken MD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6852; Orth JHC, 2005, J BIOL CHEM, V280, P36701, DOI 10.1074/jbc.M507203200; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Preininger Anita M, 2004, Sci STKE, V2004, pre3, DOI 10.1126/stke.2182004re3; Reher R, 2018, CHEMMEDCHEM, V13, P1634, DOI 10.1002/cmdc.201800304; Reher R, 2018, J NAT PROD, V81, P1628, DOI 10.1021/acs.jnatprod.8b00222; Rensing DT, 2015, ORG LETT, V17, P2270, DOI 10.1021/acs.orglett.5b00944; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Siekhaus DE, 2003, NAT CELL BIOL, V5, P231, DOI 10.1038/ncb941; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Skinner JJ, 2017, P NATL ACAD SCI USA, V114, P13453, DOI 10.1073/pnas.1711543114; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Taniguchi M, 2004, BIOORGAN MED CHEM, V12, P3125, DOI 10.1016/j.bmc.2004.04.006; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Walther TH, 2014, CURR OPIN STRUC BIOL, V27, P63, DOI 10.1016/j.sbi.2014.05.003; Xiong XF, 2016, NAT CHEM, V8, P1035, DOI [10.1038/NCHEM.2577, 10.1038/nchem.2577]; Yasui F, 2008, BRIT J PHARMACOL, V154, P890, DOI 10.1038/bjp.2008.140; Zaima K, 2013, J NAT MED-TOKYO, V67, P196, DOI 10.1007/s11418-012-0644-0; Zhang H, 2018, EUR J MED CHEM, V156, P847, DOI 10.1016/j.ejmech.2018.07.023; Zhang H, 2017, CHEMMEDCHEM, V12, P830, DOI 10.1002/cmdc.201700155	67	19	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5747	5758		10.1074/jbc.RA118.007250	http://dx.doi.org/10.1074/jbc.RA118.007250			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30745359	Green Published, hybrid			2022-12-26	WOS:000465077500002
J	Zhao, M; Li, WB; Liu, KC; Li, HL; Lan, XP				Zhao, Meng; Li, Weibin; Liu, Kuancan; Li, Huiling; Lan, Xiaopeng			C4-HSL aptamers for blocking qurom sensing and inhibiting biofilm formation in Pseudomonas aeruginosa and its structure prediction and analysis	PLOS ONE			English	Article							CYSTIC-FIBROSIS; MICROBIAL PATHOGENESIS; BACTEREMIA; INFECTION; SIGNAL	This study aimed to screen DNA aptamers against the signal molecule C4-HSL of the rhl system for the inhibition of biofilm formation of Pseudomonas aeruginosa using an improved systematic evolution of ligand by exponential enrichment (SELEX) method based on a structure- switching fluorescent activating bead. The aptamers against the C4-HSL with a high affinity and specifity were successfully obtained and evaluated in real-time by this method. Results of biofilm inhibition experiments in vitro showed that the biofilm formation of P. aeruginosa was efficiently reduced to about 1/3 by the aptamers compared with that of the groups without the aptamers. Independent secondary structure simulation and computeraided tertiary structure prediction (3dRNA) showed that the aptamers contained a highly conserved Y-shaped structural unit. Therefore, this study benefits the search for new methods for the detection and treatment of P. aeruginosa biofilm formation.	[Zhao, Meng; Lan, Xiaopeng] Second Mil Med Univ, Shanghai, Peoples R China; [Zhao, Meng; Li, Weibin; Liu, Kuancan; Li, Huiling; Lan, Xiaopeng] 900th Hosp Joint Serv Support Force, Inst Lab Med, Fuzhou, Fujian, Peoples R China	Naval Medical University	Lan, XP (corresponding author), Second Mil Med Univ, Shanghai, Peoples R China.; Lan, XP (corresponding author), 900th Hosp Joint Serv Support Force, Inst Lab Med, Fuzhou, Fujian, Peoples R China.	Lanxp@sina.com	liu, kuancan/AAE-4400-2020	liu, kuancan/0000-0002-2470-7479; Lan, Xiaopeng/0000-0002-3603-1568	Fujian Provincial Department of Science and Technology (CN) [2010Y0044, 2012D026]; National Natural Science Foundation of China [81271928]	Fujian Provincial Department of Science and Technology (CN); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Fujian Provincial Department of Science and Technology (CN) (no. 2012D026), the Fujian Provincial Department of Science and Technology (CN) (no. 2010Y0044), and the National Natural Science Foundation of China (no. 81271928).	Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290; Ben Jacob E, 2004, TRENDS MICROBIOL, V12, P366, DOI 10.1016/j.tim.2004.06.006; Bin Seo H, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-017-0054-7; BODEY GP, 1983, REV INFECT DIS, V5, P279; Carrasquilla C, 2011, ANAL CHEM, V83, P7984, DOI 10.1021/ac2020432; Carrasquilla C, 2011, ANAL CHEM, V83, P957, DOI 10.1021/ac102679r; Chen F, 2004, BIOTECHNOL PROGR, V20, P1325, DOI 10.1021/bp049928b; Ding X, 2011, J MED MICROBIOL, V60, P1827, DOI 10.1099/jmm.0.024166-0; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Dubeau D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-263; Eberl L, 2004, INT J MED MICROBIOL, V294, P123, DOI 10.1016/j.ijmm.2004.06.022; El Solh AA, 2008, AM J RESP CRIT CARE, V178, P513, DOI 10.1164/rccm.200802-239OC; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hachem RY, 2007, ANTIMICROB AGENTS CH, V51, P1905, DOI 10.1128/AAC.01015-06; Harmanci AO, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-130; Huang YY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01887; Huang Y, 2012, CHEM COMMUN, V48, P7480, DOI 10.1039/c2cc33021k; Karig D, 2005, BIOTECHNOL BIOENG, V89, P709, DOI 10.1002/bit.20371; Lau PS, 2014, ADV BIOCHEM ENG BIOT, V140, P69, DOI 10.1007/10_2013_223; Lepine F, 2003, BBA-GEN SUBJECTS, V1622, P36, DOI 10.1016/S0304-4165(03)00103-X; Liang JF, 2011, CHEM COMMUN, V47, P5476, DOI 10.1039/c1cc10965k; MENDELSON MH, 1994, CLIN INFECT DIS, V18, P886, DOI 10.1093/clinids/18.6.886; Nutiu R, 2003, J AM CHEM SOC, V125, P4771, DOI 10.1021/ja028962o; Santiago EB, 1996, REV CLIN ESP, V196, P698; Schurr MJ, 1997, MOL MICROBIOL, V24, P411, DOI 10.1046/j.1365-2958.1997.3411711.x; Shih PC, 2002, J ANTIMICROB CHEMOTH, V49, P309, DOI 10.1093/jac/49.2.309; Nguyen VT, 2017, CURR OPIN BIOTECH, V45, P15, DOI 10.1016/j.copbio.2016.11.020; Wang Wen-min, 2010, Zhejiang Da Xue Xue Bao Yi Xue Ban, V39, P103; Wang XY, 2010, ANAL CHIM ACTA, V658, P128, DOI 10.1016/j.aca.2009.11.007; Xu ZJ, 2011, BIOINFORMATICS, V27, P626, DOI 10.1093/bioinformatics/btq726; Yu H, 1998, INFECT IMMUN, V66, P280, DOI 10.1128/IAI.66.1.280-288.1998; Zhang SS, 2008, ANAL CHEM, V80, P8382, DOI 10.1021/ac800857p; Zhang YY, 2013, INDIAN J MICROBIOL, V53, P28, DOI 10.1007/s12088-012-0340-5; Zhao YJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00734; Zhu X, 2011, ANAL CHIM ACTA, V684, P121, DOI 10.1016/j.aca.2010.10.038	35	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212041	10.1371/journal.pone.0212041	http://dx.doi.org/10.1371/journal.pone.0212041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779754	Green Submitted, Green Published, gold			2022-12-26	WOS:000459062900025
J	Ersoy, Z; Brucet, S; Bartrons, M; Mehner, T				Ersoy, Zeynep; Brucet, Sandra; Bartrons, Mireia; Mehner, Thomas			Short-term fish predation destroys resilience of zooplankton communities and prevents recovery of phytoplankton control by zooplankton grazing	PLOS ONE			English	Article							FOOD-WEB COMPLEXITY; TOP-DOWN CONTROL; SHALLOW LAKES; MESOCOSM EXPERIMENTS; RELATIVE IMPORTANCE; TROPHIC CASCADES; SIZE DIVERSITY; DANISH LAKES; BODY-SIZE; PLANKTON	Planktivorous fish predation directly affects zooplankton biomass, community and size structure, and may indirectly induce atrophic cascade to phytoplankton. However, it is not clear how quickly the zooplankton community structure and the cascading effects on phytoplankton recover to the unaffected state (i.e. resilience) once short-term predation by fish stops. The resilience has implications for the ecological quality and restoration measures in aquatic ecosystems. To assess the short-term zooplankton resilience against fish predation, we conducted a mesocosm experiment consisting of 10 enclosures, 6 with fish and 4 without fish. Plankton communities from a natural lake were used to establish phytoplankton and zooplankton in the mesocosms. High biomasses (about 20 g wet mass m(-3)) of juvenile planktivorous fish (perch, Perca fluviatilis) were allowed to feed on zooplankton in fish enclosures for four days. Thereafter, we removed fish and observed the recovery of the zooplankton community and its cascading effect on trophic interactions in comparison with no fish enclosures for four weeks. Short-term fish predation impaired resilience in zooplankton community by modifying community composition, as large zooplankton, such as calanoids, decreased just after fish predation and did not re-appear afterwards, whereas small cladocerans and rotifers proliferated. Total zooplankton biomass increased quickly within two weeks after fish removal, and at the end even exceeded the biomass measured before fish addition. Despite high biomass, the dominance of small zooplankton released phytoplankton from grazer control in fish enclosures. Accordingly, the zooplankton community did not recover from the effect of fish predation, indicating low short-term resilience. In contrast, in no fish enclosures without predation disturbance, a high zooplankton:phytoplankton biomass ratio accompanied by low phytoplankton yield (Chlorophyll-a:Total phosphorus ratio) reflected phytoplankton control by zooplankton over the experimental period. Comprehensive views on short and long-term resilience of zooplankton communities are essential for restoration and management strategies of aquatic ecosystems to better predict responses to global warming, such as higher densities of planktivorous fish.	[Ersoy, Zeynep; Brucet, Sandra; Bartrons, Mireia] Univ Vic, Cent Univ Catalonia, Aquat Ecol Grp, Vic, Spain; [Ersoy, Zeynep; Mehner, Thomas] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Biol & Ecol Fishes, Berlin, Germany; [Brucet, Sandra] ICREA, Catalan Inst Res & Adv Studies, Barcelona, Spain	Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); ICREA	Ersoy, Z (corresponding author), Univ Vic, Cent Univ Catalonia, Aquat Ecol Grp, Vic, Spain.; Ersoy, Z; Mehner, T (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Biol & Ecol Fishes, Berlin, Germany.	zeynep.ersoy@uvic.cat; mehner@igb-berlin.de	Ersoy, Zeynep/B-8354-2018; Mehner, Thomas/B-8665-2008; Bartrons, Mireia/D-3452-2014	Ersoy, Zeynep/0000-0003-2344-9874; Mehner, Thomas/0000-0002-3619-165X; Bartrons, Mireia/0000-0003-0617-9577	"International Leibniz-lnstitute of Freshwater Ecology and Inland Fisheries (IGB) Fellowship Programme, Freshwater Science"; UVic-UCC; International Mobility Grant of Antiga Caxia Mannleu & BBVA Foundation; Deutsche Forschungsgemeinschaft (DFG) [Me 1686/7-1]; International Research Stay Grant from UVic-UCC; Open Access Fund of the Leibniz Association; Open Access Fund of the Leibniz-Institute of Freshwater Ecology and Inland Fisheries (IGB)	"International Leibniz-lnstitute of Freshwater Ecology and Inland Fisheries (IGB) Fellowship Programme, Freshwater Science"; UVic-UCC; International Mobility Grant of Antiga Caxia Mannleu & BBVA Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); International Research Stay Grant from UVic-UCC; Open Access Fund of the Leibniz Association; Open Access Fund of the Leibniz-Institute of Freshwater Ecology and Inland Fisheries (IGB)	This study was funded by "International Leibniz-lnstitute of Freshwater Ecology and Inland Fisheries (IGB) Fellowship Programme, Freshwater Science" (https.//www.igb-berlin.de/en/fellowship-programme) to ZE. ZE was further supported by Predoctoral Fellowship and International Research Stay Grant from UVic-UCC, and International Mobility Grant of Antiga Caxia Mannleu & BBVA Foundation. SB and TM were supported by the Deutsche Forschungsgemeinschaft (http//www dfg.de/en/) (DFG, grant no. Me 1686/7-1). MB was supported by International Research Stay Grant from UVic-UCC. The publication of this article was funded by the Open Access Fund of the Leibniz Association and the Open Access Fund of the Leibniz-Institute of Freshwater Ecology and Inland Fisheries (IGB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2006, GLOBAL CHANGE BIOL, V12, P652, DOI 10.1111/j.1365-2486.2006.01125.x; Altermatt F, 2015, METHODS ECOL EVOL, V6, P218, DOI 10.1111/2041-210X.12312; Arguelles M, FISH SHIFT FEEDING B; Attayde JL, 2001, LIMNOL OCEANOGR, V46, P1001, DOI 10.4319/lo.2001.46.5.1001; Balayla D, 2010, HYDROBIOLOGIA, V646, P159, DOI 10.1007/s10750-010-0164-4; Bartrons M, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00392.1; Beklioglu M, 1996, FRESHWATER BIOL, V36, P315, DOI 10.1046/j.1365-2427.1996.00092.x; Beklioglu M, 2017, WATER-SUI, V9, DOI 10.3390/w9020127; Blanchard JL, 2017, TRENDS ECOL EVOL, V32, P174, DOI 10.1016/j.tree.2016.12.003; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; BRABRAND A, 1990, CAN J FISH AQUAT SCI, V47, P364, DOI 10.1139/f90-038; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Brucet S, 2018, ECOGRAPHY, V41, P1064, DOI 10.1111/ecog.03255; Brucet S, 2017, FRESHWATER BIOL, V62, P1819, DOI 10.1111/fwb.12997; Brucet S, 2010, LIMNOL OCEANOGR, V55, P1697, DOI 10.4319/lo.2010.55.4.1697; Burks RL, 2002, FRESHWATER BIOL, V47, P343, DOI 10.1046/j.1365-2427.2002.00824.x; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Carpenter SR, 2001, ECOL MONOGR, V71, P163, DOI 10.1890/0012-9615(2001)071[0163:TCNALP]2.0.CO;2; Chang CW, 2014, ECOLOGY, V95, P897, DOI 10.1890/13-0742.1; CHRISTOFFERSEN K, 1993, LIMNOL OCEANOGR, V38, P561, DOI 10.4319/lo.1993.38.3.0561; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; DABORN G R, 1976, Canadian Field-Naturalist, V90, P56; DeLong JP, 2015, AM NAT, V185, P354, DOI 10.1086/679735; Donald DB, 2001, CAN J FISH AQUAT SCI, V58, P1822, DOI 10.1139/cjfas-58-9-1822; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Ersoy Z, 2017, FRESHWATER BIOL, V62, P1942, DOI 10.1111/fwb.13039; Fiogbe ED, 2003, AQUACULTURE, V216, P243, DOI 10.1016/S0044-8486(02)00409-X; Gutierrez MF, 2016, WATER-SUI, V8, DOI 10.3390/w8080341; Florian N, 2016, LIMNETICA, V35, P397; Hairston NG, 1996, LIMNOL OCEANOGR, V41, P1087, DOI 10.4319/lo.1996.41.5.1087; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; Hillebrand H, 2018, ECOL LETT, V21, P21, DOI 10.1111/ele.12867; Hilt S, 2017, BIOSCIENCE, V67, P928, DOI 10.1093/biosci/bix106; Iglesias C, 2011, HYDROBIOLOGIA, V667, P133, DOI 10.1007/s10750-011-0645-0; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jakobsen TS, 2003, MAR ECOL PROG SER, V262, P277, DOI 10.3354/meps262277; Jeppesen E, 2003, ECOSYSTEMS, V6, P313, DOI 10.1007/PL00021503; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1616, DOI 10.1111/j.1365-2427.2005.01413.x; Jeppesen E, 2004, FRESHWATER BIOL, V49, P432, DOI 10.1111/j.1365-2427.2004.01199.x; Jeppesen E, 2014, J LIMNOL, V73, P88, DOI 10.4081/jlimnol.2014.844; Jeppesen E, 2012, HYDROBIOLOGIA, V694, P1, DOI 10.1007/s10750-012-1182-1; Jeppesen E, 2010, HYDROBIOLOGIA, V646, P73, DOI 10.1007/s10750-010-0171-5; Knapp RA, 2001, ECOL MONOGR, V71, P401, DOI 10.1890/0012-9615(2001)071[0401:RAROAL]2.0.CO;2; Knapp RA, 2005, ECOL APPL, V15, P835, DOI 10.1890/04-0619; Knapp RA, 2008, ECOL APPL, V18, P1850, DOI 10.1890/08-0044.1; Kramer AM, 2008, ECOLOGY, V89, P2760, DOI 10.1890/07-1505.1; Lauridsen TL, 1996, LIMNOL OCEANOGR, V41, P794, DOI 10.4319/lo.1996.41.4.0794; Lemmens P, 2018, ECOSYSTEMS, V21, P166, DOI 10.1007/s10021-017-0144-x; Matsuzaki SS, 2007, FUND APPL LIMNOL, V168, P27, DOI 10.1127/1863-9135/2007/0168-0027; McCauley E., 1984, IBP HDB, P228; McFeeters BJ, 2011, FRESHWATER BIOL, V56, P1447, DOI 10.1111/j.1365-2427.2011.02586.x; McNaught AS, 1999, LIMNOL OCEANOGR, V44, P127, DOI 10.4319/lo.1999.44.1.0127; Meerhoff M, 2007, FRESHWATER BIOL, V52, P1009, DOI 10.1111/j.1365-2427.2007.01748.x; Mehner T, 2002, FRESHWATER BIOL, V47, P2453, DOI 10.1046/j.1365-2427.2002.01003.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Noges T, 2016, HYDROBIOLOGIA, V780, P59, DOI 10.1007/s10750-016-2849-9; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PECK S B, 1975, Canadian Field-Naturalist, V89, P181; Pekcan-Hekim Z, 2006, NATURWISSENSCHAFTEN, V93, P356, DOI 10.1007/s00114-006-0114-1; Pimm SL, 1991, BALANCE NATURE ECOLO; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; PROCTOR VW, 1964, ECOLOGY, V45, P656, DOI 10.2307/1936124; R Core Team, 2018, R LANG ENV STAT COMP; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; Sarnelle O, 2004, LIMNOL OCEANOGR, V49, P1382, DOI 10.4319/lo.2004.49.4_part_2.1382; SCHINDLER DE, 1992, CAN J FISH AQUAT SCI, V49, P2498, DOI 10.1139/f92-276; Schindler DE, 2001, ECOSYSTEMS, V4, P308, DOI 10.1007/s10021-001-0013-4; Shatwell T, 2012, LIMNOL OCEANOGR, V57, P541, DOI 10.4319/lo.2012.57.2.0541; Sommer U, 2002, ECOL RES, V17, P161, DOI 10.1046/j.1440-1703.2002.00476.x; Sondergaard M, 2008, ECOSYSTEMS, V11, P1291, DOI 10.1007/s10021-008-9193-5; Sondergaard M, 2017, WATER-SUI, V9, DOI 10.3390/w9010043; Stewart RIA, 2013, ADV ECOL RES, V48, P71, DOI 10.1016/B978-0-12-417199-2.00002-1; Tavsanoglu UN, 2015, HYDROBIOLOGIA, V753, P47, DOI 10.1007/s10750-015-2192-6; VANNI MJ, 1987, ECOL MONOGR, V57, P61, DOI 10.2307/1942639; Velthuis M, 2017, IMPACT TEMPERATURE N, V8, P1; Verdonschot PFM, 2013, HYDROBIOLOGIA, V704, P453, DOI 10.1007/s10750-012-1294-7; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woodward G, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0274; Ye L, 2013, J ANIM ECOL, V82, P1052, DOI 10.1111/1365-2656.12067; zen O A, 2017, FRESHWATER BIOL, V62, P1819; Zhang JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058115, 10.1371/journal.pone.0076378]	84	18	19	7	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212351	10.1371/journal.pone.0212351	http://dx.doi.org/10.1371/journal.pone.0212351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768619	Green Published, Green Submitted, gold			2022-12-26	WOS:000458766300033
J	Liu, SL; Wang, XH; Xu, YH; Zhang, R; Xiao, SY; Wang, YP; Zhang, LX				Liu, Shuangli; Wang, Xiaohui; Xu, Yonghua; Zhang, Rui; Xiao, Shengyuan; Wang, Yingping; Zhang, Lianxue			Antifeedant and ovicidal activities of ginsenosides against Asian corn borer, Ostrinia furnacalis (Guenee)	PLOS ONE			English	Article							20(S)-PROTOPANAXADIOL; BIOTRANSFORMATION	Introduction Ginsenosides, including protopanaxdiol (PPD) and protopanaxtriol (PPT) type ginsenosides, have been identified as natural insecticidess. This study aimed to investigate the anti-feedant and ovicidal activities of total ginsenosides, protopanaxdiol saponins (PDS) and protopanaxtriol saponins (PTS) against Asian corn borer, O. furnacalis (Guenee). Methods and results O. furnacalis egg masses (> 40 eggs) at 0-, 1- and 2-day-old were dipped into ginsenosides and egg hatchability was significantly inhibited by total ginsenosides, PDS, and PTS in dose and egg-age dependent manners. 100 mg/ml PDS had the strongest ovicidal activity against 0- (80.58 +/- 0.95%), 1- (71.48 +/- 5.70%), and 2-day-old eggs (64.31 +/- 3.20%). In no-choice and choice feeding tests, we observed that the 3rd instar larvae consumed decreased area of leaves treated with ginsenosides, and the antifeedant activities of total ginsenosides, PDS, and PTS against the 3rd instar larvae were time and dose-dependent, with higher activities at 48 h. 100 mg/ml PDS had relative higher antifeedant activity (88.39 +/- 3.43% in no-choice and 80.9 +/- 4.36% in choice) than total ginsenosides and PTS at all time intervals, except at 48 h in no-choice test. In further experiments, we found PPD ginsenosides (Rb1, Rb2, Rc, and Rd) had relative higher time and dose dependent antifeedant activities than PPT ginsenosides (Re and Rg1). Conclusions Our results suggested the insecticidal action of total ginsenosides, PDS, and PTS on O. furnacalis. All ginsenosides, especially PDS, showed antifeedant and ovicidal activities against O. furnacalis.	[Liu, Shuangli; Xu, Yonghua; Zhang, Rui; Xiao, Shengyuan; Wang, Yingping; Zhang, Lianxue] Jilin Agr Univ, Natl & Local Joint Engn Res Ctr Ginseng Breeding, Changchun, Jilin, Peoples R China; [Wang, Xiaohui] Jilin Acad Agr Sci, Res Ctr Agr Environm & Resources, Changchun, Jilin, Peoples R China	Jilin Agricultural University; Jilin Academy of Agricultural Sciences	Wang, YP; Zhang, LX (corresponding author), Jilin Agr Univ, Natl & Local Joint Engn Res Ctr Ginseng Breeding, Changchun, Jilin, Peoples R China.	YINGPINGW@126.COM; ZLX863@163.com			Natural Science Fund Project of Jilin Province Science and Technology Department [20190201263JC]; Special Fund for Agro-scientific Research in the Public Interest [201303111]	Natural Science Fund Project of Jilin Province Science and Technology Department; Special Fund for Agro-scientific Research in the Public Interest	This work was supported by Natural Science Fund Project of Jilin Province Science and Technology Department (20190201263JC) and Special Fund for Agro-scientific Research in the Public Interest (201303111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai-Hua Z, 2014, EVID-BASED COMPL ALT, V10; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bak DH, 2016, INT J MOL MED, V37, P378, DOI 10.3892/ijmm.2015.2440; Chen X.J., 2016, EVID-BASED COMPL ALT, V2016, P1; Golawska S, 2010, POL J ENVIRON STUD, V19, P913; Guo JF, 2019, PLANT BIOTECHNOL J, V17, P88, DOI 10.1111/pbi.12949; Kojima W, 2010, J INSECT PHYSIOL, V56, P1349, DOI 10.1016/j.jinsphys.2010.04.021; Law CKM, 2014, CHIN MED-UK, V9, DOI 10.1186/1749-8546-9-11; Lee IS, J IMMUNOLOGY RES; Li B, 2016, ONCOL LETT, V11, P1693, DOI 10.3892/ol.2016.4155; Li L, 2018, J GINSENG RES, V42, P412, DOI 10.1016/j.jgr.2017.04.007; Liu CY, 2014, PROCESS BIOCHEM, V49, P813, DOI 10.1016/j.procbio.2014.02.011; Liu H., 2014, J JILIN I CHEM TECHN, V31, P4; Murthy HN, 2018, ANTICANCER PLANTS NA, P429, DOI [10.1007/978-981-10-8064-7, DOI 10.1007/978-981-10-8064-7]; Oh HA, 2015, BIOL PHARM BULL, V38, P331, DOI 10.1248/bpb.b14-00669; Park EK, 2004, INT ARCH ALLERGY IMM, V133, P113, DOI 10.1159/000076383; Peng Bin (et al), 2011, Journal of Chongqing Medical University, V36, P419; Sang YH, 2017, J GINSENG RES, V42, P496, DOI [10.1016/j.jgr.2017.1006.1003, DOI 10.1016/J.JGR.2017.1006.1003]; Sun JH, 2007, VACCINE, V25, P1114, DOI 10.1016/j.vaccine.2006.09.054; Tan Shi-Qiang, 2013, Zhongguo Zhong Yao Za Zhi, V38, P1692; Wanderi C, 2016, ANTICANCER RES, V36, P925; Wang CZ, 2008, ANTICANCER RES, V28, P2545; Xu FY, 2016, AM J TRANSL RES, V8, P1708; Yang H, 2018, IND CROP PROD, V124, P412, DOI 10.1016/j.indcrop.2018.07.054; Yang XD, 2015, FITOTERAPIA, V100, P208, DOI 10.1016/j.fitote.2014.11.019; Yu SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00262-0; Zhang AH, 2015, EVID-BASED COMPL ALT, V2015; Zhang AH, 2017, SAUDI J BIOL SCI, V24, P1751, DOI 10.1016/j.sjbs.2017.11.005; Zhang B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0581-2	29	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0211905	10.1371/journal.pone.0211905	http://dx.doi.org/10.1371/journal.pone.0211905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768606	Green Published, gold, Green Submitted			2022-12-26	WOS:000458766300014
J	Ndabi, J; Nevill, AM; Sandercock, GRH				Ndabi, Joyce; Nevill, Alan M.; Sandercock, Gavin R. H.			Cross-cultural comparisons of aerobic and muscular fitness in Tanzanian and English youth: An allometric approach	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; SCHOOL-AGE-CHILDREN; BODY-SIZE; NUTRITION TRANSITION; MOTOR-PERFORMANCE; STRENGTH; ADOLESCENTS; SCHOOLCHILDREN; VARIABLES; OBESITY	Comparisons of physical fitness measures between children or within group measures over time are potentially confounded by differences in body size. We compared measures of strength (handgrip) and aerobic fitness (running-speed [20m shuttle-run]) of 10.0-15.9 year-olds from Dar es Salaam, Tanzania (n = 977) with schoolchildren from England (n = 1014) matched for age and sex. Differences in fitness were analyzed using general linear models, with allometric scaling for body size (mass and stature) and further adjustments for physical activity. Mean handgrip of Tanzanians was lower than English youth (F= 165.0, P<0.001, eta(2)(p) =.079). The difference became trivial when run-speed was scaled for body size (eta(2)(p)=.008). Running-speed of the English children was higher than in Tanzanians (F= 16.0, P<0.001, eta(2)(p) =.014). Allometric scaling for accentuated this between-county difference in running-speed (eta(2)(p)=.019) but when adjusted for physical activity between-country differences in running-speed were trivial (eta(2)(p)=.008). These data contradict those studies showing poor muscular fitness in African youth and highlight the need for appropriate scaling techniques to avoid confounding by differences in body size. In contrast to those from rural areas, our sample of contemporary urban Tanzanians were less aerobically fit than European youth. Differences were independent of body size. Lower aerobic fitness of urban Tanzanian youth may be due to reported physical activity levels lower than those of English youth and lower still than previously reported in rural Tanzania.	[Ndabi, Joyce] Univ Dar Es Salaam, Dept Phys Educ & Sports Sci, Dar Es Salaam, Tanzania; [Nevill, Alan M.] Univ Essex, Sch Sport Exercise & Rehabil Sci, Colchester, Essex, England; [Sandercock, Gavin R. H.] Univ Wolverhampton, Fac Educ Hlth & Wellbeing, Walsall, W Midlands, England	University of Dar es Salaam; University of Essex; University of Wolverhampton	Sandercock, GRH (corresponding author), Univ Wolverhampton, Fac Educ Hlth & Wellbeing, Walsall, W Midlands, England.	gavins@essex.ac.uk	Nevill, Alan/Q-1010-2019	Nevill, Alan/0000-0003-0506-3652; Sandercock, Gavin/0000-0002-5443-6518	Tanzania Commission for Science and Technology [DB03405]	Tanzania Commission for Science and Technology	GS and AN received no funding for this study. JN was funded by the Tanzania Commission for Science and Technology (DB03405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandstad A, 2006, BRIT J SPORT MED, V40, P287, DOI 10.1136/bjsm.2005.020040; Adamo KB, 2011, INT J PEDIATR OBES, V6, pE225, DOI 10.3109/17477166.2010.543683; Valdivia AB, 2015, SCAND J MED SCI SPOR, V25, pe155, DOI 10.1111/sms.12231; dos Santos FK, 2016, ANN HUM BIOL, V43, P191, DOI 10.3109/03014460.2015.1024738; Fairclough S, 2005, HEALTH EDUC RES, V20, P14, DOI 10.1093/her/cyg101; Forum WE, 2015, WORLD EC FORUM; Heroux M, 2013, ISRN Obes, V2013, P134835, DOI 10.1155/2013/134835; Hill A, 2010, TANZ 45 ISOCARP C 20; Jaric S, 2003, EXERC SPORT SCI REV, V31, P8, DOI 10.1097/00003677-200301000-00003; Jinabhai CC, 2003, EUR J CLIN NUTR, V57, P358, DOI 10.1038/sj.ejcn.1601534; Jurimae T, 2009, HOMO, V60, P225, DOI 10.1016/j.jchb.2008.05.004; Keding G, 2016, WORLD REV NUTR DIET, V115, P68, DOI 10.1159/000442073; Keding GB, 2011, FOOD NUTR BULL, V32, P218, DOI 10.1177/156482651103200306; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P342, DOI 10.1123/pes.9.4.342; Lang JJ, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096224; Maletnlema TN, 2002, PUBLIC HEALTH NUTR, V5, P163, DOI 10.1079/PHN2001289; MALINA RM, 1987, AM J PHYS ANTHROPOL, V73, P489, DOI 10.1002/ajpa.1330730411; Mbalilaki JA, 2007, NUTR METAB CARDIOVAS, V17, P344, DOI 10.1016/j.numecd.2006.03.003; Mkalawa CC., 2014, URBAN PLANN TRANSPOR, V2, P423; Muthuri SK, 2014, INT J ENV RES PUB HE, V11, P3327, DOI 10.3390/ijerph110303327; Nevill A, 2009, PEDIATR EXERC SCI, V21, P220, DOI 10.1123/pes.21.2.220; Nevill AM, 2005, YEARB PHYS ANTHROPOL, V48, P141, DOI 10.1002/ajpa.20356; Nevill AM, 1998, J APPL PHYSIOL, V84, P963, DOI 10.1152/jappl.1998.84.3.963; Nevill AM, 2004, ANN HUM BIOL, V31, P436, DOI 10.1080/03014460410001723996; Prista A, 2003, AM J CLIN NUTR, V77, P952, DOI 10.1093/ajcn/77.4.952; Prista A, 2009, PEDIATR EXERC SCI, V21, P384, DOI 10.1123/pes.21.4.384; Silva S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149493; Unwin N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-272; Voss C, 2013, PEDIATR INT, V55, P498, DOI 10.1111/ped.12092	29	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0211414	10.1371/journal.pone.0211414	http://dx.doi.org/10.1371/journal.pone.0211414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5KT	30768600	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000458766300007
J	Sone, D; Watanabe, M; Maikusa, N; Sato, N; Kimura, Y; Enokizono, M; Okazaki, M; Matsuda, H				Sone, Daichi; Watanabe, Masako; Maikusa, Norihide; Sato, Noriko; Kimura, Yukio; Enokizono, Mikako; Okazaki, Mitsutoshi; Matsuda, Hiroshi			Reduced resilience of brain gray matter networks in idiopathic generalized epilepsy: A graph-theoretical analysis	PLOS ONE			English	Article							JUVENILE MYOCLONIC EPILEPSY; TEMPORAL-LOBE EPILEPSY; VOXEL-BASED MORPHOMETRY; BLOOD-FLOW NETWORKS; COGNITIVE DECLINE; FRONTAL-LOBE; ABNORMALITIES; MRI; THALAMUS; CONNECTIVITY	Purpose The pathophysiology of idiopathic generalized epilepsy (IGE) is still unclear, but graph theory may help to understand it. Here, we examined the graph-theoretical findings of the gray matter network in IGE using anatomical covariance methods. Materials and methods We recruited 33 patients with IGE and 35 age- and sex-matched healthy controls. Gray matter images were obtained by 3.0-T 3D T1-weighted MRI and were normalized using the voxel-based morphometry tools of Statistical Parametric Mapping 12. The normalized images were subjected to graph-theoretical group comparison using the Graph Analysis Toolbox with two different parcellation schemes. Initially, we used the Automated Anatomical Labeling template, whereas the Hammers Adult atlas was used for the second analysis. Results The resilience analyses revealed significantly reduced resilience of the IGE gray matter networks to both random failure and targeted attack. No significant between-group differences were found in global network measures, including the clustering coefficient and characteristic path length. The IGE group showed several changes in regional clustering, including an increase mainly in wide areas of the bilateral frontal lobes. The second analysis with another region of interest (ROI) parcellation generated the same results in resilience and global network measures, but the regional clustering results differed between the two parcellation schemes. Conclusion These results may reflect the potentially weak network organization in IGE. Our findings contribute to the accumulation of knowledge on IGE.	[Sone, Daichi; Watanabe, Masako; Okazaki, Mitsutoshi] Natl Ctr Neurol & Psychiat, Dept Psychiat, Tokyo, Japan; [Sone, Daichi; Maikusa, Norihide; Matsuda, Hiroshi] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Tokyo, Japan; [Sato, Noriko; Kimura, Yukio; Enokizono, Mikako] Natl Ctr Neurol & Psychiat, Dept Radiol, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Sone, D (corresponding author), Natl Ctr Neurol & Psychiat, Dept Psychiat, Tokyo, Japan.; Sone, D (corresponding author), Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Tokyo, Japan.	daichisone@gmail.com	Sone, Daichi/J-7634-2019	Sone, Daichi/0000-0001-9617-706X	Japan Epilepsy Research Foundation [17009]; Japan Society for the Promotion of Science [JP17H07385]	Japan Epilepsy Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants from the Japan Epilepsy Research Foundation (JERF TENKAN 17009) and the Japan Society for the Promotion of Science (KAKENHI Grant Number JP17H07385) (both to DS). Japan Epilepsy Research Foundation: https://www.epi-fj.jp/index html Japan Society for the Promotion of Science: https://www.jsps.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bai XX, 2010, J NEUROSCI, V30, P5884, DOI 10.1523/JNEUROSCI.5101-09.2010; Bernhardt BC, 2015, EPILEPSY BEHAV, V50, P162, DOI 10.1016/j.yebeh.2015.06.005; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bernhardt BC, 2009, NEUROIMAGE, V46, P373, DOI 10.1016/j.neuroimage.2009.01.055; Caciagli L, 2017, NEUROLOGY, V89, P506, DOI 10.1212/WNL.0000000000004176; Chan CH, 2006, EPILEPSIA, V47, P399, DOI 10.1111/j.1528-1167.2006.00435.x; Chowdhury FA, 2014, EPILEPSIA, V55, P835, DOI 10.1111/epi.12604; Ciumas C, 2006, NEUROLOGY, V67, P683, DOI 10.1212/01.wnl.0000230171.23913.cf; Drakesmith M, 2015, NEUROIMAGE, V118, P313, DOI 10.1016/j.neuroimage.2015.05.011; Evans AC, 2013, NEUROIMAGE, V80, P489, DOI 10.1016/j.neuroimage.2013.05.054; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Haneef Z, 2014, SEIZURE-EUR J EPILEP, V23, P809, DOI 10.1016/j.seizure.2014.07.004; Helms G, 2006, J NEUROL NEUROSUR PS, V77, P489, DOI 10.1136/jnnp.2005.074682; Henley SMD, 2010, AM J NEURORADIOL, V31, P711, DOI 10.3174/ajnr.A1939; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Huang W, 2011, J NEURORADIOLOGY, V38, P298, DOI 10.1016/j.neurad.2010.12.007; Joo EY, 2008, J NEUROL, V255, P520, DOI 10.1007/s00415-008-0727-8; Kim JH, 2007, NEUROIMAGE, V37, P1132, DOI 10.1016/j.neuroimage.2007.06.025; Kim JH, 2012, EPILEPSIA, V53, P1371, DOI 10.1111/j.1528-1167.2012.03544.x; Li JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19290-5; Lin JJ, 2014, ANN NEUROL, V76, P660, DOI 10.1002/ana.24240; Mory SB, 2011, EPILEPSY BEHAV, V21, P407, DOI 10.1016/j.yebeh.2011.05.018; Mueller SG, 2015, PSYCHIAT RES-NEUROIM, V234, P194, DOI 10.1016/j.pscychresns.2015.09.006; Nuyts S, 2017, EPILEPSIA, V58, P2025, DOI 10.1111/epi.13928; Panayiotopoulos CP, 2005, EPILEPSIA, V46, P1, DOI 10.1111/j.1528-1167.2005.00330.x; Pardoe H, 2008, NEUROIMAGE, V42, P611, DOI 10.1016/j.neuroimage.2008.05.007; Perani S, 2018, EPILEPSIA, V59, P226, DOI 10.1111/epi.13955; PREVETT MC, 1995, NEUROLOGY, V45, P1396, DOI 10.1212/WNL.45.7.1396; Roebling R, 2009, EPILEPSIA, V50, P2456, DOI 10.1111/j.1528-1167.2009.02127.x; Santarnecchi E, 2015, CORTEX, V64, P293, DOI 10.1016/j.cortex.2014.11.005; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Seneviratne U, 2014, EPILEPSIA, V55, P1157, DOI 10.1111/epi.12688; Sone D., 2018, EPILEPSY SEIZURE, V10, P33, DOI [10.3805/eands.10.33, DOI 10.3805/EANDS.10.33]; Sone D, 2017, EPILEPSY RES, V129, P95, DOI 10.1016/j.eplepsyres.2016.12.009; Sone D, 2016, EPILEPSY BEHAV, V62, P239, DOI 10.1016/j.yebeh.2016.07.016; Sone D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158728; Takeda K, 2017, BRAIN DEV-JPN, V39, P678, DOI 10.1016/j.braindev.2017.04.010; Tschernegg M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00625; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaessen MJ, 2012, CEREB CORTEX, V22, P2139, DOI 10.1093/cercor/bhr298; Vaughan DN, 2016, NEUROLOGY, V87, P1934, DOI 10.1212/WNL.0000000000003289; Vlooswijk MCG, 2011, NEUROLOGY, V77, P938, DOI 10.1212/WNL.0b013e31822cfc2f; Vollmar C, 2012, NEUROLOGY, V78, P1555, DOI 10.1212/WNL.0b013e3182563b44; Wandschneider B, 2012, EPILEPSIA, V53, P2091, DOI 10.1111/epi.12003; Whelan CD, 2018, BRAIN, V141, P391, DOI 10.1093/brain/awx341; Yasuda CL, 2015, EPILEPSIA, V56, P1992, DOI 10.1111/epi.13225; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	53	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0212494	10.1371/journal.pone.0212494	http://dx.doi.org/10.1371/journal.pone.0212494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5KT	30768622	Green Published, Green Submitted, gold			2022-12-26	WOS:000458766300043
J	Nivelle, R; Gennotte, V; Kalala, EJK; Ngoc, NB; Muller, M; Melard, C; Rougeot, C				Nivelle, Renaud; Gennotte, Vincent; Kalala, Emery Jules Kembolo; Nguyen Bich Ngoc; Muller, Marc; Melard, Charles; Rougeot, Carole			Temperature preference of Nile tilapia (Oreochromis niloticus) juveniles induces spontaneous sex reversal	PLOS ONE			English	Article							PREFERRED TEMPERATURE; THERMAL PREFERENCE; ANIMAL PERSONALITY; FINAL PREFERENDUM; BEHAVIORAL FEVER; DIFFERENTIATION; GROWTH; OPTIMUM; ZEBRAFISH; CATFISH	Nile tilapia (Oreochromis niloticus) is an African freshwater fish that displays a genetic sex determination system (XX vertical bar XY) where high temperatures (above 32 degrees C to 36.5 degrees C) induce masculinization. In Nile tilapia, the thermosensitive period was reported from 10 to 30 days post fertilization. In their natural environment, juveniles may encounter high temperatures that are above the optimal temperature for growth (27-30 degrees C). The relevance of the thermal sex reversal mechanism in a natural context remains unclear. The main objective of our study is to determine whether sexually undifferentiated juveniles spontaneously prefer higher, unfavorable temperatures and whether this choice skews the sex ratio toward males. Five full-sib progenies (from 100% XX crosses) were subjected to (1) a horizontal three-compartment thermal step gradient (thermal continuum 28 degrees C-32 degrees C-36.5 degrees C) during the thermosensitive period, (2) a control continuum (28 degrees C-28 degrees C-28 degrees C) and (3) a thermal control tank (36.5 degrees C). During the first days of the treatment, up to an average of 20% of the population preferred the masculinizing compartment of the thermal continuum (36.5 degrees C) compared to the control continuum. During the second part of the treatment, juveniles preferred the lower, nonmasculinizing 32 degrees C temperature. This short exposure to higher temperatures was sufficient to significantly skew the sex ratio toward males, compared to congeners raised at 28 degrees C (from 5.0 +/- 6.7% to 15.6 +/- 16.5% of males). The proportion of males was significantly different in the thermal continuum, thermal control tank and control continuum, and it was positively correlated among populations. Our study shows for the first time that Nile tilapia juveniles can choose a masculinizing temperature during a short period of time. This preference is sufficient to induce sex reversal to males within a population. For the first time, behavior is reported as a potential player in the sex determination mechanism of this species.	[Nivelle, Renaud; Gennotte, Vincent; Kalala, Emery Jules Kembolo; Melard, Charles; Rougeot, Carole] Univ Liege, Res & Educ Ctr Aquaculture CEFRA, Tihange, Belgium; [Nivelle, Renaud; Nguyen Bich Ngoc; Muller, Marc] Univ Liege, Interdisciplinary Res Inst Biomed Sci GIGA I3, Lab Organogenesis & Regenerat, Liege, Belgium	University of Liege; University of Liege	Nivelle, R (corresponding author), Univ Liege, Res & Educ Ctr Aquaculture CEFRA, Tihange, Belgium.; Nivelle, R (corresponding author), Univ Liege, Interdisciplinary Res Inst Biomed Sci GIGA I3, Lab Organogenesis & Regenerat, Liege, Belgium.	rnivelle@uliege.be	Bich-Ngoc, Nguyen/S-6443-2019	Bich-Ngoc, Nguyen/0000-0002-1299-9363; Nivelle, Renaud/0000-0002-2772-0660	FRIA-FNRS (Fond pour la Formation et la Recherche dans l'Industrie et dans l'Agriculture); ULiege-ARC progam (Actions de Recherches Concertees) [ARC 15/19-7]	FRIA-FNRS (Fond pour la Formation et la Recherche dans l'Industrie et dans l'Agriculture)(Fonds de la Recherche Scientifique - FNRS); ULiege-ARC progam (Actions de Recherches Concertees)	RN is a Ph.D. grant holder from FRIA-FNRS (Fond pour la Formation et la Recherche dans l'Industrie et dans l'Agriculture). MMis a "Maitre de Recherche" at the "Fonds National de Recherche Scientifique". This study was supported by ULiege-ARC progam (Actions de Recherches Concertees, ARC 15/19-7).	[Anonymous], 2012, INT J AQUAC, DOI [10.1002/dvdy.23924, DOI 10.1002/DVDY.23924]; Azaza MS, 2008, J THERM BIOL, V33, P98, DOI 10.1016/j.jtherbio.2007.05.007; Baras E, 2000, J FISH BIOL, V57, P210, DOI 10.1111/j.1095-8649.2000.tb00787.x; Baras E, 2002, J FISH BIOL, V61, P645, DOI 10.1111/j.1095-8649.2002.tb00902.x; Baroiller JF, 2009, COMP BIOCHEM PHYS A, V153, P30, DOI 10.1016/j.cbpa.2008.11.018; BAROILLER JF, 1995, J EXP ZOOL, V273, P216, DOI 10.1002/jez.1402730306; BEITINGER TL, 1979, AM ZOOL, V19, P319; Bezault E, 2007, AQUACULTURE S1, V272; Boltana S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1381; BRITZ PJ, 1987, AQUACULTURE, V63, P205, DOI 10.1016/0044-8486(87)90072-X; BRUTON MN, 1975, J FISH BIOL, V7, P423, DOI 10.1111/j.1095-8649.1975.tb04618.x; Capel B, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.60; Cerqueira M, 2016, J ANIM ECOL, V85, P1389, DOI 10.1111/1365-2656.12555; Cnaani A, 2008, SEX DEV, V2, P43, DOI 10.1159/000117718; CONOVER DO, 1984, AM NAT, V123, P297, DOI 10.1086/284205; CONOVER DO, 1981, SCIENCE, V213, P577, DOI 10.1126/science.213.4507.577; CRAWSHAW LI, 1977, J FISH RES BOARD CAN, V34, P730, DOI 10.1139/f77-113; D'Cotta H, 2001, MOL REPROD DEV, V59, P265, DOI 10.1002/mrd.1031; Denzer H.W., 1967, FAO FISHERIES REPORT, V44, P358; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Fry F.E.J., 1971, P1; GUERRERO RD, 1974, PROG FISH CULT, V36, P56, DOI 10.1577/1548-8659(1974)36[56:AASMFS]2.0.CO;2; Ivarez N, 2008, PLOS ONE, V3; JOBLING M, 1981, J FISH BIOL, V19, P439, DOI 10.1111/j.1095-8649.1981.tb05847.x; Kobayashi K., 2018, REPROD DEV STRATEGIE; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; LODI E, 1980, Bollettino di Zoologia, V47, P1; MAIR GC, 1991, THEOR APPL GENET, V82, P144, DOI 10.1007/BF00226205; MullerBelecke A, 1995, AQUACULTURE, V137, P57, DOI 10.1016/0044-8486(95)01114-5; Nakamura M, 1982, B SOC SCI FISH; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Perrin N, 2009, EVOLUTION, V63, P3043, DOI 10.1111/j.1558-5646.2009.00837.x; Piferrer F, 2013, DEV DYNAM, V242, P360, DOI 10.1002/dvdy.23924; Rakus K, 2017, CELL HOST MICROBE, V21, P244, DOI 10.1016/j.chom.2017.01.010; Rey S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2124; Rey S, 2017, DEV COMP IMMUNOL, V67, P287, DOI 10.1016/j.dci.2016.09.008; Rey S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2266; Rey S, 2015, ZEBRAFISH, V12, P243, DOI 10.1089/zeb.2014.1076; REYNOLDS WW, 1978, COMP BIOCHEM PHYS A, V59, P225, DOI 10.1016/0300-9629(78)90211-6; REYNOLDS WW, 1978, COMP BIOCHEM PHYS A, V60, P107, DOI 10.1016/0300-9629(78)90044-0; REYNOLDS WW, 1979, AM ZOOL, V19, P211; Rougeot C, 2008, AQUACULTURE, V276, P205, DOI 10.1016/j.aquaculture.2008.02.001; Santi S, 2017, J EXP ZOOL PART A, V327, P28, DOI 10.1002/jez.2066; Schartl M, 2004, CURR OPIN GENET DEV, V14, P634, DOI 10.1016/j.gde.2004.09.005; Shao CW, 2014, GENOME RES, V24, P604, DOI 10.1101/gr.162172.113; Tessema M, 2006, AQUACULTURE, V258, P270, DOI 10.1016/j.aquaculture.2006.04.041; Trewavas E., 1983, TILAPIINE FISHES GEN, DOI [DOI 10.5962/BHL.TITLE.123198, 10.1016/j.foodcont.2016.07.004]; Wessels S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3930-0; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson K, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P48, DOI 10.1017/CBO9780511542053.004	50	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212504	10.1371/journal.pone.0212504	http://dx.doi.org/10.1371/journal.pone.0212504			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763381	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900084
J	Tanimoto, K; Matsuzaki, H; Okamura, E; Ushiki, A; Fukamizu, A; Engel, JD				Tanimoto, Keiji; Matsuzaki, Hitomi; Okamura, Eiichi; Ushiki, Aki; Fukamizu, Akiyoshi; Engel, James Douglas			Transvection-like interchromosomal interaction is not observed at the transcriptional level when tested in the Rosa26 locus in mouse	PLOS ONE			English	Article							BETA-GLOBIN GENE; CONTROL REGION; CHROMATIN-STRUCTURE; HYPERSENSITIVE SITES; REGULATORY ELEMENTS; EXPRESSION; ACTIVATION; GENOME; GAMMA; LCR	Long-range associations between enhancers and their target gene promoters have been shown to play critical roles in executing genome function. Recent variations of chromosome capture technology have revealed a comprehensive view of intra- and interchromosomal contacts between specific genomic sites. The locus control region of the beta-globin genes (beta-LCR) is a super-enhancer that is capable of activating all of the beta-like globin genes within the locus in cis through physical interaction by forming DNA loops. CTCF helps to mediate loop formation between LCR-HS5 and 3'HS1 in the human beta-globin locus, in this way thought to contribute to the formation of a "chromatin hub". The beta-globin locus is also in close physical proximity to other erythrocyte-specific genes located long distances away on the same chromosome. In this case, erythrocyte-specific genes gather together at a shared "transcription factory" for co-transcription. Theoretically, enhancers could also activate target gene promoters at the identical loci, yet on different chromosomes in trans, a phenomenon originally described as transvection in Drosophilla. Although close physical proximity has been reported for the beta-LCR and the beta-like globin genes when integrated at the mouse homologous loci in trans, their structural and functional interactions were found to be rare, possibly because of a lack of suitable regulatory elements that might facilitate such trans interactions. Therefore, we re-evaluated presumptive transvection-like enhancer-promoter communication by introducing CTCF binding sites and erythrocyte-specific transcription units into both LCR-enhancer and beta-promoter alleles, each inserted into the mouse ROSA26 locus on separate chromosomes. Following cross-mating of mice to place the two mutant loci at the identical chromosomal position and into active chromation in trans, their transcriptional output was evaluated. The results demonstrate that there was no significant functional association between the LCR and the beta-globin gene in trans even in this idealized experimental context.	[Tanimoto, Keiji; Matsuzaki, Hitomi; Fukamizu, Akiyoshi] Univ Tsukuba, Fac Life & Environm Sci, Life Sci Ctr Survival Dynam, TARA, Tsukuba, Ibaraki, Japan; [Tanimoto, Keiji; Matsuzaki, Hitomi; Ushiki, Aki; Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Okamura, Eiichi] Tokushima Univ, Grad Sch Biomed Sci, Tokushima, Japan; [Engel, James Douglas] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Tsukuba; University of Tsukuba; Tokushima University; University of Michigan System; University of Michigan	Tanimoto, K (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Life Sci Ctr Survival Dynam, TARA, Tsukuba, Ibaraki, Japan.; Tanimoto, K (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	keiji@tara.tsukuba.ac.jp	Tanimoto, Keiji/B-2600-2014	Tanimoto, Keiji/0000-0003-1971-6546; Matsuzaki, Hitomi/0000-0002-8890-5933; Ushiki, Aki/0000-0002-0889-4577	JSPS (Japan Society for the Promotion of Science) [26292189]	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by research grants from JSPS (Japan Society for the Promotion of Science, https://www.jsps.go.jp/jgrantsinaid/) KAKENHI Grant Number 26292189 [Grant-in-Aid for Scientific Research (B) to K.T.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; Bungert J, 1999, MOL CELL BIOL, V19, P3062; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Du MJ, 2008, INT J BIOCHEM CELL B, V40, P1481, DOI 10.1016/j.biocel.2007.11.004; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Epner E, 1998, MOL CELL, V2, P447, DOI 10.1016/S1097-2765(00)80144-6; Fang XD, 2007, J MOL BIOL, V365, P31, DOI 10.1016/j.jmb.2006.09.072; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Kim YW, 2016, INT J BIOCHEM CELL B, V75, P45, DOI 10.1016/j.biocel.2016.03.013; Kim YW, 2011, NUCLEIC ACIDS RES, V39, P6944, DOI 10.1093/nar/gkr253; Leach KM, 2001, MOL CELL BIOL, V21, P2629, DOI 10.1128/MCB.21.8.2629-2640.2001; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Liu QH, 1997, P NATL ACAD SCI USA, V94, P169, DOI 10.1073/pnas.94.1.169; Long QM, 1998, GENOMICS, V54, P542, DOI 10.1006/geno.1998.5608; Matsuzaki H, 2015, DEVELOPMENT, V142, P3833, DOI 10.1242/dev.126003; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Noordermeer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000016; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Okamura E, 2013, MOL CELL BIOL, V33, P858, DOI 10.1128/MCB.01003-12; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Routledge SJE, 2002, J MOL BIOL, V323, P601, DOI 10.1016/S0022-2836(02)01011-2; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Tanimoto K, 2003, MOL CELL BIOL, V23, P8946, DOI 10.1128/MCB.23.24.8946-8952.2003; TARTOF KD, 1991, CELL, V65, P201, DOI 10.1016/0092-8674(91)90153-P; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	51	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0203099	10.1371/journal.pone.0203099	http://dx.doi.org/10.1371/journal.pone.0203099			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763343	gold, Green Published, Green Submitted			2022-12-26	WOS:000458763900001
J	Brezonik, PL; Finlay, JC; Griffin, CG; Arnold, WA; Boardman, EH; Germolus, N; Hozalski, RM; Olmanson, LG				Brezonik, Patrick L.; Finlay, Jacques C.; Griffin, Claire G.; Arnold, William A.; Boardman, Evelyn H.; Germolus, Noah; Hozalski, Raymond M.; Olmanson, Leif G.			Iron influence on dissolved color in lakes of the Upper Great Lakes States	PLOS ONE			English	Article							ORGANIC-MATTER; SURFACE WATERS; CARBON; CDOM; COMPLEXATION; ABSORPTION; ABSORBENCY; BINDING; TRENDS; DOC	Colored dissolved organic matter (CDOM), a major component of the dissolved organic carbon (DOC) pool in many lakes, is an important controlling factor in lake ecosystem functioning. Absorption coefficients at 440 nm (a(440), m(-1)), a common measure of CDOM, exhibited strong associations with dissolved iron (Fe-diss) and DOC in 280 lakes of the Upper Great Lakes States (UGLS: Minnesota, Wisconsin, and Michigan), as has been found in Scandinavia and elsewhere. Linear regressions between the three variables on UGLS lake data typically yielded R-2 values of 0.6-0.9, suggesting that some underlying common processes influence organic matter and Fe-diss. Statistical and experimental evidence, however, supports only a minor role for iron contributions to a(440) in UGLS lakes. Although both DOC and Fe-diss were significant variables in linear and log-log regressions on a(440), DOC was the stronger predictor; adding Fediss to the linear a(440)-DOC model improved the R-2 only from 0.90 to 0.93. Furthermore, experimental additions of Fe-III to colored lake waters had only small effects on a(440) (average increase of 0.242 m(-1) per 100 mu g/L of added Fe-III). For 136 visibly stained waters (with a(440) > 3.0 m(-1)), where allochthonous DOM predominates, DOM accounted for 92.3 +/- 5.0% of the measured a(440) values, and Fe-diss accounted for the remainder. In 75% of the lakes, Fediss accounted for < 10% of a(440), but contributions of 15-30% were observed for 7 river-influenced lakes. Contributions of Fediss in UGLS lakes to specific UV absorbance at 254 nm (SUVA(254)) generally were also low. Although Fe-diss accounted for 5-10% of measured SUVA(254) in a few samples, on average, 98.1% of the SUVA(254) signal was attributable to DOM and only 1.9% to Fe-diss. DOC predictions from measured a(440) were nearly identical to those from a(440) corrected to remove Fe-diss contributions. Overall, variations in Fe-diss in most UGLS lakes have very small effects on CDOM optical properties, such as a(440) and SUVA(254), and negligible effects on the accuracy of DOC estimated from a(440), data for which can be obtained at broad regional scales by remote sensing methods.	[Brezonik, Patrick L.; Arnold, William A.; Germolus, Noah; Hozalski, Raymond M.] Univ Minnesota, Dept Civil Environm & Geoengn, Minneapolis, MN 55455 USA; [Finlay, Jacques C.; Griffin, Claire G.; Boardman, Evelyn H.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Olmanson, Leif G.] Univ Minnesota, Dept Forest Resources, Remote Sensing Lab, St Paul, MN USA; [Boardman, Evelyn H.] Fitzgerald Environm Associates LLC, Colchester, VT USA; [Germolus, Noah] MIT, Parsons Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Massachusetts Institute of Technology (MIT)	Brezonik, PL (corresponding author), Univ Minnesota, Dept Civil Environm & Geoengn, Minneapolis, MN 55455 USA.	brezonik@umn.edu	; Finlay, Jacques/B-6081-2011	Hozalski, Raymond/0000-0002-7541-0165; Griffin, Claire/0000-0003-1944-6072; Arnold, William/0000-0003-0814-5469; Finlay, Jacques/0000-0002-7968-7030; Germolus, Noah/0000-0002-6919-4021	University of Minnesota Office of the Vice President for Research; University of Minnesota's Faculty Retirees Association; National Science Foundation [CBET 1510332]; Minnesota Environmental and Natural Resources Trust fund; Minnesota Sea Grant; University of Minnesota's U-Spatial Program; University of Minnesota's Agricultural Experiment Station; National Science Foundation; Univ. of Minnesota's Office of the VP for Research; Univ. of Minnesota's Office of the Retirees Association; Univ. of Minnesota's U-Spatial Program; Univ. of Minnesota's Sea Grant Program; Univ. of Minnesota's Agricultural Experiment Station	University of Minnesota Office of the Vice President for Research(University of Minnesota System); University of Minnesota's Faculty Retirees Association; National Science Foundation(National Science Foundation (NSF)); Minnesota Environmental and Natural Resources Trust fund; Minnesota Sea Grant; University of Minnesota's U-Spatial Program; University of Minnesota's Agricultural Experiment Station(University of Minnesota System); National Science Foundation(National Science Foundation (NSF)); Univ. of Minnesota's Office of the VP for Research; Univ. of Minnesota's Office of the Retirees Association; Univ. of Minnesota's U-Spatial Program; Univ. of Minnesota's Sea Grant Program; Univ. of Minnesota's Agricultural Experiment Station	PLB received a grant from the University of Minnesota Office of the Vice President for Research and the University of Minnesota's Faculty Retirees Association, no grant number provided (https://umra.umn.edu). RMH, PLB, and JCF received a grant from the National Science Foundation, CBET 1510332 (www.nsf.gov). JCF, PLB, LGO, and RMH received a grant from the Minnesota Environmental and Natural Resources Trust fund, as recommended by the Legislative Citizen Commission on Minnesota Resources, no grant number provided (https://www.lccmr.leg.mn/). JCF received a grant from the Minnesota Sea Grant, no grant number provided (www.seagrant.umn.edu). LGO also received salary support from the University of Minnesota's U-Spatial Program and Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge support from the National Science Foundation, the Minnesota Environmental and Natural Resources Trust fund, as recommended by the Legislative-Citizen Commission on Minnesota Resources, and Univ. of Minnesota's Office of the VP for Research and Retirees Association, U-Spatial Program, Sea Grant Program, and Agricultural Experiment Station. We thank numerous collaborators and student workers for assistance in sample collection and analysis. The senior author gratefully acknowledges mentoring early in his career by G.F. Lee, himself an iron researcher.	Aschan O, 1908, J PRAKTISCHE CHEMIE, V77, P172, DOI 10.1002/prac.19080770114; Brezonik PL, 2019, ECOL APPL, V29, DOI 10.1002/eap.1871; Brezonik PL, 2015, REMOTE SENS ENVIRON, V157, P199, DOI 10.1016/j.rse.2014.04.033; Brezonik PL, 2011, WATER CHEM; Dilling J, 2002, WATER RES, V36, P5037, DOI 10.1016/S0043-1354(02)00365-2; Ekstrom SM, 2016, J GEOPHYS RES-BIOGEO, V121, P479, DOI 10.1002/2015JG003141; Emmenegger L, 2001, LIMNOL OCEANOGR, V46, P49, DOI 10.4319/lo.2001.46.1.0049; Garcia-Mina JM, 2006, ORG GEOCHEM, V37, P1960, DOI 10.1016/j.orggeochem.2006.07.027; Garmo OA, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-1880-6; Griffin CG, 2018, WATER RES, V144, P719, DOI 10.1016/j.watres.2018.08.007; Haaland S, 2010, ENVIRON SCI TECHNOL, V44, P2975, DOI 10.1021/es903179j; Hutchinson G. E., 1957, TREATISE LIMNOLOGY; Jane SF, 2017, J GEOPHYS RES-BIOGEO, V122, P546, DOI 10.1002/2016JG003630; Kohler SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070598; Kritzberg ES, 2012, BIOGEOSCIENCES, V9, P1465, DOI 10.5194/bg-9-1465-2012; Kutser T, 2005, REMOTE SENS ENVIRON, V94, P535, DOI 10.1016/j.rse.2004.11.009; Lohammar G., 1938, WASSERCHEMIE HOHERE; Maloney KO, 2005, BIOGEOCHEMISTRY, V75, P393, DOI 10.1007/s10533-005-1675-3; MILES CJ, 1981, ENVIRON SCI TECHNOL, V15, P1089, DOI 10.1021/es00091a010; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Olmanson LG, 2016, REMOTE SENS ENVIRON, V185, P119, DOI 10.1016/j.rse.2016.01.007; Pace ML, 2002, LIMNOL OCEANOGR, V47, P333, DOI 10.4319/lo.2002.47.2.0333; Peacock M, 2015, ENVIRON SCI-PROC IMP, V17, P1290, DOI [10.1039/c5em00126a, 10.1039/C5EM00126A]; Poulin BA, 2014, ENVIRON SCI TECHNOL, V48, P10098, DOI 10.1021/es502670r; Rose AL, 2003, MAR CHEM, V84, P85, DOI 10.1016/S0304-4203(03)00113-0; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; SEDLACEK J, 1987, SCI TOTAL ENVIRON, V62, P275, DOI 10.1016/0048-9697(87)90510-9; SENESI N, 1977, GEOCHIM COSMOCHIM AC, V41, P969, DOI 10.1016/0016-7037(77)90156-9; Shapiro J., 1964, J AM WATER WORKS ASS, V56, P1062, DOI DOI 10.1002/J.1551-8833.1964.TB01303.X; Singley JE, 1966, J AWWA, V58, P455; THEIS TL, 1974, ENVIRON SCI TECHNOL, V8, P569, DOI 10.1021/es60091a008; Tranvik LJ, 2002, NATURE, V415, P861, DOI 10.1038/415861b; Voelker BM, 1996, ENVIRON SCI TECHNOL, V30, P1106, DOI 10.1021/es9502132; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Weyhenmeyer GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088104; Xiao YH, 2013, LIMNOL OCEANOGR, V58, P653, DOI 10.4319/lo.2013.58.2.0653; Xie HX, 2004, ENVIRON SCI TECHNOL, V38, P4113, DOI 10.1021/es035407t	37	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211979	10.1371/journal.pone.0211979	http://dx.doi.org/10.1371/journal.pone.0211979			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759145	gold, Green Published, Green Submitted			2022-12-26	WOS:000458761300065
J	Castells-Nobau, A; Eidhof, I; Fenckova, M; Brenman-Suttner, DB; Scheffer-de Gooyert, JM; Christine, S; Schellevis, RL; van der Laan, K; Quentin, C; van Ninhuijs, L; Hofmann, F; Ejsmont, R; Fisher, SE; Kramer, JM; Sigrist, SJ; Simon, AF; Schenck, A				Castells-Nobau, Anna; Eidhof, Ilse; Fenckova, Michaela; Brenman-Suttner, Dova B.; Scheffer-de Gooyert, Jolanda M.; Christine, Sheren; Schellevis, Rosa L.; van der Laan, Kiran; Quentin, Christine; van Ninhuijs, Lisa; Hofmann, Falko; Ejsmont, Radoslaw; Fisher, Simon E.; Kramer, Jamie M.; Sigrist, Stephan J.; Simon, Anne F.; Schenck, Annette			Conserved regulation of neurodevelopmental processes and behavior by FoxP in Drosophila	PLOS ONE			English	Article							FORKHEAD-DOMAIN; ULTRASONIC VOCALIZATION; REPETITION SUPPRESSION; TRANSCRIPTION FACTORS; GLUTAMATE-RECEPTOR; LANGUAGE DISORDER; MUSHROOM BODIES; HIGH-THROUGHPUT; SEVERE SPEECH; GENE	FOXP proteins form a subfamily of evolutionarily conserved transcription factors involved in the development and functioning of several tissues, including the central nervous system. In humans, mutations in FOXP1 and FOXP2 have been implicated in cognitive deficits including intellectual disability and speech disorders. Drosophila exhibits a single ortholog, called FoxP, but due to a lack of characterized mutants, our understanding of the gene remains poor. Here we show that the dimerization property required for mammalian FOXP function is conserved in Drosophila. In flies, FoxP is enriched in the adult brain, showing strong expression in similar to 1000 neurons of cholinergic, glutamatergic and GABAergic nature. We generate Drosophila loss-of-function mutants and UAS-FoxP transgenic lines for ectopic expression, and use them to characterize FoxP function in the nervous system. At the cellular level, we demonstrate that Drosophila FoxP is required in larvae for synaptic morphogenesis at axonal terminals of the neuromuscular junction and for dendrite development of dorsal multidendritic sensory neurons. In the developing brain, we find that FoxP plays important roles in alpha-lobe mushroom body formation. Finally, at a behavioral level, we show that Drosophila FoxP is important for locomotion, habituation learning and social space behavior of adult flies. Our work shows that Drosophila FoxP is important for regulating several neurodevelopmental processes and behaviors that are related to human disease or vertebrate disease model phenotypes. This suggests a high degree of functional conservation with vertebrate FOXP orthologues and established flies as a model system for understanding FOXP related pathologies.	[Castells-Nobau, Anna; Eidhof, Ilse; Fenckova, Michaela; Scheffer-de Gooyert, Jolanda M.; Christine, Sheren; Schellevis, Rosa L.; van der Laan, Kiran; van Ninhuijs, Lisa; Hofmann, Falko; Kramer, Jamie M.; Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, Nijmegen, Netherlands; [Brenman-Suttner, Dova B.; Simon, Anne F.] Western Univ, Dept Biol, Fac Sci, London, ON, Canada; [Quentin, Christine; Sigrist, Stephan J.] Free Univ Berlin, Inst Biol, Genet, Berlin, Germany; [Quentin, Christine; Sigrist, Stephan J.] Charite Univ Med Berlin, NeuroCure Cluster Excellence, Berlin, Germany; [Ejsmont, Radoslaw] Max Planck Inst Mol Cell Biol & Genet MPI CBG, Dresden, Germany; [Fisher, Simon E.] Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands; [Fisher, Simon E.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Ejsmont, Radoslaw] Brain & Spine Inst ICM, Brain Dev Team, Paris, France; [Kramer, Jamie M.] Western Univ, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	Radboud University Nijmegen; Western University (University of Western Ontario); Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Max Planck Society; Radboud University Nijmegen; UDICE-French Research Universities; Sorbonne Universite; Western University (University of Western Ontario)	Schenck, A (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, Nijmegen, Netherlands.	Annette.Schenck@radboudumc.nl	Schenck, Annette/E-4514-2012; Fenckova, Michaela/AGY-9276-2022; Castells-Nobau, Anna/AAL-1905-2021; Castells-Nobau, Anna/AAA-3846-2020; Fisher, Simon E./E-9130-2012; Fenckova, Michaela/H-8622-2017	Schenck, Annette/0000-0002-6918-3314; Fenckova, Michaela/0000-0002-5716-1652; Fisher, Simon E./0000-0002-3132-1996; Fenckova, Michaela/0000-0002-5716-1652; van der Laan, Kiran/0000-0002-0889-207X; Ejsmont, Radoslaw/0000-0001-7176-7848; Castells-Nobau, Anna/0000-0002-6024-8353; Eidhof, Ilse/0000-0002-1567-3078; Kramer, Jamie/0000-0002-0924-1279; Hofmann, Falko/0000-0002-5032-0411	TOP grant from the Netherlands Organization for Scientific Research [NWO-ZonMW912-12-109]; internal Radboudumc/Donders institute junior researcher fellowship	TOP grant from the Netherlands Organization for Scientific Research; internal Radboudumc/Donders institute junior researcher fellowship	This study was in part supported by a TOP grant from the Netherlands Organization for Scientific Research (NWO-ZonMW912-12-109, https://www.nwo.nl/) to A.S., and by an internal Radboudumc/Donders institute junior researcher fellowship to S.E.F and A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin SD, 2004, J NEUROSCI, V24, P6871, DOI 10.1523/JNEUROSCI.1538-04.2004; Atkinson EG, 2018, CELL, V174, P1424, DOI 10.1016/j.cell.2018.06.048; Bacon C, 2015, MOL PSYCHIATR, V20, P632, DOI 10.1038/mp.2014.116; Bly M, 2005, SCHIZOPHR RES, V78, P337, DOI 10.1016/j.schres.2005.04.011; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Brenman-Suttner DB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21731-0; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Castells-Nobau A, 2017, JOVE-J VIS EXP, DOI 10.3791/55395; Chabout J, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00197; Clovis YM, 2012, DEVELOPMENT, V139, P3332, DOI 10.1242/dev.078063; Copf T, 2015, EUR J NEUROSCI, V42, P2234, DOI 10.1111/ejn.13002; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; DasGupta S, 2014, SCIENCE, V344, P901, DOI 10.1126/science.1252114; Demontis D., 2017, BIORXIV, DOI [10.1101/145581, DOI 10.1038/s41588-019-0344-8]; Dinstein I, 2012, NEURON, V75, P981, DOI 10.1016/j.neuron.2012.07.026; EIDHOF I, 2017, JOVE J VIS EXP NOV, P42737, DOI DOI 10.3791/55892; Ejsmont RK, 2009, NAT METHODS, V6, P435, DOI [10.1038/NMETH.1334, 10.1038/nmeth.1334]; Santos ME, 2011, MOL BIOL EVOL, V28, P237, DOI 10.1093/molbev/msq182; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Engel JE, 1996, J NEUROSCI, V16, P3486; Ethridge LE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.48; Ewbank MP, 2015, CEREB CORTEX, V25, P3381, DOI 10.1093/cercor/bhu149; Fenckova M., 2019, BIORXIV, DOI [10.1101/285981, DOI 10.1101/285981]; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fernandez M, 2018, NEUROSCIENCE, V370, P148, DOI 10.1016/j.neuroscience.2017.07.013; Fernandez RW, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0369; French CA, 2012, MOL PSYCHIATR, V17, P1077, DOI 10.1038/mp.2011.105; French CA, 2007, GENESIS, V45, P440, DOI 10.1002/dvg.20305; French CA, 2019, MOL PSYCHIATR, V24, P447, DOI 10.1038/s41380-018-0199-x; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Gessaroli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074959; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gong XH, 2004, AM J MED GENET B, V127B, P113, DOI 10.1002/ajmg.b.20162; Groschner LN, 2018, CELL, V173, P894, DOI 10.1016/j.cell.2018.03.075; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hisaoka T, 2010, NEUROSCIENCE, V166, P551, DOI 10.1016/j.neuroscience.2009.12.055; Horn D, 2010, HUM MUTAT, V31, pE1851, DOI 10.1002/humu.21362; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kaestner KH, 2000, GENE DEV, V14, P142; Kaur K, 2015, BEHAV BRAIN RES, V284, P77, DOI 10.1016/j.bbr.2015.02.001; Kim CH, 2009, ADV EXP MED BIOL, V665, P17; Kiya T, 2008, INSECT MOL BIOL, V17, P53, DOI 10.1111/j.1365-2583.2008.00775.x; Kleinhans NM, 2009, AM J PSYCHIAT, V166, P467, DOI 10.1176/appi.ajp.2008.07101681; Knoth IS, 2018, J NEURODEV DISORD, V10, DOI 10.1186/s11689-018-9223-3; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Kramer JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000569; Kumar V, 2009, MOL BIOL CELL, V20, P2254, DOI 10.1091/mbc.E08-10-1072; Kurt S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033130; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lawton KJ, 2014, BEHAV BRAIN RES, V268, P213, DOI 10.1016/j.bbr.2014.04.009; Lee HH, 2004, DEV DYNAM, V229, P357, DOI 10.1002/dvdy.10443; Lee T, 1999, DEVELOPMENT, V126, P4065; Letteboer SJF, 2008, METHODS MOL BIOL, V484, P145, DOI 10.1007/978-1-59745-398-1_10; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohoff' FW, 2008, NEUROSCI LETT, V434, P41, DOI 10.1016/j.neulet.2008.01.024; Lohoff FW, 2006, NEUROPSYCHOPHARMACOL, V31, P2739, DOI 10.1038/sj.npp.1301196; McNeil AR, 2015, JOVE-J VIS EXP, DOI 10.3791/53242; Mendoza E, 2015, J COMP NEUROL, V523, P1318, DOI 10.1002/cne.23731; Mendoza E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100648; Menon KP, 2013, WIRES DEV BIOL, V2, P647, DOI 10.1002/wdev.108; Morgan A, 1993, GENEREVIEWS; Morikawa Y, 2009, NEUROSCIENCE, V162, P1150, DOI 10.1016/j.neuroscience.2009.05.022; Morikawa Y, 2009, DEV NEUROSCI-BASEL, V31, P511, DOI 10.1159/000243715; Mosca TJ, 2010, NAT NEUROSCI, V13, P935, DOI 10.1038/nn.2593; Myatt DR, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00004; Nahm M, 2010, J CELL BIOL, V191, P661, DOI 10.1083/jcb.201007086; Newbury DF, 2002, AM J HUM GENET, V70, P1318, DOI 10.1086/339931; Nguyen M, 2014, NEUROCHEM INT, V66, P15, DOI 10.1016/j.neuint.2014.01.002; Nijhof B, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004823; Nudel R, 2013, WIRES COGN SCI, V4, P547, DOI 10.1002/wcs.1247; Nykky J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086124; Pellicano E, 2013, NEUROPSYCHOLOGIA, V51, P1504, DOI 10.1016/j.neuropsychologia.2013.03.021; Penagarikano O, 2012, TRENDS MOL MED, V18, P156, DOI 10.1016/j.molmed.2012.01.003; Precious SV, 2016, EXP NEUROL, V282, P9, DOI 10.1016/j.expneurol.2016.05.002; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Qureshi R, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S14; Ramaswami M, 2014, NEURON, V82, P1216, DOI 10.1016/j.neuron.2014.04.035; Reuter MS, 2017, J MED GENET, V54, P64, DOI 10.1136/jmedgenet-2016-104094; Rhee DY, 2014, CELL REP, V8, P2031, DOI 10.1016/j.celrep.2014.08.038; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Sarov M, 2016, ELIFE, V5, DOI 10.7554/eLife.12068; Schatton A, 2018, J COMP NEUROL, V526, P1589, DOI 10.1002/cne.24430; Schatton A, 2017, EUR J NEUROSCI, V46, P2534, DOI 10.1111/ejn.13713; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmid S, 2015, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00097; Schon C, 2006, DEV GENES EVOL, V216, P641, DOI 10.1007/s00427-006-0073-8; Schulz RA, 1996, ONCOGENE, V12, P1827; Scorcioni R, 2008, NAT PROTOC, V3, P866, DOI 10.1038/nprot.2008.51; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Simon AF, 2012, GENES BRAIN BEHAV, V11, P243, DOI 10.1111/j.1601-183X.2011.00740.x; Sin C, 2015, J MOL NEUROSCI, V55, P437, DOI 10.1007/s12031-014-0359-7; Siper PM, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0172-6; Sollis E, 2017, HUM MUTAT, V38, P1542, DOI 10.1002/humu.23303; Sollis E, 2016, HUM MOL GENET, V25, P546, DOI 10.1093/hmg/ddv495; Stessman HAF, 2017, NAT GENET, V49, P515, DOI 10.1038/ng.3792; Swartz JR, 2013, J AM ACAD CHILD PSY, V52, P84, DOI 10.1016/j.jaac.2012.10.012; Takahashi H, 2009, ADV EXP MED BIOL, V665, P117; Takahashi K, 2008, J NEUROSCI RES, V86, P3106, DOI 10.1002/jnr.21770; Tam WY, 2011, NEUROSCIENCE, V172, P562, DOI 10.1016/j.neuroscience.2010.10.023; Tanabe Y, 2012, J NEUROCHEM, V122, P72, DOI 10.1111/j.1471-4159.2011.07524.x; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; Teodoro RO, 2013, EMBO J, V32, P2039, DOI 10.1038/emboj.2013.147; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Teramitsu I, 2006, J NEUROSCI, V26, P7390, DOI 10.1523/JNEUROSCI.1662-06.2006; Teufel A, 2003, BBA-GENE STRUCT EXPR, V1627, P147, DOI 10.1016/S0167-4781(03)00074-5; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Tsui D, 2013, J NEUROSCI, V33, P244, DOI 10.1523/JNEUROSCI.1665-12.2013; Turk-Browne NB, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.016.2008; van Bon BWM, 2013, HUM MOL GENET, V22, P3138, DOI 10.1093/hmg/ddt170; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wang CH, 2017, ELIFE, V6, DOI 10.7554/eLife.26886; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Wise A, 2015, J NEUROGENET, V29, P135, DOI 10.3109/01677063.2015.1064916; Xie TT, 2018, CELL REP, V23, P652, DOI 10.1016/j.celrep.2018.03.068; Yaniv SP, 2016, WIRES DEV BIOL, V5, P618, DOI 10.1002/wdev.241	128	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211652	10.1371/journal.pone.0211652	http://dx.doi.org/10.1371/journal.pone.0211652			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL0PE	30753188	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600017
J	Miguel, CPV; Mejias, A; Leber, A; Sanchez, PJ				Miguel, Claudia P. Vicetti; Mejias, Asuncion; Leber, Amy; Sanchez, Pablo J.			A decade of antimicrobial resistance in Staphylococcus aureus: A single center experience	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; METHICILLIN-RESISTANT; TRIMETHOPRIM-SULFAMETHOXAZOLE; PRACTICE GUIDELINES; DISEASES SOCIETY; SKIN; CLINDAMYCIN; CHILDREN; EPIDEMIOLOGY; SURVEILLANCE	Background The emergence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) resulted in the recommended use of clindamycin and trimethoprim-sulfamethoxazole (TMP-SMX) for suspected S. aureus infections. The objective of this study was to determine the resistance to methicillin, clindamycin, and TMP-SMX in S. aureus isolates during a 10-year period. Methods Retrospective review of the antimicrobial susceptibilities of all S. aureus isolates in the outpatient and inpatient settings at Nationwide Children's Hospital from 1/1/2005 to 12/31/2014. Duplicate isolates from the same site and year and those obtained for MRSA surveillance or from patients with cystic fibrosis were excluded. Results Of the 57,788 S. aureus isolates from 2005-2014, 40,795 (71%) were included. In the outpatient setting, methicillin resistance decreased from 54% to 44% (p<0.001) while among inpatient isolates, no significant change was observed. From 2009-2014, resistance to clindamycin among outpatient isolates increased from 16% to 17% (p = 0.002) but no significant trend was observed among inpatient isolates (18% to 22%). Similarly, TMP-SMX resistance increased in outpatient S. aureus isolates from 2005-2014 (0.9% to 4%, p<0.001) but not among inpatient isolates. Among both inpatient and outpatient isolates, methicillin-susceptible S. aureus (MSSA) exhibited higher resistance to both clindamycin and TMP-SMX than MRSA. In addition, resistance to methicillin, clindamycin and TMP-SMX varied widely according to the site of specimen collection. Conclusion In a decade where >40,000 S. aureus isolates were identified at a large pediatric hospital, substantial changes in methicillin, clindamycin, and TMP-SMX resistance occurred. These findings highlight the importance of ongoing surveillance of the local antimicrobial resistance in S. aureus in order to guide empiric antimicrobial therapy.	[Miguel, Claudia P. Vicetti; Mejias, Asuncion] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Dept Pediat,Div Pediat Infect Dis, Columbus, OH 43210 USA; [Mejias, Asuncion] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Ctr Vaccines & Immun,Res Inst, Columbus, OH 43210 USA; [Leber, Amy] Nationwide Childrens Hosp, Dept Lab Med, Columbus, OH USA; [Sanchez, Pablo J.] Ohio State Univ, Coll Med, Nationwide Childrens Hosp,Res Inst, Dept Pediat,Div Neonatol,Ctr Perinatal Res, Columbus, OH 43210 USA; [Miguel, Claudia P. Vicetti] UnityPoint Hlth, Cedar Falls, IA 50613 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Miguel, CPV (corresponding author), Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Dept Pediat,Div Pediat Infect Dis, Columbus, OH 43210 USA.; Miguel, CPV (corresponding author), UnityPoint Hlth, Cedar Falls, IA 50613 USA.	claudia.vicettimiguel@unitypoint.org	Mejias, Asuncion/AAC-5998-2019	Mejias, Asuncion/0000-0002-5983-8006				Acree ME, 2017, INFECT CONT HOSP EP, V38, P1226, DOI 10.1017/ice.2017.177; Buckingham SC, 2004, PEDIATR INFECT DIS J, V23, P619, DOI 10.1097/01.inf.0000131981.67342.c4; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; David MZ, 2014, CLIN INFECT DIS, V59, P798, DOI 10.1093/cid/ciu410; Fergie JE, 2001, PEDIATR INFECT DIS J, V20, P860, DOI 10.1097/00006454-200109000-00007; Gandra S, 2014, CLIN INFECT DIS, V58, P306, DOI 10.1093/cid/cit682; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Herigon JC, 2010, PEDIATRICS, V125, pE1294, DOI 10.1542/peds.2009-2867; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Kaplan SL, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0101; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kaplan SL, 2005, PEDIATR INFECT DIS J, V24, P457, DOI 10.1097/01.inf.0000164162.00163.9d; Karamatsu ML, 2012, PEDIATR EMERG CARE, V28, P131, DOI 10.1097/PEC.0b013e318243fa36; Khamash DF, 2019, J PEDIAT INF DIS SOC, V8, P351, DOI 10.1093/jpids/piy062; Landrum ML, 2012, JAMA-J AM MED ASSOC, V308, P50, DOI 10.1001/jama.2012.7139; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Marcinak JF, 2003, CURR OPIN INFECT DIS, V16, P265, DOI 10.1097/00001432-200306000-00014; Martinez-Aguilar G, 2003, PEDIATR INFECT DIS J, V22, P593, DOI 10.1097/00006454-200307000-00006; Messina AF, 2011, PEDIATR INFECT DIS J, V30, P1019, DOI 10.1097/INF.0b013e31822db658; Miller LG, 2015, NEW ENGL J MED, V372, P1093, DOI 10.1056/NEJMoa1403789; Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693; Ray GT, 2013, DIAGN MICR INFEC DIS, V76, P24, DOI 10.1016/j.diagmicrobio.2013.02.020; Sader HS, 2012, CLIN INFECT DIS, V55, pS181, DOI 10.1093/cid/cis560; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Sutter DE, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3099; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Walter J, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2271-6	28	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212029	10.1371/journal.pone.0212029	http://dx.doi.org/10.1371/journal.pone.0212029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753206	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600038
J	Miguez-Soto, B; Fernandez-Cruz, J; Fernandez-Lopez, J				Miguez-Soto, B.; Fernandez-Cruz, J.; Fernandez-Lopez, J.			Mediterranean and Northern Iberian gene pools of wild Castanea sativa Mill. are two differentiated ecotypes originated under natural divergent selection	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; EUROPEAN POPULATIONS; F-STATISTICS; CHESTNUT; DIVERSITY; TEMPERATURE; ADAPTATION; TRAITS; TREES; DOMESTICATION	Nine wild Iberian provenances of Castanea sativa Mill. grouped in two gene pools, North Iberian Peninsula and Mediterranean, were evaluated for several adaptive traits in two provenance-progeny trials with the aim of evaluating the role of natural selection in shaping adaptive variation and increasing our understanding of the genetic structure of this species, as well as reporting complete information on the genetic variation among and within the studied populations. An annual growth rhythm experiment was evaluated during the first 3 years after establishment for phenology, growth, stem form and survival, and a periodic drought-stress experiment was evaluated for dry weight, growth, survival and other related drought traits in both well-watered and drought-stress treatments. The high genetic variability reported in both trials is largely due to the genetic variation among populations. The significant differences reported between quantitative genetic and neutral marker differentiation indicated the local adaptation of these populations through directional selection, mainly for phenology, growth and biomass allocation. A clinal variation among populations was determined through correlations of phenology with latitude and xerothermic index of the provenances, showing that central and southern Mediterranean populations had earlier phenology than northern populations and that drought played a relevant role in this differentiation. The significant correlation between phenological traits and the ancestry values in the Mediterranean gene pool supported the different pattern of behavior between both gene pools and also indicated the existence of two ecotypes: xeric and mesophytic ecotypes, corresponding to Mediterranean and North Iberian gene pools, respectively. The results obtained in the drought-stress experiment confirmed that, in general terms, xeric populations showed a greater adaptability to drought, with more developed root systems and higher survival than northern populations. Moreover, the genetic variability observed within populations indicated the potential response capacity of Iberian C. sativa populations to undergo fast adaptive evolution.	[Miguez-Soto, B.; Fernandez-Cruz, J.; Fernandez-Lopez, J.] Forestry Res Ctr Lourizan, Dept Forest Breeding, Pontevedra, Spain		Fernandez-Lopez, J (corresponding author), Forestry Res Ctr Lourizan, Dept Forest Breeding, Pontevedra, Spain.	josefa.fernandez.lopez@xunta.ga	Míguez-Soto, Beatriz/R-4055-2018; Fernandez Cruz, Javier/R-4951-2018	Míguez-Soto, Beatriz/0000-0003-2947-7876; Fernandez Cruz, Javier/0000-0002-7001-995X	INTERREG IIIB Espacio Atlantico [092CastaneaREG]; INDITEX	INTERREG IIIB Espacio Atlantico; INDITEX	'092CastaneaREG (2004-2006)' funded by 'INTERREG IIIB Espacio Atlantico": financed the experimental work. Chestnut Breeding Program of Galicia 2016 funded by INDITEX financed the analyses and the manuscript elaboration.	Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Martin MA, 2012, TREE GENET GENOMES, V8, P127, DOI 10.1007/s11295-011-0427-x; [Anonymous], 2013, PROC GUID STAT PROC; Lopez-Saez JA, 2017, VEG HIST ARCHAEOBOT, V26, P167, DOI 10.1007/s00334-016-0575-x; Augspurger CK, 2013, ECOLOGY, V94, P41, DOI 10.1890/12-0200.1; Baliuckas V, 1999, SILVAE GENET, V48, P17; Brunner I, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00547; Bussotti F, 2015, ENVIRON EXP BOT, V111, P91, DOI 10.1016/j.envexpbot.2014.11.006; Conedera M, 2004, VEG HIST ARCHAEOBOT, V13, P161, DOI 10.1007/s00334-004-0038-7; Conedera M, 2009, ACTA HORTIC, V866, P297; De Kort H, 2013, EVOL ECOL, V27, P1081, DOI 10.1007/s10682-012-9624-9; Delpierre N, 2016, ANN FOREST SCI, V73, P5, DOI 10.1007/s13595-015-0477-6; Diaz R, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009059; Ducousso A, 1996, ANN SCI FOREST, V53, P775, DOI 10.1051/forest:19960253; ELKASSABY YA, 1992, FOREST CHRON, V68, P687, DOI 10.5558/tfc68687-6; Endler J.A., 1977, Monographs in Population Biology, pi; Eriksson G, 2003, SCAND J FOREST RES, V18, P320, DOI 10.1080/02827580310015422; ERIKSSON G, 1993, FOREST ECOL MANAG, V62, P15, DOI 10.1016/0378-1127(93)90039-P; EXCOFFIER L, 1992, GENETICS, V131, P479; Fahrmeir L, 1994, MULTIVARIATE STAT MO, P548; Falconer D. S., 1989, Introduction to quantitative genetics.; Fernandez-Cruz J, 2016, CONSERV GENET, V17, P949, DOI 10.1007/s10592-016-0835-4; Fernandez-Cruz J, 2012, CONSERV GENET, V13, P1589, DOI 10.1007/s10592-012-0408-0; Fernandez-Lopez J, 2005, ACTA HORTIC, P181, DOI 10.17660/ActaHortic.2005.693.21; Fernandez-Lopez J., 2005, Investigacion Agraria, Sistemas y Recursos Forestales, V14, P13; Fernandez-Lopez J, 2010, FOREST SYST, V19, P156, DOI 10.5424/fs/2010192-01311; Fernandez-Lopez J., 2003, EUFORGEN TECHNICAL G; Fisher RA, 1930, GENETICAL THEORY NAT; Fussi B, 2012, REPORT REV AVAILABLE; Gilbert KJ, 2015, EVOLUTION, V69, P2154, DOI 10.1111/evo.12713; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; HOULE D, 1992, GENETICS, V130, P195; Jensen JS, 2010, SCAND J FOREST RES, V25, P400, DOI 10.1080/02827581.2010.512873; Kirby KJ, 2015, EUROPE'S CHANGING WOODS AND FORESTS FROM WILDWOOD TO MANAGED LANDSCAPES, P3, DOI 10.1079/9781780643373.0003; Koner C, 2010, PLANT SCI, V327, P1461; Konig A. O., 2005, CONSERVATION MANAGEM, P238; Krebs P, 2004, VEG HIST ARCHAEOBOT, V13, P145, DOI 10.1007/s00334-004-0041-z; Kremer A, 2014, FUNCT ECOL, V28, P22, DOI 10.1111/1365-2435.12169; LANDE R, 1992, EVOLUTION, V46, P381, DOI 10.1111/j.1558-5646.1992.tb02046.x; Lauteri M, 1997, FUNCT ECOL, V11, P675, DOI 10.1046/j.1365-2435.1997.00140.x; Lauteri M, 1999, ACTA HORTIC, P345, DOI 10.17660/ActaHortic.1999.494.53; Lauteri M, 2004, J EVOLUTION BIOL, V17, P1286, DOI 10.1111/j.1420-9101.2004.00765.x; Lauteri M, 1997, SISEF P, V1, P303; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Leinonen T, 2013, NAT REV GENET, V14, P179, DOI 10.1038/nrg3395; Luquez V, 2008, TREE GENET GENOMES, V4, P279, DOI 10.1007/s11295-007-0108-y; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Lynch M., 1998, GENETICS ANAL QUANTI; Martin MA, 2010, TREE GENET GENOMES, V6, P735, DOI 10.1007/s11295-010-0287-9; Mattioni C, 2008, TREE GENET GENOMES, V4, P563, DOI 10.1007/s11295-008-0132-6; Mattioni C, 2013, AM J BOT, V100, P951, DOI 10.3732/ajb.1200194; Matyas C, 1996, EUPHYTICA, V92, P45, DOI 10.1007/BF00022827; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Michalakis Y, 1996, GENETICS, V142, P1061; Miguez-Soto B, 2015, NEW FOREST, V46, P23, DOI 10.1007/s11056-014-9445-5; Miguez-Soto B, 2012, TREE GENET GENOMES, V8, P409, DOI 10.1007/s11295-011-0451-x; Morgenstern EK, 1996, GEOGRAPHIC VARIATION; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Myking T., 2000, Baltic Forestry, V6, P56; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pliura A, 2002, SILVAE GENET, V51, P152; Pliura A., 1998, NOBLE HARDWOODS NETW, P8; Pritchard JK, 2000, GENETICS, V155, P945; PROUT T, 1993, GENETICS, V134, P369; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Sobrino CM, 2004, VEG HIST ARCHAEOBOT, V13, P1, DOI 10.1007/s00334-003-0028-1; SOLIGNAT G, 1975, BIOL FLORALE CHATAIG; SPITZE K, 1993, GENETICS, V135, P367; Stephan W, 2016, MOL ECOL, V25, P79, DOI 10.1111/mec.13288; Vihera-Aarnio A, 2005, TREE PHYSIOL, V25, P101, DOI 10.1093/treephys/25.1.101; VILLANI F, 1992, GENOME, V35, P251, DOI 10.1139/g92-038; Villani F, 1999, J EVOLUTION BIOL, V12, P233, DOI 10.1046/j.1420-9101.1999.00033.x; vonWuehlisch G, 1995, SILVAE GENET, V44, P343; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2009, GENETICS, V183, P1055, DOI 10.1534/genetics.108.099812; WRIGHT S, 1951, ANN EUGENIC, V15, P323	79	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211315	10.1371/journal.pone.0211315	http://dx.doi.org/10.1371/journal.pone.0211315			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753199	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600010
J	Hebert-Magee, S; Yu, H; Behring, M; Jadhav, T; Shanmugam, C; Frost, A; Eltoum, IE; Varambally, S; Manne, U				Hebert-Magee, Shantel; Yu, Han; Behring, Michael; Jadhav, Trafina; Shanmugam, Chandrakumar; Frost, Andra; Eltoum, Isam-Eldin; Varambally, Sooryanarayana; Manne, Upender			The combined survival effect of codon 72 polymorphisms and p53 somatic mutations in breast cancer depends on race and molecular subtype	PLOS ONE			English	Article							POPULATION; GENOTYPES; VARIANTS; WOMEN; GENE; AGE	Background The codon 72 polymorphism in the p53 gene relates to the risk of breast cancer (BC), but this relationship in racially diverse populations is not known. The present study examined the prognostic value of this polymorphism for African American (AA) and Caucasian (CA) BC patients separately and considered the confounding variables of molecular subtypes and somatic mutations in p53. Methods Tissue sections of BCs from 116 AAs and 160 CAs were evaluated for p53 mutations and genotyped for the codon 72 polymorphism. The relationships of phenotypes to clinicopathologic features were determined by gamma 2 analyses; patient survival was estimated by Kaplan-Meier univariate and Cox regression multivariate models in a retrospective cohort study design. Results The proportion of single nucleotide polymorphism (SNP) 72 alleles differed for races. Many cancers of AAs were Pro/Pro, but most for CAs were Arg/Arg. A higher frequency of missense p53 mutations was evident for AAs. There was an interaction between the SNP allele and p53 mutations for AA women only. The proportion of women with both the Pro/Pro allele and a p53 somatic mutation was higher for AA than CA women. The interaction between missense p53 mutations and Pro/Pro had a negative effect on survival, particularly for AAs with luminal cancers. Conclusions For BCs, the survival effect of SNP72 combined with a p53 missense mutation is dependent on race and molecular subtype. Although such a mutation is a marker of poor prognosis, it is relevant to identify the variant Pro/Pro in the case of AAs, especially those with luminal sub-types of BC.	[Hebert-Magee, Shantel; Yu, Han; Behring, Michael; Jadhav, Trafina; Shanmugam, Chandrakumar; Frost, Andra; Eltoum, Isam-Eldin; Varambally, Sooryanarayana; Manne, Upender] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Hebert-Magee, Shantel] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA; [Shanmugam, Chandrakumar] RVM Inst Med Sci & Res Ctr, Dept Pathol, Siddipet, Telangana, India	University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Central Florida	Manne, U (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	upendermanne@uabmc.edu		behring, michael/0000-0002-5162-322X; Manne, Upender/0000-0002-1545-3032	NIH [U54 CA118948, P20 CA192973]; Charles Barkley Foundation; NATIONAL CANCER INSTITUTE [U54CA118948, P20CA192973, P30CA013148] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles Barkley Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by grants from the NIH (U54 CA118948 and P20 CA192973); institutional funds awarded to Dr. Manne; and a Charles Barkley Foundation grant awarded to Dr. Hebert-Magee. There are no conflict of interest disclosures from any authors.	1000 Genomes Project Consortium, 2010, Nature, V467, P1061, DOI 10.1038/nature09534; ALEXANDROVA EM, 2017, CELL DEATH DIS, V8; Bonafe M, 2003, CLIN CANCER RES, V9, P4860; Borresen-Dale AL, 2003, HUM MUTAT, V21, P292, DOI 10.1002/humu.10174; BUCHMAN VL, 1988, GENE, V70, P245, DOI 10.1016/0378-1119(88)90196-5; Bundred NJ, 2001, CANCER TREAT REV, V27, P137, DOI 10.1053/ctrv.2000.0207; CARBONE D, 1991, ONCOGENE, V6, P1691; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Dai XF, 2015, AM J CANCER RES, V5, P2929; Danforth DN, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3429; Deshpande AD, 2009, J SURG RES, V153, P105, DOI 10.1016/j.jss.2008.05.020; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Fodermayr M, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.1130; Fredricks DN, 1999, BIOTECHNIQUES, V26, P198, DOI 10.2144/99262bm04; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; Graf J, 2001, LEUKEMIA LYMPHOMA, V41, P655, DOI 10.3109/10428190109060356; Keenan T, 2015, J CLIN ONCOL, V33, P3621, DOI 10.1200/JCO.2015.62.2126; Langerod A, 2002, CANCER EPIDEM BIOMAR, V11, P1684; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Markossian TW, 2012, WOMEN HEALTH, V52, P317, DOI 10.1080/03630242.2012.674091; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; Monzavi-Karbassi B, 2016, ONCOL LETT, V12, P1337, DOI 10.3892/ol.2016.4804; Pietsch EC, 2006, ONCOGENE, V25, P1602, DOI 10.1038/sj.onc.1209367; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Putcha BDK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129216; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Tryka KA, 2014, NUCLEIC ACIDS RES, V42, pD975, DOI 10.1093/nar/gkt1211; Vos M, 2003, CANCER GENET CYTOGEN, V140, P23, DOI 10.1016/S0165-4608(02)00638-6; Wang Fahui, 2010, Int J Public Pol, V5, P237; Wilkins K, 2011, HUM MOL GENET, V20, P4831, DOI 10.1093/hmg/ddr422; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681	32	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211734	10.1371/journal.pone.0211734	http://dx.doi.org/10.1371/journal.pone.0211734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730944	Green Submitted, gold, Green Published			2022-12-26	WOS:000458026000054
J	Jain, S; Poromarto, S; Osorno, JM; McClean, PE; Nelson, BD				Jain, Shalu; Poromarto, Susilo; Osorno, Juan M.; McClean, Phillip E.; Nelson, Berlin D.			Genome wide association study discovers genomic regions involved in resistance to soybean cyst nematode (Heterodera glycines) in common bean	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PHASEOLUS-VULGARIS; COPY-NUMBER; DISEASE RESISTANCE; CORE COLLECTION; GENES; REPRODUCTION; DIVERSITY; SEQUENCE; FAMILY	Common bean (Phaseolus vulgaris L.) is an important high protein crop grown worldwide. North Dakota and Minnesota are the largest producers of common beans in the USA, but crop production is threatened by soybean cyst nematode (SCN; Heterodera glycines Ichinohe) because most current cultivars are susceptible. Greenhouse screening data using SCN HG type 0 from 317 plant introductions (PI's) from the USDA core collection was used to conduct a genome wide association study (GWAS). These lines were divided into two subpopulations based on principal component analysis (Middle American vs. Andean). Phenotypic results based on the female index showed that accessions could be classified as highly resistant (21% and 27%), moderately resistant (51% and 48%), moderately susceptible (27% and 22%) and highly susceptible (1% and 3%) for Middle American and Andean gene pools, respectively. Mixed models with two principal components (PCs) and kinship matrix for Middle American genotypes and Andean genotypes were used in the GWAS analysis using 3,985 and 4,811 single nucleotide polymorphic (SNP) markers, respectively which were evenly distributed across all 11 chromosomes. Significant peaks on Pv07, and Pv11 in Middle American and on Pv07, Pv08, Pv09 and Pv11 in Andean group were found to be associated with SCN resistance. Homologs of soybean rhg1, a locus which confers resistance to SCN in soybean, were identified on chromosomes Pv01 and Pv08 in the Middle American and Andean gene pools, respectively. These genomic regions may be the key to develop SCN-resistant common bean cultivars.	[Jain, Shalu; Nelson, Berlin D.] North Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA; [Poromarto, Susilo] Sebelas Maret Univ, Dept Agrotechnol, Surakarta, Jawa Tengah, Indonesia; [Osorno, Juan M.; McClean, Phillip E.] North Dakota State Univ, Dept Plant Sci, Fargo, ND USA	North Dakota State University Fargo; Sebelas Maret University; North Dakota State University Fargo	Jain, S (corresponding author), North Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA.	shalu.jain@ndsu.edu	Osorno, Juan M/C-6971-2009		Specialty Crop Block Grant [NDSU FAR0023187]; Northarvest Bean Growers Association [NDSU FAR0018281]	Specialty Crop Block Grant; Northarvest Bean Growers Association	This work was supported by Specialty Crop Block Grant, NDSU FAR0023187 (https://www.nd.gov/ndda/administrative-services-division/specialty-crop-block-grant-program) to BDN, SJ, JMO and the Northarvest Bean Growers Association, NDSU FAR0018281 (http://www.northarvestbean.org/) to BDN, SJ, JMO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NW, 2005, TRENDS CELL BIOL, V15, P626, DOI 10.1016/j.tcb.2005.09.001; Bao Y, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.11.0039; Bayless AM, 2016, P NATL ACAD SCI USA, V113, pE7375, DOI 10.1073/pnas.1610150113; Bekal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145601; Bradley CA, 2004, PLANT DIS, V88, P1287, DOI 10.1094/PDIS.2004.88.11.1287A; Chen ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169954; Chowdhury I, 2017, PHYTOPATHOL, V107; Cook DE, 2014, PLANT PHYSIOL, V165, P630, DOI 10.1104/pp.114.235952; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Derrien T, 2007, BIOINFORMATICS, V23, P498, DOI 10.1093/bioinformatics/btl618; El Kasmi F, 2013, MOL BIOL CELL, V24, P1593, DOI 10.1091/mbc.E13-02-0074; Gepts P, 2019, EVALUATION REPRESENT, DOI [10.25338/B8KP45, DOI 10.25338/B8KP45]; Ghosh Jayanta K., 2006, INTRO BAYESIAN ANAL; Guo B, 2005, THEOR APPL GENET, V111, P965, DOI 10.1007/s00122-005-0031-2; Han YP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1800-1; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; Jain S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159338; Lakhssassi N, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep45226; Lee TG, 2015, MOL ECOL, V24, P1774, DOI 10.1111/mec.13138; Li YH, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.04.0020; Liu SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14822; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; Lu YL, 2010, P NATL ACAD SCI USA, V107, P19585, DOI 10.1073/pnas.1006105107; Ma YS, 2006, J INTEGR PLANT BIOL, V48, P722, DOI 10.1111/j.1744-7909.2006.00256.x; Mamidi S, 2013, HEREDITY, V110, P267, DOI 10.1038/hdy.2012.82; Mamidi S, 2011, FUNCT PLANT BIOL, V38, P953, DOI 10.1071/FP11124; McClean PE, 2012, GENET RESOUR CROP EV, V59, P499, DOI 10.1007/s10722-011-9699-0; McClean PE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-184; Meziadi C, 2016, PLANT SCI, V242, P351, DOI 10.1016/j.plantsci.2015.09.006; Miklas PN, 2006, EUPHYTICA, V147, P105, DOI 10.1007/s10681-006-4600-5; Mitchell DC, 2009, J AM DIET ASSOC, V109, P909, DOI 10.1016/j.jada.2009.02.029; Mudryj AN, 2014, APPL PHYSIOL NUTR ME, V39, P1197, DOI 10.1139/apnm-2013-0557; Niblack T.L., 2008, PLANT HLTH PROG, V9, P29, DOI [10.1094/PHP-2008-0118-01-RS, DOI 10.1094/PHP-2008-0118-01-RS]; Niblack TL, 2005, PLANT DIS, V89, P1020, DOI 10.1094/PD-89-1020; Osorno JM, 2018, ACHIEVING SUSTAINABL, V1; Poromarto SH, 2012, PHYTOPATHOLOGY, V102, P93; Poromarto SH, 2010, PLANT DIS, V94, P1299, DOI 10.1094/PDIS-05-10-0326; Poromarto SH, 2009, PLANT DIS, V93, P507, DOI 10.1094/PDIS-93-5-0507; SCHMITT DP, 1992, CROP SCI, V32, P275, DOI 10.2135/cropsci1992.0011183X003200010056x; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Smith JR, 2003, J NEMATOL, V35, P23; Soltani A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00767; Soltani A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01183; Tylka GL, 2017, PLANT HLTH PROG, V18, P167, DOI [10.1094/PHP-05-17-0031-BR, 10.1094/php-05-17-0031-br]; Vuong TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1811-y; Vuong TD, 2010, THEOR APPL GENET, V121, P1253, DOI 10.1007/s00122-010-1385-7; Wen L, 2017, THESIS; Wrather A., 2010, PLANT HLTH PROG, V11, DOI [10.1094/PHP-2010-0102-01-RS, DOI 10.1094/PHP-2010-0102-01-RS]; Wu XL, 2009, THEOR APPL GENET, V118, P1093, DOI 10.1007/s00122-009-0965-x; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	53	10	10	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0212140	10.1371/journal.pone.0212140	http://dx.doi.org/10.1371/journal.pone.0212140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730982	gold, Green Submitted, Green Published			2022-12-26	WOS:000458026000099
J	Newman, D; Levine, E; Kishore, SP				Newman, Daniel; Levine, Erica; Kishore, Sandeep P.			Prevalence of multiple chronic conditions in New York State, 2011-2016	PLOS ONE			English	Article							DISABILITY	Introduction To design effective policy and interventions, public health officials must have an accurate and granular picture of the state of multiple chronic conditions (MCC) in their region. The objective of this research is to describe the prevalence and distribution of MCC in New York State. Methods We performed a secondary data analysis of the Behavioral Risk Factor Surveillance System (BRFSS) from 2011 through 2016 for New York adults (n = 76,186). We analyzed the self-reported prevalence of individuals having 0, 1, 2, or >= 3 chronic conditions by sex, race/ethnicity, age, health insurance type, annual household income, and whether respondents lived in New York City. We also examined the most common condition dyads and triads. Finally, we assessed the prevalence of MCC (2 or more chronic conditions) by county across New York State, and neighborhood within New York City. Results During 2011-2016, 25.2% of adults in New York State had zero chronic conditions, 24.1% had 1 condition, 18.4% had 2 conditions, and 32.4% had 3 or more. The most prevalent dyad was hypertension and high cholesterol in 17.0% of individuals. The most prevalent triad was hypertension, high cholesterol, and arthritis in 4.5% of individuals. County prevalence of MCC ranged from 42.6% in Westchester County to 66.1% in Oneida County. The prevalence of MCC in New York City neighborhoods ranged from 33.5% in Gramercy Park-Murray Hill to 60.6% in High Bridge-Morrisania. Conclusion This research contributes to the field's understanding of multiple chronic conditions and allows policy and public health leaders in New York to better understand the prevalence and distribution of MCC.	[Newman, Daniel; Levine, Erica; Kishore, Sandeep P.] Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Newman, D (corresponding author), Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA.	daniel.newman@icahn.mssm.edu		Newman, Daniel/0000-0002-5954-5668	Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai; Department of Medical Education at the Icahn School of Medicine at Mount Sinai	Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai; Department of Medical Education at the Icahn School of Medicine at Mount Sinai	This work was supported by the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai, and the Department of Medical Education at the Icahn School of Medicine at Mount Sinai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ML, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160613; Adams ML, 2017, PREV MED, V105, P169, DOI 10.1016/j.ypmed.2017.09.013; Anderson G, 2010, CHRONIC CARE MAKING; [Anonymous], 2017, PREV CHRON DIS SUPP; [Anonymous], BRFSS REP; [Anonymous], 2010, MULT CHRON COND STRA, P2; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Bauman M., 2017, MULTIPLE CHRONIC CON; Bayliss Elizabeth A, 2005, Health Qual Life Outcomes, V3, P51; Beasley JW, 2004, ANN FAM MED, V2, P405, DOI 10.1370/afm.94; Clark NM, 2015, CLIN PEDIATR, V54, P353, DOI 10.1177/0009922815574073; Freid Virginia M, 2012, NCHS Data Brief, P1; Gupta S, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160264; Lochner Kimberly A, 2013, Medicare Medicaid Res Rev, V3, DOI 10.5600/mmrr.003.03.b02; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Machlin SR, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120172; Marengoni A, 2009, J INTERN MED, V265, P288, DOI 10.1111/j.1365-2796.2008.02017.x; McPhail SM, 2016, RISK MANAG HEALTHC P, V9, P143, DOI 10.2147/RMHP.S97248; New York City Department of Health and Mental Hygiene, 2006, COMM HLTH PROF GRAM; New York City Department of Health and Mental Hygiene, 2006, COMM HLTH PROF HIGH; New York State Department of Health, NYC NEIGHB ZIP COD D; New York State Department of Health, VIT STAT NEW YORK ST; Newman AB, 2008, J GERONTOL A-BIOL, V63, P603, DOI 10.1093/gerona/63.6.603; NYC Department of Health, NYC 2010 CENS QUER; R Core Team, 2018, R LANG ENV STAT COMP; Rezaee ME, 2015, POPUL HEALTH MANAG, V18, P421, DOI 10.1089/pop.2014.0124; U.S. Census Bureau, 2010, ANN EST RES POP NEW; U.S. Centers for Medicare & Medicaid Services, 2017, CHRON COND; United State Centers for Disease Control and Prevention, COMP DAT BRFSS 2011, DOI [10.4236/health.2013.510A2002, DOI 10.4236/HEALTH.2013.510A2002]; US Department of Health and Human Services, HHS IN MULT CHRON CO; Voetsch K, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150509; Ward BW, 2016, MMWR-MORBID MORTAL W, V65, P735, DOI 10.15585/mmwr.mm6529a3; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389; Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211965	10.1371/journal.pone.0211965	http://dx.doi.org/10.1371/journal.pone.0211965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730970	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000079
J	Olaru, G; Wilhelm, O; Nordin, S; Witthoft, M; Koteles, F				Olaru, Gabriel; Wilhelm, Oliver; Nordin, Steven; Witthoeft, Michael; Koteles, Ferenc			Modern health worries: Deriving two measurement invariant short scales for cross-cultural research with Ant Colony Optimization	PLOS ONE			English	Article							SOMATOSENSORY AMPLIFICATION; FIT INDEXES; DIFFERENTIAL ITEM; SOMATIC SYMPTOMS; NORMATIVE DATA; SENSITIVITY; ANXIETY; COMPLEMENTARY; TECHNOLOGIES; MATTER	Worries about possible harmful effects of new technologies (modern health worries) have intensely been investigated in the last decade. However, the comparability of translated self-report measures across countries is often problematic. This study aimed to overcome this problem by developing psychometrically sound brief versions of the widely used 25-item Modern Health Worries Scale (MHWS) suitable for multi-country use. Based on data of overall 5,176 individuals from four European countries (England, Germany, Hungary, Sweden), Ant Colony Optimization was used to identify the indicators that optimize model fit and measurement invariance across countries. Two scales were developed. A short (12-item) version of the MHWS that represents the four-factor structure of the original version and an ultra-short (4-item) scale that only measures the general construct. Both scales show that overall levels of health worries were highest in England and Hungary, but that the main reason for concern (e.g. electromagnetic radiation or food related fears) differs considerably between these countries. This study also shows that even if measurement invariance of translated self-report instruments across countries is problematic, it can be optimized by using adequate item selection procedures. Differences of modern health worries across countries and recommendations for cross-cultural research are discussed.	[Olaru, Gabriel] Univ Kassel, Psychol Assessment, Kassel, Germany; [Wilhelm, Oliver] Ulm Univ, Individual Differences & Psychol Assessment, Ulm, Germany; [Nordin, Steven] Umea Univ, Dept Psychol, Umea, Sweden; [Witthoeft, Michael] Johannes Gutenberg Univ Mainz, Dept Clin Psychol Psychotherapy & Expt Psychopath, Mainz, Germany; [Koteles, Ferenc] Eotvos Lorand Univ, Inst Hlth Promot & Sport Sci, Budapest, Hungary	Universitat Kassel; Ulm University; Umea University; Johannes Gutenberg University of Mainz; Eotvos Lorand University	Olaru, G (corresponding author), Univ Kassel, Psychol Assessment, Kassel, Germany.	gabriel.olaru@uni-kassel.de	Wilhelm, Oliver/K-6455-2012; Olaru, Gabriel/AAL-5282-2020	Olaru, Gabriel/0000-0002-7430-7350; Koteles, Ferenc/0000-0001-5460-5759	Hungarian National Scientific Research Fund [K 124132]	Hungarian National Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This research was supported by the Hungarian National Scientific Research Fund (K 124132; received by FK), https://nkfih.gov.hu/funding/otka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Asparouhov T, 2014, STRUCT EQU MODELING, V21, P329, DOI 10.1080/10705511.2014.915181; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Bailer J, 2008, Z KL PSYCH PSYCHOTH, V37, P61, DOI 10.1026/1616-3443.37.1.61; Bailers J, 2008, J TOXICOL ENV HEAL A, V71, P766, DOI 10.1080/15287390801985562; Baliatsas C, 2015, J PSYCHOSOM RES, V79, P355, DOI 10.1016/j.jpsychores.2015.09.004; Borsboom D, 2006, MED CARE, V44, pS176, DOI 10.1097/01.mlr.0000245143.08679.cc; Brascher AK, 2017, ENVIRON RES, V156, P265, DOI 10.1016/j.envres.2017.03.040; Chen FF, 2005, STRUCT EQU MODELING, V12, P471, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Church AT, 2011, J PERS SOC PSYCHOL, V101, P1068, DOI 10.1037/a0025290; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; Domotor Z, 2019, J HEALTH PSYCHOL, V24, P1756, DOI 10.1177/1359105317699681; Eldridge-Thomas B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065713; European Commission, 2013, FLASH EUR 360 ATT EU; Fan XT, 2007, MULTIVAR BEHAV RES, V42, P509, DOI 10.1080/00273170701382864; Freyler A, 2013, J HEALTH PSYCHOL, V18, P773, DOI 10.1177/1359105313479629; Gonzalez-Roma V, 2006, MULTIVAR BEHAV RES, V41, P29, DOI 10.1207/s15327906mbr4101_3; Greiff S, 2017, WHY PSYCHOL ASSESSME; Heene M, 2011, PSYCHOL METHODS, V16, P319, DOI 10.1037/a0024917; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Indregard AMR, 2013, INT J BEHAV MED, V20, P371, DOI 10.1007/s12529-012-9246-1; Janssen AB, 2015, EUROPEAN J PSYCHOL A, V33, P409, DOI DOI 10.1027/1015-5759/A000299; Jeswani M, 2010, BRIT J HEALTH PSYCH, V15, P599, DOI 10.1348/135910709X477511; Jungmann SM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00994; Koteles F, 2015, J HEALTH PSYCHOL, V20, P1549, DOI 10.1177/1359105313516661; Koteles F, 2014, EUR J MENT HEALTH, V9, P20, DOI 10.5708/EJMH.9.2014.1.2; Koteles F, 2013, INT J BEHAV MED, V20, P38, DOI 10.1007/s12529-011-9217-y; Koteles F, 2012, SCAND J PSYCHOL, V53, P144, DOI 10.1111/j.1467-9450.2011.00908.x; Koteles F, 2011, SCAND J PSYCHOL, V52, P174, DOI 10.1111/j.1467-9450.2010.00846.x; Koteles F, 2016, SCAND J PSYCHOL, V57, P313, DOI 10.1111/sjop.12297; Lahrach Y, 2017, J PSYCHOSOM RES, V99, P89, DOI 10.1016/j.jpsychores.2017.06.004; Lai KK, 2016, MULTIVAR BEHAV RES, V51, P220, DOI 10.1080/00273171.2015.1134306; Leite WL, 2008, MULTIVAR BEHAV RES, V43, P411, DOI 10.1080/00273170802285743; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; Marsh HW, 2010, PSYCHOL ASSESSMENT, V22, P471, DOI 10.1037/a0019227; McNeish D, 2018, J PERS ASSESS, V100, P43, DOI 10.1080/00223891.2017.1281286; Morin AJS, 2013, QUANT METH EDUC BEHA, P395; Moshagen M, 2017, PSYCHOL METHODS; Muthen L.K., 2017, MPLUS USERS GUIDE; Nordin S, 2013, SCAND J PUBLIC HEALT, V41, P293, DOI 10.1177/1403494813475532; Olaru G, 2018, J PERS; Olaru G, 2015, J RES PERS, V59, P56, DOI 10.1016/j.jrp.2015.09.001; Palmquist E, 2017, INT J BEHAV MED, V24, P54, DOI 10.1007/s12529-016-9576-5; Petrie KJ, 2002, BRIT MED J, V324, P690, DOI 10.1136/bmj.324.7339.690; Petrie KJ, 2001, J PSYCHOSOM RES, V51, P395, DOI 10.1016/S0022-3999(01)00219-7; Rief W, 2012, J PSYCHOSOM RES, V72, P318, DOI 10.1016/j.jpsychores.2011.11.017; Sass DA, 2014, STRUCT EQU MODELING, V21, P167, DOI 10.1080/10705511.2014.882658; Satorra A, 2010, PSYCHOMETRIKA, V75, P243, DOI 10.1007/S11336-009-9135-Y; Schroeders U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167110; Schroeders U, 2016, INTELLIGENCE, V58, P22, DOI 10.1016/j.intell.2016.06.003; Soto CJ, 2018, PSYCHOL ASSESS; Spangenberg L, 2014, J HEALTH PSYCHOL, V19, P1302, DOI 10.1177/1359105313488980; Strait L, 2012, J CLIN RES BIOETHICS, V3, DOI [10.4172/2155-9627.1000126&pdate=2012-01-25, DOI 10.4172/2155-9627.1000126&PDATE=2012-01-25]; van Prooijen JW, 2015, SOC PSYCHOL PERS SCI, V6, P570, DOI 10.1177/1948550614567356; Witthoft M, 2018, PSYCHOL HEALTH, V33, P361, DOI 10.1080/08870446.2017.1357814; Yarkoni T, 2010, J RES PERS, V44, P180, DOI 10.1016/j.jrp.2010.01.002	57	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211819	10.1371/journal.pone.0211819	http://dx.doi.org/10.1371/journal.pone.0211819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5RX	30730928	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000063
J	Wang, YF; Zhang, XL; Tian, JL; Shan, JJ; Hu, YF; Zhai, YQ; Guo, J				Wang, Yifan; Zhang, Xiaolong; Tian, Jilai; Shan, Jinjun; Hu, Yunfeng; Zhai, Yiqian; Guo, Jun			Talin promotes integrin activation accompanied by generation of tension in talin and an increase in osmotic pressure in neurite outgrowth	FASEB JOURNAL			English	Article						neuronal polarization; DOK1; intracellular mechanical force	NERVE GROWTH-FACTOR; AXON GROWTH; CALCIUM-CHANNELS; VINCULIN BINDING; STRUCTURAL TENSION; LIVE CELLS; ADHESION; FORCE; COMPLEX; CYTOSKELETON	Neuronal polarization depends on the interaction of intracellular chemical and mechanical activities in which the cytoplasmic protein, talin, plays a pivotal role during neurite growth. To better understand the mechanism underlying talin function in neuronal polarization, we overexpressed several truncated forms of talin and found that the presence of the rod domain within the overexpressed talin is required for its positive effect on neurite elongation because the neurite number only increased when the talin head region was overexpressed. The tension in the talin rod was recognized using a Forster resonance energy transfer-based tension probe. Nerve growth factor treatment resulted in inward tension of talin elicited by microfilament force and outward osmotic pressure. By contrast, the glial scar-inhibitor aggrecan weakened these forces, suggesting that interactions between inward pull forces in the talin rod and outward osmotic pressure participate in neuronal polarization. Integrin activation is also involved in up-regulation of talin tension and osmotic pressure. Aggrecan stimuli resulted in up-regulation of docking protein 1 (DOK1), leading to the down-regulation of integrin activity and attenuation of the intracellular mechanical force. Our study suggests interactions between the intracellular inward tension in talin and the outward osmotic pressure as the effective channel for promoting neurite outgrowth, which can be up-regulated by integrin activation and down-regulated by DOK1.Wang, Y., Zhang, X., Tian, J., Shan, J., Hu, Y., Zhai, Y., Guo, J. Talin promotes integrin activation accompanied by generation of tension in talin and an increase in osmotic pressure in neurite outgrowth.	[Wang, Yifan; Zhang, Xiaolong; Tian, Jilai; Hu, Yunfeng; Zhai, Yiqian; Guo, Jun] Nanjing Univ Chinese Med, State Key Lab Cultivat Base Tradit Chinese Med TC, Sch Med & Life Sci, Nanjing, Jiangsu, Peoples R China; [Wang, Yifan; Zhang, Xiaolong; Tian, Jilai; Hu, Yunfeng; Zhai, Yiqian; Guo, Jun] Nanjing Univ Chinese Med, Key Lab Drug Targets & Drugs Degenerat Dis, Nanjing, Jiangsu, Peoples R China; [Shan, Jinjun; Guo, Jun] Nanjing Univ Chinese Med, Jiangsu Key Lab Pediat Resp Dis, Inst Pediat, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Guo, J (corresponding author), Nanjing Univ Chinese Med, Dept Biochem & Mol Biol, Sch Med & Life Sci, 138 Xianling St, Nanjing 210023, Jiangsu, Peoples R China.	guoj@njucm.edu.cn	Tian, Jilai/X-1727-2019	Tian, Jilai/0000-0002-5695-9881; jun, Guo/0000-0002-8525-8267	National Natural Science Foundation of China [81573409]; Natural Science Foundation of Jiangsu Province [BK20161574]; Priority Academic Program Development of Jiangsu Higher Education Institutions (Integration of Traditional Chinese and Western Medicine); Postgraduate Research and Practice Innovation Program of Jiangsu Province [KYCX18_1565]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (Integration of Traditional Chinese and Western Medicine); Postgraduate Research and Practice Innovation Program of Jiangsu Province	This work was supported by grants from the National Natural Science Foundation of China (81573409) and Natural Science Foundation of Jiangsu Province (BK20161574), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (Integration of Traditional Chinese and Western Medicine) and Postgraduate Research and Practice Innovation Program of Jiangsu Province (KYCX18_1565). The authors declare no conflicts of interest.	Alvarez B, 2008, J CELL PHYSIOL, V214, P474, DOI 10.1002/jcp.21215; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Arcangeli A, 2006, TRENDS CELL BIOL, V16, P631, DOI 10.1016/j.tcb.2006.10.003; Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Athamneh AIM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07402-6; Atherton P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10038; Ayali A, 2010, INTEGR BIOL-UK, V2, P178, DOI 10.1039/b927402b; Bharadwaj M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14348; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Cerna J, 2006, J MOL BIOL, V362, P954, DOI 10.1016/j.jmb.2006.07.075; Chang DD, 1997, J CELL BIOL, V138, P1149, DOI 10.1083/jcb.138.5.1149; Cheah M, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7030020; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen TT, 2019, ANTIOXID REDOX SIGN, V30, P1503, DOI 10.1089/ars.2017.7366; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Davis MJ, 2002, CELL BIOCHEM BIOPHYS, V36, P41, DOI 10.1385/CBB:36:1:41; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; Dehmelt L, 2006, BRAIN CELL BIOL, V35, P39, DOI 10.1007/s11068-006-9001-0; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Ellis SJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004756; Eva R, 2014, CURR OPIN NEUROBIOL, V27, P179, DOI 10.1016/j.conb.2014.03.018; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024808; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Goult BT, 2013, J BIOL CHEM, V288, P8238, DOI 10.1074/jbc.M112.438119; Gov NS, 2009, EUR PHYS J E, V29, P337, DOI 10.1140/epje/i2009-10476-8; Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376; Guo J, 2014, P NATL ACAD SCI USA, V111, pE5252, DOI 10.1073/pnas.1411683111; Guo J, 2014, ANTIOXID REDOX SIGN, V20, P986, DOI 10.1089/ars.2013.5708; Guo YC, 2018, REV NEUROSCIENCE, V29, P125, DOI 10.1515/revneuro-2017-0047; Hirata H, 2014, AM J PHYSIOL-CELL PH, V306, pC607, DOI 10.1152/ajpcell.00122.2013; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Ingber DE, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/4/046603; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Jacquemet G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13297; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kassianidou E, 2015, BBA-MOL CELL RES, V1853, P3065, DOI 10.1016/j.bbamcr.2015.04.006; Kerstein PC, 2017, J NEUROSCI, V37, P1568, DOI 10.1523/JNEUROSCI.2769-16.2016; Kerstein PC, 2013, J NEUROSCI, V33, P273, DOI 10.1523/JNEUROSCI.2142-12.2013; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Koser DE, 2016, NAT NEUROSCI, V19, P1592, DOI 10.1038/nn.4394; Kukkurainen S, 2014, MOL BIOSYST, V10, P3217, DOI 10.1039/c4mb00341a; Lantoine J, 2016, BIOMATERIALS, V89, P14, DOI 10.1016/j.biomaterials.2016.02.041; Li H, 2014, REV NEUROSCIENCE, V25, P527, DOI 10.1515/revneuro-2013-0062; Li JF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/470418; Liu JM, 2015, NAT STRUCT MOL BIOL, V22, P383, DOI 10.1038/nsmb.2999; Mercier PL, 2011, MOL ONCOL, V5, P438, DOI 10.1016/j.molonc.2011.07.003; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Morgan JR, 2004, J CELL BIOL, V167, P43, DOI 10.1083/jcb.200406020; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931; NEBE B, 1995, EXP CELL RES, V218, P479, DOI 10.1006/excr.1995.1181; Neumann J, 2016, PROTEIN ENG DES SEL, V29, P503, DOI 10.1093/protein/gzw031; NUCKOLLS GH, 1990, J CELL BIOL, V110, P1635, DOI 10.1083/jcb.110.5.1635; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Roca-Cusachs P, 2013, P NATL ACAD SCI USA, V110, pE1361, DOI 10.1073/pnas.1220723110; Roossien DH, 2014, J CELL SCI, V127, P3593, DOI 10.1242/jcs.152611; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Saxena M, 2017, NANO LETT, V17, P7242, DOI 10.1021/acs.nanolett.7b02476; SCHWARTZ MA, 1991, P NATL ACAD SCI USA, V88, P7849, DOI 10.1073/pnas.88.17.7849; Seng S, 2006, MOL CELL BIOL, V26, P8371, DOI 10.1128/MCB.02167-05; Shakibael M, 2003, HISTOL HISTOPATHOL, V18, P343, DOI 10.14670/HH-18.343; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Staniszewska I, 2008, J CELL SCI, V121, P504, DOI 10.1242/jcs.000232; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tan CL, 2015, MOL CELL NEUROSCI, V68, P1, DOI 10.1016/j.mcn.2015.03.011; Tan CL, 2011, J NEUROSCI, V31, P6289, DOI 10.1523/JNEUROSCI.0008-11.2011; Tavares L, 2015, GLIA, V63, P1155, DOI 10.1002/glia.22806; Toriyama M, 2013, CURR BIOL, V23, P529, DOI 10.1016/j.cub.2013.02.017; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Triplett JW, 2006, AM J PHYSIOL-CELL PH, V291, pC909, DOI 10.1152/ajpcell.00113.2006; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van't Hoff JH., 1887, ZPHYSIK CHEM, V1, P481, DOI DOI 10.1515/ZPCH-1887-0151; Waitkus-Edwards KR, 2002, CIRC RES, V90, P473, DOI 10.1161/hh0402.105899; Wang DY, 2016, MOL NEUROBIOL, V53, P4582, DOI 10.1007/s12035-015-9394-9; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wu L, 2008, ONCOGENE, V27, P1439, DOI 10.1038/sj.onc.1210770; Wu X, 2001, J BIOL CHEM, V276, P30285, DOI 10.1074/jbc.M102436200; Xu XH, 2011, CNS DRUGS, V25, P555, DOI 10.2165/11587830-000000000-00000; Yang C, 2015, BBA-MOL CELL RES, V1853, P1889, DOI 10.1016/j.bbamcr.2015.05.001; Yao MX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11966; Ye F, 2014, CELL, V156, DOI 10.1016/j.cell.2014.02.048; Yoshimura T, 2006, ANN NY ACAD SCI, V1086, P116, DOI 10.1196/annals.1377.013; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	103	11	11	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6311	6326		10.1096/fj.201801949RR	http://dx.doi.org/10.1096/fj.201801949RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30768370	Bronze			2022-12-26	WOS:000466932600040
J	Ren, LL; Ding, SY; Song, YH; Li, B; Ramanathan, M; Co, J; Amieva, MR; Khavari, PA; Greenberg, HB				Ren, Lili; Ding, Siyuan; Song, Yanhua; Li, Bin; Ramanathan, Muthukumar; Co, Julia; Amieva, Manuel R.; Khavari, Paul A.; Greenberg, Harry B.			Profiling of rotavirus 3UTR-binding proteins reveals the ATP synthase subunit ATP5B as a host factor that supports late-stage virus replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA virus; RNA-binding protein; virus assembly; virology; proteomics; ATP synthase; RNA-protein interaction; biotin proximity ligation; nonenveloped double-stranded RNA virus; rotavirus; viral gastroenteritis; virus-host interaction	PURIFICATION-MASS-SPECTROMETRY; RNA-BINDING; MESSENGER-RNA; GENOME REPLICATION; STRAND RNA; POLYMERASE; MODEL; MECHANISM; SEQUENCE; IDENTIFICATION	Genome replication and virion assembly of segmented RNA viruses are highly coordinated events, tightly regulated by sequence and structural elements in the UTRs of viral RNA. This process is poorly defined and likely requires the participation of host proteins in concert with viral proteins. In this study, we employed a proteomics-based approach, named RNA-protein interaction detection (RaPID), to comprehensively screen for host proteins that bind to a conserved motif within the rotavirus (RV) 3 terminus. Using this assay, we identified ATP5B, a core subunit of the mitochondrial ATP synthase, as having high affinity to the RV 3UTR consensus sequences. During RV infection, ATP5B bound to the RV 3UTR and co-localized with viral RNA and viroplasm. Functionally, siRNA-mediated genetic depletion of ATP5B or other ATP synthase subunits such as ATP5A1 and ATP5O reduced the production of infectious viral progeny without significant alteration of intracellular viral RNA levels or RNA translation. Chemical inhibition of ATP synthase diminished RV yield in both conventional cell culture and in human intestinal enteroids, indicating that ATP5B positively regulates late-stage RV maturation in primary intestinal epithelial cells. Collectively, our results shed light on the role of host proteins in RV genome assembly and particle formation and identify ATP5B as a novel pro-RV RNA-binding protein, contributing to our understanding of how host ATP synthases may galvanize virus growth and pathogenesis.	[Ren, Lili; Ding, Siyuan; Song, Yanhua; Li, Bin; Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Ren, Lili; Ding, Siyuan; Song, Yanhua; Li, Bin; Co, Julia; Amieva, Manuel R.; Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Ren, Lili; Ding, Siyuan; Song, Yanhua; Li, Bin; Khavari, Paul A.; Greenberg, Harry B.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA; [Ren, Lili] Nanjing Tech Univ, Sch Pharmaceut Sci, Nanjing 211816, Jiangsu, Peoples R China; [Song, Yanhua; Li, Bin] Jiangsu Acad Agr Sci, Inst Vet Med, Nanjing 210014, Peoples R China; [Ramanathan, Muthukumar; Khavari, Paul A.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Nanjing Tech University; Jiangsu Academy of Agricultural Sciences; Stanford University	Ding, SY; Greenberg, HB (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA.; Ding, SY; Greenberg, HB (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Ding, SY; Greenberg, HB (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA.	syding@stanford.edu; hbgreen@stanford.edu	Ramanathan, Muthukumar/ABE-7524-2020; Amieva, Manuel/U-2581-2017	greenberg, harry/0000-0002-2128-9080; Ding, Siyuan/0000-0002-5338-260X; Amieva, Manuel/0000-0002-5601-4490	Early Career Award (Thrasher Research Fund); Instructor Support Program (Stanford Maternal and Child Health Research Institute); National Institutes of Health [K99 AI135031, R01 AR49737, R01 AR43799, R01 AI021362, R56 AI021362, U19 AI116484]; VA Merit Review Grant [GRH0022]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125249, U19AI116484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049737, R01AR043799] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000158] Funding Source: NIH RePORTER	Early Career Award (Thrasher Research Fund); Instructor Support Program (Stanford Maternal and Child Health Research Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by an Early Career Award (Thrasher Research Fund), Instructor Support Program (Stanford Maternal and Child Health Research Institute), National Institutes of Health Grant K99 AI135031 (to S. D.), and National Institutes of Health Grants R01 AR49737 and R01 AR43799 (to P. A. K.), National Institutes of Health Grants R01 AI021362, R56 AI021362, and U19 AI116484 and VA Merit Review Grant GRH0022 (to H. B. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Austin RJ, 2002, J AM CHEM SOC, V124, P10966, DOI 10.1021/ja026610b; Bachler M, 1999, RNA, V5, P1509, DOI 10.1017/S1355838299991574; Bagaria A, 2012, PROTEIN SCI, V21, P229, DOI 10.1002/pro.2007; Ball JM, 2005, VIRAL IMMUNOL, V18, P27, DOI 10.1089/vim.2005.18.27; BASS DM, 1990, J VIROL, V64, P322, DOI 10.1128/JVI.64.1.322-330.1990; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Borodavka A, 2017, ELIFE, V6, DOI 10.7554/eLife.27453; Boudreaux CE, 2015, VIROLOGY, V477, P32, DOI 10.1016/j.virol.2015.01.003; Boudreaux CE, 2013, J GEN VIROL, V94, P1818, DOI 10.1099/vir.0.052951-0; Bowman GD, 2000, J MOL BIOL, V304, P861, DOI 10.1006/jmbi.2000.4250; Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243; Chen D, 2001, VIROLOGY, V282, P221, DOI 10.1006/viro.2001.0825; Chen DY, 2000, RNA, V6, P1455, DOI 10.1017/S1355838200001187; De Lorenzo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166719; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Din SY, 2018, ELIFE, V7, DOI 10.7554/eLife.39494; Ding SY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03782-z; Ding SY, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005929; Ding SY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001758; Estes MK, 2013, ROTAVIRUSES FIELDS V, P1347; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; Fajardo T, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070167; Fajardo T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005321; Feng NG, 1997, J INFECT DIS, V175, P330, DOI 10.1093/infdis/175.2.330; Fongsaran C, 2014, ARCH VIROL, V159, P3353, DOI 10.1007/s00705-014-2210-4; Foulke-Abel J, 2014, EXP BIOL MED, V239, P1124, DOI 10.1177/1535370214529398; GALLEGOS CO, 1989, VIROLOGY, V172, P616, DOI 10.1016/0042-6822(89)90204-3; Graindorge A, 2008, NUCLEIC ACIDS RES, V36, P1861, DOI 10.1093/nar/gkn031; Gratia M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145998; Green VA, 2016, CELL HOST MICROBE, V20, P107, DOI 10.1016/j.chom.2016.06.005; Gridley CL, 2014, CURR OPIN VIROL, V9, P31, DOI 10.1016/j.coviro.2014.08.008; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Hilbert BJ, 2015, P NATL ACAD SCI USA, V112, pE3792, DOI 10.1073/pnas.1506951112; Hyser JM, 2010, MBIO, V1, DOI 10.1128/mBio.00265-10; KAPAHNKE R, 1986, NUCLEIC ACIDS RES, V14, P3215, DOI 10.1093/nar/14.8.3215; Leveque N, 2017, J VIROL, V91, DOI 10.1128/JVI.00423-17; Li B, 2017, P NATL ACAD SCI USA, V114, pE3642, DOI 10.1073/pnas.1619266114; Li W, 2010, NUCLEIC ACIDS RES, V38, P7718, DOI 10.1093/nar/gkq663; Long CP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006242; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lu X, 2008, STRUCTURE, V16, P1678, DOI 10.1016/j.str.2008.09.006; Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369; McDonald SM, 2011, TRENDS MICROBIOL, V19, P136, DOI 10.1016/j.tim.2010.12.002; McHugh CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb4152; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Nadal M, 2010, P NATL ACAD SCI USA, V107, P16078, DOI 10.1073/pnas.1007144107; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oeffinger M, 2012, PROTEOMICS, V12, P1591, DOI 10.1002/pmic.201100509; Patton JT, 1996, J VIROL, V70, P3961, DOI 10.1128/JVI.70.6.3961-3971.1996; Patton JT, 1999, J VIROL, V73, P1382, DOI 10.1128/JVI.73.2.1382-1391.1999; Patton JT, 1996, J VIROL, V70, P7940, DOI 10.1128/JVI.70.11.7940-7947.1996; Pennington JD, 2002, ORG LETT, V4, P3823, DOI 10.1021/ol026829v; PONCET D, 1994, EMBO J, V13, P4165, DOI 10.1002/j.1460-2075.1994.tb06734.x; Ramanathan M, 2018, NAT METHODS, V15, P207, DOI [10.1038/NMETH.4601, 10.1038/nmeth.4601]; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rialdi A, 2017, CELL, V169, P679, DOI 10.1016/j.cell.2017.04.021; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sanchez-Tacuba L, 2015, J VIROL, V89, P12145, DOI 10.1128/JVI.01874-15; Saxena K, 2016, J VIROL, V90, P43, DOI 10.1128/JVI.01930-15; SHAW RD, 1986, VIROLOGY, V155, P434, DOI 10.1016/0042-6822(86)90205-9; Silva-Ayala D, 2013, P NATL ACAD SCI USA, V110, P10270, DOI 10.1073/pnas.1304932110; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Stauber N, 1997, J VIROL, V71, P7220; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Uzri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069825; van den Pol AN, 2014, J VIROL, V88, P3695, DOI 10.1128/JVI.03509-13; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Wentz MJ, 1996, J VIROL, V70, P7833, DOI 10.1128/JVI.70.11.7833-7841.1996; Yan YM, 2017, NUCLEIC ACIDS RES, V45, pW365, DOI 10.1093/nar/gkx407; Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhu S, 2017, NATURE, V546, P667, DOI 10.1038/nature22967	76	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5993	6006		10.1074/jbc.RA118.006004	http://dx.doi.org/10.1074/jbc.RA118.006004			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30770472	hybrid, Green Published			2022-12-26	WOS:000465077500030
J	Wang, PF; Zuo, YN; Sun, JF; Zuo, T; Zhang, SY; Guo, SC; Shi, XL; Liang, MF; Zhou, P; Zhang, LQ; Wang, XQ				Wang, Pengfei; Zuo, Yanan; Sun, Jianfeng; Zuo, Teng; Zhang, Senyan; Guo, Shichun; Shi, Xuanling; Liang, Mifang; Zhou, Paul; Zhang, Linqi; Wang, Xinquan			Structural and functional definition of a vulnerable site on the hemagglutinin of highly pathogenic avian influenza A virus H5N1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza; influenza virus; monoclonal antibody; structural biology; X-ray crystallography; vaccine development; virology; mutagenesis; infectious disease; epitope; H5N1; HPAI; neutralizing antibody; vulnerable site	CONSERVED EPITOPE; MONOCLONAL-ANTIBODIES; IDENTIFICATION; TRANSMISSION; MOLECULE; BINDING; PLASMA; CELLS	Most neutralizing antibodies against highly pathogenic avian influenza A virus H5N1 recognize the receptor-binding site (RBS) on the globular head domain and the stem of H5N1 hemagglutinin (HA). Through comprehensive analysis of multiple human protective antibodies, we previously identified four vulnerable sites (VS1-VS4) on the globular head domain. Among them, the VS1, occupying the opposite side of the RBS on the same HA, was defined by the epitope of antibody 65C6. In this study, we report the crystal structures of two additional human H5N1 antibodies isolated from H5N1-infected individuals, 3C11 and AVFluIgG01, bound to the head at 2.33- and 2.30-angstrom resolution, respectively. These two new antibody epitopes have large overlap with and extend beyond the original VS1. Site-directed mutagenesis experiments identified eight pivotal residues (Ser-126b, Lys-165, Arg-166, Ser-167, Tyr-168, Asn-169, Thr-171, and Asn-172) critical for 65C6-, 3C11-, and AVFluIgG01-binding and neutralization activities. These residues formed a unique Y-shaped surface on H5N1 globular head and are highly conserved among H5N1 viruses. Our results further support the existence of a vulnerable site distinct from the RBS and the stem region of H5N1 HA, and future design of immunogens should take this particular site into consideration.	[Wang, Pengfei; Sun, Jianfeng; Zhang, Senyan; Wang, Xinquan] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Collaborat Innovat Ctr Biotherapy, Key Lab Prot Sci,Sch Life Sci,Minist Educ, Beijing 100084, Peoples R China; [Zuo, Yanan; Zuo, Teng; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing Adv Innovat Ctr Struct Biol,Sch Med, Dept Basic Med Sci,Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China; [Guo, Shichun] Tsinghua Univ, Dept Comp Sci, Beijing 100084, Peoples R China; [Liang, Mifang] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Control & Prevent, Beijing 102206, Peoples R China; [Zhou, Paul] Chinese Acad Sci, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai 200031, Peoples R China	Tsinghua University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; Tsinghua University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Wang, XQ (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Collaborat Innovat Ctr Biotherapy, Key Lab Prot Sci,Sch Life Sci,Minist Educ, Beijing 100084, Peoples R China.; Zhang, LQ (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing Adv Innovat Ctr Struct Biol,Sch Med, Dept Basic Med Sci,Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China.	zhanglinqi@tsinghua.edu.cn; xinquanwang@mail.tsinghua.edu.cn	zhang, sen/GXH-3513-2022; ZHANG, LIN/GYD-9123-2022		Ministry of Science and Technology of the People's Republic of China (MOST) [2018ZX10731101-002, 2017ZX10201101, 2016YFD0500307, 2014CB542500-03]; National Natural Science Foundation of China (NSFC) [31470751, U1405228, 81530065, 81661128042]	Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of the People's Republic of China (MOST) Grants 2018ZX10731101-002, 2017ZX10201101, 2016YFD0500307, and 2014CB542500-03 (to L.Z. and X.W.) and National Natural Science Foundation of China (NSFC) Grants 31470751, U1405228, 81530065, and 81661128042 (to L.Z. and X.W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Benjamin E, 2014, J VIROL, V88, P6743, DOI 10.1128/JVI.03562-13; Cao ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038126; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiu C, 2015, CURR TOP MICROBIOL, V386, P381, DOI 10.1007/82_2014_425; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; Du LY, 2013, J VIROL, V87, P2215, DOI 10.1128/JVI.02344-12; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gronsang D, 2017, ARCH VIROL, V162, P2257, DOI 10.1007/s00705-017-3350-0; Han T, 2011, BIOCHEM BIOPH RES CO, V409, P253, DOI 10.1016/j.bbrc.2011.04.139; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hu HX, 2012, J VIROL, V86, P2978, DOI 10.1128/JVI.06665-11; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kallewaard NL, 2016, CELL, V166, P596, DOI 10.1016/j.cell.2016.05.073; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Li Y, 2013, J EXP MED, V210, P1493, DOI 10.1084/jem.20130212; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian MR, 2013, J VIROL, V87, P3571, DOI 10.1128/JVI.01292-12; Raymond DD, 2018, P NATL ACAD SCI USA, V115, P168, DOI 10.1073/pnas.1715471115; Rockman S, 2013, MOL IMMUNOL, V53, P435, DOI 10.1016/j.molimm.2012.10.001; Rudneva IA, 2010, VIRAL IMMUNOL, V23, P181, DOI 10.1089/vim.2009.0086; Sano K, 2017, VACCINE, V35, P5388, DOI 10.1016/j.vaccine.2017.08.034; Schrauwen EJA, 2012, J VIROL, V86, P3975, DOI 10.1128/JVI.06828-11; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Wang QS, 2018, NUCL SCI TECH, V29, DOI 10.1007/s41365-018-0398-9; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8708; Xiong XL, 2015, P NATL ACAD SCI USA, V112, P9430, DOI 10.1073/pnas.1510816112; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359; Zuo T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9855; Zuo YA, 2018, J BIOL CHEM, V293, P16503, DOI 10.1074/jbc.RA118.004604	44	3	3	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4290	4303		10.1074/jbc.RA118.007008	http://dx.doi.org/10.1074/jbc.RA118.007008			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30737282	Green Published, hybrid			2022-12-26	WOS:000462969500002
J	Englehardt, JD; Chiu, WA				Englehardt, James D.; Chiu, Weihsueh A.			A general dose-response relationship for chronic chemical and other health stressors and mixtures based on an emergent illness severity model	PLOS ONE			English	Article							RISK-ASSESSMENT; IN-VITRO; DISTRIBUTIONS; CARCINOGENICITY; UNCERTAINTIES; TOXICITY; EXPOSURE	Current efforts to assess human health response to chemicals based on high-throughput in vitro assay data on intra-cellular changes have been hindered for some illnesses by lack of information on higher-level extracellular, inter-organ, and organism-level interactions. However, a dose-response function (DRF), informed by various levels of information including apical health response, can represent a template for convergent top-down, bottom-up analysis. In this paper, a general DRF for chronic chemical and other health stressors and mixtures is derived based on a general first-order model previously derived and demonstrated for illness progression. The derivation accounts for essential autocorrelation among initiating event magnitudes along a toxicological mode of action, typical of complex processes in general, and reveals the inverse relationship between the minimum illness-inducing dose, and the illness severity per unit dose (both variable across a population). The resulting emergent DRF is theoretically scale-inclusive and amenable to low-dose extrapolation. The two-parameter single-toxicant version can be monotonic or sigmoidal, and is demonstrated preferable to traditional models (multistage, lognormal, generalized linear) for the published cancer and non cancer datasets analyzed: chloroform (induced liver necrosis in female mice); bromate (induced dysplastic focia in male inbred rats); and 2-acetylaminofluorene (induced liver neoplasms and bladder carcinomas in 20,328 female mice). Common- and dissimilar-mode mixture models are demonstrated versus orthogonal data on toluene/benzene mixtures (mortality in Japanese medaka, Oryzias latipes, following embryonic exposure). Findings support previous empirical demonstration, and also reveal how a chemical with a typical monotonically -increasing DRF can display a J-shaped DRF when a second, antagonistic common mode chemical is present. Overall, the general DRF derived here based on an autocorrelated first-order model appears to provide both a strong theoretical/biological basis for, as well as an accurate statistical description of, a diverse, albeit small, sample of observed dose response data. The further generalizability of this conclusion can be tested in future analyses comparing with traditional modeling approaches across a broader range of datasets.	[Englehardt, James D.] Univ Miami, Civil Architectural & Environm Engn, Coral Gables, FL 33124 USA; [Chiu, Weihsueh A.] Texas A&M Univ, Vet Integrat Biosci, College Stn, TX USA	University of Miami; Texas A&M University System; Texas A&M University College Station	Englehardt, JD (corresponding author), Univ Miami, Civil Architectural & Environm Engn, Coral Gables, FL 33124 USA.	jenglehardt@miami.edu		Englehardt, James/0000-0001-9779-1811	National Science Foundation [1038257]; NIH [P42 ES027704]; NSF [1038257]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES027704] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Partial support for this work was obtained from the National Science Foundation (nsf.gov) grant no. 1038257 (JDE) and NIH grant no. P42 ES027704 (WAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Linda Teuschler is thanked for her advice and data. Bill Hartley is acknowledged and Aurunthavarani Thiyagarajah is thanked for making their data available. Alan Heldman, Juan Carlos Ramos, and Alan Becker are thanked for their input, Jeff Swartout is thanked for his collaboration in parallel work on first -order systems with discrete outcomes, and Kaitlyn Huarto is thanks for technical assistance. Anonymous reviewers of this work since original submission by the first author in 2007 are thanked for suggestions which solely improved context and clarity. This article was made possible, in part, by NSF grant 1038257 and NIH grant P42 ES027704. Its contents are solely the responsibility of the grantees and do not necessarily represent the official views of the NSF or the NIH.	Armitage P., 1961, 4 BERK S MATH STAT P, P19; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barabasi AL, SCIENCE, P80; Bell SM, 2016, TOXICOL SCI, V150, P510, DOI 10.1093/toxsci/kfw017; Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887; Borgert CJ, 2013, REGUL TOXICOL PHARM, V67, P83, DOI 10.1016/j.yrtph.2013.06.007; BROWN SL, 1994, ENVIRON SOFTW, V9, P161, DOI 10.1016/0266-9838(94)90028-0; Chiu WA, 2017, ALTEX-ALTERN ANIM EX, V34, P377, DOI 10.14573/altex.1608251; Chiu WA, 2015, ENVIRON HEALTH PERSP, V123, P1241, DOI 10.1289/ehp.1409385; Cook NJ, 2012, STRUCT SAF, V34, P418, DOI 10.1016/j.strusafe.2011.08.002; Crump KS, 1996, HUM EXP TOXICOL, V15, P787, DOI 10.1177/096032719601501001; CRUMP KS, 1976, CANCER RES, V36, P2973; CRUMP KS, 1984, FUND APPL TOXICOL, V4, P854, DOI 10.1016/0272-0590(84)90107-6; Englehardt JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129042; Englehardt JD, 2004, HUM ECOL RISK ASSESS, V10, P69, DOI 10.1080/10807030490280963; ENGLEHARDT JD, 1995, J ENVIRON ENG-ASCE, V121, P455, DOI 10.1061/(ASCE)0733-9372(1995)121:6(455); Englehardt JD, 2002, RISK ANAL, V22, P369, DOI 10.1111/0272-4332.00016; Englehardt JD, 2008, EPA600R08033 NAT CTR; Englehardt JD, 2014, 2014 SOC RISK AN ANN; Festing, 1998, INBRED STRAINS MICE; GUESS HA, 1976, MATH BIOSCI, V32, P15, DOI 10.1016/0025-5564(76)90051-1; Haas CN, QUANTITATIVE MICROBI; Harlow DG, 2002, INT J MATER PROD TEC, V17, P482, DOI 10.1504/IJMPT.2002.005472; Hertzberg R., 2000, SUPPLEMENTARY GUIDAN; Hertzberg RC, 2002, SCI TOTAL ENVIRON, V288, P31, DOI 10.1016/S0048-9697(01)01113-5; Holst GR, 2000, 2000 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL II, PROCEEDINGS, P235, DOI 10.1109/ICIP.2000.899284; Inter-Organization Programme for the Sound Management of Chemicals, 2014, GUID DOC EV EXPR UNC; Iudicello JJ, 2009, HUM ECOL RISK ASSESS, V15, P1168, DOI 10.1080/10807030903304781; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Judson R, 2014, BASIC CLIN PHARMACOL, V115, P69, DOI 10.1111/bcpt.12239; Judson RS, 2017, REGUL TOXICOL PHARM, V91, P39, DOI 10.1016/j.yrtph.2017.09.022; Kim JY, 2015, J BIOTECHNOL, V205, P24, DOI 10.1016/j.jbiotec.2015.01.003; KUROKAWA Y, 1986, J NATL CANCER I, V77, P977; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; Lee SK, 2002, TOXICOL SCI, V65, P26, DOI 10.1093/toxsci/65.1.26; Li RC, 2012, RISK ANAL, V32, P345, DOI 10.1111/j.1539-6924.2011.01672.x; McBride S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054585; Mittnik S, 1993, ECONOMET REV, V12, P261; National Research Council, 2007, TOX TEST 21 CENT VIS; National Toxicology Program, TEST STAT TEF TRANSG; National Toxicology Program, 2006, NTP TECHN REP TOX CA; National Toxicology Program, TEST STAT 2 2 4 4 5; Oleaga C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20030; Pearce RG, 2017, J STAT SOFTW, V79, DOI [10.18637/jss.v079.104, 10.18637/jss.v079.i04]; Pelkonen O, 2017, ARCH TOXICOL, V91, P2763, DOI 10.1007/s00204-017-1986-x; Rhomberg LR, 2010, CRIT REV TOXICOL, V40, P671, DOI 10.3109/10408444.2010.499504; Richard AM, 2016, CHEM RES TOXICOL, V29, P1225, DOI 10.1021/acs.chemrestox.6b00135; Safe Drinking Water Committee, 1980, BOARD TOXICOLOGY ENV, V2; SCHER SCENIHR SCCS, 2011, TOX ASS CHEM MIXT; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Shah I, 2016, ENVIRON HEALTH PERSP, V124, P910, DOI 10.1289/ehp.1409029; Slob W, 2014, RISK ANAL, V34, P1401, DOI 10.1111/risa.12194; Staffa JA, 1979, INN CANC RISK ASS ED; Stewart James A, 2006, J Physiol Anthropol, V25, P133, DOI 10.2114/jpa2.25.133; STUART A, 1994, KENDALLS ADV THEORY, VI; Syracuse Research Corp. NY Cincinnati Univ. OHD of EH Environmental Protection Agency OH, 1988, TECHN SUPP DOC RISK; Teunis PFM, 2000, RISK ANAL, V20, P513, DOI 10.1111/0272-4332.204048; Teuschler LK, 2000, DRUG CHEM TOXICOL, V23, P307, DOI 10.1081/DCT-100100117; Teuschler LK, 2005, CHEMOSPHERE, V58, P1283, DOI 10.1016/j.chemosphere.2004.09.075; Thomas RS, 2012, TOXICOL SCI, V128, P398, DOI 10.1093/toxsci/kfs159; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Wetmore BA, 2015, TOXICOL SCI, V148, P121, DOI 10.1093/toxsci/kfv171; Whelan M, 2013, 26389 EUR EN JOINT R	63	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2019	14	2							e0211780	10.1371/journal.pone.0211780	http://dx.doi.org/10.1371/journal.pone.0211780			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5KT	30768598	Green Published, Green Submitted, gold			2022-12-26	WOS:000458766300010
J	Oh, IS; Baek, YH; Kim, HJ; Lee, M; Shin, JY				Oh, In-Sun; Baek, Yeon-Hee; Kim, Hye-Jun; Lee, Mose; Shin, Ju-Young			Differential completeness of spontaneous adverse event reports among hospitals/clinics, pharmacies, consumers, and pharmaceutical companies in South Korea	PLOS ONE			English	Article							DRUG REACTION REPORTS; MEDICATION ERRORS; PHARMACOVIGILANCE CENTER; SIGNAL-DETECTION; QUALITY; SAFETY	The differential pattern and characteristics of completeness in adverse event (AE) reports generated by hospitals/clinics, pharmacies, consumer and pharmaceutical companies remain unknown. Thus, we identified the characteristics of complete AE reports, compared with those of incomplete AE reports, using a completeness score. We used Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database (KIDS-KD) between January 1, 2016 and December 31, 2016. The completeness score was determined out of a total of 100 points, based on the presence of information on temporal relationships, age and sex of patients, AE progress, name of reported medication, reporting group by profession, causality assessment, and informational text. AE reports were organized into four groups based on affiliation: hospitals/clinics, pharmacies, consumers, and pharmaceutical companies. Affiliations that had median completeness scores greater than 80 points were classified as 'well-documented' and these reports were further analyzed by logistic regression to estimate the adjusted odds ratios and 95% confidence intervals. We examined 228,848 individual reports and 735,745 drug-AE combinations. The median values of the completeness scores were the highest for hospitals/clinics (95 points), followed by those for consumers (85), pharmacies (75), and manufacturers (72). Reports with causality assessment of 'certain', 'probable', or 'possible' were more likely to be 'well-documented' than reports that had causality assessments of 'unlikely'. Serious reports of AEs were positively associated with 'well-documented' reports and negatively associated with hospitals/clinics.	[Oh, In-Sun; Baek, Yeon-Hee; Kim, Hye-Jun; Lee, Mose; Shin, Ju-Young] Sungkyunkwan Univ, Sch Pharm, Suwon, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU)	Shin, JY (corresponding author), Sungkyunkwan Univ, Sch Pharm, Suwon, Gyeonggi Do, South Korea.	shin.jy@skku.edu		Baek, Yeon-Hee/0000-0001-9597-6310	National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety of South Korea [17172-186]	National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety of South Korea	This study was funded by the National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety of South Korea (grant no: 17172-186) to JYS.; The authors would like to thank the Korea Institute of Drug Safety and Risk Management for their cooperation in providing access to the Korea Adverse Event Reporting System Database (KIDS-KD). This study was funded by the National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety of South Korea (Grant no: 17172-186). We thank Editage for their assistance with English language editing.	Aagaard L, 2009, DRUG SAFETY, V32, P1067, DOI 10.2165/11316680-000000000-00000; Aronson JK, 2009, BRIT J CLIN PHARMACO, V67, P599, DOI 10.1111/j.1365-2125.2009.03415.x; Avery AJ, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15200; Benjamin DM, 2003, J CLIN PHARMACOL, V43, P768, DOI 10.1177/0091270003254794; Bergvall T, 2014, DRUG SAFETY, V37, P65, DOI 10.1007/s40264-013-0131-x; Blenkinsopp A, 2007, BRIT J CLIN PHARMACO, V63, P148, DOI 10.1111/j.1365-2125.2006.02746.x; Brajovic S, 2012, PHARMACOEPIDEM DR S, V21, P565, DOI 10.1002/pds.3223; Durrieu G, 2016, DRUG SAFETY, V39, P1189, DOI 10.1007/s40264-016-0463-4; Gedde-Dahl A, 2007, PHARMACOEPIDEM DR S, V16, P999, DOI 10.1002/pds.1400; Hazell L, 2013, DRUG SAFETY, V36, P199, DOI 10.1007/s40264-013-0021-2; Kim KS, 2011, J NURS MANAGE, V19, P346, DOI 10.1111/j.1365-2834.2011.01249.x; Mendes D, 2014, J NURS MANAGE, V22, P322, DOI 10.1111/jonm.12003; Moore TJ, 2016, PHARMACOEPIDEM DR S, V25, P713, DOI 10.1002/pds.3979; Park HJ, 2015, REGUL TOXICOL PHARM, V71, P478, DOI 10.1016/j.yrtph.2015.02.001; Plessis L, 2017, EUR J CLIN PHARMACOL, V73, P751, DOI 10.1007/s00228-017-2223-5; Runciman WB, 2003, INT J QUAL HEALTH C, V15, pI49, DOI 10.1093/intqhc/mzg085; Sanchez-Sanchez B, 2012, DRUG SAFETY, V35, P837, DOI 10.2165/11631810-000000000-00000; Shanmugapriya S, 2017, INDIAN J MED SPEC, V8, P175, DOI 10.1016/j.injms.2017.05.001; Shin JY, 2014, PHARMACOEPIDEM DR S, V23, P1115, DOI 10.1002/pds.3715; Shin JY, 2017, EVALUATION COMPLETEN; Shin YS, 2009, PHARMACOEPIDEM DR S, V18, P910, DOI 10.1002/pds.1796; Sim DW, 2016, PHARMACOEPIDEM DR S, V25, P1279, DOI 10.1002/pds.4049; Soukavong M, 2016, J KOREAN MED SCI, V31, P1355, DOI 10.3346/jkms.2016.31.9.1355; Stephenson WP, 2007, PHARMACOEPIDEM DR S, V16, P359, DOI 10.1002/pds.1323; Uppsala Monitoring Centre, 2018, US WHO UMC SYST STAN; WHO, 2005, ADV REACT TERM WHO A; Yu YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132916	27	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212336	10.1371/journal.pone.0212336	http://dx.doi.org/10.1371/journal.pone.0212336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763386	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900070
J	Holmes, VM; de Motes, CM; Richards, PT; Roldan, J; Bhargava, AK; Orange, JS; Krummenacher, C				Holmes, Veronica M.; de Motes, Carlos Maluquer; Richards, Paige T.; Roldan, Jessenia; Bhargava, Arjun K.; Orange, Jordan S.; Krummenacher, Claude			Interaction between nectin-1 and the human natural killer cell receptor CD96	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; GLYCOPROTEIN-D; POLIOVIRUS RECEPTOR; NK-CELL; ENTRY MEDIATOR; DOWN-REGULATION; MOLECULAR-CLONING; SECRETED FORMS; PVR CD155; ADHESION	Regulation of Natural Killer (NK) cell activity is achieved by the integration of both activating and inhibitory signals acquired at the immunological synapse with potential target cells. NK cells express paired receptors from the immunoglobulin family which share common ligands from the nectin family of adhesion molecules. The activating receptor CD226 (DNAM-1) binds to nectin-2 and CD155, which are also recognized by the inhibitory receptor TIGIT. The third receptor in this family is CD96, which is less well characterized and may have different functions in human and mouse models. Human CD96 interacts with CD155 and ligation of this receptor activates NK cells, while in mice the presence of CD96 correlates with decreased NK cell activation. Mouse CD96 also binds nectin-1, but the effect of this interaction has not yet been determined. Here we show that human nectin-1 directly interacts with CD96 in vitro. The binding site for CD96 is located on the nectin-1 V-domain, which comprises a canonical interface that is shared by nectins to promote cell adhesion. The affinity of nectin-1 for CD96 is lower than for other nectins such as nectin-3 and nectin-1 itself. However, the affinity of nectin-1 for CD96 is similar to its affinity for herpes simplex virus glycoprotein D (HSV gD), which binds the nectin-1 V-domain during virus entry. The affinity of human CD96 for nectin-1 is lower than for its known activating ligand CD155. We also found that human erythroleukemia K562 cells, which are commonly used as susceptible targets to assess NK cell cytotoxicity did not express nectin-1 on their surface and were resistant to HSV infection. When expressed in K562 cells, nectin-1-GFP accumulated at cell contacts and allowed HSV entry. Furthermore, overexpression of nectin-1-GFP led to an increased susceptibility of K562 cells to NK-92 cell cytotoxicity.	[Holmes, Veronica M.; Bhargava, Arjun K.] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA; [de Motes, Carlos Maluquer] Univ Surrey, Dept Microbial Sci, Guildford, Surrey, England; [Richards, Paige T.; Roldan, Jessenia; Krummenacher, Claude] Rowan Univ, Dept Biol Sci, Glassboro, NJ 08028 USA; [Orange, Jordan S.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Krummenacher, Claude] Rowan Univ, Dept Mol & Cellular Biosci, Glassboro, NJ 08028 USA	University of Pennsylvania; University of Surrey; Rowan University; Columbia University; Rowan University	Krummenacher, C (corresponding author), Rowan Univ, Dept Biol Sci, Glassboro, NJ 08028 USA.; Krummenacher, C (corresponding author), Rowan Univ, Dept Mol & Cellular Biosci, Glassboro, NJ 08028 USA.	krummenacher@rowan.edu	de Motes, Carlos Maluquer/AAF-8092-2021	de Motes, Carlos Maluquer/0000-0003-4712-4601; orange, jordan/0000-0001-7117-7725; Richards, Paige/0000-0002-9488-3101; Krummenacher, Claude/0000-0002-3492-4987	Public Health Service grants from the National Institute of Allergy and Infectious Diseases [R56-A1097171, R01-A1067946, R01-A1120989]; College of Sciences and Mathematics at Rowan University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067946, R01AI120989] Funding Source: NIH RePORTER	Public Health Service grants from the National Institute of Allergy and Infectious Diseases; College of Sciences and Mathematics at Rowan University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Public Health Service grants R56-A1097171 to C.K., R01-A1067946 and R01-A1120989 to J.S.O. from the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/), and by the College of Sciences and Mathematics at Rowan University (https://www.rowan.edu/home/science-mathematics).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacsa S, 2011, J GEN VIROL, V92, P733, DOI 10.1099/vir.0.027052-0; BALLAS ZK, 1990, J ALLERGY CLIN IMMUN, V85, P453, DOI 10.1016/0091-6749(90)90155-W; Barron MJ, 2008, HUM MOL GENET, V17, P3509, DOI 10.1093/hmg/ddn243; Bhargava AK, 2016, VIROLOGY, V499, P267, DOI 10.1016/j.virol.2016.09.019; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Carlsten M, 2009, J IMMUNOL, V183, P4921, DOI 10.4049/jimmunol.0901226; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Chan CJ, 2012, CURR OPIN IMMUNOL, V24, P246, DOI 10.1016/j.coi.2012.01.009; Cheshenko N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006766; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Cocchi F, 1998, J VIROL, V72, P9992, DOI 10.1128/JVI.72.12.9992-10002.1998; de Andrade LF, 2014, IMMUNOL CELL BIOL, V92, P237, DOI 10.1038/icb.2013.95; De Pelsmaeker S, 2018, J VIROL, V92, DOI 10.1128/JVI.02105-17; Deuss FA, 2017, J BIOL CHEM, V292, P11413, DOI 10.1074/jbc.M117.786483; Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; Fan Q, 2012, J VIROL, V86, P4468, DOI 10.1128/JVI.00041-12; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Fuchs A, 2006, SEMIN CANCER BIOL, V16, P359, DOI 10.1016/j.semcancer.2006.07.002; Gao J, 2017, CANCER SCI, V108, P1934, DOI 10.1111/cas.13324; Georgiev H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01072; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; GONG JH, 1994, LEUKEMIA, V8, P652; Grauwet K, 2014, P NATL ACAD SCI USA, V111, P16118, DOI 10.1073/pnas.1409485111; Handler CG, 1996, J VIROL, V70, P6067, DOI 10.1128/JVI.70.9.6067-6070.1996; Harrison OJ, 2012, NAT STRUCT MOL BIOL, V19, P906, DOI 10.1038/nsmb.2366; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Hsu JL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004811; Huber MT, 2001, J VIROL, V75, P10309, DOI 10.1128/JVI.75.21.10309-10318.2001; Inagaki M, 2005, DEVELOPMENT, V132, P1525, DOI 10.1242/dev.01697; Kaname T, 2007, AM J HUM GENET, V81, P835, DOI 10.1086/522014; Kearney CJ, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1196308; KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Krummenacher C, 2004, VIROLOGY, V322, P286, DOI 10.1016/j.virol.2004.02.005; Krummenacher C, 2003, J VIROL, V77, P8985, DOI 10.1128/JVI.77.16.8985-8999.2003; Krummenacher C, 2002, J VIROL, V76, P2424, DOI 10.1128/JVI.76.5.2424-2433.2002; Krummenacher C, 1999, J VIROL, V73, P8127, DOI 10.1128/JVI.73.10.8127-8137.1999; Krummenacher C, 1998, J VIROL, V72, P7064, DOI 10.1128/JVI.72.9.7064-7074.1998; Krummenacher C, 2000, J VIROL, V74, P10863, DOI 10.1128/JVI.74.23.10863-10872.2000; Krummenacher C, 2013, ADV EXP MED BIOL, V790, P178, DOI 10.1007/978-1-4614-7651-1_10; Levi-Schaffer F, 2018, TRENDS IMMUNOL, V39, P112, DOI 10.1016/j.it.2017.10.001; Li A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006314; Lu GW, 2014, J VIROL, V88, P13678, DOI 10.1128/JVI.01906-14; Mandai K, 2015, CURR TOP DEV BIOL, V112, P197, DOI 10.1016/bs.ctdb.2014.11.019; Martin TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082696; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Meyer D, 2009, J BIOL CHEM, V284, P2235, DOI 10.1074/jbc.M807698200; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Mizutani K, 2016, BIOCHEM J, V473, P2691, DOI 10.1042/BCJ20160235; Monaco-Shawver L, 2011, J LEUKOCYTE BIOL, V89, P113, DOI 10.1189/jlb.0410200; Mori Masahiro, 2014, Adv Neurobiol, V8, P91; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Munz C, 2017, F1000RES, V6, pF1000; Narita H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197368; Noyce RS, 2012, TRENDS MICROBIOL, V20, P429, DOI 10.1016/j.tim.2012.05.006; Oosterhoff D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/358462; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Prod'homme V, 2010, J GEN VIROL, V91, P2034, DOI 10.1099/vir.0.021931-0; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; Samanta D, 2017, MOL IMMUNOL, V81, P151, DOI 10.1016/j.molimm.2016.12.003; Samanta D, 2012, P NATL ACAD SCI USA, V109, P14836, DOI 10.1073/pnas.1212912109; Seth S, 2007, BIOCHEM BIOPH RES CO, V364, P959, DOI 10.1016/j.bbrc.2007.10.102; SISK WP, 1994, J VIROL, V68, P766, DOI 10.1128/JVI.68.2.766-775.1994; Stamm H, 2018, MAMM GENOME, V29, P694, DOI 10.1007/s00335-018-9770-7; Stanietsky N, 2010, FEBS LETT, V584, P4895, DOI 10.1016/j.febslet.2010.08.047; Stengel KF, 2012, P NATL ACAD SCI USA, V109, P5399, DOI 10.1073/pnas.1120606109; Stiles KM, 2008, VIROLOGY, V373, P98, DOI 10.1016/j.virol.2007.11.012; Stiles KM, 2010, J VIROL, V84, P11646, DOI 10.1128/JVI.01550-10; Stiles KM, 2010, VIROLOGY, V399, P109, DOI 10.1016/j.virol.2009.12.034; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; TESSIER DC, 1991, GENE, V98, P177, DOI 10.1016/0378-1119(91)90171-7; Tomasec P, 2005, NAT IMMUNOL, V6, P181, DOI 10.1038/ni1156; WANG PL, 1992, J IMMUNOL, V148, P2600; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Watzl C, 2012, FRONT BIOSCI-LANDMRK, V17, P1418, DOI 10.2741/3995; Whitbeck JC, 1997, J VIROL, V71, P6083, DOI 10.1128/JVI.71.8.6083-6093.1997; Willis SH, 1998, J VIROL, V72, P5937, DOI 10.1128/JVI.72.7.5937-5947.1998; Willis SH, 1998, METH MOLEC MED, V10, P131, DOI 10.1385/0-89603-347-3:131; Xu F, 2017, CANCER IMMUNOL IMMUN, V66, P1367, DOI 10.1007/s00262-017-2031-x; Yamada M, 2018, SURG TODAY, V48, P510, DOI 10.1007/s00595-017-1618-3; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Yu ZK, 2007, MOL THER, V15, P103, DOI 10.1038/sj.mt.6300009; Zhang N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1571; Zhang Z, 2012, TOHOKU J EXP MED, V226, P59, DOI [10.6120/tjem.226.59, 10.1620/tjem.226.59]; Zhu YW, 2016, J EXP MED, V213, P167, DOI 10.1084/jem.20150785	90	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0212443	10.1371/journal.pone.0212443	http://dx.doi.org/10.1371/journal.pone.0212443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759143	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300086
J	Williams, CA; Wedgwood, KCA; Mohammadi, H; Prouse, K; Tomlinson, OW; Tsaneva-Atanasova, K				Williams, Craig A.; Wedgwood, Kyle C. A.; Mohammadi, Hossein; Prouse, Katie; Tomlinson, Owen W.; Tsaneva-Atanasova, Krasimira			Cardiopulmonary responses to maximal aerobic exercise in patients with cystic fibrosis	PLOS ONE			English	Article							OXYGEN-UPTAKE; COMPUTATIONAL MODEL; CELLULAR-METABOLISM; MATHEMATICAL-MODEL; PULMONARY-FUNCTION; SKELETAL-MUSCLE; GAS-EXCHANGE; YOUNG-PEOPLE; BLOOD-FLOW; CHILDREN	Cystic fibrosis (CF) is a debilitating chronic condition, which requires complex and expensive disease management. Exercise has now been recognised as a critical factor in improving health and quality of life in patients with CF. Hence, cardiopulmonary exercise testing (CPET) is used to determine aerobic fitness of young patients as part of the clinical management of CF. However, at present there is a lack of conclusive evidence for one limiting system of aerobic fitness for CF patients at individual patient level. Here, we perform detailed data analysis that allows us to identify important systems-level factors that affect aerobic fitness. We use patients' data and principal component analysis to confirm the dependence of CPET performance on variables associated with ventilation and metabolic rates of oxygen consumption. We find that the time at which participants cross the gas exchange threshold (GET) is well correlated with their overall performance. Furthermore, we propose a predictive modelling framework that captures the relationship between ventilatory dynamics, lung capacity and function and performance in CPET within a group of children and adolescents with CF. Specifically, we show that using Gaussian processes (GP) we can predict GET at the individual patient level with reasonable accuracy given the small sample size of the available group of patients. We conclude by presenting an example and future perspectives for improving and extending the proposed framework. The modelling and analysis have the potential to pave the way to designing personalised exercise programmes that are tailored to specific individual needs relative to patient's treatment therapies.	[Williams, Craig A.; Tomlinson, Owen W.] Univ Exeter, Childrens Hlth & Exercise Res Ctr, Sport & Hlth Sci, Exeter, Devon, England; [Wedgwood, Kyle C. A.; Mohammadi, Hossein; Prouse, Katie; Tsaneva-Atanasova, Krasimira] Univ Exeter, Dept Math, Exeter, Devon, England; [Wedgwood, Kyle C. A.; Mohammadi, Hossein; Prouse, Katie; Tsaneva-Atanasova, Krasimira] Univ Exeter, Living Syst Inst, Exeter, Devon, England; [Wedgwood, Kyle C. A.; Tsaneva-Atanasova, Krasimira] Univ Exeter, Ctr Biomed Modelling & Anal, Exeter, Devon, England; [Mohammadi, Hossein; Tsaneva-Atanasova, Krasimira] Univ Exeter, EPSRC Ctr Predict Modelling Healthcare, Exeter, Devon, England	University of Exeter; University of Exeter; University of Exeter; University of Exeter; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Exeter	Williams, CA (corresponding author), Univ Exeter, Childrens Hlth & Exercise Res Ctr, Sport & Hlth Sci, Exeter, Devon, England.	c.a.williams@exeter.ac.uk	Tomlinson, Owen William/S-6595-2019; Tsaneva-Atanasova, Krasimira T/AAG-6766-2019; Williams, Craig Anthony/AAQ-8954-2020	Tomlinson, Owen William/0000-0003-4063-7682; Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Williams, Craig Anthony/0000-0002-1740-6248; Mohammadi, Hossein/0000-0003-2602-6017	Wellcome Trust [WT105618MA]; ISSF2 Wellcome Trust Seed Corn Fund; Engineering and Physical Sciences Research Council [EP/N014391/1]; EPSRC [EP/N014391/1] Funding Source: UKRI; MRC [MR/P01478X/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); ISSF2 Wellcome Trust Seed Corn Fund; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	KCAW was generously supported by the Wellcome Trust Institutional Strategic Support Award (WT105618MA) and the ISSF2 Wellcome Trust Seed Corn Fund. KTA gratefully acknowledges the financial support of the Engineering and Physical Sciences Research Council via grant EP/N014391/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2015, J CLIN EPIDEMIOL, V68, P1336, DOI 10.1016/j.jclinepi.2014.12.010; ANDREASSON B, 1987, ACTA PAEDIATR SCAND, V76, P70, DOI 10.1111/j.1651-2227.1987.tb10417.x; Angelis A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1061-3; [Anonymous], 2017, STAND CAR GOOD CLIN; Bailer-Jones CAL, 1997, P AUSTR AS PAC FOR I; Balfour-Lynn IM, 2014, PAEDIATR RESPIR REV, V15, P2, DOI 10.1016/j.prrv.2014.04.003; Barker AR, 2011, BRIT J SPORT MED, V45, P498, DOI 10.1136/bjsm.2009.063180; Bates JHT, 2009, LUNG MECHANICS: AN INVERSE MODELING APPROACH, P1, DOI 10.1017/CBO9780511627156; Batzel JJ, 2005, J MATH BIOL, V50, P293, DOI 10.1007/s00285-004-0293-3; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bell C, 2001, EXP PHYSIOL, V86, P667, DOI 10.1113/eph8602150; Benson AP, 2013, J APPL PHYSIOL, V115, P743, DOI 10.1152/japplphysiol.00184.2013; Chen VCP, 2006, IIE TRANS, V38, P273, DOI 10.1080/07408170500232495; Cloutier M, 2009, J R SOC INTERFACE; COOPER PJ, 1990, PEDIATR PULM, V8, P16, DOI 10.1002/ppul.1950080107; Crooke PS, 2002, MATH COMPUT MODEL, V35, P1297, DOI 10.1016/S0895-7177(02)00086-9; Cystic Fibrosis Trust, 2016, UK CYST FIBR REG 201; DAngelo C, 2007, MULTISCALE MODELLING; Dash RK, 2008, IEEE T BIO-MED ENG, V55, P1298, DOI 10.1109/TBME.2007.913422; Dash RK, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-14; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Elstad M, 2002, J PHYSIOL-LONDON, V543, P719, DOI 10.1113/jphysiol.2002.019422; Eriksson A, 2016, MATH COMP MODEL DYN, V22, P21, DOI 10.1080/13873954.2015.1083592; Forrester AIJ, 2007, P MATH PHYS ENG SCI; Forrester AIJ, 2009, PROG AEROSP SCI, V45, P50, DOI 10.1016/j.paerosci.2008.11.001; Fresiello L, 2015, J BIOMED INFORM, V57, P100, DOI 10.1016/j.jbi.2015.07.004; Fresiello L, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00189; Goodson HV, 2010, METHOD CELL BIOL, V95, P175, DOI 10.1016/S0091-679X(10)95010-3; Gutierrez G, 2004, AM J RESP CRIT CARE, V169, P525, DOI 10.1164/rccm.200305-702OC; Hardman JG, 2006, BRIT J ANAESTH, V97, P589, DOI 10.1093/bja/ael272; Hardman JG, 1998, BRIT J ANAESTH, V81, P327, DOI 10.1093/bja/81.3.327; Hayes D, 2014, AM J RESP CRIT CARE, V190, P898, DOI 10.1164/rccm.201407-1382OC; Hebestreit H, 2015, RESPIRATION, V90, P332, DOI 10.1159/000439057; Hermans MP, 2013, EUR J PREV CARDIOL, V20, P1095, DOI 10.1177/2047487312449414; Holford N, 2010, CLIN PHARMACOL THER, V88, P166, DOI 10.1038/clpt.2010.114; Hulzebos HJ, 2012, J CYST FIBROS, V11, P550, DOI 10.1016/j.jcf.2012.05.004; Jin R, 2001, STRUCT MULTIDISCIP O, V23, P1, DOI 10.1007/s00158-001-0160-4; Jin R, 2002, P DETC 02 ASME 2002; Jones DR, 1998, J GLOBAL OPTIM, V13, P455, DOI 10.1023/A:1008306431147; Kalaitzis AA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-180; Kapellos GE, 2010, MATH BIOSCI, V225, P83, DOI 10.1016/j.mbs.2010.03.003; Kek K, 2006, ENG MED BIOL SOC 200; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Kim J, 2007, ANN BIOMED ENG, V35, P69, DOI [10.1007/s10439-006-9201-x, 10.1007/s10439-006-9210-x]; Kleijnen JPC, 2009, EUR J OPER RES, V192, P707, DOI 10.1016/j.ejor.2007.10.013; Krauss M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002750; Lai N, 2007, ANN BIOMED ENG, V35, P956, DOI 10.1007/s10439-007-9271-4; Lai N, 2007, J APPL PHYSIOL, V103, P1366, DOI 10.1152/japplphysiol.00489.2007; Lawrence N. D., 2007, ADV NEURAL INFORM PR, P785; Li YJ, 2012, CELL MOL BIOENG, V5, P92, DOI 10.1007/s12195-011-0210-y; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Liu JZ, 2002, BIOPHYS J, V82, P2344, DOI 10.1016/S0006-3495(02)75580-X; Mazzoleni MJ, 2016, SPORTS ENG, V19, P117, DOI 10.1007/s12283-015-0193-3; McCahon RA, 2008, BRIT J ANAESTH, V101, P358, DOI 10.1093/bja/aen181; Middleton PG, 2014, PAEDIATR RESPIR REV, V15, P281, DOI 10.1016/j.prrv.2014.05.003; Mintun MA, 2001, P NATL ACAD SCI USA, V98, P6859, DOI 10.1073/pnas.111164398; Moppett IK, 2007, ANESTH ANALG, V105, P1094, DOI 10.1213/01.ane.0000284620.37846.e5; Moxnes JF, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-7; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Ng LJ, 2012, EUR J APPL PHYSIOL, V112, P1229, DOI 10.1007/s00421-011-2062-5; NIXON PA, 1992, NEW ENGL J MED, V327, P1785, DOI 10.1056/NEJM199212173272504; Noble D, 2002, SCIENCE, V295, P1678, DOI 10.1126/science.1069881; ORENSTEIN DM, 1981, CHEST, V80, P392, DOI 10.1378/chest.80.4.392; Perez M, 2014, PEDIATR PULM, V49, P641, DOI 10.1002/ppul.22878; Peronnet F, 2006, RESP PHYSIOL NEUROBI, V150, P4, DOI 10.1016/j.resp.2005.04.005; Pianosi P, 2005, THORAX, V60, P50, DOI 10.1136/thx.2003.008102; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Reynolds A, 2010, J THEOR BIOL, V264, P161, DOI 10.1016/j.jtbi.2010.01.011; Stirling J, 2008, J NONLINEAR MATH PHY, V15, P426, DOI 10.2991/jnmp.2008.15.s3.41; Sacks J., 1989, STAT SCI, V4, P409, DOI [10.1214/ss/1177012413, DOI 10.1214/SS/1177012413]; SALH W, 1989, THORAX, V44, P1006, DOI 10.1136/thx.44.12.1006; Saynor ZL, 2013, J CYST FIBROS, V12, P644, DOI 10.1016/j.jcf.2013.04.012; Saynor ZL, 2013, J SCI MED SPORT, V16, P539, DOI 10.1016/j.jsams.2013.01.010; Saynor ZL, 2014, MED SCI SPORT EXER, V46, P2271, DOI 10.1249/MSS.0000000000000369; Schneiderman-Walker J, 2000, J PEDIATR-US, V136, P304, DOI 10.1067/mpd.2000.103408; Schwaighofer A., 2004, ADV NEURAL INFORM PR; Seethala RR, 2010, CURR OPIN CRIT CARE, V16, P196, DOI 10.1097/MCC.0b013e328338c121; Stevens D, 2010, J CYST FIBROS, V9, P302, DOI 10.1016/j.jcf.2010.03.004; Stevens D, 2011, APPL PHYSIOL NUTR ME, V36, P920, DOI [10.1139/h11-117, 10.1139/H11-117]; Swain PS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13766; Taylor-Robinson D, 2012, THORAX, V67, P860, DOI 10.1136/thoraxjnl-2011-200953; Thin AG, 2004, RESP MED, V98, P1063, DOI 10.1016/j.rmed.2004.03.016; Thin AG, 2002, CHEST, V121, P1761, DOI 10.1378/chest.121.6.1761; Timischl S., 1998, GLOBAL MODEL CARDIOV; Titsias MK, 2009, VARIATIONAL LEARNING; Ursino M, 1998, AM J PHYSIOL-HEART C, V275, pH1733, DOI 10.1152/ajpheart.1998.275.5.H1733; Vilozni D, 2007, CHEST, V131, P356, DOI 10.1378/chest.06-1351; Walter G, 1999, J PHYSIOL-LONDON, V519, P901, DOI 10.1111/j.1469-7793.1999.0901n.x; Weir E, 2017, ARCH DIS CHILD, V102, P440, DOI 10.1136/archdischild-2016-310651; Wheatley CM, 2011, EXERC SPORT SCI REV, V39, P155, DOI 10.1097/JES.0b013e3182172a5a; Williams CA, 2013, J SPORT HEALTH SCI, V2, P39, DOI 10.1016/j.jshs.2012.11.002; Zakynthinaki MS, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/	92	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211219	10.1371/journal.pone.0211219	http://dx.doi.org/10.1371/journal.pone.0211219			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759119	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300033
J	Chen, J; Jing, X; Liu, X; Volkmann, AM; Chen, Y; Liu, Y; Li, DD; Han, DL; Guo, YT; Gao, F; Han, N; Wang, XY; Zhao, HZ; Shi, XJ; Dong, YA; Chen, LM; Napier, D; Ma, J				Chen, Jiageng; Jing, Xiyue; Liu, Xiaoqian; Volkmann, Anna-Mari; Chen, Yunfeng; Liu, Yuanyuan; Li, Dandan; Han, Duolan; Guo, Yuting; Gao, Fei; Han, Na; Wang, Xuying; Zhao, Haozuo; Shi, Xinjun; Dong, Yanan; Chen, Liming; Napier, David; Ma, Jun			Assessment of factors affecting diabetes management in the City Changing Diabetes (CCD) study in Tianjin	PLOS ONE			English	Article							QUALITY-OF-LIFE; CARE; PREVALENCE; KNOWLEDGE; MELLITUS; ADULTS; HEALTH; CHINA	Objective This study aimed to identify the local levels of vulnerability among patients with Type-II diabetes (T2DM) in Tianjin. The study was aimed at curbing the rise of T2DM in cities. Methods 229 participants living with T2DM were purposively sampled from hospitals in Tianjin. Collected data were coded and analysed following well-established thematic analysis principles. Results Twelve themes involving 29 factors were associated with diabetes patients' vulnerability: 1. Financial constraints (Low Income, Unemployment, No Medical Insurance/Low ratio reimbursement); 2. Severity of disease (Appearance of symptoms, complications, co-morbidities, high BMI, poor disease control); 3. Health literacy (No/Low/Wrong knowledge of health literacy); 4. Health beliefs (Perceived diabetes indifferently, Passively Acquire Health Knowledge, Distrust of primary health services); 5. Medical environment (Needs not met by Medical Services); 6. Life restrictions (Daily Life, Occupational Restriction); 7. Lifestyle change (Adhering to traditional or unhealthy diet, Lack of exercise, Low-quality sleep); 8. Time poverty (Healthcare-seeking behaviours were limited by work, Healthcare-seeking behaviours were limited by family issues); 9. Mental Condition (Negative emotions towards diabetes, Negative emotions towards life); 10. Levels of Support (Lack of community support, Lack of support from Friends and Family, Lack of Social Support); 11. Social integration (Low Degree of Integration, Belief in Suffering Alone); 12. Experience of transitions (Diet, Dwelling Environment). Conclusion Based on our findings, specific interventions targeting individual patients, family, community and society are needed to improve diabetes control, as well as patients' mental health care and general living conditions.	[Chen, Jiageng; Jing, Xiyue; Liu, Xiaoqian; Chen, Yunfeng; Liu, Yuanyuan; Li, Dandan; Han, Duolan; Guo, Yuting; Gao, Fei; Han, Na; Wang, Xuying; Zhao, Haozuo; Shi, Xinjun; Dong, Yanan; Ma, Jun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China; [Volkmann, Anna-Mari; Napier, David] UCL, London, England; [Chen, Liming] Tianjin Med Univ, Metab Dis Hosp, Tianjin, Peoples R China	Tianjin Medical University; University of London; University College London; Tianjin Medical University	Ma, J (corresponding author), Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China.; Napier, D (corresponding author), UCL, London, England.; Chen, LM (corresponding author), Tianjin Med Univ, Metab Dis Hosp, Tianjin, Peoples R China.	xfx22081@vip.163.com; d.napier@ucl.ac.uk; junma@tmu.edu.cn			Novo Nordisk (China) Pharmaceuticals CO [SD20150204]	Novo Nordisk (China) Pharmaceuticals CO	The funder in study design played the role of data collection and decision to publish. The study was funded by Novo Nordisk (China) Pharmaceuticals CO (Award NO.: SD20150204), http://www.novonordisk.com.cn/.	Alouki K, 2016, LIFESTYLE INTERVENTI, V2016, DOI [10.1155/2016/2159890, DOI 10.1155/2016/2159890]; Atlas D., 2021, IDF DIABETES ATLAS, V10th edn; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bootle S, 2015, DIABETES RES CLIN PR, V109, P6, DOI 10.1016/j.diabres.2015.04.004; CCD, 2015, CHIN NAT PLAN NCD PR; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Federation I. D., 2006, IDF DIABETES ATLAS; Federation ID, 2013, IDF DIABETES ATLAS; Gerstein HC, 2006, CAN MED ASSOC J, V174, P25, DOI 10.1503/cmaj.050649; Gois Carlos, 2012, BMC Res Notes, V5, P271, DOI 10.1186/1756-0500-5-271; HAMMAN RF, 1992, DIABETES METAB REV, V8, P287, DOI 10.1002/dmr.5610080402; Hayes A, 2016, VALUE HEALTH, V19, P36, DOI 10.1016/j.jval.2015.10.010; Hu J, 2013, J CLIN NURS, V22, P51, DOI 10.1111/j.1365-2702.2012.04273.x; KING H, 1993, DIABETES CARE, V16, P157, DOI 10.2337/diacare.16.1.157; Kueh YC, 2017, PSYCHOL HEALTH MED, V22, P138, DOI 10.1080/13548506.2016.1147055; Kueh YC, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0303-8; Miao YD, 2014, IRAN J PUBLIC HEALTH, V43, P769; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; Ngo-Metzger Q, 2012, J GEN INTERN MED, V27, P432, DOI 10.1007/s11606-011-1910-7; Pachucki MC, 2015, CURR OBES REP, V4, P217, DOI 10.1007/s13679-015-0145-z; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Voils CI, 2013, PREV MED, V56, P46, DOI 10.1016/j.ypmed.2012.11.001; WHO, 2015, REP ON DIAB; Xu WL, 2012, CAN J DIABETES, V36, P108, DOI 10.1016/j.jcjd.2012.04.014; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; ZIMMET PZ, 1995, DIABETES CARE, V18, P1050, DOI 10.2337/diacare.18.7.1050	27	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0209222	10.1371/journal.pone.0209222	http://dx.doi.org/10.1371/journal.pone.0209222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753195	Green Published, Green Submitted, gold			2022-12-26	WOS:000458395600004
J	Zhang, XM; Estoque, RC; Xie, HL; Murayama, Y; Ranagalage, M				Zhang, Xinmin; Estoque, Ronald C.; Xie, Hualin; Murayama, Yuji; Ranagalage, Manjula			Bibliometric analysis of highly cited articles on ecosystem services	PLOS ONE			English	Article							CLIMATE-CHANGE; LAND-USE; LINKING BIODIVERSITY; LANDSCAPE PATTERN; PAYMENTS; TRADEOFFS; SCIENCE; IMPACTS; FUTURE; VALUES	This paper presents global research trends involving highly cited articles on ecosystem services from 1981 to 2017 based on a bibliometric analysis of such articles from the SCI-E and SSCI databases of the Web of Science. The analysis revealed that there were 132 highly cited articles, most of which were published between 2005 and 2014. Based on author keywords, the term ecosystem services was strongly linked to biodiversity. The top three journals in terms of total number of highly cited articles published were Ecological Economics, PNAS, and Ecological Indicators. Despite ranking sixth overall, Science ranked first in both impact factor and total citations per article. The US, UK, Netherlands, Spain, and Sweden were the top five most productive and cooperative countries in the world based on total number of highly cited articles and co-authorship network, respectively. The US was highly connected to Canada, the Netherlands, China and the UK. Stockholm University and Stanford University were the most productive institutions in Europe and North America, respectively. Stanford University is associated with many scholars in the field of ecosystem services research because of the InVEST model. Robert Costanza was the most prolific and highly cited author, the latter being largely due to the first valuation of the world's ecosystem services and natural capital, he and his co-authors published in 1997 in Nature. Terrestrial, urban, and forest ecosystems were the top types of ecosystems assessed. Regulating and provisioning services were the major ecosystem services studied. Quantitative and qualitative assessments were the main research focus. Most of these highly cited studies on ecosystem services are done on areas geographically located in North America and Europe.	[Zhang, Xinmin; Ranagalage, Manjula] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Estoque, Ronald C.] Natl Inst Environm Studies, Ctr Social & Environm Syst Res, Tsukuba, Ibaraki, Japan; [Xie, Hualin] Jiangxi Univ Finance & Econ, Inst Ecol Civilizat, Nanchang, Jiangxi, Peoples R China; [Murayama, Yuji] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Ranagalage, Manjula] Rajarata Univ Sri Lanka, Fac Social Sci & Humanities, Mihintale, Sri Lanka	University of Tsukuba; National Institute for Environmental Studies - Japan; Jiangxi University of Finance & Economics; University of Tsukuba; Rajarata University of Sri Lanka	Zhang, XM (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	xinmin@geoenv.tsukuba.ac.jp	Estoque, Ronald C./Q-3769-2016; Ranagalage, Manjula/J-3729-2019; Murayama, Yuji/B-3161-2014; Murayama, Yuji/V-3578-2019	Estoque, Ronald C./0000-0001-9681-492X; Ranagalage, Manjula/0000-0001-7540-0103; Murayama, Yuji/0000-0003-4397-6882; Murayama, Yuji/0000-0003-4397-6882; Zhang, Xinmin/0000-0002-5180-8371; Xie, Hualin/0000-0002-4951-4526	Japan Society for the Promotion of Science (JSPS) [17J00502, 16K12816]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Japan Society for the Promotion of Science (JSPS) under a grant for Doctoral Fellowship (ID No. 17J00502) and Challenging Exploratory Research (ID No. 16K12816).	Aksnes DW, 2003, RES EVALUAT, V12, P159, DOI 10.3152/147154403781776645; Andrew ME, 2015, GISCI REMOTE SENS, V52, P344, DOI 10.1080/15481603.2015.1033809; Balvanera P, 2012, ECOSYST SERV, V2, P56, DOI 10.1016/j.ecoser.2012.09.006; Balvanera P, 2014, BIOSCIENCE, V64, P49, DOI 10.1093/biosci/bit003; Barbosa FG, 2015, ECOL MODEL, V313, P77, DOI 10.1016/j.ecolmodel.2015.06.014; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Boumans R, 2002, ECOL ECON, V41, P529, DOI 10.1016/S0921-8009(02)00098-8; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; CASTRO R, 1997, GLOB C KNOWL DEV INF; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Chiu WT, 2005, SCIENTOMETRICS, V63, P3, DOI 10.1007/s11192-005-0201-7; Clarivate Analytics, 2018, J CITATION REPORTS; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 2007, ECOL ECON, V61, P478, DOI 10.1016/j.ecolecon.2006.03.021; Costanza R, 2016, ECOL ECON, V123, P68, DOI 10.1016/j.ecolecon.2016.01.007; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Costanza R, 2012, ECOSYST SERV, V1, P16, DOI 10.1016/j.ecoser.2012.06.002; Daily G.C., 1997, ISSUES ECOLOGY, V1, P1; de Groot R, 2012, ECOSYST SERV, V1, P50, DOI 10.1016/j.ecoser.2012.07.005; Ehrlich P.R., 1981, EXTINCTION; Englund O, 2017, ECOL INDIC, V73, P492, DOI 10.1016/j.ecolind.2016.10.009; Mastrangelo ME, 2015, ECOSYST SERV, V16, P63, DOI 10.1016/j.ecoser.2015.10.001; Estoque RC, 2019, AMBIO, V48, P619, DOI 10.1007/s13280-018-1090-3; Estoque RC, 2016, LANDSCAPE ECOL, V31, P1481, DOI 10.1007/s10980-016-0341-6; Estoque RC, 2013, LANDSCAPE URBAN PLAN, V116, P60, DOI 10.1016/j.landurbplan.2013.04.008; Fahimnia B, 2015, INT J PROD ECON, V162, P101, DOI 10.1016/j.ijpe.2015.01.003; Fu BJ, 2015, J SOIL SEDIMENT, V15, P833, DOI 10.1007/s11368-015-1082-x; Fu HZ, 2016, SCIENTOMETRICS, V109, P337, DOI 10.1007/s11192-016-1992-4; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Ho Y. S., 2015, CAN SOC SCI, V11, P50, DOI DOI 10.3968/6453S; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Jack BK, 2008, P NATL ACAD SCI USA, V105, P9465, DOI 10.1073/pnas.0705503104; Jiang W, 2017, ECOSYST SERV, V26, P10, DOI 10.1016/j.ecoser.2017.05.012; Jim CY, 2008, J ENVIRON MANAGE, V88, P665, DOI 10.1016/j.jenvman.2007.03.035; Khan MA, 2012, SCI TOTAL ENVIRON, V431, P122, DOI 10.1016/j.scitotenv.2012.05.035; Kosoy N, 2008, GEOFORUM, V39, P2073, DOI 10.1016/j.geoforum.2008.08.007; Kreuter UP, 2001, ECOL ECON, V39, P333, DOI 10.1016/S0921-8009(01)00250-6; Kull CA, 2015, GEOFORUM, V61, P122, DOI 10.1016/j.geoforum.2015.03.004; Li BJ, 2016, ECOL INDIC, V71, P416, DOI 10.1016/j.ecolind.2016.07.017; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Loomis J, 2000, ECOL ECON, V33, P103, DOI 10.1016/S0921-8009(99)00131-7; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Maes J, 2012, BIOL CONSERV, V155, P1, DOI 10.1016/j.biocon.2012.06.016; Martinez MA, 2014, SCIENTOMETRICS, V98, P1971, DOI 10.1007/s11192-013-1155-9; Maseyk FJF, 2017, CONSERV LETT, V10, P211, DOI 10.1111/conl.12242; McDonough K, 2017, ECOSYST SERV, V25, P82, DOI 10.1016/j.ecoser.2017.03.022; MEA, 2005, EC HUM WELL BEING SY, DOI DOI 10.1119/1.2344558; MEA, 2003, ECOSYSTEMS HUMAN WEL; Mori H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057371; Perianes-Rodriguez A, 2016, J INFORMETR, V10, P1178, DOI 10.1016/j.joi.2016.10.006; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Reed MS, 2017, GLOBAL ENVIRON CHANG, V43, P92, DOI 10.1016/j.gloenvcha.2016.12.009; Ricketts TH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13106; Robertson MM, 2004, GEOFORUM, V35, P361, DOI 10.1016/j.geoforum.2003.06.002; Robertson MM, 2006, ENVIRON PLANN D, V24, P367, DOI 10.1068/d3304; Rodriguez JP, 2006, ECOL SOC, V11; Runting RK, 2017, GLOBAL CHANGE BIOL, V23, P28, DOI 10.1111/gcb.13457; Schagner JP, 2013, ECOSYST SERV, V4, P33, DOI 10.1016/j.ecoser.2013.02.003; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Sherrouse BC, 2011, APPL GEOGR, V31, P748, DOI 10.1016/j.apgeog.2010.08.002; Shoyama K, 2017, ECOSYST SERV, V26, P316, DOI 10.1016/j.ecoser.2017.03.013; Sutton PC, 2002, ECOL ECON, V41, P509, DOI 10.1016/S0921-8009(02)00097-6; Tallis H, 2009, ANN NY ACAD SCI, V1162, P265, DOI 10.1111/j.1749-6632.2009.04152.x; Tan J, 2014, SCIENTOMETRICS, V98, P1473, DOI 10.1007/s11192-013-1125-2; *TEEB, 2010, EC EC BIOD TEEB EC E; Troy A, 2006, ECOL ECON, V60, P435, DOI 10.1016/j.ecolecon.2006.04.007; van de Sand I, 2012, ECOL SOC, V17, DOI 10.5751/ES-04561-170111; van den Belt M, 2014, ECOSYST SERV, V9, P115, DOI 10.1016/j.ecoser.2014.05.005; Waltman L, 2015, J INFORMETR, V9, P872, DOI 10.1016/j.joi.2015.08.001; Wang MH, 2011, DESALIN WATER TREAT, V28, P353, DOI 10.5004/dwt.2011.2412; Wangai PW., 2016, INT J SUSTAINABLE BU, V5, P225, DOI [10.1016/j.ijsbe.2016.08.005, DOI 10.1016/J.IJSBE.2016.08.005]; Wen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058432; Wu KY, 2013, CITIES, V31, P276, DOI 10.1016/j.cities.2012.08.003; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010; Xiang CY, 2017, ECOL ENG, V99, P400, DOI 10.1016/j.ecoleng.2016.11.028; Xu WH, 2017, P NATL ACAD SCI USA, V114, P1601, DOI 10.1073/pnas.1620503114; Zhang J, 2016, J ASSOC INF SCI TECH, V67, P967, DOI 10.1002/asi.23437; Zhang L, 2010, ECOL ENG, V36, P973, DOI 10.1016/j.ecoleng.2010.04.029; Zhang Lingling, 2016, Acta Ecologica Sinica, V36, P5967; Zhao B, 2004, LAND USE POLICY, V21, P139, DOI 10.1016/j.landusepol.2003.10.003; Zheng XY, 2018, LAND USE POLICY, V79, P94, DOI 10.1016/j.landusepol.2018.07.043	84	68	70	16	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0210707	10.1371/journal.pone.0210707	http://dx.doi.org/10.1371/journal.pone.0210707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL0OI	30742632	Green Published, Green Submitted, gold			2022-12-26	WOS:000458393400066
J	Takenaka, N; Araki, N; Satoh, T				Takenaka, Nobuyuki; Araki, Natsumi; Satoh, Takaya			Involvement of the protein kinase Akt2 in insulin-stimulated Rac1 activation leading to glucose uptake in mouse skeletal muscle	PLOS ONE			English	Article							SMALL GTPASE RAC1; NUCLEOTIDE-EXCHANGE FACTOR; GLUT4 TRANSLOCATION; PLASMA-MEMBRANE; RALA DOWNSTREAM; MICE LACKING; GLUCOSE-TRANSPORTER-4; RECRUITMENT; ADIPOCYTES; TRANSPORT	Translocation of the glucose transporter GLUT4 to the sarcolemma accounts for glucose uptake in skeletal muscle following insulin administration. The protein kinase Akt2 and the small GTPase Rac1 have been implicated as essential regulators of insulin-stimulated GLUT4 translocation. Several lines of evidence suggest that Rac1 is modulated downstream of Akt2, and indeed the guanine nucleotide exchange factor FLJ00068 has been identified as an activator of Rac1. On the other hand, the mechanisms whereby Akt2 and Rac1 are regulated in parallel downstream of phosphoinositide 3-kinase are also proposed. Herein, we aimed to provide additional evidence that support a critical role for Akt2 in insulin regulation of Rac1 in mouse skeletal muscle. Knockdown of Akt2 by RNA interference abolished Rac1 activation following intravenous administration of insulin or ectopic expression of a constitutively activated phosphoinositide 3-kinase mutant. The activation of another small GTPase RalA and GLUT4 translocation to the sarcolemma following insulin administration or ectopic expression of a constitutively activated form of phosphoinositide 3-kinase, but not Rac1, were also diminished by downregulation of Akt2 expression. Collectively, these results strongly support the notion that Rac1 acts downstream of Akt2 leading to the activation of RalA and GLUT4 translocation to the sarcolemma in skeletal muscle.	[Takenaka, Nobuyuki; Araki, Natsumi; Satoh, Takaya] Osaka Prefecture Univ, Dept Biol Sci, Cell Biol Lab, Sakai, Osaka, Japan	Osaka Metropolitan University	Satoh, T (corresponding author), Osaka Prefecture Univ, Dept Biol Sci, Cell Biol Lab, Sakai, Osaka, Japan.	tkysato@b.s.osakafu-u.ac.jp	Satoh, Takaya/K-2628-2014	Satoh, Takaya/0000-0001-9543-700X	Ministry of Education, Culture, Sports, Science and Technology of Japan [17K15093]; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation)	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number, 17K15093; URL, https://www.jsps.go.jp/) to NT and a grant from the Naito Foundation (no grant number; URL, https://www.naito-f.or.jp/) to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2001, AM J PHYSIOL-CELL PH, V280, pC637, DOI 10.1152/ajpcell.2001.280.3.C637; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Baumeister MA, 2006, BIOCHEM J, V400, P563, DOI 10.1042/BJ20061020; Bielnicki JA, 2011, J BIOL CHEM, V286, P35163, DOI 10.1074/jbc.M111.270918; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; Chiu TT, 2013, J BIOL CHEM, V288, P17520, DOI 10.1074/jbc.M113.467647; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; Khayat ZA, 2000, J CELL SCI, V113, P279; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; MacKrell JG, 2012, DIABETES, V61, P995, DOI 10.2337/db11-1299; MARCUSOHN J, 1995, CURR BIOL, V5, P1296, DOI 10.1016/S0960-9822(95)00256-9; Nozaki S, 2013, CELL SIGNAL, V25, P1361, DOI 10.1016/j.cellsig.2013.02.023; Nozaki S, 2012, CELL SIGNAL, V24, P2111, DOI 10.1016/j.cellsig.2012.07.013; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Randhawa VK, 2008, J BIOL CHEM, V283, P27208, DOI 10.1074/jbc.M804282200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Satoh T, 2014, INT J MOL SCI, V15, P18677, DOI 10.3390/ijms151018677; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Sylow L, 2014, CELL SIGNAL, V26, P323, DOI 10.1016/j.cellsig.2013.11.007; Sylow L, 2013, DIABETES, V62, P1865, DOI 10.2337/db12-1148; Takenaka N, 2017, CELL SIGNAL, V39, P108, DOI 10.1016/j.cellsig.2017.08.004; Takenaka N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155292; Takenaka N, 2015, BIOCHEM J, V469, P445, DOI 10.1042/BJ20150218; Takenaka N, 2015, ANAL BIOCHEM, V476, P5, DOI 10.1016/j.ab.2014.09.013; Takenaka N, 2014, CELL SIGNAL, V26, P2460, DOI 10.1016/j.cellsig.2014.07.002; Takenaka N, 2014, FEBS J, V281, P1493, DOI 10.1111/febs.12719; Ueda S, 2008, BIOL CELL, V100, P645, DOI 10.1042/BC20070160; Ueda S, 2010, FASEB J, V24, P2254, DOI 10.1096/fj.09-137380	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0212219	10.1371/journal.pone.0212219	http://dx.doi.org/10.1371/journal.pone.0212219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735546	gold, Green Published, Green Submitted			2022-12-26	WOS:000458181200061
J	Canova, C; Anello, P; Amidei, CB; Parolin, V; Zanier, L; Simonato, L				Canova, Cristina; Anello, Paola; Amidei, Claudio Barbiellini; Parolin, Vito; Zanier, Loris; Simonato, Lorenzo			Use of healthcare services at the end of life in decedents compared to their surviving counterparts: A case-control study among adults born before 1946 in Friuli Venezia Giulia	PLOS ONE			English	Article							LONG-TERM-CARE; HOSPITAL UTILIZATION; OLDER-ADULTS; LAST YEARS; DEATH; POPULATION; CANCER; AGE; EXPENDITURE; TIME	Background There is a heterogeneous literature on healthcare utilization patterns at the end of life. The objective of this study is to examine the impact of closeness to death on the utilization of acute hospital-based healthcare services and some primary healthcare services and compare differences in gender, age groups and major causes of death disease specific mortality. Methods A matched case-control study, nested in a cohort of 411,812 subjects, linked to administrative databases was conducted. All subjects were residents in the Friuli Venezia Giulia Region (Italy), born before 1946, alive in January 2000 and were followed up to December 2014. Overall, 158,571 decedents/cases were matched by gender and year of birth to one control, alive at least one year after their matched case's death (index-date). Hospital admissions, emergency department visits, drug prescriptions, specialist visits and laboratory tests that occurred 365 days before death/index-date, have been evaluated. Odds Ratios (ORs) for healthcare utilization were estimated through conditional regression models, further adjusted for Charlson Comorbidity Index and stratified by gender, age groups and major causes of death. Results Decedents were significantly more likely of having at least one hospital admission (OR 7.0, 6.9-7.1), emergency department visit (OR 5.2, 5.1-5.3), drug prescription (OR 2.8, 2.7-2.9), specialist visit (OR 1.4, 1.4-1.4) and laboratory test (OR 2.7, 2.6-2.7) than their matched surviving counterparts. The ORs were generally lower in the oldest age group (95+) than in the youngest (55-74). Healthcare utilization did not vary by sex, but was higher in subjects who died of cancer. Conclusion Closeness to death appeared to be strongly associated with healthcare utilization in adult/elderly subjects. The risk seems to be greater among younger age groups than older ones, especially for acute based services. Reducing acute healthcare at the EOL represents an important issue to improve the quality of life in proximity to death.	[Canova, Cristina; Anello, Paola; Amidei, Claudio Barbiellini; Parolin, Vito; Simonato, Lorenzo] Univ Padua, Dept Cardiothoracovasc Sci & Publ Hlth, Padua, Italy; [Zanier, Loris] Friuli Venezia Giulia Reg, Hlth Directorate, Epidemiol Serv, Udine, Italy	University of Padua	Canova, C (corresponding author), Univ Padua, Dept Cardiothoracovasc Sci & Publ Hlth, Padua, Italy.	cristina.canova@unipd.it		Barbiellini Amidei, Claudio/0000-0002-7792-3781				Atella V, 2014, SOC SCI MED, V114, P10, DOI 10.1016/j.socscimed.2014.05.029; Bahler C, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0698-2; Bekelman JE, 2016, JAMA-J AM MED ASSOC, V315, P272, DOI 10.1001/jama.2015.18603; Bentur N, 2014, AM J HOSP PALLIAT ME, V31, P723, DOI 10.1177/1049909113499604; Bird Chloe E, 2002, J Palliat Med, V5, P705, DOI 10.1089/109662102320880525; Brameld KJ, 1998, J EPIDEMIOL COMMUN H, V52, P740, DOI 10.1136/jech.52.11.740; Brockmann H, 2002, SOC SCI MED, V55, P593, DOI 10.1016/S0277-9536(01)00190-3; Calver J, 2006, AUST NZ J PUBL HEAL, V30, P143, DOI 10.1111/j.1467-842X.2006.tb00107.x; Casotto V, 2017, J PAIN SYMPTOM MANAG, V54, P167, DOI 10.1016/j.jpainsymman.2017.04.004; Dagli Rushabh J, 2014, J Int Oral Health, V6, pi; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; Dormont B, 2006, HEALTH ECON, V15, P947, DOI 10.1002/hec.1165; Forma L, 2017, EUR J PUBLIC HEALTH, V27, P665, DOI 10.1093/eurpub/ckw260; Forma L, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-14; Forma L, 2009, EUR J PUBLIC HEALTH, V19, P313, DOI 10.1093/eurpub/ckp028; Frogatt K, 2017, PALLIATIVE CARE SYST, P99; Gabriele S, DEMOGRAPHIC FACTORS, P33; Geue C, 2014, EUR J HEALTH ECON, V15, P885, DOI 10.1007/s10198-013-0543-7; Gill TM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2361; Goldsbury DE, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1202-8; Goodridge D, 2008, RESP MED, V102, P885, DOI 10.1016/j.rmed.2008.01.007; Howard M, 2017, J PALLIAT MED, V20, P344, DOI 10.1089/jpm.2016.0283; Howdon D, 2018, J HEALTH ECON, V57, P60, DOI 10.1016/j.jhealeco.2017.11.001; Ishizaki T, 2017, GERIATR GERONTOL INT, V17, P737, DOI 10.1111/ggi.12777; Jacobzone S, 2003, GENEVA PAP R I-ISS P, V28, P254, DOI 10.1111/1468-0440.00222; Jakobsson E, 2007, HEALTH POLICY, V82, P276, DOI 10.1016/j.healthpol.2006.10.003; Kronman AC, 2008, J GEN INTERN MED, V23, P1330, DOI 10.1007/s11606-008-0638-5; Legramante JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165939; Levinsky NG, INFLUENCE AGE MEDICA, P7; Liddle R, CONSULTATION PAPER B, P56; Louis DZ, 2016, TUMORI J, V102, P614, DOI 10.5301/tj.5000544; Lyngaa T, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1124-1; Mariotto AB, 2013, J CLIN EPIDEMIOL, V66, P1376, DOI 10.1016/j.jclinepi.2013.07.002; Matthews RS, SAS PROGRAMS SELECT, P9; McGrail K, 2000, AGE AGEING, V29, P249, DOI 10.1093/ageing/29.3.249; Moore PV, 2017, SOC SCI MED, V184, P1, DOI 10.1016/j.socscimed.2017.04.038; Moorin R, 2012, J HEALTH SERV RES PO, V17, P197, DOI 10.1258/jhsrp.2012.011130; Pellizzari M, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12742; Pot AM, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-139; Reeve E, 2018, EXPERT OPIN DRUG SAF, V17, P39, DOI 10.1080/14740338.2018.1397625; Rosenwax LK, 2011, HOSP EMERGENCY DEP U, V194, P4; Sampaio PYS, 2014, J CLIN GERONTOL GERI, V5, P82, DOI 10.1016/j.jcgg.2014.02.005; Seshamani M, 2004, HEALTH ECON, V13, P303, DOI 10.1002/hec.826; Tanuseputro P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121759; Tran B, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009410; Van den Block L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-69; Westerhout EWMT, 2006, CESIFO ECON STUD, V52, P1, DOI 10.1093/cesifo/ifj001; Yang Z, 2003, J GERONTOL B-PSYCHOL, V58, pS2, DOI 10.1093/geronb/58.1.S2; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	49	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0212086	10.1371/journal.pone.0212086	http://dx.doi.org/10.1371/journal.pone.0212086			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5RX	30730965	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000096
J	He, WM; Liang, BS; Wang, CL; Li, SW; Zhao, Y; Huang, Q; Liu, ZX; Yao, ZQ; Wu, QJ; Liao, WJ; Zhang, SY; Liu, YJ; Xiang, Y; Liu, J; Shi, M				He, Wanming; Liang, Bishan; Wang, Chunlin; Li, Shaowei; Zhao, Yang; Huang, Qiong; Liu, Zexian; Yao, Zhiqi; Wu, Qijing; Liao, Wangjun; Zhang, Shuyi; Liu, Yajing; Xiang, Yi; Liu, Jia; Shi, Min			MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer	ONCOGENE			English	Article							TGF-BETA; DRUG-RESISTANCE; CELLS; MECHANISMS; CHEMOTHERAPY; METASTASIS; METABOLISM; SURVIVAL	Chemotherapy is the preferred treatment for advanced stage gastric cancer (GC) patients and chemotherapy resistance is the major obstacle to effective cancer therapy. Increasing evidence suggests that mesenchymal stem cells (MSCs) make important contributions to development of drug resistance. However, the underlying mechanism remains elusive. In this study, we discovered that abundant MSCs in tumor tissues predicted a poor prognosis in GC patients. MSCs promoted stemness and chemoresistance in GC cells through fatty acid oxidation (FAO) in vitro and in vivo. Mechanically, transforming growth factor beta 1 (TGF-beta 1) secretion by MSCs activated SMAD2/3 through TGF-beta receptors and induced long non-coding RNA (lncRNA) MACC1-AS1 expression in GC cells, which promoted FAO-dependent stemness and chemoresistance through antagonizing miR-145-5p. Moreover, pharmacologic inhibition of FAO with etomoxir (ETX) attenuated MSC-induced FOLFOX regiment resistance in vivo. These results suggest that FAO plays an important role in MSC-mediated stemness and chemotherapy resistance in GC and FAO inhibitors in combination with chemotherapeutic drugs present as a promising strategy to overcome chemoresistance.	[He, Wanming; Liang, Bishan; Wang, Chunlin; Li, Shaowei; Zhao, Yang; Huang, Qiong; Yao, Zhiqi; Wu, Qijing; Liao, Wangjun; Zhang, Shuyi; Liu, Yajing; Xiang, Yi; Liu, Jia; Shi, Min] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Liu, Zexian] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; State Key Lab Oncology South China; Sun Yat Sen University	Shi, M (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China.	nfyyshimin@163.com	Liu, Zexian/D-1153-2011	Liu, Zexian/0000-0001-9698-0610	National Key R&D Program of China [2017YFC1105000]; National Natural Science Foundation of China [81702398]; Natural Science Foundation of Guangdong Province of China [2016A020215232]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province)	This study was supported by National Key R&D Program of China (grant number 2017YFC1105000), National Natural Science Foundation of China (grant number 81702398), and Natural Science Foundation of Guangdong Province of China (grant number 2016A020215232).	Ajani JA, 2016, J NATL COMPR CANC NE, V14, P1286, DOI 10.6004/jnccn.2016.0137; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Chen CT, 2010, BBA-GEN SUBJECTS, V1800, P257, DOI 10.1016/j.bbagen.2009.09.001; Davidson M, 2015, CLIN COLORECTAL CANC, V14, P239, DOI 10.1016/j.clcc.2015.05.013; Di Francesco AM, 2016, J CELL PHYSIOL, V231, P2081, DOI 10.1002/jcp.25318; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Digklia A, 2016, WORLD J GASTROENTERO, V22, P2403, DOI 10.3748/wjg.v22.i8.2403; Graversen M, 2017, CLIN EXP METASTAS, V34, P309, DOI 10.1007/s10585-017-9849-7; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hao SH, 2017, NEOPLASIA, V19, P1022, DOI 10.1016/j.neo.2017.10.005; Houthuijzen J, 2012, BRIT J CANCER, V106, P1901, DOI 10.1038/bjc.2012.201; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hung SP, 2013, CELL TRANSPLANT, V22, P1869, DOI 10.3727/096368912X657954; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Kastaniotis AJ, 2017, BBA-MOL CELL BIOL L, V1862, P39, DOI 10.1016/j.bbalip.2016.08.011; Kim HM, 2012, ANN SURG ONCOL, V19, pS539, DOI 10.1245/s10434-011-2040-5; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Lin YY, 2014, MOL CELL BIOL, V34, P2339, DOI 10.1128/MCB.00042-14; Liu B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0706-7; Liu RL, 2015, TUMOR BIOL, V36, P5011, DOI 10.1007/s13277-015-3152-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Novikova IV, 2013, J MOL BIOL, V425, P3731, DOI 10.1016/j.jmb.2013.02.030; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Ricci-Vitiani L, 2009, J MOL MED, V87, P1097, DOI 10.1007/s00109-009-0518-4; Roberto M, 2016, EXPERT REV ANTICANC, V16, P717, DOI 10.1080/14737140.2016.1184979; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shitara K, 2017, GASTRIC CANCER, V20, pS102, DOI 10.1007/s10120-016-0648-7; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Wang H, 2017, J CELL PHYSIOL, V232, P1030, DOI 10.1002/jcp.25499; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang TY, 2018, CELL METAB, V27, P136, DOI 10.1016/j.cmet.2017.11.001; Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Xu Z, 2016, NEURO-ONCOLOGY, V18, P830, DOI 10.1093/neuonc/nov298; Ye HM, 2012, CANCER INVEST, V30, P513, DOI 10.3109/07357907.2012.692171; Yuan SX, 2016, HEPATOLOGY, V63, P499, DOI 10.1002/hep.27893; Zhan M, 2016, TUMOR BIOL, V37, P10553, DOI 10.1007/s13277-016-4957-6; Zhao Y, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0820-2; Zhao Y, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0648-1	49	147	153	4	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2019	38	23					4637	4654		10.1038/s41388-019-0747-0	http://dx.doi.org/10.1038/s41388-019-0747-0			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB4KM	30742067	hybrid, Green Published			2022-12-26	WOS:000470240300014
J	Andrews, D; Oliviero, G; De Chiara, L; Watson, A; Rochford, E; Wynne, K; Kennedy, C; Clerkin, S; Doyle, B; Godson, C; Connell, P; O'Brien, C; Cagney, G; Crean, J				Andrews, Darrell; Oliviero, Giorgio; De Chiara, Letizia; Watson, Ariane; Rochford, Emily; Wynne, Kieran; Kennedy, Ciaran; Clerkin, Shane; Doyle, Benjamin; Godson, Catherine; Connell, Paul; O'Brien, Colm; Cagney, Gerard; Crean, John			Unravelling the transcriptional responses of TGF-: Smad3 and EZH2 constitute a regulatory switch that controls neuroretinal epithelial cell fate specification	FASEB JOURNAL			English	Article						PRC2; differentiation; chromatin; interactome	REPRESSIVE COMPLEX 2; E-CADHERIN; DEVELOPMENTAL GENES; GENOME-WIDE; BETA; EXPRESSION; METHYLATION; CHROMATIN; REVEALS; SNAIL	Cell differentiation is directed by extracellular cues and intrinsic epigenetic modifications, which control chromatin organization and transcriptional activation. Central to this process is PRC2, which modulates the di- and trimethylation of lysine 27 on histone 3; however, little is known concerning the direction of PRC2 to specific loci. Here, we have investigated the physical interactome of EZH2, the enzymatic core of PRC2, during retinoic acid-mediated differentiation of neuroepithelial, pluripotent NT2 cells and the dedifferentiation of neuroretinal epithelial ARPE19 cells in response to TGF-. We identified Smad3 as an EZH2 interactor in both contexts. Co-occupation of the CDH1 promoter by Smad3 and EZH2 and the cooperative, functional nature of the interaction were established. We propose that the interaction between Smad3 and EZH2 targets the core polycomb assembly to defined regions of the genome to regulate transcriptional repression and forms a molecular switch that controls promoter access through epigenetic mechanisms leading to gene silencing.Andrews, D., Oliviero, G., De Chiara, L., Watson, A., Rochford, E., Wynne, K., Kennedy, C., Clerkin, S., Doyle, B., Godson, C., Connell, P., O'Brien, C., Cagney, G., Crean, J. Unravelling the transcriptional responses of TGF-: Smad3 and EZH2 constitute a regulatory switch that controls neuroretinal epithelial cell fate specification.	[Andrews, Darrell; Kennedy, Ciaran; Clerkin, Shane; Godson, Catherine; Crean, John] Univ Coll Dublin, Diabet Complicat Res Ctr, Dublin, Ireland; [Rochford, Emily; Wynne, Kieran; Kennedy, Ciaran; Clerkin, Shane; Doyle, Benjamin; Cagney, Gerard; Crean, John] Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst Biomol & Biomed Sci, Dublin, Ireland; [Andrews, Darrell; Godson, Catherine; Connell, Paul; O'Brien, Colm] Univ Coll Dublin, UCD Sch Med & Med Sci, Dublin, Ireland; [Oliviero, Giorgio] Univ Coll Dublin, Natl Inst Bioproc Res & Training, Dublin, Ireland; [Watson, Ariane] Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland; [De Chiara, Letizia] Univ Florence, Ctr Eccellenza DeNothe, Dept Biomed Expt & Clin Sci, Florence, Italy; [Connell, Paul; O'Brien, Colm] Mater Misericordiae Univ Hosp, Dept Ophthalmol, Dublin, Ireland	University College Dublin; University College Dublin; University College Dublin; University College Dublin; University College Dublin; University of Florence; Mater Misericordiae University Hospital; University College Dublin	Crean, J (corresponding author), Univ Coll Dublin, Diabet Complicat Res Ctr, UCD Sch Biomol & Biomed Sci, Conway Inst Biomol & Biomed Sci, Dublin 4, Ireland.	john.crean@ucd.ie	De Chiara, Letizia/AAK-1209-2021	De Chiara, Letizia/0000-0002-8548-2031; Watson, Ariane/0000-0002-1969-0190; /0000-0002-4337-6177; Godson, Catherine/0000-0003-0655-1041; WYNNE, KIERAN/0000-0001-5759-5285; Kennedy, Ciaran/0000-0003-1967-8754	Science Foundation Ireland (SFI); Irish Research Council (IRC); Fighting Blindness Foundation	Science Foundation Ireland (SFI)(Science Foundation Ireland); Irish Research Council (IRC)(Irish Research Council for Science, Engineering and Technology); Fighting Blindness Foundation	The authors acknowledge the help of the University College Dublin (UCD) Conway Genomics and Proteomics Core Facilities. The authors also acknowledge Dr. Adrian Bracken (Trinity College Dublin), for the kind gift of EZH2 antibody for coimmunoprecipitation experiments. This study was supported by Science Foundation Ireland (SFI), the Irish Research Council (IRC), and the Fighting Blindness Foundation. The authors declare no conflicts of interest.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bertero A, 2018, NATURE, V555, P256, DOI 10.1038/nature25784; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Casari A, 2014, DEV BIOL, V396, P81, DOI 10.1016/j.ydbio.2014.09.025; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; De Chiara L, 2017, SCI REP-UK, V7, DOI 10.1038/srep42407; De Chiara Letizia, 2017, Sci Rep, V7, P46802, DOI 10.1038/srep46802; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Du D, 2018, EMBO REP, V19, P135, DOI 10.15252/embr.201744250; Estaras C, 2012, DEVELOPMENT, V139, P2681, DOI 10.1242/dev.078345; Faherty N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-525; Faherty N, 2012, J CELL SCI, V125, P5621, DOI 10.1242/jcs.105528; Feller C, 2015, MOL CELL, V57, P559, DOI 10.1016/j.molcel.2014.12.008; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Heninger Anne-Kristin, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4824; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Javaid S, 2013, CELL REP, V5, P1679, DOI 10.1016/j.celrep.2013.11.034; Jesus ABD, 2009, CELL CYCLE, V8, P394; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kloet SL, 2016, NAT STRUCT MOL BIOL, V23, P682, DOI 10.1038/nsmb.3248; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lin Y., 2014, CURR PHARM DEDS, V20, P1968; Liu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21602; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Monteiro R, 2016, DEV CELL, V38, P358, DOI 10.1016/j.devcel.2016.06.024; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Oliviero G, 2016, MOL CELL PROTEOMICS, V15, P3450, DOI 10.1074/mcp.M116.062240; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tien CL, 2015, DEVELOPMENT, V142, P722, DOI 10.1242/dev.111997; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Turriziani Benedetta, 2014, Biology (Basel), V3, P320, DOI 10.3390/biology3020320; Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Yoon SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7546; Yoshitake Y, 1999, DEV BIOL, V215, P375, DOI 10.1006/dbio.1999.9473; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	48	6	6	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6667	6681		10.1096/fj.201800566RR	http://dx.doi.org/10.1096/fj.201800566RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30779601				2022-12-26	WOS:000466932600068
J	Kim, AR; Park, JI; Oh, HT; Kim, KM; Hwang, JH; Jeong, MG; Kim, EH; Hwang, ES; Hong, JH				Kim, A. Rum; Park, Jung Il; Oh, Ho Taek; Kim, Kyung Mm; Hwang, Jun-Ha; Jeong, Mi Gyeong; Kim, Ee-Hyun; Hwang, Eun Sook; Hong, Jeong-Ho			TAZ stimulates liver regeneration through interleukin-6-induced hepatocyte proliferation and inhibition of cell death after liver injury	FASEB JOURNAL			English	Article						CCl4; fibrogenesis; cytokine; partial hepatectomy	ORGAN SIZE CONTROL; NF-KAPPA-B; TISSUE HOMEOSTASIS; SIGNALING PATHWAY; HIPPO/YAP PATHWAY; RAPID ACTIVATION; DNA-SYNTHESIS; STAT3; GROWTH; PROGRESSION	In response to liver injury, the liver undergoes a regeneration process to retain its mass and function. However, the regeneration mechanism has not been fully clarified. This study investigated the role of transcriptional coactivator with PDZ-binding motif (TAZ), a Hippo-signaling effector, in liver regeneration. We observed that TAZ stimulates liver regeneration after liver injury. After partial hepatectomy (PHx) or carbon tetrachloride damage, TAZ was required for liver regeneration to increase hepatic cell proliferation and resist hepatic apoptosis, which were decreased in liver-specific TAZ knockout (LKO) mice. TAZ stimulated macrophage infiltration, resulting in IL-6 production, which induced liver regeneration. In LKO mice, IL-6-induced activation of signal transducer and activator of transcription 3, ERK, and PKB was decreased. We also observed that periductal fibrogenesis was significantly increased in LKO mice during liver regeneration after PHx, which was caused by increased hepatic apoptosis. Our results suggest that TAZ stimulates liver regeneration through IL-6-induced hepatocyte proliferation and inhibition of cell death after liver injury.Kim, A. R., Park, J. I., Oh, H. T., Kim, K. M., Hwang, J.-H., Jeong, M. G., Kim, E.-H., Hwang, E. S., Hong, J.-H. TAZ stimulates liver regeneration through interleukin-6-induced hepatocyte proliferation and inhibition of cell death after liver injury.	[Kim, A. Rum; Park, Jung Il; Oh, Ho Taek; Kim, Kyung Mm; Hwang, Jun-Ha; Hong, Jeong-Ho] Korea Univ, Sch Life Sci & Biotechnol, Dept Life Sci, 145 Anam Ro, Seoul 02841, South Korea; [Jeong, Mi Gyeong; Kim, Ee-Hyun; Hwang, Eun Sook] Ewha Womans Univ, Coll Pharm, Seoul, South Korea	Korea University; Ewha Womans University	Hwang, ES; Hong, JH (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Dept Life Sci, 145 Anam Ro, Seoul 02841, South Korea.	eshwang@ewha.ac.kr; jh_hong@korea.ac.kr			National Research Foundation of Korea (NRF) grants - Korean government [2015R1A5A1009024, 2017R1D1A1B03034651, 2018R1A5A2025286]; Korea Basic Science Institute [C39531]; Korea University	National Research Foundation of Korea (NRF) grants - Korean government; Korea Basic Science Institute; Korea University	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean government (2015R1A5A1009024, 2017R1D1A1B03034651, and 2018R1A5A2025286). This work was also supported by the Korea Basic Science Institute (C39531), and a grant from Korea University. The authors declare no conflict of interests.	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Bai HB, 2012, HEPATOLOGY, V56, P1097, DOI 10.1002/hep.25769; Bansal MB, 2005, J HEPATOL, V42, P548, DOI 10.1016/j.jhep.2004.11.043; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bohm F, 2010, EMBO MOL MED, V2, P294, DOI 10.1002/emmm.201000085; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Byun MR, 2017, CANCER LETT, V410, P32, DOI 10.1016/j.canlet.2017.09.003; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; CRESSMAN DE, 1995, HEPATOLOGY, V21, P1443, DOI 10.1016/0270-9139(95)90068-3; CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Forbes SJ, 2016, NAT REV GASTRO HEPAT, V13, P473, DOI 10.1038/nrgastro.2016.97; Grijalva JL, 2014, AM J PHYSIOL-GASTR L, V307, pG196, DOI 10.1152/ajpgi.00077.2014; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Higgins GM, 1931, ARCH PATHOL, V12, P186; Ichikawa T, 2001, HEPATOLOGY, V34, P918, DOI 10.1053/jhep.2001.29132; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Jin X, 2007, HEPATOLOGY, V46, P802, DOI 10.1002/hep.21728; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; Lee CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03956-7; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; Loforese G, 2017, EMBO MOL MED, V9, P46, DOI 10.15252/emmm.201506089; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Moh A, 2007, LAB INVEST, V87, P1018, DOI 10.1038/labinvest.3700630; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Preisegger KH, 1999, LAB INVEST, V79, P103; Rechnagel R O, 1973, CRC Crit Rev Toxicol, V2, P263, DOI 10.3109/10408447309082019; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Su T, 2015, ELIFE, V4, DOI 10.7554/eLife.02948; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Yi J, 2016, HEPATOLOGY, V64, P1757, DOI 10.1002/hep.28768; Yimlamai D, 2015, J HEPATOL, V63, P1491, DOI 10.1016/j.jhep.2015.07.008; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang WJ, 2015, CANCER RES, V75, P4450, DOI 10.1158/0008-5472.CAN-14-3396; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	50	18	19	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5914	5923		10.1096/fj.201801256RR	http://dx.doi.org/10.1096/fj.201801256RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30742777	Bronze			2022-12-26	WOS:000466932600010
J	Li, JM; Kang, F; Gong, XS; Bai, Y; Dai, JJ; Zhao, CR; Dou, C; Cao, Z; Liang, MM; Dong, R; Jiang, H; Yang, XC; Dong, SW				Li, Jianmei; Kang, Fei; Gong, Xiaoshan; Bai, Yun; Dai, Jingjin; Zhao, Chunrong; Dou, Ce; Cao, Zhen; Liang, Mengmeng; Dong, Rui; Jiang, Hong; Yang, Xiaochao; Dong, Shiwu			Ceria nanoparticles enhance endochondral ossification-based critical-sized bone defect regeneration by promoting the hypertrophic differentiation of BMSCs via DHX15 activation	FASEB JOURNAL			English	Article						endochondral bone formation; bone regeneration; cerium oxide	MESENCHYMAL STEM-CELLS; CHONDROGENIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; GROWTH; P38; VASCULARIZATION; DEGRADATION; CANCER; MMP13	Central ischemic necrosis is one of the biggest obstacles in the clinical application of traditional tissue-engineered bone (TEB) in critical-sized bone defect regeneration. Because of its ability to promote vascular invasion, endochondral ossification-based TEB has been applied for bone defect regeneration. However, inadequate chondrocyte hypertrophy can hinder vascular invasion and matrix mineralization during endochondral ossification. In light of recent studies suggesting that ceria nanoparticles (CNPs) improve the blood vessel distribution within TEB, we modified TEB scaffold surfaces with CNPs and investigated the effect and mechanism of CNPs on endochondral ossification-based bone regeneration. The CNPs used in this study were synthesized by the microemulsion method and modified with alendronate-anchored polyethylene glycol 600. We showed that CNPs accelerated new bone formation and enhanced endochondral ossification-based bone regeneration in both a subcutaneous ectopic osteogenesis model and a mouse model of critical-sized bone defects. Mechanistically, CNPs significantly promoted endochondral ossification-based bone regeneration by ensuring sufficient hypertrophic differentiation via the activation of the RNA helicase, DEAH (Asp-Glu-Ala-His) box helicase 15, and its downstream target, p38 MAPK. These results suggested that CNPs could be applied as a biomaterial to improve the efficacy of endochondral ossification-based bone regeneration in critical-sized bone defects.Li, J., Kang, F., Gong, X., Bai, Y., Dai, J., Zhao, C., Dou, C., Cao, Z., Liang, M., Dong, R., Jiang, H., Yang, X., Dong, S. Ceria nanoparticles enhance endochondral ossification-based critical-sized bone defect regeneration by promoting the hypertrophic differentiation of BMSCs via DHX15 activation.	[Li, Jianmei; Kang, Fei; Gong, Xiaoshan; Bai, Yun; Dai, Jingjin; Zhao, Chunrong; Dou, Ce; Cao, Zhen; Liang, Mengmeng; Dong, Rui; Jiang, Hong; Yang, Xiaochao; Dong, Shiwu] Third Mil Med Univ, Sch Biomed Engn, Dept Biomed Mat Sci, Gaotanyan St 30, Chongqing 400038, Peoples R China; [Dong, Shiwu] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University; Army Medical University	Yang, XC; Dong, SW (corresponding author), Third Mil Med Univ, Sch Biomed Engn, Dept Biomed Mat Sci, Gaotanyan St 30, Chongqing 400038, Peoples R China.	xcyang@tmmu.edu.cn; dongshiwu@tmmu.edu.cn			National Key Technology Research and Development Program of China [2017YFC1103300]; Nature Science Foundation of China [31870962, 81471782]; Key Project of Logistics Research Plan of the People's Liberation Army [AWS17J004]; Innovation Funding of the Third Military Medical University [2018XYY05]	National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Logistics Research Plan of the People's Liberation Army; Innovation Funding of the Third Military Medical University	This work was funded by the National Key Technology Research and Development Program of China (2017YFC1103300), the Nature Science Foundation of China (31870962 and 81471782), the Key Project of Logistics Research Plan of the People's Liberation Army (AWS17J004), and the Innovation Funding of the Third Military Medical University (2018XYY05). The authors declare no conflicts of interest.	Akiyama M, 2009, CELL TRANSPLANT, V18, P443, DOI 10.3727/096368909788809820; Ba PF, 2017, MOL MED REP, V16, P63, DOI 10.3892/mmr.2017.6563; Bai Y, 2018, FASEB J, V32, P4573, DOI 10.1096/fj.201701411R; Das S, 2013, NANOMEDICINE-UK, V8, P1483, DOI [10.2217/NNM.13.133, 10.2217/nnm.13.133]; Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31; Feng Q, 2017, ACTA BIOMATER, V53, P329, DOI 10.1016/j.actbio.2017.02.015; Huang L, 2001, J POLYM SCI POL PHYS, V39, P496, DOI 10.1002/1099-0488(20010301)39:5<496::AID-POLB1023>3.0.CO;2-H; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Kaivalya M, 2011, J BIOCHEM MOL TOXIC, V25, P108, DOI 10.1002/jbt.20366; Kang HM, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201802642; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Li J, 2016, BIOMED RES INT, V2016, P1; Li JJ, 2015, BIOMATERIALS, V54, P226, DOI 10.1016/j.biomaterials.2015.03.001; Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Mandoli C, 2010, ADV FUNCT MATER, V20, P1617, DOI 10.1002/adfm.200902363; Mariani E, 2014, INT J MOL SCI, V15, P8667, DOI 10.3390/ijms15058667; Mosallanejad K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004841; Nishimura R, 2012, J BIOL CHEM, V287, P33179, DOI 10.1074/jbc.M111.337063; Rivera-Gil P, 2011, NANO TODAY, V6, P20, DOI 10.1016/j.nantod.2010.12.006; Rocca A, 2015, INT J NANOMED, V10, P433, DOI 10.2147/IJN.S76329; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Sivaraj KK, 2016, DEVELOPMENT, V143, P2706, DOI 10.1242/dev.136861; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Tai MF, 2016, J NANOMATER, V2016, DOI 10.1155/2016/8612505; Thakor AS, 2013, CA-CANCER J CLIN, V63, P395, DOI 10.3322/caac.21199; Thompson EM, 2016, TISSUE ENG PT A, V22, P556, DOI [10.1089/ten.tea.2015.0457, 10.1089/ten.TEA.2015.0457]; Thompson EM, 2015, J TISSUE ENG REGEN M, V9, P889, DOI 10.1002/term.1918; Thouverey C, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.80; Tortelli F, 2010, BIOMATERIALS, V31, P242, DOI 10.1016/j.biomaterials.2009.09.038; Tortelli F, 2009, EUR CELLS MATER, V17, P1; Veiseh O, 2015, NAT REV DRUG DISCOV, V14, P45, DOI 10.1038/nrd4477; Verseijden F, 2010, CELL TRANSPLANT, V19, P1007, DOI 10.3727/096368910X492571; Wang JR, 2016, GENETICS, V202, P1055, DOI 10.1534/genetics.115.180109; Wang PH, 2015, SCIENCE, V350, P826, DOI 10.1126/science.aab3145; Wei M, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0310-5; Xiang JY, 2016, ACS APPL MATER INTER, V8, P4489, DOI 10.1021/acsami.6b00158; Xiao YF, 2016, INT J NANOMED, V11, P3023, DOI 10.2147/IJN.S103648; Xu JB, 2016, ADV FUNCT MATER, V26, P2463, DOI 10.1002/adfm.201504070; Xue WQ, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7571363; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yang ZY, 2014, RSC ADV, V4, P59965, DOI 10.1039/c4ra12007h; Yokel RA, 2012, TOXICOL SCI, V127, P256, DOI 10.1093/toxsci/kfs067; Zhang KY, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201701642	44	15	15	2	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6378	6389		10.1096/fj.201802187R	http://dx.doi.org/10.1096/fj.201802187R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30776318	Bronze			2022-12-26	WOS:000466932600045
J	Chen, QH; Guo, XX; Deng, NS; Liu, LL; Chen, S; Wang, AL; Li, RY; Huang, Y; Ding, XH; Yu, HY; Hu, SP; Nie, HX				Chen, Qianhui; Guo, Xuxue; Deng, Nishan; Liu, Linlin; Chen, Shuo; Wang, Ailing; Li, Ruiyun; Huang, Yi; Ding, Xuhong; Yu, Hongying; Hu, Suping; Nie, Hanxiang			alpha-Galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						asthma; cellular immune response; allergen; antibody; antigen; alpha-galactosylceramide; asthma; inflammation; allergy; cytokine response; lung disease; invariant NKT cells; regulatory T cells; Th2 cell response	REGULATORY T-CELLS; LUNG DENDRITIC CELLS; NKT CELLS; AIRWAY INFLAMMATION; CUTTING EDGE; TOLERANCE; AUTOIMMUNE; MATURATION; MAINTENANCE; MECHANISMS	Asthma is a common inflammatory pulmonary disorder involving a diverse array of immune cells such as proinflammatory T helper 2 (Th2) cells. We recently reported that intraperitoneal injection of -galactosylceramide (-GalCer) can stimulate the lung invariant natural killer T (iNKT) cells and does not lead to airway inflammation in WT mice. Other studies indicate that iNKT cells play an important role in inducing regulatory T cells (Treg cells) and peripheral tolerance. Using iNKT cell- knockout mice, functional inactivation of Treg cells, and co-culture experiments in murine asthma models, we investigated the immunoregulatory effects of -GalCer treatment before allergen sensitization on Th2 cell responses. We also studied whether -GalCer's effects require lung Treg cells induced by activated iNKT cells. Our results disclosed that intraperitoneal administration of -GalCer before allergen sensitization could promote the expansion and suppressive activity of lung CD4(+)FoxP3(+) Treg cells. These effects were accompanied by down-regulated Th2 cell responses and decreased immunogenic maturation of lung dendritic cells in WT mice. However, these changes were absent in CD1d(-/-) mice immunized and challenged with ovalbumin or house dust mites, indicating that the effects of -GalCer on Treg cells mainly require iNKT cells. Moreover, functional inactivation of Treg cells could reverse the inhibitory ability of this -GalCer therapy on Th2 cell responses in a murine asthma model. Our findings indicate that intraperitoneal administration of -GalCer before the development of asthma symptoms induces the generation of lung Treg cells via iNKT cells and may provide a potential therapeutic strategy to prevent allergic asthma.	[Chen, Qianhui; Guo, Xuxue; Deng, Nishan; Liu, Linlin; Chen, Shuo; Li, Ruiyun; Huang, Yi; Ding, Xuhong; Yu, Hongying; Hu, Suping; Nie, Hanxiang] Wuhan Univ, Dept Resp & Crit Med, Renmin Hosp, 238 Jiefang Rd, Wuhan 430060, Hubei, Peoples R China; [Wang, Ailing] Wuhan Univ, Dept Nursing, Sch Hlth Sci, Wuhan 430060, Hubei, Peoples R China	Wuhan University; Wuhan University	Nie, HX (corresponding author), Wuhan Univ, Dept Resp & Crit Med, Renmin Hosp, 238 Jiefang Rd, Wuhan 430060, Hubei, Peoples R China.	nhxbj@sohu.com			National Natural Science Foundation of China [81770036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grant 81770036. The authors declare that they have no conflicts of interest with the contents of this article.	Afshar R, 2008, CLIN EXP ALLERGY, V38, P1847, DOI 10.1111/j.1365-2222.2008.03119.x; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Barron L, 2010, J IMMUNOL, V185, P6426, DOI 10.4049/jimmunol.0903940; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Caielli S, 2010, J IMMUNOL, V185, P7317, DOI 10.4049/jimmunol.1000400; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; Dalod M, 2014, EMBO J, V33, P1104, DOI 10.1002/embj.201488027; Dascher CC, 2003, TRENDS IMMUNOL, V24, P412, DOI 10.1016/S1471-4906(03)00179-0; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Grindebacke H, 2004, CLIN EXP ALLERGY, V34, P1364, DOI 10.1111/j.1365-2222.2004.02067.x; Hachem P, 2005, EUR J IMMUNOL, V35, P2793, DOI 10.1002/eji.200535268; He Q, 2017, AM J PHYSIOL-LUNG C, V313, pL973, DOI 10.1152/ajplung.00340.2016; Hoffmann F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00107; Jiang SP, 2005, EUR J IMMUNOL, V35, P1193, DOI 10.1002/eji.200425899; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Kearley J, 2008, J ALLERGY CLIN IMMUN, V122, P617, DOI 10.1016/j.jaci.2008.05.048; Kim S, 2008, EXPERT REV VACCINES, V7, P1519, DOI 10.1586/14760584.7.10.1519; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lee JH, 2007, CLIN EXP IMMUNOL, V148, P53, DOI 10.1111/j.1365-2249.2007.03329.x; Li P, 2015, CLIN EXP ALLERGY, V45, P1126, DOI 10.1111/cea.12521; Liu RL, 2005, J IMMUNOL, V175, P7898, DOI 10.4049/jimmunol.175.12.7898; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Ly D, 2006, J IMMUNOL, V177, P3695, DOI 10.4049/jimmunol.177.6.3695; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Matsuda H, 2005, AM J RESP CELL MOL, V33, P22, DOI 10.1165/rcmb.2004-0010OC; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Nie HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119901; Novak J, 2011, CYTOKINE, V53, P263, DOI 10.1016/j.cyto.2010.11.001; Palomares O, 2014, GENES IMMUN, V15, P511, DOI 10.1038/gene.2014.45; Pham MN, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00651; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Ronet C, 2005, J IMMUNOL, V175, P899, DOI 10.4049/jimmunol.175.2.899; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Thorburn AN, 2010, AM J RESP CELL MOL, V43, P511, DOI 10.1165/rcmb.2009-0342TR; Tomura M, 1999, J IMMUNOL, V163, P93; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zhang GQ, 2011, AM J PHYSIOL-LUNG C, V301, pL975, DOI 10.1152/ajplung.00114.2011	53	6	7	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5438	5455		10.1074/jbc.RA118.005418	http://dx.doi.org/10.1074/jbc.RA118.005418			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30745361	Green Published, hybrid			2022-12-26	WOS:000464517500017
J	Pollock, RA; Zaman, L; Chandran, V; Gladman, DD				Pollock, Remy A.; Zaman, Laila; Chandran, Vinod; Gladman, Dafna D.			Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis	PLOS ONE			English	Article							GENE; INTERLEUKIN-22; INHERITANCE; IL-22; HERITABILITY; NEUTROPHIL; DISCOVERY; MIGRATION; COMPLEX; SKIN	Psoriasis and its associated inflammatory arthritis, psoriatic arthritis (PsA), have a clear heritable component, but a large proportion of the heritable risk remains unexplained by gene sequence variation. This study aimed to determine if epigenetic factors contribute to the missing heritability in psoriatic disease. DNA methylation profiling was performed on sperm cells from 23 probands with psoriasis without PsA (PsC), 13 PsA probands, and 18 unaffected controls. Differentially methylated CpGs and regions (DMRs) were identified and validated by pyrosequencing. Underlying AluY and copy number variation (CNV) in the HCG26 and IL22 genes, respectively, were assessed by genotyping. Array, subject's age, age of psoriasis onset, psoriasis severity, and medication usage were found to influence methylation at many genes and were included as covariates in the analysis. Between PsC probands vs. controls, 169 DMRs were found; 754 DMRs were found between PsA probands vs. controls, and 86 between PsA and PsC probands (adjusted p< 0.05). Differences in methylation across DMRs were generally subtle (< 10%) but correlated well with pyrosequencing. Biological inference prioritized notable DMRs associated with skin disease (SIGLEC14, JAM3, PCOLCE, RXRB), skin and/or joint disease (MBP, OSBPL5, SNORD115, HCG26), and joint disease (IL22, ELF5, PPP2R2D, PTPRN2, HCG26). Hypermethylation of the DMR within the first exon of arthritis-associated IL22 showed significant correlation (rho = 0.34, 95% CI 0.06-0.57, p = 0.01) between paired sperm and blood samples, independent of a CNV within the same region. Further studies are needed to rule out underlying genetic causes and determine if these represent heritable, constitutional epimutations, or are the result of exposure of germ cells to endogenous or exogenous environmental factors.	[Pollock, Remy A.; Zaman, Laila; Chandran, Vinod; Gladman, Dafna D.] Univ Hlth Network, Krembil Res Inst, Ctr Prognosis Studies Rheumat Dis, Psoriat Arthrit Program, Toronto, ON, Canada; [Chandran, Vinod; Gladman, Dafna D.] Univ Toronto, Div Rheumatol, Dept Med, Fac Med, Toronto, ON, Canada; [Chandran, Vinod; Gladman, Dafna D.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Chandran, Vinod] Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Gladman, DD (corresponding author), Univ Hlth Network, Krembil Res Inst, Ctr Prognosis Studies Rheumat Dis, Psoriat Arthrit Program, Toronto, ON, Canada.; Gladman, DD (corresponding author), Univ Toronto, Div Rheumatol, Dept Med, Fac Med, Toronto, ON, Canada.; Gladman, DD (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	dafna.gladman@utoronto.ca			CIHR Banting and Best Doctoral Research Award; Krembil Research Institute Postdoctoral Fellowship; CIHR-IMHA studentship; CIHR-Janssen studentship; Arthritis Research Foundation; National Psoriasis Foundation; Krembil Foundation	CIHR Banting and Best Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Krembil Research Institute Postdoctoral Fellowship; CIHR-IMHA studentship; CIHR-Janssen studentship; Arthritis Research Foundation(Versus Arthritis); National Psoriasis Foundation; Krembil Foundation	RAP was supported by a CIHR Banting and Best Doctoral Research Award and Krembil Research Institute Postdoctoral Fellowship, and LZ was supported by CIHR-IMHA and CIHR-Janssen studentships. The study was funded by the Arthritis Research Foundation, the National Psoriasis Foundation, and the Krembil Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SR, 2014, J EXP MED, V211, P1231, DOI 10.1084/jem.20131853; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Burden AD, 1998, J INVEST DERMATOL, V110, P958, DOI 10.1046/j.1523-1747.1998.00213.x; Chandran V, 2009, ANN RHEUM DIS, V68, P664, DOI 10.1136/ard.2008.089367; Chandran V, 2010, J AUTOIMMUN, V34, pJ314, DOI 10.1016/j.jaut.2009.12.001; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; DUFFY DL, 1993, J AM ACAD DERMATOL, V29, P428, DOI 10.1016/0190-9622(93)70206-9; Eder L, 2015, CURR OPIN RHEUMATOL, V27, P91, DOI 10.1097/BOR.0000000000000136; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Gentleman R, GENEFILTER GENEFILTE; Gladman DD, 2014, MODERATE TO SEVERE PSORIASIS, 4TH EDITION, P315; Horsthemke B, 2006, CURR TOP MICROBIOL, V310, P45; Johnston A, 2014, J INVEST DERMATOL, V134, P1501, DOI 10.1038/jid.2014.81; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Krausz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044479; Lonnberg AS, 2013, BRIT J DERMATOL, V169, P412, DOI 10.1111/bjd.12375; Martos SN, 2015, PROG BIOPHYS MOL BIO, V118, P44, DOI 10.1016/j.pbiomolbio.2015.02.011; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Oey H, 2014, TRENDS GENET, V30, P519, DOI 10.1016/j.tig.2014.08.005; Pan Du GF, 2014, ANAL ILLUMINA INFINI; Pedersen OB, 2008, ANN RHEUM DIS, V67, P1417, DOI 10.1136/ard.2007.078428; Peters TJ, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-6; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Pollock R, 2017, PSORIASIS PSORIATIC, P9; Pollock RA TA, 2015, ARTHRITIS CARE RES H; Prans E, 2013, HUM IMMUNOL, V74, P792, DOI 10.1016/j.humimm.2013.01.006; Rahman P, 1999, ARTHRITIS RHEUM, V42, P1228, DOI 10.1002/1529-0131(199906)42:6<1228::AID-ANR20>3.0.CO;2-3; Rahman P, 2005, ANN RHEUM DIS, V64, P37, DOI 10.1136/ard.2004.030775; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Stuart PE, 2015, AM J HUM GENET, V97, P816, DOI 10.1016/j.ajhg.2015.10.019; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; TRAUPE H, 1992, AM J MED GENET, V42, P649, DOI 10.1002/ajmg.1320420504; Vasku V, 2007, DERMATOLOGY, V214, P118, DOI 10.1159/000098569; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou PH, 2014, NATURE, V506, P52, DOI 10.1038/nature12988	48	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212043	10.1371/journal.pone.0212043	http://dx.doi.org/10.1371/journal.pone.0212043			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779748	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900027
J	Chon, D; Yoo, KB; Kim, JH				Chon, Doukyoung; Yoo, Ki Bong; Kim, Jae-Hyun			Belief about the future possibility of national aging security system and its association with mortality	PLOS ONE			English	Article							SUBJECTIVE LIFE EXPECTANCY; HEALTH; EXPECTATIONS; RISK	In line with well-known subjective measures of health, such as self-rated health and subjective life expectancy, an individual's belief about future security provided by the government could also be an important factor affecting his life expectancy. The aim of this study was to use the response of the elderly Korean population in regards to the National Aging Security System (NASS), and assess its association with the risk of mortality even with SRH included in the analysis. Data from the Korean Longitudinal Study of Ageing (KLoSA) from 2006 to 2016 were assessed using longitudinal data analysis and 10,254 research subjects were included at baseline in 2006. To analyze the association between belief about future possibility of NASS and all-cause mortality, Cox proportional hazards model was used. In terms of the future possibility of NASS, people who thought more negatively displayed greater risk of mortality at the end of the follow-up. With the Positive group as reference: Moderate group showed a 18% increase (HR = 1.178, 95% CI: 1.022, 1.357), and Negative groups showed a 19% increase (HR = 1.192, 95% CI: 1.043, 1.362). The results of our study showed that people's belief regarding future security could be associated with mortality rates. Our finding is important, because it provides additional support to the importance of considering subjective measures of health in epidemiological research. Furthermore, the findings of our research could be useful in terms of future policy making.	[Chon, Doukyoung] Ajou Univ, Dept Prevent Med & Publ Hlth, Sch Med, Suwon, South Korea; [Chon, Doukyoung] Ajou Univ, Inst Aging, Med Ctr, Suwon, South Korea; [Yoo, Ki Bong] Yonsei Univ, Coll Hlth Sci, Wonju, South Korea; [Kim, Jae-Hyun] Dankook Univ, Dept Hlth Adm, Coll Hlth Sci, Cheonan, South Korea; [Kim, Jae-Hyun] Dankook Univ, Inst Hlth Promot & Policy, Cheonan, South Korea	Ajou University; Ajou University; Yonsei University; Dankook University; Dankook University	Kim, JH (corresponding author), Dankook Univ, Dept Hlth Adm, Coll Hlth Sci, Cheonan, South Korea.; Kim, JH (corresponding author), Dankook Univ, Inst Hlth Promot & Policy, Cheonan, South Korea.	kjh930529@gmail.com		Kim, Jae-Hyun/0000-0002-3531-489X				Arno PS, 2011, J PUBLIC HEALTH POL, V32, P234, DOI 10.1057/jphp.2011.2; Brouwer WBF, 2005, SOC SCI MED, V61, P1083, DOI 10.1016/j.socscimed.2005.01.008; Everson SA, 1996, PSYCHOSOM MED, V58, P113, DOI 10.1097/00006842-199603000-00003; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Hone T, 2017, HEALTH AFFAIR, V36, P149, DOI 10.1377/hlthaff.2016.0966; Idler E, 2004, J HEALTH SOC BEHAV, V45, P336, DOI 10.1177/002214650404500307; Jeon B, 2017, SOC SCI MED, V178, P175, DOI 10.1016/j.socscimed.2017.02.013; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kang MS, 2012, J KOREAN MED SCI, V27, pS21, DOI 10.3346/jkms.2012.27.S.S21; Kim JH, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0763-0; Kobayashi LC, 2017, ANN BEHAV MED, V51, P327, DOI 10.1007/s12160-016-9855-z; Mirowsky J, 1997, J GERONTOL B-PSYCHOL, V52, pS125, DOI 10.1093/geronb/52B.3.S125; Mirowsky J, 2000, SOC PSYCHOL QUART, V63, P133, DOI 10.2307/2695888; Nazzal C, 2016, HEALTH POLICY PLANN, V31, P700, DOI 10.1093/heapol/czv120; Organisation for Economic Co-operation and Development OECD, 2017, HLTH GLANC 2017 OECD, DOI [10.1787/health_glance-2017-en, DOI 10.1787/HEALTH_GLANCE-2017-EN]; Scott-Sheldon LAJ, 2010, AM J HEALTH BEHAV, V34, P349, DOI 10.5993/AJHB.34.3.10; Siegel M, 2003, GERONTOLOGY, V49, P265, DOI 10.1159/000070409; Smith VK, 2001, AM ECON REV, V91, P1126, DOI 10.1257/aer.91.4.1126; Strawbridge WJ, 1999, RES AGING, V21, P402, DOI 10.1177/0164027599213003; van Nooten F, 2004, HEALTH ECON, V13, P819, DOI 10.1002/hec.873; Woo H, 2017, RES AGING, V39, P879, DOI 10.1177/0164027516637410	21	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212282	10.1371/journal.pone.0212282	http://dx.doi.org/10.1371/journal.pone.0212282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5JX	30763373	Green Submitted, Green Published, gold			2022-12-26	WOS:000458763900059
J	Leonhardt, S; Hoppe, B; Stengel, E; Noll, L; Moll, J; Bassler, C; Dahl, A; Buscot, F; Hofrichter, M; Kellner, H				Leonhardt, Sabrina; Hoppe, Bjoern; Stengel, Elisa; Noll, Lisa; Moll, Julia; Baessler, Claus; Dahl, Andreas; Buscot, Francois; Hofrichter, Martin; Kellner, Harald			Molecular fungal community and its decomposition activity in sapwood and heartwood of 13 temperate European tree species	PLOS ONE			English	Article							COARSE WOODY DEBRIS; INHABITING FUNGI; PICEA-ABIES; MANGANESE PEROXIDASE; ENZYME-ACTIVITIES; FAGUS-SYLVATICA; BEECH-FORESTS; DEADWOOD; DECAY; DIVERSITY	Deadwood is an important structural component in forest ecosystems and plays a significant role in global carbon and nutrient cycling. Relatively little is known about the formation and decomposition of CWD by microbial communities in situ and about the factors controlling the associated processes. In this study, we intensively analyzed the molecular fungal community composition and species richness in relation to extracellular enzyme activity and differences in decomposing sapwood and heartwood of 13 temperate tree species (four coniferous and nine deciduous species, log diameter 30-40 cm and 4 m long) in an artificial experiment involving placing the logs on the forest soil for six years. We observed strong differences in the molecular fungal community composition and richness among the 13 tree species, and specifically between deciduous and coniferous wood, but unexpectedly no difference was found between sapwood and heartwood. Fungal species richness correlated positively with wood extractives and negatively with fungal biomass. A distinct fungal community secreting lignocellulolytic key enzymes seemed to dominate the decomposition of the logs in this specific phase. In particular, the relative sequence abundance of basidiomycetous species of the Meruliaceae (e.g. Bjerkandera adusta) correlated with ligninolytic manganese peroxidase activity. Moreover, this study reveals abundant white-rot causing Basidiomycota and soft-rot causing Ascomycota during this phase of wood decomposition.	[Leonhardt, Sabrina; Hofrichter, Martin; Kellner, Harald] Tech Univ Dresden, Int Inst Zittau, Dept Bio & Environm Sci, Zittau, Germany; [Hoppe, Bjoern; Moll, Julia; Buscot, Francois] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany; [Hoppe, Bjoern] Julius Kuehn Inst, Inst Natl & Int Plant Hlth, Braunschweig, Germany; [Stengel, Elisa] Univ Wurzburg, Field Stn Fabrikschleichach, Rauhenebrach, Germany; [Noll, Lisa] Univ Vienna, Dept Microbiol & Ecosyst Sci, Vienna, Austria; [Baessler, Claus] Bavarian Forest Natl Pk, Grafenau, Germany; [Dahl, Andreas] Tech Univ Dresden, Ctr Mol & Cellular Bioengn, CMCB Technol Platform, Deep Sequencing Grp, Dresden, Germany; [Buscot, Francois] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Technische Universitat Dresden; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Julius Kuhn-Institut; University of Wurzburg; University of Vienna; Technische Universitat Dresden	Leonhardt, S (corresponding author), Tech Univ Dresden, Int Inst Zittau, Dept Bio & Environm Sci, Zittau, Germany.	Sabrina.leonhardt@tu-dresden.de	Dahl, Andreas/E-3783-2017; Buscot, Francois/A-4125-2016	Dahl, Andreas/0000-0002-2668-8371; Buscot, Francois/0000-0002-2364-0006; Hofrichter, Martin/0000-0001-5174-7604; Bassler, Claus/0000-0001-8177-8997; Hoppe, Bjorn/0000-0001-8689-4911	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" [BA5127/1-1, BU 941/17-1, KE 1742/2-1]	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (BA5127/1-1, BU 941/17-1, HO 1961/6-1 and KE 1742/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Arnstadt T, 2016, FOREST ECOL MANAG, V382, P129, DOI 10.1016/j.foreco.2016.10.004; Arnstadt T, 2016, EUR J FOREST RES, V135, P109, DOI 10.1007/s10342-015-0920-0; Baber K, 2016, FOREST ECOL MANAG, V377, P161, DOI 10.1016/j.foreco.2016.07.011; Baldrian P, 2016, FUNGAL ECOL, V23, P109, DOI 10.1016/j.funeco.2016.07.001; Cornwell WK, 2009, GLOBAL CHANGE BIOL, V15, P2431, DOI 10.1111/j.1365-2486.2009.01916.x; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Dix NJ, 1995, FUNGAL ECOL, P549; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Eichlerova I, 2015, FUNGAL ECOL, V13, P10, DOI 10.1016/j.funeco.2014.08.002; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Folman LB, 2008, FEMS MICROBIOL ECOL, V63, P181, DOI 10.1111/j.1574-6941.2007.00425.x; Freeman C, 1997, SOIL BIOL BIOCHEM, V29, P203, DOI 10.1016/S0038-0717(96)00305-7; Fukami T, 2010, ECOL LETT, V13, P675, DOI 10.1111/j.1461-0248.2010.01465.x; Gianoulis TA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002558; Gossner MM, 2016, BIOL CONSERV, V201, P92, DOI 10.1016/j.biocon.2016.06.032; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; HARMON ME, 1991, BIOSCIENCE, V41, P604, DOI 10.2307/1311697; Hatakka A, 2010, MYCOTA, V10, P319; Heilmann-Clausen J, 2005, BIOL CONSERV, V122, P633, DOI 10.1016/j.biocon.2004.10.001; Hendgen M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27743-0; Hofrichter M, 2002, ENZYME MICROB TECH, V30, P454, DOI 10.1016/S0141-0229(01)00528-2; Hofrichter M, 2001, APPL ENVIRON MICROB, V67, P4588, DOI 10.1128/AEM.67.10.4588-4593.2001; Hoiland K, 1996, NORD J BOT, V16, P643, DOI 10.1111/j.1756-1051.1996.tb00283.x; Hoppe B, 2016, FUNGAL DIVERS, V77, P367, DOI 10.1007/s13225-015-0341-x; Hori C, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01133-18; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Kahl T, 2017, FOREST ECOL MANAG, V391, P86, DOI 10.1016/j.foreco.2017.02.012; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kohler A, 2015, NAT GENET, V47, P410, DOI 10.1038/ng.3223; Krah FS, 2018, J ECOL, V106, P1428, DOI 10.1111/1365-2745.12939; Krieglsteiner G.J., 2000, GROSSPILZE BADEN WUR, V1-4; Kubartova A, 2012, MOL ECOL, V21, P4514, DOI 10.1111/j.1365-294X.2012.05723.x; Leonhardt S, 2018, GENOME ANNOUNCEMENTS, V6, DOI [10.1128/genomeA.01510-17, 10.1128/genomea.01510-17]; Leopold DR, 2017, ECOL LETT, V20, P1054, DOI 10.1111/ele.12803; Ligges U, 2003, SCATTERPLOT3D R PACK; Lonsdale D, 2008, EUR J FOREST RES, V127, P1, DOI 10.1007/s10342-007-0182-6; Makipaa R, 2017, ISME J, V11, P1964, DOI 10.1038/ismej.2017.57; Martinez AT, 2005, INT MICROBIOL, V8, P195; Moll J, 2018, ENVIRON MICROBIOL, V20, P3744, DOI 10.1111/1462-2920.14376; Moreira MT, 2000, BIOPROCESS ENG, V23, P663, DOI 10.1007/s004490000217; NEWELL SY, 1988, APPL ENVIRON MICROB, V54, P1876, DOI 10.1128/AEM.54.7.1876-1879.1988; Noll L, 2016, FOREST ECOL MANAG, V378, P181, DOI 10.1016/j.foreco.2016.07.035; Odor P, 2006, BIOL CONSERV, V131, P58, DOI 10.1016/j.biocon.2006.02.004; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Purahong W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02120; Purahong W, 2018, ISME J, V12, P289, DOI 10.1038/ismej.2017.177; Purahong W, 2016, FUNGAL ECOL, V22, P98, DOI 10.1016/j.funeco.2016.01.002; QUACK W, 1982, PHYTOCHEMISTRY, V21, P2921; Rajala T, 2015, FUNGAL ECOL, V18, P48, DOI 10.1016/j.funeco.2015.08.007; Rajala T, 2012, FEMS MICROBIOL ECOL, V81, P494, DOI 10.1111/j.1574-6941.2012.01376.x; Reina R, 2014, FUNGAL GENET BIOL, V72, P99, DOI 10.1016/j.fgb.2014.07.009; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; ROLLHANSEN F, 1979, EUR J FOREST PATHOL, V9, P308; Ruiz-Duenas FJ, 2013, MYCOLOGIA, V105, P1428, DOI 10.3852/13-059; Rytioja J, 2014, MICROBIOL MOL BIOL R, V78, P614, DOI 10.1128/MMBR.00035-14; Rytioja J, 2014, FUNGAL GENET BIOL, V72, P91, DOI 10.1016/j.fgb.2013.12.008; Stemmer M, 2004, SOIL BIOL BIOCHEM, V36, P519, DOI 10.1016/j.soilbio.2003.11.004; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Swift M., 1977, ECOL BULL, V25, P193; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Tsujiyama Sho-ichi, 2005, Mycoscience, V46, P268, DOI 10.1007/s10267-005-0243-y; Valaskova V, 2009, ISME J, V3, P1218, DOI 10.1038/ismej.2009.64; van der Wal A, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1393; Vetrovsky T, 2013, BIOL FERT SOILS, V49, P1027, DOI 10.1007/s00374-013-0801-y; Watkinson S, 2006, FUNGI BIOGEOCHEMICAL, P151, DOI [10.1017/CBO9780511550522.008, DOI 10.1017/CBO9780511550522.008]	68	34	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212120	10.1371/journal.pone.0212120	http://dx.doi.org/10.1371/journal.pone.0212120			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763365	gold, Green Published, Green Submitted			2022-12-26	WOS:000458763900045
J	Wang, S; Shen, HW; Chai, H; Liang, Y				Wang, Sai; Shen, Hai-Wei; Chai, Hua; Liang, Yong			Complex harmonic regularization with differential evolution in a memetic framework for biomarker selection	PLOS ONE			English	Article							VARIABLE SELECTION; HUMAN BREAST; GENETIC ALGORITHM; EXPRESSION; REGRESSION; IDENTIFICATION; POLYMORPHISMS; OPTIMIZATION; MICROARRAY; MEDIATE	For studying cancer and genetic diseases, the issue of identifying high correlation genes from high-dimensional data is an important problem. It is a great challenge to select relevant biomarkers from gene expression data that contains some important correlation structures, and some of the genes can be divided into different groups with a common biological function, chromosomal location or regulation. In this paper, we propose a penalized accelerated failure time model CHR-DE using a non-convex regularization (local search) with differential evolution (global search) in a wrapper-embedded memetic framework. The complex harmonic regularization (CHR) can approximate to the combination l(p) (1/2 <= p < 1) and l(q) (1 <= q < 2) for selecting biomarkers in group. And differential evolution (DE) is utilized to globally optimize the CHR's hyperparameters, which make CHR-DE achieve strong capability of selecting groups of genes in high-dimensional biological data. We also developed an efficient path seeking algorithm to optimize this penalized model. The proposed method is evaluated on synthetic and three gene expression datasets: breast cancer, hepatocellular carcinoma and colorectal cancer. The experimental results demonstrate that CHR-DE is a more effective tool for feature selection and learning prediction.	[Wang, Sai; Shen, Hai-Wei; Chai, Hua; Liang, Yong] Macau Univ Sci & Technol, Fac Informat Technol, Taipa, Macau, Peoples R China; [Liang, Yong] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China	Macau University of Science & Technology; Macau University of Science & Technology	Liang, Y (corresponding author), Macau Univ Sci & Technol, Fac Informat Technol, Taipa, Macau, Peoples R China.; Liang, Y (corresponding author), Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China.	yliang@must.edu.mo		liang, yong/0000-0002-2858-2810	Macau Science and Technology Develop Funds of Macao SAR of China [003/2016/AFJ]; China NSFC [61661166011]	Macau Science and Technology Develop Funds of Macao SAR of China; China NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the Macau Science and Technology Develop Funds (Grant No. 003/2016/AFJ) of Macao SAR of China and China NSFC project under contract 61661166011 to YL.	Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; [Anonymous], ENCY MACHINE LEARNIN; Arias-Romero LE, 2013, EXPERT OPIN THER TAR, V17, P1263, DOI 10.1517/14728222.2013.828037; Bosman PAN, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P585, DOI 10.1145/2330163.2330247; Bouter A, 2017, PROCEEDINGS OF THE 2017 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE (GECCO'17), P705, DOI 10.1145/3071178.3071272; Chen HZ, 2014, MOL MED REP, V10, P2868, DOI 10.3892/mmr.2014.2585; Chu GJ, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/857398; Collado-Hidalgo A, 2008, BRAIN BEHAV IMMUN, V22, P1197, DOI 10.1016/j.bbi.2008.05.009; Datta S., 2005, STAT METHODOL, V2, P65, DOI DOI 10.1016/J.STAMET.2004.11.003; Datta S, 2007, BIOMETRICS, V63, P259, DOI 10.1111/j.1541-0420.2006.00660.x; Dawkins R., 2016, SELFISH GENE; Deb K., 2014, SEARCH METHODOLOGIES, P403, DOI DOI 10.1007/978-1-4614-6940-7_15; Donahue J., 2017, ARXIV171109846; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Foekens JA, 2000, CANCER RES, V60, P636; Friedman JH, 2012, INT J FORECASTING, V28, P722, DOI 10.1016/j.ijforecast.2012.05.001; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao XS, 2011, BMB REP, V44, P70, DOI 10.5483/BMBRep.2011.44.1.70; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Guo R, 2013, INT J BIOCHEM CELL B, V45, P347, DOI 10.1016/j.biocel.2012.10.006; Hansen M, 1996, IEEE C EVOL COMPUTAT, P312, DOI 10.1109/ICEC.1996.542381; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Huang HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149675; Kamohara Y, 2008, SURGERY, V144, P119, DOI 10.1016/j.surg.2008.04.008; Kasai H, 2003, J HISTOCHEM CYTOCHEM, V51, P567, DOI 10.1177/002215540305100502; Ke TW, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/617150; Khushaba RN, 2011, EXPERT SYST APPL, V38, P11515, DOI 10.1016/j.eswa.2011.03.028; Kim JE, 2003, ONCOGENE, V22, P2045, DOI 10.1038/sj.onc.1206269; Lanzi PL, 1997, PROCEEDINGS OF 1997 IEEE INTERNATIONAL CONFERENCE ON EVOLUTIONARY COMPUTATION (ICEC '97), P537, DOI 10.1109/ICEC.1997.592369; Li YF, 2013, BIOCHEM BIOPH RES CO, V431, P560, DOI 10.1016/j.bbrc.2013.01.016; Liu XY, 2020, IEEE ACM T COMPUT BI, V17, P1329, DOI 10.1109/TCBB.2019.2897301; Liu XY, 2018, IEEE ACCESS, V6, P22863, DOI 10.1109/ACCESS.2018.2818682; Merz P., 2001, Complex Systems, V13, P297; Neri F, 2012, SWARM EVOL COMPUT, V2, P1, DOI 10.1016/j.swevo.2011.11.003; Nguyen QH, 2009, IEEE T EVOLUT COMPUT, V13, P604, DOI 10.1109/TEVC.2008.2009460; Noman N, 2008, IEEE T EVOLUT COMPUT, V12, P107, DOI 10.1109/TEVC.2007.895272; Okabe H, 2001, CANCER RES, V61, P2129; Price K, 2005, DIFFERENTIAL EVOLUTI, DOI [10.1126/scisignal.2004088, DOI 10.1126/SCISIGNAL.2004088]; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Shin JE, 2011, MOL CELLS, V31, P181, DOI 10.1007/s10059-011-0020-z; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tanaka K, 2001, BBA-MOL BASIS DIS, V1536, P1, DOI 10.1016/S0925-4439(01)00026-6; Tang J, 2007, EXPT BIOL MED; Tang J, 2009, EXP BIOL MED, V234, P35, DOI 10.3181/0806-RM-187; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vesterstrom J, 2004, IEEE C EVOL COMPUTAT, P1980; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; Wang W, 2001, CANCER EPIDEM BIOMAR, V10, P931; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xu ZB, 2012, IEEE T NEUR NET LEAR, V23, P1013, DOI 10.1109/TNNLS.2012.2197412; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zeng LM, 2014, STATISTICS-ABINGDON, V48, P49, DOI 10.1080/02331888.2012.719513; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zhao YX, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-30; Zhu ZX, 2007, PATTERN RECOGN, V40, P3236, DOI 10.1016/j.patcog.2007.02.007; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	59	4	4	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0210786	10.1371/journal.pone.0210786	http://dx.doi.org/10.1371/journal.pone.0210786			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763332	Green Published, Green Submitted, gold			2022-12-26	WOS:000458763900007
J	Ercibengoa, M; Alonso, M; Vicente, D; Morales, M; Garcia, E; Marimon, JM				Ercibengoa, Maria; Alonso, Marta; Vicente, Diego; Morales, Maria; Garcia, Ernesto; Maria Marimon, Jose			Utility of MALDI-TOF MS as a new tool for Streptococcus pneumoniae serotyping	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; MULTIPLEX PCR ASSAY; STAPHYLOCOCCUS-AUREUS; MASS-SPECTROMETRY; CAPSULAR POLYSACCHARIDE; CULTURE-CONDITIONS; IDENTIFICATION; DIFFERENTIATION; IMMUNOASSAY; PNEUMOCOCCI	Nowadays, more than 95 different Streptococcus pneumoniae serotypes are known, being less than one third responsible for the majority of severe pneumococcal infections. After the introduction of conjugate vaccines, a change in the epidemiology of the serotypes causing invasive pneumococcal disease has been observed making the surveillance of circulating serotypes especially relevant. Some recent studies have used matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) technology to identify the most frequent pneumococcal serotypes that cause invasive disease. The objectives of this study were to evaluate the efficacy of previously described discriminatory peaks determined by MALDI-TOF MS for the identification of serotypes 6B, 19F, 19A and 35B using reference and clinical isolates and to try to identify other discriminatory peaks for serotypes 11A, 19F and 19A using transformed pneumococcal strains. Most of the proposed peaks defined in the literature for the identification of serotypes 6B, 19F, 19A, 35B were not found in the spectra of the 10 reference isolates nor in those of the 60 clinical isolates tested corresponding to these four serotypes. The analysis and comparison of the mass spectra of genetically modified pneumococci (transformed strains) did not allow the establishment of new discriminatory peaks for serotypes 11A, 19F, and 19A. MALDI-TOF MS in the usual range of 2,000 to 20,000 m/z did not prove to be a valid technique for direct S. pneumoniae serotyping.	[Ercibengoa, Maria; Alonso, Marta; Vicente, Diego; Maria Marimon, Jose] Hosp Univ Donostia, Inst Invest Sanitaria Biodonostia, San Sebastian, Spain; [Ercibengoa, Maria; Alonso, Marta; Vicente, Diego; Morales, Maria; Garcia, Ernesto; Maria Marimon, Jose] CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Ercibengoa, Maria; Vicente, Diego] Univ Basque Country, UPV EHU, Prevent Med & Hlth Publ Dept, San Sebastian, Spain; [Morales, Maria; Garcia, Ernesto] CSIC, Ctr Invest Biol, Dept Biotecnol Microbiana & Plantas, Madrid, Spain; [Ercibengoa, Maria] Donostia Univ Hospital, Biodonostia Inst, Dept Microbiol, Paseo Dr Beguiristain S-N, Donostia San Sebastian, Spain	Instituto de Investigacion Sanitaria Biodonostia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Instituto de Investigacion Sanitaria Biodonostia	Ercibengoa, M (corresponding author), Hosp Univ Donostia, Inst Invest Sanitaria Biodonostia, San Sebastian, Spain.; Ercibengoa, M (corresponding author), CIBER Enfermedades Resp CIBERES, Madrid, Spain.; Ercibengoa, M (corresponding author), Univ Basque Country, UPV EHU, Prevent Med & Hlth Publ Dept, San Sebastian, Spain.; Ercibengoa, M (corresponding author), Donostia Univ Hospital, Biodonostia Inst, Dept Microbiol, Paseo Dr Beguiristain S-N, Donostia San Sebastian, Spain.	maria.ercibengoaarana@osakidetza.eus	MARIMON, JOSE MARIA/AAM-5581-2021; Ercibengoa, María/ABH-9481-2020	MARIMON, JOSE MARIA/0000-0002-2787-7094; Partearroyo Lacaba, Olvido/0000-0002-1692-4481	Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES) [CB06/06/0056, CB06/06/0003]	Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES)	This work was funded in part by a grant of the Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), CB06/06/0056 and CB06/06/0003. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai S, 2001, MICROBIOL IMMUNOL, V45, P159, DOI 10.1111/j.1348-0421.2001.tb01284.x; Arrecubieta C, 1996, J EXP MED, V184, P449, DOI 10.1084/jem.184.2.449; AUSTRIAN R, 1976, MT SINAI J MED, V43, P699; Bader O, 2013, PROTEOMICS, V13, P788, DOI 10.1002/pmic.201200468; Balazova T, 2014, FEMS MICROBIOL LETT, V353, P77, DOI 10.1111/1574-6968.12408; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Bronsdon MA, 2004, J CLIN MICROBIOL, V42, P1596, DOI 10.1128/JCM.42.4.1596-1600.2004; Dingle TC, 2013, CLIN LAB MED, V33, P589, DOI 10.1016/j.cll.2013.03.001; Domenech M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125636; Domenech M, 2014, ENVIRON MICROBIOL, V16, P1193, DOI 10.1111/1462-2920.12370; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Ercibengoa M, 2017, CLIN LAB, V63, P1935, DOI 10.7754/Clin.Lab.2017.170619; Fenoll A, 1997, J CLIN MICROBIOL, V35, P764, DOI 10.1128/JCM.35.3.764-766.1997; Goldstein JE, 2013, LETT APPL MICROBIOL, V57, P144, DOI 10.1111/lam.12092; Griffin PM, 2012, J CLIN MICROBIOL, V50, P2918, DOI 10.1128/JCM.01000-12; Hettick JM, 2004, ANAL CHEM, V76, P5769, DOI 10.1021/ac049410m; HOLLIDAY MG, 1985, J HOSP INFECT, V6, P110, DOI 10.1016/S0195-6701(85)80029-3; Jauneikaite E, 2015, J MICROBIOL METH, V113, P41, DOI 10.1016/j.mimet.2015.03.006; Keys CJ, 2004, INFECT GENET EVOL, V4, P221, DOI 10.1016/j.meegid.2004.02.004; LAFONG AC, 1988, J CLIN PATHOL, V41, P230, DOI 10.1136/jcp.41.2.230; Lankinen KS, 2004, J MICROBIOL METH, V56, P193, DOI 10.1016/j.mimet.2003.10.021; Lasch P, 2014, J MICROBIOL METH, V100, P58, DOI 10.1016/j.mimet.2014.02.015; Lawrence ER, 2003, J CLIN MICROBIOL, V41, P601, DOI 10.1128/JCM.41.2.601-607.2003; Leung MH, 2012, J CLIN MICROBIOL, V50, P2419, DOI 10.1128/JCM.06384-11; Llull D, 1999, J EXP MED, V190, P241, DOI 10.1084/jem.190.2.241; MALDI Biotarget 48, 2018, DISP MALDI TARG MICR; Mansson V, 2018, EMERG INFECT DIS, V24, P443, DOI 10.3201/eid2403.170459; Marimon JM, 2010, J MICROBIOL METH, V80, P274, DOI 10.1016/j.mimet.2010.01.011; Marimon JM, 2016, J CLIN MICROBIOL, V54, P2197, DOI 10.1128/JCM.01156-16; Nakano S, 2015, EUR J CLIN MICROBIOL, V34, P2191, DOI 10.1007/s10096-015-2468-9; Park MK, 2000, CLIN DIAGN LAB IMMUN, V7, P486, DOI 10.1128/CDLI.7.3.486-489.2000; Pavlovic Melanie, 2013, Open Microbiol J, V7, P135, DOI 10.2174/1874285801307010135; Pinto TCA, 2017, SCI REP-UK, V7, DOI 10.1038/srep45572; Podolsky SH, 2005, AM J PUBLIC HEALTH, V95, P2144, DOI 10.2105/AJPH.2004.048397; Qian J, 2008, ANAL BIOANAL CHEM, V392, P439, DOI 10.1007/s00216-008-2288-1; Shah H N, 2014, J ANAL BIOANALYTIC S, Vs2; Siira L, 2012, J CLIN MICROBIOL, V50, P2727, DOI 10.1128/JCM.00689-12; Smart L, 2009, ACTA PATHOLOGICA M B, V94B, P409; Ueda O, 2015, J HOSP INFECT, V90, P147, DOI 10.1016/j.jhin.2014.11.025; Varghese R, 2017, J MICROBIOL METH, V141, P48, DOI 10.1016/j.mimet.2017.07.015; Varvio SL, 2009, J INFECT DIS, V200, P1144, DOI 10.1086/605651; Williamson YM, 2008, APPL ENVIRON MICROB, V74, P5891, DOI 10.1128/AEM.00791-08; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002	44	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212022	10.1371/journal.pone.0212022	http://dx.doi.org/10.1371/journal.pone.0212022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753210	Green Published, gold			2022-12-26	WOS:000458395600037
J	Mota, MC; Silva, CM; Balieiro, LCT; Goncalves, BF; Fahmy, WM; Crispim, CA				Mota, Maria Carliana; Silva, Catarina Mendes; Tibiletti Balieiro, Laura Cristina; Goncalves, Bruna Fernandes; Fahmy, Walid Makin; Crispim, Cibele Aparecida			Association between social jetlag food consumption and meal times in patients with obesity-related chronic diseases	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; CALORIC-INTAKE; WEIGHT-LOSS; DIET; SLEEP; MISALIGNMENT; CHRONOTYPE; METABOLISM; IMPACT	Chronic disruption of the synchronous relationship between endogenous and exogenous circadian timing is associated with the development of obesity and metabolic disease. Social jetlag is a measure of circadian misalignment and has been identified as a risk factor for overweight and related diseases. However, the mechanisms involved in this relationship remain underexplored. The objective of this study was to investigate the association between social jetlag and food consumption at late meal timing in patients with obesity-related chronic diseases. This study included 792 individuals (73% female; age 55.9 +/- 12.4 years) in which the prevalence of social jetlag (> 1h) was 24.4% (n = 194). Participants with social jetlag reported late meal timing for breakfast, early afternoon snack and dinner. Individuals with social jetlag also reported a higher intake of total calories (kcal), protein, total fat, saturated fat, cholesterol, and servings of meat and eggs and sweets in relation to those without social jetlag. Regarding the consumption during each meal of the day, participants with social jetlag had consumed more calories, saturated fat and cholesterol during dinner; more protein, total fat, saturated fat, and cholesterol during lunch; and more total fat and saturated fat during morning snack. In addition, individuals with social jetlag had a higher risk of inadequate consumption of total fat, saturated fat and cholesterol intake when compared with those without social jetlag. We conclude that social jetlag is associated with a poor diet and later meal times, which should be avoided in individuals with obesity-related chronic diseases. More studies are needed to confirm these findings.	[Mota, Maria Carliana; Silva, Catarina Mendes; Tibiletti Balieiro, Laura Cristina; Goncalves, Bruna Fernandes; Crispim, Cibele Aparecida] Univ Fed Uberlandia, Fac Med, Uberlandia, MG, Brazil; [Fahmy, Walid Makin] Hosp & Maternidade Municipal Uberlandia, Dept Obstet, Uberlandia, MG, Brazil	Universidade Federal de Uberlandia	Crispim, CA (corresponding author), Univ Fed Uberlandia, Fac Med, Uberlandia, MG, Brazil.	cibelecrispim@gmail.com	Crispim, Cibele CAC/R-1269-2016; Silva, Catarina/GVS-9316-2022; Mota, Maria/P-2856-2018	Crispim, Cibele CAC/0000-0002-6638-8197; Mota, Maria/0000-0003-4920-8948	FAPEMIG [CDS-APQ-02242-14]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by FAPEMIG [Grant no. CDS-APQ-02242-14, 2014] and by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) doctoral grants to MCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the doctoral grants to MCM.	Almoosawi S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091131; Alves MS, 2017, J BIOL RHYTHM, V32, P83, DOI 10.1177/0748730416682110; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bravo R, 2014, CHRONOBIOL INT, V31, P363, DOI 10.3109/07420528.2013.859151; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Crispim CA, 2011, METABOLISM, V60, P1726, DOI 10.1016/j.metabol.2011.04.014; de Assumpcao D, 2017, CIENC SAUDE COLETIVA, V22, P347, DOI 10.1590/1413-81232017222.16962015; de Castro JM, 2004, J NUTR, V134, P104, DOI 10.1093/jn/134.1.104; De Castro JM, 2007, BRIT J NUTR, V98, P1077, DOI 10.1017/S0007114507754296; Espitia-Bautista E, 2017, METABOLISM, V72, P83, DOI 10.1016/j.metabol.2017.04.006; Exelmans L, 2016, SOC SCI MED, V148, P93, DOI 10.1016/j.socscimed.2015.11.037; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Garaulet M, 2014, PHYSIOL BEHAV, V134, P44, DOI 10.1016/j.physbeh.2014.01.001; Gibson RS, 2017, ADV NUTR, V8, P980, DOI 10.3945/an.117.016980; Gill S, 2015, CELL METAB, V22, P789, DOI 10.1016/j.cmet.2015.09.005; Guilbert J J, 2003, Educ Health (Abingdon), V16, P230; Hammad S, 2016, LIPIDS, V51, P507, DOI 10.1007/s11745-015-4113-x; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hayat I, 2014, CRIT REV FOOD SCI, V54, P580, DOI 10.1080/10408398.2011.596639; Institute of Medicine (IOM), 2005, DIET REF INT EN CARB; Jakubowicz D, 2013, OBESITY, V21, P2504, DOI 10.1002/oby.20460; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Laakso M, 2002, INT J OBESITY, V26, P873, DOI 10.1038/sj.ijo.0802002; Larcher S, 2016, EUR J ENDOCRINOL, V175, P411, DOI 10.1530/EJE-16-0188; Leung GKW, 2019, CLIN NUTR, V38, P465, DOI 10.1016/j.clnu.2017.11.010; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; McHill AW, 2017, AM J CLIN NUTR, V106, P1213, DOI 10.3945/ajcn.117.161588; McHill AW, 2014, P NATL ACAD SCI USA, V111, P17302, DOI 10.1073/pnas.1412021111; Melkani GC, 2017, J PHYSIOL-LONDON, V595, P3691, DOI 10.1113/JP273094; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Mota MC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06723-w; MS-Brazilian Ministry of Health, 2021, COVID19 PAN; Nguyen J, 2010, NAT SCI SLEEP, V2, P9; Oishi K, 2012, CHRONOBIOL INT, V29, P799, DOI 10.3109/07420528.2012.699127; Panico S, 2014, CANCER TREAT RES, V159, P69, DOI 10.1007/978-3-642-38007-5_5; Parsons MJ, 2015, INT J OBESITY, V39, P842, DOI 10.1038/ijo.2014.201; Philippi S. T., 1999, Revista de Nutricao, V12, P65, DOI 10.1590/S1415-52731999000100006; Raina Sunil Kumar, 2013, N Am J Med Sci, V5, P498, DOI 10.4103/1947-2714.117329; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Saneei P, 2014, NUTR METAB CARDIOVAS, V24, P1253, DOI 10.1016/j.numecd.2014.06.008; Sargent C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020170; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Silva CM, 2016, CHRONOBIOL INT, V33, P740, DOI 10.3109/07420528.2016.1167712; Stoner L, 2018, CHILD OBES, V14, P158, DOI 10.1089/chi.2017.0272; Tan E, 2014, CURR OPIN CLIN NUTR, V17, P343, DOI 10.1097/MCO.0000000000000061; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wong PM, 2015, J CLIN ENDOCR METAB, V100, P4612, DOI 10.1210/jc.2015-2923; World Health Organization, 2008, WAIST CIRCUMFERENCE; World Health Organization, 2000, TECHNICAL REPORT	49	52	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212126	10.1371/journal.pone.0212126	http://dx.doi.org/10.1371/journal.pone.0212126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753224	Green Published, gold, Green Submitted			2022-12-26	WOS:000458395600045
J	Al-Shehri, MM; El-Azab, AS; El-Gendy, MA; Hamidaddin, MA; Darwish, IA				Al-Shehri, Mona M.; El-Azab, Adel S.; El-Gendy, Manal A.; Hamidaddin, Mohammed A.; Darwish, Ibrahim A.			Synthesis of hapten, generation of specific polyclonal antibody and development of ELISA with high sensitivity for therapeutic monitoring of crizotinib	PLOS ONE			English	Article							ENZYME-IMMUNOASSAY; TANDEM; VALIDATION; SORAFENIB; LAPATINIB; DASATINIB; IMATINIB; PLASMA	Crizotinib (CZT) is a potent drug used for treatment of non-small cell lung cancer (NSCLC); however, its circulating concentration variability has been associated with acquired resistance and toxicity, restricting the success of cancer treatment. As such, the development of an assay that monitors CZT plasma concentrations in patients is a valuable tool in cancer treatment. In this study, a hapten of CZT was synthesized by introducing the acetohydrazide moiety as a spacer into the chemical structure of CZT. The chemical structure of the CZT acetohydrazide (hapten) was confirmed by mass, H-1-, and C-13-NMR spectrometric techniques. The hapten was coupled to each of bovine serum albumin (BSA) and keyhole limpet hemocyanin (KLH) proteins by ethyl-3-(3-dimethylaminopropyl) carbodiimide as a coupling reagent. CZT-KLH conjugate was used for immunization and generation of a polyclonal antibody recognizing CZT with high affinity (IC50 = 0.5 ng/mL). The polyclonal antibody was used in the development of an ELISA for determination of CZT. The ELISA involved a competitive binding reaction between CZT, in its samples, and immobilized CZT-BSA conjugate for the binding sites on a limited amount of the anti-CZT antibody. The assay limit of detection was 0.03 ng/mL and the working range was 0.05 - 24 ng/mL. Analytical recovery of CZT from spiked plasma was 101.98 +/- 2.99%. The precisions of the assay were satisfactory; RSD was 3.2 - 6.5% and 4.8 - 8.2%, for the intra- and inter-assay precision, respectively. The assay is superior to all the existing chromatographic methods for CZT in terms of its procedure simplicity, convenience, and does not require treatment of plasma samples prior to the analysis. The proposed ELISA is anticipated to effectively contribute to the therapeutic monitoring of CZT in clinical settings.	[Al-Shehri, Mona M.; El-Azab, Adel S.; El-Gendy, Manal A.; Hamidaddin, Mohammed A.; Darwish, Ibrahim A.] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh, Saudi Arabia; [Hamidaddin, Mohammed A.] Sanaa Univ, Dept Med & Analyt Chem, Fac Pharm, Sanaa, Yemen	King Saud University	Darwish, IA (corresponding author), King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh, Saudi Arabia.	idarwish@ksu.edu.sa		Darwish, Ibrahim A/0000-0003-3821-623X	Deanship of Scientific Research at King Saud University [RGP-225]	Deanship of Scientific Research at King Saud University(King Saud University)	This work was supported by the Deanship of Scientific Research at King Saud University to ID. Research group No. RGP-225. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliperti LA, 2011, ANN SURG ONCOL, V18, P603, DOI 10.1245/s10434-010-1442-0; American Cancer Society, NON TRADITIONAL REF; ANDERSON DJ, 1989, CLIN CHEM, V35, P2152; Bi GF, 2016, CHIN J CLIN PHARM, V11, P1031; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Darwish Ibrahim A, 2006, Int J Biomed Sci, V2, P217; Darwish IA, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-38; Darwish IA, 2011, J IMMUNOASS IMMUNOCH, V32, P57, DOI 10.1080/15321819.2010.538109; Darwish IA, 2010, MICROCHIM ACTA, V170, P67, DOI 10.1007/s00604-010-0390-5; Darwish IA, 2009, TALANTA, V79, P1478, DOI 10.1016/j.talanta.2009.06.021; Engvall E, 1980, Methods Enzymol, V70, P419; ERLANGER BF, 1973, PHARMACOL REV, V25, P271; Findlay JWA, 2000, J PHARMACEUT BIOMED, V21, P1249, DOI 10.1016/S0731-7085(99)00244-7; Haouala A, 2009, J CHROMATOGR B, V877, P1982, DOI 10.1016/j.jchromb.2009.04.045; Huang XL, 2014, LAT AM J PHARM, V33, P1188; Khalil NY, 2014, LAT AM J PHARM, V33, P1019; Lange V, 2010, BE SURVIVOR LUNG CAN; NIH intramural Animal Care and Use Committees, NON TRADITIONAL REF; Qiu F, 2016, BIOMED CHROMATOGR, V30, P962, DOI 10.1002/bmc.3636; Roberts MS, 2014, J CHROMATOGR B, V960, P151, DOI 10.1016/j.jchromb.2014.04.035; Sparidans RW, 2012, J CHROMATOGR B, V905, P150, DOI 10.1016/j.jchromb.2012.08.021; Wang JZ, 2015, LAT AM J PHARM, V34, P1576; Wani TA, 2014, DIG J NANOMATER BIOS, V9, P693; WEEKS I, 1986, CLIN SCI, V70, P403, DOI 10.1042/cs0700403; Widmer Nicolas, 2008, Rev Med Suisse, V4, P1644; Zhao Wei, 2011, Handb Exp Pharmacol, V205, P77, DOI 10.1007/978-3-642-20195-0_3	26	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0212048	10.1371/journal.pone.0212048	http://dx.doi.org/10.1371/journal.pone.0212048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742664	gold, Green Published, Green Submitted			2022-12-26	WOS:000458393400040
J	Stadnikova, A; Trosan, P; Skalicka, P; Utheim, TP; Jirsova, K				Stadnikova, Andrea; Trosan, Peter; Skalicka, Pavlina; Utheim, Tor Paaske; Jirsova, Katerina			Interleukin-13 maintains the stemness of conjunctival epithelial cell cultures prepared from human limbal explants	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; IN-VITRO; GOBLET CELLS; CORNEAL; DIFFERENTIATION; TRANSPLANTATION; PROLIFERATION; GENE; LYMPHOCYTES; ISOFORMS	To use human limbal explants as an alternative source for generating conjunctival epithelium and to determine the effect of interleukin-13 (IL-13) on goblet cell number, mucin expression, and stemness. Human limbal explants prepared from 17 corneoscleral rims were cultured with or without IL-13 (IL-13+ and IL-13-, respectively) and followed up to passage 2 (primary culture [P0]-P2). Cells were characterized by alcian blue/periodic acid-Schiff (AB/PAS) staining (goblet cells); immunofluorescent staining for p63a (progenitor cells), Ki-67 (proliferation), MUC5AC (mucin, goblet cells), and keratin 7 (K7, conjunctival epithelial and goblet cells); and by quantitative real-time polymerase chain reaction for expression of the p63a (TP63), MUC5AC, MUC4 (conjunctival mucins), K3, K12 (corneal epithelial cells), and K7 genes. Clonogenic ability was determined by colony-forming efficiency (CFE) assay. Using limbal explants, we generated epithelium with conjunctival phenotype and high viability in P0, P1, and P2 cultures under IL-13+ and IL-13-conditions, i.e., epithelium with strong K7 positivity, high K7 and MUC4 expression and the presence of goblet cells (AB/PAS and MUC5AC positivity; MUC5AC expression). p63a positivity was similar in IL-13+ and IL-13-cultures and was decreased in P2 cultures; however, there was increased TP63 expression in the presence of IL-13 (especially in the P1 cultures). Similarly, IL-13 increased proliferative activity in P1 cultures and significantly promoted P0 and P1 culture CFE. IL-13 did not increase goblet cell number in the P0-P2 cultures, nor did it influence MUC5AC and MUC4 expression. By harvesting unattached cells on day 1 of P1 we obtained goblet cell rich subpopulation showing AB/PAS, MUC5AC, and K7 positivity, but with no growth potential. In conclusion, limbal explants were successfully used to develop conjunctival epithelium with the presence of putative stem and goblet cells and with the ability to preserve the stemness of P0 and P1 cultures under IL-13 influence.	[Stadnikova, Andrea; Trosan, Peter; Jirsova, Katerina] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Lab Biol & Pathol Eye, Prague, Czech Republic; [Stadnikova, Andrea; Trosan, Peter; Skalicka, Pavlina; Jirsova, Katerina] Gen Univ Hosp Prague, Prague, Czech Republic; [Skalicka, Pavlina] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech Republic; [Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Utheim, Tor Paaske] Oslo Univ Hosp, Dept Plast & Reconstruct Surg, Oslo, Norway	Charles University Prague; General University Hospital Prague; Charles University Prague; University of Oslo; University of Oslo	Jirsova, K (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Lab Biol & Pathol Eye, Prague, Czech Republic.; Jirsova, K (corresponding author), Gen Univ Hosp Prague, Prague, Czech Republic.	katerina.jirsova@lf1.cuni.cz	Stadnikova, Andrea/J-4054-2017	Stadnikova, Andrea/0000-0002-3571-3946	Norwegian Financial Mechanism 2009-2014; Ministry of Education, Youth and Sports [MSMT-28477/2014, 7F14156, BBMRI_CZ LM2015089]; SVV [260367/2017]; GAUK [250361/2017]	Norwegian Financial Mechanism 2009-2014; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); SVV; GAUK	This study was supported by Norwegian Financial Mechanism 2009-2014 and the Ministry of Education, Youth and Sports under Project Contract No. MSMT-28477/2014, project 7F14156 (AS, PT, KJ) -http://www.msmt.cz/vyzkum-a-vyvoj-2/projects and by research project BBMRI_CZ LM2015089 (PT, KJ) - http://biobanka.lf1.cuni.cz/cz/. PT was supported by SVV 260367/2017 - http://www.cuni.cz/UK-3362.html and PS by GAUK 250361/2017 - https://www.cuni.cz/UK-33.html and SVV 260367/2017 - http://www.cuni.cz/UK-3362.html. Institutional support was provided by Progres-Q25 206025-5 (PT, KJ) - https://www.cuni.cz/UK-7368.html and UNCE 204064 (PT) - https://www.cuni.cz/UK-3761.html.Oslo University Hospital, Oslo, Norway (TPU) https://www.uio.no.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LPK, 2010, INVEST OPHTH VIS SCI, V51, P758, DOI 10.1167/iovs.09-3379; Ang LPK, 2005, AM J OPHTHALMOL, V139, P611, DOI 10.1016/j.ajo.2004.10.056; Ang LPK, 2005, BRIT J OPHTHALMOL, V89, P748, DOI 10.1136/bjo.2004.055046; Birchenough GMH, 2015, MUCOSAL IMMUNOL, V8, P712, DOI 10.1038/mi.2015.32; Contreras-Ruiz L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/636812; Curran-Everett D, 2008, ADV PHYSIOL EDUC, V32, P203, DOI 10.1152/advan.90123.2008; Dalessandri T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12080; De Paiva CS, 2011, MUCOSAL IMMUNOL, V4, P397, DOI 10.1038/mi.2010.82; Di Girolamo N, 2009, TRANSPLANTATION, V87, P1571, DOI 10.1097/TP.0b013e3181a4bbf2; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; DUA HS, 1994, CURR EYE RES, V13, P87, DOI 10.3109/02713689409042401; Dyrlund TF, 2012, J PROTEOME RES, V11, P4231, DOI 10.1021/pr300358k; Eidet JR, 2015, J FUNCT BIOMATER, V6, P1064, DOI 10.3390/jfb6041064; Fukuda Ken, 2006, Allergol Int, V55, P121, DOI 10.2332/allergolint.55.121; Garcia-Posadas L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30002-x; Garcia-Posadas L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171099; Garcia-Posadas L, 2016, EYE CONTACT LENS, V42, P83, DOI 10.1097/ICL.0000000000000158; Garcia-Posadas L, 2013, INVEST OPHTH VIS SCI, V54, P7143, DOI 10.1167/iovs.13-12866; GERDES J, 1984, J IMMUNOL, V133, P1710; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; Gipson IK, 2016, PROG RETIN EYE RES, V54, P49, DOI 10.1016/j.preteyeres.2016.04.005; Gomez-Flores E, 2011, J CELL PHYSIOL, V226, P700, DOI 10.1002/jcp.22380; Gour N, 2015, CYTOKINE, V75, P68, DOI 10.1016/j.cyto.2015.05.014; Henriksson JT, 2015, INVEST OPHTH VIS SCI, V56, P4186, DOI 10.1167/iovs.14-15496; Inatomi T, 1996, INVEST OPHTH VIS SCI, V37, P1684; JACOBSEN SEW, 1994, J EXP MED, V180, P75, DOI 10.1084/jem.180.1.75; Jirsova K, 2011, INVEST OPHTH VIS SCI, V52, P5892, DOI 10.1167/iovs.10-6748; Junttila IS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00888; Kawasaki S, 2006, INVEST OPHTH VIS SCI, V47, P1359, DOI 10.1167/iovs.05-1084; Kessing SV., 1968, ACTA OPHTHALMOL S95; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; LAMBIASE A, 1995, INVEST OPHTH VIS SCI, V36, P2127; Lambiase A, 2009, INVEST OPHTH VIS SCI, V50, P4622, DOI 10.1167/iovs.08-2716; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Leonardi A, 2008, CLIN EXP IMMUNOL, V153, P17, DOI 10.1111/j.1365-2249.2008.03716.x; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; Li WW, 2010, MOL VIS, V16, P2739; Liu CY, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0136-6; Lopez-Paniagua M, 2016, EXP EYE RES, V146, P83, DOI 10.1016/j.exer.2015.12.002; Luznik Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164408; Madhira SL, 2008, MOL VIS, V14, P189; Myers R, SPECIAL STAIN TECHNI; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Pathak M, 2016, ACTA OPHTHALMOL, V94, DOI [10.1016/j.exer.2016.09.012, 10.1111/j.1755-3768.2016.0555]; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Sasamoto Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20807; Saw VPJ, 2009, AM J PATHOL, V175, P2406, DOI 10.2353/ajpath.2009.090579; Schrader S, 2010, REGEN MED, V5, P877, DOI [10.2217/rme.10.73, 10.2217/RME.10.73]; Schrader S, 2009, CURR EYE RES, V34, P913, DOI 10.3109/02713680903198045; Siebelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082355; Stewart RMK, 2015, INVEST OPHTH VIS SCI, V56, P2021, DOI 10.1167/iovs.14-16266; Tanioka H, 2006, INVEST OPHTH VIS SCI, V47, P3820, DOI 10.1167/iovs.06-0293; TSAI RJF, 1988, INVEST OPHTH VIS SCI, V29, P1565; Utheim Tor Paaske, 2013, Methods Mol Biol, V1014, P3, DOI 10.1007/978-1-62703-432-6_1; WEI ZG, 1995, INVEST OPHTH VIS SCI, V36, P236; XI XD, 1995, BRIT J HAEMATOL, V90, P921, DOI 10.1111/j.1365-2141.1995.tb05216.x	58	6	6	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0211861	10.1371/journal.pone.0211861	http://dx.doi.org/10.1371/journal.pone.0211861			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742646	Green Published, gold, Green Submitted			2022-12-26	WOS:000458393400027
J	Wang, CJ; Wu, KM; Zhang, XL; Wang, F; Zhang, HO; Ye, YY; Wu, QT; Huang, GZ; Wang, Y; Wen, B				Wang, Changjian; Wu, Kangmin; Zhang, Xinlin; Wang, Fei; Zhang, Hongou; Ye, Yuyao; Wu, Qitao; Huang, Gengzhi; Wang, Yang; Wen, Bin			Features and drivers for energy-related carbon emissions in mega city: The case of Guangzhou, China based on an extended LMDI model	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; COMMERCIAL BUILDING SECTOR; STRUCTURAL DECOMPOSITION ANALYSIS; CO2 EMISSIONS; GHG EMISSIONS; INPUT-OUTPUT; POLICY IMPLICATIONS; DIOXIDE EMISSION; ECONOMIC-GROWTH; CONSUMPTION	Based on the apparent energy consumption data, a systematic and comprehensive city-level total carbon accounting approach was established and applied in Guangzhou, China. A newly extended LMDI method based on the Kaya identity was adopted to examine the main drivers for the carbon emissions increments both at the industrial sector and the residential sector. Research results are listed as follow: (1) Carbon emissions embodied in the imported electricity played a significant important role in emissions mitigation in Guangzhou. (2) The influences and impacts of various driving factors on industrial and residential carbon emissions are different in the three different development periods, namely, the 10th five-year plan period (2003-2005), the 11th five-year plan period (2005-2010), and the 12th five-year plan period (2010-2013). The main reasons underlying these influencing mechanisms were different policy measures announced by the central and local government during the different five-year plan periods. (3) The affluence effect (g-effect) was the dominant positive effect in driving emissions increase, while the energy intensity effect of production (e-effect-Production), the economic structure effect (s-effect) and the carbon intensity effect of production (f-effect-Production) were the main contributing factors suppressing emissions growth at the industrial sector. (4) The affluence effect of urban (g-effect-AUI) was the most dominant positive driving factor on emissions increment, while the energy intensity effect of urban (e-effect-Urban) played the most important role in curbing emissions growth at the residential sector.	[Wang, Changjian; Wu, Kangmin; Zhang, Hongou; Ye, Yuyao; Wu, Qitao; Huang, Gengzhi; Wang, Yang] Guangzhou Inst Geog, Guangdong Open Lab Geospatial Informat Technol &, Key Lab Guangdong Utilizat Remote Sensing & Geog, Guangzhou, Guangdong, Peoples R China; [Zhang, Xinlin] Jiangsu Normal Univ, Sch Geog Geomat & Planning, Xuzhou, Jiangsu, Peoples R China; [Wang, Fei] Xinjiang Normal Univ, Coll Geog Sci & Tourism, Urumqi, Peoples R China; [Wen, Bin] Huanghuai Univ, Coll Econ & Management, Zhumadian, Peoples R China	Guangdong Academy of Sciences; Guangzhou Institute of Geography, Guangdong Academy of Sciences; Jiangsu Normal University; Xinjiang Normal University; Huanghuai University	Wang, CJ (corresponding author), Guangzhou Inst Geog, Guangdong Open Lab Geospatial Informat Technol &, Key Lab Guangdong Utilizat Remote Sensing & Geog, Guangzhou, Guangdong, Peoples R China.; Wang, F (corresponding author), Xinjiang Normal Univ, Coll Geog Sci & Tourism, Urumqi, Peoples R China.	wwwangcj@126.com; wangfei09@mails.ucas.ac.cn			National Natural Science Foundation of China [41501144, 41671130]; High-level Leading Talent Introduction Program of GDAS [2016GDASRC-0101]; Scientific Platform and Innovation Capability Construction Program of GDAS [2016GDASPT-0210]; GDAS' Project of Science and Technology Development [2017GDASCX-0101, 2018GDASCX-0101, 2019GDASYL-0302001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High-level Leading Talent Introduction Program of GDAS; Scientific Platform and Innovation Capability Construction Program of GDAS; GDAS' Project of Science and Technology Development	This work was supported by the National Natural Science Foundation of China (Nos. 41501144, 41671130), the High-level Leading Talent Introduction Program of GDAS (2016GDASRC-0101), and the Scientific Platform and Innovation Capability Construction Program of GDAS (2016GDASPT-0210) and the GDAS' Project of Science and Technology Development (2017GDASCX-0101, 2018GDASCX-0101, 2019GDASYL-0302001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency IE, 2009, CIT TOWNS REN EN; Andres RJ, 2012, BIOGEOSCIENCES, V9, P1845, DOI 10.5194/bg-9-1845-2012; Ang BW, 2015, ENERG POLICY, V86, P233, DOI 10.1016/j.enpol.2015.07.007; Ang BW, 2005, ENERG POLICY, V33, P867, DOI 10.1016/j.enpol.2003.10.010; Ang BW, 2004, ENERG POLICY, V32, P1131, DOI 10.1016/S0301-4215(03)00076-4; Ang BW, 2001, ENERGY, V26, P537, DOI 10.1016/S0360-5442(01)00022-6; Bai XM, 2014, NATURE, V509, P158, DOI 10.1038/509158a; Bank W, 2016, WORLD DEV IND; Bi J, 2011, ENERG POLICY, V39, P4785, DOI 10.1016/j.enpol.2011.06.045; Chen B, 2017, RENEW SUST ENERG REV, V67, P662, DOI 10.1016/j.rser.2016.09.027; Chen GQ, 2013, COMMUN NONLINEAR SCI, V18, P2493, DOI 10.1016/j.cnsns.2012.12.029; Davis SJ, 2010, P NATL ACAD SCI USA, V107, P5687, DOI 10.1073/pnas.0906974107; Dhakal S, 2010, CURR OPIN ENV SUST, V2, P277, DOI 10.1016/j.cosust.2010.05.007; Dhakal S, 2009, ENERG POLICY, V37, P4208, DOI 10.1016/j.enpol.2009.05.020; Feng KS, 2014, ECOL INDIC, V47, P26, DOI 10.1016/j.ecolind.2014.04.045; Feng KS, 2013, P NATL ACAD SCI USA, V110, P11654, DOI 10.1073/pnas.1219918110; Guan D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036540; Guangdong Provincial Development and Reform Commission, 2013, 12 5 YEAR PLAN EN DE; Guizhou Energy Administration, 12 5 YEAR PLAN POW I; Helm D, 2012, NATURE, V491, P663, DOI 10.1038/491663a; Hoekstra R, 2003, ENERG ECON, V25, P39, DOI 10.1016/S0140-9883(02)00059-2; Kang JD, 2014, ENERGY, V68, P562, DOI 10.1016/j.energy.2014.01.023; Kennedy C, 2009, ENVIRON SCI TECHNOL, V43, P7297, DOI 10.1021/es900213p; Li B, 2015, NAT HAZARDS, V76, P1667, DOI 10.1007/s11069-014-1574-9; Li JS, 2013, ENERG POLICY, V59, P819, DOI 10.1016/j.enpol.2013.04.042; Li JS, 2013, RENEW SUST ENERG REV, V22, P23, DOI 10.1016/j.rser.2012.11.072; Liang S, 2011, ENERG POLICY, V39, P2910, DOI 10.1016/j.enpol.2011.02.069; Lin JY, 2013, ENERG POLICY, V58, P220, DOI 10.1016/j.enpol.2013.03.007; Liu Z, 2015, ECOL MODEL, V318, P118, DOI 10.1016/j.ecolmodel.2015.02.001; Liu Z, 2015, NATURE, V524, P335, DOI 10.1038/nature14677; Liu Z, 2015, NATURE, V522, P279, DOI 10.1038/522279a; Liu Z, 2013, NATURE, V500, P143, DOI 10.1038/500143a; Liu Z, 2012, ENERGY, V37, P245, DOI 10.1016/j.energy.2011.11.040; Lombardi M, 2017, ENVIRON IMPACT ASSES, V66, P43, DOI 10.1016/j.eiar.2017.06.005; Ma MD, 2018, ENERGY, V165, P350, DOI 10.1016/j.energy.2018.09.070; Ma MD, 2019, SCI TOTAL ENVIRON, V650, P822, DOI 10.1016/j.scitotenv.2018.08.078; Ma MD, 2019, SCI TOTAL ENVIRON, V651, P42, DOI 10.1016/j.scitotenv.2018.09.118; Ma MD, 2018, SCI TOTAL ENVIRON, V634, P884, DOI 10.1016/j.scitotenv.2018.04.043; Ma MD, 2017, J CLEAN PROD, V143, P784, DOI 10.1016/j.jclepro.2016.12.046; Malakoff D, 2014, SCIENCE, V346, P903, DOI 10.1126/science.346.6212.903; Meng J, 2017, J CLEAN PROD, V161, P1275, DOI 10.1016/j.jclepro.2017.02.185; Mi ZF, 2015, J CLEAN PROD, V103, P455, DOI 10.1016/j.jclepro.2014.06.011; Mi ZF, 2018, EARTHS FUTURE, V6, P1007, DOI 10.1029/2018EF000840; Mi ZF, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa69cf; Mi ZF, 2016, APPL ENERG, V184, P1073, DOI 10.1016/j.apenergy.2016.06.094; Ming Z., 2013, RENEW ENERGY, V60, P454; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Rosa EA, 2012, NAT CLIM CHANGE, V2, P581, DOI 10.1038/NCLIMATE1506; Rosenzweig C, 2010, NATURE, V467, P909, DOI 10.1038/467909a; Shan YL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq0390; Shan YL, 2018, SCI DATA, V5, DOI 10.1038/sdata.2017.201; Shan YL, 2017, J CLEAN PROD, V161, P1215, DOI 10.1016/j.jclepro.2017.06.075; Shan YL, 2016, APPL ENERG, V184, P742, DOI 10.1016/j.apenergy.2016.03.073; Shao S, 2016, RENEW SUST ENERG REV, V55, P516, DOI 10.1016/j.rser.2015.10.081; Shao S, 2011, ENERG POLICY, V39, P6476, DOI 10.1016/j.enpol.2011.07.049; Su B, 2012, ENERG ECON, V34, P177, DOI 10.1016/j.eneco.2011.10.009; Sugar L, 2012, J IND ECOL, V16, P552, DOI 10.1111/j.1530-9290.2012.00481.x; Tan XC, 2016, APPL ENERG, V162, P1345, DOI 10.1016/j.apenergy.2015.06.071; Tian X, 2013, ENERG POLICY, V53, P279, DOI 10.1016/j.enpol.2012.10.054; Tollefson J, 2014, NATURE, V515, P473, DOI 10.1038/515473a; Vause J, 2013, ENERG POLICY, V60, P697, DOI 10.1016/j.enpol.2013.04.069; Wang CJ, 2017, SCIENCE, V357, P764, DOI 10.1126/science.aao2785; Wang CJ, 2017, J GEOGR SCI, V27, P365, DOI 10.1007/s11442-017-1382-8; Wang CJ, 2017, RENEW SUST ENERG REV, V67, P51, DOI 10.1016/j.rser.2016.09.006; [王长建 Wang Changjian], 2016, [地理学报, Acta Geographica Sinica], V71, P1105; [王长建 Wang Changjian], 2016, [生态学报, Acta Ecologica Sinica], V36, P2151; Wang CJ, 2015, FRONT EARTH SCI-PRC, V9, P65, DOI 10.1007/s11707-014-0442-y; Wang CJ, 2014, ENVIRON SCI TECHNOL, V48, P13559, DOI 10.1021/es505198t; Wang CJ, 2014, SUSTAINABILITY-BASEL, V6, P8164, DOI 10.3390/su6118164; Wang F, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9020274; Wang HS, 2014, ENERG POLICY, V68, P482, DOI 10.1016/j.enpol.2013.12.066; Wang M, 2018, STRUCT CHANGE ECON D, V46, P136, DOI 10.1016/j.strueco.2018.05.003; Wang MW, 2011, ENERG POLICY, V39, P6981, DOI 10.1016/j.enpol.2011.07.041; Wang YF, 2013, ENERG POLICY, V58, P312, DOI 10.1016/j.enpol.2013.03.022; Wang YS, 2013, ENVIRON SCI POLICY, V27, P151, DOI 10.1016/j.envsci.2012.12.005; Wang ZH, 2016, ECOL INDIC, V61, P634, DOI 10.1016/j.ecolind.2015.10.015; Wang ZH, 2015, ECOL INDIC, V48, P41, DOI 10.1016/j.ecolind.2014.07.035; Wang ZH, 2012, APPL ENERG, V100, P277, DOI 10.1016/j.apenergy.2012.05.038; WRI (World Resources Institute) and WBCSD (World Business Council for Sustainable Development), 2013, NON TRADITIONAL REF; WRI (World Resources Institute) C40 Cities Climate Leadership Group ICLEI (International Council for Local Environmental Initiatives). WRI (World Resources Institute) C40 Cities Climate Leadership Group ICLEI ( nternational Council for Local Environmental Initiatives), 2014, NON TRADITIONAL REF; Wu R, 2016, J CLEAN PROD, V112, P4151, DOI 10.1016/j.jclepro.2015.07.017; Xi FM, 2011, ENERG POLICY, V39, P5999, DOI 10.1016/j.enpol.2011.06.063; Yang XJ, 2013, SCIENCE, V342, P310, DOI 10.1126/science.342.6156.310-a; Zhao M, 2010, ENERGY, V35, P2505, DOI 10.1016/j.energy.2010.02.049; Zhao RQ, 2014, RENEW SUST ENERG REV, V33, P589, DOI 10.1016/j.rser.2014.02.020	87	16	17	10	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0210430	10.1371/journal.pone.0210430	http://dx.doi.org/10.1371/journal.pone.0210430			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL0OI	30742627	gold, Green Published, Green Submitted			2022-12-26	WOS:000458393400007
J	Houghton, LA; Trilok-Kumar, G; Mcintosh, D; Haszard, JJ; Harper, MJ; Reid, M; Erhardt, J; Bailey, K; Gibson, RS				Houghton, Lisa A.; Trilok-Kumar, Geeta; Mcintosh, Deborah; Haszard, Jillian J.; Harper, Michelle J.; Reid, Malcolm; Erhardt, Juergen; Bailey, Karl; Gibson, Rosalind S.			Multiple micronutrient status and predictors of anemia in young children aged 12-23 months living in New Delhi, India	PLOS ONE			English	Article							BIOMARKERS REFLECTING INFLAMMATION; SOLUBLE TRANSFERRIN RECEPTOR; RETINOL-BINDING-PROTEIN; LOW SERUM SELENIUM; NUTRITIONAL DETERMINANTS; PRESCHOOL-CHILDREN; VITAMIN-D; IRON-DEFICIENCY; PLASMA FERRITIN; MICROBIOLOGICAL ASSAY	Anemia has been identified as a severe public health concern among young children in India, however, information on the prevalence of anemia attributed to micronutrient deficiencies is lacking. We aimed to assess multiple micronutrient status (iron, zinc, selenium, vitamin A, vitamin D, folate and vitamin B12) in young Indian children and to investigate the role of these seven micronutrients and other non-nutritional factors on hemoglobin concentrations and anemia. One-hundred and twenty children aged 12 to 23 months were included in a cross-sectional nutritional assessment survey, of which 77 children provided a blood sample. Hemoglobin (Hb), serum ferritin, soluble transferrin receptor (sTfR), total body iron, zinc, selenium, retinol binding protein (RBP), folate, vitamin B12 and 25-hydroxyvitamin D (25(OH) D) were measured, and adjusted for inflammation using C-reactive protein (CRP) and alpha-1-acid glycoprotein (AGP), where appropriate. Predictors for hemoglobin and anemia were identified in multiple regression models. Most of the children were classified as anemic, of which 86 to 93% was associated with iron deficiency depending on the indicator applied. Deficiencies of folate (37%), and notably vitamin D (74%) were also common; fewer children were classified with deficiencies of vitamin B12 (29%), zinc (25%), and vitamin A (17%) and selenium deficiency was nearly absent. Multiple micronutrient deficiencies were common with over half (57%) deficient in three or more micronutrients, and less than 10% of children were classified with adequate status for all the micronutrients measured. Iron status was found to be the only nutritional factor statistically significantly inversely associated with anemia (P = 0.003) in multivariate analysis after controlling for sex. A coordinated multi-micronutrient program is urgently needed to combat the co-existing micronutrient deficiencies in these young children to improve micronutrient status and reduce the high burden of childhood anemia.	[Houghton, Lisa A.; Mcintosh, Deborah; Haszard, Jillian J.; Harper, Michelle J.; Bailey, Karl; Gibson, Rosalind S.] Univ Otago, Dept Human Nutr, Dunedin, New Zealand; [Trilok-Kumar, Geeta] Univ Delhi, Inst Home Econ, Dept Biochem, New Delhi, India; [Reid, Malcolm] Univ Otago, Dept Chem, Dunedin, New Zealand; [Erhardt, Juergen] VitMin Lab, Willstaett, Germany	University of Otago; University of Delhi; University of Otago	Houghton, LA (corresponding author), Univ Otago, Dept Human Nutr, Dunedin, New Zealand.	lisa.houghton@otago.ac.nz	Trilok-Kumar, Geeta/AAF-5978-2021; Houghton, Lisa/F-5305-2011	Trilok-Kumar, Geeta/0000-0001-8442-2881; Houghton, Lisa/0000-0002-2276-6205; Reid, Malcolm/0000-0002-4129-0214	India NZ Education Council Joint Research Grant	India NZ Education Council Joint Research Grant	This work was supported by a grant from the India NZ Education Council Joint Research Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal KS, 2002, ARCH DIS CHILD, V87, P111, DOI 10.1136/adc.87.2.111; Anderson VP, 2008, ASIA PAC J CLIN NUTR, V17, P72; [Anonymous], 2011, VIT MIN NUTR INF SYS; [Anonymous], NAT FAM HLTH SURV 20; Arsenault JE, 2011, EUR J CLIN NUTR, V65, P184, DOI 10.1038/ejcn.2010.234; Awasthi S, 2013, LANCET, V381, P1469, DOI 10.1016/S0140-6736(12)62125-4; Bains K, 2015, FOOD NUTR BULL, V36, P254, DOI 10.1177/0379572115597396; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; De-Regil LM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008959.pub2; Ekbote VH, 2010, INDIAN J PEDIATR, V77, P61, DOI 10.1007/s12098-009-0263-2; Engle-Stone R, 2017, J NUTR, V147, P1426, DOI 10.3945/jn.116.245076; Engle-Stone R, 2017, AM J CLIN NUTR, V106, p402S, DOI 10.3945/ajcn.116.142323; Engle-Stone R, 2013, J NUTR, V143, P369, DOI 10.3945/jn.112.167775; Engle-Stone R, 2011, J NUTR, V141, P2233, DOI 10.3945/jn.111.145805; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Grant FKE, 2012, AM J CLIN NUTR, V95, P1231, DOI 10.3945/ajcn.111.029900; Hess SY, 2007, FOOD NUTR BULL, V28, pS403, DOI 10.1177/15648265070283S303; Hira CK, 2004, PUBLIC HEALTH NUTR, V7, P39, DOI 10.1079/PHN2003513; Hirve S, 2013, INDIAN J PEDIATR, V80, P990, DOI 10.1007/s12098-013-1063-2; Hotz C., 2004, FOOD NUTR BULL, V25, pS91; IOM, 2011, DIETARY REFERENCE IN; Jin HJ, 2013, BLOOD RES, V48, P40, DOI 10.5045/br.2013.48.1.40; Jung S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130016; Kapil U, 2015, BIOMED J, V38, P162, DOI 10.4103/2319-4170.137768; Kapil U, 2011, INDIAN J PEDIATR, V78, P1069, DOI 10.1007/s12098-011-0379-z; Karakochuk CD, 2017, EUR J CLIN NUTR, V71, P1467, DOI 10.1038/ejcn.2017.127; Kasvosve I, 2006, CLIN CHIM ACTA, V371, P130, DOI 10.1016/j.cca.2006.02.034; Kim YL, 2016, YONSEI MED J, V57, P1159, DOI 10.3349/ymj.2016.57.5.1159; Kumar GT, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2975; Kumar T, 2014, NUTRITION, V30, P531, DOI 10.1016/j.nut.2013.09.015; Lakshminarayanan Subitha, 2015, J Nat Sci Biol Med, V6, P24, DOI 10.4103/0976-9668.149073; Lander RL, 2008, ASIA PAC J CLIN NUTR, V17, P429; LEWIS CA, 1992, ANN NY ACAD SCI, V669, P360; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Lohman T.J., 1998, ANTHROPOMETRIC STAND; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; Mburu ASW, 2010, EUR J CLIN NUTR, V64, P510, DOI 10.1038/ejcn.2010.33; Merrill RD, 2017, AM J CLIN NUTR, V106, p348S, DOI 10.3945/ajcn.116.142315; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; Nagar R, 2015, J COMMUN GENET, V6, P1, DOI 10.1007/s12687-014-0195-z; Namaste SML, 2017, AM J CLIN NUTR, V106, p359S, DOI 10.3945/ajcn.116.141762; Namaste SML, 2017, AM J CLIN NUTR, V106, p333S, DOI 10.3945/ajcn.116.142273; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Pasricha SR, 2011, AM J CLIN NUTR, V94, P1358, DOI 10.3945/ajcn.111.018580; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Raiten DJ, 2015, J NUTR, V145, p1039S, DOI 10.3945/jn.114.194571; Rawat R, 2009, EUR J CLIN NUTR, V63, P787, DOI 10.1038/ejcn.2008.33; Righetti AA, 2013, AM J CLIN NUTR, V97, P1364, DOI 10.3945/ajcn.112.050302; Rohner F, 2017, AM J CLIN NUTR, V106, p372S, DOI 10.3945/ajcn.116.142232; Rustein SO, 2004, DHS WEALTH INDEX; Semba RD, 2009, EUR J CLIN NUTR, V63, P93, DOI 10.1038/sj.ejcn.1602889; Smith EM, 2015, CURR OPIN ENDOCRINOL, V22, P432, DOI 10.1097/MED.0000000000000199; StataCorp, 2013, STAT STAT SOFTW REL; Suchdev PS, 2016, ADV NUTR, V7, P349, DOI 10.3945/an.115.010215; TaneJa S, 2007, AM J CLIN NUTR, V86, P1302, DOI 10.1093/ajcn/86.5.1302; Taneja S, 2009, AM J CLIN NUTR, V90, P385, DOI 10.3945/ajcn.2009.27707; Thomson CD, 2004, EUR J CLIN NUTR, V58, P391, DOI 10.1038/sj.ejcn.1601800; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Tiwari L, 2004, COMMUNICATION; Trilok-Kumar G, 2015, INT J EPIDEMIOL, V44, P894, DOI 10.1093/ije/dyv116; Van Nhien N, 2008, J NUTR SCI VITAMINOL, V54, P454, DOI 10.3177/jnsv.54.454; Walke Sneha P, 2014, Int Sch Res Notices, V2014, P165152, DOI 10.1155/2014/165152; WHO, 2011, ANTHR PERS COMP; WHO, 2006, WHO CHILD GROWTH STA; Wieringa FT, 2002, J NUTR, V132, P3061, DOI 10.1093/jn/131.10.3061; Wirth JP, 2017, AM J CLIN NUTR, V106, p416S, DOI 10.3945/ajcn.116.143073; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2015, GLOB PREV AN 2011; Yadav SK, 2005, J ENVIRON MANAGE, V75, P129, DOI 10.1016/j.jenvman.2004.11.013	71	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0209564	10.1371/journal.pone.0209564	http://dx.doi.org/10.1371/journal.pone.0209564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735503	Green Submitted, Green Published, gold			2022-12-26	WOS:000458181200008
J	Noar, RD; Thomas, E; Daub, ME				Noar, Roslyn D.; Thomas, Elizabeth; Daub, Margaret E.			A novel polyketide synthase gene cluster in the plant pathogenic fungus Pseudocercospora fijiensis	PLOS ONE			English	Article							BLACK SIGATOKA DISEASE; LEAF STREAK DISEASE; MYCOSPHAERELLA-FIJIENSIS; BANANA; RESISTANCE; CULTIVARS; PROGRESS; AGENT; AFLJ	Pseudocercospora fijiensis, causal agent of black Sigatoka of banana, produces polyketide synthase (PKS) pathways shown to be important in disease development by related Dothideomycete fungi. Genome analysis of the P. fijiensis PKS8-1 gene identified it as part of a gene cluster including genes encoding two transcription factors, a regulatory protein, a glyoxylase/beta-lactamase-like protein, an MFS transporter, a cytochrome P450, two aldo/keto reductases, a dehydrogenase, and a decarboxylase. Genome analysis of the related pathogens Pseudocercospora musae, Pseudocercospora eumusae, and Pseudocercospora pini-densiflorae, identified orthologous clusters containing a nearly identical combination of genes. Phylogenetic analysis of PKS8-1 identified homology to PKS proteins in the monodictyphenone and cladofulvin pathways in Aspergillus nidulans and Cladosporium fulvum, respectively. Analysis of clustered genes showed that the PKS8-1 cluster shares genes for enzymes involved in the production of the emodin intermediate in the monodictyphenone and cladofulvin pathways, but differs in many genes, suggesting production of a different metabolic product. Time course analysis of gene expression in infected banana showed up-regulation of PKS8-1 and four of eight clustered genes as early as 2 weeks postinoculation and remaining high through 9 weeks. Overexpression of the pathway through constitutive expression of an aflR-like transcription factor gene in the cluster resulted in increased expression in culture of PKS8-1 as well as the four clustered genes that are upregulated in infected plants. No differences were seen in timing or severity of disease symptoms with the overexpression strains relative to controls, however gene expression analysis showed no difference in expression in planta by an overexpression strain relative to controls. Thus constitutive expression of the aflR-like gene is not sufficient to upregulate the pathway above normal expression in planta. Pathway expression during all phases of disease development and conservation of the pathway in related Pseudocercospora species support a role for this pathway in disease.	[Noar, Roslyn D.] North Carolina State Univ, Dept Plant Pathol, Raleigh, NC USA; [Thomas, Elizabeth; Daub, Margaret E.] North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Daub, ME (corresponding author), North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA.	margaret_daub@ncsu.edu			Dole Food Company; NC State College of Agriculture and Life Sciences; National Science Foundation; National Institutes of Health	Dole Food Company; NC State College of Agriculture and Life Sciences; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a gift from Dole Food Company to MED, by funds from the NC State College of Agriculture and Life Sciences to MED, and by graduate fellowships from the National Science Foundation and National Institutes of Health to RDN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie C, 2009, ACTA HORTIC, V828, P171; Alakonya AE, 2018, PLANT PATHOL, V67, P759, DOI 10.1111/ppa.12824; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Isaza REA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005876; Arnaud MB, 2012, NUCLEIC ACIDS RES, V40, pD653, DOI 10.1093/nar/gkr875; Belalcazar S., 2000, Better Crops International, V14, P12; Beltran-Garcia MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091616; Busogoro JP, 2004, BANANA IMPROVEMENT: CELLULAR, MOLECULAR BIOLOGY, AND INDUCED MUTATIONS, P161; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang PK, 2003, MOL GENET GENOMICS, V268, P711, DOI 10.1007/s00438-003-0809-3; Chang TC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005904; Chiang YM, 2010, APPL ENVIRON MICROB, V76, P2067, DOI 10.1128/AEM.02187-09; Churchill ACL, 2011, MOL PLANT PATHOL, V12, P307, DOI 10.1111/j.1364-3703.2010.00672.x; Collemare J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085877; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Daub ME, 2013, ANTIOXID REDOX SIGN, V19, P970, DOI 10.1089/ars.2012.5080; Dong XX, 2016, PHYTOTHER RES, V30, P1207, DOI 10.1002/ptr.5631; Droc G, 2013, BANANA GENOME HUB, V2013, DOI [10.1093/database/bat035, DOI 10.1093/DATABASE/BAT035]; Du W, 2007, FOOD ADDIT CONTAM, V24, P1043, DOI 10.1080/02652030701513826; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Hadrami A, 2005, EUR J PLANT PATHOL, V113, P241, DOI 10.1007/s10658-005-8675-y; Flaherty JE, 1997, APPL ENVIRON MICROB, V63, P3995, DOI 10.1128/AEM.63.10.3995-4000.1997; Goodwin S.B., 2014, GENOMICS PLANT ASS F, P123; Griffiths S, 2016, P NATL ACAD SCI USA, V113, P6851, DOI 10.1073/pnas.1603528113; HAMER JE, 1987, MOL CELL BIOL, V7, P2352, DOI 10.1128/MCB.7.7.2352; Heiser I, 2003, PHYSIOL MOL PLANT P, V62, P29, DOI 10.1016/S0885-5765(03)00007-9; Hoss R, 2000, J PHYTOPATHOL, V148, P387, DOI 10.1046/j.1439-0434.2000.00530.x; Huffman J, 2010, BIOPOLYMERS, V93, P764, DOI 10.1002/bip.21483; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maddison WP, 2015, MODULAR SYSTEM EVOLU; Marin DH, 2003, PLANT DIS, V87, P208, DOI 10.1094/PDIS.2003.87.3.208; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mendoza-Rodriguez MF, 2018, TROP PLANT PATHOL, V43, P1, DOI 10.1007/s40858-017-0188-7; Noar RD, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3031-5; Noar RD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158471; Norgrove L, 2013, AGROFOREST SYST, V87, P349, DOI 10.1007/s10457-012-9555-z; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Onyilo F, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00291; Onyilo F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00830; Ploetz RC, 2004, APSNET ED CTR, V1, P1999, DOI DOI 10.1094/PHI-I-2001-0126-01; Rodriguez HA, 2016, PLANT DIS, V100, P1170, DOI 10.1094/PDIS-08-15-0950-RE; Timm ES, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160083; Shafran H, 2008, FUNGAL GENET BIOL, V45, P1147, DOI 10.1016/j.fgb.2008.04.011; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stergiopoulos I, 2014, MOL PLANT PATHOL, V15, P447, DOI 10.1111/mpp.12104; Stergiopoulos I, 2012, MOL BIOL EVOL, V29, P3371, DOI 10.1093/molbev/mss143; Stergiopoulos I, 2010, P NATL ACAD SCI USA, V107, P7610, DOI 10.1073/pnas.1002910107; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; STIERLE AA, 1991, EXPERIENTIA, V47, P853, DOI 10.1007/BF01922472; Sweigard JA, 1997, FUNGAL GENETNEWSLETT, V44; THOROLD C. A., 1940, Tropical Agriculture, Trinidad and Tobago, V17, P213; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Utermark J., 2008, NAT PROTOC ONLINE, DOI [10.1038/nprot.2008.83, DOI 10.1038/NPROT.2008.83]; VICENTE-CHANDLER J., 1966, Journal of Agriculture of the University of Puerto Rico, V50, P218	60	5	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0212229	10.1371/journal.pone.0212229	http://dx.doi.org/10.1371/journal.pone.0212229			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735556	Green Submitted, gold, Green Published			2022-12-26	WOS:000458181200062
J	Jacobsen, KK; Johansen, JS; Mellemgaard, A; Bojesen, SE				Jacobsen, Katja Kemp; Johansen, Jakob Sidenius; Mellemgaard, Anders; Bojesen, Stig Egil			AHRR (cg05575921) methylation extent of leukocyte DNA and lung cancer survival	PLOS ONE			English	Article							HYDROCARBON RECEPTOR REPRESSOR; CIGARETTE-SMOKING; ADENOCARCINOMA; ASSOCIATION; EPIGENOME; TIME; LOCI	Background Prior studies have shown that AHRR (cg05575921) hypomethylation may be a marker of smoking, lung cancer risk and potentially lung cancer survival (in some lung cancer subtypes). It is unknown if AHRR (cg05575921) hypomethylation is associated with reduced survival among lung cancer patients. Methods In bisulfite treated leukocyte DNA from 465 lung cancer patients from the Copenhagen prospective lung cancer study, we measured AHRR (cg05575921) methylation. 380 died during max follow-up of 4.4 years. Cox proportional hazard models were used to analyze survival as a function of AHRR (cg05575921) methylation. Results We observed the expected inverse correlation between cumulative smoking and AHRR methylation, as methylation (%) decreased (Coefficient -0.03; 95% confidence interval, -0.04- -0.02, p = 8.6x10(-15)) for every pack-year. Cumulative smoking > 60 pack-years was associated with reduced survival (hazard ratio and 95% confidence interval 1.48; 1.05-2.09), however, AHRR (cg05575921) methylation was not associated with survival when adjusted for sex, body mass index, smoking status, ethnicity, performance status, TNM Classification, and histology type of lung cancer. Conclusion AHRR (cg05575921) methylation is linked to smoking but does not provide independent prognostic information in lung cancer patients.	[Jacobsen, Katja Kemp] Univ Coll Copenhagen, Fac Hlth & Technol, Dept Technol, Copenhagen, Denmark; [Johansen, Jakob Sidenius; Mellemgaard, Anders] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Oncol, Copenhagen, Denmark; [Bojesen, Stig Egil] Univ Copenhagen, Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Bojesen, Stig Egil] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	University College Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Jacobsen, KK (corresponding author), Univ Coll Copenhagen, Fac Hlth & Technol, Dept Technol, Copenhagen, Denmark.	katj@kp.dk		Bojesen, Stig/0000-0002-4061-4133; Jacobsen, Katja Kemp/0000-0002-0680-9631	Lundbeck Foundation	Lundbeck Foundation(Lundbeckfonden)	The salary of Katja Kemp Jacobsen was funded by a Post doc grant from Lundbeck Foundation. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Belinsky SA, 2005, CLIN CANCER RES, V11, P6505, DOI 10.1158/1078-0432.CCR-05-0625; Bojesen SE, 2017, THORAX, V72, P646, DOI 10.1136/thoraxjnl-2016-208789; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Dogan MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-151; Elliott HR, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-4; Farhat FS, 2013, THER ADV MED ONCOL, V5, P249, DOI 10.1177/1758834013492001; Fasanelli F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10192; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Guida F, 2015, HUM MOL GENET, V24, P2349, DOI 10.1093/hmg/ddu751; Guo NL, 2009, LUNG CANCER, V66, P386, DOI 10.1016/j.lungcan.2009.02.012; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Jakobsen E, 2016, ACTA ONCOL, V55, P2, DOI 10.3109/0284186X.2016.1150608; Joehanes R, 2016, CIRC-CARDIOVASC GENE, V9, P436, DOI 10.1161/CIRCGENETICS.116.001506; Kim MH, 2014, LUNG CANCER, V84, P196, DOI 10.1016/j.lungcan.2014.01.022; McKay JD, 2017, NAT GENET, V49, P1126, DOI 10.1038/ng.3892; Monick MM, 2012, AM J MED GENET B, V159B, P141, DOI 10.1002/ajmg.b.32021; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Philibert RA, 2012, EPIGENETICS-US, V7, P1331, DOI 10.4161/epi.22520; Reynolds LM, 2015, CIRC-CARDIOVASC GENE, V8, P707, DOI 10.1161/CIRCGENETICS.115.001097; Reynolds LM, 2016, NICOTINE TOB RES; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Shenker NS, 2013, HUM MOL GENET, V22, P843, DOI 10.1093/hmg/dds488; Vilmar AC, 2011, EUR RESPIR REV, V20, P45, DOI 10.1183/09059180.00007310; Walters S, 2013, THORAX, V68, P551, DOI 10.1136/thoraxjnl-2012-202297; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; World Health Organization, 2018, CANCER; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812; Zhang Y, 2016, INT J CANCER, V139, P2482, DOI 10.1002/ijc.30374	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211745	10.1371/journal.pone.0211745	http://dx.doi.org/10.1371/journal.pone.0211745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730943	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000055
J	Spychala, A; Ruther, U				Spychala, Andre; Ruether, Ulrich			FTO affects hippocampal function by regulation of BDNF processing	PLOS ONE			English	Article							OBESITY-ASSOCIATED GENE; NEUROTROPHIC FACTOR; FAT MASS; CELL-PROLIFERATION; ALZHEIMERS-DISEASE; HUMAN BRAIN; STRESS; NEUROGENESIS; PROBDNF; GLUCOCORTICOIDS	Initially, the function of the fat mass and obesity associated (Fto) gene seemed to be primarily the regulation of the body weight. Here we show that loss of Fto results in a hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis. In consequence, Fto(-/-) mice display an anxiety-like behavior and impairments in working memory. Furthermore, differentiation of neurons is affected in the hippocampus. As a cause of these impairments we identified a processing defect of the neurotrophin BDNF which is most likely the result of a reduced expression of MMP-9. Therefore, we propose FTO as a possible new target to develop novel approaches for the treatment of diseases associated with hippocampal disorders. In parallel, we also would like to make the point that any anti-obesity therapy via blocking FTO function can have negative effects on the proper function of the hippocampus.	[Spychala, Andre; Ruether, Ulrich] Heinrich Heine Univ, Inst Anim Dev & Mol Biol, Dusseldorf, Germany; [Spychala, Andre] Heinrich Heine Univ, Inst Cardiovasc Physiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Ruther, U (corresponding author), Heinrich Heine Univ, Inst Anim Dev & Mol Biol, Dusseldorf, Germany.	ruether@hhu.de		Spychala, Andre/0000-0002-5731-9923	Heinrich Heine University	Heinrich Heine University	We would like to thank S. Schable for help in the analyses of mouse behavior, C. Gerhardt and Renate Dildrop for critical reading and suggestions for the manuscript and the Heinrich Heine University for financial support.	Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Cabrera RJ, 1999, BRAZ J MED BIOL RES, V32, P1229, DOI 10.1590/S0100-879X1999001000009; Chicoine E, 2002, BIOCHEM BIOPH RES CO, V297, P765, DOI 10.1016/S0006-291X(02)02283-0; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Ho AJ, 2010, P NATL ACAD SCI USA, V107, P8404, DOI 10.1073/pnas.0910878107; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Ikels K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105349; Keller L, 2011, J ALZHEIMERS DIS, V23, P461, DOI 10.3233/JAD-2010-101068; LAWRENCE MS, 1994, BRAIN RES, V646, P303, DOI 10.1016/0006-8993(94)90094-9; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lee SJ, 2016, INT NEUROUROL J, V20, pS57, DOI 10.5213/inj.1632600.309; Levone BR, 2015, NEUROBIOL STRESS, V1, P147, DOI 10.1016/j.ynstr.2014.11.003; Li LP, 2017, HUM MOL GENET, V26, P2398, DOI 10.1093/hmg/ddx128; Lin L, 2014, HUM MOL GENET, V23, P3299, DOI 10.1093/hmg/ddu043; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Liston C, 2011, P NATL ACAD SCI USA, V108, P16074, DOI 10.1073/pnas.1110444108; Liu H, 2015, NUCLEIC ACIDS RES, V43, pD197, DOI 10.1093/nar/gku1024; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nagappan G, 2009, P NATL ACAD SCI USA, V106, P1267, DOI 10.1073/pnas.0807322106; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Ou LC, 2006, NEUROPSYCHOPHARMACOL, V31, P287, DOI 10.1038/sj.npp.1300830; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Rivera M, 2012, MOL PSYCHIATR, V17, P604, DOI 10.1038/mp.2011.45; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Schloesser RJ, 2009, NEUROREPORT, V20, P553, DOI 10.1097/WNR.0b013e3283293e59; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sugimoto T, 2001, JPN J CANCER RES, V92, P152, DOI 10.1111/j.1349-7006.2001.tb01077.x; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; VANDEWEERD HA, 1994, J EXP ANIM SCI, V36, P117; Vanmeer P, 2005, BIOCHEM J, V389, P593, DOI 10.1042/BJ20042023; VIRGIN CE, 1991, J NEUROCHEM, V57, P1422, DOI 10.1111/j.1471-4159.1991.tb08309.x; Weinstock M, 2005, BRAIN BEHAV IMMUN, V19, P296, DOI 10.1016/j.bbi.2004.09.006; Widagdo J, 2016, J NEUROSCI, V36, P6771, DOI 10.1523/JNEUROSCI.4053-15.2016; Wiemerslage L, 2016, EUR J NEUROSCI, V43, P1173, DOI 10.1111/ejn.13177; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Workman JL, 2015, HIPPOCAMPUS, V25, P329, DOI 10.1002/hipo.22375; Yeo GSH, 2012, J NEUROENDOCRINOL, V24, P393, DOI 10.1111/j.1365-2826.2011.02254.x; Yin YX, 2010, J NEUROCHEM, V114, P110, DOI 10.1111/j.1471-4159.2010.06745.x; Zhang ZB, 2012, CANCER LETT, V319, P89, DOI 10.1016/j.canlet.2011.12.033	51	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211937	10.1371/journal.pone.0211937	http://dx.doi.org/10.1371/journal.pone.0211937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730976	gold, Green Published, Green Submitted			2022-12-26	WOS:000458026000076
J	von Martels, JZH; Bourgonje, AR; Harmsen, HJM; Faber, KN; Dijkstra, G				von Martels, Julius Z. H.; Bourgonje, Arno R.; Harmsen, Hermie J. M.; Faber, Klaas Nico; Dijkstra, Gerard			Assessing intestinal permeability in Crohn's disease patients using orally administered Cr-52-EDTA	PLOS ONE			English	Article							ETHYLENEDIAMINETETRAACETIC ACID; COLONIC PERMEABILITY; FECAL CALPROTECTIN; ESCHERICHIA-COLI; CR-51 EDTA; BOWEL; INFLAMMATION; MARKERS; BARRIER; BIOMARKERS	Background Intestinal permeability can be assessed by monitoring renal excretion of orally administered radioactively Cr-51-labeled ethylenediaminetetraacetic acid (Cr-51-EDTA). Although considered safe, patient participation in using radio-labeled tracers is low. Here, we used orally administered Cr-52-EDTA as non-radioactive alternative to assess intestinal permeability in CD and analyzed the association with disease activity, disease location and gut microbial dysbiosis. Materials and methods 60 CD patients with low (n = 25) and increased (n = 35) fecal calprotectin levels (cut-off: 100 mu g/g feces) ingested 20 mL Cr-52-EDTA (20 mmol/L) solution whereafter 24-h urine was collected. Urinary Cr-52-EDTA concentrations were quantified using Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Fecal Enterobacteriaceae and Faecalibacterium prausnitzii were quantified using FISH. Correlations between urinary Cr-52-EDTA excretion and other parameters were established using nonparametric Spearman's correlation coefficients (rho). Results CD patients with increased fecal calprotectin levels (> 100 mu g/g) demonstrated an elevated urinary Cr-52-EDTA/creatinine ratio (772 vs. 636 mu mol/mol, P = 0.132). Patients with primarily colonic disease showed the highest Cr-52-EDTA excretion. Importantly, a positive correlation was observed for the urinary Cr-52-EDTA/creatinine ratio and fecal calprotectin levels (rho = 0.325, P < 0.05). Finally, urinary Cr-52-EDTA/creatinine ratio negatively correlated with the relative abundance of Faecalibacterium prausnitzii (rho = -0.221, P = 0.092), while positively correlating with Enterobacteriaceae (rho = 0.202, P = 0.126). Conclusions Orally administered and renal excreted Cr-52-EDTA may be used to assess intestinal permeability in CD and correlates with fecal calprotectin levels and bacterial species relevant to CD. This test may improve non-invasive detection of disease exacerbations and help monitor disease activity.	[von Martels, Julius Z. H.; Bourgonje, Arno R.; Faber, Klaas Nico; Dijkstra, Gerard] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Harmsen, Hermie J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands	University of Groningen; University of Groningen	von Martels, JZH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.	j.z.h.von.martels@umcg.nl		/0000-0003-4563-7462; Bourgonje, Arno/0000-0001-5754-3821	Top Institute of Food and Nutrition (TIFN) in Wageningen; Center for Development & Innovation of the University Medical Center Groningen; JSM MD-PhD trajectory grant from the Junior Scientific Masterclass of the University of Groningen, the Netherlands [17-57]	Top Institute of Food and Nutrition (TIFN) in Wageningen; Center for Development & Innovation of the University Medical Center Groningen; JSM MD-PhD trajectory grant from the Junior Scientific Masterclass of the University of Groningen, the Netherlands(Netherlands Government)	The research position of drs. J.Z.H. von Martels is financed by the Top Institute of Food and Nutrition (TIFN) in Wageningen and the Center for Development & Innovation of the University Medical Center Groningen. The research position of Arno R. Bourgonje is supported by a JSM MD-PhD trajectory grant (grant number: 17-57) from the Junior Scientific Masterclass of the University of Groningen, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABAKKEN L, 1989, SCAND J GASTROENTERO, V24, P351, DOI 10.3109/00365528909093059; Ahmad R, 2017, MUCOSAL IMMUNOL, V10, P307, DOI 10.1038/mi.2016.128; AINSWORTH M, 1989, SCAND J GASTROENTERO, V24, P993, DOI 10.3109/00365528909089246; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Andersen R, 1995, ACTA RADIOL, V36, P247, DOI 10.1177/0284185195036S39930; ANDRE F, 1988, GUT, V29, P511, DOI 10.1136/gut.29.4.511; Antoni L, 2014, WORLD J GASTROENTERO, V20, P1165, DOI 10.3748/wjg.v20.i5.1165; Arnott IDR, 2000, SCAND J GASTROENTERO, V35, P1163; Arslan G, 2001, NUCL MED COMMUN, V22, P997, DOI 10.1097/00006231-200109000-00009; Benitez JM, 2013, GUT, V62, P1806, DOI 10.1136/gutjnl-2012-303957; Berstad A, 2000, SCAND J GASTROENTERO, V35, P64; BINNERTS WT, 1968, VET REC, V82, P470; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; BJARNASON I, 1983, GASTROENTEROLOGY, V85, P318; BJARNASON I, 1994, SCAND J GASTROENTERO, V29, P630, DOI 10.3109/00365529409092484; Bourgonje AR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193202; Cao Y, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/872725; D'Inca R, 1999, AM J GASTROENTEROL, V94, P2956, DOI 10.1111/j.1572-0241.1999.01444.x; Goulle JP, 2005, FORENSIC SCI INT, V153, P39, DOI 10.1016/j.forsciint.2005.04.020; Harmsen HJM, 2012, CLIN VACCINE IMMUNOL, V19, P515, DOI 10.1128/CVI.05517-11; Harmsen HJM, 2002, APPL ENVIRON MICROB, V68, P2982, DOI 10.1128/AEM.68.6.2982-2990.2002; Hiippala K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080988; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Irvine EJ, 2000, GASTROENTEROLOGY, V119, P1740, DOI 10.1053/gast.2000.20231; JENKINS AP, 1992, SCAND J GASTROENTERO, V27, P769, DOI 10.3109/00365529209011181; JENKINS RT, 1988, CLIN INVEST MED, V11, P151; Jones J, 2008, CLIN GASTROENTEROL H, V6, P1218, DOI 10.1016/j.cgh.2008.06.010; Jorgensen J, 2001, SCAND J GASTROENTERO, V36, P521, DOI 10.1080/003655201750153395; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; Lehmann FS, 2015, THER ADV GASTROENTER, V8, P23, DOI 10.1177/1756283X14553384; MAXTON DG, 1986, CLIN SCI, V71, P71, DOI 10.1042/cs0710071; Oman H, 1995, SCAND J GASTROENTERO, V30, P1172, DOI 10.3109/00365529509101627; OMORAIN CA, 1986, J LAB CLIN MED, V108, P430; Palmela C, 2018, GUT, V67, P574, DOI 10.1136/gutjnl-2017-314903; PELED Y, 1985, AM J GASTROENTEROL, V80, P770; PIRONI L, 1990, DIGEST DIS SCI, V35, P582, DOI 10.1007/BF01540405; POULSEN LK, 1994, INFECT IMMUN, V62, P5191, DOI 10.1128/IAI.62.11.5191-5194.1994; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Sands BE, 2015, GASTROENTEROLOGY, V149, P1275, DOI 10.1053/j.gastro.2015.07.003; Scaioli E, 2015, ANN GASTROENTEROL, V28, P247; Secondulfo M, 2001, DIGEST LIVER DIS, V33, P680, DOI 10.1016/S1590-8658(01)80045-1; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Sigthorsson G, 2000, GUT, V47, P527, DOI 10.1136/gut.47.4.527; Sipponen T, 2008, INFLAMM BOWEL DIS, V14, P40, DOI 10.1002/ibd.20312; Soderholm JD, 1999, GUT, V44, P96, DOI 10.1136/gut.44.1.96; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suau A, 2001, SYST APPL MICROBIOL, V24, P139, DOI 10.1078/0723-2020-00015; Suenaert P, 2005, INFLAMM BOWEL DIS, V11, P667, DOI 10.1097/01.MIB.0000168371.87283.4b; Takeuchi Ken, 2004, Novartis Found Symp, V263, P151; Ten Bruggencate SJM, 2006, J NUTR, V136, P70, DOI 10.1093/jn/136.1.70; Ten Bruggencate SJM, 2005, J NUTR, V135, P837, DOI 10.1093/jn/135.4.837; Teshima CW, 2012, ANN NY ACAD SCI, V1258, P159, DOI 10.1111/j.1749-6632.2012.06612.x; Thjodleifsson B, 2003, GASTROENTEROLOGY, V124, P1728, DOI 10.1016/S0016-5085(03)00383-4; Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506; TURCK D, 1987, J PEDIATR GASTR NUTR, V6, P535, DOI 10.1097/00005176-198707000-00007; von Martels JZH, 2017, ANAEROBE, V44, P3, DOI 10.1016/j.anaerobe.2017.01.001; Wang LR, 2015, J IMMUNOL METHODS, V421, P44, DOI 10.1016/j.jim.2014.12.015; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H	60	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211973	10.1371/journal.pone.0211973	http://dx.doi.org/10.1371/journal.pone.0211973			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730969	Green Published, Green Submitted, gold			2022-12-26	WOS:000458026000081
J	Vazquez-Dominguez, I; Gonzalez-Sanchez, L; Lopez-Nieva, P; Fernandez-Navarro, P; Villa-Morales, M; Cobos-Fernandez, MA; Sastre, I; Fraga, MF; Fernandez, AF; Malumbres, M; Salazar-Roa, M; Grana-Castro, O; Santos, J; Llamas, P; Lopez-Lorenzo, JL; Fernandez-Piqueras, J				Vazquez-Dominguez, Irene; Gonzalez-Sanchez, Laura; Lopez-Nieva, Pilar; Fernandez-Navarro, Pablo; Villa-Morales, Maria; Cobos-Fernandez, Maria A.; Sastre, Isabel; Fraga, Mario F.; Fernandez, Agustin F.; Malumbres, Marcos; Salazar-Roa, Maria; Grana-Castro, Osvaldo; Santos, Javier; Llamas, Pilar; Lopez-Lorenzo, Jose L.; Fernandez-Piqueras, Jose			Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma	ONCOGENE			English	Article							FBW7 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; STEM-CELLS; BETA-FORM; CYCLIN-E; LEUKEMIA; MUTATIONS; NOTCH1; EXPRESSION; CHILDHOOD	FBXW7 is a driver gene in T-cell lymphoblastic neoplasia acting through proteasome degradation of key proto-oncogenes. FBXW7 encodes three isoforms, alpha, beta and gamma, which differ only in the N-terminus. In this work, massive sequencing revealed significant downregulation of FBXW7 in a panel of primary T-cell lymphoblastic lymphomas characterised by the absence of mutations in its sequence. We observed that decreased expression mainly affected the FBXW7 beta isoform and to a lesser extent FBXW7 alpha and may be attributed to the combined effect of epigenetic changes, alteration of upstream factors and upregulation of miRNAs. Transient transfections with miRNA mimics in selected cell lines resulted in a significant decrease of total FBXW7 expression and its different isoforms separately, with the consequent increment of critical substrates and the stimulation of cell proliferation. Transient inhibition of endogenous miRNAs in a T-cell lymphoblastic-derived cell line (SUP-T1) was capable of reversing these proliferative effects. Finally, we show how FBXW7 isoforms display different roles within the cell. Simultaneous downregulation of the alpha and gamma isoforms modulates the amount of CCNE1, whilst the beta-isoform alone was found to have a prominent role in modulating the amount of c-MYC. Our data also revealed that downregulation of all isoforms is a sine qua non condition to induce a proliferative pattern in our cell model system. Taking these data into account, potential new treatments to reverse downregulation of all or a specific FBXW7 isoform may be an effective strategy to counteract the proliferative capacity of these tumour cells.	[Vazquez-Dominguez, Irene; Gonzalez-Sanchez, Laura; Lopez-Nieva, Pilar; Villa-Morales, Maria; Cobos-Fernandez, Maria A.; Sastre, Isabel; Santos, Javier; Fernandez-Piqueras, Jose] UAM, CSIC, CBMSO, Madrid, Spain; [Vazquez-Dominguez, Irene; Gonzalez-Sanchez, Laura; Lopez-Nieva, Pilar; Villa-Morales, Maria; Cobos-Fernandez, Maria A.; Santos, Javier; Llamas, Pilar; Lopez-Lorenzo, Jose L.; Fernandez-Piqueras, Jose] IIS Fdn Jimenez Diaz, Madrid, Spain; [Gonzalez-Sanchez, Laura; Lopez-Nieva, Pilar; Villa-Morales, Maria; Santos, Javier; Fernandez-Piqueras, Jose] Consorcio Invest Biomed Enfermedades Raras CIBERE, Madrid, Spain; [Fernandez-Navarro, Pablo] Inst Salud Carlos III, Ctr Nacl Epidemiol, Unidad Epidemiol Ambiental & Canc, Madrid, Spain; [Fernandez-Navarro, Pablo] Consorcio Invest Biomed Epidemiol & Salud Publ CI, Madrid, Spain; [Fraga, Mario F.] Univ Oviedo Principado Asturias, CSIC, CINN, Oviedo, Spain; [Fernandez, Agustin F.] Inst Invest Sanitaria Principado Asturias ISPA HU, Fdn Invest Biosanitaria Asturias FINBA, Unidad Epigenet Canc, IUOPA, Oviedo, Spain; [Malumbres, Marcos; Salazar-Roa, Maria] CNIO, Grp Div Celular & Canc, Madrid, Spain; [Grana-Castro, Osvaldo] CNIO, Unidad Bioinformat Biol Estruct & Biocomputac, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Fundacion Jimenez Diaz; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion en Nanomateriales y Nanotecnologia (CINN); University of Oviedo; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Fernandez-Piqueras, J (corresponding author), UAM, CSIC, CBMSO, Madrid, Spain.; Fernandez-Piqueras, J (corresponding author), IIS Fdn Jimenez Diaz, Madrid, Spain.; Fernandez-Piqueras, J (corresponding author), Consorcio Invest Biomed Enfermedades Raras CIBERE, Madrid, Spain.	jfpiqueras@cbm.csic.es	Domínguez, Irene Vázquez/R-4512-2018; Fraga, Mario F/H-7824-2017; Fernandez, Agustin F./N-7302-2014; Santos, Javier/ABF-5755-2021; VILLA-MORALES, MARIA C./H-8797-2015; Malumbres, Marcos/E-8834-2011	Domínguez, Irene Vázquez/0000-0001-9753-521X; Fraga, Mario F/0000-0001-8450-2603; Fernandez, Agustin F./0000-0002-3792-4085; Santos, Javier/0000-0002-4168-6251; VILLA-MORALES, MARIA C./0000-0001-7906-0169; Malumbres, Marcos/0000-0002-0829-6315; Grana-Castro, Osvaldo/0000-0003-1615-4242; Llamas Sillero, Pilar/0000-0002-8552-3219; Gonzalez-Sanchez, Laura/0000-0002-4749-2423	Spanish Ministry of Economy and Competitiveness [SAF2015-70561-R, BES-2013-065740]; Autonomous Community of Madrid, Spain [B2017/BMD-3778]; Spanish Association against Cancer (AECC, 2018) [PROYE18054PIRI]; Instituto de Salud Carlos III (ISCIII) [ACCI-CIBERER-17]; Fundacion Ramon Areces; Banco de Santander	Spanish Ministry of Economy and Competitiveness(Spanish Government); Autonomous Community of Madrid, Spain; Spanish Association against Cancer (AECC, 2018); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Ramon Areces; Banco de Santander	Spanish Ministry of Economy and Competitiveness (SAF2015-70561-R; MINECO/FEDER, EU; BES-2013-065740); the Autonomous Community of Madrid, Spain (B2017/BMD-3778; LINFOMAS-CM); the Spanish Association against Cancer (AECC, 2018; PROYE18054PIRI) and the Instituto de Salud Carlos III (ISCIII) (ACCI-CIBERER-17). Institutional grants from the Fundacion Ramon Areces and Banco de Santander to the CBMSO are also acknowledged.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Akhoondi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2788; Andres-Leon E, 2015, MIRGATE CURATED DATA, V2015; Atak ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038463; Balamurugan K, 2010, EMBO J, V29, P4106, DOI 10.1038/emboj.2010.280; Baldus CD, 2009, HAEMATOL-HEMATOL J, V94, P1383, DOI 10.3324/haematol.2008.005272; Bonn BR, 2013, BLOOD, V121, P3153, DOI 10.1182/blood-2012-12-474148; Burkhardt B, 2010, BRIT J HAEMATOL, V149, P653, DOI 10.1111/j.1365-2141.2009.08006.x; Callens C, 2012, J CLIN ONCOL, V30, P1966, DOI 10.1200/JCO.2011.39.7661; Cheng YB, 2013, J INVEST DERMATOL, V133, P1794, DOI 10.1038/jid.2013.58; Correia NC, 2013, LEUKEMIA, V27, P1603, DOI 10.1038/leu.2013.63; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; de Leval L, 2009, CRIT REV ONCOL HEMAT, V72, P125, DOI 10.1016/j.critrevonc.2009.01.002; Feng DD, 2011, J CELL MOL MED, V15, P2164, DOI 10.1111/j.1582-4934.2010.01213.x; Gedman AL, 2009, LEUKEMIA, V23, P1417, DOI 10.1038/leu.2009.64; Grinkevich VV, 2009, CANCER CELL, V15, P441, DOI 10.1016/j.ccr.2009.03.021; Gu Z, 2008, GENES GENET SYST, V83, P347, DOI 10.1266/ggs.83.347; Gu ZD, 2008, BIOCHEM BIOPH RES CO, V377, P685, DOI 10.1016/j.bbrc.2008.10.047; Guo DM, 2009, LEUKEMIA RES, V33, P678, DOI 10.1016/j.leukres.2008.10.026; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Hu JP, 2017, ONCOTARGETS THER, V10, P3709, DOI 10.2147/OTT.S141652; Huang HS, 2014, ONCOTARGET, V5, P493, DOI 10.18632/oncotarget.1643; Jin HY, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00340; Katt ME, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00012; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kimura T, 2003, CANCER SCI, V94, P431, DOI 10.1111/j.1349-7006.2003.tb01460.x; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; Kourtis N, 2015, NAT CELL BIOL, V17, P322, DOI 10.1038/ncb3121; Kumar V, 2014, LEUKEMIA, V28, P2324, DOI 10.1038/leu.2014.133; Lai EC, 2015, RNA, V21, P675, DOI 10.1261/rna.051193.115; Malyukova A, 2007, CANCER RES, V67, P5611, DOI 10.1158/0008-5472.CAN-06-4381; Mansour MR, 2013, J EXP MED, V210, P1545, DOI 10.1084/jem.20122516; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Mussolin L, 2014, LEUKEMIA, V28, P1909, DOI 10.1038/leu.2014.134; Neumann M, 2015, ONCOTARGET, V6, P2754, DOI 10.18632/oncotarget.2218; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Park MJ, 2009, BRIT J HAEMATOL, V145, P198, DOI 10.1111/j.1365-2141.2009.07607.x; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Rocher-Ros V, 2010, ONCOGENE, V29, P2950, DOI 10.1038/onc.2010.57; Sancho R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001586; Sionov RV, 2013, CELL CYCLE, V12, P3547, DOI 10.4161/cc.26591; Spruck CH, 2002, CANCER RES, V62, P4535; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Trausch-Azar JS, 2015, J CELL PHYSIOL, V230, P842, DOI 10.1002/jcp.24812; Tremblay CS, 2014, CURR OPIN HEMATOL, V21, P320, DOI 10.1097/MOH.0000000000000058; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Wang LX, 2014, ONCOTARGET, V5, P2000, DOI 10.18632/oncotarget.1859; Wei XF, 2015, ONCOTARGET, V6, P18389, DOI 10.18632/oncotarget.4089; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Xu WS, 2016, SEMIN CANCER BIOL, V36, P62, DOI 10.1016/j.semcancer.2015.09.005; Yumimoto K, 2015, J CLIN INVEST, V125, P621, DOI 10.1172/JCI78782; Zhou ZY, 2015, ONCOL REP, V34, P2215, DOI 10.3892/or.2015.4227	63	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2019	38	23					4620	4636		10.1038/s41388-019-0746-1	http://dx.doi.org/10.1038/s41388-019-0746-1			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB4KM	30742097				2022-12-26	WOS:000470240300013
J	Au, DF; Ostrovsky, D; Fu, RQ; Vugmeyster, L				Au, Dan Fai; Ostrovsky, Dmitry; Fu, Riqiang; Vugmeyster, Liliya			Solid-state NMR reveals a comprehensive view of the dynamics of the flexible, disordered N-terminal domain of amyloid- fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; nuclear magnetic resonance (NMR); solid state NMR; intrinsically disordered protein; fibril; neurodegeneration; protein misfolding; protein dynamics; R1 relaxation; zinc	NUCLEAR-MAGNETIC-RESONANCE; FAMILIAL ALZHEIMERS-DISEASE; A-BETA-PEPTIDES; HYDROPHOBIC CORE; SIDE-CHAIN; CONFORMATIONAL DYNAMICS; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; PROTEIN DYNAMICS; METHYL-GROUPS	Amyloid fibril deposits observed in Alzheimer's disease comprise amyloid- (A) protein possessing a structured hydrophobic core and a disordered N-terminal domain (residues 1-16). The internal flexibility of the disordered domain is likely essential for A aggregation. Here, we used H-2 static solid-state NMR methods to probe the dynamics of selected side chains of the N-terminal domain of A(1-40) fibrils. Line shape and relaxation data suggested a two-state model in which the domain's free state undergoes a diffusive motion that is quenched in the bound state, likely because of transient interactions with the structured C-terminal domain. At 37 degrees C, we observed freezing of the dynamics progressively along the A sequence, with the fraction of the bound state increasing and the rate of diffusion decreasing. We also found that without solvation, the diffusive motion is quenched. The solvent acted as a plasticizer reminiscent of its role in the onset of global dynamics in globular proteins. As the temperature was lowered, the fraction of the bound state exhibited sigmoidal behavior. The midpoint of the freezing curve coincided with the bulk solvent freezing for the N-terminal residues and increased further along the sequence. Using H-2 R-1 measurements, we determined the conformational exchange rate constant between the free and bound states under physiological conditions. Zinc-induced aggregation leads to the enhancement of the dynamics, manifested by the faster conformational exchange, faster diffusion, and lower freezing-curve midpoints.	[Au, Dan Fai; Vugmeyster, Liliya] Univ Colorado, Dept Chem, 1201 Laurimer St, Denver, CO 80204 USA; [Ostrovsky, Dmitry] Univ Colorado, Dept Math, Denver, CO 80204 USA; [Fu, Riqiang] Natl High Field Magnet Lab, Tallahassee, FL 32310 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver	Vugmeyster, L (corresponding author), Univ Colorado, Dept Chem, 1201 Laurimer St, Denver, CO 80204 USA.	liliya.vugmeyster@ucdenver.edu			National Institutes of Health [1R15-GM111681]; National Science Foundation [1726947]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM111681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R15-GM111681 and National Science Foundation Grant 1726947. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Ayton S, 2015, NEUROTHERAPEUTICS, V12, P109, DOI 10.1007/s13311-014-0312-z; Bauer T, 2017, J BIOMOL NMR, V67, P51, DOI 10.1007/s10858-016-0083-4; Berlow RB, 2018, J MOL BIOL, V430, P2309, DOI 10.1016/j.jmb.2018.04.003; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Brannstrom K, 2014, J AM CHEM SOC, V136, P10956, DOI 10.1021/ja503535m; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Bush AI, 2013, J ALZHEIMERS DIS, V33, pS277, DOI 10.3233/JAD-2012-129011; Delgado DA, 2016, J BIOL CHEM, V291, P12233, DOI 10.1074/jbc.M116.720656; Doster W, 2008, EUR BIOPHYS J BIOPHY, V37, P591, DOI 10.1007/s00249-008-0274-3; Dubochet J, 1982, ADV OPTICAL ELECT MI, P107; Fawzi NL, 2014, ANGEW CHEM INT EDIT, V53, P10345, DOI 10.1002/anie.201405180; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Fukuda H, 1999, BIOORG MED CHEM LETT, V9, P953, DOI 10.1016/S0960-894X(99)00121-3; GALL CM, 1982, P NATL ACAD SCI-BIOL, V79, P101, DOI 10.1073/pnas.79.1.101; Gauto DF, 2017, SOLID STATE NUCL MAG, V87, P86, DOI 10.1016/j.ssnmr.2017.04.002; Gor'kov PL, 2007, J MAGN RESON, V185, P77, DOI 10.1016/j.jmr.2006.11.008; Hamley IW, 2012, CHEM REV, V112, P5147, DOI 10.1021/cr3000994; Harris Jonathan Gil, 1994, ELECT MICROSCOPY BIO, P203; HIRSCHINGER J, 1990, MACROMOLECULES, V23, P2153, DOI 10.1021/ma00210a009; HIYAMA Y, 1986, J AM CHEM SOC, V108, P2715, DOI 10.1021/ja00270a034; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Hu ZW, 2017, J BIOL CHEM, V292, P2611, DOI 10.1074/jbc.M116.757179; Hubin E, 2014, CELL MOL LIFE SCI, V71, P3507, DOI 10.1007/s00018-014-1634-z; Hubin E, 2015, CELL MOL LIFE SCI, V72, P4899, DOI 10.1007/s00018-015-1983-2; Iannuzzi C, 2014, PROTEIN SCI, V23, P1208, DOI 10.1002/pro.2501; Istrate AN, 2016, SCI REP-UK, V6, DOI 10.1038/srep21734; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Jawhar S, 2011, J BIOL CHEM, V286, P38825, DOI 10.1074/jbc.R111.288308; Karamanos TK, 2015, PROG NUCL MAG RES SP, V88-89, P86, DOI 10.1016/j.pnmrs.2015.05.002; Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897; Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Krushelnitsky A, 2018, J BIOMOL NMR, V71, P53, DOI 10.1007/s10858-018-0191-4; Krushelnitsky A, 2014, J MAGN RESON, V248, P8, DOI 10.1016/j.jmr.2014.09.007; Kulikova AA, 2015, MOL BIOL+, V49, P217, DOI 10.1134/S0026893315020065; Kumar S, 2012, J BIOL CHEM, V287, P8641, DOI 10.1074/jbc.M111.279133; Kumar S, 2011, AGING-US, V3, P803, DOI 10.18632/aging.100362; Kummer MP, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt258; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; Kurauskas V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00165-8; Kussell E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.168101; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lakomek NA, 2017, CHEM-EUR J, V23, P9425, DOI 10.1002/chem.201701738; Larion Mioara, 2015, Intrinsically Disord Proteins, V3, pe1011008, DOI 10.1080/21690707.2015.1011008; Larsen FH, 1998, MOL PHYS, V95, P1185, DOI 10.1080/00268979809483250; Lewandowski JR, 2015, SCIENCE, V348, P578, DOI 10.1126/science.aaa6111; Linser R, 2014, J BIOMOL NMR, V59, P1, DOI 10.1007/s10858-014-9822-6; Liu HY, 2018, ANGEW CHEM INT EDIT, V57, P8017, DOI 10.1002/anie.201802490; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma PX, 2014, ANGEW CHEM INT EDIT, V53, P4312, DOI 10.1002/anie.201311275; Malinska M, 2015, ACTA CRYSTALLOGR D, V71, P1444, DOI 10.1107/S1399004715007816; Viet MH, 2013, ACS CHEM NEUROSCI, V4, P1446, DOI 10.1021/cn400110d; Mazzitelli S, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0381-9; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Meints GA, 2008, J AM CHEM SOC, V130, P7305, DOI 10.1021/ja075775n; Miller Y, 2012, COORDIN CHEM REV, V256, P2245, DOI 10.1016/j.ccr.2011.12.022; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Miura T, 2000, BIOCHEMISTRY-US, V39, P7024, DOI 10.1021/bi0002479; Miura T, 2010, YAKUGAKU ZASSHI, V130, P495, DOI 10.1248/yakushi.130.495; Molugu TR, 2017, CHEM REV, V117, P12087, DOI 10.1021/acs.chemrev.6b00619; Morris C, 2018, CHEM-EUR J, V24, P9494, DOI 10.1002/chem.201801805; Noy D, 2008, J AM CHEM SOC, V130, P1376, DOI 10.1021/ja076282l; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Paravastu AK, 2006, BIOPHYS J, V90, P4618, DOI 10.1529/biophysj.105.076927; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Persson PO, 2004, SIAM REV, V46, P329, DOI 10.1137/S0036144503429121; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Quinn CM, 2012, J MAGN RESON, V222, P1, DOI 10.1016/j.jmr.2012.05.014; Quinn CM, 2009, J BIOMOL NMR, V45, P5, DOI 10.1007/s10858-009-9346-7; Rezaei-Ghaleh N, 2016, J BIOL CHEM, V291, P16059, DOI 10.1074/jbc.M116.728956; Rezaei-Ghaleh N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11359; Ringe D, 2003, BIOPHYS CHEM, V105, P667, DOI 10.1016/S0301-4622(03)00096-6; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Rovo P, 2018, CHEMPHYSCHEM, V19, P34, DOI 10.1002/cphc.201701238; Rovo P, 2017, J PHYS CHEM B, V121, P6117, DOI 10.1021/acs.jpcb.7b03333; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheidt HA, 2012, J BIOL CHEM, V287, P2017, DOI 10.1074/jbc.M111.308619; Serra-Vidal B, 2014, ACS CHEM BIOL, V9, P2678, DOI 10.1021/cb500621x; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Shannon MD, 2019, CHEMPHYSCHEM, V20, P311, DOI 10.1002/cphc.201800779; Shimizu T, 2002, J NEUROSCI RES, V70, P451, DOI 10.1002/jnr.10350; Smith AA, 2016, J BIOMOL NMR, V65, P171, DOI 10.1007/s10858-016-0047-8; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Thirumalai D, 2012, ACCOUNTS CHEM RES, V45, P83, DOI 10.1021/ar2000869; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tougu V, 2011, METALLOMICS, V3, P250, DOI 10.1039/c0mt00073f; Tsvetkov PO, 2010, BIOPHYS J, V99, pL84, DOI 10.1016/j.bpj.2010.09.015; Vold R. R., 1991, ADV MAGN OPT RESON, V16, P85; Vold R.R., 1994, NUCL MAGNETIC RESONA, P27; Vold RL, 2009, PHYS CHEM CHEM PHYS, V11, P7008, DOI 10.1039/b907343d; Vold RL, 2009, J MAGN RESON, V198, P57, DOI 10.1016/j.jmr.2009.01.008; Vugmeyster L, 2019, CHEMPHYSCHEM, V20, P333, DOI 10.1002/cphc.201800454; Vugmeyster L, 2018, METHODS, V148, P136, DOI 10.1016/j.ymeth.2018.04.030; Vugmeyster L, 2017, PROG NUCL MAG RES SP, V101, P1, DOI 10.1016/j.pnmrs.2017.02.001; Vugmeyster L, 2017, J PHYS CHEM B, V121, P7267, DOI 10.1021/acs.jpcb.7b04726; Vugmeyster L, 2016, BIOPHYS J, V111, P2135, DOI 10.1016/j.bpj.2016.10.001; Vugmeyster L, 2016, J BIOL CHEM, V291, P18484, DOI 10.1074/jbc.M116.740530; Vugmeyster L, 2011, BIOCHEMISTRY-US, V50, P10637, DOI 10.1021/bi201515b; Vugmeyster L, 2010, J PHYS CHEM B, V114, P15799, DOI 10.1021/jp1082467; Wang SSS, 2003, BIOCHEMISTRY-US, V42, P9507, DOI 10.1021/bi0342766; Wang T, 2017, J AM CHEM SOC, V139, P6242, DOI 10.1021/jacs.7b02089; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xu L, 2016, CHEM COMMUN, V52, P1733, DOI 10.1039/c5cc08107f; Xu L, 2014, PROTEINS, V82, P3286, DOI 10.1002/prot.24669; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039	116	15	15	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5840	5853		10.1074/jbc.RA118.006559	http://dx.doi.org/10.1074/jbc.RA118.006559			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30737281	hybrid, Green Published			2022-12-26	WOS:000465077500016
J	Folk, WP; Kumari, A; Iwasaki, T; Pyndiah, S; Johnson, JC; Cassimere, EK; Abdulovic-Cui, AL; Sakamuro, D				Folk, Watson P.; Kumari, Alpana; Iwasaki, Tetsushi; Pyndiah, Slovenie; Johnson, Joanna C.; Cassimere, Erica K.; Abdulovic-Cui, Amy L.; Sakamuro, Daitoku			Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ataxia telangiectasia; E2F transcription factor; DNA damage response; tumor suppressor gene; chemoresistance; genomic instability; cancer; p53; BIN1; double-stranded DNA breaks; MRN complex	DNA-DAMAGE-RESPONSE; ESCHERICHIA-COLI; MRE11 COMPLEX; HISTONE H2AX; REPAIR; PHOSPHORYLATION; INHIBITION; GAMMA-H2AX; MECHANISMS; APOPTOSIS	The tumor suppressor bridging integrator 1 (BIN1) is a corepressor of the transcription factor E2F1 and inhibits cell-cycle progression. BIN1 also curbs cellular poly(ADP-ribosyl)ation (PARylation) and increases sensitivity of cancer cells to DNA-damaging therapeutic agents such as cisplatin. However, how BIN1 deficiency, a hallmark of advanced cancer cells, increases cisplatin resistance remains elusive. Here, we report that BIN1 inactivates ataxia telangiectasia-mutated (ATM) serine/threonine kinase, particularly when BIN1 binds E2F1. BIN1 + 12A (a cancer-associated BIN1 splicing variant) also inhibited cellular PARylation, but only BIN1 increased cisplatin sensitivity. BIN1 prevented E2F1 from transcriptionally activating the human ATM promoter, whereas BIN1 + 12A did not physically interact with E2F1. Conversely, BIN1 loss significantly increased E2F1-dependent formation of MRE11A/RAD50/NBS1 DNA end-binding protein complex and efficiently promoted ATM autophosphorylation. Even in the absence of dsDNA breaks (DSBs), BIN1 loss promoted ATM-dependent phosphorylation of histone H2A family member X (forming H2AX, a DSB biomarker) and mediator of DNA damage checkpoint 1 (MDC1, a H2AX-binding adaptor protein for DSB repair). Of note, even in the presence of transcriptionally active (i.e. proapoptotic) TP53 tumor suppressor, BIN1 loss generally increased cisplatin resistance, which was conversely alleviated by ATM inactivation or E2F1 reduction. However, E2F2 or E2F3 depletion did not recapitulate the cisplatin sensitivity elicited by E2F1 elimination. Our study unveils an E2F1-specific signaling circuit that constitutively activates ATM and provokes cisplatin resistance in BIN1-deficient cancer cells and further reveals that H2AX emergence may not always reflect DSBs if BIN1 is absent.	[Folk, Watson P.; Sakamuro, Daitoku] Augusta Univ, Biochem & Canc Biol Grad Program, Augusta, GA 30912 USA; [Folk, Watson P.; Kumari, Alpana; Iwasaki, Tetsushi; Sakamuro, Daitoku] Augusta Univ, Dept Biochem & Mol Biol, Med Coll Georgia, Augusta, GA 30912 USA; [Folk, Watson P.; Kumari, Alpana; Iwasaki, Tetsushi; Sakamuro, Daitoku] Augusta Univ, Tumor Signaling & Angiogenesis Program, Georgia Canc Ctr, Augusta, GA 30912 USA; [Iwasaki, Tetsushi] Kobe Univ, Div Signal Pathways, Biosignal Res Ctr, Kobe, Hyogo 657, Japan; [Pyndiah, Slovenie; Cassimere, Erica K.] Louisiana State Univ, Mol Signaling Program, Stanley S Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Johnson, Joanna C.; Cassimere, Erica K.] Purdue Univ, Med Chem & Mol Pharmacol Grad Program, W Lafayette, IN 47907 USA; [Abdulovic-Cui, Amy L.] Augusta Univ, Dept Biol Sci, Coll Sci & Math, Augusta, GA 30904 USA; [Pyndiah, Slovenie] Univ Paris Diderot, INSERM, UMRS1162, F-75010 Paris, France; [Cassimere, Erica K.] Texas Southern Univ, Dept Biol, Coll Sci Engn & Technol, Houston, TX 77004 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Kobe University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Georgia; Augusta University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Texas Southern University	Sakamuro, D (corresponding author), 1410 Laney Walker Blvd, Augusta, GA 30912 USA.	dsakamuro@augusta.edu			National Institutes of Health [R01CA140379]; United States Army Department of Defense Prostate Cancer Program [DAMD 17-02-1-0131]; first Georgia Cancer Center Polatty Award for Innovative Cancer Research (2018 -2019); Augusta University Graduate School (2014-2015); R. August Roesel Memorial Award Research Excellence for Biochemistry and Cancer Biology (2016); Georgia Cancer Center Postdoctoral Award (2015-2016); International Education and Research Scholarship by Kobe University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Department of Defense Prostate Cancer Program; first Georgia Cancer Center Polatty Award for Innovative Cancer Research (2018 -2019); Augusta University Graduate School (2014-2015); R. August Roesel Memorial Award Research Excellence for Biochemistry and Cancer Biology (2016); Georgia Cancer Center Postdoctoral Award (2015-2016); International Education and Research Scholarship by Kobe University	This work was supported in part by National Institutes of Health Grant R01CA140379, United States Army Department of Defense Prostate Cancer Program DAMD 17-02-1-0131, and the first Georgia Cancer Center Polatty Award for Innovative Cancer Research (2018 -2019) (to D.S.). D. S. holds a 1999 United States Patent with G. Prendergast, Patent No. 6,410,238, "Box-dependent Myc-interacting protein (Bin1) compositions and uses thereof" (The Wistar Institute of Anatomy and Biology, Philadelphia, PA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a fellowship from Augusta University Graduate School (2014-2015) and the R. August Roesel Memorial Award Research Excellence for Biochemistry and Cancer Biology (2016).; First recipient of the Georgia Cancer Center Postdoctoral Award (2015-2016).; Supported by an International Education and Research Scholarship provided by the President of Kobe University (2013-2014).	Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Basourakos SP, 2017, CURR MED CHEM, V24, P1586, DOI 10.2174/0929867323666161214114948; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bowden NA, 2014, CANCER LETT, V346, P163, DOI 10.1016/j.canlet.2014.01.005; Budke B, 2012, NUCLEIC ACIDS RES, V40, P7347, DOI 10.1093/nar/gks353; Burkle A, 2001, CANCER LETT, V163, P1, DOI 10.1016/S0304-3835(00)00694-7; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carnevale J, 2012, MOL CELL BIOL, V32, P900, DOI 10.1128/MCB.06286-11; Cassimere EK, 2009, CELL DEATH DIFFER, V16, P1641, DOI 10.1038/cdd.2009.98; Chang MY, 2007, CANCER RES, V67, P7605, DOI 10.1158/0008-5472.CAN-07-1100; Chen J, 2011, CELL CYCLE, V10, P1287, DOI 10.4161/cc.10.8.15341; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Cunningham LL, 2017, NEW ENGL J MED, V377, P2465, DOI 10.1056/NEJMra1616601; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Earley JN, 2011, ANTIOXID REDOX SIGN, V14, P2465, DOI 10.1089/ars.2010.3369; EINHORN LH, 1977, ANN INTERN MED, V87, P293, DOI 10.7326/0003-4819-87-3-293; EINHORN LH, 1979, NEW ENGL J MED, V300, P289, DOI 10.1056/NEJM197902083000605; Frame FM, 2006, ONCOGENE, V25, P3258, DOI 10.1038/sj.onc.1209352; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Ge K, 2000, INT J CANCER, V86, P155, DOI 10.1002/(SICI)1097-0215(20000415)86:2<155::AID-IJC2>3.0.CO;2-M; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Ge K, 2000, INT J CANCER, V85, P376; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Kinney EL, 2008, J CELL PHYSIOL, V216, P621, DOI 10.1002/jcp.21437; Kumari A, 2015, CELL DEATH DIFFER, V22, P311, DOI 10.1038/cdd.2014.146; Kumari A, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060158; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Lin WC, 2001, GENE DEV, V15, P1833; Liu YG, 2001, CARCINOGENESIS, V22, P851, DOI 10.1093/carcin/22.6.851; Lundgaard GL, 2011, J CELL BIOCHEM, V112, P2992, DOI 10.1002/jcb.23222; Manohar S, 2018, J NEPHROL, V31, P15, DOI 10.1007/s40620-017-0392-z; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Paull TT, 2015, ANNU REV BIOCHEM, V84, P711, DOI 10.1146/annurev-biochem-060614-034335; Pyndiah S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001556; Ramalingam A, 2007, CELL CYCLE, V6, P1914, DOI 10.4161/cc.6.15.4514; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; ROSENBERG B, 1967, J BIOL CHEM, V242, P1347; Routhier EL, 2003, ONCOGENE, V22, P637, DOI 10.1038/sj.onc.1206162; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Sakamuro D, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.981447; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Weber AM, 2015, PHARMACOL THERAPEUT, V149, P124, DOI 10.1016/j.pharmthera.2014.12.001; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453	60	11	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5700	5719		10.1074/jbc.RA118.005699	http://dx.doi.org/10.1074/jbc.RA118.005699			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30733337	Green Published, hybrid			2022-12-26	WOS:000464517500037
J	Jijon-Moreno, S; Baca, BE; Castro-Fernandez, DC; Ramirez-Mata, A				Jijon-Moreno, Saul; Eugenia Baca, Beatriz; Carolina Castro-Fernandez, Diana; Ramirez-Mata, Alberto			TyrR is involved in the transcriptional regulation of biofilm formation and D-alanine catabolism in Azospirillum brasilense Sp7	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN; PSEUDOMONAS; REPRESSION; DOMAIN; GENES; RANGE; GMP; VISUALIZATION; COLONIZATION	Azospirillum brasilense is one of the most studied species of diverse agronomic plants worldwide. The benefits conferred to plants inoculated with Azospirillum have been primarily attributed to its capacity to fix atmospheric nitrogen and synthesize phytohormones, especially indole-3-acetic acid (IAA). The principal pathway for IAA synthesis involves the intermediate metabolite indole pyruvic acid. Successful colonization of plants by Azospirillum species is fundamental to the ability of these bacteria to promote the beneficial effects observed in plants. Biofilm formation is an essential step in this process and involves interactions with the host plant. In this study, the tyrR gene was cloned, and the translated product was observed to exhibit homology to TyrR protein, a NtrC/NifA-type activator. Structural studies of TyrR identified three putative domains, including a domain containing binding sites for aromatic amino acids in the N-terminus, a central AAA+ ATPase domain, and a helix-turn-helix DNA binding motif domain in the C-terminus, which binds DNA sequences in promoter-operator regions. In addition, a bioinformatic analysis of promoter sequences in A. brasilense Sp7 genome revealed that putative promoters encompass one to three TyrR boxes in genes predicted to be regulated by TyrR. To gain insight into the phenotypes regulated by TyrR, a tyrR-deficient strain derived from A. brasilense Sp7, named A. brasilense 2116 and a complemented 2116 strain harboring a plasmid carrying the tyrR gene were constructed. The observed phenotypes indicated that the putative transcriptional regulator TyrR is involved in biofilm production and is responsible for regulating the utilization of D-alanine as carbon source. In addition, TyrR was observed to be absolutely required for transcriptional regulation of the gene dadA encoding a D-amino acid dehydrogenase. The data suggested that TyrR may play a major role in the regulation of genes encoding a glucosyl transferase, essential signaling proteins, and amino acids transporters.	[Jijon-Moreno, Saul; Eugenia Baca, Beatriz; Carolina Castro-Fernandez, Diana; Ramirez-Mata, Alberto] Benemerita Univ Autonoma Puebla, Inst Ciencias, Ctr Invest Ciencias Microbiol, Puebla, Puebla, Mexico	Benemerita Universidad Autonoma de Puebla	Ramirez-Mata, A (corresponding author), Benemerita Univ Autonoma Puebla, Inst Ciencias, Ctr Invest Ciencias Microbiol, Puebla, Puebla, Mexico.	alberto.ramirez@correo.buap.mx		Ramirez-Mata, Alberto/0000-0002-2119-2254	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [INFRA-2014-01-225923]; Vicerectoria de investigacion y estudios de posgrado (VIEP); Consejo Nacional de Ciencia y Tecnologia (CONACYT) [INFRA-2014-01-225923]; Vicerrectoria de Investigacion y Estudios de Posgrado (VIEP); CONACyT	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Vicerectoria de investigacion y estudios de posgrado (VIEP); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Vicerrectoria de Investigacion y Estudios de Posgrado (VIEP); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT), Grants INFRA-2014-01-225923, and the financial support of Vicerectoria de investigacion y estudios de posgrado (VIEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the financial support from the Consejo Nacional de Ciencia y Tecnologia (CONACYT), Grant INFRA-2014-01-225923 and Vicerrectoria de Investigacion y Estudios de Posgrado (VIEP). SJM was recipient of a scholarship of CONACyT. We wish to thank Maria L. Xiqui-Vazquez for his technical support. We are indebted for the constructive criticism and suggestion made by Reviewers.	ALEXEYEV MF, 1995, GENE, V160, P63, DOI 10.1016/0378-1119(95)00108-I; ANDREWS AE, 1991, J BACTERIOL, V173, P5079, DOI 10.1128/jb.173.16.5079-5085.1991; ARGAET VP, 1994, J BIOL CHEM, V269, P5171; Di Palma AA, 2013, FEMS MICROBIOL LETT, V338, P77, DOI 10.1111/1574-6968.12030; Bashan Y, 2010, ADV AGRON, V108, P77, DOI 10.1016/S0065-2113(10)08002-8; Blatny JM, 1997, APPL ENVIRON MICROB, V63, P370, DOI 10.1128/AEM.63.2.370-379.1997; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Carreno-Lopez R, 2000, MOL GEN GENET, V264, P521, DOI 10.1007/s004380000340; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Coulson TJD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121241; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deng ZL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00110; Dixon MP, 2002, J BIOL CHEM, V277, P23186, DOI 10.1074/jbc.M112184200; Fazli M, 2014, ENVIRON MICROBIOL, V16, P1961, DOI 10.1111/1462-2920.12448; FRANKLIN FCH, 1976, MOL GEN GENET, V149, P229, DOI 10.1007/BF00332894; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Green MR S, 2012, MOL CLONING LAB MANU, V2012, P1; Hener C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041109; Hill PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019220; Hou XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114435; Jijon-Moreno S, 2015, ANTON LEEUW INT J G, V107, P1501, DOI 10.1007/s10482-015-0444-0; Khan MS, 2017, BIOFILMS PLANT SOIL; Kwack YaS, 2015, DIRECT SUBMISSION, V80, P702; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Leyn SA, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000061; Fagotti DDL, 2019, J BASIC MICROB, V59, P38, DOI 10.1002/jobm.201800324; Limoli DH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0011-2014; Matsuyama BY, 2016, P NATL ACAD SCI USA, V113, pE209, DOI 10.1073/pnas.1523148113; McMillan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098162; O'Dowd RW, 1997, SOIL BIOL BIOCHEM, V29, P1665, DOI 10.1016/S0038-0717(97)00080-1; Pereg-Gerk L, 1998, MOL PLANT MICROBE IN, V11, P177, DOI 10.1094/MPMI.1998.11.3.177; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PITTARD AJ, 1991, MOL MICROBIOL, V5, P1585, DOI 10.1111/j.1365-2958.1991.tb01904.x; Pittard J, 2005, MOL MICROBIOL, V55, P16, DOI 10.1111/j.1365-2958.2004.04385.x; Qiu W, 2016, MOL ORAL MICROBIOL, V31, P435, DOI 10.1111/omi.12146; Ramirez-Mata A, 2018, MICROBIOL RES, V215, P155, DOI 10.1016/j.micres.2018.07.007; Ramirez-Mata A, 2016, RES MICROBIOL, V167, P190, DOI 10.1016/j.resmic.2015.12.004; Rippe K, 1998, J MOL BIOL, V278, P915, DOI 10.1006/jmbi.1998.1746; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ryu RJ, 2008, J BACTERIOL, V190, P7200, DOI 10.1128/JB.00804-08; Sarwar Z, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00020-16; Scharf BE, 2016, PLANT MOL BIOL, V90, P549, DOI 10.1007/s11103-016-0432-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shelud'ko AV, 2015, MICROBIOLOGY+, V84, P144, DOI 10.1134/S0026261715010129; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith HQ, 1997, J BACTERIOL, V179, P5914, DOI 10.1128/jb.179.18.5914-5921.1997; Spaepen S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001438; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Takahashi S, 2015, BIOENGINEERED, V6, P237, DOI 10.1080/21655979.2015.1052917; TARRAND JJ, 1978, CAN J MICROBIOL, V24, P967, DOI 10.1139/m78-160; Verger D, 2007, J MOL BIOL, V367, P102, DOI 10.1016/j.jmb.2006.12.018; Wang YJ, 2001, PROTEIN SCI, V10, P592, DOI 10.1110/ps.45301; Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514; Yang J, 2004, MOL MICROBIOL, V52, P243, DOI 10.1111/j.1365-2958.2003.03965.x; Yang J, 2007, J BACTERIOL, V189, P6080, DOI 10.1128/JB.00482-07; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yaron S, 2014, MICROB BIOTECHNOL, V7, P496, DOI 10.1111/1751-7915.12186; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	59	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0211904	10.1371/journal.pone.0211904	http://dx.doi.org/10.1371/journal.pone.0211904			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763337	gold, Green Published, Green Submitted			2022-12-26	WOS:000458763900028
J	Brasch, ME; Passucci, G; Gulvady, AC; Turner, CE; Manning, ML; Henderson, JH				Brasch, Megan E.; Passucci, Giuseppe; Gulvady, Anushree C.; Turner, Christopher E.; Manning, M. Lisa; Henderson, James H.			Nuclear position relative to the Golgi body and nuclear orientation are differentially responsive indicators of cell polarized motility	PLOS ONE			English	Article							MEMORY; MIGRATION	Cell motility is critical to biological processes from wound healing to cancer metastasis to embryonic development. The involvement of organelles in cell motility is well established, but the role of organelle positional reorganization in cell motility remains poorly understood. Here we present an automated image analysis technique for tracking the shape and motion of Golgi bodies and cell nuclei. We quantify the relationship between nuclear orientation and the orientation of the Golgi body relative to the nucleus before, during, and after exposure of mouse fibroblasts to a controlled change in cell substrate topography, from flat to wrinkles, designed to trigger polarized motility. We find that the cells alter their mean nuclei orientation, in terms of the nuclear major axis, to increasingly align with the wrinkle direction once the wrinkles form on the substrate surface. This change in alignment occurs within 8 hours of completion of the topographical transition. In contrast, the position of the Golgi body relative to the nucleus remains aligned with the pre-programmed wrinkle direction, regardless of whether it has been fully established. These findings indicate that intracellular positioning of the Golgi body precedes nuclear reorientation during mouse fibroblast directed migration on patterned substrates. We further show that both processes are Rho-associated kinase (ROCK) mediated as they are abolished by pharmacologic ROCK inhibition whereas mouse fibroblast motility is unaffected. The automated image analysis technique introduced could be broadly employed in the study of polarization and other cellular processes in diverse cell types and micro-environments. In addition, having found that the nuclei Golgi vector may be a more sensitive indicator of substrate features than the nuclei orientation, we anticipate the nuclei Golgi vector to be a useful metric for researchers studying the dynamics of cell polarity in response to different micro-environments.	[Brasch, Megan E.; Henderson, James H.] Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA; [Brasch, Megan E.; Manning, M. Lisa; Henderson, James H.] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13244 USA; [Passucci, Giuseppe; Manning, M. Lisa] Syracuse Univ, Dept Phys, Syracuse, NY USA; [Gulvady, Anushree C.; Turner, Christopher E.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	Syracuse University; Syracuse University; Syracuse University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Henderson, JH (corresponding author), Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA.; Henderson, JH (corresponding author), Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13244 USA.	jhhender@syr.edu	Manning, Lisa/B-1746-2012	Manning, Lisa/0000-0001-7682-2324; GULVADY, ANUSHREE/0000-0002-5451-9380; Henderson, James/0000-0003-3355-5953	Simons Foundation [446222];  [NSF-CMMI-1334611];  [NSF-1334493];  [NIH-GM047607];  [NSF-DMR-1352184]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607] Funding Source: NIH RePORTER	Simons Foundation; ; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported primarily by NSF-CMMI-1334611 (JHH and MLM). Additional support was provided by NSF-1334493 (CET), NIH-GM047607 (CET), NSF-DMR-1352184 (MLM), and The Simons Foundation #446222 (GP and MLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0386; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Davidson P, 2010, ACTA BIOMATER, V6, P2590, DOI 10.1016/j.actbio.2010.01.038; Davis KA, 2011, JOVE-J VIS EXP, DOI 10.3791/2903; Davis KA, 2011, BIOMATERIALS, V32, P2285, DOI 10.1016/j.biomaterials.2010.12.006; Desai RA, 2009, J CELL SCI, V122, P905, DOI 10.1242/jcs.028183; Ebara M, 2014, POLYMER, V55, P5961, DOI 10.1016/j.polymer.2014.09.009; Ebara M, 2014, INT J NANOMED, V9, P117, DOI 10.2147/IJN.S50677; Elliott LCC, 2011, PHYS CHEM CHEM PHYS, V13, P4326, DOI 10.1039/c0cp01805h; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gao YX, 2009, OPT EXPRESS, V17, P4685, DOI 10.1364/OE.17.004685; Gong T, 2014, ADV HEALTHC MATER, V3, P1608, DOI 10.1002/adhm.201300692; Gu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29516; Le DM, 2011, ADV MATER, V23, P3278, DOI 10.1002/adma.201100821; Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k; Mengsteab PY, 2016, BIOMATERIALS, V86, P1, DOI 10.1016/j.biomaterials.2016.01.062; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Pipparelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062095; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; Shoelson B., 2016, CLUSTERDATA; Song F, 2017, ACS APPL MATER INTER, V9, P22176, DOI 10.1021/acsami.7b04757; Tseng LF, 2013, ACTA BIOMATER, V9, P8790, DOI 10.1016/j.actbio.2013.06.043; Uto K, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201601439; Vinogradova T, 2009, CELL CYCLE, V8, P2168, DOI 10.4161/cc.8.14.9074; Wang J, 2017, J MAT SCI MAT M, V28; Wang J, 2017, BIOMATERIALS, V140, P150, DOI 10.1016/j.biomaterials.2017.06.016; Yadav S., 2011, COLD SPRING HARB PER, V3; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Yang P, 2013, SOFT MATTER, V9, P4705, DOI 10.1039/c3sm00024a; Zaburdaev V, 2011, PHYS REV LETT, V106	32	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211408	10.1371/journal.pone.0211408	http://dx.doi.org/10.1371/journal.pone.0211408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759123	gold, Green Published, Green Submitted			2022-12-26	WOS:000458761300043
J	Imai, T; Okami, K				Imai, Takeo; Okami, Kyoko			Facial cues to age perception using three-dimensional analysis	PLOS ONE			English	Article							SHAPE; FACE; MORPHOLOGY; MODEL	To clarify cues for age perception, the three-dimensional head and face forms of Japanese women were analyzed. It is known that age-related transformations are mainly caused by changes in soft tissue during adulthood. A homologous polygon model was created by fitting template meshes to each study participant to obtain three-dimensional data for analyzing whole head and face forms. Using principal component analysis of the vertices coordinates of these models, 26 principal components were extracted (contribution ratios >0.5%), which accounted for more than 90% of the total variance. Among the principal components, five had a significant correlation with the perceived ages of the participants (p < 0.05). Transformations with these principal components in the age-related direction produced aged faces. Moreover, the older the perceived age, the larger the ratio of age-manifesting participants, namely participants who had one or more age-related principal component score greater than +1.0 sigma in the age-related direction. Therefore, these five principal components were regarded as aging factors. A cluster analysis of the five aging factors revealed that all of the participants fell into one of four groups, meaning that specific combinations of factors could be used as cues for age perception in each group. These results suggest that Japanese women can be classified into four groups according to age-related transformations of soft tissue in the face.	[Imai, Takeo; Okami, Kyoko] Kao Corp, Skin Care Lab, Odawara, Kanagawa, Japan	KAO Corporation	Imai, T (corresponding author), Kao Corp, Skin Care Lab, Odawara, Kanagawa, Japan.	imai.takeo@kao.co.jp		Imai, Takeo/0000-0003-4926-7024	Kao Corporation	Kao Corporation	This study was fully funded by Kao Corporation (http://www.kao.com/) and all authors were permanent employees of Kao Corporation. Kao Corporation provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albert AM, 2007, FORENSIC SCI INT, V172, P1, DOI 10.1016/j.forsciint.2007.03.015; [Anonymous], 1988, SOCIAL APPL ASPECTS; Asamizu H, 2013, ITE TECHNICAL REPORT, V37, P57; Azour BZ, 3 INT S 3D DAT PROC; Ball RM, 2012, P AS WORKSH 3D SCANN, P101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanz V, 1999, COMP GRAPH, P187, DOI 10.1145/311535.311556; Changseok Choi, 1999, FUZZ-IEEE'99. 1999 IEEE International Fuzzy Systems. Conference Proceedings (Cat. No.99CH36315), P1603, DOI 10.1109/FUZZY.1999.790144; Christensen Kaare, 2009, BMJ, V339, pb5262; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; CUNNINGHAM MR, 1986, J PERS SOC PSYCHOL, V50, P925, DOI 10.1037/0022-3514.50.5.925; Doual JM, 1997, SURG RADIOL ANAT, V19, P175, DOI 10.1007/s00276-997-0175-7; Fink B, 2008, J EUR ACAD DERMATOL, V22, P493, DOI 10.1111/j.1468-3083.2007.02512.x; Fu Y, 2010, IEEE T PATTERN ANAL, V32, P1955, DOI 10.1109/TPAMI.2010.36; Fukuda Y., 2005, International Journal of Cosmetic Science, V27, P283, DOI 10.1111/j.1467-2494.2005.00282.x; Ganceviciene R, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.22804; George PA, 2000, VIS COGN, V7, P485, DOI 10.1080/135062800394621; GEORGE PA, 1995, PERCEPTION, V24, P1059, DOI 10.1068/p241059; Grover R., 2006, AESTHET SURG J, V26, pS4, DOI [10.1016/j.asj.2005.09.012, DOI 10.1016/J.ASJ.2005.09.012]; Hill H, 2012, P 43 NIPS INT S FAC, P92; Hunter D, 2012, CRANIOFACIAL IDENTIFICATION, P57; Hunter DW, 2009, VISAPP 2009 P 4 INT, V2; Imaizumi K, 2015, INT J LEGAL MED, V129, P385, DOI 10.1007/s00414-014-1114-x; Jones AL, 2018, EVOL HUM BEHAV, V39, P19, DOI 10.1016/j.evolhumbehav.2017.09.005; Kouchi M, 2004, ERGONOMICS, V47, P1499, DOI 10.1080/00140130412331290907; Kouchi M, 2014, WOODHEAD PUBL SER TE, P67, DOI 10.1533/9780857096890.1.67; Kouchi M, 2010, P AHFE INT C; Lanitis A, 2002, IEEE T PATTERN ANAL, V24, P442, DOI 10.1109/34.993553; Leong IF, 2007, COMPUT AIDED DESIGN, V39, P568, DOI 10.1016/j.cad.2007.03.003; Levine RA, 2003, AESTHET PLAST SURG, V27, P265, DOI 10.1007/s00266-003-2112-4; Luximon A, 2003, ERGONOMICS, V46, P364, DOI 10.1080/0014013021000045225; Luximon Y, 2012, COMPUT AIDED DESIGN, V44, P40, DOI 10.1016/j.cad.2011.01.011; MARK LS, 1980, PERCEPT PSYCHOPHYS, V27, P117, DOI 10.3758/BF03204298; Martin R., 1988, HDB VERGLEICHENDEN B; Mochimaru M, 2009, 17 WORLD C ERG IEA 2; Mochimaru M, 2006, SAE TECHNICAL PAPER; Murakami Motoko, 1999, Applied Human Science, V18, P195, DOI 10.2114/jpa.18.195; Park U., 2008, 2008 8 IEEE INT C AU, P1, DOI 10.1109/AFGR.2008.4813408; Porcheron A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057985; Ramos-e-Silva M, 2013, CLIN DERMATOL, V31, P750, DOI 10.1016/j.clindermatol.2013.05.013; RHODES G, 1988, PERCEPTION, V17, P43, DOI 10.1068/p170043; Rhodes MG, 2009, APPL COGNITIVE PSYCH, V23, P1, DOI 10.1002/acp.1442; ROWLAND DA, 1995, IEEE COMPUT GRAPH, V15, P70, DOI 10.1109/38.403830; Russell R, 2017, ADAPT HUM BEHAV PHYS, V3, P293, DOI 10.1007/s40750-017-0068-x; Sayama K., 2000, JPN J PSYCHON SCI, V19, P8; Scandrett CM, 2006, PATTERN RECOGN LETT, V27, P1776, DOI 10.1016/j.patrec.2006.02.007; Scherbaum K, 2007, COMPUT GRAPH FORUM, V26, P285, DOI 10.1111/j.1467-8659.2007.01050.x; Starbuck J, 2011, AM J PHYS ANTHROPOL, V146, P560, DOI 10.1002/ajpa.21583; TODD JT, 1980, SCI AM, V242, P132, DOI 10.1038/scientificamerican0280-132; Toma AM, 2012, EUR J ORTHODONT, V34, P655, DOI 10.1093/ejo/cjr106; Tsukahara K., 2000, International Journal of Cosmetic Science, V22, P247, DOI 10.1046/j.1467-2494.2000.00033.x; Zebrowitz L., 1997, READING FACES WINDOW, P14	53	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0209639	10.1371/journal.pone.0209639	http://dx.doi.org/10.1371/journal.pone.0209639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL5IX	30759092	Green Submitted, Green Published, gold			2022-12-26	WOS:000458761300011
J	Zhang, ML; Wu, J; Sun, RQ; Tao, XT; Wang, XX; Kang, Q; Wang, H; Zhang, L; Liu, P; Zhang, JY; Xia, YK; Zhao, YZ; Yang, Y; Xiong, Y; Guan, KL; Zou, YZ; Ye, D				Zhang, Mengli; Wu, Jian; Sun, Renqiang; Tao, Xiaoting; Wang, Xiaoxia; Kang, Qi; Wang, Hui; Zhang, Lei; Liu, Peng; Zhang, Jinye; Xia, Yukun; Zhao, Yuzheng; Yang, Yi; Xiong, Yue; Guan, Kun-Liang; Zou, Yunzeng; Ye, Dan			SIRT5 deficiency suppresses mitochondrial ATP production and promotes AMPK activation in response to energy stress	PLOS ONE			English	Article							PYRUVATE-KINASE M2; PRESSURE-OVERLOAD; OXIDATIVE-PHOSPHORYLATION; MURINE MODEL; PROTEIN; DESUCCINYLATION; SUCCINYLATION; HYPERTROPHY; ULTRASOUND; DYSFUNCTION	Sirtuin 5 (SIRT5) is a member of the NAW-dependent sirtuin family of protein deacylase that catalyzes removal of post-translational modifications, such as succinylation, malonylation, and glutarylation on lysine residues. In light of the SIRT5's roles in regulating mitochondrion function, we show here that SIRT5 deficiency leads to suppression of mitochondrial NADH oxidation and inhibition of ATP synthase activity. As a result, SIRT5 deficiency decreases mitochondrial ATP production, increases AMP/ATP ratio, and subsequently activates AMP-activated protein kinase (AMPK) in cultured cells and mouse hearts under energy stress conditions. Moreover, Sirt5 knockout attenuates transverse aortic constriction (TAC)-induced cardiac hypertrophy and cardiac dysfunction in mice, which is associated with decreased ATP level, increased AMP/ATP ratio and enhanced AMPK activation. Our study thus uncovers an important role of SIRT5 in regulating cellular energy metabolism and AMPK activation in response to energy stress.	[Zhang, Mengli; Sun, Renqiang; Kang, Qi; Zhang, Lei; Liu, Peng; Zhang, Jinye; Xia, Yukun; Xiong, Yue; Guan, Kun-Liang; Ye, Dan] Fudan Univ, Key Lab Metab & Mol Med, Minist Educ, Shanghai, Peoples R China; [Zhang, Mengli; Sun, Renqiang; Kang, Qi; Zhang, Lei; Liu, Peng; Zhang, Jinye; Xia, Yukun; Xiong, Yue; Guan, Kun-Liang; Ye, Dan] Fudan Univ, Mol & Cell Biol Lab, Key Lab Med Epigenet & Metab, Inst Biomed Sci,Shanghai Med Coll, Shanghai, Peoples R China; [Wu, Jian; Zou, Yunzeng] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai, Peoples R China; [Wu, Jian; Zou, Yunzeng] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China; [Tao, Xiaoting] Fudan Univ, Shanghai Med Coll, Dept Thorac Surg, Shanghai, Peoples R China; [Tao, Xiaoting] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Wang, Xiaoxia; Wang, Hui] Waters Corp Shanghai Sci & Technol Co Ltd, Shanghai, Peoples R China; [Zhao, Yuzheng; Yang, Yi] East China Univ Sci & Technol, Sch Pharm, Shanghai, Peoples R China; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Ye, Dan] Fudan Univ, Dept Gen Surg, Huashan Hosp, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Waters Corporation; East China University of Science & Technology; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego; Fudan University	Guan, KL; Ye, D (corresponding author), Fudan Univ, Key Lab Metab & Mol Med, Minist Educ, Shanghai, Peoples R China.; Guan, KL; Ye, D (corresponding author), Fudan Univ, Mol & Cell Biol Lab, Key Lab Med Epigenet & Metab, Inst Biomed Sci,Shanghai Med Coll, Shanghai, Peoples R China.; Zou, YZ (corresponding author), Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai, Peoples R China.; Zou, YZ (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China.; Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Guan, KL (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.; Ye, D (corresponding author), Fudan Univ, Dept Gen Surg, Huashan Hosp, Shanghai, Peoples R China.	kuguan@ucsd.edu; zou.yunzeng@zs-hospital.sh.cn; yedan@fudan.edu.cn	Xia, Yukun/HGT-9369-2022; Guan, Kun-Liang/ADK-7088-2022	Xia, Yukun/0000-0002-8728-9745; Wu, Jian/0000-0003-4259-8322; Zhao, Yuzheng/0000-0001-5400-0135	National Key R&D Program of China [2016YFA0501800]; National Natural Science Foundation of China [31871431, 81522033]; Shanghai Committee of Science and Technology, China [16JC1404000]; Waters corporation Shanghai Science & Technology Co Ltd	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); Waters corporation Shanghai Science & Technology Co Ltd	This work was supported by the National Key R&D Program of China (http://www.most.gov.cn/) (no. 2016YFA0501800 to DY), the National Natural Science Foundation of China grants (http://www.nsfc.gov.cn/english/site_1/index.html) (no. 31871431 and no. 81522033 to DY) and the Shanghai Committee of Science and Technology, China (http:/www.stcsm.gov.cn/english/) (no.16JC1404000 to DY). This work was also supported by Waters corporation Shanghai Science & Technology Co Ltd (http./www.waters.com/waters/home.htm?locale=zh_CN) (salaries to XXW and HW). The funder provided support in the form of salaries for authors (XXW and HW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The other funders in our study also had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; Boylston JA, 2015, J MOL CELL CARDIOL, V88, P73, DOI 10.1016/j.yjmcc.2015.09.005; Buler M, 2014, FASEB J, V28, P3225, DOI 10.1096/fj.13-245241; Cao TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103793; Chen XF, 2018, EMBO REPORTS; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Fan J, 2011, MOL CELL BIOL, V31, P4938, DOI 10.1128/MCB.06120-11; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Hershberger KA, 2018, J BIOL CHEM, V293, P10630, DOI 10.1074/jbc.RA118.002187; Hershberger KA, 2017, J BIOL CHEM, V292, P19767, DOI 10.1074/jbc.M117.809897; Huang JY, 2017, AM J PHYSIOL-HEART C, V313, pH138, DOI 10.1152/ajpheart.00004.2017; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; Kim M, 2014, CIRC RES, V114, P966, DOI 10.1161/CIRCRESAHA.114.302364; Kurmi K, 2018, CELL REP, V22, P1365, DOI 10.1016/j.celrep.2018.01.030; Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036; Li F, 2015, MOL CELL, V60, P661, DOI 10.1016/j.molcel.2015.10.017; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Lin R, 2014, AGING CELL, V13, P507, DOI 10.1111/acel.12200; Liu L, 2015, BEHAV BRAIN RES, V281, P215, DOI 10.1016/j.bbr.2014.12.035; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lozoya OA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005707; Meng Z, 2015, NATURE COMMUNICATION; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mootha VK, 1997, AM J PHYSIOL-HEART C, V272, pH769, DOI 10.1152/ajpheart.1997.272.2.H769; Morris-Blanco KC, 2016, SCI REP-UK, V6, DOI 10.1038/srep29790; Nadanaciva S, 2007, TOXICOL IN VITRO, V21, P902, DOI 10.1016/j.tiv.2007.01.011; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nickel AG, 2015, CELL METAB, V22, P472, DOI 10.1016/j.cmet.2015.07.008; Nishida Y, 2015, MOL CELL, V59, P321, DOI 10.1016/j.molcel.2015.05.022; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Pillai VB, 2010, CARDIOVASC RES, V88, P250, DOI 10.1093/cvr/cvq250; Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778; Ram R, 2011, AM J PHYSIOL-HEART C, V301, pH1765, DOI 10.1152/ajpheart.00559.2011; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rothermel BA, 2005, PHYSIOL GENOMICS, V23, P18, DOI 10.1152/physiolgenomics.00061.2005; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schisler JC, 2013, J CLIN INVEST, V123, P3588, DOI 10.1172/JCI69080; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang F, 2017, CELL REP, V19, P2331, DOI 10.1016/j.celrep.2017.05.065; Wang YG, 2017, NATURE, V552, P273, DOI 10.1038/nature25003; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Wu J, 2013, ULTRASOUND MED BIOL, V39, P2053, DOI 10.1016/j.ultrasmedbio.2013.04.022; Wu J, 2012, ULTRASOUND MED BIOL, V38, P1030, DOI 10.1016/j.ultrasmedbio.2012.01.018; Yang X, 2018, CANCER RES, V78, P372, DOI 10.1158/0008-5472.CAN-17-1912; Ye XY, 2017, ONCOTARGET, V8, P6984, DOI 10.18632/oncotarget.14346; You JY, 2013, J CARDIOVASC PHARM, V61, P142, DOI 10.1097/FJC.0b013e31827a0278; Yu JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02806; Zeng J, 2013, ENVIRON SCI TECHNOL, V47, P7457, DOI 10.1021/es400490f; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702; Zhang YX, 2017, J BIOL CHEM, V292, P10239, DOI 10.1074/jbc.M117.785022; Zhang YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122297; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhao YZ, 2011, CELL METAB, V14, P555, DOI 10.1016/j.cmet.2011.09.004; Zhou LS, 2016, EMBO REP, V17, P811, DOI 10.15252/embr.201541643	69	22	22	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211796	10.1371/journal.pone.0211796	http://dx.doi.org/10.1371/journal.pone.0211796			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759120	Green Published, Green Submitted, gold			2022-12-26	WOS:000458761300058
J	Garcia-Masso, X; Skypala, J; Jandacka, D; Estevan, I				Garcia-Masso, Xavier; Skypala, Jiri; Jandacka, Daniel; Estevan, Isaac			Reliability of a new analysis to compute time to stabilization following a single leg drop jump landing in children	PLOS ONE			English	Article							COORDINATION; STABILITY; FOOT	Although a number of different methods have been proposed to assess the time to stabilization (TTS), none is reliable in every axis and no tests of this type have been carried out on children. The purpose of this study was thus to develop a new computational method to obtain TTS using a time-scale (frequency) approach [i.e. continuous wavelet transformation (WAV)] in children. Thirty normally-developed children (mean age 10.16 years, SD = 1.52) participated in the study. Every participant performed 30 single-leg drop jump landings with the dominant lower limb (barefoot) on a force plate from three different heights (15cm, 20cm and 25cm). Five signals were used to compute the TTS: i) Raw, ii) Root mean squared, iii) Sequential average processing, iv) the fitting curve of the signal using an unbounded third order polynomial fit, and v) WAV. The reliability of the TTS was determined by computing both the Intraclass Correlation Coefficient (ICC) and the Standard Error of the Measurement (SEM). In the antero-posterior and vertical axes, the values obtained with the WAV signal from all heights were similar to those obtained by raw, root mean squared and sequential average processing. The values obtained for the medio-lateral axis were relatively small. This WAV provided substantial-to-good ICC values and low SEM for almost all the axes and heights. The results of the current study thus suggest the WAV method could be used to compute overall TTS when studying children's dynamic postural stability.	[Garcia-Masso, Xavier] Univ Valencia, Dept Teaching Mus Visual & Corporal Express, HUMAG Res Grp, Valencia, Spain; [Skypala, Jiri; Jandacka, Daniel] Univ Ostrava, Dept Human Movement Studies, Human Mot Diagnost Ctr, Ostrava, Czech Republic; [Estevan, Isaac] Univ Valencia, Dept Teaching Mus Visual & Corporal Express, AFIPS Res Grp, Valencia, Spain	University of Valencia; University Hospital Ostrava; University of Ostrava; University of Valencia	Estevan, I (corresponding author), Univ Valencia, Dept Teaching Mus Visual & Corporal Express, AFIPS Res Grp, Valencia, Spain.	isaac.estevan@uv.es	Skypala, Jiri/R-3690-2019; Jandacka, Daniel/B-6035-2011; García-Massó, Xavier/L-8222-2014; Estevan, Isaac/AAG-4285-2021	Skypala, Jiri/0000-0002-3617-2926; Jandacka, Daniel/0000-0003-2653-2569; Estevan, Isaac/0000-0003-3748-2288; Garcia-Masso, Xavier/0000-0002-5925-4537	University of Valencia [UV-INV-EPDI16-380811]; grant Healthy aging in industrial environment [4 HAIE CZ.02.1.01/0.0/0.0/16_019/0000798]	University of Valencia; grant Healthy aging in industrial environment	IE was supported by the University of Valencia (Grant number UV-INV-EPDI16-380811) for the study design, data collection and analysis, and preparation of the manuscript. DJ was supported by the grant Healthy aging in industrial environment (program 4 HAIE CZ.02.1.01/0.0/0.0/16_019/0000798) for the study design, data collection and analysis, and decision to publish.	Bujang MA, 2017, ARCHIVES OF OROFACIA, V12; Colby SM, 1999, J ORTHOP SPORT PHYS, V29, P444, DOI 10.2519/jospt.1999.29.8.444; DuPrey KM, 2016, AM J SPORT MED, V44, P1487, DOI 10.1177/0363546516629635; Flanagan EP, 2008, J STRENGTH COND RES, V22, P1677, DOI 10.1519/JSC.0b013e318182034b; Fransz DP, 2017, J BIOMECH, V63, P206, DOI 10.1016/j.jbiomech.2017.07.036; Fransz DP, 2016, GAIT POSTURE, V50, P137, DOI 10.1016/j.gaitpost.2016.09.002; Fransz DP, 2016, J BIOMECH, V49, P496, DOI 10.1016/j.jbiomech.2015.12.048; Fransz DP, 2015, GAIT POSTURE, V41, P63, DOI 10.1016/j.gaitpost.2014.08.018; Fransz DP, 2013, CLIN BIOMECH, V28, P591, DOI 10.1016/j.clinbiomech.2013.06.002; Garcia-Masso X, 2016, MICROSC RES TECHNIQ, V79, P1105, DOI 10.1002/jemt.22764; Hutchinson A.B., 2016, BMJ OPEN SPORTS EXER, V2, DOI 10.1136/bmjsem-2016-000135; Kapoula Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Lazaridis SN, 2013, PEDIATR EXERC SCI, V25, P101, DOI 10.1123/pes.25.1.101; Liu K, 2013, J APPL BIOMECH, V29, P634, DOI 10.1123/jab.29.5.634; McKay H, 2005, BRIT J SPORT MED, V39, P10, DOI 10.1136/bjsm.2003.008615; Petrie A., 2005, MED STAT GLANCE; Raffalt PC, 2016, HUM MOVEMENT SCI, V46, P63, DOI 10.1016/j.humov.2015.12.004; Ross SE, 2005, J ATHL TRAINING, V40, P298; Shaw MY, 2008, J ATHL TRAINING, V43, P164, DOI 10.4085/1062-6050-43.2.164; THELEN E, 1995, AM PSYCHOL, V50, P79, DOI 10.1037/0003-066X.50.2.79; Tulloch E, 2012, J ORTHOP SPORT PHYS, V42, P676, DOI 10.2519/jospt.2012.3790; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Wang Z, 2014, NEUROSCI BIOBEHAV R, V47, P194, DOI 10.1016/j.neubiorev.2014.08.007; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wright CJ, 2016, J ATHL TRAINING, V51, P5, DOI 10.4085/1062-6050-51.2.10	25	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212124	10.1371/journal.pone.0212124	http://dx.doi.org/10.1371/journal.pone.0212124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753223	Green Submitted, Green Published, gold			2022-12-26	WOS:000458395600043
J	Sheth, PM; Douchant, K; Uyanwune, Y; Larocque, M; Anantharajah, A; Borgundvaag, E; Dales, L; McCreight, L; McNaught, L; Moore, C; Ragan, K; McGeer, A; Broukhanski, G				Sheth, Prameet M.; Douchant, Katya; Uyanwune, Yvonne; Larocque, Michael; Anantharajah, Arravinth; Borgundvaag, Emily; Dales, Lorraine; McCreight, Liz; McNaught, Laura; Moore, Christine; Ragan, Kelsey; McGeer, Allison; Broukhanski, George			Evidence of transmission of Clostridium difficile in asymptomatic patients following admission screening in a tertiary care hospital	PLOS ONE			English	Article							MULTILOCUS VARIABLE-NUMBER; TANDEM-REPEAT ANALYSIS; MULTIINSTITUTIONAL OUTBREAK; TOXIN PRODUCTION; SEVERE DISEASE; COLONIZATION; INFECTION; EPIDEMIC; CARRIERS; ACQUISITION	Background Clostridium difficile (CD) is the leading cause of infectious health-care associated diarrhea. However, little is known regarding CD carriage and transmission amongst asymptomatic colonizers. We evaluated carriage, characterized strains and examined epidemiologic linkages in asymptomatic colonized CD patients. Methods Rectal swabs from asymptomatic patients admitted to the general medicine ward from April 1-June 30 2012 were collected. PCR-confirmed CD colonies were ribotyped and characterized by Modified-Multi Locus Variable Number Tandem Repeat Analysis (MMLVA). Results 1549-swabs were collected from 474-patients. Overall, 50/474(10.6%) were CD PCR-positive, 24/50 were colonized at admission, while 26/50 were first identified > = 72 hours after admission. Amongst the 50 CD PCR-positive patients, 90% were asymptomatically colonized and 80% of individuals carried toxigenic CD-strains, including ribotype-027 (5/45:11%). MMLVA revealed five-clusters involving 15-patients harboring toxigenic (4/5) and non-toxigenic CD strains (1/5). In two clusters, patients were CD positive on admission while in the other three clusters involving 10 patients, we observed CD transmission from asymptomatically colonized patients to 8 previously CD-negative patients. Conclusions We identified increasing rates of colonization during admission to medical wards. MMLVA typing effectively discriminated between strains and suggests that 20% of patients with CD colonization acquired their strain(s) from asymptomatically colonized individuals in hospital.	[Sheth, Prameet M.; Douchant, Katya] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Sheth, Prameet M.] Kingston Gen Hosp, Div Microbiol, Kingston, ON, Canada; [Uyanwune, Yvonne; Broukhanski, George] Publ Hlth Ontario Labs, Toronto, ON, Canada; [Larocque, Michael; Anantharajah, Arravinth; Borgundvaag, Emily; Dales, Lorraine; McCreight, Liz; McNaught, Laura; Moore, Christine; Ragan, Kelsey; McGeer, Allison] Mt Sinai Hosp, Dept Microbiol, Toronto, ON, Canada	McMaster University; Queens University - Canada; Queens University - Canada; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Sheth, PM (corresponding author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada.; Sheth, PM (corresponding author), Kingston Gen Hosp, Div Microbiol, Kingston, ON, Canada.; Broukhanski, G (corresponding author), Publ Hlth Ontario Labs, Toronto, ON, Canada.; McGeer, A (corresponding author), Mt Sinai Hosp, Dept Microbiol, Toronto, ON, Canada.	prameet.sheth@queensu.ca; amcgeer@mtsinai.on.ca; george.broukhanski@oahpp.ca	McGeer, Allison/AAB-6885-2020	McGeer, Allison/0000-0001-5647-6137; Broukhanski, George/0000-0002-3313-3243				Adams DA, 2007, ANTIMICROB AGENTS CH, V51, P2674, DOI 10.1128/AAC.01582-06; Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6; Bourgault AM, 2006, ANTIMICROB AGENTS CH, V50, P3473, DOI 10.1128/AAC.00479-06; Brazier JS, 1999, J HOSP INFECT, V43, P317, DOI 10.1016/S0195-6701(99)90431-0; Broukhanski G, 2011, J MED MICROBIOL, V60, P1095, DOI 10.1099/jmm.0.029819-0; Broukhanski G, 2011, J CLIN MICROBIOL, V49, P1983, DOI 10.1128/JCM.02359-10; Brouwer MSM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3601; Cheng VCC, 2011, EUR J CLIN MICROBIOL, V30, P1371, DOI 10.1007/s10096-011-1231-0; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; CLABOTS CR, 1989, J CLIN MICROBIOL, V27, P2386, DOI 10.1128/JCM.27.10.2386-2387.1989; Cleary RK, 1998, DIS COLON RECTUM, V41, P1435, DOI 10.1007/BF02237064; Curry SR, 2013, CLIN INFECT DIS, V57, P1094, DOI 10.1093/cid/cit475; D'Agata EMC, 2002, CLIN INFECT DIS, V34, P167, DOI 10.1086/338234; Djuretic T, 1999, J HOSP INFECT, V41, P213, DOI 10.1016/S0195-6701(99)90018-X; Donskey CJ, 2018, INFECT CONT HOSP EP, V39, P909, DOI 10.1017/ice.2018.106; Perez-Cobas AE, 2013, GUT, V62, P1591, DOI 10.1136/gutjnl-2012-303184; Eyre DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078445; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Fawley WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118150; Hung YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069577; Jazmati N, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.00426-18, 10.1128/JCM.00426-18]; Kato H, 2001, J MED MICROBIOL, V50, P720, DOI 10.1099/0022-1317-50-8-720; Kundrapu S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1514-2; Lanzas C, 2014, INFECT CONT HOSP EP, V35, P1043, DOI 10.1086/677162; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Longtin Y, 2016, JAMA INTERN MED, V176, P796, DOI [10.1001/jamainternmed.2016.0177, 10.1001/jama]; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Miyajima F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022804; Mutters R, 2009, J HOSP INFECT, V71, P43, DOI 10.1016/j.jhin.2008.10.021; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Ozaki E, 2004, J MED MICROBIOL, V53, P167, DOI 10.1099/jmm.0.05376-0; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sayedy L, 2010, WORLD J GASTRO ENDOS, V2, P293, DOI 10.4253/wjge.v2.i8.293; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Truong C, 2017, DIAGN MICR INFEC DIS, V87, P365, DOI 10.1016/j.diagmicrobio.2016.12.014; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127; Walker AS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001172; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilkins TD, 2003, J CLIN MICROBIOL, V41, P531, DOI 10.1128/JCM.41.2.531-534.2003; Zhang XX, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1729-2; Ziakas PD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117195	44	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0207138	10.1371/journal.pone.0207138	http://dx.doi.org/10.1371/journal.pone.0207138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742636	Green Published, Green Submitted, gold			2022-12-26	WOS:000458393400003
J	Eouzan, I; Garnery, L; Pinto, MA; Delalande, D; Neves, CJ; Fabre, F; Lesobre, J; Houte, S; Estonba, A; Montes, I; Sime-Ngando, T; Biron, DG				Eouzan, Iris; Garnery, Lionel; Alice Pinto, M.; Delalande, Damien; Neves, Catia J.; Fabre, Francis; Lesobre, Jerome; Houte, Sylvie; Estonba, Andone; Montes, Iratxe; Sime-Ngando, Telesphore; Biron, David G.			Hygroregulation, a key ability for eusocial insects: Native Western European honeybees as a case study	PLOS ONE			English	Article							RELATIVE-HUMIDITY; TEMPERATURE REGULATION; NEST THERMOREGULATION; BEE COLONY; HIVE; HYMENOPTERA; IMPACTS; WINTER	Sociality has brought many advantages to various hymenoptera species, including their ability of regulating physical factors in their nest (e.g., temperature). Although less studied, humidity is known to be important for egg, larval and pupal development, and also for nectar concentration. Two subspecies of Apis mellifera of the M evolutionary lineage were used as models to test the ability of a superorganism (i.e. honeybee colony) to regulate the humidity in its nest (i.e. "hygroregulation hypothesis") in four conservation centers: two in France (A. m. mellifera) and two in Portugal (A. m. iberiensis). We investigated the ability of both subspecies to regulate the humidity in hives daily, but also during the seasons for one complete year. Our data and statistical analysis demonstrated the capacity of the bees to regulate humidity in their hive, regardless of the day, season or subspecies. Furthermore, the study showed that humidity in beehives is stable even during winter, when brood is absent, and when temperature is known to be less stable in the beehives. These results suggest that humidity is important for honeybees at every life stage, maybe because of the 'imprint' of the evolutionary history of this hymenopteran lineage.	[Eouzan, Iris; Fabre, Francis; Lesobre, Jerome; Sime-Ngando, Telesphore; Biron, David G.] Univ Clermont Auvergne, CNRS, UMR 6023, Lab Microorganismes Genome & Environm, Campus Univ Cezeaux, Clermont Ferrand, France; [Garnery, Lionel; Delalande, Damien] CNRS, UMR 9191, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France; [Garnery, Lionel] St Quentin En Yvelines Univ Versailles, Versailles, France; [Alice Pinto, M.; Neves, Catia J.] Inst Politecn Braganc, Ctr Invest Montanha CIMO, Campus Santa Apolonia, Braganca, Portugal; [Houte, Sylvie] Univ Rochelle, CNRS, UMR 7372, Ctr Etud Biol Chize, Villiers En Bois, France; [Estonba, Andone; Montes, Iratxe] Univ Basque Country, UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Barrio Sarriena S-N, Leioa, Bizkaia, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Instituto Politecnico de Braganca; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); University of Basque Country	Eouzan, I (corresponding author), Univ Clermont Auvergne, CNRS, UMR 6023, Lab Microorganismes Genome & Environm, Campus Univ Cezeaux, Clermont Ferrand, France.	iris.eouzan@gmail.com	Pinto, Maria Alice/AAF-4226-2020	Fabre, Francis/0000-0003-4712-5620; Pinto, Maria Alice/0000-0001-9663-8399; Estonba, Andone/0000-0003-2851-5201; Eouzan, Iris/0000-0003-1380-596X	Ministry of National Education, Higher Education and Research (France); research project BEEHOPE - European call for projects 2013-2014 BiodivERsA/FACCE-JPI from research agency of France [ANR-14-EBID-0001]; research project BEEHOPE - European call for projects 2013-2014 BiodivERsA/FACCE-JPI from research agency of Spain [PCIN-2014-090]; research project BEEHOPE - European call for projects 2013-2014 BiodivERsA/FACCE-JPI from research agency of Portugal [BiodivERsA / 0002/2014]; Fundação para a Ciência e a Tecnologia [BiodivERsA/0002/2014] Funding Source: FCT	Ministry of National Education, Higher Education and Research (France); research project BEEHOPE - European call for projects 2013-2014 BiodivERsA/FACCE-JPI from research agency of France; research project BEEHOPE - European call for projects 2013-2014 BiodivERsA/FACCE-JPI from research agency of Spain; research project BEEHOPE - European call for projects 2013-2014 BiodivERsA/FACCE-JPI from research agency of Portugal; Fundação para a Ciência e a Tecnologia	This work was supported in part by the research project BEEHOPE funded by the European call for projects 2013-2014 BiodivERsA/FACCE-JPI from research agencies of France (ANR-14-EBID-0001), Spain (PCIN-2014-090) and Portugal (BiodivERsA / 0002/2014). I. Eouzan is financed by a doctoral grant from the Ministry of National Education, Higher Education and Research (France).	Abou-Shaara HF, 2017, INSECT SOC, V64, P455, DOI 10.1007/s00040-017-0573-8; Abou-Shaara HF., 2012, ENVIRON EXP BIOL, V10, P133; Amiri E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140272; Annoscia D, 2012, J INSECT PHYSIOL, V58, P1548, DOI 10.1016/j.jinsphys.2012.09.008; Ayton S, 2016, J EXP BIOL, V219, P1552, DOI 10.1242/jeb.137588; Bollazzi M, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.13701; Buxton PA, 1932, BIOL REV BIOL P CAMB, V7, P275; Cabrera VMS, 2013, REV CIENC AGROPECU, V1, P62; Cheng CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2583; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Clement H., 2015, TRAITE RUSTICA APICU; COOPER PD, 1985, J EXP BIOL, V114, P1; DARCHEN R, 1973, Apidologie, V4, P341, DOI 10.1051/apido:19730405; DOULL K M, 1976, Apidologie, V7, P61, DOI 10.1051/apido:19760104; Ellis MB, 2008, J INSECT PHYSIOL, V54, P1516, DOI 10.1016/j.jinsphys.2008.08.011; Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2; FAHRENHOLZ L, 1989, J COMP PHYSIOL B, V159, P551, DOI 10.1007/BF00694379; Frouz J, 2000, INSECT SOC, V47, P229, DOI 10.1007/PL00001708; Han F, 2012, ECOL EVOL, V2, P1949, DOI 10.1002/ece3.312; HEINRICH B, 1971, J EXP BIOL, V54, P141; HEINRICH B, 1974, SCIENCE, V185, P747, DOI 10.1126/science.185.4153.747; Heusner A., 1964, Insectes Sociaux Paris, V11, P239, DOI 10.1007/BF02222676; Himmer A, 1932, BIOL REV BIOL P CAMB, V7, P224; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Human H, 2006, NATURWISSENSCHAFTEN, V93, P397, DOI 10.1007/s00114-006-0117-y; Johnson R., 2007, RECENT HONEY BEE COL; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; Kraus B, 1997, NATURWISSENSCHAFTEN, V84, P217, DOI 10.1007/s001140050382; Martin-Hernandez R, 2011, PARASITOL RES, V109, P605, DOI 10.1007/s00436-011-2292-9; Meikle WG, 2017, APIDOLOGIE, V48, P666, DOI 10.1007/s13592-017-0512-8; Miguel I, 2011, APIDOLOGIE, V42, P150, DOI 10.1051/apido/2010048; Noyes PD, 2009, ENVIRON INT, V35, P971, DOI 10.1016/j.envint.2009.02.006; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Pettis JS, 2010, APIDOLOGIE, V41, P256, DOI 10.1051/apido/2010013; POTTS LR, 1984, INSECT SOC, V31, P335, DOI 10.1007/BF02223616; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Sachs DIR, 2017, BEES APIS MELLIFERA; Schafer MO, 2011, ANN ENTOMOL SOC AM, V104, P476, DOI 10.1603/AN10142; SEELEY TD, 1985, ECOL ENTOMOL, V10, P81, DOI 10.1111/j.1365-2311.1985.tb00537.x; SOUTHWICK EE, 1987, BIOSCIENCE, V37, P395, DOI 10.2307/1310562; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; Thomas MB, 2003, TRENDS ECOL EVOL, V18, P344, DOI 10.1016/S0169-5347(03)00069-7; Weidenmuller A, 2002, ANIM BEHAV, V63, P1065, DOI 10.1006/anbe.2002.3020; Willmer P, 1997, J THERM BIOL, V22, P453, DOI 10.1016/S0306-4565(97)00064-8; Woodrow AW, 1935, J ECON ENTOMOL, V28, P565, DOI 10.1093/jee/28.3.565	46	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0200048	10.1371/journal.pone.0200048	http://dx.doi.org/10.1371/journal.pone.0200048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735488	Green Published, gold, Green Submitted			2022-12-26	WOS:000458181200002
J	Hasan, SMT; Khan, MA; Ahmed, T				Hasan, S. M. Tafsir; Khan, Md. Alfazal; Ahmed, Tahmeed			Inadequate maternal weight gain in the third trimester increases the risk of intrauterine growth restriction in rural Bangladesh	PLOS ONE			English	Article							PREPREGNANCY BODY-MASS; LOW-BIRTH-WEIGHT; GESTATIONAL-AGE; PREGNANT-WOMEN; NEWBORN SIZE; OBESE WOMEN; OUTCOMES; NUTRITION; PATTERNS; RECOMMENDATIONS	Objective To estimate the effect of inadequate maternal weight gain in the third trimester on the risk of intrauterine growth restriction (IUGR) in rural Bangladesh. Methods This study analyzed data from 1,463 mother-infant pairs in Matlab, Bangladesh which were available through the electronic databases of Matlab Health and Demographic Surveillance System and Matlab hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b). All the mothers were admitted to Matlab hospital for childbirth from January 2012 to December 2014, and they had singleton live births at term. Third-trimester weight gain (kg) was calculated by subtracting the estimated weight at the end of the second trimester from the weight taken before childbirth. Inadequate third-trimester weight gain was defined as 4 kg or less irrespective of pre-gravid nutritional status. IUGR was defined as a birth weight below 2500 g in full-term newborns (LBW-Term), and a birth weight for gestational age and infant sex less than the 10th percentile (SGA-10th) and 2 standard deviations below the mean birth weight (SGA-2SD) based on the international newborn standards from the INTERGROWTH-21 st project. Multivariable logistic regression models were fitted to determine the independent effect of inadequate weight gain in the third trimester on the risk of IUGR. Results A total of 824 (56.3%) women experienced inadequate weight gain in the third trimester of pregnancy. In this study, 215 (14.7%), 573 (39.2%) and 220 (15.0%) infants were born as LBW-Term, SGA-10th and SGA-2SD, respectively. In the multivariable logistic regression models, compared to adequate weight gain in the third-trimester, the odds ratios (OR) for LBW-Term, SGA-10th and SGA-2SD for inadequate weight gain were 1.8 (95% CI:1.3, 2.5; p < 0.001), 1.4 (95% CI:1.1, 1.8; p = 0.002) and 1.8 (95% CI: 1.3, 2.4; p = 0.001), respectively. Conclusions Both inadequate third-trimester weight gain and IUGR are prevailing public health concerns in rural Bangladesh. Inadequate weight gain in the third trimester substantially increased the risk of IUGR. Public health programs focusing on the promotion of adequate weight gain in the third trimester of pregnancy with an ultimate aim to decrease IUGR should be implemented.	[Hasan, S. M. Tafsir; Khan, Md. Alfazal; Ahmed, Tahmeed] Icddr B, Nutr & Clin Serv Div, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Ahmed, T (corresponding author), Icddr B, Nutr & Clin Serv Div, Dhaka, Bangladesh.	tahmeed@icddrb.org	Hasan, S. M. Tafsir/AAK-6954-2020	Hasan, S. M. Tafsir/0000-0002-6062-4072; Khan, Md Alfazal/0000-0002-7916-482X	Swedish International Development Cooperation Agency (Sida); Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	Swedish International Development Cooperation Agency (Sida); Government of Bangladesh; Government of Canada(CGIAR); Government of Sweden; Government of UK	This research study was funded by Swedish International Development Cooperation Agency (Sida). icddr,b acknowledges with gratitude the commitment of Sida to its research efforts. icddr,b is also grateful to the Governments of Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; ABRAMS B, 1995, OBSTET GYNECOL, V86, P163, DOI 10.1016/0029-7844(95)00118-B; Agarwal D K, 1998, Indian Pediatr, V35, P733; Ahmed T., 2005, NATL NUTR PROGRAMME; Alam DS, 2003, EUR J CLIN NUTR, V57, P151, DOI 10.1038/sj.ejcn.1601514; Aliyu AA, 2017, PAN AFRICAN MED J, V26; [Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; Barker DJP, 1997, BRIT MED BULL, V53, P96; Bernstein IM, 1997, AM J OBSTET GYNECOL, V176, P28, DOI 10.1016/S0002-9378(97)80006-3; Bertino E, 2007, ARCH DIS CHILD-FETAL, V92, pF7, DOI 10.1136/adc.2006.096214; Bisai S, 2010, ETHIOP J HEALTH SCI, V20, P153; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blomberg M, 2011, OBSTET GYNECOL, V117, P1065, DOI 10.1097/AOG.0b013e318214f1d1; BROOK CGD, 1972, LANCET, V2, P624; Brown JE, 2002, AM J CLIN NUTR, V76, P205, DOI 10.1093/ajcn/76.1.205; Carmichael SL, 1997, OBSTET GYNECOL, V89, P865, DOI 10.1016/S0029-7844(97)00047-1; Cho EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140376; Chu SY, 2008, NEW ENGL J MED, V358, P1444, DOI 10.1056/NEJMoa0706786; Clayton PE, 2007, J CLIN ENDOCR METAB, V92, P804, DOI 10.1210/jc.2006-2017; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Coffey D, 2015, P NATL ACAD SCI USA, V112, P3302, DOI 10.1073/pnas.1416964112; de Bie HMA, 2010, HORM RES PAEDIAT, V73, P6, DOI 10.1159/000271911; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Drehmer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054704; Durie DE, 2011, OBSTET GYNECOL, V118, P569, DOI 10.1097/AOG.0b013e3182289f42; Food and Agriculture Organization of the United Nations United Nations University World Health Organization, 2001, HUM EN REQ REP JOINT; Fraser A, 2011, AM J CLIN NUTR, V93, P1285, DOI 10.3945/ajcn.110.008326; Goldstein RF, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1128-1; Hasan SMT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196190; HICKEY CA, 1995, OBSTET GYNECOL, V85, P909, DOI 10.1016/0029-7844(95)00067-2; Hill B, 2016, WOMEN HEALTH ISS, V26, P123, DOI 10.1016/j.whi.2015.09.012; icddr b., 2016, HLTH DEM SURV SYST M, V48; ICDDR B, 2016, 133 ICDDR B, V49; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S17; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Institute of Medicine, 1992, NUTR ISS DEV COUNT 1, DOI [10.17226/1979, DOI 10.17226/1979]; Institute of Medicine (Subcommittees on Nutritional Status and Weight Gain During Pregnancy and Dietary Intake and Nutrient Supplements During Pregnancy Committee on Nutritional Status During Pregnancy and Lactation Food and Nutrition Board), 1990, NUTR PREGN 1; Jahan K, 2014, FOOD NUTR BULL, V35, P414, DOI 10.1177/156482651403500403; Jebeile H, 2016, AM J OBSTET GYNECOL, V214, P465, DOI 10.1016/j.ajog.2015.12.049; Kelly A, 1996, INT J GYNECOL OBSTET, V53, P219, DOI 10.1016/0020-7292(96)02652-5; Kisuule I, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-121; Lee ACC, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3677; Lee SE, 2013, PUBLIC HEALTH NUTR, V16, P1340, DOI 10.1017/S1368980012004417; Margerison-Zilko CE, 2012, MATERN CHILD HLTH J, V16, P1215, DOI 10.1007/s10995-011-0846-1; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Mola GDL, 2011, PAPUA NEW GUINEA MED, V54, P164; National Institutes of Health. Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2013, PREGN COND INF; Neufeld L, 1999, AM J HUM BIOL, V11, P627, DOI 10.1002/(SICI)1520-6300(199909/10)11:5<627::AID-AJHB6>3.0.CO;2-X; Ornoy A, 2011, REPROD TOXICOL, V32, P205, DOI 10.1016/j.reprotox.2011.05.002; Ota E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000032.pub3; Prakash K, 2001, BAHRAIN MED B, V23, P22; Radhakrishnan U, 2014, J OBSTET GYNAECOL RE, V40, P25, DOI 10.1111/jog.12115; Sekiya N, 2007, GYNECOL OBSTET INVES, V63, P45, DOI 10.1159/000095286; SiegaRiz AM, 1996, J NUTR, V126, P146, DOI 10.1093/jn/126.1.146; Simas TAM, 2011, J WOMENS HEALTH, V20, P837, DOI 10.1089/jwh.2010.2429; Starling AP, 2015, AM J CLIN NUTR, V101, P302, DOI 10.3945/ajcn.114.094946; Stevens B, 2015, MATERN CHILD NUTR, V11, P415, DOI 10.1111/mcn.12183; Strauss RS, 1999, J NUTR, V129, P988, DOI 10.1093/jn/129.5.988; U. S. National Library of Medicine, PREGN TRIM; Vesco KK, 2011, OBSTET GYNECOL, V117, P812, DOI 10.1097/AOG.0b013e3182113ae4; Villar J, 1982, Obstet Gynecol Surv, V37, P499, DOI 10.1097/00006254-198208000-00001; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; WHO, 2016, WHO TECH REP SER, V997, P1; Widdowson E. M, 1974, SCI F PEDIATRICS, P44; Winkvist A, 2002, AM J CLIN NUTR, V75, P1072, DOI 10.1093/ajcn/75.6.1072; Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]; Youns M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169335; Zanardo V, 2016, ITAL J PEDIATR, V42, DOI 10.1186/s13052-016-0284-1	69	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0212116	10.1371/journal.pone.0212116	http://dx.doi.org/10.1371/journal.pone.0212116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735555	Green Submitted, gold, Green Published			2022-12-26	WOS:000458181200058
J	Dribin, TE; Michelson, KA; Monuteaux, MC; Stack, AM; Farbman, KS; Schneider, LC; Neuman, MI				Dribin, Timothy E.; Michelson, Kenneth A.; Monuteaux, Michael C.; Stack, Anne M.; Farbman, Karen S.; Schneider, Lynda C.; Neuman, Mark I.			Identification of children with anaphylaxis at low risk of receiving acute inpatient therapies	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT PATIENTS; REPEAT EPINEPHRINE TREATMENTS; BIPHASIC REACTIONS; ALLERGIC REACTIONS; CLINICAL PREDICTORS; MULTICENTER; SEVERITY; CARE	Objective Opportunity exists to reduce unnecessary hospitalizations for children with anaphylaxis given wide variation in admission rates across U.S. emergency departments (EDs). We sought to identify children hospitalized with anaphylaxis at low risk of receiving epinephrine and other acute inpatient therapies, as these patients may be candidates for ED discharge rather than inpatient hospitalization. Methods We conducted a single-center retrospective cohort study of children 1-21 years of age hospitalized with anaphylaxis from 2009 to 2016. Acute inpatient therapies included intramuscular (IM) or racemic epinephrine, bronchodilators, fluid boluses, vasopressors, non-invasive ventilation, or intubation. We derived age-specific (pre-verbal [<36 months] vs. verbal [>= 36 months]) prediction rules using recursive partitioning to identify children at low risk of receiving acute inpatient therapies. Results During the study period 665 children were hospitalized for anaphylaxis, of whom 108 (16.2%) received acute inpatient therapies. The prediction rule for patients < 36 months (no wheezing, no cardiac involvement [hypotension or wide pulse pressure]) had a sensitivity of 90.5% (CI 69.6-98.8%) and a negative predictive value of 98.3% (CI 94.1-99.8%) for identifying children at low risk of receipt of acute inpatient therapies during hospitalization. For children >= 36 months, the prediction rule (no wheezing, no cardiac involvement, presence of gastrointestinal symptoms) had a sensitivity of 90.8% (CI 82.7-96.0%) and a negative predictive value of 92.4% (CI 85.6-96.7%). Conclusions We derived age specific prediction rules for children hospitalized with anaphylaxis at low risk of receiving epinephrine and other acute inpatient therapies. These children may be candidates for ED discharge rather than inpatient hospitalization.	[Dribin, Timothy E.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Div Emergency Med, Cincinnati, OH 45221 USA; [Michelson, Kenneth A.; Monuteaux, Michael C.; Stack, Anne M.; Farbman, Karen S.; Neuman, Mark I.] Harvard Med Sch, Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Schneider, Lynda C.] Harvard Med Sch, Boston Childrens Hosp, Div Allergy & Immunol, Boston, MA USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Dribin, TE (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Div Emergency Med, Cincinnati, OH 45221 USA.	Timothy.Dribin@cchmc.org	Schneider, Lynda C/AAY-6545-2021	Schneider, Lynda C/0000-0002-5633-0178; Dribin, Tim/0000-0002-7483-1750	Boston Children's Hospital House Officer Award	Boston Children's Hospital House Officer Award	This work was supported by the Boston Children's Hospital House Officer Award to TED. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba AC, 2017, JAMA-J AM MED ASSOC, V318, P1377, DOI 10.1001/jama.2017.12126; Alqurashi W, 2015, ANN ALLERG ASTHMA IM, V115, P217, DOI 10.1016/j.anai.2015.05.013; Banerji A, 2010, ALLERGY ASTHMA PROC, V31, P308, DOI 10.2500/aap.2010.31.3375; Brown SGA, 2004, J ALLERGY CLIN IMMUN, V114, P371, DOI 10.1016/j.jaci.2004.04.029; Campbell RL, 2015, J ALLER CL IMM-PRACT, V3, P576, DOI 10.1016/j.jaip.2015.04.009; Campbell RL, 2014, ANN ALLERG ASTHMA IM, V113, P599, DOI 10.1016/j.anai.2014.10.007; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Collins GS, 2014, BMJ-BRIT MED J, V68, P134; DOUGLAS DM, 1994, J ALLERGY CLIN IMMUN, V93, P977, DOI 10.1016/S0091-6749(94)70044-3; Ellis, 2010, OPEN ALLERGY J, V3, P24, DOI [10.2174/1874838401003010024, DOI 10.2174/1874838401003010024]; Ellis AK, 2007, ANN ALLERG ASTHMA IM, V98, P64, DOI 10.1016/S1081-1206(10)60861-7; Farbman KS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4114; Gaeta TJ, 2007, ANN ALLERG ASTHMA IM, V98, P360, DOI 10.1016/S1081-1206(10)60883-6; Grunau BE, 2014, ANN EMERG MED, V63, P736, DOI 10.1016/j.annemergmed.2013.10.017; Ko BS, 2015, ANN ALLERG ASTHMA IM, V115, P312, DOI 10.1016/j.anai.2015.07.015; Lee JM, 2000, PEDIATRICS, V106, P762, DOI 10.1542/peds.106.4.762; Lee S, 2017, J ALLER CL IMM-PRACT, V5, P1295, DOI 10.1016/j.jaip.2017.07.020; Lee S, 2016, CURR OPIN ALLERGY CL, V16, P346, DOI 10.1097/ACI.0000000000000279; Lee S, 2015, J ALLER CL IMM-PRACT, V3, P408, DOI 10.1016/j.jaip.2014.12.010; Lee SG, 2014, J ALLER CL IMM-PRACT, V2, P281, DOI 10.1016/j.jaip.2014.01.012; Lieberman P, 2005, ANN ALLERG ASTHMA IM, V95, P217, DOI 10.1016/S1081-1206(10)61217-3; Lieberman P, 2010, J ALLERGY CLIN IMMUN, V126; Linden A., 2017, KFOLDCLASS STATA MOD; Manivannan V, 2009, ANN ALLERG ASTHMA IM, V103, P395, DOI 10.1016/S1081-1206(10)60358-4; Mehr S, 2009, CLIN EXP ALLERGY, V39, P1390, DOI 10.1111/j.1365-2222.2009.03276.x; Michelson KA, 2016, ACAD EMERG MED, V23, P623, DOI 10.1111/acem.12922; Motosue MS, 2017, J ALLERGY CLIN IMMUN; Motosue MS, 2017, J ALLERGY CLIN IMMUN, V5; Muraro A, 2007, ALLERGY, V62, P857, DOI 10.1111/j.1398-9995.2007.01421.x; Ralston M, 2006, PALS PROVIDER MANUAL; Rohacek M, 2014, ALLERGY, V69, P791, DOI 10.1111/all.12404; Rudders SA, 2010, PEDIATRICS, V125, pE711, DOI 10.1542/peds.2009-2832; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Simons FER, 2011, WORLD ALLERGY ORGAN, V4, P13, DOI 10.1097/WOX.0b013e318211496c; Soar J, 2008, RESUSCITATION, V77, P157, DOI 10.1016/j.resuscitation.2008.02.001; Tole JW, 2007, IMMUNOL ALLERGY CLIN, V27, P309, DOI 10.1016/j.iac.2007.03.011; Ye YM, 2015, ALLERGY ASTHMA IMMUN, V7, P22, DOI 10.4168/aair.2015.7.1.22	37	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211949	10.1371/journal.pone.0211949	http://dx.doi.org/10.1371/journal.pone.0211949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730977	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000077
J	Masconi, KL; Matsha, TE; Erasmus, RT; Kengne, AP				Masconi, Katya L.; Matsha, Tandi E.; Erasmus, Rajiv T.; Kengne, Andre P.			Effect of model updating strategies on the performance of prevalent diabetes risk prediction models in a mixed-ancestry population of South Africa	PLOS ONE			English	Article							VALIDATION; SCORE; RULES	Background Prediction model updating methods are aimed at improving the prediction performance of a model in a new setting. This study sought to critically assess the impact of updating techniques when applying existent prevalent diabetes prediction models to a population different to the one in which they were developed, evaluating the performance in the mixed-ancestry population of South Africa. Methods The study sample consisted of 1256 mixed-ancestry individuals from the Cape Town Bellville-South cohort, of which 173 were excluded due to previously diagnosed diabetes and 162 individuals had undiagnosed diabetes. The primary outcome, undiagnosed diabetes, was based on an oral glucose tolerance test. Model updating techniques and prediction models were identified via recent systematic reviews. Model performance was assessed using the C-statistic and expected/ observed (E/O) events rates ratio. Results Intercept adjustment and logistic calibration improved calibration across all five models (Cambridge, Kuwaiti, Omani, Rotterdam and Simplified Finnish diabetes risk models). This was improved further by model revision, where likelihood ratio tests showed that the effect of body mass index, waist circumference and family history of diabetes required additional adjustment (Omani, Rotterdam and Finnish models). However, discrimination was poor following internal validation of these models. Re-estimation of the regression coefficients did not increase performance, while the addition of new variables resulted in the highest discriminatory and calibration performance combination for the models it was undertaken in. Conclusions While the discriminatory performance of the original existent models during external validation were higher, calibration was poor. The highest performing models, based on discrimination and calibration, were the Omani diabetes model following model revision, and the Cambridge diabetes risk model following the addition of waist circumference as a predictor. However, while more extensive methods incorporating development population information were superior over simpler methods, the increase in model performance was not great enough for recommendation.	[Masconi, Katya L.; Erasmus, Rajiv T.] NHLS, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa; [Masconi, Katya L.; Erasmus, Rajiv T.] Univ Stellenbosch, Cape Town, South Africa; [Masconi, Katya L.; Kengne, Andre P.] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Matsha, Tandi E.] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Technol, Cape Town, South Africa; [Kengne, Andre P.] Univ Cape Town, Dept Med, Cape Town, South Africa	Stellenbosch University; South African Medical Research Council; Cape Peninsula University of Technology; University of Cape Town	Kengne, AP (corresponding author), South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa.; Kengne, AP (corresponding author), Univ Cape Town, Dept Med, Cape Town, South Africa.	andre.kengne@mrc.ac.za	Kengne, Andre Pascal/ABB-3696-2020	Kengne, Andre Pascal/0000-0002-5183-131X	South African National Research Foundation; Carl & Emily Fuchs Foundation	South African National Research Foundation(National Research Foundation - South Africa); Carl & Emily Fuchs Foundation	This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. KLM was supported by a scholarship from the South African National Research Foundation and the Carl & Emily Fuchs Foundation.	Al Khalaf M. M., 2010, Eastern Mediterranean Health Journal, V16, P725; Al-Lawati JA, 2007, DIABETES RES CLIN PR, V77, P438, DOI 10.1016/j.diabres.2007.01.013; Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213; Bergmann A, 2007, HORM METAB RES, V39, P677, DOI 10.1055/s-2007-985353; Brown N, 2012, DIABETES RES CLIN PR, V98, P369, DOI 10.1016/j.diabres.2012.09.005; DOBSON AJ, 1991, STAT MED, V10, P457, DOI 10.1002/sim.4780100317; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Ivanov J, 1999, CIRCULATION, V99, P2098, DOI 10.1161/01.CIR.99.16.2098; Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018; Kengne AP, 2014, CRIT REV CL LAB SCI, V51, P1, DOI 10.3109/10408363.2013.853025; Masconi K, 2015, DIABETOLOGY METABOLI; Masconi KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139210; Matsha TE, 2012, CARDIOVASC J AFR, V23, P5, DOI 10.5830/CVJA-2010-087; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Moons KG, 2012, HEART; POSES RM, 1986, ANN INTERN MED, V105, P586, DOI 10.7326/0003-4819-105-4-586; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; WHO, 2003, SCREEN TYP 2 DIAB WH; WIGTON RS, 1986, ARCH INTERN MED, V146, P81, DOI 10.1001/archinte.146.1.81	22	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211528	10.1371/journal.pone.0211528	http://dx.doi.org/10.1371/journal.pone.0211528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730899	Green Published, gold, Green Submitted			2022-12-26	WOS:000458026000031
J	Nakayama, R; Ueno, Y; Ueda, K; Honda, T				Nakayama, Ryota; Ueno, Yumiko; Ueda, Keiji; Honda, Tomoyuki			Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1	ONCOGENE			English	Article							PRIMARY EFFUSION LYMPHOMA; HUMAN L1 ELEMENT; KAPPA-B PATHWAY; DNA-SEQUENCES; ENDOTHELIAL ICAM-1; ACTIVATION; EXPRESSION; CANCER; GENE; VFLIP	Kaposi's sarcoma (KS)-associated herpesvirus (KSHV), a gamma-2 herpesvirus, is the causative agent of KS, primary effusion lymphoma (PEL), and a plasma cell variant of multicentric Castleman's disease. Although KSHV latency is detected in KS-related tumors, oncogenic pathways activated by KSHV latent infection are not fully understood. Here, we found that retrotransposition of long interspersed element-1 (L1), a retrotransposon in the human genome, was enhanced in PEL cells. Among the KSHV latent genes, viral FLICE-inhibitory protein (vFLIP) enhanced L1 retrotransposition in an NF-kappa B-dependent manner. Intracellular cell adhesion molecule-1 (ICAM-1), an NF-kappa B target, regulated the vFLIP-mediated enhancement of L1 retrotransposition. Furthermore, ICAM-1 downregulated the expression of Moloney leukemia virus 10 (MOV10), an L1 restriction factor. Knockdown of ICAM-1 or overexpression of MOV10 relieved the vFLIP-mediated enhancement of L1 retrotransposition. Collectively, during KSHV latency, vFLIP upregulates ICAM-1 in an NF-kappa B-dependent manner, which, in turn, downregulates MOV10 expression and thereby enhances L1 retrotransposition. Because active L1 retrotransposition can lead to genomic instability, which is commonly found in KS and PEL, activation of L1 retrotransposition during KSHV latency may accelerate oncogenic processes through enhancing genomic instability. Our results suggest that L1 retrotransposition may be a novel target for impeding tumor development in KSHV-infected patients.	[Nakayama, Ryota; Ueno, Yumiko; Ueda, Keiji; Honda, Tomoyuki] Osaka Univ, Dept Microbiol & Immunol, Div Virol, Grad Sch Med, Osaka, Japan	Osaka University	Honda, T (corresponding author), Osaka Univ, Dept Microbiol & Immunol, Div Virol, Grad Sch Med, Osaka, Japan.	thonda@virus.med.osaka-u.ac.jp			MEXT/JSPS KAKENHI [15K08496, 18H02664, 18K19449]; Takeda Science Foundation; Senri Life Science Foundation; Suzuken Memorial Foundation; Shimizu Foundation for Immunology and Neuroscience; NOVARTIS Foundation (Japan) for the Promotion of Science	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Senri Life Science Foundation; Suzuken Memorial Foundation; Shimizu Foundation for Immunology and Neuroscience; NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis)	This study was supported in part by the MEXT/JSPS KAKENHI Grant Numbers 15K08496, 18H02664, and 18K19449 (T.H.), and grants from the Takeda Science Foundation, Senri Life Science Foundation, Suzuken Memorial Foundation, The Shimizu Foundation for Immunology and Neuroscience Grant for 2015, and The NOVARTIS Foundation (Japan) for the Promotion of Science (T.H.).	Adamson P, 1999, J IMMUNOL, V162, P2964; Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Belancio VP, 2009, GENOME MED, V1, DOI 10.1186/gm97; Boshoff C, 2001, ANNU REV MED, V52, P453, DOI 10.1146/annurev.med.52.1.453; BOVI PD, 1986, CANCER RES, V46, P6333; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Burwinkel B, 1998, J MOL BIOL, V277, P513, DOI 10.1006/jmbi.1998.1641; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chen JM, 2005, HUM GENET, V117, P411, DOI 10.1007/s00439-005-1321-0; Choi J, 2018, NUCLEIC ACIDS RES, V46, P1912, DOI 10.1093/nar/gkx1312; Coscoy L, 2007, NAT REV IMMUNOL, V7, P391, DOI 10.1038/nri2076; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dai LX, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-18; Delabesse E, 1997, J CLIN PATHOL, V50, P664, DOI 10.1136/jcp.50.8.664; Denli AM, 2015, CELL, V163, P583, DOI 10.1016/j.cell.2015.09.025; Ding D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003065; Dittmer DP, 2016, J CLIN INVEST, V126, P3165, DOI 10.1172/JCI84418; Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; DUPIN N, 1995, NEW ENGL J MED, V333, P798; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Ehrlich ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091359; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Gaidano G, 1997, HUM PATHOL, V28, P748, DOI 10.1016/S0046-8177(97)90187-8; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Gill PS, 1998, P NATL ACAD SCI USA, V95, P8257, DOI 10.1073/pnas.95.14.8257; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Goodier JL, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0070-z; Goodier JL, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-11; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Holland J, 1997, J BIOL CHEM, V272, P9108; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; Honda T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02537; Honda T, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00021; JAENISCH R, 1981, CELL, V24, P519, DOI 10.1016/0092-8674(81)90343-3; Katano H, 2000, VIROLOGY, V269, P335, DOI 10.1006/viro.2000.0196; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Lau CC, 2014, CANCER CELL, V25, P335, DOI 10.1016/j.ccr.2014.01.030; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Li XY, 2013, J BIOL CHEM, V288, P21148, DOI 10.1074/jbc.M113.465856; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Mesri EA, 2014, CELL HOST MICROBE, V15, P266, DOI 10.1016/j.chom.2014.02.011; MIKI Y, 1992, CANCER RES, V52, P643; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; MOOSLEHNER K, 1991, MOL CELL BIOL, V11, P886, DOI 10.1128/MCB.11.2.886; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Nishikawa Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103243; Parravicini C, 2000, AM J PATHOL, V156, P743, DOI 10.1016/S0002-9440(10)64940-1; Punj V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037498; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Scott EC, 2016, GENOME RES, V26, P745, DOI 10.1101/gr.201814.115; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Staudt Michelle R., 2003, Current Drug Targets - Infectious Disorders, V3, P129, DOI 10.2174/1568005033481150; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Swanton C, 1997, NATURE, V390, P184, DOI 10.1038/36606; Xie Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1076	70	13	13	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4340	4351		10.1038/s41388-019-0726-5	http://dx.doi.org/10.1038/s41388-019-0726-5			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30770900				2022-12-26	WOS:000469339100010
J	Torok-Nagy, B; Antal, J; Denes, B				Torok-Nagy, Beata; Antal, Jozsef; Denes, Bela			Generation and characterization of D-dimer specific monoclonal antibodies for use in latex agglutination test	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; PROBABILITY; RECOGNIZES; DIAGNOSIS; EPITOPE; ASSAYS	The commercially available D-dimer assays used in the clinical practice often show differences in the results, and their specificity and sensitivity are rather unsatisfactory. Our aim was to develop a new monoclonal antibody against D-dimer with a proper specificity, and estimating its suitability using in a latex agglutination diagnostic test. Monoclonal antibodies were generated using hybridoma technology. Their titer was determined by a self-developed ELISA method. The cross-reactions of the antibodies were tested. Characterization of the epitope specificity of a selected antibody was performed through digestion of D-dimer followed by Western blotting. The amino acid sequences of the active antigen fragments were determined. According to the ELISA results, 38 cell groups were constated as antibody-producing hybridomas, among them 7 gave raised titer of antibody and were cloned. Based on the cross-reaction analysis, none of the antibodies gave cross-reaction with fibrin-E and fibrinogen-E fragments but reacted with fibrin D and fibrinogen D fragments. A low cross-reaction was showed with fibrinogen and fibrin X and Y. Contrary to the others, antibody 2B9 gave no cross-reaction with fibrinogen and reacted weakly with fibrin X and Y fragments. According to the epitope analysis the antibody 2B9 binds to amino acids 94-99 and to amino acids 140-147 on the beta chain and it recognizes the amino acids 23-32 and 93-98 on the gamma chain of D-dimer. Considering the characteristics of the above mentioned monoclonal antibody 2B9, we found that it is suitable to be a basis for a D-dimer diagnostic test with proper specificity.	[Torok-Nagy, Beata] Univ Vet Med, Doctoral Sch, Budapest, Hungary; [Antal, Jozsef] Diagon Ltd, Dept Coagulat, Budapest, Hungary; [Denes, Bela] Natl Food Chain Safety Off, Vet Diagnost Directorate, Lab Immunol, Budapest, Hungary	University of Veterinary Medicine Budapest	Torok-Nagy, B (corresponding author), Univ Vet Med, Doctoral Sch, Budapest, Hungary.	mail.nagy.beata@gmail.com		Denes, Bela/0000-0002-9889-529X	National Food Chain Safety Office (NFCSO); Diagon Ltd.	National Food Chain Safety Office (NFCSO); Diagon Ltd.	This work is supported by National Food Chain Safety Office (NFCSO) and Diagon Ltd. The authors thank Mrs. Annamaria Stoll Gasparne (Veterinary Diagnostic Directorate of the NFCSO) for technical assistance.	Adam SS, 2009, BLOOD, V113, P2878, DOI 10.1182/blood-2008-06-165845; Dempfle CE, 2005, J THROMB HAEMOST, V3, P377, DOI 10.1111/j.1538-7836.2005.01101.x; Dempfle CE, 2001, THROMB HAEMOSTASIS, V85, P671; DEVINE DV, 1988, AM J CLIN PATHOL, V89, P663, DOI 10.1093/ajcp/89.5.663; Doh H-J, 2009, Patent No. 0298100; Doh HJ, 2006, THROMB RES, V118, P353, DOI 10.1016/j.thromres.2005.07.024; Douma RA, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1475; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; HAGER K, 1995, GERONTOLOGY, V41, P159; Holczer T, 2016, 58 NAT C HUNG SOC LA, V54; Kogan AE, 2016, BLOOD COAGUL FIBRIN, V27, P542, DOI 10.1097/MBC.0000000000000453; Mullier F, 2014, BLOOD COAGUL FIBRIN, V25, P309, DOI 10.1097/MBC.0000000000000020; Olson J. D., 2011, H59A CLSI, P8; Reber G, 1998, BLOOD COAGUL FIBRIN, V9, P387, DOI 10.1097/00001721-199806000-00012; Reber G, 2009, STANDARDIZATION D DI, P99; RYLATT DB, 1983, THROMB RES, V31, P767, DOI 10.1016/0049-3848(83)90108-1; Wells PS, 2007, J THROMB HAEMOST, V5, P41, DOI 10.1111/j.1538-7836.2007.02493.x; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; Wylie FG, 1997, BLOOD COAGUL FIBRIN, V8, P87, DOI 10.1097/00001721-199703000-00002; Wylie FG, 1995, BLOOD COAGUL FIBRIN, V6, P738, DOI 10.1097/00001721-199512000-00007	21	1	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2019	14	2							e0212104	10.1371/journal.pone.0212104	http://dx.doi.org/10.1371/journal.pone.0212104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5JX	30763351	Green Submitted, Green Published, gold			2022-12-26	WOS:000458763900042
J	Yajima, T; Arao, M; Yajima, K; Takahashi, H; Yasuda, K				Yajima, Takahiro; Arao, Maiko; Yajima, Kumiko; Takahashi, Hiroshi; Yasuda, Keigo			The associations of fat tissue and muscle mass indices with all-cause mortality in patients undergoing hemodialysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; BODY-COMPOSITION; MAINTENANCE HEMODIALYSIS; ABDOMINAL FAT; INFLAMMATION; SARCOPENIA; CONSENSUS; SURVIVAL; DEPOSITION; MORBIDITY	Protein-energy wasting, which involves loss of fat and muscle mass, is prevalent and is associated with mortality in hemodialysis (HD) patients. We investigated the associations of fat tissue and muscle mass indices with all-cause mortality in HD patients. The study included 162 patients undergoing HD. The fat tissue index (FTI) and skeletal muscle mass index (SMI), which represent respective tissue masses normalized to height squared, were measured by bioimpedance analysis after dialysis. Patients were divided into the following four groups according to the medians of FTI and SMI values: group 1 (G1), lower FTI and lower SMI; G2, higher FTI and lower SMI; G3, lower FTI and higher SMI; and G4, higher FTI and higher SMI. The associations of the FTI, SMI, and body mass index (BMI) with all-cause mortality were evaluated. During a median follow-up of 2.5 years, 29 patients died. The 5-year survival rates were 48.6%, 76.1%, 95.7%, and 87.4% in the G1, G2, G3, and G4 groups, respectively (P = 0.0002). The adjusted hazard ratio values were 0.34 (95% confidence interval [CI] 0.10-0.95, P = 0.040) for G2 vs. G1, 0.13 (95%CI 0.01-0.69, P = 0.013) for G3 vs. G1, and 0.25 (95%CI 0.07-0.72, P = 0.0092) for G4 vs. G1, respectively. With regard to model discrimination, on adding both FTI and SMI to a model with established risk factors, the C-index increased significantly when compared with the value for a model with BMI (0.763 vs. 0.740, P = 0.016). Higher FTI and/or higher SMI values were independently associated with reduced risks of all-cause mortality in HD patients. Moreover, the combination of the FTI and SMI may more accurately predict all-cause mortality when compared with BMI. Therefore, these body composition indicators should be evaluated simultaneously in this population.	[Yajima, Takahiro; Arao, Maiko] Matsunami Gen Hosp, Dept Nephrol, Gifu, Japan; [Yajima, Kumiko; Yasuda, Keigo] Matsunami Gen Hosp, Dept Internal Med, Gifu, Japan; [Takahashi, Hiroshi] Fujita Hlth Univ, Sch Med, Div Med Stat, Toyoake, Aichi, Japan	Fujita Health University	Yajima, T (corresponding author), Matsunami Gen Hosp, Dept Nephrol, Gifu, Japan.	yajima5639@gmail.com						Abbott KC, 2004, KIDNEY INT, V65, P597, DOI 10.1111/j.1523-1755.2004.00385.x; Caetano C, 2016, J RENAL NUTR, V26, P81, DOI 10.1053/j.jrn.2015.10.005; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cordeiro AC, 2010, NEPHROL DIAL TRANSPL, V25, P562, DOI 10.1093/ndt/gfp492; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Gotch FA, 2000, BLOOD PURIFICAT, V18, P276, DOI 10.1159/000014449; Honda H, 2007, AM J CLIN NUTR, V86, P633, DOI 10.1093/ajcn/86.3.633; Ikizler TA, 1999, KIDNEY INT, V55, P1945, DOI 10.1046/j.1523-1755.1999.00410.x; Johansen KL, 2015, CURR OPIN NEPHROL HY, V24, P268, DOI 10.1097/MNH.0000000000000120; Kalantar-Zadeh K, 2006, AM J CLIN NUTR, V83, P202; Kaysen GA, 2005, AM J CLIN NUTR, V82, P988, DOI 10.1093/ajcn/82.5.988; Kim JK, 2019, KOREAN J INTERN MED, V34, P599, DOI 10.3904/kjim.2017.083; Kittiskulnam P, 2017, KIDNEY INT, V92, P238, DOI 10.1016/j.kint.2017.01.024; Marcelli D, 2015, CLIN J AM SOC NEPHRO, V10, P1192, DOI 10.2215/CJN.08550814; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Morabia A, 1999, BRIT J NUTR, V82, P49, DOI 10.1017/S0007114599001117; Mulasi U, 2015, NUTR CLIN PRACT, V30, P180, DOI 10.1177/0884533614568155; Noori N, 2010, CLIN J AM SOC NEPHRO, V5, P2258, DOI 10.2215/CJN.02080310; Obi Y, 2015, CURR OPIN CLIN NUTR, V18, P254, DOI 10.1097/MCO.0000000000000171; Onofriescu M, 2014, AM J KIDNEY DIS, V64, P111, DOI 10.1053/j.ajkd.2014.01.420; Park J, 2014, PROG CARDIOVASC DIS, V56, P415, DOI 10.1016/j.pcad.2013.10.005; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Romero-Corral A, 2007, EUR HEART J, V28, P2087, DOI 10.1093/eurheartj/ehm243; Rosenberger J, 2014, J RENAL NUTR, V24, P172, DOI 10.1053/j.jrn.2014.01.002; Samaras K, 2010, OBESITY, V18, P884, DOI 10.1038/oby.2009.443; Tangvoraphonkchai K, 2017, EUR J CLIN NUTR, V71, P169, DOI 10.1038/ejcn.2016.187; Wagenknecht LE, 2003, DIABETES, V52, P2490, DOI 10.2337/diabetes.52.10.2490; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yajima T, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040480	34	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2019	14	2							e0211988	10.1371/journal.pone.0211988	http://dx.doi.org/10.1371/journal.pone.0211988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL5IX	30759133	Green Published, gold, Green Submitted			2022-12-26	WOS:000458761300066
J	Lupi, ACD; Lira, BS; Gramegna, G; Trench, B; Alves, FRR; Demarco, D; Peres, LEP; Purgatto, E; Freschi, L; Rossi, M				Duarte Lupi, Alessandra Cavalcanti; Lira, Bruno Silvestre; Gramegna, Giovanna; Trench, Bruna; Rodrigues Alves, Frederico Rocha; Demarco, Diego; Pereira Peres, Lazaro Eustaquio; Purgatto, Eduardo; Freschi, Luciano; Rossi, Magdalena			Solanum lycopersicum GOLDEN 2-LIKE 2 transcription factor affects fruit quality in a light- and auxin-dependent manner	PLOS ONE			English	Article							VITAMIN-E; CHLOROPLAST DEVELOPMENT; TOCOPHEROL BIOSYNTHESIS; STARCH DEGRADATION; DOWN-REGULATION; TOMATO; DEFICIENT; METABOLISM; EXPRESSION; CYTOKININ	Plastids are organelles responsible for essential aspects of plant development, including carbon fixation and synthesis of several secondary metabolites. Chloroplast differentiation and activity are highly regulated by light, and several proteins involved in these processes have been characterised. Such is the case of the GOLDEN 2-LIKE (GLK) transcription factors, which induces the expression of genes related to chloroplast differentiation and photosynthesis. The tomato (Solanum lycopersicum) genome harbours two copies of this gene, SlGLK1 and SlGLK2, each with distinct expression patterns. While the former predominates in leaves, the latter is mainly expressed in fruits, precisely at the pedicel region. During tomato domestication, the selection of fruits with uniform ripening fixed the mutation Slglk2, nowadays present in most cultivated varieties, what penalised fruit metabolic composition. In this study, we investigated how SlGLK2 is regulated by light, auxin and cytokinin and determined the effect of SlGLK2 on tocopherol (vitamin E) and sugar metabolism, which are components of the fruit nutritional and industrial quality. To achieve this, transcriptional profiling and biochemical analysis were performed throughout fruit development and ripening from SlGLK2, Slglk2, SlGLK2-overexpressing genotypes, as well as from phytochrome and hormonal deficient mutants. The results revealed that SlGLK2 expression is regulated by phytochrome-mediated light perception, yet this gene can induce chloroplast differentiation even in a phytochrome-independent manner. Moreover, auxin was found to be a negative regulator of SlGLK2 expression, while SlGLK2 enhances cytokinin responsiveness. Additionally, SlGLK2 enhanced chlorophyll content in immature green fruits, leading to an increment in tocopherol level in ripe fruits. Finally, SlGLK2 overexpression resulted in higher total soluble solid content, possibly by the regulation of sugar metabolism enzyme-encoding genes. The results obtained here shed light on the regulatory network that interconnects SlGLK2, phytohormones and light signal, promoting the plastidial activity and consequently, influencing the quality of tomato fruit.	[Duarte Lupi, Alessandra Cavalcanti; Lira, Bruno Silvestre; Gramegna, Giovanna; Trench, Bruna; Rodrigues Alves, Frederico Rocha; Demarco, Diego; Freschi, Luciano; Rossi, Magdalena] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil; [Pereira Peres, Lazaro Eustaquio] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Ciencias Biol, Piracicaba, SP, Brazil; [Purgatto, Eduardo] Univ Sao Paulo, Dept Alimentos & Nutr Expt, Fac Ciencias Farmaceut, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Rossi, M (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil.	mmrossi@usp.br	Demarco, Diego/C-6122-2012; Peres, Lazaro/GRS-0221-2022; Rossi, Magdalena/B-7847-2012; Freschi, Luciano/B-3807-2008; Purgatto, Eduardo/C-7707-2009; Lira, Bruno Silvestre/G-2874-2017	Demarco, Diego/0000-0002-8244-2608; Peres, Lazaro/0000-0002-8761-5934; Rossi, Magdalena/0000-0003-3650-772X; Freschi, Luciano/0000-0002-0737-3438; Purgatto, Eduardo/0000-0002-7372-1197; Lira, Bruno Silvestre/0000-0002-0820-6682; Alves, Frederico/0000-0002-2540-4699; GRAMEGNA, GIOVANNA/0000-0001-8585-7801	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) fellowship; FAPESP (Brazil) [2016/01128-9, 2014/10651-1]; CNPq (Brazil); CAPES, Brazil [001]; USP (Universidade de Sao Paulo, Brazil); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); USP (Universidade de Sao Paulo, Brazil); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	B.S.L., G.G., F.R.R.A. and B.T. were recipients of FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) fellowships. M.R. and D.D. were funded by a fellowship from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). A.C.D.L. was recipient of a CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) fellowship. This work was partially supported by grants from FAPESP (Brazil; 2016/01128-9, 2014/10651-1), CNPq (Brazil), CAPES (Finance Code 001, Brazil) and USP (Universidade de Sao Paulo, Brazil).	Ajjawi I, 2004, TRENDS BIOTECHNOL, V22, P104, DOI 10.1016/j.tibtech.2004.01.008; Almeida J, 2016, J EXP BOT, V67, P919, DOI 10.1093/jxb/erv504; Almeida J, 2015, PHYTOCHEMISTRY, V111, P72, DOI 10.1016/j.phytochem.2014.11.007; Almeida J, 2011, J EXP BOT, V62, P3781, DOI 10.1093/jxb/err055; Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Bianchetti RE, 2018, J EXP BOT, V69, P3573, DOI 10.1093/jxb/ery145; Bianchetti RE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08448-2; Booth SL, 2004, AM J CLIN NUTR, V80, P143; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canene-Adams K, 2005, J NUTR, V135, P1226, DOI 10.1093/jn/135.5.1226; Cortleven A, 2015, J EXP BOT, V66, P4999, DOI 10.1093/jxb/erv132; DellaPenna D, 2005, J PLANT PHYSIOL, V162, P729, DOI 10.1016/j.jplph.2005.04.004; Di Rienzo J., INFOSTAT VERSION 201; Fitter DW, 2002, PLANT J, V31, P713, DOI 10.1046/j.1365-313X.2002.01390.x; Cocaliadis MF, 2014, J EXP BOT, V65, P4589, DOI 10.1093/jxb/eru165; Freschi L, 2010, J PLANT PHYSIOL, V167, P1577, DOI 10.1016/j.jplph.2010.06.002; GEA, 1990, J NUTR, V120, P233, DOI [10.1093/jn/120.3.233, DOI 10.1093/JN/120.3.233]; Isogai M, 1998, J GEN VIROL, V79, P1487, DOI 10.1099/0022-1317-79-6-1487; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jones B, 2002, PLANT J, V32, P603, DOI 10.1046/j.1365-313X.2002.01450.x; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kendrick RE, 1997, PLANT CELL ENVIRON, V20, P746, DOI 10.1046/j.1365-3040.1997.d01-109.x; Kobayashi K, 2017, PLANT PHYSIOL, V173, P2340, DOI 10.1104/pp.16.01368; Kobayashi K, 2012, PLANT CELL, V24, P1081, DOI 10.1105/tpc.111.092254; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Lira BS, 2016, PLANT CELL PHYSIOL, V57, P642, DOI 10.1093/pcp/pcw021; Lytovchenko A, 2011, PLANT PHYSIOL, P111; Mene-Saffrane L, 2010, P NATL ACAD SCI USA, V107, P17815, DOI 10.1073/pnas.1006971107; Miret JA, 2015, ANN NY ACAD SCI, V1340, P29, DOI 10.1111/nyas.12639; Miyazawa Y, 1999, PLANT PHYSIOL, V121, P461, DOI 10.1104/pp.121.2.461; Morris MC, 2015, ALZHEIMERS DEMENT, V11, P32, DOI 10.1016/j.jalz.2013.12.015; Muramoto T, 2005, PLANT CELL PHYSIOL, V46, P661, DOI 10.1093/pcp/pci062; Nguyen CV, 2014, PLANT CELL, V26, P585, DOI 10.1105/tpc.113.118794; Oh K, 2006, PLANTA, V224, P133, DOI 10.1007/s00425-005-0202-z; Pan Y, 2013, PLANT PHYSIOL, P112; PARKS BM, 1987, PLANT MOL BIOL, V9, P97, DOI 10.1007/BF00015642; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pino LE, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-23; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Powell ALT, 2012, SCIENCE, V336, P1711, DOI 10.1126/science.1222218; Purgatto E, 2002, J PLANT PHYSIOL, V159, P1105, DOI 10.1078/0176-1617-00875; Purgatto E, 2001, PLANTA, V212, P823, DOI 10.1007/s004250000441; Pyke K, 2011, METHODS MOL BIOL, V774, P19, DOI 10.1007/978-1-61779-234-2_2; Quadrana L, 2013, PLANT MOL BIOL, V81, P309, DOI 10.1007/s11103-012-0001-4; Rastogi A, 2014, PLANT CELL ENVIRON, V37, P392, DOI 10.1111/pce.12161; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rizvi Saliha, 2014, Sultan Qaboos Univ Med J, V14, pe157; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sagar M, 2013, PLANT PHYSIOL, V161, P1362, DOI 10.1104/pp.113.213843; Song Y, 2014, MOL PLANT, V7, P1776, DOI 10.1093/mp/ssu109; Stone WL, 2004, ANN NY ACAD SCI, V1031, P223, DOI 10.1196/annals.1331.022; Terry MJ, 1999, PLANT PHYSIOL, V119, P143, DOI 10.1104/pp.119.1.143; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928	57	17	20	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0212224	10.1371/journal.pone.0212224	http://dx.doi.org/10.1371/journal.pone.0212224			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0PE	30753245	gold, Green Published			2022-12-26	WOS:000458395600055
J	Useche, SA; Montoro, LV; Ruiz, JI; Vanegas, C; Sanmartin, J; Alfaro, E				Useche, Sergio A.; Montoro, Luis V.; Ruiz, Jose I.; Vanegas, Cesar; Sanmartin, Jaime; Alfaro, Elisa			Workplace burnout and health issues among Colombian correctional officers	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; OCCUPATIONAL STRESS; PHYSICAL-ACTIVITY; MENTAL-HEALTH; JOB-STRESS; SOCIAL SUPPORT; WORK STRESS; DEPRESSION; NURSES; ASSOCIATIONS	Introduction Correctional employees typically work under adverse conditions that may enhance the occurrence of different negative psychological states. Burnout constitutes a high-risk phenomenon that may affect people's physical/mental health and welfare, especially in vulnerable occupational groups. Objectives The aim of this study was to characterize the burnout profile of correctional officers, and to associate their burnout profile with health issues and lifestyle factors. Methods The full sample was composed of 219 Colombian correctional officers with a mean age of 30.18 years. A questionnaire composed of three sections was employed: demographic data, burnout, and health information. Results A high proportion of participants reported burnout indicators, also significantly correlated to their health indicators and lifestyle factors. Cluster analyses were used in order to characterize the burnout/age (model A) and burnout/age/psychological disturbance (model B) profiles of correctional officers. Furthermore, significant differences were found when comparing frequencies of alcohol consumption and physical exercise (lifestyle indicators) and perceived social support of officers depending on their profile. Conclusions the discussion focused on the negative impact of burnout on health, and on the importance of strengthening occupational programs aimed at reducing the impact of hazardous working conditions that contribute to the development of burnout, and to the arise different mid and long-term health complains among correctional workers.	[Useche, Sergio A.; Montoro, Luis V.; Sanmartin, Jaime] Univ Valencia, INTRAS Fac Psychol, Valencia, Spain; [Ruiz, Jose I.] Univ Nacl Colombia, Lab Psychol & Law, Bogota, Colombia; [Vanegas, Cesar] Natl Penitentiary & Prison Inst, Natl Penitentiary Sch, Funza, Colombia; [Alfaro, Elisa] Univ Valencia, Fac Med, Valencia, Spain	University of Valencia; Universidad Nacional de Colombia; University of Valencia	Useche, SA (corresponding author), Univ Valencia, INTRAS Fac Psychol, Valencia, Spain.	sergio.useche@uv.es	Sanmartin, Jaime/I-1767-2013; Montoro, Luis/M-3965-2019; Useche, Sergio A./O-7552-2014	Sanmartin, Jaime/0000-0002-2770-2577; Montoro, Luis/0000-0003-0169-4705; Useche, Sergio A./0000-0002-5099-4627; Ruiz Perez, Jose Ignacio/0000-0002-8996-9736				Abarghouei Mohammad Reza, 2016, Electron Physician, V8, P2625, DOI 10.19082/2625; Ahola K, 2009, J AFFECT DISORDERS, V115, P150, DOI 10.1016/j.jad.2008.09.021; Al-Dubai SAR, 2010, J OCCUP HEALTH, V52, P58, DOI 10.1539/joh.O8030; Alonso F., 2017, COGENT MED, V4, DOI [10.1080/2331205X.2017.1303920, DOI 10.1080/2331205X.2017.1303920]; Alonso F, 2017, AM J APPL PSYCHOL, V5, P25, DOI [10.12691/ajap-5-1-5, DOI 10.12691/AJAP-5-1-5]; Aronsson G, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4153-7; Arroyave L, 2019, J IMMIGR MINOR HEALT, V21, P578, DOI 10.1007/s10903-018-0746-1; Arvidsson I, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3498-7; Awa WL, 2010, PATIENT EDUC COUNS, V78, P184, DOI 10.1016/j.pec.2009.04.008; Barnett R C, 1999, J Occup Health Psychol, V4, P307, DOI 10.1037/1076-8998.4.4.307; Bell NS, 2003, ALCOHOL CLIN EXP RES, V27, P826, DOI 10.1097/01.ALC.0000067978.27660.73; Bezerra CD, 2016, CIENC SAUDE COLETIVA, V21, P2135, DOI 10.1590/1413-81232015217.00502016; Boudoukha AH, 2011, ENCEPHALE, V37, P284, DOI 10.1016/j.encep.2010.08.006; Bourbonnais R, 2005, REV EPIDEMIOL SANTE, V53, P127, DOI 10.1016/S0398-7620(05)84583-3; Bretland RJ, 2015, PEERJ, V3, DOI 10.7717/peerj.891; Burnout Maslach C., PROFESSIONAL BURNOUT; Calvert GM, 1999, J OCCUP ENVIRON MED, V41, P960, DOI 10.1097/00043764-199911000-00007; Campos J, 2016, ABCD-ARQ BRAS CIR DI, V29, P102, DOI [10.1590/0102-6720201600S10025, 10.1590/0102-6720201600s10025]; Cendales-Ayala B, 2017, J OCCUP HEALTH PSYCH, V22, P518, DOI 10.1037/ocp0000040; Chung YS, 2013, TRANSPORT RES REC, P1, DOI 10.3141/2388-01; Clemente M, 2015, PRISON J, V95, P244, DOI 10.1177/0032885515575275; Conn VS, 2009, AM J PREV MED, V37, P330, DOI 10.1016/j.amepre.2009.06.008; Demerouti E, 2014, J OCCUP HEALTH PSYCH, V19, P96, DOI 10.1037/a0035062; Dennis AM, 2007, J PSYCHIATR MENT HLT, V14, P267, DOI 10.1111/j.1365-2850.2007.01073.x; DIGNAM JT, 1986, AM J COMMUN PSYCHOL, V14, P177, DOI 10.1007/BF00911820; Finney C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-82; Fuentes J., 2007, APUNTES PSICOLOGIA, V25, P157; Gallavan DB, 2013, PSYCHOL SERV, V10, P115, DOI 10.1037/a0031341; Garrosa E, 2008, INT J NURS STUD, V45, P418, DOI 10.1016/j.ijnurstu.2006.09.003; Ghaddar A, 2008, J OCCUP HEALTH, V50, P92, DOI 10.1539/joh.50.92; Gil-Monte PR., 1997, DESGASTE PSIQUICO TR; Gluschkoff K, 2016, OCCUP MED-OXFORD, V66, P564, DOI 10.1093/occmed/kqw086; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; GÓMEZ ORTIZ VIVIOLA, 2015, Rev. colomb. psicol., V24, P185, DOI 10.15446/rcp.v24n1.42081; Gu JK, 2013, SAF HEALTH WORK-KR, V4, P52, DOI 10.5491/SHAW.2013.4.1.52; Harizanova Stanislava N, 2013, Folia Med (Plovdiv), V55, P73; Higashiguchi K, 1999, J OCCUP HEALTH, V41, P215, DOI 10.1539/joh.41.215; Hu NC, 2016, J OCCUP ENVIRON MED, V58, P514, DOI 10.1097/JOM.0000000000000715; Huerta-Franco Maria-Raquel, 2013, World J Gastrointest Pathophysiol, V4, P108, DOI 10.4291/wjgp.v4.i4.108; Huibers M. J. H., 2003, Occupational and Environmental Medicine, V60, pi26, DOI 10.1136/oem.60.suppl_1.i26; Iacovides A, 2003, J AFFECT DISORDERS, V75, P209, DOI 10.1016/S0165-0327(02)00101-5; Kadzielski JJ, 2012, J HAND SURG-AM, V37A, P1812, DOI 10.1016/j.jhsa.2012.05.023; Khamisa N, 2013, INT J ENV RES PUB HE, V10, P2214, DOI 10.3390/ijerph10062214; Komissarova E. M., 2011, Meditsina Truda i Promyshlennaya Ekologiya, P19; Konda Srinivas, 2013, Correct Today, V75, P122; Konda S, 2012, J SAFETY RES, V43, P181, DOI 10.1016/j.jsr.2012.06.002; Kuhn CM, 2017, CAN J ANESTH, V64, P158, DOI 10.1007/s12630-016-0781-0; Lambert EG, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015590444; Lambert EG, 2012, PRISON J, V92, P3, DOI 10.1177/0032885511428794; Lambert EG, 2010, PRISON J, V90, P94, DOI 10.1177/0032885509357586; Lamontagne AD, 2007, INT J OCCUP ENV HEAL, V13, P268, DOI 10.1179/oeh.2007.13.3.268; LANDSBERGIS PA, 1994, SCAND J WORK ENV HEA, V20, P349, DOI 10.5271/sjweh.1386; Langballe EM, 2009, WORK, V32, P179, DOI 10.3233/WOR-2009-0804; Lavigne E, 2010, INT J LAW PSYCHIAT, V33, P122, DOI 10.1016/j.ijlp.2009.12.005; Lennartsson AK, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00008; Lopes-Cardozo B, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE.0044948]; Lourel M, 2007, ENCEPHALE, V33, P947, DOI 10.1016/j.encep.2006.10.001; Malkina-Pykh I., 2015, ASS BURNOUT SECONDAR, DOI [10.13140/RG.2.1.3766.8962, DOI 10.13140/RG.2.1.3766.8962]; Maslach C., 2009, CIENCIA TRABAJO, V11, P37; Maslach C., MASLACH BURNOUT INVE; May RW, 2018, STRESS, V21, P211, DOI 10.1080/10253890.2018.1433161; McCraty Rollin, 2012, Glob Adv Health Med, V1, P44, DOI 10.7453/gahmj.2012.1.5.013; MELVIN KB, 1985, CRIM JUSTICE BEHAV, V12, P241, DOI 10.1177/0093854885012002006; Morse G, 2012, ADM POLICY MENT HLTH, V39, P341, DOI 10.1007/s10488-011-0352-1; Naczenski LM, 2017, J OCCUP HEALTH, V59, P477, DOI 10.1539/joh.17-0050-RA; NCCHC. Health Training for Correctional Officers, 2013, HLTH TRAIN CORR OFF; Neveu JP, 2007, J ORGAN BEHAV, V28, P21, DOI 10.1002/job.393; Oliveira RV, 2016, WORK, V55, P215, DOI 10.3233/WOR-162367; Ozbay Fatih, 2007, Psychiatry (Edgmont), V4, P35; Pagnin D, 2014, ACAD PSYCHIATR, V38, P438, DOI 10.1007/s40596-014-0093-z; Paisley K, 2007, CHILD ADOL PSYCH CL, V16, P829, DOI 10.1016/j.chc.2007.05.013; Penson R T, 2000, Oncologist, V5, P425; Pereira-Lima K, 2015, PSYCHOL HEALTH MED, V20, P353, DOI 10.1080/13548506.2014.936889; Peterson U, 2011, J OCCUP ENVIRON MED, V53, P788, DOI 10.1097/JOM.0b013e318222b1dc; Philip P, 2005, ACCIDENT ANAL PREV, V37, P473, DOI 10.1016/j.aap.2004.07.007; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Quick JC, 2013, PREVENTIVE STRESS MA, DOI [10.1037/13942-000, DOI 10.1037/13942-000]; Raazavi T., 2001, DISCUSSION PAPERS AC; Reeves D. W, 2014, THESIS; Rodríguez Amaya Reynaldo Mauricio, 2014, rev.colomb.psiquiatr., V43, P146, DOI 10.1016/j.rcp.2014.03.001; Rose S, 2015, WINTHROP MCNAIR RES, V1, P68; Ruiz JI, 2001, ACTA COLOMB PSICOL, V6, P41; SARSANGI V., 2015, Q INT ARCH HLTH SCI, V2, P13; Schaufeli WB, 2000, INT J STRESS MANAGE, V7, P19, DOI 10.1023/A:1009514731657; Schneider S, 2005, J OCCUP HEALTH, V47, P414, DOI 10.1539/joh.47.414; Schonfeld IS, 2016, J CLIN PSYCHOL, V72, P22, DOI 10.1002/jclp.22229; Shad R, 2015, CUREUS, V7, DOI 10.7759/cureus.361; Stimpfel AW, 2012, HEALTH AFFAIR, V31, P2501, DOI 10.1377/hlthaff.2011.1377; Takeda F, 2005, J OCCUP HEALTH, V47, P119, DOI 10.1539/joh.47.119; Taylor AH, 2006, ANNU REV PUBL HEALTH, V27, P371, DOI 10.1146/annurev.publhealth.27.021405.102117; Useche S., 2017, J ENV OCCUP SCI, V6, P1, DOI [10.5455/jeos.20170202074636, DOI 10.5455/JE0S.20170202074636]; USECHE SA, 2018, SAGE OPEN, V8, DOI DOI 10.1177/2158244018782336; Useche SA, 2018, PEERJ, V6, DOI 10.7717/peerj.6249; Useche SA, 2017, ACCIDENT ANAL PREV, V104, P106, DOI 10.1016/j.aap.2017.04.023; Rueda ZV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080592; VAUX A, 1986, AM J COMMUN PSYCHOL, V14, P195, DOI 10.1007/BF00911821; Viljoen M, 2017, WORK, V56, P499, DOI 10.3233/WOR-172518; Wang Y, 2015, INT ARCH OCC ENV HEA, V88, P589, DOI 10.1007/s00420-014-0987-9; Westgaard RH, 1999, SCAND J WORK ENV HEA, V25, P19; Zou GY, 2016, IND HEALTH, V54, P389, DOI 10.2486/indhealth.2015-0103	100	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2019	14	2							e0211447	10.1371/journal.pone.0211447	http://dx.doi.org/10.1371/journal.pone.0211447			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL0PE	30753198	Green Published, gold, Green Submitted			2022-12-26	WOS:000458395600011
J	Wangai, FK; Masika, MM; Lule, GN; Karari, EM; Maritim, MC; Jaoko, WG; Museve, B; Kuria, A				Wangai, Frederick K.; Masika, Moses M.; Lule, Godfrey N.; Karari, Emma M.; Maritim, Marybeth C.; Jaoko, Walter G.; Museve, Beatrice; Kuria, Antony			Bridging antimicrobial resistance knowledge gaps: The East African perspective on a global problem	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; INFECTIONS; NAIROBI; HOSPITALS	Background There is worldwide concern of rapidly increasing antimicrobial resistance (AMR). However, there is paucity of resistance surveillance data and updated antibiograms in Africa in general. This study was undertaken in Kenyatta National Hospital (KNH) -the largest public tertiary referral centre in East & Central Africa-to help bridge existing AMR knowledge and practice gaps. Methods A retrospective review of VITEK 2 (bioMerieux) records capturing antimicrobial susceptibility data for the year 2015 was done and analysed using WHONET and SPSS. Results Analysis of 624 isolates revealed AMR rates higher than most recent local and international reports. 88% of isolates tested were multi-drug resistant (MDR) whereas 26% were extensively-drug resistant (XDR). E. coli and K. pneumoniae had poor susceptibility to penicillins (8-48%), cephalosporins (16-43%), monobactams (17-29%), fluoroquinolones (22-44%) and trimethoprim-sulfamethoxazole (7%). Pseudomonas aeruginosa and Acinetobacter baumanii were resistant to penicillins and cephalosporins, with reduced susceptibility to carbapenems (70% and 27% respectively). S aureus had poor susceptibility to penicillins (3%) and trimethoprim-sulfamethoxazole (29%) but showed excellent susceptibility to imipenem (90%), vancomycin (97%) and linezolid (99%). Conclusions The overwhelming resistance to commonly used antibiotics heralds a clarion call towards strengthening antimicrobial stewardship programmes and regular AMR regional surveillance.	[Wangai, Frederick K.; Lule, Godfrey N.; Karari, Emma M.; Maritim, Marybeth C.] Univ Nairobi, Unit Clin Infect Dis, Dept Clin Med & Therapeut, Sch Med,Coll Hlth Sci, Nairobi, Kenya; [Masika, Moses M.; Jaoko, Walter G.] Univ Nairobi, Dept Microbiol, Sch Med, Coll Hlth Sci, Nairobi, Kenya; [Museve, Beatrice; Kuria, Antony] Kenyatta Natl Hosp, Microbiol Lab, Nairobi, Kenya	University of Nairobi; University of Nairobi; Kenyatta National Hospital	Wangai, FK (corresponding author), Univ Nairobi, Unit Clin Infect Dis, Dept Clin Med & Therapeut, Sch Med,Coll Hlth Sci, Nairobi, Kenya.	fkwangai@gmail.com	Jaoko, Walter/AAN-5048-2020	Jaoko, Walter/0000-0002-7134-6581; Wangai, Frederick/0000-0002-6544-8936; Masika, Moses Muia/0000-0003-3385-0821				AgaKhan University Hospital Nairobi Department of Pathology, 2015, ANT SUSC REP 2015; Becker K, 2006, J CLIN MICROBIOL, V44, P229, DOI 10.1128/JCM.44.1.229-231.2006; CDC, 2013, ANTIBIOTIC RESISTANC; Center for Disease Dynamics Economics & Policy, 2015, NON TRADITIONAL REF; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; CLSI, 2014, M39A4 CLSI, VFourth; Falagas ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068024; French GL, 2009, CLIN MICROBIOL INFEC, V15, P10, DOI 10.1111/j.1469-0691.2009.03092.x; Kahlmeter G, GLOBAL PRIORITY LIST; Kesah C, 2003, CLIN MICROBIOL INFEC, V9, P153, DOI 10.1046/j.1469-0691.2003.00531.x; Leopold SJ, 2014, J ANTIMICROB CHEMOTH, V69, P2337, DOI 10.1093/jac/dku176; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maina D, 2013, MICROBIOL DISCOV, V1; Maina D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147659; Maina EK, 2013, INT J INFECT DIS, V17, pE115, DOI 10.1016/j.ijid.2012.09.006; Merz A, 2014, J FOOD SAF FOOD QUAL, V65, P137, DOI 10.2376/0003-925X-65-137; Musicha P, 2017, LANCET INFECT DIS, V17, P1042, DOI 10.1016/S1473-3099(17)30394-8; Ndegwa LK, 2014, AM J INFECT CONTROL, V42, P985, DOI 10.1016/j.ajic.2014.05.022; Ngumi ZWW, 2006, DERMATOLOGY, V212, P4, DOI 10.1159/000089192; Omari MA, 1997, E AFR MED J, V74, P134; Omuse G, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0171-z; Ratemo NK, 2014, THESIS; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Storberg Viktor, 2014, Infection Ecology & Epidemiology, V4, P20342, DOI 10.3402/iee.v4.20342; World Health Organization, 2014, ANT RES GLOB REP SUR	26	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2019	14	2							e0212131	10.1371/journal.pone.0212131	http://dx.doi.org/10.1371/journal.pone.0212131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL0OI	30742669	Green Submitted, gold, Green Published			2022-12-26	WOS:000458393400052
J	Imada, M; Yagyuu, T; Ueyama, Y; Maeda, M; Yamamoto, K; Kurokawa, S; Jo, J; Tabata, Y; Tanaka, Y; Kirita, T				Imada, Mitsuhiko; Yagyuu, Takahiro; Ueyama, Yoshihiro; Maeda, Masahiko; Yamamoto, Kazuhiko; Kurokawa, Satoshi; Jo, Jun-ichiro; Tabata, Yasuhiko; Tanaka, Yasuhito; Kirita, Tadaaki			Prevention of tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaws with basic fibroblast growth factor: An experimental study in rats	PLOS ONE			English	Article							CONTROLLED-RELEASE; GELATIN HYDROGEL; POSITION PAPER; VASCULARIZATION; ANGIOGENESIS; ASSOCIATION; QUALITY	Osteonecrosis of the jaw induced by administration of bisphosphonates (BPs), BP-related osteonecrosis (BRONJ), typically develops after tooth extraction and is medically challenging. As BPs inhibit oral mucosal cell growth, we hypothesized that suppression of the wound healing-inhibiting effects could prevent BRONJ onset after tooth extraction. Since basic fibroblast growth factor (bFGF) promotes wound healing, but has a short half-life, we examined whether the initiation of BRONJ could be prevented by applying a bFGF-containing gelatin hydrogel over the extraction sockets of BRONJ model rats. Forty-three rats, received two intravenous injections of zoledronic acid 60 mu g/kg, once per week for a period of 2 weeks, underwent extraction of a unilateral lower first molar. The rats here were randomly assigned to the bFGF group (n = 15 rats, gelatin hydrogel sheets with incorporated bFGF applied over the sockets); the phosphate-buffered saline (PBS) group (n = 14 rats, gelatin hydrogel sheets without bFGF applied over the sockets); or the control group (n = 14 rats, nothing applied over the sockets). One rat in the bFGF group was sacrificed immediately after tooth extraction. Twenty-one rats were sacrificed at 3 weeks, and the remaining 21 rats were sacrificed at 8 weeks after tooth extractions. The harvested mandibles were analyzed using micro-computed tomography and sections were evaluated qualitatively for mucosal disruption and osteonecrosis. The incidence of osteonecrosis at 8 weeks after tooth extraction was 0% in the bFGF group, 100% in the PBS group, and 85.7% in the control group. The frequency of complete coverage of the extraction socket by mucosal tissue was significantly greater in the bFGF group than in the other groups. These results suggest that application of bFGF in the extraction socket promoted socket healing, which prevented BRONJ development. The growth-stimulating effects of bFGF may have offset the inhibition of wound healing by BP.	[Imada, Mitsuhiko; Yagyuu, Takahiro; Ueyama, Yoshihiro; Maeda, Masahiko; Yamamoto, Kazuhiko; Kurokawa, Satoshi; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Kashihara, Nara, Japan; [Jo, Jun-ichiro; Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Regenerat Sci & Engn, Lab Biomat,Sakyo Ku, Kyoto, Japan; [Tanaka, Yasuhito] Nara Med Univ, Dept Orthoped Surg, Kashihara, Nara, Japan	Nara Medical University; Kyoto University; Nara Medical University	Yagyuu, T (corresponding author), Nara Med Univ, Dept Oral & Maxillofacial Surg, Kashihara, Nara, Japan.	t-yagyuu@naramed-u.ac.jp	Yagyuu, Takahiro/GZK-7684-2022					Abtahi J, 2013, INT J ORAL MAX SURG, V42, P632, DOI 10.1016/j.ijom.2013.02.007; Akita S, 2005, BURNS, V31, P855, DOI 10.1016/j.burns.2005.04.008; Akita S, 2006, J BURN CARE RES, V27, P333, DOI 10.1097/01.BCR.0000216742.23127.7A; Borke JL, 2015, J CRANIO MAXILL SURG, V43, P1144, DOI 10.1016/j.jcms.2015.05.021; Collin-Osdoby P, 2002, J BONE MINER RES, V17, P1859, DOI 10.1359/jbmr.2002.17.10.1859; GLOBUS RK, 1988, ENDOCRINOLOGY, V123, P98, DOI 10.1210/endo-123-1-98; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95; Hortobagyi GN, 1996, NEW ENGL J MED, V335, P1785, DOI 10.1056/NEJM199612123352401; Kuroda Y, 2016, INT ORTHOP, V40, P1747, DOI 10.1007/s00264-015-3083-1; Landesberg R, 2008, J ORAL MAXIL SURG, V66, P839, DOI 10.1016/j.joms.2008.01.026; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lodi G, 2010, J ORAL MAXIL SURG, V68, P107, DOI 10.1016/j.joms.2009.07.068; Marui A, 2007, CIRC J, V71, P1181, DOI 10.1253/circj.71.1181; Nakagawa N, 1999, BIOCHEM BIOPH RES CO, V265, P158, DOI 10.1006/bbrc.1999.1601; O'Ryan FS, 2009, J ORAL MAXIL SURG, V67, P1363, DOI 10.1016/j.joms.2009.03.005; Okabe K, 2013, MOD PLAST SURG, V3, P108, DOI DOI 10.4236/mps.2013.33022; Park JW, 2017, MOLECULES, V22, DOI 10.3390/molecules22081259; Park KK., 2011, NEW APPROACH ENHANCE; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; RODAN SB, 1989, CONNECT TISSUE RES, V20, P283, DOI 10.3109/03008208909023898; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Sakakibara Y, 2002, J THORAC CARDIOV SUR, V124, P50, DOI 10.1067/mtc.2002.121293; Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127; TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2; Tabata Y, 1998, BIOMATERIALS, V19, P807, DOI 10.1016/S0142-9612(98)00233-6; Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0; Tanaka E, 1996, BIOL PHARM BULL, V19, P1141; Vescovi P, 2011, ORAL ONCOL, V47, P191, DOI 10.1016/j.oraloncology.2010.11.007; Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461; Yamashiro K, 2017, CLIN CASE REP, V5, P97, DOI 10.1002/ccr3.751; Yamazaki T, 2013, J HARD TISSUE BIOL, V22, P493; Yokota K, 2017, J HARD TISSUE BIOL, V26, P203, DOI 10.2485/jhtb.26.203; YOKOTA S, 2002, J JPN STOMATOL SOC, V51, P324; Yoneda T, 2017, J BONE MINER METAB, V35, P6, DOI 10.1007/s00774-016-0810-7	34	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211928	10.1371/journal.pone.0211928	http://dx.doi.org/10.1371/journal.pone.0211928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735554	Green Submitted, Green Published, gold			2022-12-26	WOS:000458181200044
J	Po, JW; Ma, YF; Balakrishna, B; Brungs, D; Azimi, F; de Souza, P; Becker, TM				Po, Joseph W.; Ma, Yafeng; Balakrishna, Bavanthi; Brungs, Daniel; Azimi, Farhad; de Souza, Paul; Becker, Therese M.			Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status	PLOS ONE			English	Article							TUMOR-CELLS; HETEROGENEITY; DNA; EXPRESSION; SURVIVAL; IPILIMUMAB; INTRATUMOR; RESISTANCE; NIVOLUMAB; BRAF	Personalised medicine targeted to specific biomarkers such as BRAF and c-Kit has radically improved the success of melanoma therapy. More recently, further advances have been made using therapies targeting the immune response. In particular, therapies targeting the PD-1/PD-L1 or CTLA-4 axes alone or in combination have shown more sustained responses in 30-60% of patients. However, these therapies are associated with considerable toxicities and useful biomarkers to predict responders and non-responders are slow to emerge. Here we developed a reliable melanoma circulating tumor cell (CTC) detection method with PD-L1 evaluation on CTCs. A set of melanoma cell surface markers was tested as candidates for targeted melanoma CTC isolation and a melanoma specific immunostaining-based CTC identification protocol combined with PD-L1 detection was established. In vitro testing of the effect of exposure to blood cells on melanoma cell PD-L1 expression was undertaken. Immunomagnetic targeting isolated melanoma CTCs in up to 87.5% of stage IV melanoma patient blood samples and 3 8.6% of these had some PD-L1 expressing CTCs. Our in vitro data demonstrate PD-L1 induction on melanoma cells in the blood. This study established a robust, reliable method to isolate melanoma CTCs and detect expression of PD-L1 on these cells.	[Po, Joseph W.; Ma, Yafeng; Brungs, Daniel; de Souza, Paul; Becker, Therese M.] Ingham Inst Appl Med Res, Ctr Circulating Tumor Cell Diagnost & Res, Liverpool, NSW, Australia; [Po, Joseph W.; de Souza, Paul; Becker, Therese M.] Western Sydney Univ, Sch Med, Penrith, NSW, Australia; [Ma, Yafeng; de Souza, Paul; Becker, Therese M.] Univ New South Wales, South Western Sydney Med Sch, Liverpool, NSW, Australia; [Balakrishna, Bavanthi; Azimi, Farhad; de Souza, Paul] Liverpool Hosp, Liverpool, NSW, Australia; [Brungs, Daniel] Wollongong Hosp, Illawarra Canc Ctr, Wollongong, NSW, Australia	Ingham Institute for Applied Medical Research; Western Sydney University; University of New South Wales Sydney; Liverpool Hospital; Wollongong Hospital	Becker, TM (corresponding author), Ingham Inst Appl Med Res, Ctr Circulating Tumor Cell Diagnost & Res, Liverpool, NSW, Australia.; Becker, TM (corresponding author), Western Sydney Univ, Sch Med, Penrith, NSW, Australia.; Becker, TM (corresponding author), Univ New South Wales, South Western Sydney Med Sch, Liverpool, NSW, Australia.	t.becker@unsw.edu.au	Ma, Yafeng/AEU-4277-2022; de Souza, Paul/P-5069-2019	Ma, Yafeng/0000-0002-0522-8771; Becker, Therese/0000-0002-5636-9902	Rotary Health Australia PhD Scholarship; Cancer Institute New South Wales through the Centre for Oncology Education and Research Translation (CONCERT)	Rotary Health Australia PhD Scholarship; Cancer Institute New South Wales through the Centre for Oncology Education and Research Translation (CONCERT)	JP is recipient of a Rotary Health Australia PhD Scholarship. DB, PdS, YM and TB are supported by the Cancer Institute New South Wales through the Centre for Oncology Education and Research Translation (CONCERT).	Alix-Panabieres C, 2016, CANCER DISCOV, V6, P479, DOI 10.1158/2159-8290.CD-15-1483; Anantharaman A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2758-3; Aya-Bonilla CA, 2017, ONCOTARGET, V8, P67355, DOI 10.18632/oncotarget.18641; Becker TM, 2010, J INVEST DERMATOL, V130, P2144, DOI 10.1038/jid.2010.117; BENIZHAK O, 1994, AM J DERMATOPATH, V16, P241, DOI 10.1097/00000372-199406000-00003; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Freeman JB, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-192; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gowrishankar K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123410; Gray ES, 2015, ONCOTARGET, V6, P42008, DOI 10.18632/oncotarget.5788; Gray ES, 2015, J INVEST DERMATOL, V135, P2040, DOI 10.1038/jid.2015.127; Grzywa TM, 2017, TRANSL ONCOL, V10, P956, DOI 10.1016/j.tranon.2017.09.007; Hall CS, 2018, J AM COLL SURGEONS, V227, P116, DOI 10.1016/j.jamcollsurg.2018.04.026; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hutarew G, 2016, MEMO-MAG EUR MED ONC, V9, P201, DOI 10.1007/s12254-016-0292-2; Hwang WL, 2018, ADV DRUG DELIVER REV, V125, P122, DOI 10.1016/j.addr.2018.01.003; Johnson DB, 2016, EXPERT OPIN EMERG DR, V21, P195, DOI 10.1080/14728214.2016.1184644; Kee D, 2017, EJSO-EUR J SURG ONC, V43, P594, DOI 10.1016/j.ejso.2016.07.014; Khoja L, 2013, J INVEST DERMATOL, V133, P1582, DOI 10.1038/jid.2012.468; Koyanagi K, 2006, CANCER RES, V66, P6111, DOI 10.1158/0008-5472.CAN-05-4198; Lee JH, 2017, ANN ONCOL, V28, P1130, DOI 10.1093/annonc/mdx026; Lim SY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0757-5; Mazel M, 2015, MOL ONCOL, V9, P1773, DOI 10.1016/j.molonc.2015.05.009; Nicolazzo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31726; Parra ER, 2018, APPL IMMUNOHISTO M M, V26, P83, DOI 10.1097/PAI.0000000000000531; Pearl RA, 2008, J PLAST RECONSTR AES, V61, P265, DOI 10.1016/j.bjps.2007.04.010; Po Joseph W, 2018, J Circ Biomark, V7, p1849454418782617, DOI 10.1177/1849454418782617; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Rao C, 2011, INT J ONCOL, V38, P755, DOI 10.3892/ijo.2011.896; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Sakaizawa K, 2012, BRIT J CANCER, V106, P939, DOI 10.1038/bjc.2012.12; Salvianti F, 2016, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00076; Satelli A, 2014, CANCER RES, V74, P1645, DOI 10.1158/0008-5472.CAN-13-1739; Schats KA, 2017, HISTOPATHOLOGY, V70, P253, DOI 10.1111/his.13056; Sullivan JP, 2014, CANCER DISCOV, V4, P1299, DOI 10.1158/2159-8290.CD-14-0471; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Vareki SM, 2017, CRIT REV ONCOL HEMAT, V116, P116, DOI 10.1016/j.critrevonc.2017.06.001; Vilain RE, 2017, CLIN CANCER RES, V23, P5024, DOI 10.1158/1078-0432.CCR-16-0698; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Yang JB, 2009, CANCER RES, V69, P7538, DOI 10.1158/0008-5472.CAN-08-4626; Zhang CF, 2016, CANCER LETT, V374, P216, DOI 10.1016/j.canlet.2016.02.024	42	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2019	14	2							e0211866	10.1371/journal.pone.0211866	http://dx.doi.org/10.1371/journal.pone.0211866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK7PK	30735560	Green Submitted, Green Published, gold			2022-12-26	WOS:000458181200036
J	Goldsmit, J; McKindsey, C; Archambault, P; Howland, KL				Goldsmit, Jesica; McKindsey, Christopher; Archambault, Philippe; Howland, Kimberly L.			Ecological risk assessment of predicted marine invasions in the Canadian Arctic	PLOS ONE			English	Article							BALLAST WATER EXCHANGE; VESSEL SEA-CHESTS; LITTORINA-LITTOREA; CLIMATE-CHANGE; BIOLOGICAL INVASIONS; PROPAGULE PRESSURE; NORTH-AMERICA; MYA-ARENARIA; COASTAL; FUTURE	Climate change is impacting environmental conditions, especially with respect to temperature and ice cover in high latitude regions. Predictive models and risk assessment are key tools for understanding potential changes associated with such impacts on coastal regions. In this study relative ecological risk assessment was done for future potential introductions of three species in the Canadian Arctic: periwinkle Littorina littorea, soft shell clam Mya arenaria and red king crab Paralithodes camtschaticus. These species occur in locations connected to Canadian Arctic ports through shipping and have the potential to be introduced via ballast water discharge. The methodology proposed in this study is unique in the sense that it considers not only ballast water origin, but also the distribution of the species being assessed and the sensitivity of the receiving habitat. It combines detailed information (ballast water source of each tank, transit time, time of the year when the water is released, environmental suitability of receiving habitat, impact, and habitat sensitivity) in order to assess ecological risk. Through the use of this approach it is highlighted that domestic discharge events pose a higher relative overall risk on a vessel-specific and cumulative annual bases than international discharges. The main ports of Deception Bay and Churchill were classified as being at moderate to high relative risk for L. littorea and M. arenaria, especially from domestic vessels, while relative overall risk for P. camtschaticus was low for international vessels and null for domestic vessels due to few ships transiting from its range of distribution to Canadian Arctic ports. This work can serve as an approach to help build a list of potential high risk species-a "grey" watch list-for the Canadian Arctic, and provides useful information for consideration in future decision making actions such as the identification of high risk pathways, species and ports.	[Goldsmit, Jesica; McKindsey, Christopher] Maurice Lamontagne Inst, Fisheries & Oceans Canada, Mont Joli, PQ, Canada; [Goldsmit, Jesica; Archambault, Philippe] Laval Univ, Sci & Engn Fac, Dept Biol, Quebec City, PQ, Canada; [Howland, Kimberly L.] Freshwater Inst, Fisheries & Oceans Canada, Arctic Res Div, Winnipeg, MB, Canada	Fisheries & Oceans Canada; Laval University; Fisheries & Oceans Canada	Goldsmit, J (corresponding author), Maurice Lamontagne Inst, Fisheries & Oceans Canada, Mont Joli, PQ, Canada.; Goldsmit, J (corresponding author), Laval Univ, Sci & Engn Fac, Dept Biol, Quebec City, PQ, Canada.	jesica.goldsmit@dfo-mpo.gc.ca	McKindsey, Chris/AAH-6773-2020	McKindsey, Chris/0000-0002-3026-6454; Goldsmit, Jesica/0000-0002-1758-2700; Howland, Kimberly/0000-0002-5442-3290; Archambault, Philippe/0000-0001-5986-6149	Natural Sciences and Engineering Research Council; Canadian Aquatic Invasive Species Network [385408-09]; Fisheries and Oceans Canada: Aquatic Climate Change Adaptation Service Program; Nunavut Wildlife Management Board [3-14-07]; Quebec-Ocean [2016-RS-!86795]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Aquatic Invasive Species Network; Fisheries and Oceans Canada: Aquatic Climate Change Adaptation Service Program; Nunavut Wildlife Management Board; Quebec-Ocean	This study was funded by Natural Sciences and Engineering Research Council's (http://www.nserc-crsng.gc.ca) to KLH, Canadian Aquatic Invasive Species Network (385408-09) to PA, Fisheries and Oceans Canada: Aquatic Climate Change Adaptation Service Program to KLH, Nunavut Wildlife Management Board (3-14-07; https://www.nwmb.com) to KLH, and Quebec-Ocean (2016-RS-!86795; http://www.quebec-ocean.ulaval.ca/) to PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarluk-Consulting Gartner Lee Limited Chris Anderson, 2005, STRAT PLAN IQ DEEPW; Alvsvag J, 2009, BIOL INVASIONS, V11, P587, DOI 10.1007/s10530-008-9273-7; [Anonymous], 2008, LEYNDARDOMAR SJAVARI; Archambault P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012182; Arctic-Council, 2009, ARCT MAR SHIPP ASS; Ashton GV, 2008, AQUAT BIOL, V3, P133, DOI 10.3354/ab00070; Bailey SA, 2011, ENVIRON SCI TECHNOL, V45, P2554, DOI 10.1021/es102655j; Barnhart KR, 2016, NAT CLIM CHANGE, V6, P280, DOI [10.1038/nclimate2848, 10.1038/NCLIMATE2848]; Barry SC, 2008, ICES J MAR SCI, V65, P121, DOI 10.1093/icesjms/fsn004; Bomford M., 2008, RISK ASSESSMENT MODE; Bouma TJ, 2009, HELGOLAND MAR RES, V63, P95, DOI 10.1007/s10152-009-0146-y; Brawley SH, 2009, P NATL ACAD SCI USA, V106, P8239, DOI 10.1073/pnas.0812300106; Briski E, 2012, BIOL INVASIONS, V14, P1843, DOI 10.1007/s10530-012-0194-0; Burgiel S., 2006, INVASIVE ALIEN SPECI, P66; Byers JE, 2005, ECOLOGY, V86, P487, DOI 10.1890/03-0580; CAFF, 2013, ARCTIC BIODIVERSITY; Carlton J. T, 2001, INTRO SPECIES US COA; Carlton JT, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P25; Carlton James T., 1992, Journal of Shellfish Research, V11, P489; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; CARLTON JT, 1985, OCEANOGR MAR BIOL, V23, P313; CARVER CE, 2002, ASSESSMENT RISK BALL; Casas-Monroy O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118267; Casas-Monroy O, 2011, AQUAT INVASIONS, V6, P231, DOI 10.3391/ai.2011.6.3.01; Chan F. T., 2012, RISK ASSESSMENT SHIP; Chan FT, 2019, GLOBAL CHANGE BIOL, V25, P25, DOI 10.1111/gcb.14469; Chan FT, 2015, CAN J FISH AQUAT SCI, V72, P1230, DOI 10.1139/cjfas-2014-0473; Chan FT, 2013, BIOL INVASIONS, V15, P295, DOI 10.1007/s10530-012-0284-z; Chang AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016035; CHASE ME, 1995, J EXP MAR BIOL ECOL, V186, P277, DOI 10.1016/0022-0981(94)00165-A; Cordell JR, 2009, AQUAT CONSERV, V19, P322, DOI 10.1002/aqc.986; Coutts ADM, 2007, MAR POLLUT BULL, V54, P875, DOI 10.1016/j.marpolbul.2007.03.011; David M, 2015, INVAD NAT SPRING SER, V8, P133, DOI 10.1007/978-94-017-9367-4_7; DiBacco C, 2012, ICES J MAR SCI, V69, P483, DOI 10.1093/icesjms/fsr133; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Drake JM, 2005, AM MIDL NAT, V154, P459, DOI 10.1674/0003-0031(2005)154[0459:TAPAOS]2.0.CO;2; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Drolet D, 2016, BIOL INVASIONS, V18, P279, DOI 10.1007/s10530-015-1008-y; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ENGLUND VPM, 1994, J MOLLUS STUD, V60, P465, DOI 10.1093/mollus/60.4.465; Falk-Petersen J, 2011, ICES J MAR SCI, V68, P479, DOI 10.1093/icesjms/fsq192; Force USANST, 1996, REP AQ NUIS SPEC TAS; Fretter V, 1985, J MOLL STUD S15; Frey MA, 2014, MANAG BIOL INVASION, V5, P21, DOI 10.3391/mbi.2014.5.1.02; Garcia-de-Lomas J, 2015, BEHAV INFORM TECHNOL, P1; Gavrilchuk K., 2014, CAN TECH REP FISH AQ; Genovesi P, 2011, EUROPEAN STRATEGY IN; Gibbs MT, 2015, ICES J MAR SCI; Gislason OS, 2014, BIOL INVASIONS, V16, P1865, DOI 10.1007/s10530-013-0632-7; Golder (Golder Associates Ltd.), 2018, 1663724048RREV0 BAFF; Goldsmit J, 2019, MAR POLLUT BULL, V139, P74, DOI 10.1016/j.marpolbul.2018.11.062; Goldsmit J, 2018, BIOL INVASIONS, V20, P501, DOI 10.1007/s10530-017-1553-7; Goldsmit J, 2014, AQUAT INVASIONS, V9, P327, DOI 10.3391/ai.2014.9.3.08; Gollasch S, 2000, J PLANKTON RES, V22, P923, DOI 10.1093/plankt/22.5.923; GOSHIMA S, 1982, Publications from the Amakusa Marine Biological Laboratory Kyushu University, V6, P119; Gray DK, 2007, LIMNOL OCEANOGR, V52, P2386, DOI 10.4319/lo.2007.52.6.2386; Harley CDG, 2013, MAR BIOL, V160, P1529, DOI 10.1007/s00227-013-2206-8; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hedge LH, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-000375.1; Herborg LM, 2007, ECOL APPL, V17, P663, DOI 10.1890/06-0239; Hewitt CL, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P456; Hewitt CL, 2006, ALIEN SPECIES AQUACU; Hines AH, 2000, SUMMARY NIS PRINCE W; IMO, 2018, INT CONV CONTR MAN S, P506; Jing L, 2012, ENVIRON REV, V20, P83, DOI [10.1139/a2012-002, 10.1139/A2012-002]; JOHANNESSON K, 1988, MAR BIOL, V99, P507, DOI 10.1007/BF00392558; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; Kenchington E, 2011, IDENTIFICATION MEGA; Kirchmeier-Young MC, 2017, J CLIMATE, V30, P553, DOI 10.1175/JCLI-D-16-0412.1; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Kumschick S, 2015, BIOSCIENCE, V65, P55, DOI 10.1093/biosci/biu193; Kumschick S, 2013, DIVERS DISTRIB, V19, P1095, DOI 10.1111/ddi.12110; Lambert G, 2010, AQUAT INVASIONS, V5, P369, DOI 10.3391/ai.2010.5.4.06; Landeira JM, 2018, POLAR SCI, V16, P86, DOI 10.1016/j.polar.2018.02.002; Leget F, 2017, TRANSPORT ESPECES DI; Locke Andrea, 2009, Aquatic Invasions, V4, P71, DOI 10.3391/ai.2009.4.1.7; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2007, INVASION ECOLOGY; MacDonald IR, 2010, DEEP-SEA RES PT II, V57, P136, DOI 10.1016/j.dsr2.2009.08.012; Mandrak NE, 2011, NATL DETAILED LEVEL; Mandrak NE, 2015, AQUAT ECOSYST HEALTH, V18, P312, DOI 10.1080/14634988.2015.1046357; Mathieson AC, 2010, RHODORA, V112, P396, DOI 10.3119/09-12.1; McCollin T, 2008, MAR POLLUT BULL, V56, P834, DOI 10.1016/j.marpolbul.2008.02.004; McCollin T, 2007, HARMFUL ALGAE, V6, P531, DOI 10.1016/j.hal.2006.04.015; Meier WN, 2014, REV GEOPHYS, V52, P185, DOI 10.1002/2013RG000431; Melia N, 2016, GEOPHYS RES LETT, V43, P9720, DOI 10.1002/2016GL069315; Miller AW, 2014, NAT CLIM CHANGE, V4, P413, DOI 10.1038/nclimate2244; Minchin Dan, 2009, V204, P109; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Moore AM, 2014, BIOINVASIONS REC, V3, P225, DOI 10.3391/bir.2014.3.4.03; MORGAN RP, 1978, ESTUARIES, V1, P255; MURPHY DJ, 1979, PHYSIOL ZOOL, V52, P219, DOI 10.1086/physzool.52.2.30152565; Niimi AJ, 2004, ENVIRON MANAGE, V33, P712, DOI 10.1007/s00267-004-3072-4; Obolewski K., 2005, BALT COAST ZONE, V9, P13; Occhipinti-Ambrogi A, 2007, MAR POLLUT BULL, V55, P342, DOI 10.1016/j.marpolbul.2006.11.014; ORLOV YI, 1978, MAR BIOL, V48, P373, DOI 10.1007/BF00391642; Oug Eivind, 2011, Marine Biodiversity, V41, P467, DOI 10.1007/s12526-010-0068-6; Papacostas KJ, 2017, MAR ECOL PROG SER, V565, P251, DOI 10.3354/meps12001; Pavlova LV, 2007, BENTHOS ELIMINATION; Petersen JK, 2008, ECOL APPL, V18, P497, DOI 10.1890/07-0752.1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Piepenburg Dieter, 2011, Marine Biodiversity, V41, P51, DOI 10.1007/s12526-010-0059-7; Pizzolato L, 2016, GEOPHYS RES LETT, V43, P12146, DOI 10.1002/2016GL071489; Reid D. G., 1996, SYSTEMATICS EVOLUTIO; Renaud PE, 2015, PROG OCEANOGR, V139, P244, DOI 10.1016/j.pocean.2015.07.007; Ricciardi A, 1998, CAN J FISH AQUAT SCI, V55, P1759, DOI 10.1139/cjfas-55-7-1759; Ricciardi A, 2013, ECOL MONOGR, V83, P263, DOI 10.1890/13-0183.1; Rodin VE., 1989, AKSG9004 U AL; RUIZ G, 2005, BIOL STUDY CONTAINER; Ruiz G.M., 2007, GLERL142 NOAA; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Ruiz GM, 1997, AM ZOOL, V37, P621; Ruiz GM, 2015, AQUAT ECOSYST HEALTH, V18, P299, DOI 10.1080/14634988.2015.1027534; Ruiz GM, 2009, SMITHSONIAN AT THE POLES: CONTRIBUTIONS TO INTERNATIONAL POLAR YEAR SCIENCE, P347, DOI 10.5479/si.097884601X.26; Simard N, 2004, LAURENTIAN CHANNEL A; Simard N, 2011, J PLANKTON RES, V33, P1378, DOI 10.1093/plankt/fbr038; Smith LC, 2013, P NATL ACAD SCI USA, V110, pE1191, DOI 10.1073/pnas.1214212110; Sousa R, 2009, BIOL INVASIONS, V11, P2367, DOI 10.1007/s10530-009-9422-7; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Stewart DB, 2015, ECOLOGICAL OCEANOGRA; Strasser M, 1998, HELGOLANDER MEERESUN, V52, P309, DOI 10.1007/BF02908905; Streftaris N, 2005, OCEANOGR MAR BIOL, V43, P419; Stroeve J, 2007, GEOPHYS RES LETT, V34; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; Tetu PL, 2015, POLAR GEOGR, V38, P107, DOI 10.1080/1088937X.2015.1028576; Therriault T., 2008, RISK ASSESSMENT EURO; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Thresher RE, 2004, BIOL INVASIONS, V6, P295, DOI 10.1023/B:BINV.0000034598.28718.2e; Tremblay P., 2017, EVALUATION RISQUE PO; Verling E, 2005, P ROY SOC B-BIOL SCI, V272, P1249, DOI 10.1098/rspb.2005.3090; Vermeij GJ, 2008, SCIENCE, V321, P780, DOI 10.1126/science.1160852; Villac MC, 2011, MAR ECOL PROG SER, V425, P47, DOI 10.3354/meps08999; Villac MC, 2000, HARMFUL ALGAE, P470; Ware C, 2014, DIVERS DISTRIB, V20, P10, DOI 10.1111/ddi.12117; Williams SL, 2013, BIOSCIENCE, V63, P952, DOI 10.1525/bio.2013.63.12.8; Wonham MJ, 2001, MAR ECOL PROG SER, V215, P1, DOI 10.3354/meps215001; Xu J, 2014, P 20 ACM SIGKDD INT, P1699	139	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211815	10.1371/journal.pone.0211815	http://dx.doi.org/10.1371/journal.pone.0211815			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730941	gold, Green Published, Green Submitted			2022-12-26	WOS:000458026000061
J	Kazek, M; Kaczmarek, A; Wronska, AK; Bogus, MI				Kazek, Michalina; Kaczmarek, Agata; Wronska, Anna Katarzyna; Bogus, Mieczyslawa Irena			Diet influences the bacterial and free fatty acid profiles of the cuticle of Galleria mellonella larvae	PLOS ONE			English	Article							BREVIBACILLUS-LATEROSPORUS; MODEL HOST; ANTIMICROBIAL ACTIVITY; BEAUVERIA-BASSIANA; CALLIPHORA-VICINA; DENDROLIMUS-PINI; INSECTS; GERMINATION; BEESWAX; GROWTH	The evolutionary success of insects is arguably due to their ability to build up a complex, highly-adaptable and very effective defense system against numerous pathogens, including entomopathogenic fungi. This system relies on the humoral immune system and cellular defense reactions. The first line of defense against biological pathogens is a cuticle formed of several layers. The cuticular lipids may contain hydrocarbons, free fatty acids (FFA), alcohols, waxes, glycerides, aldehydes and sterols. Cuticular fatty acids may also play a role in defending against fungal invasion. Our present findings show that the diet of insects can have a significant effect on their sensitivity and defense response to pathogens; for example, while G. mellonella larvae fed on beeswax had a similar appearance to those reared on a semi-artificial diet, they possessed a different cuticular free fatty acid (FFA) profile to those fed on a semi-artificial diet, and were less sensitive to Conidiobolus coronatus infection. It is possible that the presence of heneicosenoic acid (C21:1) and other long-chain free fatty acids (C22:0, C24:0, C26:0), as well as Brevibacillus laterosporus bacteria, on the cuticle of larvae fed on beeswax, plays a protective role against fungal invasion. Insect pests represent a global problem. An understanding of the basic mechanisms underlying the fungal infection of insects might provide a clearer insight into their defenses, thus allowing the design of more effective, and environmentally-friendly, means of controlling them. The greater wax moth is an excellent model for the study of immunology resistance. Knowledge of the influence of diet on pathogen resistance in insects can be also useful for creating a model of human diseases caused by pathogens, such as Candia albicans.	[Kazek, Michalina; Kaczmarek, Agata; Wronska, Anna Katarzyna; Bogus, Mieczyslawa Irena] Polish Acad Sci, Witold Stefanski Inst Parasitol, Twarda, Poland; [Bogus, Mieczyslawa Irena] BIOMIBO, Warsaw, Poland	Polish Academy of Sciences; Witold Stefanski Institute of Parasitology of the Polish Academy of Sciences	Kazek, M (corresponding author), Polish Acad Sci, Witold Stefanski Inst Parasitol, Twarda, Poland.	m.kamut@twarda.pan.pl	Wrońska, Anna/HHZ-6185-2022; Wrońska, Anna/AAN-8684-2020; Kaczmarek, Agata/ABG-3240-2020; Kaczmarek, Agata/ABG-3202-2020	Wrońska, Anna/0000-0001-5171-0828; Kaczmarek, Agata/0000-0001-7319-7973; Kaczmarek, Agata/0000-0001-7319-7973; Michalina, Kazek/0000-0003-4119-9434	National Centre for Research and Development [POIG.01.04.00-14-019/12]; Marshal's Office of the Mazowieckie Voivodeship [RPMA.01.02.00-14-5626/16]	National Centre for Research and Development(National Centre for Research & Development, Poland); Marshal's Office of the Mazowieckie Voivodeship	This work was partly supported by National Centre for Research and Development grant POIG.01.04.00-14-019/12 to MIB and by the Marshal's Office of the Mazowieckie Voivodeship grant RPMA.01.02.00-14-5626/16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aist, 1984, INFECTION PROCESSES, P90; Banville N, 2012, VIRULENCE, V3, P497, DOI 10.4161/viru.21972; Bogus MI, 2007, J INSECT PHYSIOL, V53, P909, DOI 10.1016/j.jinsphys.2007.02.016; Bogus MI, 2010, EXP PARASITOL, V125, P400, DOI 10.1016/j.exppara.2010.04.001; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; BREY PT, 1986, J INVERTEBR PATHOL, V48, P34, DOI 10.1016/0022-2011(86)90140-0; Buchwald R, 2006, J EXP BIOL, V209, P3984, DOI 10.1242/jeb.02472; CALLAGHAN AA, 1969, T BRIT MYCOL SOC, V53, P87, DOI 10.1016/S0007-1536(69)80010-0; Champion OL, 2016, VIRULENCE, V7, P840, DOI 10.1080/21505594.2016.1203486; Chandel S, 2010, J PHYTOPATHOL, V158, P470, DOI 10.1111/j.1439-0434.2009.01635.x; de Oliveira EJ, 2004, APPL ENVIRON MICROB, V70, P6657, DOI 10.1128/AEM.70.11.6657-6664.2004; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Fratini F, 2016, ASIAN PAC J TROP MED, V9, P817, DOI 10.1016/j.apjtm.2016.07.003; Goh HMS, 2017, VIRULENCE, V8, P1525, DOI 10.1080/21505594.2017.1279766; Golebiowski M, 2014, J APPL MICROBIOL, V116, P269, DOI 10.1111/jam.12370; Golebiowski M., 2009, B ENTOMOL RES, V102, P453, DOI [10.1017/S0007485311000800, DOI 10.1017/S0007485311000800]; Golebiowski M, 2008, INSECT BIOCHEM MOLEC, V38, P619, DOI 10.1016/j.ibmb.2008.03.005; Golebiowski M, 2012, J EXP BIOL, V215, P3419, DOI 10.1242/jeb.073155; Jackson LL, 1976, CHEM BIOCH NATURAL W, P201; Jacobsen ID, 2014, VIRULENCE, V5, P237, DOI 10.4161/viru.27434; James RR, 2003, J INVERTEBR PATHOL, V84, P67, DOI 10.1016/j.jip.2003.08.006; Junqueira JC, 2012, VIRULENCE, V3, P474, DOI 10.4161/viru.22493; Kamut M, 2014, ANIM SCI PAP REP, V32, P107; King SRB, 2010, APPL ANIM BEHAV SCI, V125, P22, DOI 10.1016/j.applanim.2010.03.006; Kwadha CA, 2017, INSECTS, V8, DOI 10.3390/insects8020061; Li JY, 2009, J PROTEOME RES, V8, P2620, DOI 10.1021/pr8006123; Olaitan Peter B, 2007, Afr Health Sci, V7, P159; Onmaz AC, 2013, VET RES COMMUN, V37, P65, DOI 10.1007/s11259-012-9537-7; Orlova MV, 1998, APPL ENVIRON MICROB, V64, P2723; RIVERS DB, 1991, J INVERTEBR PATHOL, V58, P444, DOI 10.1016/0022-2011(91)90191-R; Ruiu L, 2011, J MED ENTOMOL, V48, P345, DOI 10.1603/ME09299; Ruiu L, 2008, ENVIRON ENTOMOL, V37, P505, DOI 10.1603/0046-225X(2008)37[505:IHFMDC]2.0.CO;2; Ruiu Luca, 2013, Insects, V4, P476, DOI 10.3390/insects4030476; Sackett WG., 1919, B CEXP STAD, V252, P1; SAITO T, 1983, APPL ENTOMOL ZOOL, V18, P225, DOI 10.1303/aez.18.225; SEHNAL F, 1966, Z WISS ZOOL ABT A, V174, P53; Singer S, 1996, ADV APPL MICROBIOL, V42, P219, DOI 10.1016/S0065-2164(08)70374-5; Sivaraman U, 2016, J CLIN DIAGN RES, V10, pDD1, DOI 10.7860/JCDR/2016/15665.7560; SMITH RJ, 1982, J INVERTEBR PATHOL, V39, P15, DOI 10.1016/0022-2011(82)90153-7; TULLOCH AP, 1980, BEE WORLD, V61, P47, DOI 10.1080/0005772X.1980.11097776; Tysset C, 1991, CONTRUBUTION STUDY I, P21; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Wieloch W., 2005, PESTICIDES, V4, P133; Wronska AK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192715	44	16	17	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2019	14	2							e0211697	10.1371/journal.pone.0211697	http://dx.doi.org/10.1371/journal.pone.0211697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK5RX	30730940	Green Submitted, Green Published, gold			2022-12-26	WOS:000458026000047
